INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(2, 'Anatomy', 'PM2393. Derivatives of Mesoderm', '<div _ngcontent-bnw-c142=\\ class=\ng-tns-c142-9 ng-star-inserted\ style=\\>\n      <div _ngcontent-bnw-c142=\\ class=\ng-tns-c142-9 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Mesoderm derivatives</strong></td>\n</tr>\n<tr>\n<td><strong>Paraxial mesoderm</strong></td>\n<td>\n<ul>\n<li>Skeletal muscles of the trunk, limbs,<strong>&nbsp;</strong>head, and neck</li>\n<li>Extraocular muscles</li>\n<li>Intrinsic muscles of the tongue</li>\n<li>Bones: Vertebrae, ribs</li>\n<li>Dermis of Skin</li>\n<li>Duramater</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Intermediate mesoderm</strong></td>\n<td>\n<ul>\n<li>Urinary system: Kidneys, ureters, trigone of the urinary bladder</li>\n<li>Dorsal part of prostatic urethra (males)</li>\n<li>Gonads: Testes and ovaries</li>\n<li>Genital ducts</li>\n<li>Adrenal cortex</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Lateral plate mesoderm</strong></td>\n<td>\n<ul>\n<li>Bones: Sternum, limb bones</li>\n<li>Serous membranes of body cavities: Pleura, pericardium, peritoneum</li>\n<li>GIT layers: Lamina propria, muscularis mucosae, submucosa, muscularis externa, adventitia</li>\n<li>Blood cells: Microglia, Kupffer cells</li>\n<li>Cardiovascular system</li>\n<li>Lymphatic system</li>\n<li>Laryngeal cartilages</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(3, 'Anatomy,', 'PM2351. Embryology of the ear', '<div _ngcontent-bnw-c142=\\ class=\ng-tns-c142-9 ng-star-inserted\ style=\\>\n      <div _ngcontent-bnw-c142=\\ class=\ng-tns-c142-9 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Structures of the ear</strong></td>\n<td><strong>Embryological origin</strong></td>\n</tr>\n<tr>\n<td>Auricle or pinna</td>\n<td>1st and 2nd pharyngeal arch</td>\n</tr>\n<tr>\n<td>External auditory meatus</td>\n<td>1st pharyngeal arch</td>\n</tr>\n<tr>\n<td>Tympanic membrane</td>\n<td>All 3 germ layers</td>\n</tr>\n<tr>\n<td>Malleus and incus</td>\n<td>1st pharyngeal arch</td>\n</tr>\n<tr>\n<td>Stapes suprastructure</td>\n<td>2nd pharyngeal arch</td>\n</tr>\n<tr>\n<td>Stapes footplate and annular ligament</td>\n<td>Otic capsule</td>\n</tr>\n<tr>\n<td>Tympanic cavity</td>\n<td>1st pharyngeal pouch</td>\n</tr>\n<tr>\n<td>Eustachian tube</td>\n<td>1st pharyngeal pouch</td>\n</tr>\n<tr>\n<td>Membranous labyrinth</td>\n<td>Otic vesicle</td>\n</tr>\n<tr>\n<td>Semicircular canals and utricle</td>\n<td>Pars superior</td>\n</tr>\n<tr>\n<td>Saccule and cochlea</td>\n<td>Pars inferior</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(4, 'Obstetrics & Gynaecology,', 'PM2348. Homologous structures in male and female genitalia', '<div _ngcontent-bnw-c142=\\ class=\ng-tns-c142-9 ng-star-inserted\ style=\\>\n      <div _ngcontent-bnw-c142=\\ class=\ng-tns-c142-9 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Females</strong></td>\n<td><strong>Embryonal structure</strong></td>\n<td><strong>Males</strong></td>\n</tr>\n<tr>\n<td>Ovary</td>\n<td><strong>Genital ridge</strong></td>\n<td>Testis</td>\n</tr>\n<tr>\n<td>Ova</td>\n<td><strong>Primordial germ cells</strong></td>\n<td>Spermatozoa</td>\n</tr>\n<tr>\n<td>Labia majora</td>\n<td><strong>Labioscrotal swelling</strong></td>\n<td>Scrotum</td>\n</tr>\n<tr>\n<td>Labia minora</td>\n<td><strong>Urogenital folds</strong></td>\n<td>Ventral aspect of the penis - penile urethra</td>\n</tr>\n<tr>\n<td>Glans clitoris</td>\n<td><strong>Genital tubercle</strong></td>\n<td>Glans penis</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\>Vestibular bulbs</p>\n&nbsp;</td>\n<td><strong>Genital tubercle</strong></td>\n<td>\n<p class=\p1\>Corpus cavernosum</p>\n<p class=\p1\>Corpus spongiosum</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\>Urethral and paraurethral glands /Skenes glands</p>\nLower part of Vagina&nbsp;</td>\n<td><strong>Urogenital sinus</strong></td>\n<td>&nbsp;\n<p class=\p1\>Prostate gland</p>\n</td>\n</tr>\n<tr>\n<td>Greater vestibular glands/Bartholins glands</td>\n<td><strong>Urogenital sinus</strong></td>\n<td>Bulbourethral glands/Cowpers glands</td>\n</tr>\n<tr>\n<td>Granulosa cells</td>\n<td><strong>Sex cords</strong></td>\n<td>Seminiferous tubules and Sertoli cells</td>\n</tr>\n<tr>\n<td>Round ligament</td>\n<td><strong>Gubernaculum</strong></td>\n<td>Gubernaculum testis</td>\n</tr>\n<tr>\n<td>Epoophoron and paroophoron</td>\n<td><strong>Mesonephric tubules</strong></td>\n<td>Efferent ductules and paradidymis</td>\n</tr>\n<tr>\n<td>Gartner duct (remnant structure)</td>\n<td><strong>Mesonephric duct/Wolffian duct</strong></td>\n<td>Epididymis, ductus deferens, and ejaculatory duct</td>\n</tr>\n<tr>\n<td>Uterus, fallopian tube, cervix and the upper vaginal wall</td>\n<td><strong>Paramesonephric duct/Mullerian duct</strong></td>\n<td>Prostatic utricle and the appendix of testis (remnant structure)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(5, 'Obstetrics & Gynaecology,', 'PM2236. Twinning', '<div _ngcontent-bnw-c142=\\ class=\ng-tns-c142-9 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-bnw-c142=\\ class=\ng-tns-c142-9 ng-star-inserted\>\n        <img _ngcontent-bnw-c142=\\ class=\img-responsive ng-tns-c142-9 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c4c8753494db4694a4b67e77bcea1502x1280x5795.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(6, 'Surgery', 'PM2508. Patient Positioning in Operation Theatre', '<div _ngcontent-cnv-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n      <!---->\n      <div _ngcontent-cnv-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-cnv-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ada28967e12f4224bf885433eb416e6cx600x2287.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(7, 'Anatomy', 'PM1974. Neural crest derivatives', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table class=\t1\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Neural</strong></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Mesenchymal</strong></p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>All ganglions</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Connective tissue and bones of the face and skull&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>All enteric plexus</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Dermis of the head and face</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Schwann cells and Satellite glial cells</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Odontoblasts (Dentine)</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Adrenal Medulla</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Arachnoid and Piamater&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Parafolliular C cells of Thyroid</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Conotruncal septum in the heart</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Melanoblast/Melanocytes (except Retinal Pigment Epithelium)</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(8, 'Ophthalmology,', 'PM1888. Summary of ocular embryogenesis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Period after conception</strong></div>\n</td>\n<td>\n<div><strong>Major milestone</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3 weeks</div>\n</td>\n<td>\n<div>\n<ul>\n<li><strong>Optic groove&nbsp;</strong>appears</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>4<sup>th</sup> week</div>\n</td>\n<td>\n<div>\n<ul>\n<li>Optic pit develops into an optic vesicle</li>\n<li><strong>Lens plate</strong> forms</li>\n<li><strong>Embryonic fissure</strong> develops&nbsp;</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>1<sup>st</sup> month</div>\n</td>\n<td>\n<div>\n<ul>\n<li><strong>Lens pit</strong> develops, followed by formation of the&nbsp;<strong>lens vesicle</strong></li>\n<li><strong>Hyaloid vessels</strong> develop</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>1.5 months</div>\n</td>\n<td>\n<div>\n<ul>\n<li>Closure of the embryonic fissure</li>\n<li>Differentiation of retinal pigment epithelium</li>\n<li>Appearance of eyelid folds and&nbsp;<strong>nasolacrimal duct</strong></li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>7<sup>th</sup> week</div>\n</td>\n<td>\n<div>\n<ul>\n<li>Embryonic nucleus of the&nbsp;lens</li>\n<li><strong>Sclera</strong> begins to form</li>\n<li>Migration of waves of the neural crest</li>\n<li>1<sup>st</sup> wave: corneal and trabecular endothelium</li>\n<li>2<sup>nd</sup> wave: corneal stroma</li>\n<li>3<sup>rd</sup> wave: iris stroma</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3<sup>rd</sup>&nbsp; month</div>\n</td>\n<td>\n<div>\n<ul>\n<li>Differentiation of precursors of rods and cone</li>\n<li><strong>Anterior chamber</strong> appears</li>\n<li><strong>Fetal nucleus</strong> starts to develop</li>\n<li>Sclera condenses&nbsp;</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>4<sup>th</sup> month</div>\n</td>\n<td>\n<div>\n<ul>\n<li>Formation of&nbsp;<strong>retinal vasculature</strong> begins</li>\n<li><strong>Hyaloid vessels regress</strong></li>\n<li>Formation of physiological optic disc cup and <strong>lamina cribrosa</strong></li>\n<li><strong>Canal of Schlemm</strong> appears</li>\n<li><strong>Bowmans membrane</strong> develops</li>\n<li>Formation of the&nbsp;major arterial circle and <strong>sphincter muscle </strong>of the&nbsp;iris</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>5<sup>th</sup> month</div>\n</td>\n<td>\n<div>\n<ul>\n<li>Photoreceptors differentiate</li>\n<li>Eyelid separation begins</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>6<sup>th</sup> month</div>\n</td>\n<td>\n<div>\n<ul>\n<li>Differentiation of the&nbsp;<strong>dilator pupillae</strong> muscle</li>\n<li><strong>Nasolacrimal</strong> system becomes<strong> patent</strong></li>\n<li>Cones differentiate</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>7<sup>th</sup> month</div>\n</td>\n<td>\n<div>\n<ul>\n<li>Rods differentiate</li>\n<li><strong>Myelination of optic nerve</strong> begins</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>8<sup>th</sup> month</div>\n</td>\n<td>\n<div>\n<ul>\n<li>Completion of the&nbsp;anterior chamber angle</li>\n<li><strong>Hyaloid vessels disappear</strong></li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>9<sup>th</sup> month</div>\n</td>\n<td>\n<div>\n<ul>\n<li>Pupillary membrane disappears</li>\n</ul>\n</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(9, 'Ophthalmology,', 'PM1239. Embryological derivatives of the eye', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Neural Ectoderm</strong></p>\n</td>\n<td>\n<p><strong>Surface Ectoderm</strong></p>\n</td>\n<td>\n<p><strong>Mesoderm</strong></p>\n</td>\n<td>\n<p><strong>Neural Crest </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Smooth muscles of iris (sphincter and dilator pupillae)</p>\n</td>\n<td>\n<p>Crystalline lens</p>\n</td>\n<td>\n<p>Extraocular muscles&nbsp;</p>\n</td>\n<td>\n<p>Corneal stroma, keratocytes, and endothelium</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ciliary epithelium</p>\n</td>\n<td>\n<p>Corneal epithelium</p>\n</td>\n<td>\n<p>Superotemporal part of Sclera</p>\n</td>\n<td>\n<p>Sclera&nbsp;(except&nbsp;supero-temporally)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iris epithelium&nbsp;</p>\n</td>\n<td>\n<p>Conjunctival epithelium</p>\n</td>\n<td>\n<p>Choroidal vessels</p>\n</td>\n<td>\n<p>Iris and&nbsp; Choroid stroma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fibers of the optic nerve</p>\n</td>\n<td>\n<p>Lacrimal gland&nbsp;</p>\n</td>\n<td>\n<p>Primary vitreous</p>\n</td>\n<td>\n<p>Uveal&nbsp;melanocytes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Secondary and tertiary vitreous</p>\n</td>\n<td>\n<p>Tarsal glands</p>\n</td>\n<td>\n<p>Vascular&nbsp;&nbsp;&nbsp;&nbsp; endothelium</p>\n</td>\n<td>\n<p>Conjunctival melanocytes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Retina and retinal pigment epithelium</p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>\n<p>Ciliary muscles</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(10, 'Paediatrics,', 'PM1215. Locations of Congenital Heart Disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/51b03a1175d241a3a9e4f641a4f8880ax631x622.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(11, 'Anatomy,', 'PM1065. Difference between gastroschisis and omphalocele', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Characteristic</strong></td>\n<td><strong>Gastroschisis</strong></td>\n<td><strong>Omphalocele</strong></td>\n</tr>\n<tr>\n<td>Defect size (diameter)</td>\n<td>2-3 cm</td>\n<td>2-15 cm</td>\n</tr>\n<tr>\n<td>Sac</td>\n<td>Never</td>\n<td>Always, may be ruptured</td>\n</tr>\n<tr>\n<td>Gestational age</td>\n<td>Prematurity</td>\n<td>Term</td>\n</tr>\n<tr>\n<td>Umbilical cord</td>\n<td>Adjacent to the defect (defect is seen usually on its right side)&nbsp;</td>\n<td>Attached to sac</td>\n</tr>\n<tr>\n<td>Herniated viscera</td>\n<td>Small bowel, stomach, colon</td>\n<td>Small bowel, stomach, colon, liver</td>\n</tr>\n<tr>\n<td>Malrotation</td>\n<td>Yes</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Bowel character</td>\n<td>Inflammatory, edematous</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>Enternal nutrition</td>\n<td>Delayed</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>Associated abnormalities</td>\n<td>Uncommon (10% atresia)</td>\n<td>Common (50%)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(12, 'Anatomy', 'PM0981. Embryological structures and their derivatives in the genital system', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\205\>\n<p><strong>Embryological structure</strong></p>\n</td>\n<td width=\205\>\n<p><strong>Derivative in female</strong></p>\n</td>\n<td width=\205\>\n<p><strong>Derivative in male</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Genital ridge</p>\n</td>\n<td width=\205\>\n<p>Ovary</p>\n</td>\n<td width=\205\>\n<p>Testis</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Genital swelling</p>\n</td>\n<td width=\205\>\n<p>Labia majora</p>\n</td>\n<td width=\205\>\n<p>Scrotum</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Genital fold</p>\n</td>\n<td width=\205\>\n<p>Labia minora</p>\n</td>\n<td width=\205\>\n<p>Ventral aspect of the penis, penile urethra</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Genital tubercle</p>\n</td>\n<td width=\205\>\n<p>Clitoris</p>\n</td>\n<td width=\205\>\n<p>Glans penis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(13, 'Anatomy', 'PM0957. Brainstem Nuclei Derived from Alar and Basal Lamina', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\278\>\n<p><strong>Alar Lamina</strong></p>\n</td>\n<td width=\200\>\n<p><strong>Basal Lamina</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\278\>\n<p><strong>Midbrain&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\278\>\n<p>Colliculi</p>\n<p>Substantia nigra</p>\n<p>Red nucleus</p>\n<p>Mesencephalic nucleus of trigeminal nerve (GSA)</p>\n</td>\n<td width=\200\>\n<p>Oculomotor nucleus (GSE)</p>\n<p>Edinger-Westphal nucleus (GVE)</p>\n<p>Trochlear nucleus (GSE)</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\278\>\n<p><strong>Pons&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\278\>\n<p>Pontine nuclei</p>\n<p>Vestibular nuclei (SSA)</p>\n<p>Cochlear nuclei (SSA)</p>\n<p>Main sensory nucleus of trigeminal nerve (GSA)</p>\n<p>Nucleus of spinal tract of trigeminal nerve (GSA)</p>\n<p>Nucleus of tractus solitaries (SVA and GVA)</p>\n</td>\n<td width=\200\>\n<p>Motor nucleus of trigeminal nerve (SVE)</p>\n<p>Motor nucleus of facial nerve (SVE)</p>\n<p>Nucleus of abducent nerve (GSE)</p>\n<p>Superior salivatory nucleus (GVE)</p>\n<p>Lacrimatory nucleus (GVE)</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\278\>\n<p><strong>Medulla Oblongata&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\278\>\n<p>Inferior olivary nuclei</p>\n<p>Vestibular nuclei (SSA)</p>\n<p>Nucleus of spinal tract of trigeminal nerve (GSA)</p>\n<p>Nucleus of tractus solitarius(SVA and GVA)</p>\n<p>Part of dorsal nucleus vagus (GVA)</p>\n</td>\n<td width=\200\>\n<p>Part of dorsal nucleus of vagus (GVE)</p>\n<p>Inferior salivatory nucleus (GVE)</p>\n<p>Nucleus ambiguous (SVE)</p>\n<p>Hypoglossal nucleus (GSE)</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Abbreviations</strong></p>\n<p>GSA: General Somatic Afferent</p>\n<p>GSE: General Somatic Efferent</p>\n<p>GVA: General Visceral Afferent</p>\n<p>GVE: General Visceral Efferent</p>\n<p>SSA: Special Somatic Afferent</p>\n<p>SVA: Special Visceral Afferent</p>\n<p>SVE: Special Visceral Efferent</p></div><!---->\n      <!---->\n    </div><!---->'),
(14, 'Anatomy', 'PM0955. Divisions of the Developing Brain', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d1a0b9bf78c84473b8735b0a4eb1c2f4x1280x1183.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\146\>\n<tbody>\n<tr>\n<td><span><strong>Divisions of the Developing Brain</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Forebrain vesicle/Prosencephalon</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span>Telencephalon</span></p>\n<ul>\n<li><span>Cerebral cortex</span></li>\n<li><span>Subcortical white matter</span></li>\n<li><span>Amygdala</span></li>\n<li><span>Basal ganglia</span></li>\n<li><span>Hippocampus</span></li>\n<li><span>Olfactory bulb and tract</span></li>\n<li><span>Cavities: Lateral ventricles</span></li>\n</ul>\n<p><span>Diencephalon</span></p>\n<ul>\n<li><span>Thalamus</span></li>\n<li><span>Hypothalamus</span></li>\n<li><span>Epithalamus</span></li>\n<li><span>Subthalamus</span></li>\n<li><span>Optic nerve and retina</span></li>\n<li><span>Cavities: 3rd ventricle</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span><strong>Midbrain vesicle/Mesencephalon</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span>Mesencephalon</span></p>\n<ul>\n<li><span>Midbrain</span></li>\n<li><span>Cavities: Cerebral Aqueduct</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Hindbrain&nbsp;vesicle/Rhombencephalon</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Metencephalon</span></p>\n<ul>\n<li><span>Pons</span></li>\n<li><span>Cerebellum&nbsp;</span></li>\n</ul>\n<p><span>Myelencephalon</span></p>\n<ul>\n<li><span>Medulla oblongata</span></li>\n</ul>\n<p><span>Common Cavity: 4th Ventricle&nbsp;</span></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(15, 'Anatomy,', 'PM0930. Development of Larynx', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Part</strong></td>\n<td>\n<p><strong>Derivatives</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>2<sup>nd</sup>&nbsp;arch<sup>&nbsp;</sup></strong></p>\n</td>\n<td>\n<p>Upper part of the body of <strong>hyoid </strong>bone, lesser cornu&nbsp;of hyoid bone, stylohyoid ligament</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>3<sup>rd&nbsp;&nbsp;</sup>arch</strong></p>\n</td>\n<td>\n<p>Lower part of the body of <strong>hyoid</strong> bone and greater cornua</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>4<sup>th</sup> arch</strong></p>\n</td>\n<td>\n<p>Upper part of <strong>thyroid</strong> cartilage</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>6<sup>th</sup> arch<sup>&nbsp;</sup></strong></p>\n</td>\n<td>\n<p>Lower part of <strong>thyroid</strong> cartilage, <strong>cricoid</strong> cartilage, <strong>corniculate</strong> cartilage, <strong>cuneiform</strong> cartilage, <strong>intrinsic muscles of larynx</strong></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(16, 'Anatomy', 'PM0923. Blood Supply and Derivatives of the Primitive Gut', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Blood Supply&nbsp;</strong></td>\n<td><strong>Adult derivatives</strong></td>\n</tr>\n<tr>\n<td>Foregut</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td rowspan=\5\>Celiac artery (lower esophagus to&nbsp; duodenum)</td>\n<td>Pharynx</td>\n</tr>\n<tr>\n<td>Esophagus</td>\n</tr>\n<tr>\n<td>Stomach</td>\n</tr>\n<tr>\n<td>Upper duodenum</td>\n</tr>\n<tr>\n<td>Glands of pharyngeal pouches, respiratory tract, liver, gall bladder, pancreas</td>\n</tr>\n<tr>\n<td>Midgut</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td rowspan=\5\>Superior mesentric artery</td>\n<td>Lower duodenum</td>\n</tr>\n<tr>\n<td>Jejunum and ileum</td>\n</tr>\n<tr>\n<td>Cecum and vermiform appendix</td>\n</tr>\n<tr>\n<td>Ascending colon</td>\n</tr>\n<tr>\n<td>Proximal 2/3 of transverse colon</td>\n</tr>\n<tr>\n<td>Hindgut</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td rowspan=\5\>Inferior&nbsp;mesentric artery</td>\n<td>Distal 1/3 of transverse colon</td>\n</tr>\n<tr>\n<td>Descending&nbsp;colon</td>\n</tr>\n<tr>\n<td>Rectum</td>\n</tr>\n<tr>\n<td>Superior part of anal canal</td>\n</tr>\n<tr>\n<td>Urogenital sinus</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(17, 'Anatomy', 'PM0894. Derivatives of Various Aortic Arches', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The <strong>aortic arches</strong> or <strong>pharyngeal arch arteries</strong> are a series of six paired embryological vascular structures which give rise to the great arteries of the neck and head. They are ventral to the dorsal aorta and arise from the aortic sac.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9aeeaefabc8046dfa0c43fcd35211902x1280x1431.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The following table shows various arterial structures derived from the aortic arches:<strong>&nbsp;</strong></p>\n<table>\n<tbody>\n<tr>\n<td width=\208\>\n<p><strong>Aortic arches</strong></p>\n</td>\n<td width=\208\>\n<p><strong>Arterial Structures</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p>First aortic arches</p>\n</td>\n<td width=\208\>\n<p>Part of maxillary arteries bilaterally</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p>Second aortic arches</p>\n</td>\n<td width=\208\>\n<p>Stapedial and hyoid arteries bilaterally</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p>Third aortic arches</p>\n</td>\n<td width=\208\>\n<p>Common carotid arteries and proximal portion of internal carotid arteries bilaterally</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p>Fourth aortic arches</p>\n</td>\n<td width=\208\>\n<p>Right: Proximal portion of the right subclavian artery</p>\n<p>Left: aortic arch</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p>Fifth aortic arch</p>\n</td>\n<td width=\208\>\n<p>Regress completely</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p>Sixth aortic arch</p>\n</td>\n<td width=\208\>\n<p>Right: proximal right pulmonary artery</p>\n<p>Left: proximal left pulmonary artery, ductus arteriosus</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(18, 'Anatomy', 'PM0893. Remnants of Various Embryonic Parts of the Cardiovascular System', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\312\>\n<p><strong>Embryonic part</strong></p>\n</td>\n<td width=\312\>\n<p><strong>Remnants </strong></p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Ductus arteriosus</p>\n</td>\n<td width=\312\>\n<p>Ligamentum arteriosum</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Umbilical artery</p>\n</td>\n<td width=\312\>\n<p>Proximal part: Superior vesical artery; Distal part: Medial umbilical ligament</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Umbilical vein (left)</p>\n</td>\n<td width=\312\>\n<p>Ligamentum teres</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Ductus venosus</p>\n</td>\n<td width=\312\>\n<p>Ligamentum venosum</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Septum primum</p>\n</td>\n<td width=\312\>\n<p>Floor of fossa ovalis</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Septum secundum</p>\n</td>\n<td width=\312\>\n<p>Lower free edge: Annulus ovalis</p>\n<p>&nbsp;curved upper Margin: limbus fossa ovalis</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(19, 'Anatomy', 'PM0876. Development of Interatrial septum', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The<strong> Inter-atrial septum</strong>&nbsp;develops from Septum Primum and Septum Secundum</li>\n<li>The <strong>septum primum</strong> begins to develop at 28 days. It is a thin, crescentic fold of endocardium that arises craniodorsally and grows down to the AV cushions, leaving an <strong>ostium primum</strong> below its free edge.</li>\n<li>Septum primum&nbsp;<strong>fuses with the AV cushions</strong> at approximately 35 days, obliterating the ostium primum.</li>\n<li>The <strong>ostium secundum</strong> is an opening in the <strong>upper part of the septum primum</strong>. It forms at about 33 days, i.e., before the ostium primum closes.</li>\n<li>The <strong>septum secundum</strong>&nbsp;is a thick muscular septum that arises to the <strong>right of the septum primum</strong>.<strong>&nbsp;</strong>It grows from the roof of the atrium but <strong>does not reach the AV cushion</strong>. The gap between the two septa is known as <strong>foramen ovale</strong>.</li>\n<li>After birth, the <strong>foramen ovale is obliterated</strong> by the fusion of the septum primum with the septum secundum.</li>\n<li>In terms of adult anatomy, the <strong>annulus ovalis/limbus of fossa ovalis</strong> is the lower free edge of the <strong>septum secundum</strong>, while the floor of <strong>fossa ovalis</strong> represents the <strong>septum primum</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3985caef13264683a923fe2cbfd41b8dx1280x2019.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(20, 'Anatomy', 'PM0775. Timeline of Various Events Occurring during the Pre-embryonic Phase Development (1st two weeks)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\122\>\n<p><strong>Time after Fertilization</strong></p>\n</td>\n<td width=\439\>\n<p><strong>Event</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\122\>\n<p>&lt; 24 hrs</p>\n</td>\n<td width=\439\>\n<p>Zygote is formed; cleavage begins immediately</p>\n</td>\n</tr>\n<tr>\n<td width=\122\>\n<p>2–3 days</p>\n</td>\n<td width=\439\>\n<p>5–8 cell stage</p>\n</td>\n</tr>\n<tr>\n<td width=\122\>\n<p>3–4 days</p>\n</td>\n<td width=\439\>\n<p>Stage of compaction and formation of morula with 16 cells</p>\n</td>\n</tr>\n<tr>\n<td width=\122\>\n<p>4–5 days</p>\n</td>\n<td width=\439\>\n<p>Formation of blastocyst</p>\n</td>\n</tr>\n<tr>\n<td width=\122\>\n<p>5–6 days</p>\n</td>\n<td width=\439\>\n<p>Zona pellucida disappears</p>\n</td>\n</tr>\n<tr>\n<td width=\122\>\n<p>6–7 days</p>\n</td>\n<td width=\439\>\n<p>Implantation of the blastocyst</p>\n</td>\n</tr>\n<tr>\n<td width=\122\>\n<p>9 days</p>\n</td>\n<td width=\439\>\n<p>Bilaminar disc formation</p>\n</td>\n</tr>\n<tr>\n<td width=\122\>\n<p>12 days</p>\n</td>\n<td width=\439\>\n<p>Formation of extraembryonic mesoderm</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(21, 'Anatomy', 'PM0724. Classification of Stem Cells', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\205\>\n<p><strong>Types of stem cells</strong></p>\n</td>\n<td width=\205\>\n<p><strong>Capacity to differentiate</strong></p>\n</td>\n<td width=\205\>\n<p><strong>Examples</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Totipotent cells</p>\n</td>\n<td width=\205\>\n<p>They can form embryonic and extraembryonic cells</p>\n</td>\n<td width=\205\>\n<p>Zygote, early blastomeres</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Pluripotent cells</p>\n</td>\n<td width=\205\>\n<p>They can form all cell types of an embryonic body but cannot form that of the placenta and umbilical cord</p>\n</td>\n<td width=\205\>\n<p>Inner cell mass</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Multipotent cells</p>\n</td>\n<td width=\205\>\n<p>They form more than one category of cells</p>\n</td>\n<td width=\205\>\n<p>Hematopoietic stem cells</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Oligopotent cells</p>\n</td>\n<td width=\205\>\n<p>They form only one category of cells</p>\n</td>\n<td width=\205\>\n<p>Vascular stem cells</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Unipotent</p>\n</td>\n<td width=\205\>\n<p>They can form only one type of cell</p>\n</td>\n<td width=\205\>\n<p>Liver cell</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(22, 'Paediatrics,', 'PM0535. Clinical features of DiGeorge syndrome- Mnemonic', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>DiGeorge</strong> <strong>syndrome</strong>&nbsp;is a cellular immunodeficiency disorder caused by the deletion of a small segment of <strong>chromosome 22 (22q11)&nbsp;</strong>leading to a developmental defect involving the endodermal derivatives of the <strong>third and fourth pharyngeal pouches</strong>.&nbsp;(Thymus and parathyroid glands)</p>\n<p>The clinical features can be remembered with the <strong>mnemonic</strong> – <strong>CATCH</strong></p>\n<ul>\n<li><strong>C – C</strong>ardiac defects</li>\n<li><strong>A – A</strong>bnormal facies</li>\n<li><strong>T – T</strong>hymic aplasia</li>\n<li><strong>C – C</strong>left palate</li>\n<li><strong>H – H</strong>ypocalcemia</li>\n</ul>\n<p>The image below shows the abnormal facies in DiGeorge syndrome.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5b6e236b65034a479699ad3df12785ffx720x731.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(23, 'Pathology,', 'PM0177. Tissue Stem Cells and their Location', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\283\>\n<tbody>\n<tr>\n<td><strong>Tissue&nbsp;</strong></td>\n<td><strong>Location&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Brain&nbsp;</td>\n<td>Subventricular&nbsp;zone and dentate gyrus</td>\n</tr>\n<tr>\n<td>Skin&nbsp;</td>\n<td>Bulge region of the&nbsp;hair follicle&nbsp;</td>\n</tr>\n<tr>\n<td>Cornea&nbsp;</td>\n<td>Limbus&nbsp;</td>\n</tr>\n<tr>\n<td>Intestine&nbsp;</td>\n<td>Paneth cells near base of crypt&nbsp;</td>\n</tr>\n<tr>\n<td>Liver&nbsp;&nbsp;</td>\n<td>Canal of&nbsp;Hering&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(24, 'Physiology,', 'PM2250. Layers of the cerebellar cortex', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The cerebellar cortex is divided into 3 layers. They are:</p>\n<ul>\n<li><strong>Molecular layer</strong> - It is the <strong>outermost</strong> layer. It contains <strong>stellate cells </strong>and<strong> basket cells</strong>. They receive excitatory input from the parallel fibers and form&nbsp;<strong>inhibitory</strong>&nbsp;synapses on the Purkinje cells. It contains many myelinated and unmyelinated nerve fibers giving it a pale appearance in H and E staining.</li>\n<li><strong>Purkinje layer</strong> -&nbsp;It is the <strong>middle</strong> layer. It contain flask-shaped cell bodies of <strong>Purkinje cells</strong>. Their dendrites pass into the molecular layer. The axons of the Purkinje cells passes through the granular layer into the white matter and synapses with the cerebellar nuclei.</li>\n<li><strong>Granular layer</strong> - It is the <strong>innermost</strong> layer. It contains the cell bodies of the <strong>granule cells </strong>as well as&nbsp;<strong>Golgi cells</strong>. It receives excitatory input from the mossy fibers. They end on the dendrites of the granule cells and these complexes are called <strong>glomeruli</strong>. The axon from the granule cells travels to the molecular layer and bifurcates in a T-shape. These branches form the T and are called parallel fibers. These parallel fibers form excitatory synapses with the Purkinje cells. The granule cells form the <strong>only excitatory neurons</strong> in the cerebellar cortex. Golgi cells receive input from parallel fibers and mossy fibers. They send inhibitory output to the granule cells.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9d1e054c1658410d84897598ebb34ca3x1280x1767.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Neurotransmitters released:</p>\n<ul>\n<li>Stellate, basket, Golgi and Purkinje cells- <strong>GABA</strong></li>\n<li>Granule cells - <strong>Glutamate</strong></li>\n</ul>\n<p>The <strong>only output</strong> from the cerebellar cortex is <strong>inhibitory</strong> from the <strong>Purkinje cells</strong> to the <strong>deep cerebellar nuclei</strong>.</p></div><!---->\n      <!---->\n    </div><!---->'),
(25, 'Anatomy,', 'PM2248. Layers of Cerebral Cortex', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Layers of Cerebral Cortex</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Molecular layer (I)</strong></p>\n<ul>\n<li>the superficial layer deep to the pia mater.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>External granular layer (II)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>External pyramidal layer (III)</strong></p>\n<ul>\n<li>gives rise to association and commissural fibers.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Internal granular layer (IV)</strong></p>\n<ul>\n<li>receives thalamocortical fibers from the thalamic nuclei of the ventral tier (e.g., ventral posterolateral [VPL] and ventral posteromedial [VPM] nuclei).</li>\n<li>in the striate cortex (area 17), receives input from the lateral geniculate body</li>\n<li>myelinated fibers of this layer form the stripe of Gennari—visible to the naked eye</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Internal pyramidal layer (V)</strong></p>\n<ul>\n<li>gives rise to corticobulbar, corticospinal, and corticostriatal fibers</li>\n<li>contains the giant cells of Betz that are found only in the motor cortex (area 4) of the precentral gyrus and the anterior paracentral lobule</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Multiform layer (VI)</strong></p>\n<ul>\n<li>the deepest layer of the cortex. It gives rise to projection, commissural, and association fibers.</li>\n<li>the major source of corticothalamic fibers.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Note: </strong>Cerebrum has 2 types of layer arrangements,&nbsp;neocortex has 6 layers and allocortex has 3 layers.&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/bba3f8444ad44c6395141769698f8909x1280x1851.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(26, 'Dermatology,', 'PM1880. Cells of the epidermis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Cells of the epidermis</strong></td>\n<td><strong>Origin and location</strong></td>\n<td><strong>Characteristic features</strong></td>\n</tr>\n<tr>\n<td><strong>Keratino-cytes</strong></td>\n<td>\n<p><strong>Present in- All Layers of Epidermis</strong> (90-95% of all epidermal cells)</p>\n<p><strong>Derived from-</strong>Ectoderm</p>\n<p>Differentiated <strong>in situ</strong></p>\n</td>\n<td>Rich in the <strong>intermediate filaments</strong> called <strong>keratin</strong> that provides mechanical strength to the cell. The keratinocytes in basal layer divide and generate the upper layers.&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Melano-cytes</strong></td>\n<td>\n<p><strong>Present in- Stratum basale</strong></p>\n<p><strong>Derived from-Neural Crest</strong></p>\n<p><strong>Migrate&nbsp;to the epidermis</strong></p>\n</td>\n<td>Synthesize <strong>melanin</strong> in granules called <strong>melanosomes</strong> that is transferred to keratinocytes of epidermis <strong>through elongated processes called dendrites</strong>. Each melanocyte transfers melanosomes to <strong>36 </strong>keratinocytes. This is called as<strong> Epidermal melanin unit</strong> (36K:1M)&nbsp; &nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Merkel&nbsp; &nbsp;</strong><strong>cells</strong></p>\n</td>\n<td>\n<p><strong>Present in-Stratum basale</strong> (RETE RIDGES)</p>\n<p><strong>Derived from-Ectoderm/ Neural Crest</strong></p>\n<p><strong>Differentiates</strong><strong> in-situ</strong></p>\n</td>\n<td>Also known as <strong>Touch cells or Haascheiban cells</strong>.&nbsp;They are&nbsp;<strong>Type 1 slow adapting</strong> <strong>touch receptors</strong>. <strong>&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Langerhans cells</strong></td>\n<td>\n<p><strong>Present in-Stratum spinosum</strong></p>\n<p><strong>Derived from-&nbsp;</strong>Bone Marrow</p>\n<p><strong>Migrate</strong>&nbsp;to Epidermis</p>\n</td>\n<td>They are dendritic <strong>Antigen Presenting Cells (APCs)</strong>. &nbsp; Characterized by presence of rod shaped or Tennis Racket shaped granules called <strong>Birbeck granules</strong> which are seen on&nbsp;electron microscopy. &nbsp; Immunohistochemical Markers are <strong>CD1a</strong>,<strong> CD207(Langerin) and S100</strong>. <strong>&nbsp;</strong>&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/874d6f95161c4f0895a7ce32c3c33ca5x1280x1169.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(27, 'Anatomy', 'PM1071. Various Types of Epithelium, Their Location and Functions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/088fb644eda04a0a9a022d1ae8b2113ex1280x3136.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(28, 'Anatomy', 'PM1075. Various Types of Exocrine Glands with Examples', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/59cee07cf6e04b0b8386a46a65ff2d90x1280x1498.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Simple gland:</strong> All the secretory cells of an exocrine gland discharge into one duct<strong>.</strong></p>\n<p><strong>Compound gland:</strong> There are a number of groups of secretory cells, each group discharging into its own duct. These ducts unite to form larger ducts that ultimately drain on to an epithelial surface.</p>\n<p>In both simple and compound glands, the secretory cells may be arranged in various ways.</p>\n<ol>\n<li>The secretory element may be <strong>tubular</strong>. The tube may be straight, coiled, or branched.</li>\n<li>The cells may form rounded sacs or <strong>acini</strong>.</li>\n<li>They may form flask shaped structures called <strong>alveoli</strong>.</li>\n</ol></div><!---->\n      <!---->\n    </div><!---->'),
(29, 'Anatomy', 'PM0709. Comparison between Types of Sweat Glands', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\205\>\n<p><strong>Feature</strong></p>\n</td>\n<td width=\205\>\n<p><strong>Apocrine sweat gland</strong></p>\n</td>\n<td width=\205\>\n<p><strong>Eccrine sweat gland</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Activity</p>\n</td>\n<td width=\205\>\n<p>Active at puberty</p>\n</td>\n<td width=\205\>\n<p>Throughout life</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Opening on the surface</p>\n</td>\n<td width=\205\>\n<p>Around hair shaft</p>\n</td>\n<td width=\205\>\n<p>Through sweat pores</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Function</p>\n</td>\n<td width=\205\>\n<p>Provides peculiar odour</p>\n</td>\n<td width=\205\>\n<p>Maintains temperature</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Nervous control</p>\n</td>\n<td width=\205\>\n<p>Postganglionic sympathetic neurons which are adrenergic</p>\n</td>\n<td width=\205\>\n<p>Postganglionic sympathetic neurons which are cholinergic</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Secretions</p>\n</td>\n<td width=\205\>\n<p>Viscid with lipids and proteins</p>\n</td>\n<td width=\205\>\n<p>Watery with salts</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(30, 'Physiology,', 'PM0706. Microanatomy of Muscle Fibres', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Each muscle consists of numerous <strong>muscle</strong> <strong>fibres</strong>.</li>\n<li>Each skeletal muscle fibre is <strong>multi</strong> <strong>nucleated</strong>, bonded by <strong>sarcolemma</strong>, enclosing <strong>sarcoplasm</strong>, smooth muscle and cardiac muscles are uninucleated.&nbsp;</li>\n<li>Within the <strong>sarcoplasm</strong>, there are several hundreds of <strong>nuclei</strong> arranged in the periphery just beneath the sarcolemma.</li>\n<li>The sarcoplasm also consists of evenly distributed, longitudinal threads called <strong>myofibrils</strong>.</li>\n<li><strong>Each myofibril</strong> consists of <strong>thick (myosin) and thin (actin) filaments</strong> overlapping each other.</li>\n<li>The portion of myofibril which consists of thick filaments is known as <strong>A band</strong> or <strong>dark band</strong>, and the portion of a myofibril between two A bands consisting of only thin filaments is known <strong>I band or Light band</strong>.</li>\n<li>Thus the <strong>A band</strong> consists of <strong>both thick and thin filaments</strong>, where as <strong>I band</strong> consists of only thin filaments.</li>\n<li>In the <strong>middle of ‘A’ band</strong>, there are <strong>only thick filaments</strong> with no overlapping thin filaments. This zone is known as ‘<strong>H’ zone</strong>. In the middle of H zone, there is a dark band known as ‘<strong>M’ band</strong>.</li>\n<li>In the <strong>middle of I band</strong>, there is a dark ‘<strong>Z’ disc or Krauses membrane</strong>.</li>\n<li>The segment of the myofibril between two Z discs is known as the <strong>sarcomere</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(31, 'Anatomy,', 'PM2326. Brodmann areas', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/985d9f9c21e142b787a38323bc997372x600x535.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1c16e1eaa21a41bf97b6cbe2769e08f8x600x487.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Area of the Brain(Brodmann)</strong></td>\n<td><strong>Location</strong></td>\n</tr>\n<tr>\n<td><strong>3, 1</strong> and <strong>2</strong> -&nbsp;Primary sensory area</td>\n<td>\n<p>Postcentral gyrus</p>\n<p>Extends to the posterior part of the paracentral lobule medially</p>\n</td>\n</tr>\n<tr>\n<td><strong>4</strong> -&nbsp;Primary motor area</td>\n<td>\n<p>Precentral gyrus</p>\n<p>Extends to the anterior part of the paracentral lobule medially</p>\n</td>\n</tr>\n<tr>\n<td><strong>6</strong>-&nbsp;Premotor area</td>\n<td>\n<p>Anterior to Area 4</p>\n<p>In the posterior parts of superior, middle and inferior frontal gyri</p>\n</td>\n</tr>\n<tr>\n<td><strong>5</strong> and <strong>7</strong> -&nbsp;Sensory association area</td>\n<td>Superior parietal lobule</td>\n</tr>\n<tr>\n<td><strong>8</strong> -&nbsp;Frontal eye field</td>\n<td>Posterior part of middle frontal gyrus, anterior to the facial area of the precentral gyrus</td>\n</tr>\n<tr>\n<td><strong>44</strong> and&nbsp;<strong>45</strong> -&nbsp;Broca’s(Motor speech) area</td>\n<td>Inferior frontal gyrus of the dominant hemisphere</td>\n</tr>\n<tr>\n<td>\n<p><strong>41</strong> and <strong>42</strong> -&nbsp;</p>\n<p>Primary auditory area</p>\n</td>\n<td>Superior surface of the superior temporal gyrus(Heschl’s gyrus)</td>\n</tr>\n<tr>\n<td><strong>22</strong>* -&nbsp;Wernicke’s(Sensory speech) area</td>\n<td>Superior temporal gyrus</td>\n</tr>\n<tr>\n<td><strong>17</strong> -&nbsp;Primary visual(striate) area</td>\n<td>Walls and floor of the posterior part of calcarine sulcus (postcalcarine sulcus) in the occipital lobe</td>\n</tr>\n<tr>\n<td>\n<p><strong>18</strong> and&nbsp;<strong>19</strong>-&nbsp;</p>\n<p>Visual association area</p>\n</td>\n<td>Remaining part of the medial and superolateral surfaces of the occipital lobe</td>\n</tr>\n<tr>\n<td><strong>28</strong> -&nbsp;Primary olfactory area</td>\n<td>Anterior part of the parahippocampal gyrus and uncus</td>\n</tr>\n<tr>\n<td><strong>43</strong> -&nbsp;Gustatory(taste) area</td>\n<td>Inferior part of the parietal lobe, posterior to the general sensory area of the mouth</td>\n</tr>\n</tbody>\n</table>\n<p>*There is uncertainty about the extent of the Wernickes area. Some authorities consider areas 39 and 40 as part of Wernickes area in addition to area 22.</p></div><!---->\n      <!---->\n    </div><!---->'),
(32, 'Anatomy', 'PM2269. Blood supply of internal capsule.', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>&nbsp;</div>\n<table><colgroup><col></colgroup>\n<tbody>\n<tr>\n<td>\n<div>Blood supply of internal capsule.</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anterior limb&nbsp;</p>\n<ul>\n<li>Recurrent artery of Heubner</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div>Genu&nbsp;</div>\n<ul>\n<li>Recurrent artery of Heubner</li>\n<li>Charcots artery (lenticulostriate artery or artery of cerebral hemorrrahge)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div>Posterior limb</div>\n<ul>\n<li>Charcots artery (branch of Middle cerebral artery)</li>\n<li>Anterior choroidal artery ( branch of internal carotid artery)</li>\n<li>Posterolateral branches of posterior cerebral artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div>Sublentiform part</div>\n<ul>\n<li>Anterior choroidal artery</li>\n<li>Posterior cerebral artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div>Retrolentiform part</div>\n<ul>\n<li>Posterolateral branches of posterior cerebral artery</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(33, 'Anatomy', 'PM2266. Internal carotid artery branches', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table><colgroup><col></colgroup>\n<tbody>\n<tr>\n<td>\n<div><strong>Part</strong></div>\n</td>\n<td>\n<div><strong>Course</strong></div>\n</td>\n<td><strong>Branches</strong></td>\n</tr>\n<tr>\n<td>\n<div><strong>Cervical part</strong></div>\n</td>\n<td>\n<div>Originates from the bifurcation of the common carotid artery. It has a dilation at the lower end which is known as carotid sinus. It ascends in front of the transverse process of the upper three cervical vertebrae.</div>\n</td>\n<td>\n<div>&nbsp;No branches given</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Petrous part</strong></div>\n</td>\n<td>\n<div>Passes through the carotid canal in the petrous part of the temporal bone</div>\n</td>\n<td>\n<ul>\n<li>Caroticotympanic branch</li>\n<li>Artery to the pterygoid canal</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Cavernous part</strong></div>\n</td>\n<td>\n<div>Runs in the cavernous sinus</div>\n</td>\n<td>\n<ul>\n<li>Branch to the trigeminal ganglion</li>\n<li>Meningeal branch</li>\n<li>Branch to the cavernous sinus</li>\n<li>Hypophyseal branches</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Cerebral part/ Supracavernal part</strong></div>\n</td>\n<td>\n<div>Enters subarachnoid space by piercing arachnoid mater and divides into the anterior and middle cerebral arteries.</div>\n</td>\n<td>\n<ul>\n<li>Ophthalmic artery</li>\n<li>Anterior choroidal artery</li>\n<li>Posterior communicating artery</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>The petrous, cavernous and intracranial parts of the internal carotid artery are called the <strong>carotid siphon</strong> because of its sigmoid course.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/88f367df1dc04e41ab088b2970715e7ax1280x1642.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(34, 'Anatomy', 'PM2261. Thalamus and its connections', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>\n<table width=\665\>\n<tbody>\n<tr>\n<td>Nuclei</td>\n<td>Input</td>\n<td>Output</td>\n<td>Function</td>\n</tr>\n<tr>\n<td>Anterior&nbsp;</td>\n<td>\n<p>Mamillothalamic tract, cingulate gyrus, hypothalamus</p>\n</td>\n<td>Cingulate gyrus, hypothalamus</td>\n<td>Regulation of alertness and attention, acquisition of memory</td>\n</tr>\n<tr>\n<td>Dorsomedial</td>\n<td>\n<p>Prefrontal cortex, hypothalamus, other thalamic nuclei</p>\n</td>\n<td>Prefrontal cortex, hypothalamus, other thalamic nuclei</td>\n<td>Integration of somatic, visceral, and olfactory information and relation to emotional feelings and subjective states</td>\n</tr>\n<tr>\n<td>Lateral dorsal, lateral posterior and pulvinar</td>\n<td>Cerebral cortex and other thalamic nuclei&nbsp;</td>\n<td>Cerebral cortex and other thalamic nuclei</td>\n<td>&nbsp;Unknown</td>\n</tr>\n<tr>\n<td>Ventral postero lateral</td>\n<td>\n<p>Medial lemniscus</p>\n<p>spinothlamic pathway</p>\n</td>\n<td>Primary somatosensory area cortex</td>\n<td>Relays common sensations to consciousness</td>\n</tr>\n<tr>\n<td>Ventral posteromedial</td>\n<td>\n<p>Gustatory</p>\n<p>Trigeminal</p>\n</td>\n<td>Primary somatosensory area cortex</td>\n<td>Relays common sensations to consciousness</td>\n</tr>\n<tr>\n<td>Ventral anterior</td>\n<td>Reticular formation, substantia nigra, corpus striatum, premotor cortex, other thalamic nuclei</td>\n<td>Reticular formation, substantia nigra, corpus striatum, premotor cortex, other thalamic nuclei</td>\n<td>Influences activity of motor cortex</td>\n</tr>\n<tr>\n<td>Ventral lateral</td>\n<td>Cerebellum, reticular formation, substantia nigra, corpus striatum, premotor cortex, other thalamic nuclei</td>\n<td>Cerebellum, reticular formation, substantia nigra, corpus striatum, premotor cortex, other thalamic nuclei</td>\n<td>Influences activity of motor cortex</td>\n</tr>\n<tr>\n<td>Intralaminar</td>\n<td>Reticular formation, spinothalamic and trigeminothalamic tracts</td>\n<td>To cerebral cortex via other thalamic nuclei and corpus striatum</td>\n<td>Influences level of consciousness and alertness</td>\n</tr>\n<tr>\n<td>Midline</td>\n<td>Reticular formation</td>\n<td>Unknown</td>\n<td>Unknown</td>\n</tr>\n<tr>\n<td>Reticular</td>\n<td>Cerebral cortex, reticular formation</td>\n<td>Other thalamic nuclei</td>\n<td>Cerebral cortex regulating thalamus</td>\n</tr>\n<tr>\n<td>Medial geniculate body</td>\n<td>Inferior colliculus, lateral lemniscus from the predominantly opposite ear</td>\n<td>Auditory radiation to superior temporal gyrus</td>\n<td>Hearing</td>\n</tr>\n<tr>\n<td>Lateral geniculate body</td>\n<td>Optic tract</td>\n<td>Optic radiation to the visual cortex of occipital lobe</td>\n<td>Visual information from the opposite field of vision</td>\n</tr>\n</tbody>\n</table>\n&nbsp;</div></div><!---->\n      <!---->\n    </div><!---->'),
(35, 'Anatomy', 'PM2258. Phylogenetic Classification of cerebellum', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Cerebellum Phylogenetic Classification:&nbsp;</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Archicerebellum (oldest part)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lobes: Flocculonodular lobe, Lingula</p>\n<p>Main connection:&nbsp;Vestibulo-cerebellar</p>\n<p>Nuclei: Fastigial&nbsp;</p>\n<p>Function:&nbsp;Maintenance of body equilibrium</p>\n</td>\n</tr>\n<tr>\n<td><strong>Paleocerebellum</strong></td>\n</tr>\n<tr>\n<td>\n<p>Lobes: Whole anterior lobe (except Lingula), Pyramid and Uvula</p>\n<p>Main connection: Spino-cerebellar</p>\n<p>Nuclei: Interposed (Globose and Emboliform)&nbsp;</p>\n<p>Function:&nbsp;Maintenance of muscle tone and finer control of movements</p>\n</td>\n</tr>\n<tr>\n<td><strong>Neocerebellum (most recent part)</strong></td>\n</tr>\n<tr>\n<td>\n<p>Whole&nbsp;posterior lobe except Pyramid and Uvula</p>\n<p>Main connection:&nbsp; Cortico-ponto-cerebellar</p>\n<p>Nuclei: Dentate</p>\n<p>Function: Fine coordination of voluntary movements</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(36, 'Anatomy', 'PM2256. Boundaries of the 3rd ventricle', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Roof:</strong> Choroid plexus</p>\n<p><strong>Lateral wall:</strong></p>\n<ul>\n<li>Thalamus</li>\n<li>Hypothalamus</li>\n</ul>\n<p><strong>Anterior wall:&nbsp;</strong></p>\n<ul>\n<li>Anterior commissure</li>\n<li>Lamina terminalis</li>\n</ul>\n<p><strong>Posterior wall:&nbsp;</strong></p>\n<ul>\n<li>Pineal gland</li>\n<li>Posterior commissure</li>\n<li>Aqueduct of Sylvius</li>\n</ul>\n<p><strong>Floor:&nbsp;</strong></p>\n<ul>\n<li>Optic chiasma</li>\n<li>Infundibulum</li>\n<li>Mamillary bodies</li>\n<li>Posterior perforating substance</li>\n<li>Tegmentum of midbrain</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0adcffec16404c7494c80b6792ccd690x600x523.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(37, 'Anatomy', 'PM2255. Cerebellar Circuitry', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Cerebellar circuitry includes:</p>\n<p>Afferents- Climbing and mossy fibers</p>\n<ul>\n<li>Climbing fibers -\n<ul>\n<li>Origin - contralateral inferior olivary nucleus in the medulla oblongata</li>\n<li>Terminates on - Purkinje cell</li>\n</ul>\n</li>\n<li>Mossy fibers -\n<ul>\n<li>Origin - multiple sources in the spinal cord and brainstem</li>\n<li>Terminates on - Granule cell</li>\n</ul>\n</li>\n</ul>\n<p>Intrinsic components</p>\n<ul>\n<li>Granule cell backward inhibition - done by Golgi cells- prevent transmission from mossy fibers to the granule cells</li>\n<li>Purkinje cells forward inhibition- done by stellate and basket cells</li>\n</ul>\n<p>Efferents -</p>\n<ul>\n<li>The output from the cerebellar cortex - from Purkinje cells inhibitory output to the deep cerebellar nuclei</li>\n<li>The output from the cerebellum - from deep cerebellar nuclei\n<ul>\n<li>Globose, emboliform, and dentate - via superior cerebellar peduncle</li>\n<li>Fastigial - via inferior cerebellar peduncle</li>\n</ul>\n</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/08d7e9790f8b4fe4afdec9aa33c384b3x1280x1767.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(38, 'Anatomy', 'PM2253. Cerebellar peduncles and their connections', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Peduncle</strong></td>\n<td><strong>Afferent fibers</strong></td>\n<td><strong>Efferent fibers</strong></td>\n</tr>\n<tr>\n<td>\n<p>Superior cerebellar peduncle</p>\n</td>\n<td>\n<p>Anterior spinocerebellar tract</p>\n</td>\n<td>\n<ul>\n<li>Globose - emboliform-rubral pathway</li>\n<li>Dentatothalamic pathway</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Middle cerebellar peduncle -<strong>Largest</strong>, most lateral and <strong>only afferent</strong></td>\n<td>Corticopontocerebellar pathway</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Inferior cerebellar peduncle</td>\n<td>\n<ul>\n<li>Posterior spinocerebellar tract</li>\n<li>Cuneocerebellar tract</li>\n<li>Olivocerebellar tract</li>\n<li>Reticulocerebellar tract</li>\n<li>Trigeminocerebellar tract</li>\n<li>Vestibulocerebellar tract</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Fastigial vestibular pathway</li>\n<li>Fastigial reticular pathway</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/34cdc17d883b41d688f40950d3f0c6efx600x489.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(39, 'Anatomy', 'PM2251. Neurons and fibers of the cerebellum', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Neurons and fibers of the cerebellum&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Purkinje cell</strong></td>\n</tr>\n<tr>\n<td>\n<p>conveys the only output from the cerebellar cortex</p>\n<p>projects inhibitory output (gamma-aminobutyric acid [GABA]) to the cerebellar and&nbsp;vestibular nuclei</p>\n<p>excited by parallel and climbing fibers</p>\n<p>inhibited (by GABA) by basket and stellate cells</p>\n</td>\n</tr>\n<tr>\n<td><strong>Granule cell</strong></td>\n</tr>\n<tr>\n<td>\n<p>excites (by glutamate) Purkinje, basket, stellate, and Golgi cells via parallel fibers</p>\n<p>inhibited by Golgi cells</p>\n<p>excited by mossy fibers</p>\n</td>\n</tr>\n<tr>\n<td><strong>Mossy fibers</strong></td>\n</tr>\n<tr>\n<td>\n<p>fiber type: afferent excitatory fibers</p>\n<p>tracts: spinocerebellar and pontocerebellar tracts</p>\n<p>transmitter:glutamate</p>\n<p>termination: on granule cells</p>\n<p>excite granule cells to discharge via their parallel fibers</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Climbing fibers</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>fiber type: afferent excitatory fibers&nbsp;</p>\n<p>tract: olivocerebellar tract</p>\n<p>transmitter: aspartate</p>\n<p>termination: on neurons of the cerebellar nuclei and on dendrites of Purkinje cell</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>afferent excitatory ﬁbers of the spinocerebellar</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d592c57158bc4d40b3fdeae3b56e79c5x1280x1767.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(40, 'Anatomy', 'PM2247. Internal capsule parts and fibers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Part of Internal<br>capsule</td>\n<td>Motor<br>fibers/descending tracts</td>\n<td>Sensory fibers/<br>ascending tracts</td>\n</tr>\n<tr>\n<td>Anterior limb</td>\n<td>\n<ul>\n<li>Frontopontine</li>\n</ul>\n</td>\n<td>Anterior thalamic radiation</td>\n</tr>\n<tr>\n<td><strong>Genu</strong></td>\n<td>\n<ul>\n<li>Corticonuclear</li>\n<li>Corticospinal</li>\n</ul>\n</td>\n<td>Superior thalamic<br>radiation</td>\n</tr>\n<tr>\n<td><strong>Posterior limb</strong></td>\n<td>\n<ul>\n<li><strong>Corticospinal</strong></li>\n<li>Corticorubral</li>\n<li>Frontopontine</li>\n</ul>\n</td>\n<td>Superior thalamic<br>radiation</td>\n</tr>\n<tr>\n<td>Retrolentiform part</td>\n<td>\n<ul>\n<li>Parietopontine</li>\n<li>Occipitopontine</li>\n</ul>\n<p>&nbsp;</p>\n<ul>\n<li>Occipitotectal</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Posterior thalamic<br>radiation</li>\n</ul>\n<p>&nbsp;</p>\n<ul>\n<li>Optic<br>radiation</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Sublentiform part</td>\n<td>\n<ul>\n<li>Temporopontine</li>\n<li>Parietopontine</li>\n</ul>\n</td>\n<td>Auditory radiation</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(41, 'Anatomy', 'PM2246. Corpus  Callosum', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Parts of the corpus callosum:</strong></p>\n<ul>\n<li><strong>Rostrum:</strong> connects frontal lobes (eg: orbitofrontal cortex)</li>\n<li><strong>Genu:</strong> connects frontal lobes. It is the anterior-most part.</li>\n<li><strong>Trunk or Body:</strong> connects temporal lobes.</li>\n<li><strong>Splenium:</strong>&nbsp;connects the two occipital lobes. It is the thickest part.</li>\n</ul>\n<p>Note: Isthmus is a part which separates the body from splenium, some books mention it as a part.</p>\n<ul>\n<li>The fibers of the genu curve forward into frontal lobes and form <strong>forceps minor</strong>.</li>\n<li>The fibers of the trunk extend laterally as radiation of corpus callosum.</li>\n<li>The fibers from the trunk and the splenium which form the lateral wall of the inferior horn of the lateral ventricle constitute the <strong>tapetum.</strong></li>\n<li>The fibers from the splenium arching backwards into the occipital lobe form <strong>forceps major.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cdf78937ae524771aec56a67e252b9bax1280x1188.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(42, 'Anatomy', 'PM2240. White matter tracts of the brain', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Commissural fibers:</strong>&nbsp;connect corresponding regions of two hemispheres.</p>\n<p>They include</p>\n<ul>\n<li>Corpus callosum</li>\n<li>Anterior and posterior commissure</li>\n<li>Habenular commissure</li>\n<li>Hippocampal commissure of fornix</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Association fibers:</strong>&nbsp;connect various cortical regions within the same hemisphere.</p>\n<p>They are classified as&nbsp;</p>\n<ul>\n<li>Short association fibers: lie immediately under the cortex and connect adjacent gyri. Eg- arcuate fasciculus</li>\n<li>Long association fibers:\n<ul>\n<li>Uncinate fasciculus</li>\n<li>Cingulum</li>\n<li>Superior longitudinal fasciculus</li>\n<li>Inferior longitudinal fasciculus</li>\n<li>Fronto-occipital fasciculus</li>\n<li>Fornix (except hippocampal commissure of fornix)</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/34dcc45f34114e9e968caa2f3060181ex1280x1285.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Projection fibers:</strong>&nbsp;fibers passing to and from the brainstem to the cerebral cortex.&nbsp;</p>\n<ul>\n<li>Internal capsule</li>\n<li>Corona radiata</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/545b77e4b1dd4a6f803e840b3678549bx600x581.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(43, 'Anatomy', 'PM2239. Dural Venous Sinuses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\368\>\n<tbody>\n<tr>\n<td>Dural venous sinus</td>\n<td>Drains into</td>\n</tr>\n<tr>\n<td colspan=\2\>Unpaired sinuses</td>\n</tr>\n<tr>\n<td>Superior sagittal sinus</td>\n<td>Confluence of sinuses or continues as right transverse sinus</td>\n</tr>\n<tr>\n<td>Inferior sagittal sinus</td>\n<td>joins the great cerebral vein to form the straight sinus</td>\n</tr>\n<tr>\n<td>&nbsp;Straight sinus</td>\n<td>forms the left transverse sinus</td>\n</tr>\n<tr>\n<td>Occipital sinus</td>\n<td>Confluence of sinuses</td>\n</tr>\n<tr>\n<td colspan=\2\>Paired sinuses</td>\n</tr>\n<tr>\n<td>Superior petrosal sinus</td>\n<td>transverse sinus</td>\n</tr>\n<tr>\n<td>Inferior petrosal sinus</td>\n<td>Internal jugular vein</td>\n</tr>\n<tr>\n<td>Transverse sinus</td>\n<td>continue as sigmoid sinus</td>\n</tr>\n<tr>\n<td>Sigmoid sinus</td>\n<td>continuous with the internal jugular vein</td>\n</tr>\n<tr>\n<td>Cavernous sinus</td>\n<td>Superior and inferior petrosal sinuses</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e717fc57ad1c4c5eb83a21118bb9589cx600x1277.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(44, 'Anatomy', 'PM2233. Spinal Tract Decussations.', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e64f7962a697405da865e5cdcc262263x1280x2558.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table title=\Page 397\ border=\1\>\n<tbody>\n<tr>\n<td class=\\><strong>Name</strong></td>\n<td class=\\>\n<div><strong>Decussation</strong></div>\n</td>\n</tr>\n<tr>\n<td class=\\>\n<div>Gracile</div>\n<div>fasciculus</div>\n&nbsp;</td>\n<td class=\\>\n<div>In medulla</div>\n</td>\n</tr>\n<tr>\n<td class=\\>\n<div>Cuneate</div>\n<div>fasciculus</div>\n&nbsp;</td>\n<td class=\\>\n<div>In medulla</div>\n</td>\n</tr>\n<tr>\n<td class=\\>\n<div>Spino-</div>\n<div>thalamic</div>\n&nbsp;</td>\n<td class=\\>\n<div>In spinal cord</div>\n</td>\n</tr>\n<tr>\n<td class=\\>\n<div>Spino-</div>\n<div>reticular</div>\n&nbsp;</td>\n<td class=\\>\n<div>In spinal cord (some fibers)</div>\n</td>\n</tr>\n<tr>\n<td class=\\>\n<div>Posterior</div>\n<div>spino-</div>\n<div>cerebellar</div>\n&nbsp;</td>\n<td class=\\>\n<div>None</div>\n</td>\n</tr>\n<tr>\n<td class=\\>\n<div>Anterior</div>\n<div>spino-</div>\n<div>cerebellar</div>\n&nbsp;</td>\n<td class=\\>\n<div>In spinal cord</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table title=\Page 397\ border=\1\>\n<tbody>\n<tr>\n<td class=\\><strong>&nbsp;Name</strong></td>\n<td class=\\>\n<div><strong>&nbsp;</strong></div>\n<div><strong>Decussation</strong></div>\n<div><strong>&nbsp;</strong></div>\n</td>\n</tr>\n<tr>\n<td class=\\>\n<div>Lateral</div>\n<div>cortico-</div>\n<div>spinal</div>\n&nbsp;</td>\n<td class=\\>\n<div>In medulla</div>\n</td>\n</tr>\n<tr>\n<td class=\\>\n<div>Anterior</div>\n<div>cortico-</div>\n<div>spinal</div>\n&nbsp;</td>\n<td class=\\>\n<div>In spinal cord</div>\n</td>\n</tr>\n<tr>\n<td class=\\>\n<div>Tecto-</div>\n<div>spinal</div>\n&nbsp;</td>\n<td class=\\>\n<div>In midbrain</div>\n</td>\n</tr>\n<tr>\n<td class=\\>\n<div>Lateral</div>\n<div>reticulo-</div>\n<div>spinal</div>\n&nbsp;</td>\n<td class=\\>\n<div>None</div>\n</td>\n</tr>\n<tr>\n<td class=\\>\n<div>Medial</div>\n<div>reticulo-</div>\n<div>spinal</div>\n&nbsp;</td>\n<td class=\\>\n<div>None</div>\n</td>\n</tr>\n<tr>\n<td class=\\>\n<div>Lateral</div>\n<div>vestibulo-</div>\n<div>spinal</div>\n&nbsp;</td>\n<td class=\\>\n<div>None</div>\n</td>\n</tr>\n<tr>\n<td class=\\>\n<div>Medial</div>\n<div>vestibulo-</div>\n<div>spinal</div>\n&nbsp;</td>\n<td class=\\>\n<div>In medulla (c fibers)</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(45, 'Anatomy,', 'PM2232. Descending tracts of spinal cord', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\699\>\n<tbody>\n<tr>\n<td>Tract</td>\n<td>Corticospinal tract</td>\n<td>Reticulospinal tract</td>\n<td>Tectospinal tract</td>\n<td>Rubrospinal tract</td>\n<td>Vestibulospinal tract</td>\n<td>Olivospinal tract</td>\n</tr>\n<tr>\n<td>Function</td>\n<td>Control of rapid, skilled, voluntary movements</td>\n<td>Inhibits or facilitate voluntary movement</td>\n<td>Control of reflex postural movements concerning sight</td>\n<td>Facilitates activity of flexor muscles and inhibits the activity of extensor muscles</td>\n<td>Facilitates activity of extensor muscles and inhibits the activity of flexor muscles</td>\n<td>Unknown</td>\n</tr>\n<tr>\n<td>Origin</td>\n<td>Primary motor cortex (area 4), secondary motor cortex (area 6), parietal lobes</td>\n<td>\n<p>Reticular formation</p>\n</td>\n<td>Superior colliculus</td>\n<td>Red nucleus</td>\n<td>Vestibular nuclei</td>\n<td>Inferior olivary nuclei</td>\n</tr>\n<tr>\n<td>Site of crossover</td>\n<td>\n<p>Lateral corticospinal tract - in lower medulla&nbsp;</p>\n<p>Anterior corticospinal tract - spinal cord at the level of destination</p>\n</td>\n<td>\n<p>Some decussate at various levels</p>\n<p>Some fibers dont decussate</p>\n</td>\n<td>Soon after origin</td>\n<td>Immediately after origin</td>\n<td><strong>Uncrossed</strong></td>\n<td>Brainstem</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a9152c84c6aa407a86afa6da5100e86ex1280x1248.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(46, 'Physiology,', 'PM2231. Ascending tracts of spinal cord', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Pathway</strong></td>\n<td><strong>Dorsal column</strong></td>\n<td><strong>Anterior spinothalamic tract</strong></td>\n<td><strong>Lateral spinothalamic tract</strong></td>\n</tr>\n<tr>\n<td>Receptor</td>\n<td>Meissner corpuscles, pacinian corpuscles, muscle spindles, golgi tendon organs</td>\n<td>Free nerve endings</td>\n<td>Free nerve endings&nbsp;</td>\n</tr>\n<tr>\n<td>First-order neuron</td>\n<td>\n<p>First-order neurons from the receptors enter spinal cord from dorsal root &gt;</p>\n<p>ascend ipsilaterally as fasciculus gracilis and fasciculus cuneatus &gt;</p>\n<p>synapse in nucleus gracilis and nucleus cuneatus in medulla &gt;&nbsp;</p>\n</td>\n<td colspan=\2\>First-order neurons from dorsal root ganglion ascend for a few segments and synapse with the cells in the posterior gray column &gt;</td>\n</tr>\n<tr>\n<td>Second-order neuron</td>\n<td>\n<p>second-order neurons from nucleus gracilis and nucleus cuneatus continue as <strong>internal arcuate fibers</strong> &gt;&nbsp;</p>\n<p>decussate in the lower medulla and ascends as <strong>medial lemniscus</strong> on the contralateral side &gt;</p>\n<p>synapse in the ventral posterolateral nucleus of the thalamus</p>\n</td>\n<td colspan=\2\>\n<p>Second-order neurons from the posterior gray column crossover to the opposite side and ascend as anterior and lateral spinothalamic tract &gt;</p>\n<p>form the <strong>spinal lemniscus</strong> in the medulla &gt;</p>\n<p>ascend through pons and synapses in the ventral posterolateral nucleus of thalamus &gt;</p>\n</td>\n</tr>\n<tr>\n<td>Third-order neuron</td>\n<td>third-order neuron from the ventral posterolateral nucleus of thalamus ascend in the posterior limb of internal capsule and corona radiata and terminate in somatosensory cortex</td>\n<td colspan=\2\>Third-order neurons from the ventral posterolateral nucleus of thalamus ascend through the posterior limb of internal capsule and corona radiata and terminate in the somatosensory cortex</td>\n</tr>\n<tr>\n<td>Decussation</td>\n<td>Medulla</td>\n<td>Spinal cord - few segments above the entry point&nbsp;&nbsp;</td>\n<td>Spinal cord- one segment above the entry point</td>\n</tr>\n<tr>\n<td>Sensations carried</td>\n<td>Proprioception, Fine touch(discriminative touch), pressure intesity, vibration, position sense</td>\n<td>Crude touch, pressure&nbsp;</td>\n<td>Pain and temperature</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7bf456a051bd463f8309af97c40c6506x1280x1248.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(47, 'Anatomy', 'PM2141. Origins of cranial nerves at the base of the brain', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/521c0fb7637a49bc98549d02ec59d22dx600x618.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Cranial nerve origins as seen in gross anatomy:</p>\n<ul>\n<li>III cranial nerve: Midbrain at the level of the superior colliculus. &nbsp;</li>\n<li>IV cranial nerve: Midbrain at the level of inferior colliculus - the only nerve the <strong>exits from the dorsal aspect</strong></li>\n<li>V cranial nerve: The substance of pons&nbsp;</li>\n<li>VI, VII, and VIII cranial nerves:&nbsp; Pontomedullary junction</li>\n<li>IX, X, and XI cranial nerves(nucleus ambiguus): Posterolateral sulcus&nbsp; &nbsp;</li>\n<li>XII cranial nerve: Anterolateral sulcus (between pyramid and olive)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(48, 'Anatomy', 'PM2140. Arrangement of cranial nerve nuclei in the brainstem', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Functional Component</strong></td>\n<td><strong>Cranial nerves&nbsp;</strong></td>\n</tr>\n<tr>\n<td>\n<p>General Somatic Efferent (SE/GSE)</p>\n</td>\n<td>3,4,6,12</td>\n</tr>\n<tr>\n<td>\n<p>Special Visceral Efferent (SVE/BrE)</p>\n</td>\n<td>\n<p>5,7,9,10,11</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>General Visceral Efferent&nbsp; (GVE)</p>\n</td>\n<td>3,7,9,10</td>\n</tr>\n<tr>\n<td>\n<p>General Visceral Afferent (GVA)</p>\n</td>\n<td rowspan=\2\>7,9,10</td>\n</tr>\n<tr>\n<td>\n<p>Special Visceral Afferent&nbsp;(BrA/SVA)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>General Somatic Afferent (SA/GSA)</p>\n</td>\n<td>5,7,9,10</td>\n</tr>\n<tr>\n<td>\n<p>Special Somatic Afferent (SSA)</p>\n</td>\n<td>2,8</td>\n</tr>\n</tbody>\n</table>\n<p>GVE represents the parasympathetic supply; so all cranial nerves having parasympathetic fibers, have the GVE component.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f85b03ec72444bf9ba28fdda5b29fc3cx1280x1567.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(49, 'Anatomy,', 'PM2121. Functions of Main Hypothalamic Nuclei', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table border=\1\ width=\416\>\n<tbody>\n<tr>\n<td>Hypothalamic Nucleus</td>\n<td>Function</td>\n</tr>\n<tr>\n<td>Supraoptic&nbsp;</td>\n<td>Synthesizes vasopressin (ADH)</td>\n</tr>\n<tr>\n<td>Paraventricular</td>\n<td>Synthesizes oxytocin</td>\n</tr>\n<tr>\n<td>Preoptic &amp; anterior Nuclei</td>\n<td>Control parasymphathetic system</td>\n</tr>\n<tr>\n<td>Posterior &amp; Lateral</td>\n<td>Control symphathetic system</td>\n</tr>\n<tr>\n<td>Anterior</td>\n<td>Regulate temperature(response to heat)</td>\n</tr>\n<tr>\n<td>Posterior</td>\n<td>Regulate temperature(response to cold)</td>\n</tr>\n<tr>\n<td>Lateral</td>\n<td>\n<div class=\page\ title=\Page 655\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Initiate eating and increase food intake (Hunger center)<br>Increase water intake (Thirst center)</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>Medial</td>\n<td>\n<div class=\page\ title=\Page 655\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Inhibit eating and reduce food intake (satiety center)</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 655\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Suprachiasmatic</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Controls circadian rhythm</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(50, 'Anatomy', 'PM2063. Arteries supplying specific parts of the brain', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Parts of Brain</strong></td>\n<td><strong>Arteries supplying it</strong></td>\n</tr>\n<tr>\n<td>Basal ganglia</td>\n<td>\n<ul>\n<li>Lateral striate artery - a branch of MCA</li>\n<li>Medial striate artery - a branch of ACA</li>\n<li>Anterior and posterior&nbsp; choroidal arteries</li>\n<li>Thalamogeniculate branch of PCA</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Internal capsule</td>\n<td>\n<ul>\n<li>Lateral striate artery - a branch of MCA</li>\n<li>Medial striate artery (Recurrent artery of Heubner) - a branch of ACA</li>\n<li>Anterior choroidal artery - a branch of ICA</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Thalamus</td>\n<td>\n<ul>\n<li>Posterior communicating arteries</li>\n<li>Posterior cerebral arteries</li>\n<li>Basilar artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Midbrain</td>\n<td>\n<ul>\n<li>Posterior cerebral arteries</li>\n<li>Superior cerebellar arteries</li>\n<li>Basilar artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Pons</td>\n<td>\n<ul>\n<li>Basilar artery</li>\n<li>Anterior inferior cerebellar artery</li>\n<li>Superior cerebellar arteries.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Medulla oblongata</td>\n<td>\n<ul>\n<li>Vertebral artery</li>\n<li>Anterior and posterior spinal arteries</li>\n<li>Posterior inferior cerebellar arteries</li>\n<li>Basilar artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Cerebellum</td>\n<td>\n<ul>\n<li>Superior cerebellar arteries</li>\n<li>Anterior inferior cerebellar arteries</li>\n<li>Posterior inferior cerebellar arteries</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>ACA - Anterior cerebral artery</p>\n<p>MCA- Middle cerebral artery</p>\n<p>PCA - Posterior cerebral artery</p>\n<p>ICA - Internal carotid artery</p></div><!---->\n      <!---->\n    </div><!---->'),
(51, 'Anatomy,', 'PM2017. Abnormal movements', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp;Movement</strong></td>\n<td><strong>Site</strong></td>\n<td><strong>Description</strong></td>\n<td><strong>Cause</strong></td>\n</tr>\n<tr>\n<td>Intentional tremor</td>\n<td>Cerebellum</td>\n<td>Only on activity&nbsp;</td>\n<td>\n<ul>\n<li>Trauma</li>\n<li>Stroke</li>\n<li>Alcohol</li>\n<li>Drugs</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Resting tremor</td>\n<td>\n<p>Substantia nigra</p>\n<p>Red nucleus</p>\n</td>\n<td>Disappear on movement</td>\n<td>\n<ul>\n<li>&nbsp;Parkinsonism</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hyperkinetic tremor</td>\n<td>Sympathetic overactivity&nbsp;</td>\n<td>Precipitated by emotion , stress</td>\n<td>\n<ul>\n<li>Anxiety&nbsp;</li>\n<li>Hyperthyroidism&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Asterixis</td>\n<td>Cortex</td>\n<td>Inability to sustain a muscle contraction while performing a complex motor movement</td>\n<td>\n<ul>\n<li>Hepatic encephalopathy&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Chorea</td>\n<td>Caudate nucleus and putamen</td>\n<td>&nbsp;Rapid jerky movement</td>\n<td>\n<ul>\n<li>Rheumatic chorea</li>\n<li>Huntington chorea</li>\n<li>Drug induced&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hemibalismus</td>\n<td>Subthalamic nucleus</td>\n<td>Unilateral wild flinging violent movement of large proximal joints</td>\n<td>\n<ul>\n<li>Vascular&gt;degenerative&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Athetosis</td>\n<td>Basal ganglia- Globus Pallidum</td>\n<td>Slow writhing movement involving distal joints</td>\n<td>\n<ul>\n<li>Vascular&nbsp;</li>\n<li>Degenerative&nbsp;</li>\n<li>Infiltrative</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(52, 'Anatomy', 'PM2010. Classification of sulci of brain', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Types of sulci</strong>:</p>\n<p>On the basis of function, theyre divided as:</p>\n<ul>\n<li><strong>Limiting sulcus</strong> - A sulcus that separates areas differing in structure and function at its floor. E.g. <strong>Central sulcus</strong> - separates motor and sensory area.</li>\n<li><strong>Axial sulcus -&nbsp;</strong>Sulcus that develops along the axis of a rapidly growing/ developing area. E.g.&nbsp;<strong>Posterior part of calcarine sulcus</strong> - primary visual area grows along this sulcus.</li>\n<li><strong>Operculated sulcus - </strong>A sulcus that separates two areas by its lip and contains a third area in its walls.<strong>&nbsp;</strong>E.g.&nbsp;<strong>Lunate sulcus</strong> - separates striate and peristriate areas.</li>\n</ul>\n<p>On the basis of depth, theyre divided as:</p>\n<ul>\n<li><strong>Complete sulcus -&nbsp;</strong>Deep enough to indent the wall of the lateral ventricle. E.g&nbsp;<strong>Anterior part of calcarine sulcus&nbsp;</strong>-&nbsp; forms calcar avis at the lateral ventricle,&nbsp;<strong>Collateral sulcus</strong> -&nbsp; forms collateral eminence at the inferior horn of the lateral ventricle</li>\n<li><strong>Incomplete sulcus</strong> - Superficially situated and does not indent the lateral ventricle. E.g. <strong>paracentral sulcus</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(53, 'Medicine,', 'PM1982. Medullary syndromes and Weber syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table class=\t1\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Syndrome</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Vessel involved</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Clinical features</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Medial Medullary syndrome / Dejerine syndrome</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Vertebral artery/Anterior spinal artery</p>\n</td>\n<td class=\td1\ valign=\top\>\n<ul>\n<li class=\p1\>C/L loss of conscious proprioception</li>\n<li class=\p1\>C/L hemiplegia</li>\n<li class=\p1\>I/L tongue paralysis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Lateral Medullary syndrome / Wallenberg syndrome</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Vertebral artery&gt;Posterior inferior cerebellar artery</p>\n</td>\n<td class=\td1\ valign=\top\>\n<ul>\n<li class=\p1\>C/L loss of pain/temperature on the body</li>\n<li class=\p1\>I/L loss of pain/temperature on face</li>\n<li class=\p1\>Ataxia</li>\n<li class=\p1\>Nystagmus</li>\n<li class=\p1\>Vertigo</li>\n<li class=\p1\>Horners syndrome</li>\n<li class=\p1\>dysphagia</li>\n<li class=\p1\>Ipsilateral bulbar paralysis</li>\n<li class=\p1\>Loss of gag reflex</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Webers syndrome</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Posterior cerebral artery</p>\n</td>\n<td class=\td1\ valign=\top\>\n<ul>\n<li class=\p1\>I/L Oculomotor nerve palsy - ptosis with fixed dilated pupil pointed down and out</li>\n<li class=\p1\>C/L hemiplegia</li>\n<li class=\p1\>C/L paralysis of the lower face</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>C/L- Contralateral</p>\n<p>I/L-Ipsilateral</p></div><!---->\n      <!---->\n    </div><!---->'),
(54, 'Medicine,', 'PM1687. Site of Lesion of Movement Disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\312\>\n<p><strong>Movement disorder</strong></p>\n</td>\n<td width=\312\>\n<p><strong>Site of Lesion</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Athetosis</p>\n</td>\n<td width=\312\>Globus pallidus</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Chorea</p>\n</td>\n<td width=\312\>\n<p>Putamen, Caudate</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Hemiballismus</p>\n</td>\n<td width=\312\>\n<p>Subthalamic Nucleus</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Parkinsonism</p>\n</td>\n<td width=\312\>\n<p>Substantia Nigra&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>&nbsp;</strong></p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(55, 'Medicine,', 'PM1648. Conus medullaris syndrome vs Cauda equina syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<div class=\page\ title=\Page 1126\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Conus medullaris syndrome</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 1126\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Cauda equina syndrome</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>Injury</td>\n<td>\n<div class=\page\ title=\Page 1126\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Vertebral column injuries between T12 and L2</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Vertebral column injuries distal to L2</td>\n</tr>\n<tr>\n<td>Pathophysiology</td>\n<td>\n<div class=\page\ title=\Page 1126\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Upper and lower motor neuron involvement</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Lower motor neuron involvement</td>\n</tr>\n<tr>\n<td>Motor strength&nbsp;</td>\n<td>\n<div class=\page\ title=\Page 1126\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Symmetrical motor impairment&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Asymmetrical motor impairment</td>\n</tr>\n<tr>\n<td>Reflexes</td>\n<td>Knee jerk preserved, ankle jerk affected</td>\n<td>Both knee and ankle jerk affected</td>\n</tr>\n<tr>\n<td>Sphincter dysfunction</td>\n<td>Urinary retention presents early in the disease course</td>\n<td>Urinary retention presents late in the disease course</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td colspan=\2\>\n<div class=\page\ title=\Page 1126\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Absent bulbocavernosus reflex</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td colspan=\2\>\n<div class=\page\ title=\Page 1126\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Radicular pain and low back pain</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(56, 'Physiology,', 'PM0920. Components of limbic system', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/bb352c4e483544f194265bc72f929c2ax1280x1410.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(57, 'Anatomy,', 'PM0431. Important Root Values and Cranial Nerve Nuclei', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>Nerve/Nuclei</td>\n<td>Nerve Roots/Cranial Nerves</td>\n</tr>\n<tr>\n<td>Pudendal nerve</td>\n<td>S2S3S4</td>\n</tr>\n<tr>\n<td>Ulnar nerve</td>\n<td>C7C8T1</td>\n</tr>\n<tr>\n<td>Radial nerve</td>\n<td>C5C6C7C8T1</td>\n</tr>\n<tr>\n<td>Musculocutaneous nerve</td>\n<td>C5C6C7</td>\n</tr>\n<tr>\n<td>Phrenic nerve</td>\n<td>C3C4C5</td>\n</tr>\n<tr>\n<td>Nucleus ambigous</td>\n<td>9, 10, 11 cranial nerve nuclei</td>\n</tr>\n<tr>\n<td>Nucleus tractus solitarious</td>\n<td>7, 9, 10 cranial nerve nuclei</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(58, 'Medicine,', 'PM0063. Blood supply of Brain', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The brain is supplied by Internal Carotid arteries and Vertebrobasilar arteries.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7f88db8a6d4542c2953dc02777ebd7d5x1200x2398.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Areas supplied by various arteries</td>\n</tr>\n<tr>\n<td>Anterior Cerebral Artery</td>\n</tr>\n<tr>\n<td>\n<p>Course - Curves around the corpus&nbsp;callosum within the sagittal&nbsp;fissure</p>\n<p>Supply - Dorsomedial frontal&nbsp;and parietal lobes</p>\n<p><strong>Effects of occlusion of the anterior cerebral artery (ACA</strong>):&nbsp;</p>\n<p><strong>- Contralateral Paralysis (or weakness) of muscles of the leg and foot</strong> -&nbsp;Upper part of motor area affected.</p>\n<p>- <strong>Contralateral Loss (or dulling) of sensations from the leg and foot</strong> -&nbsp;Upper part of the sensory area affected.</p>\n</td>\n</tr>\n<tr>\n<td>Middle Cerebral Artery</td>\n</tr>\n<tr>\n<td>\n<p>Course - Runs within Sylvian fissure</p>\n<p>Supply -&nbsp;Lateral convexity of the cerebral cortex</p>\n<p><strong>Effects of occlusion of middle cerebral artery (MCA):</strong></p>\n<p>- <strong>Contralateral Hemiplegia</strong> -&nbsp; loss of sensations. The face and arms are most affected, foot and leg are spared.&nbsp;&nbsp;</p>\n<p>- <strong>Aphasia&nbsp;</strong>- Broca’s and Wernicke’s areas affected, especially if the thrombosis is in the left hemisphere in a right-handed person.&nbsp;&nbsp;</p>\n<p>- <strong>Contralateral Homonymous hemianopia</strong> -&nbsp;due to the involvement of optic radiation. &nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Posterior Cerebral Artery</td>\n</tr>\n<tr>\n<td>\n<p>Course -&nbsp;Curves behind the midbrain</p>\n<p>Supply - Occipital lobe and inferior and medial temporal lobe</p>\n<p><strong>Effects of occlusion of posterior cerebral artery (PCA):</strong></p>\n<p><strong>- Contralateral homonymous hemianopia with macular sparing</strong> -&nbsp;Affected Cortical blood supply &gt;&nbsp;Damage to association cortex of visual area causes visual hallucinations (distortion of colour vision).</p>\n<p>Note: Macular sparing is due to collateral circulation from MCA to that cortical region.&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(59, 'Anatomy', 'PM0062. Circumventricular Organs (CVO)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The following are the <strong>circumventricular organs (CVO)</strong> or areas<strong> devoid of the blood-brain barrier</strong>:</p>\n<ul>\n<li>Pineal body</li>\n<li>Neurohypophysis</li>\n<li>Organum Vasculosum of Lamina Terminalis (OVLT)</li>\n<li>Median Eminence (hypothalamus)</li>\n<li>Subcommissural organ</li>\n<li>Subfornical organ</li>\n<li>Area Postrema</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(60, 'Anatomy', 'PM0061. Subarachnoid Cisterns', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ce7c5ffbc91b4ad6a50560129bb16256x600x632.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Subarachnoid cistern</td>\n<td>Interpeduncular / basal cistern</td>\n<td>Cisterna Magns ( Cerebellomedullary cistern )- <strong>largest cistern</strong></td>\n<td>Quadrigeminal cistern/ Superior cistern/ vein of Galen cistern/ Peripineal cistern</td>\n<td>Cerebellopontine cistern</td>\n<td>Pontine cistern</td>\n<td>Sylvian/Lateral sulcus cistern</td>\n</tr>\n<tr>\n<td>Location</td>\n<td>Base of brain in the interpeduncular fossa</td>\n<td>Angle between the inferior surface of cerebellum and medulla. Continuous with the IV ventricle through foramen of Magendie</td>\n<td>Between the splenium of corpus callosum and superior cerebellar surface behind the midbrain</td>\n<td>Lateral angle between the cerebellum and pons</td>\n<td>Ventral surface of the pons</td>\n<td>Over the lateral sulcus</td>\n</tr>\n<tr>\n<td>Content</td>\n<td>Circle of Willis, origins of anterior inferior cerebellar and superior cerebellar arteries and abducens nerves</td>\n<td>Vertebral arteries, origin of PICA, cranial nerves IX, X, XI, XII.</td>\n<td>Great cerebral vein of Galen</td>\n<td>V, VII and VIII cranial nerves, anterior inferior cerebellar arteries, superior petrosal veins</td>\n<td>Basilar artery</td>\n<td>Middle cerebral artery and veins</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(61, 'Anatomy', 'PM0037. Circle of Willis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3c3f179b24c04fcf89203a3d92261b52x1280x1574.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(62, 'Anaesthesia,', 'PM0036. Extent of important structures/spaces in the Spinal cord', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/06cf8ecf33f34dc3acc7e3ccc8cfb78ax1280x1465.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Structure / Space</strong>&nbsp;</td>\n<td><strong>Terminal extent&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Spinal cord at birth&nbsp;</td>\n<td>L3 upper border&nbsp;</td>\n</tr>\n<tr>\n<td>Spinal cord at 2 years&nbsp;</td>\n<td>L1 lower border&nbsp;</td>\n</tr>\n<tr>\n<td>Adult Spinal cord&nbsp;</td>\n<td>L1 lower border&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Filum terminale&nbsp;</td>\n<td>1st coccygeal segment&nbsp;</td>\n</tr>\n<tr>\n<td>Filum terminale internum , Dural sac</td>\n<td>S2 lower border&nbsp;</td>\n</tr>\n<tr>\n<td>Filum terminale externum&nbsp;</td>\n<td>1st coccygeal segment&nbsp;</td>\n</tr>\n<tr>\n<td>Piamater&nbsp;</td>\n<td>1st coccygeal segment&nbsp;</td>\n</tr>\n<tr>\n<td>Subarachnoid sheath and space, Subdural space&nbsp;</td>\n<td>S2 lower border&nbsp;</td>\n</tr>\n<tr>\n<td>Cervical enlargement&nbsp;</td>\n<td>C3-T2 spinal segments&nbsp;</td>\n</tr>\n<tr>\n<td>Lumbar enlargement&nbsp;</td>\n<td>L1-S3 spinal segments&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(63, 'Anatomy', 'PM2485. Structures passing through skull foramina', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Opening</strong></td>\n<td><strong>Transmits</strong></td>\n</tr>\n<tr>\n<td><strong>Optic canal</strong></td>\n<td>\n<ul>\n<li>Optic nerves</li>\n<li>Ophthalmic arteries</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Superior orbital fissure</strong></td>\n<td>\n<ul>\n<li>Lacrimal nerve (V1)</li>\n<li>Frontal nerve (V1)</li>\n<li>Nasociliary nerve (V1)</li>\n<li>CNs III, IV, VI</li>\n<li>Superior ophthalmic vein</li>\n<li>Inferior ophthalmic vein</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen rotundum</strong></td>\n<td>\n<ul>\n<li>Maxillary division of CN V (V2)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen ovale</strong></td>\n<td>\n<ul>\n<li><strong>M</strong>andibular division of CN V (V3)</li>\n<li><strong>A</strong>ccessory meningeal artery</li>\n<li><strong>L</strong>esser petrosal nerve</li>\n<li><strong>E</strong>missary veins</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen spinosum</strong></td>\n<td>\n<ul>\n<li>Middle meningeal artery</li>\n<li>Nervus spinosus</li>\n<li>Middle meningeal vein</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen lacerum</strong></td>\n<td>\n<ul>\n<li>Deep petrosal nerve</li>\n<li>Meningeal branch of ascending pharyngeal artery&nbsp;</li>\n<li>Emissary vein</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Carotid canal</strong></td>\n<td>\n<ul>\n<li>Internal carotid artery</li>\n<li>Venous and sympathetic plexus around artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Jugular foramen</strong></td>\n<td>\n<ul>\n<li>Inferior petrosal sinus</li>\n<li>Meningeal branch of ascending pharyngeal artery&nbsp;</li>\n<li>CNs IX,X &amp; XI</li>\n<li>Sigmoid Sinus continuing as IJV&nbsp;</li>\n<li>Middle meningeal branch of occipital artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Hypoglossal canal</strong></td>\n<td>\n<ul>\n<li>Hypoglossal nerve (CN XII)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen magnum</strong></td>\n<td>\n<div class=\ng-scope\>\n<div class=\ng-scope\>\n<ul>\n<li class=\ng-binding\>Osseo-ligamentous (anterior) compartment:&nbsp;\n<ul>\n<li>Apical ligament and tip of dens</li>\n<li>Upper band of cruciate ligament</li>\n<li>Membrana tectoria</li>\n</ul>\n</li>\n<li>Neuro-vascular (posterior)&nbsp;compartment:\n<ul>\n<li>Lower end of the medulla oblongata with meninges</li>\n<li>Fourth part of vertebral artery surrounded by sympathetic plexus of nerves</li>\n<li>Spinal roots of accessory nerves</li>\n<li>Anterior and posterior spinal arteries</li>\n<li>Tonsil of cerebellum.</li>\n</ul>\n</li>\n</ul>\n</div>\n</div>\n<div class=\ng-scope\>&nbsp;</div>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/eb322d15a4d242c895dee477b2b4413cx1280x3352.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(64, 'Anatomy', 'PM2407. Triangles of the Neck', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a82026f1f1064cb5943393291ae9ccb9x600x666.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(65, 'Anatomy,', 'PM2406. Structures passing in the gaps between pharyngeal constrictors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Location</strong></span></td>\n<td><span><strong>Structures passing</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span>Between the <strong>base of the skull</strong> and <strong>superior constrictor</strong></span></p>\n<p><span>(Sinus of <strong>Morgagni</strong>)</span></p>\n</td>\n<td>\n<p><span>Mnemonic: <strong>PALE</strong></span></p>\n<p><span><strong>P</strong>alatine branches of ascending pharyngeal artery</span></p>\n<p><span><strong>A</strong>scending palatine artery</span></p>\n<p><span><strong>L</strong>evator veli palatini muscle</span></p>\n<p><span><strong>E</strong>ustachian tube&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Between <strong>superior</strong> and <strong>middle constrictors</strong></span></td>\n<td>\n<p><span>Glossopharyngeal nerve</span></p>\n<p><span>Stylopharyngeus muscle</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Between <strong>middle</strong> and <strong>inferior constrictors</strong></span></td>\n<td>\n<p><span>Internal laryngeal nerve</span></p>\n<p><span>Superior laryngeal vessels</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Below <strong>inferior constrictor</strong></span></td>\n<td>\n<p><span>Recurrent laryngeal nerve</span></p>\n<p><span>Inferior laryngeal vessels</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a3ffb2155d8a45e19b344165aaa5a450x1280x1535.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(66, 'Anatomy', 'PM2404. Lymphatic drainage of the tongue', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a1fe4d06952446bca97ad6f44b6a06a4x1200x2849.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\>\n<p><strong>Lymphatics of tongue</strong>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tip of tongue</p>\n</td>\n<td>\n<p>Submental lymph nodes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Marginal part of anterior 2/3<sup>rd</sup> of tongue</p>\n</td>\n<td>\n<p>U/L Submandibular nodes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Central part of anterior 2/3<sup>rd</sup> of tongue</p>\n</td>\n<td>B/L Jugulodigastric and Jugulo-omohyoid lymph nodes</td>\n</tr>\n<tr>\n<td>\n<p>Posterior 1/3<sup>rd</sup> of tongue</p>\n</td>\n<td>\n<p>B/L Jugulodigastric and Jugulo-omohyoid lymph nodes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Root of tongue</p>\n</td>\n<td>\n<p>B/L upper deep cervical nodes</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(67, 'Anatomy', 'PM2403. Branches of mandibular nerve', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Branches of mandibular nerve</strong></td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Branches from the main trunk</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Branches</strong></p>\n</td>\n<td>\n<p><strong>Sensory and motor supply</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nerve to Medial Pterygoid (motor)</p>\n</td>\n<td>\n<p><strong>Medial Pterygoid</strong></p>\n<p>Tensor Tympani</p>\n<p>Tensor Veli Palatini muscles</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nervous spinosus (sensory)</p>\n</td>\n<td>Dura of the middle cranial fossa</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Branches from the anterior division</strong>&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Muscular branches (motor)</p>\n</td>\n<td><strong>Lateral pterygoid</strong> and <strong>Masseter</strong></td>\n</tr>\n<tr>\n<td>\n<p>Deep temporal nerves (2 branches)</p>\n</td>\n<td><strong>Temporalis muscle</strong> and periosteum of temporal fossa</td>\n</tr>\n<tr>\n<td>\n<p>Buccal nerve (sensory)</p>\n</td>\n<td>Buccal mucosa</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Branches from the posterior division</strong>&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Auriculotemporal and&nbsp;lingual nerve&nbsp;</td>\n<td>Sensory supply</td>\n</tr>\n<tr>\n<td>\n<p>Inferior alveolar nerve (motor and sensory)</p>\n</td>\n<td>\n<p>Mylohyoid</p>\n<p>Anterior belly of the Digastric</p>\n<p>Sensation to the lower teeth</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7d82455c1ad94ac39dac6fce31c98ca6x600x759.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(68, 'Anatomy', 'PM2400. Muscles of mastication', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\793\>\n<tbody>\n<tr>\n<td><strong>Muscles</strong></td>\n<td><strong>Origin</strong></td>\n<td><strong>Insertion</strong></td>\n<td><strong>Action</strong></td>\n</tr>\n<tr>\n<td>Lateral pterygoid</td>\n<td>\n<p>Upper head - Infratemporal surface, sphenoid bone</p>\n<p>Lower head - Lateral pterygoid plate</p>\n</td>\n<td>\n<p>Upper head - Pterygoid fovea&nbsp;</p>\n<p>Lower head - TMJ capsule and articular disc</p>\n</td>\n<td>\n<p>Depresses mandible (with suprahyoid muscles)</p>\n<p>Jaw protrusion</p>\n<p>Grinding(Side to side) movements</p>\n</td>\n</tr>\n<tr>\n<td>Medial pterygoid</td>\n<td>\n<p>Superficial head - Maxilla</p>\n<p>Deep head - Lateral pterygoid plate, Palatine bone</p>\n</td>\n<td>\n<p>Angle of mandible</p>\n<p>Ramus of mandible behind mandibular foramen</p>\n</td>\n<td>\n<p>Elevates mandible&nbsp;&nbsp;</p>\n<p>Jaw protrusion</p>\n<p>Grinding(side to side) movements</p>\n</td>\n</tr>\n<tr>\n<td>Temporalis</td>\n<td>\n<p>Temporal fossa</p>\n<p>Temporal fascia</p>\n</td>\n<td>\n<p>Ramus of mandible</p>\n<p>Coronoid process</p>\n</td>\n<td>\n<p>Elevates mandible</p>\n<p>Side-to-side movements</p>\n<p>Jaw retraction</p>\n</td>\n</tr>\n<tr>\n<td>Masseter</td>\n<td>Zygomatic arch</td>\n<td>Ramus of mandible</td>\n<td>\n<p>Elevates mandible</p>\n<p>Jaw protrusion</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8682ae3ead154d7c8c9ac439a714e155x1279x1400.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a663026380df4d5dbe4f265e393e9407x1280x1287.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c28a6ebb37304b3e8aeaa285e8840a23x1280x1288.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(69, 'Anatomy', 'PM2397. Modifications of Deep cervical fascia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The deep fascia in the neck is condensed to form the following layers:</p>\n<p><strong>I</strong><strong>nvesting layer -</strong>&nbsp;It forms the roof of the posterior triangle and splits to enclose:</p>\n<ul>\n<li>Parotid gland</li>\n<li>Submandibular gland</li>\n</ul>\n<p><strong>Pretracheal fascia -&nbsp;</strong>It splits to enclose the&nbsp;thyroid gland to form its false capsule. This capsule is thickened posteriorly and on either side forms the suspensory ligament which is known as the ligament of Berry.</p>\n<p><strong>Carotid sheath</strong> -&nbsp;is formed anteriorly by pre tracheal fascia and posteriorly by the prevertebral fascia. It encloses:</p>\n<ul>\n<li>Common carotid artery</li>\n<li>Internal carotid artery</li>\n<li>Internal jugular vein</li>\n<li>Vagus nerve&nbsp;</li>\n</ul>\n<p><strong>Prevertebral fascia</strong> -&nbsp;It forms the floor of the posterior triangle and the axillary sheath. Inferiorly, it blends with the anterior longitudinal ligament.</p>\n<p><strong>Buccopharyngeal fascia -&nbsp;</strong>It covers the outer surface of the pharyngeal constrictors and the buccinator. Posteriorly, its separated from the prevertebral fascia by the retropharyngeal space.</p>\n<p><strong>Pharyngobasilar fascia -&nbsp;</strong>It fills the gap between superior constrictor and base of the skull.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/bd75f5b454334bb6854958c8ac664100x600x848.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(70, 'Anatomy', 'PM2268. Arteries supplying the cranial fossae', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Region</td>\n<td>Arteries</td>\n</tr>\n<tr>\n<td>Anterior Cranial Fossa</td>\n<td>\n<ul>\n<li>Anterior meningeal branches of anterior and posterior ethmoid arteries</li>\n<li>Meningeal branches of internal carotid arteries</li>\n<li>A branch of middle meningeal artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Middle Cranial Fossa</td>\n<td>\n<ul>\n<li>Middle and accessory meningeal branches of the maxillary artery</li>\n<li>A branch of the ascending pharyngeal artery</li>\n<li>Branches of the internal carotid artery</li>\n<li>A recurrent branch of the lacrimal artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Posterior Cranial Fossa</td>\n<td>\n<ul>\n<li>Meningeal branches of the occipital artery</li>\n<li>Posterior meningeal branches of the vertebral artery</li>\n<li>Dorsal meningeal and tentorial arteries arising from the meningohypophysial trunk</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Note:&nbsp;Meningeal branches of ICA do not supply the posterior cranial fossa.</p></div><!---->\n      <!---->\n    </div><!---->'),
(71, 'Anatomy', 'PM2242. Functional components of cranial nerves', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>\n<table border=\1\><colgroup><col></colgroup>\n<tbody>\n<tr>\n<td>\n<div><strong>Functional components of cranial nerves&nbsp;</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Oculomotor: CN-3</strong></div>\n<ul>\n<li>\n<div>Extraocular skeletal muscles – GSE</div>\n</li>\n<li>\n<div>Preganglionic fibres to ciliary ganglion - GVE</div>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Trochlear: CN-4</strong></div>\n<ul>\n<li>\n<div>Extraocular skeletal muscle (SO)- GSE</div>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Trigeminal: CN-5</strong></div>\n<ul>\n<li>\n<div>Sensation from the face - GSA</div>\n</li>\n<li>\n<div>Motor to 1st arch - Br E (SVE)</div>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Abducent: CN-6</strong></div>\n<ul>\n<li>\n<div>Extraocular skeletal muscle (lateral rectus)- GSE</div>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Facial: CN-7</strong></div>\n<ul>\n<li>\n<div>General sensory from ear - GSA</div>\n</li>\n<li>\n<div>Special (taste) sensation - Br A</div>\n</li>\n<li>\n<div>Motor to 2nd arch - Br E</div>\n</li>\n<li>\n<div>Parasympathetic to submandibular and pterygopalatine ganglia - GVE</div>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Vestibulocochlear: CN-8</strong></div>\n<ul>\n<li>\n<div>Hearing/balance - SSA</div>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Glossopharyngeal: CN-9</strong></div>\n<ul>\n<li>\n<div>Sensory from pharynx/tongue – GVA</div>\n</li>\n<li>\n<div>Taste - Br A</div>\n</li>\n<li>\n<div>General sensation from ear – GSA</div>\n</li>\n<li>\n<div>Parasympathetic to otic ganglion - GVE</div>\n</li>\n<li>\n<div>Motor to 3rd arch - Br E</div>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Vagus: CN-10</strong></div>\n<ul>\n<li>\n<div>Sensory from ear - GSA</div>\n</li>\n<li>\n<div>Sensory from pharynx/larynx – GVA</div>\n</li>\n<li>\n<div>Taste - Br A</div>\n</li>\n<li>\n<div>Parasympathetic ganglia in thorax/abdomen - GVE</div>\n</li>\n<li>\n<div>Motor to 4th/6th arch - Br E</div>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Accessory: CN-11</strong></div>\n<ul>\n<li>\n<div>Motor to 6th arch (through vagus) - Br E</div>\n</li>\n<li>\n<div>Motor to sternocleidomastoid and trapezius - GSE</div>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Hypoglossal: CN-12</strong></div>\n<ul>\n<li>\n<div>Motor to lingual muscles – GSE</div>\n</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>abbr.</strong></p>\n<p><strong>A</strong> - afferent , <strong>E</strong> - efferent , <strong>Br</strong> - Branchial (word special (derived from branchial arches) can also be used instead of branchial, but due to confusion with special sensory (carrying special senses) its better avoided), <strong>V - </strong>Visceral, <strong>G</strong> - General, <strong>CN</strong> - cranial nerve,&nbsp; <strong>SO</strong> - superior oblique muscle.</p>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(72, 'Anatomy,', 'PM2228. Superior orbital fissure', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/58e3dbd8d4244b95a597e4eb9198b732x600x865.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Structures passing through the Superior orbital fissure</strong></p>\n<p><strong>Above the common tendinous ring: LFT (Superolateral compartment)</strong></p>\n<ul>\n<li><strong>L</strong>acrimal nerve</li>\n<li><strong>F</strong>rontal nerve</li>\n<li><strong>T</strong>rochlear nerve</li>\n<li>Superior opthalmic vein</li>\n</ul>\n<p><strong>Within the common tendinous ring: BAN (Intermediate compartment)</strong></p>\n<ul>\n<li><strong>B</strong>oth divisions of oculomotor nerve</li>\n<li><strong>A</strong>bducens nerve</li>\n<li><strong>N</strong>asociliary nerve</li>\n</ul>\n<p><strong>Below the common tendinous ring (Inferomedial compartment)</strong></p>\n<ul>\n<li>Inferior ophthalmic vein&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->'),
(73, 'Anatomy', 'PM2139. Structures passing through skull foramina', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Opening</strong></td>\n<td><strong>Transmits</strong></td>\n</tr>\n<tr>\n<td><strong>Optic canal</strong></td>\n<td>\n<ul>\n<li>Optic nerves</li>\n<li>Ophthalmic arteries</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Superior orbital fissure</strong></td>\n<td>\n<ul>\n<li>Lacrimal nerve (V1)</li>\n<li>Frontal nerve (V1)</li>\n<li>Nasociliary nerve (V1)</li>\n<li>CNs III, IV, VI</li>\n<li>Superior ophthalmic vein</li>\n<li>Inferior ophthalmic vein</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen rotundum</strong></td>\n<td>\n<ul>\n<li>Maxillary division of CN V (V2)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen ovale</strong></td>\n<td>\n<ul>\n<li><strong>M</strong>andibular division of CN V (V3)</li>\n<li><strong>A</strong>ccessory meningeal artery</li>\n<li><strong>L</strong>esser petrosal nerve</li>\n<li><strong>E</strong>missary veins</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen spinosum</strong></td>\n<td>\n<ul>\n<li>Middle meningeal artery</li>\n<li>Nervus spinosus</li>\n<li>Middle meningeal vein</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen lacerum</strong></td>\n<td>\n<ul>\n<li>Deep petrosal nerve</li>\n<li>Meningeal branch of ascending pharyngeal artery&nbsp;</li>\n<li>Emissary vein</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Carotid canal</strong></td>\n<td>\n<ul>\n<li>Internal carotid artery</li>\n<li>Venous and sympathetic plexus around artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Jugular foramen</strong></td>\n<td>\n<ul>\n<li>Inferior petrosal sinus</li>\n<li>Meningeal branch of ascending pharyngeal artery&nbsp;</li>\n<li>CNs IX,X &amp; XI</li>\n<li>Sigmoid Sinus continuing as IJV&nbsp;</li>\n<li>Middle meningeal branch of occipital artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Hypoglossal canal</strong></td>\n<td>\n<ul>\n<li>Hypoglossal nerve (CN XII)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Foramen magnum</strong></td>\n<td>\n<div class=\ng-scope\>\n<div class=\ng-scope\>\n<ul>\n<li class=\ng-binding\>Osseo-ligamentous (anterior) compartment:&nbsp;\n<ul>\n<li>Apical ligament and tip of dens</li>\n<li>Upper band of cruciate ligament</li>\n<li>Membrana tectoria</li>\n</ul>\n</li>\n<li>Neuro-vascular (posterior)&nbsp;compartment:\n<ul>\n<li>Lower end of the medulla oblongata with meninges</li>\n<li>Fourth part of vertebral artery surrounded by sympathetic plexus of nerves</li>\n<li>Spinal roots of accessory nerves</li>\n<li>Anterior and posterior spinal arteries</li>\n<li>Tonsil of cerebellum.</li>\n</ul>\n</li>\n</ul>\n</div>\n</div>\n<div class=\ng-scope\>&nbsp;</div>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/59dee8c948d642d8b7e732620bd2e2a7x600x1522.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(74, 'ENT,', 'PM1978. Muscles of larynx', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><span>Remember 2 exceptions:</span></p>\n<ul>\n<li><span>All muscles are<strong> adductors</strong>,<strong> except PCA </strong>(an abductor)</span></li>\n<li><span>All muscles are supplied by the<strong> recurrent laryngeal nerve</strong>,<strong> except cricothyroid </strong>(superior laryngeal nerve)</span></li>\n</ul>\n<table class=\t1\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>Action</strong></span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>Muscle</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>Opening</strong> of the inlet of larynx</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>Thyroepiglotticus</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>Closing</strong> of the inlet of larynx</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>Aryepiglotticus, Interarytenoids</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>Abductor</strong> of vocal cords</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>Posterior cricoarytenoid</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>Adductor</strong> of vocal cords</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>Lateral cricoarytenoid</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>Tensor</strong> of vocal cords</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>Cricothyroid</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>Relaxer</strong> of vocal cord</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>Thyroarytenoid</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>Modulator</strong> of larynx</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>Vocalis</span></div>\n</td>\n</tr>\n</tbody>\n</table>\n<p class=\p1\><span><strong>Safety muscle</strong> of larynx: <strong>Posterior cricoarytenoid</strong></span></p>\n<p class=\p1\><span>Safety muscle of tongue: Genioglossus</span></p>\n<p class=\p1\><span>The muscle of <strong>whispering</strong>: <strong>Lateral cricoarytenoid</strong></span></p>\n<p class=\p1\><span><strong>Vocalis</strong> is known as the modulator of larynx because, the <strong>anterior part</strong> of the vocalis muscle can <strong>tense</strong> the vocal cord, and its <strong>posterior part</strong> can <strong>relax</strong> the vocal cord.</span></p></div><!---->\n      <!---->\n    </div><!---->'),
(75, 'Anatomy,', 'PM1429. The sphenoid sinus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It occupies the <strong>body of the sphenoid</strong></p>\n<p>Ostium of the sphenoid sinus is situated high up in the anterior wall and <strong>opens into the sphenoethmoidal recess</strong>, medial to the superior or supreme turbinate</p>\n<p>It is lined by <strong>ciliated columnar epithelium</strong> with goblet cells. Cilia are more marked near the ostium, which facilitates mucus drainage into the nasal cavity</p>\n<p>Relations of the sphenoid sinus:</p>\n<ul>\n<li>The<strong> lateral</strong> wall of the sphenoid is related to the <strong>optic nerve </strong>and<strong> carotid artery</strong></li>\n<li>The<strong> floor</strong> of the sinus is related to the <strong>Vidian nerve</strong></li>\n<li>The<strong> anterior</strong> part of the roof is related to the <strong>olfactory tract, optic chiasma,</strong> and<strong> frontal lobe</strong></li>\n<li>The<strong> posterior</strong> part is related to the <strong>pituitary gland in the sella turcica </strong>and&nbsp;the<strong> cavernous sinus.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/face00ae45b44fa88a120a3723a3e6bex1280x1567.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(76, 'Anatomy,', 'PM1428. Nasal Septum', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Septum proper is an osseocartilaginous framework made up of:</p>\n<ul>\n<li>Septal or <strong>quadrilateral</strong> cartilage</li>\n<li><strong>Perpendicular plate</strong> of ethmoid</li>\n<li><strong>Vomer</strong></li>\n<li>Others – crest of nasal bones, nasal spine of frontal bone, rostrum of sphenoid, crest of palatine bones and the crest maxilla, and the anterior nasal spine of maxilla</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/057b97bf8e764f04b58aceffa9f4f3e9x1280x1399.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(77, 'Anatomy,', 'PM1424. Structures opening into meatuses of nose', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Inferior</strong> meatus: <strong>Nasolacrimal duct</strong>, guarded by&nbsp;the valve of Hasner</li>\n<li><strong>Middle</strong> meatus: <strong>Frontal</strong> sinus, <strong>maxillary</strong> sinus, <strong>anterior</strong> <strong>ethmoidal</strong> sinus. All these together form the <strong>osteo-meatal complex</strong> or Picadle’s circle.</li>\n<li><strong>Superior</strong> meatus: <strong>Posterior ethmoidal</strong> sinus</li>\n<li><strong>Sphenoethmoidal</strong> recess: <strong>Sphenoid</strong> sinus</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f5343a3b0bac4006b313352b92fd8c07x1280x1759.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(78, 'ENT,', 'PM1422. Boundaries of the nasal valve', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Laterally:&nbsp;<strong>Lower border of upper lateral cartilage</strong> and fibrofatty tissue and <strong>anterior</strong> end of inferior turbinate</li>\n<li>Medially:&nbsp;<strong>Cartilaginous nasal septum </strong></li>\n<li>Caudally: Floor of the <strong>pyriform aperture</strong></li>\n</ul>\n<p>The nasal valve is the <strong>narrowest part </strong>and offers<strong> maximum resistance </strong>to airflow</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4ddd3eb6e384496aaabb5e7b3eaaa1fbx1280x1022.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(79, 'ENT,', 'PM1405. Compartments of the parapharyngeal space', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><span><strong>Prestyloid</strong></span></td>\n<td><span><strong>Poststyloid</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Relation to styloid</strong></span></td>\n<td><span>Anterior</span></td>\n<td><span>Posterior</span></td>\n</tr>\n<tr>\n<td><span><strong>Relations</strong></span></td>\n<td>\n<p><span>Medially: Tonsillar fossa</span></p>\n<p><span>Laterally: Medial pterygoid muscle</span></p>\n</td>\n<td>\n<p><span>Medially: Posterior part of the lateral pharyngeal wall</span></p>\n<p><span>Laterally: Parotid gland</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Contents</strong></span></td>\n<td><span>Medial pterygoid muscle</span></td>\n<td>\n<p><span>Carotid artery</span></p>\n<p><span>Jugular vein, IX<sup>th</sup>, X<sup>th</sup>, XI<sup>th</sup>, XII<sup>th</sup> cranial nerves</span></p>\n<p><span>Sympathetic trunk</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Presentation</strong></span></td>\n<td>\n<p><span><strong>Prolapse</strong> of tonsil&nbsp;and tonsillar fossa,</span></p>\n<p><span>Spasm of medial pterygoid muscle leading to <strong>trismus</strong></span></p>\n</td>\n<td>\n<p><span>The pharynx bulging behind the posterior pillar</span></p>\n<p><span>Injury to of CN IX, X, XI, and XII leading to&nbsp;</span><strong><span>vocal cord paralysis</span></strong></p>\n<p><span>Sympathetic chain injury leading to <strong>Horner’s syndrome</strong></span></p>\n<p><span>Swelling of the parotid region</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(80, 'ENT,', 'PM1294. Parts of Pharynx', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Part</strong></span></div>\n</td>\n<td>\n<div><span><strong>Cervical vertebrae</strong></span></div>\n</td>\n<td>\n<div><span><strong>Extent</strong></span></div>\n</td>\n<td>\n<div><span><strong>Structures</strong></span></div>\n</td>\n<td>\n<div><span><strong>Lining epithelium</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Nasopharynx</strong></span></div>\n</td>\n<td>\n<div><span>Skull base-C1</span></div>\n</td>\n<td>\n<div><span>Skull base- palate</span></div>\n</td>\n<td>\n<div><span>Adenoids, ET opening, Torus&nbsp;tubaris, Fossa of Rossenmuller, Posterior pharyngeal wall (PPW)</span></div>\n</td>\n<td>\n<div><span>Pseudostratified ciliated columnar</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Oropharynx</strong></span></div>\n</td>\n<td>\n<div><span>C1-C3</span></div>\n</td>\n<td>\n<div><span>Palate-hyoid</span></div>\n</td>\n<td>\n<div><span>Base of tongue, Pillars, tonsils, PPW</span></div>\n</td>\n<td>\n<div><span>Stratified squamous</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Hypopharynx</strong></span></div>\n</td>\n<td>\n<div><span>C3-C6</span></div>\n</td>\n<td>\n<div><span>Hyoid to cricoid</span></div>\n</td>\n<td>\n<div><span>Pyriform sinus, Post-cricoid region, PPW</span></div>\n</td>\n<td>\n<div><span>Stratified squamous</span></div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(81, 'Anatomy', 'PM1250. Divisions of Maxillary Artery and Its Branches', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a2303ab13e0649d5b993147ad8be02c9x1280x1346.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>1st part/Mandibular part:</strong>&nbsp;</p>\n<ul>\n<li>Extend - Neck of the mandible to lower border of Lateral pterygoid</li>\n<li>Common Pattern - All branches from this part enter the bone.</li>\n<li>Branches\n<ul>\n<li>middle meningeal,</li>\n<li>accessory meningeal,</li>\n<li>inferior alveolar,</li>\n<li>deep auricular&nbsp;</li>\n<li>anterior tympanic arteries.</li>\n</ul>\n</li>\n</ul>\n<p><strong>2nd part/Pterygoid part</strong>:</p>\n<ul>\n<li>Location - In the infratemporal fossa</li>\n<li>Common Pattern - All are muscular branches.</li>\n<li>Branches\n<ul>\n<li>Artery to lateral pterygoid,</li>\n<li>medial pterygoid,</li>\n<li>Masseteric artery</li>\n<li>2 deep temporal arteries.</li>\n</ul>\n</li>\n</ul>\n<p><strong>3rd part/Pterygopalatine part</strong>:</p>\n<ul>\n<li>Location - pterygopalatine fossa</li>\n<li>Branches\n<ul>\n<li>Artery of pterygoid canal,</li>\n<li>Infra-orbital artery,</li>\n<li>Greater palatine,</li>\n<li>Sphenopalatine artery,</li>\n<li>pharyngeal artery,</li>\n<li>posterior superior alveolar artery.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(82, 'Surgery,', 'PM1249. Blood Supply to the Thyroid Gland', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Arterial supply of the thyroid gland</strong></p>\n<table>\n<tbody>\n<tr>\n<td width=\319\>\n<p><strong>Vessel</strong></p>\n</td>\n<td width=\319\>\n<p><strong>Origin</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Superior thyroid artery</p>\n</td>\n<td width=\319\>\n<p>External carotid artery</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Inferior thyroid artery</p>\n</td>\n<td width=\319\>\n<p>Thyrocervical trunk (1<sup>st</sup> part of Subclavian artery)</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Arteria thyroidea ima</p>\n</td>\n<td width=\319\>\n<p>Brachiocephalic trunk/arch of aorta</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Note: Inferior thyroid artery supplies the parathyroid gland</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e0f52063eae64ee5a81910c4c655d1c6x1279x1337.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Venous drainage of the thyroid gland</strong></p>\n<table>\n<tbody>\n<tr>\n<td width=\319\>\n<p><strong>Vessel</strong></p>\n</td>\n<td width=\319\>\n<p><strong>Origin</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Superior and middle thyroid veins</p>\n<p>4th vein of Kocher (if present)</p>\n</td>\n<td width=\319\>\n<p>Tributary of internal jugular vein</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Inferior thyroid vein</p>\n</td>\n<td width=\319\>\n<p>Tributary of brachiocephalic vein</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b211c9cc0d374685bb8d4da175f209dfx1279x1337.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(83, 'Anatomy', 'PM1228. Sensory Innervation of Tongue', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\208\>\n<p><strong>Area </strong></p>\n</td>\n<td width=\208\>\n<p><strong>General sensory </strong></p>\n</td>\n<td width=\208\>\n<p><strong>Special sensory </strong></p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p>Anterior 2/3rds</p>\n</td>\n<td width=\208\>\n<p>Lingual nerve (CN V)</p>\n</td>\n<td width=\208\>\n<p>Chorda tympani (CN VII)</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p>Posterior 1/3rd</p>\n</td>\n<td width=\208\>\n<p>Glossopharyngeal nerve (CN IX)</p>\n</td>\n<td width=\208\>\n<p>Glossopharyngeal nerve (CN IX)</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p>Posterior most tongue (vallecullae, epiglottis)</p>\n</td>\n<td width=\208\>\n<p>Internal laryngeal nerve (CN X)</p>\n</td>\n<td width=\208\>\n<p>Internal laryngeal nerve (CN X)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/23b73ac60e974a18ae2714559fe75c58x1280x1399.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(84, 'ENT,', 'PM1097. Lymph Node Levels in the Neck', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c37de0fe12b444bba6fcde5d01fb83adx1280x1421.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Levels</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>\n<p>IA</p>\n</td>\n<td>\n<p>Submental</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IB</p>\n</td>\n<td>\n<p>Submandibular</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>II</p>\n</td>\n<td>\n<p>Upper jugular</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>III</p>\n</td>\n<td>\n<p>Middle jugular</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IV</p>\n</td>\n<td>\n<p>Lower Jugular</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VA and VB</p>\n</td>\n<td>\n<p>Posterior triangle group</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VI</p>\n</td>\n<td>\n<p>Pre&nbsp;tracheal</p>\n<p>Para tracheal</p>\n<p>Pre laryngeal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VII (Controversial)</p>\n</td>\n<td>\n<p>Mediastinum (Some don’t consider it to be part of cervical nodes)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(85, 'ENT,', 'PM1091. Nerves of Larynx', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/01db8c67ccfd4505ae52b2b0312f0ecdx1280x2954.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(86, 'Ophthalmology,', 'PM1084. Sympathetic and parasympathetic nerve supply to iris muscles', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Dilator pupillae/radial muscle of iris: Sympathetic postganglionic nerves from cervical ganglion.</li>\n<li>Constrictor pupillae/circular muscle of iris: Parasympathetic postganglionic nerves from ciliary ganglion (Edinger Westphal nucleus).</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(87, 'Anatomy,', 'PM0927. Cartilages of Larynx', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a3250114c2ec4cabafa97b58afbb13dbx600x1074.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Unpaired Cartilages</strong></div>\n</td>\n<td>\n<div><strong>Paired Cartilages</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Thyroid</li>\n<li>Cricoid</li>\n<li>Epiglottis</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Arytenoid</li>\n<li>Corniculate</li>\n<li>Cuneiform</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<div><strong>Hyaline</strong></div>\n</td>\n<td>\n<div><strong>Fibroelastic</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Thyroid</li>\n<li>Cricoid</li>\n<li>Arytenoids</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Epiglottis</li>\n<li>Corniculate</li>\n<li>Cuneiform</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(88, 'Anatomy', 'PM0860. Derivatives of Branchial Apparatus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Arch</td>\n<td>Nerve</td>\n<td>Skeletal derivatives</td>\n<td>Pouch Derivatives</td>\n<td>Muscle Derivatives</td>\n<td>Artery&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>1st (mandibular arch)</p>\n</td>\n<td>Trigeminal (V) - Maxillary and mandibular divisions</td>\n<td>\n<ul>\n<li>Incus</li>\n<li>Malleus</li>\n<li>Anterior ligament of malleus</li>\n<li>Spine of sphenoid</li>\n<li>Sphenomandibular ligament&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Auditory tube</li>\n<li>Middle ear cavity&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Tensor tympani</li>\n<li>Muscles of mastication&nbsp;</li>\n<li>Mylohyoid</li>\n<li>Anterior belly of digastric</li>\n<li>Tensor veli palatini</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Maxillary artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>2nd (hyoid arch)</p>\n</td>\n<td>Facial (VII)</td>\n<td>\n<ul>\n<li>Stapes</li>\n<li>Styloid process (temporal)</li>\n<li>Lesser cornu and upper hyoid</li>\n<li>Stylohyoid ligament</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Palatine tonsil</li>\n<li>Tonsillar fossa&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Stapedius</li>\n<li>Stylohyoid&nbsp;</li>\n<li>Facial Muscles (Buccinator, Platysma, Posterior belly of digastric)</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Stapedial artery</li>\n<li>Hyoid artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>3rd</td>\n<td>Glossopharyngeal (IX)</td>\n<td>\n<ul>\n<li>Greater cornu of hyoid</li>\n<li>Lower part of hyoid body</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Inferior parathyroids</li>\n<li>Thymus&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Stylopharyngeus</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Common carotid</li>\n<li>Proximal internal carotid arteries&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>4th</td>\n<td>Superior laryngeal of Vagus (X)</td>\n<td>\n<ul>\n<li>Thyroid cartilage</li>\n<li>Corniculate cartilage</li>\n<li>Cuneiform cartilage&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Superior parathyroids,</li>\n<li>Parafollicular C cells of Thyroid (from ultimobranchial body)</li>\n</ul>\n&nbsp;</td>\n<td><br>\n<ul>\n<li>Pharyngeal muscles</li>\n<li>Larynx -Cricothyroid</li>\n<li>Levator veli palatini</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Right side:&nbsp;Right subclavian artery (proximal portion)</li>\n</ul>\n<ul>\n<li>Left side:&nbsp;Arch of the aorta from the left common carotid to the left subclavian arteries</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>6th</td>\n<td>Recurrent laryngeal of Vagus (X)</td>\n<td>\n<ul>\n<li class=\p1\>Arytenoid cartilages</li>\n</ul>\n&nbsp;</td>\n<td>&nbsp;</td>\n<td>\n<ul>\n<li>All intrinsic muscles of the larynx (except the cricothyroid muscle)</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Right side: right pulmonary artery&nbsp;</li>\n<li>Left side: left pulmonary artery and ductus arteriosus</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(89, 'Anatomy,', 'PM0676. Parts of Intratemporal Division of Facial Nerve', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>\n<table class=\t1\ width=\376\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td class=\td1\ valign=\top\><strong>Segment</strong></td>\n<td class=\td1\ valign=\top\><strong>Within</strong></td>\n<td class=\td1\ valign=\top\><strong>From</strong></td>\n<td class=\td1\ valign=\top\><strong>To</strong></td>\n<td class=\td1\ valign=\top\><strong>Length <span>(mm)</span></strong></td>\n<td class=\td1\ valign=\top\><strong>Remarks</strong></td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\><strong>Meatal</strong></td>\n<td class=\td1\ valign=\top\>Internal Acoustic Meatus</td>\n<td class=\td1\ valign=\top\>Porus acousticus <span>(medial end of IAM)</span></td>\n<td class=\td1\ valign=\top\>Fundus <span>(lateral end of IAM)</span></td>\n<td class=\td1\ valign=\top\>8-10</td>\n<td class=\td1\ valign=\top\>Only intra-temporal segment that is not within fallopian canal</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\><strong>Labyrinthine</strong></td>\n<td class=\td1\ valign=\top\>Fallopian canal</td>\n<td class=\td1\ valign=\top\>Fundus</td>\n<td class=\td1\ valign=\top\>1<span class=\s1\><sup>st</sup></span> genu/ geniculate ganglion</td>\n<td class=\td1\ valign=\top\>3-5</td>\n<td class=\td1\ valign=\top\>Shortest and the narrowest</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\><strong>Tympanic/ Horizontal</strong></td>\n<td class=\td1\ valign=\top\>Fallopian canal</td>\n<td class=\td1\ valign=\top\>1<span class=\s1\><sup>st</sup></span> genu</td>\n<td class=\td1\ valign=\top\>2<span class=\s1\><sup>nd</sup></span> genu</td>\n<td class=\td1\ valign=\top\>11</td>\n<td class=\td1\ valign=\top\>Runs on medial wall of middle ear</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\><strong>Mastoid/ Vertical</strong></td>\n<td class=\td1\ valign=\top\>Fallopian canal</td>\n<td class=\td1\ valign=\top\>2<span class=\s1\><sup>nd</sup></span> genu</td>\n<td class=\td1\ valign=\top\>Stylomastoid foramen</td>\n<td class=\td1\ valign=\top\>13</td>\n<td class=\td1\ valign=\top\>Runs in posterior wall of middle ear</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(90, 'Anatomy,', 'PM0547. Chorda Tympani', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Branch of the vertical segment or the 4<sup>th</sup> part of facial nerve.</p>\n<p>Gives out branches in the posterior wall of the middle ear.</p>\n<p><strong>Course: </strong></p>\n<ul>\n<li>Runs obliquely in the posterior wall and enters middle ear medial to the tympanic membrane.</li>\n<li>Travels posterior to anterior.</li>\n<li>Between the malleus and incus.</li>\n<li>Leaves middle ear at petrotympanic fissure or canal of Huguier.</li>\n<li>Enters the infratemporal fossa.</li>\n<li>Joins the lingual nerve &amp; relays in submandibular ganglion.</li>\n</ul>\n<p><strong>Supply:</strong></p>\n<ul>\n<li>Carries taste from anterior 2/3<sup>rd</sup> tongue.</li>\n<li>Gives parasympathetic secretomotor to submandibular &amp; sublingual glands.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(91, 'Anatomy,', 'PM0501. External Auditory Canal', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Part</strong></span></td>\n<td><span><strong>Cartilaginous</strong></span></td>\n<td><span><strong>Bony</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Proportions</strong></span></td>\n<td><span>Lateral 1/3</span></td>\n<td><span>Medial 2/3</span></td>\n</tr>\n<tr>\n<td><span><strong>Length</strong></span></td>\n<td><span>8mm</span></td>\n<td><span>16mm</span></td>\n</tr>\n<tr>\n<td><span><strong>Made of</strong></span></td>\n<td><span>Auricular yellow elastic cartilage</span></td>\n<td><span>Bony margins of the temporal bone (squamous part superiorly and mastoid part posteriorly)</span></td>\n</tr>\n<tr>\n<td><span><strong>Direction</strong></span></td>\n<td><span>Upward, backward, medially</span></td>\n<td><span>Downward, forward, medially</span></td>\n</tr>\n<tr>\n<td><span><strong>Skin is</strong></span></td>\n<td><span>Thick</span></td>\n<td><span>Thin, continuous over tympanic membrane</span></td>\n</tr>\n<tr>\n<td><span><strong>Skin contains</strong></span></td>\n<td><span>Hair, ceruminous &amp; pilosebaceous glands. Produce wax</span></td>\n<td><span>---</span></td>\n</tr>\n<tr>\n<td><span><strong>Deficiencies</strong></span></td>\n<td><span>Fissures of Santorini</span></td>\n<td><span>Foramen of Huschke</span></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(92, 'ENT,', 'PM0454. Differences between infant & adult ET', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><strong>Infant ET</strong></p>\n</td>\n<td>\n<p><strong>Adult ET</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Length</strong></p>\n</td>\n<td>\n<p>13–18 mm</p>\n</td>\n<td>\n<p><strong>36 mm</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Angle with horizontal</strong></p>\n</td>\n<td>\n<p><strong>10<sup>0</sup> </strong>(more horizontal)</p>\n<p><strong>Normalizes at 7 years</strong></p>\n</td>\n<td>\n<p><strong>45<sup>0</sup></strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Isthmus</strong></p>\n</td>\n<td>\n<p>Straight</p>\n</td>\n<td>\n<p>Angulated</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Width</strong></p>\n</td>\n<td>\n<p><strong>Wider bony part</strong></p>\n</td>\n<td>\n<p>Narrow</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cartilage</strong></p>\n</td>\n<td>\n<p><strong>Flaccid </strong></p>\n</td>\n<td>\n<p>Rigid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Elastin at roof</strong></p>\n</td>\n<td>\n<p>Less dense</p>\n</td>\n<td>\n<p>Very dense</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Ostmann’s pad of fat</strong></p>\n</td>\n<td>\n<p>Less in volume</p>\n</td>\n<td>\n<p>More in volume</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(93, 'ENT,', 'PM0453. Measurements of EAC and ET', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><strong>External Auditory Canal</strong></p>\n</td>\n<td>\n<p><strong>Eustachian tube</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Total length</strong></p>\n</td>\n<td>\n<p>24 mm</p>\n</td>\n<td>\n<p>36 mm</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Bony </strong><span>(close to the middle ear)</span></p>\n</td>\n<td>\n<p>16 mm <strong>(2/3)</strong></p>\n</td>\n<td>\n<p>12 mm (<strong>1/3</strong>)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cartilaginous</strong></p>\n</td>\n<td>\n<p>8 mm (<strong>1/3</strong>)</p>\n</td>\n<td>\n<p>24 mm (<strong>2/3)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Isthmus </strong><span>(narrowest part)</span></p>\n</td>\n<td>\n<p>In the bony part</p>\n</td>\n<td>\n<p>At the junction</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(94, 'Anatomy', 'PM2245. Spaces around shoulder joint', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Space</strong></td>\n<td colspan=\2\><strong>Boundaries</strong></td>\n<td><strong>Contents</strong></td>\n</tr>\n<tr>\n<td rowspan=\3\><strong>Triangular space</strong><br>(Upper triangular space)</td>\n<td>Superior</td>\n<td>Teres minor posteriorly<br>Subscapularis anteriorly</td>\n<td rowspan=\3\>Circumflex scapular vessels</td>\n</tr>\n<tr>\n<td>Inferior</td>\n<td>Teres major</td>\n</tr>\n<tr>\n<td>Lateral</td>\n<td>Long head of triceps</td>\n</tr>\n<tr>\n<td rowspan=\3\><strong>Triangular interval</strong><br>(Lower triangular space)</td>\n<td>Superior</td>\n<td>Teres major posteriorly<br>Subscapularis anteriorly</td>\n<td rowspan=\3\>\n<p>Profunda brachii vessels</p>\n<p><strong>Radial nerve</strong></p>\n</td>\n</tr>\n<tr>\n<td>Medial</td>\n<td>Long head of triceps</td>\n</tr>\n<tr>\n<td>Lateral</td>\n<td>Humerus</td>\n</tr>\n<tr>\n<td rowspan=\4\><strong>Quadrangular space</strong></td>\n<td>Superior</td>\n<td>Teres minor</td>\n<td rowspan=\4\>Posterior circumflex humeral vessels\n<p><strong>Axillary nerve</strong></p>\n</td>\n</tr>\n<tr>\n<td>Inferior</td>\n<td>Teres major</td>\n</tr>\n<tr>\n<td>Medial</td>\n<td>Long head of triceps</td>\n</tr>\n<tr>\n<td>Lateral</td>\n<td>Surgical neck of humerus&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6b90f0eeb6ba496e855cc78de0009c19x1280x2586.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(95, 'Anatomy,', 'PM2091. Upper limb nerve integrity tests', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\ width=\222\>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Nerve</strong></td>\n<td>\n<p>&nbsp; <strong>&nbsp; Test</strong></p>\n</td>\n<td>\n<p>&nbsp; &nbsp;<strong> Muscle</strong></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Ulnar&nbsp; &nbsp;nerve</td>\n<td>\n<p>&nbsp;1.Book test</p>\n<p>&nbsp;2.Card test</p>\n<p>&nbsp;3.Froments sign</p>\n<p>&nbsp;4.Egawa test</p>\n</td>\n<td>\n<p>&nbsp;1.Adductor&nbsp; &nbsp;pollicis</p>\n<p>&nbsp;2.Palmar&nbsp; &nbsp;interossei</p>\n<p>&nbsp;3.Flexor pollicis&nbsp; &nbsp;substitutes for&nbsp; &nbsp;adductor pollicis</p>\n<p>&nbsp;4.Dorsal&nbsp; &nbsp;interossei</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Median&nbsp; &nbsp;nerve</td>\n<td>\n<p>&nbsp;1.Ape thumb</p>\n<p>&nbsp;2.Pen test</p>\n<p>&nbsp;3.Pincer grasp&nbsp; &nbsp;(Kiloh Nevin&nbsp; &nbsp;Sign)</p>\n<p>&nbsp;4.Pointing index&nbsp; &nbsp;(ochners&nbsp; clasp/Benediction&nbsp; &nbsp;test)</p>\n</td>\n<td>\n<p>&nbsp;1.Thenar&nbsp; &nbsp;muscles</p>\n<p>&nbsp;2. Abductor&nbsp; &nbsp;pollicis brevis</p>\n<p>&nbsp;3. Flexor&nbsp; &nbsp;digitorum&nbsp; &nbsp;profundus+&nbsp; &nbsp;Flexor pollicis&nbsp; &nbsp;longus (Ant.&nbsp; &nbsp;interosseous&nbsp; &nbsp;nerve)</p>\n<p>&nbsp;4.Flexor&nbsp; &nbsp;Digitorum&nbsp; &nbsp;superficialis+&nbsp; &nbsp;Lateral half of&nbsp; &nbsp;Flexor&nbsp; &nbsp;digitorum&nbsp; &nbsp;profundus</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Radial&nbsp; &nbsp;nerve</td>\n<td>\n<p>&nbsp;1.Thumb and&nbsp; &nbsp;finger drop</p>\n<p>&nbsp;2. Wrist drop</p>\n</td>\n<td>\n<p>&nbsp;1.Extensors(Post.&nbsp; &nbsp;interosseous&nbsp; &nbsp;nerve)</p>\n<p>&nbsp;2.Extensors of&nbsp; &nbsp;wrist.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(96, 'Anatomy,', 'PM2089. Erbs and Klumpkes Palsies.', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Features</strong></td>\n<td><strong>Erbs palsy</strong></td>\n<td><strong>Klumpkes Palsy</strong></td>\n</tr>\n<tr>\n<td><strong>Causes</strong></td>\n<td>\n<p><strong>Undue separtion of head and shoulder.</strong>&nbsp;Upper plexus root involved.&nbsp;</p>\n<p>Eg.Shoulder dystocia at delivery, motor vehicle accidents</p>\n</td>\n<td>\n<p><strong>Hyperabduction of shoulder.</strong>&nbsp;Lower plexus root involved.</p>\n<p>Eg. Difficult breech delivery, Holding on to something (e.g. a branch) during a fall, Cervical rib syndrome, Scalene syndrome</p>\n</td>\n</tr>\n<tr>\n<td><strong><span>Nerves roots&nbsp;</span></strong></td>\n<td><strong>C5 and C6</strong></td>\n<td><strong>C8 and T1</strong></td>\n</tr>\n<tr>\n<td><strong>Muscles involved</strong></td>\n<td>\n<p>Deltoid, Supraspinatus<strong>&nbsp;- loss of abduction&nbsp;</strong></p>\n<p>Infraspinatus -<strong>&nbsp;loss of lateral rotation&nbsp;</strong></p>\n<p>Biceps brachii -<strong>&nbsp;loss of flexion and supination&nbsp;</strong></p>\n</td>\n<td>All intrinsic muscles of the hand</td>\n</tr>\n<tr>\n<td><strong>Position of the upper limb/hand</strong></td>\n<td>Policemans tip/Waiters tip/ Porters tip position</td>\n<td>Claw hand</td>\n</tr>\n<tr>\n<td><strong>Sensory loss </strong>+<strong>/-</strong></td>\n<td>Along the outer aspect of the arm</td>\n<td>Along the medial border of forearm and hand</td>\n</tr>\n<tr>\n<td><strong>ANS signs&nbsp;</strong></td>\n<td>Absent</td>\n<td>\n<p>Horner syndrome</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(97, 'Anatomy', 'PM2088. Brachial Plexus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Brachial Plexus</strong></p>\n<ul>\n<li>C5 to T1</li>\n<li>Roots (from spinal cord) &gt; Trunks (in the neck)&gt; Divisions (passing behind clavicle) &gt; Cords and Branches (in the axilla).</li>\n<li>Covered by prevertebral fascia extension called \axillary sheath\</li>\n</ul>\n<p><strong>Trunks</strong>:</p>\n<ul>\n<li>Upper trunk: C5 and C6</li>\n<li>Middle trunk: C7.</li>\n<li>Lower trunk: C8 and T1</li>\n</ul>\n<p><strong>Divisions</strong>:</p>\n<ul>\n<li>Anterior&nbsp;divisions - Forms lateral and medial cords supplying mainly flexors&nbsp;</li>\n<li>Posterior divisions - Forms posterior cord which suppy mainly extensors&nbsp;</li>\n</ul>\n<p><strong>Cords</strong>:</p>\n<ul>\n<li>Lateral cord: Formed by <strong>anterior divisions</strong> of the <strong>upper and middle</strong> trunks.</li>\n<li>Posterior cord: Formed by <strong>all 3 posterior divisions&nbsp;</strong></li>\n<li>Medial cord: Formed by <strong>anterior division</strong> of the <strong>lower</strong> trunk.</li>\n</ul>\n<p><strong>Branches</strong>:&nbsp;</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td><strong>&nbsp;Parts&nbsp;</strong></td>\n<td>\n<p><strong>Branches</strong></p>\n</td>\n</tr>\n<tr>\n<td>Roots</td>\n<td>\n<p>Dorsal scapular nerve (C5)</p>\n<p>Long thoracic nerve of Bell (C5-C7)</p>\n</td>\n</tr>\n<tr>\n<td>Upper trunk</td>\n<td>\n<p>Suprascapular nerve (C5, C6)</p>\n<p>Nerve to Subclavius (C5, C6).</p>\n</td>\n</tr>\n<tr>\n<td>Lateral cord (LML)</td>\n<td>\n<p><strong>L</strong>ateral pectoral nerve (C5-C7)</p>\n<p><strong>M</strong>usculocutaneous nerve (C5-C7)</p>\n<p><strong>L</strong>ateral root of median nerve (C5-C7)</p>\n</td>\n</tr>\n<tr>\n<td>Medial cord (UM4)</td>\n<td>\n<p><strong>M</strong>edial pectoral (C8,T1)</p>\n<p><strong>M</strong>edial cutaneous nerve of forearm (C8,T1)</p>\n<p><strong>M</strong>edial cutaneous nerve of arm (C8,T1)</p>\n<p><strong>U</strong>lnar nerve (C8,T1)</p>\n<p><strong>M</strong>edial root of median nerve (C8,T1)</p>\n</td>\n</tr>\n<tr>\n<td>Posterior cord (STARS)</td>\n<td>\n<p>Upper<strong> S</strong>ubscapular nerve (C5,C6)</p>\n<p><strong>T</strong>horacodorsal nerve (C6-C8)</p>\n<p>Axillary (C5,C6)</p>\n<p><strong>R</strong>adial&nbsp;(C5-T1)</p>\n<p>Lower <strong>S</strong>ubscapular (C5,C6)</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>Note :&nbsp;However<strong> Ulnar Nerve</strong> near its <strong>origin</strong>, often receives a communicating branch from the lateral root of the median nerve originating from the lateral cord and carrying fibers from <strong>C7</strong>.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/458c2974cce64f408d370c34cfcc04e3x1280x3167.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d1b0eda952d74e0d8a5a1dc74f003051x1280x1224.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(98, 'Anatomy,', 'PM2053. Bursitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp; &nbsp; &nbsp;&nbsp;<strong>Bursitis</strong></td>\n<td>&nbsp; &nbsp; &nbsp;<strong>Site</strong> &nbsp;</td>\n</tr>\n<tr>\n<td><strong>Students elbow/miners elbow</strong></td>\n<td>Olecranon bursitis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Housemaid’s knee</strong></td>\n<td>Prepatellar bursitis (commonest)</td>\n</tr>\n<tr>\n<td><strong>Clergyman’s knee</strong></td>\n<td>Infrapatellar bursitis</td>\n</tr>\n<tr>\n<td><strong>Weaver’s bottom</strong></td>\n<td>Ischial bursitis</td>\n</tr>\n<tr>\n<td><strong>Tailor’s ankle</strong></td>\n<td>Lateral malleolus bursitis</td>\n</tr>\n<tr>\n<td><strong>Bunion</strong></td>\n<td>Medial side of great toe 1st metatarsal head bursitis</td>\n</tr>\n<tr>\n<td><strong>Bunionette</strong></td>\n<td>5th toe of foot-5th metatarsal head bursitis</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(99, 'Anatomy,', 'PM2002. Dermatome of upper limb', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/50277ea064d74c0cbba44fae8826eb84x1280x1754.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->'),
(100, 'Anatomy,', 'PM1499. Compression neuropathies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Syndrome&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>Nerve involved</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pronator teres syndrome</p>\n</td>\n<td>\n<p>Median nerve (proximally compressed beneath ligament of Struthers, bicipital aponeurosis, or origins of pronator teres)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Radial tunnel (Arcade of Frohse) syndrome</p>\n</td>\n<td>\n<p>Posterior Interosseous nerve (in proximal forearm)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cubital tunnel syndrome</p>\n</td>\n<td>\n<p>Ulnar nerve behind medial epicondyle</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cheiralgia Paresthetica (Wartenburg syndrome)</p>\n</td>\n<td>\n<p>Superficial sensory branch of radial nerve</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carpal tunnel syndrome</p>\n</td>\n<td>\n<p>Median nerve (at wrist)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Guyons canal syndrome</p>\n</td>\n<td>\n<p>Ulnar nerve(at wrist)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thoracic outlet syndrome</p>\n</td>\n<td>\n<p>Lower trunk of brachial plexus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tarsal tunnel syndrome</p>\n</td>\n<td>\n<p>Posterior tibial nerve</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Piriformis syndrome</p>\n</td>\n<td>\n<p>Sciatic nerve</p>\n</td>\n</tr>\n<tr>\n<td>Meralgia paresthetica</td>\n<td>Lateral cutaneous nerve of thigh</td>\n</tr>\n<tr>\n<td>Mortons Metatarsalgia</td>\n<td>Interdigital plantar nerve&nbsp;</td>\n</tr>\n<tr>\n<td>Notalgia Paresthetica</td>\n<td>Superficial sensory&nbsp;neuropathy in the infrascapular area (Pruritus + Dysaesthesia)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(101, 'Anatomy', 'PM0772. Spaces of Hand', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\144\>\n<p><strong>Spaces of hand </strong></p>\n</td>\n<td width=\144\>\n<p><strong>Features </strong></p>\n</td>\n<td width=\144\>\n<p><strong>Extensions/communications </strong></p>\n</td>\n<td width=\144\>\n<p><strong>Clinical correlation </strong></p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p><strong>Thenar space </strong></p>\n</td>\n<td width=\144\>\n<p>Located under lateral half of hollow of palm.</p>\n<p>Contains FPL, other flexor tendons of index finger</p>\n</td>\n<td width=\144\>\n<p>Proximally: limited by anterior and posterior walls of carpal tunnel</p>\n<p>Distally: communicates with 1<sup>st</sup> web space through 1st lumbrical</p>\n</td>\n<td width=\144\>\n<p>Infection: from radial bursa / synovial sheath of index finger</p>\n<p>Drainage: incision in web space of thumb</p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p><strong>Midpalmar space </strong></p>\n</td>\n<td width=\144\>\n<p>Under medial half of hollow of palm</p>\n<p>Contains flexor tendons of medial 3 digits</p>\n</td>\n<td width=\144\>\n<p>Proximally: continuous with forearm space of parona</p>\n<p>Distally: continuous with medial 3 web spaces through medial 3 lumbricals.</p>\n</td>\n<td width=\144\>\n<p>Infection: ulnar bursa is inlet, lumbrical canals are outlet.</p>\n<p>Drainage: incision in medial 2 web spaces</p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p><strong>Ulnar bursa </strong></p>\n</td>\n<td width=\144\>\n<p>Common synovial flexor sheath envelops tendons of FDS, FDP</p>\n</td>\n<td width=\144\>\n<p>Proximally: extend into forearm 2.5cm proximal to flexor retinaculum</p>\n<p>Distally: extends in palm upto midshaft of metacarpals.</p>\n<p>Medially: continuous with synovial sheath of little finger</p>\n</td>\n<td width=\144\>\n<p>Drainage: incision on radial margin of hypothenar eminence</p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p><strong>Radial bursa </strong></p>\n</td>\n<td width=\144\>\n<p>Synovial flexor sheath for FPL</p>\n</td>\n<td width=\144\>\n<p>Proximally:</p>\n<p>extend into forearm 2.5cm proximal to flexor retinaculum</p>\n<p>Distally: continuous with digital synovial sheaths of thumb</p>\n</td>\n<td width=\144\>\n<p>Drainage: medial margin of thenar eminence</p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p><strong>Forearm space of parona </strong></p>\n</td>\n<td width=\144\>\n<p>Facial interval below flexor tendons of distal part of forearm</p>\n</td>\n<td width=\144\>\n<p>Proximally: continuous with intermuscular spaces of forearm</p>\n<p>Distally: reaches level of wrist</p>\n</td>\n<td width=\144\>\n<p>Infection: from ulnar bursa</p>\n<p>Drainage: vertical incision on distal part of forearm</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(102, 'Anatomy', 'PM0771. Structures Passing through the Extensor Retinaculum Compartments', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\205\>\n<p><strong>Extensor Retinaculum</strong></p>\n<p><strong>Compartments </strong></p>\n</td>\n<td width=\371\>\n<p><strong>Structures passing through them</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>I</p>\n</td>\n<td width=\371\>\n<p>Abductor pollicis longus (APL)</p>\n<p>Extensor pollicis brevis (EPB)</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>II</p>\n</td>\n<td width=\371\>\n<p>Extensor carpi radialis longus (ECRL)</p>\n<p>Extensor carpi radialis brevis (ECRB)</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>III</p>\n</td>\n<td width=\371\>\n<p>Extensor pollicis longus (EPL)</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p><strong>IV</strong></p>\n</td>\n<td width=\371\>\n<p><strong>Extensor digitorum (ED)</strong></p>\n<p><strong>Extensor indicis (EI)</strong></p>\n<p><strong>Posterior interosseous nerve</strong></p>\n<p><strong>Anterior interosseous artery</strong>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>V</p>\n</td>\n<td width=\371\>\n<p>Extensor digiti minimi (EDM)</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>VI</p>\n</td>\n<td width=\371\>\n<p>Extensor carpi ulnaris (ECU)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b73c237522d64e4382f9e015b8fe4ac9x1280x1410.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(103, 'Anatomy', 'PM0757. Types of Joints in the Upper Limb', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\205\>\n<p><strong>Joint </strong></p>\n</td>\n<td width=\192\>\n<p><strong>Type </strong></p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Sternoclavicular</p>\n</td>\n<td width=\192\>\n<p>Saddle</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Acromioclavicular</p>\n</td>\n<td width=\192\>\n<p>Plane synovial</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Shoulder</p>\n</td>\n<td width=\192\>\n<p>Ball and socket</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Elbow</p>\n</td>\n<td width=\192\>\n<p>Hinge</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Superior and inferior radioulnar</p>\n</td>\n<td width=\192\>\n<p>Pivot (trochoid)</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Middle radioulnar</p>\n</td>\n<td width=\192\>\n<p>Syndesmosis</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Wrist</p>\n</td>\n<td width=\192\>\n<p>Ellipsoid more than condylar</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>1<sup>st</sup> carpometacarpal</p>\n</td>\n<td width=\192\>\n<p>Saddle (sellar)</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Metacarpophalangeal</p>\n</td>\n<td width=\192\>\n<p>Ellipsoid more than condylar</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Intercarpal and midcarpal</p>\n</td>\n<td width=\192\>\n<p>Plane synovial</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Interphalangeal</p>\n</td>\n<td width=\192\>\n<p>Hinge</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(104, 'Anatomy', 'PM0034. Dermatome and root value of the upper limb', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c2be60bf355046ae976ab020465d8113x1280x1710.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Key Sensory Areas:</strong></p>\n<ul>\n<li>C5 - Upper lateral part of arm</li>\n<li>C6 - Palmar pad of thumb</li>\n<li>C7 -&nbsp;Pad of index finger</li>\n<li>C8 -&nbsp;Pad of little finger</li>\n<li>T1 -&nbsp;Skin on medial aspect of elbow</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(105, 'Anatomy', 'PM2386. Divisions and contents of the mediastinum', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4a16336888534350bce06ecc2f4483afx425x480.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\3\><strong>Major contents of thoracic cavity</strong></td>\n</tr>\n<tr>\n<td colspan=\2\><span><strong>Superior</strong> mediastinum</span></td>\n<td>\n<ul>\n<li><span>Trachea</span></li>\n<li><span>Esophagus</span></li>\n<li><span>Thoracic duct</span></li>\n<li><span>Thymus</span></li>\n<li><span>Vessels-</span>\n<ul>\n<li><span>Aortic arch</span></li>\n<li><span>Left common carotid artery</span></li>\n<li><span>Left subclavian artery</span></li>\n<li><span>Brachiocephalic trunk</span></li>\n<li><span>Right and left brachiocephalic veins</span></li>\n<li><span>Superior vena cava (upper half)</span></li>\n<li><span>Azygos vein near its opening into superior vena cava</span></li>\n</ul>\n</li>\n<li><span>Left recurrent laryngeal nerve</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td rowspan=\3\><span><strong>Inferior</strong> mediastinum</span></td>\n<td><span>Anterior</span></td>\n<td>\n<ul>\n<li><span>Thymus (inferior extension)</span></li>\n<li><span>Mediastinal branches of internal thoracic vessels</span></li>\n<li><span>Sternopericardial ligaments</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Middle</span></td>\n<td>\n<ul>\n<li><span>Heart</span></li>\n<li><span>Phrenic nerve</span></li>\n<li><span>Tracheal bifurcation and bronchi</span></li>\n<li><span>Roots of great vessels</span>\n<ul>\n<li><span>Ascending aorta</span></li>\n<li><span>Superior vena cava (lower half)</span></li>\n<li><span>Inferior vena cava</span></li>\n<li><span>Pulmonary trunk and branches</span></li>\n<li><span>Pericardiophrenic arteries and veins</span></li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Posterior</span></td>\n<td>\n<ul>\n<li><span>Thoracic aorta</span></li>\n<li><span>Thoracic duct</span></li>\n<li><span>Esophagus</span></li>\n<li><span>Vagus nerve</span></li>\n<li><span>Azygos vein</span></li>\n<li><span>Hemiazygos vein</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(106, 'Anatomy', 'PM2243. Articulations of ribs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\page\ title=\Page 57\>&nbsp;<strong>Joints</strong>\n<ul>\n<li>Costovertebral: Rib to the vertebral body&nbsp;&nbsp;</li>\n<li>Costotransverse: Rib to the transverse process of&nbsp;vertebra</li>\n<li>Costochondral: Rib to the costal cartilage</li>\n</ul>\n<p><strong>Articulations with the vertebrae</strong></p>\n<p><strong>Ribs 2 to 9: </strong>3 articulations</p>\n<ul>\n<li>Head of the rib to the inferior costal facet of the vertebral body above</li>\n<li>Head of the rib to the superior&nbsp;costal facet of the corresponding vertebral body</li>\n<li>Tubercle of the rib to the transverse process of the corresponding vertebra</li>\n</ul>\n</div></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/73cb880dfb6841158fb3683089ed6611x1280x1168.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Rib 1: </strong>2 articulations</p>\n<ul>\n<li>Head of the rib to the corresponding vertebral body</li>\n<li>Tubercle of the rib to the transverse process of the corresponding vertebra</li>\n</ul>\n<p><strong>Ribs 10, 11 and 12</strong>: 1 articulation</p>\n<ul>\n<li>10th rib - upper border of the tenth thoracic vertebra near its pedicle</li>\n<li>11th, 12th ribs - Head of the rib to the corresponding vertebral body</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Articulations with the sternum</strong></p>\n<p>Ribs<strong> 1- 7:&nbsp;True ribs -</strong>&nbsp;Articulate directly with a single costal cartilages&nbsp;</p>\n<p>Ribs<strong> 8 - 10:</strong>&nbsp;<strong>False ribs -&nbsp;</strong>Articulate with a common costal cartilage.</p>\n<p>Ribs <strong>11 and 12: Floating ribs</strong> -&nbsp;Do not articulate with the sternum</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a88200db4fea40dfa49d9e0929d1ce72x1280x1248.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(107, 'Anatomy', 'PM2117. Angle of Louis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p class=\p1\>The <strong>angle of Loius (sternal angle)</strong> is formed by the manubriosternal joint at the level of<strong> 2<sup>nd</sup> costal cartilage</strong> anteriorly.</p>\n<p class=\p1\>A plane joining the angle of Louis to the<strong> intervertebral disc between T4 and T5</strong>, called the <strong>sternal plane</strong> marks the following anatomical landmarks:&nbsp;</p>\n<ul class=\ul1\>\n<li class=\li1\>Separates superior mediastinum form inferior mediastinum.&nbsp;</li>\n<li class=\li1\>Marks the position superior limit of pericardium.</li>\n<li class=\li1\>Bifurcation of pulmonary trunk</li>\n<li class=\li1\>Bifurcation of&nbsp;trachea (newer studies&nbsp;shows its lower)&nbsp;&nbsp;</li>\n<li class=\li1\>Origin of arch of aorta.</li>\n<li class=\li1\>Site where superior venacava pierces the pericardium.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(108, 'Anatomy', 'PM1991. Diaphragmatic openings', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p class=\p1\><strong>Major openings through the diaphragm</strong></p>\n<table class=\t1\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Level of opening</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>T8</strong></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>T10</strong></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>T12 </strong></p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p>Located in</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p>In the central tendon</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p>In the muscular part</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p>In crus of the diaphragm</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Structures passing through</p>\n<p class=\p1\>&nbsp;</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p><strong>Inferior Vena cava</strong></p>\n<p>Right phrenic nerve&nbsp;</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p><strong>Oesophagus</strong></p>\n<p>Vagus nerve- right and left</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p><strong>Aorta</strong></p>\n<p>Thoracic duct</p>\n<p>Azygous vein</p>\n<p>Hemiazygous vein</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p class=\p2\>&nbsp;</p>\n<p class=\p2\><strong>Minor openings through the diaphragm</strong></p>\n<ul>\n<li class=\p1\>Space of Larry (Costo-Xiphoid gap) - Superior epigastric artery</li>\n<li class=\p1\>Medial arcuate ligament - Sympathetic chain</li>\n<li class=\p1\>Lateral arcuate ligament - Subcostal nerves and vessels</li>\n</ul>\n<p class=\p1\>&nbsp;</p>\n<p class=\p1\>Note:</p>\n<p class=\p1\><strong>Splanchnic nerves</strong> pass through the&nbsp;<strong>right and left crus</strong> of the diaphragm.</p>\n<p class=\p1\><strong>The azygous vein</strong>&nbsp;may sometimes pass through the&nbsp;<strong>right crus</strong> of the diaphragm.</p>\n<p class=\p1\><strong>The hemizygous vein</strong> may sometimes pass through the&nbsp;<strong>left crus</strong> of the diaphragm.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/25c7336f2f9b4248a92856873fdc8f0cx600x815.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(109, 'Anatomy', 'PM1782. Structures passing through heart sulci', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/66211583e27e45358399989b1083dc4dx1280x2559.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(110, 'Anatomy', 'PM1291. Bronchopulmonary Segments', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lobe </strong></p>\n</td>\n<td>\n<p><strong>Right lung </strong></p>\n</td>\n<td>\n<p><strong>Left lung </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Superior lobe</p>\n</td>\n<td>\n<p>I apical</p>\n<p>II posterior</p>\n<p>III anterior</p>\n</td>\n<td>\n<p>I apical</p>\n<p>II posterior</p>\n<p>III anterior</p>\n<p>IV superior lingual</p>\n<p>V inferior lingual</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Middle lobe</p>\n</td>\n<td>\n<p>IV lateral</p>\n<p>V medial</p>\n</td>\n<td>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inferior lobe</p>\n</td>\n<td>\n<p>VI superior (apical)</p>\n<p>VII medial basal</p>\n<p>VIII anterior basal</p>\n<p>IX lateral basal</p>\n<p>X posterior basal</p>\n</td>\n<td>\n<p>VI superior (apical)</p>\n<p>VII medial basal</p>\n<p>VIII anterior basal</p>\n<p>IX lateral basal</p>\n<p>X posterior basal</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Note :</strong>&nbsp;</p>\n<div class=\page\ title=\Page 607\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Apicoposterior segment:</strong>&nbsp;Left (apical + posterior) segments.&nbsp; &nbsp;</p>\n<p><strong>Anteromedial basal segment: </strong>Left&nbsp;(anterior + medial basal) segments.</p>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/01868187d7f74433b19480bb937cf49ex1280x2559.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/968042a00a124d5a89c8e1c6cc219882x1280x2559.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(111, 'Anatomy', 'PM1284. Surface marking for Lungs and Pleura', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\201\>\n<p><strong>Level </strong></p>\n</td>\n<td width=\201\>\n<p><strong>Costodiaphragmatic line (inferior border of pleura)</strong></p>\n</td>\n<td width=\201\>\n<p><strong>Lower border of lung (2 ribs higher)</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\201\>\n<p>Mid-clavicular line</p>\n</td>\n<td width=\201\>\n<p>8<sup>th</sup> rib</p>\n</td>\n<td width=\201\>\n<p>6<sup>th</sup> rib</p>\n</td>\n</tr>\n<tr>\n<td width=\201\>\n<p>Mid-axillary line</p>\n</td>\n<td width=\201\>\n<p>10<sup>th</sup> rib</p>\n</td>\n<td width=\201\>\n<p>8<sup>th</sup> rib</p>\n</td>\n</tr>\n<tr>\n<td width=\201\>\n<p>Paravertebral line</p>\n</td>\n<td width=\201\>\n<p>12<sup>th</sup> rib</p>\n</td>\n<td width=\201\>\n<p>10<sup>th</sup> rib</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/44d7ff6591af4dd5bbac052f2cd379e2x1280x1818.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(112, 'Anatomy,', 'PM1281. Respiratory Muscles', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\651\>\n<tbody>\n<tr>\n<td>\n<p><strong>Type of respiration </strong></p>\n</td>\n<td>\n<p><strong>Inspiration (rib elevators) </strong></p>\n</td>\n<td>\n<p><strong>Expiration (rib depressors)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Quiet respiration</p>\n</td>\n<td>\n<p>Diaphragm (chief muscle)</p>\n<p>External intercostals</p>\n</td>\n<td>\n<p>Passive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Deep inspiration</p>\n</td>\n<td>\n<p>External intercostals</p>\n<p>Scalene muscles</p>\n<p>Sternocleidomastoid</p>\n<p>Levator costarum</p>\n<p>Serratus posterior superior</p>\n<p>Innermost intercostals</p>\n</td>\n<td>\n<p>Passive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Forced respiration</p>\n</td>\n<td>\n<p>Levator scapulae</p>\n<p>Trapezius</p>\n<p>Rhomboids</p>\n<p>Pectoral muscles</p>\n<p>Serratus anterior</p>\n</td>\n<td>\n<p>Anterior abdominals</p>\n<p>Internal intercostals</p>\n<p>Transverse thoracis</p>\n<p>Serratus posterior inferior</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(113, 'Anatomy', 'PM1162. Structures related to the mediastinal surface and hilum of the lungs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Right lung:</p>\n<ul>\n<li>Anterior to the hilum -<strong>&nbsp;superior vena cava </strong>and <strong>right brachiocephalic vein. </strong></li>\n<li>Posterior to this groove-&nbsp;&nbsp;<strong>azygous vein. </strong></li>\n<li>Behind the hilum and pulmonary ligament- <strong>oesophagus</strong>.</li>\n<li>The <strong>cardiac impression</strong>&nbsp;-&nbsp;right auricle,&nbsp;right atrium and&nbsp;right ventricle</li>\n<li>Posteroinferiorly -<strong>&nbsp;inferior vena cava</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/31cd8fd201e643a389790a1188c717cfx600x690.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Left lung:</p>\n<ul>\n<li>The <strong>cardiac impression -&nbsp;</strong>left ventricle and auricle and right ventricle</li>\n<li>Large groove that arches over the hilum and descends behind -&nbsp;&nbsp;<strong>Arch of aorta and descending aorta.</strong></li>\n<li>Arrow groove that ascends to the apex-&nbsp;<strong>left subclavian artery</strong></li>\n<li>Superior to the aortic groove-&nbsp;&nbsp;<strong>thoracic duct and esophagus</strong>.</li>\n<li>Anterior to subclavian groove -&nbsp;<strong>left brachiocephalic vein</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ce67d3683b64459a8f933032f965f622x600x722.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(114, 'Anatomy', 'PM1161. Surface Marking of the Heart Valves', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6534f6581a6745628bd38e1e22b0f752x1280x2708.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(115, 'Anatomy', 'PM0857. Spinous Processes and their Significance', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/288a49ff123a49228684741d1c3d8cdex1280x1586.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Spinous process </strong></p>\n</td>\n<td>\n<p><strong>Significance </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C2 spinous process</p>\n</td>\n<td>\n<p>Most superior bony protuberance in the midline inferior to the skull</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C7 spinous process</p>\n</td>\n<td>\n<p>Lower extent of ligamentum nuchae</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>T3</strong> spinous process</p>\n</td>\n<td>\n<p>Level of the <strong>root of the spine </strong>of the scapula</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>T7</strong> spinous process</p>\n</td>\n<td>\n<p>Level of the <strong>inferior angle</strong> of the scapula</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T12 spinous process</p>\n</td>\n<td>\n<p>Midpoint of a vertical line between the inferior angle of the scapula and the iliac crest</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>L4 spinous process</p>\n</td>\n<td>\n<p>Level marks the highest point of the iliac crest</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>S2 spinous process</p>\n</td>\n<td>\n<p>Sacral dimples that mark the position of the posterior superior iliac spine are level</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>In thoracic vertebrae, the tips of <strong>thoracic spinous processes lie at the level of the vertebral body below. </strong></p>\n<p>E.g., T3 spinous process lies at the level of T4 vertebral body</p>\n<p>In lumbar and sacral regions, the <strong>tips of spinous processes reflect the position of their corresponding vertebral bodies</strong></p>\n<p>E.g., L 4 spinous process lies at approximately the L4 vertebral level</p></div><!---->\n      <!---->\n    </div><!---->'),
(116, 'Anatomy', 'PM0699. Distribution of Coronary Arteries', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\234\>\n<p><strong>Right Coronary Artery (RCA)</strong></p>\n</td>\n<td width=\234\>\n<p><strong>Left Coronary Artery (LCA)</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\234\>\n<ul>\n<li><strong>RV</strong></li>\n<li><strong>RA</strong></li>\n<li><strong>Posteroinferior 1/3<sup>rd</sup> of IVS</strong></li>\n<li><strong>SA node in 65% patients</strong></li>\n<li><strong>AV node in 80% patients </strong></li>\n<li>Variable part of diaphragmatic aspect of LV</li>\n<li>Part of LA</li>\n</ul>\n</td>\n<td width=\234\>\n<ul>\n<li><strong>Most of LV</strong></li>\n<li><strong>Most of LA </strong></li>\n<li><strong>Anterior 2/3<sup>rd</sup> of IVS</strong></li>\n<li>Narrow strip of RV</li>\n<li>SA node in 35% people</li>\n<li>AV node in 20% people</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(117, 'Obstetrics & Gynaecology,', 'PM2366. Perineal Body', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The perineal body is not a structure but an <strong>aggregation of fibromuscular tissue</strong> located in the midline at the junction between the anal and urogenital triangles, just ventral to the anal sphincter.</p>\n<p><strong>Ten muscles</strong> of the perineum converge and interlace in the perineal body.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Category</strong></td>\n<td><strong>Muscles</strong></td>\n</tr>\n<tr>\n<td><strong>Two unpaired</strong></td>\n<td>\n<ul>\n<li>Fibres of longitudinal muscle coat of anal canal</li>\n<li>Fibres from External anal sphincter</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Four Paired</strong></td>\n<td>\n<ul>\n<li>Bulbospongiosus</li>\n<li>Superficial transverse perenei</li>\n<li>Deep transverse perenei</li>\n<li>Levator ani</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Note: In females, sphincter urethrovaginalis is also attached here.</p></div><!---->\n      <!---->\n    </div><!---->'),
(118, 'Anatomy', 'PM2282. Gluteal Muscles', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>&nbsp;</div>\n<table><colgroup><col></colgroup>\n<tbody>\n<tr>\n<td>\n<div><strong>Gluteus Medius</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Origin</strong>- Outer surface of <strong>ilium</strong> between anterior and posterior gluteal lines.</div>\n<div><strong>Insertion</strong> -Oblique ridge on the <strong>lateral</strong> surface of the <strong>greater trochanter.</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Gluteus Minimus</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Origin</strong>- Outer surface of ilium between anterior and inferior gluteal lines</div>\n<div><strong>Insertion</strong> -Ridge on the <strong>anterior</strong> surface of <strong>greater trochanter</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Gluteus Maximus</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Origin</strong> - Posterior aspect of dorsal ilium posterior to posterior gluteal line, posterior superior iliac crest, posterior inferior aspect of sacrum and coccyx, and sacrotuberous ligament</p>\n<p><strong>Insertion</strong> -&nbsp;Primarily in <strong>fascia lata</strong> at the iliotibial band; also into the gluteal tuberosity on posterior femoral surface</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(119, 'Anatomy', 'PM2281. Sciatic nerve divisions and supply', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>&nbsp;</div>\n<table border=\1\><colgroup><col></colgroup>\n<tbody>\n<tr>\n<td>\n<div><strong>Sciatic nerve divisions and its supply&nbsp;</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Tibial division</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Motor:&nbsp;</div>\n<div>semitendinous,&nbsp;semimembranous,&nbsp;long head biceps femoris,&nbsp;gastrocnemius&nbsp;popliteus,&nbsp;plantaris,&nbsp;soleus,&nbsp;tibialis posterior,&nbsp;flexor digitorum longus,&nbsp;flexor hallucis longus, abductor hallucis, flexor digit­orum brevis, flexor hallucis brevis, addcutor hallucis, foot interossei, abductor digiti minimi.</div>\n<div>&nbsp;</div>\n<div>Sensory:&nbsp;</div>\n<div>none</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Peroneal division</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Motor:</div>\n<div>short head of biceps femoris, foot interossei, Tibialis anterior, Extensor Hallucis longus, Extensor digitorum longus and Peroneus tertius, Peroneus Longus, Peroneus Brevis.</div>\n<div>&nbsp;</div>\n<div>Sensory:</div>\n<div>articular branch to knee joint</div>\n<div>sural nerve branch&nbsp;</div>\n<div>- closeby structure: saphenous vein, achilles tendon</div>\n<div>- anastomoses: br. of peroneal nerve</div>\n<div>- termination as: lateral dorsal cutaneous nerve&nbsp;&nbsp;</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(120, 'Anatomy', 'PM2280. Various muscles of the gluteal region and their innervation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Muscles</strong></p>\n</td>\n<td>\n<p><strong>Innervation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gluteus maximus</p>\n</td>\n<td>\n<p>&nbsp;Inferior gluteal nerve</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gluteus medius and minimus</p>\n</td>\n<td>\n<p>&nbsp;Superior gluteal nerve</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyriformis</p>\n</td>\n<td>\n<p>&nbsp;Nerve to pyriformis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Obturator internus, Gemellus superior</p>\n</td>\n<td>\n<p>&nbsp;Nerve to obturator internus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Quadratus femoris, Gemellus inferior</p>\n</td>\n<td>\n<p>&nbsp;Nerve to quadratus femoris</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(121, 'Anatomy', 'PM2214. Lymphatic drainage of pelvic structures', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\ width=\620\>\n<tbody>\n<tr>\n<td><strong>LYMPH NODES</strong></td>\n<td><strong>STRUCTURES DRAINING</strong></td>\n</tr>\n<tr>\n<td>Para - aortic lymph nodes</td>\n<td>Ovaries /Testis</td>\n</tr>\n<tr>\n<td>External iliac lymph nodes</td>\n<td>Uterine body, cervix, superior bladder</td>\n</tr>\n<tr>\n<td>Internal iliac lymph nodes</td>\n<td>Prostate, cervix, corpus cavernosum,proximal vagina</td>\n</tr>\n<tr>\n<td>Superficial inguinal lymph nodes</td>\n<td>Distal vagina, vulva, scrotum, distal anal canal</td>\n</tr>\n<tr>\n<td>Deep inguinal lymph nodes</td>\n<td>Glans penis</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>*Ref - Snells Clinical Anatomy - 4e&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(122, 'Anatomy,', 'PM2080. Calots triangle and hepatobiliary triangle', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Boundaries</strong></td>\n<td><strong>Calots Triangle</strong></td>\n<td><strong>Hepatobiliary Triangle</strong></td>\n</tr>\n<tr>\n<td>\n<p>Superiorly</p>\n</td>\n<td>Superior border of the cystic artery</td>\n<td>Inferior surface of the liver</td>\n</tr>\n<tr>\n<td>\n<p>Medially</p>\n</td>\n<td colspan=\2\>Common hepatic duct</td>\n</tr>\n<tr>\n<td>\n<p>Inferiorly</p>\n</td>\n<td colspan=\2\>Cystic duct</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/31ed9f9d009e43dbb6eef6616e0696bfx1280x1611.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Contents of Calot’s triangle:</p>\n<ul>\n<li><strong>Lymph node of Lund</strong> - Sentinel lymph node for the gallbladder</li>\n<li><strong>Branching of cystic artery</strong> from the right hepatic artery</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(123, 'Anatomy', 'PM2078. Common sites of porto-systemic anastomosis in portal hypertension', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Left gastric vein [portal] to Distal oesophageal [systemic] veins: Presents with oesophageal and gastric variceal bleeding</li>\n<li>Superior rectal veins to Middle and inferior rectal veins: Presents with rectal varices and lower GI tract bleeding</li>\n<li>Tributaries of left branch of portal vein in ligamentum teres to Periumbilical branches of epigastric and intercostal veins: Forms <strong>caput medusae</strong></li>\n<li>Tributaries of right branch of portal vein overlying ‘bare area’ of liver to Retroperitoneal veins draining into azygos, hemiazygos, lumbar, intercostal and phrenic veins</li>\n<li>Omental and colonic veins near hepatic and splenic ﬂexures to Retroperitoneal veins near hepatic and splenic ﬂexures</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(124, 'Anatomy,', 'PM1851. Fallopian tube', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Gross anatomy:</strong></p>\n<p>The fallopian tube is divided into the following parts:</p>\n<div class=\page\ title=\Page 31\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li><strong>Intramural/Interstitial portion:</strong>&nbsp;&nbsp;\n<ul>\n<li>Intrauterine</li>\n<li>The narrowest and shortest part</li>\n</ul>\n</li>\n<li><strong>Isthmus:</strong>\n<ul>\n<li>The most common site for tubectomy</li>\n</ul>\n</li>\n<li><strong>Ampulla:</strong>\n<ul>\n<li>The longest and widest part</li>\n<li>The most common site for - fertilization and ectopic pregnancy</li>\n</ul>\n</li>\n<li><strong>Infundibulum</strong></li>\n</ul>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6b727bd9f7374ff5820d26e5f0792421x1279x1178.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Histology:</strong></p>\n<p>The ampulla, isthmus and infundibulum are extrauterine. Theyre covered by three layers:&nbsp;</p>\n<div class=\section\>\n<ul class=\p-rich_text_list p-rich_text_list__bullet\>\n<li><strong>Mesosalpinx</strong>&nbsp;- It is the peritoneal layer. Also called serosa.</li>\n<li><strong>Myosalpinx -&nbsp;</strong>It contains smooth muscle and has 2 layers:\n<ul>\n<li>Inner circular&nbsp;</li>\n<li>Outer longitudinal</li>\n</ul>\n</li>\n<li><strong>Endosalpinx</strong>&nbsp;- It is the mucosal layer. It has the following features:\n<ul>\n<li>Numerous branching folds, filling the entire lumen</li>\n<li>Basement membrane</li>\n<li>Ciliated, columnar epithelium&nbsp;</li>\n<li>Peg cells - non-ciliated epithelium. They help in the capacitation of sperms.&nbsp;</li>\n</ul>\n</li>\n</ul>\n</div></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5cb4de67c0044d44bfa3a39d78a56832x510x533.GIF\><!---->\n      </div><!---->\n    </div><!---->'),
(125, 'Anatomy,', 'PM1580. Characteristic differentiating features of the jejunum and ileum', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Characteristic</strong></p>\n</td>\n<td>\n<p><strong>Jejunum</strong></p>\n</td>\n<td>\n<p><strong>Ileum</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Position</p>\n</td>\n<td>\n<p>Upper 2/5</p>\n</td>\n<td>\n<p>Lower 3/5</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diameter</p>\n</td>\n<td>\n<p>More</p>\n</td>\n<td>\n<p>Less</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Wall</p>\n</td>\n<td>\n<p>Thick</p>\n</td>\n<td>\n<p>Thin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Circular folds</p>\n</td>\n<td>\n<p>Large and numerous, with large villi</p>\n</td>\n<td>\n<p>Few and small, with less abundant villi</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vascularity</p>\n</td>\n<td>\n<p>More</p>\n</td>\n<td>\n<p>Less</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vasa recta</p>\n</td>\n<td>\n<p>Long</p>\n</td>\n<td>\n<p>Short</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Colour</p>\n</td>\n<td>\n<p>Deep red</p>\n</td>\n<td>\n<p>Pale pink</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lymphatic follicles</p>\n</td>\n<td>\n<p>Solitary</p>\n</td>\n<td>\n<p>Aggregated</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fat in mesentry</p>\n</td>\n<td>\n<p>Less</p>\n</td>\n<td>\n<p>More</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(126, 'Surgery,', 'PM1371. Passaro’s Triangle', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Around <strong>90% of gastrinomas</strong> are found in this triangle.</p>\n<p>Its boundaries are as follows:</p>\n<ul>\n<li>Junction of the cystic duct and common bile duct</li>\n<li>Junction of the 2<sup>nd</sup> and 3<sup>rd</sup> parts of the duodenum</li>\n<li>Junction of the body and neck of the pancreas</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/78538d8853224efd93d30bd4a826420dx1280x1347.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(127, 'Obstetrics & Gynaecology,', 'PM1352. Nerve supply in the pelvis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Organ </strong>&nbsp;</td>\n<td><strong>Spinal Segments </strong>&nbsp;</td>\n<td><strong>Nerves</strong></td>\n</tr>\n<tr>\n<td>Perineum, vulva, lower vagina</td>\n<td>S2–4</td>\n<td>Pudendal, inguinal, genitofemoral, posterofemoral cutaneous</td>\n</tr>\n<tr>\n<td>Upper vagina, cervix, lower uterine segment</td>\n<td>S2–4</td>\n<td>Pelvic parasympathetic</td>\n</tr>\n<tr>\n<td>Uterine fundus, proximal fallopian tubes, broad ligament</td>\n<td>T11–12, L1</td>\n<td>Sympathetic via hypogastric plexus</td>\n</tr>\n<tr>\n<td>Outer two-thirds of fallopian tubes</td>\n<td>T9–10</td>\n<td>Sympathetic via aortic and superior mesenteric plexus</td>\n</tr>\n<tr>\n<td>Ovaries</td>\n<td>T10-T11</td>\n<td>Sympathetic via renal and aortic plexus and celiac and mesenteric ganglia</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<div class=\page\ title=\Page 35\>&nbsp;</div></div><!---->\n      <!---->\n    </div><!---->'),
(128, 'Obstetrics & Gynaecology,', 'PM1351. Contents of the Broad ligament', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>One tube - Fallopian tube</li>\n<li>Two ligaments:\n<ul>\n<li>Round ligament of uterus</li>\n<li>Ovarian ligament</li>\n</ul>\n</li>\n<li>Two arteries:\n<ul>\n<li>Uterine artery</li>\n<li>Ovarian artery</li>\n</ul>\n</li>\n<li>Two nerve plexus:\n<ul>\n<li>Uterovaginal plexus</li>\n<li>Ovarian plexus</li>\n</ul>\n</li>\n<li>Three embryological remnants:\n<ul>\n<li>Epoophoron (Wolffian body)</li>\n<li>Paroophoron (Wolffian body)</li>\n<li>Gartner’s duct (Wolffian duct)</li>\n</ul>\n</li>\n<li>Other structures:\n<ul>\n<li>Lymph vessels and lymph nodes</li>\n<li>Fibrous connective tissue</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/11e9e8c00e094ece8e73a5e02653ace5x600x652.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(129, 'Anatomy,', 'PM1292. Length of various structures in the human body', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\109\>\n<p><strong>Length</strong></p>\n</td>\n<td width=\336\>\n<p><strong>Structures</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\109\>\n<p><strong>4 cm</strong></p>\n</td>\n<td width=\336\>\n<p><strong>Inguinal canal</strong></p>\n<p><strong>Female urethra</strong></p>\n<p><strong>Anal canal</strong></p>\n<p>Auditory tube</p>\n<p>Cystic duct</p>\n<p><strong>Optic nerve</strong></p>\n<p>Prostatic urethra</p>\n</td>\n</tr>\n<tr>\n<td width=\109\>\n<p><strong>5 cm</strong></p>\n</td>\n<td width=\336\>\n<p>Male larynx</p>\n<p>Left main bronchus</p>\n<p>Parotid and submandibular ducts</p>\n<p>Testes</p>\n<p><strong>First part of the duodenum</strong></p>\n<p><strong>Neck of the femur</strong></p>\n<p><strong>Medial and lateral walls of the orbit</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\109\>\n<p><strong>7.5 cm</strong></p>\n</td>\n<td width=\336\>\n<p><strong>Anterior wall of the vagina</strong></p>\n<p>Virgin uterus</p>\n<p>Second part of the duodenum</p>\n<p><strong>Bile duct</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\109\>\n<p><strong>9 cm&nbsp;</strong></p>\n</td>\n<td width=\336\>\n<p>Appendix</p>\n<p>Multiparous uterus</p>\n<p><strong>Posterior wall of the vagina</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\109\>\n<p><strong>11 cm</strong></p>\n</td>\n<td width=\336\>\n<p><strong>Trachea</strong></p>\n<p>Kidney</p>\n<p>Uterine tube</p>\n<p>Third part of the duodenum</p>\n</td>\n</tr>\n<tr>\n<td width=\109\>\n<p><strong>12 cm</strong></p>\n</td>\n<td width=\336\>\n<p><strong>Pharynx</strong></p>\n<p><strong>Rectum</strong></p>\n<p>Spleen</p>\n</td>\n</tr>\n<tr>\n<td width=\109\>\n<p><strong>15 cm</strong></p>\n</td>\n<td width=\336\>\n<p>Adductor canal</p>\n<p><strong>Ascending colon</strong></p>\n<p>Pancreas</p>\n<p><strong>Root of mesentry</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\109\>\n<p><strong>25 cm</strong></p>\n</td>\n<td width=\336\>\n<p><strong>Esophagus</strong></p>\n<p><strong>Duodenum</strong></p>\n<p><strong>Ureter</strong></p>\n<p><strong>Descending colon</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\109\>\n<p><strong>45 cm</strong></p>\n</td>\n<td width=\336\>\n<p><strong>Spinal cord</strong></p>\n<p><strong>Thoracic duct</strong></p>\n<p><strong>Vas deferens</strong></p>\n<p><strong>Sartorius</strong></p>\n<p><strong>Femur</strong></p>\n<p><strong>Transverse colon</strong></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(130, 'Anatomy,', 'PM1265. Features of anal canal above and below pectinate line', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><strong>Above Pectinate line</strong></p>\n</td>\n<td>\n<p><strong>Below Pectinate line</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Embryonic origin</strong></p>\n</td>\n<td>\n<p><strong>Endoderm</strong></p>\n</td>\n<td>\n<p><strong>Ectoderm</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lining</p>\n</td>\n<td>\n<p>Simple columnar</p>\n</td>\n<td>\n<p><strong>Stratified squamous</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Arterial supply</p>\n</td>\n<td>\n<p>Superior rectal artery</p>\n</td>\n<td>\n<p>Inferior rectal&nbsp; artery</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Venous drainage</p>\n</td>\n<td>\n<p><strong>Portal: </strong>Superior rectal vein</p>\n</td>\n<td>\n<p><strong>Systemic:</strong>&nbsp;Inferior rectal vein</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lymphatic drainage</p>\n</td>\n<td>\n<p>To pelvic and lumbar nodes</p>\n</td>\n<td>\n<p>To inguinal nodes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nerve supply</p>\n</td>\n<td>\n<p>Visceral—Autonomic fibers</p>\n</td>\n<td>\n<p><strong>Somatic</strong><strong>—Inferior rectal nerves </strong>(branches of pudendal nerve )</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Physiology</p>\n</td>\n<td>\n<p>Sensation quickly diminishes</p>\n</td>\n<td>\n<p><strong>Sensitive to pain</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cancer</p>\n</td>\n<td>\n<p><strong>Adenocarcinoma</strong></p>\n</td>\n<td>\n<p>Squamous cell carcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Varices</p>\n</td>\n<td>\n<p>Internal hemorrhoids, Painless</p>\n</td>\n<td>\n<p><strong>External hemorrhoids, Painful</strong></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(131, 'Anatomy', 'PM1237. Sacral Plexus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Sacral plexus</strong>&nbsp;is formed from the ventral rami of <strong>L4–S4</strong> spinal nerves.&nbsp;</p>\n<p>The following table shows the branches of sacral plexus, their root value, muscles innervated, and cutaneous branches.<strong><u>&nbsp;</u></strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Nerve</strong></p>\n</td>\n<td>\n<p><strong>Root value</strong></p>\n</td>\n<td>\n<p><strong>Innervated muscles</strong></p>\n</td>\n<td>\n<p><strong>Cutaneous branches</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Superior gluteal</p>\n</td>\n<td>\n<p>L4-S1 (From dorsal division)</p>\n</td>\n<td>\n<p>Gluteus medius</p>\n<p>Gluteus minimus</p>\n<p>Tensor fasciae lata</p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inferior gluteal</p>\n</td>\n<td>\n<p>L5-S2 (From dorsal division</p>\n</td>\n<td>\n<p>Gluteus maximus</p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Posterior femoral&nbsp;cutaneous nerve&nbsp;</p>\n</td>\n<td>\n<p>S1-S3</p>\n<p>(From dorsal division of S1, S2 and ventral division of S2, S3)</p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Posterior cutaneous femoral</p>\n<p>•&nbsp;Inferior cluneal nerves</p>\n<p>•&nbsp;Perineal branches</p>\n</td>\n</tr>\n<tr>\n<td colspan=\4\>\n<p><strong>Direct branches from plexus</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nerve to Piriformis</p>\n</td>\n<td>\n<p>S1-2</p>\n</td>\n<td>\n<p>Piriformis</p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nerve to Obturator internus</p>\n</td>\n<td>\n<p>L5, S1-2</p>\n</td>\n<td>\n<p>Obturator internus&nbsp;and&nbsp;Superior gemellus</p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nerve to Quadratus femoris</p>\n</td>\n<td>\n<p>L4-5, S1</p>\n</td>\n<td>\n<p>Quadratus femoris&nbsp;and&nbsp;Inferior gemellus</p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\4\>\n<p><strong>Sciatic Nerve</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sciatic</p>\n</td>\n<td>\n<p>L4-S3</p>\n</td>\n<td>\n<p>Semitendinosus&nbsp;(Tib)</p>\n<p>Semimembranosus&nbsp;(Tib)</p>\n<p>Biceps femoris</p>\n<p>• Long head (Tib)</p>\n<p>• Short head (Fib)</p>\n<p>Adductor magnus&nbsp;(medial part, Tib)</p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\2\>\n<p><strong>Common fibular</strong></p>\n</td>\n<td rowspan=\2\>\n<p>L4-S2</p>\n</td>\n<td rowspan=\2\>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Lateral sural cutaneous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Communicating fibular</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Tibial nerve</strong></p>\n</td>\n<td>\n<p>L4-S3</p>\n</td>\n<td>\n<p>Triceps surae</p>\n<p>Plantaris</p>\n<p>Popliteus</p>\n<p>Tibialis posterior</p>\n<p>Flexor digitorum longus</p>\n<p>Flexor hallucis longus</p>\n</td>\n<td>\n<p>Medial sural cutaneous, Lateral calcaneal, Medial&nbsp; calcaneal, Lateral dorsal cutaneous</p>\n</td>\n</tr>\n<tr>\n<td colspan=\4\>\n<p><strong>Pudendal and coccygeal</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pudendal</p>\n<p>(Pudendal plexus)</p>\n</td>\n<td>\n<p>S2-S4</p>\n</td>\n<td>\n<p>Muscles of the&nbsp;pelvic floor:</p>\n<p>Levator ani</p>\n<p>Superficial transverse perineal</p>\n<p>Deep transverse perineal</p>\n<p>Bulbospongiosus</p>\n<p>Ischiocavernosus</p>\n<p>Sphincter anus externus</p>\n<p>Urethral sphincter</p>\n</td>\n<td>\n<p>Inferior rectal</p>\n<p>Perineal</p>\n<p>•&nbsp;Posterior scrotal/labial</p>\n<p>•&nbsp;Dorsal penis/clitoris</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Coccygeal</p>\n<p>(Coccygeal plexus)</p>\n</td>\n<td>\n<p>S5-Co1</p>\n</td>\n<td>\n<p>Coccygeus</p>\n</td>\n<td>\n<p>Anococcygeal</p>\n<p>Dorsal branches</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1eaa725d82cc403dae459834ac9588eax1279x1531.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(132, 'Obstetrics & Gynaecology,', 'PM1166. Supports of the uterus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>A. Primary supports</strong></p>\n<ul>\n<li><strong>Muscular or active support of the uterus:</strong>\n<ul>\n<li>Pelvic diaphragm</li>\n<li>Perineal body</li>\n<li>Urogenital diaphragm</li>\n</ul>\n</li>\n<li><strong>Ligamentous (fibromuscular or mechanical) support:</strong>\n<ul>\n<li>Transverse cervical ligaments of Mackenrodt or cardinal ligament</li>\n<li>Uterosacral ligament</li>\n<li>Round ligament of the uterus</li>\n<li>Pubocervical ligament</li>\n<li>Uterine axis</li>\n</ul>\n</li>\n</ul>\n<p><strong>B. Secondary supports formed by peritoneal ligaments:</strong></p>\n<ul>\n<li>Broad ligament</li>\n<li>Uterovesical fold of peritoneum</li>\n<li>Rectovaginal fold of peritoneum</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(133, 'Surgery,', 'PM1159. Couinauds liver segments', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The <strong>Couinaud classification</strong> is currently the most widely used system to describe functional liver anatomy.</p>\n<ul>\n<li>Based on the <strong>distribution of hepatic portal venous branches</strong> in the parenchyma</li>\n<li>Each segment has its own dual vascular inflow, biliary drainage and lymphatic drainage</li>\n</ul>\n<p><strong>Segment I</strong> corresponds to the gross anatomical <strong>caudate lobe</strong> and is considered as posterior segment.</p>\n<p>Other segments:</p>\n<table width=\0\>\n<tbody>\n<tr>\n<td width=\238\>\n<p><strong>Liver sections</strong></p>\n</td>\n<td width=\286\>\n<p><strong>Couinauds Segments</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\238\>\n<p>Right anterior sections</p>\n</td>\n<td width=\286\>\n<p>Segments V,VIII</p>\n</td>\n</tr>\n<tr>\n<td width=\238\>\n<p>Right Posterior sections</p>\n</td>\n<td width=\286\>\n<p>Segments VI, VII</p>\n</td>\n</tr>\n<tr>\n<td width=\238\>\n<p>Left medial sections</p>\n</td>\n<td width=\286\>\n<p>Segment IV (<strong>quadrate lobe</strong>)</p>\n</td>\n</tr>\n<tr>\n<td width=\238\>\n<p>Left lateral sections</p>\n</td>\n<td width=\286\>\n<p>Segment II,&nbsp;III</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8db329e3f1de43dbb358b097349abc84x600x1249.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(134, 'Anatomy,', 'PM1129. Relations of epiploic foramen and lesser sac', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Relations of epiploic foramen:</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>Anterior</p>\n</td>\n<td>\n<ul>\n<li>Hepatoduodenal ligament containing hepatic artery, portal vein, and common bile duct</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Posterior</p>\n</td>\n<td>\n<ul>\n<li>Inferior vena cava</li>\n<li>Right suprarenal gland</li>\n<li>Body of T12 vertebra</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Superior</p>\n</td>\n<td>\n<ul>\n<li>Caudate lobe of the liver</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inferior</p>\n</td>\n<td>\n<ul>\n<li>1st part of duodenum</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>Relations of lesser sac:</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>Anterior</p>\n</td>\n<td>\n<ul>\n<li>Caudate lobe of liver</li>\n<li>Lesser omentum</li>\n<li>Stomach</li>\n<li>First 2 layers of the greater omentum</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Posterior</p>\n</td>\n<td>\n<p>Structures forming the stomach bed:</p>\n<ul>\n<li>Pancreas</li>\n<li>Splenic artery</li>\n<li>Left kidney and suprarenal gland</li>\n<li>Commencement of abdominal aorta and coeliac artery</li>\n<li>Left crus of the diaphragm</li>\n<li>Splenic flexure of the colon</li>\n<li>Transverse mesocolon</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Superior</p>\n</td>\n<td>\n<ul>\n<li>Reflection of the peritoneum from the esophagus to the diaphragm</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inferior</p>\n</td>\n<td>\n<ul>\n<li>Continuation of 2nd and 3rd layers of the greater omentum</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9940ab3ecf6944718889681351185ca3x1280x1549.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(135, 'Anatomy,', 'PM1128. Peritoneal folds and their contents', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The following table shows various peritoneal folds (omenta, mesenteries and ligaments) and their contents.</p>\n<table width=\100%\>\n<tbody>\n<tr>\n<td width=\51%\>\n<p><strong>Peritoneal</strong> <strong>fold</strong></p>\n</td>\n<td width=\48%\>\n<p><strong>Content</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\51%\>\n<p>Lesser omentum</p>\n<p>a)&nbsp;&nbsp;&nbsp; Hepatoduodenal ligament&nbsp;</p>\n<p>b)&nbsp;&nbsp;&nbsp; Hepatogastric ligament&nbsp;</p>\n</td>\n<td width=\48%\>\n<p>&nbsp;</p>\n<p>Hepatic artery, portal vein, and common bile duct</p>\n<p>Right and left gastric vessels</p>\n</td>\n</tr>\n<tr>\n<td width=\51%\>\n<p>Greater omentum (along the greater curvature of the stomach)</p>\n</td>\n<td width=\48%\>\n<p>Right and left gastro-epiploic vessels</p>\n</td>\n</tr>\n<tr>\n<td width=\51%\>\n<p>Gastrosplenic ligament</p>\n</td>\n<td width=\48%\>\n<p>Short gastric and left gastro-epiploic branches of splenic artery</p>\n</td>\n</tr>\n<tr>\n<td width=\51%\>\n<p>Gastrophrenic ligament</p>\n</td>\n<td width=\48%\>\n<p>Left inferior phrenic artery</p>\n</td>\n</tr>\n<tr>\n<td width=\51%\>\n<p>Gastrocolic ligament</p>\n</td>\n<td width=\48%\>\n<p>Right gastroepiploic artery</p>\n</td>\n</tr>\n<tr>\n<td width=\51%\>\n<p>Splenorenal/Lienorenal ligament</p>\n</td>\n<td width=\48%\>\n<p>Splenic vessels. Also contains the tail of the pancreas</p>\n</td>\n</tr>\n<tr>\n<td width=\51%\>\n<p>Mesentery</p>\n</td>\n<td width=\48%\>\n<p>Jejunal and ileal branches of superior mesenteric artery</p>\n</td>\n</tr>\n<tr>\n<td width=\51%\>\n<p>Transverse mesocolon</p>\n</td>\n<td width=\48%\>\n<p>Middle colic vessels</p>\n</td>\n</tr>\n<tr>\n<td width=\51%\>\n<p>Sigmoid mesocolon</p>\n</td>\n<td width=\48%\>\n<p>Sigmoid and superior rectal vessels</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/682a83236eea4834801e008fc9aa9611x1280x3716.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(136, 'Anatomy,', 'PM1045. The Triangle of Doom', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>The triangle of doom</strong> is bounded</p>\n<ul>\n<li>Medially by the vas deferens</li>\n<li>Laterally by the vessels of the spermatic cord (gonadal vessels)</li>\n<li>Inferiorly by peritoneal reflection</li>\n</ul>\n<p><strong>Apex </strong>oriented superiorly at <strong>internal ring</strong>.</p>\n<p><strong>The contents</strong> of the space include</p>\n<ul>\n<li>External iliac vessels</li>\n<li>Deep circumflex iliac vein</li>\n<li>Genital branch of the genitofemoral nerve</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3b35f594bf0b4482aff734ac2f73ab62x1280x1055.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(137, 'Surgery,', 'PM1038. Boundaries of Hesselbach’s triangle', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Lateral - inferior epigastric artery</li>\n<li>Medial - lateral border of rectus abdominis</li>\n<li>Inferior - inguinal ligament</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/18dc8430e3d0464aa62433640a547105x600x645.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Direct inguinal hernia</strong> emerges through<strong> Hesselbach’s triangle</strong> (Hence situated <strong>medial to inferior epigastric artery</strong>)</p>\n<p><strong>Indirect inguinal hernia </strong>enters deep inguinal ring (Hence it is <strong>lateral to inferior epigastric artery)</strong></p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(138, 'Surgery,', 'PM1037. Inguinal canal', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It is a <strong>4 cm long intermuscular canal </strong>directed downwards, forwards, and medially.</p>\n<p>It extends <strong>from the deep inguinal ring to the superficial ring.</strong></p>\n<p><strong>Boundaries:</strong></p>\n<div class=\panel-body ng-scope\>\n<table width=\601\>\n<tbody>\n<tr>\n<td>\n<p>Boundary</p>\n</td>\n<td>Structures forming</td>\n</tr>\n<tr>\n<td>\n<p>Anterior wall</p>\n</td>\n<td>\n<ul>\n<li>Skin, superficial fascia, external oblique aponeurosis (whole extent)</li>\n<li>Muscle fibers of internal oblique (lateral 1/3<sup>rd</sup>)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Posterior wall</p>\n</td>\n<td>\n<ul>\n<li>Parietal peritoneum, extraperitoneal tissues, fascia transversalis (whole extent)</li>\n<li>Medially reinforced by the conjoint tendon and reflected part of the inguinal ligament</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Roof</p>\n</td>\n<td>\n<ul>\n<li>Arched fibers of internal oblique and transversus abdominis forming the conjoint tendon medially</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Floor</p>\n</td>\n<td>\n<ul>\n<li>Grooved surface of the inguinal ligament</li>\n<li>Lacunar ligament at the medial end</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n&nbsp;</div></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Deep inguinal ring&nbsp;</strong>is an oval opening in the&nbsp;<strong>fascia transversalis</strong> situated 1.25cm above the mid-inguinal point.</p>\n<p><strong>Superficial inguinal ring </strong>is a&nbsp;triangular opening in<strong> external oblique aponeurosis</strong> situated 1cm above and lateral to pubic crest (or medial to the pubic tubercle).</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5f5fca36f32146b3bfa76b1c85145cfex600x606.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4556d0df7eaa4ac1b0c1d9f99e82d1f3x720x620.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(139, 'Anatomy,', 'PM0592. Abdominal planes and their landmarks', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3a8342468e1f4b4eac719ca7d878730cx1280x2558.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Planes that divide the abdomen into 9 regions are:</p>\n<ul>\n<li><strong>Horizontal planes</strong>&nbsp;\n<ul>\n<li>At the level of<strong> L3</strong> - <strong>Subcostal plane</strong> (between 10<sup>th</sup> costal cartilages). It corresponds to the 3<sup>rd</sup> part of the duodenum</li>\n<li>At the level of<strong> L5</strong> - <strong>Transtubercular plane</strong> (between tubercles of iliac crests). It corresponds to the origin of inferior vena cava.&nbsp;</li>\n</ul>\n</li>\n<li><strong>Vertical planes</strong>&nbsp;(paramedian or lateral planes)\n<ul>\n<li>From mid-clavicular point to mid-inguinal point on both sides&nbsp;</li>\n</ul>\n</li>\n</ul>\n<p>The&nbsp;nine regions&nbsp;of the abdomen include:</p>\n<ul>\n<li>Right hypochondriac, epigastric, left hypochondriac</li>\n<li>Right lumbar, umbilical (central), left lumbar</li>\n<li>Right iliac, hypogastric (suprapubic), left iliac</li>\n</ul>\n<p>Other planes and angles in the abdomen are:</p>\n<ul class=\ul1\>\n<li class=\li1\><strong>Transpyloric </strong>(Addisons)<strong> plane -&nbsp;</strong>passes&nbsp;<strong>midway</strong>&nbsp;between the&nbsp;<strong>suprasternal notch</strong>&nbsp;and the&nbsp;<strong>upper border of the pubic</strong>&nbsp;<strong>symphysis</strong>.</li>\n<li class=\li1\><strong>Supracristal plane -</strong> passes through the <strong>highest point </strong>of the<strong> iliac crest</strong> on both sides. It corresponds to the level of the<strong> L4 body</strong> or L4/5 disc and its spinous process. It is an important landmark when performing a lumbar puncture or spinal injection. The bifurcation of the abdominal aorta lies approximately in this plane.</li>\n<li class=\li1\>The <strong>plane </strong>of the <strong>pubic crest -</strong>&nbsp;passes through the <strong>upper border </strong>of the<strong> pubic symphysis</strong>. In supine, this plane intersects the tip of the coccyx and the femoral head.</li>\n<li class=\li1\><strong>Renal angle -</strong>&nbsp;between the <strong>12th rib</strong> and the outer border of<strong> erector spinae </strong>muscle. The lower border of normal kidneys may occasionally be felt here.&nbsp;</li>\n<li class=\li1\><strong>Lumbar triangle of Petit -</strong>&nbsp;formed below by the <strong>iliac crest</strong>, anteriorly by <strong>external oblique,</strong> and posteriorly by <strong>latissimus dorsi</strong>. Lumbar hernia can occur here.&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(140, 'Anatomy,', 'PM0565. Retroperitoneal structures', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The retroperitoneal structures are posterior to the peritoneal sac and do not have a mesentery. (Mnemonic:<strong> SAD PUCKER)</strong></p>\n<ul>\n<li><strong>S</strong>uprarenal gland</li>\n<li><strong>A</strong>orta</li>\n<li><strong>D</strong>uodenum (2<sup>nd</sup> and 3<sup>rd</sup> Part)</li>\n<li><strong>P</strong>ancreas (except the tail)</li>\n<li><strong>U</strong>reters</li>\n<li><strong>C</strong>eliac Plexus</li>\n<li><strong>C</strong>olon (Ascending and Descending)</li>\n<li><strong>K</strong>idneys</li>\n<li><strong>E</strong>sophagus</li>\n<li><strong>R</strong>ectum</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(141, 'Surgery,', 'PM0563. Inguinal canal and spermatic cord contents', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Inguinal canal contents:</strong></p>\n<table width=\494\>\n<tbody>\n<tr>\n<td><strong>Male</strong></td>\n<td><strong>Female</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li><strong>Spermatic cord </strong>&nbsp;(with genital branch of genitofemoral nerve)</li>\n<li><strong>Ilioinguinal nerve</strong></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><strong>Round ligament</strong> of the uterus&nbsp;</li>\n<li>Genital branch of genitofemoral nerve</li>\n<li><strong>Ilioinguinal nerve</strong></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/89792db95d08484bb9c1ea17a218e53fx1279x1221.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Spermatic cord contents:</strong></p>\n<ul>\n<li>Three arteries:\n<ul>\n<li>Testicular artery</li>\n<li>Deferential artery</li>\n<li>Cremasteric artery</li>\n</ul>\n</li>\n<li>Two nerves:\n<ul>\n<li>Genital branch of the genitofemoral nerve</li>\n<li>Sympathetic nerve fibers</li>\n</ul>\n</li>\n<li>Three other structures:\n<ul>\n<li>Ductus deferens</li>\n<li>Pampiniform plexus of veins</li>\n<li>Lymphatic vessels</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b8ee5e974da547ccb2d3ff910e6fdd22x1279x1263.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(142, 'Anatomy,', 'PM0560. Transition of layers from abdominal wall to scrotum', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Layers of the abdominal wall</strong></p>\n</td>\n<td>\n<p><strong>Corresponding layers of the scrotum</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Skin</p>\n</td>\n<td>\n<p>Skin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Superficial fascia</p>\n<p>(Camper and Scarpa)</p>\n</td>\n<td>\n<p>Colles’ fascia and dartos muscle</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>External oblique muscle</p>\n</td>\n<td>\n<p>External spermatic fascia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Internal oblique muscle</p>\n</td>\n<td>\n<p>Cremasteric fascia and muscle</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;Transverse abdominus muscle</p>\n</td>\n<td>\n<p>Does not continue</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Transversalis fascia</p>\n</td>\n<td>\n<p>Internal spermatic fascia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Extraperitoneal fat</p>\n</td>\n<td>\n<p>Extraperitoneal fat</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Parietal peritoneum</p>\n</td>\n<td>\n<p>Tunica vaginalis</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ca5415f018714345a1bf62527049964dx1280x1869.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(143, 'Anatomy,', 'PM0559. Branches of the abdominal aorta', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Branches of the abdominal aorta:</strong></p>\n<ul>\n<li>Anterior branches (unpaired):\n<ul>\n<li>Celiac trunk - T12</li>\n<li>Superior mesenteric artery - L1</li>\n<li>Inferior mesenteric artery - L3</li>\n</ul>\n</li>\n<li>Lateral branches (paired):\n<ul>\n<li>Inferior phrenic artery - T12</li>\n<li>Middle suprarenal artery - T12</li>\n<li>Renal artery - L1, L2</li>\n<li>Gonadal artery - L2</li>\n</ul>\n</li>\n<li>Dorsal branches:\n<ul>\n<li>Lumbar artery (four pairs) - L1 to L4</li>\n<li>Median sacral artery - L4&nbsp;</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(144, 'Anatomy', 'PM2401. Eponyms named after Friedrich Trendelenburg', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Trendelenburg sign</strong>: This sign is demonstrated by asking the patient to stand on one limb. When the patient stands on the affected limb, the pelvis severely drops over the swing limb.&nbsp;This is seen in the paralysis of gluteus medius and minimus, dislocated hip, fracture neck of femur</li>\n<li><strong>Trendelenburg gait</strong>: This gait is seen in patients with Trendelenburg sign. The body swings to the opposite side every time when the weight is borne on the same side.&nbsp;</li>\n<li><strong>Trendelenberg position: </strong>It is a position in which the patient is placed on a bed which is put into incline such that the patients head is lower than his feet&nbsp;(<strong>head-down position</strong>)</li>\n<li><strong>Reverse Trendelenberg position: </strong>It is a position in which the patient is placed on a bed which is put into incline such that the patients feet are lower than his head (head-up position)</li>\n<li><strong>Brodie Trendelenburg test:&nbsp;</strong>It is a test for presence of incompetent valves in lower limb.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(145, 'Anatomy', 'PM2396. Muscles causing the movements at Hip joint', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\517\>\n<tbody>\n<tr>\n<td><strong>Movements</strong></td>\n<td><strong>Principal muscles involved in the movements</strong></td>\n</tr>\n<tr>\n<td>Flexion</td>\n<td>\n<p>Psoas major</p>\n<p>Iliacus</p>\n<p>Rectus femoris</p>\n</td>\n</tr>\n<tr>\n<td>Extension</td>\n<td>\n<p>Gluteus maximus</p>\n<p>Biceps femoris</p>\n<p>Semitendinosus</p>\n<p>Semimembranosus (hamstrings)</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Abduction</td>\n<td>\n<p>Gluteus medius</p>\n<p>Gluteus minimus</p>\n<p>Gluteus maximus (upper muscle fibres)</p>\n<p>Assisted by tensor fascia lata, piriformis and sartorius.</p>\n</td>\n</tr>\n<tr>\n<td>Adduction</td>\n<td>\n<p>Adductor longus</p>\n<p>Adductor brevis</p>\n<p>Adductor magnus</p>\n<p>Gracilis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Medial rotation</td>\n<td>\n<p>Gluteus medius</p>\n<p>Gluteus minimus</p>\n<p>Tensor Fascia Lata</p>\n<p>Adductor muscles.</p>\n</td>\n</tr>\n<tr>\n<td>Lateral rotation</td>\n<td>\n<p>Gluteus maximus</p>\n<p>Obturator internus</p>\n<p>Superior and inferior gemelli</p>\n<p>Quadratus femoris</p>\n<p>Piriformis</p>\n<p>Assisted by obturator externus and sartorius</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(146, 'Anatomy', 'PM2395. Comparative features of the medial and lateral longitudinal arches of the foot.', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\100%\>\n<tbody>\n<tr>\n<td width=\35%\>\n<p><strong>Features</strong></p>\n</td>\n<td width=\32%\>\n<p><strong>Medial Longitudinal arch</strong></p>\n</td>\n<td width=\32%\>\n<p><strong>Lateral longitudinal arch</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\35%\>\n<p>Anterior pillar</p>\n</td>\n<td width=\32%\>\n<p>Talus, navicular, 3 cuneiform and 1<sup>st</sup>, 2nd and 3<sup>rd</sup> metatarsal</p>\n</td>\n<td width=\32%\>\n<p>Cuboid and 4<sup>th</sup>, 5<sup>th</sup> metatarsals</p>\n</td>\n</tr>\n<tr>\n<td width=\35%\>\n<p>Posterior pillar</p>\n</td>\n<td width=\32%\>\n<p>Medial half of calcaneum</p>\n</td>\n<td width=\32%\>\n<p>Lateral half of calcaneum</p>\n</td>\n</tr>\n<tr>\n<td width=\35%\>\n<p>Main joint involved</p>\n</td>\n<td width=\32%\>\n<p>Talo calcaneonavicular joint (TCN)</p>\n</td>\n<td width=\32%\>\n<p>Calcaneocuboid joint</p>\n</td>\n</tr>\n<tr>\n<td width=\35%\>\n<p>Summit</p>\n</td>\n<td width=\32%\>\n<p>Superior articular surface of Talus</p>\n</td>\n<td width=\32%\>\n<p>Superior articular surface of Calcaneum (at the leveled Subtalar joint)</p>\n</td>\n</tr>\n<tr>\n<td width=\35%\>\n<p>Extremities (piers)</p>\n</td>\n<td width=\32%\>\n<p>Tuberosity of calcaneum posteriorly and Heads of 1<sup>st</sup>, 2<sup>nd</sup>, 3<sup>rd</sup> metatarsal anteriorly</p>\n</td>\n<td width=\32%\>\n<p>Plantar surface of calcaneum posteriorly and Heads of 4<sup>th</sup>, 5<sup>th</sup> metatarsals anteriorly</p>\n</td>\n</tr>\n<tr>\n<td width=\35%\>\n<p>Ligament/intersegmental ties</p>\n</td>\n<td width=\32%\>\n<p>Plantar calcaneonavicular ligament (<strong>spring ligament</strong>)</p>\n</td>\n<td width=\32%\>\n<p>Long and short plantar ligaments</p>\n</td>\n</tr>\n<tr>\n<td width=\35%\>\n<p>Tie beams</p>\n</td>\n<td width=\32%\>\n<p>Plantar aponeurosis (medial part)</p>\n<p>Abductor hallucis</p>\n<p>Medial part of&nbsp; flexor digitorum brevis</p>\n</td>\n<td width=\32%\>\n<p>Plantar aponeurosis (lateral part)</p>\n<p>Abductor digiti minimi</p>\n</td>\n</tr>\n<tr>\n<td width=\35%\>\n<p>Slings</p>\n</td>\n<td width=\32%\>\n<p>Tibialis anterior&nbsp;</p>\n<p>Tibialis posterior</p>\n<p>Flexor hallucis longus</p>\n<p>Flexor digitorum longus</p>\n<p>&nbsp;</p>\n</td>\n<td width=\32%\>\n<p>Peroneus longus</p>\n<p>Peroneus brevis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(147, 'Anatomy', 'PM2354. Adductor Canal', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/84378bd2e4bf4e9db5353d045f805a19x600x694.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Boundaries of Adductor Canal</strong></td>\n</tr>\n<tr>\n<td><strong>Antero-lateral wall</strong></td>\n<td>Vastus medialis</td>\n</tr>\n<tr>\n<td><strong>Postero-medial wall (Floor)</strong></td>\n<td>\n<p>Adductor longus (above),</p>\n<p>Adductor magnus (below)</p>\n</td>\n</tr>\n<tr>\n<td><strong>Medial wall(Roof)</strong></td>\n<td>\n<p>Fibrous band connecting vastus medialis with adductor longus<strong>(Subsartorial fascia)</strong></p>\n<p>Sartorius</p>\n<p>Subsartorial nerve plexus</p>\n</td>\n</tr>\n<tr>\n<td><strong>Contents</strong></td>\n<td>\n<p>Femoral artery</p>\n<p>Femoral vein</p>\n<p>Saphenous nerve</p>\n<p>Nerve to vastus medialis</p>\n<p>Descending genicular artery&nbsp;</p>\n<p>Deep lymph vessels</p>\n<p>Two terminal divisions of the obturator nerve</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(148, 'Anatomy,', 'PM2284. Movements and muscles tested - lower limb', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\4\ width=\154\>\n<p><strong>Finding Location of a lesion in the lower limb:</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p><strong>Movement</strong></p>\n</td>\n<td width=\182\>\n<p><strong>Muscle</strong></p>\n</td>\n<td width=\154\>\n<p><strong>Spinal nerve level</strong></p>\n</td>\n<td width=\154\>\n<p><strong>Nerve</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Hip flexion</p>\n</td>\n<td width=\182\>\n<p>Iliopsoas</p>\n</td>\n<td width=\154\>\n<p>L1, 2</p>\n</td>\n<td width=\154\>\n<p>Femoral</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Hip adduction</p>\n</td>\n<td width=\182\>\n<p>Adductors</p>\n</td>\n<td width=\154\>\n<p>L2, 3</p>\n</td>\n<td width=\154\>\n<p>Obturator</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Hip extension</p>\n</td>\n<td width=\182\>\n<p>Gluteus maximus</p>\n</td>\n<td width=\154\>\n<p>L5, S1</p>\n</td>\n<td width=\154\>\n<p>Inferior gluteal</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Knee flexion</p>\n</td>\n<td width=\182\>\n<p>Hamstrings</p>\n</td>\n<td width=\154\>\n<p>S1</p>\n</td>\n<td width=\154\>\n<p>Sciatic</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Knee extension</p>\n</td>\n<td width=\182\>\n<p>Quadriceps femoris</p>\n</td>\n<td width=\154\>\n<p>L3, 4</p>\n</td>\n<td width=\154\>\n<p>Femoral</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Ankle dorsiflexion</p>\n</td>\n<td width=\182\>\n<p>Tibialis anterior</p>\n</td>\n<td width=\154\>\n<p>L4</p>\n</td>\n<td width=\154\>\n<p>Deep fibular</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Ankle eversion</p>\n</td>\n<td width=\182\>\n<p>Fibularis longus and fibularis brevis</p>\n</td>\n<td width=\154\>\n<p>L5, S1</p>\n</td>\n<td width=\154\>\n<p>Superficial fibular</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Ankle inversion</p>\n</td>\n<td width=\182\>\n<p>Tibialis posterior</p>\n</td>\n<td width=\154\>\n<p>L4, 5</p>\n</td>\n<td width=\154\>\n<p>Tibial</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Ankle plantar flexion</p>\n</td>\n<td width=\182\>\n<p>Gastrocnemius/soleus</p>\n</td>\n<td width=\154\>\n<p>S1, 2</p>\n</td>\n<td width=\154\>\n<p>Tibial</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Great toe extension</p>\n</td>\n<td width=\182\>\n<p>Extensor hallucis longus</p>\n</td>\n<td width=\154\>\n<p>L5</p>\n</td>\n<td width=\154\>\n<p>Deep fibular</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(149, 'Anatomy', 'PM2283. Various muscles of the leg and their innervation:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Muscles of the anterior compartment of the leg and dorsum of foot</strong></p>\n</td>\n<td>\n<p><strong>Nerve Supply</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tibialis anterior</p>\n</td>\n<td rowspan=\5\>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Deep Peroneal Nerve</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Extensor hallucis longus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Extensor digitorum longus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Peroneus tertius</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Extensor digitorum brevis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Muscles of the lateral component of the leg</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Peroneus longus</p>\n</td>\n<td rowspan=\2\>\n<p>&nbsp;</p>\n<p>Superficial Peroneal Nerve</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Peroneus brevis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Superficial muscles of the&nbsp;</strong><strong>posterior compartment of the leg</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gastrocnemius</p>\n</td>\n<td rowspan=\3\>\n<p>&nbsp;</p>\n<p>Tibial Nerve</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Soleus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Plantaris</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Deep muscles of the posterior compartment of the leg</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Popliteus</p>\n</td>\n<td rowspan=\4\>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Tibial Nerve</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Flexor digitorum longus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Flexor hallucis longus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tibialis posterior</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(150, 'Anatomy', 'PM1241. Femoral Triangle', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The femoral triangle is a depressed, intermuscular space present in the anteromedial aspect of the proximal thigh.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6c2eaf00759943729de1af4074dcc219x600x1189.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Boundaries of Femoral triangle are:</strong></p>\n<p><strong>Medially</strong>- Medial border of Adductor longus</p>\n<p><strong>Laterally</strong>- Medial border of Sartorius</p>\n<p><strong>Base</strong>- Inguinal ligament</p>\n<p><strong>Floor</strong> (lateral to medial)- Iliacus, Psoas major, Pectineus, Adductor longus</p>\n<p><strong>Roof</strong>- Skin, Superficial fascia, Fascia lata, superficial branches of femoral vessels–superficial epigastric, superficial external pudendal, superficial circumflex iliac vessels and GSV.&nbsp;</p>\n<p>Note: Femoral branch of genitofemoral nerve which forms a content of the triangle also forms its roof as it pierces the fascia to supply the skin over the triangle.&nbsp;</p>\n<p><strong>Contents:</strong></p>\n<ul>\n<li>Femoral sheath containing lymph node of Cloquet, <strong>femoral vein, femoral artery, femoral branch of genitofemoral nerve.</strong></li>\n<li>Femoral nerve and its branches</li>\n<li>Lateral femoral cutaneous nerve of thigh</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(151, 'Anatomy', 'PM1236. Lumbar Plexus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Lumbar plexus</strong>&nbsp;is formed by the divisions of the first four lumbar nerves (<strong>L1-L4</strong>) and from contributions of the subcostal nerve (<strong>T12)</strong>, which is the last thoracic nerve.&nbsp;</p>\n<p>The following table shows the branches of the lumbar plexus, their root value, muscles innervated, and cutaneous branches:&nbsp;</p>\n<table border=\all\>\n<tbody>\n<tr>\n<td>\n<p><strong>Nerve</strong></p>\n</td>\n<td>\n<p><strong>Root value</strong></p>\n</td>\n<td>\n<p><strong>Innervated muscles</strong></p>\n</td>\n<td>\n<p><strong>Cutaneous branches</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iliohypogastric</p>\n</td>\n<td>\n<p>T12-L1</p>\n</td>\n<td rowspan=\2\>\n<p>Transversus abdominis</p>\n<p>Abdominal internal oblique</p>\n</td>\n<td>\n<p>Anterior cutaneous ramus</p>\n<p>Lateral cutaneous ramus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ilioinguinal</p>\n</td>\n<td>\n<p>L1</p>\n</td>\n<td>\n<p>Anterior scrotal nerves in males</p>\n<p>Anterior labial nerves in females</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Genitofemoral</p>\n</td>\n<td>\n<p>L1, L2</p>\n</td>\n<td>\n<p>Cremaster in males</p>\n</td>\n<td>\n<p>Femoral ramus</p>\n<p>Genital ramus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lateral femoral cutaneous nerve of thigh</p>\n</td>\n<td>\n<p>L2, L3</p>\n</td>\n<td>\n<p>------</p>\n</td>\n<td>\n<p>Lateral femoral cutaneous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Obturator</p>\n</td>\n<td>\n<p>L2, L3, L4</p>\n</td>\n<td>\n<p>Obturator externus</p>\n<p>Adductor longus</p>\n<p>Adductor brevis</p>\n<p>Gracilis</p>\n<p>Pectineus</p>\n<p>Adductor magnus</p>\n</td>\n<td>\n<p>Cutaneous ramus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Femoral</p>\n</td>\n<td>\n<p>L2, L3, L4</p>\n</td>\n<td>\n<p>Iliacus</p>\n<p>Pectineus</p>\n<p>Sartorius</p>\n<p>Quadriceps femoris</p>\n</td>\n<td>\n<p>Anterior cutaneous branches</p>\n<p>Saphenous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Segmental branches</p>\n</td>\n<td>\n<p>T12-L4</p>\n</td>\n<td>\n<p>Psoas major</p>\n<p>Quadratus lumborum</p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/da0be4b4cd4a4ebfa93c36cb93f4e8edx600x824.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(152, 'Anatomy,', 'PM1050. Anatomy of Femoral Canal', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/fe0e0019edd541f18ba6f16ab11eec83x1280x3069.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(153, 'Anatomy,', 'PM0127. Unhappy triad of knee joint', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It is also called <strong>ODonoghues triad</strong>/ terrible triad/ horrible triad of the knee. It mostly occurs in football, basketball &amp; rugby players,&nbsp;due to a lateral blow to the knee.</p>\n<p>It is characterized by injury to:&nbsp;</p>\n<ul>\n<li><strong>M</strong>edial meniscus</li>\n<li><strong>A</strong>nterior cruciate ligament</li>\n<li><strong>T</strong>ibial collateral ligament</li>\n</ul>\n<p>(Mnemonic – MAT)</p>\n<p>The image below shows the unhappy triad of the knee joint on MRI (PDW SPIR):</p>\n<ol>\n<li>Rupture of the anterior cruciate ligament</li>\n<li>Rupture of the medial collateral ligament</li>\n<li>Inner meniscal tear (image shows complex rupture of the posterior horn).</li>\n</ol></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a4c2d7a49f734c69a162b45753aaf44ax800x388.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(154, 'Medicine,', 'PM1642. Spinal Cord Segments and Corresponding Vertebral Bodies.', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table class=\t1\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Spinal Cord Level</strong></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Corresponding Vertebral Body</strong></p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Upper cervical</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Same as cord level</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Lower cervical</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>1 level higher</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Upper thoracic</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>2 levels higher</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Lower thoracic</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>2 to 3 levels higher</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Lumbar</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>T10-T12</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Sacral</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>T12-L1</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(155, 'Anatomy', 'PM1160. Vertebral Spines as Landmarks for the Viscera', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Spine/space </strong></p>\n</td>\n<td>\n<p><strong>Vertebral body level </strong></p>\n</td>\n<td>\n<p><strong>Viscera </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C5</p>\n</td>\n<td>\n<p>C6</p>\n</td>\n<td>\n<p>Cricoid cartilage</p>\n<p>Start of esophagus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C7</p>\n</td>\n<td>\n<p>C7-T1</p>\n</td>\n<td>\n<p>Lung apex</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T3</p>\n</td>\n<td>\n<p>Upper T4</p>\n</td>\n<td>\n<p>Aorta reaches vertebral column,</p>\n<p>Medial part of the scapular spine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T3-T4 space</p>\n</td>\n<td>\n<p>T4-T5 disc</p>\n</td>\n<td>\n<p>Sternal plane/angle of Louis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T4</p>\n</td>\n<td>\n<p>Upper T5</p>\n</td>\n<td>\n<p>Concavity of aortic arch</p>\n<p>Azygos vein into SVC</p>\n<p>Bifurcation of pulmonary trunk</p>\n<p>Upper border of heart</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T6</p>\n</td>\n<td>\n<p>T7</p>\n</td>\n<td>\n<p>Tracheal bifurcation (The level of bifurcation of the trachea varies from the lower third of the T4 to the middle of the T7.&nbsp;The average position is at the level of the lower third of the T5 )&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T7</p>\n</td>\n<td>\n<p>Upper T8</p>\n</td>\n<td>\n<p>Inferior angle of scapula</p>\n<p>Lower border of heart</p>\n<p>IVC crosses diaphragm</p>\n<p>Central tendon of diaphragm</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T12-L1 space</p>\n</td>\n<td>\n<p>Mid L1</p>\n</td>\n<td>\n<p>Lowest level of pleura</p>\n<p>Pylorus, transpyloric plane</p>\n<p>Hilum of left kidney</p>\n<p>Origin of renal arteries and superior mesenteric artery</p>\n<p>Neck of pancreas</p>\n<p>Spinal cord termination&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>L1-L2 space</p>\n</td>\n<td>\n<p>Mid L2</p>\n</td>\n<td>\n<p>Head of pancreas</p>\n<p>Duodenojejunal flexure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>L2-L3 space</p>\n</td>\n<td>\n<p>Mid L3</p>\n</td>\n<td>\n<p>Lower border of kidney&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>L3-L4 space</p>\n</td>\n<td>\n<p>Mid L4</p>\n</td>\n<td>\n<p>Bifurcation of aorta</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>L4-L5 space</p>\n</td>\n<td>\n<p>Mid L5</p>\n</td>\n<td>\n<p>Formation of IVC</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(156, 'Anatomy', 'PM2389. General rules of ossification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>1. Primary ossification center is single and appears before birth.&nbsp;</p>\n<p><strong>Exceptions:&nbsp;</strong>Carpal bones&nbsp;ossify after birth. Clavicle&nbsp;has 2 primary ossification centers.</p>\n<p>2. Secondary ossification centers can be single or multiple and appear after birth.</p>\n<p><strong>Exceptions:</strong> Secondary center for lower end of femur appears before birth (9<sup>th</sup> month of fetal life). Epiphysis of the upper end of tibia (proximal epiphysis) may appear before birth in some individuals.</p>\n<p>3. Secondary centers of ossification which appear first are last to unite.</p>\n<p><strong>Exceptions:</strong> Lower end of fibula. The secondary center at the lower end of fibula appears during the first year (before the upper end which appears in 3<sup>rd</sup> or 4<sup>th</sup> year) but fuses between 15<sup>th</sup> and 17<sup>th</sup> year, before the upper end that fuses between the 17<sup>th</sup> and 19<sup>th</sup> year.</p>\n<p>4. The secondary ossification centers fuse together to form a single epiphysis, which then fuses with the diaphysis.</p>\n<p><strong>Exceptions:</strong>&nbsp;Upper end of femur. The three secondary centers at the upper end of femur (head - 1<sup>st</sup> year, greater trochanter- 4<sup>th</sup> year, lesser trochanter- 12<sup>th</sup> year) fuse independently with the shaft.&nbsp;</p>\n<p>5. The direction of the nutrient artery is opposite to the direction of the growing end of the bone. &nbsp; &nbsp; &nbsp; &nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(157, 'Anatomy', 'PM2388. Types of Synovial Joints', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\4\><strong>Classification of Synovial Joints</strong></td>\n</tr>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Articular surfaces</strong></td>\n<td><strong>Movement</strong></td>\n<td><strong>Examples</strong></td>\n</tr>\n<tr>\n<td><strong>1. Plane</strong></td>\n<td>Almost flat</td>\n<td>Minimal sliding movements</td>\n<td>Intercarpal, intermetacarpal, carpometacarpal (except first), intertarsal, intermetatarsal, tarsometatarsal, joints between articular processes of vertebrae, cricothyroid joint, cricoarytenoid joint, superior tibiofibular, interchondral joint (5-9 ribs), costovertebral, costotransverse, acromioclavicular, chondrosternal (except first) joints</td>\n</tr>\n<tr>\n<td><strong>2. Hinge</strong></td>\n<td>Pulley shaped</td>\n<td>Uniaxial - flexion &amp; extension</td>\n<td>Elbow, ankle, interphalangeal joints</td>\n</tr>\n<tr>\n<td><strong>3. Pivot</strong></td>\n<td>Central pivot (peg) surrounded by osteoligamentous ring</td>\n<td>Uniaxial - rotation (supination and pronation)</td>\n<td>Superior and inferior radioulnar joints, median atlantoaxial joint</td>\n</tr>\n<tr>\n<td><strong>4. Condylar (bicondylar)</strong></td>\n<td>2 convex condyles articulate with concave or flat surfaces on the other side</td>\n<td>Biaxial - but predominantly one axis movement (flexion &amp; extension) with limited rotation</td>\n<td>Knee joint, temporomandibular joint</td>\n</tr>\n<tr>\n<td><strong>5. Ellipsoid</strong></td>\n<td>Oval convex surface fitting into an elliptical concavity</td>\n<td>Biaxial - flexion &amp; extension, abduction &amp; adduction, circumduction</td>\n<td>Radiocarpal (wrist), metacarpophalangeal joints</td>\n</tr>\n<tr>\n<td><strong>6. Saddle</strong></td>\n<td>Each articular surface has a concave and convex region fitting the convex and concave regions of the other surface</td>\n<td>Biaxial - mainly 2 axis, flexion &amp; extension,&nbsp; abduction &amp; adduction; very limited coupled axial rotation (conjunct rotation)&nbsp;</td>\n<td>First carpometacarpal joint (of thumb), calcaneocuboid joints, incudomalleolar joint, sternoclavicular joint</td>\n</tr>\n<tr>\n<td><strong>7. Ball &amp; Socket</strong></td>\n<td>Globular head fitting into a cup-shaped socket</td>\n<td>Multiaxial - flexion &amp; extension, abduction &amp; adduction, circumduction, and rotation</td>\n<td>Shoulder, hip, talocalcaneonavicular, incudostapedial joint</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(158, 'Anatomy', 'PM2313. Types of Cartilage', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Type of Cartilage</strong></td>\n<td><strong>Hyaline Cartilage</strong></td>\n<td><strong>Elastic Cartilage</strong></td>\n<td><strong>Fibrocartilage</strong></td>\n</tr>\n<tr>\n<td><strong>Colour</strong></td>\n<td><span>Bluish opalescent</span></td>\n<td><span>Yellow</span></td>\n<td><span>White</span></td>\n</tr>\n<tr>\n<td><strong>Collagen type</strong></td>\n<td>Type 2</td>\n<td>Type 2</td>\n<td>Type 1 (mainly) and type 2</td>\n</tr>\n<tr>\n<td><strong>Perichondrium</strong></td>\n<td>Present (except at epiphyses &amp; articular cartilage)</td>\n<td>Present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td><strong>Calcification</strong></td>\n<td>Occurs with old age</td>\n<td>No calcification</td>\n<td>Occurs only with bone repair</td>\n</tr>\n<tr>\n<td><strong>Cells</strong></td>\n<td>Chondroblasts &amp; chondrocytes</td>\n<td>Chondroblasts &amp; chondrocytes</td>\n<td>Fibroblasts &amp; chondrocytes</td>\n</tr>\n<tr>\n<td><strong>Fibres</strong></td>\n<td>Thin collagen</td>\n<td>Elastic fibres</td>\n<td>Thick collagen</td>\n</tr>\n<tr>\n<td><strong>Examples</strong></td>\n<td>\n<p>Arytenoids except for apices</p>\n<p>Cricoid cartilage</p>\n<p>Thyroid cartilage</p>\n<p>Trachea and bronchi</p>\n<p>Articular cartilage at ends of bones</p>\n<p>Epiphyseal plate</p>\n<p>Costal cartilages of ribs</p>\n<p>Temporary skeleton in embryo</p>\n</td>\n<td>\n<p>Apices of arytenoid</p>\n<p>Epiglottis</p>\n<p>Corniculate cartilages</p>\n<p>Cuneiform cartilages</p>\n<p>Eustachian tube</p>\n<p>Pinna(Auricle)</p>\n<p>External auditory meatus&nbsp;</p>\n</td>\n<td>\n<p>Articular discs e.g. of Temporomandibular joint and Sternoclavicular joint</p>\n<p>Intervertebral discs</p>\n<p>Menisci</p>\n<p>Glenoid and acetabular labrum&nbsp;&nbsp;&nbsp;</p>\n<p>Pubic symphysis</p>\n<p>Manubriosternal joint</p>\n<p>Lining of the bony grooves for tendons</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c35a8db73d4b4edc82a707f81f3dcfdfx1280x3831.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(159, 'Physiology,', 'PM1973. Classification of muscles according to their shape/direction of muscle fibers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table class=\t1\ border=\1\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Muscles with parallel fasciculi</strong></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Muscles with oblique fasciculi</strong></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Muscles with spiral or twisted fasciculi</strong></p>\n<p class=\p2\><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Quadrilateral:</strong> Thyrohyoid</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Triangular:&nbsp;</strong>Temporalis, Adductor longus,&nbsp;</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Spiral:</strong> Pectoralis major, Latissimus dorsi, Supinator and&nbsp;Trapezius</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Strap like:</strong> Sartorius, Sternohyoid</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Unipennate:&nbsp;</strong>Extensor digitorum longus, Flexor pollicis longus, Peroneus tertius, Palmar interossei</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Partially cruciate and partially spiral:</strong> Masseter, Adductor magnus, Sternoclediomastoid&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Strap like with tendinous intersections:</strong> Rectus abdominis</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Bipennate:</strong> Rectus femoris, Flexor hallucis longus, Peroneus longus, Dorsal interossei</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p2\>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Fusiform:</strong> Biceps brachii, digastric</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Multipennate: </strong>Deltoid, Subscapularis</p>\n</td>\n<td class=\td1\ valign=\top\>&nbsp;</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p2\>&nbsp;</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Circumpennate:</strong> Tibialis anterior</p>\n</td>\n<td class=\td1\ valign=\top\>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(160, 'Anatomy', 'PM0708. Comparison of Lymph and Blood Capillaries', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\308\>\n<p><strong>Lymph capillaries</strong></p>\n</td>\n<td width=\308\>\n<p><strong>Blood capillaries</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Colourless, difficult to observe</p>\n</td>\n<td width=\308\>\n<p>Reddish, easy to observe</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Blind (closed at the tip)</p>\n</td>\n<td width=\308\>\n<p>Joined to arterioles at one end and to venules at another end</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Wider than blood capillaries</p>\n</td>\n<td width=\308\>\n<p>Narrower than lymph capillaries</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Wall consist of thin endothelium and poorly developed basement membrane</p>\n</td>\n<td width=\308\>\n<p>Wall consist of normal endothelium and basement membrane</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Contain colourless lymph</p>\n</td>\n<td width=\308\>\n<p>Contain red blood</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Have relatively low pressure</p>\n</td>\n<td width=\308\>\n<p>Have relatively high pressure</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Absorb tissue fluid from intercellular spaces</p>\n</td>\n<td width=\308\>\n<p>Add tissue fluid to intercellular spaces</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(161, 'Anatomy,', 'PM0705. Differentiating Features between Skeletal, Smooth and Cardiac Muscles', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\663\>\n<tbody>\n<tr>\n<td width=\54\>\n<p>&nbsp;</p>\n</td>\n<td width=\190\>\n<p><strong>Skeletal Muscle</strong></p>\n</td>\n<td width=\210\>\n<p><strong>Smooth Muscle</strong></p>\n</td>\n<td width=\210\>\n<p><strong>Cardiac Muscle</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Location</p>\n</td>\n<td width=\190\>\n<p>&nbsp;</p>\n<p>Limbs, body wall, tongue, pharynx, and beginning of the esophagus</p>\n</td>\n<td width=\210\>\n<p>&nbsp;</p>\n<p>Esophagus (distal part), urogenital tract, urinary bladder, blood vessels, iris of the eye, arrector pili muscle</p>\n</td>\n<td width=\210\>\n<p>&nbsp;</p>\n<p>Wall of the heart</p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Cell shape</p>\n</td>\n<td width=\190\>\n<p>Long and cylindrical</p>\n</td>\n<td width=\210\>\n<p>Short, elongated, fusiform,or spindle-shaped</p>\n</td>\n<td width=\210\>\n<p>Short, narrow, and cylindrical</p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Branching</p>\n</td>\n<td width=\190\>\n<p>Fibers unbranched</p>\n</td>\n<td width=\210\>\n<p>Fibers unbranched</p>\n</td>\n<td width=\210\>\n<p>Fibers branched</p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Nucleus</p>\n</td>\n<td width=\190\>\n<p>Multinucleated, peripheral</p>\n</td>\n<td width=\210\>\n<p>Uninucleated, central</p>\n</td>\n<td width=\210\>\n<p>Uninucleated, central</p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Membrane</p>\n</td>\n<td width=\190\>\n<p>Bounded by sarcolemma</p>\n</td>\n<td width=\210\>\n<p>Bounded by plasmalemma</p>\n</td>\n<td width=\210\>\n<p>Bounded by plasmalemma</p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Striations</p>\n</td>\n<td width=\190\>\n<p>Light and dark bands</p>\n</td>\n<td width=\210\>\n<p>Absent</p>\n</td>\n<td width=\210\>\n<p>Faint light and dark bands&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Cell-cell Junction</p>\n</td>\n<td width=\190\>\n<p>No&nbsp;</p>\n</td>\n<td width=\210\>\n<p>Gap junction (Nexus)</p>\n</td>\n<td width=\210\>Intercalated Disc</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>T Tubules</p>\n</td>\n<td width=\190\>\n<p>A-I junction, triad</p>\n</td>\n<td width=\210\>\n<p>None</p>\n</td>\n<td width=\210\>Z-line, diad</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Nerve supply</p>\n</td>\n<td width=\190\>\n<p>Somatic nervous system</p>\n</td>\n<td width=\210\>\n<p>Autonomic nervous system</p>\n</td>\n<td width=\210\>\n<p>Autonomic nervous system</p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Blood supply</p>\n</td>\n<td width=\190\>\n<p>Abundant</p>\n</td>\n<td width=\210\>\n<p>Scanty</p>\n</td>\n<td width=\210\>\n<p>Abundant</p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Source of ↑ cytosolic Ca<sup>2+</sup></p>\n</td>\n<td width=\190\>Sarcoplasmic reticulum (SR)&nbsp;</td>\n<td width=\210\>\n<p>SR and ECF&nbsp;</p>\n</td>\n<td width=\210\>SR and ECF</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Special Features</p>\n</td>\n<td width=\190\>Well developed Sarcoplasmic reticulum and T-Tubules</td>\n<td width=\210\>\n<p>Dense bodies, caveolae, and cytoplasmic vesicles</p>\n</td>\n<td width=\210\>Intercalated Disc</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Regeneration</p>\n</td>\n<td width=\190\>Limited (Satellite cells)</td>\n<td width=\210\>\n<p>Present</p>\n</td>\n<td width=\210\>None</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Ca<sup>2+</sup> regulation</p>\n</td>\n<td width=\190\>Troponin&nbsp;</td>\n<td width=\210\>\n<p>Calmodulin (myosin)</p>\n</td>\n<td width=\210\>Troponin</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Contraction</p>\n</td>\n<td width=\190\>\n<p>Very rapid</p>\n</td>\n<td width=\210\>\n<p>Slow</p>\n</td>\n<td width=\210\>\n<p>Rapid</p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Fatigue</p>\n</td>\n<td width=\190\>\n<p>Get fatigued soon</p>\n</td>\n<td width=\210\>\n<p>Do not get fatigued</p>\n</td>\n<td width=\210\>\n<p>Never get fatigued</p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Control</p>\n</td>\n<td width=\190\>\n<p>Voluntary</p>\n</td>\n<td width=\210\>\n<p>Involuntary</p>\n</td>\n<td width=\210\>\n<p>Involuntary</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cd4784af8b7d40b1948877804cc07e58x1280x2577.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(162, 'Anatomy', 'PM0703. Types of Epiphysis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>There are four types of epiphysis.</p>\n<p><strong>Pressure epiphysis</strong></p>\n<ul>\n<li>Articular and assist in the transmission of weight</li>\n<li>Found in regions of the bone that are under pressure during movement or locomotion</li>\n<li>Examples: Head of the humerus, Head of the femur, Condyles of femur and tibia</li>\n</ul>\n<p><strong>Traction epiphysis</strong></p>\n<ul>\n<li>Non-articular and&nbsp;do not transmit weight</li>\n<li>Provide attachment to one or more tendons that exert traction on the epiphysis</li>\n<li>Traction epiphyses ossify later than pressure epiphyses</li>\n<li>Examples: Greater and lesser tubercles of the humerus, and greater and lesser trochanters of the femur</li>\n</ul>\n<p><strong>Atavistic epiphysis</strong></p>\n<ul>\n<li>An independent bone in lower animals but in humans has fused to another bone</li>\n<li>Examples: Coracoid process&nbsp;is fused to the scapula in humans but is a separate bone in four-legged animals</li>\n</ul>\n<p><strong>Aberrant epiphysis</strong></p>\n<ul>\n<li>Deviations from the normal and are not always present</li>\n<li>Example:&nbsp;Epiphysis at the head of the first metacarpal and at the base of the other metacarpal bones</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(163, 'Anatomy,', 'PM0702. Differences between Compact and Cancellous bones', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The table below shows the differences between Compact and Cancellous bones:</p>\n<table>\n<tbody>\n<tr>\n<td width=\208\>\n<p>&nbsp;</p>\n</td>\n<td width=\208\>\n<p><strong>Compact bone</strong></p>\n</td>\n<td width=\208\>\n<p><strong>Cancellous (spongy) bone</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p><strong>Location</strong></p>\n</td>\n<td width=\208\>\n<p>Outer Cortex</p>\n</td>\n<td width=\208\>\n<p>Inner Medulla</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p><strong>Lamellae</strong></p>\n</td>\n<td width=\208\>\n<p>Arranged to form Harversian system</p>\n</td>\n<td width=\208\>\n<p>Arranged in a meshwork, so Haversian systems are absent</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p><strong>Bone marrow</strong></p>\n</td>\n<td width=\208\>\n<p>Yellow, stores fat after puberty. It is red before puberty</p>\n</td>\n<td width=\208\>\n<p>Red, produce RBCs, granular series of WBC and platelets</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p><strong>Nature</strong></p>\n</td>\n<td width=\208\>\n<p>Hard and ivory like</p>\n</td>\n<td width=\208\>\n<p>Spongy</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(164, 'Anatomy,', 'PM0666. Types of Muscle fibers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\154\>\n<p>&nbsp;</p>\n</td>\n<td width=\154\>\n<p><strong>Type I or 1</strong></p>\n</td>\n<td width=\154\>\n<p><strong>Type IIA or 2A</strong></p>\n</td>\n<td width=\154\>\n<p><strong>Type IIB or 2X</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Other names</p>\n</td>\n<td width=\154\>\n<p>Slow, oxidative (SO)</p>\n</td>\n<td width=\154\>\n<p>Fast, oxidative, glycolytic (FOG)</p>\n</td>\n<td width=\154\>\n<p>Fast, glycolytic (FG)</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Function</p>\n</td>\n<td width=\154\>\n<p>Sustained forces, such as postural muscles</p>\n</td>\n<td width=\154\>\n<p>Powerful fast movements</p>\n</td>\n<td width=\154\>\n<p>Powerful fast movements</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Main source of ATP</p>\n</td>\n<td width=\154\>\n<p>Oxidative phosphorylation</p>\n</td>\n<td width=\154\>\n<p>Oxidative phosphorylation</p>\n</td>\n<td width=\154\>\n<p>Glycolysis</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Size of the motor unit</p>\n</td>\n<td width=\154\>\n<p>Small</p>\n</td>\n<td width=\154\>\n<p>Large</p>\n</td>\n<td width=\154\>\n<p>Large</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Mitochondria</p>\n</td>\n<td width=\154\>\n<p>Many</p>\n</td>\n<td width=\154\>\n<p>Intermediate</p>\n</td>\n<td width=\154\>\n<p>Few</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Capillaries</p>\n</td>\n<td width=\154\>\n<p>Many</p>\n</td>\n<td width=\154\>\n<p>Many</p>\n</td>\n<td width=\154\>\n<p>Few</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Myoglobin content</p>\n</td>\n<td width=\154\>\n<p>High</p>\n</td>\n<td width=\154\>\n<p>High</p>\n</td>\n<td width=\154\>\n<p>Low</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Colour</p>\n</td>\n<td width=\154\>\n<p>Red</p>\n</td>\n<td width=\154\>\n<p>Red</p>\n</td>\n<td width=\154\>\n<p>White</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Myosin ATPase activity</p>\n</td>\n<td width=\154\>\n<p>Low</p>\n</td>\n<td width=\154\>\n<p>High</p>\n</td>\n<td width=\154\>\n<p>High</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Glycolytic capacity</p>\n</td>\n<td width=\154\>\n<p>Low</p>\n</td>\n<td width=\154\>\n<p>Intermediate</p>\n</td>\n<td width=\154\>\n<p>High</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Oxidative capacity</p>\n</td>\n<td width=\154\>\n<p>High</p>\n</td>\n<td width=\154\>\n<p>Intermediate</p>\n</td>\n<td width=\154\>\n<p>Low</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Resistance to Fatigue</p>\n</td>\n<td width=\154\>\n<p>Fatigue Resistant</p>\n</td>\n<td width=\154\>\n<p>Fatigue Resistant</p>\n</td>\n<td width=\154\>\n<p>Fatigue Susceptible</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(165, 'Biochemistry', 'PM0909. Factors Affecting the Rate of Reaction', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Factors Affecting The Rate of Reaction</strong></p>\n</td>\n<td>\n<p><strong>Mechanism</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Concentration of enzyme</p>\n</td>\n<td>\n<p>Directly proportional to the rate of reaction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Concentration of substrate</p>\n</td>\n<td>\n<p>Directly proportional within a limited range of substrate concentration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Temperature</p>\n</td>\n<td>\n<p>Rate of reaction increases with increase in temperature to maximum then declines.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>pH</p>\n</td>\n<td>\n<p>There is specific pH for every enzyme at which rate of reaction is maximum &amp; above or below that pH rate declines.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Product concentration</p>\n</td>\n<td>\n<p>Inversely related to the rate of reaction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Activators</p>\n</td>\n<td>\n<p>Increase the rate of reaction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Time</p>\n</td>\n<td>\n<p>Related to Alteration in pH &amp; temperature</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Light &amp; Radiations</p>\n</td>\n<td>\n<p>It may inactivate certain enzymes</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(166, 'Biochemistry', 'PM2311. Pyruvate metabolism', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Enzyme involved</strong></td>\n<td>\n<p><strong>Fate of pyruvate</strong></p>\n</td>\n</tr>\n<tr>\n<td>1</td>\n<td>Cahill cycle (Alanine aminotransferase)</td>\n<td>\n<p>Carries amino group from muscle to liver.</p>\n<p>Converts alanine to pyruvate and vise-versa.</p>\n</td>\n</tr>\n<tr>\n<td>2</td>\n<td>Pyruvate carboxylase</td>\n<td>Formation of oxaloacetate from pyruvate to be used in the TCA cycle</td>\n</tr>\n<tr>\n<td>3</td>\n<td>Pyruvate dehydrogenase</td>\n<td>Pyruvate to acetyl Co-A to be used in the TCA cycle</td>\n</tr>\n<tr>\n<td>4</td>\n<td>Lactic acid dehydrogenase</td>\n<td>Pyruvate to lactate(Anaerobic glycolysis)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(167, 'Biochemistry', 'PM2309. Transport of ammonia in blood (Cahill and Cori cycle)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/aab20ad1ba7a4eeea5138dd6d3455e08x1280x1597.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(168, 'Biochemistry', 'PM2194. Essential Pentosuria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ccd1ed18d1004b4ea6d73d8d019c7d27x1280x1752.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(169, 'Biochemistry', 'PM2054. Irreversible enzymes in gluconeogenesis pathway', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The&nbsp;enzymes can be remembered using the mnemonic <strong>P</strong>athway <strong>P</strong>roduces <strong>F</strong>resh <strong>G</strong>lucose.</p>\n<table>\n<tbody>\n<tr>\n<td>Enzymes</td>\n<td>Reaction and site</td>\n<td>Cofactors</td>\n</tr>\n<tr>\n<td><strong>P</strong>yruvate carboxylase</td>\n<td>\n<p>Pyruvate → Oxaloacetate</p>\n<p>mitochondria</p>\n</td>\n<td>\n<p>Biotin, ATP</p>\n<p>Activated by acetyl-CoA</p>\n</td>\n</tr>\n<tr>\n<td><strong>P</strong>hosphoenolpyruvate carboxykinase</td>\n<td>Oxaloacetate&nbsp;→ PhosphoenolPyruvate (cytosol)</td>\n<td>GTP</td>\n</tr>\n<tr>\n<td><strong>F</strong>ructose-1,6-bisphosphatase</td>\n<td>Fructose-1,6-bisphosphate&nbsp;→ fructose-6-phosphate (cytosol)</td>\n<td>\n<p>Citrate(+ve)</p>\n<p>Fructose 2,6 bisphosphate (-ve)</p>\n</td>\n</tr>\n<tr>\n<td><strong>G</strong>lucose-6-phosphatase</td>\n<td>Glucose-6-phosphate&nbsp;→ glucose Endoplasmic reticulum</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(170, 'Biochemistry', 'PM0982. Phases of HMP Shunt and the Enzymes Involved', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\262\>\n<p><strong>Phases</strong></p>\n</td>\n<td width=\376\>\n<p><strong>Enzymes</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\262\>\n<p>Irreversible oxidative phase</p>\n<p>&nbsp;</p>\n</td>\n<td width=\376\>\n<p>Glucose-6-phosphate dehydrogenase</p>\n<p>6-Phosphogluconate dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td width=\262\>\n<p>Reversible non-oxidative phase</p>\n<p>&nbsp;</p>\n</td>\n<td width=\376\>\n<p>3-Epimerase or Keto-isomerase</p>\n<p>Transketolase</p>\n<p>Transaldolase</p>\n<p>Phosphohexose isomerase</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(171, 'Biochemistry', 'PM0964. Glycogen Storage Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/782e85c36f0648698a222dca988adfabx1280x1863.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficiency</strong></p>\n</td>\n<td>\n<p><strong>Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type 0</p>\n</td>\n<td>\n<p>Glycogen synthase</p>\n</td>\n<td>\n<p>Hypoglycemia</p>\n<p>Early death</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ia</p>\n<p><strong>Von Gierkes disease</strong></p>\n</td>\n<td>\n<p>Glucose-6- phosphatase</p>\n</td>\n<td>\n<p>Hepatomegaly and renomegaly&nbsp;due to glycogen accumulation</p>\n<p>Severe fasting hypoglycemia</p>\n<p>Growth failure</p>\n<p>Lactic acidosis</p>\n<p>Hyperuricemia</p>\n<p>Hyperlipidemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ib</p>\n</td>\n<td>\n<p>Endoplasmic reticulum glucose-6- phosphate transporter</p>\n</td>\n<td>\n<p>Same as Von Gierkes disease</p>\n<p>Recurrent infections due to impaired neutrophil function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type II</p>\n<p><strong>Pompes disease</strong></p>\n</td>\n<td>\n<p>Lysosomal α1,4:1,6 glucosidase</p>\n<p>(Acid maltase)</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Death by age ~ 2 years (infantile variant)</p>\n<p>Cardiomegaly and heart failure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type III</p>\n<p><strong>Coris/Forbes disease</strong></p>\n<p>(Limit dextrinosis)</p>\n</td>\n<td>\n<p>Glycogen debranching enzyme</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Fasting hypoglycemia</p>\n<p>Hepatomegaly due to accumulation of branched-chain polysaccharide (limit dextrins)</p>\n<p>Growth retardation</p>\n<p>Normal lactate and uric acid levels</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type IV</p>\n<p><strong>Andersen disease</strong></p>\n</td>\n<td>\n<p>Glycogen branching enzyme</p>\n</td>\n<td>\n<p>Failure to thrive</p>\n<p>Hepatomegaly due to accumulation of polysaccharides with few branch points</p>\n<p>Death at age ~ 5 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type V</p>\n<p><strong>McArdle disease</strong></p>\n</td>\n<td>\n<p>Muscle glycogen phosphorylase</p>\n</td>\n<td>\n<p>Exercise-induced cramps</p>\n<p>Renal failure due to rhabdomyolysis and myoglobinuria</p>\n<p>Second wind phenomenon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VI</p>\n<p><strong>Hers disease</strong></p>\n</td>\n<td>\n<p>Liver glycogen phosphorylase</p>\n</td>\n<td>\n<p>Generally benign</p>\n<p>Mild hypoglycemia</p>\n<p>Hepatomegaly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VII</p>\n<p><strong>Taruis disease</strong></p>\n</td>\n<td>\n<p>Muscle phosphofructokinase</p>\n</td>\n<td>\n<p>Exercise-induced muscle cramps and weakness</p>\n<p>Growth retardation</p>\n<p>Hemolytic anemia</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(172, 'Biochemistry', 'PM0963. Glycogenolysis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0e1fd3aae6064ad0a2937e2a53c63076x1280x1364.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(173, 'Biochemistry', 'PM0962. Steps in Glycogenesis & Respective Enzymes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\319\>\n<p><strong>Steps</strong></p>\n</td>\n<td width=\319\>\n<p><strong>Enzymes</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Glucose Phosphorylation</p>\n</td>\n<td width=\319\>\n<p>Hexokinase&nbsp;in Muscle</p>\n<p>Glucokinase&nbsp;in Liver</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Glucose-6-PO4 to Glucose-1-PO4 conversion</p>\n</td>\n<td width=\319\>\n<p>Phosphoglucomutase</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Attachment of UTP to Glucose-1-PO4</p>\n</td>\n<td width=\319\>\n<p>UDP Glucose Pyrophosphorylase</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Attachment of UDP-Glucose to Glycogen Primer (Glycogenin)</p>\n</td>\n<td width=\319\>\n<p>Glycogen initiator synthase</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Glycogen synthesis</p>\n</td>\n<td width=\319\>\n<p>Glycogen synthase</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Glycogen Branches formation</p>\n</td>\n<td width=\319\>\n<p>Branching enzyme (amylo-[1—4]—&gt;[1—6]-transglucosidase)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(174, 'Biochemistry', 'PM0961. Structural Bond of Various Polysaccharides', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\187\>\n<p><strong>Polysaccharides</strong></p>\n</td>\n<td width=\452\>\n<p><strong>Structure</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\187\>\n<p>Amylose starch</p>\n</td>\n<td width=\452\>\n<p>Unbranched chain, α (1→4) glycosidic&nbsp; linkages of glucose. Hollow helix</p>\n</td>\n</tr>\n<tr>\n<td width=\187\>\n<p>Amylopectin&nbsp; starch</p>\n</td>\n<td width=\452\>\n<p>α (1→4) glycosidic linkages with α (1→6) glycosidic branches every 24-30 glucose molecule. Hollow helix</p>\n</td>\n</tr>\n<tr>\n<td width=\187\>\n<p>Glycogen</p>\n</td>\n<td width=\452\>\n<p>α (1→4) glycosidic linkages with α (1→6) glycosidic branches every 8-12 glucose molecule. Hollow helix</p>\n</td>\n</tr>\n<tr>\n<td width=\187\>\n<p>Cellulose</p>\n</td>\n<td width=\452\>\n<p>Unbranched beta (1→4) glycosidic linkages of glucose. Linear</p>\n</td>\n</tr>\n<tr>\n<td width=\187\>\n<p>Chitin</p>\n</td>\n<td width=\452\>\n<p>Unbranched beta (1→4) glycosidic linkages of N-acetylglucosamine. Linear</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e524177809ef4294bcfeb64714a90170x1280x442.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(175, 'Biochemistry', 'PM0944. Test for Carbohydrates', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\253\>\n<p><strong>Purpose of test</strong></p>\n</td>\n<td width=\161\>\n<p><strong>Names of tests</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\253\>\n<p>Test for all carbohydrates</p>\n</td>\n<td width=\161\>\n<p>Molisch test</p>\n</td>\n</tr>\n<tr>\n<td width=\253\>\n<p>For reducing sugars</p>\n</td>\n<td width=\161\>\n<p>Benedicts test</p>\n</td>\n</tr>\n<tr>\n<td width=\253\>\n<p>Differentiate between mono- and disaccharides</p>\n</td>\n<td width=\161\>\n<p>Barfoed’s test &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>\n<p>Moore’s test &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>\n<p>Fehling’s test</p>\n</td>\n</tr>\n<tr>\n<td width=\253\>\n<p>Differentiate aldoses and ketoses</p>\n</td>\n<td width=\161\>\n<p>Seliwanoff’s test</p>\n<p>Rapid furfural test</p>\n<p>Foulger’s test</p>\n</td>\n</tr>\n<tr>\n<td width=\253\>\n<p>Detect Deoxy sugars</p>\n</td>\n<td width=\161\>\n<p>Feulgen Staining</p>\n</td>\n</tr>\n<tr>\n<td width=\253\>\n<p>Test for Pentoses</p>\n</td>\n<td width=\161\>\n<p>Bial’s test</p>\n</td>\n</tr>\n<tr>\n<td width=\253\>\n<p>Test for Galactose</p>\n</td>\n<td width=\161\>\n<p>Mucic acid test</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(176, 'Biochemistry', 'PM0943. Method of Glucose Estimation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\319\>\n<p><strong>Reductometric methods</strong></p>\n</td>\n<td width=\319\>\n<p><strong>Enzymatic methods</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Nelson Somogyi method</p>\n<p>Folin Wu method</p>\n<p>O-Toluidine method</p>\n<p>&nbsp;</p>\n</td>\n<td width=\319\>\n<p>Hexokinase method</p>\n<p>Glucose Oxidase Peroxidase Method</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(177, 'Biochemistry', 'PM0939. MPS and Their Respective Enzyme Deficiencies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>MPS</strong></td>\n<td><strong>Enzyme defective</strong></td>\n<td><strong>GAGs affected</strong></td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td>Hurler-, Scheie-,&nbsp;<br>Hurler-scheie syndrome</td>\n<td>MPS I</td>\n<td>α-L-Iduronidase</td>\n<td>\n<p>Dermatan sulfate,<br>Heparan sulfate</p>\n</td>\n<td>Mental retardation,<br>coarse facial features,&nbsp;<br>Hepatosplenomegaly<br>Cloudy cornea</td>\n</tr>\n<tr>\n<td>Hunter syndrome</td>\n<td>MPS II</td>\n<td>Iduronate sulfatase</td>\n<td>Dermatan sulfate,&nbsp;<br>Heparan sulfate</td>\n<td>Mental retardation</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome A</td>\n<td>MPS IIIA</td>\n<td>Heparan sulfate-N-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>Delay in development<br>Motor dysfunction</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome B</td>\n<td>MPS III B</td>\n<td>α-N-Acetylglucosaminidase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome C</td>\n<td>MPS III C</td>\n<td>α-glucosaminide N-acetyltransferase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome D</td>\n<td>MPS III D</td>\n<td>N-acetylglucosamine 6-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Morquio syndrome A</td>\n<td>MPS IV A</td>\n<td>Galactosamine&nbsp;6-sulfatase</td>\n<td>Keratan sulfate&nbsp;<br>Chondroitin 6-sulfate&nbsp;</td>\n<td>Skeletal dysplasia<br>short stature</td>\n</tr>\n<tr>\n<td>Morquio syndrome B</td>\n<td>MPS IV B</td>\n<td>β-galactosidase</td>\n<td>Keratan sulfate</td>\n<td>As MPS IV A</td>\n</tr>\n<tr>\n<td>Maroteaux-lamy&nbsp;syndrome&nbsp;</td>\n<td>MPS VI</td>\n<td>N-acetylgalactosamine 4-sulfatase</td>\n<td>Dermatan sulfate</td>\n<td>Curvature of the spine,<br>Short stature<br>Skeletal dysplasia<br>Cardiac defects</td>\n</tr>\n<tr>\n<td>Sly&nbsp;syndrome&nbsp;</td>\n<td>MPS VII</td>\n<td>β-glucuronidase</td>\n<td>Dermatan sulfate<br>Heparan sulfate<br>Chondroitin 4-sulfate&nbsp;<br>Chondroitin 6-sulfate&nbsp;<br><br></td>\n<td>Short stature<br>Skeletal dysplasia<br>Hepatomegaly<br>Cloudy cornea</td>\n</tr>\n<tr>\n<td>Natowicz&nbsp;syndrome&nbsp;</td>\n<td>MPS IX</td>\n<td>Hyaluronidase</td>\n<td>Hyaluronic acid</td>\n<td>Joint Pain<br>Short stature&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(178, 'Biochemistry', 'PM0937. Important Disaccharides and Their Compositions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\187\>\n<p><strong>Disaccharides</strong></p>\n</td>\n<td width=\238\>\n<p><strong>Monosaccharide units</strong></p>\n</td>\n<td width=\213\>\n<p><strong>Linkage</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\187\>\n<p>Maltose</p>\n</td>\n<td width=\238\>\n<p>glucose + glucose</p>\n</td>\n<td width=\213\>\n<p>α-1,4</p>\n</td>\n</tr>\n<tr>\n<td width=\187\>\n<p>Isomaltose</p>\n</td>\n<td width=\238\>\n<p>glucose + glucose</p>\n</td>\n<td width=\213\>\n<p>α-1,6</p>\n</td>\n</tr>\n<tr>\n<td width=\187\>\n<p>Lactose</p>\n</td>\n<td width=\238\>\n<p>galactose + glucose&nbsp;</p>\n</td>\n<td width=\213\>\n<p>β-1,4</p>\n</td>\n</tr>\n<tr>\n<td width=\187\>\n<p>Lactulose</p>\n</td>\n<td width=\238\>\n<p>galactose + fructose</p>\n</td>\n<td width=\213\>\n<p>β-1,4</p>\n</td>\n</tr>\n<tr>\n<td width=\187\>\n<p>Sucrose</p>\n</td>\n<td width=\238\>\n<p>glucose+fructose</p>\n</td>\n<td width=\213\>\n<p>α-1,ß-2</p>\n</td>\n</tr>\n<tr>\n<td width=\187\>\n<p>Trehalose</p>\n</td>\n<td width=\238\>\n<p>&nbsp;</p>\n<p>glucose+glucose</p>\n</td>\n<td width=\213\>\n<p>α-1,1</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(179, 'Biochemistry', 'PM0936. Aldoses and Ketoses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td width=\213\>\n<p><strong>Carbohydrate</strong></p>\n</td>\n<td width=\213\>\n<p><strong>Aldose</strong></p>\n</td>\n<td width=\213\>\n<p><strong>Ketose</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Triose</p>\n</td>\n<td width=\213\>\n<p>Glyceraldehyde</p>\n</td>\n<td width=\213\>\n<p>Dihydroxy Acetone</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Tetroses</p>\n</td>\n<td width=\213\>\n<p>Erythrose</p>\n</td>\n<td width=\213\>\n<p>Erythrulose</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Pentoses</p>\n</td>\n<td width=\213\>\n<p>Ribose,Xylose,Arabinose</p>\n</td>\n<td width=\213\>\n<p>Ribulose, Xylulose</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Hexoses</p>\n</td>\n<td width=\213\>\n<p>Glucose, Galactose, Mannose</p>\n</td>\n<td width=\213\>\n<p>Fructose</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Heptoses</p>\n</td>\n<td width=\213\>\n<p>&nbsp;</p>\n</td>\n<td width=\213\>\n<p>Sedoheptulose</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(180, 'Biochemistry', 'PM0856. Lysosomal storage diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Lysosomal Storage Diseases</strong></td>\n<td><strong>Enzyme-deficient</strong></td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Sphingolipidoses</strong></td>\n</tr>\n<tr>\n<td>Gaucher disease</td>\n<td>Glucocerebrosidase</td>\n</tr>\n<tr>\n<td>Tay-Sachs disease</td>\n<td>Hexosaminidase A</td>\n</tr>\n<tr>\n<td>Fabry disease</td>\n<td>α-galactosidase A</td>\n</tr>\n<tr>\n<td>Krabbe disease</td>\n<td>\n<p>Galactocerebrosidase</p>\n<p>(Galactosylceramidase)</p>\n</td>\n</tr>\n<tr>\n<td>Niemann-Pick disease</td>\n<td>Sphingomyelinase</td>\n</tr>\n<tr>\n<td><strong>Mucopolysaccharidoses</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Hurler syndrome</td>\n<td>α-L-iduronidase</td>\n</tr>\n<tr>\n<td>Hunter syndrome</td>\n<td>Iduronate-2-sulfatase</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Others:</strong></td>\n</tr>\n<tr>\n<td>Pompe disease</td>\n<td>Lysosomal acid&nbsp;α-1,4- glucosidase</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(181, 'Biochemistry', 'PM0816. Diseases due to glycoprotein defect', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Diseases</strong></td>\n<td><strong>Defect</strong></td>\n<td><strong>Characteristics</strong></td>\n</tr>\n<tr>\n<td>I-cell disease</td>\n<td>Mutation in GNPTA gene leading to a deficiency in enzyme UDP-N-acetylglucoseamine-1-phosphotransferase</td>\n<td>\n<ul>\n<li>Coarse facial features</li>\n<li>Corneal erosion</li>\n<li>Failure to thrive</li>\n<li>Hepatomegaly</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Leukocyte adhesion deficiency, type II</td>\n<td>Mutations affecting activity of Golgi-located GDP-fucose transporter&nbsp;</td>\n<td>\n<ul>\n<li>Neutrophil rolling</li>\n<li>Life-threatening, recurrent bacterial infections</li>\n<li>Psychomotor and mental retardation</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Paroxysmal nocturnal hemoglobinuria</td>\n<td>Genetic mutation leading to the inability to synthesize the glycosyl-phosphatidylinositol (GPI) anchor that binds certain surface proteins to cell membranes.</td>\n<td>\n<ul>\n<li>Lysis of red cells</li>\n<li>Abdominal pain</li>\n<li>Back pain</li>\n<li>Esophageal spasms</li>\n<li>Erectile dysfunction</li>\n<li>Fatigue</li>\n<li>Progressive chronic renal failure</li>\n<li>Thrombophilia</li>\n<li>Bone marrow failure</li>\n<li>Venous thrombosis</li>\n<li>Aplastic anemia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Ehlers–Danlos syndrome</td>\n<td>Deficiency or mutation in Lysyl hydroxylase-1 &nbsp;</td>\n<td>\n<ul>\n<li>Neonatal kyphoscoliosis</li>\n<li>Generalized joint laxity</li>\n<li>Skin fragility</li>\n<li>Severe muscle hypotonia at birth</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Oligosaccharidoses</td>\n<td>Lack of a specific lysosomal hydrolase for glycoproteins</td>\n<td>\n<ul>\n<li>Delay in intellectual and physical development.</li>\n<li>Seizure</li>\n<li>Joint stiffness and pain</li>\n<li>Problems with vision and hearing</li>\n<li>Anaemia, nose bleeds, and easy bleeding or bruising</li>\n<li>Swollen abdomen due to enlarged spleen or liver.&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Congenital disorders of glycosylation &nbsp;</td>\n<td>Glycosylation of a variety of tissue proteins and/or lipids is deficient or defective</td>\n<td>\n<ul>\n<li>Fatal, malfunction of several different organ systems</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Familial tumoral calcinosis (FTC)</td>\n<td>UDP-GalNAc transferase 3</td>\n<td>\n<ul>\n<li>Calcium deposits in skin and subcutaneous tissues</li>\n<li>Unresponsiveness to parathyroid hormone</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Walker–Warburg syndrome (WWS)</td>\n<td>Defective α-dystroglycan</td>\n<td>\n<ul>\n<li>Agenesis of&nbsp;corpus callosum</li>\n<li>Anal atresia</li>\n<li>Atresia of the external auditory canal</li>\n<li>Blindness</li>\n<li>Buphthalmos</li>\n<li>Cerebellar dysplasia</li>\n<li>Cleft upper lip</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hereditary erythroblastic multinuclearity with positive acidified serum lysis test (HEMPAS)</td>\n<td>Defects in alpha–mannosidase II</td>\n<td>\n<ul>\n<li>Ineffective erythropoiesis</li>\n<li>Haemolysis &amp; erythroblast morphological abnormalities</li>\n<li>Hypoglycosylation of some red blood cell (RBC) membrane proteins</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(182, 'Biochemistry', 'PM0808. Some Important Methods Used to Study Glycoproteins', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Method</strong></td>\n<td><strong>Use</strong></td>\n</tr>\n<tr>\n<td>Periodic acid-Schiff stain</td>\n<td>Detects glycoprotein as pink bands</td>\n</tr>\n<tr>\n<td>Mass spectrometry</td>\n<td>Molecular mass, composition, sequence, and sometimes branching of a glycan chain. can be used for site-specific glycosylation profiling.</td>\n</tr>\n<tr>\n<td>NMR spectroscopy</td>\n<td>To identify specific sugars, their sequence, linkages, and the anomeric nature of glycosidic chain.</td>\n</tr>\n<tr>\n<td>Amino acid&nbsp;or&nbsp;cDNA sequencing</td>\n<td>Determination of amino acid sequence.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(183, 'Biochemistry', 'PM0807. Glycoprotein and their functions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Functions</strong></td>\n<td><strong>Glycoproteins</strong></td>\n</tr>\n<tr>\n<td>Structural component</td>\n<td>Collagens</td>\n</tr>\n<tr>\n<td>Lubricant and protective</td>\n<td>Mucins</td>\n</tr>\n<tr>\n<td>Transport</td>\n<td>Transferrin, ceruloplasmin</td>\n</tr>\n<tr>\n<td>Immunologic</td>\n<td>Immunoglobulins, histocompatibility antigens</td>\n</tr>\n<tr>\n<td>Hormone</td>\n<td>Chorionic gonadotropin, TSH</td>\n</tr>\n<tr>\n<td>Enzyme</td>\n<td>eg, alkaline phosphatase</td>\n</tr>\n<tr>\n<td>Antifreeze</td>\n<td>Plasma proteins of cold-water fish</td>\n</tr>\n<tr>\n<td>Interact with specific carbohydrates</td>\n<td>Lectins, selectins</td>\n</tr>\n<tr>\n<td>Regulate folding of proteins</td>\n<td>Calnexin, calreticulin</td>\n</tr>\n<tr>\n<td>Haemostasis</td>\n<td>Specific glycoproteins on the surface membranes of platelets</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(184, 'Biochemistry', 'PM0525. Reducing Equivalents and Their Uses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p>Reducing agents</p>\n</td>\n<td>\n<p>Uses</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NADPH</p>\n</td>\n<td>\n<p>Lipid synthesis</p>\n<p>Cholesterol synthesis&nbsp;</p>\n<p>Fatty acid chain elongation</p>\n<p>Cytochrome P450&nbsp;hydroxylation&nbsp;of&nbsp;aromatic compounds, steroids,&nbsp;alcohols, and&nbsp;drugs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NADH</p>\n</td>\n<td>\n<p>Metabolizes alcohol</p>\n<p>Glycolysis &amp; Krebs cycle</p>\n<p>Oxidative phosphorylation</p>\n<p>β- Oxidation of fatty acid</p>\n<p>Catalyzes reactions in muscle and liver cells</p>\n<p>Electron Transport Chain</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FADH<sub>2</sub></p>\n</td>\n<td>\n<p>Krebs cycle</p>\n<p>Electron Transport Chain</p>\n<p>Oxidative Phosphorylation</p>\n<p>Cytochrome P450 hydroxylase cycle</p>\n<p>β-Oxidation of fatty acid</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(185, 'Biochemistry', 'PM0091. Steps involved in TCA cycle', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Step 1</strong></td>\n</tr>\n<tr>\n<td>\n<p>Acetyl CoA + Oxaloacetate → Citrate</p>\n<p>&nbsp; &nbsp; &nbsp;(2C &nbsp;+ 4C &nbsp;= &nbsp; 6C)</p>\n<p>Enzyme: Citrate Synthase</p>\n<p><strong>Irreversible</strong>, Exothermic reaction</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 2</strong></td>\n</tr>\n<tr>\n<td>\n<p>Citrate → Cis –aconitate&nbsp; → Isocitrate&nbsp;</p>\n<p>( 6C &nbsp; &nbsp;→ &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;6C → &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 6C)</p>\n<p>Enzyme:&nbsp;&nbsp; <strong>Aconitase</strong></p>\n<p>Cofactor:&nbsp;&nbsp; Fe<sup>2+</sup></p>\n<p>The Reaction occurs in 2 steps: &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</p>\n<p>1<sup>st</sup> step:&nbsp; Dehydration&nbsp; &nbsp; &nbsp;&nbsp;</p>\n<p>2<sup>nd</sup> step:&nbsp; Rehydration</p>\n<p>Inhibited by:<strong> Fluoroacetate (Non- Competitive)</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 3</strong></td>\n</tr>\n<tr>\n<td>\n<p>Isocitrate →[Oxalosuccinate]→α- Keto glutarate</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; (6C) → &nbsp; &nbsp; &nbsp; &nbsp; [6C] &nbsp; &nbsp; &nbsp; &nbsp; → &nbsp; &nbsp; &nbsp; &nbsp; (<strong>5C</strong>)</p>\n<p>Enzyme:&nbsp; Isocitrate Dehydrogenase</p>\n<p>Cofactor:&nbsp;&nbsp; Mn<sup>2+ </sup>or Mg<sup>2+</sup></p>\n<p>Reaction: &nbsp;Oxidative &nbsp;Decarboxylation</p>\n<p><strong>Intermediate:&nbsp;&nbsp; Oxalosuccinate [ Unstable]</strong></p>\n<p>Release:&nbsp;&nbsp;&nbsp; 1 NADH and CO2</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 4</strong></td>\n</tr>\n<tr>\n<td>\n<p>α- Keto glutarate → Succcinyl Co A&nbsp;</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp;(5C &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; → &nbsp; &nbsp; &nbsp; &nbsp; 4C)</p>\n<p>Enzyme: α- Ketoglutarate Dehydrogenase(Multienzyme complex)</p>\n<p>Reaction:&nbsp; Oxidative Decarboxylation</p>\n<p>Inhibited by: <strong>Arsenite&nbsp; (Non – Competitive)</strong></p>\n<p>Physiologically <strong>unidirectional</strong> step.</p>\n<p>Release: 1 NADH and CO2</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 5</strong></td>\n</tr>\n<tr>\n<td>\n<p>Succinyl- CoA&nbsp; → Succinate</p>\n<p>&nbsp; &nbsp; &nbsp; ( 4C &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;→ &nbsp; &nbsp; &nbsp; &nbsp; 4C )</p>\n<p>Enzyme<strong>:&nbsp; Succinate Thiokinase</strong></p>\n<p>Cofactor: Mg<sup>2+</sup></p>\n<p>Release:&nbsp; 1 ATP / GTP</p>\n<p><strong>Substrate level phosphorylation</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 6</strong></td>\n</tr>\n<tr>\n<td>\n<p>Succinate&nbsp; →&nbsp;&nbsp; Fumarate</p>\n<p>( 4C &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;→ &nbsp; &nbsp; &nbsp; &nbsp; 4C )</p>\n<p>Enzyme:&nbsp; Succinate Dehydrogenase (Part of 2<sup>nd</sup> complex ETC)</p>\n<p>Cofactor:&nbsp; <strong>FAD and Fe-S protein</strong>&nbsp;</p>\n<p>The only enzyme of TCA cycle attached to the <strong>inner</strong> <strong>mitochondrial membrane.</strong></p>\n<p>Inhibited by:&nbsp;<strong>Malonate</strong>&nbsp;(<strong> competitive)</strong></p>\n<p>Release: FADH<sub>2</sub></p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 7</strong></td>\n</tr>\n<tr>\n<td>\n<p>Fumarate&nbsp; →&nbsp;&nbsp; Malate</p>\n<p>( 4C &nbsp; &nbsp; &nbsp; &nbsp; → &nbsp; &nbsp; 4C )</p>\n<p>Enzyme:&nbsp; Fumarate Hydratase</p>\n<p>Reaction: Hydration</p>\n</td>\n</tr>\n<tr>\n<td><strong>Step 8</strong></td>\n</tr>\n<tr>\n<td>\n<p>Malate&nbsp; →&nbsp; Oxaloacetate &nbsp;</p>\n<p>( 4C &nbsp; &nbsp; → &nbsp; &nbsp; &nbsp; &nbsp;4C )</p>\n<p>Enzyme:&nbsp; Malate Dehydrogenase</p>\n<p>Release:&nbsp; 1 NADH</p>\n<p>Oxaloacetate<strong> is</strong> <strong>regenerated.</strong></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/76825a8fa7b34db89430c4b5211dd573x1280x1018.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(186, 'Biochemistry', 'PM0081. Biologically important Glycosoaminoglycans(GAGs)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>GAG</strong></p>\n</td>\n<td>\n<p><strong>Disaccharide repeat units</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Keratan sulfate</p>\n</td>\n<td>\n<p>N Acetyl Glucosamine + Galactose</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyaluronic acid</p>\n</td>\n<td>\n<p>N Acetyl Glucosamine + Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chondroitin sulfate</p>\n</td>\n<td>\n<p>N Acetyl Galactosamine + Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dermatan Sulfate</p>\n</td>\n<td>\n<p>N Acetyl Galactosamine + Iduronic/ Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heparan sulfate</p>\n</td>\n<td>\n<p>N Acetyl(Fewer N-sulphated than Heparin)Glucosamine&nbsp;+ Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heparin</p>\n</td>\n<td>\n<p>N Sulphated Glucosamine + Iduronic acid</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(187, 'Biochemistry', 'PM0080. Energy production in TCA Cycle', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Reaction</strong></td>\n<td><strong>&nbsp;Enzyme</strong></td>\n<td><strong>Method of ATP Generation</strong></td>\n<td><strong>Net ATP Produced</strong></td>\n</tr>\n<tr>\n<td>Isocitrate to alpha keto glutarate</td>\n<td>Isocitrate dehydrogenase</td>\n<td>From NADH</td>\n<td>1*2.5 ATP per NADH = 2.5 ATP</td>\n</tr>\n<tr>\n<td>Alpha keto glutarate to Succinyl CoA</td>\n<td>α-Ketoglutarate dehydrogenase complex</td>\n<td>From NADH</td>\n<td>1*2.5 ATP per NADH = 2.5 ATP</td>\n</tr>\n<tr>\n<td>Succinyl Co A to Succinate</td>\n<td>Succinate thiokinase</td>\n<td>GTP</td>\n<td>1GTP</td>\n</tr>\n<tr>\n<td>Succinate to fumarate</td>\n<td>Succinate dehydrogenase</td>\n<td>From FADH2</td>\n<td>1*1.5 ATP per FADH2 = 1.5 ATP</td>\n</tr>\n<tr>\n<td>Malate to Oxaloacetate</td>\n<td>Malate dehydrogenase</td>\n<td>From NADH</td>\n<td>1*2.5 ATP per NADH = 2.5 ATP</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td><strong>Total ATP produced per turn of the TCA</strong></td>\n<td>10 ATP</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(188, 'Biochemistry', 'PM0079. Inhibitors of metabolic pathways', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Inhibitors of glycolysis</strong></p>\n<table width=\322\>\n<tbody>\n<tr>\n<td><strong>Agent</strong></td>\n<td><strong>Enzyme</strong></td>\n</tr>\n<tr>\n<td>Iodoacetate</td>\n<td>Glyceraldehyde 3-phosphate dehydrogenase</td>\n</tr>\n<tr>\n<td>Arsenate</td>\n<td>Phosphoglycerate kinase</td>\n</tr>\n<tr>\n<td>Fluoride</td>\n<td>Enolase</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>Inhibitors of TCA cycle</strong></p>\n<table width=\321\>\n<tbody>\n<tr>\n<td><strong>Agent</strong></td>\n<td><strong>Enzyme</strong></td>\n</tr>\n<tr>\n<td>Fluoroacetate</td>\n<td>Aconitase</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 176\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Arsenite</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>α-ketoglutarate dehydrogenase</td>\n</tr>\n<tr>\n<td>Malonate</td>\n<td>Succinate dehydrogenase</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>Inhibitors of electron transport</strong></p>\n<table width=\321\>\n<tbody>\n<tr>\n<td><strong>Complex</strong></td>\n<td><strong>Inhibitors</strong></td>\n</tr>\n<tr>\n<td>Complex I</td>\n<td>Piercidin, Amobarbital, Rotenone</td>\n</tr>\n<tr>\n<td>Complex II</td>\n<td>TTFA, Carboxin, Malonate</td>\n</tr>\n<tr>\n<td>Complex III</td>\n<td>BAL, Antimycin A</td>\n</tr>\n<tr>\n<td>Complex IV</td>\n<td>Hydrogen sulphide, Carbon monoxide, Cyanide</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>Inhibitors of oxidative phosphorylation</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Agent</strong></td>\n<td><strong>Mechanism</strong></td>\n</tr>\n<tr>\n<td>Atractyloside</td>\n<td>Inhibits ADP and ATP Transporter</td>\n</tr>\n<tr>\n<td>Oligomycin</td>\n<td>Blocks flow of protons through Fo complex</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(189, 'Biochemistry', 'PM0078. Electron transport chain: components and its inhibitors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/bcc617cb8a8343ff8c0208d7726a0ba7x1280x1468.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c87ed88288804113994e57192a28d6f8x1280x969.JPEG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(190, 'Biochemistry', 'PM0030. Sites of various pathways in cell', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Sites of metabolism</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mitochondria</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fatty acid oxidation (βoxidation)</p>\n<p>Acetyl CoA production</p>\n<p>TCA Cycle</p>\n<p>Oxidative phosphorylation</p>\n<p>Ketogenesis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cytoplasm</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glycolysis</p>\n<p>HMP Shunt</p>\n<p>Synthesis of steroids(SER)</p>\n<p>Proteins (RER and Ribosomes)</p>\n<p>Fatty acids</p>\n<p>Cholesterol</p>\n<p>Nucleotides</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Both</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heme synthesis</p>\n<p>Urea cycle</p>\n<p>Gluconeogenesis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(191, 'Biochemistry', 'PM0002. Glucose transporters and their locations', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Tissue location</strong></td>\n<td><strong>Function</strong></td>\n</tr>\n<tr>\n<td><strong>GLUT 1</strong></td>\n</tr>\n<tr>\n<td><strong>Brain, RBC, Placenta</strong>, kidney, colon</td>\n<td>Basal glucose uptake</td>\n</tr>\n<tr>\n<td><strong>GLUT 2</strong></td>\n</tr>\n<tr>\n<td><strong>Liver</strong>, pancreatic beta cell, small intestine, kidney</td>\n<td>Rapid uptake/release of glucose. Low affinity and high km</td>\n</tr>\n<tr>\n<td><strong>GLUT 3</strong></td>\n</tr>\n<tr>\n<td><strong>Neurons</strong>, kidney, placenta</td>\n<td>High affinity for glucose</td>\n</tr>\n<tr>\n<td><strong>GLUT 4</strong></td>\n</tr>\n<tr>\n<td>Heart, skeletal muscle, adipose tissue</td>\n<td>Insulin-dependent glucose uptake</td>\n</tr>\n<tr>\n<td><strong>GLUT 5</strong></td>\n</tr>\n<tr>\n<td>Small intestine, testis, sperm</td>\n<td><strong>Fructose transporter</strong></td>\n</tr>\n<tr>\n<td><strong>GLUT 8</strong></td>\n</tr>\n<tr>\n<td><strong>Blastocyst</strong>, testis, brain</td>\n<td>Insulin-dependent glucose uptake in blastocyst. Transports glucose to Mature spermatozoa.</td>\n</tr>\n<tr>\n<td><strong>GLUT 9</strong></td>\n</tr>\n<tr>\n<td>Liver, kidney</td>\n<td><strong>Urate transporter</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(192, 'Biochemistry,', 'PM2322. Carcinoid syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/db331361dc434bed8535d417b2cfcb4fx1280x1845.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(193, 'Biochemistry,', 'PM2310. Maple syrup urine disease(MSUD)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/431a47e4c13446e19249e1e6d5459e66x1280x1324.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(194, 'Medicine,', 'PM2307. Menkes disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3f0c58fe358940b393c96afe12ef3455x1280x1951.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(195, 'Biochemistry', 'PM2306. Synthesis of collagen and its disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\291\>\n<tbody>\n<tr>\n<td>1. Collagen backbone</td>\n<td>Preprocollagen - Glycin-proline-lysine</td>\n</tr>\n<tr>\n<td>2. Hydroxylation</td>\n<td>\n<p>Of proline and lysine in the presence of Vit C.</p>\n<p>Deficiency of Vit C causes <strong>Scurvy.</strong></p>\n</td>\n</tr>\n<tr>\n<td>3. Glycosylation</td>\n<td>Formation of procollagen and resulting triple helix</td>\n</tr>\n<tr>\n<td>4. Cleavage of terminals of procollagen</td>\n<td>Resulting in the formation of tropocollagen</td>\n</tr>\n<tr>\n<td>5. Cross-linking by lysyl oxidase (copper-containing enzyme)</td>\n<td>\n<p>Formation of mature collagen.</p>\n<p>Defect causes <strong>Menkes disease</strong> and <strong>Ehlers-Danlos syndrome</strong>)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(196, 'Paediatrics,', 'PM2305. Phenylketonuria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1a79bc9a0618454db8f2bfa6916ae3bbx1280x1001.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ol>\n<li>BH<sub>4</sub> - tetrahydrobiopterin (or sapropterin, a synthetic form of BH<sub>4</sub>)</li>\n</ol></div><!---->\n      <!---->\n    </div><!---->'),
(197, 'Paediatrics,', 'PM2304. Homocystinuria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c84307c25b08404ebad0ed6c97f95b35x1280x1169.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The concept for treatment:</p>\n<ul>\n<li>Since homocysteine is produced from methionine, decreased dietary intake of methionine decreases the formation of homocysteine.</li>\n<li>As the end product of this cycle is cysteine, increased dietary intake of cysteine will decrease the conversion of methionine to homocysteine through negative feedback.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(198, 'Biochemistry', 'PM2196. Amino Acid Derivatives', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7b53b3afcc1c47e792f684ad0097deeex1280x1310.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(199, 'Biochemistry', 'PM1791. Types of Chromatography', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Chromatography types</strong></td>\n<td><strong>Property used for separation</strong></td>\n</tr>\n<tr>\n<td>Paper chromatography</td>\n<td>Based on <strong>polarity</strong>, <strong>Least polar</strong> moves <strong>faster</strong></td>\n</tr>\n<tr>\n<td>Thin layer chromatography</td>\n<td>Based on <strong>polarity</strong>, <strong>Least polar</strong> moves <strong>faster</strong></td>\n</tr>\n<tr>\n<td>Ion exchange chromatography</td>\n<td>Based on <strong>charge – charge</strong> interaction</td>\n</tr>\n<tr>\n<td>Size exclusion chromatography</td>\n<td>Based on <strong>descending order</strong> of <strong>Stokes radius</strong> which is a function of <strong>molecular mass and shape</strong></td>\n</tr>\n<tr>\n<td>Affinity chromatography</td>\n<td>Based on <strong>specific ligand binding</strong> behaviour</td>\n</tr>\n<tr>\n<td>Hydrophobic interaction chromatography</td>\n<td>Based on <strong>hydrophobic </strong>interaction</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(200, 'Biochemistry', 'PM1402. Types of flavoprotein', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Flavoprotein oxidases</strong></td>\n<td><strong>Location</strong></td>\n<td><strong>Action</strong></td>\n</tr>\n<tr>\n<td>L-amino acid oxidase</td>\n<td>Kidney</td>\n<td>Specificity for the oxidative deamination of the naturally occurring l-amino acids</td>\n</tr>\n<tr>\n<td>Xanthine oxidase</td>\n<td>Uricotelic animals</td>\n<td>Conversion of purine bases to uric acid</td>\n</tr>\n<tr>\n<td>Aldehyde dehydrogenase</td>\n<td>Mammalianlivers</td>\n<td>Acts upon aldehydes and <em>N</em>-heterocyclic substrates&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(201, 'Biochemistry', 'PM1401. Structure of proteins', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0fd214b3bb95411197397c70b51294d9x1280x2196.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(202, 'Paediatrics,', 'PM0627. Inborn Errors of Amino Acid Metabolism and Their Associated Urine Odor', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>Inborn Error of Metabolism</strong></p>\n</td>\n<td>\n<p><strong>Urine Odor</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease</p>\n</td>\n<td>\n<p>Maple syrup</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hawkinsinuria</p>\n</td>\n<td>\n<p>Swimming pool</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3-Hydroxy-3-methylglutaric aciduria</p>\n</td>\n<td>\n<p>Cat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n<p>Glutaric acidemia (type II)</p>\n</td>\n<td>\n<p>Sweaty feet</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypermethioninemia</p>\n<p>Tyrosinemia</p>\n</td>\n<td>\n<p>Boiled cabbage</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Multiple carboxylase deficiency</p>\n</td>\n<td>\n<p>Tomcat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Mousy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trimethylaminuria</p>\n</td>\n<td>\n<p>Rotting fish</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Oasthouse syndrome</p>\n</td>\n<td>\n<p>Dried malt/hops</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(203, 'Paediatrics,', 'PM0625. Amino acid Enzymatic Disorders and the Associated Enzymes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(204, 'Paediatrics,', 'PM0590. Types of tyrosinemia  with deficient enzymes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Disease</strong></div>\n</td>\n<td>\n<div><strong>Enzyme-deficient</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Tyrosinemia type 1 (Hepatorenal, Hereditary tyrosinemia, Tyrosinosis)</div>\n</td>\n<td>\n<div>Fumarylacetoacetate hydrolase (FAAH)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Tyrosinemia type 2 (Oculocutaneous)</div>\n</td>\n<td>\n<div>Tyrosine aminotransferase</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Tyrosinemia type 3 (Neonatal tyrosinemia)</div>\n</td>\n<td>\n<div>4-Hydroxyphenylpyruvate dioxygenase (4-HPPD)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Hawkinsinuria</div>\n</td>\n<td>\n<div>Missense mutations in the gene for 4-HPPD</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(205, 'Biochemistry', 'PM0579. Amino Acids and their Biological Amines', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Amino Acid</strong></p>\n</td>\n<td>\n<p><strong>Biogenic Amines &amp; their Derivatives</strong></p>\n</td>\n<td>\n<p><strong>Significance</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidine</p>\n</td>\n<td>\n<p>Histamine</p>\n</td>\n<td>\n<p>Inflammatory mediator, vasodilator, bronchoconstrictor</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosine</p>\n</td>\n<td>\n<p>Tyramine</p>\n<p>Norepinephrine</p>\n<p>Epinephrine</p>\n<p>Dopamine</p>\n<p>Melanin</p>\n</td>\n<td>\n<p>Regulation of blood pressure</p>\n<p>Neurotransmitter in the sympathetic system</p>\n<p>Involved in fight and flight responses</p>\n<p>Pigmentation of skin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tryptophan</p>\n</td>\n<td>\n<p>Serotonin</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Melatonin</p>\n</td>\n<td>\n<p>Neurotransmitter in the CNS</p>\n<p>Regulation of mood, temperature, blood pressure, GI motility</p>\n<p>Sleep-wake cycle</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lysine</p>\n</td>\n<td>\n<p>Cadaverine</p>\n</td>\n<td>\n<p>Partially responsible for the distinctive smell of urine and semen</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glutamic acid</p>\n</td>\n<td>\n<p>GABA</p>\n</td>\n<td>\n<p>Inhibitory neurotransmitter in the CNS</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Serine</p>\n</td>\n<td>\n<p>Ethanolamine</p>\n<p>&nbsp;</p>\n<p>Choline</p>\n</td>\n<td>\n<p>A component of the cell membrane phospholipids (cephalin)</p>\n<p>Synthesis of acetylcholine, component of surfactant</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>Note<strong>: Tyramine&nbsp;</strong>is an indirectly acting sympathomimetic and is known to cause <strong>cheese reaction</strong>, a type of hypertensive crisis when taken along with certain drugs such as MAO inhibitors.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->'),
(206, 'Biochemistry', 'PM0576. Catabolism of Glycine', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/344a38db4e9a4303bec7efaac3551731x401x452.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(207, 'Biochemistry', 'PM0575. Xanthurenic aciduria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8420bf92bb3745a5b67c15c29e42ec1ax1280x1065.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(208, 'Biochemistry', 'PM0574. Carbamoyl phosphate synthetase I & II', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7531186f51cf4308837f31a5d44ff27ex1280x960.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(209, 'Biochemistry', 'PM0573. Urea Cycle and its disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/18bcc23295f14f9f9b7463912fdb6eeax1280x2235.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(210, 'Biochemistry', 'PM0572. Reactions or Tests to Identify Specific Groups or Amino Acids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Reactions</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Specific Group or Amino Acid</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Biuret Reaction</p>\n</td>\n<td width=\231\>\n<p>Two peptide linkages</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Ninhydrin Reaction</p>\n</td>\n<td width=\231\>\n<p>Alpha-amino acids</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Xanthoproteic Reaction</p>\n</td>\n<td width=\231\>\n<p>Benzene ring of aromatic amino acids</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Millons Reaction</p>\n</td>\n<td width=\231\>\n<p>Phenolic group (Tyrosine)</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Hopkins-Cole Reaction</p>\n</td>\n<td width=\231\>\n<p>Indole ring (Tryptophan)</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Sakaguchi Reaction</p>\n</td>\n<td width=\231\>\n<p>Guanidine group (Arginine)</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Nitroprusside Reaction</p>\n</td>\n<td width=\231\>\n<p>Sulfhydryl groups (Cysteine)</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Sulfur Test</p>\n</td>\n<td width=\231\>\n<p>Sulfhydryl groups (Cysteine)</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Pauly’s Test</p>\n</td>\n<td width=\231\>\n<p>Imidazole ring (Histidine)</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Folin-Ciocalteu’s Test</p>\n</td>\n<td width=\231\>\n<p>Phenolic group (Tyrosine)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(211, 'Biochemistry', 'PM0571. Amino Acids and their Special Groups', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\135\>\n<p><strong>Amino Acid</strong></p>\n</td>\n<td width=\157\>\n<p><strong>Special Groups</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\135\>\n<p>Arginine</p>\n</td>\n<td width=\157\>\n<p>Guanidinium</p>\n</td>\n</tr>\n<tr>\n<td width=\135\>\n<p>Phenylalanine</p>\n</td>\n<td width=\157\>\n<p>Benzene</p>\n</td>\n</tr>\n<tr>\n<td width=\135\>\n<p>Tyrosine</p>\n</td>\n<td width=\157\>\n<p>Phenol</p>\n</td>\n</tr>\n<tr>\n<td width=\135\>\n<p>Histidine</p>\n</td>\n<td width=\157\>\n<p>Imidazole</p>\n</td>\n</tr>\n<tr>\n<td width=\135\>\n<p>Proline</p>\n</td>\n<td width=\157\>\n<p>Pyrrolidine</p>\n</td>\n</tr>\n<tr>\n<td width=\135\>\n<p>Methionine</p>\n</td>\n<td width=\157\>\n<p>Thioether Linkage</p>\n</td>\n</tr>\n<tr>\n<td width=\135\>\n<p>Tryptophan</p>\n</td>\n<td width=\157\>\n<p>Indole</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(212, 'Biochemistry', 'PM0570. Classification of amino acids  on the basis of their polarity and nature (Acidic/Basic)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Polar/Hydrophilic</strong></p>\n</td>\n<td>\n<p><strong>Non-Polar/Hydrophobic</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<ol>\n<li>Serine</li>\n<li>Threonine*</li>\n<li>Asparagine</li>\n<li>Glutamine</li>\n<li>Aspartic acid</li>\n<li>Glutamic acid</li>\n<li>Lysine*</li>\n<li>Arginine</li>\n<li>Histidine*</li>\n<li>Cysteine&nbsp;</li>\n<li>Glycine</li>\n</ol>\n</td>\n<td>\n<ol>\n<li>Alanine</li>\n<li>Valine*</li>\n<li>Leucine*</li>\n<li>Isoleucine*</li>\n<li>Phenylalanine*</li>\n<li>Tryptophan*</li>\n<li>Methionine*</li>\n<li>Proline</li>\n<li>Tyrosine</li>\n</ol>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Acidic</strong></p>\n</td>\n<td>\n<p><strong>Basic</strong></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;\n<ol>\n<li>Aspartic acid (<strong>most acidic)</strong></li>\n<li>Glutamic acid</li>\n</ol>\n</td>\n<td>\n<ol>\n<li>Lysine*</li>\n<li>Arginine (<strong>most basic)</strong></li>\n<li>Histidine</li>\n</ol>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;* Denotes one of the nine essential amino acids.&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(213, 'Biochemistry', 'PM0569. Amino Acid Classification Based on Metabolism (Glucogenic/Ketogenic ) and Nutritional requirement (Essential/Non essential)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Glucogenic</strong></p>\n</td>\n<td>\n<p><strong>Ketogenic</strong></p>\n</td>\n<td>\n<p><strong>Both</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Non-essential</p>\n</td>\n<td>\n<p>Alanine</p>\n<p>Arginine (semi-essential)</p>\n<p>Asparagine</p>\n<p>Aspartate</p>\n<p>Cysteine</p>\n<p>Glutamate</p>\n<p>Glutamine</p>\n<p>Glycine</p>\n<p>Proline</p>\n<p>Serine</p>\n</td>\n<td>&nbsp;</td>\n<td>Tyrosine</td>\n</tr>\n<tr>\n<td>\n<p>Essential</p>\n</td>\n<td>\n<p>Histidine</p>\n<p>Methionine</p>\n<p>Valine</p>\n<p>Threonine</p>\n</td>\n<td>\n<p>Leucine</p>\n<p>Lysine</p>\n</td>\n<td>\n<p>Isoleucine</p>\n<p>Phenylalanine</p>\n<p>Tryptophan</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(214, 'Biochemistry', 'PM2219. Cholesterol synthesis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/df36006c4ce64fe88295b170ef95d661x600x910.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(215, 'Medicine,', 'PM2169. Familial Dyslipidemias', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Type</td>\n<td>Increased levels&nbsp;</td>\n<td>Manifestation</td>\n</tr>\n<tr>\n<td>1. Hyperchylomicronemia(type I hyperlipoproteinemia)</td>\n<td>Chylomicrons, VLDL, TG&nbsp;</td>\n<td>Pancreatitis, hepatosplenomegaly, and xanthomas</td>\n</tr>\n<tr>\n<td>2.&nbsp;Familial hypercholesterolemia(type II&nbsp;hyperlipoproteinemia)</td>\n<td>LDL and cholesterol</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>3. Dysbetalipoproteinemia(type III hyperlipoproteinemia)</td>\n<td>Chylomicrons and VLDL</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>4. Hypertriglyceridemia(type IV hyperlipoproteinemia)</td>\n<td>VLDL and TG</td>\n<td>Pancreatitis</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(216, 'Biochemistry', 'PM2109. Unsaturated Fatty acids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Unsaturated Fatty acids</p>\n<table width=\467\>\n<tbody>\n<tr>\n<td>Common name</td>\n<td>No. of Carbon atoms: <strong>Number of double bonds</strong>; Position of double bonds</td>\n<td>Family&nbsp;</td>\n<td>Occurrence</td>\n</tr>\n<tr>\n<td>Palmitoleic</td>\n<td>16:<strong>1</strong>;9</td>\n<td>ω7</td>\n<td>In nearly all fats</td>\n</tr>\n<tr>\n<td>Oleic</td>\n<td>18:<strong>1</strong>;9</td>\n<td>ω9</td>\n<td>The most common fatty acid in<br>natural fats, olive oil</td>\n</tr>\n<tr>\n<td>Elaidic</td>\n<td>18:<strong>1</strong>;9</td>\n<td>ω9</td>\n<td>Hydrogenated and ruminant fats</td>\n</tr>\n<tr>\n<td>Linoleic</td>\n<td>18:<strong>2</strong>;9,12</td>\n<td>ω6</td>\n<td>Corn, peanut, cottonseed, soybean, and<br>many plant oils</td>\n</tr>\n<tr>\n<td>γ-Linolenic</td>\n<td>18:<strong>3</strong>;6,9,12</td>\n<td>ω6</td>\n<td>Some plants, eg, oil of evening primrose,<br>borage oil; minor fatty acid in animals</td>\n</tr>\n<tr>\n<td>α-Linolenic</td>\n<td>18:<strong>3</strong>;9,12,15</td>\n<td>ω3</td>\n<td>Linseed oil</td>\n</tr>\n<tr>\n<td>Arachidonic</td>\n<td>20:<strong>4</strong>;5,8,11,14</td>\n<td>ω6</td>\n<td>Animal fats,&nbsp; Phospholipids in animals</td>\n</tr>\n<tr>\n<td>Timnodonic acid</td>\n<td>20:<strong>5</strong>;5,8,11,14,17</td>\n<td>ω3</td>\n<td>Fish oils, eg.&nbsp;cod<br>liver, mackerel, menhaden, salmon oils</td>\n</tr>\n<tr>\n<td>Cervonic acid</td>\n<td>22:<strong>6</strong>;4,7,10,13,16,19</td>\n<td>ω3</td>\n<td>Fish oils, algal oils, Phospholipids in brain</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(217, 'Biochemistry', 'PM1018. Hormone sensitive lipase  Vs lipoprotein lipase', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;HSL</td>\n<td>&nbsp;Lipoprotein lipase</td>\n</tr>\n<tr>\n<td>Location</td>\n<td>&nbsp;Adipocyte</td>\n<td>&nbsp;Capillaries</td>\n</tr>\n<tr>\n<td>Action</td>\n<td>&nbsp;Hydrolyse TAG in adipose&nbsp; &nbsp;tissue</td>\n<td>&nbsp;Hydrolyse TAG in chylomicron , VLDL</td>\n</tr>\n<tr>\n<td>Acts in the state of</td>\n<td>&nbsp;Fasting (Glucagon)</td>\n<td>&nbsp;Fed (Insulin)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(218, 'Biochemistry', 'PM0768. Action of various prostaglandins on different organs:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Organs</td>\n<td><strong>PGE<sub>2</sub></strong></td>\n<td><strong>PGF<sub>2α</sub></strong></td>\n<td><strong>PGI<sub>2</sub></strong></td>\n<td><strong>TXA<sub>2</sub></strong></td>\n</tr>\n<tr>\n<td><strong>Blood vessel</strong></td>\n<td>Vasodilatation, ↓ BP</td>\n<td>Vasodilatation (mostly),&nbsp;Largerveins constrict, little effect on BP</td>\n<td>Vasodilatation,&nbsp;↓ ↓ BP</td>\n<td>Vasoconstriction</td>\n</tr>\n<tr>\n<td><strong>Heart</strong></td>\n<td>Weak inotropic, reflexcardiac stimulation</td>\n<td>Weak inotropic</td>\n<td>-</td>\n<td>-</td>\n</tr>\n<tr>\n<td><strong>Platelet</strong></td>\n<td>Variable effect</td>\n<td>-</td>\n<td>Antiaggregatory</td>\n<td>Aggregation &amp; release reaction</td>\n</tr>\n<tr>\n<td><strong>Uterus</strong></td>\n<td>Contraction (in vivo),Softening of cervix</td>\n<td>Contraction (in vivo &amp; in vitro),Softening of cervix</td>\n<td>-</td>\n<td>-</td>\n</tr>\n<tr>\n<td><strong>Bronchi</strong></td>\n<td>Dilatation, Inhibit histamine release</td>\n<td>Constriction</td>\n<td>Dilatation, Inhibit histamine release</td>\n<td>Constriction</td>\n</tr>\n<tr>\n<td><strong>Stomach</strong></td>\n<td>↓ acid secretion, ↑ mucus production</td>\n<td>-</td>\n<td>↓ acid secretion,mucosal vasodilatation</td>\n<td>-</td>\n</tr>\n<tr>\n<td><strong>Intestine</strong></td>\n<td>Contracts longitudinal &amp; relaxes, circular muscles, peristalsis ↑, Cl¯ &amp; water secretion↑</td>\n<td>Spasmogenic, ↑ fluid &amp; electrolytesecretion (weak)</td>\n<td>Weak spasmogenic, inhibit toxin-induced fluid secretion</td>\n<td>Weak spasmogenic</td>\n</tr>\n<tr>\n<td><strong>Kidney</strong></td>\n<td>Natriuresis,&nbsp;↓ Cl¯ reabsorption, inhibit ADH action,vasodilatation, renin release</td>\n<td>-</td>\n<td>Natriuresis, vasodilatation,renin release</td>\n<td>Vasoconstriction</td>\n</tr>\n<tr>\n<td><strong>CNS</strong></td>\n<td>Pyrogenic, variety of effects on i.e. inj.</td>\n<td>-</td>\n<td>-</td>\n<td>-</td>\n</tr>\n<tr>\n<td><strong>Release of NA</strong></td>\n<td>↑ or ↓</td>\n<td>↑ or ↓</td>\n<td>-</td>\n<td>-</td>\n</tr>\n<tr>\n<td><strong>Afferent nerve</strong></td>\n<td>Sensitize to noxious stimuli</td>\n<td>-</td>\n<td>Same as PGE2</td>\n<td>-</td>\n</tr>\n<tr>\n<td><strong>Endocrine</strong></td>\n<td>Release of ant. Pituitaryhormones, steroids, insulin;TSH-like action</td>\n<td>Release of gonadotropins &amp;prolactin</td>\n<td>-</td>\n<td>-</td>\n</tr>\n<tr>\n<td><strong>Metabolism</strong></td>\n<td>Antilipolytic, insulin like action,mobilization of bone Ca<sup>2+</sup></td>\n<td>-</td>\n<td>-</td>\n<td>-</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(219, 'Biochemistry', 'PM0767. Enzymes for COX pathway', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>COX pathway products</td>\n<td>Enzymes for synthesis</td>\n</tr>\n<tr>\n<td>PGI<sub>2</sub></td>\n<td>Prostacyclin synthase</td>\n</tr>\n<tr>\n<td>PGD<sub>2</sub></td>\n<td>Isomerase</td>\n</tr>\n<tr>\n<td>PGE<sub>2</sub></td>\n<td>Isomerase</td>\n</tr>\n<tr>\n<td>PGF<sub>2α</sub></td>\n<td>Reductase</td>\n</tr>\n<tr>\n<td>TXA<sub>2</sub></td>\n<td>Thromboxane synthase</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(220, 'Biochemistry,', 'PM0765. Difference in COX-1 and COX-2', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>COX-1</td>\n<td>COX-2</td>\n</tr>\n<tr>\n<td>Synthesize PGs that have housekeeping function (Gastroprotective, haemostasis, renoprotective)</td>\n<td>Synthesize PGs that mediates Inflammation, pain &amp; fever</td>\n</tr>\n<tr>\n<td>Range of expression is 2-4 folds</td>\n<td>Range of expression is 10-80 folds</td>\n</tr>\n<tr>\n<td>Constitutive enzyme</td>\n<td>Inducible enzyme</td>\n</tr>\n<tr>\n<td>Present in most of the cells (Platelets, endothelium, kidney, stomach)</td>\n<td>Inflammatory sites (Synoviocytes, Fibroblast, Monocytes)&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(221, 'Biochemistry', 'PM0753. Examples of Sphingolipidoses (Lipids-Storage Disease)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/eaf86bca861342ff84c303230efbb8bax1280x2017.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>S. No.</strong></p>\n</td>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Deficiency</strong></p>\n</td>\n<td>\n<p><strong>Lipid </strong></p>\n<p><strong>Accumulating</strong></p>\n</td>\n<td>\n<p><strong>Clinical Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Tay–Sachs disease</p>\n</td>\n<td>\n<p>Hexosaminidase A</p>\n</td>\n<td>\n<p>Ganglioside</p>\n</td>\n<td>\n<p>Mental retardation, blindness, muscular weakness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>Sandhoffs disease</p>\n</td>\n<td>\n<p>Hexosaminidase A and B</p>\n</td>\n<td>\n<p>Globoside &amp; Ganglioside</p>\n</td>\n<td>\n<p>Similar to Tay–Sachs disease but also has hepatosplenomegaly and skeletal dysplasias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>\n<p>Fabrys disease</p>\n</td>\n<td>\n<p>α-Galactosidase</p>\n</td>\n<td>\n<p>Globotriaosyl-ceramide</p>\n</td>\n<td>\n<p>Skin rash, kidney failure (full symptoms only in males; X-linked recessive)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>4</p>\n</td>\n<td>\n<p>Metachromatic leukodystrophy</p>\n</td>\n<td>\n<p>Arylsulfatase A</p>\n</td>\n<td>\n<p>3-Sulfogalactosyl-ceramide</p>\n</td>\n<td>\n<p>Mental retardation and psychologic disturbances in adults; demyelination</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5</p>\n</td>\n<td>\n<p>Krabbe disease</p>\n</td>\n<td>\n<p>β-Galactosidase</p>\n</td>\n<td>\n<p>Galactosylceramide</p>\n</td>\n<td>\n<p>Mental retardation; myelin almost absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>6</p>\n</td>\n<td>\n<p>Gauchers disease</p>\n</td>\n<td>\n<p>β-Glucosidase</p>\n</td>\n<td>\n<p>Glucosylceramide</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, erosion of long bones, mental retardation in infants</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>7</p>\n</td>\n<td>\n<p>Niemann–Pick disease</p>\n</td>\n<td>\n<p>Sphingomyelinase</p>\n</td>\n<td>\n<p>Sphingomyelin</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, mental retardation; fatal in early life</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>8</p>\n</td>\n<td>\n<p>Farbers disease</p>\n</td>\n<td>\n<p>Ceramidase</p>\n</td>\n<td>\n<p>Ceramide</p>\n</td>\n<td>\n<p>Hoarseness, dermatitis, skeletal deformation, mental retardation; fatal in early life</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(222, 'Biochemistry', 'PM0750. Composition of Glycosphingolipids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td width=\308\>\n<p><strong>Glycosphingolipid </strong></p>\n</td>\n<td width=\308\>\n<p><strong>Composition</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Cerebroside (glucocerebroside)</p>\n</td>\n<td width=\308\>\n<p>Cer-Glc</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>Globoside (lactosylceramide)</td>\n<td width=\308\>&nbsp;Cer-Glc-Gal</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Ganglioside (GM 3)</p>\n</td>\n<td width=\308\>\n<p>Cer-Glc-Gal-NANA</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Globoside (Forssman antigen)</p>\n</td>\n<td width=\308\>\n<p>Cer-Glc-Gal-Gal-GalNac-GalNac</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\616\>\n<p>Cer = ceramide; Gal = galactose</p>\n<p>Glc = glucose; GalNac = N-acetylgalactosamine<br><br>NANA = n-acetylneuraminic acid</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(223, 'Biochemistry', 'PM0749. Types of Sphingolipids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\215\>\n<p>Glycosphingolipid</p>\n</td>\n<td width=\189\>\n<p>Cerebrosides</p>\n<p>Gangliosides</p>\n<p>Globosides</p>\n<p>&nbsp;</p>\n</td>\n<td width=\212\>\n<p>Oligosaccharide moiety attached to the ceramide unit</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>Sphingophospholipid</p>\n</td>\n<td width=\189\>\n<p>Sphingomyelin</p>\n</td>\n<td width=\212\>\n<p>Phosphate attached to the ceramide unit</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(224, 'Biochemistry', 'PM0748. Classification of Lipids on the Basis of Base-promoted Hydrolysis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\ width=\308\>\n<p><strong>Saponifiable lipids (yield free fatty acid salts residue)</strong></p>\n</td>\n<td width=\308\>\n<p><strong>Non-saponifiable lipids(no fatty acid residues)</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>&nbsp;Glycerol Esters</p>\n</td>\n<td width=\154\>\n<p>Non-glycerol Esters</p>\n</td>\n<td rowspan=\2\ width=\308\>\n<p>Steroids</p>\n<p>Eicosanoids</p>\n<p>Terpenes</p>\n<p>Pheromones</p>\n<p>Fat-soluble vitamins&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Triacylglycerols</p>\n<p>Phosphoglycerols</p>\n</td>\n<td width=\154\>\n<p>Waxes</p>\n<p>Sphingolipids</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(225, 'Paediatrics,', 'PM0747. Pulmonary Surfactant Composition', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\291\>\n<p><strong>Constituents</strong></p>\n</td>\n<td width=\104\>\n<p><strong>Percentage</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\291\>\n<p>Phospholipids, mainly dipalmitoylphosphatidylcholine (DPPC)</p>\n</td>\n<td width=\104\>\n<p>70% to 80%</p>\n</td>\n</tr>\n<tr>\n<td width=\291\>\n<p>Proteins</p>\n</td>\n<td width=\104\>\n<p>10%</p>\n</td>\n</tr>\n<tr>\n<td width=\291\>\n<p>Neutral lipids</p>\n</td>\n<td width=\104\>\n<p>10%</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(226, 'Biochemistry', 'PM0746. Types of Phospholipids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\329\>\n<p><strong>Glycerophospholipids</strong></p>\n</td>\n<td width=\208\>\n<p><strong>Sphingophospholipids</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\329\>\n<p>Phosphatidylcholine or lecithin</p>\n<p>Phosphatidylethanolamine or cephalin</p>\n<p>Phosphatidylinositol</p>\n<p>Phosphatidylserine</p>\n<p>Plasmalogens</p>\n<p>Lysophospholipids or lysolecithin</p>\n<p>Cardiolipin</p>\n</td>\n<td width=\208\>\n<p>Sphingomyeline</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(227, 'Biochemistry', 'PM0745. Distribution of  Various Apolipoproteins on Lipoproteins', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\215\>\n<p><strong>Lipoprotein</strong></p>\n</td>\n<td width=\246\>\n<p><strong>Apolipoprotein</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>Chylomicrons</p>\n</td>\n<td width=\246\>\n<p>A-I, A-II, A-IV, B-48, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>Chylomicrons remnants</p>\n</td>\n<td width=\246\>\n<p>B-48, E</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>VLDL</p>\n</td>\n<td width=\246\>\n<p>B-100, C-I, C-II, C-III, E</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>IDL</p>\n</td>\n<td width=\246\>\n<p>B-100, E</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>LDL</p>\n</td>\n<td width=\246\>\n<p>B-100</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>HDL</p>\n</td>\n<td width=\246\>\n<p>A-I, A-II, A-IV, C-I, C-II, C-III, D, E</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>Pre- β- HDL</p>\n</td>\n<td width=\246\>\n<p>A-I</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(228, 'Biochemistry', 'PM0742. Lipoprotein: Types, Sources and Action', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\140\>\n<p><strong>Lipoproteins</strong></p>\n</td>\n<td width=\271\>\n<p><strong>Source</strong></p>\n</td>\n<td width=\205\>\n<p><strong>Action</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\140\>\n<p>Chylomicrons</p>\n</td>\n<td width=\271\>\n<p>Derived from intestinal absorption of triacylglycerol and other lipids</p>\n</td>\n<td width=\205\>\n<p>Carry exogenous/dietary triacylglycerol from the intestine to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td width=\140\>\n<p>Very low density lipoproteins (VLDL)</p>\n</td>\n<td width=\271\>\n<p>Derived from the liver</p>\n</td>\n<td width=\205\>\n<p>Carry endogenous triacylglycerol from the liver to peripheral organs</p>\n</td>\n</tr>\n<tr>\n<td width=\140\>\n<p>Low-density lipoproteins (LDL)</p>\n</td>\n<td width=\271\>\n<p>Derived from VLDL</p>\n</td>\n<td width=\205\>\n<p>Involved in cholesterol transport</p>\n</td>\n</tr>\n<tr>\n<td width=\140\>\n<p>Highdensity lipoproteins (HDL)</p>\n</td>\n<td width=\271\>\n<p>Derived from Liver, intestine, VLDL, chylomicrons</p>\n</td>\n<td width=\205\>\n<p>Involved in reverse cholesterol &amp; Phospholipids transport and also in VLDL and chylomicron metabolism</p>\n</td>\n</tr>\n<tr>\n<td width=\140\>\n<p>Intermediate density lipoproteins(IDL)</p>\n</td>\n<td width=\271\>\n<p>VLDL</p>\n</td>\n<td width=\205\>\n<p>Triacylglycerol &amp; cholesterol transport</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(229, 'Biochemistry', 'PM0741. Fatty Acid Elongation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\177\>\n<p>Elongation&nbsp; Site</p>\n</td>\n<td width=\439\>\n<p>Elongation steps</p>\n</td>\n</tr>\n<tr>\n<td width=\177\>\n<p>Cytosol</p>\n</td>\n<td width=\439\>\n<p>De novo lipogenesis forming palmitate, myristate and stearate&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\177\>\n<p>Mitochondria</p>\n</td>\n<td width=\439\>\n<p>Fatty acid elongation occurs by a reversal of beta-oxidation.</p>\n<p>Elongation acts primarily on fatty acyl CoA substrates shorter than 16 carbons.</p>\n</td>\n</tr>\n<tr>\n<td width=\177\>\n<p>Endoplasmic Reticulum</p>\n</td>\n<td width=\439\>\n<p>Elongating fatty acids 12-carbons and longer.</p>\n<p>Utilizes fatty acids derived from de novo lipogenesis, as well as fatty acids derived from the diet.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(230, 'Biochemistry', 'PM0736. Rotheras Test Procedure', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/73b9ba92c9384966a6760940ce51d4fcx287x140.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Rotheras test, positive for ketone bodies.</p></div><!---->\n      <!---->\n    </div><!---->'),
(231, 'Biochemistry', 'PM0735. Ketone body utilisation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c4f64f2c484149b98ae69f977b81491ax600x597.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>1.&nbsp;3-Hydroxybutyrate dehydrogenase</p>\n<p>2.&nbsp;CoA Transferase</p>\n<p>3.&nbsp;Thiolase</p></div><!---->\n      <!---->\n    </div><!---->'),
(232, 'Biochemistry', 'PM0734. Acetyl CoA Utilization', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/14ab8ff3813548b784d602ba185d89f6x1280x1163.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(233, 'Biochemistry', 'PM0733. Energetics of beta oxidation of palmitic acid (16 C fatty acid)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>One&nbsp;cycle of&nbsp;β-oxidation of a fatty acid produces&nbsp;1 FADH<sub>2</sub>, 1 NADH, and 1 acetyl-CoA.</p>\n<p>Therefore the energetics of palmitic acid (C<sub>16</sub>)&nbsp;:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>Mechanism</p>\n</td>\n<td>\n<p>ATP Formed (mol)/mol Product</p>\n</td>\n<td>\n<p>Total ATP Formed</p>\n<p>(mol)/mol</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\2\>\n<p>Beta oxidation - 7 cycles</p>\n</td>\n<td>\n<p>7 FADH<sub>2&nbsp;</sub>(7x1.5)</p>\n</td>\n<td>\n<p>10.5</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>7 NADH (7x2.5)</p>\n</td>\n<td>\n<p>17.5</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>From Acetyl CoA (TCA cycle)</p>\n</td>\n<td>\n<p>8 Acetyl CoA (8x10)</p>\n</td>\n<td>\n<p>80</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Energy used in the activation</p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>-2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Net ATP yield</p>\n</td>\n<td colspan=\2\>\n<p><strong>106</strong></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(234, 'Biochemistry', 'PM0729. Types, Location and Properties of Fatty acid oxidation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>Types of Oxidation</strong></p>\n</td>\n<td>\n<p><strong>Location</strong></p>\n</td>\n<td>\n<p><strong>Properties</strong></p>\n</td>\n<td>\n<p><strong>Associated Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Beta oxidation</p>\n</td>\n<td>\n<p>Mitochondria</p>\n</td>\n<td>\n<p>A catabolic process by which two-carbons are cleaved from the fatty acid molecule and released as acetyl CoA starting from the carboxyl end.</p>\n<p>The chain is broken between the α(2) and&nbsp;β(3) carbon.</p>\n<p>1 round of beta-oxidation yield 1FADH2, 1NADH, and 1 Acetyl CoA.</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Alpha oxidation</p>\n</td>\n<td>\n<p>Peroxisome</p>\n</td>\n<td>\n<p>The presence of the 3-methyl group of phytanic acid prevents degradation by beta-oxidation.</p>\n<p>The chain is broken between the terminal carboxyl group and α(2) carbon removing that carbon as CO2. The remaining chain is activated with CoA and then undergoes&nbsp;β-Oxidation.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>\n<p>Classic Refsums Disease</p>\n<p>Defective enzyme- Phytanoyl Coa hydroxylase.</p>\n<p>Clinical features include:</p>\n<p>Ichthyosis, Retinitis pigmentosa, Decreased vision, Peripheral neuropathy, Ataxia</p>\n<p class=\p2\>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Omega oxidation</p>\n</td>\n<td>\n<p>Endoplasmic Reticulum</p>\n</td>\n<td>\n<p>An alternative pathway to beta-oxidation occurs in microsomes.</p>\n<p>Involves the&nbsp;oxidation&nbsp;of the ω carbon (terminal methyl group) resulting in dicarboxylic acid.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Peroxisomal Beta oxidation</p>\n</td>\n<td>\n<p>Peroxisome</p>\n</td>\n<td>\n<p>Very-long-chain fatty acids undergo preliminary β-oxidation in peroxisomes up to&nbsp;octanoyl CoA.&nbsp;The shortened fatty acids undergo further β-oxidation in the mitochondria.</p>\n<p>It is not an energy-yielding process.</p>\n</td>\n<td>\n<p>Zellweger (cerebrohepatorenal) syndrome</p>\n<p>A rare inherited absence of peroxisomes in all tissues.</p>\n<p class=\p2\>They accumulate C<span class=\s1\>26</span>—C<span class=\s1\>38 </span>polyenoic acids in brain tissue and also exhibit a generalized loss of peroxisomal functions. The disease causes severe neurologic symptoms, and most patients die in the first year of life.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(235, 'Biochemistry', 'PM0720. Enzymes Involved in Fatty acid Transfer Across Mitochondrial membrane', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\205\>\n<p>Enzyme</p>\n</td>\n<td width=\205\>\n<p>Site of action</p>\n</td>\n<td width=\205\>\n<p>Action</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Acyl-CoA synthetase</p>\n</td>\n<td width=\205\>\n<p>Outer mitochondrial membrane</p>\n</td>\n<td width=\205\>\n<p>Converts free fatty acid into Acyl CoA</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Carnitine palmitoyl transferase-I</p>\n</td>\n<td width=\205\>\n<p>Outer mitochondrial membrane</p>\n</td>\n<td width=\205\>\n<p>Transfers long-chain acyl group from CoA to carnitine, forming acylcarnitine.</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Carnitine-acylcarnitine translocase</p>\n</td>\n<td width=\205\>\n<p>Inner&nbsp; mitochondrial membrane</p>\n</td>\n<td width=\205\>\n<p>Help Acylcarnitine to penetrate the inner membrane</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Carnitine palmitoyl transferase-II</p>\n</td>\n<td width=\205\>\n<p>Inner&nbsp; mitochondrial membrane</p>\n</td>\n<td width=\205\>\n<p>Along with carnitine palmitoyl transferase I oxidizes long-chain fatty acids in the mitochondria.&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7d27598800f5469bade0f988478cd9f3x1280x1913.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(236, 'Biochemistry', 'PM0714. Composition of oils', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Oil</strong></p>\n</td>\n<td>\n<p><strong>Saturated fatty acid</strong></p>\n</td>\n<td>\n<p><strong>Mono-unsaturated fatty acid</strong></p>\n</td>\n<td>\n<p><strong>Poly-unsaturated fatty acid</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Coconut oil</p>\n</td>\n<td>\n<p><strong>92.1%</strong></p>\n</td>\n<td>\n<p>6.2%</p>\n</td>\n<td>\n<p>1.6%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sunflower oil</p>\n</td>\n<td>\n<p>11%</p>\n</td>\n<td>\n<p><strong>30%</strong></p>\n</td>\n<td>\n<p>&nbsp;62%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Soybean oil</p>\n</td>\n<td>\n<p>14%</p>\n</td>\n<td>\n<p>23%</p>\n</td>\n<td>\n<p>63%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Safflower oil</p>\n</td>\n<td>\n<p>10%</p>\n</td>\n<td>\n<p>14%</p>\n</td>\n<td>\n<p><strong>76%</strong></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(237, 'Biochemistry', 'PM0712. Saturated fatty acids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Saturated fatty acids</p>\n<table>\n<tbody>\n<tr>\n<td>Common name</td>\n<td>No. of Carbon atoms</td>\n<td>Occurrence</td>\n</tr>\n<tr>\n<td>Acetic acid</td>\n<td>2</td>\n<td>End product of carbohydrate fermentation in ruminants</td>\n</tr>\n<tr>\n<td>Butyric acid</td>\n<td>4</td>\n<td>Butter</td>\n</tr>\n<tr>\n<td>Valeric acid</td>\n<td>5</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Caproic acid</td>\n<td>6</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Lauric acid</td>\n<td>12</td>\n<td>Spermaceti, cinnamon, palm kernel,<br>coconut oils, laurels, butter</td>\n</tr>\n<tr>\n<td>Myristic acid</td>\n<td>14</td>\n<td>Nutmeg, palm kernel, coconut oils,<br>myrtles, butter</td>\n</tr>\n<tr>\n<td>Palmitic acid</td>\n<td>16</td>\n<td>Common in all animal and plant fats</td>\n</tr>\n<tr>\n<td>Stearic acid</td>\n<td>18</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(238, 'Biochemistry', 'PM0641. Ketogenesis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6d83bb1f03624a0486d7aad26f9fe2b8x1280x2005.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(239, 'Biochemistry', 'PM0638. Biosynthesis of Fatty acids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/2673d3200a674b2bba3a4d486bab813fx556x716.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(240, 'Biochemistry', 'PM0637. Beta-oxidation of Fatty Acids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e5378985a79641669d91f9ecd81a4d9bx907x799.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Note:&nbsp;<strong>Carnitine palmitoyltransferase I</strong>&nbsp;(<strong>CPT1</strong>) is also known as&nbsp;<strong>carnitine acyltransferase I</strong>,</p></div><!---->\n      <!---->\n    </div><!---->'),
(241, 'Biochemistry', 'PM0631. Classification of Lipids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ad4b42c8ef9e4716bb7eaa0e81ebd201x600x789.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(242, 'Biochemistry', 'PM0480. Fatty Acid Synthesis Pathway', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\308\>\n<p>Steps</p>\n</td>\n<td width=\308\>\n<p>Reactions</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Activation</p>\n</td>\n<td width=\308\>\n<p>Acetyl-CoA carboxylation</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Elongation</p>\n</td>\n<td width=\308\>\n<p>The malonyl-CoA pathway</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Condensation step&nbsp;</p>\n</td>\n<td width=\308\>\n<p>Covalent linking of acetyl-CoA and Malonyl-CoA (with the release of CoA and carbon dioxide)</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Reduction step&nbsp;</p>\n</td>\n<td width=\308\>\n<p>Acetoacetyl-ACP to ß-hydroxybutryl-ACP (using up one NADPH2)</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Dehydration step&nbsp;</p>\n</td>\n<td width=\308\>\n<p>ß-hydroxybutryl-ACP to crotonyl-ACP (with the release of a water molecule)</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Another reduction step</p>\n</td>\n<td width=\308\>\n<p>Crotonyl-ACP to butryl-ACP (using up a second NADPH2)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(243, 'Biochemistry', 'PM2426. Enzyme classification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>There are seven groups of enzymes according to IUBMB.</p>\n<table>\n<tbody>\n<tr>\n<td>E.C. NO.</td>\n<td>Enzyme class</td>\n<td>Type of reaction catalyzed with examples</td>\n</tr>\n<tr>\n<td>1</td>\n<td><strong>O</strong>xidoreductases</td>\n<td>\n<p>Catalyze redox reactions</p>\n<ul>\n<li>Dehydrogenase</li>\n<li>Oxygenase</li>\n<li>Oxidase</li>\n<li>Catalase</li>\n<li>Peroxidase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>2</td>\n<td><strong>T</strong>ransferases</td>\n<td>\n<p>Catalyze the transfer of functional groups from one substrate to another.</p>\n<ul>\n<li>Kinases</li>\n<li>Transaminases</li>\n<li>Transmethylases</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>3</td>\n<td><strong>H</strong>ydrolases</td>\n<td>\n<p>Catalyze hydrolytic cleavage of C-C, C-O, C-N, and other covalent bonds.</p>\n<ul>\n<li>Lipase</li>\n<li>Arginase</li>\n<li>Pepsin</li>\n<li>Esterase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>4</td>\n<td><strong>L</strong>yases</td>\n<td>\n<p>Catalyze the cleavage of C-C, C-O, C-N, and other covalent bonds by atom elimination, thereby generating double bonds.</p>\n<ul>\n<li>Aldolase</li>\n<li>Fumarase</li>\n<li>HMG-CoA lyase</li>\n<li>Arginosuccinase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>5</td>\n<td><strong>I</strong>somerases</td>\n<td>\n<p>Catalyze structural changes within a molecule.</p>\n<ul>\n<li>Phosphohexoisomerase</li>\n<li>Mutase</li>\n<li>Racemase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>6</td>\n<td><strong>L</strong>igases</td>\n<td>\n<p>Catalyze the joining together of two molecules in reactions.</p>\n<ul>\n<li>Acetyl CoA carboxylase</li>\n<li>PRPP synthetase</li>\n<li>Carbamoyl phosphate synthetase</li>\n<li>Glutamine synthetase</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>7</td>\n<td><strong>T</strong>ranslocases</td>\n<td>Catalyze the movement of molecules or ions across membranes.</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(244, 'Biochemistry', 'PM2425. Metals as cofactors and prosthetic groups in enzymes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Metal</strong></td>\n<td><strong>&nbsp;Enzymes</strong></td>\n</tr>\n<tr>\n<td>Zinc</td>\n<td>\n<p>Carbonic anhydrase</p>\n<p>Carboxypeptidase</p>\n<p>Alcohol dehydrogenase</p>\n<p>Alkaline phosphatase</p>\n<p>ALA dehydratase</p>\n<p>Lactate dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>Selenium</td>\n<td>\n<p>Glutathione peroxidase</p>\n<p>Thioredoxin reductase</p>\n<p>De-iodinase</p>\n</td>\n</tr>\n<tr>\n<td>Magnesium</td>\n<td>\n<p>Phosphofructokinase</p>\n<p>Hexokinase</p>\n<p>Glucose -6-phosphatase</p>\n<p>Mutase</p>\n<p>Enolase</p>\n</td>\n</tr>\n<tr>\n<td>Copper</td>\n<td>\n<p>Cytosolic superoxide dismutase</p>\n<p>Tyrosinase</p>\n<p>Cyt c oxidase</p>\n<p>Lysyl oxidase</p>\n<p>Amino acid oxidase</p>\n</td>\n</tr>\n<tr>\n<td>Molybdenum</td>\n<td>\n<p>Dinitrogenase</p>\n<p>Xanthine oxidase</p>\n<p>Sulfite oxidase</p>\n</td>\n</tr>\n<tr>\n<td>Manganese</td>\n<td>\n<p>Mitochondrial superoxide dismutase</p>\n<p>Enolase</p>\n<p>Arginase</p>\n<p>Hexokinase</p>\n<p>Phosphofructokinase</p>\n<p>Ribonucleotide reductase</p>\n</td>\n</tr>\n<tr>\n<td>Iron</td>\n<td>Succinate Dehydrogenase</td>\n</tr>\n<tr>\n<td>Calcium</td>\n<td>\n<p>&nbsp; &nbsp;Lipase</p>\n<p>Lecithinase</p>\n</td>\n</tr>\n<tr>\n<td>Nickel</td>\n<td>&nbsp; &nbsp;Urease</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(245, 'Biochemistry', 'PM2421. Heme containing proteins', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Protein</strong></td>\n<td><strong>Function</strong></td>\n</tr>\n<tr>\n<td>&nbsp;Hemoglobin</td>\n<td>&nbsp; Transport of oxygen in the blood</td>\n</tr>\n<tr>\n<td>&nbsp;Myoglobin</td>\n<td>&nbsp; Storage of oxygen in muscle</td>\n</tr>\n<tr>\n<td>&nbsp;Cytochrome C</td>\n<td>&nbsp; Involvement in the electron transport chain</td>\n</tr>\n<tr>\n<td>&nbsp;Cytochrome P450</td>\n<td>&nbsp;Hydroxylation of xenobiotics</td>\n</tr>\n<tr>\n<td>&nbsp;Catalase</td>\n<td>&nbsp;Degradation of hydrogen peroxide</td>\n</tr>\n<tr>\n<td>&nbsp;Tryptophan pyrrolase</td>\n<td>&nbsp;Oxidation of tryptophan</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(246, 'Biochemistry', 'PM2312. Enzymes active in phosphorylated and dephosphorylated state', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Phosphorylated state</strong></p>\n<p>(Low insulin)</p>\n</td>\n<td>\n<p><strong>Dephosphorylated state</strong></p>\n<p>(High insulin)</p>\n</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Fructose 2,6 bisphosphatase</li>\n<li>PEP carboxykinase</li>\n<li>Pyruvate carboxylase</li>\n<li>Glycogen phosphorylase</li>\n<li>Hormone-sensitive lipase</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Phosphofructokinase</li>\n<li>Pyruvate dehydrogenase</li>\n<li>Glycogen synthase</li>\n<li>Acetyl CoA carboxylase</li>\n<li>HMG CoA reductase</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(247, 'Biochemistry,', 'PM1398. Drugs precipitating porphyria: \BOOST CHAP\', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The mnemonic \<strong>BOOST CHAP</strong>\ can be used to remember the drugs precipitating porphyria.</p>\n<p><strong>B</strong>: Barbiturates</p>\n<p><strong>O</strong>: OCPs</p>\n<p><strong>O</strong>: Orphenadrine</p>\n<p><strong>S</strong>: Sulphonamides</p>\n<p><strong>T</strong>: Tetracyclines</p>\n<p><strong>C</strong>: Chloramphenicol, carbamazepine</p>\n<p><strong>H</strong>: Halothane, Hydralazine</p>\n<p><strong>A</strong>: Alcohol</p>\n<p><strong>P</strong>: Phenytoin</p></div><!---->\n      <!---->\n    </div><!---->'),
(248, 'Biochemistry', 'PM0913. Some Examples of Suicidal Inhibitors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\308\>\n<p><strong>Suicidal Inhibitors</strong></p>\n</td>\n<td width=\308\>\n<p><strong>Enzyme</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Allopurinol</p>\n</td>\n<td width=\308\>\n<p>Xanthine oxidase</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Aspirin</p>\n</td>\n<td width=\308\>\n<p>Cyclooxygenase</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>5-Flurouracil</p>\n</td>\n<td width=\308\>\n<p>Thymidylate synthase</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Penicillin</p>\n</td>\n<td width=\308\>\n<p>Transpeptidase</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>DFMO</p>\n</td>\n<td width=\308\>\n<p>Ornithine Decarboxylase</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(249, 'Biochemistry', 'PM0912. Difference between Competitive & Non-Competitive inhibitors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Reversible inhibitors are of two types:</p>\n<ul>\n<li>Competitive inhibitors</li>\n<li>Non-Competitive inhibitors</li>\n</ul>\n<p>Difference between Competitive &amp; Non-Competitive inhibitors</p>\n<table>\n<tbody>\n<tr>\n<td width=\308\>\n<p><strong>Competitive inhibitors</strong></p>\n</td>\n<td width=\308\>\n<p><strong>Non-Competitive inhibitors</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Succinate dehydrogenase is inhibited by Malonate</p>\n</td>\n<td width=\308\>\n<p>Pyruvate kinase is inhibited by alanine</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Substrate &amp; inhibitor are chemically similar &amp; have same shape</p>\n</td>\n<td width=\308\>\n<p>Substrate &amp; inhibitor are chemically not similar &amp; have different shape</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Inhibitor binds to active site</p>\n</td>\n<td width=\308\>\n<p>Inhibitor binds away from active site, i.e., at allosteric site</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Inhibitor does not change the shape of the active site</p>\n</td>\n<td width=\308\>\n<p>Inhibitor changes the shape of the active site</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Increase in substrate concentration reduces the inhibition</p>\n</td>\n<td width=\308\>\n<p>Increase in substrate concentration does not affect the inhibition</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Vmax remains constant</p>\n</td>\n<td width=\308\>\n<p>Vmax decreases</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Km Increases</p>\n</td>\n<td width=\308\>\n<p>Km remains constant</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(250, 'Biochemistry', 'PM0911. Difference between Reversible and Irreversible Inhibitors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\308\>\n<p><strong>Reversible Inhibitors</strong></p>\n</td>\n<td width=\308\>\n<p><strong>Irreversible Inhibitors</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Binds via non-covalent interaction</p>\n</td>\n<td width=\308\>\n<p>Binds via covalent interactions</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>No chemical change</p>\n</td>\n<td width=\308\>\n<p>Inhibitor binds to the substrate &amp; prevent catalytic activity of enzymes</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Can be reversed, as there is no bonding between the inhibitor &amp; substrate</p>\n</td>\n<td width=\308\>\n<p>Irreversibility due to strong covalent bonding</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(251, 'Biochemistry,', 'PM0855. Principal Serum Enzymes Used in Clinical Diagnosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\250\>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Serum Enzyme</strong></td>\n<td><strong>Major Diagnostic Use/Location</strong></td>\n</tr>\n<tr>\n<td colspan=\2\>Aminotransferases&nbsp;</td>\n</tr>\n<tr>\n<td>Aspartate aminotransferase (AST/SGOT)</td>\n<td>Liver function</td>\n</tr>\n<tr>\n<td>Alanine aminotransferase (ALT/SGPT)</td>\n<td>Viral hepatitis</td>\n</tr>\n<tr>\n<td colspan=\2\>Creatine kinase</td>\n</tr>\n<tr>\n<td>CK-MM</td>\n<td>Skeletal muscle,&nbsp;Muscle disorders</td>\n</tr>\n<tr>\n<td>CK-BB</td>\n<td>Brain,&nbsp;Brain injury, meningitis, abnormal cell growth, severe shock, stroke, hypothermia, or restricted blood flow to the bowel.</td>\n</tr>\n<tr>\n<td>CK-MB</td>\n<td>Heart and skeletal muscle, Myocardial Infarction, Muscular dystrophy</td>\n</tr>\n<tr>\n<td colspan=\2\>Lactate dehydrogenase (LDH)</td>\n</tr>\n<tr>\n<td>HHHH (I<sub>1</sub>)/LDH-1</td>\n<td>Heart &amp; RBC;Myocardial infarction</td>\n</tr>\n<tr>\n<td>HHHM(I<sub>2</sub>)/LDH-2</td>\n<td>Reticuloendothelial system</td>\n</tr>\n<tr>\n<td>HHMM(I<sub>3</sub>)/LDH-3</td>\n<td>Lungs</td>\n</tr>\n<tr>\n<td>HMMM(I<sub>4</sub>)/LDH-4</td>\n<td>Liver &amp; Skeletal Muscles</td>\n</tr>\n<tr>\n<td>MMMM(I<sub>5</sub>)/LDH-5</td>\n<td>Liver &amp; Skeletal Muscles; Liver diseases</td>\n</tr>\n<tr>\n<td colspan=\2\>Others</td>\n</tr>\n<tr>\n<td>Amylase, Lipase and Acid Phosphatase</td>\n<td>Acute pancreatitis</td>\n</tr>\n<tr>\n<td>Ceruloplasmin</td>\n<td>Hepatolenticular degeneration (Wilson disease)</td>\n</tr>\n<tr>\n<td>γ-Glutamyl transferase</td>\n<td>Liver diseases (Alcoholic Liver Disease)</td>\n</tr>\n<tr>\n<td>β-Glucocerebrosidase</td>\n<td>Gaucher disease</td>\n</tr>\n<tr>\n<td>Alkaline Phosphatase (isozymes)</td>\n<td>Bone disorders, obstructive liver diseases</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(252, 'Biochemistry', 'PM0844. Types of porphyria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Clinically porphyrias can be classified into:</p>\n<ul>\n<li>Hepatic porphyria</li>\n<li>Erythropoietic porphyria</li>\n</ul>\n<p><strong>Hepatic porphyria</strong> is caused due to enzyme deficiency <strong>early</strong> in the pathway of heme synthesis. There is an accumulation of<strong> ALA and PBG</strong>. The patient principally presents with <strong>neurovisceral symptoms</strong>.</p>\n<p><strong>Erythropoietic porphyria</strong> is caused due to enzyme deficiency <strong>late</strong> in the pathway of heme synthesis. There is an accumulation of <strong>porphyrins</strong> which leads to <strong>cutaneous photosensitivity</strong>.</p>\n<p><strong>Image: Heme synthesis pathway:</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/bfe6e70c1b9c4d3292b7f3c41271337ax1280x2068.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Porphyria type</strong></span></div>\n</td>\n<td>\n<div><span><strong>Deficient&nbsp;</strong> <strong>enzyme</strong></span></div>\n</td>\n<td>\n<div><span><strong>Lab findings</strong></span></div>\n</td>\n<td>&nbsp;</td>\n<td>\n<div><span><strong>Symptoms</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>X-linked dominant protoporphyria</span></div>\n<div><span>(XLDPP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate synthase 2</span></div>\n<div><span>(ALAS - 2)</span></div>\n</td>\n<td>Decreased RBC count and hemoglobin</td>\n<td>\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Aminolevulinate dehydratase deficiency porphyria</span></div>\n<div><span>(ALADP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate dehydratase</span></div>\n<div><span>(ALAD)</span></div>\n</td>\n<td>Increased urinary ALA and coproporphyrin III&nbsp;</td>\n<td><span>Neurovisceral symptoms</span></td>\n<td>\n<div><span>Abdominal pain, neuropathy</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Acute intermittent porphyria</span></div>\n<div><span>(AIP)</span></div>\n</td>\n<td>\n<div><span>Hydroxymethylbilane synthase</span></div>\n<div><span>(Uroporphyrin I synthase)</span></div>\n</td>\n<td>Increased urinary ALA and PBG&nbsp;</td>\n<td><span>Neurovisceral symptoms</span>&nbsp;</td>\n<td>\n<div><span>Periodic abdominal pain,&nbsp;peripheral neuropathy, psychiatric symptoms, tachycardia</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Congenital Erythropoietic porphyria</span></div>\n<div><span>(CEP)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen III synthase</span></div>\n<div><span>(UROS)</span></div>\n</td>\n<td>Increased urinary, fecal and red cell uroporphyrin I</td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Severe photosensitivity with erythema, swelling and blistering, hemolytic anemia, splenomegaly</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Porphyria cutanea tarda (PCT)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen decarboxylase</span></div>\n<div><span>(UROD)</span></div>\n</td>\n<td>Increased uroporphyrin I</td>\n<td>&nbsp;\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity with&nbsp;vesicles&nbsp;and&nbsp;bullae</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Hereditary coproporphyria</span></div>\n<div><span>(HCP)</span></div>\n</td>\n<td>\n<div><span>Coproporphyrinogen oxidase</span></div>\n<div><span>(CPOX)</span></div>\n</td>\n<td>Increased urinary ALA, PBG, and coproporphyrin III and fecal coproporphyrin III</td>\n<td>Both</td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, abdominal colic</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Variegate porphyria</span></div>\n<div><span>(VP)</span></div>\n</td>\n<td>\n<div><span>Protoporphyrinogen oxidase</span></div>\n<div><span>(PPOX)</span></div>\n</td>\n<td>Increased urinary ALA, PBG, and coproporphyrin III and fecal protoporphyrin IX</td>\n<td>Both</td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, developmental delay</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Erythropoietic protoporphyria</span></div>\n<div><span>(EPP)</span></div>\n</td>\n<td>\n<div><span>Ferrochelatase</span></div>\n<div><span>(FECH)</span></div>\n</td>\n<td>Increased fecal and red cell protoporphyrin IX&nbsp;</td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Non-blistering Photosensitivity with skin lesions</span></div>\n</td>\n</tr>\n</tbody>\n</table>\n<div><span>&nbsp;</span></div>\n<div><span>Most porphyrias are <strong>autosomal dominant</strong> <strong>except</strong></span></div>\n<div>\n<ul>\n<li><span>ALAD enzyme deficiency porphyria</span></li>\n<li><span>Congenital erythropoietic porphyria</span></li>\n<li><span>Erythropoietic protoporphyria</span></li>\n<li><span>X-linked protoporphyria</span></li>\n</ul>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(253, 'Biochemistry', 'PM0766. Site of synthesis of various Cox products', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>COX pathway products</td>\n<td>Site of synthesis</td>\n</tr>\n<tr>\n<td>Whole range of COX products</td>\n<td>Lung &amp; Spleen</td>\n</tr>\n<tr>\n<td>Thromboxane</td>\n<td>Primarily Platelets</td>\n</tr>\n<tr>\n<td>Prostacyclin</td>\n<td>Endothelium of blood vessels</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(254, 'Paediatrics,', 'PM0595. Human Porphyrias and Their Features', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<div><span><strong>Acute intermittent porphyria</strong></span></div>\n</td>\n<td>\n<div><span><strong>Porphyria cutanea tarda</strong></span></div>\n</td>\n<td>\n<div><span><strong>Erythropoietic protoporphyria</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Presenting symptoms</strong></span></div>\n</td>\n<td>\n<div><span>Neurologic</span></div>\n</td>\n<td>\n<div><span>Chronic skin blistering, fragility</span></div>\n</td>\n<td>\n<div><span>Acute skin swelling, pain</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Onset</strong></span></div>\n</td>\n<td>\n<div><span>Adult-onset</span></div>\n</td>\n<td><span>Adult-onset</span></td>\n<td><span>Childhood-onset</span></td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Exacerbating factors</strong></span></div>\n</td>\n<td>\n<div><span>Drugs (like P450 inducers), progesterone, dietary restriction</span></div>\n</td>\n<td>\n<div><span>Iron, alcohol, smoking, estrogens, hepatitis C, HIV, halogenated hydrocarbons</span></div>\n</td>\n<td>\n<div><span>---</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Most important screening Tests</strong></span></div>\n</td>\n<td>\n<div><span>Urinary porphobilinogen</span></div>\n</td>\n<td>\n<div><span>Plasma (or urine)</span></div>\n<div><span>porphyrins</span></div>\n</td>\n<td>\n<div><span>Erythrocyte (or plasma) porphyrins</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Treatment</strong></span></div>\n</td>\n<td>\n<div><span>Hemin, glucose</span></div>\n</td>\n<td>\n<div><span>Phlebotomy, low-dose hydroxychloroquine</span></div>\n</td>\n<td>\n<div><span>Beta-carotene</span></div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(255, 'Biochemistry', 'PM0032. Rate determining enzymes and their key regulators', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\750\>\n<tbody>\n<tr>\n<td>Pathway</td>\n<td>Enzyme&nbsp;</td>\n<td>Regulating factors</td>\n</tr>\n<tr>\n<td>Glycolysis</td>\n<td>Phosphofructokinase (PFK-1)</td>\n<td>\n<p>AMP+, Fructose 2,6 bi-phosphate+</p>\n<p>ATP-, Citrate-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;gluconeogenesis</td>\n<td>Fructose-1,6-bisphosphatase</td>\n<td>\n<p>ATP+, Acetyl CoA+</p>\n<p>AMP-, Fructose 2,6 bi-phosphate-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Krebs cycle</td>\n<td>Isocitrate dehydrogenase</td>\n<td>\n<p>ADP+,</p>\n<p>ATP-, NADH-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;glycogenesis</td>\n<td>Glycogen synthase</td>\n<td>\n<p>Glucose-6-phosphate+, insulin+, cortisol+,</p>\n<p>Epinephrine-, glucagon-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;glycogenolysis</td>\n<td>Glycogen phosphorylase</td>\n<td>\n<p>Epinephrine+, glucagon+, AMP+</p>\n<p>Glucose-6-phosphate-, insulin-, ATP-</p>\n</td>\n</tr>\n<tr>\n<td>HMP shunt&nbsp;</td>\n<td>Glucose-6-phosphate dehydrogenase (G6PD)</td>\n<td>\n<p>NADP+</p>\n<p>NADPH-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Denovo pyrimidine synthesis</td>\n<td>Carbamoyl phosphate synthetase II</td>\n<td>\n<p>ATP+</p>\n<p>UTP-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Denovo purine synthesis</td>\n<td>Glutamine-phosphoribosylpyrophosphate (PRPP) amidotransferase</td>\n<td>AMP-, IMP-, GMP-</td>\n</tr>\n<tr>\n<td>&nbsp;Urea cycle</td>\n<td>Carbamoyl phosphate synthetase I</td>\n<td>N-acetyl glutamate (NAG)+</td>\n</tr>\n<tr>\n<td>&nbsp;Fatty acid synthesis</td>\n<td>Acetyl-CoA carboxylase (ACC)</td>\n<td>\n<p>Insulin+, citrate+</p>\n<p>Glucagon-, palmitoyl-CoA-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Fatty acid oxidation</td>\n<td>Carnitine acyltransferase I</td>\n<td>Malonyl-CoA-</td>\n</tr>\n<tr>\n<td>&nbsp;Cholesterol synthesis</td>\n<td>HMG-CoA reductase</td>\n<td>\n<p>Insulin+, thyroxine+</p>\n<p>Glucagon-, cholesterol-</p>\n</td>\n</tr>\n<tr>\n<td>Ketogenesis</td>\n<td>HMG-CoA synthase</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>+ Positive effect on the pathway.</p>\n<p>- Negative effect on the pathway.</p></div><!---->\n      <!---->\n    </div><!---->'),
(256, 'Pathology,', 'PM2419. Factors affecting iron absorption', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Enhancers:</strong></p>\n<ul>\n<li>Ascorbic acid</li>\n<li>Citric acid</li>\n<li>Amino acid</li>\n<li>Sugars in the diet</li>\n</ul>\n<p><strong>Inhibitors:</strong></p>\n<ul>\n<li>Tannins</li>\n<li>Carbonate</li>\n<li>Oxalate</li>\n<li>Phosphate</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(257, 'Orthopaedics,', 'PM2197. Parathyroid Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c6b63d4374934158b4021e7aa5b159f2x1200x1541.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(258, 'Community Medicine,', 'PM1826. Folic Acid in Pregnancy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Condition</strong></td>\n<td><strong>Daily dosage of folic acid</strong></td>\n</tr>\n<tr>\n<td>Prophylaxis - to prevent neural tube defects (NTDs)</td>\n<td>\n<p>400 mcg (WHO)</p>\n<p>500 mcg (<span>MoHFW- India)</span></p>\n</td>\n</tr>\n<tr>\n<td>Treatment of folic acid deficiency</td>\n<td>\n<p>800 mcg (WHO)</p>\n<p>1 mg (MoHFW-India)</p>\n</td>\n</tr>\n<tr>\n<td>Previous child with NTD</td>\n<td>\n<p>5 mg<strong>*</strong> (WHO)</p>\n<p>4 mg (NCBI)</p>\n<p>5 mg (MoHFW-India)</p>\n</td>\n</tr>\n<tr>\n<td>Sickle cell disease</td>\n<td>5 mg&nbsp;</td>\n</tr>\n<tr>\n<td>Thalassemia</td>\n<td>5 mg</td>\n</tr>\n<tr>\n<td>Epilepsy</td>\n<td>4 mg</td>\n</tr>\n</tbody>\n</table>\n<p>WHO: World Health Organization</p>\n<p>MoHFW-India: Ministry of Health and Family Welfare</p>\n<p><strong>*</strong>more acceptable (most references)</p>\n<p><strong>Controversial</strong>: Latest ACOG guidelines mention 0.4mg of folic acid to be given to epileptic pregnant women / pregnant women on ASM (Anti-seizure medications).<br>Williams Obstetrics, 26th Edition and Harrisons Medicine 21st edition mention the dose to be 4mg per day.</p></div><!---->\n      <!---->\n    </div><!---->'),
(259, 'Biochemistry', 'PM1158. Types of Antioxidants', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\0\>\n<tbody>\n<tr>\n<td>\n<p><strong>Preventive Antioxidants</strong></p>\n</td>\n<td>\n<p><strong>Chain-breaking Antioxidants</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Catalase</li>\n<li>Glutathione peroxidase</li>\n<li>Chelator of metal Ions-Ceruloplasmin &amp; Transferrin</li>\n</ul>\n</td>\n<td><br>\n<ul>\n<li>Superoxide dismutase</li>\n<li>Urate</li>\n<li>Vitamin E</li>\n<li>Polyphenols</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(260, 'Biochemistry', 'PM1157. Reactive Oxygen Species', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\>\n<p><strong>Radicals</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Reactive oxygen species</strong></p>\n</td>\n<td>\n<p><strong>Antioxidant</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Superoxide</p>\n</td>\n<td>\n<p>Vitamin C , SOD</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hydroxyl</p>\n</td>\n<td>\n<p>Vitamin C, Glutathione</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hydroperoxyl</p>\n</td>\n<td>\n<p>Vitamin C , Vitamin E, Glutathione, Carotenoid, Ubiquinol</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkoxyl</p>\n</td>\n<td>\n<p>Vitamin C</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Peroxyl</p>\n</td>\n<td>\n<p>Vitamin C , Vitamin E, Glutathione, Carotenoid, Ubiquinol</p>\n</td>\n</tr>\n<tr>\n<td>Singlet Oxygen</td>\n<td>&nbsp;Vitamin C , Carotenoid</td>\n</tr>\n</tbody>\n</table>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\>\n<p><strong>Non-Radicals</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Reactive oxygen species</strong></p>\n</td>\n<td>\n<p><strong>Antioxidant</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hydrogen peroxide</p>\n</td>\n<td>\n<p>Vitamin C, Glutathione, catalase</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(261, 'Biochemistry', 'PM1156. Daily Recommended Dose of Water-Soluble Vitamins', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\215\>\n<p>Vitamins</p>\n</td>\n<td width=\401\>\n<p>Recommended daily dose</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>Vitamin B1</p>\n</td>\n<td width=\401\>\n<p>1–1.5 mg/day</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>Vitamin B2</p>\n</td>\n<td width=\401\>\n<p>1–1.5 mg/day</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>Vitamin B3</p>\n</td>\n<td width=\401\>\n<p>16–20 mg/day</p>\n<p>Lactation: 20<u>+</u>5 mg/day</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>Pantothenic acid</p>\n</td>\n<td width=\401\>\n<p>8–10 mg/day</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>Vitamin B6</p>\n</td>\n<td width=\401\>\n<p>1–2 mg/day</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>Biotin</p>\n</td>\n<td width=\401\>\n<p>30&nbsp;μg/day</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>Folic acid</p>\n</td>\n<td width=\401\>\n<p>300–400 μg/day</p>\n<p>Pregnancy: 600 μg/day</p>\n<p>Lactation:500 μg/day</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>Vitamin B12</p>\n</td>\n<td width=\401\>\n<p>1.5–2.5 μg/day</p>\n<p>Pregnancy: 2.5–2.8 μg/day</p>\n<p>Lactation: 2.5 μg/day</p>\n</td>\n</tr>\n<tr>\n<td width=\215\>\n<p>Vitamin C</p>\n</td>\n<td width=\401\>\n<p>75 mg/day</p>\n<p>Pregnancy &amp; lactation: 100–120 mg/day</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(262, 'Biochemistry', 'PM1155. Conditions Associated with Pellagra-like Symptoms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\196\>\n<p>Condition/Disease</p>\n</td>\n<td width=\420\>\n<p>Reason for niacin deficiency</p>\n</td>\n</tr>\n<tr>\n<td width=\196\>\n<p>Hartnup disease</p>\n</td>\n<td width=\420\>\n<p>Intestinal &amp; renal malabsorption of tryptophan</p>\n</td>\n</tr>\n<tr>\n<td width=\196\>\n<p>Carcinoid syndrome</p>\n</td>\n<td width=\420\>\n<p>Overproduction of serotonin that causes diversion of&nbsp; tryptophan from NAD+ Pathway</p>\n</td>\n</tr>\n<tr>\n<td width=\196\>\n<p>Vitamin B6 deficiency</p>\n</td>\n<td width=\420\>\n<p>Defective kynureninase pathway</p>\n</td>\n</tr>\n<tr>\n<td width=\196\>\n<p>Maize rich diet</p>\n</td>\n<td width=\420\>\n<p>Niacin is in unavailable niacytin form</p>\n</td>\n</tr>\n<tr>\n<td width=\196\>\n<p>Jowar diet (Sorghum)</p>\n</td>\n<td width=\420\>\n<p>Increase leucine content inhibit QPRTase enzyme</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(263, 'Medicine,', 'PM1154. Vitamin Deficiency States (Water-soluble Vitamins)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke–Korsakoff’s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \Nutritional melalgia\)</p>\n<div class=\page\ title=\Page 90\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(264, 'Biochemistry', 'PM1153. Biochemical Assay for Vitamin Deficiency State', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\308\>\n<p><strong>Vitamin</strong></p>\n</td>\n<td width=\308\>\n<p><strong>Assay and test</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Vitamin B1 (Thiamine)</p>\n</td>\n<td width=\308\>\n<p>RBC Trans-ketolase</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Vitamin B2 (Riboflavin)</p>\n</td>\n<td width=\308\>\n<p>RBC glutathione reductase</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Vitamin B6 (Pyridoxine)</p>\n</td>\n<td width=\308\>\n<p>RBC transaminase</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Vitamin B9 (Folic acid)</p>\n</td>\n<td width=\308\>\n<p>FIGLU excretion/Histidine load test</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Vitamin B12 (Cobalamine)</p>\n</td>\n<td width=\308\>\n<p>Serum methyl malonate level</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(265, 'Biochemistry', 'PM1131. Active Forms and Functions of Water-Soluble Vitamins', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td rowspan=\2\>\n<p>Vitamin</p>\n</td>\n<td colspan=\2\>\n<p>Coenzyme</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Name</p>\n</td>\n<td>\n<p>Function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B1(Thiamine)</p>\n</td>\n<td>\n<p>Thiamine pyrophosphate (TPP)</p>\n</td>\n<td>\n<p>Decarboxylation</p>\n<p>Transketolase reaction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B2(Riboflavin)</p>\n</td>\n<td>\n<p>Flavin-adenine-dinucelotide (FAD)</p>\n</td>\n<td>\n<p>Hydrogen Transfer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B3(Nicotinic acid, niacin)</p>\n</td>\n<td>\n<p>Nicotinamide-adenine dinucleotide(NAD<sup>+</sup>)</p>\n</td>\n<td>\n<p>Hydrogen Transfer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B5(Pantothenic acid)</p>\n</td>\n<td>\n<p>Coenzyme A</p>\n</td>\n<td>\n<p>Transfer of an acyl group</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B6(Pyridoxine)</p>\n</td>\n<td>\n<p>Pyridoxal Phosphate(PLP)</p>\n</td>\n<td>\n<p>Transamination</p>\n<p>Decarboxylation</p>\n<p>Co-factor of glycogen phosphorylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B7(Biotin)</p>\n</td>\n<td>\n<p>Biotin</p>\n</td>\n<td>\n<p>Carboxylation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B9(Folic acid)</p>\n</td>\n<td>\n<p>Tetrahydrofolic acid (THFA)</p>\n</td>\n<td>\n<p>Donor of methyl/formyl group</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B12(Cobalamin)</p>\n</td>\n<td>\n<p>Methylcobalamin and Adenosylcobalamin</p>\n</td>\n<td>\n<p>Co-factor of methionine synthase and methylmalonyl&nbsp;CoA mutase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C (Ascorbic acid)</p>\n</td>\n<td>Ascorbic acid and dehydroascorbic acid</td>\n<td>\n<p>Oxidation-reduction</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(266, 'Biochemistry', 'PM1120. Active Forms of Vitamin A', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p>Active Form</p>\n</td>\n<td>\n<p>Function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Retinol</p>\n</td>\n<td>\n<p>Reproduction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Retinal</p>\n</td>\n<td>\n<p>Vision</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Retinoic acid</p>\n</td>\n<td>\n<p>Epithelial differentiation, gene expression, growth and development</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(267, 'Biochemistry', 'PM1117. Basal Metabolic Rate', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\196\>\n<p><strong>BMR is increased in</strong></p>\n</td>\n<td width=\246\>\n<p><strong>BMR is decreased in</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\196\>\n<p>Fever</p>\n</td>\n<td width=\246\>\n<p>Protein energy malnutrition</p>\n</td>\n</tr>\n<tr>\n<td width=\196\>\n<p>Hyperthyroidism</p>\n</td>\n<td width=\246\>\n<p>Hypothyroidism</p>\n</td>\n</tr>\n<tr>\n<td width=\196\>\n<p>Cold environment</p>\n</td>\n<td width=\246\>\n<p>Addison disease</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\2\ width=\196\>\n<p>Cachexia</p>\n<p>&nbsp;</p>\n</td>\n<td width=\246\>\n<p>Starvation</p>\n</td>\n</tr>\n<tr>\n<td width=\196\>\n<p>Cushing’s syndrome</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(268, 'Biochemistry', 'PM1116. Calorific Value of Food Stuff', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\140\>\n<p>Food Stuff</p>\n</td>\n<td width=\198\>\n<p>Caloric Value (KCal/g)</p>\n</td>\n</tr>\n<tr>\n<td width=\140\>\n<p>Carbohydrate</p>\n</td>\n<td width=\198\>\n<p>4</p>\n</td>\n</tr>\n<tr>\n<td width=\140\>\n<p>Protein</p>\n</td>\n<td width=\198\>\n<p>4.2</p>\n</td>\n</tr>\n<tr>\n<td width=\140\>\n<p>Fat</p>\n</td>\n<td width=\198\>\n<p>9</p>\n</td>\n</tr>\n<tr>\n<td width=\140\>\n<p>Alcohol</p>\n</td>\n<td width=\198\>\n<p>7</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(269, 'Biochemistry,', 'PM0602. Major Sites of Absorption of Hematopoietic Factors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>D</strong>uodenum + upper jejunum: <strong>I</strong>ron</li>\n<li><strong>J</strong>ejunum: <strong>F</strong>olate</li>\n<li>Terminal <strong>I</strong>leum: Vitamin <strong>B</strong>12</li>\n</ul>\n<p><strong>Mnemonic - D</strong>ude<strong> I</strong>s <strong>J</strong>ust <strong>F</strong>eeling <strong>I</strong>ll <strong>B</strong>ro</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7b5aa9349c7142d495c2d6b273d05861x902x206.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(270, 'Community Medicine,', 'PM0089. Fat-soluble vitamins', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td rowspan=\2\><strong>Vitamin</strong></td>\n<td rowspan=\2\><strong>Active form</strong></td>\n<td rowspan=\2\><strong>Deficiency</strong></td>\n<td rowspan=\2\><strong>Toxicity</strong></td>\n<td colspan=\3\><strong>Required dietary allowance</strong></td>\n</tr>\n<tr>\n<td>Children</td>\n<td>Male</td>\n<td>Female</td>\n</tr>\n<tr>\n<td>Vitamin A</td>\n<td>\n<p>Retinol</p>\n<p>Retinal</p>\n<p>Retinoic acid</p>\n</td>\n<td>\n<p>Night blindness, xerophthalmia,</p>\n<p>Acne, psoriasis,</p>\n<p>Impaired immunity</p>\n</td>\n<td>\n<p>Affects lysosomes</p>\n<p>Acute- pseudotumor cerebrii, exfoliative dermatitis</p>\n<p>Chronic-fractures</p>\n</td>\n<td>\n<p>390-630mcg (1-9 years)</p>\n<p>770-1000mcg (10-18 years)</p>\n</td>\n<td>1000mcg&nbsp;</td>\n<td>&nbsp;\n<p>Adult - 840mcg</p>\n<p>Pregnancy - 900mcg</p>\n<p>Lactation - 950 mcg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin D</td>\n<td>1,25-Dihydro-cholecalciferol</td>\n<td>\n<p>Children- Rickets</p>\n<p>Adults-osteomalacia</p>\n</td>\n<td>Calcinosis</td>\n<td>&nbsp;\n<p>400 IU (&lt;1 year)</p>\n<p>600 IU (&gt;1 year)</p>\n</td>\n<td>&nbsp;600 IU</td>\n<td>\n<p>Adult - 600 IU</p>\n<p>Pregnancy - 600 IU</p>\n<p>Lactation - 600 IU</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin E</td>\n<td>α-tocopherol</td>\n<td>\n<p>Hemolytic anemia,</p>\n<p>axonal degeneration,</p>\n<p>spinocerebellar ataxia</p>\n</td>\n<td>\n<p>Reduced platelet aggregation,&nbsp;</p>\n<p>Interferes with vitamin K</p>\n</td>\n<td>&nbsp;5-8 mg</td>\n<td>&nbsp;10 mg</td>\n<td>\n<p>Adult - 8 mg</p>\n<p>Pregnancy - 10 mg</p>\n<p>Lactation - 12 mg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin K</td>\n<td>\n<p>Menedione</p>\n<p>Menoquinone</p>\n<p>Phyloquinone</p>\n</td>\n<td>\n<p>Elevated prothrombin time and bleeding</p>\n<p>Haemorrhagic disease of newborn</p>\n</td>\n<td>\n<p>Hemolysis</p>\n<p>Hyperbilirubinemia</p>\n<p>Kernicterus</p>\n</td>\n<td>\n<p>&lt;1 year - 2-3&nbsp;µg</p>\n<p>Children - 30-50&nbsp;µg</p>\n&nbsp;</td>\n<td>55 µg&nbsp;</td>\n<td>55 µg&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>Note:The <strong>RDA</strong> for <strong>Vitamin D</strong> in the <strong>elderly</strong> (&gt;60 years) is <strong>800 IU</strong>.</p></div><!---->\n      <!---->\n    </div><!---->'),
(271, 'Biochemistry', 'PM2327. Purine salvage deficiencies: Lesch-Nyhan syndrome and Adenosine deaminase deficiency(SCID)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Severe Combined Immunodeficiency(SCID):</strong></p>\n<p><strong>Adenosine deaminase</strong>&nbsp;enzyme deficiency is one of the major cause of SCID. It is also called as&nbsp;<strong>Glanzmann–Riniker syndrome.</strong></p>\n<p>SCID patients are usually affected by severe bacterial, viral, or fungal infections early in life and often present with interstitial lung disease, chronic diarrhea, and failure to thrive.</p>\n<p><strong>Lesch-Nyhan syndrome:</strong></p>\n<p>It is due to deficiency of the enzyme<strong> Hypoxanthine-guanine phosphoribosyltransferase(HGPRT). </strong>It is an X-linked recessive disease.</p>\n<p>Clinical features:</p>\n<ul>\n<li><span class=\fontstyle0\>Intellectual disability</span></li>\n<li><span class=\fontstyle0\>Self-mutilation</span></li>\n<li><span class=\fontstyle0\>Aggression</span></li>\n<li>Hyperuricemia&nbsp;</li>\n<li><span class=\fontstyle0\>Gout<br></span></li>\n</ul>\n<p><span class=\fontstyle0\>Treatment:</span></p>\n<ul>\n<li><span class=\fontstyle0\>Allopurinol</span></li>\n<li><span class=\fontstyle0\>Febuxostat</span></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(272, 'Biochemistry', 'PM2151. Operon system', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>Control of operon/ Regulation of gene expression&nbsp;</td>\n<td>Type of operon</td>\n<td>Metabolite</td>\n<td>Final outcome</td>\n<td>Examples</td>\n</tr>\n<tr>\n<td rowspan=\2\>\n<p><strong>Negative control</strong></p>\n<p>(an active repressor <strong>inhibits transcription</strong>)</p>\n&nbsp;</td>\n<td>\n<p><strong>Inducible operons</strong></p>\n<p>(repressor bound to operon)</p>\n</td>\n<td>binds to repressor and inhibits its binding to the operon by causing a conformational change</td>\n<td>Transcription</td>\n<td><strong>lactose operon</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Repressible operons</strong></p>\n<p>(repressor unable to bind to operon)</p>\n</td>\n<td>binds to repressor and induces its binding to the operon by causing a conformational change</td>\n<td>No&nbsp;Transcription</td>\n<td><strong>Tryptophan operon</strong></td>\n</tr>\n<tr>\n<td rowspan=\2\>\n<p><strong>Positive control</strong></p>\n<p>(an active activator/ regulator <strong>promotes transcription</strong>)</p>\n&nbsp;</td>\n<td>\n<p><strong>Inducible operons</strong></p>\n<p>(activator unable to bind to operon)</p>\n</td>\n<td>binds to activator and induces its binding to operon by causing a conformational change</td>\n<td>Transcription</td>\n<td>cAMP-CAT operon</td>\n</tr>\n<tr>\n<td>\n<p><strong>Repressible operons&nbsp;</strong></p>\n<p>(activator bound to operon)</p>\n</td>\n<td>binds to activator and inhibits its binding to operon by causing a conformational change&nbsp;</td>\n<td>No Transcription</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/30993953bbe44f8d9ce20feb967f3289x719x599.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(273, 'Biochemistry', 'PM1111. Structural Alterations of the β -Globin Gene', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\149\>\n<p>Alteration</p>\n</td>\n<td width=\217\>\n<p>Function affected</p>\n</td>\n<td width=\250\>\n<p>Disease</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\4\ width=\149\>\n<p>Point Mutation</p>\n</td>\n<td width=\217\>\n<p>Protein folding</p>\n</td>\n<td width=\250\>\n<p>Sickle cell disease</p>\n</td>\n</tr>\n<tr>\n<td width=\217\>\n<p>Transcriptional control</p>\n</td>\n<td width=\250\>\n<p>β-Thalassemia</p>\n</td>\n</tr>\n<tr>\n<td width=\217\>\n<p>Frameshift &amp; nonsense mutations</p>\n</td>\n<td width=\250\>\n<p>β-Thalassemia</p>\n</td>\n</tr>\n<tr>\n<td width=\217\>\n<p>RNA processing</p>\n</td>\n<td width=\250\>\n<p>β-Thalassemia</p>\n</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Deletion</p>\n</td>\n<td width=\217\>\n<p>mRNA production</p>\n</td>\n<td width=\250\>\n<p>β<sup>0</sup>-Thalassemia</p>\n<p>Hemoglobin Lepore</p>\n</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Rearrangement</p>\n</td>\n<td width=\217\>\n<p>mRNA production</p>\n</td>\n<td width=\250\>\n<p>β-Thalassemia type III</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(274, 'Biochemistry', 'PM1110. Localization of Human Genes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\233\>\n<p>Gene</p>\n</td>\n<td width=\123\>\n<p>Chromosome</p>\n</td>\n<td width=\288\>\n<p>Disease Implicated</p>\n</td>\n</tr>\n<tr>\n<td width=\233\>\n<p>Insulin</p>\n</td>\n<td width=\123\>\n<p>11p15</p>\n</td>\n<td width=\288\>\n<p>Diabetes</p>\n</td>\n</tr>\n<tr>\n<td width=\233\>\n<p>Prolactin</p>\n</td>\n<td width=\123\>\n<p>6p23-q12</p>\n</td>\n<td width=\288\>\n<p>Sheehan syndrome</p>\n</td>\n</tr>\n<tr>\n<td width=\233\>\n<p>Growth hormone</p>\n</td>\n<td width=\123\>\n<p>17q21-qter</p>\n</td>\n<td width=\288\>\n<p>Growth Hormone deficiency</p>\n</td>\n</tr>\n<tr>\n<td width=\233\>\n<p>α-Globin</p>\n</td>\n<td width=\123\>\n<p>16p12-pter</p>\n</td>\n<td width=\288\>\n<p>α-Thalassemia</p>\n</td>\n</tr>\n<tr>\n<td width=\233\>\n<p>β-Globin</p>\n</td>\n<td width=\123\>\n<p>11p12</p>\n</td>\n<td width=\288\>\n<p>β-Thalassemia,</p>\n<p>sickle cell anaemia</p>\n</td>\n</tr>\n<tr>\n<td width=\233\>\n<p>Adenosine deaminase</p>\n</td>\n<td width=\123\>\n<p>20q13-qter</p>\n</td>\n<td width=\288\>\n<p>Adenosine deaminase deficiency</p>\n</td>\n</tr>\n<tr>\n<td width=\233\>\n<p>Phenylalanine hydroxylase</p>\n</td>\n<td width=\123\>\n<p>12q24</p>\n</td>\n<td width=\288\>\n<p>Phenylketonuria</p>\n</td>\n</tr>\n<tr>\n<td width=\233\>\n<p>Hypoxanthine-guanine</p>\n<p>phosphoribosyltransferase</p>\n</td>\n<td width=\123\>\n<p>Xq26-q27</p>\n</td>\n<td width=\288\>\n<p>Lesch-Nyhan syndrome</p>\n</td>\n</tr>\n<tr>\n<td width=\233\>\n<p>DNA segment G8</p>\n</td>\n<td width=\123\>\n<p>4p</p>\n</td>\n<td width=\288\>\n<p>Huntington chorea</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(275, 'Biochemistry', 'PM1109. Some Enzymes Used in Recombinant DNA Research', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\206\>\n<p>Enzymes</p>\n</td>\n<td width=\410\>\n<p>Use</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>Phosphatases</p>\n</td>\n<td width=\410\>\n<p>Removal of 5′-PO4 groups prior to kinase labeling; also used to prevent self-ligation</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>DNA ligase</p>\n</td>\n<td width=\410\>\n<p>Joining of DNA molecules</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>DNA polymerase I</p>\n</td>\n<td width=\410\>\n<p>Synthesis of double-stranded cDNA; nick translation; generation of blunt ends from sticky ends</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>Thermostable DNA polymerases</p>\n</td>\n<td width=\410\>\n<p>Polymerase chain reaction (DNA synthesis)</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>DNAse I</p>\n</td>\n<td width=\410\>\n<p>Nick translation; mapping of hypersensitive sites; mapping protein-DNA interactions</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>Exonuclease III</p>\n</td>\n<td width=\410\>\n<p>DNA sequencing; ChIP-exo, mapping of DNA-protein interactions</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>λ Exonuclease</p>\n</td>\n<td width=\410\>\n<p>DNA sequencing</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>Polynucleotide kinase</p>\n</td>\n<td width=\410\>\n<p>32P end-labeling of DNA or RNA</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>Reverse transcriptase</p>\n</td>\n<td width=\410\>\n<p>Synthesis of cDNA from mRNA; RNA (5′ end) mapping studies</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>RNAse H</p>\n</td>\n<td width=\410\>\n<p>Synthesis of cDNA from mRNA</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>S1 nuclease</p>\n</td>\n<td width=\410\>\n<p>Removal of “hairpin” in synthesis of cDNA; RNA mapping studies (both 5′ and 3′ ends)</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>Terminal transferase</p>\n</td>\n<td width=\410\>\n<p>Homopolymer tailing</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>Recombinases (CRE, INT, FLP)</p>\n</td>\n<td width=\410\>\n<p>Generation of specific chimeric DNA molecules, work both in vitro and in vivo</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(276, 'Biochemistry', 'PM1108. Difference between Lac & tryptophan operon', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\308\>\n<p><strong>Lac Operon</strong></p>\n</td>\n<td width=\308\>\n<p><strong>Tryptophan Operon</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Inducible gene complex</p>\n</td>\n<td width=\308\>\n<p>Repressible gene complex</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Catabolic system</p>\n</td>\n<td width=\308\>\n<p>Anabolic system</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Contain 3 structural genes</p>\n</td>\n<td width=\308\>\n<p>Contains 5 structural gene</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Produce 3 inducible enzymes</p>\n</td>\n<td width=\308\>\n<p>Produce 5 Repressible enzymes</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Repressor protein is active</p>\n</td>\n<td width=\308\>\n<p>Repressor protein is inactive</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>High lactose turn transcription on , in low glucose level</p>\n</td>\n<td width=\308\>\n<p>High tryptophan transcription off</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Lactose act as inducer</p>\n</td>\n<td width=\308\>\n<p>Tryptophan act as co-repressor</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Has only 1 type of gene regulation-Negative&nbsp; control</p>\n</td>\n<td width=\308\>\n<p>Has only 1 type of gene regulation-Negative control</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Usually OFF, Get activated under certain conditions</p>\n</td>\n<td width=\308\>\n<p>Usually ON, inactive at high level of tryptophan.</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>cAMP is necessary for CAP to switch transcription on</p>\n</td>\n<td width=\308\>\n<p>cAMP is not&nbsp; necessary</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(277, 'Biochemistry', 'PM1107. Types of Genes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\308\>\n<p>Types</p>\n</td>\n<td width=\308\>\n<p>Properties</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Housekeeping gene</p>\n</td>\n<td width=\308\>\n<p>Gene turned on in all cells at all times (e.g., transcription machinery, translation machinery, energy conversion, etc.)</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Cell type specific gene</p>\n</td>\n<td width=\308\>\n<p>Genes that are turned on &amp; off in each cell.</p>\n<p>It gives a cell its special properties &amp; functions.</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Developmental regulatory gene</p>\n</td>\n<td width=\308\>\n<p>Genes specific to certain stages during growth &amp; development.</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Inducible&nbsp; gene</p>\n</td>\n<td width=\308\>\n<p>Gene not normally expressing but get expressed in response to some external stimuli (e.g., hormones)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(278, 'Biochemistry', 'PM1064. Human Diseases of DNA Damage Repair', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>DNA damage repair type</strong></p>\n</td>\n<td>\n<p><strong>Diseases</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Nonhomologous End Joining Repair (NHEJ)</p>\n</td>\n<td>\n<p>Severe combined immunodeficiency disease (SCID)</p>\n<p>Radiation sensitive severe combined immunodeficiency disease(RS-SCID)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Homologous Repair (HR)</p>\n</td>\n<td>\n<p>AT-like disorder (ATLD)</p>\n<p>Nijmegen breakage syndrome (NBS)</p>\n<p>Bloom syndrome (BS)</p>\n<p>Werner syndrome (WS)</p>\n<p>Rothmund-Thomson syndrome (RTS)</p>\n<p>Breast cancer suspectibility 1 and 2 (BRCA1, BRCA2)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Nucleotide Excision Repair (NER)</p>\n</td>\n<td>\n<p>Xeroderma pigmentosum (XP)</p>\n<p>Cockayne syndrome (CS)</p>\n<p>Trichothiodystrophy (TTD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Base Excision Repair (BER)</p>\n</td>\n<td>\n<p>MUTYH-associated polyposis (MAP)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Mismatch Repair (MMR)</p>\n</td>\n<td>\n<p>Hereditary nonpolyposis colorectal cancer (HNPCC)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(279, 'Biochemistry', 'PM1063. DNA Repair Mechanisms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\622\>\n<tbody>\n<tr>\n<td><strong>Damaging agents</strong></td>\n<td><strong>Damage caused</strong></td>\n<td><strong>Repair mechanisms</strong></td>\n</tr>\n<tr>\n<td>\n<p>Ionizing radiation</p>\n<p>X-rays</p>\n<p>Anti-tumor drugs</p>\n</td>\n<td>\n<p>Double-strand breaks</p>\n<p>Single-strand breaks</p>\n<p>Intrastrand crosslinks</p>\n<p>Interstrand crosslinks</p>\n</td>\n<td>Non-homologous end joining (NHEJ)</td>\n</tr>\n<tr>\n<td>\n<p>UV light</p>\n<p>Chemicals</p>\n</td>\n<td>\n<p>Bulky adducts</p>\n<p>Pyrimidine dimers</p>\n</td>\n<td>Nucleotide excision repair (NER)</td>\n</tr>\n<tr>\n<td>\n<p>Oxygen radicals</p>\n<p>Hydrolysis&nbsp;</p>\n<p>Alkylating agents</p>\n</td>\n<td>\n<p>Abasic sites single-strand breaks</p>\n<p>8-oxoguanine lesions</p>\n</td>\n<td>Base excision repair (BER)</td>\n</tr>\n<tr>\n<td>Replication errors</td>\n<td>\n<p>Bases mismatch</p>\n<p>Insertions</p>\n<p>Deletions</p>\n</td>\n<td>Mismatch repair (MMR)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(280, 'Biochemistry', 'PM1062. Types of Damage to DNA', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\0\>\n<tbody>\n<tr>\n<td width=\195\>\n<p>Single-base alteration</p>\n</td>\n<td width=\167\>\n<p>Two-base alteration</p>\n</td>\n<td width=\179\>\n<p>Chain breaks</p>\n</td>\n<td width=\158\>\n<p>Cross-linkage</p>\n</td>\n</tr>\n<tr>\n<td width=\195\>\n<p>Depurination</p>\n<p>Deamination of cytosine to uracil</p>\n<p>Deamination of adenine to hypoxanthine</p>\n<p>Alkylation of base</p>\n<p>Base-analog incorporation</p>\n</td>\n<td width=\167\>\n<p>UV light-induced thymine-thymine (pyrimidine) dimer</p>\n<p>Bifunctional alkylating agent cross-linkage</p>\n</td>\n<td width=\179\>\n<p>Ionizing radiation</p>\n<p>Radioactive disintegration of backbone element</p>\n<p>Oxidative free radical formation</p>\n</td>\n<td width=\158\>\n<p>Between bases in same or opposite strands</p>\n<p>Between DNA and protein molecules (e.g., histones)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(281, 'Biochemistry', 'PM1061. Types of DNA polymerase', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p>Prokaryotic Enzymes (eg in E.coli)</p>\n</td>\n<td>Eukaryotic Enzymes</td>\n<td>Functions</td>\n</tr>\n<tr>\n<td>&nbsp;I</td>\n<td>&nbsp;</td>\n<td>Gap filling following DNA replication, repair and recombination</td>\n</tr>\n<tr>\n<td>II</td>\n<td>&nbsp;</td>\n<td>DNA proofreading and repair</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>β</td>\n<td>DNA repair</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>γ</td>\n<td>Mitochondrial DNA synthesis</td>\n</tr>\n<tr>\n<td>III</td>\n<td>ε</td>\n<td>Processive, leading strand synthesis</td>\n</tr>\n<tr>\n<td>DnaG</td>\n<td>α</td>\n<td>Primase</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>δ</td>\n<td>Processive, lagging strand synthesis</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(282, 'Biochemistry', 'PM1060. Enzymes Involved in DNA Replication', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Prokaryotic DNA replication enzymes and their function:</p>\n<table>\n<tbody>\n<tr>\n<td>Enzyme</td>\n<td>Function</td>\n</tr>\n<tr>\n<td>DNA Polymerase I (Pol I)</td>\n<td>Gap filling following DNA replication, repair, and recombination</td>\n</tr>\n<tr>\n<td>DNA polymerase II (Pol II)</td>\n<td>DNA proofreading and repair</td>\n</tr>\n<tr>\n<td>DNA polymerase III (Pol III)</td>\n<td>\n<p>Processive, leading strand synthesis, DNA proofreading</p>\n</td>\n</tr>\n<tr>\n<td>DnaG</td>\n<td>\n<p>Primase&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Helicase</td>\n<td>ATP-driven processive unwinding of DNA.</td>\n</tr>\n<tr>\n<td>Primase</td>\n<td>Initiates synthesis of RNA primers.</td>\n</tr>\n<tr>\n<td>Topoisomerase</td>\n<td>Relieve torsional strain that results from helicase-induced unwinding.</td>\n</tr>\n<tr>\n<td>Single-strand binding proteins (SSBs)</td>\n<td>Prevents premature reannealing of dsDNA.</td>\n</tr>\n<tr>\n<td>DNA ligase</td>\n<td>Seals the single strand nick between the nascent chain and Okazaki fragments on lagging strand.</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>Eukaryotic DNA polymerases:</p>\n<table>\n<tbody>\n<tr>\n<td>Eukaryotic DNA Polymerases</td>\n<td>Functions</td>\n<td>Proofreading</td>\n</tr>\n<tr>\n<td>α&nbsp;</td>\n<td>Primase (initiates DNA synthesis)</td>\n<td>-</td>\n</tr>\n<tr>\n<td><em>β</em></td>\n<td>DNA repair</td>\n<td>-</td>\n</tr>\n<tr>\n<td>\n<p>γ</p>\n</td>\n<td>Mitochondrial DNA synthesis</td>\n<td>+</td>\n</tr>\n<tr>\n<td>&nbsp;δ&nbsp;</td>\n<td>Processive, lagging strand synthesis(forms and elongates Okazaki fragments from primer)</td>\n<td>+</td>\n</tr>\n<tr>\n<td>&nbsp;<em>ε&nbsp;</em></td>\n<td>Processive, leading strand synthesis</td>\n<td>+</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(283, 'Biochemistry', 'PM1059. Role of Histones', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\140\>\n<p>Types</p>\n</td>\n<td width=\477\>\n<p>Function</p>\n</td>\n</tr>\n<tr>\n<td width=\140\>\n<p>H1 histones</p>\n</td>\n<td width=\477\>\n<p>Stabilize the 30-nm chromatin fiber</p>\n</td>\n</tr>\n<tr>\n<td width=\140\>\n<p>H2 histones</p>\n</td>\n<td width=\477\>\n<p>H2A–H2B dimers stabilize the primary particle and firmly bind two additional half-turns of DNA</p>\n</td>\n</tr>\n<tr>\n<td width=\140\>\n<p>H3 histones</p>\n</td>\n<td rowspan=\2\ width=\477\>\n<p>(H3–H4)2 tetramer has a central role in the formation</p>\n<p>of the nucleosome</p>\n</td>\n</tr>\n<tr>\n<td width=\140\>\n<p>H4 histones</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(284, 'Biochemistry', 'PM1058. RNA polymerase in Humans and Their Major Products', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\196\>\n<p>Types</p>\n</td>\n<td width=\284\>\n<p>Major Products</p>\n</td>\n</tr>\n<tr>\n<td width=\196\>\n<p>RNA polymerase I</p>\n</td>\n<td width=\284\>\n<p>rRNA</p>\n</td>\n</tr>\n<tr>\n<td width=\196\>\n<p>RNA polymerase II</p>\n</td>\n<td width=\284\>\n<p>mRNA, miRNA, snRNA, lncRNA</p>\n</td>\n</tr>\n<tr>\n<td width=\196\>\n<p>RNA polymerase III</p>\n</td>\n<td width=\284\>\n<p>tRNA, 5srRNA</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(285, 'Biochemistry', 'PM1056. Differences between DNA & RNA Synthesis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\243\>\n<p>RNA synthesis</p>\n</td>\n<td width=\373\>\n<p>DNA synthesis</p>\n</td>\n</tr>\n<tr>\n<td width=\243\>\n<p>Ribonucleotides are used</p>\n</td>\n<td width=\373\>\n<p>Deoxyribonucleotides are used</p>\n</td>\n</tr>\n<tr>\n<td width=\243\>\n<p>Uracil is the complementary base for Adenine</p>\n</td>\n<td width=\373\>\n<p>Thymine is the complementary base for Adenine</p>\n</td>\n</tr>\n<tr>\n<td width=\243\>\n<p>Primer is not involved as RNA polymerases have the ability to initiate synthesis de novo</p>\n</td>\n<td width=\373\>\n<p>Primer&nbsp;is necessary because DNA polymerases can only attach new&nbsp;DNA&nbsp;nucleotides to an existing strand of nucleotides</p>\n</td>\n</tr>\n<tr>\n<td width=\243\>\n<p>Only portions of the genome are vigorously transcribed or copied into RNA</p>\n</td>\n<td width=\373\>\n<p>The entire genome must be copied, once and only once during DNA replication</p>\n</td>\n</tr>\n<tr>\n<td width=\243\>\n<p>No highly active, efficient proofreading function</p>\n</td>\n<td width=\373\>\n<p>Highly active, efficient proofreading function is performed by DNA polymerase</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(286, 'Biochemistry', 'PM1055. Types of RNA', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\308\>\n<p>Protein coding RNA</p>\n</td>\n<td width=\308\>\n<p>Non Protein coding RNA</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>mRNA</p>\n</td>\n<td width=\308\>\n<p>Ribosomal RNAs (rRNA)</p>\n<p>Long noncoding RNAs (lncRNAs)</p>\n<p>Transfer RNAs (tRNA)</p>\n<p>Small nuclear RNAs (snRNAs)</p>\n<p>Micro and silencing RNAs (miRNAs and siRNAs)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(287, 'Biochemistry', 'PM1051. Regulators of Pyrimidine Synthesis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\121\>\n<p>Enzyme</p>\n</td>\n<td width=\121\>\n<p>Inhibitor</p>\n</td>\n<td width=\142\>\n<p>Activator</p>\n</td>\n</tr>\n<tr>\n<td width=\121\>\n<p>Carbamoyl phosphate synthetase II</p>\n</td>\n<td width=\121\>\n<p>UTP</p>\n</td>\n<td width=\142\>\n<p>ATP</p>\n<p>PRPP</p>\n</td>\n</tr>\n<tr>\n<td width=\121\>\n<p>Aspartate transcarbamoylase</p>\n</td>\n<td width=\121\>CTP</td>\n<td width=\142\>\n<p>ATP</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(288, 'Biochemistry', 'PM1048. Diseases Associated with Purine Degradation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\205\>\n<p>Disease</p>\n</td>\n<td width=\205\>\n<p>Enzyme</p>\n</td>\n<td width=\205\>\n<p>Characteristics</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>Gout</p>\n</td>\n<td width=\205\>\n<p>PRPP synthetase superactivity</p>\n</td>\n<td width=\205\>\n<p>Hyperuricemia</p>\n<p>Gouty arthritis</p>\n<p>Urolithiasis</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>PNP deficiency</p>\n</td>\n<td width=\205\>\n<p>Purine nucleoside</p>\n<p>Phosphorylase</p>\n</td>\n<td width=\205\>\n<p>Recurrent infections and neurodevelopmental delay. Affects only T-cells.</p>\n</td>\n</tr>\n<tr>\n<td width=\205\>\n<p>&nbsp;ADA Deficiency</p>\n</td>\n<td width=\205\>\n<p>Adenosine Deaminase Deficiency</p>\n</td>\n<td width=\205\>\n<p>Untreated ADA-deficient children usually die before</p>\n<p>2 years of age from overwhelming infection</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(289, 'Biochemistry', 'PM1046. Enzymes and Steps Involved in Purine Degradation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\177\>\n<p>Enzymes</p>\n</td>\n<td width=\439\>\n<p>Reaction</p>\n</td>\n</tr>\n<tr>\n<td width=\177\>\n<p>AMP deaminase</p>\n</td>\n<td width=\439\>\n<p>AMP to IMP</p>\n</td>\n</tr>\n<tr>\n<td width=\177\>\n<p>Adenosine deaminase</p>\n</td>\n<td width=\439\>\n<p>Adenosine to Inosine</p>\n</td>\n</tr>\n<tr>\n<td width=\177\>\n<p>5-nucleotidase</p>\n</td>\n<td width=\439\>\n<p>IMP &amp; GMP to Inosine &amp; Guanosine respectively</p>\n</td>\n</tr>\n<tr>\n<td width=\177\>\n<p>Purine nucleoside phosphorylase</p>\n</td>\n<td width=\439\>\n<p>Inosine &amp; Guanosine to Hypoxanthine &amp; guanine respectively</p>\n</td>\n</tr>\n<tr>\n<td width=\177\>\n<p>Xanthine oxidase</p>\n</td>\n<td width=\439\>\n<p>Hypoxanthine to Xanthine &amp; Xanthine to uric acid</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(290, 'Biochemistry', 'PM1044. Enzymes of Purine Synthesis Pathway and Their Regulators', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\308\>\n<p><strong>Enzymes</strong></p>\n</td>\n<td width=\308\>\n<p><strong>Regulators</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>PRPP Glutamyl Amidotransferase</p>\n</td>\n<td width=\308\>\n<p>Inhibited by Amp &amp; GMP</p>\n<p>Activator &nbsp;PRPP</p>\n<p>Activated by Glutamine</p>\n<p>Diazanorleucine(inhibitor)</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>PRPP synthetase</p>\n</td>\n<td width=\308\>\n<p>Activator pi</p>\n<p>Inhibitors &nbsp;purine ribonucleotides</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Formyltransferase</p>\n</td>\n<td width=\308\>\n<p>Methotrexate, Anti-folate drugs</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>VI Synthetase</p>\n</td>\n<td width=\308\>\n<p>Azaserine</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Adenylosuccinase ,IMP Dehydrogenase</p>\n</td>\n<td width=\308\>\n<p>6-mercaptopurine</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>IMP Dehydrogenase</p>\n</td>\n<td width=\308\>\n<p>mycophenolic acid</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(291, 'Biochemistry', 'PM1019. Fluorescent In Situ Hybridisation (FISH)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It is a simple technique for the detection of specific genetic information on a morphologically intact tissue using fluorescent probes.</p>\n<p>The fluorescent probes are added to cells usually arrested in the metaphase stage of cell division (when every chromosome is separately).</p>\n<p><strong>Types of FISH</strong>:</p>\n<p>1) <strong>Chromosomal painting</strong>: Each chromosome is identified by using a different colour of the fluorescent probe, however, each chromosome does not have a unique colour. Since the fluorescent dyes are limited.</p>\n<p>2) <strong>Multicolour FISH</strong>: 23 distinct fluorescent colours made by mixing 5 fluorophores. Thus each chromosome is identified by a unique colour. It is also known as spectral karyotyping (SKY). It offers various advantages such as</p>\n<ul>\n<li>Detects structural and numeric abnormalities in chromosomes.</li>\n<li>Detects gene amplification and subtle microdeletions</li>\n<li>Maps a newly isolated gene to its correct chromosomal loci</li>\n</ul>\n<p>However, this process requires prior knowledge of the genes and chromosomes.</p>\n<p>3) <strong>Interphase FISH</strong>: It is a rapid procedure of FISH, wherein growing cells are not needed. It is used in prenatal diagnosis and in tumour diagnosis.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The image shown is of a Multicolor FISH also known as Spectral karyotyping with a unique colour to each chromosome pair.</p></div><!---->\n      <!---->\n    </div><!---->'),
(292, 'Paediatrics,', 'PM0941. Enzyme Replacement Therapy for Lysosomal Storage Disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;Lysosomal Storage Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficient</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Replacement Therapy</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hurler Syndrome (MPS I)</p>\n</td>\n<td>\n<p>α-L -iduronidase</p>\n</td>\n<td>\n<p>Laronidase (Aldurazyme)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hunter Syndrome (MPS II)</p>\n</td>\n<td>\n<p>Iduronate sulfate sulfatase</p>\n</td>\n<td>\n<p>Idursulfase (Elaprase)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Morquio A Syndrome (MPS IVA)</p>\n</td>\n<td>\n<p>N-Acetylgalactosamine-6-sulfate sulfatase</p>\n</td>\n<td>\n<p>Elosulfase (Vimizim)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maroteaux–Lamy Syndrome (MPS VI)</p>\n</td>\n<td>\n<p>N -Acetylgalactosamine-α-4-sulfate sulfatase (arylsulfatase B)</p>\n</td>\n<td>\n<p>Galsulfase (Naglazyme)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sly syndrome (MPS VII)</p>\n</td>\n<td>β-Glucuronidase</td>\n<td>\n<p>rhGUS (recombinant human&nbsp;β-Glucuronidase is under Phase III trial)</p>\n</td>\n</tr>\n<tr>\n<td>Wolman disease</td>\n<td>Lysosomal acid lipase</td>\n<td>\n<p><em> Sebelipase alfa</em>(Kanuma, Alexion)</p>\n</td>\n</tr>\n<tr>\n<td>Metachromatic leukodystrophy</td>\n<td>Arylsulfatase A</td>\n<td>\n<p>rhARSA (recombinant human arylsulfatase A is under Phase I/II trial)</p>\n</td>\n</tr>\n<tr>\n<td>Fabry disease&nbsp;</td>\n<td>α-galactosidase A</td>\n<td>\n<p><em>agalsidase beta</em> (Fabrazyme, Genzyme)</p>\n<p><em>agalsidase alfa</em> (Replagal, Shire HGT)</p>\n</td>\n</tr>\n<tr>\n<td>Gaucher disease</td>\n<td>β-glucosidase</td>\n<td>\n<p><em>imiglucerase </em>[Cerezyme, Genzyme]</p>\n<p><em>velaglucerase alfa </em>[VPRIV, Shire HGT]</p>\n<p><em>taliglucerase alfa </em>(Uplyso, Protalix<br>Biotherapeutics)</p>\n<p><em>eliglusta</em>t (Cerdelga, Sanofi-Genzyme)</p>\n</td>\n</tr>\n<tr>\n<td>Pompe disease</td>\n<td>acid α-1,4-glucosidase (acid maltase)&nbsp;</td>\n<td>\n<p><em>alglucosidase alfa </em>(Myozyme)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(293, 'Biochemistry', 'PM0751. Niemann-Pick Disease Types and Symptoms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\308\>\n<p><strong>Types</strong></p>\n</td>\n<td width=\308\>\n<p><strong>Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Type A</p>\n</td>\n<td width=\308\>\n<p>First few months of life</p>\n<p>Abdominal (belly area) swelling within 3 - 6 months</p>\n<p>Cherry red spot in the eye</p>\n<p>Feeding difficulties</p>\n<p>Loss of early motor skills (gets worse over time)</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Type B</p>\n</td>\n<td width=\308\>\n<p>Late childhood or the teenage years.&nbsp;</p>\n<p>Abdominal swelling may occur in young children.&nbsp;</p>\n<p>There is almost no brain and nervous system involvement, such as loss of motor skills.&nbsp;</p>\n<p>Some patients may have repeated respiratory infections</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Type C</p>\n</td>\n<td width=\308\>\n<p>Between early infancy to adulthood Difficulty moving limbs (dystonia)</p>\n<p>Enlarged spleen</p>\n<p>Enlarged liver</p>\n<p>Jaundice at (or&nbsp;shortly after) birth</p>\n<p>Dementia</p>\n<p>Seizures</p>\n<p>Slurred, irregular speech</p>\n<p>Cataplexy</p>\n<p>Tremors</p>\n<p>Vertical supranuclear gaze palsy</p>\n<p>Ataxia</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>Type D</p>\n</td>\n<td width=\308\>\n<p>Same As C</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(294, 'Biochemistry', 'PM2095. Start and stop codons', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Start codon: AUG - Methionine</strong></p>\n<p><strong>Stop codons:</strong></p>\n<ul>\n<li><strong>UGA-&nbsp;</strong>Selenocysteine (21<sup>st</sup> Amino acid )</li>\n<li><strong>UAG-&nbsp;</strong>Pyrrolysine (22<sup>nd</sup> Amino acid)</li>\n<li><strong>UAA</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(295, 'Biochemistry', 'PM0414. Ribosomal Assembly (Prokaroytes)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Ribosomal assembly in prokaryotes:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Ribosomal subunits</strong></td>\n<td><strong>Components</strong></td>\n</tr>\n<tr>\n<td><strong>30 S</strong></td>\n<td>16s rRNA + Proteins</td>\n</tr>\n<tr>\n<td><strong>40 S</strong></td>\n<td>18s rRNA + 30 Proteins</td>\n</tr>\n<tr>\n<td><strong>50 S</strong></td>\n<td>23s rRNA + 5s rRNA + Proteins</td>\n</tr>\n<tr>\n<td><strong>60 S</strong></td>\n<td>28s rRNA + 5.8s rRNA + 5s rRNA + 50 Proteins</td>\n</tr>\n<tr>\n<td><strong>70 S</strong></td>\n<td>30S + 50S</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(296, 'Medicine,', 'PM2344. Types of Jaundice', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Type of jaundice</strong></td>\n<td><strong>Serum bilirubin</strong></td>\n<td><strong>Urine Urobilinogen</strong></td>\n<td><strong>Urine bilirubin</strong></td>\n</tr>\n<tr>\n<td>Pre-hepatic</td>\n<td>↑ Indirect</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;↑</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;-</td>\n</tr>\n<tr>\n<td>Hepatic</td>\n<td>↑ Direct and indirect</td>\n<td>&nbsp; Normal/&nbsp;↓</td>\n<td>&nbsp; &nbsp; &nbsp; +/-</td>\n</tr>\n<tr>\n<td>Post-hepatic</td>\n<td>↑ Direct</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;+</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(297, 'Physiology', 'PM2358. Na+ - K+ ATPase pump', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Na+/K+ - ATPase Pump is an example of <strong>primary active transport</strong></li>\n<li>It is the most common pump, present in all parts of the body.&nbsp;</li>\n<li>It regulates cell volume, and also maintains RMP of the cell.</li>\n<li>It is a heterodimer made up of an α and a β subunit.</li>\n<li><strong>ICF</strong> side of the <strong>αlpha subunit</strong> binds <strong>ATP and 3 Na<sup>+</sup> ions.</strong> It also has a phosphorylation site.</li>\n<li><strong>ECF</strong> side of the <strong>αlpha</strong> subunit has binding sites for<strong> 2K<sup>+</sup> ions</strong> and ouabain.</li>\n<li>The <strong>beta</strong> subunit contains <strong>3 ECF glycosylation sites</strong>.&nbsp;</li>\n<li>It is an electrogenic pump with a <strong>coupling ratio of 3:2.</strong></li>\n<li>The pump is stimulated by thyroid hormones, insulin, aldosterone and G-actin whereas it is inhibited by ouabain and related digitalis glycosides</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d00233d0bfc6421fb8d54c57710f5e97x1280x1339.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(298, 'Medicine,', 'PM2317. Membrane receptors and their mechanisms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>1. G protein coupled receptor(GPCR)</strong></p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;<strong>Effect</strong></td>\n<td><strong>2nd messenger</strong></td>\n<td>&nbsp;<strong>Action</strong></td>\n</tr>\n<tr>\n<td>Gs</td>\n<td>Activates adenylate cyclase</td>\n<td>Stimulation of cAMP production</td>\n<td>Activates protein kinase A</td>\n</tr>\n<tr>\n<td>Gi</td>\n<td>Inhibits adenylate cyclase</td>\n<td>Inhibition of cAMP production</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Gq</td>\n<td>Activates phospholipase C</td>\n<td>Liberate DAG and IP3 which mobilize Ca2+ from endoplasmic reticulum</td>\n<td>Activates protein kinase C</td>\n</tr>\n</tbody>\n</table>\n<p><br><strong>2. Guanylyl cyclase receptor</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Effector</strong></td>\n<td><strong>2nd messenger</strong></td>\n</tr>\n<tr>\n<td>Guanylyl cyclase</td>\n<td>Stimulation of cGMP production</td>\n</tr>\n</tbody>\n</table>\n<p><br><strong>3. Receptor tyrosine kinase</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Effector</strong></td>\n<td><strong>2nd messenger</strong></td>\n</tr>\n<tr>\n<td>Tyrosine kinase</td>\n<td>MAP kinase</td>\n</tr>\n</tbody>\n</table>\n<p><br><strong>4. Cytokine receptor tyrosine kinase</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Effector</strong></td>\n<td><strong>2nd messenger</strong></td>\n</tr>\n<tr>\n<td>JAK, tyrosine kinase</td>\n<td>STAT, MAP kinase</td>\n</tr>\n</tbody>\n</table>\n<p><br><strong>5. Serine kinase</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Effector</strong></td>\n<td><strong>2nd messenger</strong></td>\n</tr>\n<tr>\n<td>Serine kinase</td>\n<td>Smads</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(299, 'Physiology', 'PM1972. Resting membrane potential (RMP) in tissues', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Tissue</strong></p>\n</td>\n<td>\n<p><strong>RMP(mV)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neuron</p>\n</td>\n<td>\n<p>-70</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Skeletal muscle</p>\n</td>\n<td>\n<p>-90</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Myocardial muscle</p>\n</td>\n<td>\n<p>-90</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Smooth muscle</p>\n</td>\n<td>\n<p>-20 to -65</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(300, 'Physiology', 'PM1957. Extracellular fluid vs Intracellular fluid', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Extracellular fluid</strong></td>\n<td><strong>Intracellular fluid</strong></td>\n</tr>\n<tr>\n<td>Na<sup>+</sup></td>\n<td><strong>142 mEq/L</strong></td>\n<td>10&nbsp;mEq/L</td>\n</tr>\n<tr>\n<td>K<sup>+</sup></td>\n<td>4&nbsp;mEq/L</td>\n<td><strong>140&nbsp;mEq/L</strong></td>\n</tr>\n<tr>\n<td>Ca<sup>++</sup></td>\n<td><strong>2.4&nbsp;mEq/L</strong></td>\n<td>0.0001&nbsp;mEq/L</td>\n</tr>\n<tr>\n<td>Cl<sup>-</sup></td>\n<td><strong>103&nbsp;mEq/L</strong></td>\n<td>4&nbsp;mEq/L</td>\n</tr>\n<tr>\n<td>HCO<sub>3</sub><sup>-</sup></td>\n<td><strong>28&nbsp;mEq/L</strong></td>\n<td>10&nbsp;mEq/L</td>\n</tr>\n<tr>\n<td>PO₄³⁻</td>\n<td>4&nbsp;mEq/L</td>\n<td><strong>75&nbsp;mEq/L</strong></td>\n</tr>\n<tr>\n<td>Glucose</td>\n<td><strong>90&nbsp;mg/dL</strong></td>\n<td>0-20 mg/dL</td>\n</tr>\n<tr>\n<td>Proteins</td>\n<td>2 g/dl (5mEq/L)</td>\n<td><strong>16 g/dL (40&nbsp;mEq/L)</strong></td>\n</tr>\n<tr>\n<td>pH</td>\n<td>7.4</td>\n<td>&nbsp;7.0</td>\n</tr>\n<tr>\n<td>Osmolarity</td>\n<td>282 mOsm/L</td>\n<td>281 mOsm/L</td>\n</tr>\n<tr>\n<td>Major Cation</td>\n<td>Na<sup>+</sup></td>\n<td>K<sup>+</sup></td>\n</tr>\n<tr>\n<td>Major Anion</td>\n<td>Cl<sup>-</sup></td>\n<td>Phosphate</td>\n</tr>\n<tr>\n<td>Buffer</td>\n<td>HCO3<sup>-</sup></td>\n<td>Protein</td>\n</tr>\n<tr>\n<td>Most osmotically active ion</td>\n<td>Na<sup>+</sup></td>\n<td>K<sup>+</sup></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(301, 'Physiology', 'PM1906. Graded potential vs Action potential', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\558\>\n<tbody>\n<tr>\n<td>\n<p><strong>Graded Potential</strong></p>\n</td>\n<td>\n<p><strong>Action Potential</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Amplitude proportionate to strength of stimulus. It is graded.</p>\n</td>\n<td>\n<p>Independent of stimulus intensity – all or none response</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Can be depolarising or hyperpolarizing</p>\n</td>\n<td>\n<p>Depolarizing</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Is conducted decrementally - amplitude decreases with distance</p>\n</td>\n<td>\n<p>Self-propagated unchanged in amplitude</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Generated spontaneously or in response to stimuli- physical, chemical</p>\n</td>\n<td>\n<p>Generated only in response to Membrane Depolarization</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Can be summated</p>\n</td>\n<td>\n<p>Cannot be summated</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Has no threshold and refractory period</p>\n</td>\n<td>\n<p>Has a threshold about 15 mv depolarized relative to the resting potential.</p>\n<p>Has a refractory period</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Not always followed by some action</p>\n</td>\n<td>\n<p>Always followed by some action</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(302, 'Physiology', 'PM1905. Absolute and relative refractory period', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Types of refractory periods</strong></p>\n</td>\n<td>\n<p><strong>Absolute refractory period</strong></p>\n</td>\n<td>\n<p><strong>Relative&nbsp; refractory period</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Property</strong></p>\n</td>\n<td>\n<p>No stimulus, no matter how strong, will&nbsp; not excite the nerve</p>\n</td>\n<td>Stronger than normal stimuli can cause excitation&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;<strong>Period</strong></td>\n<td>Period from the time the firing level is reached until repolarization is about one-third complete</td>\n<td>Begins at the end of the Absolute refractory period to the start of after-depolarization&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;<strong>Basis</strong></td>\n<td>Closure of the Inactivation Gates of the Na<sup>+ </sup>channel in response to depolarization</td>\n<td>&nbsp;\n<p>Na<sup>+</sup> channels are reset and can open upon arrival of a stronger stimuli</p>\n<p>K<sup>+</sup> channel remain open</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(303, 'Physiology', 'PM1895. Sensory Receptors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/fcdc661d9f2e42bb9fd76395875319b2x600x1200.JPEG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(304, 'Physiology', 'PM1497. Glucose Transporters', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\154\>&nbsp;</td>\n<td width=\154\>\n<p><strong>Function</strong></p>\n</td>\n<td width=\154\>\n<p><strong>Major sites of expression</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p><strong>Secondary active transport</strong></p>\n<p><strong>(Na </strong><strong><sup>+</sup></strong> <strong>-glucose cotransport)</strong></p>\n</td>\n<td width=\154\>&nbsp;</td>\n<td width=\154\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>SGLT 1</p>\n</td>\n<td width=\154\>\n<p>Absorption of glucose</p>\n</td>\n<td width=\154\>\n<p>Small intestine, renal tubules</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>SGLT 2</p>\n</td>\n<td width=\154\>\n<p>Absorption of glucose</p>\n</td>\n<td width=\154\>\n<p>Renal tubules</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p><strong>Facilitated diffusion</strong></p>\n</td>\n<td width=\154\>&nbsp;</td>\n<td width=\154\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>GLUT 1</p>\n</td>\n<td width=\154\>\n<p>Basal glucose uptake</p>\n</td>\n<td width=\154\>\n<p>Placenta, blood-brain barrier, brain, red cells, kidneys, colon, many other organs</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>GLUT 2</p>\n</td>\n<td width=\154\>\n<p>β-cell glucose sensor; transport out of intestinal and renal epithelial cells</p>\n</td>\n<td width=\154\>\n<p>β cells of islets, liver, epithelial cells of small intestine, kidneys</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>GLUT 3</p>\n</td>\n<td width=\154\>\n<p>Basal glucose uptake</p>\n</td>\n<td width=\154\>\n<p>Brain, placenta, kidneys, many other organs</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>GLUT 4</p>\n</td>\n<td width=\154\>\n<p>Insulin-stimulated glucose uptake</p>\n</td>\n<td width=\154\>\n<p>Skeletal and cardiac muscle, adipose tissue, other tissues</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>GLUT 5</p>\n</td>\n<td width=\154\>\n<p>Fructose transport</p>\n</td>\n<td width=\154\>\n<p>Jejunum, sperm</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>GLUT 6</p>\n</td>\n<td width=\154\>Function not known</td>\n<td width=\154\>Brain, spleen, leucocytes</td>\n</tr>\n<tr>\n<td width=\154\>GLUT 7</td>\n<td width=\154\>Glucose-6-phosphate transporter in the endoplasmic reticulum</td>\n<td width=\154\>Liver</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(305, 'Physiology', 'PM1340. Factors affecting K+ distribution between ECF and ICF concentration', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\543\>\n<tbody>\n<tr>\n<td><strong>Shift of K+ into the cell&nbsp;→ ↓ ECF K+</strong></td>\n<td><strong>&nbsp;Shift of K+ out of the cell→↑ECF K+</strong></td>\n</tr>\n<tr>\n<td>Insulin</td>\n<td>Insulin deficiency(DM)</td>\n</tr>\n<tr>\n<td>Aldosterone</td>\n<td>Aldosterone deficiency (Addisons disease)</td>\n</tr>\n<tr>\n<td>Metabolic alkalosis</td>\n<td>Hypertonicity (eg: hyperglycemia)</td>\n</tr>\n<tr>\n<td>Diarrhoea</td>\n<td>β-blockers</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Cell lysis Eg: intravascular hemolysis, tumour lysis syndrome, rhabdomyolysis</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Strenous exercise</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(306, 'Physiology', 'PM0730. Transient Receptor Potential (TRP) Ion Channels/Receptors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\122\>\n<p><strong>TRP channel type</strong></p>\n</td>\n<td width=\303\>\n<p><strong>Stimulus</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\122\>\n<p>TRPV1</p>\n</td>\n<td width=\303\>\n<p>Capsaicin , temperatures &gt;43<sup>0</sup>C</p>\n</td>\n</tr>\n<tr>\n<td width=\122\>\n<p>TRPV2</p>\n</td>\n<td width=\303\>\n<p>Temperatures &gt;52 <sup>0</sup>C</p>\n</td>\n</tr>\n<tr>\n<td width=\122\>\n<p>TRPV3</p>\n</td>\n<td width=\303\>\n<p>Camphor, temperatures &gt;35<sup>0</sup>C (31-39<sup>0</sup>C)</p>\n</td>\n</tr>\n<tr>\n<td width=\122\>\n<p>TRPV4</p>\n</td>\n<td width=\303\>\n<p>Temperature &gt;27<sup>0</sup>C, upto 34<sup>0</sup>C</p>\n</td>\n</tr>\n<tr>\n<td width=\122\>\n<p>TRPM8</p>\n</td>\n<td width=\303\>\n<p>Temperature around 8 to 28<sup>0</sup>C, menthol and mints</p>\n</td>\n</tr>\n<tr>\n<td width=\122\>\n<p>TRPA1</p>\n</td>\n<td width=\303\>\n<p>Temperature below 17<sup>0</sup>C , Noxious mechanical and chemical stimuli</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(307, 'Physiology', 'PM0463. Disturbances in body fluids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\100%\>\n<tbody>\n<tr>\n<td width=\18%\>\n<p><strong>Type</strong></p>\n</td>\n<td width=\16%\>\n<p><strong>Example</strong></p>\n</td>\n<td width=\11%\>\n<p><strong>ECF volume</strong></p>\n</td>\n<td width=\11%\>\n<p><strong>ICF volume</strong></p>\n</td>\n<td width=\15%\>\n<p><strong>Osmolarity</strong></p>\n</td>\n<td width=\15%\>\n<p><strong>Hematocrit</strong></p>\n</td>\n<td width=\12%\>\n<p><strong>Plasma proteins</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\18%\>\n<p>Isosmotic volume contraction</p>\n</td>\n<td width=\16%\>\n<p>Diarrhea,</p>\n<p>Burns</p>\n</td>\n<td width=\11%\>\n<p>↓</p>\n</td>\n<td width=\11%\>\n<p>No change</p>\n</td>\n<td width=\15%\>\n<p>No change</p>\n</td>\n<td width=\15%\>\n<p>↑</p>\n</td>\n<td width=\12%\>\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td width=\18%\>\n<p>Hyperosmotic volume contraction</p>\n</td>\n<td width=\16%\>\n<p>Sweating,</p>\n<p>Fever,</p>\n<p>Diabetes insipidus</p>\n</td>\n<td width=\11%\>\n<p>↓</p>\n</td>\n<td width=\11%\>\n<p>↓</p>\n</td>\n<td width=\15%\>\n<p>↑</p>\n</td>\n<td width=\15%\>\n<p>No change</p>\n</td>\n<td width=\12%\>\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td width=\18%\>\n<p>Hyposmotic volume contraction</p>\n</td>\n<td width=\16%\>\n<p>Adrenal insufficiency</p>\n</td>\n<td width=\11%\>\n<p>↓</p>\n</td>\n<td width=\11%\>\n<p>↑</p>\n</td>\n<td width=\15%\>\n<p>↓</p>\n</td>\n<td width=\15%\>\n<p>↑</p>\n</td>\n<td width=\12%\>\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td width=\18%\>\n<p>Isosmotic volume expansion</p>\n</td>\n<td width=\16%\>\n<p>Infusion of isotonic NaCl</p>\n</td>\n<td width=\11%\>\n<p>↑</p>\n</td>\n<td width=\11%\>\n<p>No change</p>\n</td>\n<td width=\15%\>\n<p>No change</p>\n</td>\n<td width=\15%\>\n<p>↓</p>\n</td>\n<td width=\12%\>\n<p>↓</p>\n</td>\n</tr>\n<tr>\n<td width=\18%\>\n<p>Hyperosmotic volume expansion</p>\n</td>\n<td width=\16%\>\n<p>High NaCl intake</p>\n</td>\n<td width=\11%\>\n<p>↑</p>\n</td>\n<td width=\11%\>\n<p>↓</p>\n</td>\n<td width=\15%\>\n<p>↑</p>\n</td>\n<td width=\15%\>\n<p>↓</p>\n</td>\n<td width=\12%\>\n<p>↓</p>\n</td>\n</tr>\n<tr>\n<td width=\18%\>\n<p>Hyposmotic volume expansion</p>\n</td>\n<td width=\16%\>\n<p>SIADH</p>\n</td>\n<td width=\11%\>\n<p>↑</p>\n</td>\n<td width=\11%\>\n<p>↑</p>\n</td>\n<td width=\15%\>\n<p>↓</p>\n</td>\n<td width=\15%\>\n<p>No change</p>\n</td>\n<td width=\12%\>\n<p>↓</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(308, 'Physiology', 'PM0462. Daily fluid intake and output', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Normal (in mL/day)</strong></p>\n</td>\n<td width=\122\>\n<p><strong>Prolonged, Heavy Exercise (mL/day)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Intake</strong></p>\n</td>\n<td>&nbsp;</td>\n<td width=\122\>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Fluids ingested</p>\n</td>\n<td>\n<p>2100</p>\n</td>\n<td width=\122\>\n<p>-</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>From metabolism</p>\n</td>\n<td>\n<p>200</p>\n</td>\n<td width=\122\>\n<p>200</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Total intake</strong></p>\n</td>\n<td>\n<p><strong>2300</strong></p>\n</td>\n<td width=\122\>\n<p><strong>-</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Output</strong></p>\n</td>\n<td>&nbsp;</td>\n<td width=\122\>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Insensible loss : skin</p>\n</td>\n<td>\n<p>350</p>\n</td>\n<td width=\122\>\n<p>350</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Insensible loss : lungs</p>\n</td>\n<td>\n<p>350</p>\n</td>\n<td width=\122\>\n<p>650</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sweat</p>\n</td>\n<td>\n<p>100</p>\n</td>\n<td width=\122\>\n<p>5000</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Feces</p>\n</td>\n<td>\n<p>100</p>\n</td>\n<td width=\122\>\n<p>100</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Urine</p>\n</td>\n<td>\n<p>1400</p>\n</td>\n<td width=\122\>\n<p>500</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Total output</strong></p>\n</td>\n<td>\n<p><strong>2300</strong></p>\n</td>\n<td width=\122\>\n<p><strong>6600</strong></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(309, 'Physiology', 'PM0461. Indicators for measurement of body fluids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\99\>\n<p><strong>Compartments</strong></p>\n</td>\n<td width=\301\>\n<p><strong>Indicators</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\99\>\n<p>Plasma volume</p>\n</td>\n<td width=\301\>\n<ul>\n<li>Evans’ blue(T1824)</li>\n<li>Human serum albumin tagged with radioactive iodine<sup>125</sup></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\99\>\n<p>RBC volume</p>\n</td>\n<td width=\301\>\n<p>Tagging RBC with cr-51, Fe-59, 32P, also antigenic tagging</p>\n</td>\n</tr>\n<tr>\n<td width=\99\>\n<p>ECF volume</p>\n</td>\n<td width=\301\>\n<ul>\n<li>Inulin</li>\n<li>Sucrose</li>\n<li>Mannitol</li>\n<li>Sodium thiosulphate</li>\n<li>Sodium thiocyanate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\99\>\n<p>Interstitial fluid</p>\n</td>\n<td width=\301\>\n<p>Cannot be measured directly.</p>\n<p>ECF minus plasma volume gives the value</p>\n</td>\n</tr>\n<tr>\n<td width=\99\>\n<p>ICF</p>\n</td>\n<td width=\301\>\n<p>Cannot be measured directly.</p>\n<p>TBW minus ECF gives the value (D2O minus Mannitol)</p>\n</td>\n</tr>\n<tr>\n<td width=\99\>\n<p>TBW</p>\n</td>\n<td width=\301\>\n<p>D2O (<sup>2</sup>H<sub>2</sub>O)</p>\n<p>Tritium oxide (<sup>3</sup>H<sub>2</sub>O)</p>\n<p>Antipyrine</p>\n<p>Aminopyrine</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(310, 'Physiology', 'PM0460. Body Fluids Compartments', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8cc7d2c1c562482e8d734067f1adbe98x1200x1204.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>In ECF, a third specialised compartment, called the <strong>transcellular compartment</strong> (not shown in flow chart), is quantitatively small and includes the cerebrospinal, pleural, peritoneal, pericardial, synovial, intraocular and digestive fluids. It constitutes &lt;1% of TBW (1-2L).</li>\n<li>The ECF volume/intracellular fluid volume ratio is larger in infants and children than it is in adults, but the <strong>absolute volume of ECF in children is, of course, smaller than in adults</strong>. Therefore, <strong>dehydration develops more rapidly and is frequently more severe in children.</strong></li>\n<li>All solutes and water that enter or leave the body do so via the ECF.</li>\n<li>The ICF and ECF are in osmotic equilibrium. Water moves between these compartments only when an osmotic pressure gradient exists.</li>\n<li>Equilibration of ICF and ECF osmolality occurs primarily by shifts in water and not shifts in solutes.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(311, 'Physiology', 'PM0458. Nernst potential for different ions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Ion</strong></p>\n</td>\n<td><strong>Valency (Z)</strong></td>\n<td>&nbsp;<strong>Equilibrium potential (mV)</strong></td>\n</tr>\n<tr>\n<td>&nbsp;Na<sup>+</sup></td>\n<td>+1</td>\n<td>&nbsp;+60</td>\n</tr>\n<tr>\n<td>&nbsp;K<sup>+</sup></td>\n<td>+1</td>\n<td>&nbsp;-90</td>\n</tr>\n<tr>\n<td>\n<p>Cl<sup>-</sup></p>\n</td>\n<td>\n<p>-1</p>\n</td>\n<td>\n<p>-70</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ca<sup>2+</sup></p>\n</td>\n<td>\n<p>+2</p>\n</td>\n<td>\n<p>+130</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mg<sup>2+</sup></p>\n</td>\n<td>\n<p>+2</p>\n</td>\n<td>\n<p>+9</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(312, 'Physiology', 'PM0439. Characteristics of Carrier Mediated Transport', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Properties</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>Stereospecificity</td>\n<td>For example- D-Glucose is transport by facilitated diffusion but not L-isomer. Simple diffusion in contrast will not distinguish between the two.</td>\n</tr>\n<tr>\n<td>Saturation</td>\n<td>The transport rate increases as the concentration of the solute increases until the carriers are saturated (Tm).</td>\n</tr>\n<tr>\n<td>Competition</td>\n<td>Structurally related solutes compete for transport sites on carrier molecules.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(313, 'Physiology', 'PM0438. Characteristics of different types of transport', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\709\>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Simple diffusion</strong></td>\n<td><strong>Facilitated diffusion</strong></td>\n<td><strong>Primary active transport</strong></td>\n<td>Secondary active transport <strong>Cotransport</strong></td>\n<td>Secondary active transport <strong>Countertransport</strong></td>\n</tr>\n<tr>\n<td>Electrochemical gradient</td>\n<td>Downhill</td>\n<td>Downhill</td>\n<td>Uphill</td>\n<td>Uphill</td>\n<td>Uphill</td>\n</tr>\n<tr>\n<td>Carrier mediated</td>\n<td>No</td>\n<td>Yes</td>\n<td>Yes</td>\n<td>Yes</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Metabolic energy</td>\n<td>No</td>\n<td>No</td>\n<td>Yes</td>\n<td>Indirect</td>\n<td>Indirect</td>\n</tr>\n<tr>\n<td>Na<sup>+</sup> gradient</td>\n<td>No</td>\n<td>No</td>\n<td>--</td>\n<td>Yes (same direction)</td>\n<td>Yes (opposite direction)</td>\n</tr>\n<tr>\n<td>\n<p>Inhibits Na<sup>+</sup>-K<sup>+</sup> pump</p>\n&nbsp;</td>\n<td>--</td>\n<td>--</td>\n<td>Inhibits</td>\n<td>Inhibits</td>\n<td>&nbsp;Inhibits</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(314, 'Physiology', 'PM0437. Factors influencing the rate of net diffusion of a substance across a membrane', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Fick’s Law of Diffusion → J = -DA (<sup>Δc</sup>/<sub>Δx</sub>)</p>\n<div class=\page\ title=\Page 19\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>where,</p>\n<p>J is the net rate of diffusion,</p>\n<p>D is the diffusion coefficient,</p>\n<p>A is the area, and</p>\n<p>Δc/Δx is the concentration gradient.</p>\n</div>\n</div>\n</div>\n</div>\n<table>\n<tbody>\n<tr>\n<td><strong>Factors</strong></td>\n<td><strong>Effect on diffusion</strong></td>\n</tr>\n<tr>\n<td>↑ Thickness of the membrane</td>\n<td>↓</td>\n</tr>\n<tr>\n<td>↑ Lipid Solubility</td>\n<td>↑</td>\n</tr>\n<tr>\n<td>↑ Temperature</td>\n<td>↑</td>\n</tr>\n<tr>\n<td>↑&nbsp; Size of the molecule</td>\n<td>↓</td>\n</tr>\n<tr>\n<td>↑&nbsp; Area of the Membrane</td>\n<td>↑</td>\n</tr>\n<tr>\n<td>↑ Distribution of Protein Channels</td>\n<td>↑</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(315, 'Physiology', 'PM0435. Transport across the cell membrane', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0833346517b646d9ace5388b9f4110b9x1280x1915.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(316, 'Physiology', 'PM0337. Physiological changes in aging', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\143\>\n<p><strong>Systems</strong></p>\n</td>\n<td width=\282\>\n<p><strong>Changes</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>General Changes</p>\n</td>\n<td width=\282\>\n<p>↓ BMR</p>\n<p>↓ Lean body mass,↑ adiposity</p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>Skin</p>\n</td>\n<td width=\282\>\n<p>Thinning of epidermis and dermis due to ↓ in elastin and collagen</p>\n<p>melanocytes→↓ photoprotection</p>\n<p>Net effect- Wrinkling of skin</p>\n<p>active melanocytes in hair follicles→ graying of hair</p>\n<p>nail growth</p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>Skeletal muscle</p>\n</td>\n<td width=\282\>\n<p>Steady ↓ in skeletal muscle mass (Sarcopenia)</p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>Bone</p>\n</td>\n<td width=\282\>\n<p>Bone resorption exceeds formation →Bone loss → Osteoporosis</p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>Synovial Joint</p>\n</td>\n<td width=\282\>\n<p>Thinning and altered mechanical features of articular cartilage → Osteoarthritis</p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>Central nervous system</p>\n</td>\n<td width=\282\>\n<p><strong>Sensory</strong>- deteriorates with age</p>\n<p>Hearing loss particularly for high frequency</p>\n<p>Vision- deteriorates due to presbyopia, cataract, glaucoma, macular degeneration</p>\n<p>Reduction in taste and olfactory sensation</p>\n<p><strong>Motor</strong>- Slowing of reaction time (time between stimulus and motor response), slowing of central processing</p>\n<p><strong>Cognitive functions</strong> decline</p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>Cardiovascular system</p>\n</td>\n<td width=\282\>\n<p>arterial distensibility,↓ arterial compliance→↑SBP,↓DBP→↑Pulse pressure</p>\n<p>↓Arterial compliance→↑afterload</p>\n<p>EDV no change, thus, preload not affected</p>\n<p>Blunting of baroreceptor reflex→postural hypotension</p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>Respiratory System</p>\n</td>\n<td width=\282\>\n<p>Decreased strength and endurance of respiratory muscles due to atrophy→ ↓ in both static and forced expiratory volume</p>\n<p>Small airways tend to collapse due to degeneration of collagen and elastin</p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>Exercise</p>\n</td>\n<td width=\282\>\n<p>↓ Vo<sub>2max</sub></p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>Renals</p>\n</td>\n<td width=\282\>\n<p>↓GFR linearly with age</p>\n<p>↓ clearance</p>\n<p>↓ in capacity and compliance of bladder</p>\n<p>Prostrate enlargement</p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>Gastrointestinal tract</p>\n</td>\n<td width=\282\>\n<p>↓ in exocrine gland secretion (eg-↓ gastric acidity)</p>\n<p>↓ in colonic motility</p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>Endocrines</p>\n</td>\n<td width=\282\>\n<p>↓ IGF-1, DHEA, TSH</p>\n<p>↑PTH</p>\n<p>Menopause, andropause</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(317, 'Physiology', 'PM0335. Cytoskeleton', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\120\>\n<p><strong>Cytoskeleton</strong></p>\n</td>\n<td width=\120\>\n<p><strong>Microfilaments</strong></p>\n</td>\n<td width=\120\>\n<p><strong>Intermediate Filaments</strong></p>\n</td>\n<td width=\120\>\n<p><strong>Microtubules</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\120\>\n<p>Diameter</p>\n</td>\n<td width=\120\>\n<p>5-9 nm</p>\n</td>\n<td width=\120\>\n<p>8-14 nm</p>\n</td>\n<td width=\120\>\n<p>25 nm</p>\n</td>\n</tr>\n<tr>\n<td width=\120\>\n<p>Examples</p>\n</td>\n<td width=\120\>\n<p>Filamentous (F) actin</p>\n<p>Globular (G) actin</p>\n</td>\n<td width=\120\>\n<p>Keratin, vimentin, desmin, glial fibrillary acid protein, peripherin, neurofilaments, lamins</p>\n</td>\n<td width=\120\>\n<p>Dynamin, Dynein, Kinesin,tubulin</p>\n</td>\n</tr>\n<tr>\n<td width=\120\>\n<p>Functions</p>\n</td>\n<td width=\120\>\n<p>Play a vital role in various cellular contractile systems,</p>\n<p>including muscle contraction and amoeboid movement (lamellopodia)</p>\n<p>serve as mechanical stiffeners for microvilli</p>\n</td>\n<td width=\120\>\n<p>Help resist mechanical stress</p>\n<p>Lamins connect nuclear membrane to cell membrane</p>\n<p>Keratin prevents blistering of the skin</p>\n<p>Vimentin forms a flexible scaffolding for the cell and help it resist external pressure</p>\n</td>\n<td width=\120\>\n<p>Maintain asymmetric cell shapes and coordinate complex cell movements</p>\n<p>specifically serving as tracks for transport of secretory vesicles within a cell using molecular motors</p>\n<p>serving as the main structural and functional component of cilia and flagella</p>\n<p>forming a mitotic spindle during cell division</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(318, 'Physiology', 'PM0334. Class of intermediate filaments and their distribution', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\239\>\n<p><strong>Proteins</strong></p>\n</td>\n<td width=\239\>\n<p><strong>Distribution</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Cytokeratin</p>\n</td>\n<td width=\239\>\n<p>Epithelial cells</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Vimentin</p>\n</td>\n<td width=\239\>\n<p>Various mesenchymal cells (fibroblast)</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Desmin</p>\n</td>\n<td width=\239\>\n<p>Muscle</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Glial Fibrillary Acid Protein</p>\n</td>\n<td width=\239\>\n<p>Glial cells</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Peripherin</p>\n</td>\n<td width=\239\>\n<p>Neurons</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Neurofilaments</p>\n</td>\n<td width=\239\>\n<p>Neurons</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Lamins</p>\n</td>\n<td width=\239\>\n<p>Nuclear lamina</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(319, 'Physiology', 'PM0331. Cell Organelles and Enzyme Markers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\129\>\n<p><strong>Organelles</strong></p>\n</td>\n<td width=\296\>\n<p><strong>Enzyme Markers</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Nucleus</p>\n</td>\n<td width=\296\>\n<p>RNA polymerase</p>\n<p>Histone deacetylase</p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Mitochondria</p>\n</td>\n<td width=\296\>\n<p>ATP synthase, glutamate dehydrogenase, creatine kinase</p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Endoplasmic reticulum</p>\n</td>\n<td width=\296\>\n<p>Glucose-6-Phosphatase</p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Lysosome</p>\n</td>\n<td width=\296\>\n<p>Acid phosphatase, cathepsin</p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Golgi</p>\n<p>apparatus</p>\n</td>\n<td width=\296\>\n<p>Galactosyl transferase</p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Peroxisomes</p>\n</td>\n<td width=\296\>\n<p>Catalase, uric acid oxidase</p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Cytosol</p>\n</td>\n<td width=\296\>\n<p>Lactate dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Plasma membrane</p>\n</td>\n<td width=\296\>\n<p>5’-Nucleotidase, Adenylyl cyclase,</p>\n<p>Na-K ATPase</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(320, 'Physiology', 'PM0328. Major Lipids of Cell Membrane', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Major Lipids of Cell Membrane</strong></p>\n<ul>\n<li><strong>Phospholipids</strong>\n<ul>\n<li>Phosphatidylcholine (lecithin)</li>\n<li>Phosphatidylserine</li>\n<li>Phosphatidylethanolamine (cephalin)</li>\n</ul>\n</li>\n<li>\n<p><strong>Sphingolipids -&nbsp;</strong>Sphingomyelin</p>\n</li>\n<li>\n<p><strong>Cholesterol&nbsp;</strong></p>\n</li>\n</ul>\n<p>&nbsp;</p>\n<ul>\n<li>In <strong>prokaryotes,</strong> the membranes are relatively simple and are composed of phospholipids and phosphatidylcholine, but in <strong>eukaryotes </strong>cell membranes also contain various glycosphingolipids, sphingomyelin, and cholesterol.</li>\n<li>Lipids are <strong>amphipathic</strong> molecules forming a lipid bilayer.</li>\n<li><strong>Carbohydrates</strong> are present as glycolipid and glycoprotein.</li>\n<li>Entire outer surface of the cell has a loose carbohydrate coat called <strong>glycocalyx.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(321, 'Physiology', 'PM0327. Composition of Cell Membrane', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Composition of Cell Membrane</strong></p>\n<table>\n<tbody>\n<tr>\n<td width=\96\>\n<p><strong>Component</strong></p>\n</td>\n<td width=\123\>\n<p><strong>Percentage by Weight&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>Protein</p>\n</td>\n<td width=\123\>\n<p>55</p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>Phospholipid</p>\n</td>\n<td width=\123\>\n<p>25</p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>Cholesterol</p>\n</td>\n<td width=\123\>\n<p>13</p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>Other lipids</p>\n</td>\n<td width=\123\>\n<p>4</p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>Carbohydrates</p>\n</td>\n<td width=\123\>\n<p>3</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Proteins</strong> are present as integral and peripheral proteins.</p></div><!---->\n      <!---->\n    </div><!---->'),
(322, 'Physiology', 'PM0289. Compensatory responses to hemorrhagic shock', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Baroreceptor reflex</li>\n<li>CNS Ischemic response</li>\n<li>Reverse stress relaxation</li>\n<li>↑ secretion of renin by kidneys and formation of Angiotensin II</li>\n<li>↑ secretion of ADH</li>\n<li>↑Norepinephrine and epinephrine</li>\n<li>Compensatory mechanisms that return the blood volume back toward normal, including\n<ul>\n<li>Absorption of large quantities of fluid from the intestinal tract</li>\n<li>Absorption of fluid into the blood capillaries from the interstitial spaces of the body</li>\n<li>Conservation of water and salt by the kidneys</li>\n<li>Increased thirst and increased appetite for salt</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(323, 'Physiology', 'PM0287. Starling Forces', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Starling Forces</strong></p>\n<table>\n<tbody>\n<tr>\n<td width=\143\>\n<p>Forces favouring filtration</p>\n</td>\n<td width=\206\>\n<p>P<sub>c </sub>=capillary hydrostatic pressure</p>\n<p>π<sub>i</sub>=interstitial colloidal osmotic pressure</p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>Forces opposing filtration</p>\n</td>\n<td width=\206\>\n<p>P<sub>i</sub>=interstitial hydrostatic pressure</p>\n<p>π<sub>c</sub>=capillary colloidal osmotic pressure</p>\n</td>\n</tr>\n</tbody>\n</table>\n<table>\n<tbody>\n<tr>\n<td width=\122\>\n<p>Factors that increase filtration</p>\n</td>\n<td width=\287\>\n<p>↑P<sub>c</sub>- caused by increased arterial pressure</p>\n<p>↓P<sub>i</sub></p>\n<p>↓π<sub>c </sub>– caused by decreased protein concentration</p>\n<p>↑π<sub>i</sub> – caused by inadequate lymphatic function</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(324, 'Physiology', 'PM0097. Causes of Increased and Decreased 2,3- DPG', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Increase in 2,3-DPG</p>\n<ul>\n<li>Chronic hypoxia</li>\n<li>Anemia</li>\n<li>Acclimatization (high altitude)</li>\n<li>Thyroid</li>\n<li>Growth hormone</li>\n<li>Androgens</li>\n<li>Exercise</li>\n</ul>\n<p>Decrease in 2,3-DPG</p>\n<ul>\n<li>Blood stored in blood bank</li>\n<li>Acidosis</li>\n</ul>\n<p>NOTE:Because acidosis inhibits red cell glycolysis, the 2,3-DPG concentration falls when the pH is low.</p></div><!---->\n      <!---->\n    </div><!---->'),
(325, 'Physiology', 'PM2362. Sarcomere', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2a96ee0f49dd43f388fc7e96e279f5ccx1280x2273.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(326, 'Physiology', 'PM2359. Length-tension relationship', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/458827a5d4e74fa9838df4c652365377x1280x1201.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The passive tension curve measures the tension exerted by this skeletal muscle at each length when it is not stimulated.</li>\n<li>The total tension curve represents the tension developed when the muscle contracts isometrically in response to a maximal stimulus.</li>\n<li>The active tension is the difference between the total tension and passive tension</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(327, 'Physiology', 'PM2332. Slow vs rapidly adapting receptors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\369\>\n<tbody>\n<tr>\n<td><strong>Slow adapting</strong></td>\n<td><strong>Rapidly adapting receptors</strong></td>\n</tr>\n<tr>\n<td>Also called tonic receptors</td>\n<td>Also called phasic receptors</td>\n</tr>\n<tr>\n<td>They are expanded on free nerve endings.</td>\n<td>They are encapsulated nerve endings.</td>\n</tr>\n<tr>\n<td>Responds to steady stimulus</td>\n<td>Respond to rate of change of stimulus</td>\n</tr>\n<tr>\n<td>With steady stimulus, tonic receptors keep responding steadily.</td>\n<td>With steady stimulus, receptor responds initially but stops or adapts rapidly.</td>\n</tr>\n<tr>\n<td>Examples: Merkels disc, Ruffinis end organs, Joint capsule, Muscle spindle, Golgi tendon organs</td>\n<td>Examples: Pacinian corpuscle, Meissners corpuscles, Hair end organs &nbsp;&nbsp;&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(328, 'Physiology', 'PM2201. Pre and post-ganglionic lesions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Features</strong></td>\n<td><strong>Preganglionic</strong></td>\n<td><strong>Postganglionic</strong></td>\n</tr>\n<tr>\n<td>Site</td>\n<td>Proximal to dorsal Root ganglion</td>\n<td>Distal to Dorsal Root Ganglion</td>\n</tr>\n<tr>\n<td>Injury</td>\n<td>Avulsion of nerve root from spinal cord</td>\n<td>Disruption of distal nerve root, trunk or the peripheral nerve</td>\n</tr>\n<tr>\n<td>Prognosis</td>\n<td>Poor</td>\n<td>Good</td>\n</tr>\n<tr>\n<td>Histamine test</td>\n<td>Positive</td>\n<td>Negative</td>\n</tr>\n<tr>\n<td>Surgical repairability</td>\n<td>Irreparable</td>\n<td>Repairable</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>Histamine Test:</strong></p>\n<p>Normally, a Triple Response is produced on the intradermal injection of Histamine.</p>\n<div class=\page\ title=\Page 296\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Central capillary dilatation -&gt; Surrounding flare -&gt; Wheal.</p>\n<p>&nbsp;</p>\n<p>Conclusions:</p>\n<p><strong>Normal Sensate</strong> Skin with <strong>Normal Triple</strong> Response -&gt; <strong>No Nerve Injury</strong></p>\n<p><strong>Normal Triple</strong> Response over <strong>anesthetic skin</strong> -&gt; <strong>Pre</strong>ganglionic Lesion</p>\n<p><strong>Incomplete Triple</strong> Response <strong>over anesthetic</strong> skin -&gt; <strong>Post</strong>ganglionic Lesion</p>\n<p>&nbsp;</p>\n<p>In postganglionic lesions, incomplete triple response as no flare because of the disrupted pathway to the ganglion.</p>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(329, 'Physiology', 'PM1945. Types of Smooth Muscles', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\638\>\n<tbody>\n<tr>\n<td width=\319\>\n<p><strong>Single unit/ unitary/visceral smooth muscle&nbsp;</strong></p>\n</td>\n<td width=\319\>\n<p><strong>Multi-unit smooth muscle</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>A mass of many smooth muscle fibers that contract together as a single unit</p>\n</td>\n<td width=\319\>\n<p>Made up of discrete, separate smooth muscle fibers, each operating independently&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>The cell membranes are joined by <strong>many gap junctions</strong> and function in a syncytial fashion</p>\n</td>\n<td width=\319\>\n<p><strong>No gap junctions</strong> in between fibers.</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>En passant nerve endings are present for <strong>fewer cells</strong> with excitation spreading to other cells by gap junctions</p>\n<p>In addition they respond to hormones and other circulating substances</p>\n</td>\n<td width=\319\>\n<p>Innervated by a single nerve ending (en passant endings of nerve fibers)</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Examples: Muscles of the gut, bile ducts, ureters, uterus and many blood vessels (Hollow viscera)</p>\n</td>\n<td width=\319\>\n<p>Examples : ciliary muscle of the eye, the iris, the piloerector muscles and arterioles</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>(Blood vessels have both unitary and multi-unit smooth muscles)</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(330, 'Physiology', 'PM1939. Heat production in muscle', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Heat Produced</strong></td>\n<td><strong>Isotonic Contraction</strong></td>\n<td><strong>Isometric Contraction</strong></td>\n</tr>\n<tr>\n<td>\n<p>Resting heat</p>\n<p>The heat given off at rest due to the basal metabolic process</p>\n</td>\n<td>+</td>\n<td>+</td>\n</tr>\n<tr>\n<td>\n<p>Initial heat</p>\n<p>The heat produced in excess of resting heat during contraction</p>\n</td>\n<td>+</td>\n<td>+</td>\n</tr>\n<tr>\n<td>\n<p>Recovery Heat</p>\n<p>The heat liberated by metabolic processes that restore the muscle to its precontraction state. Approximately equal to initial heat.</p>\n</td>\n<td>+</td>\n<td>+</td>\n</tr>\n<tr>\n<td>\n<p><strong>Relaxation</strong> <strong>Heat</strong></p>\n<p>The extra heat liberated by the muscle to restore it to previous length.</p>\n</td>\n<td><strong>+</strong></td>\n<td><strong>-</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(331, 'Physiology', 'PM1810. Comparison between EPSP vs IPSP', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>EPSP</strong></td>\n<td><strong>IPSP</strong></td>\n</tr>\n<tr>\n<td>EPSP is an electrical charge on the postsynaptic membrane, which is caused by the <strong>binding of excitatory neurotransmitters</strong> and makes the <strong>postsynaptic membrane</strong> <strong>more likely</strong> to generate an action potential.</td>\n<td>IPSP is an electric charge on the postsynaptic membrane, which is caused by the <strong>binding of inhibitory neurotransmitters</strong> and makes the <strong>postsynaptic membrane less likely</strong> to generate an action potential.</td>\n</tr>\n<tr>\n<td>EPSP is caused by <strong>Influx </strong>of <strong>Na<sup>+ </sup>or Ca<sup>2+</sup></strong> ions</td>\n<td>IPSP is caused by <strong>Influx of Cl<sup>- </sup>ions mainly </strong>(also by <strong>efflux of K<sup>+</sup></strong> ions)</td>\n</tr>\n<tr>\n<td>Results in <strong>depolarization</strong> of membrane</td>\n<td>Results in <strong>hyperpolarization </strong>of membrane</td>\n</tr>\n<tr>\n<td><strong>Increases the firing rate</strong> of action potential on postsynaptic membrane</td>\n<td><strong>Decreases the firing rate</strong> of action potential on post synaptic membrane</td>\n</tr>\n<tr>\n<td>Neurotransmitters involved – <strong>Glutamate, Aspartate</strong></td>\n<td>Neurotransmitters involved – <strong>Glycine, GABA</strong></td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>EPSP- Excitatory PostSynaptic Potentials</p>\n<p>IPSP- Inhibitory&nbsp;PostSynaptic Potentials</p></div><!---->\n      <!---->\n    </div><!---->'),
(332, 'Pharmacology,', 'PM0687. Agents affecting neuromuscular transmission', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Example</strong></p>\n</td>\n<td>\n<p><strong>Action </strong></p>\n</td>\n<td>\n<p><strong>Effect on Neuromuscular Transmission</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Botulinum toxin</p>\n</td>\n<td>\n<p>Blocks release of ACh from presynaptic terminal</p>\n</td>\n<td>\n<p>Total blockade of terminals</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Curare</p>\n</td>\n<td>\n<p>Competes with ACh for receptors on motor end plate</p>\n</td>\n<td>\n<p>Decreases size of EPP; maximal doses produce end plate paralysis of respiratory muscles and death</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neostigmine</p>\n</td>\n<td>\n<p>Inhibits acetylcholinesterase</p>\n</td>\n<td>\n<p>Prolongs and enhances action of ACh at</p>\n<p>muscle end plate</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemicholinium</p>\n</td>\n<td>\n<p>Blocks reuptake of choline</p>\n</td>\n<td>\n<p>Depletes ACh stores from presynaptic terminal</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/7aebdeaa8e114b268d3acf4a54197c7cx750x517.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(333, 'Physiology', 'PM0626. Numerical classification of sensory nerve fibers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\54\>\n<p><strong>Number </strong></p>\n</td>\n<td width=\234\>\n<p><strong>Origin </strong></p>\n</td>\n<td width=\71\>\n<p><strong>Fibre type</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Ia</p>\n</td>\n<td width=\234\>\n<p>Muscle Spindle, annulo-spiral ending</p>\n</td>\n<td width=\71\>\n<p>Aα</p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>Ib</p>\n</td>\n<td width=\234\>\n<p>Golgi tendon organ</p>\n</td>\n<td width=\71\>\n<p>Aα</p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>II</p>\n</td>\n<td width=\234\>\n<p>Muscle Spindle, flower spray ending; touch, pressure</p>\n</td>\n<td width=\71\>\n<p>Aβ</p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>III</p>\n</td>\n<td width=\234\>\n<p>Pain and cold receptors; some touch receptors</p>\n</td>\n<td width=\71\>\n<p>Aδ</p>\n</td>\n</tr>\n<tr>\n<td width=\54\>\n<p>IV</p>\n</td>\n<td width=\234\>\n<p>Pain, temperature, and other receptors</p>\n</td>\n<td width=\71\>\n<p>C</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(334, 'Physiology,', 'PM0624. Relative susceptibility of nerve fibres to conduction block by various agents', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\286\>\n<tbody>\n<tr>\n<td>\n<p><strong>Susceptibility</strong></p>\n</td>\n<td>\n<p><strong>Most susceptible</strong></p>\n</td>\n<td>\n<p><strong>Intermediate</strong></p>\n</td>\n<td>\n<p><strong>Least susceptible</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Local anaesthetic</p>\n</td>\n<td>\n<p>C</p>\n</td>\n<td>\n<p>B</p>\n</td>\n<td>\n<p>A</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypoxia</p>\n</td>\n<td>\n<p>B</p>\n</td>\n<td>\n<p>A</p>\n</td>\n<td>\n<p>C</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pressure</p>\n</td>\n<td>\n<p>A</p>\n</td>\n<td>\n<p>B</p>\n</td>\n<td>\n<p>C</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>Controversial:&nbsp;</strong>There is a difference in the opinion quoted by various standard textbooks and authors.</p>\n<div class=\ng-scope\>\n<div class=\ng-scope\>\n<p class=\ng-binding\>According to Katzung pharmacology 14th edition page no. 465,&nbsp;<strong> B=C &gt; A delta &gt; A gamma &gt; A beta &gt; A alpha</strong></p>\n<p>Ganongs Physiology 26th edition, page no. 92, Nerve fibre most susceptible to local anesthetics is<strong> C &gt; B &gt; A</strong></p>\n</div>\n</div>\n<div class=\ng-scope\>\n<div class=\ng-scope\>\n<p>Hence, the correct answer would solely depend on the reference book the examiner referred to while making the question.</p>\n</div>\n</div>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(335, 'Anaesthesia,', 'PM0623. Types of mammalian nerve fibres (Erlanger and Gassers classification)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\ width=\445\>\n<tbody>\n<tr>\n<td width=\88\>\n<p><strong>Fiber type</strong></p>\n</td>\n<td width=\127\>\n<p><strong>Function</strong></p>\n</td>\n<td width=\79\>\n<p><strong>Fiber diameter(μm)</strong></p>\n</td>\n<td width=\76\>\n<p><strong>Conduction velocity(m/s)</strong></p>\n</td>\n<td width=\75\>\n<p><strong>Spike duration(ms)</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\88\>\n<p>Aα</p>\n</td>\n<td width=\127\>\n<p>Proprioception, somatic motor</p>\n</td>\n<td width=\79\>\n<p>12-20</p>\n</td>\n<td width=\76\>\n<p>70-120</p>\n</td>\n<td width=\75\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\88\>\n<p>Aβ</p>\n</td>\n<td width=\127\>\n<p>Touch, pressure</p>\n</td>\n<td width=\79\>\n<p>5-12</p>\n</td>\n<td width=\76\>\n<p>30-70</p>\n</td>\n<td width=\75\>\n<p>0.4-0.5</p>\n</td>\n</tr>\n<tr>\n<td width=\88\>\n<p>Aγ</p>\n</td>\n<td width=\127\>\n<p>Motor to muscle spindles</p>\n</td>\n<td width=\79\>\n<p>3-6</p>\n</td>\n<td width=\76\>\n<p>15-30</p>\n</td>\n<td width=\75\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\88\>\n<p>Aδ</p>\n</td>\n<td width=\127\>\n<p>Pain, temperature</p>\n</td>\n<td width=\79\>\n<p>2-5</p>\n</td>\n<td width=\76\>\n<p>12-30</p>\n</td>\n<td width=\75\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\88\>\n<p>B</p>\n</td>\n<td width=\127\>\n<p>Preganglionic autonomic</p>\n</td>\n<td width=\79\>\n<p>&lt;3</p>\n</td>\n<td width=\76\>\n<p>3-15</p>\n</td>\n<td width=\75\>\n<p>1.2</p>\n</td>\n</tr>\n<tr>\n<td width=\88\>\n<p>C</p>\n<p>Dorsal root</p>\n</td>\n<td width=\127\>\n<p>Pain, temperature</p>\n</td>\n<td width=\79\>\n<p>0.4-1.2</p>\n</td>\n<td width=\76\>\n<p>0.5-2</p>\n</td>\n<td width=\75\>\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td width=\88\>\n<p>C Sympathetic</p>\n</td>\n<td width=\127\>\n<p>Post ganglionic sympathetic</p>\n</td>\n<td width=\79\>\n<p>0.3-1.3</p>\n</td>\n<td width=\76\>\n<p>0.7-2.3</p>\n</td>\n<td width=\75\>\n<p>2</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(336, 'Physiology', 'PM0622. Number of Na+ Channels per square Micrometer in Myelinated Mammalian Neurons', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\184\>\n<tbody>\n<tr>\n<td width=\104\>\n<p><strong>Surface of Myelin </strong></p>\n</td>\n<td width=\80\>\n<p>&lt;25</p>\n</td>\n</tr>\n<tr>\n<td width=\104\>\n<p><strong>Axonal terminal</strong></p>\n</td>\n<td width=\80\>\n<p>20-75</p>\n</td>\n</tr>\n<tr>\n<td width=\104\>\n<p><strong>Cell body </strong></p>\n</td>\n<td width=\80\>\n<p>50-75</p>\n</td>\n</tr>\n<tr>\n<td width=\104\>\n<p><strong>Initial segment </strong></p>\n</td>\n<td width=\80\>\n<p>350-500</p>\n</td>\n</tr>\n<tr>\n<td width=\104\>\n<p><strong>Node of Ranvier </strong></p>\n</td>\n<td width=\80\>\n<p>2000-12000</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>NOTE-</strong> Along the axons of unmyelinated neuron the number is about 110</p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(337, 'Physiology', 'PM0621. Classification of neurons based on the number of neuronal processes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\384\>\n<tbody>\n<tr>\n<td width=\93\>&nbsp;</td>\n<td width=\188\>\n<p><strong>Structure </strong></p>\n</td>\n<td width=\103\>\n<p><strong>Example </strong></p>\n</td>\n</tr>\n<tr>\n<td width=\93\>\n<p>Unipolar</p>\n<p>&nbsp;</p>\n</td>\n<td width=\188\>\n<p>These neurons have a <strong>single&nbsp;process</strong> with different segments serving as receptive surfaces and releasing terminals</p>\n</td>\n<td width=\103\>\n<p>Neurons seen in invertebrates</p>\n</td>\n</tr>\n<tr>\n<td width=\93\>\n<p>Bipolar</p>\n</td>\n<td width=\188\>\n<p><strong>Two processes</strong> exit from the cell body-a dendrite and an axon</p>\n</td>\n<td width=\103\>\n<p>Retinal bipolar ganglion cells</p>\n</td>\n</tr>\n<tr>\n<td width=\93\>\n<p>Pseudounipolar</p>\n</td>\n<td width=\188\>\n<p>Subclass of bipolar cells</p>\n<p>As the cell develops, a <strong>single process</strong> splits into two, both of which function as axons- one going to skin or muscles and another to spinal cord</p>\n</td>\n<td width=\103\>\n<p>Dorsal root ganglia</p>\n</td>\n</tr>\n<tr>\n<td width=\93\>\n<p>Multipolar</p>\n</td>\n<td width=\188\>\n<p><strong>Many processes</strong> exit from the cell body. Have one axon and many dendrites</p>\n</td>\n<td width=\103\>\n<p>Spinal motor neuron</p>\n<p>Hippocampal pyramidal cells</p>\n<p>Cerebellar Purkinje cells</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/44ae52461c2b43188f947f02a6272a77x720x540.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(338, 'Physiology', 'PM0620. Glial cells and their functions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\520\>\n<tbody>\n<tr>\n<td width=\194\>\n<p><strong>Cells </strong></p>\n</td>\n<td width=\326\>\n<p><strong>Functions </strong></p>\n</td>\n</tr>\n<tr>\n<td width=\194\>\n<p>Microglia<strong> (immune system cells)</strong></p>\n</td>\n<td width=\326\>\n<p><strong>Scavenger cells</strong> that remove debris resulting from injury, infection, and disease.</p>\n</td>\n</tr>\n<tr>\n<td width=\194\>\n<p>Oligodendrocytes</p>\n</td>\n<td width=\326\>\n<p><strong>Myelin formation</strong> in central nervous system</p>\n</td>\n</tr>\n<tr>\n<td width=\194\>\n<p>Schwann cells</p>\n</td>\n<td width=\326\>\n<p><strong>Myelin formation</strong> in peripheral nervous system</p>\n</td>\n</tr>\n<tr>\n<td width=\194\>\n<p>Astrocytes :</p>\n<ul>\n<li>Fibrous – in white matter</li>\n<li>Protoplasmic – in grey matter</li>\n</ul>\n</td>\n<td width=\326\>\n<p>Astrocytes form the tight junctions making <strong>blood–brain barrier</strong></p>\n<p>Produce substances that are tropic to neuron</p>\n<p>They help maintain the appropriate concentration of ions by taking up K<sup>+ </sup></p>\n<p>They take up glutamate and convert into&nbsp; glutamine</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(339, 'Anaesthesia,', 'PM0489. Peripheral Nerve Classification and LA Sensitivity', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>CLASSIFICATION OF PERIPHERAL NERVES ACCORDING TO ANATOMY, PHYSIOLOGY, AND FUNCTION:</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td><strong>Fiber class</strong></td>\n<td><strong>Subclass</strong></td>\n<td><strong>Myelin</strong></td>\n<td><strong>Diameter(µm)</strong></td>\n<td><strong>Conduction velocity(m/sec)</strong></td>\n<td><strong>Location</strong></td>\n<td><strong>Function</strong></td>\n<td><strong>Susceptibility to LA Block</strong></td>\n</tr>\n<tr>\n<td>A</td>\n<td>alpha</td>\n<td>+</td>\n<td>6-22</td>\n<td>30-120</td>\n<td>Efferent to muscles</td>\n<td>Motor, proprioception</td>\n<td>++</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>beta</td>\n<td>+</td>\n<td>6-22</td>\n<td>30-120</td>\n<td>Afferent from skin&nbsp;and joints</td>\n<td>Tactile, proprioception</td>\n<td>++</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>gamma</td>\n<td>+</td>\n<td>3-6</td>\n<td>15-35</td>\n<td>Efferent to muscle spindles</td>\n<td>Muscle tone</td>\n<td>+++</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>delta</td>\n<td>+</td>\n<td>1-4</td>\n<td>5-25</td>\n<td>Afferent sensory nerves</td>\n<td>Pain, cold,&nbsp;temperature, touch</td>\n<td>+++</td>\n</tr>\n<tr>\n<td>B</td>\n<td>&nbsp;</td>\n<td>+</td>\n<td>&lt;3</td>\n<td>3-15</td>\n<td>Preganglionic&nbsp;sympathetic</td>\n<td>Various autonomic&nbsp;functions</td>\n<td>++++</td>\n</tr>\n<tr>\n<td>C</td>\n<td>sC</td>\n<td>-</td>\n<td>0.3-1.3</td>\n<td>0.7-1.3</td>\n<td>Postganglionic sympathetic</td>\n<td>Various autonomic&nbsp;functions</td>\n<td>++++</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>dC</td>\n<td>-</td>\n<td>0.4-1.2</td>\n<td>0.1-2.0</td>\n<td>Afferent sensory nerves</td>\n<td>Various autonomic&nbsp;functions<br>Pain, warm temperature, touch</td>\n<td>+</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;The relative susceptibility of nerve fibers to conduction blocks produced by various agents:</p>\n<table width=\286\>\n<tbody>\n<tr>\n<td>\n<p><strong>Susceptibility</strong></p>\n</td>\n<td>\n<p><strong>Most susceptible</strong></p>\n</td>\n<td>\n<p><strong>Intermediate</strong></p>\n</td>\n<td>\n<p><strong>Least susceptible</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Local anesthetic</p>\n</td>\n<td>\n<p>C</p>\n</td>\n<td>\n<p>B</p>\n</td>\n<td>\n<p>A</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypoxia</p>\n</td>\n<td>\n<p>B</p>\n</td>\n<td>\n<p>A</p>\n</td>\n<td>\n<p>C</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pressure</p>\n</td>\n<td>\n<p>A</p>\n</td>\n<td>\n<p>B</p>\n</td>\n<td>\n<p>C</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Controversial: </strong>Nerve fibers most susceptible to local anesthetics:</p>\n<ul>\n<li>As per Katzung Pharmacology 14th edition page 465-&nbsp;<strong>&nbsp;B=C &gt; A delta&gt; A gamma&gt; A beta&gt; A alpha</strong></li>\n<li class=\ng-scope\>\n<div class=\ng-scope\>\n<p>As per Ganongs Physiology&nbsp;23rd edition page no-<strong>&nbsp;C &gt;B&gt;A</strong></p>\n</div>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(340, 'Medicine,', 'PM2382. Brown Sequard syndrome (Hemisection of spinal cord)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8982f4e2daba47c98143bb74883be74bx1280x3027.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(341, 'Medicine,', 'PM2333. CNS deficits and site of lesions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Term</strong></td>\n<td><strong>Defnition</strong></td>\n<td><strong>Site of lesion</strong></td>\n</tr>\n<tr>\n<td>Agnosia</td>\n<td>Inability to accurately perceive objects through normally functioning sensory mechanisms</td>\n<td>Posterior parietal cortex</td>\n</tr>\n<tr>\n<td>\n<p>Dyslexia</p>\n<p>(word blindness)</p>\n</td>\n<td>\n<p>Inability to interpret their meanings</p>\n<p>(the person may be able to see words and even know that they are words but not be able to interpret their meanings)</p>\n</td>\n<td>Angular gyrus</td>\n</tr>\n<tr>\n<td>Aphasia</td>\n<td>inability to produce and/or understand language</td>\n<td>\n<p class=\p1\>All components of the language network are interconnected with each other and with</p>\n<p class=\p1\>surrounding parts of the frontal, parietal, and temporal lobes. Damage</p>\n<p class=\p1\>to this network gives rise to language impairments resulting in aphasia.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(342, 'Ophthalmology,', 'PM1950. Lesions in the optic pathway', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/99e36d0f854b491da018065066ccac41x1280x2202.PNG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5e6706752b2243f395c0320ea0a3ef7cx1280x1910.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Transection</strong> of the <strong>pathways</strong> at the locations indicated by the letters causes the visual field defects shown in the diagram above.</p>\n<ul>\n<li>The fibers from the nasal half of each retina decussate in the optic chiasm, so that the fibers in the optic tracts are those from the temporal half of one retina and the nasal half of the other.</li>\n<li>A <strong>lesion</strong> that interrupts<strong>&nbsp;the</strong>&nbsp;<strong>optic nerve</strong> causes <strong>blindness</strong> in <strong>that eye</strong>.</li>\n<li><strong>Lesions</strong> affecting the <strong>optic chiasma</strong> destroy fibers from both nasal hemiretinas and produce a <strong>heteronymous</strong> (opposite sides of the visual fields) <strong>hemianopia.</strong></li>\n<li>A <strong>lesion</strong> in <strong>one optic tract</strong> causes blindness in half of the visual field and is called <strong>homonymous</strong> (same side of both visual fields)&nbsp;<strong>hemianopia (half-blindness).</strong></li>\n<li><strong>Occipital lesions</strong> may <strong>spare</strong> the fibers from the <strong>macula</strong>&nbsp;because of the separation in the brain of these fibers from the other subserving vision.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(343, 'Physiology', 'PM1876. Connections and Neurotransmitters in Basal Ganglia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>&nbsp;</strong></td>\n<td><strong>Input</strong></td>\n<td><strong>Output</strong></td>\n<td><strong>Neurotransmitter</strong></td>\n</tr>\n<tr>\n<td><strong>Corpus Striatum</strong></td>\n<td>Cerebral cortex and Thalamus</td>\n<td>GPe and GPi</td>\n<td>\n<p>95% GABA (small neurons)</p>\n<p>5% Ach (large neurons) / Somatostatin (Medium neurons)</p>\n</td>\n</tr>\n<tr>\n<td><strong>GPe</strong></td>\n<td>Striatum</td>\n<td>GPi and Subthalamic nucleus</td>\n<td>GABA&nbsp;</td>\n</tr>\n<tr>\n<td><strong>GPi and Substantia nigra pars reticulate (SNpR)</strong></td>\n<td>Striatum and GPe</td>\n<td>Ventrolateral and ventroanterior Thalamus</td>\n<td>GABA</td>\n</tr>\n<tr>\n<td><strong>Subthalamic nucleus</strong></td>\n<td>GPe</td>\n<td>GPi and GPe</td>\n<td><strong>Glutamate</strong></td>\n</tr>\n<tr>\n<td><strong>Substantia Nigra pars compacta (SNpC)</strong></td>\n<td>Striatum</td>\n<td>Striatum</td>\n<td>Dopamine</td>\n</tr>\n<tr>\n<td><strong>Ventrolateral Thalamus</strong></td>\n<td>GPi and SNpR</td>\n<td>Premotor Cortex</td>\n<td><strong>Glutamate</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(344, 'Medicine,', 'PM1806. Root values of the Reflexes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;Reflex</td>\n<td>&nbsp;Nerve</td>\n<td>&nbsp;Root Value</td>\n</tr>\n<tr>\n<td>Biceps</td>\n<td>Musculocutaneous</td>\n<td>C5, C6</td>\n</tr>\n<tr>\n<td>Brachioradialis</td>\n<td>Radial</td>\n<td>C5, C6</td>\n</tr>\n<tr>\n<td>Triceps</td>\n<td>Radial</td>\n<td>C7, C8</td>\n</tr>\n<tr>\n<td>Finger</td>\n<td>Median and Ulnar</td>\n<td>C8</td>\n</tr>\n<tr>\n<td>Adductor</td>\n<td>Obturator</td>\n<td>L2, L3</td>\n</tr>\n<tr>\n<td>Knee</td>\n<td>Femoral</td>\n<td>L3, L4</td>\n</tr>\n<tr>\n<td>Ankle</td>\n<td>Tibial branch of Sciatic</td>\n<td>S1, S2</td>\n</tr>\n<tr>\n<td>Plantar</td>\n<td>&nbsp;Tibial</td>\n<td>L5- S2</td>\n</tr>\n<tr>\n<td>Abdominal</td>\n<td>\n<p>Upper quadrants- Intercostal nerves&nbsp;</p>\n<p>Lower Quadrants- Intercostal, iliohypogastric &amp; ilioinguinal</p>\n</td>\n<td>\n<p>Upper Quadrants-T7- T10&nbsp;</p>\n<p>Lower Quadrants-T10- Upper Lumbar segments</p>\n</td>\n</tr>\n<tr>\n<td>Cremasteric</td>\n<td>Ilioinguinal and Genitofemoral</td>\n<td>L1, L2</td>\n</tr>\n<tr>\n<td>Anal</td>\n<td>&nbsp;</td>\n<td>S2, S3, S4</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(345, 'Physiology', 'PM1798. Effect of ANS on metabolic functions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td colspan=\2\><strong>Adrenergic system</strong></td>\n<td colspan=\2\><strong>Cholinergic system</strong></td>\n</tr>\n<tr>\n<td><strong>&nbsp;</strong></td>\n<td><strong>Action</strong></td>\n<td><strong>Receptor</strong></td>\n<td><strong>Action</strong></td>\n<td><strong>Receptor</strong></td>\n</tr>\n<tr>\n<td>Liver</td>\n<td>Gluconeogenesis</td>\n<td>β2, α<sub>1</sub></td>\n<td>-</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Liver</td>\n<td>Glycogenolysis</td>\n<td>β<sub>2</sub>, α<sub>1</sub></td>\n<td>-&nbsp;</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Fat cells</td>\n<td>Lipolysis</td>\n<td>β<sub>3</sub></td>\n<td>-</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Pancreatic acini</td>\n<td>Decreased secretion</td>\n<td>α</td>\n<td>Increased secretion</td>\n<td>M3, M2</td>\n</tr>\n<tr>\n<td>Pancreatic islets – β cells</td>\n<td>Decreased secretion</td>\n<td>α<sub>2</sub></td>\n<td>Increased secretion</td>\n<td>M3</td>\n</tr>\n<tr>\n<td>Kidney</td>\n<td>Renin release</td>\n<td>β1</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(346, 'Physiology', 'PM1797. Effect of ANS in the Genitourinary system', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\388\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Adrenergic System</strong></td>\n<td><strong>Adrenergic System</strong></td>\n<td><strong>Cholinergic System</strong></td>\n<td><strong>Cholinergic System</strong></td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Action</strong></td>\n<td><strong>Receptor</strong> &nbsp;</td>\n<td><strong>Action</strong></td>\n<td><strong>Receptor</strong> &nbsp;</td>\n</tr>\n<tr>\n<td><strong>Bladder wall - Detrusor</strong></td>\n<td><strong>Relaxation</strong> - Storage</td>\n<td>β2</td>\n<td><strong>Contraction</strong> - Expulsion</td>\n<td><strong>M3</strong> &nbsp;</td>\n</tr>\n<tr>\n<td><strong>Trigone, Sphincter</strong></td>\n<td><strong>Contraction</strong> - Storage</td>\n<td><strong>α1</strong></td>\n<td><strong>Relaxation</strong> - Expulsion&nbsp;</td>\n<td><strong>M3</strong> &nbsp;</td>\n</tr>\n<tr>\n<td><strong>Pregnant uterus</strong><strong>&nbsp;</strong></td>\n<td>\n<p><strong>Relaxation </strong></p>\n<p><strong>Contraction </strong></p>\n</td>\n<td>\n<p>β2</p>\n<p><strong>α1</strong></p>\n</td>\n<td>\n<p>------</p>\n<p>Contraction</p>\n</td>\n<td>\n<p><strong>------</strong> &nbsp;</p>\n<p><strong>M3</strong> &nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Penis </strong></td>\n<td>Ejaculation</td>\n<td><strong>α1</strong></td>\n<td>Erection</td>\n<td>&nbsp;<strong>M3</strong> &nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(347, 'Physiology', 'PM1796. Effects of ANS in the GI tract', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\474\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td colspan=\2\><strong>Adrenergic System</strong></td>\n<td colspan=\2\><strong>Cholinergic system</strong></td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Action</strong></td>\n<td><strong>Receptor</strong></td>\n<td><strong>Action</strong></td>\n<td><strong>Receptor</strong></td>\n</tr>\n<tr>\n<td><strong>Motility</strong></td>\n<td><strong>Decreased</strong></td>\n<td><strong>α1, α2, </strong>β2</td>\n<td><strong>Increased</strong></td>\n<td><strong>M3</strong></td>\n</tr>\n<tr>\n<td><strong>Sphincter</strong></td>\n<td><strong>Contraction</strong></td>\n<td><strong>α1</strong></td>\n<td><strong>Relaxation</strong>&nbsp;</td>\n<td><strong>M3</strong></td>\n</tr>\n<tr>\n<td><strong>Secretions</strong></td>\n<td>Inhibition</td>\n<td><strong>α2</strong></td>\n<td><strong>Increased</strong></td>\n<td><strong>M3</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(348, 'Physiology', 'PM1795. Effects of ANS on blood vessels', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\495\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td colspan=\2\><strong>Adrenergic System</strong></td>\n<td colspan=\2\><strong>Cholinergic system</strong></td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Action</strong></td>\n<td><strong>Receptor</strong></td>\n<td><strong>Action</strong></td>\n<td><strong>Receptor</strong></td>\n</tr>\n<tr>\n<td><strong>Skeletal muscle vessels and Coronary vessels</strong></td>\n<td>Dilation predominantly</td>\n<td><strong>β2</strong></td>\n<td>--------</td>\n<td>--------</td>\n</tr>\n<tr>\n<td><strong>Skin, Splanchnic vessels</strong></td>\n<td>Constriction predominantly</td>\n<td><strong>α1, α2</strong></td>\n<td>--------</td>\n<td>--------</td>\n</tr>\n<tr>\n<td><strong>Salivary gland vessels</strong></td>\n<td>Constriction&nbsp;</td>\n<td><strong>α1, α2</strong></td>\n<td>Dilation</td>\n<td>M3</td>\n</tr>\n<tr>\n<td><strong>Endothelium of vessels in heart,</strong> <strong>brain, viscera</strong></td>\n<td>--------</td>\n<td>--------</td>\n<td>Synthesizes and releases EDRF - <strong>Dilation</strong></td>\n<td><strong>M3, M5</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(349, 'Physiology', 'PM1794. Effect of ANS in the Heart', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table width=\323\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td colspan=\2\><strong>Adrenergic System</strong> &nbsp;</td>\n<td colspan=\2\><strong>Cholinergic System</strong></td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Action</strong></td>\n<td><strong>Receptor</strong></td>\n<td><strong>Action</strong></td>\n<td><strong>Receptor</strong></td>\n</tr>\n<tr>\n<td><strong>SA node</strong></td>\n<td>Accelerates Heart rate ++</td>\n<td>β<strong>1 &gt; </strong>β2</td>\n<td>Decelerates heart rate + +</td>\n<td><strong>M2</strong></td>\n</tr>\n<tr>\n<td><strong>Contractility</strong></td>\n<td>Increases contractility</td>\n<td>β<strong>1 &gt; </strong>β2</td>\n<td>Decreases contractility (Only atria)&nbsp;</td>\n<td><strong>M2</strong></td>\n</tr>\n<tr>\n<td><strong>Ectopic pacemakers</strong></td>\n<td>Accelerates</td>\n<td>β<strong>1 &gt; </strong>β2</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Conduction velocity</strong></td>\n<td>Increases conduction velocity</td>\n<td>β<strong>1 &gt; </strong>β2</td>\n<td>Decreases conduction velocity (Only Atria, AV node)</td>\n<td><strong>M2</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(350, 'Pharmacology,', 'PM1793. Effect of ANS in the Eye', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\483\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td colspan=\2\><strong>Adrenergic System</strong></td>\n<td colspan=\2\><strong>Cholinergic system</strong></td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Action</strong></td>\n<td><strong>Receptor</strong></td>\n<td><strong>Action</strong></td>\n<td><strong>Receptor</strong></td>\n</tr>\n<tr>\n<td><strong>Iris radial muscle</strong></td>\n<td>Contraction - <strong>Mydriasis</strong></td>\n<td><strong>α1</strong></td>\n<td>---------</td>\n<td>---------</td>\n</tr>\n<tr>\n<td><strong>Iris circular muscle</strong></td>\n<td>---------</td>\n<td>---------</td>\n<td>Contraction - <strong>Miosis</strong>&nbsp;</td>\n<td><strong>M3</strong></td>\n</tr>\n<tr>\n<td><strong>Ciliary Muscle</strong></td>\n<td>Relaxation – Far vision</td>\n<td>β2</td>\n<td>Contraction – Near vision</td>\n<td><strong>M3</strong></td>\n</tr>\n<tr>\n<td><strong>Lacrimal glands</strong></td>\n<td>Secretion +</td>\n<td><strong>α</strong></td>\n<td>Secretion +</td>\n<td><strong>M3, M2</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(351, 'Physiology', 'PM1744. Agents causing contraction or relaxation of mesangial cells', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Contraction of mesangial cells:</strong></p>\n<ul>\n<li>Endothelins</li>\n<li>Angiotensin II</li>\n<li>Vasopressin</li>\n<li>Norepinephrine</li>\n<li>Platelet-activating factor</li>\n<li>Platelet-derived growth factor</li>\n<li>Thromboxane A2</li>\n<li>PGF2</li>\n<li>Leukotrienes C4 and D4</li>\n<li>Histamine</li>\n</ul>\n<p><strong>Relaxation of mesangial cells:</strong></p>\n<ul>\n<li>ANP</li>\n<li>Dopamine</li>\n<li>PGE2</li>\n<li>cAMP</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(352, 'Physiology', 'PM1323. Neurotransmitters and Hormones that influence Feeding and Satiety Centers in the Hypothalamus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Increased Appetite (Orexigenic)</strong></p>\n</td>\n<td>\n<p><strong>Decreased Appetite (Anorexigenic)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Neuropeptide Y</strong></p>\n<p>Agouti-related protein (AGRP)</p>\n<p>Melanin-concentrating hormone (MCH)</p>\n<p><strong>Orexins A and B</strong></p>\n<p>Endorphins</p>\n<p>Galanin</p>\n<p>Amino acids (glutamate and γ aminobutyric acid)</p>\n<p>Cortisol</p>\n<p><strong>Ghrelin</strong></p>\n<p>Growth hormone-releasing hormone (GHRH)</p>\n<p>Endocannabinoids</p>\n</td>\n<td>\n<p><strong>Melanocyte-stimulating hormone</strong> (MSH)</p>\n<p><strong>Leptin</strong></p>\n<p>Serotonin</p>\n<p>Norepinephrine</p>\n<p><strong>Corticotropin-releasing hormone (CRH)</strong></p>\n<p><strong>Insulin</strong></p>\n<p><strong>Cholecystokinin (CCK)</strong></p>\n<p>Glucagon-like peptide</p>\n<p><strong>Cocaine-and amphetamine-regulated transcript (CART)</strong></p>\n<p>Bombesin</p>\n<p>Peptide YY</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(353, 'Physiology', 'PM0998. Effects of Various Lesions and Brainstem Transections', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Label </strong></p>\n</td>\n<td>\n<p><strong>Level of transection</strong></p>\n</td>\n<td>\n<p><strong>Vagi intact</strong></p>\n</td>\n<td>\n<p><strong>Vagi cut</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>A</strong></p>\n</td>\n<td>\n<p>Complete transection above pons</p>\n</td>\n<td>\n<p>Regular breathing continues</p>\n</td>\n<td>\n<p>Regular breathing continues but depth of inspiration increases</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>B</strong></p>\n</td>\n<td>\n<p>Mid-pontine level section</p>\n</td>\n<td>\n<p>Regular breathing continues</p>\n</td>\n<td>\n<p>Apneusis develops</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>C</strong></p>\n</td>\n<td>\n<p>Transection midway between pons and medulla</p>\n</td>\n<td>\n<p>Irregular but rhythmic respiration</p>\n</td>\n<td>\n<p>Irregular but rhythmic respiration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>D</strong></p>\n</td>\n<td>\n<p>Complete transection below medulla</p>\n</td>\n<td>\n<p>Spontaneous respiration ceases</p>\n</td>\n<td>\n<p>Spontaneous respiration ceases</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/39cb62fbde5d48f1a31a124e477fe181x1280x1749.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p class=\p2\>CP - middle cerebellar peduncle</p>\n<p class=\p2\>DRG - Dorsal group of respiratory neurons</p>\n<p class=\p2\>IC - inferior colliculus</p>\n<p class=\p2\>NPBL - nucleus parabrachialis (pneumotaxic center)</p>\n<p class=\p2\>VRG - ventral group of respiratory neurons</p>\n<p class=\p2\>4th vent - fourth ventricle.</p></div><!---->\n      <!---->\n    </div><!---->'),
(354, 'Physiology', 'PM0997. Respiratory Centres', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Respiratory center component</strong></p>\n</td>\n<td>\n<p><strong>Primary function</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pre-Bőtzinger complex</p>\n</td>\n<td>\n<p>Pacemaker cells of spontaneous or automatic breathing</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dorsal Respiratory Group (DRG)</p>\n</td>\n<td>\n<p>Respiratory rhythm generator (inspiratory ramp signal)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ventral Respiratory Group (VRG)</p>\n</td>\n<td>\n<p>Overdrive mechanism</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pneumotaxic centre</p>\n</td>\n<td>\n<p>Controls the “switch off” point of inspiratory ramp signal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Apneustic centre</p>\n</td>\n<td>\n<p>Delays switch off signal- promotes inspiration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vagi</p>\n</td>\n<td>\n<p>Inhibits inspiratory discharge</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(355, 'Physiology', 'PM0922. Functions of hypothalamus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\408\>\n<tbody>\n<tr>\n<td>\n<ul>\n<li><strong>Ventromedial</strong>\n<ul>\n<li>Satiety</li>\n</ul>\n</li>\n<li><strong>Arcuate</strong>\n<ul>\n<li>Either increase or decrease appetite</li>\n</ul>\n</li>\n<li><strong>Paraventricular nucleus</strong>\n<ul>\n<li>Oxytocin release</li>\n<li>Satiety</li>\n<li>ACTH and beta lipotropin and blood pressure</li>\n</ul>\n</li>\n<li><strong>Medial Preoptic and anterior hypothalamus</strong>\n<ul>\n<li>Body temperature regulation - <br>Anterior: responds to heat <br>Posterior: responds to cold</li>\n<li>Sweating</li>\n</ul>\n</li>\n<li><strong>Supra optic</strong>\n<ul>\n<li>Vasopressin</li>\n</ul>\n</li>\n<li><strong>Preoptic</strong>\n<ul>\n<li>&nbsp;FSH and LH via GRH</li>\n</ul>\n</li>\n<li><strong>Anterior hypothalamus</strong>\n<ul>\n<li>Osmoreceptor</li>\n</ul>\n</li>\n<li><strong>Lateral hypothalamus</strong>\n<ul>\n<li>Hunger</li>\n<li>Thirst</li>\n</ul>\n</li>\n</ul>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(356, 'Physiology', 'PM0921. Reward and punishment centers in brain', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/e51a34e1b7404306a6bdd3bce25f48e1x592x398.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(357, 'Physiology', 'PM0919. Divisions of thalamic nuclei', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/d5110100ee3242acbe4948e4d5235bd5x492x438.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(358, 'Physiology', 'PM0918. Divisions of thalamus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Three major divisions</strong></p>\n<ul>\n<li>Anterior nuclear group</li>\n<li>Medial nuclear group</li>\n<li>Lateral nuclear group</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2425864f3b5246a29517d34dcb964bb4x1280x2636.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><!---->'),
(359, 'Physiology', 'PM0917. Functions of principal afferent systems to cerebellum', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Afferent Tracts</td>\n<td>Transmits</td>\n</tr>\n<tr>\n<td><strong>Vestibulocerebellar</strong></td>\n<td>Vestibular impulses from labyrinths, direct and via vestibular nuclei</td>\n</tr>\n<tr>\n<td><strong>Dorsal spinocerebellar</strong></td>\n<td>Proprioceptive and exteroceptive impulses from body</td>\n</tr>\n<tr>\n<td><strong>Ventral spinocerebellar</strong></td>\n<td>Proprioceptive and exteroceptive impulses from body</td>\n</tr>\n<tr>\n<td><strong>Cuneocerebellar</strong></td>\n<td>Proprioceptive impulses, especially from head and neck</td>\n</tr>\n<tr>\n<td><strong>Tectocerebellar</strong></td>\n<td>Auditory and visual impulses via inferior and superior colliculi</td>\n</tr>\n<tr>\n<td><strong>Pontocerebellar</strong></td>\n<td>Impulses from motor and other parts of cerebral cortex via pontine nuclei</td>\n</tr>\n<tr>\n<td><strong>Olivocerebellar</strong></td>\n<td>Proprioceptive input from whole body via relay in inferior olive</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(360, 'Physiology', 'PM0915. Functional divisions of the cerebellum', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Dorsal Spinocerebellum</strong></td>\n<td><strong>Ventral Spinocerebellum</strong></td>\n<td><strong>Cerebrocerebellum (neocerebellum)</strong></td>\n<td><strong>Vestibulocerebellum (flocculonodular lobe)&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Constituents</strong></td>\n<td>Vermis (except the nodulus)</td>\n<td>The adjacent medial portion of the hemisphere</td>\n<td>The lateral portion of hemispheres</td>\n<td>Nodulus and flocculus&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Afferent (input)</strong></td>\n<td>Somatosensory from the trunk, visual, auditory, and vestibular</td>\n<td>Somatosensory input from the limbs</td>\n<td>From the cerebral motor cortex, premotor, and somatosensory cortex</td>\n<td>&nbsp;Vestibular input, visual input, somatosensory from the neck</td>\n</tr>\n<tr>\n<td><strong>Efferent (output)</strong></td>\n<td>Via Fastigial nucleus to the medial descending system</td>\n<td>Via interposed nucleus to lateral corticospinal and rubrospinal systems</td>\n<td>Via dentate nucleus to motor, premotor and prefrontal cortex</td>\n<td>&nbsp;To vestibular nuclei in the brain stem (direct projection)</td>\n</tr>\n<tr>\n<td><strong>Functions &nbsp; &nbsp;</strong></td>\n<td>\n<p>Maintains posture and helps in the execution of gross movements</p>\n<p>It controls the interplay between agonist and antagonist group of muscles</p>\n</td>\n<td>Controls the&nbsp; distal muscles of the limbs (smoothens and coordinates movements)</td>\n<td>Planning the sequence of voluntary movements &nbsp; &nbsp;</td>\n<td>\n<p>&nbsp;Participates in maintaining equilibrium and posture</p>\n<p>&nbsp;</p>\n<p>Controls ocular movements</p>\n<p>It is responsible for regulating the stability of the head and body in space</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c0baab5ab6b74bfc9431db10c9c9fdfbx720x842.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(361, 'Physiology', 'PM0907. Forms of Memory', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>From physiologic point of view memory is divided into explicit and implicit forms.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1c881fbfcdfc4d689ab3dcd3b68aad8fx1280x802.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9629b6b0ef314e459062d7b6674917b4x1280x928.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(362, 'Physiology,', 'PM0905. Difference between  NREM and REM Sleep', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\472\>\n<tbody>\n<tr>\n<td width=\146\>\n<p><strong>Physiological Process</strong></p>\n</td>\n<td width=\177\>\n<p><strong>NREM</strong></p>\n</td>\n<td width=\149\>\n<p><strong>REM</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\146\>\n<p>Brain activity</p>\n</td>\n<td width=\177\>\n<p>Decreases from wakefulness</p>\n</td>\n<td width=\149\>\n<p>Increases in motor and sensory areas, while other areas are similar to&nbsp;NREM</p>\n</td>\n</tr>\n<tr>\n<td width=\146\>\n<p>Heart rate</p>\n</td>\n<td width=\177\>\n<p>Slows from wakefulness</p>\n</td>\n<td width=\149\>\n<p>Increases and varies compared to&nbsp;NREM</p>\n</td>\n</tr>\n<tr>\n<td width=\146\>\n<p>Blood pressure</p>\n</td>\n<td width=\177\>\n<p>Decreases from wakefulness</p>\n</td>\n<td width=\149\>\n<p>Increases (up to 30 percent) and varies from&nbsp;NREM</p>\n</td>\n</tr>\n<tr>\n<td width=\146\>\n<p>Sympathetic nerve activity</p>\n</td>\n<td width=\177\>\n<p>Decreases from wakefulness</p>\n</td>\n<td width=\149\>\n<p>Increases significantly from wakefulness</p>\n</td>\n</tr>\n<tr>\n<td width=\146\>\n<p>Muscle tone</p>\n</td>\n<td width=\177\>\n<p>Similar to wakefulness</p>\n</td>\n<td width=\149\>\n<p>Absent</p>\n</td>\n</tr>\n<tr>\n<td width=\146\>\n<p>Blood flow to brain</p>\n</td>\n<td width=\177\>\n<p>Decreases from wakefulness</p>\n</td>\n<td width=\149\>\n<p>Increases from&nbsp;NREM, depending on brain region</p>\n</td>\n</tr>\n<tr>\n<td width=\146\>\n<p>Respiration</p>\n</td>\n<td width=\177\>\n<p>Decreases from wakefulness</p>\n</td>\n<td width=\149\>\n<p>Increases and&nbsp; varies from&nbsp;NREM, but may show brief stoppages; coughing suppressed</p>\n</td>\n</tr>\n<tr>\n<td width=\146\>\n<p>Airway resistance</p>\n</td>\n<td width=\177\>\n<p>Increases from wakefulness</p>\n</td>\n<td width=\149\>\n<p>Increases and&nbsp; varies from wakefulness</p>\n</td>\n</tr>\n<tr>\n<td width=\146\>\n<p>Body temperature</p>\n</td>\n<td width=\177\>\n<p>Is regulated at lower set point than wakefulness; shivering initiated at lower temperature than during wakefulness</p>\n</td>\n<td width=\149\>\n<p>Is not regulated; no shivering or sweating; temperature drifts toward that of the local environment</p>\n</td>\n</tr>\n<tr>\n<td width=\146\>\n<p>Sexual arousal</p>\n</td>\n<td width=\177\>\n<p>Occurs infrequently</p>\n</td>\n<td width=\149\>\n<p>Greater than&nbsp;NREM</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(363, 'Physiology', 'PM0904. Neurochemical changes in Sleep-Wake Cycle', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b66dc216f1a34c7cb8b3c905e77a9949x1280x1914.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(364, 'Physiology', 'PM0903. Distribution of Sleep Stages in Young Adults', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\107\>\n<p><strong>Stage</strong></p>\n</td>\n<td width=\135\>\n<p><strong>% of Total Sleep Time</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\107\>\n<p>NREM 1</p>\n</td>\n<td width=\135\>\n<p>5</p>\n</td>\n</tr>\n<tr>\n<td width=\107\>\n<p>NREM 2</p>\n</td>\n<td width=\135\>\n<p>50-60</p>\n</td>\n</tr>\n<tr>\n<td width=\107\>\n<p>NREM 3 and 4</p>\n</td>\n<td width=\135\>\n<p>15-20</p>\n</td>\n</tr>\n<tr>\n<td width=\107\>\n<p>REM</p>\n</td>\n<td width=\135\>\n<p>20-25</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(365, 'Medicine,', 'PM0902. Stages of Arousal and Sleep', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Stage</strong></p>\n</td>\n<td>\n<p><strong>Behaviour</strong></p>\n</td>\n<td>\n<p><strong>EEG</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alert wakefulness</p>\n</td>\n<td>\n<p>Awake, alert with eyes open</p>\n</td>\n<td>\n<p><strong>Beta rhythm</strong>(14-30 Hz)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Relaxed wakefulness</p>\n</td>\n<td>\n<p>Awake, relaxed with eyes closed</p>\n</td>\n<td>\n<ul>\n<li><strong>Mainly alpha rhythm</strong> (8–13 Hz)</li>\n<li>Changes to the beta rhythm in response to internal or external stimuli.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Relaxed drowsiness</p>\n</td>\n<td>\n<ul>\n<li>Fatigued and tired</li>\n<li>The head droops, momentary lapses of attention</li>\n<li>Sleepy but not asleep</li>\n</ul>\n</td>\n<td>\n<p><strong>Decrease in alpha-wave</strong> amplitude and frequency</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NREM 1 (N1) (5%)</p>\n</td>\n<td>\n<ul>\n<li><strong>Light sleep-easily aroused</strong> by moderate stimuli or even by muscle jerks</li>\n<li>Continuous lack of awareness</li>\n</ul>\n</td>\n<td>\n<ul>\n<li><strong>Mixed frequency waves&nbsp;</strong> (predominantly 2-7 Hz).</li>\n<li>Gap in alpha rhythm is filled with theta (4–8 Hz) and delta (slower than 4 Hz) activity</li>\n<li><strong>Vertex waves</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>NREM 2 (N2) (50-60%)</p>\n</td>\n<td>\n<p>Further lack of sensitivity to activation and arousal</p>\n</td>\n<td>\n<ul>\n<li><strong>Predominant theta activity</strong> (4-7 Hz)</li>\n<li><strong>K-complex and sleep spindles</strong> occur periodically</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>NREM 3 and 4 (N3) (15-20%)</p>\n</td>\n<td>\n<ul>\n<li><strong>Deep sleep</strong></li>\n<li>Arousal only with vigorous stimuli</li>\n<li><strong>Sleep-arousal most difficult</strong></li>\n</ul>\n</td>\n<td>\n<p><strong>Delta&gt;theta activity</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>REM (paradoxical) sleep (20-25%)</p>\n</td>\n<td>\n<ul>\n<li>50–90 min after sleep onset, episodes repeated every 60–90 min, each episode lasting about 10 min</li>\n<li><strong>Dreaming occurs, rapid eye movements,</strong> increase in brain O<sub>2 </sub>consumption</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>EEG resembles that of alert awake state.</li>\n<li><strong>Saw tooth waves</strong></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Note:&nbsp;According to the new classification, stage 3 and 4 of NREM are grouped together as N3. So as per recent staging NREM has 3 stages (N1, N2, N3)</p></div><!---->\n      <!---->\n    </div><!---->'),
(366, 'Medicine,', 'PM0901. EEG Waves', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\510\>\n<tbody>\n<tr>\n<td width=\59\>\n<p><strong>EEG Waves</strong></p>\n</td>\n<td width=\69\>\n<p><strong>Frequency (in Hz)</strong></p>\n</td>\n<td width=\71\>\n<p><strong>Amplitude (in μV)</strong></p>\n</td>\n<td width=\135\>\n<p><strong>Location where it is best-recorded</strong></p>\n</td>\n<td width=\177\>\n<p><strong>Reactivity </strong></p>\n</td>\n</tr>\n<tr>\n<td width=\59\>\n<p>Alpha rhythm</p>\n</td>\n<td width=\69\>\n<p>8-13</p>\n</td>\n<td width=\71\>\n<p>50-100</p>\n</td>\n<td width=\135\>\n<p>Parieto-occipital regions</p>\n</td>\n<td width=\177\>\n<p>Adults at rest- awake but relaxed with eyes closed, wandering mind</p>\n</td>\n</tr>\n<tr>\n<td width=\59\>\n<p>Beta rhythm</p>\n</td>\n<td width=\69\>\n<p>13-30</p>\n</td>\n<td width=\71\>\n<p>5-10</p>\n</td>\n<td width=\135\>\n<p>Frontal regions</p>\n</td>\n<td width=\177\>\n<p>Adults with eyes open</p>\n</td>\n</tr>\n<tr>\n<td width=\59\>\n<p>Theta waves</p>\n</td>\n<td width=\69\>\n<p>4-8</p>\n</td>\n<td width=\71\>\n<p>&lt;200</p>\n</td>\n<td width=\135\>\n<p>Parietal and temporal regions in children;</p>\n<p>In experimental animals- hippocampus</p>\n</td>\n<td width=\177\>\n<p>Normally seen in children during moderate sleep;</p>\n<p>In adults who are in deep relaxation and meditation;</p>\n<p>Seen in excess- depression</p>\n</td>\n</tr>\n<tr>\n<td width=\59\>\n<p>Delta waves</p>\n</td>\n<td width=\69\>\n<p>0.5-4</p>\n</td>\n<td width=\71\>\n<p>20-200 (large amplitude)</p>\n</td>\n<td width=\135\>\n<p>Occipito-temporal</p>\n</td>\n<td width=\177\>\n<p>Deep sleep;</p>\n<p>Appearance in awake state- Organic brain damage</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(367, 'Medicine,', 'PM0840. Features of Motor Neuron Lesions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\239\>\n<p><strong>Upper Motor Neuron Lesion</strong></p>\n</td>\n<td width=\239\>\n<p><strong>Lower Motor Neuron Lesion</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Upper motor neuron typically refer to corticospinal tract neurons that innervate spinal motor neurons, but they can also include brainstem neurons that control spinal motor neurons</p>\n</td>\n<td width=\239\>\n<p>Lower motor neurons are those whose axons terminate on skeletal muscles</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Little or no muscle wasting&nbsp;→ weakness of relatively large group of muscles</p>\n</td>\n<td width=\239\>\n<p>Muscle atrophy → muscle weakness of an individual and specific muscle</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Hypertonia</p>\n</td>\n<td width=\239\>\n<p>Hypotonia</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Increased or exaggerated deep tendon reflexes (hyperreflexia)</p>\n</td>\n<td width=\239\>\n<p>Hyporeflexia or areflexia</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Spasticity</p>\n</td>\n<td width=\239\>\n<p>Flaccidity</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Positive Babinski sign (abnormal plantar extensor reflex)</p>\n</td>\n<td width=\239\>\n<p>Fasciculations</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(368, 'Physiology', 'PM0838. Postural Reflexes and Centres', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Reflexes</strong></p>\n</td>\n<td>\n<p><strong>Integrated in</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stretch reflex</p>\n<p>Positive supporting reaction</p>\n<p>Negative supporting reaction</p>\n</td>\n<td>\n<p>Spinal cord</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tonic labyrinthine and tonic neck reflexes (Antigravity reflexes, attitudinal reflexes)</p>\n</td>\n<td>\n<p>Medulla</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Righting reflexes (except optical righting reflexes)</p>\n<p>Labyrinthine righting reflexes</p>\n<p>Neck righting reflexes</p>\n<p>Body on head righting reflexes</p>\n<p>Body on body righting reflexes</p>\n</td>\n<td>\n<p>Midbrain</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Conditioned reflex</p>\n<p>Optical righting reflexes</p>\n<p>Hopping and placing reaction</p>\n</td>\n<td>\n<p>Cortex</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(369, 'Physiology', 'PM0837. Summary of Muscle Reflexes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Reflex</strong></p>\n</td>\n<td>\n<p><strong>Number of synapses</strong></p>\n</td>\n<td>\n<p><strong>Stimulus</strong></p>\n</td>\n<td>\n<p><strong>Afferent fibers</strong></p>\n</td>\n<td>\n<p><strong>Response</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stretch reflex</p>\n<p>(knee-jerk)</p>\n</td>\n<td>\n<p>Monosynaptic</p>\n</td>\n<td>\n<p>Muscle is stretched</p>\n</td>\n<td>\n<p>Ia</p>\n</td>\n<td>\n<p>Contraction of the muscle</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Golgi tendon reflex/ Inverse stretch reflex (clasp-knife)</p>\n</td>\n<td>\n<p>Disynaptic</p>\n</td>\n<td>\n<p>Muscle contraction</p>\n</td>\n<td>\n<p>Ib</p>\n</td>\n<td>\n<p>Relaxation of muscle</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Flexor-withdrawal reflex (after touching a hot stove)</p>\n</td>\n<td>\n<p>Polysynaptic</p>\n</td>\n<td>\n<p>Pain</p>\n</td>\n<td>\n<p>II, III, and IV</p>\n</td>\n<td>\n<p>Ipsilateral flexion; contralateral extension</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(370, 'ENT,', 'PM0836. Central Auditory Pathway', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a62bcecbf06942c5be3d165abac9655cx1280x2105.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>E.Coli - MA</strong> (mnemonic)</p>\n<p><strong>E</strong>ighth nerve&nbsp;</p>\n<p><strong>C</strong>ochlear nuclei&nbsp;</p>\n<p><strong>O</strong>livary complex&nbsp;</p>\n<p><strong>L</strong>ateral lemniscus&nbsp;</p>\n<p><strong>I</strong>nferior colliculus&nbsp;</p>\n<p><strong>M</strong>edial geniculate body&nbsp;</p>\n<p><strong>A</strong>uditory cortex</p>\n<p>Most of the primary auditory cortex is in the temporal lobe, but the association cortices extend over much of the insular lobe and even onto the lateral portion of the parietal lobe.</p></div><!---->\n      <!---->\n    </div><!---->'),
(371, 'Physiology', 'PM0834. Properties of Rod Vision and Cone Vision', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Rods</td>\n<td>Cones</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>120 million</li>\n<li>More in peripheral retina</li>\n<li>High sensitivity</li>\n<li>Night vision (Scotopic vision)</li>\n<li>Low acuity</li>\n<li>Gray colour vision (achromatic vision)</li>\n<li>On activation produces hyperpolarising current</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>6 million in number</li>\n<li>More Concentrated in fovea</li>\n<li>Low sensitivity</li>\n<li>Day vision (Photopic vision)</li>\n<li>High acuity</li>\n<li>Colour vision (Chromatic vision)</li>\n<li>On activation produces hyperpolarising current</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/17d09d85563542a39727b8a060b7747fx1280x2558.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(372, 'Ophthalmology,', 'PM0833. Differences between Rods and Cones', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2e0bcea6190f41a8a96d5b7e9f3ed74fx490x475.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(373, 'Ophthalmology,', 'PM0789. Order of neurons in the visual pathway', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Order of neurons in the visual pathway</strong></td>\n</tr>\n<tr>\n<td>\n<p>First-order neurons</p>\n</td>\n<td>\n<p>Photoreceptors <br>(<strong>rods and cones</strong>)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Second-order neurons</p>\n</td>\n<td>\n<p><strong>Bipolar cells</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Third-order neurons</p>\n</td>\n<td>\n<p>Ganglion cells <br>(<strong>optic nerve</strong>)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fourth-order neurons</p>\n</td>\n<td>\n<p>Axons from the lateral geniculate body <br>(<strong>optic radiation</strong>)</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cdcd5b915c494c13b1a523d97fa017b0x1280x1418.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(374, 'Physiology', 'PM0770. Dual Pain Pathway', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Features</strong></p>\n</td>\n<td>\n<p><strong>Neo Spinothalamic Tract</strong></p>\n</td>\n<td>\n<p><strong>Paleo Spinothalamic Tract</strong>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Conduction Velocity</p>\n</td>\n<td>\n<p>Fast (6 to 30 m/s)</p>\n</td>\n<td>\n<p>Slow (0.5 to 2 m/s)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nociceptor</p>\n</td>\n<td>\n<p>Aδ</p>\n</td>\n<td>\n<p>C</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neurotransmitter</p>\n</td>\n<td>\n<p>Glutamate</p>\n</td>\n<td>\n<p>Substance P</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Major relay of second order neuron</p>\n</td>\n<td>\n<p>Thalamus</p>\n</td>\n<td>\n<p>Reticular Nuclei, Tectum, periaqueductal region</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thalamic Nucleus</p>\n</td>\n<td>\n<p>Ventrobasal complex</p>\n</td>\n<td>\n<p>Intralaminar Nucleus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Projections of third order neuron</p>\n</td>\n<td>\n<p>Somatosensory cortex</p>\n</td>\n<td>\n<p>Frontal lobe, Limbic cortex, Insula</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Localisation</p>\n</td>\n<td>\n<p>Good when stimulated with Dorsal column pathway</p>\n</td>\n<td>\n<p>Poor</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Function</p>\n</td>\n<td>\n<p>Perception of Discriminative aspect of pain</p>\n</td>\n<td>\n<p>Perception of Affect component of pain</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(375, 'Physiology', 'PM0764. Somatosensory Pathways', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Dorsal Column-Medial Lemniscal System</td>\n<td>Anterolateral System</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Fine touch</li>\n<li>Tactile localisation</li>\n<li>Two-point discrimination</li>\n<li>Proprioception</li>\n<li>Pressure sensations related to fine degrees of judgement of pressure intensity</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Pain</li>\n<li>Thermal sensations</li>\n<li>Crude touch and pressure sensations</li>\n<li>Itch and tickle sensations</li>\n<li>Sexual sensations</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->'),
(376, 'Physiology', 'PM0728. Cutaneous Mechanoreceptor Systems', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\526\>\n<tbody>\n<tr>\n<td width=\131\>\n<p><strong>Receptor </strong></p>\n</td>\n<td width=\90\>\n<p>Merkel’s disc</p>\n</td>\n<td width=\108\>\n<p>Meissner corpuscle</p>\n</td>\n<td width=\99\>\n<p>Ruffini end organ</p>\n</td>\n<td width=\99\>\n<p>Pacinian corpuscle</p>\n</td>\n</tr>\n<tr>\n<td width=\131\>\n<p><strong>Location</strong></p>\n</td>\n<td width=\90\>\n<p>Tip of epidermis(Basal keratinocytes)</p>\n</td>\n<td width=\108\>\n<p>Dermal papillae</p>\n</td>\n<td width=\99\>\n<p>Dermis</p>\n</td>\n<td width=\99\>\n<p>Dermis</p>\n</td>\n</tr>\n<tr>\n<td width=\131\>\n<p><strong>Best stimuli</strong></p>\n</td>\n<td width=\90\>\n<p>&nbsp;</p>\n<p>Sustained pressure and touch<span class=\Apple-converted-space\>&nbsp;</span></p>\n</td>\n<td width=\108\>\n<p>&nbsp;</p>\n<p>Slow vibration<span class=\Apple-converted-space\>&nbsp;</span></p>\n</td>\n<td width=\99\>\n<p>&nbsp;</p>\n<p>Stretch and fluttering vibration<span class=\Apple-converted-space\>&nbsp;</span></p>\n</td>\n<td width=\99\>\n<p>&nbsp;</p>\n<p>Fast vibration and deep pressure<span class=\Apple-converted-space\>&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td width=\131\>\n<p><strong>Adaptation </strong></p>\n</td>\n<td width=\90\>\n<p>Slow</p>\n</td>\n<td width=\108\>\n<p>Rapid</p>\n</td>\n<td width=\99\>\n<p>Slow</p>\n</td>\n<td width=\99\>\n<p>Rapid</p>\n</td>\n</tr>\n<tr>\n<td width=\131\>\n<p><strong>Best frequency</strong></p>\n</td>\n<td width=\90\>\n<p>5</p>\n</td>\n<td width=\108\>\n<p>50</p>\n</td>\n<td width=\99\>\n<p>-</p>\n</td>\n<td width=\99\>\n<p>200</p>\n</td>\n</tr>\n<tr>\n<td width=\131\>\n<p><strong>Threshold for vibration</strong></p>\n</td>\n<td width=\90\>\n<p>8</p>\n</td>\n<td width=\108\>\n<p>2</p>\n</td>\n<td width=\99\>\n<p>40</p>\n</td>\n<td width=\99\>\n<p>0.01</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(377, 'Physiology', 'PM0727. Classification of Senses based on Type of Receptors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Types of Receptors</td>\n</tr>\n<tr>\n<td>MECHANORECEPTORS</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Pacinian corpuscles,</li>\n<li>Meissners corpuscles</li>\n<li>Merkels discs</li>\n<li>Golgi Tendon and Muscle spindles</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>THERMORECEPTORS</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Warm and Cold Receptors</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>NOCICEPTORS</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Free nerve endings</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>ELECTROMAGNETIC RECEPTORS</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Rods and Cons</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>CHEMORECEPTORS</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Olfactory and gustatory receptors</li>\n<li>Receptors of aortic and carotid bodies</li>\n<li>Receptors in hypothalamus for Blood Glucose</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->'),
(378, 'Physiology', 'PM0725. Classification of Sense based on source of Stimulus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\517\>\n<tbody>\n<tr>\n<td colspan=\2\>Receptor Classification</td>\n</tr>\n<tr>\n<td>INTEROCEPTORS</td>\n<td>Baroreceptors</td>\n</tr>\n<tr>\n<td>EXTEROCEPTORS</td>\n<td>Touch receptors</td>\n</tr>\n<tr>\n<td>TELECEPTORS</td>\n<td>Rods &amp; Cones</td>\n</tr>\n<tr>\n<td>PROPRIOCEPTOS</td>\n<td>Muscle spindle &amp; Golgi tendon organs</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(379, 'Physiology,', 'PM0686. Opioid Receptors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>Receptor</strong></p>\n</td>\n<td>\n<p><strong>Effect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>μ</strong></p>\n</td>\n<td>\n<p>Miosis</p>\n<p>Urine retention</p>\n<p>Sedation</p>\n<p>Slowed GI transit - constipation</p>\n<p>Supraspinal and spinal analgesia</p>\n<p>Respiratory depression</p>\n<p>Muscular rigidity</p>\n<p>Euphoria&nbsp;</p>\n<p>Modulation of hormone and neurotransmitter release</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>δ</strong></p>\n</td>\n<td>\n<p>Supraspinal and spinal analgesia&nbsp;</p>\n<p>Modulation of hormone<br>and neurotransmitter release</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>κ</strong></p>\n</td>\n<td>\n<p>Slowed GI transit - constipation</p>\n<p>Supraspinal and spinal analgesia</p>\n<p>Psychotomimetic effect- Dysphoria</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(380, 'Physiology', 'PM0685. Neurotransmitter and Location of their Nuclear Group', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Neurotransmitter</strong></p>\n</td>\n<td>\n<p><strong>Location of their nuclear group</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Norepinephrine</p>\n</td>\n<td>\n<p>Locus coeruleus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Serotonin</p>\n</td>\n<td>\n<p>Raphe nuclei</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dopamine</p>\n</td>\n<td>\n<p>Substantia nigra and ventral tegmental area</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acetylcholine</p>\n</td>\n<td>\n<p>Basal forebrain complex</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GABA</p>\n</td>\n<td>\n<p>Nucleus accumbens</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histamine</p>\n</td>\n<td>\n<p>Hypothalamus</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(381, 'Physiology', 'PM0684. Neurotransmitters and Type of Receptor', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Neurotransmitter </strong></p>\n</td>\n<td>\n<p><strong>Receptor </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glutamate</p>\n</td>\n<td>\n<p>Ligand-gated ion channel-kainate,&nbsp;NMDA, AMPA</p>\n<p>Metabotropic (mGluR)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GABA</p>\n</td>\n<td>\n<p>Ligand-gated (GABA A and GABA C)</p>\n<p>GPCR (GABA B)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acetylcholine</p>\n</td>\n<td>\n<p>Muscarinic – GPCR</p>\n<p>Nicotinic – Ligand</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Norepinephrine</p>\n</td>\n<td>\n<p>GPCR</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Serotonin</p>\n</td>\n<td>\n<p>GPCR (except 5HT3 which is ligand gated)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dopamine</p>\n</td>\n<td>\n<p>GPCR</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(382, 'Physiology', 'PM0683. Neurotransmitter and Catabolic Enzymes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Neurotransmitter&nbsp;</strong></td>\n<td><strong>Major enzymes&nbsp;</strong></td>\n<td><strong>Major final end product&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Epinephrine, norepinephrine, dopamine</td>\n<td>Monoamine oxidase, Catecholamine-o-methyltransferase&nbsp;</td>\n<td>Vanillyl mandelate(VMA)&nbsp;</td>\n</tr>\n<tr>\n<td>serotonin, dopamine</td>\n<td>Monoamine oxidase&nbsp;</td>\n<td>5-Hydroxy indole acetic acid(5-HIAA)&nbsp;</td>\n</tr>\n<tr>\n<td>Histamine&nbsp;</td>\n<td>Diamine oxidase, N-Methyltransferase&nbsp;</td>\n<td>Imidazoleacetic acid, N-methylimidazole-acetic acid&nbsp;</td>\n</tr>\n<tr>\n<td>GABA&nbsp;</td>\n<td>Aminotransferase&nbsp;</td>\n<td><strong>Succinate&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Acetylcholine</td>\n<td>&nbsp;Acetylcholine esterase</td>\n<td>&nbsp;choline</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Clinical importance:</strong></p>\n<p class=\redesignmargintopadded\>5-HIAA testing is a 24-hour urine test that is&nbsp;<strong>specific to carcinoid tumors</strong>.&nbsp;This test is the most common biochemical test for carcinoid tumors associated with carcinoid syndrome.</p>\n<p class=\redesignmargintopadded\>Symptoms like secretory diarrhoea and valvular heart disease in carcinoid syndrome are due to serotonin.</p></div><!---->\n      <!---->\n    </div><!---->'),
(383, 'Physiology', 'PM0682. Acetyl Choline Receptors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\212\>\n<p><strong>Type</strong></p>\n</td>\n<td width=\213\>\n<p><strong>Location</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\425\>\n<p><strong>Nicotinic (ionotropic) receptors</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\212\>\n<p>N<sub>M</sub></p>\n</td>\n<td width=\213\>\n<p>Neuromuscular junction</p>\n</td>\n</tr>\n<tr>\n<td width=\212\>\n<p>N<sub>N</sub></p>\n</td>\n<td width=\213\>\n<p>Autonomic ganglia</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\425\>\n<p><strong>Muscarinic (metabotropic) receptors</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\212\>\n<p>M<sub>1</sub>, M<sub>4</sub>, M<sub>5</sub></p>\n</td>\n<td width=\213\>\n<p>CNS</p>\n</td>\n</tr>\n<tr>\n<td width=\212\>\n<p>M<sub>2</sub></p>\n</td>\n<td width=\213\>\n<p>Heart</p>\n</td>\n</tr>\n<tr>\n<td width=\212\>\n<p>M<sub>3</sub></p>\n</td>\n<td width=\213\>\n<p>Glands and smooth muscle</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(384, 'Physiology', 'PM0680. Differences between Chemical and Electrical Synapses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\144\>\n<p><strong>Property</strong></p>\n</td>\n<td width=\141\>\n<p><strong>Chemical Synapse</strong></p>\n</td>\n<td width=\140\>\n<p><strong>Electrical Synapse</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p><strong>Distance between pre- and post-synaptic membranes</strong></p>\n</td>\n<td width=\141\>\n<p>20-40 nm</p>\n</td>\n<td width=\140\>\n<p>4nm</p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p><strong>Cytoplasmic continuity between pre- and post-synaptic cells</strong></p>\n</td>\n<td width=\141\>\n<p>No</p>\n</td>\n<td width=\140\>\n<p>Yes</p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p><strong>Ultrastructural components</strong></p>\n</td>\n<td width=\141\>\n<p>Presynaptic vesicles and active zones; post synaptic receptors</p>\n</td>\n<td width=\140\>\n<p>Gap junctions</p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p><strong>Agents of transmission</strong></p>\n</td>\n<td width=\141\>\n<p>Chemical transmitter</p>\n</td>\n<td width=\140\>\n<p>Ion current</p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p><strong>Synaptic delay</strong></p>\n</td>\n<td width=\141\>\n<p>Significant: atleast 0.3 ms, usually 1-5 ms or longer</p>\n</td>\n<td width=\140\>\n<p>Virtually absent</p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p><strong>Direction of transmission</strong></p>\n</td>\n<td width=\141\>\n<p>Unidirectional</p>\n</td>\n<td width=\140\>\n<p>Usually bidirectional</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(385, 'Physiology,', 'PM0406. Oculocardiac Reflex', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Traction on the extraocular muscles or pressure on the globe causes bradycardia, atrioventricular block, ventricular ectopy, or asystole.</p>\n<p>In particular, it is seen with traction on the <strong>medial rectus</strong> muscle, but it can occur with stimulation of any of the orbital contents, including the periosteum.</p>\n<p><strong>Reflex arc involves</strong>-</p>\n<ul>\n<li>Afferent: Orbital contents to ciliary ganglion to ophthalmic division of the <strong>trigeminal nerve</strong> to the sensory nucleus of trigeminal</li>\n<li>Efferent: <strong>Vagus nerve</strong> to the heart.</li>\n</ul>\n<p><strong>Procedures evoking the reflex-</strong></p>\n<ul>\n<li><strong>Strabismus surgery</strong> in the paediatric age (most common)&nbsp;</li>\n<li>Cataract extraction</li>\n<li>Enucleation</li>\n<li>Retinal detachment repair.</li>\n</ul>\n<p><strong>Management-</strong></p>\n<ul>\n<li>Temporary cessation of surgical stimulation until heart rate increases</li>\n<li>Adequate ventilation, oxygenation, and depth of anaesthesia</li>\n<li><strong>IV atropine</strong> (10 mcg/kg) if bradycardia persists</li>\n<li>In recalcitrant episodes, local anaesthetic infiltration of the rectus muscles.</li>\n</ul>\n<p>Pretreatment with intravenous <strong>atropine</strong> or<strong> glycopyrrolate</strong> can be effective in preventing this condition.</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(386, 'Psychiatry,', 'PM0380. Events occurring in NREM and REM sleep', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Events occurring during <strong>NREM&nbsp;stages 3 and 4</strong>:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Events</strong></span></p>\n</td>\n<td>\n<p><span><strong>Description</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Somnambulism</strong></span></p>\n</td>\n<td>\n<p><span>Sleepwalking</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Sleep terror or Night terror</strong></span></p>\n</td>\n<td>\n<p><span>Also called pavor nocturnus.</span></p>\n<p><span>Awakens with a scream or intense anxiety. Has increased autonomic disturbances.</span></p>\n<p><span>They do not have a memory of this when they wake up.</span></p>\n<p><span>Runs in families and seen more frequently in childhood and boys.</span></p>\n<p><span>Treatment with benzodiazepines is rarely required.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Nocturnal enuresis</strong></span></p>\n</td>\n<td>\n<p><span>Behavioral therapy is the mainstay.</span></p>\n<p><span>Drugs like desmopressin and imipramine are used.</span></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>Events occurring in <strong>REM sleep</strong>:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Events</strong></span></p>\n</td>\n<td>\n<p><span><strong>Description</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Nightmares</strong></span></p>\n</td>\n<td>\n<p><span>Fearful sleep without autonomic disturbances that are well remembered in the morning.</span></p>\n<p><span>TCAs may be used for treatment.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Nocturnal penile tumescence</strong></span></p>\n</td>\n<td>\n<p><span>A normal phenomenon that can be used to differentiate between psychogenic and organic impotence.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Narcolepsy</strong></span></p>\n</td>\n<td>\n<p><span>A disorder of the REM sleep characterized by disturbed sleep in the night, leading to excessive sleep in the morning.</span></p>\n<p><span>Associated with symptoms such as cataplexy, hypnogogic and hypnopompic hallucination, and sleep paralysis.</span></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;<strong>*Hypnogogic hallucinations</strong> are those that occur at the start of sleep and <strong>hypnopompic hallucinations</strong> are those that occur at the end of sleep.</p>\n<p>&nbsp;</p>\n<p>Others:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Events</strong></span></p>\n</td>\n<td>\n<p><span><strong>Description</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Bruxism&nbsp;</strong>(teeth grinding)</span></p>\n</td>\n<td>\n<p><span>Occurs in stage 2 NREM sleep.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Frontal lobe epilepsy</strong></span></p>\n</td>\n<td>\n<p><span>Occurs in stage 2 NREM sleep.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Sleep talking</strong></span></p>\n</td>\n<td>\n<p><span>Occurs in all stages of sleep and may accompany night terrors and sleepwalking.</span></p>\n<p><span>Common in children.</span></p>\n<p><span>No treatment is necessary.</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(387, 'Physiology', 'PM0200. Effect of the Autonomic Nervous System on Heart', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\141\>\n<p><strong>ANS</strong></p>\n</td>\n<td colspan=\2\ width=\285\>\n<p><strong>Effects</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\141\>\n<p>Right vagus</p>\n</td>\n<td width=\142\>\n<p>Inhibits SA node</p>\n</td>\n<td width=\143\>\n<p>Decreases the heart rate</p>\n</td>\n</tr>\n<tr>\n<td width=\141\>\n<p>Left vagus</p>\n</td>\n<td width=\142\>\n<p>Inhibits AV node</p>\n</td>\n<td width=\143\>\n<p>Slow AV conduction</p>\n</td>\n</tr>\n<tr>\n<td width=\141\>\n<p>Right Stellate ganglion</p>\n</td>\n<td width=\142\>\n<p>Stimulates SA node</p>\n</td>\n<td width=\143\>\n<p>Increases the heart rate</p>\n</td>\n</tr>\n<tr>\n<td width=\141\>\n<p>Left stellate ganglion</p>\n</td>\n<td width=\142\>\n<p>Stimulate AV node</p>\n</td>\n<td width=\143\>\n<p>Shortened AV conduction time</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(388, 'Pharmacology,', 'PM0093. Basics of autonomic nervous system', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Autonomic nervous system</strong></span></td>\n<td><span><strong>Para-sympathetic system</strong></span></td>\n<td><span><strong>Sympathetic system</strong></span></td>\n</tr>\n<tr>\n<td><span>Outflow</span></td>\n<td>\n<div><span>Cranio-sacral</span></div>\n<ul>\n<li>\n<div><span>Cranial nerve nuclei - III, VII, IX, X</span></div>\n</li>\n<li>\n<div><span>Sacral segments - S2 to S4</span></div>\n</li>\n</ul>\n</td>\n<td><span>Thoraco-lumbar</span>\n<ul>\n<li><span>T1 - L2</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Pre-ganglionic receptor</span></td>\n<td><span>N<sub>n</sub> (Nicotinic neuronal)</span></td>\n<td><span>N<sub>n</sub></span></td>\n</tr>\n<tr>\n<td>\n<p><span>Pre-ganglionic neurotransmitter&nbsp;</span><span>(from CNS)</span></p>\n</td>\n<td><span>Acetylcholine</span></td>\n<td><span>Acetylcholine</span></td>\n</tr>\n<tr>\n<td><span>Post-ganglionic receptors</span></td>\n<td><span>Muscarinic or Nicotinic</span></td>\n<td><span>Alpha or Beta</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Post-Ganglionic neurotransmitter&nbsp;</span><span>(to the organ)</span></p>\n</td>\n<td><span>Acetylcholine</span></td>\n<td><span>Nor-epinephrine</span><br><span>Exceptions</span>\n<ul>\n<li><span>Renal system-Dopamine</span></li>\n<li><span>Sweat and adrenal glands - Acetylcholine</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Features</span></td>\n<td>\n<ul>\n<li><span>The ganglion is located closer to the effector organ</span></li>\n<li><span>Pre-ganglionic fibers are longer</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><span>The ganglion is located closer to the spinal cord</span></li>\n<li><span>Post-ganglionic fibers are longer</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><span>Note: The nerve roots arising from the CNS are all nicotinic cholinergic.</span></p></div><!---->\n      <!---->\n    </div><!---->'),
(389, 'Physiology', 'PM1835. Flow-volume graph/Loop', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0d448a20301a4373b39e03a726675434x1280x3207.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><!---->'),
(390, 'Medicine,', 'PM1012. Pulmonary surfactant', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It <strong>lowers</strong> the surface <strong>tension</strong> of the&nbsp;water layer at the alveolar surface, which <strong>increases</strong> lung <strong>compliance</strong>, thereby making it easier for the lungs to expand.&nbsp;It is secreted by<strong> type II</strong> alveolar cells. It is a mixture of phospholipids and protein.</p>\n<p>4 unique apoproteins of surfactant: Surfactant proteins are (SP)-A, SP-B, SP-C, and SP-D.</p>\n<ul>\n<li><strong>SP-A</strong> - Regulation of the feedback uptake of surfactant by the type II alveolar epithelial cells that secrete it.</li>\n<li><strong>SP-B &amp; SP-C</strong> - Key protein members of the monomolecular film of surfactant.</li>\n<li><strong>SP-D</strong> - Organization of SP-B and SP-C into the surfactant layer.</li>\n</ul>\n<p>A deep breath increases its secretion by stretching the type II cells. Its concentration decreases when breaths are small.</p>\n<p>In the fetus, surfactant synthesis is variable. The surfactant may be present as early as gestational week 24 and is almost always present by gestational <strong>week 35.</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(391, 'Medicine,', 'PM1010. Lung volumes and capacities', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>Measurement</strong></p>\n</td>\n<td>\n<p><strong>Description</strong></p>\n</td>\n<td>\n<p><strong>Normal Value</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Tidal volume (TV)</strong></p>\n</td>\n<td>\n<p>The amount of air that moves into the lungs with each inspiration (or the amount that moves out with each expiration) during quiet breathing</p>\n</td>\n<td>\n<p>500–750 mL.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inspiratory reserve volume&nbsp;</strong><strong>(IRV)</strong></p>\n</td>\n<td>\n<p>The air inspired with a maximal inspiratory effort in excess of the TV</p>\n</td>\n<td>\n<p>∼3 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Expiratory reserve volume (ERV)</strong></p>\n</td>\n<td>\n<p>The volume expelled by an active expiratory effort after passive expiration</p>\n</td>\n<td>\n<p>∼1.1 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Residual volume (RV)</strong></p>\n</td>\n<td>\n<p>The air left in the lungs after a maximal expiratory effort</p>\n</td>\n<td>\n<p>∼1.2 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Total lung capacity (TLC)</strong></p>\n</td>\n<td>\n<p>IRV+TV+ERV+RV</p>\n</td>\n<td>\n<p>∼5.8 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Vital capacity (VC)</strong></p>\n</td>\n<td>\n<p>IRV+TV+ERV</p>\n</td>\n<td>\n<p>∼4.5 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inspiratory capacity (IC)</strong></p>\n</td>\n<td>\n<p>TV+IRV</p>\n</td>\n<td>\n<p>∼3.5 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Expiratory capacity (EC)</strong></p>\n</td>\n<td>\n<p>TV+ERV</p>\n</td>\n<td>\n<p>∼1.6 L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Functional residual capacity (FRC)</strong></p>\n</td>\n<td>\n<p>ERV+RV</p>\n</td>\n<td>\n<p>∼2.3 L</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/06c833b7f0ac40998f328de5bbe2816bx1279x973.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(392, 'Medicine,', 'PM1009. Acclimatization to high altitude', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/07859b7f9cce4e0ab7654ab13244b120x1061x606.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(393, 'Medicine,', 'PM1008. Characteristics of different types of Hypoxia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>Hypoxic</strong></p>\n</td>\n<td>\n<p><strong>Anaemic</strong></p>\n</td>\n<td>\n<p><strong>Stagnant</strong></p>\n</td>\n<td>\n<p><strong>Histotoxic</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Etiology</strong></p>\n</td>\n<td>\n<p>↓ in paO<sub>2</sub></p>\n</td>\n<td>\n<p>↓ in available Hb</p>\n</td>\n<td>\n<p>O<sub>2</sub> carrying capacity is normal but O<sub>2</sub> delivery is decreased</p>\n</td>\n<td>\n<p>No O<sub>2</sub> utilization at tissue level</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Examples</strong></p>\n</td>\n<td>\n<p>High altitude, lung disease</p>\n</td>\n<td>\n<p>Anemia, CO poisoning</p>\n</td>\n<td>\n<p>Heart failure, shock, Haemorrhage</p>\n</td>\n<td>\n<p>Cyanide Poisoning</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>paO<sub>2</sub></strong></p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Dissolved O<sub>2 </sub>content</strong></p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>O<sub>2</sub> combined with Hb</strong></p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Chemoreceptor stimulation</strong></p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>Not stimulated</p>\n</td>\n<td>\n<p>+++</p>\n</td>\n<td>\n<p>+++</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Amount of reduced Hb</strong></p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>Total Hb↓, HHb↑</p>\n</td>\n<td>\n<p>↑↑↑</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cyanosis </strong></p>\n</td>\n<td>\n<p>Can be present</p>\n</td>\n<td>\n<p>Unlikely</p>\n</td>\n<td>\n<p>Can be present</p>\n</td>\n<td>\n<p>unlikely</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(394, 'Physiology', 'PM1001. Respiratory responses to exercise', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\395\>\n<tbody>\n<tr>\n<td width=\165\>\n<p><strong>Parameter</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Response</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\165\>\n<p>O<sub>2</sub> consumption</p>\n</td>\n<td width=\231\>\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td width=\165\>\n<p>CO<sub>2</sub> production</p>\n</td>\n<td width=\231\>\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td width=\165\>\n<p>Ventilation rate</p>\n</td>\n<td width=\231\>\n<p>↑ (matches O<sub>2</sub> consumption/CO<sub>2</sub> production)</p>\n</td>\n</tr>\n<tr>\n<td width=\165\>\n<p>Arterial Po<sub>2</sub> and Pco<sub>2</sub></p>\n</td>\n<td width=\231\>\n<p>No change</p>\n</td>\n</tr>\n<tr>\n<td width=\165\>\n<p>Arterial pH</p>\n</td>\n<td width=\231\>\n<p>No change in moderate exercise</p>\n<p>↓ in strenuous exercise (lactic acidosis)</p>\n</td>\n</tr>\n<tr>\n<td width=\165\>\n<p>Venous Pco<sub>2</sub></p>\n</td>\n<td width=\231\>\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td width=\165\>\n<p>Pulmonary blood flow (cardiac output)</p>\n</td>\n<td width=\231\>\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td width=\165\>\n<p>V/Q ratios</p>\n</td>\n<td width=\231\>\n<p>More evenly distributed in lung</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(395, 'Physiology,', 'PM0996. Factors affecting 2,3 -DPG', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>↑ in 2, 3-DPG</strong></td>\n<td><strong>↓ in 2, 3-DPG</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Chronic hypoxia</li>\n<li>Anemia</li>\n<li>Acclimitization (high altitude)</li>\n<li>Thyroid hormone</li>\n<li>Growth hormone</li>\n<li>Androgens</li>\n<li>Exercise</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Stored blood</li>\n<li>Acidosis</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(396, 'Physiology', 'PM0983. Structure of Airways', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\755\>\n<tbody>\n<tr>\n<td>\n<p><strong>Features</strong></p>\n</td>\n<td>\n<p><strong>Trachea </strong></p>\n</td>\n<td>\n<p><strong>Bronchi&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>Terminal bronchioles </strong></p>\n</td>\n<td>\n<p><strong>Respiratory bronchioles </strong></p>\n</td>\n<td>\n<p><strong>Alveoli </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cartilage </strong></p>\n</td>\n<td>\n<p>Present</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Smooth muscle </strong></p>\n</td>\n<td>\n<p>Little</p>\n</td>\n<td>\n<p>Little</p>\n</td>\n<td>\n<p>Maximum</p>\n</td>\n<td>\n<p>More</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Epithelium </strong></p>\n</td>\n<td>\n<p>Pseudostratified ciliated columnar epithelium</p>\n</td>\n<td>\n<p>Pseudostratified ciliated columnar epithelium</p>\n</td>\n<td>\n<p>Ciliated Cuboidal epithelium</p>\n</td>\n<td>\n<p>Ciliated cuboidal epithelium</p>\n</td>\n<td>\n<p>Non-ciliated simple squamous epithelium</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Secretory glands </strong></p>\n</td>\n<td>\n<p>Present</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(397, 'Physiology', 'PM0113. Zones of Pulmonary Blood Flow', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Zone 1</strong></p>\n<p><strong>Zero perfusion </strong></p>\n<ul>\n<li>Does not exist in normal lungs.</li>\n<li>Occurs when the Pulmonary arterial pressure becomes less than alveolar air pressure.</li>\n<li>Pulmonary capillaries become collapsed.</li>\n</ul>\n<p><strong>Zone 2</strong></p>\n<p><strong>Intermittent blood flow </strong></p>\n<ul>\n<li>This occurs during systole when the pulmonary arterial pressure raises more than alveolar air pressure.</li>\n<li>In normal lungs, this zone occurs from apex to hilum of the lungs.</li>\n</ul>\n<p><strong>Zone 3</strong></p>\n<p><strong>Continuous blood flow </strong></p>\n<ul>\n<li>Here pulmonary arterial pressure is greater than alveolar air pressure during the entire cardiac cycle.</li>\n<li>In normal lungs, this zone occurs from the middle zone of lungs to base.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(398, 'Physiology', 'PM0105. Physiological significance of Hering-Breuer inflation and deflation reflex', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Advantage of Hering-Breuer inflation reflex</strong></p>\n<ul>\n<li>By cutting down the inspiration time-\n<ul>\n<li>Prevents overinflation of the lungs</li>\n<li>Lungs operate at lower lung volumes thus wastage of energy is prevented</li>\n</ul>\n</li>\n</ul>\n<p><strong>Advantage of Hering-Breuer deflation reflex</strong></p>\n<ul>\n<li>Prevents atelectasis of the lungs</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(399, 'Physiology', 'PM0104. Respiratory responses mediated by airway and lung receptors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/38e7d7cee2ab441caecb6c037e97f626x833x612.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(400, 'Physiology', 'PM0103. Side effect of opioids on Respiration', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>There are NK1 receptors and μ-opioid receptors on the neurons of pre-BOTC (pre-Bötzinger complex), and substance P stimulates and opioids inhibit respiration by acting on them. Thus, depression of respiration is a side effect that limits the use of opioids in the treatment of pain.</p></div><!---->\n      <!---->\n    </div><!---->'),
(401, 'Physiology', 'PM0096. Oxygen myoglobin dissociation curve', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The shape of O2-myoglobin dissociation curve is a rectangular hyperbola. It lies to the left of OHDC.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(402, 'Physiology', 'PM0095. P50', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>P<sub>50</sub>= the partial pressure of oxygen at which Hb is 50% saturated. Its value is about 26mmHg</p>\n<p>When the oxygen hemoglobin dissociation curve shifts to the right, P<sub>50</sub> increases.</p>\n<p>Or in other words, higher the P<sub>50</sub>, lower is the affinity of Hemoglobin for O<sub>2.</sub></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/59e08c6c2d5c4a5ea66fb8e49162cc29x934x712.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(403, 'Physiology', 'PM0090. Hyaline membrane disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;Infant Respiratory Distress Syndrome(IRDS):</p>\n<ul>\n<li>Surfactant deficiency is an important cause of I<strong>nfant respiratory distress syndrome (IRDS)</strong> also known as <strong>hyaline membrane disease</strong>&nbsp;develops in infants born before their surfactant system is functional.</li>\n<li>In IRDS there is <strong>high surface tension</strong> in the lungs resulting in <strong>atelectasis.</strong></li>\n<li>During<strong> fetal life</strong>, Cl- &nbsp;is secreted along&nbsp;with fluid by the pulmonary epithelial cells. <strong>At birth</strong>, there is a shift to Na+ reabsorption by these cells via ENaC and fluid is absorbed along with Na+.</li>\n<li>Prolonged immaturity of ENaC contributes to pulmonary edema in IRDS.</li>\n<li><strong>Overproduction/ dysregulation</strong> of <strong>surfactant proteins</strong> can also lead to respiratory distress and is the cause of <strong>Pulmonary Alveolar Proteinosis (PAP)</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(404, 'Medicine,', 'PM0087. Lung Compliance', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Compliance is the change in lung volume per unit change in the surrounding pressure.</p>\n<p>It is represented by the formula:</p>\n<p><strong>Compliance = ΔV/ΔP</strong></p>\n<p><strong>Factors Affecting Compliance</strong></p>\n<ul>\n<li><strong>Lung volume</strong>:<strong> smaller</strong> the lungs, <strong>smaller</strong> is the compliance</li>\n<li>For a given lung size, the compliance becomes less at extremes of lung volume</li>\n<li><strong>Compliance</strong> is slightly greater when measured during<strong> deflation</strong> than during in<strong>flation</strong></li>\n<li>If the surface tension is more, compliance is less</li>\n<li>Compliance measured with saline is more than compliance measured with air.</li>\n</ul>\n<p><strong>Compliance is decreased</strong>&nbsp;in conditions such as:</p>\n<ul>\n<li><strong>Pulmonary</strong>&nbsp;<strong>fibrosis</strong>: Due to increased fibrous tissue in the lung, making it less elastic, and thus less expandable.</li>\n<li><strong>Alveolar</strong>&nbsp;<strong>edema</strong>, which prevents the expansion of some alveoli.</li>\n<li>If lung remains&nbsp;<strong>unventilated</strong>&nbsp;for a long time, in a low volume lung, due to atelectasis (collapse) of lung units or increased surface tension.</li>\n<li>Increased pulmonary venous pressure.</li>\n</ul>\n<p><strong>Compliance is increased&nbsp;</strong>in conditions such as:</p>\n<ul>\n<li>Pulmonary emphysema</li>\n<li><strong>Normal</strong>&nbsp;<strong>aging</strong>&nbsp;lung</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(405, 'Physiology', 'PM0084. Important Points about Bronchial Tree', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Glands and cartilage are maximum in trachea and bronchi.</li>\n<li>Smooth muscle is maximum in terminal bronchioles.</li>\n<li>Cilia are present upto respiratory bronchiole.</li>\n<li>Clara cells—the non-ciliated cuboidal epithelial cells that secrete important defense markers and serve as progenitor cells after injury<strong>–</strong>make up a large portion of epithelial lining in the latter portions of the conducting airway (terminal bronchioles).</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(406, 'Physiology,', 'PM2416. JVP waveform and the abnormalities', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/18bbe4a977c84587903e8637a0d9303cx1280x1005.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>1) The <strong>a-wave</strong> corresponds to <strong>atrial contraction</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Prominent a-waves</strong></td>\n<td>Pulmonary hypertension, right atrial thrombus/ mass, and tricuspid stenosis</td>\n</tr>\n<tr>\n<td><strong>Cannon a-waves</strong></td>\n<td>\n<p>Complete AV block, ventricular tachycardia, and premature atrial/ junctional/ ventricular beats</p>\n</td>\n</tr>\n<tr>\n<td><strong>Absent a-waves</strong></td>\n<td>Atrial fibrillation</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>2) The <strong>c-wave</strong> corresponds to the <strong>bulging of tricuspid valve</strong> into right atrium during ventricular contraction.</p>\n<p>&nbsp;</p>\n<p>3) The <strong>x-descent</strong> corresponds to <strong>atrial relaxation</strong> during atrial diastole.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Absent x-descent</strong></td>\n<td>Severe tricuspid regurgitation</td>\n</tr>\n<tr>\n<td><strong>Rapid x-descent</strong></td>\n<td>Cardiac tamponade</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>4) The <strong>v-wave</strong> corresponds to the <strong>venous filling</strong> of right atrium.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Dominant v-waves</strong></td>\n<td>Tricuspid regurgitation</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>5) The <strong>y-descent</strong> corresponds to the&nbsp;<strong>passive emptying of the right atrium</strong> into right ventricle.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Prolonged y-descent</strong></td>\n<td>Tricuspid stenosis</td>\n</tr>\n<tr>\n<td><strong>Rapid y-descent</strong></td>\n<td>\n<p>Constrictive pericarditis and isolated severe tricuspid regurgitation</p>\n</td>\n</tr>\n<tr>\n<td><strong>Absent y-descent</strong></td>\n<td>Cardiac tamponade</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(407, 'Physiology', 'PM2360. Cardiac pressure - volume loop', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The volume-pressure curve represents the changes in volume and pressure in the left ventricle during a single cardiac cycle. The relationship between ventricular pressure(Y-axis) and volume (X-axis) throughout the cardiac cycle is represented by this loop.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9e16df890d0c42a982ca9f3d4a89ee5ax1280x1425.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Phase I: Period of filling (between A and B)</p>\n<p>Phase II: Period of isovolumic contraction&nbsp;(between B and C)</p>\n<p>Phase III: Period of ejection&nbsp;(between C and D)</p>\n<p>Phase IV: Period of isovolumic relaxation&nbsp;(between D and A)</p>\n<p>where,</p>\n<ul>\n<li>A - Mitral valve opens</li>\n</ul>\n<ul>\n<li>B - Mitral valve closes</li>\n</ul>\n<ul>\n<li>C - Aortic valve opens</li>\n</ul>\n<ul>\n<li>D - Aortic valve closes</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(408, 'Physiology', 'PM2341. Cardiac action potential', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8bcb5562f2364898be34ccc5d5699871x1280x1241.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(409, 'Physiology', 'PM2337. Pacemaker potential', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9295c7d5637f47559417f23733dbf3bbx449x459.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/432cb8746ec2493083cd12c222dc5a8bx1279x1606.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(410, 'Physiology', 'PM1830. Central and Peripheral Chemoreceptors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Central chemoreceptor</strong></td>\n<td><strong>Peripheral chemoreceptor</strong></td>\n</tr>\n<tr>\n<td>Location</td>\n<td>Ventral aspect of medulla</td>\n<td>Carotid bodies (Bifurcation of common carotid artery) and aortic bodies (Arch of aorta)</td>\n</tr>\n<tr>\n<td>Stimulus</td>\n<td>Arterial PCO<sub>2</sub> and H<sup>+</sup> ions (Sensitive to changes in arterial PCo<sub>2</sub> but stimulus is H<sup>+</sup> ions in CSF)</td>\n<td>Arterial PO<sub>2</sub> (dissolved form), PCO<sub>2</sub> and H<sup>+</sup> ions</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(411, 'Medicine,', 'PM1211. ECG Leads', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>LA – Left arm: RA – Right arm: LL – Left leg: LF – Left foot</p>\n<ul>\n<li><strong>Limb leads measure the electrical activity in the frontal plane</strong></li>\n<li><strong>Chest leads measure the electrical activity in the horizontal plane<br><br><br></strong></li>\n</ul>\n<table border=\1\>\n<tbody>\n<tr>\n<td rowspan=\2\>Limb Lead</td>\n<td colspan=\2\>Location</td>\n<td rowspan=\2\>Augmented limb leads</td>\n<td rowspan=\2\>Location</td>\n<td rowspan=\2\>Chest leads</td>\n<td rowspan=\2\>Location</td>\n</tr>\n<tr>\n<td>+</td>\n<td>-</td>\n</tr>\n<tr>\n<td>I</td>\n<td>LA<br><br></td>\n<td>&nbsp;RA</td>\n<td>aVF</td>\n<td>LF +ve</td>\n<td>V1</td>\n<td>4th intercostal space. just to the right of the sternum</td>\n</tr>\n<tr>\n<td>II</td>\n<td>LL<br><br></td>\n<td>&nbsp;RA</td>\n<td>aVL</td>\n<td>LA +ve</td>\n<td>V2</td>\n<td>4th intercostal space. just to the left of the sternum</td>\n</tr>\n<tr>\n<td>III</td>\n<td>LL<br><br></td>\n<td>LA&nbsp;</td>\n<td>aVR</td>\n<td>RA +ve</td>\n<td>V3</td>\n<td>midway between V2 and V4</td>\n</tr>\n<tr>\n<td colspan=\5\ rowspan=\3\>&nbsp;</td>\n<td>V4</td>\n<td>Midclavicular line. fifth intercostal</td>\n</tr>\n<tr>\n<td>V5</td>\n<td>Anterior axillary line, same level as V4</td>\n</tr>\n<tr>\n<td>V6</td>\n<td>Midaxillary line, the same level as V4 and V5</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(412, 'Physiology', 'PM0288. Summary of Pathogenesis of Major Findings in Congestive Heart Failure', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Summary of Pathogenesis of Major Findings in Congestive Heart Failure</strong></p>\n<table width=\454\>\n<tbody>\n<tr>\n<td width=\129\>\n<p><strong>Abnormality</strong></p>\n</td>\n<td width=\325\>\n<p><strong>Cause</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Weakness, exercise intolerance, fatigue</p>\n</td>\n<td width=\325\>\n<p>Left ventricle output inadequate to perfuse muscles; especially, failure of output to rise with exercise</p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Ankle, sacral edema</p>\n</td>\n<td width=\325\>\n<p>Increased peripheral venous pressure →increased fluid transudation.</p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Hepatomegaly</p>\n</td>\n<td width=\325\>\n<p>Increased peripheral venous pressure →increased resistance to portal flow.</p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Pulmonary congestion</p>\n</td>\n<td width=\325\>\n<p>Increased pulmonary venous pressure →pulmonary venous distention and transudation of fluid into air spaces</p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Dyspnea on exertion</p>\n</td>\n<td width=\325\>\n<p>Failure of left ventricular output to rise during exercise → increased pulmonary venous pressure</p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Paroxysmal dyspnea, pulmonary edema</p>\n</td>\n<td width=\325\>\n<p>Probably a sudden failure of left heart output to keep up with the right heart output →acute rise in pulmonary venous and capillary pressure →transudation of fluid into air spaces.</p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Orthopnea</p>\n</td>\n<td width=\325\>\n<p>Normal pooling of blood in lungs in supine position added to the already congested pulmonary vascular system; increased venous return not put out by the left ventricle. (Relieved by sitting up, raising the head of the bed, lying on extra pillows.)</p>\n</td>\n</tr>\n<tr>\n<td width=\129\>\n<p>Cardiac dilation</p>\n</td>\n<td width=\325\>\n<p>Greater ventricular end-diastolic volume.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(413, 'Physiology', 'PM0285. Types of Blood Vessels', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Types of Blood Vessels</strong></p>\n<table>\n<tbody>\n<tr>\n<td width=\72\>\n<p><strong>TYPES</strong></p>\n</td>\n<td width=\336\>\n<p><strong>FEATURES</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\72\>\n<p>Windkessel vessels</p>\n</td>\n<td width=\336\>\n<p>Aorta and large arteries.</p>\n<p>Abundant elastic tissues in the inner and external elastic lamina</p>\n<p>Shows elastic recoil (<strong>windkessel effect</strong>) when stretched</p>\n</td>\n</tr>\n<tr>\n<td width=\72\>\n<p>Resistance vessels</p>\n</td>\n<td width=\336\>\n<p>Arterioles</p>\n<p>Have less elastic tissue and lot of smooth muscle (maximum wall thickness to lumen ratio)</p>\n<p><strong>Major site of resistance</strong> to blood flow</p>\n</td>\n</tr>\n<tr>\n<td width=\72\>\n<p>Exchange vessels</p>\n</td>\n<td width=\336\>\n<p>Capillaries</p>\n<p>Do not have smooth muscles, consist of single layer of endothelial cells surrounded by a basement membrane</p>\n<p>Site of exchange of nutrients, water and gases</p>\n<p><strong>Types</strong></p>\n<ul>\n<li>Continuous- brain, retina (have tight junctions)</li>\n<li>Fenestrated- glomeruli, choroid plexus</li>\n<li>Sinusoidal- liver, spleen</li>\n</ul>\n<p>Blood flow regulation is by contraction and relaxation of the arterioles and precapillary sphincter</p>\n</td>\n</tr>\n<tr>\n<td width=\72\>\n<p>Capacitance vessels</p>\n</td>\n<td width=\336\>\n<p>Venules &amp; veins</p>\n<p>Thin-walled, easily distensible (<strong>maximum percentage of blood volume)</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\72\>\n<p>Shunt vessels</p>\n</td>\n<td width=\336\>\n<p>AV anastomoses</p>\n<p>Have thick muscular walls with rich innervation</p>\n<p>Found in – finger tips, ear lobes</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(414, 'Physiology', 'PM0223. Factors Affecting Heart Rate', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\479\>\n<p><strong>Heart rate is accelerated by</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\479\>\n<ul>\n<li>Decreased activity of arterial baroreceptors</li>\n<li>Increased activity of atrial stretch receptors</li>\n<li>Inspiration</li>\n<li>Excitement</li>\n<li>Anger</li>\n<li>Pain</li>\n<li>Hypoxia</li>\n<li>Exercise</li>\n<li>Thyroid hormones</li>\n<li>Fever</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\479\>\n<p><strong>The Heart is slowed by</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\479\>\n<ul>\n<li>Increased activity of arterial baroreceptors</li>\n<li>Expiration</li>\n<li>Grief</li>\n<li>Stimulation of pain fibers in trigeminal nerve</li>\n<li>Increased intracranial pressure</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(415, 'Physiology', 'PM0221. Humoral Regulation of BP', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/05f60d2ff68442eeb6b59339cce74ab5x692x403.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(416, 'Physiology', 'PM0220. Normal value for hemodynamic parameters', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\ width=\284\>\n<p><strong>Parameter </strong></p>\n</td>\n<td width=\141\>\n<p><strong>Pressure (mmHg)</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\3\ width=\143\>\n<p>Arterial BP</p>\n</td>\n<td width=\141\>\n<p>Systolic</p>\n</td>\n<td width=\141\>\n<p>90-140</p>\n</td>\n</tr>\n<tr>\n<td width=\141\>\n<p>Diastolic</p>\n</td>\n<td width=\141\>\n<p>60-90</p>\n</td>\n</tr>\n<tr>\n<td width=\141\>\n<p>Mean Arterial Pressure (MAP)</p>\n</td>\n<td width=\141\>\n<p>70-105</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\2\ width=\143\>\n<p>Right ventricle</p>\n</td>\n<td width=\141\>\n<p>Systolic</p>\n</td>\n<td width=\141\>\n<p>15-25</p>\n</td>\n</tr>\n<tr>\n<td width=\141\>\n<p>Diastolic</p>\n</td>\n<td width=\141\>\n<p>0-8</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\3\ width=\143\>\n<p>Pulmonary artery</p>\n</td>\n<td width=\141\>\n<p>Systolic</p>\n</td>\n<td width=\141\>\n<p>15-25</p>\n</td>\n</tr>\n<tr>\n<td width=\141\>\n<p>Diastolic</p>\n</td>\n<td width=\141\>\n<p>8-15</p>\n</td>\n</tr>\n<tr>\n<td width=\141\>\n<p>Mean</p>\n</td>\n<td width=\141\>\n<p>10-20</p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>Pulmonary capillary wedge pressure</p>\n</td>\n<td width=\141\>\n<p>Mean</p>\n</td>\n<td width=\141\>\n<p>6-12</p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>Left atrium</p>\n</td>\n<td width=\141\>\n<p>Mean</p>\n</td>\n<td width=\141\>\n<p>6-12</p>\n</td>\n</tr>\n<tr>\n<td width=\143\>\n<p>Right atrium (central venous pressure)</p>\n</td>\n<td width=\141\>\n<p>Mean</p>\n</td>\n<td width=\141\>\n<p>2-6</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(417, 'Physiology', 'PM0219. Phases of Korotkoff Sounds', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Phase</strong></p>\n</td>\n<td>\n<p><strong>Description</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>K-1</p>\n</td>\n<td>\n<p>Tapping sound</p>\n<p>Corresponds to systolic BP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>K-2</p>\n</td>\n<td>\n<p>Murmur (soft swishing sound)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>K-3</p>\n</td>\n<td>\n<p>Loud and clear tapping sound</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>K-4</p>\n</td>\n<td>\n<p>Muffled sound</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>K-5</p>\n</td>\n<td>\n<p>Disappearance of sounds</p>\n<p>Corresponds to Diastolic BP</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>NOTE- K-4 (muffled sound) corresponds to DBP in</strong>-</p>\n<ul>\n<li>Adults after exercise</li>\n<li>Children</li>\n<li>Hyperthyroidism</li>\n<li>Aortic regurgitation</li>\n<li>Patients with arteriovenous fistulas for hemodialysis</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(418, 'Physiology', 'PM0218. Blood Pressure and its determinants', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\239\>\n<p><strong>Type of Blood Pressure</strong></p>\n</td>\n<td width=\239\>\n<p><strong>Determinant</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Systolic BP (SBP)</p>\n</td>\n<td width=\239\>\n<p>Stroke volume (directly proportional)</p>\n<p>Compliance of aorta (inversely proportional)</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Diastolic BP (DBP)</p>\n</td>\n<td width=\239\>\n<p>Elastic recoil of aorta/major vessels (directly proportional)</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Pulse pressure (PP)</p>\n</td>\n<td width=\239\>\n<p>Ratio of stroke volume to compliance of the arterial tree</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Mean blood pressure (MAP)</p>\n</td>\n<td width=\239\>\n<p>Cardiac output</p>\n<p>Total peripheral resistance</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(419, 'Physiology,', 'PM0203. Normal ECG waves and intervals', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\213\>\n<p><strong>ECG wave/interval</strong></p>\n</td>\n<td width=\213\>\n<p><strong>Physiological correlates</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>P wave</p>\n</td>\n<td width=\213\>\n<p>Atrial depolarization</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>QRS complex (up to 0.10s)</p>\n</td>\n<td width=\213\>\n<p>Ventricular depolarization</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>T wave</p>\n</td>\n<td width=\213\>\n<p>Ventricular repolarization</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>U wave</p>\n</td>\n<td width=\213\>\n<p>Repolarization of ventricular myocytes with long action potential</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>PR interval&nbsp; (0.12-0.2s)&nbsp;</p>\n</td>\n<td width=\213\>\n<p>Atrial depolarization and conduction through AV node</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>QT interval&nbsp; (up to 0.43s)</p>\n</td>\n<td width=\213\>\n<p>Ventricular depolarization and Ventricular repolarization</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>ST interval (Average 0.32s)</p>\n<p>(QT minus QRS)</p>\n</td>\n<td width=\213\>\n<p>Plateau portion of ventricular action potential+ Ventricular repolarisation</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>ST segment</p>\n</td>\n<td width=\213\>\n<p>Plateau portion of ventricular action potential</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/70e10acc7b9f4c249713071ae9311e21x1280x1789.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(420, 'Medicine,', 'PM0202. Augmented Unipolar Limb Leads', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\134\>\n<p><strong>Lead type</strong></p>\n</td>\n<td width=\137\>\n<p><strong>Positive input</strong></p>\n</td>\n<td width=\138\>\n<p><strong>Negative input</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>aVR</p>\n</td>\n<td width=\137\>\n<p>Right arm (VR)</p>\n</td>\n<td width=\138\>\n<p>Mean of left arm (VL) and left foot (VF) potential</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>aVL</p>\n</td>\n<td width=\137\>\n<p>Left arm (VL)</p>\n</td>\n<td width=\138\>\n<p>Mean of right arm (VR) and left foot (VF) potential</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>aVF</p>\n</td>\n<td width=\137\>\n<p>Left foot (VF)</p>\n</td>\n<td width=\138\>\n<p>Mean of right arm (VR) and left arm (VL) potential</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(421, 'Physiology', 'PM0201. Normal pattern of ECG in different Leads', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>LEADS Normal pattern of ECG in different Leads</strong></p>\n<table>\n<tbody>\n<tr>\n<td width=\211\>\n<p><strong>Lead</strong></p>\n</td>\n<td width=\215\>\n<p><strong>Features</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>aVR</p>\n</td>\n<td width=\215\>\n<p>All deflections are negative</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>aVL, aVF</p>\n</td>\n<td width=\215\>\n<p>Predominantly positive or biphasic</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>V1, V2</p>\n</td>\n<td width=\215\>\n<p>No Q wave, large S wave</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>V3</p>\n</td>\n<td width=\215\>\n<p>Biphasic</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>V4, V5, V6</p>\n</td>\n<td width=\215\>\n<p>Small Q wave, tall R wave</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>Leads I, II, III</p>\n</td>\n<td width=\215\>\n<p>All positive deflection, largest in lead II</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(422, 'Physiology', 'PM0199. Time of impulse arrival at different regions of the heart', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\369\>\n<tbody>\n<tr>\n<td><strong>Regions</strong></td>\n<td><strong>Time (in seconds)</strong></td>\n</tr>\n<tr>\n<td>SA node</td>\n<td>0</td>\n</tr>\n<tr>\n<td>AV node</td>\n<td>0.03 (from SA node to AV node)</td>\n</tr>\n<tr>\n<td><strong>Bundle of His&nbsp; </strong></td>\n<td><strong>0.12 (AV nodal conduction time or AV nodal delay)</strong></td>\n</tr>\n<tr>\n<td>Ventricular septum</td>\n<td>0.16 (conduction time through Bundle of His)</td>\n</tr>\n<tr>\n<td>Endocardium</td>\n<td>0.17-0.19 (starting of the ventricular depolarization</td>\n</tr>\n<tr>\n<td>Epicardium</td>\n<td>0.21-0.22 (complete depolarization of the heart)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(423, 'Physiology', 'PM0198. Conduction Speeds in Cardiac Tissue', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td width=\134\>\n<p><strong>Tissue</strong></p>\n</td>\n<td width=\150\>\n<p><strong>Conduction rate(m/s)</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>SA Node</p>\n</td>\n<td width=\150\>\n<p>0.05</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>Atrial pathways</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>AV Node</p>\n</td>\n<td width=\150\>\n<p>0.05</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>Bundle of His</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>Purkinje system</p>\n</td>\n<td width=\150\>\n<p>4</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>Ventricular muscle</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(424, 'Physiology', 'PM0197. Firing rate of SA Node and Latent Pacemakers in the Heart', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\352\>\n<tbody>\n<tr>\n<td>\n<p><strong>Location</strong></p>\n</td>\n<td>\n<p><strong>Intrinsic firing rate(impulses/min)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>SA Node</p>\n</td>\n<td>70-80</td>\n</tr>\n<tr>\n<td>\n<p>AV node</p>\n</td>\n<td>\n<p>40-60</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bundle of His</p>\n</td>\n<td>\n<p>40</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Purkinje fibers</p>\n</td>\n<td>\n<p>15-20</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ventricles</p>\n</td>\n<td>\n<p>~20</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(425, 'Physiology', 'PM0171. Heart sounds', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\48\>\n<p><strong>Heart Sound</strong></p>\n</td>\n<td width=\85\>\n<p><strong>Frequency</strong></p>\n</td>\n<td width=\71\>\n<p><strong>Duration</strong></p>\n</td>\n<td width=\166\>\n<p><strong>Associated Event</strong></p>\n</td>\n<td width=\92\>\n<p><strong>ECG Correlation</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\48\>\n<p>S1</p>\n</td>\n<td width=\85\>\n<p>25-45 Hz</p>\n</td>\n<td width=\71\>\n<p>0.15 sec</p>\n</td>\n<td width=\166\>\n<p>Closure of AV Valves-Onset of Ventricular systole</p>\n</td>\n<td width=\92\>\n<p>Later half of R wave</p>\n</td>\n</tr>\n<tr>\n<td width=\48\>\n<p>S2</p>\n</td>\n<td width=\85\>\n<p>50 Hz</p>\n</td>\n<td width=\71\>\n<p>0.12 sec</p>\n</td>\n<td width=\166\>\n<p>Closure of Semilunar Valves-Onset of ventricular diastole</p>\n</td>\n<td width=\92\>\n<p>Later half of T wave</p>\n</td>\n</tr>\n<tr>\n<td width=\48\>\n<p>S3</p>\n</td>\n<td width=\85\>\n<p>Low</p>\n</td>\n<td width=\71\>\n<p>0.1 sec</p>\n</td>\n<td width=\166\>\n<p>First rapid filling phase of ventricular diastole</p>\n</td>\n<td width=\92\>\n<p>Between the T and P wave</p>\n</td>\n</tr>\n<tr>\n<td width=\48\>\n<p>S4</p>\n</td>\n<td width=\85\>\n<p>Below 20 Hz</p>\n</td>\n<td width=\71\>\n<p>0.1 sec</p>\n</td>\n<td width=\166\>\n<p>Last rapid filling phase of ventricular diastole due to atrial contraction</p>\n</td>\n<td width=\92\>\n<p>Following P wave</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(426, 'Medicine,', 'PM0170. Cardiac parameters', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\154\>\n<p><strong>Parameter</strong></p>\n</td>\n<td width=\154\>\n<p><strong>Definition</strong></p>\n</td>\n<td width=\154\>\n<p><strong>Normal Value</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Stroke Volume (SV)</p>\n</td>\n<td width=\154\>\n<p>Amount of blood ejected by each ventricle per stroke</p>\n</td>\n<td width=\154\>\n<p>70-90 ml</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>End-Diastolic volume (EDV)</p>\n</td>\n<td width=\154\>\n<p>Amount of blood in the ventricle at the end of diastole</p>\n</td>\n<td width=\154\>\n<p>130 ml</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>End-Systolic Volume</p>\n</td>\n<td width=\154\>\n<p>EDV-SV</p>\n</td>\n<td width=\154\>\n<p>~50 ml</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Ejection Fraction</p>\n</td>\n<td width=\154\>\n<p>(SV/EDV) x100</p>\n</td>\n<td width=\154\>\n<p>55%-68%</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Cardiac Output (CO)</p>\n</td>\n<td width=\154\>\n<p>SV x HR</p>\n</td>\n<td width=\154\>\n<p>~5 L/min</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Cardiac Index</p>\n</td>\n<td width=\154\>\n<p>CO/BSA (m2)</p>\n</td>\n<td width=\154\>\n<p>3.2 L/min/m2</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>BSA - Body surface area</p>\n<p>HR - Heart rate</p></div><!---->\n      <!---->\n    </div><!---->'),
(427, 'Physiology', 'PM0169. Duration of cardiac Cycle', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0d9186af5cd14040987e798d592d0312x1280x1601.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\127\>\n<p><strong>Cardiac Cycle Events</strong></p>\n</td>\n<td width=\106\>\n<p><strong>Systole(s)</strong></p>\n</td>\n<td width=\108\>\n<p><strong>Diastole(s)</strong></p>\n</td>\n<td width=\88\>\n<p><strong>Total (s)</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\127\>\n<p>Ventricles</p>\n</td>\n<td width=\106\>\n<p>0.3</p>\n</td>\n<td width=\108\>\n<p>0.5</p>\n</td>\n<td width=\88\>\n<p>0.8</p>\n</td>\n</tr>\n<tr>\n<td width=\127\>\n<p>Atria</p>\n</td>\n<td width=\106\>\n<p>0.1</p>\n</td>\n<td width=\108\>\n<p>0.7</p>\n</td>\n<td width=\88\>\n<p>0.8</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(428, 'Physiology', 'PM1322. Daily fluid turnover in the gastrointestinal tract', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\160\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\160\>\n<p><strong>Volume (in mL)</strong></p>\n</td>\n<td width=\160\>\n<p><strong>Volume (in mL)</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p><strong>Ingested </strong></p>\n</td>\n<td width=\160\>\n<p>&nbsp;</p>\n</td>\n<td width=\160\>\n<p>2000</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p><strong>Endogenous secretions</strong></p>\n</td>\n<td width=\160\>\n<p>&nbsp;</p>\n</td>\n<td width=\160\>\n<p>7000</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>1.&nbsp;&nbsp;&nbsp;&nbsp; Salivary glands</p>\n</td>\n<td width=\160\>\n<p>1500</p>\n</td>\n<td rowspan=\6\ width=\160\>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>2.&nbsp;&nbsp;&nbsp;&nbsp; Stomach</p>\n</td>\n<td width=\160\>\n<p>2500</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>3.&nbsp;&nbsp;&nbsp;&nbsp; Bile</p>\n</td>\n<td width=\160\>\n<p>500</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>4.&nbsp;&nbsp;&nbsp;&nbsp; Pancreas</p>\n</td>\n<td width=\160\>\n<p>1500</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>5.&nbsp;&nbsp;&nbsp;&nbsp; Intestine</p>\n</td>\n<td width=\160\>\n<p>1000</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>Total</p>\n</td>\n<td width=\160\>\n<p>7000</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\319\>\n<p><strong>Total input</strong></p>\n</td>\n<td width=\160\>\n<p>9000</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\319\>\n<p><strong>Reabsorbed</strong></p>\n</td>\n<td width=\160\>\n<p>8800</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>1.&nbsp;&nbsp;&nbsp;&nbsp; Jejunum</p>\n</td>\n<td width=\160\>\n<p>5500</p>\n</td>\n<td rowspan=\4\ width=\160\>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>2.&nbsp;&nbsp;&nbsp;&nbsp; Ileum</p>\n</td>\n<td width=\160\>\n<p>2000</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>3.&nbsp;&nbsp;&nbsp;&nbsp; Colon</p>\n</td>\n<td width=\160\>\n<p>1300</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>Total</p>\n</td>\n<td width=\160\>\n<p>8800</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p><strong>Balance in the stool</strong></p>\n</td>\n<td width=\160\>\n<p>&nbsp;</p>\n</td>\n<td width=\160\>\n<p>9000-8800=200</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->'),
(429, 'Physiology', 'PM1321. Classification of proteases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/19d2833448ca477991a93b378109add6x1000x712.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(430, 'Physiology', 'PM1303. Factors regulating gastric emptying', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\239\>\n<p><strong>Factors that Increase gastric emptying</strong></p>\n</td>\n<td width=\239\>\n<p><strong>Factors that Decrease gastric emptying</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Distension of the stomach</p>\n</td>\n<td width=\239\>\n<p>Distension of the duodenum</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Food rich in carbohydrate</p>\n</td>\n<td width=\239\>\n<p>Food rich in fats &gt; proteins</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Stimulation of parasympathetic nervous system</p>\n</td>\n<td width=\239\>\n<p>Stimulation of sympathetic nervous system</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>&nbsp;</p>\n</td>\n<td width=\239\>\n<p>Presence of fat in duodenum</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>&nbsp;</p>\n</td>\n<td width=\239\>\n<p>High acidity (low pH) of the duodenal chyme</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Isotonic chyme</p>\n</td>\n<td width=\239\>\n<p>Hypertonic &gt;&gt;hypotonic duodenal content</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\239\>\n<p>Breakdown products of protein digestion in the duodenum</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\239\>\n<p>Presence of any irritation in the duodenal mucosa</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Gastrin</p>\n</td>\n<td width=\239\>\n<p>CCK, Secretin, GIP</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(431, 'Physiology', 'PM1301. Mechanism of peristalsis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/fd2cb6f000bb4468a6be9203185befdax1280x1685.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(432, 'Physiology', 'PM1300. Types of gastrointestinal motility', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0742a6d113034bb2b4e75da8602e1608x1280x2345.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(433, 'Physiology', 'PM1299. Rate of basal electrical rhythm in various regions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Segment</strong></p>\n</td>\n<td>\n<p><strong>Rate of BER</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stomach</p>\n</td>\n<td>\n<p>4/min</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Duodenum</strong></p>\n</td>\n<td>\n<p><strong>12/min</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Distal ileum</p>\n</td>\n<td>\n<p>8/min</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cecum</p>\n</td>\n<td>\n<p>2/min</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sigmoid</p>\n</td>\n<td>\n<p>6/min</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(434, 'Physiology', 'PM1290. Source and actions of gastrointestinal hormones', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Action</strong></p>\n</td>\n<td>\n<p><strong>Gastrin</strong></p>\n</td>\n<td>\n<p><strong>CCK</strong></p>\n</td>\n<td>\n<p><strong>Secretin</strong></p>\n</td>\n<td>\n<p><strong>GIP</strong></p>\n</td>\n<td>\n<p><strong>Motilin</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Source</strong></p>\n</td>\n<td>\n<p>G cells in the stomach (antrum)</p>\n</td>\n<td>\n<p>I cells of duodenum and jejunum</p>\n</td>\n<td>\n<p>S cells deep in the mucosa of upper small intestine</p>\n</td>\n<td>\n<p>K cells in mucosa of duodenum and jejunum</p>\n</td>\n<td>\n<div class=\page\ title=\Page 749\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Mo cells of the duodenum and jejunum</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Acid secretion</strong></p>\n</td>\n<td>S</td>\n<td>&nbsp;</td>\n<td>I</td>\n<td>I</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Gastric emptying</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>I</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pancreatic HCO<sup>3-</sup></strong></p>\n</td>\n<td>&nbsp;</td>\n<td>S</td>\n<td>S</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pancreatic enzymes</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>S</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Insulin release</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;S</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Gall bladder contraction</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>S</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Biliary&nbsp;</strong></p>\n<p><strong>HCO<sup>3-</sup></strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;S</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Gastric motility</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>S</td>\n</tr>\n<tr>\n<td>\n<p><strong>Intestinal motility</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>S</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mucosal growth</strong></p>\n</td>\n<td>S</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Exocrine pancreas growth</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>S</td>\n<td>S</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p><strong>KEY</strong></p>\n<p>S→Stimulates</p>\n<p>I→ Inhibits</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(435, 'Physiology', 'PM1289. Hormones/Paracrines regulating gastrointestinal function', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Hormones/Paracrines</strong></p>\n</td>\n<td>\n<p><strong>Cells</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Gastrin</strong></p>\n</td>\n<td>\n<p>G cells in the stomach (antrum)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>CCK</strong></p>\n</td>\n<td>\n<p>I cells of duodenum and jejunum</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Secretin</strong></p>\n</td>\n<td>\n<p>S cells deep in the mucosa of upper small intestine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>GIP</strong></p>\n</td>\n<td>\n<p>K cells in mucosa of duodenum and jejunum</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Somatostatin</strong></p>\n</td>\n<td>\n<p>D cells of pancreatic islets</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glucagon</strong></p>\n</td>\n<td>\n<p>A cells of pancreatic islets</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Motilin </strong></p>\n</td>\n<td>\n<p>Enterochromaffin cells and Mo cells in stomach, small intestine, and colon</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(436, 'Physiology', 'PM1288. Stimuli that affect gastrin secretion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Stimuli that <strong>increase gastrin secretion</strong></p>\n<ul>\n<li><strong>Luminal -&nbsp;</strong>Peptides and amino acids</li>\n<li><strong>Neural -&nbsp;</strong>Increased vagal discharge via GRP</li>\n<li><strong>Bloodborne</strong>\n<ul>\n<li>Ca <sup>2+</sup></li>\n<li>Epinephrine</li>\n</ul>\n</li>\n</ul>\n<p>Stimuli that<strong> inhibit gastrin secretion</strong></p>\n<ul>\n<li><strong>Luminal</strong>\n<ul>\n<li>Acid</li>\n<li>Somatostatin&nbsp;</li>\n</ul>\n</li>\n<li><strong>Bloodborne-&nbsp;</strong>Secretin, GIP, VIP, glucagon, calcitonin</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(437, 'Physiology', 'PM1287. Gastrointestinal Hormones', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/83112d31eef24b2ab9d7a3acf8f9c61fx1280x1181.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(438, 'Physiology', 'PM1286. Bile Salts', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Primary bile acids</strong></p>\n</td>\n<td>\n<p><strong>Secondary bile acids</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cholic acid</p>\n</td>\n<td>\n<p>Deoxycholic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chenodeoxycholic acid</p>\n</td>\n<td>\n<p>Lithocholic acid</p>\n<p>Ursodeoxycholic acid</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(439, 'Physiology', 'PM1283. Daily GIT secretions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type of secretion</strong></p>\n</td>\n<td>\n<p><strong>Daily volume (mL)</strong></p>\n</td>\n<td>\n<p><strong>pH</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Saliva</p>\n</td>\n<td>\n<p>1500</p>\n</td>\n<td>\n<p>6.0-7.0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gastric secretion</p>\n</td>\n<td>\n<p>1500-2500</p>\n</td>\n<td>\n<p>1.0-3.5 (Most acidic)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pancreatic secretion</p>\n</td>\n<td>\n<p>1000</p>\n</td>\n<td>\n<p>8.0-8.3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bile</p>\n</td>\n<td>\n<p>500</p>\n</td>\n<td>\n<p>7.8</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Small intestine secretion</p>\n</td>\n<td>\n<p>1800</p>\n</td>\n<td>\n<p>7.5-8.0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Brunner’s gland secretion</p>\n</td>\n<td>\n<p>200</p>\n</td>\n<td>\n<p>8.0-8.9 (most alkaline)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Large intestine secretion</p>\n</td>\n<td>\n<p>200</p>\n</td>\n<td>\n<p>7.5-8.0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Total</p>\n</td>\n<td>\n<p>6700</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(440, 'Physiology', 'PM1282. Regulation of pancreatic secretion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Stimulant</strong></p>\n</td>\n<td>\n<p><strong>Acts on</strong></p>\n</td>\n<td>\n<p><strong>The second messenger involved</strong></p>\n</td>\n<td>\n<p><strong>Effect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Secretin</p>\n<p>(S cells)</p>\n</td>\n<td>\n<p>Pancreatic ductal cell</p>\n</td>\n<td>\n<p>cAMP</p>\n</td>\n<td>\n<p>↑HCO3- in secretion</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CCK</p>\n<p>(I cells)</p>\n</td>\n<td>\n<p>Acinar cell</p>\n</td>\n<td>\n<p>Phospholipase C (IP3/DAG)</p>\n</td>\n<td>\n<p>↑ release of zymogen granules (enzymes)</p>\n<p>Potentiates effect of secretin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ACh</p>\n<p>(vagi)</p>\n</td>\n<td>\n<p>Acinar cell</p>\n</td>\n<td>\n<p>Phospholipase C (IP3/DAG)</p>\n</td>\n<td>\n<p>↑ release of zymogen granules (enzymes)</p>\n<p>Potentiates effect of secretin</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(441, 'Physiology', 'PM1280. Phase of gastric secretion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Phase</strong></p>\n</td>\n<td>\n<p><strong>% of HCl secretion</strong></p>\n</td>\n<td>\n<p><strong>Stimuli </strong></p>\n</td>\n<td>\n<p><strong>Mechanisms </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cephalic</p>\n</td>\n<td>\n<p>30</p>\n</td>\n<td>\n<p>Conditioning, smell, taste, chewing</p>\n</td>\n<td>\n<p>Vagus → Parietal cell</p>\n<p>Vagus →Gastrin → Parietal cell</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gastric</p>\n</td>\n<td>\n<p>60</p>\n</td>\n<td>\n<p>Distension</p>\n</td>\n<td>\n<p>Vagus →Parietal cell</p>\n<p>Vagus →Gastrin →Parietal cell</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>\n<p>Distension of antrum</p>\n</td>\n<td>\n<p>Local reflex →Gastrin →Parietal cell</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>\n<p>Amino acids, small peptides in the gastric lumen</p>\n</td>\n<td>\n<p>Gastrin →Parietal cell</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Intestinal</p>\n</td>\n<td>\n<p>10</p>\n</td>\n<td>\n<p>Amino acids, small peptides in gastric lumen</p>\n</td>\n<td>\n<p>Gastrin →Parietal cell</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>All phases</p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>\n<p>Gastrin → ECL cells →Histamine</p>\n<p>ACh →ECL cell →Histamine</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(442, 'Physiology', 'PM1279. Factors inhibiting gastric secretion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Inhibiting factors</strong></p>\n</td>\n<td>\n<p><strong>Mechanism </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Low pH (&lt; 3.0) in the stomach</strong></p>\n</td>\n<td>\n<p>When the pH of the stomach contents is &lt;3.0, <strong>gastrin secretion is inhibited and, by negative feedback</strong>, inhibits further H<sup>+</sup>&nbsp;secretion.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Somatostatin</strong></p>\n</td>\n<td>\n<p>Inhibits gastric H<sup>+</sup>&nbsp;secretion by a direct pathway and an indirect pathway.</p>\n<p><strong>Direct pathway→ </strong>somatostatin binds to receptors on the parietal cell that are coupled to adenylyl cyclase via a <strong>Gi </strong>protein, thus inhibiting adenylyl cyclase and <strong>decreasing cAMP </strong>levels. In this pathway, somatostatin antagonizes the stimulatory action of histamine on H+ secretion.</p>\n<p><strong>Indirect pathway</strong>→ somatostatin <strong>inhibits release of histamine and gastrin, </strong>thus decreasing H+ secretion indirectly.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Prostaglandins</strong></p>\n</td>\n<td>\n<p>Inhibit gastric H+ secretion by activating a <strong>Gi </strong>protein, inhibiting adenylyl cyclase and <strong>decreasing cAMP levels.</strong></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(443, 'Physiology', 'PM1278. Stimuli for gastric secretion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Stimuli</strong></p>\n</td>\n<td>\n<p><strong>Mechanism </strong></p>\n</td>\n<td>\n<p><strong>Applied aspects</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\2\>\n<p><strong>Vagal stimulation</strong></p>\n</td>\n<td>\n<p><strong>Direct pathway</strong></p>\n<p><strong>Vagus nerve innervates parietal cells </strong>and stimulates H<sup>+ </sup>secretion directly.</p>\n<p>The neurotransmitter at these synapses is <strong>Ach, </strong>the receptor on the parietal cells is <strong>muscarinic </strong>(M3)</p>\n<p>The second messengers for CCK are <strong>IP<sub>3 </sub></strong>and <strong>increased intracellular [Ca<sup>2+</sup>].</strong></p>\n</td>\n<td>\n<p><strong>Atropine, </strong>a cholinergic muscarinic antagonist, inhibits H<sup>+</sup> secretion by blocking the direct pathway, which uses ACh as a neurotransmitter. However, it does not block H<sup>+ </sup>secretion completely because it does not inhibit the indirect pathway, which uses GRP as a neurotransmitter</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Indirect pathway </strong></p>\n<p><strong>Vagus nerve innervates G cells </strong>and stimulates gastrin secretion, which then stimulates H<sup>+ </sup>secretion.</p>\n<p>The neurotransmitter at these synapses is <strong>GRP </strong>(not ACh).</p>\n</td>\n<td>\n<p><strong>Vagotomy </strong>eliminates both direct and indirect pathways.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Gastrin</strong></p>\n</td>\n<td>\n<p>Released in response to eating a meal (small peptides, distension of the stomach, vagal stimulation).</p>\n<p>Stimulates H<sup>+</sup>&nbsp;secretion by interacting with the cholecystokinin B (CCK<sub>B</sub>) receptor on the parietal cells.</p>\n<p>The second messenger for gastrin on the parietal cell is IP<sub>3</sub>/Ca<sup>2+.</sup></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Histamine</strong></p>\n</td>\n<td>\n<p>Released from enterochromaffin-like (ECL) cells in the gastric mucosa and diffuses to the nearby parietal cells.</p>\n<p>Stimulates H<sup>+</sup> secretion by activating <strong>H<sub>2 </sub>receptors </strong>on the parietal cell membrane.</p>\n<p>The H<sub>2</sub>&nbsp;receptor is coupled to adenylyl cyclase via a Gs protein.</p>\n<p>The second messenger for histamine is <strong>cAMP.</strong></p>\n</td>\n<td>\n<p>H<sub>2</sub>&nbsp;receptor–blocking drugs, such as <strong>cimetidine, </strong>inhibit H<sup>+ </sup>secretion by blocking the stimulatory effect of histamine.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(444, 'Physiology', 'PM1277. Cells of the Gastric Glands', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Cell Type</strong></p>\n</td>\n<td>\n<p><strong>Part of stomach</strong></p>\n</td>\n<td>\n<p><strong>Secretion</strong></p>\n</td>\n<td>\n<p><strong>Stimulus for secretion</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Parietal cells</p>\n</td>\n<td>\n<p>Fundus, Body</p>\n</td>\n<td>\n<p>HCl</p>\n<p>Intrinsic factor</p>\n</td>\n<td>\n<p>Gastrin</p>\n<p>Vagal stimulation (Ach)</p>\n<p>Histamine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chief cells</p>\n</td>\n<td>\n<p>Fundus, Body</p>\n</td>\n<td>\n<p>Pepsinogen</p>\n<p>Gastric lipase</p>\n</td>\n<td>\n<p>Vagal stimulation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mucous cells</p>\n</td>\n<td>\n<p>Antrum, cardia, pylorus</p>\n</td>\n<td>\n<p>Mucous</p>\n</td>\n<td>\n<p>Vagal stimulation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>G cells</p>\n</td>\n<td>\n<p>Antrum</p>\n</td>\n<td>\n<p>Gastrin</p>\n</td>\n<td>\n<p>Vagal stimulation (via GRP)</p>\n<p>Oligopeptides</p>\n<p>Inhibited by somatostatin</p>\n<p>Inhibited by H<sup>+</sup> in stomach</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Enterochromaffin like cells (ECL)</p>\n</td>\n<td>\n<p>Fundus</p>\n</td>\n<td>\n<p>Histamine</p>\n</td>\n<td>\n<p>Gastrin</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(445, 'Physiology', 'PM2330. Formulae in renal physiology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\page\ title=\Page 355\>\n<div class=\section\>\n<table><colgroup><col><col><col> </colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Term</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Equation</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Clearance rate</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>U<sub>s</sub> ×V / P<sub>s</sub></p>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>&nbsp;</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Glomerular filtration rate</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>U<sub>inulin</sub> × V / P<sub>inulin</sub></p>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>&nbsp;</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Clearance ratio</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C<sub>s</sub>/C<sub>inulin</sub></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Effective renal plasma flow</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>E<sub>RPF</sub>=C<sub>PAH</sub>=U<sub>PAH</sub> ×V / P<sub>PAH</sub></p>\n</div>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>&nbsp;</p>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>&nbsp;</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Renal blood flow</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>RPF / (1− Hematocrit)</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Excretion rate</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>U<sub>s</sub> ×V</p>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>&nbsp;</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Reabsorption rate</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>=Filtered load −Excretion rate</p>\n<p>=(GFR×P<sub>s</sub>)−(U<sub>s</sub> ×V)</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Secretion rate</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Excretion rate−Filtered load</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Cs - clearance rate of substance “s”</p>\n<p>EPAH&nbsp; - PAH extraction ratio</p>\n<p>ERPF - effective renal plasma flow</p>\n<p>GFR - glomerular filtration rate</p>\n<p>P - plasma concentration</p>\n<p>PAH - para-aminohippuric acid</p>\n<p>PPAH - renal arterial PAH concentration</p>\n<p>RBF - renal blood flow</p>\n<p>RPF - renal plasma flow</p>\n<p>S - a substance</p>\n<p>U - urine concentration</p>\n<p>V - urine flow rate</p>\n<p>VPAH - renal venous PAH concentration</p>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(446, 'Medicine,', 'PM1361. Effects of changes in Starling Forces on GFR Renal Plasma Flow, and Filtration Fraction', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;Effect</strong></p>\n</td>\n<td>\n<p><strong>GFR</strong></p>\n</td>\n<td>\n<p><strong>RPF</strong></p>\n</td>\n<td>\n<p><strong>FF(GFR/RPF)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Constriction of afferent arteriole (eg. Sympathetic stimulation) </strong></p>\n</td>\n<td>\n<p>↓</p>\n<p>(caused by ↓P<sub>G</sub>)</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>No change</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Constriction of efferent arteriole (eg angiotensin II)</strong></p>\n</td>\n<td>\n<p>↑</p>\n<p>(caused by ↑P<sub>G</sub>)</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↑</p>\n<p>(↑GFR/↓RPF)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Increased plasma protein</strong></p>\n</td>\n<td>\n<p>↓</p>\n<p>(caused by↑π <sub>G</sub>)</p>\n</td>\n<td>\n<p>No change</p>\n</td>\n<td>\n<p>↓</p>\n<p>(↓GFR/unchanged RPF)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Decreased plasma protein</strong></p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>-</p>\n</td>\n<td>\n<p>&nbsp;↑</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Ureteral stone / constriction of the ureter</strong></p>\n</td>\n<td>\n<p>↓</p>\n<p>(caused by ↑P<sub>B</sub>)</p>\n</td>\n<td>\n<p>No change</p>\n</td>\n<td>\n<p>↓</p>\n<p>(↓GFR/unchanged RPF)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Note: <strong>PB,</strong> Bowman’s capsule hydrostatic pressure; <strong>πG</strong>, glomerular capillary colloid osmotic pressure; <strong>PG</strong>, glomerular capillary hydrostatic pressure;&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(447, 'Physiology', 'PM1360. Factors Affecting GFR', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Determinants</strong></p>\n</td>\n<td>\n<p><strong>Physiological/Pathophysiological Causes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>↓K<sub>f</sub>&nbsp;(filtration coefficient)→ ↓GFR</p>\n</td>\n<td>\n<p>Renal disease, diabetes mellitus, hypertension</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>↑P<sub>B</sub>&nbsp;→ ↓GFR</p>\n</td>\n<td>\n<p>Urinary tract obstruction (e.g., kidney stones)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>↑π<sub>G </sub>→ ↓GFR</p>\n</td>\n<td>\n<p>↓ Renal blood flow&nbsp;increased plasma proteins</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>↓P<sub>G</sub>&nbsp;→ ↓GFR</p>\n<p>a) ↑afferent arteriolar resistance (R<sub>A</sub>&nbsp;)→ ↓P<sub>G</sub></p>\n</td>\n<td>\n<p>↑ Sympathetic activity, (e.g., norepinephrine, endothelin)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>b) ↓systemic arterial pressure(A<sub>P</sub>&nbsp;)→ ↓P<sub>G</sub></p>\n</td>\n<td>\n<p>&nbsp;Arterial pressure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>c) ↓efferent arteriolar resistance (R<sub>E </sub>)→ ↓P<sub>G</sub></p>\n</td>\n<td>\n<p>↓ Angiotensin II (drugs that block angiotensin II formation)</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>P<sub>G :&nbsp;</sub>Glomerular hydrostatic pressure</p>\n<p>π<sub>B :&nbsp;</sub>Colloid osmotic pressure of the proteins in Bowman’s capsule</p>\n<p>P<sub>B :&nbsp;</sub>Hydrostatic pressure in Bowman’s capsule</p>\n<p>π<sub>G :&nbsp;</sub>Colloid osmotic pressure of glomerular capillary plasma proteins&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(448, 'Physiology', 'PM1356. Differences between cortical and juxtamedullary nephron', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>Features </strong></p>\n</td>\n<td>\n<p><strong>Cortical nephron </strong></p>\n</td>\n<td>\n<p><strong>Juxtamedullary nephron </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Location of glomerulus </strong></p>\n</td>\n<td>\n<p>Upper region of cortex</p>\n</td>\n<td>\n<p>Near junction of cortex and medulla</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>% of total nephrons</strong></p>\n</td>\n<td>\n<p>85%</p>\n</td>\n<td>\n<p>15%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Size of glomeruli </strong></p>\n</td>\n<td>\n<p>small</p>\n</td>\n<td>\n<p>larger</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Loop of Henle</strong></p>\n</td>\n<td>\n<p>Short</p>\n<p>extend up to outer layer of medulla</p>\n</td>\n<td>\n<p>Long</p>\n<p>extend deep into the medulla</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Efferent arterioles</strong></p>\n</td>\n<td>\n<p>Large diameter</p>\n<p>break into peritubular capillaries</p>\n</td>\n<td>\n<p>Small diameter</p>\n<p>continue as vasa recta</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Rate of filtration </strong></p>\n</td>\n<td>\n<p>Slow</p>\n</td>\n<td>\n<p>High</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Major function</strong></p>\n</td>\n<td>\n<p>Excretion of waste products</p>\n<p>in the urine</p>\n</td>\n<td>\n<p>Concentration of urine by</p>\n<p>countercurrent mechanism</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(449, 'Physiology', 'PM1355. Difference between PCT and DCT', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>PCT</strong></p>\n</td>\n<td>\n<p><strong>DCT</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Brush border present in the apical membrane</p>\n</td>\n<td>\n<p>No brush border</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cytoplasmic carbonic anhydrase (type 2 &amp; type 4 ) present</p>\n</td>\n<td>\n<p>&nbsp;Cytoplasmic carbonic anhydrase (type 2 only)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Has ‘leaky’ tight junctions</p>\n</td>\n<td>\n<p>Has ‘tight’ tight junctions</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Paracellular transport is possible via leaky tight junctions</p>\n</td>\n<td>\n<p>No paracellular transport</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(450, 'Physiology', 'PM1347. Summary of Stimuli affecting Vasopressin Secretion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Increased vasopressin secretion</strong></p>\n</td>\n<td>\n<p><strong>Decreased vasopressin secretion</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Increased effective osmotic pressure of the plasma</p>\n<p>Decreased ECF volume</p>\n<p>Pain, emotions, stress, exercise</p>\n<p>Nausea and vomiting</p>\n<p>Standing</p>\n<p>Angiotensin II</p>\n<p>Clofibrate, carbamazepine</p>\n</td>\n<td>\n<p>Decreased effective osmotic pressure of the plasma</p>\n<p>Increased ECF volume</p>\n<p>Alcohol</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(451, 'Physiology', 'PM1344. Factors that affect renin secretion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Stimulatory</strong></p>\n<ul>\n<li>Increased sympathetic activity via renal nerves</li>\n<li>Increased circulating catecholamines</li>\n<li>Prostaglandins</li>\n<li>Na<sup>+ </sup>depletion</li>\n<li>Diuretics</li>\n<li>Upright posture</li>\n<li>Hemorrhage</li>\n<li>Hypotension</li>\n<li>Dehydration</li>\n<li>Cardiac failure</li>\n<li>Cirrhosis</li>\n<li>Constriction of the renal artery or aorta</li>\n<li>Various psychological stimuli</li>\n</ul>\n<p><strong>Inhibitory</strong></p>\n<ul>\n<li>Increased Na<sup>+</sup> and Cl<sup>-</sup> reabsorption across macula densa</li>\n<li>Increased afferent arteriolar pressure</li>\n<li>Angiotensin II</li>\n<li>ADH (vasopressin)</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(452, 'Physiology,', 'PM1338. Principal buffers in the body', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Extracellular Buffers</td>\n<td>Intracellular Buffers</td>\n<td>Bone Buffers</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li><strong>HCO</strong><sub><strong>3</strong>&nbsp;</sub>(bicarbonate) -Major buffer in ECF and body</li>\n<li>Plasma proteins</li>\n<li>Phosphate - minor</li>\n<li>NH<sub>3</sub>- minor</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Organic phosphates [e.g., AMP, ADP, ATP, 2,3-diphosphoglycerate (DPG)]</li>\n<li>Intracellular proteins</li>\n<li>Hemoglobin in RBCs</li>\n</ul>\n</td>\n<td>\n<p>It has been estimated that at least 40% of the buffering of an acute acid load takes place in the bone.</p>\n<p>In chronic acidosis continued buffering has adverse effects on bone mineralization and can result in bone diseases such as rickets, osteomalacia, and osteopenia.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->'),
(453, 'Physiology', 'PM1335. Renal tubule characteristics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\459\>\n<tbody>\n<tr>\n<td rowspan=\2\ width=\126\>\n<p><strong>Segments </strong></p>\n</td>\n<td rowspan=\2\ width=\87\>\n<p><strong>Active NaCl Transport </strong></p>\n</td>\n<td colspan=\3\ width=\246\>\n<p><strong>Permeability </strong></p>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p><strong>H<sub>2</sub>0</strong></p>\n</td>\n<td width=\78\>\n<p><strong>NaCl</strong></p>\n</td>\n<td width=\83\>\n<p><strong>Urea</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\126\>\n<p>Proximal tubule</p>\n</td>\n<td width=\87\>\n<p>++</p>\n</td>\n<td width=\85\>\n<p>++</p>\n</td>\n<td width=\78\>\n<p>+</p>\n</td>\n<td width=\83\>\n<p>+</p>\n</td>\n</tr>\n<tr>\n<td width=\126\>\n<p>Thin descending limb</p>\n</td>\n<td width=\87\>\n<p>0</p>\n</td>\n<td width=\85\>\n<p>++</p>\n</td>\n<td width=\78\>\n<p>+</p>\n</td>\n<td width=\83\>\n<p>+</p>\n</td>\n</tr>\n<tr>\n<td width=\126\>\n<p>Thin ascending limb</p>\n</td>\n<td width=\87\>\n<p>0</p>\n</td>\n<td width=\85\>\n<p>0</p>\n</td>\n<td width=\78\>\n<p>+</p>\n</td>\n<td width=\83\>\n<p>+</p>\n</td>\n</tr>\n<tr>\n<td width=\126\>\n<p>Thick ascending limb</p>\n</td>\n<td width=\87\>\n<p>++</p>\n</td>\n<td width=\85\>\n<p>0</p>\n</td>\n<td width=\78\>\n<p>0</p>\n</td>\n<td width=\83\>\n<p>0</p>\n</td>\n</tr>\n<tr>\n<td width=\126\>\n<p>Distal tubule</p>\n</td>\n<td width=\87\>\n<p>+</p>\n</td>\n<td width=\85\>\n<p>+ADH</p>\n</td>\n<td width=\78\>\n<p>0</p>\n</td>\n<td width=\83\>\n<p>0</p>\n</td>\n</tr>\n<tr>\n<td width=\126\>\n<p>Cortical collecting duct</p>\n</td>\n<td width=\87\>\n<p>+</p>\n</td>\n<td width=\85\>\n<p>+ADH</p>\n</td>\n<td width=\78\>\n<p>0</p>\n</td>\n<td width=\83\>\n<p>0</p>\n</td>\n</tr>\n<tr>\n<td width=\126\>\n<p>Inner medullary collecting duct</p>\n</td>\n<td width=\87\>\n<p>+</p>\n</td>\n<td width=\85\>\n<p>+ADH</p>\n</td>\n<td width=\78\>\n<p>0</p>\n</td>\n<td width=\83\>\n<p>+ADH</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>KEY:</strong> ADH, antidiuretic hormone; NaCl, sodium chloride; 0, minimal level of active transport or permeability; +, moderate level of active transport or permeability; ++, high level of active transport or permeability; +ADH, permeability to water or urea is increased by ADH.</p></div><!---->\n      <!---->\n    </div><!---->'),
(454, 'Physiology', 'PM1334. Summary of Transport Across Proximal and Distal Portions of the Nephron', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\476\>\n<tbody>\n<tr>\n<td colspan=\2\>\n<p><strong>Proximal Tubule</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Reabsorption</strong></td>\n<td>\n<p><strong>Secretion</strong>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>67% of filtered Na<sup>+</sup> actively reabsorbed, not subject to control; Cl<sup>–</sup> follows passively</p>\n<p>All filtered glucose and amino acids reabsorbed by secondary active transport; not subject to control</p>\n<p>Variable amounts of filtered PO4<sup>3- </sup>and other electrolytes reabsorbed; subject to control</p>\n<p>65% of filtered H<sub>2</sub>O osmotically reabsorbed; not subject to control</p>\n<p>50% of filtered urea passively reabsorbed; not subject to control</p>\n<p>Almost all filtered K<sup>+</sup> reabsorbed; not subject to control</p>\n</td>\n<td>\n<p>Variable H<sup>+</sup> secretion, depending on acid-base status of body</p>\n<p>Organic ion secretion; not subject to control</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Distal tubule</strong></td>\n</tr>\n<tr>\n<td><strong>Reabsorption</strong></td>\n<td><strong>Secretion</strong></td>\n</tr>\n<tr>\n<td>\n<p>Variable Na<sup>+</sup> reabsorption, controlled by aldosterone; Cl<sup>–</sup> follows passively</p>\n<p>Variable H<sub>2</sub>O reabsorption, controlled by vasopressin</p>\n</td>\n<td>\n<p>Variable H<sup>+ </sup>secretion, depending on acid-base status of body</p>\n<p>Variable K<sup>+</sup> secretion, controlled by aldosterone</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(455, 'Physiology', 'PM1333. Water transport along nephron', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Segment</strong></p>\n</td>\n<td>\n<p><strong>Mechanism of Water Reabsorption</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Proximal tubule(67%)</p>\n</td>\n<td>\n<p>Osmosis, AQ 1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Loop of Henle (15%)</p>\n</td>\n<td>\n<p>Descending thin limb only; aquaporin 1 channels</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Early distal convoluted tubule(0%)</p>\n</td>\n<td>\n<p>No water reabsorption</p>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 1010\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Late distal tubule and collecting duct (8-17%)</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p>Passive(aquaporin-2) under the influence of ADH</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(456, 'Physiology', 'PM1332. Transport proteins involved in the movement of Na+ and CL- across the apical membranes of renal tubular cells', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Site</strong></p>\n</td>\n<td>\n<p><strong>Apical transport</strong></p>\n</td>\n<td>\n<p><strong>Function</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\6\>\n<p>Proximal tubule(60%)</p>\n</td>\n<td>\n<p>Na<sup>+</sup>/glucose co transport</p>\n</td>\n<td>\n<p>Na<sup>+</sup> uptake , glucose uptake</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Na<sup>+</sup>/inorganic phosphate Cotransporter</p>\n</td>\n<td>\n<p>Na<sup>+</sup> uptake, phosphate uptake</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Na<sup>+</sup> amino acid Cotransporter</p>\n</td>\n<td>\n<p>Na<sup>+</sup> uptake, amino acid uptake</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Na<sup>+</sup>/lactate Cotransporter</p>\n</td>\n<td>\n<p>Na<sup>+</sup> uptake, lactate uptake</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Na<sup>+</sup>/H<sup>+</sup> exchanger</p>\n</td>\n<td>\n<p>Na<sup>+</sup> uptake , H<sup>+</sup> extrusion</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cl<sup>-</sup> / base exchanger</p>\n</td>\n<td>\n<p>Cl<sup>- </sup>uptake</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thick ascending limb(30%)</p>\n</td>\n<td>\n<p>Na<sup>+</sup>–K<sup>+</sup>–2Cl<sup>-</sup> Cotransporter</p>\n<p>Na<sup>+</sup>/H<sup>+</sup> exchanger</p>\n</td>\n<td>\n<p>Na<sup>+ </sup>uptake, Cl<sup>–</sup> uptake, K<sup>+</sup> uptake</p>\n<p>Na<sup>+</sup> uptake, H<sup>+</sup> extrusion</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Distal convoluted tubule(7%)</p>\n</td>\n<td>\n<p>NaCl Cotransporter</p>\n</td>\n<td>\n<p>Na<sup>+</sup> uptake, Cl<sup>–</sup> uptake</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Collecting duct(3%)</p>\n</td>\n<td>\n<p>Na<sup>+</sup> channel (ENaC)</p>\n</td>\n<td>\n<p>Na<sup>+</sup> uptake</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(457, 'Physiology', 'PM1331. Transport Maximums for Substances that are actively Secreted', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Substances</strong></p>\n</td>\n<td>\n<p><strong>Transport maximum</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Creatinine</p>\n</td>\n<td>\n<p>16 mg/min</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Para-amino Hippuric acid</p>\n</td>\n<td>\n<p>80 mg/min</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(458, 'Physiology', 'PM1329. Transport Maximums for Substances that are actively Reabsorbed', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Substance</strong></p>\n</td>\n<td>\n<p><strong>Transport Maximum</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucose</p>\n</td>\n<td>\n<p>375 mg/min</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phosphate</p>\n</td>\n<td>\n<p>0.1 mmol/min</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sulfate</p>\n</td>\n<td>\n<p>0.06 mmol/min</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Amino acids</p>\n</td>\n<td>\n<p>1.5 mmol/min</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Urate</p>\n</td>\n<td>\n<p>15mg/min</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lactate</p>\n</td>\n<td>\n<p>75 mg/min</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Plasma protein</p>\n</td>\n<td>\n<p>30 mg/min</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(459, 'Physiology', 'PM1328. Filtration, Reabsorption, and Excretion Rates of Different Substances by the Kidneys', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Substance</strong></p>\n</td>\n<td>\n<p><strong>Amount Filtered </strong></p>\n</td>\n<td>\n<p><strong>Amount reabsorbed </strong></p>\n</td>\n<td>\n<p><strong>Amount excreted </strong></p>\n</td>\n<td>\n<p><strong>% of Filtered Load Reabsorbed</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucose (g/day)</p>\n</td>\n<td>\n<p>180</p>\n</td>\n<td>\n<p>180</p>\n</td>\n<td>\n<p>0</p>\n</td>\n<td>\n<p>100</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bicarbonate (mEq/day)</p>\n</td>\n<td>\n<p>4320</p>\n</td>\n<td>\n<p>4318</p>\n</td>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>&gt;99.9</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sodium (mEq/day)</p>\n</td>\n<td>\n<p>25,560</p>\n</td>\n<td>\n<p>25410</p>\n</td>\n<td>\n<p>150</p>\n</td>\n<td>\n<p>99.4</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chloride (mEq/day)</p>\n</td>\n<td>\n<p>19440</p>\n</td>\n<td>\n<p>19260</p>\n</td>\n<td>\n<p>180</p>\n</td>\n<td>\n<p>99.1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Potassium (mEq/day)</p>\n</td>\n<td>\n<p>756</p>\n</td>\n<td>\n<p>664</p>\n</td>\n<td>\n<p>92</p>\n</td>\n<td>\n<p>87.8</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Urea (g/day)</p>\n</td>\n<td>\n<p>46.8</p>\n</td>\n<td>\n<p>23.4</p>\n</td>\n<td>\n<p>23.4</p>\n</td>\n<td>\n<p>50</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Creatinine (g/day)</p>\n</td>\n<td>\n<p>1.8</p>\n</td>\n<td>\n<p>0</p>\n</td>\n<td>\n<p>1.8</p>\n</td>\n<td>\n<p>0</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(460, 'Physiology', 'PM2308. Bone formation and maturation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5ad91ff813d94e56974e96c4901c603cx1280x964.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>RANK Ligand (<strong>RANK-L</strong>) is produced by mature<strong>&nbsp;</strong><strong>osteoblasts and osteoblast progenitors.</strong></p>\n<p><strong>Osteoprotegerin&nbsp;</strong>also expressed by osteoblasts&nbsp;<strong>binds to RANK-L</strong>&nbsp;and reduces bone resorption.</p>\n<p>When RANK-L binds with RANK, it&nbsp;<strong>stimulates osteoclastic proliferation</strong>&nbsp;and differentiation&nbsp;leading to the formation of mature osteoclasts which results in bone resorption.</p></div><!---->\n      <!---->\n    </div><!---->'),
(461, 'Physiology', 'PM1515. Steroid Hormones', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/b7caa2ab22a24f7c8ca01862ee0c9a21x939x524.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(462, 'Paediatrics,', 'PM1510. Biosynthesis Pathway for Androgen Synthesis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/286d58778dd0497d858e6a87d6ce7defx1280x2186.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(463, 'Pharmacology,', 'PM1505. Summary of hormones that regulate Ca2+ levels', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Features</strong></td>\n<td><strong>Parathyroid hormone</strong></td>\n<td><strong>Calcitonin</strong></td>\n<td><strong>Vitamin D</strong></td>\n</tr>\n<tr>\n<td><strong>Stimulus for secretion</strong></td>\n<td>\n<div><span>↓ Serum Ca<sup>2+</sup></span></div>\n<div><span>osteoblast</span></div>\n</td>\n<td><span>↑ Serum Ca <sup>2+</sup></span></td>\n<td>\n<div><span>↓ Serum Ca<sup>2+</sup></span></div>\n<div><span>↓ Serum Phosphate</span></div>\n<div><span>↑ PTH</span></div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Effect on bone</strong></span></td>\n<td><span>↑ Resorption</span></td>\n<td><span>↓&nbsp;Resorption</span></td>\n<td>\n<div><span>↓ Resorption </span></div>\n<div><span>(adequate calcium supply)</span></div>\n<div><span>↑ Resorption </span></div>\n<div><span>(inadequate calcium supply)</span></div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Effect on kidney</strong></span></td>\n<td>\n<div><span>↑ Ca<sup>2+&nbsp;</sup>reabsorption</span></div>\n<div><span>↓ PO<sub>4</sub><sup>3-</sup> reabsorption</span></div>\n</td>\n<td>\n<div><span>↓ Ca<sup>2+</sup> reabsorption</span></div>\n<div><span>↓ PO<sub>4</sub><sup>3-</sup> reabsorption</span></div>\n</td>\n<td>\n<div><span>↑ Ca<sup>2+</sup> reabsorption</span></div>\n<div><span>↑ PO<sub>4</sub><sup>3-</sup> reabsorption</span></div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Effect on intestine</strong></span></td>\n<td>\n<div><span>Indirectly stimulates the conversion of </span></div>\n<div><span>25-OH-D to </span></div>\n<div><span>1,25-(OH)<sub>2</sub>-D</span></div>\n</td>\n<td>&nbsp;</td>\n<td><span>↑ Ca <sup>2+ </sup>and PO<sub>4</sub><sup>3-</sup>&nbsp; absorption</span></td>\n</tr>\n<tr>\n<td><span><strong>Serum calcium</strong></span></td>\n<td><span>↑</span></td>\n<td><span>↓</span></td>\n<td><span>↑</span></td>\n</tr>\n<tr>\n<td><span><strong>Serum phosphorus</strong></span></td>\n<td><span>↓</span></td>\n<td><span>↓</span></td>\n<td><span>↑</span></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(464, 'Physiology', 'PM1503. Distribution of calcium (in mg/dL) in normal human plasma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8a216a47219f4cce93f32131dc37583bx1280x1284.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(465, 'Physiology', 'PM1498. Factors affecting insulin secretion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Stimulators</strong></td>\n<td><strong>Inhibitors</strong></td>\n</tr>\n<tr>\n<td>\n<p>Glucose</p>\n<p>Mannose</p>\n</td>\n<td>\n<p>2-Deoxyglucose</p>\n<p>Mannoheptulose</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucagon</p>\n</td>\n<td>Somatostatin&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Amino acids - leucine arginine</p>\n<p>Intestinal hormones - GIP, GLP-1, gastrin, secretin, CCK</p>\n</td>\n<td>K<sup>+</sup> depletion&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p>&nbsp;</p>\n<p>Leptin</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acetylcholine (Parasympathetic stimulation )</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>β-adrenergic stimulators</p>\n<p>Theophylline</p>\n<p>Sulfonylureas</p>\n</td>\n<td>\n<p>α-adrenergic stimulators (norepinephrine, epinephrine)β-Adrenergic blockers&nbsp; (propranolol)</p>\n<p>Diazoxide</p>\n<p>Thiazide diuretics</p>\n<p>Phenytoin&nbsp;</p>\n<p>Alloxan</p>\n<p>Microtubule inhibitors ( Taxanes, Vinca alkaloids)</p>\n<p>Insulin</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(466, 'Physiology', 'PM1495. Conditions that affect glucocorticoid secretion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Glucocorticoid secretion also increased</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Anxiety</li>\n<li>Physical trauma</li>\n<li>Hemorrhage</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Glucorticoid secretion unaffected</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>High pottasium intake</li>\n<li>Low sodium intake</li>\n<li>Constriction of inferior vena cava in thorax</li>\n<li>Standing</li>\n<li>Secondary hyperaldosteronism (in some cases of heart failure, cirrhosis, and nephrosis)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->'),
(467, 'Physiology', 'PM1494. Secretion of Adrenal Hormones by the different Zones of the Adrenal Cortex and Adrenal Medulla', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Adrenal Cortex</strong></p>\n</td>\n<td>\n<p><strong>Adrenal Medulla </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Zona glomerulosa(15%) </strong></p>\n<p>Mineralocorticoids</p>\n<p>Aldosterone</p>\n<p>Deoxycorticosterone</p>\n</td>\n<td rowspan=\3\>\n<p><strong>Norepinephrine</strong></p>\n<p><strong>Epinephrine</strong></p>\n<p><strong>Dopamine </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Zona fasiculata (50%) </strong></p>\n<p>Glucocorticoids</p>\n<p>Cortisol</p>\n<p>Corticosterone</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Zona reticularis(7%) </strong></p>\n<p>Androgens:</p>\n<ul>\n<li>DHEA</li>\n<li>Androstenedione</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->'),
(468, 'Pharmacology,', 'PM1490. Physiologic effects of thyroid hormone', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>System</td>\n<td>Effect</td>\n</tr>\n<tr>\n<td>Cardiovascular&nbsp;</td>\n<td>\n<ul>\n<li aria-level=\1\>Chronotropic and inotropic actions</li>\n<ul>\n<li aria-level=\2\>↑number of β-adrenergic receptors</li>\n<li aria-level=\2\>↑response to circulating catecholamines&nbsp;</li>\n<li aria-level=\2\>↑the proportion of α-myosin heavy chain</li>\n</ul>\n<li>↓peripheral vascular resistance</li>\n<li aria-level=\1\>↑blood volume (activates RAAS)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Musculoskeletal&nbsp;</td>\n<td>\n<ul>\n<li aria-level=\1\>Catabolic action (protein breakdown)</li>\n<li aria-level=\1\>Promotes normal growth and skeletal maturation&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Nervous</td>\n<td>\n<ul>\n<li aria-level=\1\>Promotes normal brain development</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Gastrointestinal&nbsp;</td>\n<td>\n<ul>\n<li aria-level=\1\>↑Appetite and food intake&nbsp;</li>\n<li aria-level=\1\>↑GI motility&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Respiratory&nbsp;</td>\n<td>\n<ul>\n<li aria-level=\1\>↑Respiratory rate&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Others</td>\n<td>\n<ul>\n<li aria-level=\1\>Carbohydrates: Promotes uptake of glucose into cells by</li>\n<ul>\n<li aria-level=\2\>↑Insulin secretion</li>\n<li aria-level=\2\>↑Gluconeogenesis</li>\n<li aria-level=\2\>↑Glycogenolysis</li>\n</ul>\n<li aria-level=\1\>Lipids&nbsp;</li>\n<ul>\n<li aria-level=\2\>Catabolic action (stimulates lipolysis)</li>\n<li aria-level=\2\>↓LDL (formation of LDL receptors)</li>\n</ul>\n<li aria-level=\1\>Calorigenic: ↑basal metabolic rate&nbsp;</li>\n<li aria-level=\1\>Thermogenic: Heat production&nbsp;</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(469, 'Medicine,', 'PM1488. Types of vasopressin receptors and their functions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\ng-scope\>\n<div class=\ng-scope\>\n<table border=\1\>\n<tbody>\n<tr>\n<td>Receptor</td>\n<td>Localization</td>\n<td>Functions</td>\n</tr>\n<tr>\n<td>V<sub>1a</sub></td>\n<td>\n<ul>\n<li>Vascular smooth muscle</li>\n<li>Platelets</li>\n<li>Hepatocytes</li>\n<li>Myometrium</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Vasoconstriction</li>\n<li>Platelet aggregation</li>\n<li>Glycogenolysis</li>\n<li>Uterine contraction</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>V3/V<sub>1b&nbsp;</sub></td>\n<td>\n<ul>\n<li>Anterior pituitary</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>ACTH release</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>V<sub>2</sub></td>\n<td>\n<ul>\n<li>Basolateral membrane of collecting tubule</li>\n<li>Vascular endothelium</li>\n<li>Vascular&nbsp; smooth muscle</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Upregulation of Aqp2</li>\n<li>vwF &amp; factor 8 release</li>\n<li>Vasodilation</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(470, 'Physiology', 'PM1487. Factors Regulating GH Secretion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Stimuli that increase GH secretion</strong></td>\n<td><strong>Stimuli that decrease GH secretion</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>GHRH</li>\n<li>Testosterone, Estrogen</li>\n<li>Ghrelin</li>\n<li>Glucagon<br><br></li>\n<li>↓ Blood glucose</li>\n<li>↓ FFA</li>\n<li>↑ in certain amino acids (arginine)<br><br></li>\n<li>Fasting or protein deficiency</li>\n<li>Exercise</li>\n<li>Trauma, stress, excitement</li>\n<li>Drugs like Apomorphine, L-Dopa</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Somatostatin (GHIH)</li>\n<li>Exogenous GH</li>\n<li>Somatomedins (IGF-1)</li>\n<li>Cortisol<br><br></li>\n<li>↑ Blood glucose</li>\n<li>↑ FFA<br><br></li>\n<li>REM sleep</li>\n<li>Obesity</li>\n<li>Aging</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>GHRH - Growth hormone releasing hormone<br>GHIH - Growth hormone inhibiting hormone<br>FFA - Free fatty acids</p></div><!---->\n      <!---->\n    </div><!---->'),
(471, 'Physiology', 'PM1485. Direct and Indirect (mediated via IGF-1) effects of Growth Hormone', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Indirect effects of growth hormone are mediated via IGF-I.&nbsp;</p>\n<p>Direct effects of GH are shown below.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4863370e2ad44958a01398e020bb1fe8x1280x923.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(472, 'Physiology,', 'PM1484. Factors affecting prolactin secretion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Increased Prolactin Secretion</strong></td>\n<td><strong>Decreased Prolactin Secretion</strong></td>\n</tr>\n<tr>\n<td>Sleep</td>\n<td>Dopamine</td>\n</tr>\n<tr>\n<td>Stress</td>\n<td>L-Dopa</td>\n</tr>\n<tr>\n<td>Strenuous exercise</td>\n<td>Apomorphine</td>\n</tr>\n<tr>\n<td>Sexual intercourse in women</td>\n<td>Bromocriptine and related ergot derivatives</td>\n</tr>\n<tr>\n<td>Pregnancy</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Nursing</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Breast stimulation in non-lactating women</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Estrogen</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Hypothyroidism</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>TRH</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Opioids</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Phenothiazines, butyrophenones</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Atypical antipsychotics - Risperidone</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Dopamine synthesis inhibitors - α-Methyldopa</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p>H<sub>2</sub> antagonists - Cimetidine, ranitidine</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Imipramines - Amitriptyline, amoxapine</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Serotonin reuptake inhibitors -Fluoxetine</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Calcium channel blockers - Verapamil</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p>Thioxanthenes</p>\n<p>Metoclopramide</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Catecholamine depletors - Reserpine</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(473, 'Physiology', 'PM1483. Cells of Anterior Pituitary', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/843ae844c09346af99204e0a0f875354x1280x1382.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(474, 'Physiology', 'PM1346. Actions of Angiotensin II', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Actions of Angiotensin II</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Produces powerful arteriolar constriction and a rise in SBP and DBP</p>\n<p>Acts directly on the adrenal cortex to increase aldosterone secretion</p>\n<p>Facilitates the release of Norepinephrine by a direct action on postganglionic sympathetic neurons</p>\n<p>Constricts efferent arteriole, thereby increasing filteration fraction and glomerular filteration rate, when there is decreased renal bloodflow</p>\n<p>Direct effect on renal tubules to increase Na<sup>+ </sup>reabsorption</p>\n<p>Acts on brain to decrease sensitivity of baroreceptor reflex, potentiating the pressor effect of AT II</p>\n<p>Acts on brain to increase water intake and increase secretion of ADH and ACTH</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(475, 'Physiology', 'PM0776. Properties of thyroid hormone', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Hormone property</strong></td>\n<td><strong>T3</strong></td>\n<td><strong>T4</strong></td>\n</tr>\n<tr>\n<td>Fraction of total hormone in unbound form</td>\n<td colspan=\2\>0.02%</td>\n</tr>\n<tr>\n<td>Half life</td>\n<td>1 day</td>\n<td>7 days</td>\n</tr>\n<tr>\n<td>Fraction directly from thyroid</td>\n<td>20%</td>\n<td>100%</td>\n</tr>\n<tr>\n<td>Intracellular hormone fraction</td>\n<td>~70%</td>\n<td>~20%</td>\n</tr>\n<tr>\n<td>Relative metabolic potency</td>\n<td>1</td>\n<td>0.3</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(476, 'Physiology', 'PM0375. Neurotransmitters and Neuromodulators', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\154\>\n<p><strong>Small-molecule transmitters</strong></p>\n</td>\n<td width=\251\>\n<p><strong>Large- molecule transmitters</strong></p>\n<p><strong>(Neuropeptide, Slowly Acting</strong></p>\n<p><strong>Transmitters or Growth Factors)</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p><strong>Class I</strong></p>\n<p>Acetylcholine</p>\n<p><strong>Class II: The Amines</strong></p>\n<p>Norepinephrine</p>\n<p>Epinephrine</p>\n<p>Dopamine</p>\n<p>Serotonin</p>\n<p>Histamine</p>\n<p><strong>Class III: Amino Acids</strong></p>\n<p>Gamma-aminobutyric acid</p>\n<p>Glycine</p>\n<p>Glutamate</p>\n<p>Aspartate</p>\n<p><strong>Class IV</strong></p>\n<p>Nitric oxide</p>\n<p>ATP</p>\n</td>\n<td width=\251\>\n<p><strong>Hypothalamic-Releasing Hormones</strong></p>\n<p>TRH</p>\n<p>Luteinizing hormone–releasing hormone</p>\n<p>Somatostatin (growth hormone inhibitory factor)</p>\n<p><strong>Pituitary Peptides</strong></p>\n<p>ACTH</p>\n<p>β-Endorphin</p>\n<p>α-Melanocyte-stimulating hormone</p>\n<p>Prolactin</p>\n<p>LH</p>\n<p>TSH</p>\n<p>Growth hormone</p>\n<p>ADH</p>\n<p>Oxytocin</p>\n<p><strong>Peptides that Act on Gut and Brain</strong></p>\n<p>Enkephalin</p>\n<p>Substance P</p>\n<p>Gastrin</p>\n<p>Cholecystokinin</p>\n<p>VIP</p>\n<p>Nerve growth factor</p>\n<p>Brain-derived neurotropic factor</p>\n<p>Neurotensin</p>\n<p>Insulin</p>\n<p>Glucagon</p>\n<p><strong>From Other Tissues</strong></p>\n<p>Angiotensin II</p>\n<p>Bradykinin</p>\n<p>Carnosine</p>\n<p>Sleep peptides</p>\n<p>Calcitonin</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(477, 'Physiology', 'PM0374. Abnormalities due to Loss- Of or Gain-In Mutation of GPCR or G Proteins', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\134\>\n<p><strong>Site</strong></p>\n</td>\n<td width=\129\>\n<p><strong>Type of Mutation</strong></p>\n</td>\n<td width=\144\>\n<p><strong>Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ width=\408\>\n<p><strong>Receptor (GPCR)</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>Conopsins</p>\n</td>\n<td width=\129\>\n<p>Loss</p>\n</td>\n<td width=\144\>\n<p>Color blindness</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>Rhodopsin</p>\n</td>\n<td width=\129\>\n<p>Loss</p>\n</td>\n<td width=\144\>\n<p>Congenital night blindness; two forms of retinitis pigmentosa</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>V<sub>2</sub> vasopressin</p>\n</td>\n<td width=\129\>\n<p>Loss</p>\n</td>\n<td width=\144\>\n<p>X-linked nephrogenic diabetes insipidus</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>ACTH</p>\n</td>\n<td width=\129\>\n<p>Loss</p>\n</td>\n<td width=\144\>\n<p>Familial glucocorticoid deficiency</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>TSH</p>\n</td>\n<td width=\129\>\n<p>Loss</p>\n</td>\n<td width=\144\>\n<p>Familial hypothyroidism</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>Thromboxane A2</p>\n</td>\n<td width=\129\>\n<p>Loss</p>\n</td>\n<td width=\144\>\n<p>Congenital bleeding</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>Endothelin B</p>\n</td>\n<td width=\129\>\n<p>Loss</p>\n</td>\n<td width=\144\>\n<p>Hirschsprung disease</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>LH</p>\n</td>\n<td width=\129\>\n<p>Gain</p>\n</td>\n<td width=\144\>\n<p>Familial male precocious puberty</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>TSH</p>\n</td>\n<td width=\129\>\n<p>Gain</p>\n</td>\n<td width=\144\>\n<p>Familial nonautoimmune hyperthyroidism</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>Ca<sup>2+</sup></p>\n</td>\n<td width=\129\>\n<p>Gain</p>\n</td>\n<td width=\144\>\n<p>Familial hypercalciuric hypocalcemia</p>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ width=\408\>\n<p><strong>G protein</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>G<sub>s</sub> α</p>\n</td>\n<td width=\129\>\n<p>Loss</p>\n</td>\n<td width=\144\>\n<p>Pseudohypopara thyroidism type 1a</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>G<sub>s</sub> α</p>\n</td>\n<td width=\129\>\n<p>Gain/loss</p>\n</td>\n<td width=\144\>\n<p>Testotoxicosis</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>G<sub>s</sub> α</p>\n</td>\n<td width=\129\>\n<p>Gain (mosaic)</p>\n</td>\n<td width=\144\>\n<p>McCune-Albright syndrome</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>G<sub>s</sub> α</p>\n</td>\n<td width=\129\>\n<p>Gain</p>\n</td>\n<td width=\144\>\n<p>Somatotroph adenomas with acromegaly</p>\n</td>\n</tr>\n<tr>\n<td width=\134\>\n<p>G<sub>i</sub> α</p>\n</td>\n<td width=\129\>\n<p>Gain</p>\n</td>\n<td width=\144\>\n<p>Ovarian and adrenocortical tumors</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(478, 'Physiology', 'PM0373. Calmodulin Dependent Enzymes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\ width=\406\>\n<p><strong>Calmodulin Dependent Enzymes</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p><strong>Enzyme </strong></p>\n</td>\n<td width=\251\>\n<p><strong>Important Physiological Effects</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p>Myosin light-chain kinase</p>\n</td>\n<td width=\251\>\n<p>Contraction of smooth muscles</p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p>Phosphorylase kinase</p>\n</td>\n<td width=\251\>\n<p>Phosphorylation of enzyme glycogen phosphorylase to release glucose-1-phosphate from glycogen (glycogenolysis)</p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p>Ca <sup>2+</sup> /calmodulin kinase I</p>\n<p>Ca <sup>2+</sup> /calmodulin kinase II</p>\n</td>\n<td width=\251\>\n<p>Synaptic function</p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p>Ca <sup>2+</sup> /calmodulin kinase III</p>\n</td>\n<td width=\251\>\n<p>Protein synthesis</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\406\>\n<p><strong>Calmodulin Dependent Phosphatases</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p><strong>Enzyme</strong></p>\n</td>\n<td width=\251\>\n<p><strong>Important Physiological Effects</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p>Calcineurin</p>\n</td>\n<td width=\251\>\n<p>Inactivates Ca<sup>2+</sup> channels by dephosphorylating them</p>\n<p>Prominent role in activating T cells and is inhibited by some immunosuppressants</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(479, 'Pharmacology,', 'PM0371. Mechanisms of Action of Hormones', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\431\>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Types of hormone receptors</strong></td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Hormones that bind to intracellular receptors</strong></td>\n</tr>\n<tr>\n<td rowspan=\3\>Cytoplasmic receptors</td>\n<td>Glucocorticoids</td>\n</tr>\n<tr>\n<td>Mineralocorticoids</td>\n</tr>\n<tr>\n<td>Androgens</td>\n</tr>\n<tr>\n<td rowspan=\2\>Nuclear receptors</td>\n<td>Thyroid hormones</td>\n</tr>\n<tr>\n<td>Vitamins A and D</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Hormones that bind to cell surface receptors</strong></td>\n</tr>\n<tr>\n<td colspan=\2\>1. <strong>G-protein coupled receptors</strong> (GPCR)</td>\n</tr>\n<tr>\n<td rowspan=\9\><strong>Gs</strong>: stimulation of second messenger cAMP</td>\n<td>ACTH, CRH</td>\n</tr>\n<tr>\n<td>TSH, GHRH</td>\n</tr>\n<tr>\n<td>FSH, LH, hCG</td>\n</tr>\n<tr>\n<td>Vasopressin (V<sub>2</sub> receptors)</td>\n</tr>\n<tr>\n<td>Catecholamines (β receptors)</td>\n</tr>\n<tr>\n<td>Somatostatin</td>\n</tr>\n<tr>\n<td>Glucagon</td>\n</tr>\n<tr>\n<td>Secretin</td>\n</tr>\n<tr>\n<td>Parathyroid hormone</td>\n</tr>\n<tr>\n<td rowspan=\3\><strong>Gi:&nbsp;</strong>inhibition of second messenger cAMP</td>\n<td>Catecholamines (ɑ<sub>2</sub> receptors)</td>\n</tr>\n<tr>\n<td>Acetylcholine (M2, M4)</td>\n</tr>\n<tr>\n<td>Somatostatin</td>\n</tr>\n<tr>\n<td rowspan=\11\>\n<p><strong>Gq</strong>:&nbsp;second messenger is phospholipase&nbsp;C or cGMP</p>\n</td>\n<td><strong>Phospholipase C (IP3 DAG pathway):</strong></td>\n</tr>\n<tr>\n<td>GnRH, GHRH, TRH</td>\n</tr>\n<tr>\n<td>Catecholamines (ɑ<sub>1</sub> receptors)</td>\n</tr>\n<tr>\n<td>Vasopressin (V<sub>1</sub> receptor)</td>\n</tr>\n<tr>\n<td>Gastrin</td>\n</tr>\n<tr>\n<td>Cholecystokinin</td>\n</tr>\n<tr>\n<td>Oxytocin</td>\n</tr>\n<tr>\n<td>Acetylcholine (M1, M3, M5)</td>\n</tr>\n<tr>\n<td><strong>cGMP:</strong></td>\n</tr>\n<tr>\n<td>Atrial natriuretic peptide</td>\n</tr>\n<tr>\n<td>Nitric oxide</td>\n</tr>\n<tr>\n<td colspan=\2\>2. <strong>Tyrosine kinase</strong> receptors</td>\n</tr>\n<tr>\n<td rowspan=\5\>Through the <strong>JAK-STAT</strong> (non-receptor tyrosine kinase) or <strong>MAP kinase</strong> (receptor tyrosine kinase) pathway&nbsp;</td>\n<td>Growth factors like IGF, VEGF, FGF, PDGF</td>\n</tr>\n<tr>\n<td>Growth hormone</td>\n</tr>\n<tr>\n<td>Erythropoietin</td>\n</tr>\n<tr>\n<td>Insulin</td>\n</tr>\n<tr>\n<td>Prolactin</td>\n</tr>\n</tbody>\n</table>\n<p><br>Notes: <br>1. Even though the cytoplasmic receptors are present in the cytoplasm, once the <strong>hormone-receptor complex</strong> is formed it moves to the <strong>nucleus</strong> for its actions.<br>2. While receptor tyrosine kinases have intrinsic tyrosine kinase activity, non-receptor tyrosine kinases have an external tyrosine kinase component that interacts with the receptor as and when required.&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(480, 'Medicine,', 'PM0370. Classification of Hormones According to their Chemical Structure', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Proteins and polypeptide hormones</strong></p>\n<ul>\n<li>Large proteins (&gt; 50 amino acids)\n<ul>\n<li>Anterior pituitary hormones: FSH, LH,&nbsp;GH, Prolactin</li>\n<li>Parathyroid hormone</li>\n<li>Insulin</li>\n</ul>\n</li>\n<li>Small peptides (&lt; 50 amino acids)\n<ul>\n<li>Posterior pituitary hormones: Oxytocin, ADH</li>\n<li>ACTH</li>\n<li>Glucagon</li>\n</ul>\n</li>\n</ul>\n<p><strong>Steroid hormones</strong></p>\n<ul>\n<li>Cortisol and aldosterone</li>\n<li>Estrogen and progesterone</li>\n<li>Testosterone</li>\n<li>DHEA</li>\n</ul>\n<p><strong>Derivatives of a specific amino acid</strong></p>\n<ul>\n<li>Tyrosine\n<ul>\n<li>Thyroid hormones</li>\n<li>Catecholamines</li>\n</ul>\n</li>\n<li>Tryptophan\n<ul>\n<li>Serotonin (5-HT)</li>\n<li>Melatonin</li>\n</ul>\n</li>\n<li>Arginine\n<ul>\n<li>Nitric oxide</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(481, 'Physiology', 'PM0338. Changes in Hormone Levels due to Aging', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Changes in hormone levels due to aging:</p>\n<table>\n<tbody>\n<tr>\n<td width=\160\>\n<p><strong>Decrease</strong></p>\n</td>\n<td width=\160\>\n<p><strong>No Change</strong></p>\n</td>\n<td width=\160\>\n<p><strong>Increase</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>Growth hormone&nbsp;</p>\n<p>Luteinizing hormone (men)</p>\n<p>Insulin growth factor I</p>\n<p>Testosterone</p>\n<p>Prolactin</p>\n<p>Estradiol 1</p>\n<p>DHEA and DHEAs&nbsp; Pregnenolone</p>\n<p>25(OH) vitamin D</p>\n<p>Aldosterone</p>\n<p>Vasoactive intestinal peptide</p>\n<p>Melatonin</p>\n</td>\n<td width=\160\>\n<p>&nbsp;</p>\n<p>Thyrotropin</p>\n<p>Thyroid hormones</p>\n<p>Epinephrine</p>\n<p>Glucagon-like peptide</p>\n<p>Gastric inhibitory polypeptide</p>\n</td>\n<td width=\160\>\n<p>Cholecystokinin</p>\n<p>Luteinizing hormone (women)</p>\n<p>Follicle-stimulating hormone</p>\n<p>Cortisol</p>\n<p>Norepinephrine</p>\n<p>Insulin</p>\n<p>Parathormone</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(482, 'Obstetrics & Gynaecology,', 'PM1511. Composition of human semen', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Color</strong></td>\n<td>White and opalescent</td>\n</tr>\n<tr>\n<td><strong>Sperm count</strong></td>\n<td>Average about 100 million/mL, with &lt;20% abnormal form</td>\n</tr>\n<tr>\n<td><strong>pH</strong></td>\n<td>7.35 - 7.50</td>\n</tr>\n<tr>\n<td><strong>Specific gravity</strong></td>\n<td>1.028</td>\n</tr>\n<tr>\n<td>\n<p><strong>Components from seminal vesicles</strong></p>\n<p>(contributes <strong>60%</strong> of total volume)</p>\n</td>\n<td>\n<p>Fructose</p>\n<p>Phosphorylcholine</p>\n<p>Ergothioneine</p>\n<p>Ascorbic acid</p>\n<p>Flavins</p>\n<p>Prostaglandins</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Components from prostate</strong></p>\n<p>(contributes <strong>20%</strong> of total volume)</p>\n</td>\n<td>\n<p>Spermine</p>\n<p>Citric acid</p>\n<p>Cholesterol and phospholipids</p>\n<p>Fibrinolysin and fibrinogenase</p>\n<p>Zinc</p>\n<p>Acid phosphatase</p>\n</td>\n</tr>\n<tr>\n<td><strong>Buffers</strong></td>\n<td>\n<p>Phosphate</p>\n<p>Bicarbonate</p>\n<p>Hyaluronidase</p>\n<p>Magnesium</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(483, 'Physiology,', 'PM1514. Hormonal Regulation of Menstrual Cycle', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/bbc6b519c9284220814b3e53c4f33f7ex1280x2327.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(484, 'ENT,', 'PM1751. Stapedial reflex', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Principle: A loud sound of&nbsp;<strong>70- 100dB above the hearing threshold</strong> of the patient, leads to <strong>bilateral contraction </strong>of the<strong> stapedius muscle</strong>.</p>\n<p><strong>Afferent</strong>: <strong>8<sup>th</sup></strong> cranial nerve.</p>\n<p><strong>Efferent</strong>: <strong>7<sup>th</sup></strong> cranial nerve.</p>\n<p>Centre: <strong>Superior olivary complex</strong> in the brainstem.</p>\n<p>In <strong>afferent palsy</strong>, the reflex is <strong>absent</strong> on <strong>both sides</strong>, and in <strong>efferent palsy</strong> reflex is <strong>absent</strong> only on <strong>the side</strong> of the lesion.</p>\n<p>Clinical significance:</p>\n<ul>\n<li>Can&nbsp;identify<strong> malingerers</strong>.</li>\n<li>To differentiate cochlear and retrocochlear hearing loss- the threshold is <strong>decreased</strong> in <strong>cochlear</strong> lesions because of recruitment whereas it is <strong>increased</strong> or even <strong>absent</strong> in <strong>retrocochlear</strong> lesions.</li>\n<li>Identify the <strong>site</strong> of the<strong> facial nerve lesion- </strong>its presence indicates that the lesion is beyond the nerve to stapedius.</li>\n</ul>\n<p><strong>Acoustic reflex decay</strong>- it is a feature of<strong> retrocochlear hearing loss</strong> (8<sup>th</sup> nerve lesion). A sustained tone of 500-1000Hz delivered 10dB above the acoustic reflex threshold, for a period of 10 seconds, brings the amplitude to 50% (abnormal decay).</p></div><!---->\n      <!---->\n    </div><!---->'),
(485, 'Physiology', 'PM1739. Taste sensations and their mediators', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Taste Sensations</strong></td>\n<td><strong>Mediated by</strong></td>\n</tr>\n<tr>\n<td>Salt</td>\n<td>Na+ channel</td>\n</tr>\n<tr>\n<td>Sweet</td>\n<td>G-protein coupledreceptors (GPCRs)<strong>T1R</strong> family</td>\n</tr>\n<tr>\n<td>Umami</td>\n<td>Glutamate receptor family (mGluR4) and also G- protein coulped receptors (GPCRs) <strong>T1R</strong> family</td>\n</tr>\n<tr>\n<td>Bitter sensations</td>\n<td>G-protein coupledreceptors (GPCRs)<strong>T2R</strong> family</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(486, 'ENT,', 'PM0539. Sensory receptors in the inner ear', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>End Organ</strong></span></p>\n</td>\n<td>\n<p><span><strong>Receptor</strong></span></p>\n</td>\n<td>\n<p><span><strong>Action</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Organ of Corti</span></p>\n</td>\n<td>\n<p><span>Hair cells</span></p>\n</td>\n<td>\n<p><span>Sound conduction</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Ampulla of Semicircular ducts</span></p>\n</td>\n<td>\n<p><span>Cristae</span></p>\n</td>\n<td>\n<p><span>Angular momentum</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Otolith organs: Utricle &amp; saccule</span></p>\n</td>\n<td>\n<p><span>Macula</span></p>\n</td>\n<td>\n<p><span>Linear momentum</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(487, 'Physiology', 'PM2479. Physiologic effects of thyroid hormone', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Target Tissue</strong></p>\n</td>\n<td>\n<p><strong>Effect </strong></p>\n</td>\n<td>\n<p><strong>Mechanism </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heart</p>\n</td>\n<td>\n<p>Chronotropic and inotropic</p>\n</td>\n<td>\n<p>Increased number of β-adrenergic receptors</p>\n<p>Enhanced responses to circulating catecholamines</p>\n<p>Increased proportion of α-myosin heavy chain (with higher ATPase activity)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Adipose tissue</p>\n</td>\n<td>\n<p>Catabolic</p>\n</td>\n<td>\n<p>Stimulated lipolysis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Muscle</p>\n</td>\n<td>\n<p>Catabolic</p>\n</td>\n<td>\n<p>Increased protein breakdown</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bone</p>\n</td>\n<td>\n<p>Developmental</p>\n</td>\n<td>\n<p>Promote normal growth and skeletal development</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nervous system</p>\n</td>\n<td>\n<p>Developmental</p>\n</td>\n<td>\n<p>Promote normal brain development</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gut</p>\n</td>\n<td>\n<p>Metabolic</p>\n</td>\n<td>\n<p>Increased rate of carbohydrate absorption</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lipoprotein</p>\n</td>\n<td>\n<p>Metabolic</p>\n</td>\n<td>\n<p>Formation of LDL receptors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Other</p>\n</td>\n<td>\n<p>Calorigenic</p>\n</td>\n<td>\n<p>Stimulated oxygen consumption by metabolically active tissues (exceptions: testes, uterus, lymph nodes, spleen, anterior pituitary)</p>\n<p>Increased metabolic rate</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(488, 'Pharmacology', 'PM2414. Drugs causing QT prolongation and torsades de pointes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Drugs Associated with QT Prolongation and Torsades de Pointes:</p>\n<p>Antiarrhythmics:</p>\n<ul>\n<li>Sotalol</li>\n<li>Amiodarone</li>\n<li>Quinidine</li>\n<li>Procainamide</li>\n<li>Dofetilide</li>\n<li>Ibutilide</li>\n</ul>\n<p>Antimicrobials:</p>\n<ul>\n<li>Levofloxacin</li>\n<li>Ciprofloxacin</li>\n<li>Gatifloxacin</li>\n<li>Moxifloxacin</li>\n<li>Clarithromycin</li>\n<li>Erythromycin</li>\n<li>Ketoconazole</li>\n<li>Itraconazole</li>\n<li>Rilpivirine</li>\n</ul>\n<p>Antidepressants:</p>\n<ul>\n<li>Amitriptyline</li>\n<li>Desipramine</li>\n<li>Imipramine</li>\n<li>Doxepin</li>\n<li>Fluoxetine</li>\n<li>Sertraline</li>\n<li>Venlafaxine</li>\n</ul>\n<p>Antipsychotics:</p>\n<ul>\n<li>Haloperidol</li>\n<li>Droperidol</li>\n<li>Quetiapine</li>\n<li>Ziprasidone</li>\n<li>Thioridazine</li>\n</ul>\n<p>Others:</p>\n<ul>\n<li>Cisapride</li>\n<li>Sumatriptan</li>\n<li>Zolmitriptan</li>\n<li>Arsenic</li>\n<li>Dolasetron</li>\n<li>Methadone<br>&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(489, 'Pharmacology', 'PM2379. Drug regulatory schedules 1940: (2016 update)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\292\>\n<tbody>\n<tr>\n<td><strong>Schedule</strong></td>\n<td><strong>Details</strong></td>\n</tr>\n<tr>\n<td>Schedule C</td>\n<td><strong>Biological</strong> and other special products e.g. <strong>Toxins, Insulin, Sera &amp; Antibiotics</strong>.</td>\n</tr>\n<tr>\n<td>Schedule D</td>\n<td>List of drugs <strong>exempted from the provision of import</strong> of drugs.</td>\n</tr>\n<tr>\n<td>Schedule F</td>\n<td>\n<p><strong>Blood</strong> and blood products</p>\n<p>F I - Production of Bacterial <strong>vaccines, Anti- Sera</strong></p>\n<p>F II - Specification of standards for <strong>Surgical dressing</strong></p>\n<p>FF- Specification of standard <strong>Ophthalmic</strong> preparation</p>\n</td>\n</tr>\n<tr>\n<td>Schedule G</td>\n<td>With a label of <strong>Caution, dangerous</strong> to use except under <strong>medical supervision</strong>.</td>\n</tr>\n<tr>\n<td>Schedule H</td>\n<td><strong>Prescription</strong> drugs.</td>\n</tr>\n<tr>\n<td>Schedule J</td>\n<td>List of diseases that a drug may not prevent or cure. Eg - <strong>HIV &amp; Atherosclerosis</strong></td>\n</tr>\n<tr>\n<td>Schedule M</td>\n<td>Regulations regarding good manufacturing practices</td>\n</tr>\n<tr>\n<td>Schedule P</td>\n<td>Regulations regarding&nbsp;the <strong>life period</strong> and storage of various drugs.</td>\n</tr>\n<tr>\n<td>Schedule W</td>\n<td>Drugs marketed under <strong>generic</strong> names.</td>\n</tr>\n<tr>\n<td>Schedule X</td>\n<td>Drugs having <strong>abuse</strong> and dependence liability.</td>\n</tr>\n<tr>\n<td>Schedule Y</td>\n<td>Requirement and guidelines for<strong> import/ manufacture or Clinical trials</strong> in India</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(490, 'Pharmacology', 'PM2378. Zero order vs First order kinetics of drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td width=\204\>\n<p><strong>Zero order</strong></p>\n</td>\n<td width=\204\>\n<p><strong>First order</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\204\>\n<p>Constant <strong>amount</strong> of drug is eliminated per unit time</p>\n</td>\n<td width=\204\>Constant <strong>fraction</strong> of drug is eliminated per unit time</td>\n</tr>\n<tr>\n<td width=\204\>\n<p>Rate of elimination is <strong>independent</strong> of plasma concentration</p>\n</td>\n<td width=\204\>Rate of elimination is <strong>proportional</strong> to the plasma concentration</td>\n</tr>\n<tr>\n<td width=\204\>\n<p>Clearance is <strong>more at low</strong> concentration and <strong>less at high</strong> concentration</p>\n</td>\n<td width=\204\>Clearance remains <strong>constant</strong>&nbsp;</td>\n</tr>\n<tr>\n<td width=\204\>\n<p>Half-life is <strong>less at low</strong> concentration and <strong>more at high</strong> concentration</p>\n</td>\n<td width=\204\>Half-life remains <strong>constant</strong></td>\n</tr>\n<tr>\n<td width=\204\>\n<p>Very <strong>few drugs</strong> follow zero-order kinetics, e.g.(<strong>WATT Power</strong>)</p>\n<ul>\n<li><strong>W</strong>arfarin</li>\n<li><strong>A</strong>lcohol,&nbsp;<strong>A</strong>spirin</li>\n<li><strong>T</strong>olbutamide</li>\n<li><strong>T</strong>heophylline&nbsp;</li>\n<li><strong>P</strong>henytoin</li>\n</ul>\n<p>&nbsp;</p>\n</td>\n<td width=\204\><strong>Most of the drugs</strong> follow first order kinetics&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8bee4685a9ae43ae9d112e3d0790eaffx1280x2445.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(491, 'Pharmacology', 'PM2369. Drugs metabolised by glucuronidation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Irinotecan</li>\n<li>Atazanavir</li>\n<li>Statins</li>\n<li>Benzodiazepines</li>\n<li>Estrogen</li>\n<li>morphine</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(492, 'Pharmacology', 'PM2368. Metabolism of drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Drugs metabolized by cyp3A4 enzymes:</strong></p>\n<ul>\n<li>Protease inhibitors</li>\n<li>Statins</li>\n<li>Benzodiazepines</li>\n<li>Amiodarone</li>\n<li>Estrogen</li>\n<li>Erythromycin</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(493, 'Pharmacology', 'PM2367. Dialyzable and non-dialyzable drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong><span class=\mw-headline\>Common dialyzable drugs:&nbsp;</span></strong></p>\n<ul>\n<li><strong>B</strong>arbiturates</li>\n<li><strong>L</strong>ithium</li>\n<li><strong>S</strong>alicylates</li>\n<li><strong>T</strong>heophylline/Caffeine (both are methylxanthines)</li>\n<li><strong>M</strong>ethanol</li>\n<li><strong>E</strong>thylene glycol</li>\n<li><strong>S</strong>odium valproate</li>\n<li><strong>I</strong>soniazid</li>\n<li><strong>C</strong>arbamazepine</li>\n</ul>\n<p><strong>Common Non-Dialyzable Drugs</strong> <strong>(AVOID Dialysis):</strong></p>\n<ul>\n<li><strong>A</strong>- Amphetamines</li>\n<li><strong> V</strong>- Verapamil</li>\n<li><strong>O</strong>- Opiates, Organophosphorous</li>\n<li><strong> I</strong>- Imipramine</li>\n<li><strong> D</strong>- Digoxin</li>\n<li><strong>Dialysis</strong>- Diazepam</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(494, 'Pharmacology', 'PM2365. Drugs which need Therapeutic Drug Monitoring (TDM)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Drugs with a narrow therapeutic index require therapeutic drug monitoring (TDM).</p>\n<p>The mnemonic \<strong>DATLAAT MC</strong>\ can be used.</p>\n<ul>\n<li><strong>D</strong>: Digoxin</li>\n<li><strong>A</strong>: Anti-arrhythmic</li>\n<li><strong>T</strong>: Theophylline</li>\n<li><strong>L</strong>: Lithium</li>\n<li><strong>A</strong>: Aminoglycosides</li>\n<li><strong>A</strong>: Anti-epileptics</li>\n<li><strong>T</strong>: Tricyclic antidepressants</li>\n<li><strong>M</strong>: Methotrexate</li>\n<li><strong>C</strong>: Calcineurin inhibitors</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(495, 'Pharmacology', 'PM2364. Drugs having high first pass metabolism', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Lignocaine</li>\n<li>Propranolol</li>\n<li>Salbutamol</li>\n<li>Theophylline</li>\n<li>Imipramine</li>\n<li>Nitrates<br><br></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(496, 'Pharmacology', 'PM2363. Drugs showing increased absorption in presence of food', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Lithium</li>\n<li>Fibrates</li>\n<li>Halofantrine</li>\n<li>Lumifantrine</li>\n<li>Griseofulvin</li>\n<li>Bedaquiline<br><br></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(497, 'Obstetrics & Gynaecology,', 'PM2022. Teratogenic drugs and the birth defects', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Drugs</strong></td>\n<td><strong>Adverse effects</strong></td>\n</tr>\n<tr>\n<td>Penicillamine</td>\n<td>Cutis laxa syndrome</td>\n</tr>\n<tr>\n<td><strong>Lithium</strong></td>\n<td><strong>Ebstein anomaly</strong></td>\n</tr>\n<tr>\n<td>Isotretinoin</td>\n<td>Facial-ear anomalies, heart disease, CNS anomalies</td>\n</tr>\n<tr>\n<td>Progesterone</td>\n<td>Masculinization of the female fetus</td>\n</tr>\n<tr>\n<td>Quinine</td>\n<td>Abortion, thrombocytopenia, deafness</td>\n</tr>\n<tr>\n<td>Topiramate</td>\n<td>Cleft lip</td>\n</tr>\n<tr>\n<td><strong>Valproate</strong></td>\n<td>Spina bifida, limb defects,&nbsp;<strong>autism spectrum disorder</strong>, facial and cardiac anomalies,&nbsp;<strong>Coarctation of the aorta</strong>, Aortic stenosis, Pulmonary atresia, Ventricular Septal Defect.&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Vitamin D</strong></td>\n<td><strong>Supravalvular aortic stenosis</strong></td>\n</tr>\n<tr>\n<td><strong>Warfarin</strong></td>\n<td>Fetal bleeding, <strong>hypoplastic nasal structures</strong></td>\n</tr>\n<tr>\n<td><strong>Statins</strong></td>\n<td>Vertebral, anal, cardiac, tracheoesophageal fistula, renal, arterial, limb (<strong>VACTERAL</strong>) defects</td>\n</tr>\n<tr>\n<td><strong>Phenytoin</strong></td>\n<td>Ventricular septal defect, Atrial Septal Defect, Coarctation of the aorta, Patent Ductus Arteriosus</td>\n</tr>\n<tr>\n<td>ACE inhibitors and ARBs</td>\n<td>\n<p>Hypoplasia of organs, anuria, irreversible renal failure</p>\n</td>\n</tr>\n<tr>\n<td>Carbimazole and Methimazole</td>\n<td>&nbsp;\n<p>Choanal atresia, aplasia cutis, tracheoesophageal fistula and fetal goiter</p>\n</td>\n</tr>\n<tr>\n<td>Alcohol</td>\n<td>Atrial Septal Defect, Ventricular Septal Defect</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(498, 'Pathology,', 'PM1735. Difference between microsomal and non microsomal enzymes:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>&nbsp;</strong></td>\n<td><strong>Microsomal enzymes</strong></td>\n<td><strong>Non microsomal enzymes</strong></td>\n</tr>\n<tr>\n<td><strong>Location</strong></td>\n<td><strong>Smooth endoplasmic reticulum</strong> (a system of microtubules inside the cell), primarily in liver, also in kidney, intestinal mucosa and lungs</td>\n<td><strong>Cytoplasm and mitochondria</strong> of hepatic cells as well as in other tissues including plasma.</td>\n</tr>\n<tr>\n<td><strong>Reactions catalysed</strong></td>\n<td>Most of the <strong>oxidations, reductions, hydrolysis and glucuronide conjugation</strong>.</td>\n<td>Some oxidations and reductions, many hydrolytic reactions and <strong>all conjugations except</strong> <strong>glucuronidation.</strong></td>\n</tr>\n<tr>\n<td><strong>Induction</strong></td>\n<td>Microsomal enzymes are <strong>inducible </strong>by drugs, diet and other agencies.</td>\n<td><strong>Not inducible</strong></td>\n</tr>\n<tr>\n<td><strong>Examples</strong></td>\n<td>Monooxygenases, cytochrome P450, UGTs,epoxide hydrolases, etc</td>\n<td>Esterases, amidases, some flavoprotein oxidasesand most conjugases</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(499, 'Pharmacology', 'PM1734. Phases of drug metabolism', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Phase I reactions: </strong>They<strong> a</strong><strong>ttach functional groups </strong>to the drugs. This usually leads to the inactivation of the drug.&nbsp;</p>\n<p>Examples:</p>\n<ul>\n<li>Oxidation</li>\n<li>Reduction</li>\n<li>Hydrolysis</li>\n<li>Cyclisation</li>\n<li>Deamination</li>\n</ul>\n<p><strong>Phase II reactions: </strong>They <strong>attach</strong> <strong>conjugates&nbsp;</strong>to the drugs. This&nbsp;facilitates drug elimination from the tissue.&nbsp;</p>\n<p>Examples:</p>\n<ul>\n<li>Glucuronide conjugation</li>\n<li>Sulfate conjugation</li>\n<li>Glycine conjugation</li>\n<li>Glutathione conjugation</li>\n<li>Acetylation</li>\n<li>Methylation</li>\n</ul>\n<p>All phase II reactions are mainly conducted by the non-microsomal enzymes except glucuronidation.</p></div><!---->\n      <!---->\n    </div><!---->'),
(500, 'Anaesthesia,', 'PM0505. The drugs which can be given via the Endotracheal Route', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Lidocaine</li>\n<li>Epinephrine</li>\n<li>Vasopressin</li>\n<li>Atropine</li>\n<li>Naloxone</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(501, 'Community Medicine,', 'PM0355. Phases of Clinical Trials', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Phase I</strong></p>\n<p>(First in human)</p>\n</td>\n<td>\n<p><strong>Phase II</strong></p>\n<p>(First in patient)</p>\n</td>\n<td>\n<p><strong>Phase III</strong></p>\n<p>(Multisite trial)</p>\n</td>\n<td>\n<p><strong>Phase IV</strong></p>\n<p>(Postmarketing)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>10–100&nbsp;</p>\n</td>\n<td>\n<p>50 - 500&nbsp;</p>\n</td>\n<td>\n<p>500 - 3000</p>\n</td>\n<td>\n<p>Large or according to study</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Usually healthy volunteers</p>\n</td>\n<td>\n<p>Patients with the target disease</p>\n</td>\n<td>\n<p>Patients&nbsp; with the target disease</p>\n</td>\n<td>\n<p>Real-world patients</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Open-label study</p>\n</td>\n<td>\n<p>Randomized and controlled trial or blinded</p>\n</td>\n<td>\n<p>Randomized and controlled trial or blinded</p>\n</td>\n<td>\n<p>Usually the observational or open-label</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Human pharmacology and safety</strong>: The study aims at safety and tolerability; PK parameters</p>\n</td>\n<td>\n<p><strong>Therapeutic exploration and dose-ranging</strong>: Efficacy and dose-ranging</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>Therapeutic confirmation/comparison</strong>: Indications&nbsp;are finalized and guidelines for therapeutic use are formulated. Monitoring of adverse reactions</p>\n</td>\n<td>\n<p><strong>Postmarketing surveillance/studies</strong>: Drug interactions; long-term or rare side effects</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Extends from Months to 1year</p>\n</td>\n<td>\n<p>1–2 years</p>\n</td>\n<td>\n<p>3–5 years</p>\n</td>\n<td>\n<p>Unending, after drug approval</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(502, 'Pharmacology', 'PM2136. Beta-blockers with vasodilating properties', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The beta-blockers with <strong>vasodilating</strong> property are:</p>\n<ul>\n<li>Carvedilol</li>\n<li>Labetalol</li>\n<li>Bucindolol</li>\n<li>Celiprolol</li>\n<li>Nebivolol</li>\n<li>Nipradilol</li>\n<li>Carteolol</li>\n<li>Betaxolol</li>\n<li>Bopindolol</li>\n<li>Bevantolol</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(503, 'Medicine,', 'PM1579. Anti-obesity drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Centrally acting </strong>anti-obesity drugs: The biologic effect of these agents on appetite regulation is produced by <strong>augmentation</strong> of the neurotransmission of three monoamines,&nbsp;<strong>norepinephrine</strong>, <strong>serotonin</strong> (<strong>5-HT</strong>) and&nbsp;<strong>dopamine</strong>.</p>\n<ul>\n<li><strong>Phentermine </strong>– Sympathomimetic (Phentermine is usually used in combination with <strong>topiramate</strong>)</li>\n<li><strong>Lorcaserin</strong> – Selective 5-HT2C receptor agonist</li>\n</ul>\n<p><strong>Peripherally acting </strong>medications:</p>\n<ul>\n<li><strong>Orlistat</strong> is a synthetic hydrogenated derivative of a naturally occurring <strong>lipase inhibitor,</strong> lipostatin, that is produced by the mold <em>Streptomyces toxytricini</em>.</li>\n</ul>\n<p>Anti-obesity drugs in development:</p>\n<ul>\n<li><strong>Bupropion</strong>:<strong>&nbsp;</strong>Dopamine and norepinephrine reuptake inhibitor</li>\n<li><strong>Naltrexone</strong>:<strong>&nbsp;</strong>Opioid receptor antagonist</li>\n</ul>\n<p><strong>Liraglutide</strong>:<strong>&nbsp;</strong>Glucagon-like peptide 1 receptor agonist</p>\n<p>Note: Tirzepatide is a GIP and GLP-1 agonist recently approved for weight loss treatment.</p></div><!---->\n      <!---->\n    </div><!---->'),
(504, 'Ophthalmology,', 'PM1170. Important adverse effects of anti-glaucoma drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Anti-glaucoma drug</strong></span></td>\n<td><span><strong>The adverse effects</strong></span></td>\n</tr>\n<tr>\n<td><span>Beta-blockers</span></td>\n<td>\n<p><span>Corneal hypoesthesia</span></p>\n<p><span>Systemic side effects</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Sympathomimetics</span></td>\n<td>\n<p><span>Lid retraction</span></p>\n<p><span>CNS depression and apnea in infants and children (&lt;2 years)</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Prostaglandin analogs</span></td>\n<td>\n<p><span>Eyelash hypertrichosis</span></p>\n<p><span>Macular edema</span></p>\n<p><span>Iris pigmentation (Heterochromia iridis)</span></p>\n<p><span>Peri-orbital fat depletion</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Miotics</span></td>\n<td>\n<p><span>Retinal detachment</span></p>\n<p><span>Cataract</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Carbonic anhydrase inhibitors</span></td>\n<td>\n<p><span>Systemic side effects</span></p>\n<p><span>Corneal edema</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(505, 'Pharmacology', 'PM1169. Cardioselective beta blockers: Mnemonic', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>C</strong>ardioselective <strong>B</strong>eta blockers <strong>A</strong>ct <strong>A</strong>t <strong>N</strong>othing <strong>B</strong>ut <strong>M</strong>yocardium <strong>E</strong>xclusively.</p>\n<ul>\n<li><strong>C</strong>: Celiprolol ( III )</li>\n<li><strong>B</strong>: Bisoprolol</li>\n<li><strong>A</strong>:&nbsp;Acebutolol</li>\n<li><strong>A</strong>: Atenolol</li>\n<li><strong>N</strong>: Nebivolol ( III )</li>\n<li><strong>B</strong>: Betaxolol ( III )</li>\n<li><strong>M</strong>: Metoprolol</li>\n<li><strong>E</strong>: Esmolol</li>\n</ul>\n<p>( III ) - Third generation beta blockers. All the others are second generation beta blockers</p></div><!---->\n      <!---->\n    </div><!---->'),
(506, 'Pharmacology', 'PM1168. Non-selective beta blockers with membrane stabilizing action', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Propranolol: highest </li>\n<li>Carvedilol </li>\n<li>Pindolol </li>\n<li>Labetalol</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(507, 'Pharmacology', 'PM1145. Muscarinic antagonists indicated for detrusor instability/overactive bladder', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Mechanism/Feature</strong></td>\n<td><strong>Drug</strong></td>\n</tr>\n<tr>\n<td>Direct smooth muscle relaxant &nbsp;</td>\n<td>\n<p>Flavoxate</p>\n<p>Oxybutynin</p>\n</td>\n</tr>\n<tr>\n<td>Bladder selective &nbsp;</td>\n<td>\n<p>Tolterodine</p>\n<p>Fesoterodine (prodrug)</p>\n</td>\n</tr>\n<tr>\n<td>Only quaternary compound &nbsp;</td>\n<td>Trospium</td>\n</tr>\n<tr>\n<td>M3 selective &nbsp;</td>\n<td>\n<p>Darifenacin</p>\n<p>Solifenacin</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(508, 'Pharmacology', 'PM1127. Dose dependent action of dopamine', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Dose</strong></td>\n<td><strong>Infusion rate </strong><br><strong>mcg/kg/min</strong>&nbsp;</td>\n<td><strong>Effects </strong></td>\n</tr>\n<tr>\n<td>Low</td>\n<td>&lt;2</td>\n<td><strong>D1</strong> and <strong>D2 </strong>stimulation(D1&gt;D2): Increase in renal blood flow and urine output</td>\n</tr>\n<tr>\n<td>Medium</td>\n<td>2-5</td>\n<td><strong>β<sub>1</sub></strong> stimulation: Additional cardiac stimulation</td>\n</tr>\n<tr>\n<td>High</td>\n<td>5-15</td>\n<td><strong>α<sub>1</sub></strong> stimulation: Vasoconstriction and increase in blood pressure</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(509, 'Pharmacology', 'PM1083. Cranial nerves involved in efferent and afferent outflow', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\213\>\n<p><strong>Parasympathetic outflow (efferent)</strong></p>\n</td>\n<td width=\213\>\n<p><strong>Cranial visceral sensory information (afferent)</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>III: Oculomotor</p>\n<p>VII: Facial</p>\n<p>IX: Glossopharyngeal</p>\n<p>X: Vagus</p>\n</td>\n<td width=\213\>\n<p>V: Trigeminal</p>\n<p>VII: Facial</p>\n<p>IX: Glossopharyngeal</p>\n<p>X: Vagus</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(510, 'Forensic Medicine,', 'PM0867. Muscarinic and Nicotinic Signs and symptoms of Organophosphorus Poisoning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\ width=\527\>\n<tbody>\n<tr>\n<td><strong>Mechanism</strong></td>\n<td><strong>Site affected</strong></td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td rowspan=\6\><strong>Muscarinic</strong></td>\n<td>\n<p>Exocrine glands</p>\n</td>\n<td>\n<p>Salivation, lacrimation, perspiration</p>\n</td>\n</tr>\n<tr>\n<td>Eyes</td>\n<td>\n<p>Miosis, blurred vision</p>\n</td>\n</tr>\n<tr>\n<td>GIT</td>\n<td>Abdominal cramps, vomiting, diarrhea</td>\n</tr>\n<tr>\n<td>\n<p>Respiratory tract</p>\n</td>\n<td>Increased secretions, bronchoconstriction</td>\n</tr>\n<tr>\n<td>Bladder</td>\n<td>\n<p>Urinary frequency, incontinence</p>\n</td>\n</tr>\n<tr>\n<td>CVS</td>\n<td>\n<p>Bradycardia, hypotension</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\2\><strong>Nicotinic</strong></td>\n<td>\n<p>Skeletal muscles</p>\n</td>\n<td>Muscle fasciculations, Flaccid paralysis</td>\n</tr>\n<tr>\n<td>\n<p>CVS</p>\n<p>(through cholinergic stimulation of sympathetic ganglia)</p>\n</td>\n<td>Tachycardia, Transient hypertension</td>\n</tr>\n<tr>\n<td><strong><span>Muscarinic and nicotinic</span></strong></td>\n<td>CNS</td>\n<td>Dizziness, lethargy, fatigue, headache, mental confusion, depression of respiratory centres, convulsions, coma</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(511, 'Pharmacology', 'PM0854. Benign prostatic hyperplasia treatment', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Static component: 5 alpha-reductase inhibitor [eg: Finasteride]</li>\n<li>Dynamic component: Alpha 1 blockers [eg: Tamsulosin, terazosin etc]</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(512, 'Ophthalmology,', 'PM0719. Antiglaucoma drugs: Mechanism of lowering intraocular pressure (IOP) at a glance', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Drugs that increase trabecular outflow</strong></p>\n<ul>\n<li>Miotics (e.g., pilocarpine)</li>\n<li>Epinephrine, dipivefrine</li>\n<li>Bimatoprost</li>\n<li>Rho-kinase inhibitor (Netarsudil)</li>\n</ul>\n<p><strong>Drugs that increase uveoscleral outflow</strong></p>\n<ul>\n<li>Prostaglandins (latanoprost)</li>\n<li>Epinephrine, dipivefrine</li>\n<li>Brimonidine</li>\n<li>Apraclonidine</li>\n</ul>\n<p><strong>Drugs that decrease aqueous production</strong></p>\n<ul>\n<li>Carbonic anhydrase inhibitors (e.g., acetazolamide, dorzolamide)</li>\n<li>Alpha receptor stimulators in ciliary process (e.g., epinephrine, dipivefrine, clonidine, brimonidine, apraclonidine)</li>\n<li>Beta-blockers</li>\n</ul>\n<p><strong>Hyperosmotic agents</strong> - (e.g., glycerol, mannitol, urea)</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/52d74961d2524b3bb5c22c2677259778x1280x1532.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(513, 'Medicine,', 'PM0131. Ipratropium vs Tiotropium', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span>&nbsp;</span></td>\n<td>\n<p><span><strong>Ipratropium</strong></span></p>\n</td>\n<td>\n<p><span><strong>Tiotropium </strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Duration of action</strong></span></p>\n</td>\n<td>\n<p><span>Short</span></p>\n</td>\n<td>\n<p><span>Long</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Frequency of administration</strong></span></p>\n</td>\n<td>\n<p><span>3-4 times/day</span></p>\n</td>\n<td>\n<p><span>Once daily</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Antimuscarinic action</strong></span></p>\n</td>\n<td>\n<p><span>Non-selective</span></p>\n</td>\n<td>\n<p><span>Relatively selective for M1 and M3 receptors</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Paradoxical broncho</strong></span></p>\n<p><span><strong>constriction</strong></span></p>\n</td>\n<td>\n<p><span>Present *</span></p>\n</td>\n<td>\n<p><span>Absent</span></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>*Attributed to the nebulizer solution and other additives added. Blockade of prejunctional M2 receptors that normally inhibit acetylcholine release also can contribute.</p></div><!---->\n      <!---->\n    </div><!---->'),
(514, 'Pharmacology,', 'PM2320. Drugs used in heart failure', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>Drugs used in<strong> acute decompensated heart failure:</strong></div>\n<div>&nbsp;</div>\n<div>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Intravenous vasodilators</strong></td>\n</tr>\n<tr>\n<td>\n<p>Nitroglycerine</p>\n<p>Sodium nitroprusside</p>\n</td>\n<td>Decrease preload and afterload</td>\n</tr>\n<tr>\n<td>Nesiritide</td>\n<td>Recombinant human BNP</td>\n</tr>\n</tbody>\n</table>\n</div>\n<div>&nbsp;</div>\n<div>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Intravenous positive inotropes</strong></td>\n</tr>\n<tr>\n<td>\n<p>Dobutamine</p>\n<p>Dopamine</p>\n<p>Epinephrine</p>\n<p>Norepinephrine</p>\n</td>\n<td>β1 receptor-mediated stimulation of cardiac output</td>\n</tr>\n<tr>\n<td>\n<p>Enoximone</p>\n<p>Milrinone</p>\n</td>\n<td>PDE 3/4 inhibitors</td>\n</tr>\n<tr>\n<td>\n<p>Levosimendan</p>\n<p>Pimobendan</p>\n</td>\n<td>Combined Ca<sup>2+</sup> sensitizers and PDE3 inhibitors</td>\n</tr>\n</tbody>\n</table>\n</div>\n<div>&nbsp;</div>\n<div>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Drugs used for rapid symptom relief</strong></td>\n</tr>\n<tr>\n<td>\n<p>Bumetanide</p>\n<p>Furosemide</p>\n<p>Torasemide</p>\n</td>\n<td>Loop diuretics- used for symptomatic treatment of severe heart failure and acute decompensation.</td>\n</tr>\n<tr>\n<td>Morphine</td>\n<td>Opioid - to calm the patient and decreases cardiac O2 consumption</td>\n</tr>\n</tbody>\n</table>\n</div>\n<div>&nbsp;</div>\n<div>Drugs used in<strong> chronic heart failure:</strong></div>\n<div>\n<table>\n<tbody>\n<tr>\n<td><strong>Drugs</strong></td>\n<td><strong>Uses</strong></td>\n</tr>\n<tr>\n<td>ACE inhibitors</td>\n<td>Used as first-line therapy</td>\n</tr>\n<tr>\n<td>ARBs</td>\n<td>Used in case of intolerance to ACE inhibitors</td>\n</tr>\n<tr>\n<td>Beta-blockers</td>\n<td>Used as first-line therapy &nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Spironolactone</p>\n<p>Eplerenone</p>\n</td>\n<td>Mineralocorticoid receptor antagonists - first-line drugs for symptomatic heart failure.</td>\n</tr>\n<tr>\n<td>SGLT-2 inhibitors</td>\n<td>Used as 1st line therapy- reduces mortality and morbidity</td>\n</tr>\n<tr>\n<td>Sacubitril/Valsartan</td>\n<td>Neprilysin inhibitor/ARB(ARNI)</td>\n</tr>\n<tr>\n<td>Ivabradine</td>\n<td>Inhibitor of I<sub>f</sub>&nbsp;current in the sinoatrial node</td>\n</tr>\n</tbody>\n</table>\n</div>\n<div>&nbsp;</div></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(515, 'Medicine,', 'PM1567. Anti-anginal drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Anti-anginal drugs can be divided into the following categories:</p>\n<ul>\n<li><strong>Nitrates</strong> - dilates veins &gt; arteries, reduces preload</li>\n<li><strong>Calcium channel blockers</strong> - blocks L-type calcium channels\n<ul>\n<li>Dihydropyridines - amlodipine, nifedipine</li>\n<li>Non-dihydropyridines - verapamil, diltiazem</li>\n</ul>\n</li>\n<li><strong>Beta-blockers</strong> - decreases heart rate, contractility and oxygen demand</li>\n<li>Other drugs:&nbsp;\n<ul>\n<li><strong>Ranolazine</strong> - late Na<sup>+</sup>&nbsp;channel blocker</li>\n<li><strong>Ivabradine</strong> - inhibit funny currents in SA node</li>\n<li><strong>Nicorandil</strong> - K<sup>+</sup>-ATP channel agonist</li>\n<li><strong>Trimetazidine</strong> - pFOX inhibitor</li>\n<li><strong>Fasudil</strong> - rho-kinase inhibitor</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(516, 'Medicine,', 'PM1224. Parenteral drugs used in hypertensive emergencies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\113\>\n<p>&nbsp;</p>\n</td>\n<td width=\229\>\n<p><strong>Drugs</strong></p>\n</td>\n<td width=\119\>\n<p><strong>Contraindications</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>Beta-blockers</p>\n</td>\n<td width=\229\>Labetalol, esmolol, metoprolol</td>\n<td width=\119\>\n<p>Heart block, systolic heart failure, asthma bradycardia</p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>Calcium channel blockers</p>\n</td>\n<td width=\229\>\n<p>Clevidipine, nicardipine</p>\n</td>\n<td width=\119\>\n<p>Advanced aortic stenosis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>D1 receptor agonist</p>\n</td>\n<td width=\229\>Fenoldopam</td>\n<td width=\119\>\n<p>Caution in glaucoma</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\3\ width=\113\>\n<p>Vasodilators</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n<td width=\229\>\n<p>Nitroglycerin</p>\n</td>\n<td width=\119\>Pericardial tamponade</td>\n</tr>\n<tr>\n<td width=\229\>\n<p>Nitroprusside</p>\n</td>\n<td width=\119\>Relatively contraindicated in liver failure and renal failure&nbsp;</td>\n</tr>\n<tr>\n<td width=\229\>\n<p>Hydralazine</p>\n</td>\n<td width=\119\>&nbsp;CAD, RHD</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>ACE inhibitors</p>\n</td>\n<td width=\229\>\n<p>Enalaprilat</p>\n</td>\n<td width=\119\>History of angioedema</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>Alpha-blocker</p>\n</td>\n<td width=\229\>\n<p>Phentolamine, Urapidil</p>\n</td>\n<td width=\119\>&nbsp;Aortic stenosis, AV shunt</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>Centrally acting sympatholytics</p>\n</td>\n<td width=\229\>\n<p>Clonidine</p>\n</td>\n<td width=\119\>Severe AV block, sick-sinus syndrome</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(517, 'Pharmacology,', 'PM1209. Drugs used in Pulmonary Arterial Hypertension (PAH)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Drug Class</strong></td>\n<td><strong>Examples</strong></td>\n</tr>\n<tr>\n<td>Prostacyclin derivative</td>\n<td>\n<p>Epoprostenol</p>\n<p>Iloprost</p>\n<p>Treprostinil</p>\n</td>\n</tr>\n<tr>\n<td>Endothelin receptor antagonist</td>\n<td>\n<p>Bosentan</p>\n<p>Ambrisentan</p>\n<p>Macitentan</p>\n</td>\n</tr>\n<tr>\n<td>PDE5 inhibitor</td>\n<td>\n<p>Sildenafil</p>\n<p>Tadalafil</p>\n</td>\n</tr>\n<tr>\n<td>Soluble guanyl cyclase stimulator</td>\n<td>Riociguat</td>\n</tr>\n<tr>\n<td>Calcium channel blocker</td>\n<td>\n<p>Nifedipine</p>\n<p>Diltiazem</p>\n<p>Amlodipine</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(518, 'Pharmacology', 'PM0392. Site and mechanism of action of diuretics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Diuretics&nbsp;</strong></span></td>\n<td><span><strong>Site of action&nbsp;&nbsp;</strong></span></td>\n<td>\n<p><span><strong>Enzyme/receptor</strong><strong>/transporter inhibited&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Carbonic anhydrase inhibitors&nbsp;&nbsp;</strong></span></td>\n<td><span>Proximal tubule&nbsp;&nbsp;</span></td>\n<td><span>Carbonic anhydrase&nbsp;&nbsp;</span></td>\n</tr>\n<tr>\n<td><span><strong>Loop diuretics&nbsp;</strong></span></td>\n<td><span>Thick ascending loop of Henle&nbsp;</span></td>\n<td><span>Na<sup>+</sup>- K<sup>+</sup>- 2Cl<sup>-</sup>&nbsp;symporter</span></td>\n</tr>\n<tr>\n<td><span><strong>Thiazides</strong></span></td>\n<td><span>Distal convoluted tubule&nbsp;</span></td>\n<td><span>Na<sup>+</sup>- Cl<sup>-</sup> symporter</span></td>\n</tr>\n<tr>\n<td><span><strong>Epithelial sodium channel inhibitors&nbsp;</strong></span></td>\n<td><span>Late distal tubule and collecting ducts&nbsp;&nbsp;</span></td>\n<td><span>ENaC&nbsp;</span></td>\n</tr>\n<tr>\n<td><span><strong>Aldosterone antagonists&nbsp;</strong></span></td>\n<td><span>Late distal tubule and collecting ducts&nbsp;</span></td>\n<td><span>Mineralocorticoid receptors (indirectly ENaC)&nbsp;</span></td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1eebed7de1f34fd99539e6c7613f42f0x1280x1306.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(519, 'Medicine,', 'PM0115. Anti-arrhythmic drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7d6c4d5ed4a54f70b2030d71f3d06969x1280x1697.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Class of antiarrhythmic drugs&nbsp;</strong></span></p>\n</td>\n<td>\n<p><span>&nbsp;</span></p>\n<p><span><strong>Mechanism of action</strong></span></p>\n</td>\n<td>\n<p><span><strong>Effect on action potential duration</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class I</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IA</strong></span></p>\n<p><span>Procainamide</span></p>\n<p><span>Quinidine</span></p>\n<p><span>Disopyramide</span></p>\n</td>\n<td>\n<p><span>&nbsp;</span></p>\n<p><span>Na+ channel blockers with significant K<sup>+</sup> channel blocking property</span></p>\n<p><span>&nbsp;</span></p>\n</td>\n<td>\n<p><span>Prolonged</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IB</strong></span></p>\n<p><span>Lidocaine</span></p>\n<p><span>Mexiletine</span></p>\n</td>\n<td><span>Na+ channel blockers with K<sup>+</sup> channel opening property&nbsp;</span></td>\n<td>\n<p><span>Shortened or no effect</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IC</strong></span></p>\n<p><span>Flecainide</span></p>\n<p><span>Propafenone</span></p>\n<p><span>Moricizine</span></p>\n</td>\n<td><span>Na+ channel blockers with negligible K<sup>+</sup> channel blocking property&nbsp;</span></td>\n<td>\n<p><span>Variable or no effect</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class II</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Propranolol</span></p>\n<p><span>Esmolol</span></p>\n</td>\n<td><span>β- blockers</span></td>\n<td><span>-&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class III</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Amiodarone, dronedarone</span></p>\n<p><span>Dofetilide</span></p>\n<p><span>Sotalol</span></p>\n<p><span>Ibutilide</span></p>\n<p><span>Vernakalant</span></p>\n</td>\n<td><span>K<sup>+</sup> channel blockers&nbsp;</span></td>\n<td><span>Prolonged&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Class IV</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Verapamil</span></p>\n<p><span>Diltiazem</span></p>\n</td>\n<td><span>Ca<sup>2+</sup> channel blockers</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Miscellaneous</strong></span></p>\n</td>\n<td><span>&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Adenosine</span></p>\n</td>\n<td><span>Activates adenosine receptors</span></td>\n<td><span>Shortened</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Digoxin</span></p>\n</td>\n<td><span>Na<sup>+</sup>-K<sup>+</sup> ATPase inhibitor</span></td>\n<td><span>Increases AV node refractoriness</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Magnesium</span></p>\n</td>\n<td><span>Unknown</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(520, 'Pharmacology', 'PM0092. Types of calcium channels and their blockers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Type&nbsp;of Calcium Channel</strong></td>\n<td><strong>Blockers</strong></td>\n</tr>\n<tr>\n<td>L type</td>\n<td>Verapamil, diltiazem, dihydropyridines</td>\n</tr>\n<tr>\n<td>T type</td>\n<td>Flunarizine, ethosuximide, mibefradil</td>\n</tr>\n<tr>\n<td>N type</td>\n<td>Gabapentin, ziconotide</td>\n</tr>\n<tr>\n<td>P/Q type</td>\n<td>Omega agatoxin IVa</td>\n</tr>\n<tr>\n<td>R type</td>\n<td>SNX-482, Omega agatoxin IIIa</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(521, 'Medicine,', 'PM0486. Effect of diuretics on excretion of electrolytes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Diuretics</strong></td>\n<td><strong>Sodium</strong></td>\n<td><strong>Potassium</strong></td>\n<td><strong>Calcium</strong></td>\n</tr>\n<tr>\n<td><strong>Carbonic anhydrase inhibitors</strong></td>\n<td>↑</td>\n<td>↑↑</td>\n<td>No change</td>\n</tr>\n<tr>\n<td><strong>Osmotic diuretics</strong></td>\n<td>↑↑</td>\n<td>↑</td>\n<td>↑</td>\n</tr>\n<tr>\n<td><strong>Loop diuretics</strong></td>\n<td>↑↑</td>\n<td>↑↑</td>\n<td>↑↑</td>\n</tr>\n<tr>\n<td><strong>Thiazides</strong></td>\n<td>↑</td>\n<td>↑↑</td>\n<td>↓</td>\n</tr>\n<tr>\n<td><strong>Epithelial sodium channel blockers</strong></td>\n<td>↑</td>\n<td>↓</td>\n<td>↓</td>\n</tr>\n<tr>\n<td><strong>Aldosterone antagonists</strong></td>\n<td>↑</td>\n<td>↓</td>\n<td>Insufficient data</td>\n</tr>\n</tbody>\n</table>\n<p>Acute effects of thiazides on Ca<sup>2+</sup> excretion are variable but when administered chronically, it decreases Ca<sup>2+</sup> excretion.</p></div><!---->\n      <!---->\n    </div><!---->'),
(522, 'Pharmacology', 'PM2484. Mechanism of action of common anti-epileptics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Mechanism of action of some common antiepileptics:</p>\n<table>\n<tbody>\n<tr>\n<td>Mechanism of action</td>\n<td>Antiepileptics</td>\n</tr>\n<tr>\n<td>Sodium channel blockers</td>\n<td>\n<ul>\n<li>Phenytoin</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Eslicarbazepine</li>\n<li>Lamotrigine &nbsp; &nbsp;&nbsp;</li>\n<li>Topiramate &nbsp; &nbsp; &nbsp;</li>\n<li>Felbamate</li>\n<li>Valproate</li>\n<li>Rufinamide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Calcium-channel blockers</td>\n<td>\n<ul>\n<li>Valproate</li>\n<li>Lamotrigine &nbsp;&nbsp;</li>\n<li>Ethosuximide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA<sub>A&nbsp;</sub>receptor modulators</td>\n<td>\n<ul>\n<li>Benzodiazepine</li>\n<li>Phenobarbital</li>\n<li>Felbamate</li>\n<li>Primidone</li>\n<li>Topiramate</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Stiripentol</li>\n<li>Clobazam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA uptake inhibitors</td>\n<td>\n<ul>\n<li>Tiagabine</li>\n<li>Vigabatrin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Synaptic vesicle glycoprotein 2A(SV2A) inhibitors</td>\n<td>\n<ul>\n<li>Levetiracetam</li>\n<li>Brivaracetam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>NMDA receptor antagonist</td>\n<td>\n<ul>\n<li>Felbamate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>AMPA/Kainate receptor antagonist</td>\n<td>\n<ul>\n<li>Phenobarbital</li>\n<li>Topiramate</li>\n<li>Perampanel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HCN channel activity enhancers</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Inhibitors of brain carbonic anhydrase</td>\n<td>\n<ul>\n<li>Acetazolamide</li>\n<li>Zonisamide</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Potassium-channel openers</td>\n<td>\n<ul>\n<li>Retigabine</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(523, 'Pharmacology,', 'PM2424. Medical treatment of Parkinsons disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Increase dopaminergic action</strong></td>\n<td><strong>Anti cholinergics</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Dopamine precursor</strong><strong>&nbsp; &nbsp; &nbsp; &nbsp;</strong></p>\n</td>\n<td><strong>Anti muscarinic </strong></td>\n</tr>\n<tr>\n<td>Levodopa</td>\n<td>Benzhexol (trihexyphenidyl)</td>\n</tr>\n<tr>\n<td><strong>Dopa decarboxylase inhibitor </strong></td>\n<td>Benztropine</td>\n</tr>\n<tr>\n<td>Carbedopa</td>\n<td>Procyclidine</td>\n</tr>\n<tr>\n<td>Benserazide</td>\n<td><strong>H1 antagonist </strong></td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Ergot derivatives</strong></td>\n<td>Promethazine</td>\n</tr>\n<tr>\n<td>Bromocriptine</td>\n<td>Orphenadrine</td>\n</tr>\n<tr>\n<td>Cabergoline</td>\n<td>Diphenhydramine</td>\n</tr>\n<tr>\n<td>Pergolide</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Lisuride</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine agonist-Non ergot&nbsp;derivatives</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Ropinirole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Pramipexole</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rotigotine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Apomorphine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Dopamine facilitator </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Amantadine</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>MAO-B inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Selegiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Rasagiline</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>COMT inhibitor </strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Tolcapone</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Entacapone</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(524, 'Psychiatry,', 'PM2418. Actions of antipsychotic drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Dopaminergic pathway</strong></td>\n<td><strong>Significance</strong></td>\n<td><strong>Action of drug blocking D2 receptors</strong></td>\n</tr>\n<tr>\n<td><strong>Nigrostriatal</strong></td>\n<td>Movement</td>\n<td>Extrapyramidal symptoms</td>\n</tr>\n<tr>\n<td><strong>Mesolimbic</strong></td>\n<td>Speech, grasp of reality, mentation, and mood</td>\n<td>Reduces positive symptoms of schizophrenia</td>\n</tr>\n<tr>\n<td><strong>Mesocortical</strong></td>\n<td>Motivation, pleasure, socialization</td>\n<td>May increase negative symptoms of schizophrenia</td>\n</tr>\n<tr>\n<td><strong>Tuberoinfundibular pathway</strong></td>\n<td>Inhibits prolactin release</td>\n<td>Hyperprolactinemia</td>\n</tr>\n<tr>\n<td><strong>Chemoreceptor trigger zone</strong></td>\n<td>Vomiting reflex</td>\n<td>Anti emetic</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(525, 'Psychiatry,', 'PM2415. Adverse effects of specific antidepressants', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Drug</strong></p>\n</td>\n<td>\n<p><strong>Side effect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Amitriptyline</strong></p>\n</td>\n<td>\n<p>sedation, antimuscarinic, <strong>hypotension</strong>, <strong>arrhythmia,</strong> seizures</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Fluoxetine</strong></p>\n</td>\n<td>\n<p>Nausea, anorexia,<strong> loss of libido,</strong> insomnia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Trazodone</strong></p>\n</td>\n<td>\n<p>Sedative, <strong>priapism</strong>, hypotension</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Bupropion</strong></p>\n</td>\n<td>\n<p>Seizures, mild tachycardia, hypertension</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mirtazapine</strong></p>\n</td>\n<td>\n<p>Sedative, increased appetite, weight gain</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(526, 'Anaesthesia,', 'PM2301. Unique features of Nitrous oxide', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Concentration-effect</strong></p>\n<ul>\n<li>The blood gas partition coefficient of N<sub>2</sub>O is 35 times higher&nbsp;than O<sub>2</sub> and N<sub>2,</sub>&nbsp;hence its rapid uptake diminishes its volume and&nbsp;concentrates&nbsp;the remaining anesthetics in the alveolus.</li>\n</ul>\n<p><strong>Second-gas effect</strong></p>\n<ul>\n<li>Concentration-effect of one gas over another is known as the second gas effect</li>\n<li>Increase in the partial pressure of the <strong>2nd gas</strong> (Oxygen and volatile agents) due to the <strong>rapid uptake</strong> of N<sub>2</sub>O during <strong>induction.</strong></li>\n</ul>\n<p><strong>Diffusion hypoxia (Finks effect)</strong></p>\n<ul>\n<li><strong>Rapid elimination </strong>of N<sub>2</sub>O during recovery causes a reduction in the partial pressure of oxygen leading to<strong> hypoxia</strong></li>\n<li>Avoided by using 100% oxygen for 10 minutes during recovery from anesthesia.</li>\n</ul>\n<p><strong>Nitrous oxide in gas-filled spaces</strong></p>\n<div class=\page\ title=\Page 181\>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li>It diffuses into air-containing cavities more rapidly than air (principally nitrogen) can be absorbed by the bloodstream</li>\n<li>If the walls surrounding the cavity are rigid, pressure rises instead of volume.</li>\n</ul>\n<p>Hence N<sub>2</sub>O is <strong>contraindicated</strong> in:</p>\n<ul>\n<li>Venous or arterial air embolism</li>\n<li>Acute intestinal obstruction</li>\n<li>Pneumocephalus, pneumothorax</li>\n<li>Pulmonary air cysts</li>\n<li>Intraocular air bubbles</li>\n<li>Tympanic membrane grafting.</li>\n</ul>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(527, 'Psychiatry,', 'PM2079. Antipsychotic drugs and their potential to cause side effects', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Side effect</strong></span></div>\n</td>\n<td>\n<div><span><strong>Highest potential</strong></span></div>\n</td>\n<td>\n<div><span><strong>Least potential</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Anticholinergic</strong></span></div>\n</td>\n<td>\n<div><span>Chlorpromazine, Thioridazine&nbsp;</span></div>\n</td>\n<td>\n<div><span>Haloperidol, Risperidone</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Hypotension</strong></span></div>\n</td>\n<td>\n<div><span>Chlorpromazine, Clozapine</span></div>\n</td>\n<td>\n<div><span>Haloperidol, Aripiprazole</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Sedation</strong></span></div>\n</td>\n<td>\n<div><span>Clozapine, Chlorpromazine</span></div>\n</td>\n<td>\n<div><span>Aripiprazole, Ziprasidone</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Metabolic syndrome</strong>,&nbsp;<strong>Diabetes</strong></span></div>\n</td>\n<td>\n<div><span>Clozapine, Olanzapine</span></div>\n</td>\n<td>\n<div><span>Aripiprazole, Ziprasidone</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Weight gain</strong></span></div>\n</td>\n<td>\n<div><span>Clozapine, Olanzapine</span></div>\n</td>\n<td>\n<div><span>Aripiprazole, Haloperidol</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Hyperprolactinemia</strong></span></div>\n</td>\n<td>\n<div><span>Amisulpride, Haloperidol, Risperidone</span></div>\n</td>\n<td>\n<div><span>Aripiprazole, Quetiapine</span></div>\n<div><span>Clozapine, Olanzapine- almost zero risk (mild risk)</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Extrapyramidal effects</strong></span></div>\n</td>\n<td>\n<div><span>Haloperidol</span></div>\n</td>\n<td>\n<div><span>Clozapine, Quetiapine</span></div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(528, 'Pharmacology,', 'PM1697. Important Adverse Effects of Anti-epileptic Drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Antiepileptic drugs</strong></p>\n</td>\n<td>\n<p><strong>Adverse effects</strong></p>\n</td>\n</tr>\n<tr>\n<td>Carbamazepine</td>\n<td>Stevens-Johnson syndrome (SJS), diplopia, ataxia, hyponatremia</td>\n</tr>\n<tr>\n<td>Phenytoin</td>\n<td>Gum hyperplasia, hirsutism, osteomalacia, ataxia</td>\n</tr>\n<tr>\n<td>Valproic acid</td>\n<td>Hepatotoxicity, thrombocytopenia, transient alopecia, tremors, pancreatitis</td>\n</tr>\n<tr>\n<td>Phenobarbital</td>\n<td>Sedation, depression, ataxia, automatism</td>\n</tr>\n<tr>\n<td>Vigabatrin</td>\n<td>Loss of peripheral vision</td>\n</tr>\n<tr>\n<td>Felbamate</td>\n<td>Fulminant hepatic failure, aplastic anemia</td>\n</tr>\n<tr>\n<td>Lamotrigine</td>\n<td>Hypersensitivity reactions, SJS</td>\n</tr>\n<tr>\n<td>Topiramate</td>\n<td>Paresthesias, renal calculi, weight loss, acute glaucoma</td>\n</tr>\n<tr>\n<td>Oxcarbazepine</td>\n<td>Hyponatremia, SJS</td>\n</tr>\n<tr>\n<td>Ezogabine</td>\n<td>Urinary retention</td>\n</tr>\n<tr>\n<td>Zonisamide</td>\n<td>Renal calculi</td>\n</tr>\n<tr>\n<td>Perampanel</td>\n<td>Homicidal ideation</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(529, 'Pharmacology,', 'PM1695. First-line Agents in Different Types of Seizures', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Type of seizure&nbsp;</strong></td>\n<td><strong>1st-line antiepileptic drugs</strong></td>\n</tr>\n<tr>\n<td>\n<p>Focal seizures&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine&nbsp;</li>\n<li>Lamotrigine</li>\n<li>Levetiracetam</li>\n<li>Phenytoin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GTCS&nbsp;</td>\n<td>\n<ul>\n<li aria-level=\1\>Sodium valproate</li>\n<li aria-level=\1\>Levetiracetam&nbsp;</li>\n<li aria-level=\1\>Lamotrigine&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Typical absence seizures&nbsp;</td>\n<td>\n<ul>\n<li><strong>Ethosuximide&nbsp;</strong>(drug of choice)</li>\n<li>Sodium valproate</li>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Atypical absence seizures</td>\n<td>\n<ul>\n<li aria-level=\1\>Sodium valproate&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Myoclonic seizures</td>\n<td>\n<ul>\n<li aria-level=\1\><strong>Sodium valproate</strong> (drug of choice)</li>\n<li aria-level=\1\>Lamotrigine</li>\n<li aria-level=\1\>Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(530, 'Psychiatry,', 'PM1560. Pure opioid antagonists', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Naloxone</strong>: short-acting opioid antagonist with duration of action of 1-2 hours. Used in opioid overdose and respiratory depression in newborns due to perinatal opioid use.</p>\n<p><strong>Naltrexone</strong>: long-acting opioid antagonist with effects lasting till 48 hours. Used for prevention of relapse in opioid addiction treatment. It is associated with hepatotoxicity. It does not suppress craving in opioid addiction but suppresses craving in chronic alcoholics.</p>\n<p><strong>Nalmefene</strong>: long-acting opioid antagonist with a half-life of 8-10 hours administered intravenously. Used in opioid overdose like naloxone.</p></div><!---->\n      <!---->\n    </div><!---->'),
(531, 'Medicine,', 'PM1163. CNS Stimulants and Depressants', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>CNS stimulants</strong></td>\n<td><strong>CNS depressants</strong></td>\n</tr>\n<tr>\n<td>\n<p>Directly acting on CNS:</p>\n<ul>\n<li>Cortical: Caffeine, Aminophylline, Amphetamine, Ephedrine</li>\n<li>Medullary: Picrotoxin, Adrenaline</li>\n<li>Spinal: Strychnine, Brucine</li>\n</ul>\n<p>Reflexly acting on CNS:</p>\n<ul>\n<li>Nicotine, Lobetine</li>\n</ul>\n</td>\n<td>\n<p>Sedatives: Diazepam, Oxazepam</p>\n<p>Hypnotics: Clonazepam, Nitrazepam</p>\n<p>Alcohol: Dose dependant sedative-hypnotic</p>\n<p>Narcotics: Morphine, Codeine</p>\n<p>General anesthetics: Barbiturates, Halothane</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(532, 'Anaesthesia,', 'PM0532. Classification of Local Anesthetics based on the Potency', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ol>\n<li><strong>Low Potency -&nbsp;</strong>Procaine</li>\n<li><strong>Intermediate Potency</strong>\n<ul>\n<li>Mepivacaine</li>\n<li>Prilocaine</li>\n<li>Chloroprocaine</li>\n<li>Lidocaine</li>\n</ul>\n</li>\n<li><strong>High Potency</strong>\n<ul>\n<li>Tetracaine</li>\n<li>Bupivacaine</li>\n<li>Etidocaine</li>\n</ul>\n</li>\n</ol></div><!---->\n      <!---->\n    </div><!---->'),
(533, 'Anaesthesia,', 'PM0531. Classification of local anesthetics based on duration of action', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Short</strong> duration of action ( 20-45 minutes):</p>\n<ul>\n<li>Procaine</li>\n<li>Chloroprocaine</li>\n</ul>\n<p><strong>Intermediate</strong> duration ( 60-120 minutes):</p>\n<ul>\n<li>Lidocaine</li>\n<li>Mepivacaine</li>\n<li>Prilocaine</li>\n</ul>\n<p><strong>Long</strong> duration (400-450 minutes):</p>\n<ul>\n<li>Tetracaine</li>\n<li>Bupivacaine</li>\n<li>Ropivacaine</li>\n<li>Etidocaine</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(534, 'Anaesthesia,', 'PM0529. Classification of opioids based on their action on opioid receptors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\page\ title=\Page 569\>\n<table><colgroup><col><col><col><col><col><col><col><col> </colgroup>\n<tbody>\n<tr>\n<td colspan=\1\ rowspan=\2\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Generic Name</strong></p>\n</div>\n</div>\n</td>\n<td colspan=\3\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Receptor Effects&nbsp;</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>µ</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>δ</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>κ</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Morphine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>+++</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>+</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Methadone</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>+++</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Meperidine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>+++</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Fentanyl</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>+++</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Sufentanil</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>+++</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>+</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>+</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Codeine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>±</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Pentazocine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>±</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>+</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Nalbuphine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>-</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>++</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Buprenorphine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>±</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>-</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>-</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Butorphanol</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>±</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>+++</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n<div class=\page\ title=\Page 569\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>+++, ++, +, strong agonist; ±, partial or weak agonist; -, antagonist.</p>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(535, 'Psychiatry,', 'PM0526. Non extrapyramidal side effects of antipsychotics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Typical antipsychotics</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Drug</strong></td>\n<td><strong>Side effects</strong></td>\n</tr>\n<tr>\n<td>Chlorpromazine</td>\n<td>Corneal &amp; lenticular deposits, <strong>vortex keratopathy</strong>, obstructive jaundice</td>\n</tr>\n<tr>\n<td>Thioridazine</td>\n<td>Irreversible <strong>retinal pigmentation</strong>,&nbsp;QT prolongation</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>Atypical antipsychotics</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Drug</strong></td>\n<td><strong>Side effects</strong></td>\n</tr>\n<tr>\n<td>Clozapine</td>\n<td><strong>Agranulocytosis,</strong> metabolic syndrome, diabetes, weight gain, <strong>wet pillow syndrome</strong> (excessive night time drooling)</td>\n</tr>\n<tr>\n<td>Olanzapine</td>\n<td>Metabolic syndrome, diabetes, weight gain</td>\n</tr>\n<tr>\n<td>Quetiapine</td>\n<td><strong>Cataract</strong></td>\n</tr>\n<tr>\n<td>Ziprasidone</td>\n<td><strong>QT prolongation</strong></td>\n</tr>\n<tr>\n<td>Amisulpride</td>\n<td>Hyperprolactinemia</td>\n</tr>\n<tr>\n<td>Aripiprazole</td>\n<td><strong>Hypoprolactinemia</strong>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(536, 'Anaesthesia,', 'PM0517. Ceiling effect of opioids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\184\>\n<tbody>\n<tr>\n<td><strong>Drug </strong></td>\n<td><strong>Correlation of Respiratory Depression With Dose</strong></td>\n</tr>\n<tr>\n<td>Morphine</td>\n<td><br>\n<p>Increases proportionally with dose (i.e. no ceiling effect)</p>\n</td>\n</tr>\n<tr>\n<td>Buprenorphine</td>\n<td><br>\n<p>Ceiling effect at 0.15-1.2 mg in adults</p>\n</td>\n</tr>\n<tr>\n<td>Butorphanol</td>\n<td><br>\n<p>Ceiling effect at 30-60 μg/kg</p>\n</td>\n</tr>\n<tr>\n<td>Nalbuphine</td>\n<td>\n<p>Ceiling effect at 30 mg in adults</p>\n</td>\n</tr>\n<tr>\n<td>Pentazocine&nbsp;</td>\n<td>\n<p>Ceiling effect suggested</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(537, 'Anaesthesia,', 'PM0515. High Yield Points in Opioids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Post thoracotomy pain managed by: IV fentanyl</li>\n<li>Drug of choice for controlling severe pain in cancer patients: Morphine</li>\n<li>Drug of choice for OPD analgesia: Alfentanyl</li>\n<li>Most potent: sufentanyl</li>\n<li>Shortest acting opioid-remifentanyl</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(538, 'Anaesthesia,', 'PM0514. Effects of opioid on its various receptors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\541\>\n<tbody>\n<tr>\n<td><strong>Effects</strong></td>\n<td><strong>Mu(μ) receptor</strong></td>\n<td><strong>Kappa(κ) receptor</strong></td>\n<td><strong>Delta(δ) receptor</strong></td>\n</tr>\n<tr>\n<td><strong>IUPHAR name</strong></td>\n<td>MOP</td>\n<td>KOP</td>\n<td>DOP</td>\n</tr>\n<tr>\n<td><strong>Analgesia</strong></td>\n<td>\n<p>Supraspinal</p>\n<p>spinal</p>\n</td>\n<td>Supraspinal, spinal</td>\n<td>Supraspinal; spinal (modulates mu-receptor activity)</td>\n</tr>\n<tr>\n<td><strong>Cardiovascular&nbsp;</strong></td>\n<td>Bradycardia</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Respiratory</strong></td>\n<td>Depression</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Central nervous system</strong></td>\n<td>Euphoria, sedation, prolactin release,mild hypothermia, catalepsy, indifference to environmental stimulus</td>\n<td>Sedation, dysphoria, psychomimetic reactions (hallucinations, delirium)</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Pupil</strong></td>\n<td>Miosis</td>\n<td>Miosis</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Gastrointestinal</strong></td>\n<td>Inhibition of peristalsis, nausea, vomiting</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Genitourinary</strong></td>\n<td>Urinary retention</td>\n<td>Diuresis(inhibition of vasopressin release)</td>\n<td>Urinary retention</td>\n</tr>\n<tr>\n<td><strong>Pruritus</strong></td>\n<td>&nbsp;Yes</td>\n<td>&nbsp;</td>\n<td>Yes&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Physical dependence</strong></td>\n<td>&nbsp;Yes</td>\n<td>&nbsp;Low abuse potential</td>\n<td>Yes&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Antishivering</strong></td>\n<td>&nbsp;</td>\n<td>&nbsp;Yes</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(539, 'Psychiatry,', 'PM0502. Lithium in bipolar disorder', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Guidelines for Lithium therapy</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Indications</strong>:</div>\n<div>Mania, hypomania, bipolar disorder, etc.</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Blood levels of lithium</strong>:</p>\n<p>For <strong>therapeutic</strong> purpose (treatment of acute mania) :&nbsp;<strong>0.8-1.2 mEq/L</strong></p>\n<p>For <strong>prophylaxis</strong> (to prevent relapse of bipolar disorder):&nbsp;<strong>0.5-0.8 mEq/L</strong></p>\n<p><strong>Toxic</strong> levels of lithium:&nbsp;<strong>&gt;/= 1.5 mEq/L</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Contraindications</strong>:</div>\n<div>\n<ul>\n<li>CKD</li>\n<li>Heart disease</li>\n<li>Hyponatremia or diuretic use</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Baseline studies:</strong></div>\n<div>\n<ul>\n<li>BUN (Blood Urea Nitrogen), Creatinine, Calcium, Urine analysis</li>\n<li>Thyroid function test</li>\n<li>ECG in patients with coronary risk factors</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Acute a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Tremor, ataxia, weakness</li>\n<li>Polyuria, polydipsia</li>\n<li>Vomiting, diarrhea</li>\n<li>Cognitive impairment</li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Chronic a</strong><strong>dverse effects</strong>:</div>\n<div>\n<ul>\n<li>Nephrogenic diabetes insipidus</li>\n<li>Thyroid dysfunction</li>\n<li>Hyperparathyroidism</li>\n</ul>\n</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(540, 'Anaesthesia,', 'PM0493. Anaesthetic drugs in patients with reduced renal function', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Inhaled anaesthetics:</strong></p>\n<ul>\n<li>Safe- halothane, isoflurane, desflurane</li>\n<li>Unsafe- methoxyflurane, enflurane, and sevoflurane</li>\n</ul>\n<p>&nbsp;<strong>Intravenous anaesthetics:</strong></p>\n<ul>\n<li>Safe- Propofol, Ultrashort acting barbiturates like thiopental, methohexital</li>\n<li>Unsafe- Benzodiazepines such as diazepam</li>\n</ul>\n<p>&nbsp;<strong>Opioids:</strong></p>\n<ul>\n<li>Safe- Remifentanil&gt; Fentanyl &gt; Alfentanil &gt; Sufentanil</li>\n<li>Unsafe:\n<ul>\n<li>Morphine (metabolized to morphine 3/6 glucuronide which is excreted through the kidney)</li>\n<li>Meperidine (metabolite normeperidine is excreted through the kidney)</li>\n<li>Hydromorphone (metabolite H-3-glucuronide accumulate in renal failure patients)</li>\n</ul>\n</li>\n</ul>\n<p>&nbsp;<strong>Muscle relaxants:</strong></p>\n<ul>\n<li>Safe- Atracurium, Cisatracurium</li>\n<li>Unsafe- Rocuronium, Mivacurium</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(541, 'Pharmacology,', 'PM0479. Extrapyramidal side effects of antipsychotic drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Adverse reactions</strong></span></div>\n</td>\n<td>\n<div><span><strong>Time of onset</strong></span></div>\n</td>\n<td>\n<div><span><strong>Features</strong></span></div>\n</td>\n<td>\n<div><span><strong>Treatment</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Acute dystonia</strong></span></div>\n</td>\n<td>\n<div class=\p1\><span>1 to 5 days</span></div>\n</td>\n<td>\n<div class=\p1\><span>Spasm of muscles of tongue, face, neck, back</span></div>\n</td>\n<td>\n<div class=\p1\><span>Diphenhydramine or benztropine</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Akathisia</strong></span></div>\n</td>\n<td>\n<div class=\p1\><span>5 to 60 days</span></div>\n</td>\n<td>\n<div class=\p1\><span>Restlessness</span></div>\n</td>\n<td>\n<div><span><strong>Propranolol</strong>,<strong>&nbsp;</strong>lorazepam, diphenhydramine, benztropine</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Parkinsonism</strong></span></div>\n</td>\n<td>\n<div class=\p1\><span>5 to 30 days</span></div>\n</td>\n<td>\n<div class=\p1\><span>Bradykinesia, rigidity, tremors</span></div>\n</td>\n<td>\n<div class=\p1\><span>Dose reduction, change medication, antiparkinsonian agents</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Tardive dyskinesia</strong></span></div>\n</td>\n<td>\n<div class=\p1\><span>Months to years</span></div>\n</td>\n<td>\n<div class=\p1\>\n<div class=\p1\><span>Orofacial dyskinesia (may be reversible with early recognition and drug discontinuation)</span></div>\n</div>\n</td>\n<td>\n<div class=\p1\><span>VMAT-2 inhibitors <strong>valbenazine</strong> and <strong>deutetrabenazine</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Neuroleptic malignant syndrome</strong></span></div>\n</td>\n<td>\n<div class=\p1\><span>Weeks to months</span></div>\n</td>\n<td>\n<div class=\p1\><span>Extreme rigidity, fever, unstable blood pressure</span></div>\n</td>\n<td>\n<div class=\p1\><span><strong>Dantrolene</strong></span></div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(542, 'Anaesthesia,', 'PM0422. Maximum dose of local anaesthetics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Local Anesthetic</strong></p>\n</td>\n<td colspan=\2\>\n<p><strong>Maximum dose</strong></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Plain</td>\n<td>\n<p>With adrenaline</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lidocaine</p>\n</td>\n<td>\n<p><strong>4.5 mg/kg</strong>&nbsp;up to 300 mg&nbsp;</p>\n</td>\n<td>\n<p><strong>7 mg/kg </strong>up to 500 mg</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bupivacaine&nbsp;</p>\n</td>\n<td>\n<p>175mg</p>\n</td>\n<td>200 mg</td>\n</tr>\n<tr>\n<td>\n<p>Ropivacaine</p>\n</td>\n<td>\n<p>200 mg</p>\n</td>\n<td>250 mg</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(543, 'Anaesthesia,', 'PM0420. Systemic Absorbtion of Local Anaesthetic in the Order of Occurrence', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Systemic absorption</strong> of a local anesthetic depends on <strong>vascularity.</strong></p>\n<p>The highest blood concentrations are seen following:</p>\n<ol>\n<li>Intravenous (intraarterial) injection (maximum)</li>\n<li>Intercostal nerve blockade</li>\n<li>Paracervical block</li>\n<li>Caudal epidural block</li>\n<li>Lumbar epidural block</li>\n<li>Brachial plexus block</li>\n<li>Sciatic block</li>\n<li>Subcutaneous injection (minimum)</li>\n</ol></div><!---->\n      <!---->\n    </div><!---->'),
(544, 'Pharmacology,', 'PM0415. Classification of local anesthetics based on chemical structure', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Amino ester</strong></td>\n<td><strong>Amino amide</strong></td>\n</tr>\n<tr>\n<td><strong>Stability</strong></td>\n<td>Relatively <strong>unstable</strong> in solution</td>\n<td>Relatively more <strong>stable</strong> due to the presence of methoxy group</td>\n</tr>\n<tr>\n<td>\n<p><strong>Metabolism&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>Plasma cholinesterase</strong></p>\n<p>Exception:&nbsp;<strong>Cocaine - </strong>predominantly by&nbsp;hepatic carboxylesterase</p>\n</td>\n<td>\n<p><strong>Hepatic metabolism </strong>(amidase)</p>\n<p>Exception:&nbsp;<strong>Articaine</strong>&nbsp;- plasma cholinesterase.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Duration of action</strong></p>\n</td>\n<td>\n<p>Shorter-acting</p>\n<p>Exception:&nbsp;<strong>Tetracaine</strong></p>\n</td>\n<td>\n<p>Longer-acting</p>\n<p>Exception:&nbsp;<strong>Articaine</strong>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Allergic reaction</strong></td>\n<td>High incidence due to metabolite PABA</td>\n<td>Rare</td>\n</tr>\n<tr>\n<td>\n<p><strong>Examples&nbsp;</strong></p>\n</td>\n<td>\n<ul>\n<li>Proca<strong>i</strong>ne</li>\n<li>Chlorproca<strong>i</strong>ne</li>\n<li>Coca<strong>i</strong>ne</li>\n<li>Benzoca<strong>i</strong>ne</li>\n<li>Tetraca<strong>i</strong>ne</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>L<strong>i</strong>doca<strong>i</strong>ne</li>\n<li>Mep<strong>i</strong>vaca<strong>i</strong>ne</li>\n<li>Pr<strong>i</strong>loca<strong>i</strong>ne</li>\n<li>Bup<strong>i</strong>vaca<strong>i</strong>ne</li>\n<li>Rop<strong>i</strong>vaca<strong>i</strong>ne</li>\n<li>Et<strong>i</strong>doca<strong>i</strong>ne</li>\n<li>D<strong>i</strong>buca<strong>i</strong>ne</li>\n<li>Art<strong>i</strong>ca<strong>i</strong>ne</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(545, 'Anaesthesia,', 'PM0364. Classification of  Opioids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Naturally Occurring:</strong></p>\n<ul>\n<li>Morphine</li>\n<li>Codeine (methyl morphine)</li>\n<li>Papaverine</li>\n<li>Thebaine</li>\n</ul>\n<p><strong>Semisynthetic:</strong></p>\n<ul>\n<li>Heroin (diacetyl morphine)</li>\n<li>Dihydromorphone, morphinone</li>\n<li>Thebaine derivatives (e.g., etorphine, buprenorphine)</li>\n</ul>\n<p><strong>Synthetic:</strong></p>\n<ul>\n<li>Morphinan series (e.g., levorphanol, butorphanol)</li>\n<li>Diphenylpropylamine series (e.g., methadone)</li>\n<li>Benzomorphan series (e.g., pentazocine)</li>\n<li>Phenylpiperidine series (e.g., meperidine, fentanyl, sufentanil, alfentanil, remifentanil)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(546, 'Psychiatry,', 'PM0340. Pharmacological treatment of psychosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>First-generation </strong>antipsychotics are generally not preferred due to the higher risk of<strong> extrapyramidal side effects/ tardive dyskinesia.</strong></p>\n<p><strong>Second-generation</strong> antipsychotics are preferred drugs:</p>\n<ul>\n<li>Risperidone</li>\n<li>Olanzapine</li>\n<li>Quetiapine</li>\n<li>Aripiprazole</li>\n<li>Ziprasidone</li>\n<li>Paliperidone</li>\n</ul>\n<p><strong>Benzodiazepines</strong> can be added to treat associated agitation. It is the <strong>drug of choice for catatonia</strong>.</p>\n<p>Special situations:</p>\n<ul>\n<li><strong>Emergency</strong>: Use a <strong>short-acting intramuscular agent</strong> such as <strong>haloperidol</strong>, fluphenazine, olanzapine, or ziprasidone.</li>\n<li>Chronic compliance: Long-acting injectable is used.</li>\n<li>Treatment resistance (2 failed trials): Consider Clozapine.</li>\n<li><strong>All meds ineffective</strong>: May consider <strong>ECT</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(547, 'Anaesthesia,', 'PM0247. Muscle relaxant with histamine release.', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Muscle relaxants causing histamine release leading to hypotension, tachycardia, flushing:</p>\n<p><strong>Most</strong> likely:<strong>&nbsp;d-tubocurarine</strong></p>\n<p>Likely:<strong>&nbsp;</strong></p>\n<ul>\n<li>Atracurium</li>\n<li>Mivacurium</li>\n<li>Succinyl choline</li>\n</ul>\n<p>Least likely:</p>\n<ul>\n<li>Vecuronium</li>\n<li>Cisatracurium</li>\n<li>Rocuronium</li>\n<li>Pancuronium</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(548, 'Anaesthesia,', 'PM0242. Side effects of succinyl choline', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>The following are the side effects of succinyl choline:</strong></p>\n<ul>\n<li>Cardiovascular effects:\n<ul>\n<li>Sinus bradycardia</li>\n<li>Junctional rhythms</li>\n<li>Ventricular dysrhythmias</li>\n</ul>\n</li>\n<li>Hyperkalemia</li>\n<li>Myalgia</li>\n<li>Masseter spasm: Succinyl choline can trigger malignant hyperthermia</li>\n<li>Increased intracranial pressure:&nbsp;Succinylcholine may lead to an activation of the EEG and slight increases in CBF&nbsp;and ICP in some patients.</li>\n<li>Increased intraocular pressure</li>\n<li>Increased intragastric pressure</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(549, 'Pharmacology,', 'PM0241. High yield in muscle relaxants', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>\n<div><strong>Shortest</strong> <strong>acting</strong> <strong>non-depolarizing</strong> muscle relaxant:\n<ul>\n<li>Gantacurium (Not FDA approved)</li>\n<li><strong>Mivacurium</strong>:&nbsp;<strong>12-20 minutes</strong>.<strong>&nbsp;</strong>(FDA approved)</li>\n</ul>\n</div>\n</li>\n<li>\n<div><strong>Shortest acting</strong> <strong>depolarizing</strong> muscle relaxant: <strong>Succinylcholine</strong> (3-6 minutes)</div>\n</li>\n<li>\n<div>Muscle relaxant having the <strong>maximum duration of action</strong>: <strong>Doxacurium</strong> (benzylisoquinoline) &gt; Pancuronium (Aminosteroid)</div>\n</li>\n<li>\n<div>Muscle relaxant causing pain on IV injection site: Rocuronium</div>\n</li>\n<li>\n<div>Muscle relaxant which <strong>crosses placenta</strong>: <strong>Gallamine</strong></div>\n</li>\n<li>\n<div>Muscle relaxant acting directly on muscle: Dantrolene</div>\n</li>\n<li>\n<div>Muscle relaxants with central action: benzodiazepine, mephenesin, baclofen, carisoprodol, metaxalone</div>\n</li>\n<li>\n<div>Muscle relaxant and mode of clearance:</div>\n<ul>\n<li>\n<div><strong>Hepatic</strong> clearance: Pancuronium,&nbsp;rapacuronium and vecuronium</div>\n</li>\n<li>\n<div><strong>Biliary</strong> clearance: Vecuronium and rocuronium</div>\n</li>\n<li>\n<div><strong>Renal</strong> clearance: Doxacurium, pancuronium, vecuronium, and pipecuronium</div>\n</li>\n</ul>\n</li>\n<li>\n<div>Muscle relaxant with <strong>sympathetic stimulation</strong>:</div>\n<ul>\n<li>\n<div><strong>Gallamine</strong></div>\n</li>\n<li>\n<div><strong>Pancuronium</strong></div>\n</li>\n</ul>\n</li>\n<li>\n<div>Muscle relaxant with <strong>vagolytic activity</strong>:</div>\n<ul>\n<li>\n<div><strong>Gallamine</strong></div>\n</li>\n<li>\n<div><strong>Pancuronium</strong></div>\n</li>\n<li>\n<div><strong>Rocuronium (mild)</strong></div>\n</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(550, 'Anaesthesia,', 'PM0217. Conditions causing susceptibility to succinylcholine-induced hyperkalemia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The conditions that predispose to hyperkalemia following succinylcholine administration are:</p>\n<ul>\n<li>Burn injury</li>\n<li>Massive trauma, head and spinal cord injury</li>\n<li>Severe intra-abdominal infection</li>\n<li>Encephalitis, tetanus and stroke</li>\n<li>Neuropathy like Guillain-Barre syndrome</li>\n<li>Severe Parkinson’s disease</li>\n<li>Prolonged total body immobilization</li>\n<li>Hemorrhagic shock with metabolic acidosis</li>\n<li>Myopathies (eg, Duchenne’s dystrophy)</li>\n</ul>\n<p>So, the use of succinylcholine is relatively contraindicated in patients having these conditions.</p></div><!---->\n      <!---->\n    </div><!---->'),
(551, 'Anaesthesia,', 'PM0215. Types of muscle relaxants', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>There are 2 types of muscle relaxants: depolarizing and non-depolarizing.</p>\n<p><strong>Depolarizing</strong> Muscle Relaxant-<strong>&nbsp;Succinylcholine</strong></p>\n<p><strong>Non-Depolarizing</strong> Muscle Relaxants:</p>\n<ul>\n<li><strong>Ultra short-</strong>acting (&lt;10 minutes) - Gantacurium</li>\n<li><strong>Short</strong>-acting (10-20 minutes) -&nbsp;Mivacurium</li>\n<li><strong>Intermediate-</strong>acting (20-50 minutes)\n<ul>\n<li>Atracurium</li>\n<li>Cisatracurium</li>\n<li>Vecuronium</li>\n<li>Rocuronium</li>\n</ul>\n</li>\n<li><strong>Long-</strong>acting (&gt;50 minutes)\n<ul>\n<li>Pancuronium</li>\n<li>Doxacurium</li>\n<li>Pipecuronium</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(552, 'Anaesthesia,', 'PM0181. A list of anaesthetics and their physiological effects', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>Condition</strong></p>\n</td>\n<td>\n<p><strong>Anesthetics</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Increased Intracranial tension (ICT)</strong></p>\n</td>\n<td>\n<p>Sevoflurane</p>\n<p>Desflurane</p>\n<p>Isoflurane</p>\n<p>Enflurane</p>\n<p>Methoxiflurane</p>\n<p>Halothane</p>\n<p>Ketamine</p>\n<p>Nitrous Oxide (N2O)</p>\n<p>Succinyl-choline</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Decreased ICT</strong></p>\n</td>\n<td>\n<p>Barbiturates (e.g.thiopentone)</p>\n<p>Benzodiazepines</p>\n<p>Cyclopropane</p>\n<p>Droperidol</p>\n<p>Etomidate</p>\n<p>Lidocaine</p>\n<p>Propofol</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Increased Intraocular pressure (IOP)</strong></p>\n</td>\n<td>\n<p>Barbiturates (e.g. thiopentone)</p>\n<p>Cyclopropane</p>\n<p>Etomidate</p>\n<p>Succinyl Choline</p>\n<p>Ketamine</p>\n<p>N2O</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Decreased IOP</strong></p>\n</td>\n<td>\n<p>Morphine</p>\n<p>Halothane</p>\n<p>Hexamethonium</p>\n<p>Trimethaphan</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Increased Blood pressure</strong></p>\n</td>\n<td>\n<p>Ketamine</p>\n<p>Pentazocin</p>\n<p>Pancuronium</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Bronchodilation (preferred in asthamatics)</strong></p>\n</td>\n<td>\n<p>Ketamine (most potent)&nbsp;</p>\n<p>Sevofluorane</p>\n<p>Halothane&nbsp;</p>\n<p>Promethazine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Bronchospasmodics (contraindicated in asthamatics)</strong></p>\n</td>\n<td>\n<p>d-TC</p>\n<p>N2O</p>\n<p>Thiopentone</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(553, 'Pharmacology,', 'PM0123. Adverse effects of Phenytoin', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>Phenytoin adverse effects - Most of them<strong> start with “H”</strong></div>\n<div>&nbsp;</div>\n<ul>\n<li><strong>H</strong>yperplasia of gums</li>\n<li><strong>H</strong>irsutism</li>\n<li><strong>H</strong>ypersensitivity reactions: rashes, lymphadenopathy</li>\n<li><strong>H</strong>yperglycemia</li>\n<li><strong>H</strong>ypocalcemia and osteomalacia</li>\n<li><strong>H</strong>allucinations and behavioral abnormalities</li>\n<li><strong>H</strong>epatotoxicity</li>\n<li>Fetal <strong>H</strong>ydantoin Syndrome</li>\n<li>Cerebellar and vestibular symptoms: ataxia, nystagmus</li>\n<li><strong>H</strong>ypotension, purple glove syndrome and arrhythmias on IV use</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(554, 'Pharmacology,', 'PM2442. WHO 2018 guidelines for post exposure prophylaxis regimen in HIV', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\page\ title=\Page 39\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>An HIV post-exposure prophylaxis regimen with two ARV drugs is effective, but three drugs are preferred.</p>\n<p>The recent MOHFW January 2020 guidelines on the management of PEP in HIV recommends the replacement of 2 drug regimen with 3 drug regimen referring to WHO December 2018 guidelines on PEP management protocol in HIV. This shift towards recommending a three-drug regimen for<br>everyone was based on the availability of less toxic and better-tolerated medications.</p>\n<div class=\page\ title=\Page 39\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>ADULTS AND ADOLESCENTS:-</strong></p>\n<p>Preferred backbone regimen -&nbsp;TDF + 3TC (or FTC)</p>\n<p>New drug - &nbsp;DTG is the preferred third drug for HIV post-exposure prophylaxis</p>\n<p>New drug -&nbsp;<span>ATV/r, DRV/r, LPV/r and RAL may be considered as alternative third drug options for post-exposure prophylaxis</span></p>\n<p><strong>CHILDREN:-</strong></p>\n<div class=\page\ title=\Page 39\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Preferred backbone regimen -&nbsp;AZT + 3TC</p>\n<div class=\page\ title=\Page 39\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>ABC + 3TC or TDF + 3TC (or FTC) can be considered as alternative regimens</p>\n<p>New drug -&nbsp;DTG is the preferred third drug for HIV post-exposure prophylaxis</p>\n<p>New drug -&nbsp;<span>ATV/r, DRV/r, LPV/r and RAL may be considered as alternative third drug options for post-exposure prophylaxis</span></p>\n<p>&nbsp;</p>\n<p><span>Legend</span></p>\n<p><span>TDF - Tenofovir disoproxil fumarate&nbsp;</span></p>\n<p>3TC - Lamivudine&nbsp;</p>\n<p>FTC - Emtricitabine&nbsp;</p>\n<p>DTG - Dolutegravir&nbsp;</p>\n<p>ATV/r - Atazanavir + ritonavir&nbsp;</p>\n<p>DRV/r - Darunavir + ritonavir&nbsp;</p>\n<p>LPV/r - Lopinavir + ritonavir&nbsp;</p>\n<p>RAL - Raltegravir&nbsp;</p>\n<p>AZT - Zidovudine&nbsp;</p>\n<p>ABC - Abacavir&nbsp;</p>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n<div class=\page\ title=\Page 39\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(555, 'Microbiology,', 'PM2433. Acute bacterial meningitis - causes and empirical treatment', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Patient Group</strong></td>\n<td><strong>Bacterial Pathogen</strong></td>\n<td><strong>Empirical Therapy</strong></td>\n</tr>\n<tr>\n<td>Age&lt;1 month</td>\n<td>\n<p><em>E. coli</em></p>\n<p>Group B Streptococci</p>\n<p>Enterobacteriacea</p>\n<p><em>Listeria monocytogenes</em></p>\n</td>\n<td>3rd generation Cephalosporin+<br>Ampicillin</td>\n</tr>\n<tr>\n<td>1 month - 2 years</td>\n<td>\n<p><em>E. coli</em></p>\n<p>Group B Streptococci</p>\n<p><em>H. influenza</em></p>\n<p><em>S. pneumonia</em></p>\n<p><em>N. meningitidis</em></p>\n</td>\n<td>3rd generation Cephalosporin+<br>Ampicillin+<br>Vancomycin (if PRSP suspected)</td>\n</tr>\n<tr>\n<td>2 - 50 years and no risk factors for Listeria</td>\n<td><em>S. pneumoniae</em><br><em>N. meningitidis</em><br><br></td>\n<td>\n<p>3rd generation cephalosporin+<br>Vancomycin</p>\n</td>\n</tr>\n<tr>\n<td>Age &gt; 50 yrs and/or risk factors for Listeria</td>\n<td><em>S. pneumoniae</em><br><em>N. meningitidis</em><br><em>L. monocytogenes</em><br>Group B Streptococci</td>\n<td>\n<p>3rd generation cephalosporin+<br>Vancomycin+<br>Ampicillin</p>\n</td>\n</tr>\n<tr>\n<td>Post-craniotomy/Head trauma/CSF Rhinorrhea</td>\n<td>Gram negative bacilli</td>\n<td>\n<p>Ceftazidime+<br>Vancomycin</p>\n</td>\n</tr>\n<tr>\n<td>Post-shunt surgery/ Ommaya reservoir</td>\n<td>\n<p><em>S. aureus</em><br>Coagulase-negative staphylococci</p>\n</td>\n<td>Ceftazidime+<br>Vancomycin</td>\n</tr>\n<tr>\n<td>Immunocompromised state&nbsp;</td>\n<td>\n<p><em>&nbsp;S. pneumoniae&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; </em></p>\n<p><em>N. meningitidis&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</em></p>\n<p><em>L. monocytogenes&nbsp; &nbsp; &nbsp; &nbsp;</em></p>\n<p>Gram negative bacilli&nbsp;</p>\n</td>\n<td>\n<p>Vancomycin+&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Ampicillin+&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Cefepime&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;OR&nbsp;</p>\n<p>Vancomycin+&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Meropenem&nbsp; &nbsp; &nbsp;&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>*PRSP= penicillin-resistant S pneumoniae&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(556, 'Pharmacology,', 'PM2339. Mechanism of action of Antifungal drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/223d24b7e0d84721a94c23176114c9dax1280x2560.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(557, 'Medicine,', 'PM2190. Empirical Antibiotic Treatment of Community-Acquired Pneumonia (CAP)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>Situation&nbsp;</td>\n<td>Treatment Regimen</td>\n</tr>\n<tr>\n<td>&nbsp;<strong>Outpatient</strong></td>\n<td>\n<p><strong>Previously healthy</strong>:</p>\n<p>&nbsp;Macrolide / Doxycycline</p>\n<p><strong>Comorbidities</strong>:</p>\n<p>Respiratory Fluoroquinolone&nbsp;</p>\n<p><strong>&nbsp; &nbsp; &nbsp; Or&nbsp;&nbsp;</strong>&nbsp; &nbsp; &nbsp;</p>\n<p>β-lactam + Macrolide / Doxycycline</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inpatients</strong></p>\n<p><strong>Non - ICU</strong></p>\n</td>\n<td>\n<p>Respiratory<strong>&nbsp;</strong>Fluoroquinolone&nbsp;</p>\n<p><strong>Or&nbsp;</strong></p>\n<p>β-lactam&nbsp;<strong>+</strong>&nbsp;Macrolide / Doxycycline</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inpatients</strong></p>\n<p><strong>ICU</strong></p>\n</td>\n<td>\n<p>β-lactam</p>\n<p><strong>+</strong></p>\n<p>Respiratory Fluoroquinolone <strong>Or</strong>&nbsp;Azithromycin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\><strong>If Pseudomonas</strong></p>\n&nbsp;</td>\n<td>\n<p><strong>&nbsp;</strong>Anti-pseudomonal&nbsp;β-lactam</p>\n<p><strong>+</strong></p>\n<p>Fluoroquinolone*&nbsp;<strong>Or</strong> Aminoglycoside</p>\n<p><strong>+ </strong></p>\n<p>Azithromycin</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p class=\p1\><strong>If CA-MRSA</strong></p>\n</td>\n<td>\n<p>Site based regimen</p>\n<p><strong>+</strong></p>\n<p>Linezolid <strong>Or&nbsp;</strong>Vancomycin</p>\n<p><strong>+</strong></p>\n<p>Clindamycin&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Note:</strong></p>\n<p>Macrolide - Azithromycin / Clarithromycin</p>\n<p>Fluoroquinolones :</p>\n<ul>\n<li>Respiratory Fluoroquinolone - Levofloxacin* / Moxifloxacin / (Gemifloxacin - only outpatient)&nbsp;</li>\n<li>Ciprofloxacin*</li>\n</ul>\n<p>β-lactam :</p>\n<ul>\n<li>Outpatient with comorbidities&nbsp;\n<ul>\n<li>PO - Amoxicillin (+/- clavulanate)/ Cefpodoxime / Cefuroxime&nbsp;</li>\n<li>IV - Ceftriaxone</li>\n</ul>\n</li>\n<li>Inpatient, Non-ICU (IV)&nbsp;\n<ul>\n<li>Ampicillin / Ceftriaxone / Cefotaxime / Ertapenem</li>\n</ul>\n</li>\n<li>Inpatient, ICU (IV)&nbsp;\n<ul>\n<li>Ampicillin-Sulbactam / Ceftriaxone / Cefotaxime</li>\n</ul>\n</li>\n<li>Anti-pseudomonal&nbsp;β-lactam (IV)&nbsp;\n<ul>\n<li>Piperacillin-Tazobactam / Cefepime / Imipenem / Meropenem&nbsp;</li>\n</ul>\n</li>\n</ul>\n<p class=\p1\>Aminoglycoside - Amikacin / T<span class=\s1\>obramycin</span></p></div><!---->\n      <!---->\n    </div><!---->'),
(558, 'Microbiology,', 'PM2042. List of intrinsic drug resistance in bacteria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Organism</strong></td>\n<td><strong>Intrinsic Drug Resistance</strong></td>\n</tr>\n<tr>\n<td>\n<p>Acinetobacter baumanii</p>\n</td>\n<td>\n<p>Ampicillin,Amoxicillin,Ertapenem,Trimethoprim,Chloramphenicol</p>\n</td>\n</tr>\n<tr>\n<td>Pseudomonas aeruginosa</td>\n<td>Ampicillin,Amoxicillin-Clavulanate,Ceftriaxone,Ertapenem,Tetracyclines/Tigecyclines, Trimethoprim-sulfamethoxazole,Chloramphenicol</td>\n</tr>\n<tr>\n<td>Bacteroides fragilis</td>\n<td>Aminoglycosides,Ampicillin</td>\n</tr>\n<tr>\n<td>Gram positive bacteria</td>\n<td>Aztreonam</td>\n</tr>\n<tr>\n<td>Staphylococcus saprophyticus&nbsp;</td>\n<td>Novobiocin</td>\n</tr>\n<tr>\n<td>Enterococcus fecalis/fecium</td>\n<td>Cephalosporins,Aminoglycosides,Clindamycin,Polymyxin B</td>\n</tr>\n<tr>\n<td>Clostridium species&nbsp;</td>\n<td>Aminoglycosides</td>\n</tr>\n<tr>\n<td>Gram negative bacteria</td>\n<td>Vancomycin</td>\n</tr>\n<tr>\n<td>Klebsiella pneumoniae</td>\n<td>Ampicillin</td>\n</tr>\n<tr>\n<td>Enterobacter</td>\n<td>Ampicillin</td>\n</tr>\n<tr>\n<td>Aerobic bacteria</td>\n<td>Metronidazole</td>\n</tr>\n<tr>\n<td>Lactobacillus &amp; Leuconostoc</td>\n<td>Vancomycin</td>\n</tr>\n<tr>\n<td>Burkholderia</td>\n<td>Polymyxins</td>\n</tr>\n</tbody>\n</table>\n<p><strong>&nbsp;</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(559, 'Dermatology,', 'PM1966. Lepra Reactions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Lepra Reactions:</strong></p>\n<table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>Type 1 Reaction</strong></p>\n<p>(Reversal/Upgrading)</p>\n</td>\n<td>\n<p><strong>Type 2 Reaction</strong></p>\n<p>(Erythema Nodosum Leprosum)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mainly seen in the&nbsp;<strong>Borderline</strong> spectrum (BT, BB, BL)</p>\n<p><strong>Most severe</strong> in Borderline Lepromatous(BL) leprosy</p>\n</td>\n<td>Mainly seen in <strong>LL</strong>(50%)&gt;BL(15%)</td>\n</tr>\n<tr>\n<td>\n<p>Usually seen <strong>within 12 months</strong> of initiation of Multidrug Therapy</p>\n</td>\n<td><strong>Unrelated</strong> to Multidrug therapy. May occur before, during or after treatment</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type 4</strong> Hypersensitivity</p>\n<p>Due to <strong>enhanced cell-mediated response</strong>&nbsp;increased destruction of bacilli following treatment in reversal</p>\n</td>\n<td>\n<p><strong>Type 3</strong> Hypersensitivity</p>\n<p>Primarily Humoral</p>\n<p>(<strong>Immune complex Deposition</strong> in tissues and vessels)</p>\n<p>Cytokine involved - <strong>TNF-α</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inflammation of <strong>existing skin lesions</strong> (red, painful edematous skin lesions) that may <strong>ulcerate</strong></p>\n<p>New lesions may occur (rare)</p>\n<p><strong>Neuritis</strong>&nbsp;and <strong>Nerve abscesses&nbsp;</strong>(red, painful inflamed nerves)</p>\n</td>\n<td>\n<p><strong>New, erythematous and tender</strong>, subcutaneous and dermal nodules that are widely distributed over extremities and face</p>\n<p>Existing lesions do not change</p>\n</td>\n</tr>\n<tr>\n<td><strong>No</strong> systemic involvement</td>\n<td><strong>Systemic symptoms</strong> present - fever, myalgias, arthralgias, anorexia, keratitis, iritis, nephritis, synovitis, orchitis, lymphadenopathy</td>\n</tr>\n<tr>\n<td>\n<p><strong>Treatment:</strong></p>\n<p>Supportive therapy for mild reactions with <strong>NSAIDs</strong></p>\n<p>In case of severe reactions with neuritis and eye lesions- <strong>Oral corticosteroids</strong></p>\n<p><strong>(Drug of Choice)</strong></p>\n<p>Nerve Abscess - Additional <strong>surgical drainage</strong></p>\n<p>Other drugs: Clofazimine, Cyclosporine</p>\n</td>\n<td>\n<p><strong>Treatment:</strong></p>\n<p><strong>Oral Corticosteroids - First-line drug<br><br>Clofazimine </strong>(Steroid dependent ENL)<strong><br></strong></p>\n<p><strong>Thalidomide -most effective </strong>but not used first due to various side effects</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(560, 'Microbiology,', 'PM1936. Drug resistance and the causative point mutations in M.tuberculosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Drug resistance</strong></td>\n<td><strong>Causative mutation</strong></td>\n</tr>\n<tr>\n<td>Rifampin</td>\n<td>rpoB gene&nbsp;</td>\n</tr>\n<tr>\n<td>Isoniazid </td>\n<td>katG gene &amp; inhA&nbsp;</td>\n</tr>\n<tr>\n<td>Pyrazinamide</td>\n<td>pncA gene</td>\n</tr>\n<tr>\n<td>Ethambutol</td>\n<td>embB gene&nbsp;</td>\n</tr>\n<tr>\n<td>Aminoglycosides </td>\n<td>rrs gene&nbsp;</td>\n</tr>\n<tr>\n<td>Fluoroquinolones</td>\n<td>gyrA-gyrB genes</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(561, 'Medicine,', 'PM1856. H. pylori eradication regimen', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>1<sup>st</sup> line</strong></p>\n<p><strong>[OCA/OCM - 14 days]</strong></p>\n</td>\n<td>\n<p><strong>2<sup>nd</sup> line</strong></p>\n<p><strong>[TOMB - 14 days]</strong></p>\n</td>\n<td>\n<p><strong>3<sup>rd</sup> line /Clarithromycin-resistant cases </strong></p>\n<p><strong>[LOA - 10 days]</strong></p>\n</td>\n<td>\n<p><strong>Sequential Regimen</strong></p>\n<p><strong>[OA (5days) + OCT (5days)]</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>O</strong>meprazole</p>\n</td>\n<td><strong>T</strong>etracycline</td>\n<td><strong>L</strong>evofloxacin</td>\n<td><strong>O</strong>meprazole</td>\n</tr>\n<tr>\n<td><strong>C</strong>larithromycin</td>\n<td><strong>O</strong>meprazole</td>\n<td><strong>O</strong>meprazole</td>\n<td><strong>C</strong>larithromycin</td>\n</tr>\n<tr>\n<td><strong>A</strong>moxicillin/</td>\n<td><strong>M</strong>etronidazole</td>\n<td><strong>A</strong>moxicillin</td>\n<td><strong>A</strong>moxicillin</td>\n</tr>\n<tr>\n<td><strong>M</strong>etronidazole</td>\n<td><strong>B</strong>ismuth</td>\n<td>&nbsp;</td>\n<td><strong>T</strong>inidazole</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(562, 'Medicine,', 'PM1720. ATT Regimen for TB Patients', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>As per the latest recommendations from <strong>National Tuberculosis Elimination Programme (NTEP)</strong>, treatment of TB is now based primarily on <strong>drug susceptibility testing</strong>. This is irrespective of new cases, previously treated cases or recurrent TB cases.&nbsp;<br>All cases of TB are treated with Drug Sensitive TB Regimen, as long as the patient is sensitive to isoniazid and rifampicin. (<strong>No classification into category I or II</strong>)</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of TB Case</strong></td>\n<td><strong>Intensive Phase</strong></td>\n<td><strong>Continuation Phase</strong></td>\n</tr>\n<tr>\n<td>New and previously treated cases (H and R sensitive)</td>\n<td>2 months H R Z E</td>\n<td>4 months H R E</td>\n</tr>\n</tbody>\n</table>\n<h2><strong><span>Classification based on drug resistance.&nbsp;</span></strong></h2>\n<p><span>The<strong>&nbsp;</strong>cases are classified as:</span></p>\n<ul>\n<li><strong>Mono-resistant (MR):</strong> A TB patient, who is resistant to one 1st line anti-TB drug only.</li>\n<li><strong>Poly-Drug Resistant (PDR):</strong> A TB patient, who is resistant to more than one 1st line anti-TB drug, other than Rifampicin and isoniazid.&nbsp;</li>\n<li><strong>Rifampicin Resistant (RR):</strong> A TB patient, who is resistant to <strong>rifampicin</strong> with or without resistance to other drugs. Patients, who have rifampicin resistance, should be managed as if they are an MDR TB case.</li>\n<li><strong>Multi-Drug Resistant (MDR):</strong> A TB patient, who is resistant to <strong>both isoniazid and rifampicin.</strong></li>\n<li><strong>Extensively Drug-Resistant (XDR):</strong> A MDR TB patient who is additionally resistant to a <strong>fluoroquinolone</strong> (ofloxacin, levofloxacin, or moxifloxacin) and at least one additional group A drug (as of 2021, these are bedaquiline and linezolid)</li>\n</ul>\n<h2><strong><span>Standard DR TB regimen</span></strong></h2>\n<table>\n<tbody>\n<tr>\n<td><strong>Regimen class</strong></td>\n<td><strong>Drugs</strong></td>\n<td><strong>Comments</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/ poly-drug resistant TB regimen</strong></td>\n<td>Lfx R E Z for 6 months</td>\n<td>\n<p>6 months long</p>\n<p>Oral drugs only</p>\n</td>\n</tr>\n<tr>\n<td><strong>Shorter oral bedaquiline regime (Shorter MDR)</strong></td>\n<td>\n<p><strong>Intensive Phase:</strong></p>\n<p>Lfx Bdq(6 months) Cfz Z Hh E Eto for 4-6 months</p>\n<p><strong>Continuation phase:</strong></p>\n<p>Lfx Cfz Z E for 5 months</p>\n</td>\n<td>\n<p>9-11 months long totally</p>\n<p>Injectables used in Intensive phase.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Bdq(6 months or longer) Lfx Lzd Cfz Cs&nbsp;</td>\n<td>\n<p>18-20 months long</p>\n<p>Oral drugs only</p>\n<p>This regimen is used for XDR TB patients for 20 months.</p>\n</td>\n</tr>\n</tbody>\n</table>\n<h2>&nbsp;</h2>\n<h2><strong><span>Criteria for patients to receive standard Drug Resistant TB regimen:</span></strong></h2>\n<table>\n<tbody>\n<tr>\n<td><strong>Standard Drug Resistant TB regimen</strong></td>\n<td><strong>Inclusion criteria</strong></td>\n<td><strong>Exclusion criteria</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/poly-drug resistant TB regimen</strong></td>\n<td><strong>Isoniazid resistant</strong> TB with <strong>rifampicin sensitive</strong></td>\n<td>No specific criteria</td>\n</tr>\n<tr>\n<td><strong>Shorter MDR TB regimen</strong></td>\n<td>Patient with <strong>rifampicin resistant</strong> pulmonary or extra pulmonary TB</td>\n<td>Non drug sensitivity test based criteria:\n<ul>\n<li>Pregnancy</li>\n<li>Any extra pulmonary disease in PLHIV</li>\n<li>Disseminated meningeal or central nervous system TB</li>\n<li>Intolerance to any drug in the shorter MDR TB regimen</li>\n</ul>\nDrug sensitivity test based criteria:\n<ul>\n<li>If DST/DRT result for FQ or SLI is resistant (XDR TB)</li>\n<li>Presence of InhA mutation</li>\n<li>Resistant to Z&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Patients in whom <strong>shorter MDR TB regimen cannot be considered</strong> due to any reason</td>\n<td>None</td>\n</tr>\n</tbody>\n</table>\n<p>Legend</p>\n<p>FQ: Fluoroquinolone</p>\n<p>SLI: Second Line Injectable</p>\n<p>PLHIV: People Living with HIV</p>\n<p>Lfx: Levofloxacin</p>\n<p>H: Isoniazid</p>\n<p>Hh: High Dose Isoniazid</p>\n<p>R: Rifampicin</p>\n<p>E: Ethambutol</p>\n<p>Z: Pyrazinamide</p>\n<p>Mfx: Moxifloxacin</p>\n<p>Km: Kanamycin</p>\n<p>Am: Amikacin</p>\n<p>Eto: Ethionamide</p>\n<p>Cfz: Clofazimine</p>\n<p>Bdq: Bedaquiline</p>\n<p>Lzd: Linezolid</p>\n<p>Cs: Cycloserine</p></div><!---->\n      <!---->\n    </div><!---->'),
(563, 'Community Medicine,', 'PM1696. Treatment of Malaria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong> Drug of Choice</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;Primaquine Dose</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>P. vivax malaria </strong></p>\n</td>\n<td>\n<p><strong>Chloroquine</strong> 25 mg/kg divided as:</p>\n<p>10mg/kg on day 1</p>\n<p>10mg/kg on day 2</p>\n<p>5mg/kg on day 3</p>\n</td>\n<td>\n<p>0.25 mg/kg for 14 days</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>P. falciparum malaria</strong></p>\n<p>North East</p>\n<p>In other states</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>ACT-AL</strong> for 3 days</p>\n<p><strong>ACT-SP</strong> for 3 days&nbsp;</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>0.75mg/kg on day 2</p>\n<p>0.75mg/kg on day 2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mixed infection</strong></p>\n<p>North East</p>\n<p>In other states</p>\n</td>\n<td>\n<p><strong>ACT-AL</strong> for 3 days</p>\n<p><strong>ACT-SP</strong> for 3 days</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>0.25 mg/kg for 14 days</p>\n<p>0.25 mg/kg for 14 days</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Resistance to ACT/ Severe malaria </strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>Quinine </strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong> -</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pregnancy</strong></p>\n<p><strong>P. vivax</strong></p>\n</td>\n<td>\n<p><strong>Chloroquine </strong></p>\n</td>\n<td>\n<p><strong>Contraindicated</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pregnancy</strong></p>\n<p><strong>P. falciparum</strong></p>\n</td>\n<td>\n<p>1<sup>st&nbsp;</sup>trimester: <strong>Quinine</strong></p>\n<p>2<sup>nd</sup> and 3<sup>rd</sup> trimester<strong>: Area specific ACT</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>Contraindicated</strong></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>ACT:&nbsp;</strong>artemisinin-based combination therapy</p>\n<p><strong>AL:</strong>&nbsp;artemether-lumefantrine</p>\n<p><strong>SP</strong>: Sulfadoxine-<wbr>Pyrimethamine</p></div><!---->\n      <!---->\n    </div><!---->'),
(564, 'Pharmacology', 'PM1587. Key points on the first line drugs used in the treatment of TB', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Drugs</strong></span></td>\n<td><span><strong>Isoniazid</strong></span></td>\n<td><span><strong>Rifamycins</strong></span></td>\n<td><span><strong>Pyrazinamide</strong></span></td>\n<td><span><strong>Ethambutol</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Mechanism of action</strong></span></td>\n<td>\n<p><span>Bactericidal</span></p>\n<p><span>Blocks mycolic acid synthesis.</span></p>\n</td>\n<td>\n<p><span>Bactericidal (maximum)</span></p>\n<p><span>Inhibition of RNA polymerase, leading to the inhibition of RNA synthesis.</span></p>\n</td>\n<td>\n<p><span>Bactericidal</span></p>\n<p><span>Inhibition of fatty acid synthase-I, leading to the inhibition of the cell membrane.</span></p>\n</td>\n<td>\n<p><span><strong>Bacteriostatic</strong></span></p>\n<p><span>Inhibition of arabinosyl transferase, leading to a reduction in arabinogalactan needed for the cell wall.</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Location of Mycobacteria</strong></span></td>\n<td><span>Intracellular +&nbsp; Extracellular</span></td>\n<td><span>Intracellular +&nbsp; Extracellular</span></td>\n<td><span>&nbsp;Intracellular</span></td>\n<td>&nbsp;<span>Extracellular</span></td>\n</tr>\n<tr>\n<td><span><strong>Metabolism</strong></span></td>\n<td><span>Liver&nbsp;</span></td>\n<td><span>Liver (maximum)</span></td>\n<td><span>&nbsp;Liver</span></td>\n<td>&nbsp;<span>Kidney</span></td>\n</tr>\n<tr>\n<td><span><strong>Unique side effects</strong></span></td>\n<td>\n<p><span>Shoulder hand syndrome and CNS side effects.</span></p>\n</td>\n<td><span>Orange urine, sweat, and tears. Flu-like symptoms with intermittent dosing.</span></td>\n<td>\n<p><span>The most hepatotoxic drug. It also causes hyperuricemia.</span></p>\n</td>\n<td>\n<p><span>Optic neuritis and hence, not preferred in children.</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Mechanism of resistance</strong></span></td>\n<td>\n<p><span>Kat G mutation- the most severe form of resistance.</span></p>\n<p><span>Inh a gene overexpression-&nbsp; confers cross-resistance with ethionamide.</span></p>\n</td>\n<td>\n<p class=\p1\><span>Mutation in <em>rpoB-</em>&nbsp;the gene coding for the <span class=\s1\>β </span>subunit of RNA polymerase.</span></p>\n</td>\n<td><span>Mutation of the&nbsp;<em>Pnca</em> gene.</span></td>\n<td>\n<p class=\p1\><span>Mutations in the <em>embB</em> gene.</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(565, 'Medicine,', 'PM1518. Indications of Ivermectin', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Onchocerciasis</li>\n<li>Chemoprophylaxis of filariasis</li>\n<li>Strongyloidiasis</li>\n<li>Gnathostomiasis</li>\n<li>Scabies</li>\n<li>Head lice</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(566, 'Medicine,', 'PM1516. Classification of antiretroviral drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>CLASS</strong></td>\n<td><strong>DRUGS</strong></td>\n</tr>\n<tr>\n<td>Nucleoside Reverse Transcriptase Inhibitors</td>\n<td>Zidovudine, Stavudine, Lamivudine, Abacavir, Emtricitabine, Didanosine</td>\n</tr>\n<tr>\n<td>Nucleotide Reverse Transcriptase Inhibitors</td>\n<td>Tenofovir</td>\n</tr>\n<tr>\n<td>Non-nucleoside Reverse Transcriptase Inhibitors</td>\n<td>Nevirapine, Efavirenz, Delavirdine,&nbsp;Etravirine</td>\n</tr>\n<tr>\n<td>Protease Inhibitors</td>\n<td>Saquinavir, Indinavir, Ritonavir, Nelfinavir, Lopinavir, Atazanavir, Tiprinavir, Darunavir</td>\n</tr>\n<tr>\n<td>Entry Inhibitors</td>\n<td>Enfuvirtide, Maraviroc</td>\n</tr>\n<tr>\n<td>Integrase Inhibitors</td>\n<td>Raltegravir, Elvitegravir, Dolutegravir</td>\n</tr>\n</tbody>\n</table>\n<p class=\p1\>&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(567, 'Pharmacology', 'PM1393. Cytochrome enzyme inducing potency of Rifamycins', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Rifampicin: Highest </li>\n<li>Rifapentine: Intermediate </li>\n<li>Rifabutin: Least</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(568, 'Pharmacology', 'PM1348. Nephrotoxicity risk with Amphotericin-B formulations (decreasing order)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>Nephrotoxicity Risk with Amphotericin B&nbsp;formulations:</div>\n<div>\n<ul>\n<li>\n<div>Conventional amphotericin B (C-AMB) has the highest risk of nephrotoxicity.</div>\n</li>\n<li>\n<div>C-AMB &gt; Amphotericin B lipid complex &gt; Liposomal amphotericin B.</div>\n</li>\n</ul>\n</div>\n<div>Amphotericin B colloidal dispersion has not been compared with other lipid-based formulations.&nbsp;</div></div><!---->\n      <!---->\n    </div><!---->'),
(569, 'Medicine,', 'PM1271. Protein synthesis inhibitors: Primary subunit of ribosome binding', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Mnemonic: 50 <strong>CELLS</strong> arranged into 30 <strong>TEAM</strong></p>\n<p>50s subunit binding:</p>\n<ul>\n<li><strong>C</strong>: Chloramphenicol, Clindamycin</li>\n<li><strong>E</strong>: Erythromycin (macrolides)</li>\n<li><strong>L</strong>: Lincosamides</li>\n<li><strong>L</strong>: Linezolid</li>\n<li><strong>S</strong>: Streptogramins</li>\n</ul>\n<p>30s subunit binding</p>\n<ul>\n<li><strong>Te</strong>: Tetracyclines</li>\n<li><strong>Am</strong>: Aminoglycosides</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(570, 'Pharmacology', 'PM1270. General properties of the first line drugs in TB', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>First-line drugs</strong></span></div>\n</td>\n<td>\n<div><span><strong>Isoniazid</strong></span></div>\n</td>\n<td>\n<div><span><strong>Rifampicin</strong></span></div>\n</td>\n<td>\n<div><span><strong>Pyrazinamide</strong></span></div>\n</td>\n<td>\n<div><span><strong>Ethambutol</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Mechanism</strong></span></div>\n</td>\n<td>\n<div><span>Bactericidal</span></div>\n</td>\n<td>\n<div><span>Bactericidal</span></div>\n<div><span>(Maximum)</span></div>\n</td>\n<td>\n<div><span>Bactericidal</span></div>\n</td>\n<td>\n<div><span>Bacteriostatic</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Location of Mycobacteria</strong></span></div>\n</td>\n<td>\n<div><span>Intracellular +&nbsp; Extracellular</span></div>\n</td>\n<td>\n<div><span>Intracellular +&nbsp; Extracellular</span></div>\n</td>\n<td>\n<div><span>Intracellular</span></div>\n</td>\n<td>\n<div><span>Extracellular</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Metabolism</strong></span></div>\n</td>\n<td>\n<div><span>Liver</span></div>\n</td>\n<td>\n<div><span>Liver</span></div>\n<div><span>(Maximum)</span></div>\n</td>\n<td>\n<div><span>Liver</span></div>\n</td>\n<td>\n<div><span>Kidney</span></div>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(571, 'Pharmacology', 'PM1248. Withdrawn fluoroquinolones and the associated adverse events', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Withdrawn Fluoroquinolones</strong></span></td>\n<td><span><strong>The Associated Adverse Events</strong></span></td>\n</tr>\n<tr>\n<td><span>Lomefloxacin and&nbsp;Gatifloxacin</span></td>\n<td><span>Phototoxicity, QTc prolongation</span></td>\n</tr>\n<tr>\n<td><span>Trovafloxacin</span></td>\n<td><span>Hepatotoxicity</span></td>\n</tr>\n<tr>\n<td><span>Gatifloxacin</span></td>\n<td><span>Hypoglycemia</span></td>\n</tr>\n<tr>\n<td><span>Grepafloxacin</span></td>\n<td><span>Cardiotoxicity</span></td>\n</tr>\n<tr>\n<td><span>Temafloxacin</span></td>\n<td><span>Immune hemolytic anemia</span></td>\n</tr>\n<tr>\n<td><span>Clinafloxacin</span></td>\n<td><span>Phototoxicity</span></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(572, 'Medicine,', 'PM1243. Cell wall synthesis inhibitors (mnemonic \BBC Van\)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>BBC Van:</strong></p>\n<ul>\n<li><strong>B</strong>eta lactams</li>\n<li><strong>B</strong>acitracin</li>\n<li><strong>C</strong>ycloserine</li>\n<li><strong>Van</strong>comycin</li>\n<li>Fosfomycin</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(573, 'Medicine,', 'PM0738. Direct acting antivirals (DAA) - Drugs against Hepatitis-C virus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The directly acting antivirals used in the treatment of Hepatitis C infection include:</p>\n<table>\n<tbody>\n<tr>\n<td width=\336\>\n<p><strong>Mechanism of action&nbsp;</strong></p>\n</td>\n<td width=\336\>\n<p><strong>Example</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\336\>\n<p>NS5A inhibitors (asvir)</p>\n</td>\n<td width=\336\>\n<ul>\n<li><strong>Velpatasvir</strong></li>\n<li>Daclatasvir</li>\n<li>Ledipasvir</li>\n<li>Ombitasvir</li>\n<li>Elbasvir</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\336\>\n<p>NS5B nucleos(t)ide polymerase inhibitor (buvir)</p>\n</td>\n<td width=\336\>\n<ul>\n<li><strong>Sofosbuvir</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\336\>\n<p>NS5B non nucleos(t)ide polymerase inhibitor (buvir)</p>\n</td>\n<td width=\336\>\n<ul>\n<li>Dasabuvir</li>\n<li>Beclabuvir</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\336\>\n<p>NS3/4A inhibitors (previr)</p>\n</td>\n<td width=\336\>\n<ul>\n<li>Boceprevir</li>\n<li>Telaprevir</li>\n<li>Simeprevir</li>\n<li>Paritaprevir</li>\n<li>Asunaprevir</li>\n<li>Grazoprevir</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;The following combinations of antiviral drugs can be used:</p>\n<ul>\n<li aria-level=\1\>Acute, chronic hepatitis, or compensated cirrhosis:\n<ul>\n<li>Velpatasvir (NS5A Inhibitor) + Sofosbuvir (NS5B inhibitor) x 12 weeks.</li>\n</ul>\n</li>\n<li aria-level=\1\>Decompensated cirrhosis:\n<ul>\n<li>Velpatasvir (NS5A Inhibitor) + Sofosbuvir (NS5B inhibitor) + Ribavirin (syntheticnucleotide analogue) x 12 weeks.</li>\n</ul>\n</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(574, 'Microbiology,', 'PM0452. Comparison of Mutational and Transferable Drug Resistance', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Mutational drug resistance</strong></p>\n</td>\n<td>\n<p><strong>Transferable drug resistance</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>One drug resistance at a time</p>\n</td>\n<td>\n<p>Multiple drug resistance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Low degree resistance</p>\n</td>\n<td>\n<p>High degree resistance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Can be overcome by high drug dose</p>\n</td>\n<td>\n<p>High dose ineffective</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Drug combinations can prevent</p>\n</td>\n<td>\n<p>Drug combinations cannot prevent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Resistance does not spread</p>\n</td>\n<td>\n<p>Spreads to same or different species</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mutants may be defective</p>\n</td>\n<td>\n<p>Not defective</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Virulence may be low</p>\n</td>\n<td>\n<p>Virulence not decreased</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(575, 'Pharmacology', 'PM2437. Classification of cephalosporins', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div><strong>First-generation cephalosporins</strong></div>\n<div>\n<table>\n<tbody>\n<tr>\n<td><strong>Parenteral</strong></td>\n<td><strong>Oral</strong></td>\n</tr>\n<tr>\n<td>Cefazolin</td>\n<td>Cephalexin<br>Cefadroxil</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n</div>\n<div><strong>Second-generation cephalosporins</strong></div>\n<div>\n<table>\n<tbody>\n<tr>\n<td><strong>Parenteral</strong></td>\n<td><strong>Oral</strong></td>\n</tr>\n<tr>\n<td>Cefuroxime<br>Cefoxitin<br>Cefotetan</td>\n<td>Cefaclor<br>Cefuroxime axetil<br>Cefprozil</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n</div>\n<div><strong>Third-generation cephalosporins</strong></div>\n<div>\n<table>\n<tbody>\n<tr>\n<td><strong>Parenteral</strong></td>\n<td><strong>Oral</strong></td>\n</tr>\n<tr>\n<td>\n<div>Cefotaxime <br>Ceftizoxime <br>Ceftriaxone</div>\n<div>Ceftazidime (Antipseudomonal) <br>Cefoperazone</div>\n</td>\n<td>\n<p>Cefixime <br>Cefpodoxime <br>Cefdinir<br>Ceftibuten<br>Ceftamet&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n</div>\n<div><strong>Fourth-generation cephalosporins</strong></div>\n<div>\n<table>\n<tbody>\n<tr>\n<td><strong>Parenteral</strong></td>\n<td><strong>Oral</strong></td>\n</tr>\n<tr>\n<td>Cefepime (Antipseudomonal)<br>Cefpirome</td>\n<td>&nbsp; &nbsp;---</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n</div>\n<div><strong>Fifth-generation cephalosporins</strong></div>\n<table>\n<tbody>\n<tr>\n<td><strong>Parenteral (Anti-MRSA activity)</strong></td>\n<td><strong>Oral</strong></td>\n</tr>\n<tr>\n<td>\n<div>Ceftaroline<br>Ceftobiprole&nbsp;</div>\n</td>\n<td>\n<div>&nbsp; &nbsp;---</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(576, 'Pharmacology', 'PM2436. Drugs acting on the receptors of  autonomic nervous system', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f6e046c55a374ae4ac81093fb8fb3994x1280x1240.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/29bde36a7c0d481b8a382e860850c0c6x1280x1069.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/100503ee428b41daa7181b8ec96067cax1280x1314.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b8855f99fd024bba8ec437b0c8ab5efbx1280x1992.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(577, 'Pharmacology,', 'PM2410. Classification of Anti-Thyroid Drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;Drugs <strong>inhibiting iodide trapping</strong>:</p>\n<ul>\n<li>Thiocyanates</li>\n<li>Perchlorates</li>\n<li>Nitrates</li>\n</ul>\n<p>Drugs <strong>inhibiting hormone synthesis</strong>:</p>\n<ul>\n<li>Propylthiouracil</li>\n<li>Methimazole</li>\n<li>Carbimazole</li>\n</ul>\n<p>Drugs <strong>inhibiting hormone release</strong>:</p>\n<ul>\n<li>Iodine</li>\n<li>Sodium iodide</li>\n<li>Potassium iodide</li>\n<li>Organic iodide</li>\n</ul>\n<p>Drugs <strong>inhibiting peripheral conversion:</strong></p>\n<ul>\n<li>Propylthiouracil</li>\n<li>Amiodarone</li>\n<li>Iodinated contrast dyes (Iopanoic acid)</li>\n<li>Propranolol</li>\n<li>Glucocorticoids</li>\n</ul>\n<p>Drugs that <strong>destroy thyroid tissue</strong>:</p>\n<ul>\n<li>Radioactive iodine</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/c80ec5fa0ace4523a36894c3898a9be8.JPEG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(578, 'Obstetrics & Gynaecology,', 'PM2328. Hormonal contraceptives', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div dir=\ltr\>\n<p><strong>Oral pills:</strong></p>\n<ul>\n<li>Combined oral contraceptive pills (COC)\n<ul>\n<li>Mala D -&nbsp;Levonorgestrel 0.15 mg + Ethinyl estradiol &nbsp;0.03 mg + Ferrous fumarate</li>\n<li>Mala N -&nbsp;Levonorgestrel 0.15 mg +&nbsp;Ethinyl estradiol &nbsp;0.03 mg + Ferrous fumarate&nbsp;(Govt. supply, free of cost)</li>\n</ul>\n</li>\n<li>Progesterone only pills (POP) - suitable for lactating women\n<ul>\n<li>Norethisterone 350 μg</li>\n<li>Norgestrel 75 μg</li>\n<li>Levonorgestrel (LNG) 30 μg</li>\n</ul>\n</li>\n<li>Once a month or long-acting pills - highly disappointing results\n<ul>\n<li>Quinestrol (long-acting estrogen) + short-acting progesterone</li>\n</ul>\n</li>\n<li>Gossypol - male pill : Cottonseed derivative and causes azoospermia and severe oligospermia</li>\n<li>Post-coital pills or interceptive\n<ul>\n<li>Levonorgestrel 0.75 mg, 2 doses, 12 hours apart</li>\n<li>Mifepristone 10-600 mg</li>\n<li>Ulipristal 30 mg, within 5 days of intercourse</li>\n<li>Centchroman 60 mg, 2 tablets, within 24 hrs of intercourse</li>\n<li>GnRH agonists &nbsp;</li>\n<li>CuT IUCD, inserted within 5 days</li>\n</ul>\n</li>\n</ul>\n<p><strong> Injectable contraceptives</strong></p>\n<ul>\n<li>Progesterone only injectables\n<ul>\n<li>DMPA&nbsp;150 mg IM every 3 months</li>\n<li>NET-EN&nbsp;200 mg IM every 2 months</li>\n</ul>\n</li>\n<li>Combined injectables\n<ul>\n<li>Cyclofem - DMPA 25 mg + Estradiol cypionate 5 mg</li>\n<li>Mesigyna - NET-EN 50 mg &nbsp;+ Estradiol valerate 5 mg</li>\n</ul>\n</li>\n</ul>\n<p><strong> Subdermal implants</strong></p>\n<ul>\n<li>Norplant I -&nbsp;Levonorgestrel 35 mg</li>\n<li>Norplant II or Jadelle -&nbsp;2 rods with levonorgestrel 70 mg in each and released at a rate of 50 μg/day &nbsp;</li>\n</ul>\n<p><strong>Others</strong></p>\n<ul>\n<li>Hormonal IUCD -&nbsp;Mirena which contains LNG 52 mg with release rate of&nbsp;20 μg/day</li>\n<li>Orthoevra patch -&nbsp;Norelgestomin + Ethinyl estradiol weekly for 3 weeks, then patch free for 1 week</li>\n<li>Vaginal ring or Nuvaring - Etonogestrel + ethinyl estradiol daily release, use for 3 weeks with withdrawal for 1 week</li>\n</ul>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(579, 'Obstetrics & Gynaecology,', 'PM2225. Uses of Misoprostol', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>INDICATIONS</strong></td>\n<td><strong>PRIMARY DOSE OF MISOPROSTOL</strong></td>\n<td><strong>REMARKS</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>MEDICAL TERMINATION OF PREGNANCY</strong></p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Combined Regimen(recommended):<br>Upto 12 weeks of gestation-800mcg vaginally, buccally or sublingually.<br><br></p>\n<p>Beyond 12 weeks of gestation-400mcg&nbsp;vaginally, buccally or sublingually every 3 hours<br><br><br></p>\n<p>Misoprostol only regimen:<br>Upto 12 weeks-800mcg&nbsp;vaginally, buccally or sublingually<br><br>Beyond 12 weeks-400mcg&nbsp;vaginally, bucally or sublingually every 3 hours<br><br></p>\n</td>\n<td>\n<p>Ideally used 1-2 days after 200mg of Mifepristone in the combined regimen.</p>\n<p><br>The mucosal route of administration is preferred over the oral route of administration.</p>\n<p><br>These doses also apply for incomplete and missed abortion.<br><br></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>SURGICAL ABORTION</strong></p>\n<p>12-14weeks- both medical and surgical methods can be done</p>\n<p>&gt;14weeks-surgical method&nbsp;</p>\n</td>\n<td>Cervical preparation: 400mcg vaginally/ sublingually</td>\n<td>\n<p>Another method: Oral Mifepristone 200mg 24-48 hours before the procedure</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>PPH Prophylaxis</strong></td>\n<td>\n<p>800mcg sublingual single dose OR 600mcg orally/ sublingually/rectally</p>\n<p>single dose&nbsp;for PPH secondary prevention (approx &gt;350ml blood loss)</p>\n</td>\n<td rowspan=\2\>&nbsp;Where oxytocin is not available or storage conditions are inadequate</td>\n</tr>\n<tr>\n<td><strong>PPH treatment</strong></td>\n<td>800 mcg sublingually single dose</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(580, 'Obstetrics & Gynaecology,', 'PM1783. Types of monophasic combined oral pills', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\0\>\n<tbody>\n<tr>\n<td>Type</td>\n<td>Estrogen</td>\n<td>Progestogen</td>\n</tr>\n<tr>\n<td>1st Generation</td>\n<td>Ethinyl oestradiol</td>\n<td>Norethindrone</td>\n</tr>\n<tr>\n<td>2nd&nbsp;Generation</td>\n<td>Ethinyl oestradiol</td>\n<td>Norgestrel, LNG</td>\n</tr>\n<tr>\n<td>3rd&nbsp;Generation</td>\n<td>Ethinyl oestradiol</td>\n<td>Desogestrel,gestodene norgestimate</td>\n</tr>\n<tr>\n<td>4th&nbsp;Generation<br>(Yasmin)</td>\n<td>Ethinyl oestradiol</td>\n<td>Drospirenone</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(581, 'Medicine,', 'PM1542. Causes of SIADH', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Neoplasms</strong></p>\n<p><strong>Carcinomas</strong></p>\n<ul>\n<li>Lung</li>\n<li>Duodenum</li>\n<li>Pancreas</li>\n<li>Ovary</li>\n<li>Bladder, ureter</li>\n</ul>\n<p><strong>Other neoplasms</strong></p>\n<ul>\n<li>Thymoma</li>\n<li>Mesothelioma</li>\n<li>Bronchial adenoma</li>\n<li>Carcinoid</li>\n<li>Gangliocytoma</li>\n<li>Ewing’s sarcoma</li>\n</ul>\n<p><strong>Head trauma</strong> (closed and penetrating)</p>\n<p><strong>Infections</strong></p>\n<ul>\n<li>Pneumonia</li>\n<li>Abscess</li>\n<li>Cavitation (aspergillosis)</li>\n<li>Tuberculosis</li>\n<li>Meningitis, Encephalitis</li>\n<li>AIDS</li>\n</ul>\n<p><strong>Vascular</strong></p>\n<ul>\n<li>Cerebrovascular occlusions, haemorrhage</li>\n<li>Cavernous sinus thrombosis</li>\n</ul>\n<p><strong>Neurologic</strong></p>\n<ul>\n<li>Guillain-Barre syndrome</li>\n<li>Multiple sclerosis</li>\n<li>Delirium tremens</li>\n<li>Amyotrophic lateral sclerosis</li>\n<li>Hydrocephalus</li>\n<li>Psychosis</li>\n<li>Peripheral neuropathy</li>\n</ul>\n<p><strong>Congenital malformations</strong></p>\n<p><strong>Metabolic</strong></p>\n<ul>\n<li>Acute intermittent porphyria</li>\n</ul>\n<p><strong>Respiratory</strong></p>\n<ul>\n<li>Asthma</li>\n<li>Pneumothorax</li>\n<li>Positive-pressure respiration</li>\n</ul>\n<p><strong>Drugs</strong></p>\n<ul>\n<li>Vasopressin or desmopressin</li>\n<li>Serotonin reuptake inhibitors</li>\n<li>Oxytocin (high dose)</li>\n<li>Vincristine</li>\n<li>Carbamazepine</li>\n<li>Nicotine</li>\n<li>Phenothiazines</li>\n<li>Cyclophosphamide</li>\n<li>Tricyclic antidepressants</li>\n<li>Monoamine oxidase inhibitors</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(582, 'Medicine,', 'PM1526. Drugs causing hyperprolactinemia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Dopamine receptor blockers:\n<ul>\n<li>Atypical antipsychotics: Risperidone</li>\n<li>Phenothiazines: Chlorpromazine, perphenazine</li>\n<li>Butyrophenones: Haloperidol</li>\n<li>Thioxanthenes</li>\n<li>Metoclopramide</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Dopamine synthesis inhibitors:\n<ul>\n<li>α-Methyldopa</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Catecholamine depletors:\n<ul>\n<li>Reserpine</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Opiates</li>\n</ul>\n<p>&nbsp;</p>\n<ul>\n<li>H<sub>2</sub> antagonists:\n<ul>\n<li>Cimetidine, ranitidine</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Imipramines:\n<ul>\n<li>Amitriptyline, amoxapine</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Serotonin reuptake inhibitors:\n<ul>\n<li>Fluoxetine</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Calcium channel blockers:\n<ul>\n<li>Verapamil</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Estrogens</li>\n</ul>\n<p>&nbsp;</p>\n<ul>\n<li>Thyrotropin-releasing hormone</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(583, 'Medicine,', 'PM1143. Averbuch’s Chemotherapy Protocol for Malignant Pheochromocytoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Averbuch’s chemotherapy protocol</strong> for malignant pheochromocytoma includes\n<ul>\n<li><strong>Dacarbazine </strong>(600 mg/m<sup>2 </sup>on days 1 and 2)</li>\n<li><strong>Cyclophosphamide</strong> (750 mg/m<sup>2</sup> on day 1)</li>\n<li><strong>Vincristine</strong> (1.4 mg/m<sup>2 </sup>on day 1)</li>\n</ul>\n</li>\n<li>All repeated <strong>every 21 days</strong> for three to six cycles.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(584, 'Medicine,', 'PM0991. Insulin Classification According to Duration of Action', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Inhaled insulin&nbsp;(2-3 hours)</strong></p>\n<ul>\n<li>Afrezza&nbsp;</li>\n</ul>\n<p><strong>Rapid acting (3-4 hours)</strong></p>\n<ul>\n<li>Aspart</li>\n<li>Glulisine</li>\n<li>Lispro</li>\n</ul>\n<p><strong>Short acting&nbsp;(6-8 hours)</strong></p>\n<ul>\n<li>Regular</li>\n</ul>\n<p><strong>Intermediate acting (10-16 hours)</strong></p>\n<ul>\n<li>NPH</li>\n<li>Lente</li>\n</ul>\n<p><strong>Long acting&nbsp;(12-24 hours)</strong></p>\n<ul>\n<li>Detemir</li>\n<li>Glargine</li>\n<li>Degludec <strong>(24-42 hours)</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(585, 'Pharmacology', 'PM0924. Activity of corticosteroids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Highest mineralocorticoid </strong>activity is seen with <strong>aldosterone</strong>.</p>\n<p>Highest mineralocorticoid activity in a drug that is <strong>clinically used</strong> is seen with <strong>fludrocortisone</strong>&nbsp;(aldosterone cannot be used clinically).</p>\n<p><strong>Least </strong>mineralocorticoid activity is seen with <strong>methylprednisolone</strong>.</p>\n<p>&nbsp;</p>\n<p><strong>Highest glucocorticoid</strong> activity is seen with <strong>dexamethasone </strong>and<strong> betamethasone</strong>.</p></div><!---->\n      <!---->\n    </div><!---->'),
(586, 'Pharmacology,', 'PM0886. Hormonal therapy in breast carcinoma given for ER/PR-positive cases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Role:</strong></p>\n<ul>\n<li>Reduce risk of recurrence</li>\n<li>Reduce risk of contralateral breast cancer</li>\n<li>Reduce risk of progression of in situ to invasive carcinoma</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Selective estrogen- receptor modulator</td>\n<td>Aromatase inhibitors</td>\n<td>Ovarian suppression/ ablation</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Tamoxifen</li>\n<li>Raloxifen</li>\n<li>Arzoxifen</li>\n<li>Fenoxifen</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Anastrazole</li>\n<li>Letrozole</li>\n<li>Exemestane</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Oophorectomy</li>\n<li>GnRH analogues</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(587, 'Pharmacology', 'PM0752. Classification of Bisphosphonates (mainly based on potency)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>First generation</p>\n<ul>\n<li>Etidronate ( least potent)</li>\n<li>Clodronate</li>\n<li>Tiludronate</li>\n</ul>\n<p>Second generation: 10-100 times more potent than the first generation &nbsp;</p>\n<ul>\n<li>Alendronate</li>\n<li>Pamidronate</li>\n<li>Ibandronate</li>\n</ul>\n<p>Third generation: 10,000 times more potent than the first generation &nbsp;</p>\n<ul>\n<li>Risedronate</li>\n<li>Zoledronate</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(588, 'Medicine,', 'PM0740. Side effects of Corticosteroids: mnemonic \CORTICOSTEROIDS\', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The mnemonic is \<strong>CORTICOSTEROIDS</strong>\</p>\n<p><strong>C</strong> - Cushing’s syndrome</p>\n<p><strong>O</strong> - Osteoporosis</p>\n<p><strong>R</strong> - Retardation of growth</p>\n<p><strong>T</strong> - Thin skin and easy bruisability</p>\n<p><strong>I</strong> - Infections and immunosuppression</p>\n<p><strong>C</strong> - Cataract</p>\n<p><strong>O</strong> - Oedema</p>\n<p><strong>S</strong> - Suppression of HPA axis</p>\n<p><strong>T</strong> - Thinning and ulceration of gastric mucosa</p>\n<p><strong>E</strong> - Emotional disturbance</p>\n<p><strong>R</strong> - Rise in BP</p>\n<p><strong>O</strong> - Others fatal abnormalities like hypokalemia</p>\n<p><strong>I</strong> - Increase in hair growth (hirsutism)</p>\n<p><strong>D</strong> - Diabetes mellitus precipitation</p>\n<p><strong>S</strong> - Striae</p></div><!---->\n      <!---->\n    </div><!---->'),
(589, 'Pharmacology', 'PM0739. Classification of Glucocorticoids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Short-acting</strong> (t<sub>1/2</sub> &lt; 12 hours)</p>\n<ul>\n<li>Hydrocortisone</li>\n</ul>\n<p><strong>Intermediate-acting</strong> (t<sub>1/2</sub>&nbsp;of 12-36 hours)</p>\n<ul>\n<li>Prednisolone</li>\n<li>Methylprednisolone</li>\n<li>Triamcinolone</li>\n<li>Deflazacort</li>\n</ul>\n<p><strong>Long-acting</strong> (t<sub>1/2</sub> &gt; 36 hours)</p>\n<ul>\n<li>Dexamethasone</li>\n<li>Betamethasone</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(590, 'Obstetrics & Gynaecology,', 'PM0679. Drug of choice for hyperthyroidism/thyrotoxicosis in pregnancy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>In the 1st trimester: <strong>Propylthiouracil</strong></p>\n<p>In the 2nd and 3rd trimester: <strong>Methimazole</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(591, 'Pharmacology', 'PM0553. PDE inhibitors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>PDE inhibitors</strong></span></td>\n<td><span><strong>Drugs</strong></span></td>\n<td><span><strong>Clinical application</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Non-selective PDE inhibitors</strong></span></p>\n<p><span><strong>&nbsp;</strong></span></p>\n</td>\n<td>\n<p><span>Methylated xanthines, Caffeine, Theophylline</span></p>\n</td>\n<td>\n<p><span>Asthma, COPD</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>&nbsp;</strong></span></td>\n<td>\n<p><span>Pentoxifylline</span></p>\n</td>\n<td>\n<p><span>Peripheral artery disease &nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>PDE 2 inhibitor</strong></span></td>\n<td>\n<p><span>Anagrelide</span></p>\n</td>\n<td><span>Essential thrombocytosis</span></td>\n</tr>\n<tr>\n<td><span><strong>PDE 3 inhibitor</strong></span></td>\n<td>\n<p><span>Cilostazol</span></p>\n</td>\n<td><span>Peripheral artery disease</span></td>\n</tr>\n<tr>\n<td><span><strong>&nbsp;</strong></span></td>\n<td>\n<p><span>Milrinone, Amrinone</span></p>\n</td>\n<td><span>Cardiac failure&nbsp;&nbsp;</span></td>\n</tr>\n<tr>\n<td><span><strong>PDE 4 inhibitor</strong></span></td>\n<td>\n<p><span>Roflumilast</span></p>\n</td>\n<td><span>COPD</span></td>\n</tr>\n<tr>\n<td><span><strong>&nbsp;</strong></span></td>\n<td>\n<p><span>Drotaverine</span></p>\n</td>\n<td><span>Antispasmodic drug</span></td>\n</tr>\n<tr>\n<td><span><strong>PDE 5 inhibitor</strong></span></td>\n<td>\n<p><span>Sildenafil, Vardenafil, Tadalafil (Also inhibit PDE6)</span></p>\n</td>\n<td><span>Erectile dysfunction Pulmonary hypertension</span></td>\n</tr>\n</tbody>\n</table>\n<p><span>&nbsp;</span></p></div><!---->\n      <!---->\n    </div><!---->'),
(592, 'Medicine,', 'PM2335. Important drugs for rheumatoid arthritis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div dir=\ltr\>\n<p><strong>1) NSAIDs -&nbsp;</strong>analgesic and anti-inflammatory, used as <strong>adjunctive</strong> for management of uncontrollable <strong>symptoms</strong> and in acute <strong>flares.</strong></p>\n<p dir=\ltr\><strong>2) Glucocorticoids - </strong>used in acute <strong>flare</strong> for&nbsp;rapid control and as <strong>initial therapy</strong> before the onset of action of DMARDs.&nbsp;Chronic administration of low doses is needed in patients with inadequate response to DMARDs.</p>\n<ul>\n<li dir=\ltr\>Prednisolone - oral&nbsp;</li>\n<li dir=\ltr\>Triamcinolone - intraarticular<br>&nbsp;</li>\n</ul>\n<strong><span>3) DMARDs - </span></strong><span>disease-modifying anti-rheumatoid drugs:</span></div>\n<div dir=\ltr\>&nbsp;</div>\n<div dir=\ltr\><strong>- Conventional DMARDs:</strong></div>\n<div dir=\ltr\>\n<ul>\n<li dir=\ltr\>Methotrexate (MTX)- is an antifolate drug. The DMARD of <strong>choice</strong> and the anchor drug for combination therapy. Regular <strong>LFT</strong> monitoring is required.</li>\n<li dir=\ltr\>Hydroxychloroquine- is used as <strong>monotherapy</strong> for <strong>early</strong> and <strong>mild</strong> disease and&nbsp;in combination with other DMARDs for severe cases.</li>\n<li dir=\ltr\>Sulfasalazine- is a salicylate. It <strong>reduces</strong> the radiographic <strong>progression</strong> of the disease.</li>\n<li dir=\ltr\>Leflunomide- is a pyrimidine synthase inhibitor used as an <strong>alternative</strong> to MTX.</li>\n</ul>\n</div>\n<div dir=\ltr\>\n<p><span><strong>- Biologicals:</strong></span></p>\n<ul>\n<li>TNF-α antagonists- used in combination with MTX. Has a risk of serious bacterial infections, opportunistic fungal infection &amp; reactivation of latent TB. The TNF-α inhibitors are <strong>adalimumab,</strong> golimumab, etanercept, infliximab, and certolizumab.</li>\n<li>Abatacept- a T-cell costimulation inhibitor, used in combination with MTX, leflunomide, etc.</li>\n<li>Rituximab- an <strong>anti-CD20</strong> antibody. Used in refractory disease in combination with MTX.</li>\n<li>Anakinra- an<strong> IL-1</strong> receptor <strong>antagonist</strong>. It should not be combined with anti-TNF alpha.</li>\n<li><strong>IL-6</strong> receptor <strong>antagonists</strong>- tocilizumab and sarilumab are used as monotherapy&nbsp;or combination therapy in moderate to severe disease.&nbsp;&nbsp;</li>\n</ul>\n</div>\n<div dir=\ltr\>\n<p><span><strong>- Small molecules:&nbsp;</strong></span></p>\n<ul>\n<li>Janus kinase inhibitors:&nbsp;<strong>Tofacitinib</strong>, baricitinib, and upadacitinib are used as monotherapy or combination therapy.</li>\n</ul>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(593, 'Medicine,', 'PM1929. Drugs precipitating Gout', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Drugs that precipitate gout are-</p>\n<p><strong>C</strong>yclosporine or cancer drugs<br><strong>A</strong>spirin (low dose)<br><strong>N</strong>iacin<br><strong>T</strong>hiazide<br><strong>L</strong>asix (furosemide)<br><strong>E</strong>thambutol<br><strong>A</strong>lcohol<br><strong>P</strong>yrazinamide</p>\n<p>Mnemonic for drugs precipitating gout is <strong>CANT LEAP</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(594, 'Medicine,', 'PM0642. Acid resistant penicillins: mnemonic \VODKA\', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The mnemonic \<strong>VODKA</strong>\ can be used to for acid-resistant penicillins that are active orally.</p>\n<ul>\n<li><strong>V</strong>&nbsp;- Penicillin <strong>V</strong></li>\n<li><strong>O</strong> - <strong>O</strong>xacillin</li>\n<li><strong>D</strong>&nbsp;-&nbsp;<strong>D</strong>icloxacillin</li>\n<li><strong>K</strong> - <strong>C</strong>loxacillin</li>\n<li><strong>A</strong> - <strong>A</strong>moxycillin/ Ampicillin</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(595, 'Pharmacology', 'PM0605. Factor Xa: IIa inhibition activity of antithrombin activators', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Preparation</strong></p>\n</td>\n<td>\n<p><strong>Factor Xa: IIa inhibition activity</strong></p>\n</td>\n</tr>\n</tbody>\n</table>\n<table>\n<tbody>\n<tr>\n<td>\n<p>Unfractionated heparin</p>\n</td>\n<td>\n<p><strong>1:1</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>LMWH</p>\n</td>\n<td>\n<p><strong>2:1 to 3:1</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fondaparinux</p>\n</td>\n<td>\n<p><strong>Only Xa inhibition </strong></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(596, 'Pharmacology', 'PM0580. Triptans - 5HT 1B/1D agonists', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Few important properties of triptans:</p>\n<ul>\n<li><strong>Longest </strong>acting triptan: <strong>Frovatriptan</strong></li>\n<li><strong>Fastest</strong> (Oral) acting triptan: <strong>Rizatriptan</strong></li>\n<li><strong>Least bioavailability</strong> (Oral): <strong>Sumatriptan</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(597, 'Pharmacology', 'PM0523. Some Important Points about Selective COX-2 Inhibitors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>They are also known as <strong>coxibs</strong>. They are different from non-selective COX inhibitors as follows:</p>\n<ul>\n<li aria-level=\1\>Fewer GI side effects as COX-1 is not inhibited</li>\n<li aria-level=\1\>No antiplatelet action as thromboxane A2 production is unaffected.</li>\n</ul>\n<p>Adverse effects and contraindications:</p>\n<ul>\n<li aria-level=\1\>Myocardial infarction</li>\n<li aria-level=\1\>Stroke</li>\n<li aria-level=\1\>Congestive heart failure</li>\n<li aria-level=\1\>Hypertension</li>\n<li aria-level=\1\>Renal impairment.</li>\n</ul>\n<p>Order of COX-2 selectivity</p>\n<ul>\n<li aria-level=\1\><strong>Lumiracoxib</strong> &gt; etoricoxib &gt; rofecoxib &gt; valdecoxib &gt; <strong>celecoxib</strong>.</li>\n<li aria-level=\1\>Lumiracoxib - most selective</li>\n<li aria-level=\1\>Celecoxib - least selective</li>\n</ul>\n<p>The only coxib which can be given parenterally is <strong>Parecoxib</strong>.</p></div><!---->\n      <!---->\n    </div><!---->'),
(598, 'Pharmacology', 'PM0522. Preferential COX-2 inhibitors: mnemonic \NAMED\', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The mnemonic for preferential COX-2 inhibitors is \<strong>NAMED</strong>\:</p>\n<ul>\n<li><strong>N</strong>imesulide</li>\n<li><strong>A</strong>ceclofenac</li>\n<li><strong>M</strong>eloxicam</li>\n<li><strong>E</strong>todolac</li>\n<li><strong>D</strong>iclofenac</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(599, 'Pathology,', 'PM0521. Prostaglandins effect on platelet action', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Anti-aggregatory</strong> prostaglandins:</p>\n<ul>\n<li>PGI<sub>2</sub></li>\n<li>PGD<sub>2</sub></li>\n</ul>\n<p><strong>Pro-aggregatory</strong> prostaglandins:</p>\n<ul>\n<li>Thromboxane A2</li>\n<li>PGH<sub>2</sub></li>\n<li>PGG<sub>2</sub></li>\n</ul>\n<p>Variable effects are seen with PGE<sub>2</sub></p></div><!---->\n      <!---->\n    </div><!---->'),
(600, 'Medicine,', 'PM2398. Classification of anti-platelet drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Class</strong></span></td>\n<td><span><strong>Drugs</strong></span></td>\n</tr>\n<tr>\n<td><span>Cyclooxygenase- I inhibitors</span></td>\n<td><span>Aspirin</span></td>\n</tr>\n<tr>\n<td><span>Irreversible P2Y<sub>12&nbsp;</sub>inhibitors</span></td>\n<td>\n<p><span>Ticlopidine, Clopidogrel, Prasugrel</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Reversible P2Y<sub>12&nbsp;</sub>inhibitors</span></td>\n<td><span>Ticagrelor, Cangrelor</span></td>\n</tr>\n<tr>\n<td><span>GpIIb/IIIa inhibitors</span></td>\n<td><span>Abciximab, Eptifibatide, Tirofiban</span></td>\n</tr>\n<tr>\n<td><span>Thrombin (PAR-1) receptor antagonist</span></td>\n<td><span>Vorapaxar&nbsp;</span></td>\n</tr>\n<tr>\n<td><span>Phosphodiesterase inhibitors</span></td>\n<td>\n<p class=\p1\><span>Dipyridamole</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(601, 'Pharmacology,', 'PM2385. Heparin vs. LMWH vs. Fondaparinux', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Features</strong></span></td>\n<td><span><strong>Unfractionated heparin</strong></span></td>\n<td><span><strong>LMWH</strong></span></td>\n<td><span><strong>Fondaparinux</strong></span></td>\n</tr>\n<tr>\n<td><strong><span>Structure</span></strong></td>\n<td>\n<p class=\p1\><span>A glycosaminoglycan consisting of long saccharide chains</span></p>\n</td>\n<td><span>A glycosaminoglycan consisting of short saccharide chains</span></td>\n<td><span>A synthetic pentasaccharide</span></td>\n</tr>\n<tr>\n<td><strong><span>Factor Xa inhibition&nbsp;</span></strong></td>\n<td><span>Yes</span></td>\n<td><span>Yes</span></td>\n<td><span>Yes</span></td>\n</tr>\n<tr>\n<td><strong><span>Factor IIa inhibition</span></strong></td>\n<td>\n<p><span>Yes (Xa = IIa)</span></p>\n<p><span>The long chains act Xa and IIa equally.</span></p>\n</td>\n<td>\n<p><span>Yes (Xa &gt; IIa)</span></p>\n<p><span>LMWH contains a mixture of long and short chains.</span></p>\n</td>\n<td>\n<p><span>No</span></p>\n<p><span>The pentasaccharide has no action on factor IIa</span></p>\n</td>\n</tr>\n<tr>\n<td><strong><span>Bioavailability</span></strong></td>\n<td>\n<p><span>Oral: Not absorbed</span></p>\n<p><span>S.C.: Not good&nbsp;<span>(longer chains are not absorbed well)&nbsp;</span></span></p>\n<p><span>I.V.: Good</span></p>\n</td>\n<td>\n<p><span>Oral: Not absorbed</span></p>\n<p><span>S.C.: Good&nbsp;</span></p>\n</td>\n<td>\n<p><span>Oral: Not absorbed</span></p>\n<p><span>S.C.: Very good</span></p>\n</td>\n</tr>\n<tr>\n<td><strong><span>Variable response</span></strong></td>\n<td><span>Yes&nbsp;</span></td>\n<td><span>No</span></td>\n<td><span>No</span></td>\n</tr>\n<tr>\n<td><strong><span>Metabolism</span></strong></td>\n<td><span>Cleared by the reticuloendothelial system</span>&nbsp;</td>\n<td><span>Cleared by the kidneys</span></td>\n<td><span>Cleared by the kidneys</span></td>\n</tr>\n<tr>\n<td><strong><span>Safety in renal disease</span></strong></td>\n<td><span>Safe in renal impairment</span></td>\n<td><span>Used with close monitoring</span></td>\n<td><span>Contraindicated in renal failure</span></td>\n</tr>\n<tr>\n<td><strong><span>Monitoring&nbsp;</span></strong></td>\n<td><span>Required, with <strong>aPTT</strong></span></td>\n<td><span>Required only in <strong>renal impairment</strong>,<strong>&nbsp;</strong>with <strong>anti-factor Xa assay</strong></span></td>\n<td><span>Not required</span></td>\n</tr>\n<tr>\n<td><strong><span>Protamine sulfate as antidote</span></strong></td>\n<td><span>Full reversal</span></td>\n<td><span>Partial reversal</span> <span>(acts only on the longer chains)</span></td>\n<td><span>No&nbsp;reversal</span></td>\n</tr>\n<tr>\n<td><strong><span>Risk of Heparin-induced thrombocytopenia</span></strong></td>\n<td><span>High&nbsp;</span></td>\n<td><span>Lower</span></td>\n<td><span>Least</span></td>\n</tr>\n<tr>\n<td><strong><span>Risk of osteoporosis</span></strong></td>\n<td><span>Occasionally</span></td>\n<td><span>Lower</span></td>\n<td><span>Lower</span></td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/804286e8b58a478caeb89f36ccb6b8fbx1280x2261.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(602, 'Pharmacology', 'PM1712. Specific reversal agents for anticoagulants', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Heparin: protamine sulfate </li>\n<li>Warfarin: vitamin K </li>\n<li>Rivaroxaban and other oral Xa inhibitors: andexanet alfa </li>\n<li>Dabigatran: idarucizumab</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(603, 'Medicine,', 'PM0610. Contraindications for thrombolytic therapy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The <strong>absolute contraindications</strong> for thrombolytic therapy are:</p>\n<ul>\n<li>Prior intracranial hemorrhage</li>\n<li>Known structural cerebral vascular lesion</li>\n<li>Known malignant intracranial neoplasm</li>\n<li>Ischemic stroke within 3 months</li>\n<li>Suspected aortic dissection</li>\n<li>Active bleeding or bleeding diathesis (excluding menses)</li>\n<li>Significant closed head trauma or facial trauma within 3 months</li>\n</ul>\n<p>The <strong>relative contraindications</strong> for thrombolytic therapy are:</p>\n<ul>\n<li>Uncontrolled hypertension (SBP&gt;180 mm Hg; DBP&gt;110 mmHg)</li>\n<li>Traumatic or prolonged CPR or major surgery within 3 months</li>\n<li>Recent (2-4 weeks) internal bleeding</li>\n<li>Noncompressible vascular punctures</li>\n<li>Pregnancy</li>\n<li>Active peptic ulcer</li>\n<li>Current use of warfarin and INR&gt;1.7</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(604, 'Medicine,', 'PM0609. Classification of Anticoagulants', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b14dd7e06cd44c95a1d5289e3a32ad8ax1280x1944.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Classification of anticoagulants</strong></td>\n</tr>\n<tr>\n<td>1) Vitamin K antagonist</td>\n<td>Warfarin</td>\n</tr>\n<tr>\n<td>2) Direct thrombin inhibitors (DTI)&nbsp;&nbsp;&nbsp;</td>\n<td>\n<p><strong>Parenteral:&nbsp;Monovalent</strong> DTI-&nbsp;Argatroban</p>\n<p><strong>Bivalent</strong> DTI- Lepirudin, Desirudin, Bivalirudin</p>\n<p><strong>Oral</strong>:&nbsp;Dabigatran&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>3) Indirect thrombin inhibitors&nbsp;</td>\n<td>\n<p>Unfractionated heparin</p>\n<p>Low molecular weight heparins:&nbsp;Enoxaparin, Dalteparin, Tinzaparin, Nadroparin</p>\n</td>\n</tr>\n<tr>\n<td>4) Indirect factor Xa inhibitors</td>\n<td>Fondaparinux</td>\n</tr>\n<tr>\n<td>5) <strong>Oral</strong> Direct factor Xa inhibitors</td>\n<td>Rivaro<strong>xa</strong>ban,Api<strong>xa</strong>ban, Edo<strong>xa</strong>ban,Betri<strong>xa</strong>ban</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(605, 'Medicine,', 'PM0603. Plasminogen activators (classification of fibrinolytics)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Fibrin non-specific</strong> plasminogen activators</p>\n<ul>\n<li>Streptokinase - least fibrin specific and has the lowest incidence of intracranial hemorrhage</li>\n<li>Anistreplase</li>\n<li>Urokinase</li>\n</ul>\n<p><strong>Fibrin specific</strong> plasminogen activators</p>\n<ul>\n<li>Alteplase - has the shortest half-life</li>\n<li>Tenecteplase - most fibrin specific and given as a single bolus dose</li>\n<li>Reteplase</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(606, 'Medicine,', 'PM2457. Drugs used in irritable bowel syndrome (IBS)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>For abdominal pain</p>\n<ul>\n<li>Antispasmodics - Dicyclomine</li>\n<li>Tricyclic antidepressants - Amitriptyline, Imipramine</li>\n<li>Selective serotonin reuptake inhibitor - Citalopram</li>\n</ul>\n<p>For diarrhoea</p>\n<ul>\n<li>Opiate - Loperamide</li>\n<li>5-HT3 antagonist - Alosetron</li>\n<li>Bile acid sequestrant - Cholestyramine resin</li>\n</ul>\n<p>For constipation</p>\n<ul>\n<li>Laxatives such as psyllium/ispaghula husk and polyethylene glycol</li>\n<li>Cl<sup>-</sup> channel activator - Lubiprostone</li>\n<li>Guanylate cyclase agonist - Linaclotide</li>\n<li>5-HT4 agonist - Tegaserod</li>\n<li>Selective serotonin reuptake inhibitor - Paroxetine</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(607, 'Medicine,', 'PM1565. Uses of methotrexate (mnemonic: CANCER)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Mnemonic: <strong>CANCER</strong></p>\n<p><strong>C</strong>rohn’s disease</p>\n<p><strong>A</strong>bortion</p>\n<p><strong>N</strong>on-Hodgkin lymphoma, ALL</p>\n<p><strong>C</strong>horiocarcinoma, Sarcoma</p>\n<p><strong>E</strong>ctopic pregnancy</p>\n<p><strong>R</strong>heumatoid arthritis, Psoriasis, Vasculitis</p></div><!---->\n      <!---->\n    </div><!---->'),
(608, 'Pharmacology', 'PM1517. Unique adverse effect profile of Zidovudine', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Bone marrow suppression: anemia and granulocytopenia </li>\n<li>Skeletal muscle myopathy </li>\n<li>Nail hyperpigmentation </li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(609, 'Pharmacology', 'PM1353. Classification of antineoplastic drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/fd047e306bdc4310be749978ffaf0c5dx1280x1780.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp; &nbsp;Non-cell-cycle specific drugs</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Alkylating agents</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nitrogen mustards</p>\n<ul>\n<li>Cyclophosphamide</li>\n<li>Ifosfamide</li>\n<li>Mechlorethamine</li>\n<li>Melphalan</li>\n<li>Chlorambucil</li>\n<li>Bendamustine</li>\n</ul>\n<p>Nitrosoureas</p>\n<ul>\n<li>Carmustine</li>\n<li>Lomustine</li>\n<li>Semustine</li>\n<li>Streptozocin</li>\n</ul>\n<p>Triazines (methylating agents)</p>\n<ul>\n<li>Procarbazine</li>\n<li>Dacarbazine</li>\n<li>Temozolomide</li>\n</ul>\n<p>Ethyleneimines</p>\n<ul>\n<li>Altretamine</li>\n<li>Thio-TEPA</li>\n</ul>\n<p>Alkyl sulfonates</p>\n<ul>\n<li>Busulfan</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Platinum compounds</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Cisplatin</li>\n<li>Carboplatin</li>\n<li>Oxaliplatin&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Anti-tumor antibiotics</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anthracyclines</p>\n<ul>\n<li>Doxorubicin (adriamycin)</li>\n<li>Daunorubicin (rubidomycin)</li>\n<li>Epirubicin</li>\n<li>Valrubicin</li>\n<li>Mitoxantrone</li>\n</ul>\n<p>Others</p>\n<ul>\n<li>Actinomycin-D (Dactinomycin)</li>\n<li>Mitomycin-C</li>\n<li>Bleomycin (also a G2-M phase inhibitor)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong> Cell-cycle specific drugs</strong></td>\n</tr>\n<tr>\n<td><strong>S-phase inhibitors</strong></td>\n</tr>\n<tr>\n<td><strong>Antimetabolites</strong></td>\n</tr>\n<tr>\n<td>Antifolate\n<ul>\n<li>Methotrexate</li>\n<li>Pemetrexed</li>\n<li>Pralatrexate</li>\n<li>Raltitrexed</li>\n</ul>\nPurine analogues\n<ul>\n<li>6-Mercaptopurine</li>\n<li>6-Thioguanine</li>\n<li>Fludarabine</li>\n<li>Cladribine</li>\n<li>Pentostatin</li>\n</ul>\nPyrimidine analogues\n<ul>\n<li>5-Fluorouracil</li>\n<li>Capecitabine</li>\n<li>Gemcitabine</li>\n<li>Cytarabine</li>\n</ul>\n&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Topoisomerase inhibitors</strong></td>\n</tr>\n<tr>\n<td>Topoisomerase-1 inhibitors (ca)\n<ul>\n<li>Irinotecan</li>\n<li>Topotecan</li>\n</ul>\nTopoisomerase-2 inhibitors\n<ul>\n<li>Etoposide</li>\n<li>Teniposide</li>\n</ul>\n&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Histone deacetylase inhibitors</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Vorinostat</li>\n<li>Belinostat</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Others </strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>&nbsp;Hydroxyurea</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>M-phase inhibitors (antimitotics or microtubule damaging agents)</strong></td>\n</tr>\n<tr>\n<td><strong>Vinca alkaloids</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Vincristine(Oncovin)</li>\n<li>Vinblastine</li>\n<li>Vinorelbine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Taxanes</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Paclitaxel</li>\n<li>Docetaxel</li>\n<li>Cabazitaxel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Others</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Epothilones</li>\n<li>Eribulin</li>\n<li>Estramustine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>G1-S phase inhibitor</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Epipodophyllotoxin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(610, 'Pharmacology', 'PM1082. Monoclonal antibodies nomenclature', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Murine - <strong>0%</strong> human: “<strong>omab</strong>” (Tositumomab)</p>\n<p>Chimeric - <strong>65%</strong> human: “<strong>ximab</strong>” (Rituximab)</p>\n<p>Humanized - <strong>95%</strong> human: “<strong>zumab</strong>” (Trastuzumab)</p>\n<p>Fully human - <strong>100%</strong> human: “<strong>umab</strong>” (Adalimumab)</p></div><!---->\n      <!---->\n    </div><!---->'),
(611, 'Medicine,', 'PM1081. Indications for Imatinib', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>BCR-ABL kinase mutations</strong></p>\n<ul>\n<li>Chronic myelogenous leukaemia (CML)</li>\n<li>Acute lymphoblastic leukaemia (ALL)</li>\n</ul>\n<p><strong>C-KIT mutations</strong></p>\n<ul>\n<li>Gastrointestinal stromal tumors (GIST)</li>\n</ul>\n<p><strong>PDGFR mutations</strong></p>\n<ul>\n<li>Dermatofibrosarcoma protuberans</li>\n<li>Hypereosinophilia syndrome</li>\n<li>Chronic myelomonocytic leukaemia (CML)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(612, 'Pharmacology', 'PM0925. Microtubule stabilising vs polymerisation inhibiting agents', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Mnemonic</p>\n<p><strong>Tax</strong>es stabilise economy</p>\n<ul>\n<li><strong>Tax</strong>anes stabilise microtubules</li>\n</ul>\n<p>V<strong>in</strong>ca alklaoids</p>\n<ul>\n<li>Polymerisation <strong>in</strong>hibiting agents</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(613, 'Pharmacology', 'PM0914. Cell cycle specific and non-specific cytotoxic agents', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Cell cycle specific agents</p>\n<ul>\n<li>Antimetabolites: S phase</li>\n<li>Camptothecin analogs: S Phase</li>\n<li>Taxanes, Vinca alkaloids: M phase</li>\n<li>Epipodophyllotoxin: G1-S phase</li>\n<li>Bleomycin: G2-M phase</li>\n</ul>\n<p>Cell cycle non-specific agents</p>\n<ul>\n<li>Alkylating agents</li>\n<li>Platinum analogs</li>\n<li>Anthracyclines</li>\n<li>Mitomycin, dactinomycin</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(614, 'Pharmacology', 'PM0910. Topoisomerase Inhibitors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Topoisomerase I inhibitors</p>\n<ul>\n<li>Camptothecin analogs: Irinotecan, topotecan</li>\n</ul>\n<p>Topoisoemrase II inhibitors</p>\n<ul>\n<li>Anthracyclines: doxorubicin, daunorubicin</li>\n<li>Epipodophyllotoxins: etoposide, teniposide</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(615, 'Pharmacology', 'PM2405. FDA approved drugs in 2019', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div dir=\ltr\ align=\left\>\n<table>\n<tbody>\n<tr>\n<th>\n<p dir=\ltr\><span><strong>Drug</strong></span></p>\n</th>\n<th>\n<p dir=\ltr\><span><strong>Description, mechanism of action and usage</strong></span></p>\n</th>\n</tr>\n<tr>\n<th colspan=\2\>\n<p dir=\ltr\ role=\presentation\><span><strong>I. Autonomic nervous system</strong></span></p>\n</th>\n</tr>\n<tr>\n<td>\n<p><span>1. Prabotulinum toxin A -xvfs</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>botulinum toxin type A</strong>, which is produced from the fermentation of Clostridium botulinum.</span></p>\n<p dir=\ltr\><span>It blocks the neuromuscular transmission by inhibiting the release of acetylcholine.</span></p>\n<p dir=\ltr\><span>It is indicated for the temporary improvement in the appearance of moderate to severe <strong>glabellar</strong> <strong>lines</strong> associated with corrugator and/or procerus muscle activity in adult patients.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>2. Solriamfetol</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>dopamine and norepinephrine reuptake inhibitor</strong> (<strong>DNRI</strong>).</span></p>\n<p dir=\ltr\><span>Used to treat excessive daytime sleepiness in patients with <strong>narcolepsy</strong> or <strong>obstructive sleep apnea</strong> (OSA).</span></p>\n</td>\n</tr>\n<tr>\n<th colspan=\2\>\n<p dir=\ltr\ role=\presentation\><span><strong>II. Central nervous system</strong></span></p>\n</th>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>1. Brexanolone</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a neuroactive steroid gamma-aminobutyric acid (<strong>GABA) A receptor positive modulator,</strong> which is chemically identical to endogenous <strong>allopregnanolone</strong>.</span></p>\n<p dir=\ltr\><span>Used to treat p<strong>ostpartum depression (PPD)</strong> in adult women.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>2. Lumateperone tosylate</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is an atypical <strong>antipsychotic</strong> indicated for the treatment of <strong>schizophrenia</strong>.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>3. Lemborexant</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is an <strong>Orexin receptor antagonist</strong> used in the treatment of <strong>insomnia</strong>.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>4. Siponimod</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>sphingosine1-phosphate receptor modulator.</strong></span></p>\n<p dir=\ltr\><span>It binds to <strong>S1P receptors</strong> <strong>1</strong> <strong>and 5</strong>, and blocks the capacity of lymphocytes to egress from lymph nodes, thereby, reducing the number of lymphocytes in peripheral blood and may involve reduction of lymphocyte migration into the central nervous system.</span></p>\n<br>\n<p dir=\ltr\><span>It is indicated for the treatment of relapsing forms of <strong>multiple</strong> <strong>sclerosis</strong> (MS).</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>5. Istradefylline</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is an <strong>adenosine receptor antagonist,</strong> which has a xanthine derivative structure.&nbsp;</span></p>\n<br>\n<p dir=\ltr\><span>It is indicated as adjunctive treatment to levodopa/carbidopa in adult patients with <strong>Parkinson’s</strong> <strong>disease</strong> (PD) experiencing “off” episodes.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>6. Cenobamate</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>carbamate</strong> derivative used in the treatment of<strong> partial-onset seizures</strong> in adult patients.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>7. Ubrogepant</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>calcitonin gene-related peptide (CGRP) receptor antagonist.&nbsp;</strong></span></p>\n<p dir=\ltr\><span>Used for acute treatment of <strong>migraine</strong> with or without aura.</span></p>\n</td>\n</tr>\n<tr>\n<th colspan=\2\>\n<p dir=\ltr\ role=\presentation\><span><strong>III. Cardiovascular system</strong></span></p>\n</th>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>1. Caplacizumab -yhdp</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>von Willebrand factor (vWF)-directed antibody fragment.&nbsp;</strong></span></p>\n<p dir=\ltr\><span>It targets the A1 domain of vWF, and inhibits the interaction between vWF and platelets, thereby reducing both vWF-mediated platelet adhesion and platelet consumption.</span></p>\n<p dir=\ltr\><span>It is indicated for the treatment of adult patients with <strong>acquired</strong> <strong>thrombotic</strong> <strong>thrombocytopenic</strong> <strong>purpura</strong> (<strong>aTTP</strong>), in combination with plasma exchange and immunosuppressive therapy.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>2. Tafamidis meglumine</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a selective <strong>stabilizer of transthyretin (TTR).</strong></span></p>\n<p dir=\ltr\><span>It binds to the TTR at the thyroxine-binding sites, thereby stabilizing the tetramer and slowing dissociation into monomers, which is the rate-limiting step in amyloidogenic process.</span></p>\n<p dir=\ltr\><span>Used for the treatment of the <strong>cardiomyopathy</strong> of wild type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular-related mortality or hospitalization.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>3. Ferric maltol</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is an orally administered, <strong>iron</strong> <strong>replacement product</strong> containing 30 mg of iron in a stable ferric state and 201.5 mg of maltol in the form of trimaltol ligand.</span></p>\n<p dir=\ltr\><span>Used for the treatment of <strong>iron deficiency anemia.</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>4. Luspatercept –&nbsp;aamt</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is an <strong>erythroid maturation agent.&nbsp;</strong></span></p>\n<p dir=\ltr\><span>It binds several endogenous TGF-β superfamily ligands, thereby diminishing Smad2/3 signaling and thereby promoting maturation and differentiation of erythroid precursors.</span></p>\n<p dir=\ltr\><span>It is indicated for the treatment of anemia in adult patients with <strong>beta thalassemia</strong> who require regular red blood cell (RBC) transfusions.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>5. Crizanlizumab-tmca</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>selectin blocker</strong> humanized IgG2 kappa monoclonal antibody that binds to P-selectin and blocks interactions with its ligands including P-selectin glycoprotein ligand 1.</span></p>\n<p dir=\ltr\><span>It is indicated to reduce the frequency of vasoocclusive crises in patients with <strong>sickle cell disease.</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>6. Voxelotor</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>hemoglobin S polymerization inhibitor.</strong></span></p>\n<p dir=\ltr\><span>It binds to HbS and increases the affinity of Hb for oxygen and thereby dose-dependent inhibition of HbS polymerization.&nbsp;</span></p>\n<p dir=\ltr\><span>Used to treat <strong>sickle cell disease.</strong>&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<th colspan=\2\>\n<p dir=\ltr\ role=\presentation\><span><strong>IV. Respiratory system</strong></span></p>\n</th>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>Combination of elexacaftor/ ivacaftor/ tezacaftor</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a combination of <strong>ivacaftor</strong>, a CFTR potentiator, <strong>tezacaftor,</strong> and <strong>elexacaftor</strong> indicated for the treatment of <strong>cystic</strong> <strong>fibrosis</strong> (CF) in patients aged 12 years and older who have at least one F508 del mutation in the CFTR gene.</span></p>\n</td>\n</tr>\n<tr>\n<th colspan=\2\>\n<p dir=\ltr\ role=\presentation\><span><strong>V. Gastrointestinal system</strong></span></p>\n</th>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>Tenapanor</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>sodium/hydrogen exchanger 3 (NHE3) inhibitor.</strong></span></p>\n<p dir=\ltr\><span>It causes local inhibition of NHE3, which is an antiporter expressed on the apical surface of the small intestine and colon primarily responsible for the absorption of dietary sodium. As a result, it reduces the sodium absorption from these sites, and thereby causes an increase in water secretion into the lumen.&nbsp;</span></p>\n<p dir=\ltr\><span>Used to treat <strong>irritable</strong> <strong>bowel</strong> <strong>syndrome with constipation (IBS-C).</strong></span></p>\n</td>\n</tr>\n<tr>\n<th colspan=\2\>\n<p dir=\ltr\ role=\presentation\><span><strong>VI. Endocrine system</strong></span></p>\n</th>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>Romosozumab-&nbsp;aqqg</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>humanized monoclonal antibody (IgG2)</strong> produced in a mammalian cell line (Chinese Hamster Ovary) by recombinant DNA technology</span></p>\n<p dir=\ltr\><span>It binds to and inhibits the action of sclerostin(a regulatory protein in bone metabolism), and thereby increases bone formation and reduces bone resorption.</span></p>\n<p dir=\ltr\><span>Used to treat <strong>osteoporosis in postmenopausal women</strong> at high risk of fracture.&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<th colspan=\2\>\n<p dir=\ltr\ role=\presentation\><span><strong>VII. Autacoids</strong></span></p>\n</th>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>1. Pitolisant</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is an <strong>antagonist/inverse agonist</strong> of the <strong>histamine-3 (H3) receptor.&nbsp;</strong></span></p>\n<p dir=\ltr\><span>Used to treat excessive daytime sleepiness (EDS) in adult patients with <strong>narcolepsy</strong>.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>2. Lasmiditan</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>serotonin (5-HT) 1F receptor agonist.</strong></span></p>\n<p dir=\ltr\><span>It is used for the acute treatment of <strong>migraine</strong> with or without aura in adults.&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<th colspan=\2\>\n<p dir=\ltr\ role=\presentation\><span><strong>VIII. Antimicrobials</strong></span></p>\n</th>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>1. Triclabendazole</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is an <strong>antihelminthic</strong> <strong>drug</strong> that acts against the fasciola species.</span></p>\n<p dir=\ltr\><span>Used to treat <strong>fascioliasis</strong> in patients 6 years of age and older.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>2. Combination of imipenem, cilastatin, and relebactam</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a combination of <strong>imipenem</strong>, a penem antibacterial, <strong>cilastatin</strong>, a renal dehydropeptidase inhibitor, and <strong>relebactam</strong>, a beta­ lactamase inhibitor.</span></p>\n<p dir=\ltr\><span>It is approved for use in the treatment of <strong>complicated urinary tract infections</strong> and <strong>complicated abdominal infections</strong> caused by susceptible gram-negative bacteria.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>3. Cefiderocol</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>cephalosporin</strong> antibacterial drug with activity against Gram-negative aerobic bacteria.&nbsp;</span></p>\n<p dir=\ltr\><span>It exerts <strong>bactericidal</strong> action by inhibiting cell wall biosynthesis through binding to penicillin-binding proteins (PBPs).</span></p>\n<p dir=\ltr\><span>It is indicated for the treatment of patients with <strong>complicated urinary tract infections</strong> who have limited or no alternative treatment options.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>4. Pretomanid</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is an oral <strong>nitroimidazooxazine</strong> antimycobacterial agent.</span></p>\n<p dir=\ltr\><span>It is used in combination with bedaquiline and linezolid for the treatment of adults with pulmonary extensively drug-resistant (<strong>XDR</strong>), treatment-intolerant or nonresponsive multidrug-resistant (<strong>MDR</strong>) <strong>tuberculosis (TB).&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>5. Lefamulin</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a semi-synthetic <strong>pleuromutiilin</strong> antibacterial agent.</span></p>\n<p dir=\ltr\><span>It inhibits bacterial protein synthesis by interacting with the A- and P-sites of the peptidyl transferase center (PTC) in domain V of the 23s rRNA of the 50S subunit.&nbsp;</span></p>\n<p dir=\ltr\><span>In vitro, it is <strong>bactericidal</strong> against S. pneumoniae, H. influenzae and M. pneumoniae (including macrolide-resistant strains), and <strong>bacteriostatic</strong> against S. aureus and S. pyogenes.</span></p>\n<p dir=\ltr\><span>Used in the treatment of <strong>community-acquired bacterial pneumonia (CABP).&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<th colspan=\2\>\n<p dir=\ltr\ role=\presentation\><span><strong>IX. Anticancer drugs</strong></span></p>\n</th>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>1. Erdafitinib</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>kinase inhibitor.</strong></span></p>\n<p dir=\ltr\><span>Used for the treatment of locally advanced or metastatic <strong>urothelial</strong> <strong>carcinoma</strong>, that has:</span></p>\n<ul>\n<li dir=\ltr\><span>&nbsp;susceptible FGFR3 or FGFR2 genetic alterations and</span></li>\n<li dir=\ltr\><span>progressed during or following at least one line of prior platinum-containing chemotherapy including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>2. Enfortumab vedotin-ejfv</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>Nectin-4-directed antibody</strong> and <strong>microtubule</strong> <strong>inhibitor</strong> <strong>conjugate</strong>.</span></p>\n<p dir=\ltr\><span>It is&nbsp; indicated for the treatment of adult patients with locally advanced or metastatic <strong>urothelial cancer</strong> who have:</span></p>\n<ul>\n<li><span>previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor, and&nbsp;</span></li>\n<li><span>a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic setting.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>3. Darolutamide</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is an <strong>androgen receptor (AR) inhibitor.</strong></span></p>\n<p dir=\ltr\><span>It acts by competitively inhibiting of androgen binding, AR nuclear translocation, and AR-mediated transcription.</span></p>\n<p dir=\ltr\><span>Indicated for the treatment of patients with non-metastatic <strong>castration-resistant prostate cancer.</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>4. Alpelisib</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>kinase</strong> <strong>inhibitor</strong> acting against <strong>phosphatidylinositol-3-kinase</strong> (PI3K), mainly <strong>PI3Kα</strong>.</span></p>\n<p dir=\ltr\><span>It is used in combination with fulvestrant for the treatment of <strong>breast cancer.</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>5. Fam-trastuzumab deruxtecan-nxki</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>HER2-directed antibody</strong> and <strong>topoisomerase</strong> <strong>inhibitor</strong> <strong>conjugate</strong>.</span></p>\n<p dir=\ltr\><span>It is used in the treatment of adult patients with unresectable or metastatic HER2-positive <strong>breast cancer</strong> who have received two or more prior anti-HER2-based regimens in the metastatic setting.&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>6. Selinexor</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>nuclear export inhibitor.</strong></span></p>\n<p dir=\ltr\><span>It blocks <strong>exportin 1</strong> (<strong>XPO1</strong>), and thereby reversibly inhibits nuclear export of tumor suppressor proteins (TSPs), and oncoproteins, such as c‐myc and cyclin D1. This leads to accumulation of these substances causing cell cycle arrest, and apoptosis of cancer cells.&nbsp;</span></p>\n<p dir=\ltr\><span>It is used to treat&nbsp; patients with relapsed or refractory <strong>multiple</strong> <strong>myeloma</strong> (RRMM)</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>7. Polatuzumab vedotin-piiq</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>CD79b-directed antibody–drug conjugate.</strong> It consists of three components:&nbsp;</span></p>\n<ul>\n<li dir=\ltr\><span>IgG1 monoclonal antibody</span></li>\n<li dir=\ltr\><span>Anti-mitotic agent called MMAE (monomethyl auristatin E), and</span></li>\n<li dir=\ltr\><span>A protein cleavable linker called mc-vc-PAB</span></li>\n</ul>\n<p dir=\ltr\><span>The IgG1 component binds to the binds to CD79b, a B-cell specific surface protein and gets internalized into the cell. The lysosomal enzymes then cleaves the linker mc-vc-PAB, causing release of MMAE. The MMAE then binds to the microtubules and kills dividing cells by inhibiting cell division and inducing apoptosis.</span></p>\n<p dir=\ltr\><span>It is used in combination with bendamustine and rituximab product for the treatment of&nbsp; relapsed or refractory <strong>diffuse large B-cell lymphoma.&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>8. Zanubrutinib</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is <strong>kinase inhibitor</strong> acting against <strong>Bruton’s tyrosine kinase (BTK).</strong></span></p>\n<p dir=\ltr\><span>BTK is a signaling molecule on B-cell, and plays a role in B-cell proliferation, trafficking, chemotaxis, and adhesion. Inhibition of BTK activity leads to inhibited malignant B-cell proliferation and reduced tumor growth.</span></p>\n<p dir=\ltr\><span>It is used for the treatment of adult patients with <strong>mantle cell lymphoma (MCL)</strong> who have received at least one prior therapy.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>9. Fedratinib</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>kinase</strong> <strong>inhibitor</strong> that acts against wild type and mutationally activated <strong>Janus Associated Kinase 2 (JAK2)</strong> and <strong>FMS-like tyrosine kinase 3 (FLT3).&nbsp;</strong></span></p>\n<br>\n<p dir=\ltr\><span>It is used to treat intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) <strong>myelofibrosis (MF).</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>10. Pexidartinib</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a kinase inhibitor that mainly targets the following:</span></p>\n<ul>\n<li dir=\ltr\><span>Colony stimulating factor 1 receptor (<strong>CSF1R</strong>)</span></li>\n<li dir=\ltr\><span>KIT proto-oncogene receptor tyrosine kinase (<strong>KIT</strong>), and</span></li>\n<li dir=\ltr\><span>FMS-like tyrosine kinase 3 (<strong>FLT3</strong>) harboring an internal tandem duplication (<strong>ITD</strong>) mutation.</span></li>\n</ul>\n<p dir=\ltr\><span>Used for the treatment of symptomatic <strong>tenosynovial giant cell tumor (TGCT)</strong> associated with severe morbidity or functional limitations and not amenable to improvement with surgery.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>11. Entrectinib</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>kinase</strong> <strong>inhibitor</strong> that acts against tropomyosin receptor tyrosine kinases (<strong>TRK</strong>), proto-oncogene tyrosine-protein kinase&nbsp;(<strong>ROS1</strong>), and anaplastic lymphoma kinase (<strong>ALK</strong>).</span></p>\n<p dir=\ltr\><span>It is used in the treatment of:</span></p>\n<ul>\n<li dir=\ltr\><span>Adult patients with metastatic <strong>non-small cell lung cancer (NSCLC)</strong> whose tumors are <strong>ROS1-positive.</strong></span></li>\n<li dir=\ltr\><span>Adult and pediatric patients 12 years of age and older with <strong>solid</strong> <strong>tumors</strong>.</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<th colspan=\2\>\n<p dir=\ltr\ role=\presentation\><span><strong>X. Dermatological Drugs</strong></span></p>\n</th>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>1. Risankizumab-rzaa</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a humanized i<strong>mmunoglobulin G1 (IgG1) monoclonal antibody.</strong></span></p>\n<p dir=\ltr\><span>It binds to the P19 subunit of IL-23 cytokine and inhibits its interaction with IL-23 receptor. IL-23 is involved in inflammatory and immune responses.</span></p>\n<p dir=\ltr\><span>It is indicated for the treatment of moderate-to-severe <strong>plaque psoriasis</strong> in adults who are candidates for systemic therapy or phototherapy.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>2. Trifarotene</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>retinoid</strong> used for the topical treatment of <strong>acne vulgaris</strong> in patients 9 years of age and older.&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>3. Afamelanotide</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a <strong>melanocortin receptor agonist</strong> and binds predominantly to <strong>MC1-R.</strong></span></p>\n<p dir=\ltr\><span>It is used to increase pain-free light exposure in adult patients with a history of phototoxic reactions from <strong>erythropoietic protoporphyria (EPP).</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>4. Givosiran</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a double-stranded <strong>small interfering RNA (siRNA)</strong> that acts against the aminolevulinate synthase 1 (<strong>ALAS1</strong>) mRNA in hepatocytes.&nbsp;</span></p>\n<p dir=\ltr\><span>The siRNA is covalently bound to N-acetylgalactosamine (<strong>GalNAc</strong>) residues, which enables the delivery of siRNA to hepatocytes. The siRNA through RNA interference causes degradation of ALAS1 mRNA and reduces its levels in the liver, thereby reducing the circulating levels of neurotoxic intermediates aminolevulinic acid (ALA) and porphobilinogen (PBG).</span></p>\n<p dir=\ltr\><span>It is used for the treatment of adults with <strong>acute hepatic porphyria (AHP).&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<th colspan=\2\>\n<p dir=\ltr\ role=\presentation\><span><strong>XI. Dyes and radioactive agents</strong></span></p>\n</th>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>1. Brilliant Blue G Ophthalmic Solution</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is an <strong>ophthalmic solution</strong> containing<strong> brilliant blue G (BBG)</strong> <strong>dye</strong> that selectively stains the <strong>internal limiting membrane (ILM)</strong>, which makes it easier to visualize the membrane for removal.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>2. Air polymer-type A</span></p>\n</td>\n<td>\n<p dir=\ltr\><span><strong>Air polymer-type A</strong> intrauterine foam, is an <strong>ultrasound contrast agent.</strong></span></p>\n<p dir=\ltr\><span>It is formed by mixing the clear Gel with air and sterile purified water, creating an echogenic contrast agent. When visualized with ultrasound, the foam appears echogenic or bright within the fallopian tubes and peritoneal cavity.</span></p>\n<p dir=\ltr\><span>It is indicated for <strong>sono hysterosalpingography</strong> to assess <strong>fallopian tube patency</strong> in women with known or suspected infertility.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>3. Fluorodopa F-18</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a radioactive diagnostic agent used in <strong>PET imaging</strong> to visualize <strong>dopaminergic</strong> <strong>nerve</strong> <strong>terminals</strong> in the <strong>striatum</strong> for the evaluation of adult patients with suspected <strong>Parkinsonian syndromes (PS)</strong>.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>4. Ga-68-DOTATOC</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a radioactive diagnostic agent that consists of <strong>Gallium-68</strong> and <strong>octreotide</strong>. It specifically binds to somatostatin receptors of subtype 2 (sstr2).</span></p>\n<p dir=\ltr\><span>It is indicated for localization of <strong>somatostatin receptor-positive neuroendocrine tumors (NETs).</strong></span></p>\n</td>\n</tr>\n<tr>\n<th colspan=\2\>\n<p dir=\ltr\ role=\presentation\><span><strong>XII. Other drugs</strong></span></p>\n</th>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>1. Upadacitinib</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a is a<strong> Janus kinase (JAK) inhibitor.</strong></span></p>\n<p dir=\ltr\><span>It is used in the treatment of patients with moderately to severely active <strong>rheumatoid arthritis</strong> who have had an inadequate response or intolerance to methotrexate.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>2. Golodirsen</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is an a<strong>ntisense oligonucleotide</strong> that binds to exon 53 of dystrophin pre-mRNA.</span></p>\n<p dir=\ltr\><span>It is used in the treatment of patients with <strong>Duchenne muscular dystrophy (DMD)</strong> who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>3. Brolucizumab–dbll</span></p>\n</td>\n<td>\n<p dir=\ltr\><span>It is a recombinant human vascular endothelial growth factor <strong>(VEGF) inhibitor.</strong></span></p>\n<p dir=\ltr\><span>It binds to VEGF-A and inhibits the interaction with VEGFR-1 and VEGFR-2 and thereby suppresses endothelial cell proliferation, neovascularization, and vascular permeability.</span></p>\n<p dir=\ltr\><span>Used for the treatment of <strong>Neovascular (Wet) Age-Related Macular Degeneration (AMD)</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\><span>4. Bremelanotide</span></p>\n<p dir=\ltr\><span>&nbsp;</span></p>\n</td>\n<td><span>&nbsp;</span>\n<p dir=\ltr\><span>It is a <strong>melanocortin receptor agonist.</strong></span></p>\n<p dir=\ltr\><span>It is used in the treatment of <strong>generalized hypoactive sexual desire disorder (HSDD)</strong>, which is not due to existing medical or psychiatric conditions, relationship issues, or drug abuse.</span></p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p><span>&nbsp;</span></p></div><!---->\n      <!---->\n    </div><!---->'),
(616, 'Pharmacology', 'PM1787. FDA approved drugs in 2017', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The following is the list of drugs approved by FDA in 2017, organized into specialities based on their indication.</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td><strong>Drug</strong></td>\n<td><strong>Indication</strong></td>\n</tr>\n<tr>\n<td><strong>A. Cardiology/Vascular Diseases</strong></td>\n</tr>\n<tr>\n<td>1.&nbsp;&nbsp;&nbsp; Betrixaban</td>\n<td>It is a Factor Xa (FXa) inhibitor used or the prophylaxis of <strong>venous thromboembolism (VTE)</strong> in adult patients hospitalized for an acute medical illness</td>\n</tr>\n<tr>\n<td><strong>B. Hematology</strong></td>\n</tr>\n<tr>\n<td>2.&nbsp;&nbsp;&nbsp; Copanlisib</td>\n<td>Kinase inhibitor used to treat adults with relapsed <strong>follicular lymphoma</strong> who have received at least two prior systemic therapies</td>\n</tr>\n<tr>\n<td>3.&nbsp;&nbsp;&nbsp; Inotuzumab ozogamicin</td>\n<td>CD22-directed antibody-drug conjugate (ADC) to treat adults with relapsed or refractory B-cell precursor <strong>Acute</strong> <strong>Lymphoblastic leukemia (ALL).</strong></td>\n</tr>\n<tr>\n<td>4.&nbsp;&nbsp;&nbsp; Acalabrutinib</td>\n<td>Kinase inhibitor used to treat adults with <strong>mantle cell lymphoma (MCL)</strong> who have received at least one prior therapy</td>\n</tr>\n<tr>\n<td>5.&nbsp;&nbsp;&nbsp; L-glutamine oral powder</td>\n<td>An N amino acid used to reduce the acute complications of <strong>sickle cell disease</strong> in adult and pediatric patients 5 years of age and older.</td>\n</tr>\n<tr>\n<td>6.&nbsp;&nbsp;&nbsp; Emicizumab-kxwh</td>\n<td>Bispecific factor IXa- and factor X-directed antibody used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with <strong>Hemophilia A</strong> (congenital factor VIII deficiency) with factor VIII inhibitors</td>\n</tr>\n<tr>\n<td>7.&nbsp;&nbsp;&nbsp; Enasidenib</td>\n<td>Isocitrate dehydrogenase-2 inhibitor used to treat relapsed or refractory <strong>acute myeloid leukemia</strong> <strong>(AML) </strong>with an isocitrate dehydrogenase-2 (IDH2) mutation as detected by an FDA approved test.</td>\n</tr>\n<tr>\n<td>8.&nbsp;&nbsp;&nbsp; Midostaurin</td>\n<td>Kinase inhibitor used in newly diagnosed cases of <strong>acute myeloid leukemia (AML)</strong> that is FLT3 mutation positive as detected by an FDA-approved test, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation.&nbsp;Also used in aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).&nbsp;</td>\n</tr>\n<tr>\n<td><strong>C. Gastroenterology</strong></td>\n</tr>\n<tr>\n<td>9.&nbsp;&nbsp;&nbsp; Naldemedine</td>\n<td>An opioid antagonist indicated for the treatment of <strong>opioid-induced constipation</strong></td>\n</tr>\n<tr>\n<td>10.Plecanatide</td>\n<td>Guanylate cyclase-C agonist to treat <strong>Chronic Idiopathic Constipation (CIC)</strong> in adult patients.</td>\n</tr>\n<tr>\n<td>11.Telotristat ethyl</td>\n<td>Tryptophan hydroxylase inhibitor, to treat <strong>carcinoid syndrome diarrhea</strong></td>\n</tr>\n<tr>\n<td><strong>D. Endocrinology</strong></td>\n</tr>\n<tr>\n<td>12.Semaglutide</td>\n<td>Glucagon-like peptide 1 (GLP-1) receptor agonist indicated to improve glycemic control in adults with <strong>type 2 diabetes mellitus</strong></td>\n</tr>\n<tr>\n<td>13.Dapagliflozin and saxagliptin</td>\n<td>Sodium-glucose cotransporter 2 (SGLT-2) inhibitor and a dipeptidyl peptidase-4 (DPP-4) inhibitor combination, indicated as an adjunct to diet and exercise to improve glycemic control in adults with <strong>type 2 Diabetes mellitus</strong> (T2DM) who have inadequate control with dapagliflozin or who are already treated with dapagliflozin and saxagliptin.</td>\n</tr>\n<tr>\n<td><strong>E. Hepatology</strong></td>\n</tr>\n<tr>\n<td>14.Hepatitis B vaccine (recombinant), Adjuvanted</td>\n<td>Indicated for prevention of infection caused by all known subtypes of <strong>hepatitis b virus</strong>. It isApproved for use in adults 18 years of age and older.</td>\n</tr>\n<tr>\n<td>15.Glecaprevir and Pibrentasvir</td>\n<td>Fixed-dose combination of glecaprevir, a hepatitis C virus (HCV) NS3/4A protease inhibitor, and pibrentasvir, an HCV NS5A inhibitor indicated for the treatment of patients with <strong>chronic HCV</strong> genotype (GT) 1, 2, 3, 4, 5 or 6 infection without cirrhosis and with compensated cirrhosis (Child-Pugh A)</td>\n</tr>\n<tr>\n<td>16.Sofosbuvir, Velpatasvir and Voxilaprevir</td>\n<td>Fixed-dose combination of sofosbuvir, a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor, velpatasvir, an HCV NS5A inhibitor, and voxilaprevir, an HCV NS3/4A protease inhibitor indicated for the treatment of adult patients with <strong>chronic HCV</strong> infection without cirrhosis or with compensated cirrhosis (Child-Pugh A) who have (1, 2.2, 14).</td>\n</tr>\n<tr>\n<td><strong>F. Nephrology</strong></td>\n</tr>\n<tr>\n<td>17.Etelcalcetide</td>\n<td>Calcium-sensing receptor agonist to treat <strong>secondary hyperparathyroidism</strong> in adult patients with <strong>chronic kidney disease</strong> undergoing dialysis</td>\n</tr>\n<tr>\n<td>18.Meropenem and Vaborbactam</td>\n<td>Combination of meropenem, a penem antibacterial, and vaborbactam, a beta-lactamase inhibitor to treat adults with <strong>complicated urinary tract infections</strong> including <strong>pyelonephritis</strong> caused by designated susceptible bacteria</td>\n</tr>\n<tr>\n<td><strong>G. Neurology</strong></td>\n</tr>\n<tr>\n<td>19.Deutetrabenazine</td>\n<td>Vesicular monoamine transporter 2 (VMAT2) inhibitor for the treatment of <strong>chorea</strong> associated with <strong>Huntington’s disease</strong> and <strong>tardive dyskinesia</strong> in adults</td>\n</tr>\n<tr>\n<td>20.Valbenazine</td>\n<td>Vesicular monoamine transporter 2 (VMAT2) inhibitor to treat adults with <strong>tardive dyskinesia</strong></td>\n</tr>\n<tr>\n<td>21.Edaravone</td>\n<td>Member of the substituted 2-pyrazolin-5-oneclass used to treat patients with <strong>amyotrophic lateral sclerosis (ALS)</strong></td>\n</tr>\n<tr>\n<td>22.Safinamide</td>\n<td>Monoamine oxidase type B (MAO-B) inhibitor indicated as an adjunctive treatment to levodopa/carbidopa in patients with <strong>Parkinson’s Disease (PD)</strong> experiencing “off” episodes</td>\n</tr>\n<tr>\n<td><strong>H. Rheumatology</strong></td>\n</tr>\n<tr>\n<td>23.Sarilumab</td>\n<td>Interleukin-6 (IL-6) receptor antagonist to treat adult <strong>rheumatoid arthritis</strong></td>\n</tr>\n<tr>\n<td>24.Ocrelizumab</td>\n<td>CD20-directed cytolytic antibody to treat patients with relapsing and primary progressive forms of <strong>multiple sclerosis</strong></td>\n</tr>\n<tr>\n<td><strong>I. Oncology</strong></td>\n</tr>\n<tr>\n<td>25.Abemaciclib</td>\n<td>Kinase inhibitor to treat certain advanced or <strong>metastatic breast cancers</strong></td>\n</tr>\n<tr>\n<td>26.Neratinib maleate</td>\n<td>Kinase inhibitor indicated for extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified <strong>breast cancer.</strong></td>\n</tr>\n<tr>\n<td>27.Ribociclib</td>\n<td>Kinase inhibitor used to treat postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic <strong>breast cancer</strong>.</td>\n</tr>\n<tr>\n<td>28.Durvalumab</td>\n<td>Programmed death-ligand 1 (PD-L1) blocking antibody to treat patients with locally advanced or metastatic <strong>urothelial carcinoma.</strong></td>\n</tr>\n<tr>\n<td>29.Brigatinib</td>\n<td>Kinase inhibitor to treat patients with anaplastic lymphoma kinase (ALK)-positive metastatic <strong>Non-small cell lung cancer (NSCLC)</strong> who have progressed on or are intolerant to crizotinib.</td>\n</tr>\n<tr>\n<td>30.Niraparib <strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></td>\n<td>Poly (ADP-ribose) polymerase (PARP) inhibitor indicated for the maintenance treatment for <strong>recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers </strong>who are in a complete or partial response to platinum-based chemotherapy.</td>\n</tr>\n<tr>\n<td><strong>J. Pulmonology</strong></td>\n</tr>\n<tr>\n<td>31.Benralizumab</td>\n<td>Interleukin-5 receptor alpha-directed cytolytic monoclonal antibody (IgG1, kappa) for add-on maintenance treatment of patients with <strong>severe asthma</strong> aged 12 years and older, and with an eosinophilic phenotype.</td>\n</tr>\n<tr>\n<td><strong>K. Internal medicine</strong></td>\n</tr>\n<tr>\n<td>32.Letermovir</td>\n<td>CMV DNA terminase complex inhibitor indicated for the prevention of <strong>cytomegalovirus</strong> <strong>infection</strong> following allogenic <strong>hematopoietic stem cell transplant.</strong></td>\n</tr>\n<tr>\n<td><strong>L. Dermatology</strong></td>\n</tr>\n<tr>\n<td>33.Avelumab</td>\n<td>Programmed death ligand-1 (PD-L1) blocking antibody to treat metastatic <strong>Merkel cell carcinoma</strong></td>\n</tr>\n<tr>\n<td>34.Delafloxacin</td>\n<td>Fluoroquinolone antibacterial to treat patients with <strong>acute</strong> <strong>bacterial skin infections</strong></td>\n</tr>\n<tr>\n<td>35.Dupilumab</td>\n<td>Interleukin-4 receptor alpha antagonist to treat adults with moderate-to-severe eczema (<strong>atopic</strong> <strong>dermatitis</strong>)</td>\n</tr>\n<tr>\n<td>36.Brodalumab</td>\n<td>Human interleukin-17 receptor A (IL-17RA) antagonist to treat adults with moderate-to-severe <strong>plaque psoriasis</strong></td>\n</tr>\n<tr>\n<td>37.Guselkumab</td>\n<td>Interleukin-23 blocker for the treatment of adult patients with moderate-to-severe <strong>plaque psoriasis</strong></td>\n</tr>\n<tr>\n<td>38.Ozenoxacin</td>\n<td>A quinolone antimicrobial indicated to treat <strong>impetigo</strong></td>\n</tr>\n<tr>\n<td><strong>M. Pediatrics</strong></td>\n</tr>\n<tr>\n<td>39.Vestronidase alfavjbk</td>\n<td>Recombinant human lysosomal beta glucuronidase indicated to treat pediatric and adult patients with an inherited metabolic condition called <strong>mucopolysaccharidosis type VII (MPS VII),</strong> also known as <strong>sly syndrome.</strong></td>\n</tr>\n<tr>\n<td>40.Benznidazole</td>\n<td>Nitroimidazole antimicrobial indicated to treat children ages 2 to 12 years old with <strong>chagas</strong> <strong>disease</strong></td>\n</tr>\n<tr>\n<td>41.Deflazacort</td>\n<td>Corticosteroid used to treat patients age 5 years and older with <strong>duchenne muscular dystrophy</strong> (<strong>DMD</strong>)</td>\n</tr>\n<tr>\n<td>42.Cerliponase alfa</td>\n<td>Hydrolytic lysosomal N-terminal tripeptidyl peptidase indicated to slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with late <strong>infantile neuronal ceroid lipofuscinosis type 2 (CLN2</strong>), also known as tripeptidyl peptidase 1 (TPP1) deficiency.</td>\n</tr>\n<tr>\n<td><strong>N. Obstetrics &amp; Gynecology</strong></td>\n</tr>\n<tr>\n<td>43.Secnidazole</td>\n<td>Nitroimidazole antimicrobial used for the treatment of <strong>bacterial vaginosis</strong></td>\n</tr>\n<tr>\n<td>44.Abaloparatide</td>\n<td>Human parathyroid hormone related peptide [PTHrP(1-34)] analog for the treatment of <strong>osteoporosis</strong> <strong>in postmenopausal women</strong> at high risk of fracture or those who have failed other therapies.</td>\n</tr>\n<tr>\n<td><strong>O. Ophthalmology</strong></td>\n</tr>\n<tr>\n<td>45.Latanoprostene Bunod ophthalmic solution</td>\n<td>Prostaglandin analog to treat <strong>intraocular pressure</strong> in patients with <strong>open-angle glaucoma or ocular hypertension.</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(617, 'Dermatology,', 'PM0296. Treatment Ladder for Psoriasis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Treatment Ladder for Psoriasis</strong></p>\n<p><strong>I. In Mild Psoriasis Without Arthritis</strong></p>\n<p><strong>First line</strong></p>\n<ul>\n<li>Coal tar</li>\n<li>Dithranol</li>\n<li>Potent topical steroid</li>\n<li>Vitamin D analogue</li>\n</ul>\n<p><strong>Second line</strong></p>\n<ul>\n<li>Local NB-UVB or PUVA</li>\n<li>Excimer laser</li>\n</ul>\n<p><strong>II. In Moderate or Severe Psoriasis Without Arthritis</strong></p>\n<p><strong>First line</strong></p>\n<ul>\n<li>NB-UVB or PUVA</li>\n</ul>\n<p><strong>Second line</strong></p>\n<ul>\n<li>Acitretin</li>\n<li>Apremilast</li>\n<li>Ciclosporin</li>\n<li>Fumaric acid esters (where available)</li>\n<li>Methotrexate</li>\n</ul>\n<p><strong>Third line</strong></p>\n<ul>\n<li>Adalimumab</li>\n<li>Etanercept</li>\n<li>Infliximab</li>\n<li>Secukinumab</li>\n<li>Ustekinumab</li>\n</ul>\n<p><strong>III. In Moderate or Severe Psoriasis with Psoriatic Arthritis</strong></p>\n<p><strong>First line</strong></p>\n<ul>\n<li>Apremilast</li>\n<li>Methotrexate</li>\n</ul>\n<p><strong>Second line</strong></p>\n<ul>\n<li>Adalimumab</li>\n<li>Etanercept</li>\n<li>Infliximab</li>\n<li>Ustekinumab</li>\n</ul>\n<p><strong>Third line</strong></p>\n<ul>\n<li>Combination therapy</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(618, 'Obstetrics & Gynaecology,', 'PM2438. Tocolytic agents', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>\n<table width=\148\>\n<tbody>\n<tr>\n<td><strong>Drugs</strong></td>\n<td><strong>Examples</strong></td>\n</tr>\n<tr>\n<td>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>Calcium channel blockers</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>Nifedipine <br>Nicardipine<br> Verapamil</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<div class=\page\ title=\Page 606\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>Competitive inhibition to calcium ion</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Magnesium sulfate</td>\n</tr>\n<tr>\n<td>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>Cyclo-oxygenase inhibitors</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>Indomethacin<br>Sulindac</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>Beta mimetics</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>Terbutaline<br>Ritodrine<br>Isoxsuprine</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>Oxytocin Antagonists</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>Atosiban</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>Nitric oxide (NO) Donors</div>\n</div>\n</div>\n</td>\n<td>&nbsp;Glyceryl trinitrate (GTN)</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(619, 'Microbiology', 'PM2458. Laboratory Biosafety Levels (BSL)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Biosafety level</strong></td>\n<td><strong>Lab practices</strong></td>\n<td><strong>Safety Equipment</strong></td>\n<td><strong>Facility</strong></td>\n</tr>\n<tr>\n<td><strong>BSL 1</strong></td>\n<td>\n<p>Work on open lab benches or tables.</p>\n<p>Good microbiological techniques followed</p>\n</td>\n<td>PPE (lab coats, gloves, eye protection) are worn as needed.</td>\n<td>\n<p>Sink for hand washing.</p>\n<p>Separate doors from the rest of the facility.</p>\n</td>\n</tr>\n<tr>\n<td><strong>BSL 2</strong></td>\n<td>Access restricted to the laboratory</td>\n<td>\n<p>Appropriate PPE (lab coats, gloves, eye protection, and face shields).</p>\n<p>Biological safety cabinets (BSC) to prevent potential aerosols.</p>\n<p>Autoclave or alternative method for decontamination</p>\n</td>\n<td>\n<p>Sink and eyewash easily available.</p>\n<p>Self-closing doors.&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>BSL 3</strong></td>\n<td>\n<p>Access restricted and controlled at all times.</p>\n<p>Medical surveillance of laboratory workers.</p>\n</td>\n<td>\n<p>Appropriate PPE must be worn, and respirators might be required.</p>\n<p>BSC for all activities.</p>\n</td>\n<td>\n<p>Hands-free sink and eyewash.</p>\n<p>Directional airflow from clean areas towards potentially contaminated areas.</p>\n<p>Entrance to the lab is through 2 self-closing and interlocked doors.</p>\n</td>\n</tr>\n<tr>\n<td><strong>BSL 4</strong></td>\n<td>\n<p>Change clothing before entering and shower upon exiting.</p>\n<p>Decontaminate all materials before exiting.</p>\n</td>\n<td>\n<p>BSC and full-body, air-supplied, positive pressure suit.</p>\n<p>Double-ended autoclave (through the wall).</p>\n</td>\n<td>\n<p>Laboratory in a separate building or isolated in a restricted zone.</p>\n<p>Dedicated supply and exhaust air, as well as vacuum lines and decontamination systems.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(620, 'Microbiology', 'PM2347. Types of capsules in microorganisms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Capsule&nbsp;</strong></td>\n<td><strong>Organsim</strong></td>\n</tr>\n<tr>\n<td>Polysaccharide capsule&nbsp;</td>\n<td>\n<p>&nbsp;Streptococcus pneumonia</p>\n<p>&nbsp;Klebsiella pneumonia</p>\n<p>&nbsp;Hemophilius influenza</p>\n<p>&nbsp;Neiserria meningitidis</p>\n<p>&nbsp;Salmonella typhi</p>\n<p>&nbsp;Cryptococcus neoformans</p>\n<p>&nbsp;Bordetella pertussis</p>\n<p>Clostridium perfringens</p>\n</td>\n</tr>\n<tr>\n<td>Hyaluronic acid capsule&nbsp;</td>\n<td>Streptococcus pyogenes</td>\n</tr>\n<tr>\n<td>Polypeptide (Poly-D -Glutamate) Capsule&nbsp;</td>\n<td>Bacillus anthracis</td>\n</tr>\n<tr>\n<td>F1 Protein Capsule&nbsp;</td>\n<td>Yersinia pestis</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(621, 'Microbiology', 'PM2346. History of Microbiology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Achievement</strong></td>\n<td>&nbsp;<strong>Scientist</strong></td>\n</tr>\n<tr>\n<td>Father of Microscopy/Microbiology</td>\n<td>Anton von Leeuwenhoek &nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Father of Modern Microbiology</td>\n<td>Louis Pasteur &nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Father of Bacteriology</td>\n<td>Robert Koch &nbsp;</td>\n</tr>\n<tr>\n<td>Father of Virology</td>\n<td>W M Stanley &nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Father of Mycology</td>\n<td>Raymond Sabouraud &nbsp;</td>\n</tr>\n<tr>\n<td>Father of Chemotherapy</td>\n<td>Paul Ehrlich &nbsp;</td>\n</tr>\n<tr>\n<td>Father of Antiseptic surgery</td>\n<td>Joseph Lister &nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Founder of Electron Microscope</td>\n<td>Ernst Ruska &nbsp;</td>\n</tr>\n<tr>\n<td>Founder of L forms of Bacteria</td>\n<td>Kleinberger &nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Founder of Gram Stain</td>\n<td>Hans Christian Gram&nbsp;</td>\n</tr>\n<tr>\n<td>First to describe phagocytosis</td>\n<td>Elie Metchnikoff &nbsp;</td>\n</tr>\n<tr>\n<td>Founder of PCR</td>\n<td>Karry B Mullis</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(622, 'Pathology,', 'PM2206. Various stains and their applications in Pathology and Microbiology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Staining technique</strong></td>\n<td><strong>Cells/inclusions stained</strong></td>\n<td><strong>Disorders</strong></td>\n</tr>\n<tr>\n<td><strong>H&amp;E</strong></td>\n<td>Most common stain used in routine&nbsp;<strong>histopathology</strong></td>\n<td>Commonly used for all slides</td>\n</tr>\n<tr>\n<td><strong>Papanicolaou stain</strong></td>\n<td>Universal stain for <strong>cytological</strong> preparations</td>\n<td>Cytological studies</td>\n</tr>\n<tr>\n<td><strong>PAS</strong></td>\n<td>Demonstrate&nbsp;<strong>glycogen,&nbsp;mucin,&nbsp;fungi, </strong>macrophages&nbsp;</td>\n<td>Whipples disease, adenocarcinomas,&nbsp;and glycogen-positive tumors (Ewings sarcoma, renal cell carcinoma)</td>\n</tr>\n<tr>\n<td><strong><strong>PTAH (</strong></strong><strong>Phosphotungstic acid hematoxylin)</strong></td>\n<td>Fibrin</td>\n<td>Gliosis, Ependymomas, Tumours of skeletal muscles, Fibrin deposits</td>\n</tr>\n<tr>\n<td><strong>Alcian blue</strong></td>\n<td>For <strong>acid mucins</strong>: Positive stain for mucins of the intestinal mucosa and negative stain for mucins of gastric mucosa and Brunners gland</td>\n<td>Barretts esophagus, Gastric disorders</td>\n</tr>\n<tr>\n<td><strong>Perls Prussian blue</strong></td>\n<td>Demonstrate&nbsp;<strong>hemosiderin and iron</strong></td>\n<td>Hemochromatosis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Masson–Fontana stain</strong></td>\n<td>Demonstrate <strong>melanin</strong></td>\n<td>Nevus and malignant melanoma</td>\n</tr>\n<tr>\n<td><strong>von Kossa method</strong></td>\n<td>Demonstrate&nbsp;<strong>calcium</strong></td>\n<td>Calcification of tissues</td>\n</tr>\n<tr>\n<td><strong>Van Gieson stain</strong></td>\n<td>\n<p>Demonstrate <strong>collagen </strong>in; Differentiate amyloid from collagen</p>\n</td>\n<td>Spindle-cell neoplasm; Delineate extent of fibrosis&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Masson trichrome stain</strong></td>\n<td>Demonstrate <strong>collagen and muscle</strong></td>\n<td>Connective tissue disorders, muscle and fibroblast tumors, liver cirrhosis, neuromuscular diseases&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Reticulin stain</strong></td>\n<td>Demonstrate <strong>reticulin fibers</strong></td>\n<td>Distinguish epithelial from non-epithelial neoplasm, Hodgkins lymphoma, early cirrhosis of the&nbsp;liver, myelofibrosis</td>\n</tr>\n<tr>\n<td><strong>Verhoeffs method</strong></td>\n<td>Demonstrate <strong>elastic fibers</strong></td>\n<td>Malignant hypertension, arteriovenous malformation aneurysms, Marfans syndrome, emphysema lung</td>\n</tr>\n<tr>\n<td><strong>Oil red O</strong> <strong>Sudan Black</strong> <strong>Sudan III/IV</strong></td>\n<td>Demonstrate&nbsp;<strong>fat/lipids</strong></td>\n<td>Fatty liver-fat embolism-fibroma vs. thecoma of the&nbsp;ovary-liposarcoma&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Microbiology stains:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stain</strong></td>\n<td><strong>&nbsp;Uses</strong></td>\n</tr>\n<tr>\n<td><strong>Ziehl–Neelsen Stain</strong></td>\n<td>Mycobacteria (all species, including <em>Mycobacterium leprae</em>), <em>Nocardia </em>spp. Cyst of&nbsp;<em>Cryptosporidium parvum</em>, <em>Isospora </em>spp., and&nbsp;<em>Cyclospora</em>&nbsp;spp., Head of sperms</td>\n</tr>\n<tr>\n<td><strong>Masson’s Fontana</strong></td>\n<td>Melanin and argentaffin Cells</td>\n</tr>\n<tr>\n<td><strong>Gomori Methenamine Silver</strong></td>\n<td>Fungi</td>\n</tr>\n<tr>\n<td><strong>Luxol Fast Blue (LFB)</strong></td>\n<td>Myelin</td>\n</tr>\n<tr>\n<td><strong>Phosphotungstic Acid-hematoxylin</strong></td>\n<td>Cross striations of skeletal muscle, fibrin</td>\n</tr>\n<tr>\n<td><strong>Toluidine blue</strong></td>\n<td>Mast cells</td>\n</tr>\n<tr>\n<td><strong>Warthin–Starry</strong></td>\n<td>Helicobacter pylori, spirochetes</td>\n</tr>\n<tr>\n<td><strong>Van Gieson</strong></td>\n<td>Collagen fibres</td>\n</tr>\n<tr>\n<td><strong>Mucicarmine</strong></td>\n<td>Mucin, <em>Cryptococcus</em> capsule</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(623, 'Microbiology', 'PM1942. Acid fast Organisms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\447\>\n<tbody>\n<tr>\n<td><strong>Acid-fast organisms</strong></td>\n<td><strong>Sulfuric acid (%) required for decolorization&nbsp;</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Mycobacterium tuberculosis&nbsp;</li>\n</ul>\n</td>\n<td>25%</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Mycobacterium leprae</li>\n</ul>\n</td>\n<td>5%</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<ul>\n<li>Eggs of Taenia saginata</li>\n<li>Eggs of Schistosoma mansoni</li>\n<li>Oocyst of Cryptosporidium</li>\n<li>Oocyst of Cyclospora</li>\n<li>Oocyst of Cystoisospora</li>\n</ul>\n</td>\n<td>1%</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Sperm head</li>\n<li>Legionella micdadei</li>\n<li>Nocardia</li>\n</ul>\n</td>\n<td>0.5-1%</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Bacterial spore</li>\n</ul>\n</td>\n<td>0.25-0.5%</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(624, 'Microbiology', 'PM1786. Various stains and their applications in microbiology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>A. Simple stains: </strong>Provides color contrast but gives same color to all bacteria and cells.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of stain</strong></td>\n<td><strong>Applications</strong></td>\n</tr>\n<tr>\n<td><strong>Acidic stains</strong></td>\n<td>\n<p>These include<strong> eosin, acid fuchsin, rose bengal, congo red</strong>, etc.</p>\n<p>Used to stain pathological specimens</p>\n</td>\n</tr>\n<tr>\n<td><strong>Basic stains</strong>.</td>\n<td>\n<p><strong>Loeffler’s methylene blue</strong> stain is used in <strong>Quellung reaction</strong>.&nbsp;</p>\n<p><strong>Polychrome methylene blue</strong> is used in <strong>McFadyean’s</strong> <strong>reaction.</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Neutral stains</strong></td>\n<td>\n<p><strong>Wright</strong> and <strong>Giemsa stains</strong> are <strong>Romanowsky stains</strong> used to stain peripheral blood and bone marrow smears. &nbsp;</p>\n<p><strong>Giemsa stain</strong> is used for histopathological diagnosis of malaria and other protozoan blood parasites.&nbsp;&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>B. Differential stains: </strong>Imparts different colors to different bacteria. (These contain more than one stain).</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of stain</strong></td>\n<td><strong>Applications</strong></td>\n</tr>\n<tr>\n<td><strong>Gram stain:</strong></td>\n<td>To differentiate between <strong>gram</strong> <strong>positive</strong> (stain purple/violet) and <strong>gram</strong> <strong>negative</strong> bacteria (stain pink or red).</td>\n</tr>\n<tr>\n<td><strong>Acid-fast stain:&nbsp;</strong></td>\n<td>Used in <strong>Ziehl–Neelsen staining</strong> technique for identification of <strong>acid–fast microorganisms </strong>such as <em>M. tuberculosis</em>, <em>M. leprae</em>, and Nocardia.</td>\n</tr>\n<tr>\n<td><strong>Fluorochrome staining:</strong></td>\n<td><strong>Auramine-rhodamine</strong> is used in fluorochrome staining for screening for <strong>tuberculosis</strong>.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>C. Special stains:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of stain</strong></td>\n<td><strong>Applications</strong></td>\n</tr>\n<tr>\n<td><strong>Staining volutin-containing organisms</strong></td>\n<td><em><strong>Corynebacterium</strong> <strong>diphtheriae</strong> </em>stained by <strong>Albert’s stain</strong>. Green colored bacilli showing \<strong>chinese-letter\ </strong>pattern<strong>, </strong>containing bluish-black <strong>metachromatic</strong> granules of cells<strong>.</strong></td>\n</tr>\n<tr>\n<td><strong>Flagella stain</strong></td>\n<td><em><strong>Salmonella</strong> <strong>typhimurium</strong></em> stained by <strong>modified Ryu stain</strong> to show peritrichous flagella</td>\n</tr>\n<tr>\n<td><strong>Endospore stain</strong></td>\n<td>Used in <strong>Schaeffer and Fulton staining technique</strong> to stain the endospores, where the primary stain is <strong>malachite</strong> <strong>green</strong>, and the counterstain is safranin.</td>\n</tr>\n<tr>\n<td><strong>Capsule stain</strong></td>\n<td>Used in negative staining (<em><strong>Cryptococcus</strong> <strong>neoformans</strong></em>), McFadyean’s reaction,&nbsp;Polychrome methylene blue (<strong>anthrax</strong> <strong>bacilli</strong>).</td>\n</tr>\n<tr>\n<td><strong>Silver impregnation</strong></td>\n<td><strong>Fontana’s silver impregnation</strong> method used for staining <strong>treponeme</strong> and <strong>leptospire</strong>.</td>\n</tr>\n<tr>\n<td><strong>Silver staining</strong></td>\n<td>Used in <strong>Grocott’s – Gomori’s methenamine silver stain. </strong>GMS stain is used to identify <em><strong>Pneumocystis jirovecii</strong></em>, which classically appear as <strong>crushed ping-pong balls.</strong> <strong>&nbsp;</strong> Warthin–starry silver stain for spirochetes.</td>\n</tr>\n<tr>\n<td><strong>Calcofluor white staining</strong></td>\n<td>The cell walls of fungi will bind the stain <strong>calcofluor white.&nbsp;</strong>It is especially useful for the identification of<strong> mucor</strong> and the causative agents of <strong>zygomycosis</strong>.&nbsp; It is also used in staining <strong>acanthamoeba</strong></td>\n</tr>\n<tr>\n<td><strong>Chances staining</strong></td>\n<td>For cell wall demonstration</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(625, 'Microbiology', 'PM1767. Types of flagella:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/a0958d31ed27401cbae49da4e8424bd8x846x699.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(626, 'Microbiology', 'PM1764. Methods of sterilisation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Method of disinfection or sterilisation</strong></td>\n<td><strong>Material</strong></td>\n</tr>\n<tr>\n<td>Red Heat</td>\n<td>Inoculating wire loop, tip of forceps</td>\n</tr>\n<tr>\n<td>Incineration</td>\n<td>Contaminated clothes, animal carcasses, plastics like polythene</td>\n</tr>\n<tr>\n<td>Hot air oven</td>\n<td>Glasswares, scalpels, forceps, cutting instruments, test tubes</td>\n</tr>\n<tr>\n<td>Inspissator</td>\n<td>Heat labile culture media containing egg, sugar or serum</td>\n</tr>\n<tr>\n<td>Autoclave</td>\n<td>Culture media, dressings, gloves, aprons, all instruments except sharps, suture materials except catgut</td>\n</tr>\n<tr>\n<td>Isopropyl alcohol</td>\n<td>Clinical thermometers, stethoscopes, probes</td>\n</tr>\n<tr>\n<td>Methyl alcohol</td>\n<td>Fungal spores</td>\n</tr>\n<tr>\n<td>\n<p>Beta propiolactone/</p>\n<p>formaldehyde</p>\n</td>\n<td>Fumigation of operating theatres, wards and labs</td>\n</tr>\n<tr>\n<td>2% gluteraldehyde</td>\n<td>Cystoscopes, bronchoscopes, fibre-optic endoscopes, plastic ETT, face masks</td>\n</tr>\n<tr>\n<td>Plasma sterilisation</td>\n<td>Arthroscopes, urethroscopes</td>\n</tr>\n<tr>\n<td>Ethylene oxide</td>\n<td>Heart lung machines, respirators, dental equipments, sutures, books, clothings</td>\n</tr>\n<tr>\n<td>Filtration (Seitz filters)</td>\n<td>Bacterial vaccines, intravenous solutions</td>\n</tr>\n<tr>\n<td>5% cresol, hot air oven</td>\n<td>Sharp instruments</td>\n</tr>\n<tr>\n<td>\n<p>Ionising radiation</p>\n<p>(Cold air sterilization)</p>\n</td>\n<td>Catgut, swabs, plastic, syringes, needles, gloves, catheters, grafts</td>\n</tr>\n<tr>\n<td>Chlorhexidine</td>\n<td>Disinfecting surgeon’s hands prior to surgery</td>\n</tr>\n<tr>\n<td>Iodophor</td>\n<td>Disinfecting surgical site prior to surgery</td>\n</tr>\n<tr>\n<td>70% ethanol</td>\n<td>Disinfectant skin prior to venepuncture or immunisation</td>\n</tr>\n<tr>\n<td>Thiomersal</td>\n<td>Preservative in vaccine</td>\n</tr>\n<tr>\n<td>Silver sulfadiazine</td>\n<td>Cleanse burn wounds</td>\n</tr>\n<tr>\n<td>Hypochlorite</td>\n<td>Cleanup of blood spill from a patient with hepatitis B or C</td>\n</tr>\n<tr>\n<td>Hydrogen peroxide</td>\n<td>Cleanse wounds</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(627, 'Microbiology', 'PM1732. Types of motility of microorganisms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Motility</strong></td>\n<td><strong>Microorganism</strong></td>\n</tr>\n<tr>\n<td>Darting/vibratory motility&nbsp;</td>\n<td><em>Vibrio,Campylobacter</em></td>\n</tr>\n<tr>\n<td>Swarming motility</td>\n<td><em>Cl. septicum, B.cereus, Proteus</em>, some Vibrio sp</td>\n</tr>\n<tr>\n<td>Tumbling motility&nbsp;</td>\n<td><em>Listeria monocytogenes</em></td>\n</tr>\n<tr>\n<td>Stately motility</td>\n<td>Clostridia</td>\n</tr>\n<tr>\n<td>Spinning motility</td>\n<td><em>Fusobacterium gyrans</em></td>\n</tr>\n<tr>\n<td>Cork-screw motility&nbsp;</td>\n<td><em>Treponema pallidum</em></td>\n</tr>\n<tr>\n<td>Falling leaf motility</td>\n<td>Giardia</td>\n</tr>\n<tr>\n<td>Twitching motility</td>\n<td><em>Eikenella corrodens</em></td>\n</tr>\n<tr>\n<td>Differential motility (Motility varies at different temperatures)</td>\n<td><em>Yersinia enterocolitica </em>&amp;<em> Listeria monocytogenes</em></td>\n</tr>\n<tr>\n<td>Jerky motility&nbsp;</td>\n<td><em>Trichomonas vaginalis</em></td>\n</tr>\n<tr>\n<td>Gliding motility</td>\n<td><em>Mycoplasma, Entamoeba</em></td>\n</tr>\n<tr>\n<td>Lashing motility&nbsp;</td>\n<td>Saprophytic spirochetes</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(628, 'Microbiology', 'PM1730. Diseases with usual incubation period', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>Incubation period(days)</strong></td>\n</tr>\n<tr>\n<td>Dengue</td>\n<td>5-8</td>\n</tr>\n<tr>\n<td>Typhoid</td>\n<td>10-14</td>\n</tr>\n<tr>\n<td>Herpes simplex</td>\n<td>5-8</td>\n</tr>\n<tr>\n<td>Enterovirus disease</td>\n<td>6-12</td>\n</tr>\n<tr>\n<td>Poliomyelitis</td>\n<td>5-20</td>\n</tr>\n<tr>\n<td>Measles</td>\n<td>9-12</td>\n</tr>\n<tr>\n<td>Smallpox</td>\n<td>12-14</td>\n</tr>\n<tr>\n<td>Chickenpox</td>\n<td>13-17</td>\n</tr>\n<tr>\n<td>Mumps</td>\n<td>16-20</td>\n</tr>\n<tr>\n<td>Rubella</td>\n<td>17-20</td>\n</tr>\n<tr>\n<td>Mononucleosis</td>\n<td>30-50</td>\n</tr>\n<tr>\n<td>Hepatitis A</td>\n<td>15-40</td>\n</tr>\n<tr>\n<td>Hepatitis B &amp; C</td>\n<td>50-150</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(629, 'Community Medicine,', 'PM0814. Methods of Sterilization and Disinfection', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Spectrum</td>\n<td>Uses</td>\n</tr>\n<tr>\n<td><strong>1. Heat</strong></td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Hot air oven</td>\n<td>All</td>\n<td>Glasswares, sterilizing powders, oils, swabs and dressings</td>\n</tr>\n<tr>\n<td>Autoclaving</td>\n<td>All</td>\n<td>Linen, surgical instruments, laboratory ware, media and pharmaceutical products</td>\n</tr>\n<tr>\n<td>Boiling</td>\n<td>Most pathogens, some spores</td>\n<td>Metal tools, rubber or plastic equipment, cloth&nbsp;</td>\n</tr>\n<tr>\n<td>Pasteurization</td>\n<td>Vegetative bacteria</td>\n<td>Beverages, plastic hospital equipment</td>\n</tr>\n<tr>\n<td><strong>2. Ethylene oxide gas</strong></td>\n<td>All</td>\n<td>Heat-sensitive equipment like heart-lung machines, artificial valves, fabrics, respirators, cardiac catheters, books</td>\n</tr>\n<tr>\n<td><strong>3. Radiation</strong></td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>UV</td>\n<td>All</td>\n<td>Limited value due to poor penetration, can be used for plastic syringes, catheters, and laboratory cabinets</td>\n</tr>\n<tr>\n<td>Ionising</td>\n<td>All</td>\n<td>Surgical supplies, food</td>\n</tr>\n<tr>\n<td><strong>4. Chemicals</strong></td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Alcohol</td>\n<td>Vegetative bacteria, viruses some spores</td>\n<td>Skin disinfection, hand washing</td>\n</tr>\n<tr>\n<td>Hydrogen peroxide</td>\n<td>Viruses, vegetative bacteria, spores and fungi</td>\n<td>High-level disinfectant, antiseptic for wounds and discharging ulcers</td>\n</tr>\n<tr>\n<td>Chlorine</td>\n<td>Viruses, vegetative bacteria, fungi</td>\n<td>To disinfect water</td>\n</tr>\n<tr>\n<td>Iodophors</td>\n<td>Viruses, vegetative bacteria, fungi, lethal to spore-bearing organisms</td>\n<td>Skin disinfection, disinfect blood culture bottles and medical equipment</td>\n</tr>\n<tr>\n<td>Crude phenol</td>\n<td>Gram-positive and gram-negative bacteria, but only slowly effective against spores and acid-fast bacteria.</td>\n<td>Disinfection of faeces, mopping floors and cleaning drains.</td>\n</tr>\n<tr>\n<td><strong>5. Glutaraldehyde&nbsp;</strong></td>\n<td>&nbsp;All</td>\n<td>Endoscopes, bronchoscopes</td>\n</tr>\n<tr>\n<td>6. <strong>Quarternary ammonium compounds</strong></td>\n<td>Most bacteria, fungi, lipophilic viruses&nbsp;</td>\n<td>General cleaning</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(630, 'Microbiology,', 'PM0805. Temperatures in Sterilization and Disinfection', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\181\>\n<p><strong>Method</strong></p>\n</td>\n<td width=\214\>\n<p><strong>Temperature (degree Celsius)</strong></p>\n</td>\n<td width=\195\>\n<p><strong>Usual Duration</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\181\>\n<p>Hot air oven</p>\n</td>\n<td width=\214\>\n<p>160</p>\n</td>\n<td width=\195\>\n<p>2 hours</p>\n</td>\n</tr>\n<tr>\n<td width=\181\>\n<p>Classic autoclave</p>\n</td>\n<td width=\214\>\n<p>121</p>\n</td>\n<td width=\195\>\n<p>10–15 minutes</p>\n</td>\n</tr>\n<tr>\n<td width=\181\>\n<p>Flash autoclave</p>\n</td>\n<td width=\214\>\n<p>134</p>\n</td>\n<td width=\195\>\n<p>3 minutes</p>\n</td>\n</tr>\n<tr>\n<td width=\181\>\n<p>Ethylene oxide</p>\n</td>\n<td width=\214\>\n<p>50 to 60</p>\n</td>\n<td width=\195\>\n<p>&nbsp;1 - 6 hours</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(631, 'Microbiology', 'PM0450. Differentiating features between prokaryotes and eukaryotes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Character</strong></p>\n</td>\n<td>\n<p><strong>Prokaryotes</strong></p>\n</td>\n<td>\n<p><strong>Eukaryotes</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\3\>\n<p><strong>Nucleus</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nucleolus</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nuclear membrane</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Deoxyribonucleoprotein</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chromosome</p>\n</td>\n<td>\n<p>One (circular)</p>\n</td>\n<td>\n<p>More than one (linear)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mitotic division</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n</tr>\n<tr>\n<td colspan=\3\>\n<p><strong>Cytoplasm</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cytoplasmic streaming</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pinocytosis</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mitochondria</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lysosomes</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Golgi apparatus</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Endoplasmic reticulum</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cell wall</strong></p>\n</td>\n<td>\n<p>Present</p>\n<p>Muramic acid present</p>\n</td>\n<td>\n<p>Absent</p>\n<p>(if present, muramic acid is absent)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sterols (In cell membrane)</p>\n</td>\n<td>\n<p>Absent&nbsp;</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(632, 'Microbiology', 'PM0144. Inclusion bodies seen in various conditions/diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>1. Bacterial Inclusion Bodies&nbsp;</strong></p>\n<table width=\508\>\n<tbody>\n<tr>\n<td><strong>Disease/Bacteria&nbsp;</strong></td>\n<td><strong>Inclusion bodies&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Granuloma inguinale,&nbsp;<em>Klebsiella granulomatis</em></td>\n<td>Donovan bodies</td>\n</tr>\n<tr>\n<td>Psittacosis, <em>Chlamydia psittacci&nbsp;</em></td>\n<td>Levinthal-Cole-Lille bodies (LCL bodies)</td>\n</tr>\n<tr>\n<td>Trachoma, <em>Chlamydia trachomatis</em></td>\n<td>Halberstaedter-Prowazek bodies</td>\n</tr>\n<tr>\n<td>Lymphogranuloma venereum,&nbsp;<em>Chlamydia trachomatis</em></td>\n<td>Miyagawa’s granulocorpusles</td>\n</tr>\n<tr>\n<td>Diphtheria,&nbsp;<em>Corynebacterium diptheriae</em></td>\n<td>Babes-Ernst granules</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>2. Viral Inclusion Bodies</strong></p>\n<ul>\n<li><strong>Intra-cytoplasmic Inclusion Bodies</strong></li>\n</ul>\n<table width=\513\>\n<tbody>\n<tr>\n<td><strong>Disease/Virus</strong></td>\n<td><strong>Inclusion bodies</strong></td>\n</tr>\n<tr>\n<td>Rabies</td>\n<td>Negri bodies</td>\n</tr>\n<tr>\n<td>Vaccinia, variola (smallpox)</td>\n<td>Guarnieri bodies</td>\n</tr>\n<tr>\n<td>Variola (smallpox)</td>\n<td>Paschen bodies</td>\n</tr>\n<tr>\n<td>Molluscum contagiosum</td>\n<td>Henderson-Patterson bodies</td>\n</tr>\n<tr>\n<td>Fowlpox</td>\n<td>Bollinger bodies</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li><strong>Intra-nuclear Inclusion Bodies&nbsp;</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Inclusion bodies&nbsp;</strong></td>\n<td><strong>Disease/Virus</strong></td>\n</tr>\n<tr>\n<td rowspan=\2\>Cowdry type A</td>\n<td>Lipschutz inclusions</td>\n<td>Herpes Virus</td>\n</tr>\n<tr>\n<td>Torres bodies</td>\n<td>Yellow fever</td>\n</tr>\n<tr>\n<td rowspan=\2\>Cowdry type B</td>\n<td>Basophilic inclusions</td>\n<td>Adenovirus</td>\n</tr>\n<tr>\n<td>Acidophilic inclusions</td>\n<td>Poliovirus</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li><strong>Both Intra-nuclear and Intra-cytoplasmic Inclusion Bodies&nbsp;</strong></li>\n</ul>\n<table width=\521\>\n<tbody>\n<tr>\n<td><strong>Disease/Virus&nbsp;</strong></td>\n<td><strong>Inclusion bodies&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Measles Virus</td>\n<td>Warthin-Finkedly giant cells</td>\n</tr>\n<tr>\n<td>Cytomegalovirus</td>\n<td>Owl-eye inclusions (basophilic,&nbsp;predominantly intra-nuclear, small granular intracytoplasmic inclusions are found)</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>3. Inclusion Bodies in Parasitic Infections&nbsp;</strong></p>\n<table width=\522\>\n<tbody>\n<tr>\n<td><strong>Disease/Parasite</strong></td>\n<td><strong>Inclusion bodies&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Trypanosomiasis</td>\n<td>Morula cells with IgM Deposits</td>\n</tr>\n<tr>\n<td>Kala-azar</td>\n<td>Leishman-Donovan Bodies</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>4. Miscellaneous Inclusion Bodies&nbsp;</strong></p>\n<table width=\521\>\n<tbody>\n<tr>\n<td><strong>Disease/Location</strong></td>\n<td><strong>Inclusion bodies&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Ovarian cortex</td>\n<td>Walthard Inclusions</td>\n</tr>\n<tr>\n<td>Spherical globules surrounded by granulosa cells in the ovary</td>\n<td>Call-Exner bodies</td>\n</tr>\n<tr>\n<td>Parkinsonism, Lewy body dementia&nbsp;</td>\n<td>Lewy Bodies</td>\n</tr>\n<tr>\n<td>Amyotrophic Lateral Sclerosis&nbsp;</td>\n<td>Bunina bodies</td>\n</tr>\n<tr>\n<td>Multiple Myeloma</td>\n<td>Russell Bodies</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(633, 'Microbiology', 'PM0099. Toxins that are coded by phage DNA - Mnemonic', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>A:</strong> Group A strep (S. pyogenes): pyrogenic exotoxins SpeA and SpeC</p>\n<p><strong>B:</strong> Botulinum toxin C &amp; D</p>\n<p><strong>C:</strong> Cholera toxin</p>\n<p><strong>D:</strong> Diphtheria toxin</p>\n<p><strong>E: </strong>E.coli(EHEC): Verocytotoxin (Shiga-like toxin)</p></div><!---->\n      <!---->\n    </div><!---->'),
(634, 'Microbiology,', 'PM0038. Biomedical waste disposal', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\>\n<p><span><strong>&nbsp;<span> Yellow bag </span></strong><strong><span>(non-chlorinated)</span></strong><strong><span>&nbsp;</span>&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type of Waste</p>\n</td>\n<td>&nbsp;Treatment and Disposal Options</td>\n</tr>\n<tr>\n<td>\n<p><strong>Human anatomical waste</strong></p>\n<p><strong>Animal anatomical waste</strong></p>\n</td>\n<td>\n<p><strong>Incineration</strong>/Plasma pyrolysis/Deep Burial</p>\n</td>\n</tr>\n<tr>\n<td><strong>Soiled Waste: </strong>Items like dressings, cotton swabs, and plaster casts contaminated with blood and body fluids and bags containing residual discarded blood.</td>\n<td>\n<p><strong>Incineration</strong>/Plasma pyrolysis/Deep Burial</p>\n<p>or</p>\n<p>Autoclaving/Microwaving/ Hydroclaving</p>\n<p>Later - Shredding/mutilation</p>\n</td>\n</tr>\n<tr>\n<td>Discarded linen, mattresses, beddings contaminated with blood or body fluid,<strong> routine masks, and gowns</strong></td>\n<td>\n<p>Non- chlorinated chemical disinfection<br>followed by incineration or Plazma<br>Pyrolysis or for energy recovery.<br>In absence of the above facilities, shredding,&nbsp;mutilation, or a combination of&nbsp;sterilization and shredding is used.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Microbiology, biotechnology, clinical laboratory waste</strong></p>\n<p>(Autoclave safe plastic bags used)</p>\n<p><strong>Blood bags</strong>, laboratory<br>cultures, stocks or&nbsp;specimens of microorganisms,<br>live or&nbsp;attenuated vaccines,&nbsp;human and animal cell&nbsp;cultures used in&nbsp;research, industrial&nbsp;laboratories, production&nbsp;of biological, residual&nbsp;toxins, dishes, and&nbsp;devices used for&nbsp;cultures.</p>\n</td>\n<td>\n<p>Pre-treatment with nonchlorinated chemicals</p>\n<p>Later - Incineration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Expired/discarded medicine, cytotoxic drugs</p>\n</td>\n<td>Incineration/plasma pyrolysis/ disposal in a secured landfill</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p><strong>Chemical waste</strong></p>\n<p>Chemicals used in biological production&nbsp;and used or discarded<br>disinfectants.</p>\n</td>\n<td>\n<p>Disposal- incineration/plasma<br>pyrolysis</p>\n<p>Encapsulation-&nbsp;hazardous waste treatment, storage, and&nbsp;disposal facility.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Chemical liquid</strong>&nbsp;<strong>waste</strong> :<br>Liquid waste generated&nbsp;due to the use of chemicals&nbsp;in the production of<br>biological and used or&nbsp;<strong>discarded disinfectants,</strong>&nbsp;silver X-ray film<br>developing liquid,<br>discarded formalin,<br>infected <strong>secretions,</strong><br><strong>aspirated body&nbsp;fluids</strong>,&nbsp;liquid from&nbsp;laboratories and floor&nbsp;washings, cleaning,&nbsp;house-keeping and<br>disinfecting activities&nbsp;etc.</p>\n<p>&nbsp;</p>\n</td>\n<td>After resource recovery, the chemical<br>liquid waste shall be pre-treated before&nbsp;mixing with other wastewater.&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\>\n<p><span><strong>&nbsp; Red&nbsp;bag (non-chlorinated)&nbsp;&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td><strong>&nbsp;Type of Waste</strong></td>\n<td>\n<p><strong>&nbsp;<span>Treatment and Disposal Options</span></strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Recyclable contaminated</strong> waste</p>\n<p>Contaminated waste tubing, bottles, intravenous tubes and sets, <strong>catheters,</strong> <strong>urine bags</strong>, syringes (without needles and fixed needle syringes with their needles cut), <strong>vacutainers with</strong> <strong>needles cut,</strong> and gloves.</p>\n</td>\n<td>\n<p><strong>Autoclaving/Microwaving/<br>Hydroclaving</strong></p>\n<p>Followed by Shredding/mutilation</p>\n<p>And later, Energy recovery/Plastics to diesel or fuel oil/road-making</p>\n<p>Not to be sent to landfill</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\>\n<p><strong>&nbsp; White (translucent)&nbsp;&nbsp;<br>(puncture-proof, leak-proof containers)</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Type of Waste</strong></td>\n<td>\n<p><strong>Treatment and Disposal Options</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Waste Sharps including metals.</strong></p>\n<p>Needles, syringes with fixed needles, needles from needle tip cutter or burner, scalpels, blades, or any other <strong>contaminated sharp</strong> object that may cause puncture and cuts. This includes both used, discarded, and contaminated metal sharps</p>\n</td>\n<td>\n<p>Autoclaving/ Dry heat sterilization</p>\n<p>Followed by - <strong>Shredding/mutilation</strong>/<br>encapsulation</p>\n<p>Later by - Iron foundries/sanitary landfill/waste sharps</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\>\n<p>&nbsp;<span><strong><span>&nbsp; Blue&nbsp;&nbsp;</span><br></strong></span><span><strong><span>(Puncture proof and leak proof containers with blue colored marking)</span></strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type of Waste&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;Treatment and Disposal Options</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glassware</strong></p>\n<p>Broken or discarded and contaminated glass including medicine <strong>vials</strong> and <strong>ampules except</strong> those containing <strong>cytotoxic</strong> waste.</p>\n<p><strong>Metallic body implants</strong></p>\n</td>\n<td>\n<p>Sodium hypochlorite/Autoclaving/<br>Microwaving/Hydroclaving</p>\n<p>Later - Recycling</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>&nbsp;Note: <strong>Ash</strong> from the <strong>incineration</strong> of biomedical waste shall be disposed of at a <strong>common hazardous waste treatment and disposal facility</strong>. However, it may also be disposed of in a <strong>municipal landfill</strong>, <strong>if</strong> the toxic metals in incineration ash are <strong>within</strong> the <strong>regulatory quantities</strong> as defined under the Hazardous Waste (Management and Handling and Transboundary Movement) Rules, 2008 as amended from time to time.</p></div><!---->\n      <!---->\n    </div><!---->'),
(635, 'Pathology,', 'PM2412. Types of Hypersensitivity', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Type of reaction</strong></td>\n<td><strong>Clinical Syndrome</strong></td>\n<td><strong>Time for manifestation</strong></td>\n<td><strong>Mediators</strong></td>\n</tr>\n<tr>\n<td><strong>Type I</strong>: <br>IgE type</td>\n<td>\n<p>1. Anaphylaxis</p>\n<p>2. Atopy</p>\n</td>\n<td>Minutes</td>\n<td>IgE: histamine and other pharmacological agents</td>\n</tr>\n<tr>\n<td><strong>Type II</strong>: <br>Cytolytic, cytotoxic</td>\n<td>\n<p>Antibody-mediated damage: e.g. thrombocytopenia, agranulocytosis, hemolytic anemia</p>\n</td>\n<td>Hours to days</td>\n<td>IgG, IgM</td>\n</tr>\n<tr>\n<td><strong>Type III</strong>:<br> Immune complex</td>\n<td>\n<p>1.Arthus-reaction</p>\n<p>2.Serum-sickness</p>\n</td>\n<td>Hours to days</td>\n<td>IgG, IgM, leucocytes</td>\n</tr>\n<tr>\n<td><strong>Type IV</strong>: <br>Delayed hypersensitivity</td>\n<td>\n<p>1. Tuberculin</p>\n<p>2. Contact dermatitis</p>\n</td>\n<td>Hours to days</td>\n<td>T cells, lymphokines, macrophages.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(636, 'Microbiology,', 'PM2352. Chronic granulomatous disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Chronic granulomatous disease&nbsp;</strong>(CGD) is due to the defect in <strong>NADPH oxidase</strong>. This interferes with the killing of bacteria by oxidative burst. Hence, the patients are at increased risk of infection from catalase-positive bacteria.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e4da3044afb34df1b36f9873fda741a7x1280x1775.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;It can be:</p>\n<ul>\n<li><strong>X</strong>&nbsp;<strong>linked -</strong>&nbsp;Defect in one of the membrane-bound components (gp91phox) or</li>\n<li><strong>Autosomal recessive -</strong>&nbsp;Cytoplasmic components (p47phox and p67phox)</li>\n</ul>\n<p>Diagnosis of CGD includes:</p>\n<ul>\n<li aria-level=\1\><strong>Nitroblue tetrazolium test</strong>&nbsp;- This is the standard for phagocyte oxidase activity measurement. The colorless compound NBT is reduced to blue formazan by the activity of the functional phox enzyme system. Normally, more than 95% of the granulocytes will be positive. The NBT is&nbsp;<strong>negative in CGD</strong>&nbsp;due to&nbsp;<strong>absence of phox enzyme activity</strong>.</li>\n<li aria-level=\1\><strong>Dihydrorhodamine (DHR) test&nbsp;</strong>-&nbsp;The most accurate diagnostic test for CGD. Normally functioning phagocytic cells oxidize DHR to the strongly fluorescent compound rhodamine which is quantified by flow cytometry.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(637, 'Microbiology', 'PM2187. Serological tests in microbiology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Precipitation test:</strong></p>\n<ul>\n<li>Ascolis thermoprecipitin test: Anthrax</li>\n<li>Streptococci grouping: Lancefield technique</li>\n<li>VDRL test for syphilis (slide flocculation test)</li>\n<li>Kahn test for syphilis (tube flocculation test)</li>\n<li>Elek gel precipitation test for C.diphtheria</li>\n</ul>\n<p><strong>Agglutination test:</strong></p>\n<ul>\n<li>Widal test- typhoid</li>\n<li>Weil- Felix reaction- Typhus fever</li>\n<li>Streptococcus MG agglutination test- Mycoplasma pneumoniae</li>\n<li>Paul Bunnel test- Infectious mononucleiosis</li>\n<li>Coombs test</li>\n<li>Rose Waaler test- Rheumatoid arthritis</li>\n<li>Microscopic Agglutination test-&nbsp;Leptospirosis</li>\n<li>Anti streptolysin O test</li>\n</ul>\n<p><strong>Complement fixation test:</strong></p>\n<ul>\n<li>Wasserman reaction(syphilis)</li>\n<li>Treponema pallidum immobilization test</li>\n</ul>\n<p><strong>Neutralization test:</strong></p>\n<ul>\n<li>Schik test for diptheria</li>\n<li>Anti streptolysin O test</li>\n<li>Naglers reaction (clostridium perfringens)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(638, 'Medicine,', 'PM2137. Transplant Rejection and Hypersensitivity', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\419\>\n<tbody>\n<tr>\n<td>Type of Rejection&nbsp;</td>\n<td>Type of Hypersensitivity</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<p><strong>Host vs Graft</strong></p>\n</td>\n</tr>\n<tr>\n<td>Hyperacute</td>\n<td>Type 2</td>\n</tr>\n<tr>\n<td>Acute</td>\n<td>Type 2 and 4</td>\n</tr>\n<tr>\n<td>Chronic</td>\n<td>Type 2 and 4</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Graft vs Host</strong></td>\n</tr>\n<tr>\n<td>Graft vs host reaction</td>\n<td>Type 4</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>The image given below explains the pathophysiology of hyperacute graft rejection (<strong>type II</strong> hypersensitivity).&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/988706e6c52640cabe45b6c598d1b709x1280x2089.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The image below shows the mechanism of<strong> type IV</strong> hypersensitivity in graft rejection.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/740d6c7dadda46d38620f36124adea54x1280x4218.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(639, 'Pathology,', 'PM2056. Properties of immunoglobulin classes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>IgG:</strong></p>\n<ul>\n<li>Half-life- 23 days</li>\n<li>Appears late, indicates <strong>chronic infection</strong></li>\n<li>It is the only maternal Ig to cross the placenta.</li>\n<li>Has 4 subclasses.</li>\n<li>Causes complement fixation, precipitation, and neutralization of toxins and virus.</li>\n</ul>\n<p><strong>IgM</strong>:</p>\n<ul>\n<li>Half-life- 5 days</li>\n<li>Has the highest molecular weight and is a pentamer.</li>\n<li>Polysaccharides and lipids mainly stimulate IgM secretion.</li>\n<li>Intravascular distribution.</li>\n<li>Appears early, indicates <strong>recent infection.</strong></li>\n<li>Acts<strong>&nbsp;</strong>as surface immunoglobulin on the B cells.</li>\n<li>It causes agglutination, hemolysis, complement fixation and opsonization.</li>\n</ul>\n<p><strong>IgD:</strong></p>\n<ul>\n<li>Half-life- 2-8 days.</li>\n<li>Acts as a surface immunoglobulin on the B cells.</li>\n<li>Serves as recognition receptors for antigens.</li>\n</ul>\n<p><strong>IgE:</strong></p>\n<ul>\n<li>Half-life- 1-5 days</li>\n<li>Causes type I hypersensitivity.</li>\n<li>It is the only heat labile antibody.</li>\n<li>Levels are raised in helminthic infections.</li>\n</ul>\n<p><strong>IgA:</strong></p>\n<ul>\n<li>Half-life- 6 days</li>\n<li>It is of 2 types- Serum IgA and Secretory IgA&nbsp;</li>\n<li>Secretory IgA (A dimer) results in mucosal immunity.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(640, 'Medicine,', 'PM1923. Complement deficiency and associated diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table width=\490\>\n<tbody>\n<tr>\n<td>Complement protein</td>\n<td>Effects of deficiency</td>\n</tr>\n<tr>\n<td>C1, C2, C4</td>\n<td>Immune- complex disease (SLE)</td>\n</tr>\n<tr>\n<td>C3, Factor I</td>\n<td>Susceptibility to capsulated bacteria</td>\n</tr>\n<tr>\n<td>C5-C9</td>\n<td>Susceptibility to Neisseria</td>\n</tr>\n<tr>\n<td>Factor D. properdin (factor P)</td>\n<td>Susceptibility to capsulated bacteria and Neisseria.</td>\n</tr>\n<tr>\n<td>\n<p>DAF (Decay accelerating factor)</p>\n<p>CD 59</p>\n</td>\n<td>Paroxysmal nocturnal hemoglobinuria</td>\n</tr>\n<tr>\n<td>C1-inhibitor</td>\n<td>Hereditary angioneurotic edema</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(641, 'Microbiology,', 'PM1559. Examples of Type IV Hypersensitivity', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Type IV Hypersensitivity Reactions&nbsp;</p>\n<ul>\n<li>Tuberculin reaction</li>\n<li>Lepromin test</li>\n<li>Multiple sclerosis</li>\n<li>Chronic graft rejection</li>\n<li>Contact dermatitis</li>\n<li>Sarcoidosis</li>\n<li>Primary biliary cirrhosis</li>\n<li>Type I lepra reaction</li>\n<li>Crohn’s disease</li>\n<li>Psoriasis</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f2bf7fce299546679d2c2cac15eca714x1280x4218.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(642, 'Microbiology,', 'PM1557. Types of Type II Antibody-Mediated Hypersentivity', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>There are 3 mechanisms involved in type 2 hypersensitivity reactions-&nbsp;</p>\n<ol>\n<li>Antibody-mediated <strong>cellular dysfunction-</strong>&nbsp;<strong>antibodies</strong>&nbsp;react with antigens present on <strong>cell surfaces</strong> or in the <strong>extracellular matrix</strong> cause disease by <strong>destroying</strong> these <strong>cells,</strong> triggering <strong>inflammation,</strong> or interfering with normal functions<br>\n<ol>\n<li>Myasthenia gravis (against acetylcholine receptor)</li>\n<li>Graves’ disease (against TSH receptor)</li>\n<li>Pemphigus Vulgaris (against epidermal cadherin)</li>\n<li>Pernicious anemia (against intrinsic factor)</li>\n<li>Insulin resistant diabetes (against insulin receptor</li>\n</ol>\n</li>\n<li>Antibody-mediated <strong>opsonization</strong> and <strong>phagocytosis</strong> -<strong>antibodies</strong> may deposit in <strong>tissues</strong> or <strong>blood vessels,</strong> and elicit an acute <strong>inflammatory</strong> reaction by activating <strong>complement</strong>&nbsp;and<strong> Recruiting Phagocytes</strong>\n<ol>\n<li>Transfusion reactions</li>\n<li>Erythroblastosis fetalis</li>\n<li>Autoimmune hemolytic anemia</li>\n<li>Autoimmune thrombocytopenic purpura</li>\n</ol>\n</li>\n<li><strong>Complement</strong> and <strong>Fc receptor-mediated inflammation-</strong>&nbsp;<strong>antibodies</strong>&nbsp;may deposit in&nbsp;<strong>tissues</strong>&nbsp;or&nbsp;<strong>blood vessels,</strong>&nbsp;and elicit an acute&nbsp;<strong>inflammatory</strong>&nbsp;reaction by activating&nbsp;<strong>complement</strong>\n<ol>\n<li>Goodpasture syndrome</li>\n<li>Vasculitis due to ANCA</li>\n<li>Acute rheumatic fever</li>\n<li>Vascular rejection in organ graft&nbsp;</li>\n</ol>\n</li>\n</ol></div><!---->\n      <!---->\n    </div><!---->'),
(643, 'Microbiology,', 'PM1556. Mechanisms of Hypersensitivity Reactions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\746\>\n<tbody>\n<tr>\n<td>\n<p><strong>Type</strong></p>\n</td>\n<td>\n<p><strong>Immune Mechanisms</strong></p>\n</td>\n<td>\n<p><strong>Histopathological lesions</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Immediate </strong><br><strong>&nbsp;hypersensitivity<br>(type I)<br></strong></p>\n<ul>\n<li>Anaphylaxis</li>\n<li>Allergies</li>\n<li>Bronchial asthma</li>\n<li>Atopic dermatitis</li>\n</ul>\n</td>\n<td>\n<p>Production of IgE antibody →immediate release of vasoactive amines from mast cells</p>\n</td>\n<td>\n<p>Vascular dilatation, edema, smooth muscle contraction, mucus production, tissue injury, inflammation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Antibody-mediated hypersensitivity<br>(type II)<br></strong></p>\n<ul>\n<li>Autoimmune hemolytic anemia</li>\n<li>Goodpasture syndrome</li>\n</ul>\n</td>\n<td>\n<p>Production of IgG, IgM → binds to antigen on target cell or tissue → phagocytosis or lysis of target cell by activated complement or Fc receptors; recruitment of leukocytes</p>\n</td>\n<td>\n<p>Phagocytosis and lysis of cells; inflammation;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Immune complex-mediated hypersensitivity<br> (type III)<br></strong></p>\n<ul>\n<li>SLE</li>\n<li>Serum sickness</li>\n<li>Arthus reaction</li>\n</ul>\n</td>\n<td>\n<p>Deposition of antigen-antibody complexes → complement activation →recruitment of leukocytes by complement products and Fc receptors → release of enzymes and other toxic molecules</p>\n</td>\n<td>\n<p>Inflammation, necrotizing vasculitis (fibrinoid necrosis)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cell-mediated hypersensitivity<br>(type IV)</strong></p>\n<ul>\n<li>Contact dermatitis</li>\n<li>Multiple sclerosis</li>\n<li>Type 1 diabetes</li>\n<li>Tuberculosis</li>\n</ul>\n</td>\n<td>\n<p>Activated T lymphocytes →</p>\n<p>1. Release of cytokines, inflammation, and macrophage activation</p>\n<p>2. T-cell-mediated cytotoxicity</p>\n</td>\n<td>\n<p>Perivascular cellular infiltrates; edema; granuloma formation; cell destruction</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f55cab6c8fd44a7abfe8a663dde3980ex1280x2567.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b2a98b94d6a9479b8e6e885ee59366cex1280x2089.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d92e092ef5874477a6da091ca3b1234ax1280x1360.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/56fc1dfb49434818b5057534a97d6621x1280x4218.JPEG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(644, 'Pathology,', 'PM1555. Disorders Caused by Immediate Hypersensitivity', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Clinical Syndrome</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Clinical and Pathologic Manifestations</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Anaphylaxis (may be caused by drugs, bee sting, food)</p>\n</td>\n<td width=\231\>\n<p>Fall in blood pressure (shock) caused by vascular dilation; airway obstruction due to laryngeal edema</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Bronchial asthma</p>\n</td>\n<td width=\231\>\n<p>Airway obstruction caused by bronchial smooth muscle hyperactivity; inflammation and tissue injury caused by late-phase reaction</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Allergic rhinitis, sinusitis (hay fever)</p>\n</td>\n<td width=\231\>\n<p>Increased mucus secretion; inflammation of upper airways, sinuses</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Food allergies</p>\n</td>\n<td width=\231\>\n<p>Increased peristalsis due to contraction of intestinal muscles</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(645, 'Microbiology,', 'PM1552. MHC Classes I and II', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>MHC Class I</strong></p>\n</td>\n<td>\n<p><strong>MHC Class II</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Expressed on all <strong>nucleated cells&nbsp;</strong>(except sperms) and <strong>platelets</strong></p>\n</td>\n<td>\n<p>Expressed on <strong>antigen-presenting cells</strong>:&nbsp;macrophages, B lymphocytes, dendritic cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Consist of a <strong>polymorphic α</strong>, heavy-chain, linked non-covalently to <strong>β2-microglobulin</strong></p>\n</td>\n<td>\n<p>Heterodimer consisting of non-covalently associated <strong>α</strong> and<strong> β chains, </strong>both of which are <strong>polymorphic.</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>α chains are encoded by three genes-&nbsp;<em><strong>HLA-A, HLA-B, </strong></em><strong>and </strong><em><strong>HLA-C</strong></em></p>\n</td>\n<td>\n<p>Encoded by <strong>HLA-D,</strong> with&nbsp;subregions:<strong>&nbsp;</strong>HLA-DP, HLA-DQ, and HLA-DR.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Display antigenic peptides that are derived from&nbsp;<strong>viral</strong> and<strong> tumor proteins</strong></p>\n</td>\n<td>\n<p>Present antigens that are internalized into vesicles, and derived from <strong>extracellular microbes</strong>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Class I complexes are&nbsp;recognized by<strong> CD8+ T cells</strong></p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Class II complexes are&nbsp;recognized by<strong> CD4+ T cells</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Endogenous peptide</strong> is the type of antigen presented to&nbsp;CD8+ T cells</p>\n</td>\n<td><strong>Exogenous antigen</strong> is the type of antigen presented to CD4+ T cells&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Presents antigen via the<strong> cytosolic pathway</strong></p>\n</td>\n<td>Presents antigen via the&nbsp;<strong>endocytic pathway&nbsp;</strong></td>\n</tr>\n<tr>\n<td>\n<p>Antigen binding site is present <strong>between α1/α2 groove</strong></p>\n</td>\n<td>Antigen binding site is present <strong>between α1/β1 groove&nbsp;</strong></td>\n</tr>\n<tr>\n<td>\n<p>α3 binds to CD8 molecules on cytotoxic T cells</p>\n</td>\n<td>β2 binds to CD4 on helper T cells</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(646, 'Pathology,', 'PM1551. T Helper cells- Types and functions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Cell Type </strong></p>\n</td>\n<td>\n<p><strong>T helper cell 1</strong></p>\n</td>\n<td>\n<p><strong>T helper 2 </strong></p>\n</td>\n<td>\n<p><strong>T helper 17</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Major cytokines produced</strong></p>\n</td>\n<td>\n<p>IFN-γ</p>\n</td>\n<td>\n<p>IL-4, IL-5, IL-13</p>\n</td>\n<td>\n<p>IL-17, IL-22</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cytokines that induce this subset</strong></p>\n</td>\n<td>\n<p>IFN-γ, IL-12</p>\n</td>\n<td>\n<p>IL-4</p>\n</td>\n<td>\n<p>TGF-β, IL-6, IL-1, IL-23</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Immunological reactions triggered</strong></p>\n</td>\n<td>\n<p><strong>Macrophage activation,</strong> stimulation of IgG antibody production</p>\n</td>\n<td>\n<p>Stimulation of IgE production, activation of mast cells and <strong>eosinophils</strong></p>\n</td>\n<td>\n<p>Recruitment of <strong>neutrophils,</strong> monocytes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Host defense against</strong></p>\n</td>\n<td>\n<p>Intracellular microbes</p>\n</td>\n<td>\n<p>Helminthic parasites</p>\n</td>\n<td>\n<p>Extracellular bacteria, fungi</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Role in disease</strong></p>\n</td>\n<td>\n<p>Autoimmune and other chronic inflammatory diseases (such as IBD, psoriasis, granulomatous inflammation)</p>\n</td>\n<td>\n<p>Allergies</p>\n</td>\n<td>\n<p>Autoimmune and other chronic inflammatory diseases (such as IBD, psoriasis, MS)</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(647, 'Microbiology,', 'PM1548. Differences – CD 4 and CD8 cells', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>CD 4 cells</strong></p>\n</td>\n<td width=\231\>\n<p><strong>CD 8 cells</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>60% of mature T cells</strong></p>\n</td>\n<td width=\231\>\n<p>30% of mature T cells</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>Helper T cell</strong></p>\n</td>\n<td width=\231\>\n<p>Cytotoxic/Killer T cell.</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>Secrete cytokines and help macrophages and B cells to fight infections</strong></p>\n</td>\n<td width=\231\>\n<p>Destroy host cells having microbes like viruses and tumor cells.</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>Bind to class II major histocompatibility complex (MHC) molecules that are displaying antigen</strong></p>\n</td>\n<td width=\231\>\n<p>Bind to class I MHC molecules.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ddf1469437184354bbd18b29260e71fex1280x1739.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(648, 'Paediatrics,', 'PM0601. Inactivated and Live Attenuated Polio Vaccines', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Characteristic</strong></td>\n<td>\n<p><strong>Inactivated (</strong><strong>IPV/Salk)</strong></p>\n</td>\n<td>\n<p><strong>Attenuated </strong><strong>(</strong><strong>OPV/Sabin)</strong></p>\n</td>\n</tr>\n<tr>\n<td>Prevents disease</td>\n<td>Yes</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Induces humoral IgG</td>\n<td>Yes</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Induces intestinal sIgA</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Prevents intestinal colonization</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Secondary (herd) protection by spread to others</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Reverts to virulence</td>\n<td>No</td>\n<td>Yes, very rarely</td>\n</tr>\n<tr>\n<td>May cause disease in immunocompromised</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n</tbody>\n</table>\n<p>Salk has K, so it is killed.&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(649, 'Pathology,', 'PM0536. Primary immunodeficiency disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Affected component</strong><strong>&nbsp;of the immune system</strong></p>\n</td>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Humoral immunity:&nbsp;</strong>Problems with<strong> B cells</strong>&nbsp;and their <strong>antibody&nbsp;</strong><strong>production</strong></p>\n</td>\n<td>\n<ul>\n<li>Common variable immunodeficiency</li>\n<li>Selective immunoglobulin deficiency, such as IgA deficiency</li>\n<li>Transient hypogammaglobulinemia of infancy</li>\n<li>X-linked agammaglobulinemia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cellular immunity:&nbsp;</strong>Problems with<strong> T cells&nbsp;</strong></p>\n</td>\n<td>\n<ul>\n<li>Chronic mucocutaneous candidiasis</li>\n<li>DiGeorge syndrome</li>\n<li>X-linked lymphoproliferative syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Combined </strong>humoral and cellular immunity:&nbsp;Problems with<strong> B and T cells</strong></p>\n</td>\n<td>\n<ul>\n<li>Ataxia-telangiectasia</li>\n<li>Hyperimmunoglobulinemia M syndrome</li>\n<li>Severe combined immunodeficiency</li>\n<li>Wiskott-Aldrich syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Phagocytes:&nbsp;</strong>Problems with the<strong> movement or killing&nbsp;</strong></p>\n</td>\n<td>\n<ul>\n<li>Chronic granulomatous disease</li>\n<li>Chédiak-Higashi syndrome&nbsp;(rare)</li>\n<li>Tuftsin deficiency</li>\n<li>Cyclic neutropenia</li>\n<li>Leukocyte adhesion defects</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Complement </strong>proteins:<strong>&nbsp;</strong></p>\n<p><strong>Deficiency of complement </strong>proteins</p>\n</td>\n<td>\n<ul>\n<li>Complement component 1 (C1) inhibitor deficiency (hereditary angioedema)</li>\n<li>Terminal complement deficiency (C5-C9): Recurrent Neisseria infections</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(650, 'Microbiology', 'PM0509. Various Types of Chemokines Based on their Structure', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>1.&nbsp;&nbsp; </strong><strong>CXC chemokines </strong>(α-chemokines): They are <strong>separated by one amino acid</strong>, represented by X. e.g., interleukin-8 (CXCL8)</p>\n<p><strong>2. CC chemokines </strong>(β-chemokines): They have a total of four cysteines, of which <strong>two are adjacent cysteines </strong>(amino acids), near their amino terminus. e.g., CC chemokine ligands (CCL)-1 to 28</p>\n<p><strong>3. C chemokines </strong>(γ-chemokines): They have <strong>only two cysteines</strong>; one N-terminal cysteine and one cysteine downstream. e.g., XCL1 (lymphotactin-α) and XCL2 (lymphotactin-β).</p>\n<p><strong>4. CX3C chemokines </strong>(d-chemokines): They have <strong>three amino acids between the two cysteines</strong> and are termed CX3C chemokine. e.g., fractalkine (or CX3CL1), acts as a&nbsp;chemoattractant and as an adhesion molecule.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/255f7a51de0c44fa93b73119050d6973x1280x1316.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(651, 'Pathology,', 'PM0508. Modified monocytes/macrophages in various tissues', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The following table shows various sites and the designation of the modified monocytes/macrophages:</p>\n<table width=\278\>\n<tbody>\n<tr>\n<td>\n<p><strong>Site</strong></p>\n</td>\n<td>\n<p><strong>Macrophage designation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Peripheral blood</p>\n</td>\n<td>\n<p>Monocytes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Placenta</p>\n</td>\n<td>\n<p>Hofbauer cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Liver</p>\n</td>\n<td>\n<p>Kupffer cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Brain</p>\n</td>\n<td>\n<p>Microglial cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kidney</p>\n</td>\n<td>\n<p>Mesangial cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lungs</p>\n</td>\n<td>\n<p>Alveolar macrophages</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bone</p>\n</td>\n<td>\n<p>Osteoclasts</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Connective tissue</p>\n</td>\n<td>\n<p>Histiocytes</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(652, 'Dermatology,', 'PM2456. Sexually transmitted infections', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Genital herpes</strong>- caused by <strong>herpes simplex virus</strong> (human herpesvirus 1 and 2).</p>\n<ul>\n<li>It appears as <strong>blisters</strong> (usually multiple) that lead to ulcer formation on breaking.</li>\n<li>The ulcers are <strong>painful</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8ba0cafb8f724e8caf99ab7778d022acx630x761.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Granuloma inguinale&nbsp;</strong>/ Donovanosis- caused by&nbsp;<strong>Klebsiella granulomatis</strong>&nbsp;(formerly known as Calymmatobacterium granulomatis).</p>\n<ul>\n<li>It usually causes <strong>beefy red genital ulcers</strong> that may bleed on touch.</li>\n<li>The ulcers are usually <strong>painless</strong>.</li>\n<li>Lymphadenopathy is usually absent but subcutaneous granulomas cause <strong>pseudo buboes</strong>.&nbsp;</li>\n<li>Microscopy shows <strong>Donovan bodies</strong> with closed safety pin appearance</li>\n</ul>\n<p>The given images show genital ulcer in granuloma inguinale:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4aaa8224b2e7443e94743e1015a44778x560x358.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Chancroid</strong>/ Soft chancre-&nbsp;caused by&nbsp;<strong>Haemophilus ducreyi</strong>.</p>\n<ul>\n<li>Causes genital ulcers that are <strong>non indurated</strong> with undermined edges.</li>\n<li>The ulcer is <strong>painful</strong>.</li>\n<li>Multiple/ Kissing ulcers develop due to autoinoculation from the primary ulcer.</li>\n<li>It usually causes tender unilateral<strong>&nbsp;inguinal buboes</strong>.&nbsp;</li>\n<li>Microscopy- School of fish/Railroad track appearance</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/875f994ab0a44d3a8d26f376c6b54874x597x313.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Syphilitic chancre</strong>/ Hard chancre- caused by <strong>Treponema pallidum</strong>.</p>\n<ul>\n<li>It presents as a <strong>small, button-like, indurated ulcer</strong> that is usually round/oval.</li>\n<li>The ulcer is <strong>painless</strong>.</li>\n<li>Causes <strong>painless lymphadenopathy</strong>.</li>\n<li>Microscopy- Spirochetes seen on dark ground illumination.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/03d21e32213a42c9ab3487da627b053ex336x288.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Lymphogranuloma venereum</strong>- caused by&nbsp;<strong>Chlamydia trachomatis</strong>.</p>\n<ul>\n<li>It usually presents with a transient single <strong>shallow ulcer</strong> that <strong>heals rapidly</strong> and usually goes unnoticed.</li>\n<li>The secondary stage presents with <strong>tender&nbsp;inguinal buboes</strong>.</li>\n<li><strong>Groove sign</strong> is seen when the lymph nodes above and below the inguinal ligament are enlarged leading to the appearance of a groove.</li>\n</ul>\n<p>The given images show the ulcer and the groove sign seen in LGV:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6faad0dd79004ce4898a0d4ec94391e9x495x711.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/be01c14fe5b34f6fb923eca0f40d42cex253x357.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Gonorrhea</strong>- caused by <strong>Neisseria gonorrhoeae</strong>.</p>\n<ul>\n<li>It leads to <strong>purulent inflammation</strong> of the genital mucous membranes.</li>\n<li>It may present as&nbsp;urethritis, cervicitis, epididymo‐orchitis, or pelvic inflammatory disease.</li>\n<li>The usual presentation is <strong>acute urethritis</strong> with complaints of burning dysuria and purulent discharge.</li>\n</ul>\n<p>The given image shows purulent genital inflammation due to gonorrhea:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f4fd185c143045fe944bb99f1299a4bbx379x412.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(653, 'Dermatology,', 'PM2455. Skin and soft tissue lesions caused by Staphylococcus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Staphylococcus causes a variety of skin and soft tissue infections. These include:</p>\n<p>a. <strong>Furuncle</strong>/boil- Infection of the hair follicle.</p>\n<p>The given image shows a furuncle:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e85d867deb494725875ce9b6fcc453d4x1024x683.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p>b. <strong>Carbuncle</strong>: A cluster of several furuncles:</p>\n<p>The given image shows a carbuncle:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/87a5f9e1f77542b29243f0335be022b5x1280x960.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p>c. <strong>Bullous impetigo</strong>: Results in large blisters called bullae, usually seen in areas with skin folds such as armpits, groin, buttocks, etc.</p>\n<p>The given image shows ruptured bullous impetigo:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/281f980ab1544bf8ba1a75e41288ebd0x1280x1706.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p>d. <strong>Cellulitis</strong>: It is a rapidly spreading infection of the skin and subcutaneous tissue, usually associated with wounds, incisions, burns, etc.</p>\n<p>The given image shows cellulitis following an abrasion. The red streaks indicate the involvement of the lymphatics:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/03beb37fad62438c82351579ddb30787x1280x960.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p>e. <strong>Staphylococcal scalded skin syndrome</strong>: Caused by exfoliating toxin that causes peeling of the skin.</p>\n<p>The given image shows SSSS:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d2c892194a074752b3318b1d2172c9ffx363x274.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p>Note: The conditions shown above are most commonly caused by Staphylococcus. It is important to remember that they may also be caused by other bacteria. Cellulitis is more commonly caused by Streptococcus.</p></div><!---->\n      <!---->\n    </div><!---->'),
(654, 'Dermatology,', 'PM2454. Skin and soft tissue lesions caused by Streptococcus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Streptococcus causes a variety of skin and soft tissue infections. These include:</p>\n<p>a. <strong>Impetigo</strong>- Infection of superficial layers of the skin. It presents as superficial vesicles which break down and are then encrusted by honey-colored scab. It usually occurs in children.</p>\n<p>The given image shows impetigo:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/402a0b1bedb94b8bb54931282ab18a5ax508x200.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p>b.&nbsp;<strong>Erysipelas</strong>-</p>\n<ul>\n<li>Infection of the superficial epidermis.\n<ul>\n<li>It presents as an erythematous raised lesion with sharply demarcated edges that differentiate it from the surrounding skin.\n<ul>\n<li>The given image shows erysipelas- note the clear demarcation at the nasolabial folds seen in facial erysipelas.</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/af1d1306363b448490fd435fc60ee51bx1280x1211.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p>c.&nbsp;<strong>Cellulitis</strong>- Infection of the skin and subcutaneous tissue. It presents with erythema and edema. It can be differentiated from erysipelas by - i. Erysipelas is a raised lesion whereas cellulitis is not, ii. Cellulitis is poorly demarcated from the surrounding skin whereas erysipelas is clearly demarcated.</p>\n<p>The given image shows cellulitis:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c81644e4fd8c407ea15b8e0f59c2f0bfx1280x960.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p>d.&nbsp;<strong>Necrotizing fasciitis</strong>- Infection involving the fascial planes. It presents with dark areas of necrosis, erythema, and edema.</p>\n<p>The given image shows necrotizing fasciitis with areas of erythema and necrosis:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/23196395a943480fae2f0cfdcac858dbx1280x734.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p>d.&nbsp;<strong>Myositis and myonecrosis</strong>- Infection of the muscle.</p>\n<p>The given image shows necrotizing myositis:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0e639e386c9d433e985751e75051ca46x996x690.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(655, 'Microbiology', 'PM2361. Runyon classification of Non-tubercululous Mycobacteria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Group</strong></td>\n<td><strong>Pigment</strong></td>\n<td><strong>Examples</strong></td>\n<td><strong>Disease</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>I</strong></p>\n<p>Photo-chromogens</p>\n</td>\n<td>yellow-orange on light&nbsp;</td>\n<td>\n<p>1. M. kansaii</p>\n<p>2. M. marinum</p>\n</td>\n<td>\n<p>1. Similar to TB</p>\n<p>2. Swimming pool granuloma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>II</strong></p>\n<p>Scoto-chromogens</p>\n</td>\n<td>yellow or orange in light or dark&nbsp;</td>\n<td>\n<p>M. scrofulaceum</p>\n<p>M. gordonae</p>\n</td>\n<td>Cervical adenitis</td>\n</tr>\n<tr>\n<td>\n<p><strong>III</strong></p>\n<p>Non photo-chromogens</p>\n</td>\n<td>\n<p>no pigment</p>\n</td>\n<td>\n<p>M. avium intracellulare complex (MAC),</p>\n<p>M. ulcerans,</p>\n<p>M. xenopi&nbsp;</p>\n</td>\n<td>Similar to TB, esp. in AIDS</td>\n</tr>\n<tr>\n<td>\n<p><strong>IV</strong></p>\n<p>Rapid growers</p>\n</td>\n<td>no pigment</td>\n<td>\n<p>M. fortuitum</p>\n<p>M. chelonei</p>\n</td>\n<td>Soft tissue, lung, bone, CNS, eye infections</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(656, 'Medicine,', 'PM2350. Food Poisoning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Organism</strong></td>\n<td><strong>Symptoms</strong></td>\n<td><strong>Common food source</strong></td>\n</tr>\n<tr>\n<td colspan=\3\><strong>1–6 hrs incubation&nbsp;period</strong>&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td><em>Staphylococcus aureus</em></td>\n<td>Nausea, vomiting, diarrhea</td>\n<td>Ham, poultry, potato, cream pastries, mayonnaise</td>\n</tr>\n<tr>\n<td><em>Bacillus cereus</em></td>\n<td>Nausea, vomiting, diarrhea</td>\n<td>Fried rice</td>\n</tr>\n<tr>\n<td colspan=\3\><strong>8–16 hrs incubation&nbsp;period</strong>&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td><em>Clostridium perfringes</em></td>\n<td>Abdominal cramps, diarrhea</td>\n<td>Beef, poultry, legume, gravies</td>\n</tr>\n<tr>\n<td><em>Bacillus cereus</em></td>\n<td>Abdominal cramps, diarrhea</td>\n<td>Meat, vegetables, dried beans, cereals</td>\n</tr>\n<tr>\n<td colspan=\3\><strong>&gt;16 hrs incubation period</strong>&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td><em>Vibrio cholerae</em></td>\n<td>Watery diarrhea</td>\n<td>Shellfish, water</td>\n</tr>\n<tr>\n<td><em>Salmonella</em> species</td>\n<td>Inflammatory diarrhea</td>\n<td>Beef, poultry, eggs</td>\n</tr>\n<tr>\n<td>Enterotoxigenic <em>Escherichia coli</em></td>\n<td>Watery diarrhea</td>\n<td>Salads, cheese, meats</td>\n</tr>\n<tr>\n<td>Enterohemorrhagic <em>E. coli</em></td>\n<td>Bloody diarrhea</td>\n<td>Raw milk, raw vegetables, apple juice</td>\n</tr>\n<tr>\n<td><em>Campylobacter jejuni</em></td>\n<td>Inflammatory diarrhea</td>\n<td>Poultry, raw milk</td>\n</tr>\n<tr>\n<td><em>Shigella</em> species</td>\n<td>Dysentery</td>\n<td>Potato, egg salad, lettuce</td>\n</tr>\n<tr>\n<td><em>Vibrio parahaemolyticus</em></td>\n<td>Dysentery</td>\n<td>Molluscs, crustaceans</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(657, 'Medicine,', 'PM2349. Comparison between Acute Rheumatic Fever(ARF) and Post streptococcal glomerulonephritis(PSGN)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Acute Rheumatic Fever</strong></td>\n<td><strong>Post streptococcal glomerulonephritis</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Site of infection</strong></p>\n</td>\n<td>Throat</td>\n<td>Throat or skin</td>\n</tr>\n<tr>\n<td><strong>Prior sensitisation</strong></td>\n<td>Essential</td>\n<td>Not necessary</td>\n</tr>\n<tr>\n<td><strong>Serotype of S.pyogenes</strong></td>\n<td>Any</td>\n<td>Pyodermal types-49,53-55,59-61 and pharyngitis strains 1 and 12</td>\n</tr>\n<tr>\n<td><strong>Immune response</strong></td>\n<td>Marked</td>\n<td>Moderate</td>\n</tr>\n<tr>\n<td><strong>Complement level</strong></td>\n<td>Unaffected</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td><strong>Genetic susceptibility</strong></td>\n<td>Present</td>\n<td>Not known</td>\n</tr>\n<tr>\n<td><strong>Repeated attacks</strong></td>\n<td>Common</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>\n<p><strong>Penicillin prophylaxis</strong></p>\n</td>\n<td>Essential</td>\n<td>Not indicated</td>\n</tr>\n<tr>\n<td><strong>Course</strong></td>\n<td>Progressive or static</td>\n<td>Spontaneous resolution</td>\n</tr>\n<tr>\n<td><strong>Prognosis</strong></td>\n<td>Variable</td>\n<td>Good</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(658, 'Microbiology', 'PM2345. Comparison between Meningococci and Gonococci', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Properties</strong></td>\n<td><strong>Meningococcus</strong></td>\n<td><strong>Gonococcus</strong></td>\n</tr>\n<tr>\n<td>Carbohydrates fermented</td>\n<td>Glucose and Maltose&nbsp;</td>\n<td>Only Glucose</td>\n</tr>\n<tr>\n<td>Location</td>\n<td>Both intra- and extracellular</td>\n<td>Predominantly intracellular&nbsp;</td>\n</tr>\n<tr>\n<td>Spread</td>\n<td>Respiratory or oral secretions&nbsp;</td>\n<td>Sexual or perinatal transmission</td>\n</tr>\n<tr>\n<td>Plasmids</td>\n<td>Rare&nbsp;</td>\n<td>Has plasmids that code for drug resistance</td>\n</tr>\n<tr>\n<td>\n<p>Vaccine</p>\n</td>\n<td>\n<p>Capsule-based polysaccharide and conjugate vaccines available&nbsp;</p>\n<p>(except for Type B - subcapsular antigen-based vaccine is available)&nbsp;</p>\n</td>\n<td>No vaccine due to antigenic variation of pilus proteins</td>\n</tr>\n<tr>\n<td>\n<p>Capsule</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>\n<p>Shape</p>\n</td>\n<td>\n<p>Lens/half-moon&nbsp;</p>\n</td>\n<td>Kidney&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/48d2ba254fc0410f925d202060935357x1280x769.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(659, 'Microbiology', 'PM2343. Oxygen Requirements of Bacteria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type of organism</strong></p>\n</td>\n<td><strong>Feature</strong></td>\n<td><strong>Examples&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Obligate Aerobes</strong></td>\n<td>\n<p><strong>Always require oxygen</strong> for their growth.&nbsp;</p>\n<p>Cannot ferment or respire anaerobically.</p>\n</td>\n<td>\n<p><em>M.tuberculosis&nbsp;</em></p>\n<p><em>Bacillus sp</em></p>\n<p><em>Legionella sp</em></p>\n<p><em>Bordetella sp</em></p>\n<p><em>Pseudomonas aeruginosa</em></p>\n</td>\n</tr>\n<tr>\n<td><strong>Obligate Anaerobes</strong></td>\n<td>\n<p>&nbsp;</p>\n<p><strong>Cant grow in the presence of oxygen </strong>as most of them don’t have Superoxide dismutase and Catalase.</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><em>Clostridium sp.</em></p>\n<p><em>Bacteroides sp.</em></p>\n</td>\n</tr>\n<tr>\n<td><strong>Micro-aerophilic</strong></td>\n<td>\n<p><strong>Require small amounts of oxygen</strong> (2–10%) for aerobic respiration. Higher oxygen concentrations are inhibitory.</p>\n</td>\n<td>\n<p><em>H. pylori</em></p>\n<p><em>Campylobacter jejuni&nbsp;</em></p>\n<p><em>M.bovis</em></p>\n</td>\n</tr>\n<tr>\n<td><strong>Facultative anaerobe</strong></td>\n<td>\n<p><strong>Can grow aerobically or anaerobically</strong> based on the surrounding environment</p>\n</td>\n<td>\n<p>Many organisms including Enteric gram-negative&nbsp;bacteria, <em>S. aureus, Vibrio cholerae</em></p>\n</td>\n</tr>\n<tr>\n<td><strong>Aero-tolerant</strong></td>\n<td>\n<p><strong>Are indifferent to Oxygen</strong>. They are basically anaerobic organisms but can tolerate oxygen.</p>\n</td>\n<td>\n<p><em>Peptococcus anaerobius</em></p>\n<p><em>Lactobacillus sp.</em></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(660, 'Microbiology,', 'PM2340. Stages of syphilis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong><strong>Primary syphilis:</strong></strong></p>\n<ul>\n<li aria-level=\1\><strong>Chancre</strong> - Painless, indurated, usually single. The chancre self heals in 1-4 months.</li>\n<li aria-level=\1\>Lymphadenopathy - Painless, unilateral or bilateral, shotty and rubbery inguinal nodes</li>\n<li aria-level=\1\><strong>Dory flop sign</strong> - As the chancre is too hard to fold, it will flip over once the prepuce is retracted back.</li>\n</ul>\n<p><strong>Secondary syphilis:</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/45e19098c36e4e0ba69bdbc3358cbb5fx559x788.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li aria-level=\1\>A &amp; B: Generalized non-itchy rash with no vesicles present on the palm and sole. This is the most common lesion.</li>\n<li aria-level=\1\>C &amp; D:<strong> Condyloma lata</strong>.</li>\n<li aria-level=\1\>E:<strong> Moth-eaten non-scarring alopecia</strong></li>\n<li aria-level=\1\>F: Mucous patches are flat erosions on the tongue that can coalesce to form<strong> snail track ulcers.</strong> These are the most infectious lesions.</li>\n<li aria-level=\1\>G: Pigmentary plaques</li>\n<li aria-level=\1\>H: Psoriasiform syphilitic lesions</li>\n<li aria-level=\1\>Generalized diffuse non-tender lymphadenopathy</li>\n</ul>\n<p><strong>Tertiary syphilis:</strong></p>\n<ul>\n<li aria-level=\1\><strong>Gummatous syphilis</strong> are deep punched-out ulcers, with gum-like secretions on the floor</li>\n<li aria-level=\1\><strong>Pseudo-chancre redux</strong> is a gumma occurring at the site of a previously healed ulcer&nbsp;&nbsp;</li>\n<li aria-level=\1\>CVS - Aortitis and aneurysm of the ascending aorta</li>\n<li aria-level=\1\>CNS - General paresis of the insane and tabes dorsalis&nbsp;</li>\n</ul>\n<p><strong>Latent syphilis</strong> is the period between secondary and tertiary syphilis. In this period the patient is asymptomatic clinically and only serological evidence of the infection is present. It is classified into:</p>\n<ul>\n<li aria-level=\1\>Early latent syphilis - Within 1 year of infection</li>\n<li aria-level=\1\>Late latent syphilis - After 1 year of infection</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(661, 'Microbiology,', 'PM2211. Vaccines and their Strains', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td>\n<p><strong>Strains</strong></p>\n</td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>Danish-1331 strain</p>\n</td>\n</tr>\n<tr>\n<td>OPV/IPV</td>\n<td>\n<p>Bivalent OPV</p>\n</td>\n</tr>\n<tr>\n<td>Measles</td>\n<td>\n<ul>\n<li>Edmonston Zagreb strain</li>\n<li>Schwartz strain</li>\n<li>Moraten strain</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Mumps</td>\n<td>\n<p>Jeryll-Lynn strain</p>\n</td>\n</tr>\n<tr>\n<td>Rubella</td>\n<td>\n<p>RA 27/3</p>\n</td>\n</tr>\n<tr>\n<td>Yellow fever</td>\n<td>\n<p>17D strain&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Varicella</td>\n<td>\n<p>OKA strain&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Japanese encephalitis</td>\n<td>\n<ul>\n<li>Nakayama strain</li>\n<li>Beijing P3 Strain</li>\n<li>SA-14-14-2 strain(used in India)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Swine flu vaccine</td>\n<td>\n<p>A7/ California / 2009&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>HIV vaccine</td>\n<td>\n<ul>\n<li>mVA strain</li>\n<li>rAAV strain</li>\n<li>CTL strain</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Malaria vaccine</td>\n<td>\n<ul>\n<li>SPf 66 strain ( Lytic cocktail)</li>\n<li>Pf 25 strain</li>\n<li>RTS,S/AS01 is effective against <em>P. falciparum.</em>\n<ul>\n<li>Phase 3 trial of this vaccine is complete.</li>\n<li>Phase 4 trial is under evaluation.</li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(662, 'Obstetrics & Gynaecology,', 'PM2035. Asymptomatic bacteriuria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\topbullet\>&nbsp;</div>\n<div class=\topbullet\><strong>Asymptomatic bacteriuria: </strong>Urinary tract infection without any symptoms. Criteria for diagnosis are as follows:</div>\n<div class=\topbullet\>&nbsp;</div>\n<table>\n<tbody>\n<tr>\n<td>Type of specimen</td>\n<td>Number of samples required&nbsp;</td>\n<td>Minimum colony-forming units (cfu)/mL required for diagnosis of UTI</td>\n</tr>\n<tr>\n<td>Midstream clean-catch urine specimen</td>\n<td>\n<p>For women: 2 consecutive samples</p>\n<p>For men: single sample</p>\n</td>\n<td><strong><strong>1,00,000&nbsp;</strong></strong>of the same bacterial species&nbsp;</td>\n</tr>\n<tr>\n<td>Catheterized urine specimen&nbsp;</td>\n<td>Single sample</td>\n<td>\n<p><strong><strong>100 </strong></strong>for&nbsp;asymptomatic bacteriuria (CA-ASB)</p>\n<p><strong>1000</strong> for catheter-associated urinary tract infection&nbsp;(CA-UTI)</p>\n</td>\n</tr>\n<tr>\n<td>Suprapubic aspirate</td>\n<td>Single sample</td>\n<td><strong>Any growth of microorganisms</strong> in the culture&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(663, 'Microbiology', 'PM2032. Mechanism of action of various bacterial toxins', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The mechanism of action of various bacterial toxins are as given below:</p>\n<p><span><strong>Increase in&nbsp;</strong></span><strong>cAMP</strong></p>\n<ul>\n<li>Bordetella pertusis</li>\n<li>Bacillus anthracis</li>\n<li>Vibrio cholerae - Cholera toxin</li>\n<li>Enterotoxigenic E.coli (ETEC) - heat labile toxin</li>\n</ul>\n<p><strong>Increase in cGMP</strong></p>\n<ul>\n<li>Enterotoxigenic E.coli (ETEC) - heat stable toxin</li>\n</ul>\n<p><strong>Inhibition of protein synthesis</strong></p>\n<ul>\n<li>Diptheria toxin: inhibit elongation factor-2 (EF-2)</li>\n<li>Pseudomonas: inhibit elongation factor-2 (EF-2)</li>\n<li>Clostridium difficile</li>\n<li>Enterohemorrhagic E.coli (EHEC)-Shiga-like toxin: inhibit 60S</li>\n<li>Shigella dysenteriae-&nbsp;Shiga toxin:&nbsp;inhibit 60S</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(664, 'Pathology,', 'PM1984. Vegetations in Various Types of Endocarditis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\85\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\63\>\n<p><strong>RHD</strong></p>\n</td>\n<td width=\87\>\n<p><strong>Infective endocarditis</strong></p>\n</td>\n<td width=\87\>\n<p><strong>Non- bacterial thrombotic or marantic endocarditis</strong></p>\n</td>\n<td width=\87\>\n<p><strong>Libman–Sacks endocarditis</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p><strong>Etiology</strong></p>\n</td>\n<td width=\63\>\n<p>Rheumatic</p>\n<p>heart disease</p>\n</td>\n<td width=\87\>\n<p>Infective endocarditis</p>\n</td>\n<td width=\87\>\n<p>Malignancy</p>\n<p>(M3-AML, pancreatic</p>\n<p>carcinoma), deep</p>\n<p>vein thrombosis,</p>\n<p>Trosseau syndrome</p>\n</td>\n<td width=\87\>\n<p>Systemic lupus erythematosus</p>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p><strong>Vegetations</strong></p>\n</td>\n<td width=\63\>\n<p>Small, warty</p>\n<p>Firm</p>\n<p>Friable</p>\n</td>\n<td width=\87\>\n<p>Large</p>\n<p>Bulky</p>\n<p>friable,</p>\n<p>destructive</p>\n</td>\n<td width=\87\>\n<p>Small, single or multiple, non- destructive</p>\n</td>\n<td width=\87\>\n<p>Small to medium-sized, flat, verrucuous</p>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p><strong>Site</strong></p>\n</td>\n<td width=\63\>\n<p>Along lines of closure</p>\n</td>\n<td width=\87\>\n<p>Cusps of valves, mural endocardium</p>\n</td>\n<td width=\87\>\n<p>Line of closure</p>\n</td>\n<td width=\87\>\n<p>Either or</p>\n<p>both sides of the valve leaflets.</p>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p><strong>Sterile/Infective</strong></p>\n</td>\n<td width=\63\>\n<p>Sterile</p>\n</td>\n<td width=\87\>\n<p>Non-sterile</p>\n</td>\n<td width=\87\>\n<p>Sterile</p>\n</td>\n<td width=\87\>\n<p>Sterile</p>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p><strong>Embolisation</strong></p>\n</td>\n<td width=\63\>\n<p>Uncommon</p>\n</td>\n<td width=\87\>\n<p>Very common</p>\n</td>\n<td width=\87\>\n<p>Common</p>\n</td>\n<td width=\87\>\n<p>Uncommon</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8cbba8132d2c40e08cdaa19e5a970968x1280x2262.JPEG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(665, 'Microbiology', 'PM1933. Tuberculin reaction size & candidates for treatment of latent Mycobacterium tuberculosis infection', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Risk Group</strong></td>\n<td><strong>Positive Tuberculin Reaction Size</strong></td>\n</tr>\n<tr>\n<td>HIV infected persons</td>\n<td>≥5 mm</td>\n</tr>\n<tr>\n<td>Recent contacts of a patient with TB</td>\n<td>≥5 mm</td>\n</tr>\n<tr>\n<td>Organ transplant recipients</td>\n<td>≥5 mm</td>\n</tr>\n<tr>\n<td>Persons with fibrotic lesions consistent with old TB on chest radiography</td>\n<td>≥5 mm</td>\n</tr>\n<tr>\n<td>Immunosuppressed persons</td>\n<td>≥5 mm</td>\n</tr>\n<tr>\n<td>Persons with high risk medical conditions (silicosis &amp; end stage renal disease)</td>\n<td>≥5 mm</td>\n</tr>\n<tr>\n<td>Injection drug users</td>\n<td>≥10 mm</td>\n</tr>\n<tr>\n<td>Mycobacteriology lab personnel</td>\n<td>≥10 mm</td>\n</tr>\n<tr>\n<td>Children &lt;5 years of age</td>\n<td>≥10 mm</td>\n</tr>\n<tr>\n<td>Recent immigrants from high prevalence countries</td>\n<td>\n<p>≥10 mm</p>\n</td>\n</tr>\n<tr>\n<td>Low-risk persons</td>\n<td>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;≥15 mm</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Tuberculin reactions are read at 48-72 hr as the transverse diameter of the <strong>induration, </strong>and&nbsp;the diameter of the<strong> erythema is NOT considered.&nbsp;</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(666, 'Surgery,', 'PM1367. Post-Splenectomy Care', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Vaccination:</strong></p>\n<ul>\n<li aria-level=\1\>Patients should be vaccinated <strong>at least 2 weeks prior</strong>, and ideally 10 to 12 weeks prior to <strong>elective</strong> splenectomy.&nbsp;</li>\n<li aria-level=\1\>When vaccines cannot be given prior to <strong>emergency</strong> splenectomy, vaccines should be given <strong>at least two weeks after</strong> splenectomy.</li>\n</ul>\n<p>Following vaccines are given:</p>\n<ul>\n<li aria-level=\2\><strong>Pneumococcal</strong> vaccine:&nbsp;</li>\n<ul>\n<li aria-level=\3\>A dose of PCV13 followed by PPSV23 ≥8 weeks later is advised.&nbsp;</li>\n<li aria-level=\3\>Revaccinate every <strong>five to seven years</strong> thereafter.</li>\n</ul>\n<li aria-level=\2\><strong>H. influenzae type b</strong> vaccine:</li>\n<ul>\n<li aria-level=\3\>A single dose of Hib vaccine is recommended.&nbsp;</li>\n<li aria-level=\3\>Revaccination is needed every <strong>ten years</strong>.</li>\n</ul>\n<li aria-level=\2\><strong>Meningococcal</strong> vaccination:</li>\n<ul>\n<li aria-level=\3\>Two doses of the MenACWY vaccine are given ≥8 weeks apart.</li>\n<li aria-level=\3\>Revaccination is needed every <strong>five years</strong>.</li>\n</ul>\n<li aria-level=\2\><strong>Influenza</strong> vaccination:</li>\n<ul>\n<li aria-level=\3\>Vaccination against seasonal influenza should be given annually.</li>\n</ul>\n</ul>\n<p><strong>Antibiotics:&nbsp;</strong></p>\n<p>Daily prophylaxis:&nbsp;</p>\n<ul>\n<li aria-level=\1\><strong>Penicillin</strong> and <strong>amoxicillin</strong> are preferred agents</li>\n<ul>\n<li aria-level=\2\>For at least<strong> 1 year</strong> after surgery (at least up to the age of 5 yrs in children)</li>\n<li aria-level=\2\>For immunocompromised, at least up to the age of 18 yrs</li>\n</ul>\n</ul>\n<p>Early empirical:</p>\n<ul>\n<li aria-level=\1\>Early empirical treatment to be initiated in presence of systemic <strong>symptoms of infection</strong> e.g - chills, rigor, fever, vomiting, etc.</li>\n<li aria-level=\1\><strong>Amoxicillin-clavulanic acid</strong> is the preferred choice for most adults and children</li>\n<li aria-level=\1\>If allergic to beta-lactam, use <strong>levofloxacin/moxifloxacin.</strong></li>\n</ul>\n<p><strong>Antithrombotics:</strong></p>\n<ul>\n<li aria-level=\1\><strong>Low dose heparin</strong> for at least <strong>4 weeks</strong> helps in perioperative thromboembolism prevention</li>\n<li aria-level=\1\>In presence of extreme reactive thrombocytosis (&gt;10,00,000/mm3) <strong>low dose aspirin</strong> can also be given.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(667, 'Surgery,', 'PM1366. Overwhelming Post-splenectomy Infection (OPSI)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It is the most common <strong>fatal</strong> infection following splenectomy.&nbsp;</p>\n<p>Certain components called <strong>opsonins</strong>&nbsp;<strong>attach</strong> to the <strong>encapsulated organisms</strong>, and then they are <strong>delivered to the spleen</strong>, where their uptake is facilitated by receptors present on the surface of <strong>splenic phagocytes</strong>. After splenectomy, this defence mechanism is lost leaving patients susceptible to infection from these bacteria.</p>\n<p>Most common within <strong>2-3 years</strong> following splenectomy.&nbsp;</p>\n<p><strong>Causative agents:</strong> Usually capsulated organisms like</p>\n<ul>\n<li><strong><em>Streptococcus pneumoniae</em> (Most common)</strong></li>\n<li><em>Haemophilus influenzae</em></li>\n<li><em>Neisseria meningitidis</em></li>\n<li><em>Streptococcus</em>&nbsp;species</li>\n<li><em>Salmonella</em> species</li>\n<li><em>Capnocytophaga canimorsus</em>, implicated in OPSI as a result of dog bites</li>\n</ul>\n<p><strong>Clinical features</strong></p>\n<ul>\n<li>Prodromal features like fever, chills, sore throat, malaise, diarrhea, and vomiting</li>\n<li>Rapid progression to hypotension, disseminated intravascular coagula­tion, respiratory distress, coma, and death within hours of presen­tation</li>\n<li><strong>High-grade bacteremia with no identifiable foci of infection</strong></li>\n<li><strong>Poor response to antibiotics</strong></li>\n</ul>\n<p>If an<strong> elective splenectomy </strong>is planned, prophylactic vaccinations&nbsp;against pneumococcus, meningococcus C (both repeated every 5 years), and <em>H. influenzae</em> type B (Hib) must be given <strong>atleast 2 weeks</strong> before the elective surgery.</p>\n<p>In case of an<strong> emergency splenectomy,&nbsp;</strong>patients should be&nbsp;<strong>vaccinated</strong> <strong>as soon as possible</strong> after recovery from surgery but before discharge from the&nbsp;hospital.</p></div><!---->\n      <!---->\n    </div><!---->'),
(668, 'Pathology,', 'PM1316. Rhinosporidiosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>It is a chronic granulomatous condition caused by <em><strong>Rhinosporidium seeberi</strong> </em>which is recently reclassified as a member of the protistan Mesomycetozoa</li>\n<li>It is more common in the&nbsp;<strong>southern states of India</strong></li>\n<li>It affects <strong>immunocompetent </strong>individuals</li>\n<li>Most commonly a<strong> waterborne&nbsp;</strong>disease</li>\n<li>Clinical features: Blood tinged nasal discharge, frank epistaxis, nasal stuffiness</li>\n<li>Findings:&nbsp;<br>\n<ul>\n<li>Leafy, <strong>polypoidal mass</strong>, pink to purple in color and <strong>attached to the nasal septum</strong> or lateral wall</li>\n<li>Sometimes, it extends into the nasopharynx and may hang behind the soft palate</li>\n<li>The mass is very<strong> vascular </strong>and bleeds easily on touch</li>\n<li>Its surface is studded with white dots representing the sporangia</li>\n</ul>\n</li>\n<li>Diagnosis:<strong>&nbsp;Biopsy</strong> which shows <strong>sporangia</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a813c201198c4800bbe43437de8562b9x512x382.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Histologic section showing <strong>sporangium</strong> (arrow) which is fully packed with <strong>immature sporoblasts</strong> at the periphery and mature ones at the center</p>\n<p>Treatment: <strong>Complete excision</strong> of the mass with diathermy knife and <strong>cauterization</strong> of its base. Recurrence may occur after surgical excision. <strong>Dapsone</strong> is also used.</p></div><!---->\n      <!---->\n    </div><!---->'),
(669, 'Medicine,', 'PM1234. Infectious Agents Associated with the Development of Lymphoid Malignancies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\516\>\n<thead>\n<tr>\n<td>\n<p><strong>Infectious Agent</strong></p>\n</td>\n<td>\n<p><strong>Lymphoid Malignancy</strong></p>\n</td>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>\n<p>HTLV-I</p>\n</td>\n<td>\n<p>Adult T cell leukemia/lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Epstein-Barr virus</p>\n</td>\n<td>\n<p>Burkitts lymphoma</p>\n<p>Post–organ transplant lymphoma</p>\n<p>Primary CNS diffuse large B cell lymphoma</p>\n<p>Hodgkins disease (Mixed cellularity and lymphocyte depleted)</p>\n<p>Extranodal NK/T cell lymphoma, nasal type</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HIV</p>\n</td>\n<td>\n<p>Diffuse large B cell lymphoma</p>\n<p>Burkitts lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis C virus</p>\n</td>\n<td>\n<p>Lymphoplasmacytic lymphoma (Waldenstroms macroglobulinemia)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Helicobacter pylori&nbsp;</p>\n</td>\n<td>\n<p>Gastric MALT lymphoma (Extranodal marginal zone lymphoma)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human herpesvirus 8</p>\n</td>\n<td>\n<p>Primary effusion lymphoma</p>\n<p>Multicentric Castlemans disease</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(670, 'Pathology,', 'PM0809. Microbial Etiology of Infective Endocarditis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Organism</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Predisposing condition</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Streptococcus viridians</p>\n</td>\n<td width=\231\>\n<p>Damaged valves</p>\n<p>Prosthetic valve</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Staphylococcus aureus</p>\n</td>\n<td width=\231\>\n<p>Intravenous drug abusers</p>\n<p>Native cardiac valve</p>\n<p>Prosthetic valve</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Staphylococcus epididermis</p>\n</td>\n<td width=\231\>\n<p>Prosthetic valve</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Streptococcus mutans</p>\n</td>\n<td width=\231\>\n<p>Tooth extraction</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Other causes include enterococci and the so-called <strong>HACEK group (Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, and Kingella)</strong>, all commensals in the oral cavity, gram-negative bacilli and fungi.</p></div><!---->\n      <!---->\n    </div><!---->'),
(671, 'Community Medicine,', 'PM0689. Types of Vaccines', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type</strong></p>\n</td>\n<td>\n<p><strong>Vaccines</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Live attenuated</p>\n<p>(<strong>M</strong>ost<strong>&nbsp;</strong><strong>B</strong>eautiful&nbsp;<strong>P</strong>lace&nbsp;<strong>I</strong>n&nbsp;<strong>T</strong>he <strong>W</strong>orld<strong>&nbsp;</strong>-<strong> ROME)</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>M</strong>umps</p>\n<p><strong>B</strong>CG</p>\n<p><strong>P</strong>lague</p>\n<p><strong>I</strong>nfluenza (cold-adapted)</p>\n<p><strong>T</strong>yphoid (oral)</p>\n<p>Yello<strong>W&nbsp;</strong>fever</p>\n<p><strong>R</strong>ubella and&nbsp;<strong>R</strong>otavirus</p>\n<p><strong>O</strong>ral Polio (Sabin)</p>\n<p><strong>M</strong>easles</p>\n<p>Japanese&nbsp;<strong>E</strong>ncephalitis</p>\n<p>Varicella</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Killed whole organism</p>\n<p>(<strong>RIP</strong> <strong>ACE</strong>)</p>\n</td>\n<td>\n<p><strong>R</strong>abies</p>\n<p><strong>I</strong>nfluenza</p>\n<p><strong>P</strong>olio (IPV, Salk)</p>\n<p>Hep <strong>A</strong></p>\n<p><strong>C</strong>holera</p>\n<p><strong>E</strong>ncephalitis</p>\n<p>Typhoid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Toxoid/Protein</p>\n</td>\n<td>\n<p>Diphtheria</p>\n<p>Tetanus</p>\n<p>Acellular Pertussis</p>\n<p>Anthrax</p>\n<p>Influenza subunit&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Polysaccharide</p>\n</td>\n<td>\n<p>Pneumococcus</p>\n<p>Meningococcus</p>\n<p>Hemophilus influenza type b (Hib)</p>\n<p>Typhoid (Vi)&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>Glycoconjugate</p>\n</td>\n<td>\n<p>Hib</p>\n<p>Pneumococcus</p>\n<p>MenACWY(meningococcal vaccine)&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>Recombinant</p>\n</td>\n<td>\n<p>Hepatitis B vaccine</p>\n<p>Lyme disease</p>\n<p>Cholera toxin B</p>\n<p>HPV&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(672, 'Medicine,', 'PM0545. Microbiology of Infective Endocarditis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>&nbsp;Condition</strong></td>\n<td>\n<p><strong>Most common organism</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Most common organism overall</p>\n</td>\n<td>\n<p>Staphylococcus aureus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Community-acquired native valve endocarditis</p>\n</td>\n<td>\n<p>Streptococci</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Healthcare-associated native valve endocarditis</p>\n</td>\n<td>\n<p>Staphylococcus aureus</p>\n</td>\n</tr>\n<tr>\n<td>Endocarditis in injection drug users (Right side)</td>\n<td>Staphylococcus aureus</td>\n</tr>\n<tr>\n<td>Endocarditis in injection drug users (Left side)</td>\n<td>Enterococci and Staphylococcus aureus</td>\n</tr>\n<tr>\n<td>\n<p>Single most common organism causing prosthetic valve endocarditis</p>\n</td>\n<td>\n<p>Staphylococcus aureus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Most common group of organism causing early prosthetic valve endocarditis (&lt;12 months after surgery)</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>Coagulase-negative staphylococci (CoNS)*<br><br></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Late prosthetic valve endocarditis (&gt;12 months after surgery)</p>\n</td>\n<td>\n<p>Streptococci</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acute infective endocarditis</p>\n</td>\n<td>\n<p>Staphylococcus aureus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Subacute infective endocarditis</p>\n</td>\n<td>\n<p>Streptococcus viridans</p>\n<p>Enterococci</p>\n<p>Coagulase-negative Staphylococci (CoNS)</p>\n<p>HACEK</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\>Cardiovascular implantable electronic device (CIED)-associated endocarditis</p>\n</td>\n<td>\n<p>Staphylococcus aureus&nbsp; and coagulase-negative Staphylococci (CoNS)*</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\>Culture negative endocarditis</p>\n</td>\n<td>\n<p>Prior antibiotic use</p>\n<p>Nutritionally variant streptococci</p>\n<p>HACEK organisms</p>\n<p>Coxiella burnetii</p>\n<p>Bartonella</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>NOTE :</p>\n<p>*CoNS includes Staphylococcus epidermidis&nbsp;and other coagulase-negative types<br><br>*Streptococci includes Viridans streptococci (VGS),&nbsp;Streptococcus gallolyticus&nbsp;(previously&nbsp;Streptococcus bovis&nbsp;biotype 1) and other&nbsp;non-groupable and groupable streptococci</p>\n<p>&nbsp;</p>\n<table width=\419\>\n<tbody>\n<tr>\n<td width=\210\>\n<p><strong>Microorganism </strong></p>\n</td>\n<td width=\209\>\n<p><strong>Source </strong></p>\n</td>\n</tr>\n<tr>\n<td width=\210\>\n<p>Streptococcus viridans</p>\n</td>\n<td width=\209\>\n<p>Oral cavity</p>\n</td>\n</tr>\n<tr>\n<td width=\210\>\n<p>Staphylococcus aureus</p>\n</td>\n<td width=\209\>\n<p>Skin</p>\n</td>\n</tr>\n<tr>\n<td width=\210\>\n<p>HACEK organisms</p>\n</td>\n<td width=\209\>\n<p>Upper respiratory tract</p>\n</td>\n</tr>\n<tr>\n<td width=\210\>\n<p>Streptococcus gallolyticus</p>\n</td>\n<td width=\209\>\n<p>GIT (Colon )</p>\n</td>\n</tr>\n<tr>\n<td width=\210\>\n<p>Enterococci</p>\n</td>\n<td width=\209\>\n<p>Genitourinary tract</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(673, 'Microbiology', 'PM0409. Culture media used for Vibrio cholerae', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The following are various culture media used for <em>Vibrio cholerae</em>:&nbsp;</p>\n<p><strong>Transport Media</strong></p>\n<ul>\n<li>Venkatraman-Ramakrishnan (VR) medium</li>\n<li>Cary-Blair medium</li>\n<li>Autoclaved sea water</li>\n</ul>\n<p><strong>Enrichment Media</strong></p>\n<ul>\n<li>Alkaline peptone water (APW)</li>\n<li>Monsur’s taurocholate tellurite peptone water</li>\n</ul>\n<p><strong>Selective Media</strong></p>\n<ul>\n<li>Alkaline bile salt agar (BSA)</li>\n<li>Monsur’s gelatin taurocholate trypticase tellurite agar (GTTA)</li>\n<li>Thiosulphate citrate bile sucrose (TCBS) agar <strong>- </strong>\n<ul>\n<li>Yellow colonies-<em> Vibrio cholerae</em></li>\n<li>Green colonies- <em>Vibrio parahemolyticus</em></li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(674, 'Microbiology', 'PM0402. Differences between classical and El Tor vibrios', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Differences between classical and El Tor<em>&nbsp;</em>vibrios</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Test</strong></td>\n<td><strong>Classical <em>V. cholerae</em></strong></td>\n<td><strong>El tor vibrios</strong></td>\n</tr>\n<tr>\n<td>Haemolysis</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; -</td>\n<td>+</td>\n</tr>\n<tr>\n<td>Voges-Proskauer test</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; -</td>\n<td>+</td>\n</tr>\n<tr>\n<td>Chick red cell agglutination</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; -</td>\n<td>+</td>\n</tr>\n<tr>\n<td>Polymyxin-B sensitivity</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; +</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Group IV phage sensitivity</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; +</td>\n<td>-</td>\n</tr>\n<tr>\n<td>El Tor phage 5 suseptibility</td>\n<td>-</td>\n<td>+</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(675, 'Dermatology,', 'PM0360. Cutaneous Infections/Diseases caused by Staphylococcus aureus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Cutaneous Infections/Diseases caused by </strong><em>Staphylococcus aureus</em></p>\n<p><strong>A. Direct infection of skin and adjacent tissues</strong></p>\n<ul>\n<li>Carbuncle</li>\n<li>Ecthyma</li>\n<li>Folliculitis</li>\n<li>Furunculosis</li>\n<li>Impetigo</li>\n<li>Sycosis</li>\n</ul>\n<p><strong>B. Secondary infection</strong></p>\n<ul>\n<li>Eczema, infestations, ulcers, etc.</li>\n</ul>\n<p><strong>C. Cutaneous disease due to effect of bacterial toxin</strong></p>\n<ul>\n<li>Staphylococcal scalded skin syndrome (SSSS)</li>\n<li>Toxic shock syndrome</li>\n<li>Staphylococcal scarlatina</li>\n<li>Recurrent toxin‐mediated perineal erythema</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(676, 'Dermatology,', 'PM0359. Cutaneous Infections/Diseases caused by Streptococcus pyogenes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Cutaneous infections/diseases caused by Streptococcus pyogenes</strong></p>\n<p><strong>Direct infections of skin or subcutaneous tissue</strong></p>\n<ul>\n<li>Cellulitis</li>\n<li>Impetigo</li>\n<li>Ecthyma, Erysipelas</li>\n<li>Vulvovaginitis</li>\n<li>Perianal infection</li>\n<li>Streptococcal ulcers</li>\n<li>Blistering distal dactylitis</li>\n<li>Necrotizing fasciitis</li>\n</ul>\n<p><strong>Secondary infection</strong></p>\n<ul>\n<li>Eczema, infestations, ulcers, etc.</li>\n</ul>\n<p><strong>Tissue damage from circulating toxin</strong></p>\n<ul>\n<li>Scarlet fever</li>\n<li>Toxic‐shock‐like syndrome</li>\n<li>Recurrent toxin‐mediated perineal erythema</li>\n</ul>\n<p><strong>Skin lesions due to allergic hypersensitivity to Streptococcal&nbsp;</strong><strong>antigens</strong></p>\n<ul>\n<li>Erythema nodosum</li>\n<li>Vasculitis</li>\n</ul>\n<p><strong>Skin disease provoked or influenced by Streptococcal infection&nbsp;</strong><strong>(mechanism uncertain)</strong></p>\n<ul>\n<li>Psoriasis, especially guttate forms</li>\n<li>Kawasaki disease</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(677, 'Community Medicine,', 'PM0152. Bioterrorism Agents', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Description</td>\n<td>Characteristics</td>\n<td>Examples</td>\n</tr>\n<tr>\n<td>Category A</td>\n<td>\n<p>High priority agents</p>\n<p>Easily disseminated</p>\n<p>High mortality rate</p>\n<p>Capacity to get disseminated</p>\n<p>Social disruption</p>\n<p>Requires specialised public health resources</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><em>Bacillus anthracis</em></p>\n<p><em>Clostridium botulinum</em></p>\n<p><em>Yersinia pestis</em></p>\n<p><em>Variola major</em></p>\n<p><em>Francisella tularensis</em></p>\n<p>Ebola and other hemorrhagic fevers</p>\n<p>Lassa fever and other arenaviruses</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Category B&nbsp;</td>\n<td>\n<p>Minority priority agents</p>\n<p>Moderately well disseminated</p>\n<p>Moderate morbidity and low mortality</p>\n<p>Require enhancement of CD and diagnostic capacity</p>\n</td>\n<td>\n<p><em>Coxiella burnetti</em></p>\n<p><em>Burkholderia&nbsp;mallei</em></p>\n<p><em>Burkholderia&nbsp;pseudomallei</em></p>\n<p>Ricin toxin</p>\n<p><em>Cryptosporidium parvum</em></p>\n<p><em>Salmonella typhi</em></p>\n<p><em>Chlamydia psittaci</em></p>\n</td>\n</tr>\n<tr>\n<td>Category C</td>\n<td>\n<p>Low priority agents</p>\n<p>Could be engineered for mass dissemination</p>\n<p>Readily available</p>\n<p>Easy to produce</p>\n<p>Potentially high morbidity and mortality</p>\n</td>\n<td>Emergent viruses -Nipah and Hantavirus</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(678, 'Microbiology', 'PM0145. Characteristics of Chlamydia species causing Human infections', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\ width=\45\>\n<tbody>\n<tr>\n<td><strong>Species</strong></td>\n<td><strong>Disease</strong></td>\n<td><strong>Natural host&nbsp;</strong></td>\n<td><strong>Mode of Transmission to Human</strong></td>\n<td><strong>Number of immunological types</strong></td>\n<td><strong>Diagnosis</strong></td>\n<td><strong>Treatment</strong></td>\n</tr>\n<tr>\n<td>C. trachomatis</td>\n<td>Urethritis, pneumonia, conjunctivitis, lymphogranuloma, venerum<br>Trachoma</td>\n<td>Humans</td>\n<td>Sexual contacts,<br>Perinatal transmission</td>\n<td>More than 15</td>\n<td>Inclusions in epithelial cells seen with giemsa stain or by immunofluorescence; also cell culture</td>\n<td>Tetracyclin, erythromycin</td>\n</tr>\n<tr>\n<td>C. pneumonia</td>\n<td>Atypical&nbsp;pneumonia</td>\n<td>Humans</td>\n<td>Respiratory droplets</td>\n<td>1</td>\n<td>Serological test&nbsp;</td>\n<td>Tetracyclin</td>\n</tr>\n<tr>\n<td>C. psittaci</td>\n<td>Psittacosis (pneumonia)</td>\n<td>Birds</td>\n<td>Inhalation of dried bird feces</td>\n<td>1</td>\n<td>Serological test(Cell culture rarely done)</td>\n<td>Tetracyclin</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(679, 'Microbiology,', 'PM0143. Human diseases caused by the Rickettsia and Orientia species', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Organism</strong></p>\n</td>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Vector</strong></p>\n</td>\n<td>\n<p><strong>Reservoir</strong></p>\n</td>\n<td>\n<p><strong>Clinical feature</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\5\><strong>Typhus group</strong></td>\n</tr>\n<tr>\n<td>\n<p><em>R.prowazekii</em></p>\n</td>\n<td>\n<p>Epidemic typhus &amp; Brill-Zinsser disease</p>\n</td>\n<td>\n<p>Louse</p>\n</td>\n<td>\n<p>Humans</p>\n</td>\n<td>\n<p>Rash+<br> No eschar</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>R.typhi</em></p>\n</td>\n<td>\n<p>Endemic typhus</p>\n</td>\n<td>\n<p>Rat Flea</p>\n</td>\n<td>\n<p>Rodents</p>\n</td>\n<td>\n<p>Rash +<br> No eschar</p>\n</td>\n</tr>\n<tr>\n<td colspan=\5\><strong>Spotted fever group</strong></td>\n</tr>\n<tr>\n<td>\n<p><em>R. rickettsii</em></p>\n</td>\n<td>\n<p>Rocky mountain spotted fever</p>\n</td>\n<td>\n<p>Tick (Dermacentor andersoni)</p>\n</td>\n<td>\n<p>Rodents, dogs</p>\n</td>\n<td>\n<p>Rash+<br> No eschar<br>Many systemic manifestations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>R.conori</em></p>\n</td>\n<td>\n<p>Indian tick typhus</p>\n</td>\n<td>\n<p>Tick</p>\n</td>\n<td>\n<p>Rodents,</p>\n<p>dogs</p>\n</td>\n<td>\n<p>Tache noire +</p>\n<p>Rash +</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>R.akari</em></p>\n</td>\n<td>\n<p>Rickettsial pox</p>\n</td>\n<td>\n<p>Gamasid mite</p>\n</td>\n<td>&nbsp;Mice</td>\n<td>\n<p>&nbsp;Vesicular rash</p>\n<p>Eschar +</p>\n</td>\n</tr>\n<tr>\n<td colspan=\5\><strong>Scrub Typhus</strong></td>\n</tr>\n<tr>\n<td>\n<p><em>O.</em></p>\n<p><em>tsutsugamushi</em></p>\n</td>\n<td>\n<p>Scrub typhus</p>\n</td>\n<td>\n<p>Trombiculid Mite</p>\n</td>\n<td>\n<p>Rodents</p>\n</td>\n<td>\n<p>Rash+<br> Eschar +<br> Atypical lymphocytes+</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(680, 'Microbiology', 'PM0114. Post exposure prophylaxis  for tetanus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Prophylaxis is given based on patient category:</p>\n<p>A. Full immunization or a booster dose within the past 5 years.</p>\n<p>B. Full immunization or a booster dose &gt; 5 years ago but &lt; 10 years.</p>\n<p>C. Full immunization or a booster dose &gt; 10 years ago.</p>\n<p>D. Unknown or never taken immunization</p>\n<table>\n<tbody>\n<tr>\n<td>Category</td>\n<td>Clean wound</td>\n<td>Unclean wound</td>\n</tr>\n<tr>\n<td>A</td>\n<td>Only wound care</td>\n<td>Only wound care</td>\n</tr>\n<tr>\n<td>B</td>\n<td>Wound care + TT single dose</td>\n<td>Wound care + TT single dose</td>\n</tr>\n<tr>\n<td>C</td>\n<td>Wound care + TT single dose</td>\n<td>Wound care + TT single dose + Human tetanus immunoglobulin&nbsp;</td>\n</tr>\n<tr>\n<td>D</td>\n<td>Wound care + TT complete course</td>\n<td>Wound care + TT complete course + Human tetanus immunoglobulin</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(681, 'Microbiology', 'PM0110. Differentiating features between anthrax and anthracoid bacilli.', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The following are the&nbsp;Differentiating features between anthrax and anthracoid bacilli.</p>\n<table cellspacing=\5\ cellpadding=\5\>\n<tbody>\n<tr>\n<td><strong>S.N.</strong></td>\n<td><strong>Characteristics</strong></td>\n<td><strong>Anthrax Bacilli</strong></td>\n<td><strong>Anthracoid Bacilli</strong></td>\n</tr>\n<tr>\n<td><strong>1.</strong></td>\n<td><strong>Motility</strong></td>\n<td>Non-Motile</td>\n<td>Generally Motile</td>\n</tr>\n<tr>\n<td><strong>2.</strong></td>\n<td><strong>Capsule</strong></td>\n<td>Capsulated</td>\n<td>Non-Capsulated</td>\n</tr>\n<tr>\n<td><strong>3.</strong></td>\n<td><strong>Shape</strong></td>\n<td>Grow in long chains</td>\n<td>Grow in short chains</td>\n</tr>\n<tr>\n<td><strong>4.</strong></td>\n<td><strong>Medusa Head Colony</strong></td>\n<td>Present</td>\n<td>Not Present</td>\n</tr>\n<tr>\n<td><strong>5.</strong></td>\n<td><strong>Growth in Penicillin Agar (10 units/ml)</strong></td>\n<td>No Growth</td>\n<td>Grow Usually</td>\n</tr>\n<tr>\n<td><strong>6.</strong></td>\n<td><strong>Hemolysis</strong></td>\n<td>Hemolysis absent or weak.</td>\n<td>Usually well marked</td>\n</tr>\n<tr>\n<td><strong>7.</strong></td>\n<td><strong>Gelatin Liquefaction</strong></td>\n<td>Slow Gelatin Liquefaction</td>\n<td>Rapid Gelatin Liquefaction</td>\n</tr>\n<tr>\n<td><strong>8.</strong></td>\n<td><strong>Turbidity</strong></td>\n<td>No Turbidity in broth</td>\n<td>Turbidity usually</td>\n</tr>\n<tr>\n<td><strong>9.</strong></td>\n<td><strong>Salicin Fermentation</strong></td>\n<td>Negative</td>\n<td>Usually Positive</td>\n</tr>\n<tr>\n<td><strong>10.</strong></td>\n<td><strong>Growth at 45°C</strong></td>\n<td>No Growth</td>\n<td>Grows usually</td>\n</tr>\n<tr>\n<td><strong>11.</strong></td>\n<td><strong>Chloral Hydrate</strong></td>\n<td>Growth inhibited by&nbsp; Chloral Hydrate</td>\n<td>Not Inhibited</td>\n</tr>\n<tr>\n<td><strong>12.</strong></td>\n<td><strong>Gamma Phage</strong></td>\n<td>Susceptible to gamma phage</td>\n<td>Not susceptible</td>\n</tr>\n<tr>\n<td><strong>13.</strong></td>\n<td><strong>Pathogenesis</strong></td>\n<td>Pathogenic to laboratory animals</td>\n<td>Not pathogenic</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(682, 'Microbiology', 'PM0109. Common names of various bacteria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>List of common names and scientific names of medically important bacteria:</p>\n<table cellspacing=\5\ cellpadding=\5\>\n<tbody>\n<tr>\n<td><strong>Common name</strong></td>\n<td><strong>Scientific name</strong></td>\n</tr>\n<tr>\n<td>Klebs-Loffler bacillus</td>\n<td>Corynebacterium diphtheria</td>\n</tr>\n<tr>\n<td>Koch week bacillus</td>\n<td>Haemophilus aegypticus</td>\n</tr>\n<tr>\n<td>Tubercle or Koch bacillus</td>\n<td>Mycobacterium tuberculosis</td>\n</tr>\n<tr>\n<td>Hansen’s bacillus</td>\n<td>Mycobacterium leprae</td>\n</tr>\n<tr>\n<td>Eaton agent</td>\n<td>Mycoplasma pneumonia</td>\n</tr>\n<tr>\n<td>Pfeiffer’s bacillus</td>\n<td>Haemophilus influenza</td>\n</tr>\n<tr>\n<td>Friedlander’s bacillus</td>\n<td>Klebsiella pneumoniae</td>\n</tr>\n<tr>\n<td>Glander’s Bacillus</td>\n<td>Burkholderia mallei</td>\n</tr>\n<tr>\n<td>Whitmore Bacillus</td>\n<td>Burkholderia pseudomallei</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(683, 'Microbiology', 'PM0101. Differentiation between Streptococcus pneumoniae and Streptococcus viridans', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table cellspacing=\5\ cellpadding=\5\>\n<tbody>\n<tr>\n<td><strong>Characteristics</strong></td>\n<td><strong>Streptococcus pneumoniae</strong></td>\n<td><strong>Streptococcus viridans</strong></td>\n</tr>\n<tr>\n<td>Morphology</td>\n<td>Lanceolate diplococci</td>\n<td>Cocci in chains</td>\n</tr>\n<tr>\n<td>Capsule</td>\n<td>Capsulated</td>\n<td>Non-capsulated</td>\n</tr>\n<tr>\n<td>Quellung Test</td>\n<td>Positive</td>\n<td>Negative</td>\n</tr>\n<tr>\n<td>Colonies</td>\n<td>Initially Dome Shaped, Later Draughtsman Colonies</td>\n<td>Dome shaped</td>\n</tr>\n<tr>\n<td>Growth in Liquid Media</td>\n<td>Uniform Turbidity</td>\n<td>Granular Turbidity, powdery deposit</td>\n</tr>\n<tr>\n<td>Bile solubility</td>\n<td>Bile soluble</td>\n<td>Bile insoluble</td>\n</tr>\n<tr>\n<td>Inulin fermentation</td>\n<td>Positive</td>\n<td>Negative</td>\n</tr>\n<tr>\n<td>Optochin sensitivity</td>\n<td>Sensitive</td>\n<td>Resistant</td>\n</tr>\n<tr>\n<td>Intraperitoneal inoculation in Mice</td>\n<td>Fatal infection</td>\n<td>Non-pathogenic</td>\n</tr>\n<tr>\n<td>Hemolysis</td>\n<td>Alpha-hemolytic (under aerobic conditions) or Beta-hemolytic (under anaerobic conditions)</td>\n<td>Alpha hemolytic or non-hemolytic</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(684, 'Medicine,', 'PM0100. Streptococcal antigens cross-reactive with human tissues', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table cellspacing=\5\ cellpadding=\5\>\n<tbody>\n<tr>\n<td><strong>Streptococcal antigen</strong></td>\n<td>\n<p><strong>Human antigen</strong></p>\n</td>\n<td><strong>Disease</strong></td>\n</tr>\n<tr>\n<td>Hyaluronic acid</td>\n<td>\n<p>Synovial fluid</p>\n</td>\n<td>Reactive arthritis</td>\n</tr>\n<tr>\n<td>Cell wall M protein</td>\n<td>Myocardium</td>\n<td>ARF(Acute rheumatic fever)</td>\n</tr>\n<tr>\n<td>Cell wall C carbohydrate</td>\n<td>Cardiac valves</td>\n<td>ARF (Acute rheumatic fever)</td>\n</tr>\n<tr>\n<td>Peptidoglycan</td>\n<td>Skin antigens</td>\n<td>Guttate psoriasis</td>\n</tr>\n<tr>\n<td>Cytoplasmic membrane</td>\n<td>Glomerular vascular intima</td>\n<td>Acute glomerulonephritis (AGN)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(685, 'Microbiology', 'PM0098. Methicillin-Resistant Staphylococcus aureus (MRSA)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>MRSA Definition</strong>: <strong>Methicillin</strong> MIC 8 μg/ml or more, <strong>Oxacillin</strong> MIC 4 μg/ml or more.</p>\n<p>Resistance in MRSA is mediated by <strong>mecA gene</strong> which is <strong>chromosomally coded</strong>. It alters <strong>PBP (penicillin-binding protein)</strong> present on S.aureus cell wall to <strong>PBP-2a</strong> which has less affinity for beta-lactam antibiotics.</p>\n<p>Penicillin Binding Protein:</p>\n<ul>\n<li>Normal protein present in all bacterial cell wall.</li>\n<li><strong>Transpeptidase</strong> in nature.</li>\n<li>Required for cross-linking of the peptidoglycan layer (essential for cell wall synthesis).</li>\n<li>It is also the site of attachment for- beta-lactam drugs to bind &amp; inhibit.</li>\n</ul>\n<p>Types of MRSA:</p>\n<ul>\n<li><strong>Community-acquired&nbsp;</strong>- mediated by <strong>mec A subtype IV</strong> and Possess <strong>PV Toxin(Panton-Valentine Toxin)</strong>, monodrug resistance,more virulent</li>\n<li><strong>Hospital-acquired</strong> - mediated by <strong>mec A subtype I, II, III</strong>, multidrug resistance,less virulent.</li>\n</ul>\n<p>Detection of MRSA:</p>\n<ul>\n<li>Antibiotic susceptibility test on <strong>Muller Hilton agar</strong> <strong>(Disk diffusion test)</strong> by using Methicillin or Oxacillin disc or cefoxitin disc.</li>\n<li><strong>PCR</strong> for detection of mecA gene.</li>\n</ul>\n<p>Treatment:</p>\n<ul>\n<li><strong>Vancomycin</strong> is Drug Of Choice (should be used only if other drugs are resistant ).</li>\n<li>Others- Teicoplanin, Linezolid, streptogramin, cipro/levofloxacin, cotrimoxazole, clindamycin, mupirocin, minocycline.</li>\n<li><strong>Newer Drugs</strong> – Daptomycin, <strong>ceftobiprole</strong>, tigecycline, oritavancin, dalbavancin, telavancin, delafloxacin.</li>\n<li><strong>Ceftobiprole </strong>and<strong> ceftaroline </strong>are 5th generation β lactams effective against MRSA.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(686, 'Microbiology', 'PM0026. Syphilis - Diagnostic Serology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Nontreponemal tests (VDRL, RPR)</strong></p>\n<p><strong>VDRL- </strong>Venereal disease Research Laboratory test</p>\n<p><strong>RPR</strong>- Rapid Plasma Reagin test</p>\n<ul>\n<li>Quantitative tests(titres)</li>\n<li>Reagin antibody tests; based on cardiolipin antigen</li>\n<li>VDRL can be used to test CSF whereas RPR cannot be used</li>\n<li>RPR does not require preheating of serum unlike VDRL</li>\n<li>VDRL requires light microscope for interpretation whereas RPR can be read macroscopically</li>\n<li>Decrease in titers confirms treatment</li>\n<li>Sensitivity of RPR(86%)&gt;VDRL(76%) in primary syphilis</li>\n</ul>\n<p><strong>Treponemal Tests</strong></p>\n<p><strong>FTA-ABS- </strong>Fluorescent Treponemal Antibody Absorption test</p>\n<p><strong>TPI-</strong>Treponema pallidum immobilization test</p>\n<p><strong>TPPA-</strong>Treponema pallidum particle agglutination assay</p>\n<p><strong>TPHA-</strong>Treponema pallidum haemagglutination test</p>\n<p><strong>EIA-</strong>Enzyme-linked ImmunoAssay</p>\n<ul>\n<li>Detect antibody to treponemal antigens</li>\n<li>Qualitative tests</li>\n<li>Greater sensitivity in early infection</li>\n<li>Positive even after treatment hence cannot be used to detect reinfection.</li>\n<li>First test to be positive: FTA-ABS</li>\n<li>Most specific: TPHA,TPPA, EIA</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(687, 'Microbiology', 'PM0010. Biological False Positive reactions in serologic testing of syphilis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Acute biological false-positive reactions are seen in (&lt;6 months):</p>\n<ul>\n<li>Pregnancy</li>\n<li>Upper respiratory tract infections</li>\n<li>Measles</li>\n<li>Chickenpox</li>\n<li>Hepatitis</li>\n<li>Viral pneumonia</li>\n<li>Malaria&nbsp;</li>\n<li>Following vaccination and immunization</li>\n<li>Lymphogranuloma venereum</li>\n<li>Chancroid</li>\n<li>Tuberculosis</li>\n<li>Pneumococcal pneumonia</li>\n<li>Leptospirosis</li>\n</ul>\n<p>Chronic biological false-positive reactions are seen in (&gt;6 months):&nbsp;&nbsp;</p>\n<ul>\n<li>Leprosy</li>\n<li>Systemic lupus erythematosus</li>\n<li>Rheumatoid arthritis</li>\n<li>Rheumatic fever</li>\n<li>Polyarteritis nodosa</li>\n<li>Leukemia</li>\n<li>Pernicious&nbsp;anemia</li>\n<li>Metastatic carcinoma</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(688, 'Microbiology,', 'PM0008. Comparison of Genital Ulcers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span>&nbsp;</span></td>\n<td><span><strong>Genital herpes</strong></span></td>\n<td><span><strong>&nbsp;Syphilitic chancre (Hard chancre)</strong></span></td>\n<td><span><strong>Donovanosis/ granuloma inguinale</strong></span></td>\n<td><span><strong>Chancroid (soft chancre)</strong></span></td>\n<td><span><strong>LGV</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Incubation period</strong></span></td>\n<td><span>2-7 days</span></td>\n<td>\n<p><span>10-90 days&nbsp;</span></p>\n<p><span>Average: 21days</span></p>\n</td>\n<td><span>1-12 weeks</span></td>\n<td><span>1-14 days</span></td>\n<td><span>3 days - 6 weeks</span></td>\n</tr>\n<tr>\n<td><span><strong>Causative agent</strong></span></td>\n<td><span>HSV-2&gt;HSV-1</span></td>\n<td><em><span>Treponema pallidum</span></em></td>\n<td><em><span>Klebsiella granulomatis</span></em></td>\n<td><em><span>Hemophilus ducreyi</span></em></td>\n<td>\n<p><span><em>Chlamydia trachomatis</em></span><span>&nbsp;serovars L1,L2,L3</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Clinical presentation</strong></span></td>\n<td>\n<p><span>Cluster of vesicles on erythematous base.</span></p>\n<p><span> Painful and pruritic lymphadenopathy</span></p>\n</td>\n<td>\n<p><span>Single painless ulcer with a clean base and a firm raised border. </span></p>\n<p><span>Painless lymphadenopathy</span></p>\n</td>\n<td>\n<p><span>Painless papule or nodule erodes into beefy red granulomatous ulcer with rolled edges.</span></p>\n<p><span> No lymphadenopathy, pseudobubos are seen</span></p>\n</td>\n<td>\n<p><span>Painful ulcer (ducreyi makes you cry).</span></p>\n<p><span>Painful inguinal lymphadenopathy</span></p>\n</td>\n<td>\n<p><span>Painless genital ulcer.</span></p>\n<p><span>Painful inguinal lymphadenopathy</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Diagnosis&nbsp;</strong></span></td>\n<td><span>Tzanck preparation shows multinucleated giant cells, PCR</span></td>\n<td><span>Clinical diagnosis</span></td>\n<td><span>Donovan bodies on biopsy</span></td>\n<td><span>Clinical diagnosis</span></td>\n<td><span>Nucleic acid amplification tests</span></td>\n</tr>\n<tr>\n<td><span><strong>Treatment</strong></span></td>\n<td><span>Acyclovir/famcyclovir or valacyclovir</span></td>\n<td><span>Penicillin/Ceftriaxone</span></td>\n<td>\n<p><span>Azithromycin/</span><span>Doxycycline</span></p>\n</td>\n<td><span>Azithromycin/ceftriaxone</span></td>\n<td><span>&nbsp;Doxycycline</span></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(689, 'Microbiology', 'PM2506. Interpretation of common serologic patterns in hepatitis B infection', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5552cae694994040b6b13be6442fc5adx1280x1466.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Clinical Phases</strong></td>\n<td><span><strong>HBsAg</strong></span></td>\n<td><span><strong>Anti-HBs</strong></span></td>\n<td><span><strong>HBeAg</strong></span></td>\n<td><span><strong>Anti-HBe</strong></span></td>\n<td><span><strong>Anti-HBc</strong></span></td>\n<td><span><strong>HBV DNA</strong></span></td>\n</tr>\n<tr>\n<td><span>Acute HBV - Early-phase, high infectivity</span></td>\n<td>\n<p><span>+</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV -</span><span>Window phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV - recovery phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+/-</span></td>\n</tr>\n<tr>\n<td><span>Chronic HBV, high infectivity</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Chronic HBV, low infectivity</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the recent past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the remote past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Post-vaccination</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(690, 'Microbiology', 'PM2008. Types of symmetry of viruses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Type of symmetry&nbsp;</strong></td>\n<td><strong>Examples</strong></td>\n</tr>\n<tr>\n<td><strong>Naked icosahedral</strong></td>\n<td>\n<p>Poliovirus</p>\n<p>Adenovirus</p>\n<p>Hepatitis A virus</p>\n</td>\n</tr>\n<tr>\n<td><strong>Naked helical</strong></td>\n<td>Tobacco mosaic virus</td>\n</tr>\n<tr>\n<td><strong>Enveloped icosahedral</strong></td>\n<td>\n<p>Herpes virus</p>\n<p>Yellow fever virus</p>\n<p>Rubella virus</p>\n</td>\n</tr>\n<tr>\n<td><strong>Enveloped helical</strong></td>\n<td>\n<p>Corona virus</p>\n<p>Rabies virus</p>\n<p>Influenza virus</p>\n<p>Parainfluenza virus</p>\n<p>Mumps virus</p>\n<p>Measles virus</p>\n</td>\n</tr>\n<tr>\n<td><strong>Complex</strong></td>\n<td>\n<p>Poxvirus</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(691, 'Microbiology', 'PM2006. Enveloped and non-enveloped viruses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Non-enveloped viruses</strong></td>\n<td><strong>Enveloped viruses</strong></td>\n</tr>\n<tr>\n<td><strong>DNA viruses</strong></td>\n<td>\n<p>Parvovirus</p>\n<p>Adenovirus</p>\n</td>\n<td>\n<p>Herpes virus</p>\n<p>Hepatitis B virus</p>\n<p>Poxvirus</p>\n</td>\n</tr>\n<tr>\n<td><strong>RNA viruses</strong></td>\n<td>\n<p>Picornavirus</p>\n<p>Astrovirus</p>\n<p>Reovirus</p>\n<p>Calicivirus</p>\n<p>Hepatitis A and E virus</p>\n</td>\n<td>\n<p>Hepatitis c virus</p>\n<p>Rubella virus</p>\n<p>Chikungunya virus</p>\n<p>Dengue virus</p>\n<p>Japanese encephalitis virus</p>\n<p>Kyasanur Forest disease virus</p>\n<p>Zika virus</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(692, 'Microbiology', 'PM2005. Cultivation of viruses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Animal inoculation</strong>:</p>\n<ul>\n<li>Suckling mice are used for inoculation of coxsackie and arbovirus</li>\n</ul>\n<p><strong>Tissue culture:</strong>&nbsp;Cell lines</p>\n<ul>\n<li>Primary cell lines- Rhesus kidney cell line, Human amniotic cell line, Chick embryo fibroblast</li>\n<li>Secondary cell lines- Human fibroblast cell line, MRC-5, and WI- 38</li>\n<li>Continuous cell lines- HeLa cell line, HEp-2, KB, Vero</li>\n</ul>\n<p><strong>Embryonated egg inoculation:</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1d7806bf5e5b4fe8a325cfa18450c809x1280x2559.JPEG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(693, 'Medicine,', 'PM1894. Antibodies in Hepatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Antibodies </strong></td>\n<td><strong>Seen in </strong></td>\n</tr>\n<tr>\n<td>\n<p>ANA, ASMA, pANCA, anti-SLA/LP, AMA</p>\n</td>\n<td>\n<p>Autoimmune hepatitis Type 1</p>\n</td>\n</tr>\n<tr>\n<td>Anti-liver cytosol 1</td>\n<td>\n<p>Autoimmune hepatitis Type 2</p>\n</td>\n</tr>\n<tr>\n<td>Anti-LKM 1</td>\n<td>\n<p>Autoimmune hepatitis Type 2&nbsp;</p>\n<p>Chronic hepatitis C</p>\n</td>\n</tr>\n<tr>\n<td>Anti-LKM 2</td>\n<td>Drug-induced hepatitis</td>\n</tr>\n<tr>\n<td>Anti-LKM 3</td>\n<td>\n<p>Chronic hepatitis D</p>\n</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li>ANA: Anti-nuclear antibodies (most common antibody in autoimmune hepatitis)</li>\n<li>LKM: Liver–kidney microsomes</li>\n<li>SLA/LP: Soluble liver antigen/liver-pancreas</li>\n<li>ASMA: Anti-smooth muscle actin</li>\n<li>pANCA: Perinuclear anti-neutrophil cytoplasmic antibodies</li>\n<li>AMA: Antimitochondrial antibodies</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(694, 'Medicine,', 'PM1717. AIDS-defining opportunistic infections and neoplasm', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Infections:</strong></p>\n<ul>\n<li><strong>Protozoal and helminthic infections-</strong>\n<ul>\n<li>Cryptosporidiosis or Isosporiasis (cystoisosporiasis) - Chronic intestinal</li>\n<li>Toxoplasmosis (pneumonia or CNS infection)</li>\n</ul>\n</li>\n<li><strong>Fungal infections-</strong>\n<ul>\n<li>Candidiasis (esophageal, tracheal, or pulmonary)</li>\n<li>Cryptococcosis (CNS infection)</li>\n<li>Coccidioidomycosis (disseminated)</li>\n<li>Pneumocystosis (pneumonia or disseminated infection)</li>\n<li>Histoplasmosis (disseminated)</li>\n</ul>\n</li>\n<li><strong>Bacterial infections-</strong>\n<ul>\n<li>Mycobacteriosis (“atypical,” e.g., <em>Mycobacterium avium-intracellulare</em>)&nbsp;disseminated or extrapulmonary</li>\n<li>Mycobacterium tuberculosis (pulmonary&nbsp;or extrapulmonary)</li>\n<li>Nocardiosis (pneumonia, meningitis, disseminated)</li>\n<li>Salmonella infections, disseminated</li>\n</ul>\n</li>\n<li><strong>Viral infections-</strong>\n<ul>\n<li>Cytomegalovirus (pulmonary, intestinal, retinitis, or CNS infections)</li>\n<li>Herpes simplex virus (localized or disseminated infection)</li>\n<li>Varicella-zoster virus (localized or disseminated infection)</li>\n<li>Progressive multifocal leukoencephalopathy</li>\n</ul>\n</li>\n</ul>\n<p><strong>Neoplasms:</strong></p>\n<ul>\n<li>Kaposi sarcoma</li>\n<li>Primary lymphoma of brain</li>\n<li>Invasive cancer of uterine cervix&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(695, 'Microbiology,', 'PM1680. Interpretation of common serologic patterns in hepatitis B infection', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5552cae694994040b6b13be6442fc5adx1280x1466.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Clinical Phases</strong></td>\n<td><span><strong>HBsAg</strong></span></td>\n<td><span><strong>Anti-HBs</strong></span></td>\n<td><span><strong>HBeAg</strong></span></td>\n<td><span><strong>Anti-HBe</strong></span></td>\n<td><span><strong>Anti-HBc</strong></span></td>\n<td><span><strong>HBV DNA</strong></span></td>\n</tr>\n<tr>\n<td><span>Acute HBV - Early-phase, high infectivity</span></td>\n<td>\n<p><span>+</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV -</span><span>Window phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV - recovery phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+/-</span></td>\n</tr>\n<tr>\n<td><span>Chronic HBV, high infectivity</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Chronic HBV, low infectivity</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the recent past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the remote past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Post-vaccination</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(696, 'Microbiology,', 'PM1476. The Hepatitis Viruses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>HAV</td>\n<td>HBV</td>\n<td>HCV</td>\n<td>HDV</td>\n<td>HEV</td>\n</tr>\n<tr>\n<td>Specific name</td>\n<td>Hepatovirus A</td>\n<td>Hepatitis B virus</td>\n<td>Hepacivirus C</td>\n<td>Hepatitis D virus</td>\n<td>Orthohepevirus A</td>\n</tr>\n<tr>\n<td>Family</td>\n<td>Picornaviridae</td>\n<td>Hepadnaviridae</td>\n<td>Flaviviridae</td>\n<td>Kolmioviridae (genus deltavirus)</td>\n<td>Hepeviridae</td>\n</tr>\n<tr>\n<td>Envelope</td>\n<td>Non enveloped</td>\n<td>Enveloped</td>\n<td>Enveloped</td>\n<td>Envelope from HBV</td>\n<td>Quasi-enveloped</td>\n</tr>\n<tr>\n<td>Nuclear material</td>\n<td>ssRNA</td>\n<td>Partially dsDNA</td>\n<td>ssRNA</td>\n<td>Circular defective ssRNA</td>\n<td>ssRNA</td>\n</tr>\n<tr>\n<td>Antigens</td>\n<td>HAV Ag</td>\n<td>HBsAg, HBcAg, HBeAg, HBxAg</td>\n<td>HCV Ag</td>\n<td>HBsAg, HDAg</td>\n<td>HEV Ag</td>\n</tr>\n<tr>\n<td>Antibodies</td>\n<td>Anti-HAV Ab</td>\n<td>Anti-HBs Ab, Anti-HBc Ab, Anti-HBe Ab</td>\n<td>Anti-HCV Ab</td>\n<td>Anti-HBs Ab, Anti-HDV Ab</td>\n<td>Anti-HEV Ab</td>\n</tr>\n<tr>\n<td>Auto-antibodies</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>Anti-LKM 1</td>\n<td>Anti-LKM 3</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Routes of transmission</td>\n<td>Feco-oral, parenteral, sexual</td>\n<td>Perinatal, parenteral, sexual, percutaneous, direct mucosal contact</td>\n<td>Parenteral, perinatal, percutaneous, sexual</td>\n<td>Parenteral, sexual</td>\n<td>Feco-oral, zoonotic, vertical</td>\n</tr>\n<tr>\n<td>Incubation period</td>\n<td>30 days</td>\n<td>60 days</td>\n<td>50 days</td>\n<td>60 days</td>\n<td>40 days</td>\n</tr>\n<tr>\n<td>Chances of fulminant hepatic failure</td>\n<td>0.1%</td>\n<td>0.1 to 1%</td>\n<td>0.1%</td>\n<td>5% in coinfections and 20% in superinfections</td>\n<td>1-2% in adults and up to 25% in pregnant women</td>\n</tr>\n<tr>\n<td>Extrahepatic manifestations</td>\n<td>Rash, arthralgia</td>\n<td>Polyarteritis nodosa and membranous nephropathy</td>\n<td>Essential mixed cryoglobulinemia, MPGN, Metabolic syndrome</td>\n<td>&nbsp; &nbsp; &nbsp; -</td>\n<td>GBS, Bell’s palsy, pancreatitis, &nbsp;and glomerulonephritis</td>\n</tr>\n<tr>\n<td>Resolution of acute infection</td>\n<td>2 months</td>\n<td>6 months</td>\n<td>6 months</td>\n<td>6 months</td>\n<td>3 months</td>\n</tr>\n<tr>\n<td>Progression to chronic infection</td>\n<td>No</td>\n<td>5-10%</td>\n<td>&gt;80%</td>\n<td>\n<p>10% of co-infections,</p>\n<p>90–100% of superinfections</p>\n</td>\n<td>\n<p>Only in immuno-compromised</p>\n</td>\n</tr>\n<tr>\n<td>HCC</td>\n<td>No</td>\n<td>May develop in chronic infections</td>\n<td>May develop in chronic infections</td>\n<td>May develop in chronic infections</td>\n<td>May develop in chronic infections</td>\n</tr>\n<tr>\n<td>Vaccine</td>\n<td>Available</td>\n<td>Available</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>\n<td>HBV vaccine</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; -</td>\n</tr>\n<tr>\n<td>Therapy</td>\n<td>None</td>\n<td>Entecavir, tenofovir, pegIFN-????</td>\n<td>Velpatasvir, sofosbuvir, ribavirin</td>\n<td>PegIFN-????</td>\n<td>None</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(697, 'Paediatrics,', 'PM1455. Viral infections associated with rash', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Viral infection&nbsp;</strong></td>\n<td><strong>Rash characteristics&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Chickenpox</td>\n<td>Appears 1st&nbsp;day of fever, <strong>centripetal</strong>, pleomorphic, <strong>dewdrops on rose petal</strong> appearance</td>\n</tr>\n<tr>\n<td>Measles</td>\n<td>Appears on the 4th&nbsp;day over the face and <strong>retroauricular</strong> origin</td>\n</tr>\n<tr>\n<td>Rubella</td>\n<td>Rash on day 1 over the face</td>\n</tr>\n<tr>\n<td>\n<p>Erythema infectiosum</p>\n</td>\n<td>Rash on&nbsp;cheeks (<strong>slapped&nbsp;cheek</strong> appearance), moves to trunk and extremities</td>\n</tr>\n<tr>\n<td>Exanthem&nbsp;subitum</td>\n<td>Macules&nbsp;or maculopapular rash</td>\n</tr>\n<tr>\n<td>Infectious mononucleosis</td>\n<td>Associated with maculopapular rash</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(698, 'Microbiology,', 'PM1452. Incubation period of important viral infections', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Viral infection&nbsp;</strong></td>\n<td><strong>Incubation period&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Measles</strong></td>\n<td>7 - 18 days</td>\n</tr>\n<tr>\n<td><strong>Chickenpox</strong></td>\n<td>14 - 21 days</td>\n</tr>\n<tr>\n<td><strong>Mumps</strong></td>\n<td>14 - 21 days</td>\n</tr>\n<tr>\n<td><strong>Rubella</strong></td>\n<td>14 - 21 days</td>\n</tr>\n<tr>\n<td>Erythema&nbsp;infectiosum</td>\n<td>4 - 14 days</td>\n</tr>\n<tr>\n<td>Exanthem&nbsp;subitum</td>\n<td>5 - 15 days</td>\n</tr>\n<tr>\n<td>Infectious mononucleosis</td>\n<td><strong>4 - 5 weeks</strong></td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(699, 'Microbiology,', 'PM1450. Rubella and congenital rubella syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Congenital rubella syndrome</strong>:</p>\n<ul>\n<li>The triad of Gregg in congenital rubella syndrome&nbsp;includes:\n<ul>\n<li><strong>Sensorineural hearing loss -&nbsp;</strong>Nerve deafness is the <strong>single most common</strong> finding among infants with congenital rubella syndrome</li>\n<li>Congenital <strong>cataract</strong></li>\n<li><strong>Congenital heart disease</strong>&nbsp;-<strong>&nbsp;</strong>The most common cardiac defect is&nbsp;<strong>patent ductus arteriosus</strong></li>\n</ul>\n</li>\n<li><strong>Maximum damage</strong> to the fetus occurs in the <strong>first trimester</strong></li>\n<li>Infection in the <strong>second&nbsp;trimester</strong> causes <strong>only</strong> <strong>deafness</strong></li>\n<li>If infection occurs&nbsp;<strong>after 16 weeks</strong> there are <strong>no major abnormalities</strong></li>\n<li>Diagnosis - Presence of IgM rubella antibodies in the infant shortly after birth or persistence of IgG antibodies for &gt;6 months.</li>\n</ul>\n<p>The given image shows <strong>bilateral cataract</strong> in an&nbsp;infant with congenital rubella syndrome</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f6ed3c62561f49ba90d0fb8f2eaa34a9x700x478.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The given image shows <strong>blueberry muffin rash</strong> in an&nbsp;infant with congenital rubella syndrome</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c5ddb3e330a841c3b9ba2c7cd124b750x720x508.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The image given below shows the&nbsp;<strong>salt and pepper fundus.</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c98db18501ac4a4c8f755bcef23f5267x512x341.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;<strong>Rubella</strong>:</p>\n<ul>\n<li>Also called the <strong>German measles</strong></li>\n<li>Causative organism belongs to the family <strong>Matonaviridae</strong></li>\n<li>Period of infectivity is -5 to +6 days after the onset of the rash</li>\n<li>Droplet trasmission</li>\n<li>The incubation period is 2-3 weeks</li>\n<li>The rash appears on day 1</li>\n<li><strong>Forchheimer spots are</strong> seen, which are tiny, rose-colored lesions in the oropharynx</li>\n<li>Associated with post-infectious thrombocytopenia</li>\n<li>The most serious complication is&nbsp;<strong>encephalitis</strong></li>\n<li><strong>Vaccination</strong>&nbsp;is done with&nbsp;the <strong>live attenuated RA 27/3 strain</strong> of the rubella</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(700, 'Microbiology', 'PM0619. Oncoviruses and the cancers associated with them', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Virus</strong></p>\n</td>\n<td>\n<p><strong>Genome</strong></p>\n</td>\n<td>\n<p><strong>Associated cancers&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis B</p>\n<p>(HBV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Hepatocarcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis C</p>\n<p>(HCV)</p>\n</td>\n<td>\n<p>RNA</p>\n</td>\n<td>\n<p>Hepatocarcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human</p>\n<p>T-</p>\n<p>lymphotropic</p>\n<p>virus (HTLV)</p>\n</td>\n<td>\n<p>RNA</p>\n</td>\n<td>\n<p>Adult T-cell leukemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human</p>\n<p>papilloma</p>\n<p>viruses</p>\n<p>(HPV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Cervical cancer</p>\n<p>Oropharyngeal cancer</p>\n<p>Anogenital cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kaposi’s</p>\n<p>sarcoma-</p>\n<p>associated</p>\n<p>herpesvirus</p>\n<p>(HHV-8)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Kaposi’s sarcoma, multicentric Castlemans disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Merkel cell polyomavirus</p>\n<p>(MCV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Merkel cell carcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Epstein–Barr</p>\n<p>virus (EBV)</p>\n</td>\n<td>\n<p>DNA</p>\n</td>\n<td>\n<p>Burkitt’s lymphoma, Hodgkin’s lymphoma, Post-transplant lymphoproliferative disease, and Nasopharyngeal carcinoma.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(701, 'Microbiology', 'PM0616. Differentiating Features between Smallpox and Chickenpox', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\103%\>\n<tbody>\n<tr>\n<td width=\26%\>\n<p>&nbsp;</p>\n</td>\n<td width=\35%\>\n<p>&nbsp;</p>\n<p>Smallpox (Variola)</p>\n</td>\n<td width=\37%\>\n<p>&nbsp;</p>\n<p>Chickenpox (Varicella)</p>\n</td>\n</tr>\n<tr>\n<td width=\26%\>\n<p>Incubation Period&nbsp;</p>\n</td>\n<td width=\35%\>\n<p>7–17 days</p>\n</td>\n<td width=\37%\>\n<p>14–21 days</p>\n</td>\n</tr>\n<tr>\n<td width=\26%\>\n<p>Transmission</p>\n</td>\n<td width=\35%\>\n<p>Respiratory viral shedding&nbsp;&nbsp;</p>\n<p>Through contact with the fluid found in the patients sores.&nbsp;</p>\n<p>Rarely airborne route.</p>\n</td>\n<td width=\37%\>\n<p>Aerosolized droplets from nasopharyngeal secretions.</p>\n<p>By direct cutaneous contact with vesicle fluid from skin lesions.</p>\n<p>Airborne transmission rarely</p>\n</td>\n</tr>\n<tr>\n<td width=\26%\>\n<p>Prodrome&nbsp;</p>\n</td>\n<td width=\35%\>\n<p>Fever and&nbsp;malaise&nbsp;for 2–4 days before onset of rash</p>\n</td>\n<td width=\37%\>\n<p>Minimal to none</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\26%\>\n<p>Rash</p>\n</td>\n<td width=\35%\>\n<p>centrifugal spread</p>\n<p>Usually on palms and soles</p>\n<p>Axilla is usually free</p>\n<p>Rash on extensor surfaces</p>\n</td>\n<td width=\37%\>\n<p>centripetal distribution</p>\n<p>Seldom on palms and soles; appears in crops</p>\n<p>Axilla affected</p>\n<p>Rash on flexor surfaces</p>\n</td>\n</tr>\n<tr>\n<td width=\26%\>\n<p>Pock Appearance</p>\n</td>\n<td width=\35%\>\n<p>Vesicular&nbsp; &gt;&nbsp;pustular&nbsp; &gt;</p>\n<p>umbilicated&nbsp;&gt;scab</p>\n</td>\n<td width=\37%\>\n<p>Macule &gt; Papule &gt; Vesicular on erythematous</p>\n<p>Base &gt;pustular &gt;scab</p>\n</td>\n</tr>\n<tr>\n<td width=\26%\>\n<p>Evolution of Pocks</p>\n</td>\n<td width=\35%\>\n<p>Synchronous</p>\n</td>\n<td width=\37%\>\n<p>Asynchronous</p>\n</td>\n</tr>\n<tr>\n<td width=\26%\>\n<p>Scab Formation</p>\n</td>\n<td width=\35%\>\n<p>10–14 days after onset of rash</p>\n</td>\n<td width=\37%\>\n<p>4–7 days after onset of rash</p>\n</td>\n</tr>\n<tr>\n<td width=\26%\>\n<p>Scab Separation</p>\n</td>\n<td width=\35%\>\n<p>14–28 days after onset of rash</p>\n</td>\n<td width=\37%\>\n<p>Within 14 days after onset of rash</p>\n</td>\n</tr>\n<tr>\n<td width=\26%\>\n<p>Infectivity</p>\n</td>\n<td width=\35%\>\n<p>From onset of&nbsp;exanthem&nbsp;until all scabs separate</p>\n</td>\n<td width=\37%\>\n<p>&nbsp;From 1 day before rash until all vesicles become scab. Scabs are non-infectious.</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(702, 'Dermatology,', 'PM0615. Clinical manifestations of Herpes simplex virus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ol start=\1\>\n<li><strong> Cutaneous lesions:</strong> Fever blister, herpetic whitlow, herpetic gladiatorum, eczema herpeticum.<strong> Eczema herpeticum</strong> is a generalised eruption caused by Herpes infections in children suffering from eczema</li>\n<li><strong>Mucosal</strong>: <strong>most common&nbsp;site</strong> involved is <strong>buccal mucosa</strong>. It may cause Gingivostomatitis &amp; Pharyngitis, Recurrent herpes labialis.</li>\n<li><strong>Ophthalmic:&nbsp;</strong>Follicular conjunctivitis and acute keratoconjunctivitis also occur.&nbsp;</li>\n<li><strong> Nervous System:</strong> HSV encephalitis, HSV meningitis.&nbsp;</li>\n</ol></div><!---->\n      <!---->\n    </div><!---->'),
(703, 'Microbiology', 'PM0606. Slow Virus Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Slow virus diseases</strong> are characterized by a long asymptomatic period, often months or years in duration, between the introduction of the infectious agent and the appearance of clinical illness.</p>\n<p>It can be classified into 3 groups:</p>\n<p><strong>Group A</strong>: Slowly progressive infections of sheep</p>\n<ul>\n<li>Visna</li>\n<li>Medi</li>\n</ul>\n<p><strong>Group B</strong>: Prion diseases</p>\n<p>Prion Diseases of Animals</p>\n<ul>\n<li>Scrapie</li>\n<li>MINK encephalopathy</li>\n<li>Bovine spongiform encephalopathy</li>\n</ul>\n<p>Prion Diseases of Humans</p>\n<ul>\n<li>CJD</li>\n<li>Kuru</li>\n<li>Gerstmann-Straussler-Scheinkersyndrome</li>\n<li>Fatal familial insomnia</li>\n</ul>\n<p><strong>Group C</strong></p>\n<ul>\n<li>SSPE</li>\n<li>PML</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(704, 'Microbiology', 'PM0600. Taxonomy of Arboviruses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>FAMILY</strong></p>\n</td>\n<td>\n<p><strong>GENUS</strong></p>\n</td>\n<td>\n<p><strong>IMPORTANT SPECIES</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Togaviridae</p>\n</td>\n<td>\n<p>Alphavirus</p>\n</td>\n<td>\n<p>Chikungunya, Eastern equine encephalitis virus, Western equine encephalitis virus, Venezuelan equine encephalitis virus&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Flaviviridae</p>\n</td>\n<td>\n<p>Flavivirus</p>\n</td>\n<td>\n<p>Japanese encephalitis, West Nile virus, Dengue virus, Kayasanur forest disease virus, Murray valley encephalitis virus, Yellow fever virus, Zika virus</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\3\>\n<p>Bunyaviridae</p>\n</td>\n<td>\n<p>Bunyavirus</p>\n</td>\n<td>\n<p>California encephalitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phlebovirus</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Rift valley fever virus, Sandfly fever virus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nairovirus</p>\n</td>\n<td>\n<p>Ganjam virus, Nairobi sheep disease virus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reoviridae</p>\n</td>\n<td>\n<p>Orbivirus</p>\n</td>\n<td>\n<p>African horse sickness, Blue-tongue viruses</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hantaviridae</p>\n</td>\n<td>\n<p>Orthohantavirus&nbsp;</p>\n</td>\n<td>\n<p>Prospect hill virus, Hantaan orthohantavirus</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(705, 'Microbiology', 'PM0596. Differentiating Properties of Orthomyxoviruses and Paramyxoviruses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Property</strong></td>\n<td><strong>Orthomyxovirus</strong></td>\n<td><strong>Paramyxovirus</strong></td>\n</tr>\n<tr>\n<td>Size of virion</td>\n<td>80–120 nm</td>\n<td>100–300 nm</td>\n</tr>\n<tr>\n<td>Shape</td>\n<td>Spherical; filaments in fresh isolates</td>\n<td>Pleomorphic</td>\n</tr>\n<tr>\n<td>Genome</td>\n<td>Segmented; eight pieces of RNA</td>\n<td>Single linear molecule of RNA</td>\n</tr>\n<tr>\n<td>Diameter of Nucleocapsid</td>\n<td>9 nm</td>\n<td>18 nm</td>\n</tr>\n<tr>\n<td>Site of synthesis of ribonucleoprotein</td>\n<td>Nucleus</td>\n<td>Cytoplasm</td>\n</tr>\n<tr>\n<td>Genetic reassortment</td>\n<td>Common</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Dependant RNA synthesis</td>\n<td>Required for multiplication</td>\n<td>Not required</td>\n</tr>\n<tr>\n<td>Effect of Actinomycin D</td>\n<td>Inhibits multiplication</td>\n<td>Does not inhibit</td>\n</tr>\n<tr>\n<td>Antigenic stability</td>\n<td>Variable</td>\n<td>Stable</td>\n</tr>\n<tr>\n<td>Hemolysin</td>\n<td>Absent</td>\n<td>Present</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(706, 'Medicine,', 'PM0594. 2021 NACO Guidelines on Post-exposure Prophylaxis (PEP) for HIV', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Exposure Code</strong></p>\n</td>\n<td>\n<p><strong>HIV Source Code</strong></p>\n</td>\n<td>\n<p><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PEP Recommendation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>&nbsp;1</p>\n</td>\n<td>\n<p>&nbsp;Not required</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>&nbsp;2</p>\n</td>\n<td>\n<p>&nbsp;Recommended</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>&nbsp;1</p>\n</td>\n<td>\n<p>&nbsp;Recommended</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>&nbsp;2</p>\n</td>\n<td>\n<p>&nbsp;Recommended</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>\n<p>&nbsp;1/2</p>\n</td>\n<td>\n<p>&nbsp;Recommended</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2/3</p>\n</td>\n<td>\n<p>Not known</p>\n</td>\n<td>\n<p>Consider PEP if HIV prevalence is high in the given population</p>\n</td>\n</tr>\n<tr>\n<td colspan=\3\>\n<p><strong>Exposure Codes</strong></p>\n<ul>\n<li>EC1: <strong>Mild exposure:</strong> mucous membrane/non-intact skin with small volumes/eyes or mucous membrane or subcutaneous injections following small-bore needles</li>\n<li>EC2:&nbsp;<strong>Moderate exposure: </strong>mucous membrane/non-intact skin with large volumes or percutaneous superficial exposure with a solid needle</li>\n<li>EC3:&nbsp;<strong>Severe exposure: </strong>percutaneous with large volume by hollow needle, deep puncture</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td colspan=\3\>\n<p><strong>HIV Source Codes</strong></p>\n<ul>\n<li>SC 1- HIV +ve, asymptomatic, CD count high, low viral load</li>\n<li>SC 2- HIV +ve, symptomatic, CD count low, high viral load</li>\n<li>SC unknown: HIV status unknown</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td colspan=\3\>\n<p><strong>Recommended PEP regimens</strong></p>\n<p>1) <strong>Adolescents and Adults</strong> (&gt;10 years of age and &gt;30 kg weight): Tenofovir 300 mg + Lamivudine 300 mg + Dolutegravir 50 mg</p>\n<p>2) <strong>Children&nbsp;</strong>(&gt;6 years of age and &gt;20 kg weight): Zidovudine&nbsp;(dosage as per weight band) + Lamivudine (dosage as per weight band) + Dolutegravir 50 mg</p>\n<ul>\n<li aria-level=\1\>PEP must be initiated ideally <strong>within 2 hours</strong> and certainly within 72 hours.</li>\n<li aria-level=\1\>Duration of PEP: <strong>28 days/4weeks</strong></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(707, 'Microbiology', 'PM0587. Cytopathic effects caused by viruses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Morphological changes in the cells that are caused by viruses are known as <strong>cytopathic</strong> <strong>effects</strong> (CPE) and the viruses causing these CPEs are known as <strong>cytopathogenic</strong> <strong>viruses</strong>. These CPEs can be detected by a light microscope.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type of cytopathic effect</strong></p>\n</td>\n<td>\n<p><strong>Virus</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rapid crenation of cells and degeneration of the cells</p>\n</td>\n<td>\n<p>Enterovirus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Syncytium/multinucleated giant cell formation</p>\n</td>\n<td>\n<p>Measles, mumps, respiratory syncytial virus (RSV)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Discrete focal degeneration</p>\n</td>\n<td>\n<p>Herpes virus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Large granular clumps resembling grapes</p>\n</td>\n<td>\n<p>Adenovirus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cytoplasmic vacuolation</p>\n</td>\n<td>\n<p>Simian virus 40 (SV 40)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(708, 'Microbiology', 'PM0586. Viruses with Helical Symmetry: Mnemonic: ABC FOR PARAmedics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Viruses with Helical Symmetry: Mnemonic: ABC FOR PARAmedics</strong></p>\n<ul>\n<li><strong>A</strong>renavirus</li>\n<li><strong>B</strong>unyavirus</li>\n<li><strong>C</strong>oronavirus</li>\n<li><strong>F</strong>ilovirus</li>\n<li><strong>O</strong>rthomyxovirus</li>\n<li><strong>R</strong>habdovirus</li>\n<li><strong>Para</strong>myxovirus</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(709, 'Microbiology', 'PM0582. Important Shapes of Some Viruses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>VIRUS</strong></p>\n</td>\n<td>\n<p><strong>SHAPE</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rabies virus</p>\n</td>\n<td>\n<p>Bullet shaped</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pox virus</p>\n</td>\n<td>\n<p>Brick shaped</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tobacco mosaic virus</p>\n</td>\n<td>\n<p>Rod shaped</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ebola virus</p>\n</td>\n<td>\n<p>Filamentous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Astro virus</p>\n</td>\n<td>\n<p>Star shaped</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Adenovirus</p>\n</td>\n<td>\n<p>Space vehicle shaped</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rotavirus</p>\n</td>\n<td>\n<p>Wheel shaped</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(710, 'Microbiology', 'PM2370. Systemic fungi - Histopathological findings', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0eb743b778a54477a01712589ecfe242x958x666.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Histoplasma</strong>: Tiny oval yeast cells (2- 4 μm size) with narrow-based budding within the macrophages with an underlying granulomatous response.</p>\n<hr>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/540a9635ff20406ca14c9f44eabab597x958x649.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Blastomyces</strong> : Thick-walled round yeast cells of 8- 15 μm size with single broad-based budding (figure of 8 appearance)</p>\n<hr>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b92b3162957241d9aad7ef723c0cd59ex958x656.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Coccidoides</strong> : Mature spherules of coccidioidomycus is seen in the above image. Spherules which are large sac like structures (20--80 μm size), have thick, double refractile wall, and are filled with endospores.</p>\n<hr>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b8b9b1242fbf4b278077f5ddba9dddcax800x524.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Paracoccidioides</strong> : Round thick-walled yeasts, with multiple narrow-necked buds attached circumferencially giving rise to Mickey mouse or pilot wheel appearance.</p></div><!---->\n      <!---->\n    </div><!---->'),
(711, 'Microbiology', 'PM1762. Classification of fungus based on spore formation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>It is classified into 4 types:</strong></p>\n<p><strong>Glomeromycota:</strong></p>\n<ul>\n<li>Lower fungi with non-septate hyphae.</li>\n<li>Asexual spores are called sporangiospores – within swollen sac-like structure called sporangia</li>\n<li>Sexual spores are called zygospores and oospores</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6ebc667408fd40cebe4674fab2af2abfx800x474.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Ascomycota:&nbsp;</strong></p>\n<ul>\n<li>Asexual spores are called conidia.</li>\n<li>Sexual spores are called ascospores -&nbsp;formed within a sac or ascus.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9398bc9d32bd4bb298b87d16c5afb3bex800x552.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Basidiomycota:</strong></p>\n<ul>\n<li>Asexual spores are called conidia.</li>\n<li>Sexual spores are called basidiospores (on a basidium or base).</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Deuteromycetes:&nbsp;</strong>(fungi imperfecti or hypomycetes)<strong> – </strong>sexual stages yet to be discovered.</p></div><!---->\n      <!---->\n    </div><!---->'),
(712, 'Microbiology', 'PM1761. Classification of fungus based on morphology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Fungi are classified into 4 types based on their morphology:</p>\n<ul>\n<li>Yeast</li>\n<li>Yeast-like</li>\n<li>Molds</li>\n<li>Dimorphic fungi</li>\n</ul>\n<p><strong>Yeast:</strong></p>\n<ul>\n<li>Unicellular fungi</li>\n<li>Reproduces by budding</li>\n<li>Oval to round forms</li>\n<li>Example: Cryptococcus,&nbsp;Saccharomyces.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0f583d17fa494e93b42864de8e82507cx597x599.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Yeast like:</strong></p>\n<ul>\n<li>Unicellular fungi</li>\n<li>Reproduces by budding or binary fission</li>\n<li>Spherical or oval forms</li>\n<li>Pseudohyphae may be seen.</li>\n<li>Example: Candida,&nbsp;Malassezia furfur.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/bf7e12378e26462194d6b6f9155af000x800x501.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Molds/filamentous fungi:</strong></p>\n<ul>\n<li>Have hyphae which may be septate or aseptate</li>\n<li>Aseptate or coenocytic hyphae – Rhizopus, mucor,&nbsp;Lichtheimia.</li>\n<li>Septate hyphae – Penicillium, Dermatophytes, Aspergillus, fusarium.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/129499f438c04855bf91806ab6191d23x800x547.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Dimorphic fungi</strong></p>\n<ul>\n<li>Filamentous forms in the culture at 22<sup>0</sup>C – 25<sup>0</sup>C and in the environment.</li>\n<li>Yeast form in the culture at 37<sup>0</sup>C and in tissues.</li>\n<li>Examples – Histoplasma capsulatum, Blastomyces dermatitidis, Coccidioides immitis, Paracoccidioides brasiliensis, Talaromyces&nbsp;marneffei, Sporothrix schenckii.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(713, 'Microbiology', 'PM1729. Important causative agents and colour of the grains of various types of mycetoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Causative agent</strong></td>\n<td><strong>Color of the grains</strong></td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Eumycetoma</strong></td>\n</tr>\n<tr>\n<td>Madurella mycetomatis</td>\n<td>Black</td>\n</tr>\n<tr>\n<td>M. grisea</td>\n<td>Black</td>\n</tr>\n<tr>\n<td>Pseudallescheria boydii</td>\n<td>White -yellow &nbsp;</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Actinomycetoma</strong></td>\n</tr>\n<tr>\n<td>Actinomadura madurae</td>\n<td>White -yellow &nbsp;</td>\n</tr>\n<tr>\n<td>A. pellitieri</td>\n<td>Red-yellow &nbsp;</td>\n</tr>\n<tr>\n<td>Nocardia asteroids</td>\n<td>White -yellow &nbsp;</td>\n</tr>\n<tr>\n<td>Streptomyces somaliensis</td>\n<td>yellow &nbsp;</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Botryomycosis</strong></td>\n</tr>\n<tr>\n<td>Staphylococcus species</td>\n<td>White</td>\n</tr>\n<tr>\n<td>Streptococcus species</td>\n<td>White</td>\n</tr>\n<tr>\n<td>Escherichia coli</td>\n<td>White</td>\n</tr>\n<tr>\n<td>proteus species</td>\n<td>White</td>\n</tr>\n<tr>\n<td>Pseudomonas aeruginosa</td>\n<td>White</td>\n</tr>\n<tr>\n<td>Actinobacillus lignieresi</td>\n<td>yellow &nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(714, 'Microbiology', 'PM0568. Differences between Eumycetoma and Actinomycetoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Feature</strong></p>\n</td>\n<td>\n<p><strong>Eumycetoma</strong></p>\n</td>\n<td>\n<p><strong>Actino</strong><strong>mycetoma</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Etiology</strong></p>\n</td>\n<td>\n<p>Filamentous fungi</p>\n</td>\n<td>\n<p>Fungus-like bacteria</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Grains</strong></p>\n</td>\n<td>\n<p>Madurella mycetomatis and grisia- black grains</p>\n</td>\n<td>Actinomadura madurae and Nocardia asteroids- white-yellow grains</td>\n</tr>\n<tr>\n<td>\n<p><strong>Progression</strong></p>\n</td>\n<td>\n<p>Slow</p>\n</td>\n<td>\n<p>Rapid</p>\n</td>\n</tr>\n<tr>\n<td><strong>Sites of involvement</strong>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Feet and hands</p>\n</td>\n<td>\n<p>Involvement of covered parts</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Swelling</strong></p>\n</td>\n<td>\n<p>Well circumscribed and marked in the later stage</p>\n</td>\n<td>\n<p>Ill-defined and merges with surrounding tissue</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Tissue destruction</strong></p>\n</td>\n<td>\n<p>Marked in the later stage</p>\n</td>\n<td>\n<p>Involvement of bone is earlier and extensive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Filaments</strong></p>\n</td>\n<td>\n<p>Wide (2–5</p>\n<p>μm) and septate hyphae, Periodic Schiff (PAS) positive and gram-negative easily visualized at ×400</p>\n</td>\n<td>\n<p>Slender (0.5–</p>\n<p>μm) and nonseptate, PAS negative and gram-positive filaments difficult to visualize even at ×800</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Response to treatment</strong></p>\n</td>\n<td>\n<p>Unresponsive and requires surgical debulking</p>\n</td>\n<td>\n<p>Good response</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(715, 'Microbiology', 'PM0567. Common names of various fungal infections', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Common name</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histoplasmosis</p>\n</td>\n<td>\n<p>Darling’s disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sporotrichosis</p>\n</td>\n<td>\n<p>Rose-thorn or Rose gardener’s disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Para-coccidioidomycosis</p>\n</td>\n<td>\n<p>South American blastomycosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Coccidioidomycosis</p>\n</td>\n<td>\n<p>Valley fever or desert rheumatism</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Blastomycosis</p>\n</td>\n<td>\n<p>North American blastomycosis, Gilchrists disease</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(716, 'Microbiology', 'PM0566. Characteristic features of macroconidia and microconidia of dermatophytes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Dermatophyte&nbsp;&nbsp; </strong></p>\n</td>\n<td>\n<p><strong>Macroconidia</strong></p>\n</td>\n<td>\n<p><strong>Microconidia</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Trichophyton</strong></p>\n</td>\n<td>\n<p>Thin-walled, pencil-shaped</p>\n</td>\n<td>\n<p>Small unicellular</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Microsporum</strong></p>\n</td>\n<td>\n<p>Multicellular, spindle-shaped</p>\n</td>\n<td>\n<p>Scanty</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Epidermophyton</strong></p>\n</td>\n<td>\n<p>Multicellular, pear-shaped, arranged in clusters</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Trichophyton</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b5c0756f2d86465bba74a9074871fe9ax958x650.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Microsporum</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/70a7695c37c84a5fa926a24250a7d9ffx800x600.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Epidermophyton</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/943737c2d7fa45f889fe26be57d41866x720x496.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(717, 'Microbiology,', 'PM2390. Comparison between mosquito-borne and transfusion-transmitted malaria.', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>&nbsp;</strong></td>\n<td><strong>Mosquito-borne malaria</strong></td>\n<td><strong>Transfusion transmitted malaria</strong></td>\n</tr>\n<tr>\n<td><strong>Mode of transmission</strong></td>\n<td>Mosquito bite</td>\n<td>Transfusion of infected blood or blood products</td>\n</tr>\n<tr>\n<td><strong>Infective stage</strong></td>\n<td>Sporozoite</td>\n<td>Trophozoite</td>\n</tr>\n<tr>\n<td><strong>Pre-erythrocytic stage</strong></td>\n<td>Present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td><strong>Incubation period</strong></td>\n<td>Long</td>\n<td>Short&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Complications</strong></td>\n<td>Comparatively less</td>\n<td>Associated with severe complications</td>\n</tr>\n<tr>\n<td><strong>Hypnozoites</strong></td>\n<td>May be seen in infection with P. vivax and ovale</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td><strong>Relapse</strong></td>\n<td>May occur</td>\n<td>Does not occur</td>\n</tr>\n<tr>\n<td><strong>Radical treatment</strong></td>\n<td>Required</td>\n<td>Not required</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(718, 'Microbiology', 'PM2374. Infective form and diagnostic forms - Worms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table dir=\ltr\ border=\1\ cellspacing=\0\ cellpadding=\0\><colgroup><col width=\292\><col width=\271\><col width=\293\></colgroup>\n<tbody>\n<tr>\n<td><strong>Parasite</strong></td>\n<td><strong>Infective form</strong></td>\n<td><strong>Diagnostic form</strong></td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\><strong>Cestode</strong></td>\n</tr>\n<tr>\n<td><em>Diphyllobothrium latum</em></td>\n<td>Plerocercoid larva</td>\n<td>Eggs or segments of the tapeworm</td>\n</tr>\n<tr>\n<td><em>Taenia saginata</em></td>\n<td>Cysticercus bovis</td>\n<td>Egg</td>\n</tr>\n<tr>\n<td><em>Taenia solium</em></td>\n<td>Cysticercus cellulosae</td>\n<td>Egg (for intestinal taeniasis ) / cysticercus cellulosae larva (for cysticercosis)</td>\n</tr>\n<tr>\n<td><em>Echinococcus granulosus</em></td>\n<td>Egg</td>\n<td>Protoscolices and brood capsules</td>\n</tr>\n<tr>\n<td><em>Hymenolepsis nana</em></td>\n<td>Egg</td>\n<td>Egg</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\><strong>Trematode</strong></td>\n</tr>\n<tr>\n<td><em>Schistosoma spp</em>.</td>\n<td>Cercariae</td>\n<td>Nonoperculated Eggs</td>\n</tr>\n<tr>\n<td>Other trematodes - <em>Fasciola hepatica, Fasciolopsis buski, Paragonimus westermani, Clonorchis sinensis</em></td>\n<td>Metacercaria larva</td>\n<td>Operculated Eggs</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\><strong>Nematode</strong></td>\n</tr>\n<tr>\n<td><em>Ascaris lumbricoides</em></td>\n<td>Egg</td>\n<td>Unembryonated eggs in stool</td>\n</tr>\n<tr>\n<td>\n<p><em>Ancylostoma duodenale</em></p>\n<p><em>Necator americanus</em></p>\n</td>\n<td>Filariform larva</td>\n<td>Eggs (in fresh stool), larva ( in old stool )</td>\n</tr>\n<tr>\n<td><em>Strongyloides stercoralis</em></td>\n<td>Filariform larva</td>\n<td>Rhabditiform larva</td>\n</tr>\n<tr>\n<td><em>Trichuris trichuria</em></td>\n<td>Embryonated Egg</td>\n<td>Unembryonated Egg</td>\n</tr>\n<tr>\n<td><em>Enterobius vermicularis</em></td>\n<td>Egg</td>\n<td>Eggs from perianal skin</td>\n</tr>\n<tr>\n<td>Filarial nematodes</td>\n<td>Third stage Filarial larva (L3)</td>\n<td>Microfilariae</td>\n</tr>\n<tr>\n<td><em>Trichinella spiralis</em></td>\n<td>First stage larva (L1)</td>\n<td>Trichinella antibody test</td>\n</tr>\n<tr>\n<td><em>Dracunculus medinensis</em></td>\n<td>Third stage filariform larva (L3)</td>\n<td>Adult worm</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\><strong>Hint</strong>: The infective and diagnostic forms are usually the same in the parasites causing <strong>autoinfection</strong>.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(719, 'Microbiology', 'PM2373. Infective form and diagnostic forms of various protozoa', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table dir=\ltr\ border=\1\ width=\284\ cellspacing=\0\ cellpadding=\0\><colgroup><col width=\292\><col width=\271\><col width=\293\></colgroup>\n<tbody>\n<tr>\n<td><strong>Parasite</strong></td>\n<td><strong>Infective form</strong></td>\n<td><strong>Diagnostic form</strong></td>\n</tr>\n<tr>\n<td><em>Entamoeba histolytica</em></td>\n<td>Mature quadrinucleate cyst</td>\n<td>Trophozoites, quadrinucleate cyst</td>\n</tr>\n<tr>\n<td><em>Giardia lamblia</em></td>\n<td>Quadrinucleate cyst</td>\n<td>Trophozoites, cyst</td>\n</tr>\n<tr>\n<td><em>Trichomonas vaginalis</em></td>\n<td>Trophozoites</td>\n<td>Trophozoites</td>\n</tr>\n<tr>\n<td><em>Naegleria fowleri</em></td>\n<td>Trophozoite</td>\n<td>Trophozoite in CSF</td>\n</tr>\n<tr>\n<td><em>Acanthamoeba</em></td>\n<td>Trophozoites and cysts</td>\n<td>Trophozoite in CSF</td>\n</tr>\n<tr>\n<td><em>Leishmania donovani</em></td>\n<td>Promastigote</td>\n<td>amastigotes in macrophage</td>\n</tr>\n<tr>\n<td><em>Trypanosoma cruzi</em></td>\n<td>Metacyclic Trypomastigote</td>\n<td>Trypomastigote</td>\n</tr>\n<tr>\n<td><em>Trypanosoma brucei</em></td>\n<td>Metacyclic Trypomastigote</td>\n<td>Trypomastigote</td>\n</tr>\n<tr>\n<td><em>Balantidium coli</em></td>\n<td>Cysts</td>\n<td>Cysts</td>\n</tr>\n<tr>\n<td><em>Plasmodium </em>spp.</td>\n<td>Sporozoites</td>\n<td>Schizont, immature trophozoite, mature trophozoite, gametocyte</td>\n</tr>\n<tr>\n<td><em>Babesia </em>spp.</td>\n<td>Sporozoites</td>\n<td>Maltese cross form</td>\n</tr>\n<tr>\n<td><em>Toxoplasma gondii</em></td>\n<td>All 3 morphological forms - oocyst, tachyzoite, bradyzoite</td>\n<td>Tachyzoites, tissue cysts</td>\n</tr>\n<tr>\n<td><em>Cryptosporidium parvum</em></td>\n<td>Sporulated oocyst</td>\n<td>Sporulated oocyst</td>\n</tr>\n<tr>\n<td><em>Cyclospora cayetanensis</em></td>\n<td>Sporulated oocyst</td>\n<td>unsporulated oocyst</td>\n</tr>\n<tr>\n<td><em>Isospora belli</em></td>\n<td>Sporulated oocyst</td>\n<td>unsporulated oocyst</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(720, 'Microbiology', 'PM2371. Leishmania', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4bb32dd49e0347eaaede8aacef9c84b9x1280x1280.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table dir=\ltr\ border=\1\ cellspacing=\0\ cellpadding=\0\><colgroup><col width=\160\><col width=\57\><col width=\226\></colgroup>\n<tbody>\n<tr>\n<td><strong>New world</strong></td>\n<td><strong>Disease</strong></td>\n<td><strong>Old world</strong></td>\n</tr>\n<tr>\n<td>L.chagasi</td>\n<td colspan=\1\ rowspan=\2\>\n<div>VL</div>\n</td>\n<td>L. donovani</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>L. infantum</td>\n</tr>\n<tr>\n<td>L. mexicana (Chiclero ulcer)</td>\n<td colspan=\1\ rowspan=\2\>\n<div>CL</div>\n</td>\n<td>L. tropica (Delhi boil / oriental sore )</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>L. major</td>\n</tr>\n<tr>\n<td>-</td>\n<td>DCL</td>\n<td>L. ethiopica</td>\n</tr>\n<tr>\n<td>L. braziliensis (Espundia)</td>\n<td>MCL</td>\n<td>-</td>\n</tr>\n</tbody>\n</table>\n<table dir=\ltr\ border=\1\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td>Lutzomiya</td>\n<td>Vector</td>\n<td>Phlebotomus&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>where,</p>\n<p>VL - Visceral Leishmania</p>\n<p>CL - Cutaneous Leishmania</p>\n<p>DCL - Diffuse cutaneous Leishmania</p>\n<p>MCL - Mucocutaneous Leishmania</p></div><!---->\n      <!---->\n    </div><!---->'),
(721, 'Microbiology', 'PM1766. Filarial worms and their morphology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/97c1647e773140ee8b5a9458edd4825ex1280x3506.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(722, 'Microbiology', 'PM1765. Eggs in parasitology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0fa0f4c159e7489eb20351c22109ef72x600x3219.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(723, 'Microbiology', 'PM1760. Lifecycle of Schistosoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/272e31fbc91348669c7cb449afe8acb5x624x528.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(724, 'Microbiology', 'PM1759. Eggs of Schistosoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5d38d4b525f546e1a1b8e731ca886441x1280x572.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(725, 'Microbiology', 'PM1758. Difference between plasmodium species', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>P.vivax</strong></td>\n<td><strong>P.ovale</strong></td>\n<td><strong>P.falciparum</strong></td>\n<td><strong>P.malaria</strong></td>\n</tr>\n<tr>\n<td>Discovered by</td>\n<td>Grassi &amp; Feletti</td>\n<td>Stephens</td>\n<td>Welch</td>\n<td>Laveran</td>\n</tr>\n<tr>\n<td>Erythrocyte preference</td>\n<td>Reticulocytes</td>\n<td>Reticulocytes</td>\n<td>All stages</td>\n<td>Old erythrocytes</td>\n</tr>\n<tr>\n<td>Stages found in peripheral blood</td>\n<td>Trophozoite, schizonts, gametocytes</td>\n<td>As in vivax</td>\n<td>Ring form, accole form, gametocytes</td>\n<td>Band forms</td>\n</tr>\n<tr>\n<td>Infected erythrocyte</td>\n<td>Enlarged pale with Schuffner’s dots</td>\n<td>Pear-shaped, fimbriated, Schuffner’s dots (Jame’s dots)</td>\n<td>Normal size,&nbsp;Maurer’s cleft</td>\n<td>Normal size, Ziemann’s stippling</td>\n</tr>\n<tr>\n<td>Gametocyte</td>\n<td>Spherical, fills the cell</td>\n<td>Similar to but smaller than vivax</td>\n<td>Crescent, Banana shaped</td>\n<td>Similar to but smaller than vivax</td>\n</tr>\n<tr>\n<td>Color of pigment</td>\n<td>Yellowish-brown</td>\n<td>Yellowish-brown</td>\n<td>Black</td>\n<td>Dark brown</td>\n</tr>\n<tr>\n<td>Hypnozoites</td>\n<td>Present</td>\n<td>Present</td>\n<td>Absent</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Relapse</td>\n<td>Yes</td>\n<td>Yes</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Average IP(days)</td>\n<td>14</td>\n<td>14</td>\n<td>12 (shortest)</td>\n<td>30 (longest)</td>\n</tr>\n<tr>\n<td>Duration of erythrocyte cycle(hours)</td>\n<td>48 (Benign tertian)</td>\n<td>48 (ovale tertian)</td>\n<td>48 (malignant tertian)</td>\n<td>72(Quartan malaria)</td>\n</tr>\n<tr>\n<td>Others</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>Nephrotic syndrome</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(726, 'Microbiology', 'PM1757. Various morphological stages of hemoflagellates', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It is based on the&nbsp;arrangement of the flagella in relation to the position of the nucleus and its point of emergence from the cells.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b2a3d60c324049fbb159d7eb6e51e0b1x1280x657.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Morphological characteristics</strong></td>\n<td><strong>Seen in</strong></td>\n</tr>\n<tr>\n<td><strong>Amastigote</strong></td>\n<td>\n<p>Rounded or ovoid, without any external flagellum.</p>\n<p>The nucleus, kinetoplast, and axial filaments can be seen.</p>\n<p>The axoneme extends up to the anterior end of the cell</p>\n</td>\n<td>Trypanosoma cruzi and Leishmania as the intracellular form in the vertebrate host.</td>\n</tr>\n<tr>\n<td><strong>Promastigote</strong></td>\n<td>\n<p>Lanceolate in shape.</p>\n<p><strong>Antenuclear kinetoplast-&nbsp;</strong>kinetoplast is anterior to the nucleus near the anterior end of the cell, from which flagellum emerges.</p>\n<p>There is <strong>no undulating membrane</strong></p>\n</td>\n<td>It is the infective stage of Leishmania, found in the insect vector as well as in cultures in­vitro.</td>\n</tr>\n<tr>\n<td><strong>Epimastigote</strong></td>\n<td>\n<p>Elongated.&nbsp;</p>\n<p><strong>Juxtanuclear kinetoplast </strong>-<strong>&nbsp;</strong>kinetoplast placed more posteriorly, close to and in front of the nucleus.</p>\n<p>The flagellum runs alongside the body as a short undulating membrane, before emerging from the anterior end.</p>\n</td>\n<td>\n<p>It is the form in which Trypanosoma brucei occurs in the salivary gland of the vector tsetse fly and Trypanosoma cruzi in the midgut of the vector reduviid bug.</p>\n<p><strong>Note:</strong> This stage is lacking in Leishmania.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Trypo-mastigote</strong></td>\n<td>\n<p>This stage is elongated, spindle-shaped with a <strong>central nucleus</strong>.</p>\n<p><strong>Postnuclear kinetoplast</strong>&nbsp;- kinetoplast is posterior to the nucleus and situated at the posterior end of the body.</p>\n<p>The flagellum runs alongside the entire length of the cell to form a long undulating membrane before emerging as a free flagellum from the anterior end.</p>\n</td>\n<td>\n<p>This is the infective stage of trypanosomes found in arthropod vector and in the blood of an infected vertebrate.</p>\n<p><strong>Note:</strong> This stage is lacking in Leishmania.&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(727, 'Microbiology', 'PM1756. Differential features of intestinal Entamoeba', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Features</strong></td>\n<td><strong>E. histolytica</strong></td>\n<td><strong>E. coli</strong></td>\n<td><strong>E. hartmanni</strong></td>\n</tr>\n<tr>\n<td colspan=\4\><strong>&nbsp; &nbsp;1. TROPHOZOITE</strong></td>\n</tr>\n<tr>\n<td>Size (µm)</td>\n<td>12 - 60</td>\n<td>20 - 50</td>\n<td>4 - 12</td>\n</tr>\n<tr>\n<td>Motility</td>\n<td>Active</td>\n<td>Sluggish</td>\n<td>Active</td>\n</tr>\n<tr>\n<td>Pseudopodia</td>\n<td>Finger shaped, rapidly extruded</td>\n<td>Short, blunt, slowly extruded</td>\n<td>Finger shaped, rapidly extruded</td>\n</tr>\n<tr>\n<td><strong>Cytoplasm</strong></td>\n<td><strong>Clearly defined into endoplasm and ectoplasm</strong></td>\n<td><strong>Not defined</strong></td>\n<td>Clearly defined into endoplasm and ectoplasm</td>\n</tr>\n<tr>\n<td><strong>Inclusion</strong></td>\n<td><strong>RBCs (erythro-phagocytosis), no bacteria</strong></td>\n<td>Bacteria and other particles, no RBCs</td>\n<td>Bacteria and other particles, no RBCs</td>\n</tr>\n<tr>\n<td>Nucleus</td>\n<td>Eccentric, not clearly visible in unstained films</td>\n<td>Visible in unstained films</td>\n<td>Not clearly visible in unstained films</td>\n</tr>\n<tr>\n<td><strong>Karyosome</strong></td>\n<td><strong>Small, central</strong></td>\n<td><strong>Large, eccentric</strong></td>\n<td><strong>Small, eccentric</strong></td>\n</tr>\n<tr>\n<td>Nuclear-membrane</td>\n<td>Delicate with fine chromatin dots</td>\n<td>Thick, coarse chromatin</td>\n<td>Coarse chromatin granules</td>\n</tr>\n<tr>\n<td colspan=\4\><strong>&nbsp; &nbsp;2. CYST</strong>&nbsp;&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Size (µm)</td>\n<td>10 -15</td>\n<td>10 - 30</td>\n<td>5 – 10</td>\n</tr>\n<tr>\n<td><strong>Nuclei in mature cyst</strong></td>\n<td><strong>4, central karyosome</strong></td>\n<td><strong>8, eccentric karyosome</strong></td>\n<td><strong>4</strong></td>\n</tr>\n<tr>\n<td><strong>Glycogen mass</strong></td>\n<td><strong>Seen in uninucleate stage only</strong></td>\n<td><strong>Seen upto quadrinucleate stage</strong></td>\n<td><strong>Seen in uninucleate stage only</strong></td>\n</tr>\n<tr>\n<td><strong>Chromatid bars</strong></td>\n<td><strong>1-4, with rounded ends</strong></td>\n<td><strong>Splinter like with angular ends</strong></td>\n<td><strong>Numerous, irregular shape</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(728, 'Community Medicine,', 'PM1731. Arthropod- borne diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Arthropod</strong></td>\n<td><strong>Disease transmitted</strong></td>\n</tr>\n<tr>\n<td>Anopheles mosquito</td>\n<td>Malaria, Filariasis</td>\n</tr>\n<tr>\n<td>Culex mosquito</td>\n<td>Bancroftian filariasis, Japenese encephalitis, West nile fever, Viral arthritis</td>\n</tr>\n<tr>\n<td>Aedes mosquito</td>\n<td>Yellow fever, Dengue, Chikungunya, filariasis, zika</td>\n</tr>\n<tr>\n<td>Mansoni Mosquito</td>\n<td>Filariasis, Chikungunya</td>\n</tr>\n<tr>\n<td>Housefly</td>\n<td>Typhoid and paratyphoid fever, diarrhea, dysentery, cholera, gastroenteritis, amoebiasis, helminthic infestations, poliomyelitis, conjunctivitis, trachoma, anthrax, yaws, etc.</td>\n</tr>\n<tr>\n<td>Sandfly (Phlebotomus)</td>\n<td>Kala-azar(Visceral Leishmaniasis), oriental sore, Oroya fever, Sandfly fever</td>\n</tr>\n<tr>\n<td>Tsetse fly</td>\n<td>Sleeping sickness(African Trypanosomiasis)</td>\n</tr>\n<tr>\n<td>Louse</td>\n<td>Epidemic typhus, relapsing fever, trench fever, pediculosis</td>\n</tr>\n<tr>\n<td>Rat flea</td>\n<td>Bubonic plague, endemic typhus(Murine Typhus), hymenolepis diminuta</td>\n</tr>\n<tr>\n<td>Black fly(Simulium)</td>\n<td>Onchocerciasis</td>\n</tr>\n<tr>\n<td>Reduviid bug(Kissing bug/triatominae)</td>\n<td>Chagas disease(American Trypanosomiasis)</td>\n</tr>\n<tr>\n<td>Hard tick (Ixodes species)</td>\n<td>Tick typhus, viral encephalitis, viral fevers, viral hemorrhagic fever,(e.g. Kyasanur forest disease), tularemia, tick paralysis, human babesiosis, lyme disease</td>\n</tr>\n<tr>\n<td>Soft Tick&nbsp;(Argas species)</td>\n<td>Q fever, relapsing fever, Kyasanur forest disease (KFD) (can be casued by hard tick as well)</td>\n</tr>\n<tr>\n<td>Trombiculid mite</td>\n<td>Scrub typhus, Rickettsial pox</td>\n</tr>\n<tr>\n<td>Itch mites</td>\n<td>Scabies</td>\n</tr>\n<tr>\n<td>Cyclops</td>\n<td>Guinea-worm disease, fish tapeworm (D. latum)</td>\n</tr>\n<tr>\n<td>Cockroaches</td>\n<td>Enteric pathogens</td>\n</tr>\n<tr>\n<td>Sand flea&nbsp;(Tunga penetrance, Jiggar, Chigoe flea)</td>\n<td>&nbsp;Tungiasis, Ulcer in the feetnails</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(729, 'Microbiology', 'PM0664. Helminth eggs that float in saturated salt solution', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The following are the helminths whose eggs float in a saturated salt solution. (mnemonic: <strong>THE FAN)</strong></p>\n<ul>\n<li><em><strong>T</strong>richuris trichiura</em></li>\n<li><em><strong>H</strong>ymenolepis nana</em></li>\n<li><em><strong>E</strong>nterobius vermicularis</em></li>\n<li><strong>F</strong>ertilized eggs of&nbsp;<em><strong>A</strong>scaris lumbricoides</em></li>\n<li><em><strong>A</strong>ncylostoma duodenale</em></li>\n<li><em><strong>N</strong>ecator americanus.</em></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(730, 'Microbiology', 'PM0663. Parasites with bile-stained eggs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The following are the parasites with<strong> bile-stained eggs. (</strong>mnemonic:<strong> FaT CAT)</strong></p>\n<ul>\n<li><em><strong>Fa</strong>sciola hepatica</em> (sheep liver fluke)</li>\n<li><em><strong>Fa</strong>sciolopsis buski</em> (giant intestinal fluke)</li>\n<li><em><strong>T</strong>richuris trichiura</em> (whipworm)</li>\n<li><em><strong>C</strong>lonorchis sinensis</em> (chinese liver fluke, oriental liver fluke)</li>\n<li><em><strong>A</strong>scaris lumbricoides</em> (round worm)</li>\n<li><em><strong>T</strong>aenia solium</em> (pork tapeworm)</li>\n<li><em><strong>T</strong>aenia saginata</em> (beef tapeworm)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(731, 'Microbiology', 'PM0662. Difference between T. solium and T. saginata', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>Properties</strong></p>\n</td>\n<td>\n<p><em><strong>Taenia solium</strong></em></p>\n</td>\n<td>\n<p><em><strong>Taenia saginata</strong></em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Common name</strong></p>\n</td>\n<td>\n<p>Pork tapeworm</p>\n</td>\n<td>\n<p>Beef tapeworm</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Definitive host</strong></p>\n</td>\n<td>\n<p>Human</p>\n</td>\n<td>\n<p>Human</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Intermediate</strong></p>\n<p><strong>host</strong></p>\n</td>\n<td>\n<p>Pig/Humans</p>\n</td>\n<td>\n<p>Cow</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>&nbsp;Disease&nbsp;</strong></p>\n</td>\n<td>\n<p>Taeniasis and cysticercosis</p>\n</td>\n<td>\n<p>Taeniasis only</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Transmission</strong></p>\n</td>\n<td>\n<p>Infection is common among those&nbsp;<strong>eating raw or&nbsp;</strong><strong>insufficiently cooked&nbsp;</strong><strong>measly pork</strong>&nbsp;containing the cysticerci.</p>\n</td>\n<td>\n<p>Human beings are infected through the&nbsp;<strong>eating of undercooked beef&nbsp;</strong><strong>containing the&nbsp;cysticerci</strong>&nbsp;(“measly” beef)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Size of adult worm</strong></p>\n</td>\n<td>\n<p>2-3 m</p>\n</td>\n<td>\n<p>5-10m</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scolex</strong></p>\n</td>\n<td>\n<p>The scolex head is <strong>globular</strong> in outline and has four circular suckers.</p>\n<p>The head is provided with the rostellum armed with double row of alternating large and small hooklets. The rostellar hooklets are shaped like daggers or Arabian poniards (<strong>armed scolex</strong>)</p>\n</td>\n<td>\n<p>The scolex (“head”) is&nbsp;<strong>quadrate</strong> in outline and has four circular suckers.</p>\n<p>Rostellum and hooklets are absent (i.e.&nbsp;<strong>unarmed scolex</strong>)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>&nbsp;Proglottid&nbsp;</strong></p>\n</td>\n<td>\n<p>Less than 1000 proglottids are present.</p>\n<p>The gravid uterus consists of a median longitudinal stem with<strong>&nbsp;5-13 compound lateral branches</strong>&nbsp;on each side</p>\n<p>The gravid segments are expelled passively, in chains of 5-6 at a time, and not singly.</p>\n<p><em>T.&nbsp;solium&nbsp;</em>may produce 50,000 eggs per proglottid.</p>\n</td>\n<td>\n<p>The number of proglottids varies from 1000- 2000.</p>\n<p>The gravid uterus consists of a central longitudinal stem with&nbsp;<strong>15-30 lateral branches on each side</strong>; these in turn sub-branch leaving practically no space in between.</p>\n<p>The gravid segments are expelled singly&nbsp;<em>T.&nbsp;saginata&nbsp;</em>may produce up to 100,000 eggs per proglottid.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>&nbsp;Eggs&nbsp;</strong></p>\n</td>\n<td>\n<p>The eggs are about 30-35 micrometers in diameter&nbsp;and are&nbsp;<strong>bile stained.</strong></p>\n<p>The internal oncosphere contains six refractile hooks.</p>\n<p>The&nbsp;<strong>eggs do not float&nbsp;</strong>in the saturated solution of NaCl.</p>\n<p><em>T.solium&nbsp;</em>and&nbsp;<em>T. saginata</em> eggs are morphologically indistinguishable.</p>\n</td>\n<td>\n<p>Same as <em>T. solium</em>.</p>\n<p><em>Taenia&nbsp;solium</em>&nbsp;and&nbsp;<em>Taenia&nbsp;</em><em>saginata</em>&nbsp;eggs are morphologically indistinguishable.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;<strong>Eggs (Infectious nature)</strong></p>\n</td>\n<td>\n<p>Infectious to humans (Human who ingested food contaminated with the egg of&nbsp;<em>Taenia solium</em>&nbsp;may develop cysticercosis)</p>\n</td>\n<td>\n<p>Eggs of&nbsp;<em>Taenia saginata</em>&nbsp;are not infectious. Humans who ingest <em>T. saginata</em> eggs do not develop cysticercosis.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(732, 'Microbiology', 'PM0661. Difference between cestodes, trematodes, and nematodes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Features</strong></p>\n</td>\n<td>\n<p><strong>Cestodes</strong></p>\n</td>\n<td>\n<p><strong>Trematodes</strong></p>\n</td>\n<td>\n<p><strong>Nematodes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Shape</p>\n</td>\n<td>\n<p>Tape-like, segmented</p>\n</td>\n<td>\n<p>Leaf-like unsegmented</p>\n</td>\n<td>\n<p>Elongated, cylindrical, unsegmented</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Head end</p>\n</td>\n<td>\n<p>Suckers are present, some have attached hooks</p>\n</td>\n<td>\n<p>Suckers are present but no hooks</p>\n</td>\n<td>\n<p>Hooks and suckers are absent. Well-developed buccal capsule with teeth or cutting plates are seen in some species</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alimentary canal</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Present but is incomplete, no anus</p>\n</td>\n<td>\n<p>Complete with anus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Body cavity</p>\n</td>\n<td>\n<p>Absent, but it is filled with spongy undifferentiated mesenchymal cells, in the midst of which lie the viscera</p>\n</td>\n<td>\n<p>Same as cestodes</p>\n</td>\n<td>\n<p>Present and known as pseudocele. Viscera remains suspended in the pseudocele</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sex</p>\n</td>\n<td>\n<p>Not separate: hermaphrodite (monecious)</p>\n</td>\n<td>\n<p>Not separate: hermaphrodite except Schistosoma</p>\n</td>\n<td>\n<p>Separate (diecious)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Life cycle</p>\n</td>\n<td>\n<p>Requires 2 host except Hymenolepis (1 host) and Diphyllobothrium (3 host)</p>\n</td>\n<td>\n<p>&nbsp;Requires 3 host except schistosoma (2 host)</p>\n</td>\n<td>\n<p>Requires 1 host except filarial worms</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(733, 'Microbiology', 'PM0659. Commonly known names of some important parasites', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>a. Trematodes</strong></p>\n<table>\n<tbody>\n<tr>\n<td width=\308\>\n<p><strong>Parasite</strong></p>\n</td>\n<td width=\308\>\n<p><strong>Common name</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Paragonimus westermani</em></p>\n</td>\n<td width=\308\>\n<p>Oriental lung fluke</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Fasciolopsis buski</em></p>\n</td>\n<td width=\308\>\n<p>Giant intestinal fluke</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Fasciola hepatica</em></p>\n</td>\n<td width=\308\>\n<p>Sheep liver fluke</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Clonorchis sinensis</em></p>\n</td>\n<td width=\308\>\n<p>Chinese liver fluke/oriental liver fluke</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Schistosoma japonicum</em></p>\n</td>\n<td width=\308\>\n<p>Oriental blood fluke</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>&nbsp;b.&nbsp;</strong><strong>Cestodes</strong></p>\n<table>\n<tbody>\n<tr>\n<td width=\308\>\n<p><strong>Parasite</strong></p>\n</td>\n<td width=\308\>\n<p><strong>Common name</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Taenia saginata</em></p>\n</td>\n<td width=\308\>\n<p>Beef tapeworm</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Diphyllobothrium latum</em></p>\n</td>\n<td width=\308\>\n<p>Fish tapeworm</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Taenia solium</em></p>\n</td>\n<td width=\308\>\n<p>Pork tapeworm</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Hymenolepis nana</em></p>\n</td>\n<td width=\308\>\n<p>Dwarf tapeworm</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Hymenolepis diminuta</em></p>\n</td>\n<td width=\308\>\n<p>Rat tapeworm</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Dipylidium caninum</em></p>\n</td>\n<td width=\308\>\n<p>Double-pored dog tapeworm</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>&nbsp;c.&nbsp;</strong><strong>Nematodes:</strong></p>\n<table>\n<tbody>\n<tr>\n<td width=\308\>\n<p><strong>Parasite</strong></p>\n</td>\n<td width=\308\>\n<p><strong>Common name</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Ascaris lumbricoides</em></p>\n</td>\n<td width=\308\>\n<p>Common roundworm</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Ancylostoma duodenale</em></p>\n</td>\n<td width=\308\>\n<p>Old world hookworm</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Necator americanus</em></p>\n</td>\n<td width=\308\>\n<p>American or new world hookworm</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Trichuris trichiura</em></p>\n</td>\n<td width=\308\>\n<p>Whipworm</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Enterobius vermicularis</em></p>\n</td>\n<td width=\308\>\n<p>Thread or pinworm</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p><em>Dracunculus medinensis</em></p>\n</td>\n<td width=\308\>\n<p>Guinea worm</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(734, 'Microbiology', 'PM0658. Skin tests for the diagnosis of parasitic infections', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Skin tests</strong> are performed by injecting parasitic antigen intradermally and observing the reaction. In immediate hypersensitivity reaction, wheal and flare response is seen within 30 minutes of injection, whereas in delayed type of hypersensitivity, erythema and induration are seen after 48 hours of injection.</p>\n<p>The table below shows some of the important skin tests used in the diagnosis of parasitic infections.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Skin test</strong></p>\n</td>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Casoni’s test</p>\n</td>\n<td>\n<p>Hydatid disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Montenegro test/Leishmanin test</p>\n</td>\n<td>\n<p>Kala-azar</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Frenkel’s test</p>\n</td>\n<td>\n<p>Toxoplasmosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fairley’s test</p>\n</td>\n<td>\n<p>Schistosomiasis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bachman test</p>\n</td>\n<td>\n<p>Trichinellosis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(735, 'Microbiology', 'PM0657. Important serological tests for the diagnosis of parasitic infections', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Serological tests</strong> are helpful for the detection and surveillance of many protozoal and helminthic infections.</p>\n<p>These tests are basically of 2 types:</p>\n<ul>\n<li>Tests for antigen detection</li>\n<li>Tests for antibody detection</li>\n</ul>\n<p><strong>Antigen Detection:</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Antigen</strong></p>\n</td>\n<td>\n<p><strong>Parasite</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Galactose lectin antigen</p>\n</td>\n<td>\n<p><em>Entamoeba histolytica</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Giardia-specific antigen 65</p>\n</td>\n<td>\n<p><em>Giardia lamblia</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>WKK and rk39 antigen</p>\n</td>\n<td>\n<p><em>Leishmania donovani</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HRP-2 antigen</p>\n</td>\n<td>\n<p><em>Plasmodium falciparum</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vivax-specific pLDH</p>\n</td>\n<td>\n<p><em>Plasmodium vivax</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>200 KD Ag and OG4C3 antigen</p>\n</td>\n<td>\n<p><em>Wuchereria bancrofti</em></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>Antibody detection:</strong></p>\n<ul>\n<li>Complement fixation test (CFT)</li>\n<li>Indirect hemagglutination test (IHA)</li>\n<li>Indirect immunofluorescent antibody test (IFA)</li>\n<li>Rapid immunochromatography test</li>\n<li>ELISA test</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(736, 'Microbiology', 'PM0656. Definitive and intermediate hosts of various parasites', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Parasite</strong></p>\n</td>\n<td>\n<p><strong>Definitive host</strong></p>\n</td>\n<td>\n<p><strong>Intermediate host</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Protozoa</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Plasmodium spp.</p>\n</td>\n<td>\n<p>Female Anopheles mosquito</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Babesia</p>\n</td>\n<td>\n<p>Tick</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Leishmania</p>\n</td>\n<td>\n<p>Man, dog</p>\n</td>\n<td>\n<p>Sandfly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trypanosoma brucei</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Tsetse fly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trypanosoma cruzi</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Triatomine bug</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Toxoplasma gondii</p>\n</td>\n<td>\n<p>Cat</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cestodes</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Taenia solium</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Pig</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Taenia saginata</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Cattle</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Echinococcus granulosus</p>\n</td>\n<td>\n<p>Dog</p>\n</td>\n<td>\n<p>Sheep, horses.</p>\n<p>Man is the accidental intermediate host.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Trematodes</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fasciola hepatica</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Snail</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fasciolopsis buski</p>\n</td>\n<td>\n<p>Man, pig</p>\n</td>\n<td>\n<p>Snail</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Schistosoma spp.</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Snail</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Nematodes</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trichinella spiralis</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Pig</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Wuchereria bancrofti</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Mosquito</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Brugia malayi</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Mosquito</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dracunculus medinensis</p>\n</td>\n<td>\n<p>Man</p>\n</td>\n<td>\n<p>Cyclops</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(737, 'Dermatology,', 'PM2069. Vaginal infections', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Bacterial vaginosis</strong></td>\n<td><strong>Trichomonas vaginitis</strong></td>\n<td>\n<p><strong>Candidal vaginitis</strong></p>\n</td>\n</tr>\n<tr>\n<td>Causative organism&nbsp;</td>\n<td>Altered vaginal flora- increased concentration of <strong><em>Gardnerella vaginalis</em></strong></td>\n<td><strong><em>Trichomonas vaginalis</em></strong></td>\n<td><strong><em>Candida albicans</em></strong></td>\n</tr>\n<tr>\n<td>Aetiology</td>\n<td>Increased vaginal pH</td>\n<td>Sexually transmitted</td>\n<td>Decreased immunity</td>\n</tr>\n<tr>\n<td>Sexual transmission</td>\n<td>No</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Discharge</td>\n<td>Fishy, thin, yellow</td>\n<td>Frothy, green</td>\n<td>Curdy, white</td>\n</tr>\n<tr>\n<td>Symptoms</td>\n<td>Fishy odour, no itching</td>\n<td>Itching and burning</td>\n<td>Itching, burning</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>&gt;4.5</td>\n<td>&gt;4.5</td>\n<td>&lt;4.5</td>\n</tr>\n<tr>\n<td>Speculum</td>\n<td>No vaginal epithelium inflammation</td>\n<td>Strawberry cervix</td>\n<td>Inflamed-epithelium</td>\n</tr>\n<tr>\n<td>KOH</td>\n<td>Positive Whiff test</td>\n<td>The whiff test can be positive.</td>\n<td>Pseudohyphae seen.</td>\n</tr>\n<tr>\n<td>Wet mount</td>\n<td>Clue cells. No WBCs seen</td>\n<td>Motile trichomaonads, WBCs seen</td>\n<td>WBCs seen</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>Metronidazole or Clindamycin</td>\n<td>Metronidazole, treat&nbsp;partner also</td>\n<td>Oral or vaginal azole, no need to treat partner.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(738, 'Medicine,', 'PM0660. Features of amoebic and bacillary dysentery', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Features</strong></p>\n</td>\n<td>\n<p><strong>Amoebic dysentery</strong></p>\n</td>\n<td>\n<p><strong>Bacillary dysentery</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\3\>\n<p><strong>Clinical</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Onset</p>\n</td>\n<td>\n<p>Slow</p>\n</td>\n<td>\n<p>Acute</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fever</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Toxicity</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Abdominal tenderness</p>\n</td>\n<td>\n<p>Localised</p>\n</td>\n<td>\n<p>Generalised</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tenesmus</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n</tr>\n<tr>\n<td colspan=\3\>\n<p><strong>Stool</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Frequency</p>\n</td>\n<td>\n<p>6–8 per day</p>\n</td>\n<td>\n<p>Over 10 per day</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Odor</p>\n</td>\n<td>\n<p>Offensive</p>\n</td>\n<td>\n<p>Nil</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Colour</p>\n</td>\n<td>\n<p>Dark red</p>\n</td>\n<td>\n<p>Bright red</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nature</p>\n</td>\n<td>\n<p>Feces mixed with blood and mucus</p>\n</td>\n<td>\n<p>Blood and mucus with little or no feces</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Consistency</p>\n</td>\n<td>\n<p>Not adherent</p>\n</td>\n<td>\n<p>Adherent to container</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reaction</p>\n</td>\n<td>\n<p>Acid</p>\n</td>\n<td>\n<p>Alkaline</p>\n</td>\n</tr>\n<tr>\n<td colspan=\3\>\n<p><strong>Microscopy</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cellular exudates</p>\n</td>\n<td>\n<p>Scanty</p>\n</td>\n<td>\n<p>Abundant</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Red blood cells</p>\n</td>\n<td>\n<p>Clumped, yellowish brown</p>\n</td>\n<td>\n<p>Discrete or in rouleaux, bright red</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Macrophages</p>\n</td>\n<td>\n<p>Few</p>\n</td>\n<td>\n<p>Several, some with ingested red blood cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Eosinophils</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Charcot-Leyden crystals</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Motile organisms</p>\n</td>\n<td>\n<p>Many motile amoeba</p>\n</td>\n<td>\n<p>Scanty, nonmotile (Shigella&nbsp;is a non motile bacteria)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Amoeba</p>\n</td>\n<td>\n<p>Motile trophozoites with ingested red blood cells</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(739, 'Dermatology,', 'PM0618. Skin rashes: 1st to 6th diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p>1<sup>st</sup> disease</p>\n</td>\n<td>\n<p>Measles</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2<sup>nd</sup> disease</p>\n</td>\n<td>\n<p>Scarlet fever</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3<sup>rd</sup> disease</p>\n</td>\n<td>\n<p>Rubella</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>4<sup>th</sup> disease</p>\n</td>\n<td>\n<p>Duke’s disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5<sup>th</sup> disease</p>\n</td>\n<td>\n<p>Erythema infectiosum</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>6<sup>th</sup> disease</p>\n</td>\n<td>\n<p>Roseola infantum</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(740, 'Microbiology', 'PM0106. Organisms and their transport media', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Organism</strong></td>\n<td><strong>Transport media</strong></td>\n</tr>\n<tr>\n<td>Streptococcus</td>\n<td>Pike’s media</td>\n</tr>\n<tr>\n<td>Neisseria</td>\n<td>Stuart media</td>\n</tr>\n<tr>\n<td>Shigella,&nbsp;Salmonella</td>\n<td>Cary Blair medium</td>\n</tr>\n<tr>\n<td>Vibrio cholera</td>\n<td>\n<p>Cary Blair medium</p>\n<p>Venkatraman–Ramakrishnan&nbsp;medium</p>\n<p>Autoclaved sea water</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(741, 'Microbiology', 'PM0001. Organisms and selective Culture Media', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Appropriate culture media for various bacteria:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Organism</strong></td>\n<td><strong>Medium for culture</strong></td>\n</tr>\n<tr>\n<td>Staph aureus</td>\n<td>Mannitol salt agar<br>ludlam’s medium<br>salt milk agar</td>\n</tr>\n<tr>\n<td>Strep. Pyogenes</td>\n<td>Crystal violet blood agar</td>\n</tr>\n<tr>\n<td>Neisseria meningitidis</td>\n<td>Thayer martin medium</td>\n</tr>\n<tr>\n<td>Corynebacterium</td>\n<td>Potassium tellurite agar<br>Tinsdale medium<br>Mcleod medium</td>\n</tr>\n<tr>\n<td>B.anthrax</td>\n<td>PLET medium</td>\n</tr>\n<tr>\n<td>B.cereus</td>\n<td>MYPA (Mannitol egg yolk phenol red polymyxin agar)<br>PEMBA(polymyxin in egg yolk mannitol bromothymol blue agar</td>\n</tr>\n<tr>\n<td>Clostridium&nbsp;</td>\n<td>CCFA ( cefoxitin cycloserine fructose agar)</td>\n</tr>\n<tr>\n<td>Shigella</td>\n<td>DCA, XLD, SSA</td>\n</tr>\n<tr>\n<td>Salmonella</td>\n<td>Wilson and Blair bismuth sulphite medium</td>\n</tr>\n<tr>\n<td>Vibrio</td>\n<td>TCBS<br>Monsur GTTA</td>\n</tr>\n<tr>\n<td>Pseudomonas</td>\n<td>Cetrimide agar</td>\n</tr>\n<tr>\n<td>B.pseudomallei</td>\n<td>Ashdown medium</td>\n</tr>\n<tr>\n<td>H. influenza</td>\n<td>Fildes agar <br>Levinthal medium</td>\n</tr>\n<tr>\n<td>Bordetella</td>\n<td>Bordet-Gengou glycerine potato blood agar</td>\n</tr>\n<tr>\n<td>Brucella</td>\n<td>Casteneda medium</td>\n</tr>\n<tr>\n<td>B.burgdorferi</td>\n<td>BSK medium</td>\n</tr>\n<tr>\n<td>Campylobacter</td>\n<td>\n<p>Skirrows, Butzlers and Campy BAP media</p>\n</td>\n</tr>\n<tr>\n<td>Legionella pneumophilia</td>\n<td>\n<p>BCYE medium</p>\n</td>\n</tr>\n<tr>\n<td>Leptospira</td>\n<td>EMJH medium&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(742, 'Pathology', 'PM2357. Types of calcifications', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Dystrophic calcification</strong></td>\n<td><strong>Metastatic calcification</strong></td>\n</tr>\n<tr>\n<td>Location</td>\n<td>Dead and dying tissues</td>\n<td>Normal interstitial tissues of the vasculature, kidneys, lungs, and gastric mucosa.</td>\n</tr>\n<tr>\n<td>Calcium metabolism</td>\n<td>Normal</td>\n<td>deranged causing hypercalcemia</td>\n</tr>\n<tr>\n<td>Examples</td>\n<td>\n<p>Calcific valvular stenosis</p>\n<p>Advanced Atheromatous plaque</p>\n<p>Monckeberg medial sclerosis</p>\n</td>\n<td>\n<p>Parathyroid tumors</p>\n<p>Hypercalcemia of malignancy</p>\n<p>Paget disease</p>\n<p>vitamin D intoxication</p>\n<p>Sarcoidosis</p>\n<p>Renal failure</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(743, 'Pathology', 'PM2356. Intracellular accumulations', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\326\>\n<tbody>\n<tr>\n<td>Substance accumulated</td>\n<td>Seen in</td>\n</tr>\n<tr>\n<td>\n<p>Cholesterol and cholesterol esters</p>\n</td>\n<td>\n<p>Atherosclerosis</p>\n<p>Xanthomas</p>\n<p>Cholesterolosis</p>\n<p>Niemann Pick disease type c</p>\n</td>\n</tr>\n<tr>\n<td>Mallory bodies(keratin filaments)</td>\n<td>\n<p>Alcoholic liver disease</p>\n<p>Morbid obesity</p>\n<p>Indian childhood cirrhosis</p>\n<p>Wilson’s disease</p>\n<p>Primary biliary cirrhosis</p>\n</td>\n</tr>\n<tr>\n<td>Lipofuscin</td>\n<td>Free radical injury</td>\n</tr>\n<tr>\n<td>Immunoglobulins</td>\n<td>Russel bodies and Dutcher bodies of multiple myeloma</td>\n</tr>\n<tr>\n<td>Melanin</td>\n<td>\n<p>Normal endocrine cells of the duodenal mucosa</p>\n<p>Carcinoid syndrome</p>\n<p>Alkaptonuria</p>\n</td>\n</tr>\n<tr>\n<td>Copper&nbsp;</td>\n<td>Wilson disease</td>\n</tr>\n<tr>\n<td>Hemosiderin</td>\n<td>Hemochromatosis</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(744, 'Pathology', 'PM2355. Types of granulomas', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>GRANULOMA</strong></td>\n<td><strong>SEEN IN</strong></td>\n</tr>\n<tr>\n<td>Noncaseating granuloma</td>\n<td>\n<p>Crohn’s disease</p>\n<p>Leprosy</p>\n<p>Sarcoidosis</p>\n<p>Hodgkin’s lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>Caseating granuloma</td>\n<td>\n<p>Tuberculosis</p>\n<p>Histoplasmosis</p>\n<p>Syphilis</p>\n<p>Coccidiomycosis</p>\n</td>\n</tr>\n<tr>\n<td>Foreign body granuloma</td>\n<td>\n<p>Silicosis</p>\n<p>Berylliosis</p>\n</td>\n</tr>\n<tr>\n<td>Immune granuloma</td>\n<td>\n<p>Wegener’s granulomatosis</p>\n<p>Giant cell arteritis</p>\n</td>\n</tr>\n<tr>\n<td>Durck’s granuloma</td>\n<td>Cerebral malaria</td>\n</tr>\n<tr>\n<td>Stellate granuloma</td>\n<td>Cat scratch disease</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(745, 'Pathology', 'PM2353. Types of giant cells', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Giant cells</strong></td>\n<td><strong>Seen in</strong></td>\n</tr>\n<tr>\n<td>Langhans giant cells</td>\n<td>TB Granuloma</td>\n</tr>\n<tr>\n<td>Reed Sternberg&nbsp;cells</td>\n<td>Hodgkin lymphoma</td>\n</tr>\n<tr>\n<td>Aschoff&nbsp;giant cells</td>\n<td>Rheumatic fever</td>\n</tr>\n<tr>\n<td>Touton giant cells</td>\n<td>\n<p>Juvenile xanthogranuloma,</p>\n<p>Xanthoma disseminatum,</p>\n<p>dermatofibroma</p>\n</td>\n</tr>\n<tr>\n<td>Warthin Finkeldey giant cells</td>\n<td>Measles</td>\n</tr>\n<tr>\n<td>Physiological giant cells</td>\n<td>Bone marrow osteoclast cells and megakaryocytes</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(746, 'Pathology', 'PM2265. Onion Skin Appearance in Pathology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Onion skin appearance:</p>\n<p>A&nbsp;pattern&nbsp;characterised&nbsp;by&nbsp;concentric&nbsp;laminations&nbsp;of&nbsp;differing&nbsp;radiologic&nbsp;or&nbsp;histologic&nbsp;densities. It is seen in:</p>\n<ol>\n<li><span class=\hvr\><strong>Primary sclerosing cholangitis</strong>: Onion skin fibrosis</span></li>\n<li><span class=\hvr\>Castleman disease: Onion skin appearance of Mantle zone lymphocytes</span></li>\n<li><span class=\hvr\><strong>Systemic lupus erythematosus</strong> (SLE): Onion skin lesions in spleen</span></li>\n<li><span class=\hvr\>Thrombotic thrombocytopenia purpura (TTP): Onion skinning of renal arteries and arterioles</span></li>\n<li><span class=\hvr\><strong>Ewing sarcoma</strong>: Laminated periosteal reaction (onion skin)</span></li>\n<li><span class=\hvr\><strong>Malignant hypertension</strong>: Onion skin lesion/ Hyperplastic arteriolitis</span></li>\n<li><span class=\hvr\>Tay–Sachs disease: Whorled arrangement (onion skin) of cytoplasmic inclusions within lysosomes of ganglion cells under electron microscopy</span></li>\n<li><span class=\hvr\>Lyme arthritis: Onion skin thickening of the arterial wall</span></li>\n<li><span class=\hvr\>Chronic inflammatory demyelinating polyneuropathy (CIDP) and Charcot–Marie–Tooth disease:&nbsp;Onion bulb formation of proliferated Schwann cells around the axon due to recurrent demyelination and remyelination</span></li>\n</ol></div><!---->\n      <!---->\n    </div><!---->'),
(747, 'Pathology', 'PM2227. Necrosis vs Apoptosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\page\ title=\Page 51\>\n<table><colgroup><col><col><col></colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Feature</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Necrosis</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Apoptosis</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Mechanism</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Enzymatic or ischemic process</p>\n<p>Passive process</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Genetically programmed cell death</p>\n<p>Active process</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>Physiologic or pathologic role</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Invariably <strong>pathologic</strong>&nbsp;</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Both physiologic and pathologic</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Cell size</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Enlarged (swelling)</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Reduced (<strong>shrinkage</strong>)</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Cells affected</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Group of cells</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Single cell death</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Nucleus</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Pyknosis →karyorrhexis →karyolysis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Fragmentation into nucleosome-size fragments</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Plasma membrane</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Disrupted</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Intact</strong>; altered structure</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Cellular contents</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Enzymatic digestion; may leak out of cell</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Intact</strong>; may be released in apoptotic bodies</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Inflammation</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Present</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Absent</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Marker</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>No marker</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Annexin V</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>PAGE (DNA electrophoresis)</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Smear pattern</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Step-ladder pattern</strong></p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(748, 'Pathology', 'PM2173. Pattern of nuclear body suggests the type of antibody present in patient’s serum.', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Five basic patterns of nuclear fluorescence is recognized for anti-nuclear antibodies:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Staining pattern</strong></td>\n<td><strong>Antigen</strong></td>\n</tr>\n<tr>\n<td>Homogenous or diffuse nuclear staining</td>\n<td>Antibodies to <strong>chromatin, histones, </strong>and occasionally<strong> double-stranded DNA</strong></td>\n</tr>\n<tr>\n<td>Rim or peripheral staining</td>\n<td>Antibodies <strong>to double-stranded DNA, </strong>and sometimes to <strong>nuclear envelope proteins</strong></td>\n</tr>\n<tr>\n<td>Speckled pattern</td>\n<td>\n<p>One of the most commonly observed patterns of fluorescence, the least specific.&nbsp;</p>\n<p>Antibodies to non-DNA nuclear constituents such as <strong>Sm antigen, ribonucleoprotein, and SS-A and SS-B reactive antigens</strong>.</p>\n</td>\n</tr>\n<tr>\n<td>Nucleolar pattern</td>\n<td>\n<p>Few discrete spots of fluorescence within the nucleus and represent&nbsp;<strong>antibodies to RNA</strong>.</p>\n<p><strong>Seen in systemic sclerosis.</strong></p>\n</td>\n</tr>\n<tr>\n<td>Centromeric pattern</td>\n<td>\n<p>Seen in systemic sclerosis</p>\n<p>Often contain antibodies specific for centromeres, which give rise to this pattern.</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/79cff1e8d6244910afe4f779bd0d86aax1280x4885.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(749, 'Pathology', 'PM2112. Tumor suppressor genes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\ width=\633\>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;Gene</strong></p>\n</td>\n<td>\n<p><strong>Mechanism</strong></p>\n</td>\n<td>\n<p><strong>Chromosome</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>TGF- Beta Receptor</p>\n<p>E-cadherin</p>\n</td>\n<td>\n<p>Growth inhibition&nbsp;</p>\n<p>Cell adhesion</p>\n</td>\n<td>\n<p>Chromosome 19</p>\n<p>Chromosome 16</p>\n</td>\n</tr>\n<tr>\n<td>NF1</td>\n<td>Inhibition of RAS signal transduction and of p21 cell cycle inhibitor</td>\n<td>Chromosome 17</td>\n</tr>\n<tr>\n<td>NF2</td>\n<td>Cytoskeletal instability</td>\n<td>Chromosome 22</td>\n</tr>\n<tr>\n<td>\n<p>APC/Beta-catenin</p>\n</td>\n<td>Inhibition of signal transduction</td>\n<td>Chromosome 5</td>\n</tr>\n<tr>\n<td>PTEN</td>\n<td>Pi3 kinase signal transduction</td>\n<td>Chromosome 10</td>\n</tr>\n<tr>\n<td>SMAD2 and SMAD4</td>\n<td>TGF- beta signal transduction</td>\n<td>Chromosome 18</td>\n</tr>\n<tr>\n<td>RB1</td>\n<td>Regulation of cell cycle</td>\n<td>Chromosome 13</td>\n</tr>\n<tr>\n<td>p53</td>\n<td>Cell cycle arrest and apoptosis in response to DNA damage</td>\n<td>Chromosome 17</td>\n</tr>\n<tr>\n<td>\n<p>WT1</p>\n<p>P16/INk4a</p>\n</td>\n<td>\n<p>Nuclear transcription</p>\n<p>Regulation of cell cycle by inhibition of cyclin dependent kinases</p>\n</td>\n<td>\n<p>Chromosome 11</p>\n<p>Chromosome 9</p>\n</td>\n</tr>\n<tr>\n<td>BRCA1 and BRCA2</td>\n<td>DNA repair</td>\n<td>Chromosome 17 and 13</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(750, 'Pathology', 'PM2061. Role of CK7 and CK20 Markers in Tumors of Unknown Primary', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Cytokeratin is an epithelial marker. A combination of CK7 and CK20 is used to identify the organ of origin.</p>\n<table width=\235\>\n<tbody>\n<tr>\n<td><strong>CK7</strong></td>\n<td><strong>CK20</strong></td>\n<td><strong>Common Cancers</strong></td>\n</tr>\n<tr>\n<td>+</td>\n<td>\n<p>-</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>Breast,</p>\n<p>Lung,</p>\n<p>Thyroid</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>-</td>\n<td>+</td>\n<td>Colorectal</td>\n</tr>\n<tr>\n<td>-</td>\n<td>-</td>\n<td>\n<p>&nbsp;</p>\n<p>Renal</p>\n<p>Prostate</p>\n<p>Hepatocellular</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(751, 'Paediatrics,', 'PM2055. Inheritance pattern of important diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table class=\t1\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>Autosomal dominant</strong></span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>Autosomal recessive</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>HEAV</strong>y<strong> DOMINANT</strong></span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>ABC DEF GHI</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>H</strong>: <strong>H</strong>ereditary spherocytosis, <strong>H</strong>ypercholesterolemia,&nbsp;<strong>H</strong>ypertrophic obstructive cardiomyopathy,&nbsp; <strong>H</strong>untington’s disease</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\>\n<div class=\p1\><span><strong>A</strong>: <strong>A</strong>taxia-telangiectasia,&nbsp;<strong>A</strong>lbinism, <strong>A</strong>lkaptonuria,&nbsp;</span></div>\n</div>\n<div class=\p1\><span><strong>A</strong>utosomal-recessive polycystic kidney disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>E</strong>: <strong>E</strong>hler-Danlos syndrome</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>B</strong>: <strong>B</strong>lood disorders like&nbsp;<strong>b</strong>eta-thalassemia and sickle-cell anemia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>A</strong>: <strong>A</strong>chondroplasia</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\>\n<div class=\p1\><span><strong>C</strong>: <strong>C</strong>ystic fibrosis,&nbsp;</span></div>\n</div>\n<div class=\p1\><span><strong>C</strong>ongenital adrenal hyperplasia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>V</strong>: <strong>V</strong>on Willebrand disease, Von Hippel Lindau disease</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>D</strong>: Sensorineural <strong>d</strong>eafness</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>D</strong>: <strong>D</strong>ystrophia myotonica</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\>\n<div class=\p1\><span><strong>E</strong>: <strong>E</strong>mphysema&nbsp;</span></div>\n</div>\n<div class=\p1\><span>(alpha1- antitrypsin deficiency)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>O</strong>: <strong>O</strong>steogenesis imperfecta,&nbsp;<strong>O</strong>tosclerosis (variable)</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>F</strong>: <strong>F</strong>riedrich ataxia</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>M</strong>: <strong>M</strong>arfans syndrome, Multiple endocrine neoplasias (MEN)</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>G</strong>: <strong>G</strong>aucher’s disease, <strong>G</strong>alactosemia, glycogen storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>I</strong>: <strong>I</strong>ntermittent porphyria</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>H</strong>: <strong>H</strong>omocystinuria, <strong>H</strong>emochromatosis</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>N</strong>: <strong>N</strong>eurofibromatosis 1 and 2</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>I</strong>: <strong>I</strong>nborn errors of metabolism- Phenylketonuria, lysosomal storage diseases</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\><span><strong>A</strong>: <strong>A</strong>utosomal-dominant polycystic kidney disease</span></td>\n<td class=\td1\ valign=\top\>Other conditions: Wilsons disease, sickle cell anemia, thalassemias, spinal muscular atrophy, Kartagener syndrome,&nbsp;</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\><span><strong>N</strong>: <strong>N</strong>oonans syndrome</span></td>\n<td class=\td1\ valign=\top\>Mucopolysaccharidoses (except Hunter syndrome)</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\><span><strong>T</strong>: <strong>T</strong>uberous sclerosis</span></td>\n<td class=\td1\ valign=\top\>Sphingolipidoses (except Fabry disease)</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\><span>Other conditions:<strong>&nbsp;</strong>Familial adenomatous polyposis, Hereditary hemorrhagic telangiectasia, Li-Fraumeni syndrome, Pseudohypoparathyroidism</span></td>\n<td class=\td1\ valign=\top\>&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table class=\t1\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>X-linked recessive</strong></span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>X-linked dominant</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>Lady Hardinge College Girls Don’t Care About Foolish Words</strong></span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span><strong>Red Rose </strong>for<strong> All Children</strong></span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\>\n<div class=\p1\><span>(<strong>L</strong>ady) <strong>L</strong>esch–Nyhan syndrome,&nbsp;<strong>L</strong>owe syndrome</span></div>\n</div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>(<strong>R</strong>ed) <strong>R</strong>ett’s syndrome</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>(<strong>H</strong>ardinge) <strong>H</strong>unters syndrome, <strong>H</strong>emophilia A and B</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>(<strong>R</strong>ose) <strong>R</strong>ickets</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>(<strong>C</strong>ollege) <strong>C</strong>hronic granulomatous disease</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div><span>(<strong>A</strong>ll) <strong>A</strong>lport syndrome&nbsp;(common inheritance pattern)</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>(<strong>G</strong>irls) <strong>G</strong>-6-PD deficiency</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>(<strong>C</strong>hildren) Type X <strong>C</strong>harcot–Marie–Tooth disease</span></div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>(<strong>D</strong>on’t) <strong>D</strong>uchenne muscular dystrophy, <strong>D</strong>iabetes insipidus</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p1\>&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>(<strong>C</strong>are) <strong>C</strong>olor blindness</span></div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p2\>&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\>\n<div class=\p1\><span>(<strong>A</strong>bout) <strong>A</strong>gammaglobulinemia,&nbsp;<strong>A</strong>lport syndrome, Ocular&nbsp;<strong>a</strong>lbinism</span></div>\n</div>\n</td>\n<td class=\td1\ valign=\top\>\n<div class=\p2\>&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>(Foolish)&nbsp;<strong>F</strong>abry disease</span></div>\n</td>\n<td class=\td1\ valign=\top\>&nbsp;</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\><span>(<strong>W</strong>ords) <strong>W</strong>iskott–Aldrich syndrome</span></div>\n</td>\n<td class=\td1\ valign=\top\>&nbsp;</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<div class=\p1\>\n<div class=\p1\><span>Other conditions: Menkes disease,&nbsp;</span>Ornithine transcarbamylase deficiency</div>\n</div>\n</td>\n<td class=\td1\ valign=\top\>&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p><span>&nbsp;</span></p></div><!---->\n      <!---->\n    </div><!---->'),
(752, 'Pathology', 'PM2020. Location of Important Genes on Chromosome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table class=\t1\ border=\1\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Gene</strong></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Chromosome</strong></p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><em>P73</em></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>1p</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Folate transporter</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>21q</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Neuroblastoma</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>1p</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Rhodopsin</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>3</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><em>VHL</em></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>3p</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><em>ADPKD-2</em></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>4q</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><em>APC</em></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>5q</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><em>MHC</em></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>6p</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><em>ARPKD</em></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>6</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Cystic fibrosis</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>7q</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><em>MET</em></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>7</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><em>RET</em></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>10</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><em>WT-1</em></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>11p</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><em>vWF</em></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>12</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Retinoblastoma</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>13q</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><em>BRCA_1</em></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>17q</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Fibrillin -1</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>15</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Fibrillin-2</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>5</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><em>BRCA-2</em></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>13q</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><em>NF-1</em></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>17q</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><em>P53</em></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>17</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Dystrophin</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Xp21.2</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><em>NF-2</em></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>22q</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(753, 'Pathology', 'PM1993. Mechanisms of Immune Evasion by Tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Tumors evade host immunity by the following mechanisms:</p>\n<ol>\n<li><strong>Selective outgrowth of tumor cells</strong> that do not express tumor antigens</li>\n<li><strong>Loss or reduced expression</strong> of <strong>MHC molecules</strong></li>\n<li>Upregulation of expression of factors like <strong>PD-L1 and PD-L2,</strong> which act on PD-1 receptors on T-cells and inhibit T-cell activation.</li>\n<li>Secretion of immunosuppressive factors like <strong>TGF</strong><strong>-β and</strong>&nbsp;<strong>galectin</strong></li>\n<li>Induction of<strong> immunosuppressive regulatory T cells</strong>, which could also contribute to immuno-evasion.</li>\n</ol></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/81b03c4a3cd44b26a44717cf2d7aa105x683x889.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><!---->'),
(754, 'Pathology', 'PM1992. Tumor antigens recognized by CD8+ T cells', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Antitumor activity</strong> is mediated predominantly by cell-mediated mechanisms. <strong>Tumor</strong> <strong>antigens</strong> are presented on the cell surface by <strong>MHC class I molecules</strong> and are recognized by <strong>CD8+ CTLs</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Tumor antigen class</strong></td>\n<td><strong>Examples</strong></td>\n</tr>\n<tr>\n<td>Products of mutated genes</td>\n<td>\n<p><strong>Oncogene products</strong>: mutated <em>RAS</em>, BCR/ABL fusion protein</p>\n<p><strong>Tumor suppressor gene</strong> <strong>products</strong>: mutated p53 protein</p>\n</td>\n</tr>\n<tr>\n<td>Over/aberrantly expressed cellular proteins</td>\n<td>\n<p><strong>Overexpressed</strong>: tyrosinase, gp100, MART in melanomas</p>\n<p><strong>Aberrantly expressed</strong>: cancer-testis antigens (MAGE, BAGE)</p>\n</td>\n</tr>\n<tr>\n<td>Tumor antigens produced by oncogenic viruses</td>\n<td>\n<p>Human papilloma virus&nbsp;proteins E6 and E7 in cervical carcinoma</p>\n<p>EBNA proteins in Epstein–Barr virus-induced -lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>Oncofetal antigens</td>\n<td>Carcinoembryonic antigen (CEA), α-fetoprotein (AFP).</td>\n</tr>\n<tr>\n<td>Altered cell surface glycolipids and glycoproteins</td>\n<td>\n<p><strong>CA-125, CA-19-9</strong> expressed on ovarian carcinomas.</p>\n<p><strong>MUC-1</strong> expressed in both ovarian and breast carcinomas</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(755, 'Pathology', 'PM1986. WHO classification of Lymphoid Neoplasms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\392\>\n<tbody>\n<tr>\n<td><strong>I. Precursor B-Cell Neoplasms</strong></td>\n</tr>\n<tr>\n<td>\n<p>B-cell acute lymphoblastic leukemia/lymphoma</p>\n<p>(B-ALL)</p>\n</td>\n</tr>\n<tr>\n<td><strong>II. Peripheral B-Cell Neoplasms</strong></td>\n</tr>\n<tr>\n<td>Chronic lymphocytic leukemia/small lymphocytic lymphoma<br>B-cell prolymphocytic leukemia<br>Lymphoplasmacytic lymphoma<br>Splenic and nodal marginal zone lymphomas<br>Extranodal marginal zone lymphoma<br>Mantle cell lymphoma<br>Follicular lymphoma<br>Marginal zone lymphoma<br>Hairy cell leukemia<br>Plasmacytoma/plasma cell myeloma<br>Diffuse large B-cell lymphoma<br>Burkitt lymphoma</td>\n</tr>\n<tr>\n<td><strong>III. Precursor T-Cell Neoplasms</strong></td>\n</tr>\n<tr>\n<td>\n<p>T-cell acute lymphoblastic leukemia/lymphoma</p>\n<p>(T-ALL)</p>\n</td>\n</tr>\n<tr>\n<td><strong>IV. Peripheral T-Cell and NK-Cell Neoplasms</strong></td>\n</tr>\n<tr>\n<td>T-cell prolymphocytic leukemia<br>Large granular lymphocytic leukemia<br>Mycosis fungoides/Sézary syndrome<br>Peripheral T-cell lymphoma, unspecified<br>Anaplastic large-cell lymphoma<br>Angioimmunoblastic T-cell lymphoma<br>Enteropathy-associated T-cell lymphoma<br>Panniculitis-like T-cell lymphoma<br>Hepatosplenic γδT-cell lymphoma<br>Adult T-cell leukemia/lymphoma<br>Extranodal NK/T-cell lymphoma<br>NK-cell leukemia</td>\n</tr>\n<tr>\n<td><strong>V. Hodgkin Lymphoma</strong></td>\n</tr>\n<tr>\n<td>Nodular sclerosis<br>Mixed cellularity<br>Lymphocyte-rich<br>Lymphocyte depletion<br>Lymphocyte predominance</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(756, 'Pathology', 'PM1970. Various actions of Principal Mediators of Inflammation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Histamine</td>\n<td>Vasodilation, increased vascular permeability, endothelial activation</td>\n</tr>\n<tr>\n<td>Prostaglandins</td>\n<td>Vasodilation, pain, fever</td>\n</tr>\n<tr>\n<td>Leukotrienes</td>\n<td>Increased vascular permeability, chemotaxis, leukocyte adhesion, and activation</td>\n</tr>\n<tr>\n<td>Cytokines (TNF, IL-1, IL-6)</td>\n<td>\n<p>Local: endothelial activation (expression of adhesion molecules).</p>\n<p>Systemic: fever, metabolic abnormalities, hypotension (shock)</p>\n</td>\n</tr>\n<tr>\n<td>Chemokines</td>\n<td>Chemotaxis, leukocyte activation</td>\n</tr>\n<tr>\n<td>Platelet-activating factor</td>\n<td>Vasoconstriction, Vasodilation (at low concentration), increased vascular permeability, leukocyte adhesion, chemotaxis, degranulation, oxidative burst</td>\n</tr>\n<tr>\n<td>Complement</td>\n<td>Leukocyte chemotaxis and activation, direct target killing (membrane attack complex), vasodilation (mast cell stimulation)</td>\n</tr>\n<tr>\n<td>Kinins</td>\n<td>Increased vascular permeability, smooth muscle contraction, vasodilation, pain</td>\n</tr>\n</tbody>\n</table>\n<p>Note: Thromboxane A2 (TXA2) is a prostaglandin, which is a potent <strong>vasoconstrictor</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(757, 'Pathology', 'PM1969. Principal Mediators of Inflammation and Their Source', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Mediator</strong></td>\n<td><strong>Source</strong></td>\n</tr>\n<tr>\n<td>Histamine</td>\n<td>Mast cells, basophils, platelets</td>\n</tr>\n<tr>\n<td>Prostaglandins</td>\n<td>Mast cells, leukocytes</td>\n</tr>\n<tr>\n<td>Leukotrienes</td>\n<td>Mast cells, leukocytes</td>\n</tr>\n<tr>\n<td>Cytokines (TNF, IL-1, IL-6)</td>\n<td>Macrophages, endothelial cells, mast cells</td>\n</tr>\n<tr>\n<td>Chemokines</td>\n<td>Leukocytes, activated macrophages</td>\n</tr>\n<tr>\n<td>Platelet-activating factor</td>\n<td>Leukocytes, mast cells</td>\n</tr>\n<tr>\n<td>Complement</td>\n<td>Plasma (produced in liver)</td>\n</tr>\n<tr>\n<td>Kinins</td>\n<td>Plasma (produced in liver)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(758, 'Pathology', 'PM1896. Mallory Bodies vs. Councilman Bodies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Mallory bodies</strong></td>\n<td><strong>Councilman bodies</strong></td>\n</tr>\n<tr>\n<td>Intra-cytoplasmic inclusions&nbsp;</td>\n<td>Acidophilic apoptotic bodies</td>\n</tr>\n<tr>\n<td>Due to aggregation of cytoskeletal intermediate filament</td>\n<td>&nbsp;Due to hepatocyte apoptosis&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 849\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Appears as clumped, amorphous, eosinophilic material within ballooned hepatocytes.</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Entire hepatocyte shrinks and appears as intense eosinophilic stained bodies</td>\n</tr>\n<tr>\n<td>\n<p>Seen in</p>\n<ul>\n<li>Alcoholic hepatitis</li>\n<li>Primary biliary cholangitis&nbsp;</li>\n<li>Alpha-1 antitrypsin deficiency</li>\n<li>Indian childhood cirrhosis</li>\n<li>Hepatocellular carcinoma&nbsp;</li>\n</ul>\n</td>\n<td>\n<p>Seen in &nbsp;</p>\n<ul>\n<li>Acute viral hepatitis</li>\n<li>Yellow fever</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Mallory bodies seen as clumped, amorphous eosinophilic material within ballooned hepatocytes</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c3995e141b2f4a5fb51f696160da37e3x1280x1539.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Councilman bodies where the entire cell is shrunken into intense eosinophilic apoptotic body</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e5db2e1403d1413ea08729154eb5cd37x1253x1026.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(759, 'Pathology,', 'PM1892. Pedigree chart for different inheritance patterns', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b04518e36bdd471daf76691dafd74139x1280x2969.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/195c2ef3907e4d8eac2c909799cbef3ex1280x2742.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(760, 'Pathology', 'PM1868. Immune Cell Antigens Detected by Monoclonal Antibodies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\456\>\n<tbody>\n<tr>\n<td><strong><span class=\TextRun SCXW86796565\ lang=\EN-GB\><span class=\NormalTextRun SCXW86796565\>Antigen</span></span><span class=\TextRun SCXW86796565\ lang=\EN-GB\><span class=\NormalTextRun SCXW86796565\>&nbsp;</span></span><span class=\TextRun SCXW86796565\ lang=\EN-GB\><span class=\NormalTextRun SCXW86796565\>Designation</span></span><span class=\TextRun SCXW86796565\ lang=\EN-GB\><span class=\NormalTextRun SCXW86796565\>&nbsp;and their&nbsp;</span></span><span class=\TextRun SCXW86796565\ lang=\EN-GB\><span class=\NormalTextRun SCXW86796565\>Normal Cellular Distribution</span></span><span class=\EOP SCXW86796565\>&nbsp;</span></strong></td>\n</tr>\n<tr>\n<td><strong><span class=\TextRun SCXW130168874\ lang=\EN-GB\><span class=\NormalTextRun SCXW130168874\>Primarily T-Cell Associated</span></span><span class=\EOP SCXW130168874\>&nbsp;</span></strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li aria-setsize=\-1\>CD1&nbsp;Thymocytes and Langerhans cells&nbsp;</li>\n<li aria-setsize=\-1\>CD3&nbsp;Thymocytes, mature T cells&nbsp;</li>\n<li aria-setsize=\-1\>CD4 Helper T cells, subset of thymocytes&nbsp;&nbsp;</li>\n<li aria-setsize=\-1\>CD5 T cells and a small subset of B cells&nbsp;&nbsp;</li>\n<li aria-setsize=\-1\>CD8 Cytotoxic T cells, subset of thymocytes, and some NK cells&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong><span class=\TextRun SCXW177769382\ lang=\EN-GB\><span class=\NormalTextRun SCXW177769382\>Primarily B-Cell Associated</span></span></strong><span class=\EOP SCXW177769382\>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li aria-setsize=\-1\>CD10 Pre-B cells and germinal-center B cells&nbsp;</li>\n<li aria-setsize=\-1\>CD19 Pre-B cells and mature B cells, but not plasma cells&nbsp;</li>\n<li aria-setsize=\-1\>CD20 Pre-B cells after CD19 and mature B cells, but not plasma cells&nbsp;</li>\n<li aria-setsize=\-1\>CD21 EBV receptor; mature B cells and follicular dendritic cells</li>\n</ul>\n<ul>\n<li aria-setsize=\-1\>CD23 Activated mature B cells&nbsp;</li>\n<li aria-setsize=\-1\>CD79a Marrow pre-B cells and mature B cells&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong><span class=\TextRun SCXW5554072\ lang=\EN-GB\><span class=\NormalTextRun SCXW5554072\>Primarily Monocyte or Macrophage Associated</span></span><span class=\EOP SCXW5554072\>&nbsp;</span></strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li aria-setsize=\-1\>CD11c Granulocytes, monocytes, and macrophages; also expressed&nbsp;by hairy cell leukemias&nbsp;</li>\n<li aria-setsize=\-1\>CD13 Immature and mature monocytes and granulocytes&nbsp;</li>\n<li aria-setsize=\-1\>CD14 Monocytes&nbsp;</li>\n<li aria-setsize=\-1\>CD15 Granulocytes; Reed-Sternberg cells and variants</li>\n<li aria-setsize=\-1\>CD33 Myeloid progenitors and monocytes&nbsp;&nbsp;</li>\n<li aria-setsize=\-1\>CD64 Mature myeloid cells&nbsp;&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong><span class=\TextRun SCXW245085851\ lang=\EN-GB\><span class=\NormalTextRun SCXW245085851\>Primarily NK-CellAssociated</span></span><span class=\EOP SCXW245085851\>&nbsp;</span></strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li aria-setsize=\-1\>CD16 NK cells and granulocytes&nbsp;&nbsp;</li>\n<li aria-setsize=\-1\>CD56 NK cells and a subset of T cells&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong><span class=\TextRun SCXW128063462\ lang=\EN-GB\><span class=\NormalTextRun SCXW128063462\>Primarily Stem Cell and Progenitor Cell Associated </span></span></strong><span class=\EOP SCXW128063462\>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li><span class=\TextRun SCXW128063462\ lang=\EN-GB\><span class=\NormalTextRun SCXW128063462\><span class=\TextRun SCXW257355501\ lang=\EN-GB\><span class=\NormalTextRun SCXW257355501\>CD34 Pluripotent hematopoietic stem cells and progenitor cells of many lineages</span></span><span class=\EOP SCXW257355501\>&nbsp;</span></span></span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong><span class=\TextRun SCXW128063462\ lang=\EN-GB\><span class=\NormalTextRun SCXW128063462\><span class=\TextRun SCXW237922357\ lang=\EN-GB\><span class=\NormalTextRun SCXW237922357\>Activation Markers</span></span><span class=\EOP SCXW237922357\>&nbsp;</span></span></span></strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li><span class=\TextRun SCXW128063462\ lang=\EN-GB\><span class=\NormalTextRun SCXW128063462\><span class=\TextRun SCXW58944318\ lang=\EN-GB\><span class=\NormalTextRun SCXW58944318\>CD30 Activated B cells, T cells, and monocytes; Reed-Sternberg cells and variants</span></span><span class=\EOP SCXW58944318\>&nbsp;</span></span></span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span class=\TextRun SCXW128063462\ lang=\EN-GB\><span class=\NormalTextRun SCXW128063462\><span class=\TextRun SCXW58944318\ lang=\EN-GB\><span class=\NormalTextRun SCXW58944318\><strong><span class=\TextRun SCXW110477194\ lang=\EN-GB\><span class=\NormalTextRun SCXW110477194\>Present on All Leukocytes</span></span></strong><span class=\EOP SCXW110477194\>&nbsp;</span></span></span></span></span></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li><span class=\TextRun SCXW128063462\ lang=\EN-GB\><span class=\NormalTextRun SCXW128063462\><span class=\TextRun SCXW121164674\ lang=\EN-GB\><span class=\NormalTextRun SCXW121164674\>CD45 All leukocytes; also known as leukocyte common antigen (LCA)</span></span><span class=\EOP SCXW121164674\>&nbsp;</span></span></span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(761, 'Pathology', 'PM1867. Anticoagulants in Vacutainers and their Uses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/208956b39e504182a7fab1330d186f3cx1280x2189.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(762, 'Pathology', 'PM1792. Cancer Predisposition Syndromes and Associated Genes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Syndrome </strong></td>\n<td><strong>Gene</strong></td>\n<td><strong>Chromosome</strong></td>\n<td><strong>Inheritance</strong></td>\n<td><strong>Tumors</strong></td>\n</tr>\n<tr>\n<td>Ataxia telangiectasia</td>\n<td>ATM</td>\n<td>11q22-q23</td>\n<td>AR</td>\n<td>Breast</td>\n</tr>\n<tr>\n<td>Bloom syndrome</td>\n<td>BLM</td>\n<td>15q26.1</td>\n<td>AR</td>\n<td>Several types</td>\n</tr>\n<tr>\n<td>Cowden syndrome</td>\n<td>PTEN</td>\n<td>10q23</td>\n<td>AD</td>\n<td>Breast, thyroid</td>\n</tr>\n<tr>\n<td>Autoimmune lymphoproliferative syndrome</td>\n<td>FASFASL&nbsp;</td>\n<td>10q24 1q23</td>\n<td>AD</td>\n<td>Lymphomas</td>\n</tr>\n<tr>\n<td>Familial adenomatous polyposis&nbsp;</td>\n<td>APC</td>\n<td>5q21</td>\n<td>AD</td>\n<td>Intestinal adenoma, colorectal</td>\n</tr>\n<tr>\n<td>Familial melanoma 1</td>\n<td>p16INK4</td>\n<td>9p2</td>\n<td>AD</td>\n<td>Melanoma, pancreatic</td>\n</tr>\n<tr>\n<td>Familial Wilms’ tumor</td>\n<td>WT1</td>\n<td>11p13</td>\n<td>AD</td>\n<td>Kidney (pediatric)</td>\n</tr>\n<tr>\n<td>Hereditary breast/ovarian cancer &nbsp;</td>\n<td>BRCA1BRCA2&nbsp;</td>\n<td>17q2113q12.3&nbsp;</td>\n<td>AD</td>\n<td>Breast, ovarian, colon, prostate</td>\n</tr>\n<tr>\n<td>Hereditary diffuse gastric cancer</td>\n<td>CDH1</td>\n<td>16q22</td>\n<td>AD</td>\n<td>Stomach</td>\n</tr>\n<tr>\n<td>Hereditary multiple exostoses</td>\n<td>EXT1EXT2&nbsp;</td>\n<td>8q2411p11-12&nbsp;</td>\n<td>AD</td>\n<td>Exostoses, chondrosarcoma</td>\n</tr>\n<tr>\n<td>Hereditary prostate cancer</td>\n<td>HPC1</td>\n<td>1q24-25</td>\n<td>AD</td>\n<td>Prostate</td>\n</tr>\n<tr>\n<td>Hereditary retinoblastoma</td>\n<td>RB1</td>\n<td>13q14.2</td>\n<td>AD</td>\n<td>Retinoblastoma, osteosarcoma</td>\n</tr>\n<tr>\n<td>Hereditary nonpolyposis colon cancer (HNPCC)&nbsp;</td>\n<td>MSH2MLH1MSH6PMS2&nbsp;</td>\n<td>2p163p21.32p167p22&nbsp;</td>\n<td>AD</td>\n<td>Colon, endometrial, ovarian, stomach, smallbowel, ureter carcinoma</td>\n</tr>\n<tr>\n<td>Hereditary papillary renal carcinoma&nbsp;</td>\n<td>MET</td>\n<td>7q31</td>\n<td>AD</td>\n<td>Papillary kidney</td>\n</tr>\n<tr>\n<td>Juvenile polyposis&nbsp;</td>\n<td>SMAD4</td>\n<td>18q21</td>\n<td>AD</td>\n<td>Gastrointestinal, pancreatic</td>\n</tr>\n<tr>\n<td>Li-Fraumeni</td>\n<td>TP53</td>\n<td>17p13.1</td>\n<td>AD</td>\n<td>Sarcoma, breast</td>\n</tr>\n<tr>\n<td>Multiple endocrine neoplasia type 1</td>\n<td>MEN1</td>\n<td>11q13</td>\n<td>AD</td>\n<td>Parathyroid, endocrine, pancreas, and pituitary</td>\n</tr>\n<tr>\n<td>Multiple endocrine neoplasia type 2a &nbsp;</td>\n<td>RET</td>\n<td>10q11.2</td>\n<td>AD</td>\n<td>Medullary thyroid carcinoma,pheochromocytoma</td>\n</tr>\n<tr>\n<td>Neurofibromatosis type 1 &nbsp;</td>\n<td>NF1</td>\n<td>17q11.2</td>\n<td>AD</td>\n<td>Neurofibroma, neurofibrosarcoma, brain</td>\n</tr>\n<tr>\n<td>Neurofibromatosis type 2</td>\n<td>NF2</td>\n<td>22q12.2</td>\n<td>AD</td>\n<td>Vestibular schwannoma, meningioma, spine</td>\n</tr>\n<tr>\n<td>Nevoid basal cell carcinoma syndrome(Gorlin’s syndrome)&nbsp;</td>\n<td>PTCH</td>\n<td>9q22.3</td>\n<td>AD</td>\n<td>Basal cell carcinoma, medulloblastoma,jaw cysts&nbsp;</td>\n</tr>\n<tr>\n<td>Tuberous sclerosis</td>\n<td>TSC1TSC2&nbsp;</td>\n<td>9q3416p13.3&nbsp;</td>\n<td>AD</td>\n<td>Angiofibroma, renal angiomyolipoma&nbsp;</td>\n</tr>\n<tr>\n<td>von Hippel–Lindau</td>\n<td>VHL</td>\n<td>3p25-26</td>\n<td>AD</td>\n<td>Kidney, cerebellum, pheochromocytoma</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(763, 'Pathology', 'PM1740. Pathological Named Bodies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Bodies</strong></td>\n<td><strong>Found in</strong></td>\n</tr>\n<tr>\n<td>Asteroid bodies</td>\n<td>Sarcoidosis, Sporotrichosis</td>\n</tr>\n<tr>\n<td>\n<p>Halberstaedter–Prowazek bodies</p>\n</td>\n<td>Trachoma&nbsp;</td>\n</tr>\n<tr>\n<td>Miyagawa bodies</td>\n<td>Lymphogranuloma venereum&nbsp;</td>\n</tr>\n<tr>\n<td>Levinthal–Cole–Lillie bodies</td>\n<td>Psittacosis</td>\n</tr>\n<tr>\n<td>Leishman–Donovan bodies</td>\n<td>Kala-azar&nbsp;</td>\n</tr>\n<tr>\n<td>Negri bodies</td>\n<td>Rabies</td>\n</tr>\n<tr>\n<td>Guarnieri bodies</td>\n<td>Vaccinia</td>\n</tr>\n<tr>\n<td>Bollinger bodies</td>\n<td>Fowl pox</td>\n</tr>\n<tr>\n<td>Henderson–Paterson bodies</td>\n<td>Molluscum contagiosum&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-A bodies</td>\n<td>Yellow fever, Herpes virus infection&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-B bodies</td>\n<td>Adenovirus, poliovirus</td>\n</tr>\n<tr>\n<td>Rusell bodies</td>\n<td>Multiple myeloma&nbsp;</td>\n</tr>\n<tr>\n<td>Aschoff bodies</td>\n<td>Rheumatic fever&nbsp;</td>\n</tr>\n<tr>\n<td>Call–Exner bodies</td>\n<td>Granulosa cell tumor of the&nbsp;ovary&nbsp;</td>\n</tr>\n<tr>\n<td>Civatte (colloid) bodies</td>\n<td>Lichen planus&nbsp;</td>\n</tr>\n<tr>\n<td>Michaelis–Gutmann bodies</td>\n<td>Malakoplakia&nbsp;</td>\n</tr>\n<tr>\n<td>Lewy bodies</td>\n<td>Parkinsons disease&nbsp;</td>\n</tr>\n<tr>\n<td>Pappenheimer bodies</td>\n<td>Non-heme iron pigments in siderocytes&nbsp;</td>\n</tr>\n<tr>\n<td>Howell–Jolly bodies</td>\n<td>Splenectomy, Megaloblastic Anemia, Hemolytic anemia&nbsp;</td>\n</tr>\n<tr>\n<td>Heinz bodies</td>\n<td>G-6-PD deficiency&nbsp;</td>\n</tr>\n<tr>\n<td>Gamna–Gandy bodies</td>\n<td>Congestive splenomegaly&nbsp;</td>\n</tr>\n<tr>\n<td>Mallory bodies</td>\n<td>Hyaline inclusions in hepatocytes seen in alcoholic cirrhosis, Indian childhood cirrhosis</td>\n</tr>\n<tr>\n<td>Councilman bodies</td>\n<td>Hepatocytes undergoing apoptosis,&nbsp;seen mainly in acute viral hepatitis.</td>\n</tr>\n<tr>\n<td>Psammoma bodies</td>\n<td>Dystrophic calcification in meningioma, papillary serous cystadenoma of ovary &amp; papillary carcinoma of thyroid, papillary type of renal cell carcinoma.</td>\n</tr>\n<tr>\n<td>Donovan bodies</td>\n<td>Granuloma inguinale&nbsp;</td>\n</tr>\n<tr>\n<td>Nissls bodies</td>\n<td>Cytoplasmic inclusions in neurons&nbsp;</td>\n</tr>\n<tr>\n<td>Mooser bodies</td>\n<td>Typhus fever</td>\n</tr>\n<tr>\n<td>Creola bodies</td>\n<td>Asthma&nbsp;</td>\n</tr>\n<tr>\n<td>Verocay bodies</td>\n<td>Schwannoma&nbsp;</td>\n</tr>\n<tr>\n<td>Schiller–Duval bodies</td>\n<td>Endodermal sinus tumor&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Hirano bodies</p>\n</td>\n<td>&nbsp;Alzheimer’s disease</td>\n</tr>\n<tr>\n<td>\n<p>Ferruginous bodies</p>\n</td>\n<td>Asbestosis&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(764, 'Pathology', 'PM1572. Defects in Leukocyte Function', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Leukocyte adhesion deficiency 1</p>\n</td>\n<td>\n<p>Mutations in β chain of CD11/CD18 integrins</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Leukocyte adhesion deficiency 2</p>\n</td>\n<td>\n<p>Mutations in fucosyltransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chediak–Higashi syndrome</p>\n</td>\n<td>\n<p>Decreased leukocyte functions because of mutations affecting protein involved in lysosomal membrane traffic (LYST)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic granulomatous disease</p>\n</td>\n<td>\n<p>Defect in gene encoding phagocyte oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Myeloperoxidase deficiency</p>\n</td>\n<td>\n<p>Decreased microbial killing because of defective MPO-H<sub>2</sub>O<sub>2</sub> system</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(765, 'Pathology', 'PM1571. Classification of Transplant Rejection Reactions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Hyperacute</strong>&nbsp;rejection<strong> (minutes to hours):</strong></p>\n<ul>\n<li class=\page\ title=\Page 246\>Mechanism:&nbsp;<strong>Antidonor antibodies</strong> present in the circulation of the recipient</li>\n<li class=\page\ title=\Page 246\>Histopathological findings:\n<ul>\n<li>Grossly, cyanotic and mottled graft with pale white areas</li>\n<li>Neutrophils accumulate</li>\n<li>Acute fibrinoid necrosis of vessel walls or complete occlusion by thrombi</li>\n</ul>\n</li>\n</ul>\n<p><strong>Acute</strong>&nbsp;rejection<strong> (days to weeks):</strong></p>\n<ol>\n<li class=\page\ title=\Page 246\>Acute<strong> cellular</strong> rejection (acute T cell-mediated rejection):&nbsp;&nbsp;\n<ul>\n<li class=\page\ title=\Page 246\>Mechanism:&nbsp;<strong>CD8+ CTLs</strong> directly destroy graft or <strong>CD4+</strong> cells secrete cytokines that damage graft.</li>\n<li class=\page\ title=\Page 246\>Histopathological findings:\n<ul>\n<li><strong>Tubulointerstitial pattern (type I):</strong> extensive interstitial and tubular inflammation associated with focal tubular injury</li>\n<li><strong>Vascular pattern </strong>- Inflammation (type II) and necrosis (type III): <strong>Endotheliitis</strong> (swollen endothelial cells with lymphocytes between endothelium and vessel wall)</li>\n</ul>\n</li>\n</ul>\n</li>\n<li>Acute<strong> antibody-mediated</strong> (humoral) rejection:&nbsp;\n<ul>\n<li class=\page\ title=\Page 246\>Mechanism: antibodies bind to endothelium and activate complement causing damage and graft failure</li>\n<li class=\page\ title=\Page 246\>Histopathological findings:\n<ul>\n<li>Inflammation of glomeruli and peritubular capillaries.</li>\n<li>Activation of the antibody-dependent classical complement pathway.</li>\n<li>Focal thrombosis in small vessels.&nbsp;</li>\n</ul>\n</li>\n</ul>\n</li>\n</ol>\n<p><strong>Chronic</strong>&nbsp;rejection<strong> (months to years):</strong></p>\n<ul>\n<li class=\page\ title=\Page 246\>Mechanism:&nbsp;<strong>T-cells</strong> react against alloantigens and secrete cytokines which stimulate <strong>fibroblasts</strong> and <strong>vascular smooth muscle cells</strong> (graft arteriosclerosis). Chronic rejection may also be <strong>antibody-mediated</strong>.</li>\n<li class=\page\ title=\Page 246\>Histopathological findings:\n<ul>\n<li>Predominantly vascular changes (intimal thickening and vascular occlusion)</li>\n<li>Glomerulopathy with duplication of basement membrane</li>\n<li>Interstitial fibrosis and tubular atrophy with loss of renal parenchyma</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(766, 'Pathology', 'PM1566. Staining Patterns of Antinuclear Antibodies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Staining pattern</td>\n<td>Antigen</td>\n</tr>\n<tr>\n<td>Homogenous or diffuse nuclear staining</td>\n<td>Antibodies to <strong>chromatin, histones, and, occasionally, double-stranded DNA</strong></td>\n</tr>\n<tr>\n<td>Rim or peripheral staining</td>\n<td>Antibodies <strong>to double-stranded DNA and, sometimes, to nuclear envelope proteins</strong></td>\n</tr>\n<tr>\n<td>Speckled pattern</td>\n<td>\n<p>One of the most commonly observed patterns of fluorescence, the least specific.&nbsp;</p>\n<p>Antibodies to non-DNA nuclear constituents such as <strong>Sm antigen, ribonucleoprotein, and SS-A and SS-B reactive antigens</strong>.</p>\n</td>\n</tr>\n<tr>\n<td>Nucleolar pattern</td>\n<td>\n<p>Few discrete spots of fluorescence within the nucleus and represent&nbsp;<strong>antibodies to RNA</strong>.</p>\n<p><strong>Seen in systemic sclerosis.</strong></p>\n</td>\n</tr>\n<tr>\n<td>Centromeric pattern</td>\n<td>\n<p>Seen in systemic scleroisis</p>\n<p>Often contain antibodies specific for centromeres, which give rise to this pattern.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3325c7c0883f4d26b5d9bfe137cc1ef3x418x262.PNG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/92f4b5c8c24d4479a80293425d9af6f1x418x287.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(767, 'Pathology', 'PM1562. Non–HLA Genes Associated with Autoimmune Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Gene involved</strong></p>\n</td>\n<td width=\243\>\n<p><strong>Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>FOXP3</strong></p>\n</td>\n<td width=\243\>\n<p>IPEX (an acronym for immune dysregulation, polyendocrinopathy, enteropathy, X-linked).</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>AIRE</strong></p>\n</td>\n<td width=\243\>\n<p>Autoimmune polyendocrinopathy syndrome type 1 (APS-1).</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>PTPN22</strong></p>\n</td>\n<td width=\243\>\n<p>Rheumatoid arthritis</p>\n<p>Type I DM</p>\n<p>IBD</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>IL23R</strong></p>\n</td>\n<td width=\243\>\n<p>IBD</p>\n<p>Psoriasis</p>\n<p>Ankylosing spondylitis</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>CTLA4</strong></p>\n</td>\n<td width=\243\>\n<p>Rheumatoid arthritis</p>\n<p>Type I Diabetes mellitus</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>L2RA</strong></p>\n</td>\n<td width=\243\>\n<p>Type I Diabetes mellitus</p>\n<p>Multiple sclerosis</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>NOD2</strong></p>\n<p><strong>ATG16</strong></p>\n</td>\n<td width=\243\>\n<p>Inflammatory bowel disease (IBD)&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>IRF5, IFIH1</strong></p>\n</td>\n<td width=\243\>\n<p>Systemic lupus erythematosus (SLE)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(768, 'Pathology', 'PM1553. HLA association with diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Autoimmune Gut and Skin</strong> <strong>Diseases and HLA associations</strong></td>\n</tr>\n<tr>\n<td>Gluten-sensitive enteropathy (celiac disease)</td>\n<td>DQ2 , DQ8</td>\n</tr>\n<tr>\n<td>Chronic active hepatitis</td>\n<td>DR3</td>\n</tr>\n<tr>\n<td>Dermatitis herpetiformis</td>\n<td>DR3</td>\n</tr>\n<tr>\n<td>SLE(white)</td>\n<td>DR3</td>\n</tr>\n<tr>\n<td>Sjogren’s syndrome</td>\n<td>DR3</td>\n</tr>\n<tr>\n<td>Psoriasis vulgaris</td>\n<td>Cw6</td>\n</tr>\n<tr>\n<td>Pemphigus vulgaris</td>\n<td>DR4, DQ1</td>\n</tr>\n<tr>\n<td>Bullous pemphigoid variant</td>\n<td>DQ7</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Autoimmune Endocrine</strong> <strong>Diseases and HLA associations</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Type 1 diabetes mellitus</td>\n<td>DQ8, DR4, DR3, DR2</td>\n</tr>\n<tr>\n<td>Hyperthyroidism (Graves’)</td>\n<td>B8, DR3</td>\n</tr>\n<tr>\n<td>Hyperthyroidism (Japanese)</td>\n<td>B35</td>\n</tr>\n<tr>\n<td>Adrenal insufficiency</td>\n<td>DR3</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Autoimmune Neurologic</strong> <strong>Diseases and HLA associations</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Myasthenia gravis</td>\n<td>B8</td>\n</tr>\n<tr>\n<td>Multiple sclerosis</td>\n<td>B16, DR2</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Other Important Diseases and their HLA Associations</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Ankylosing Spondylitis</p>\n</td>\n<td>B27</td>\n</tr>\n<tr>\n<td>\n<p>Reactive Arthritis</p>\n</td>\n<td>B27</td>\n</tr>\n<tr>\n<td>\n<p>Psoriatic Arthritis</p>\n</td>\n<td>B27</td>\n</tr>\n<tr>\n<td>Behcet’s disease</td>\n<td>B51</td>\n</tr>\n<tr>\n<td>Congenital adrenal hyperplasia</td>\n<td>B47</td>\n</tr>\n<tr>\n<td>Narcolepsy</td>\n<td>DR2 (<strong>DQB1*06:02)</strong></td>\n</tr>\n<tr>\n<td>Goodpasture’s syndrome (anti-GBM)</td>\n<td>DR2</td>\n</tr>\n<tr>\n<td>Abacavir hypersensitivity</td>\n<td>B57 <strong>(</strong><strong>B*57:01)</strong></td>\n</tr>\n<tr>\n<td>Hemochromatosis</td>\n<td>A3</td>\n</tr>\n<tr>\n<td>Narcolepsy</td>\n<td>Q1</td>\n</tr>\n<tr>\n<td>Rheumatoid arthritis</td>\n<td>DR4</td>\n</tr>\n<tr>\n<td>\n<p>Pernicious anemia</p>\n</td>\n<td>DR5&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;Hashimoto thyroiditis</td>\n<td>DR3, DR5</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(769, 'Pathology', 'PM1546. Innate and Adaptive Immunity', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Innate immunity</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Adaptive immunity</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Immediate maximal response</p>\n</td>\n<td width=\231\>\n<p>Lag phase between exposure and maximal response</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Non-specific</p>\n</td>\n<td width=\231\>\n<p>Highly pathogen-specific</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Limited diversity</p>\n</td>\n<td width=\231\>\n<p>Extensively diverse</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>No memory</p>\n</td>\n<td width=\231\>\n<p>Memory present</p>\n<p>Subsequent exposure → Amplified response</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Receptors: Pattern-recognition receptors</p>\n</td>\n<td width=\231\>\n<p>Receptors: T-cell and B-cell receptors</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(770, 'Pathology', 'PM0956. Classification of Vascular Tumors and Tumor-like Conditions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\303\>\n<p><strong>Benign Neoplasms, Developmental and Acquired Conditions</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\303\>\n<ul>\n<li><strong>Hemangioma</strong>\n<ul>\n<li>Capillary hemangioma</li>\n</ul>\n<ul>\n<li>Cavernous hemangioma</li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\303\>\n<ul>\n<li><strong>Pyogenic granuloma</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\303\>\n<ul>\n<li><strong>Lymphangioma</strong>\n<ul>\n<li>Simple/capillary lymphangioma</li>\n<li>Cavernous lymphangioma (cystic hygroma)</li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\303\>\n<ul>\n<li><strong>Glomus tumor</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\303\>\n<ul>\n<li><strong>Vascular ectasias</strong>\n<ul>\n<li>Nevus flammeus</li>\n<li>Spider telangiectasia (arterial spider)</li>\n<li>Hereditary hemorrhagic telangiectasis (Osler–Weber–Rendu disease)</li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\303\>\n<ul>\n<li><strong>Reactive vascular proliferation</strong>\n<ul>\n<li>Bacillary angiomatosis</li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\303\>\n<p><strong>Intermediate-grade Neoplasms</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\303\>\n<ul>\n<li>Kaposi sarcoma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\303\>\n<ul>\n<li>Hemangioendothelioma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\303\>\n<p><strong>Malignant Neoplasm</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\303\>\n<ul>\n<li>Angiosarcoma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\303\>\n<ul>\n<li>Hemangiopericytoma</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(771, 'Pathology', 'PM0806. Named Cells in Histopathology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Named cells</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Condition</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Anitschkow or caterpillar cells</p>\n</td>\n<td width=\231\>\n<p>Rheumatic heart disease</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Globoid cells</p>\n</td>\n<td width=\231\>\n<p>Krabbe disease</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Kulchitsky cells</p>\n</td>\n<td width=\231\>\n<p>Small cell carcinoma of lung</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Signet ring cells</p>\n</td>\n<td width=\231\>\n<p>Signet ring cell carcinoma</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Crumpled tissue paper macrophages</p>\n</td>\n<td width=\231\>\n<p>Gauchers disease</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Clue cells</p>\n</td>\n<td width=\231\>\n<p>Bacterial vaginosis</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Fried egg cells</p>\n</td>\n<td width=\231\>\n<p>Oligodendroglioma</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Hallmark cells</p>\n</td>\n<td width=\231\>\n<p>Anaplastic large cell lymphoma</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Shadow cells</p>\n</td>\n<td width=\231\>\n<p>Pilomatricoma</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Mott cells</p>\n</td>\n<td width=\231\>\n<p>Plasma cell myeloma</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Lepidic cells</p>\n</td>\n<td width=\231\>\n<p>Cardiac myxoma</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Spider cells</p>\n</td>\n<td width=\231\>\n<p>Rhabdomyoma</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(772, 'Pathology', 'PM0692. Biochemical Forms of Amyloid and Associated Clinical Conditions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Clinicopathological category</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Biochemical form of amyloid</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>Systemic amyloidosis</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Immunocyte dyscrasias with amyloidosis (primary amyloidosis)</p>\n</td>\n<td width=\231\>\n<p>AL</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Reactive systemic amyloidosis (secondary amyloidosis)</p>\n</td>\n<td width=\231\>\n<p>AA</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Hemodialysis-associated amyloidosis</p>\n</td>\n<td width=\231\>\n<p>Aβ2m</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>Hereditary amyloidosis</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Familial Mediterranean fever</p>\n</td>\n<td width=\231\>\n<p>AA</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Familial amyloidotic neuropathies</p>\n</td>\n<td width=\231\>\n<p>ATTR</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Systemic senile amyloidosis</p>\n</td>\n<td width=\231\>\n<p>ATTR</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>Localised</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Senile cerebral</p>\n</td>\n<td width=\231\>\n<p>Aβ</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Medullary carcinoma of thyroid</p>\n</td>\n<td width=\231\>\n<p>A Cal</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Islets of Langerhans</p>\n</td>\n<td width=\231\>\n<p>AIAPP</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Isolated atrial amyloidosis</p>\n</td>\n<td width=\231\>\n<p>AANF</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(773, 'Pathology', 'PM0673. Immune Cell Antigens Detected by Monoclonal Antibodies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Immune cells</strong></p>\n</td>\n<td>\n<p><strong>Antigens associated</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T-cell</p>\n</td>\n<td>\n<p>CD1, CD3, CD4, CD5, CD8</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B-cell</p>\n</td>\n<td>\n<p>CD10, CD19, CD20, CD21, CD23, CD79a</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Monocyte or macrophage</p>\n</td>\n<td>\n<p>CD11c, CD13, CD14, CD15, CD33, CD64</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NK-cell</p>\n</td>\n<td>\n<p>CD16, CD56</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hematopoietic stem cells</p>\n</td>\n<td>\n<p>CD34</p>\n</td>\n</tr>\n<tr>\n<td>Leukocyte common antigen</td>\n<td>CD45</td>\n</tr>\n<tr>\n<td>Activated B cells, T cells, monocytes, and Reed-Sternberg cells</td>\n<td>CD30</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(774, 'Pathology', 'PM0473. Various Banding Techniques and stains used in Karyotyping', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The following are the banding techniques and stains used in cytogenetics to produce a visible karyotype by staining condensed chromosomes.</p>\n<table>\n<tbody>\n<tr>\n<td>Banding type</td>\n<td>Staining method</td>\n</tr>\n<tr>\n<td>G-banding (Most common)</td>\n<td>Giemsa stain</td>\n</tr>\n<tr>\n<td>C-banding</td>\n<td>constitutive heterochromatin</td>\n</tr>\n<tr>\n<td>Q-banding</td>\n<td>quinacrine</td>\n</tr>\n<tr>\n<td>R-banding</td>\n<td>reverse Giemsa staining</td>\n</tr>\n<tr>\n<td>T-banding</td>\n<td>telomeric</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(775, 'Surgery,', 'PM0470. Cytokines', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Interleukins</strong></td>\n<td><strong>Main sources</strong></td>\n</tr>\n<tr>\n<td>IL-1 (α and β)</td>\n<td>Macrophages and other cell types</td>\n</tr>\n<tr>\n<td>IL-2</td>\n<td>T cells</td>\n</tr>\n<tr>\n<td>IL-3</td>\n<td>T cells</td>\n</tr>\n<tr>\n<td>IL-4</td>\n<td>T<sub>H&nbsp;</sub>cells</td>\n</tr>\n<tr>\n<td>IL-5</td>\n<td>T<sub>H&nbsp;</sub>cells</td>\n</tr>\n<tr>\n<td>IL-6</td>\n<td>T<sub>H</sub>, macrophages, fibroblasts</td>\n</tr>\n<tr>\n<td>IL-8</td>\n<td>Macrophages, others</td>\n</tr>\n<tr>\n<td>IL-10</td>\n<td>T, B cells, macrophages</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Pro-inflammatory cytokines:&nbsp;</strong></p>\n<ul>\n<li><strong>IL-1: </strong>i<span class=\fontstyle0\>nduces inﬂammation, fever, and sepsis, activates TNF-</span><span class=\fontstyle2\>α; p</span>roliferation and differentiation of T, B, and other cells; bone marrow cell proliferation</li>\n<li><strong>IL-2: </strong>promote growth and differentiation of T and B cells; cytotoxicity of T and NK cells; secretion of other lymphokines</li>\n<li><strong>IL-6: </strong>promote B cell stimulation &amp; differentiation;<span class=\fontstyle0\>&nbsp;mediator of acute phase reactions;&nbsp;</span>IgG production</li>\n<li><strong>IL-8:</strong>&nbsp;attracts and activates neutrophils in inflammatory regions; neutrophil chemotaxis</li>\n<li><strong><strong><strong>IFN-α</strong></strong></strong><strong>:</strong>&nbsp;a<span class=\fontstyle0\>ntiviral, immunoregulatory (enhance MHC class I, NK-cell activity),&nbsp;antiproliferative</span></li>\n<li><strong>TNF-α: </strong>a<span class=\fontstyle0\>ctivate macrophages and cytotoxic cells, induce cachexia, acute phase&nbsp;proteins, cytokines such as IL-1 and IL-6</span></li>\n</ul>\n<p><strong>Anti-inflammatory cytokines:&nbsp;</strong></p>\n<ul>\n<li>IL-4: proliferation of B and cytotoxic cells; increases IgG1 and IgE production; enhances MHC-class II receptor</li>\n<li><strong>IL-10:</strong>&nbsp;i<span class=\fontstyle0\>nhibits IFN-</span><span class=\fontstyle2\>γ </span><span class=\fontstyle0\>and IL-12 production; inhibits</span>&nbsp;IFN production and mononuclear cell functions</li>\n<li>IL-13</li>\n</ul>\n<p><strong>Acute inflammation and sepsis:&nbsp;</strong></p>\n<ul>\n<li>TNF-α</li>\n<li>IL-1</li>\n</ul>\n<p><strong>Special Cytokines:&nbsp;</strong></p>\n<ol>\n<li><strong>IFN-γ:&nbsp;</strong>\n<ul>\n<li>Granuloma formation</li>\n<li><span class=\fontstyle0\>Antiviral</span></li>\n<li><span class=\fontstyle0\>Immunoregulatory (enhances MHC classes I and II and macrophage&nbsp;activation)</span></li>\n<li><span class=\fontstyle0\>Antiproliferative</span></li>\n</ul>\n</li>\n<li><strong>TGF-</strong><strong>β:&nbsp;</strong>\n<ul>\n<li>Fibrosis&nbsp;</li>\n<li><span class=\fontstyle0\>Activate macrophages</span></li>\n</ul>\n</li>\n<li><strong>VEGF: </strong>\n<ul>\n<li>promotes angiogenesis&nbsp;</li>\n</ul>\n</li>\n</ol>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(776, 'Pathology', 'PM0410. Functions of Complement', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/61ef4ad6c59b4001beb2223b04b3ba29x498x600.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Inflammation:</strong>&nbsp;C3a, C5a, and, to a lesser extent, C4a are called anaphylatoxins.</li>\n<li>C5a is also a chemotactic agent.</li>\n<li><strong>Opsonization and phagocytosis:</strong>&nbsp;C3b and its cleavage product iC3b (inactive C3b) act as opsonins and promote phagocytosis by neutrophils and macrophages.</li>\n<li><strong>Cell lysis</strong></li>\n</ul>\n<p>This role of complement is important mainly for the killing of microbes with thin cell walls, such as <em>Neisseria </em>species, and deficiency of the terminal components of complement predisposes to <em>Neisseria </em>infections.</p></div><!---->\n      <!---->\n    </div><!---->'),
(777, 'Pathology', 'PM0394. Factors Influencing Healing', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Infection:</strong>&nbsp;one of the most important causes of delay in healing; prolongs inflammation; increases the local tissue injury</li>\n<li><strong>Diabetes:&nbsp;</strong>most important systemic cause of abnormal wound healing</li>\n<li><strong>Nutritional status:&nbsp;</strong>protein deficiency and vitamin C deficiency inhibit collagen synthesis and retard healing.</li>\n<li><strong>Glucocorticoids (steroids):</strong>&nbsp;anti-inflammatory effects; results in weakness of the scar due to inhibition of TGF-β production and diminished fibrosis</li>\n<li><strong>Mechanical factors: </strong>such as&nbsp;increased local pressure or torsion; may cause wounds to pull apart or dehisce</li>\n<li><strong>Poor perfusion:&nbsp;</strong>due to arteriosclerosis, diabetes, or obstructed venous drainage; also impairs healing</li>\n<li><strong>Foreign bodies:&nbsp;</strong>such as fragments of steel, glass, or even bone; impede healing</li>\n<li><strong>Type and extent of tissue injury:&nbsp;</strong>affect subsequent repair;</li>\n<li><strong>Location of the injury </strong>and the <strong>character</strong> of the injured<strong> tissue:</strong>&nbsp;also important</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(778, 'Pathology', 'PM0393. Acute phase reactants and their functions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\>\n<p><strong>\Positive\ acute-phase proteins:</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Protein</strong></p>\n</td>\n<td>\n<p><strong>Immune system&nbsp;function</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>C-reactive protein</strong></p>\n</td>\n<td>\n<p>Opsonin&nbsp;on microbes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Serum amyloid P component</strong></p>\n</td>\n<td>\n<p>Opsonin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Serum amyloid A</strong></p>\n</td>\n<td>\n<p>Recruitment of immune cells to inflammatory sites</p>\n<p>Induction of enzymes that degrade extracellular matrix</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Complement factors</strong></p>\n</td>\n<td>\n<p>Opsonization, lysis, and clumping of target cells; Chemotaxis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mannan-binding lectin</strong></p>\n</td>\n<td>\n<p>Mannan-binding lectin pathway of complement activation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Fibrinogen,&nbsp;prothrombin, factor VIII,<br>von Willebrand factor</strong></p>\n</td>\n<td>\n<p>Coagulation factors, trapping invading microbes in blood clots.<br>Some cause chemotaxis, Fibrinogen binds to red cells and induce rouleaux formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Plasminogen activator inhibitor-1 (PAI-1)</strong></p>\n</td>\n<td>\n<p>Prevents the degradation of blood clots by inhibiting plasminogen&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Alpha 2-macroglobulin</strong></p>\n</td>\n<td>\n<p>Inhibitor of coagulation by inhibiting thrombin</p>\n<p>Inhibitor of fibrinolysis by inhibiting plasmin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Ferritin</strong></p>\n</td>\n<td>\n<p>Binding iron, inhibiting microbe iron uptake</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hepcidin</strong></p>\n</td>\n<td>\n<p>Stimulates the internalization of ferroportin, preventing release of iron bound by ferritin within intestinal enterocytes and macrophages</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Ceruloplasmin</strong></p>\n</td>\n<td>\n<p>Oxidizes iron, facilitating for ferritin, inhibiting microbe iron uptake</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Haptoglobin</strong></p>\n</td>\n<td>\n<p>Binds hemoglobin, inhibiting microbe iron uptake</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Orosomucoid</strong><strong><br> </strong><strong>(Alpha-1-acid glycoprotein, AGP)</strong></p>\n</td>\n<td>\n<p>Steroid carrier</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Alpha 1-antitrypsin</strong></p>\n</td>\n<td>\n<p>Serpin, downregulates inflammation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Alpha 1-antichymotrypsin</strong></p>\n</td>\n<td>\n<p>Serpin, downregulates inflammation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Thrombopoietin</strong></p>\n</td>\n<td>\n<p>Thrombocytosis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(779, 'Pathology', 'PM0389. Selectins and Associated Ligands', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\150\>\n<p><strong>Molecule</strong></p>\n</td>\n<td width=\150\>\n<p><strong>Distribution</strong></p>\n</td>\n<td width=\150\>\n<p><strong>Ligand</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>L- selectin (CD62L)</p>\n</td>\n<td width=\150\>\n<p>Neutrophils, monocytes</p>\n<p>T cells (naïve and central memory)</p>\n<p>B cells (naïve)</p>\n</td>\n<td width=\150\>\n<p>Sialyl–Lewis X/PNAd on GlyCAM-1, CD34, MAdCAM-1 Others; expressed on endothelium (HEV)</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>E- selectin (CD62E)</p>\n</td>\n<td width=\150\>\n<p>Endothelium activated by cytokines (TNF, IL-1</p>\n</td>\n<td width=\150\>\n<p>Sialyl–Lewis X (e.g., CLA) on glycoproteins; expressed on neutrophils, monocytes, T cells (effector, memory)</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>P- selectin (CD62P)</p>\n</td>\n<td width=\150\>\n<p>Endothelium activated by cytokines (TN, IL-1), histamine, or thrombin</p>\n</td>\n<td width=\150\>\n<p>Sialyl–Lewis X on PSGL- 1 and other glycoproteins; expressed on neutrophils, monocytes, T cells (effector, memory)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(780, 'Pathology', 'PM0388. Integrins with Associated Ligands', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\150\>\n<p><strong>Integrins</strong></p>\n</td>\n<td width=\150\>\n<p><strong>Distribution</strong></p>\n</td>\n<td width=\150\>\n<p><strong>Ligands</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>LFA-1 (CD11aCD18)</p>\n</td>\n<td width=\150\>\n<p>Neutrophils, monocytes, T cells (naïve, effector, memory)</p>\n</td>\n<td width=\150\>\n<p>ICAM-1 (CD54), ICAM-2 (CD 102); expressed on endothelium (upregulated on activated endothelium)</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>MAC-1 (CD11bCD18)</p>\n</td>\n<td width=\150\>\n<p>Monocytes, dendritic cells (DCs)</p>\n</td>\n<td width=\150\>\n<p>ICAM- 1 (CD54), ICAM-2 (CD- 102); expressed on endothelium (upregulated on activated endothelium)</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>VLA-4 (CD49aCD29)</p>\n</td>\n<td width=\150\>\n<p>Monocytes</p>\n<p>T cells (naïve, effector, memory)</p>\n</td>\n<td width=\150\>\n<p>VCAM-1 (CD 106); expressed on endothelium (upregulated on activated endothelium)</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>a4b7 (CD49DCD29)</p>\n</td>\n<td width=\150\>\n<p>Monocytes</p>\n<p>T cells (gut homing naïve effector, memory)</p>\n</td>\n<td width=\150\>\n<p>VCAM- 1 (CD106), MAdCAM- 1; expressed on endothelium in gut and gut- associated lymphoid tissues</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(781, 'Pathology', 'PM0385. Comparison of Acute and Chronic Inflammation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\150\>\n<p><strong>Feature</strong></p>\n</td>\n<td width=\150\>\n<p><strong>Acute</strong></p>\n</td>\n<td width=\150\>\n<p><strong>Chronic</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Onset</p>\n</td>\n<td width=\150\>\n<p>Rapid: minutes or hours</p>\n</td>\n<td width=\150\>\n<p>Slow: days</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Cellular infiltrate</p>\n</td>\n<td width=\150\>\n<p>Mainly neutrophils</p>\n</td>\n<td width=\150\>\n<p>Monocytes/macrophages and lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Tissue injury, fibrosis</p>\n</td>\n<td width=\150\>\n<p>Usually mild and self-limited</p>\n</td>\n<td width=\150\>\n<p>Often severe and progressive</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Local and systemic signs</p>\n</td>\n<td width=\150\>\n<p>Promient</p>\n</td>\n<td width=\150\>\n<p>Less</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(782, 'Pathology', 'PM0384. Diseases Caused by Inflammation and Cells Involved', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Disorders</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Cells and Molecules involved</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>Acute</strong><em><br></em></p>\n</td>\n<td width=\231\>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>ARDS</p>\n</td>\n<td width=\231\>\n<p>Neutrophils</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Asthma</p>\n</td>\n<td width=\231\>\n<p>Eosinophls, IgE antibodies</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Glomerulonephritis</p>\n</td>\n<td width=\231\>\n<p>Antibodies complement, neutrophils, monocytes</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Septic shock</p>\n</td>\n<td width=\231\>\n<p>Cytokines</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>&nbsp;</p>\n</td>\n<td width=\231\>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>Chronic</strong></p>\n</td>\n<td width=\231\>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Arthritis</p>\n</td>\n<td width=\231\>\n<p>Lymphocytes and macrophages</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Asthma</p>\n</td>\n<td width=\231\>\n<p>Eosinophls, IgE antibodies</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Atherosclerosis</p>\n</td>\n<td width=\231\>\n<p>Macrophages, lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Pulmonary fibrosis</p>\n</td>\n<td width=\231\>\n<p>Macrophages, fibroblasts</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>ARDS: Acute respiratory distress syndrome</p></div><!---->\n      <!---->\n    </div><!---->'),
(783, 'Pathology', 'PM0324. Causes of Disseminated Intravascular Coagulation (DIC)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Disseminated intravascular coagulation (DIC) is an acute, subacute, or chronic thrombohemorrhagic disorder occurring as a secondary complication in a variety of diseases. It is characterized by the activation of the coagulation sequence that leads to the formation of microthrombi throughout the microcirculation of the body. As a consequence of the thrombotic diathesis, there is a consumption of platelets, fibrin, and coagulation factors and, secondarily, activation of fibrinolytic mechanisms.</p>\n<p><strong>Causes of DIC:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Obstetric complications</strong></td>\n<td>\n<ul>\n<li>Abruptio placenta</li>\n<li>Retained dead fetus</li>\n<li>Septic abortion</li>\n<li>Amniotic fluid embolism</li>\n<li>Toxemia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Infections</strong></td>\n<td>\n<ul>\n<li>Sepsis</li>\n<li>Meningococcemia</li>\n<li>Histoplasmosis</li>\n<li>Aspergillosis</li>\n<li>Malaria</li>\n<li>Toxemia&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Neoplasms</strong></td>\n<td>\n<ul>\n<li>Ca. pancreas</li>\n<li>Ca. prostate</li>\n<li>Ca. lung</li>\n<li>Acute promyelocytic leukemia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Massive Tissue Injury</strong></td>\n<td>\n<ul>\n<li>Traumatic injury</li>\n<li>Burns</li>\n<li>Extensive surgery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Miscellaneous</strong></td>\n<td>\n<ul>\n<li>Acute intravascular hemolysis</li>\n<li>Snake bite</li>\n<li>Shock</li>\n<li>Stroke</li>\n<li>Vasculitis</li>\n<li>Aortic aneurysm</li>\n<li>Liver disease</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(784, 'Pathology', 'PM0322. Embolism: Key Points', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Embolism: Key Points</strong></p>\n<ul>\n<li><strong>An embolus</strong> is a solid, liquid, or gaseous mass carried by blood to a site distant from its origin; most are dislodged thrombi.</li>\n<li><strong>Pulmonary emboli</strong> derive primarily from lower extremity deep vein thrombi; their effects depend mainly on the size of the embolus and the location in which it lodges. Consequences may include right-sided heart failure, pulmonary hemorrhage, pulmonary infarction, or sudden death.</li>\n<li><strong>Systemic emboli</strong>&nbsp;arise primarily from cardiac mural or valvular thrombi, aortic aneurysms, or atherosclerotic plaques; whether an embolus causes tissue infarction depends on the site of embolization and the presence or absence of collateral circulation.</li>\n<li><strong>Fat emboli:</strong>&nbsp;Fat embolism syndrome is characterized by <strong>pulmonary insufficiency</strong>, neurologic symptoms (irritability, restlessness, and even coma), <strong>anemia</strong>, and <strong>thrombocytopenia</strong> (manifesting as diffuse petechial rash). It is seen after fractures of long bones (which contain fatty marrow) or after soft-tissue trauma. It is fatal only in 10% of cases. The pathogenesis involves both mechanical obstruction and free fatty acids causing local toxic injury to endothelium.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(785, 'Pathology', 'PM0321. Thrombosis-Key Points', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>Thrombosis-Key Points:</ul>\n<ul>\n<li>Thrombus development usually is related to one or more components of the Virchow triad:\n<ul>\n<li><strong>Endothelial injury</strong> (e.g., by toxins, hypertension, inflammation, or metabolic products) associated with endothelial activation and changes in endothelial gene expression that favor coagulation</li>\n<li><strong>Abnormal blood flow</strong>—stasis or turbulence (e.g., due to aneurysms, atherosclerotic plaque)</li>\n<li><strong>Hypercoagulability</strong>, either primary (e.g., factor V Leiden, increased prothrombin synthesis, antithrombin III deficiency) or secondary (e.g., bed rest, tissue damage, malignancy, or development of antiphospholipid antibodies [antiphospholipid antibody syndrome]) or antibodies against platelet factor IV/heparin complexes [heparin-induced thrombocytopenia])</li>\n</ul>\n</li>\n<li>Thrombi may <strong>propagate</strong>, <strong>resolve</strong>, become <strong>organized</strong>, or <strong>embolize</strong>.</li>\n<li>Thrombosis causes tissue injury by <strong>local vascular occlusion</strong> or by <strong>distal embolization</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(786, 'Pathology', 'PM0320. Arterial and Venous Thrombi', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>Arterial thrombus</strong></td>\n<td><strong>Venous thrombus</strong></td>\n</tr>\n<tr>\n<td>Pathogenesis</td>\n<td>Endothelial injury or site of turbulence</td>\n<td>Stasis of blood</td>\n</tr>\n<tr>\n<td>Blood flow</td>\n<td>Associated with active blood flow</td>\n<td>Associated with sluggish blood flow</td>\n</tr>\n<tr>\n<td>Sites</td>\n<td>Coronary, cerebral and femoral arteries</td>\n<td>Superficial and deep leg veins, ovarian periuterine veins</td>\n</tr>\n<tr>\n<td>Propagation</td>\n<td>Grows in a retrograde manner from point of attachment</td>\n<td>Grows in an antegrade manner from point of attachment</td>\n</tr>\n<tr>\n<td>Line of Zahn</td>\n<td>Present</td>\n<td>Present</td>\n</tr>\n<tr>\n<td>Microscopic</td>\n<td>\n<div class=\page\ title=\Page 135\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Friable meshwork of platelets, fibrin, red cells, and degenerating leukocytes (<strong>White thrombi</strong>).</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Red cells mixed with relatively less platelets, so also called as <strong>red thrombi</strong></td>\n</tr>\n<tr>\n<td>Occlusion</td>\n<td>Incomplete lumen occlusion</td>\n<td>Complete vessel occlusion</td>\n</tr>\n<tr>\n<td>Complications</td>\n<td>Ischemia and infarction of organs</td>\n<td>Embolism, edema and ulceration</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(787, 'Pathology,', 'PM0319. Hypercoagulable states', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Primary (Genetic Conditions):</p>\n<ul>\n<li>Mutations in factor V (Most common)</li>\n<li>Antithrombin III deficiency</li>\n<li>Protein C or S deficiency</li>\n<li>Fibrinolysis defects</li>\n<li>Homocysteinemia</li>\n<li>Allelic variations in prothrombin levels</li>\n<li>Mutations in the methyl tetra hydro folate (MTHF) gene</li>\n</ul>\n<p>Secondary (Acquired Conditions):</p>\n<ul>\n<li>Prolonged bed rest or immobilization</li>\n<li>Homocysteinemia</li>\n<li>Tissue damage (Surgery, fracture, burns)</li>\n<li>Cancer</li>\n<li>Myocardial infarction, Prosthetic cardiac valves</li>\n<li>Disseminated intravascular coagulation (DIC)</li>\n<li>Heparin-induced thrombocytopenia</li>\n<li>Antiphospholipid antibody syndrome</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(788, 'Pathology,', 'PM0318. Important Anticoagulant Substances', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Antithrombin III:</strong>&nbsp;It inhibits the&nbsp;activity of thrombin and other factors like XIIa, XIa, Xa,&nbsp;and IXa. It is activated by binding to heparin-like molecules.</li>\n<li><strong>Proteins C and S:</strong>&nbsp;These proteins are vitamin K–dependent proteins which inactivate Va and VIIIa.</li>\n<li><strong>Endothelial prostacyclin (PGI2) and nitric oxide (NO):</strong>&nbsp;These are potent vasodilators and inhibitors of platelet aggregation.</li>\n<li><strong>Tissue factor pathway inhibitor: </strong>This is derived from the endothelium and inhibits tissue factor VIIa and Xa molecules.</li>\n<li><strong>Thrombomodulin:</strong>&nbsp;It is produced by all endothelial cells except those in the cerebral microcirculation. It binds to thrombin, and this complex activates protein C (in the presence&nbsp;of protein S), which finally inactivates factor V and VIII. This action results in an&nbsp;anticoagulant effect.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(789, 'Pathology', 'PM0314. Hyperemia and Congestion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Hyperemia and Congestion:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Hyperemia</strong></td>\n<td><strong>Congestion</strong></td>\n</tr>\n<tr>\n<td>Active process due to arteriolar dilation</td>\n<td>Passive process due to impaired venous outflow</td>\n</tr>\n<tr>\n<td>Edema is absent</td>\n<td>Edema is present</td>\n</tr>\n<tr>\n<td>Red color of the tissues</td>\n<td>Blue-red color of the tissue (due to deoxyhemoglobin)&nbsp;</td>\n</tr>\n<tr>\n<td>Seen in inflammation</td>\n<td>Seen in right heart failure and portal venous obstruction in cirrhosis</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(790, 'Pathology', 'PM0313. Edema: Key Points', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Edema: Key Points</strong></p>\n<p><strong>Edema</strong> is the result of the movement of fluid from the vasculature into the interstitial spaces; the fluid may be <strong>protein-poor (transudate)</strong> or <strong>protein-rich (exudate).</strong></p>\n<p><strong>Causes:</strong></p>\n<ul>\n<li><strong>Increased hydrostatic pressure</strong> (e.g., heart failure)</li>\n<li><strong>Decreased colloid osmotic pressure</strong> caused by reduced plasma albumin, either due to decreased synthesis (e.g., liver disease, protein malnutrition) or to increased loss (e.g., nephrotic syndrome)</li>\n<li><strong>Increased vascular permeability</strong> (e.g., inflammation), which is usually localized but may occur throughout the body in severe systemic inflammatory states such as sepsis</li>\n<li><strong>Lymphatic obstruction</strong> (e.g., infection or neoplasia)</li>\n<li><strong>Sodium and water retention</strong> (e.g., renal failure)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(791, 'Surgery,', 'PM0298. Tumor Markers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Tumor Markers</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Tumor Markers</strong></p>\n</td>\n<td>\n<p><strong>Tumor Types</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hormones</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human chorionic gonadotropin</p>\n</td>\n<td>\n<p>Trophoblastic tumors, nonseminonmatous testicular tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Calcitonin</p>\n</td>\n<td>\n<p>Medullary carcinoma of thyroid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Catecholamine and metabolites</p>\n</td>\n<td>\n<p>Pheochromocytoma and related tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Oncofetal Antigens</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>α-Fetoprotein</p>\n</td>\n<td>\n<p>Liver cell cancer, nonseminonmatous germ-cell tumors of the&nbsp;testis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carcinoembryonic antigen</p>\n</td>\n<td>\n<p>Carcinomas of the colon, lung, stomach, and heart</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Enzymes</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic acid phosphatase</p>\n</td>\n<td>\n<p>Prostate cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neuron-specific enolase</p>\n</td>\n<td>Small-cell cancer of the lung, neuroblastoma</td>\n</tr>\n<tr>\n<td>\n<p>Lactate dehydrogenase (LDH)</p>\n</td>\n<td>Germ-cell tumors, lymphomas, leukemias</td>\n</tr>\n<tr>\n<td>Thymidine kinase</td>\n<td>Leukemias</td>\n</tr>\n<tr>\n<td>Pyruvate kinase</td>\n<td>Renal cell carcinoma</td>\n</tr>\n<tr>\n<td>Placental alkaline phosphatase</td>\n<td>Seminoma</td>\n</tr>\n<tr>\n<td>\n<p><strong>Specific Proteins</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Immunoglobulins</p>\n</td>\n<td>\n<p>Multiple myeloma and other gammopathies</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostate-specific antigen and prostate- specific membrane antigen</p>\n</td>\n<td>\n<p>Prostate cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NMP 22</p>\n</td>\n<td>\n<p>Bladder cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mucins and Other Glycoproteins</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA-125</p>\n</td>\n<td>\n<p>Ovarian cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA- 19-9</p>\n</td>\n<td>\n<p>Colon cancer, pancreatic cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA-15-3</p>\n</td>\n<td>\n<p>Breast cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cell-Free DNA markers</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, APC, RAS</em> mutants in stool and serum</p>\n</td>\n<td>\n<p>Colon cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, RAS</em> mutants in stool and serum</p>\n</td>\n<td>\n<p>Pancreatic cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, RAS</em> mutants in sputum and serum</p>\n</td>\n<td>\n<p>Lung cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53</em> mutants in urine</p>\n</td>\n<td>\n<p>Bladder cancer</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>NMP: Nuclear matrix protein</p>\n<p>CA: Carbohydrate antigen</p></div><!---->\n      <!---->\n    </div><!---->'),
(792, 'Pathology', 'PM0293. Enzymes as Tumor Markers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Enzymes as tumor markers</strong></p>\n<table width=\501\>\n<tbody>\n<tr>\n<td><strong>Enzymes as tumor markers</strong></td>\n<td><strong>Cancers</strong></td>\n</tr>\n<tr>\n<td>Prostatic acid phosphatase (PAP)</td>\n<td>Carcinoma prostate</td>\n</tr>\n<tr>\n<td>Neuron-specific enolase (NSE)</td>\n<td>\n<p>Small-cell cancer of lung, neuroblastoma</p>\n</td>\n</tr>\n<tr>\n<td>Lactate dehydrogenase (LDH)</td>\n<td>Germ-cell tumors, lymphomas, leukemias</td>\n</tr>\n<tr>\n<td>&nbsp;Thymidine kinase</td>\n<td>Leukemias</td>\n</tr>\n<tr>\n<td>&nbsp;Pyruvate kinase</td>\n<td>Renal cell carcinoma</td>\n</tr>\n<tr>\n<td>&nbsp;Placental alkaline phosphatase</td>\n<td>Seminoma</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(793, 'Pathology', 'PM0290. Protooncogenes, Oncogenes and Oncoproteins', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Protooncogenes, Oncogenes, and Oncoproteins</strong></p>\n<ul>\n<li><strong>Proto-oncogenes</strong>: normal cellular genes whose products promote cell proliferation</li>\n<li><strong>Oncogenes</strong>: mutated or overexpressed versions of proto-oncogenes that function autonomously, having lost dependence on normal growth promoting signals</li>\n<li><strong>Oncoprotein: </strong>a protein encoded by an oncogene that drives increased cell proliferation through one of the several mechanisms</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(794, 'Pathology', 'PM0282. Inhibitors of Mitogenic Signaling Pathway', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\86\>\n<p><strong>Gene</strong></p>\n</td>\n<td width=\89\>\n<p><strong>Protein</strong></p>\n</td>\n<td width=\88\>\n<p><strong>Function</strong></p>\n</td>\n<td width=\95\>\n<p><strong>Familial Syndromes</strong></p>\n</td>\n<td width=\92\>\n<p><strong>Sporadic Cancers</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\86\>\n<p><em>APC</em></p>\n</td>\n<td width=\89\>\n<p>Adenomatous polyposis coli protein</p>\n</td>\n<td width=\88\>\n<p>Inhibitor of WNT signaling</p>\n</td>\n<td width=\95\>\n<p>Familial colonic polyps and carcinomas</p>\n</td>\n<td width=\92\>\n<p>Carcinomas of stomach, colon, pancreas, melanoma</p>\n</td>\n</tr>\n<tr>\n<td width=\86\>\n<p><em>NF1</em></p>\n</td>\n<td width=\89\>\n<p>Neurofibromin-1</p>\n</td>\n<td width=\88\>\n<p>Inhibitor of RAS/MAPK signaling</p>\n</td>\n<td width=\95\>\n<p>Neurofibromatosis type 1</p>\n<p>(neurofibromas and malignant peripheral nerve sheath tumors)</p>\n<p>&nbsp;</p>\n</td>\n<td width=\92\>\n<p>Neuroblastoma, juvenile myeloid leukemia</p>\n</td>\n</tr>\n<tr>\n<td width=\86\>\n<p><em>NF2</em></p>\n</td>\n<td width=\89\>\n<p>Merlin</p>\n</td>\n<td width=\88\>\n<p>Cytoskeletal stability, Hippo pathway signaling</p>\n</td>\n<td width=\95\>\n<p>Neurofibromatosis type 2 (acoustic schwannoma and meningioma</p>\n</td>\n<td width=\92\>\n<p>Schwannoma, meningioma</p>\n</td>\n</tr>\n<tr>\n<td width=\86\>\n<p><em>PTCH</em></p>\n</td>\n<td width=\89\>\n<p>Patched</p>\n</td>\n<td width=\88\>\n<p>Inhibitor of Hedgehog signaling</p>\n</td>\n<td width=\95\>\n<p>Gorlin syndrome (basal cell carcinoma, medulloblastoma, several benign tumors)</p>\n</td>\n<td width=\92\>\n<p>Basal cell carcinoma, medulloblastoma</p>\n</td>\n</tr>\n<tr>\n<td width=\86\>\n<p><em>PTEN</em></p>\n</td>\n<td width=\89\>\n<p>Phosphatase and tensin homologue</p>\n</td>\n<td width=\88\>\n<p>Inhibitor of PI3K/AKT signaling</p>\n</td>\n<td width=\95\>\n<p>Cowden syndrome (variety of benign skin, GI and CNS growths; Breast, endometrial and thyroid carcinoma)</p>\n</td>\n<td width=\92\>\n<p>Diverse cancers, particularly carcinomas and lymphoid tumors</p>\n</td>\n</tr>\n<tr>\n<td width=\86\>\n<p><em>SMAD2, SMAD4</em></p>\n</td>\n<td width=\89\>\n<p>SMAD2, SMAD4</p>\n</td>\n<td width=\88\>\n<p>Component of TGFb signaling pathway, repressors of MYC and CDK4 expression, inducers of CDK inhibitor expression</p>\n</td>\n<td width=\95\>\n<p>Juvenile polyposis</p>\n</td>\n<td width=\92\>\n<p>Frequently mutated (along with other components of the TGFb signaling pathway) in colonic and pancreatic carcinoma</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(795, 'Pathology', 'PM0281. Cell Cycle Regulators and Associated Cancers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\113\>\n<p><strong>Cell cycle regulator</strong></p>\n</td>\n<td width=\113\>\n<p><strong>Proto-oncogene</strong></p>\n</td>\n<td width=\113\>\n<p><strong>Mode of activation in tumor</strong></p>\n</td>\n<td width=\113\>\n<p><strong>Associated tumor</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>Cyclins</p>\n</td>\n<td width=\113\>\n<p>CCND1 (Cyclin D1)</p>\n</td>\n<td width=\113\>\n<p>Translocation</p>\n<p>Amplification</p>\n</td>\n<td width=\113\>\n<p>Mantle cell lymphoma, multiple myeloma</p>\n<p>Breast and esophageal cancers</p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>Cyclin-dependent kinase</p>\n</td>\n<td width=\113\>\n<p>CDK4</p>\n</td>\n<td width=\113\>\n<p>Amplification or point mutation</p>\n</td>\n<td width=\113\>\n<p>Glioblastoma, melanoma, sarcoma</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(796, 'Pathology', 'PM0280. Cancers associated with important oncogenes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\0\>\n<tbody>\n<tr>\n<td>\n<p><strong>Oncogenes</strong></p>\n</td>\n<td><strong>Associated cancers</strong></td>\n</tr>\n<tr>\n<td>\n<p><em>c-MYC</em></p>\n</td>\n<td>\n<p>Burkitt’s lymphoma</p>\n<p>Adenocarcinomas of the breast, lung, and colon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>N-MYC</em></p>\n</td>\n<td>\n<p>Neuroblastoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>L-MYC</em></p>\n</td>\n<td>\n<p>Small-cell carcinoma of the lung</p>\n</td>\n</tr>\n<tr>\n<td><em>K-RAS</em></td>\n<td>Colon, lung, and pancreatic tumors</td>\n</tr>\n<tr>\n<td><em>N-RAS</em></td>\n<td>\n<p>Melanoma</p>\n<p>AML</p>\n</td>\n</tr>\n<tr>\n<td><em>H-RAS</em></td>\n<td>Bladder and kidney tumors</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(797, 'Pathology', 'PM0279. Protein involved in Signal transduction and Associated Cancers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Protein involved in Signal transduction and Associated Cancers</strong></p>\n<table border=\1\>\n<tbody>\n<tr>\n<td>\n<p>GTP-binding (G) proteins</p>\n</td>\n<td>\n<p><em>KRAS</em></p>\n<p><em>HRAS</em></p>\n<p><em>NRAS</em></p>\n<p><em>GNAQ</em></p>\n<p><em>GNAS</em></p>\n</td>\n<td>\n<p>Point mutation</p>\n<p>Point mutation</p>\n<p>Point mutation</p>\n<p>Point mutation</p>\n<p>Point mutation</p>\n</td>\n<td>\n<p>Colon, lung, and pancreatic tumors</p>\n<p>Bladder and kidney tumors</p>\n<p>Melanomas, hematologic, malignancies</p>\n<p>Uveal melanoma</p>\n<p>Pituitary adenoma, other endocrine tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nonreceptor tyrosine kinase</p>\n</td>\n<td>\n<p><em>ABL</em></p>\n</td>\n<td>\n<p>Translocation</p>\n<p>Point mutation</p>\n</td>\n<td>\n<p>Chronic myelogenous leukemia</p>\n<p>Acute lymphoblastic leukemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>RAS signal transduction</p>\n</td>\n<td>\n<p><em>BRAF</em></p>\n</td>\n<td>\n<p>Point mutation, Translocation</p>\n</td>\n<td>\n<p>Melanomas, leukemias, colon carcinoma, others</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Notch signal transduction</p>\n</td>\n<td>\n<p><em>NOTCH1</em></p>\n</td>\n<td>\n<p>Point mutation, Translocation Gene rearrangement</p>\n</td>\n<td>\n<p>Leukemias, lymphomas, breast carcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>JAK/STAT signal transduction</p>\n</td>\n<td>\n<p><em>JAK2</em></p>\n</td>\n<td>\n<p>Translocation</p>\n</td>\n<td>\n<p>Myeloproliferative disorders</p>\n<p>Acute lymphoblastic leukemia</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(798, 'Pathology', 'PM0278. Growth Factor Receptors and Associated Tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Growth factor receptors and Associated Tumors</strong></p>\n<table>\n<tbody>\n<tr>\n<td width=\113\>\n<p>Category</p>\n</td>\n<td width=\113\>\n<p><em>Proto-Oncogene</em></p>\n</td>\n<td width=\113\>\n<p>Mode of activation</p>\n</td>\n<td width=\113\>\n<p>Associated tumor</p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>EGF-receptor family</p>\n</td>\n<td width=\113\>\n<p><em>ERBB1 (EGFR)</em></p>\n<p><em>ERBB2 (HER)</em></p>\n</td>\n<td width=\113\>\n<p>Mutation</p>\n<p>Amplification</p>\n</td>\n<td width=\113\>\n<p>Adenocarcinoma of lung</p>\n<p>Breast carcinoma</p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>FMS- like tyrosine kinase 3</p>\n</td>\n<td width=\113\>\n<p><em>FLT3</em></p>\n</td>\n<td width=\113\>\n<p>Point mutation</p>\n</td>\n<td width=\113\>\n<p>Leukemia</p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>Receptor for neurotrophic factors</p>\n</td>\n<td width=\113\>\n<p><em>RET</em></p>\n</td>\n<td width=\113\>\n<p>Point mutation</p>\n</td>\n<td width=\113\>\n<p>Multiple endocrine neoplasia 2A and B, familial medullary thyroid carcinoma</p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>PDGF receptor</p>\n</td>\n<td width=\113\>\n<p><em>PDGFRB</em></p>\n</td>\n<td width=\113\>\n<p>Overexpression, translocation</p>\n</td>\n<td width=\113\>\n<p>Gliomas, leukemias</p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>Receptor for KIT ligand</p>\n</td>\n<td width=\113\>\n<p><em>KIT</em></p>\n</td>\n<td width=\113\>\n<p>Point mutation</p>\n</td>\n<td width=\113\>\n<p>Gastrointestinal stromal tumors, seminomas, leukemias</p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>ALK receptors</p>\n</td>\n<td width=\113\>\n<p><em>ALK</em></p>\n</td>\n<td width=\113\>\n<p>Translocation, fusion gene formation</p>\n<p>Point mutation</p>\n</td>\n<td width=\113\>\n<p>Adenocarcinoma of lung, certain lymphomas</p>\n<p>Neuroblastoma</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(799, 'Medicine,', 'PM0276. Pathological Conditions and Associated Neoplasms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Pathological conditions and Associated neoplasms</strong></p>\n<table>\n<tbody>\n<tr>\n<td width=\150\>\n<p><strong>Pathological Condition</strong></p>\n</td>\n<td width=\150\>\n<p><strong>Associated Neoplasm (s)</strong></p>\n</td>\n<td width=\150\>\n<p><strong>Etiological Agent</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Asbestosis, silicosis</p>\n</td>\n<td width=\150\>\n<p>Mesothelioma, lung carcinoma</p>\n</td>\n<td width=\150\>\n<p>Asbestos fibers, silica particles</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Inflammatory bowel syndrome</p>\n</td>\n<td width=\150\>\n<p>Colorectal carcinoma</p>\n</td>\n<td width=\150\>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Lichen sclerosis</p>\n</td>\n<td width=\150\>\n<p>Vulvar squamous cell</p>\n</td>\n<td width=\150\>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Pancreatitis</p>\n</td>\n<td width=\150\>\n<p>Pancreatic carcinoma</p>\n</td>\n<td width=\150\>\n<p>Alcoholism, germline mutation (e.g., in the trypsinogen gene)</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Chronic cholecystitis</p>\n</td>\n<td width=\150\>\n<p>Gallbladder cancer</p>\n</td>\n<td width=\150\>\n<p>Bile acids, bacteria, gallbladder stones</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Reflux esophagitis, Barrett oesophagus</p>\n</td>\n<td width=\150\>\n<p>Esophageal carcinoma</p>\n</td>\n<td width=\150\>\n<p>Gastric acid</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Sjögren syndrome, Hashimoto thyroiditis</p>\n</td>\n<td width=\150\>\n<p>MALT lymphoma</p>\n</td>\n<td width=\150\>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Opisthorchis, cholangitis</p>\n</td>\n<td width=\150\>\n<p>Cholangiocarcinoma, colon carcinoma</p>\n</td>\n<td width=\150\>\n<p>Liver flukes (<em>Opisthorchis viverrini)</em></p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Gastritis/ulcers</p>\n</td>\n<td width=\150\>\n<p>Gastric adenocarcinoma, MALT lymphoma</p>\n</td>\n<td width=\150\>\n<p><em>Helicobacter pylori</em></p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Hepatitis</p>\n</td>\n<td width=\150\>\n<p>Hepatocellular carcinoma</p>\n</td>\n<td width=\150\>\n<p>Hepatitis B and/or C virus</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Osteomyelitis</p>\n</td>\n<td width=\150\>\n<p>Carcinoma in draining sinuses</p>\n</td>\n<td width=\150\>\n<p>Bacterial infection</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Chronic cervicitis</p>\n</td>\n<td width=\150\>\n<p>Cervical carcinoma</p>\n</td>\n<td width=\150\>\n<p>Human papillomavirus</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Chronic cystitis</p>\n</td>\n<td width=\150\>\n<p>Bladder carcinoma</p>\n</td>\n<td width=\150\>\n<p>Schistosomiasis</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>MALT: Mucosa-associated lymphoid tissue</p></div><!---->\n      <!---->\n    </div><!---->'),
(800, 'Pathology', 'PM0275. Etiological Agents for Cancers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\150\>\n<p><strong>Agents</strong></p>\n</td>\n<td width=\150\>\n<p><strong>Associated cancers</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Arsenic and arsenic compounds</p>\n</td>\n<td width=\150\>\n<p>Lung carcinoma, skin carcinoma</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Asbestos</p>\n</td>\n<td width=\150\>\n<p>Lung, oesophageal, gastric, and colon carcinomas; Mesothelioma</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Benzene</p>\n</td>\n<td width=\150\>\n<p>Acute myeloid leukemia</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Beryllium and beryllium compounds</p>\n</td>\n<td width=\150\>\n<p>Lung carcinoma</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Cadmium and cadmium compounds</p>\n</td>\n<td width=\150\>\n<p>Prostate carcinoma</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Chromium compounds</p>\n</td>\n<td width=\150\>\n<p>Lung carcinoma</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Nickel compounds</p>\n</td>\n<td width=\150\>\n<p>Lung and oropharyngeal carcinoma</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Radon and its decay products</p>\n</td>\n<td width=\150\>\n<p>Lung carcinoma</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>Vinyl chloride</p>\n</td>\n<td width=\150\>\n<p>Hepatic angiosarcoma</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(801, 'Medicine,', 'PM0272. Paraneoplastic Syndromes and Underlying Cancers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\0\ width=\472\>\n<tbody>\n<tr>\n<td width=\157\>\n<p><strong>Clinical Syndromes/&nbsp;</strong></p>\n<p><strong>Endocrinopathies</strong></p>\n</td>\n<td width=\157\>\n<p><strong>Major Forms of Underlying Cancer</strong></p>\n</td>\n<td width=\157\>\n<p><strong>Causal Mechanism</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\157\>\n<p>Cushing Syndrome</p>\n</td>\n<td width=\157\>\n<p>Small-cell carcinoma of lung</p>\n<p>Pancreatic carcinoma</p>\n<p>Neural tumours</p>\n<p>Renal carcinoma</p>\n</td>\n<td width=\157\>\n<p>ACTH or ACTH- like substance</p>\n</td>\n</tr>\n<tr>\n<td width=\157\>\n<p>Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</p>\n</td>\n<td width=\157\>\n<p>Small-cell carcinoma of lung</p>\n<p>Intracranial neoplasms</p>\n</td>\n<td width=\157\>\n<p>Antidiuretic hormone or atrial natriuretic hormones</p>\n</td>\n</tr>\n<tr>\n<td width=\157\>\n<p>Hypercalcemia</p>\n</td>\n<td width=\157\>\n<p>Squamous cell carcinoma of lung</p>\n<p>Breast carcinoma</p>\n<p>Renal carcinoma</p>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n<td width=\157\>\n<p>Parathyroid hormone-related protein(PTHRP), TGF-a, TNF, IL-1</p>\n</td>\n</tr>\n<tr>\n<td width=\157\>\n<p>Hypoglycaemia</p>\n</td>\n<td width=\157\>\n<p>Ovarian carcinoma</p>\n<p>Fibrosarcoma</p>\n<p>Other mesenchymal sarcomas</p>\n</td>\n<td width=\157\>\n<p>Insulin or insulin-like substance</p>\n</td>\n</tr>\n<tr>\n<td width=\157\>\n<p>Polycythemia</p>\n</td>\n<td width=\157\>\n<p>Renal carcinoma</p>\n<p>Cerebellar haemangioma</p>\n<p>Hepatocellular carcinoma</p>\n</td>\n<td width=\157\>\n<p>Erythropoietin</p>\n</td>\n</tr>\n<tr>\n<td width=\157\>\n<p>Osteomalacia</p>\n</td>\n<td width=\157\>\n<p>Phosphaturic mesenchymal tumor</p>\n</td>\n<td width=\157\>\n<p>FGF-23</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Disseminated intrvascular coagulation</p>\n</td>\n<td>\n<p>Acute promyelocytic leukemia</p>\n<p>Prostatic carcinoma</p>\n</td>\n<td>\n<p>Tumor products activate clotting</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>ACTH:&nbsp;Adrenocorticotropic hormone&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(802, 'Pathology,', 'PM0271. Risk Factors for Squamous Cell Carcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Risk factors for squamous cell carcinoma</strong></p>\n<ul>\n<li>UV exposure</li>\n<li><strong>Male sex</strong>- due to more sun exposure</li>\n<li>Environmental factors-<br>\n<ol>\n<li><strong>Psoralen </strong>and UVA (PUVA)</li>\n<li>Physical agents such as ionizing radiation</li>\n<li>Chemical agents such as arsenics</li>\n</ol>\n</li>\n<li><strong>HPV-16 &amp; 18</strong></li>\n<li>Immunosuppression&nbsp;</li>\n<li>Smoking</li>\n<li><strong>Chronic nonhealing wounds</strong>, burn scars, and chronic dermatosis</li>\n<li>Hereditary conditions such as xeroderma pigmentosum, <strong>epidermolysis bullosa</strong>, and oculo-cutaneous albinism</li>\n<li>Premalignant conditions like actinic keratosis, Bowen’s disease, erythroplasia of Queyrat</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(803, 'Pathology', 'PM0210. Important features of inheritance patterns', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>X-linked Recessive Conditions:</strong></p>\n<ul>\n<li><strong>All sex-linked disorders are X-linked, and almost all are recessive.</strong></li>\n<li>Several genes are located in the “male-specific region of Y;” all these are related to spermatogenesis.</li>\n<li>Males with mutations affecting the Y-linked genes are usually infertile, and hence, there is no Y-linked inheritance.</li>\n<li><strong>An affected male does not transmit the disorder to his sons, but all daughters are carriers.</strong></li>\n<li><strong>Sons of heterozygous women have, of course, a one-in-two chance of receiving the mutant gene.</strong></li>\n<li><strong><strong>Heterozygous females&nbsp;</strong>express the disorder partially</strong>&nbsp;<strong>because of random inactivation of one X chromosome</strong>.</li>\n</ul>\n<p><strong>Autosomal Dominant Disorders:</strong></p>\n<ul>\n<li>With every autosomal dominant disorder, <strong>some patients do not have affected parents.</strong> Such patients owe their disorder to new mutations involving either the egg or the sperm from which they were derived.</li>\n</ul>\n<ul>\n<li><strong>Clinical features </strong>can be <strong>modified by variations in penetrance and expressivity.</strong></li>\n</ul>\n<ul>\n<li>In many conditions, the <strong>age at onset </strong>is <strong>delayed</strong>, and <strong>symptoms and signs </strong>may not appear until<strong> adulthood (as in Huntington disease).</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(804, 'Pathology', 'PM0132. Apoptotic genes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>Group</td>\n<td>Members</td>\n<td>Details</td>\n</tr>\n<tr>\n<td>Anti-apoptotlc</td>\n<td>BCL2,<br>BCL-XL<br><br>MCL1</td>\n<td>Present in outer mitochondrial&nbsp;membrane<br>Prevent leakage of cytochrome-c and<br>other death lnducing proteins into<br>cytosol.</td>\n</tr>\n<tr>\n<td>Pro-apoptotlc</td>\n<td>BAX,<br>BAK</td>\n<td>On activation, they increase&nbsp;mitochondrial membrane permeability.</td>\n</tr>\n<tr>\n<td>Stress Sensors</td>\n<td>BAD,<br>BIM,<br>BID,<br>Puma, Noxa</td>\n<td>Act as sensors of cellular stress and&nbsp;damage and regulate the balance<br>between the other two groups</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(805, 'Pathology', 'PM0130. Classification of Amyloidosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\page\ title=\Page 270\>\n<table><colgroup><col><col><col><col> </colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Clinicopathologic Category</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Major Fibril Protein</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Chemically Related Precursor Protein</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Systemic (Generalized) Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Immunoglobulin light chain amyloidosis (<strong>primary amyloidosis</strong>)</p>\n<p>Seen in Multiple myeloma and other monoclonal plasma cell proliferation</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>AL</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Immunoglobulin light chains, chiefly λ type</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Reactive systemic amyloidosis (<strong>secondary amyloidosis</strong>)</p>\n<p>Seen in chronic inflammatory conditions</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Hemodialysis-associated amyloidosis</p>\n<p>Seen in chronic renal failure</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Aβ2m</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>β2-microglobulin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Hereditary Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Familial Mediterranean fever</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Familial amyloidotic neuropathies</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Mutated transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Systemic senile amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Normal transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Localized Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Senile cerebral amyloidosis</p>\n<p>Seen in Alzheimers disease</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Aβ</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>APP</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Endocrine disorders like Type 2 diabetes</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Medullary carcinoma thyroid</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>A Cal</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Calcitonin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Islets of Langerhans</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>AIAPP</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Islet amyloid peptide</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Isolated atrial amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>AANF</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Atrial natriuretic factor</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(806, 'Pathology', 'PM0129. Appearance of Amyloid', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Methods</strong></td>\n<td><strong>Appearance</strong></td>\n</tr>\n<tr>\n<td>On light microscopy and standard tissue stains&nbsp;(H&amp;E)&nbsp;</td>\n<td>Amorphous eosinophilic extracellular substance&nbsp;</td>\n</tr>\n<tr>\n<td>Congo red stain on ordinary light&nbsp;&nbsp;&nbsp;</td>\n<td>Pink or red&nbsp;colour&nbsp;to tissue deposits&nbsp;</td>\n</tr>\n<tr>\n<td>Congo red stain on polarizing microscopy&nbsp;&nbsp;</td>\n<td>Apple-green birefringence&nbsp;</td>\n</tr>\n<tr>\n<td>Fluorescent stains (thioflavin T and S)&nbsp;&nbsp;&nbsp;</td>\n<td>Yellow&nbsp;colour&nbsp;under UV light&nbsp;</td>\n</tr>\n<tr>\n<td>Electron microscopy&nbsp;</td>\n<td>Nonbranching fibrils of indefinite length and a&nbsp;diameter of approximately 7.5 to 10 nm.&nbsp;</td>\n</tr>\n<tr>\n<td>X-ray crystallography and infrared spectroscopy&nbsp;</td>\n<td>Characteristic cross β pleated sheet conformation&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>H&amp;E: Hematoxylin and eosin &nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(807, 'Pathology', 'PM0121. Important Stains in Pathology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\ width=\471\>\n<tbody>\n<tr>\n<td><strong>Stain</strong></td>\n<td><strong>Used for</strong></td>\n</tr>\n<tr>\n<td>Alizarin red S stain</td>\n<td>Calcium detection in tissue</td>\n</tr>\n<tr>\n<td>\n<p>Chloroacetate esterase</p>\n<p>(Leder) stain</p>\n</td>\n<td>Markers of neutrophil</td>\n</tr>\n<tr>\n<td>Halls stain</td>\n<td>Bile pigments (bilirubin)</td>\n</tr>\n<tr>\n<td>Masson–Fontana stain</td>\n<td>Melanin and some neuroendocrine cells</td>\n</tr>\n<tr>\n<td>Rhodanine stain</td>\n<td>Copper in tissue</td>\n</tr>\n<tr>\n<td>Perls prussian blue stain</td>\n<td>Iron in bone marrow macrophages&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(808, 'Pathology', 'PM0120. Special stains used for staining Lipid', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Oil Red O</li>\n<li>Sudan Black or Sudan IV</li>\n<li>Osmium tetroxide.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e7e3d66d3d444282bb04bb7e655d53edx800x600.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The image shows Oil Red O staining of lipid.&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(809, 'Pathology', 'PM1491. Classification of Iron Overload', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;Primary / Hereditary Hemochromatosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>HFE gene-related</strong></p>\n<ul>\n<li>Type 1: C282Y mutations of genes encoding HFE&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Non-HFE gene-related</strong></p>\n<ul>\n<li>Type 2: Juvenile hemochromatosis\n<ul>\n<li>2a <strong>- </strong>HJV&nbsp;mutation (hemojuvelin)</li>\n<li>2b<strong> - </strong>HAMP mutation (Hepcidin)</li>\n</ul>\n</li>\n<li>Type 3: Transferrin receptor 2 (TfR2) related&nbsp;</li>\n<li>Type 4<strong>:&nbsp;</strong>Ferroportin-related HH&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Secondary / Acquired Hemochromatosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Transfusion iron overload</strong></p>\n<ul>\n<li>Thalassemia major</li>\n<li>Sideroblastic anemia</li>\n<li>Chronic hemolytic anemias</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Chronic liver disease</strong></p>\n<ul>\n<li>Alcoholic liver disease</li>\n<li>Non-alcoholic steatohepatitis (NASH)</li>\n<li>Porphyria cutanea tarda</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 3023\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Miscellaneous</strong></p>\n</div>\n</div>\n</div>\n</div>\n<ul>\n<li>Congenital atransferrinemia</li>\n<li>African iron overload (Bantu siderosis)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(810, 'Pathology', 'PM1468. WHO Polycythemia Vera Criteria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><span><strong>Major criteria:</strong></span></p>\n<p>1. Hemoglobin <strong>&gt;16.5 g/dL</strong> in men</p>\n<p>&nbsp; &nbsp; &nbsp;Hemoglobin <strong>&gt;16.0 g/dL</strong> in women&nbsp;</p>\n<p>Or</p>\n<p>&nbsp; &nbsp; &nbsp;Hematocrit <strong>&gt;49%</strong> in men</p>\n<p>&nbsp; &nbsp; &nbsp;Hematocrit <strong>&gt;48%</strong> in women&nbsp;</p>\n<p>2. Bone marrow biopsy showing <strong>hypercellularity</strong> with <strong>trilineage hyperplasia</strong>&nbsp;(panmyelosis) and prominent erythroid, granulocytic, and megakaryocytic proliferation with pleomorphic mature megakaryocytes in the bone marrow, and&nbsp;</p>\n<p>3. Presence of&nbsp;<strong>JAK2 exon 12</strong> mutation</p>\n<p><span><strong>Minor criterion:</strong></span></p>\n<p>Subnormal serum erythropoietin level</p>\n<p>Diagnosis of polycythemia vera requires meeting either all 3 major criteria&nbsp;or the first 2 major criteria along with the minor criterion</p></div><!---->\n      <!---->\n    </div><!---->'),
(811, 'Pathology,', 'PM1285. Morphological Classification of Anemias', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Microcytic Hypochromic </strong></p>\n<p><strong>(MCV &lt;80 fl)</strong></p>\n</td>\n<td>\n<p><strong>Normocytic Normochromic &nbsp; &nbsp;</strong></p>\n<p><strong>(MCV 80 - 100 fl)</strong></p>\n</td>\n<td>\n<p><strong>Macrocytic Normochromic </strong></p>\n<p><strong>(MCV &gt;100 fl)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iron deficiency anemia</p>\n<p>Sideroblastic anemia</p>\n<p>Thalassemia</p>\n<p>Lead toxicity</p>\n</td>\n<td>\n<p>Acute blood loss</p>\n<p>Anemia of chronic disease</p>\n<p>Anemia of renal disease</p>\n<p>Hemolysis*</p>\n<p>Bone marrow suppression</p>\n<ul>\n<li>Aplastic anemia</li>\n<li>Pure red cell aplasia</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;&nbsp;</p>\n</td>\n<td>\n<p><strong>Megaloblastic:</strong></p>\n<p>Vitamin B12 deficiency</p>\n<p>Folate deficiency</p>\n<p>Thiamine deficiency</p>\n<p>Drugs - Methotrexate, Zidovudine, hydroxyurea</p>\n<p>Orotic aciduria</p>\n<p>&nbsp;</p>\n<p><strong>Non-megaloblastic:</strong></p>\n<p>Alcohol use</p>\n<p>Liver disease</p>\n<p>Hypothyroidism</p>\n<p>Hemolysis*</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>*Hemolysis can be associated with macrocytosis because of compensatory reticulocytosis. However, MCV can be normal depending on the degree of hemolysis.</p>\n<p>Note: In Orotic Aciduria, peripheral blood smear shows Hypochromic megaloblastic anemia.&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(812, 'Pathology,', 'PM0027. Autoimmune Hemolytic Anemia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Autoimmune hemolytic anemia (AIHA): A comparison of types</p>\n<table border=\0\>\n<tbody>\n<tr>\n<td><strong>Warm agglutinin AIHA</strong></td>\n<td><strong>Cold agglutinin AIHA</strong></td>\n</tr>\n<tr>\n<td colspan=\2\><strong><strong>Etiology</strong></strong></td>\n</tr>\n<tr>\n<td>\n<p>Drugs (e.g., penicillin)</p>\n<p>Viral infections</p>\n<p>Autoimmune(e.g., SLE)</p>\n<p>Immunodeficiency states</p>\n<p>Lymphoproliferative (e.g., CLL)</p>\n</td>\n<td>\n<p>Infections (e.g., <em>Mycoplasma pneumoniae</em>&nbsp;and EBV)</p>\n<p>Lymphoproliferative diseases</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<p><strong>Clinical presen</strong><strong>tation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Direct Coombs’ positive with <strong>anti-IgG, anti-C3</strong>, or both</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Livedo reticularis and acral cyanosis with cold exposure that disappears with warming</p>\n<p>Direct Coombs’ positive with <strong>anti-C3 </strong>or<strong> anti-IgM</strong>, but usually not IgG.</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<p><strong>Complications</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Venous thromboembolism</p>\n<p>Lymphoproliferative disorders</p>\n</td>\n<td>\n<p>Ischemia and peripheral gangrene</p>\n<p>Lymphoproliferative disorders</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Treatment</strong></td>\n</tr>\n<tr>\n<td>\n<p>Steroids, splenectomy, rituximab</p>\n</td>\n<td>\n<p>Avoid cold exposure, rituximab</p>\n<p>(No role for steroids,&nbsp;splenectomy, or IVIG)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(813, 'Pathology', 'PM2430. FAB classification of ALL', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\506\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><span><strong>&nbsp; &nbsp; &nbsp; &nbsp;L1</strong></span></td>\n<td><span><strong>&nbsp; &nbsp; &nbsp; &nbsp;L2</strong></span></td>\n<td><span><strong>&nbsp; &nbsp; &nbsp; &nbsp;L3</strong></span></td>\n</tr>\n<tr>\n<td><strong>&nbsp;MORPHOLOGY</strong></td>\n<td>&nbsp;small homogenous blasts</td>\n<td>&nbsp;heterogenous blasts</td>\n<td>&nbsp;cytoplasmic vacoules</td>\n</tr>\n<tr>\n<td><strong>&nbsp;AGE</strong></td>\n<td>&nbsp; &nbsp; &nbsp; child</td>\n<td>&nbsp; &nbsp; &nbsp; adult</td>\n<td>&nbsp; &nbsp; &nbsp;adult</td>\n</tr>\n<tr>\n<td><strong>&nbsp;PROGNOSIS</strong></td>\n<td>&nbsp; &nbsp; &nbsp;good</td>\n<td>&nbsp; intermediate</td>\n<td>&nbsp; &nbsp; &nbsp; poor</td>\n</tr>\n<tr>\n<td><strong>&nbsp;STAINS</strong></td>\n<td>&nbsp; &nbsp; &nbsp; PAS+</td>\n<td>&nbsp; &nbsp; &nbsp;PAS+</td>\n<td>\n<p>&nbsp; &nbsp; PAS-</p>\n<p>&nbsp; &nbsp; SBB+</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(814, 'Pathology,', 'PM2429. Causes of Thrombocytopenia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>I.&nbsp;Decreased Production of Platelets</strong></p>\n<ol>\n<li>Selective impairment of platelet production<br>\n<ul>\n<li>Drug-induced: alcohol, thiazides, cytotoxic drugs</li>\n<li>Infections: measles, human immunodeficiency virus (HIV)</li>\n</ul>\n</li>\n<li>Nutritional deficiencies - B<sub>12</sub>, folate deficiency</li>\n<li>Bone marrow failure - aplastic anemia</li>\n<li>Bone marrow replacement - leukemia, disseminated cancer, granulomatous disease</li>\n<li>Ineffective hematopoiesis - myelodysplastic syndromes&nbsp;</li>\n</ol>\n<p><strong>II. Decreased Platelet Survival</strong></p>\n<ol>\n<li>Immunologic destruction\n<ul>\n<li>Primary autoimmune - chronic immune thrombocytopenic purpura, acute immune thrombocytopenic purpura</li>\n<li>Secondary autoimmune - systemic lupus erythematosus, B-cell lymphoid neoplasms</li>\n<li>Alloimmune - posttransfusion and neonatal</li>\n<li>Drug-associated - quinidine, heparin, sulfa compounds</li>\n<li>Infections - HIV, infectious mononucleosis (transient, mild), dengue fever</li>\n</ul>\n</li>\n<li>Nonimmunologic destruction\n<ul>\n<li>Disseminated intravascular coagulation</li>\n<li>Thrombotic microangiopathies</li>\n<li>Giant hemangiomas</li>\n</ul>\n</li>\n</ol>\n<p><strong>III. Sequestration -&nbsp;</strong>The&nbsp;spleen&nbsp;normally sequesters&nbsp;30% to 35%&nbsp;of&nbsp;platelets. This can rise to 80% to 90% when the spleen is enlarged, producing moderate degrees of thrombocytopenia.</p>\n<p><strong>IV. Dilution - </strong>Transfusions</p></div><!---->\n      <!---->\n    </div><!---->'),
(815, 'Pathology,', 'PM2423. Burkitts Lymphoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Burkitts lymphoma is the most common non-Hodgkins lymphoma in children &lt; 15 years.</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;Parameter</td>\n<td>&nbsp;Features</td>\n</tr>\n<tr>\n<td>Genetic factors</td>\n<td>\n<p>Translocations -&nbsp;t(8;14), t(2;8), t(8,22)</p>\n</td>\n</tr>\n<tr>\n<td>Clinical types</td>\n<td>\n<p><strong>Endemic -</strong>&nbsp;affects children in Africa, affects jaw, maxilla and is EBV-associated</p>\n<p><strong>Sporadic -</strong>&nbsp;in adults in western countries&nbsp;</p>\n<p><strong>Immunodeficiency </strong>associated<strong> -</strong>&nbsp;HIV infection</p>\n</td>\n</tr>\n<tr>\n<td>Clinical features</td>\n<td>\n<p>Peripheral lymphadenopathy</p>\n<p>Intrabdominal mass</p>\n<p>Rapid CNS metastasis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Histology</td>\n<td>\n<p>Starry sky pattern</p>\n<p>Ki-67 stains for 100% of cells (due to&nbsp;rapid proliferation)</p>\n</td>\n</tr>\n<tr>\n<td>Immunophenotype</td>\n<td>\n<p><strong>B cell</strong>-associated antigens (CD19, CD20, CD22, CD79a)</p>\n<p><strong>Germinal center</strong>-associated markers (CD10 &amp; BCL-6)</p>\n<p>CD<strong>43</strong>,&nbsp;<strong>BCL-2</strong>&nbsp;in up to 20% of cases</p>\n<p>Expression of CD21 (the&nbsp;<span class=\nowrap\>EBV/C3d</span>&nbsp;receptor) depends on EBV status of the tumors:</p>\n<ul>\n<li><strong>Endemic</strong> type<strong>&nbsp;</strong>(EBV+) -&nbsp;<strong>CD21</strong></li>\n<li>Non-endemic&nbsp;type (EBV-) - lack CD21</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Treatment</td>\n<td>\n<p>Started immediately after diagnosis</p>\n<p>Intensive chemotherapy regimens with high doses of cyclophosphamide</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Prognosis</td>\n<td>&nbsp;Good -&nbsp;70-80% cure rate</td>\n</tr>\n</tbody>\n</table>\n<p>A variant of this condition with bone marrow involvement is called Burkitts leukemia (<strong>ALL-L3</strong>). It is associated with <strong>c-myc</strong> dysregulation.</p></div><!---->\n      <!---->\n    </div><!---->'),
(816, 'Pathology,', 'PM2420. Causes of Iron Deficiency Anemia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Dietary lack</strong></p>\n<ul>\n<li>Infants, who are at high risk due to the very small amounts of iron in milk. Human breast milk provides only about 0.3 mg/L of iron.</li>\n<li>The impoverished, who can have suboptimal diets for socioeconomic reasons at any age</li>\n<li>Older adults, who often have restricted diets with little meat because of limited income or poor dentition</li>\n<li>Teenagers, who subsist on junk food</li>\n</ul>\n<p><strong>Impaired absorption</strong></p>\n<ul>\n<li>Sprue</li>\n<li>Gastrectomy (Billroth II surgery)</li>\n</ul>\n<p><strong>Increased requirement</strong></p>\n<ul>\n<li>Growing infants, children, and adolescents</li>\n<li>Premenopausal women, particularly during pregnancy.</li>\n<li>Economically deprived women having multiple, closely spaced pregnancies are at exceptionally high risk.</li>\n</ul>\n<p><strong>Chronic blood loss</strong></p>\n<ul>\n<li>Menorrhagia</li>\n<li>Carcinoma of the cecum</li>\n<li>Hookworm infestation</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(817, 'Pathology,', 'PM2146. Differential Diagnosis of Microcytic Anaemia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Investigation</td>\n<td><strong>Iron- Deficiency Anemia</strong></td>\n<td><strong>Alpha or beta thalassemia</strong></td>\n<td><strong>Anemia of Chronic Disease</strong></td>\n</tr>\n<tr>\n<td><strong>Serum Iron</strong></td>\n<td>&lt;60 µg/dL</td>\n<td>Normal/Increased</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td><strong>Serum Ferritin</strong></td>\n<td>&lt;20 µg/L</td>\n<td>Normal/Increased</td>\n<td>Increased</td>\n</tr>\n<tr>\n<td><strong>TIBC</strong></td>\n<td>Increased</td>\n<td>Normal</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td><strong>Transferrin saturation</strong></td>\n<td>&lt;15%</td>\n<td>Normal</td>\n<td>Normal/Decreased</td>\n</tr>\n<tr>\n<td><strong>MCV</strong></td>\n<td>Decreased</td>\n<td>&nbsp;Decreased</td>\n<td>Normal/Decreased</td>\n</tr>\n<tr>\n<td><strong>RBC count</strong></td>\n<td>Decreased</td>\n<td>Normal/Increased</td>\n<td>Normal/Increased</td>\n</tr>\n</tbody>\n</table>\n<p>TIBC: Total iron-binding capacity&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(818, 'Pathology,', 'PM2064. Thalassemia syndromes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Normally each individual carries 4 functional alpha chain genes and 2 functional beta chain genes. Alpha and beta-thalassemia are inherited disorders in which there is reduced production of alpha-globin or beta-globin chains, respectively.</p>\n<ul>\n<li><strong>Alpha thalassemia:</strong>&nbsp;Gene deletion is the most common cause of reduced α-chain synthesis.</li>\n<li><strong>Beta +- thalassemia:</strong>&nbsp;The most common cause is splicing mutation.</li>\n<li><strong>Beta 0- thalassemia:</strong>&nbsp;Chain terminator mutations are the most common cause.</li>\n</ul>\n<p>The table below describes the features of typical thalassemia syndromes:</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td><strong>Alpha thalassemias</strong></td>\n<td><strong>&nbsp;Hb Barts</strong></td>\n<td><strong>HbH disease&nbsp;</strong></td>\n<td><strong>Minor</strong></td>\n<td><strong>Silent carrier</strong></td>\n</tr>\n<tr>\n<td><strong>Genotype</strong></td>\n<td>(-&nbsp;- /&nbsp;-&nbsp;- )</td>\n<td>\n<p>(α -/ - -)</p>\n<p>or</p>\n<p>(α<span>*</span> -/&nbsp;-&nbsp;-)</p>\n</td>\n<td>\n<p>(α -/α -)</p>\n<p>or</p>\n<p>(α&nbsp;α/-&nbsp;-)</p>\n</td>\n<td>(α&nbsp;α/α -)</td>\n</tr>\n<tr>\n<td><strong>Laboratory findings</strong></td>\n<td>Severe microcytic anemia with hydrops fetalis; fatal in utero</td>\n<td>Moderate microcytic anemia</td>\n<td>Mild microcytic anemia</td>\n<td>Normal hemoglobin, normal MCV</td>\n</tr>\n<tr>\n<td><strong>Hemoglobin electro-phoresis</strong></td>\n<td>Hb Barts (γ globin tetramers); Hb Portland (embryonic hemoglobin); no HbF, HbA, or HbA<sub>2</sub></td>\n<td>HbH (beta-globin tetramers -up to 30%); HbA<sub>2 </sub>(up to 4%)</td>\n<td>Hb Barts (3 to 8%)</td>\n<td>Normal</td>\n</tr>\n</tbody>\n</table>\n<p>\-\ denotes deletion of an alpha gene and \α\ denotes normal alpha gene and \α* \ refers to a mutant alpha chain gene.</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td><strong>Beta thalassemias</strong></td>\n<td><strong>Major (transfusion-dependent)</strong></td>\n<td><strong>Intermedia (non-transfusion-dependent)</strong></td>\n<td><strong>Minor (also called trait or carrier)</strong></td>\n</tr>\n<tr>\n<td><strong>Genotype</strong></td>\n<td>\n<p>β<sup>0</sup>/β<sup>0</sup></p>\n<p>or</p>\n<p>β<sup>0</sup>/β<sup>+</sup>&nbsp;</p>\n</td>\n<td>\n<p>β<sup>+</sup>/ β<sup>+</sup></p>\n</td>\n<td>\n<p>β/β<sup>0</sup></p>\n<p>or</p>\n<p>β/β<sup>+</sup></p>\n</td>\n</tr>\n<tr>\n<td><strong>Laboratory findings</strong></td>\n<td>Severe microcytic anemia with target cells (typical Hb 3 to 4 g/dL)</td>\n<td>Moderate microcytic anemia</td>\n<td>Mild microcytic anemia</td>\n</tr>\n<tr>\n<td><strong>Hemoglobin electrophoresis</strong></td>\n<td>HbA<sub>2 </sub>(5% or more); HbF (up to 95%); no HbA</td>\n<td>HbA<sub>2</sub> (4% or more); HbF (up to 50%)</td>\n<td>HbA<sub>2</sub> (4% or more); HbF (up to 5%)</td>\n</tr>\n</tbody>\n</table>\n<p>β<sup>0</sup> refers to no beta-globin production; β<sup>+</sup> refers to decreased beta-globin production.</p></div><!---->\n      <!---->\n    </div><!---->'),
(819, 'Pathology,', 'PM1998. Important Translocations in AML', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>Translocation</td>\n<td>t(8,21)\n<p>(most common)&nbsp;</p>\n</td>\n<td>t(15,17)</td>\n<td>t(16,16) or inv(16)</td>\n</tr>\n<tr>\n<td>Fusion gene</td>\n<td>\n<p>RUNX1-RUNX1T1</p>\n</td>\n<td>PML-RARα</td>\n<td>CBF-β (Core binding factor)</td>\n</tr>\n<tr>\n<td>FAB classification</td>\n<td>\n<p>Blasts with maturation/M2</p>\n</td>\n<td>Acute promyelocytic leukemia/M3</td>\n<td>Myelomonocytic/M4</td>\n</tr>\n<tr>\n<td>Clinical association</td>\n<td>Myeloid sarcoma/ chloroma</td>\n<td>DIC</td>\n<td>Eosinophilia</td>\n</tr>\n<tr>\n<td>Prognosis</td>\n<td>Good</td>\n<td>Very good</td>\n<td>Good</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(820, 'Pathology', 'PM1965. International Staging System (ISS) for multiple myeloma:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>International Staging System (ISS) for multiple myeloma:</strong></p>\n<table width=\309\>\n<tbody>\n<tr>\n<td>β2 microglobulin (mg/dL) and albumin (g/dL) level</td>\n<td>Stage</td>\n<td>Median survival months</td>\n</tr>\n<tr>\n<td>\n<p>β2M &lt; 3.5</p>\n<p>alb&nbsp;≥3.5</p>\n</td>\n<td>I</td>\n<td>62</td>\n</tr>\n<tr>\n<td>\n<p>β2M &lt; 3.5, alb &lt; 3.5</p>\n<p>or&nbsp;β2M = 3.5-5.5</p>\n</td>\n<td>II</td>\n<td>44</td>\n</tr>\n<tr>\n<td>β2M &gt; 5.5</td>\n<td>III</td>\n<td>29</td>\n</tr>\n</tbody>\n</table>\n<p>ISS is the most widely used method of assesing prognosis in multiple myeloma.</p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(821, 'Medicine,', 'PM1951. Platelet disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8a852ed6ad094d22b4add695e1529e87x1280x1740.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Finding</strong></p>\n</td>\n<td>\n<p><strong>Bernard–Soulier syndrome</strong></p>\n</td>\n<td>\n<p><strong>Glanzmann’s thrombasthenia</strong></p>\n</td>\n<td>\n<p><strong>von Willebrand Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Inheritance</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n<td>Most common (type 1): Autosomal dominant</td>\n</tr>\n<tr>\n<td>&nbsp;Defect</td>\n<td>\n<p>Absence of Gp Ib-IX-V receptor</p>\n</td>\n<td>Absence of&nbsp;Gp IIb/IIIa receptor</td>\n<td>\n<p>Type 1: Partial quantitative deficiency of&nbsp;von Willebrand factor (VWF)</p>\n<p>Type 2: Qualitative defect of VWF</p>\n<p>Type 3: Complete quantitative deficiency of VWF&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Mechanism</td>\n<td>\n<p>Lack of Gp Ib-IX-V prevents platelet <strong>adhesion</strong> to VWF</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Platelets cannot <strong>aggregate</strong> as Gp IIb/IIIa normally binds&nbsp;fibrinogen and forms bridges between platelets&nbsp;</p>\n</td>\n<td>\n<p>There are 2 mechanisms:</p>\n<p>Platelet <strong>adhesion</strong> defect - due to absent vWF that normally binds to GPIB-IX and collagen in the subendothelium</p>\n<p>Factor VIII deficiency as&nbsp;vWF usually prevents its degradation</p>\n</td>\n</tr>\n<tr>\n<td>Platelet count&nbsp;</td>\n<td>Normal platelet count/ mild thrombocytopenia&nbsp;</td>\n<td>Normal</td>\n<td>Normal (except in type 2B- thrombocytopenia)</td>\n</tr>\n<tr>\n<td>Platelet morphology</td>\n<td>Large platelets/ megathrombocytes with dense granules</td>\n<td>Normal</td>\n<td>&nbsp;Normal/ large</td>\n</tr>\n<tr>\n<td>Bleeding time</td>\n<td>\n<p>Prolonged</p>\n</td>\n<td>Prolonged</td>\n<td>&nbsp;Prolonged</td>\n</tr>\n<tr>\n<td>Platelet aggregation tests (collagen, ADP, thrombin)</td>\n<td>Normal</td>\n<td>Abnormal</td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td>Ristocetin aggregation test</td>\n<td>\n<p>Abnormal (platelets does not aggregate)</p>\n<p>Does not normalize&nbsp;after addition of normal serum</p>\n</td>\n<td>\n<p>Normal</p>\n<p>(aggregation of platelets)</p>\n</td>\n<td>Abnormal, Normalizes after addition of normal serum</td>\n</tr>\n<tr>\n<td>VWF factor levels</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;Decreased</td>\n</tr>\n<tr>\n<td>PT/PTT</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>&nbsp;PT normal, aPTT prolonged</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(822, 'Pathology,', 'PM1949. Differences between Bleeding Disorders and Coagulation disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Finding</strong></td>\n<td><strong>Bleeding disorders</strong></td>\n<td><strong>Coagulation disorders</strong></td>\n</tr>\n<tr>\n<td>Cause</td>\n<td>\n<p>Quantitative/ Qualitative platelet abnormality</p>\n</td>\n<td>Deficiency of clotting factors</td>\n</tr>\n<tr>\n<td>Sex</td>\n<td>More common in females (commonly autoimmune)</td>\n<td>More common in males (commonly X-linked)</td>\n</tr>\n<tr>\n<td>Family history</td>\n<td>Rare (except in VWD)</td>\n<td>Common</td>\n</tr>\n<tr>\n<td>Petechiae</td>\n<td>Characteristic</td>\n<td>&nbsp;Rare</td>\n</tr>\n<tr>\n<td>Superficial ecchymosis</td>\n<td>Small and Multiple</td>\n<td>Large and Solitary</td>\n</tr>\n<tr>\n<td>Bleeding from superficial cuts&nbsp;</td>\n<td>Profuse</td>\n<td>Minimal persistent</td>\n</tr>\n<tr>\n<td>Hemarthrosis</td>\n<td>Rare</td>\n<td>Characteristic (most common-knee)</td>\n</tr>\n<tr>\n<td>Deep dissecting hematomas</td>\n<td>Rare</td>\n<td>Characteristic (most common-iliopsoas)</td>\n</tr>\n<tr>\n<td>Laboratory tests</td>\n<td>Bleeding time is prolonged</td>\n<td>PT and/or PTT are prolonged</td>\n</tr>\n<tr>\n<td>Most common</td>\n<td>Inherited: VWD</td>\n<td>\n<p>Inherited: Hemophilia A</p>\n<p>Acquired: Hemorrhagic diathesis of liver disease</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>VWD:&nbsp;von Willebrand disease</p>\n<p>PT: Prothrombin time</p>\n<p>PTT: Partial thromboplastin time</p></div><!---->\n      <!---->\n    </div><!---->'),
(823, 'Pathology,', 'PM1925. Skeletal and Radiological manifestation of  Langerhan’s Cell Histiocytosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Skull:</strong></p>\n<p>Solitary or multiple punched out lytic lesion without sclerotic rim.<br>Double contour or beveled edge appearance may be seen due to asymmetrical involvement of the inner and outer table (hole within a hole sign).<br>Button sequestra representing residual bone.<br>Geographic skull.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/504d808c549645b0bcadbcefbb529c39x720x655.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Spine:</strong></p>\n<p><strong>Vertebra Plana</strong>:it is the most common cause of vertebra plana in children;mostly seen in the thoracic spine.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0469c0ef21f44d53aefb652fcca8f295x720x845.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Mandible:</strong></p>\n<p>Irregular radiolucent areas mostly involving superficial alveolar bone.</p>\n<p><strong>Floating tooth</strong>: loss of lamina dura.</p>\n<p><strong>Long Bones:</strong></p>\n<ul>\n<li>Permeative and aggressive appearing lesions occur</li>\n<li>Mainly involves <strong>diaphysis</strong> or <strong>meta diaphysis</strong></li>\n<li>Endosteal scalloping, Periosteal reaction(in healing phase),cortical thinning,intracortical tunneling and associated soft tissue mass can be seen.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(824, 'Pathology', 'PM1870. Causes of Leukocytosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Type of Leukocytosis</strong></td>\n<td><strong>Causes</strong></td>\n</tr>\n<tr>\n<td>Neutrophilic leukocytosis</td>\n<td>Acute bacterial infections, sterile inflammation (myocardial infarction, burns)</td>\n</tr>\n<tr>\n<td>Eosinophilic leukocytosis (eosinophilia)</td>\n<td>Allergic disorders such as asthma, hay fever, parasitic infestations; drug reactions; certain malignancies (e.g., Hodgkin and some non-Hodgkin lymphomas); auto-immune disorders (e.g., pemphigus, dermatitis herpetiformis) and some vasculitides</td>\n</tr>\n<tr>\n<td>Basophilic leukocytosis (basophilia)</td>\n<td>Myeloproliferative disease (e.g., chronic myelogenous leukemia)</td>\n</tr>\n<tr>\n<td>Monocytosis</td>\n<td>Chronic infections (e.g., tuberculosis), bacterial endocarditis, rickettsiosis, and malaria; autoimmune disorders (e.g., systemic lupus erythematosus); inflammatory bowel diseases (e.g., ulcerative colitis)</td>\n</tr>\n<tr>\n<td>Lymphocytosis</td>\n<td>Chronic immunologic stimulation (e.g., tuberculosis, brucellosis); viral infections (e.g., hepatitis A, cytomegalovirus, Epstein–Barr virus); <em>Bordetella pertussis</em> infection</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(825, 'Pathology', 'PM1865. Ann Arbor Staging for Hodgkin and NonHodgkin Lymphoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Distribution</strong> <strong>of</strong> <strong>disease</strong></td>\n</tr>\n<tr>\n<td>I</td>\n<td>\n<p>Involvement of a single lymph node region (I) or&nbsp;</p>\n<p>a single extra lymphatic organ or site (IE)</p>\n</td>\n</tr>\n<tr>\n<td>II</td>\n<td>\n<p>Involvement of two or more lymph node regions on the same sideof the diaphragm alone (II)</p>\n<p>or</p>\n<p>localised involvement of an&nbsp;extra lymphatic organ or site (IIE)</p>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td>\n<p>Involvement of lymphnode regions on both sides of the diaphragm&nbsp;</p>\n<p>without (III) or with (IIIE) localised involvement of an</p>\n<p>extra lymphatic organ or site</p>\n</td>\n</tr>\n<tr>\n<td>IV</td>\n<td>\n<p>Diffuse involvement of one or more extra lymphatic organs or sites</p>\n<p>with or without lymphatic involvement&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>All stages are further divided on the basis of the absence (A) or presence (B) of fever, night sweats and/or unexplained weight loss &gt;10% of body weight.</p></div><!---->\n      <!---->\n    </div><!---->'),
(826, 'Pathology,', 'PM1858. Comparison between Properties of Various Types of Polycythemia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\472\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Plasma volume</td>\n<td>RBC Mass</td>\n<td>O<sub>2&nbsp;</sub>saturation</td>\n<td>EPO concentration</td>\n</tr>\n<tr>\n<td>\n<p>Relative</p>\n<p>polycythemia</p>\n</td>\n<td><strong>&nbsp; &nbsp; ↓</strong></td>\n<td><strong>N</strong></td>\n<td><strong>N</strong></td>\n<td><strong>N</strong></td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia</p>\n<p>vera</p>\n</td>\n<td><strong>&nbsp; &nbsp; ↑</strong></td>\n<td><strong> ↑</strong></td>\n<td><strong>N</strong></td>\n<td><strong>&nbsp; ↓</strong></td>\n</tr>\n<tr>\n<td>\n<p>EPO- producing tumors</p>\n</td>\n<td><strong>N</strong></td>\n<td><strong> ↑</strong></td>\n<td><strong>N</strong></td>\n<td><strong> ↑</strong></td>\n</tr>\n<tr>\n<td>\n<p>Hypoxia</p>\n<p>(High altitude)</p>\n</td>\n<td><strong>N</strong></td>\n<td><strong> ↑</strong></td>\n<td><strong>&nbsp; ↓</strong></td>\n<td><strong> ↑</strong></td>\n</tr>\n</tbody>\n</table>\n<p>EPO: Erythropoietin</p></div><!---->\n      <!---->\n    </div><!---->'),
(827, 'Pathology', 'PM1857. Pathophysiologic Classification of Polycythemia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Pathophysiological classification of polycythemia</strong></p>\n<table width=\458\>\n<tbody>\n<tr>\n<td><strong>Relative</strong></td>\n</tr>\n<tr>\n<td>Reduced plasma volume (hemoconcentration)</td>\n</tr>\n<tr>\n<td><strong>Absolute</strong></td>\n</tr>\n<tr>\n<td><strong>Primary</strong> (Low Erythropoietin)</td>\n</tr>\n<tr>\n<td>Polycythemia vera<br>Inherited erythropoietin receptor mutations (rare)</td>\n</tr>\n<tr>\n<td><strong>Secondary</strong> (High Erythropoietin)</td>\n</tr>\n<tr>\n<td>Compensatory<br>\n<ul>\n<li>Lung disease</li>\n<li>High-altitude living</li>\n<li>Cyanotic heart disease</li>\n</ul>\nParaneoplastic<br>\n<ul>\n<li>Erythropoietin-secreting tumors (e.g., renal cell carcinoma, hepatocellular carcinoma, cerebellar hemangioblastoma)</li>\n</ul>\n<p>Hemoglobin mutants with high O<sub>2</sub> affinity</p>\n<p>Inherited defects that stabilize HIF-1α</p>\n<ul>\n<li>Chuvash polycythemia (homozygous VHL mutations)</li>\n<li>Prolyl hydroxylase mutations</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(828, 'Pathology,', 'PM1554. Schilling Test', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The Schilling test is done to determine the <strong>cause</strong> of <strong>vitamin B12 deficiency.</strong> It involves the administration of radiolabeled vitamin B12&nbsp;followed by the 24-hour&nbsp;collection of urine. The test is then repeated with an&nbsp;additional component&nbsp;that can promote vitamin B12 absorption.&nbsp;If the additional component is able to correct the defect and radiolabeled vitamin B12 is absorbed, it will be detected in the urine.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5d3f9735577a4affb67cd119f1540ba0x1280x2246.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(829, 'Pathology', 'PM1470. 2016 Criteria for Primary Myelofibrosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\440\>\n<tbody>\n<tr>\n<td>\n<p><strong>WHO overt PMF criteria</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Major criteria</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Presence of megakaryocytic proliferation and atypia, accompanied by either reticulin and/or collagen fibrosis grades 2 or 3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Not meeting WHO criteria for ET, PV, <em>BCR-ABL1</em><sup>+</sup>&nbsp;CML, myelodysplastic syndromes, or other myeloid neoplasms</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Presence of <em>JAK2</em>, <em>CALR</em>, or&nbsp;<em>MPL&nbsp;</em>mutation or in the absence of these mutations, presence of another clonal marker,&lt;<sup>†</sup>&nbsp;or absence of reactive myelofibrosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Minor criteria</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Presence of at least 1 of the following, confirmed in 2 consecutive determinations:</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anemia not attributed to a comorbid condition</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Leukocytosis ≥11 × 10 <sup>9</sup>/L</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Palpable splenomegaly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>LDH increased to more than the upper normal limit of the&nbsp;institutional reference range</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Leukoerythroblastosis</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>ET: Essential thrombocythemia&nbsp;</p>\n<p>PV: Polycythemia vera</p>\n<p>CML: Chronic myeloid leukemia</p>\n<p>LDH: Lactate dehydrogenase</p></div><!---->\n      <!---->\n    </div><!---->'),
(830, 'Pathology', 'PM1467. Leucocyte Alkaline Phosphatase Score', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Alkaline phosphatase activity is found predominantly in&nbsp;<strong>mature segmented neutrophils</strong>. LAP score is obtained by assessing the&nbsp;<strong>staining intensity</strong>&nbsp;in 100 consecutive neutrophils, with each neutrophil scored on a scale of 1–4.&nbsp;</p>\n<p><strong>Conditions</strong> that result in an <strong>increase</strong> in <strong>leukocytes</strong> in all stages of maturity will reflect a corresponding <strong>increase</strong> in <strong>LAP</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Elevated LAP score</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Decreased LAP score</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Leukemoid reaction</p>\n</td>\n<td width=\231\>\n<p>Chronic myeloid leukemia (CML)</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Pregnancy</p>\n</td>\n<td width=\231\>\n<p>Paroxysmal nocturnal hemoglobinuria</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Polycythemia vera</p>\n</td>\n<td width=\231\>\n<p>Sickle cell anemia</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Multiple myeloma</p>\n</td>\n<td width=\231\>\n<p>Hypophosphatasia</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Obstructive jaundice</p>\n</td>\n<td width=\231\>\n<p>Aplastic anemia</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Hodgkin lymphoma</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(831, 'Pathology', 'PM1466. Abnormalities Associated with Juvenile Myelomonocytic Leukemia (JMML) and Myelodysplastic Syndrome (MDS) in Children', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Juvenile myelomonocytic leukemia (JMML) is associated with all of the above.</p>\n<p>JMML:</p>\n<ul>\n<li>Formerly called juvenile chronic myelogenous leukemia</li>\n<li>Resembles Chronic myelomonocytic leukemia (CMML) more than chronic myeloid leukemia (CML)</li>\n<li>70% of the patients are children less than 3 years old, with patients ranging from 1-month-old infants to teenagers</li>\n<li><strong>In 10% of the cases, neurofibromatosis 1 and deletion of the&nbsp;<em>NF1</em> gene is observed.</strong></li>\n<li>The hallmark of JMML is hypersensitivity of marrow progenitors to granulocyte-monocyte colony stimulating factor (GM-CSF) in vitro.&nbsp;</li>\n<li>The varied clinical presentation may include failure to thrive, malaise, fever, bleeding, pallor, lymphadenopathy and hepatosplenomegaly; less frequently skin, lung and GI involvement; and rarely CNS involvement.</li>\n<li><strong>Peripheral blood</strong>: leukocytosis with neutrophilia, monocytosis, nucleated red blood cells</li>\n<li><strong>Bone marrow</strong>: Hypercellular with granulocytic hyperplasia; monocytes, 5–30%; megakaryocytes, decreased; blasts + promonocytes, &lt;20%; dysplasia, not prominent; reticulin fibrosis, rare.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>A. Associated with juvenile myelomonocytic leukemia (JMML)</td>\n</tr>\n<tr>\n<td>\n<p>Constitutional conditions</p>\n<p>Neurofibro type 1 (NF 1)</p>\n<p>Noonan syndrome</p>\n<p>Trisomy 8 mosaicism</p>\n</td>\n</tr>\n<tr>\n<td>B. Associated with myelodysplastic syndrome (MDS)</td>\n</tr>\n<tr>\n<td>\n<p>Constitutional conditions</p>\n<p>Congenital bone marrow failure</p>\n<p>Fanconi conditions</p>\n<p>Kostmann–Diamond anemia</p>\n<p>Trisomy 8 mosaicism</p>\n<p>Familial MDS (at least one first degree relative with MDS/AML)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acquired conditions</p>\n<p>Prior chemotherapy/radiation</p>\n<p>Aplastic anemia</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(832, 'Pathology', 'PM1465. 2016 Classification of MDS/MPN', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\326\>\n<tbody>\n<tr>\n<td width=\326\>\n<p><strong>Myelodysplastic/myeloproliferative neoplasms (MDS/MPN)</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\326\>\n<p>Chronic myelomonocytic leukemia (CMML)</p>\n</td>\n</tr>\n<tr>\n<td width=\326\>\n<p>Atypical chronic myeloid leukemia (aCML), <em>BCR-ABL1</em><sup>−</sup></p>\n</td>\n</tr>\n<tr>\n<td width=\326\>\n<p>Juvenile myelomonocytic leukemia (JMML)</p>\n</td>\n</tr>\n<tr>\n<td width=\326\>\n<p>MDS/MPN with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)</p>\n</td>\n</tr>\n<tr>\n<td width=\326\>\n<p>MDS/MPN, unclassifiable</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(833, 'Pathology', 'PM1464. 2016 Classification of myeloproliferative neoplasms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\297\>\n<tbody>\n<tr>\n<td width=\297\>\n<p><strong>Myeloproliferative neoplasms (MPN)</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\297\>\n<p>Chronic myeloid leukemia (CML), BCR-ABL1<sup>+</sup></p>\n</td>\n</tr>\n<tr>\n<td width=\297\>\n<p>Chronic neutrophilic leukemia (CNL)</p>\n</td>\n</tr>\n<tr>\n<td width=\297\>\n<p>Polycythemia vera (PV)</p>\n</td>\n</tr>\n<tr>\n<td width=\297\>\n<p>Primary myelofibrosis (PMF)</p>\n<ul>\n<li>PMF, prefibrotic/early stage</li>\n<li>PMF, overt fibrotic stage</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\297\>\n<p>Essential thrombocythemia (ET)</p>\n</td>\n</tr>\n<tr>\n<td width=\297\>\n<p>Chronic eosinophilic leukemia, not otherwise specified (NOS)</p>\n</td>\n</tr>\n<tr>\n<td width=\297\>\n<p>MPN, unclassifiable</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(834, 'Pathology', 'PM1461. Classification of MDS', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>NAME</strong></td>\n<td><strong>RING SIDEROBLASTS</strong></td>\n<td><strong>MYELOBLASTS</strong></td>\n</tr>\n<tr>\n<td>MDS with single lineage dysplasia ( MDS- SLD)</td>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>&lt;15%</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><br>BM-&lt;5%<br>PS- &lt;1%</p>\n</div>\n</div>\n</div>\n</div>\n<div class=\page\ title=\Page 776\>&nbsp;</div>\n<div class=\page\ title=\Page 776\>&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>MDS with multilineage dysplasia (MDS-MLD)</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>&lt;15%</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>BM-&lt;5%<br>PS- &lt;1%</p>\n</div>\n</div>\n</div>\n</div>\n<div class=\page\ title=\Page 776\>&nbsp;</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>MDS-RS with single lineage dysplasia (MDS-RS-SLD)</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>≥15%</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>BM-&lt;5%<br>PS- &lt;1%</p>\n</div>\n</div>\n</div>\n</div>\n<div class=\page\ title=\Page 776\>&nbsp;</div>\n&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>MDS-RS with multilineage dysplasia (MDS-RS-MLD)</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>≥15%</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>BM-&lt;5%<br>PS- &lt;1%</p>\n</div>\n</div>\n</div>\n</div>\n<div class=\page\ title=\Page 776\>&nbsp;</div>\n&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>MDS with isolated 5q deletion</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>None or any</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>BM-&lt;5%<br>PS- &lt;1%</p>\n</div>\n</div>\n</div>\n</div>\n<div class=\page\ title=\Page 776\>&nbsp;</div>\n&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>MDS with excess blasts (MDS-EB)</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>None or any</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>BM 5-19% OR PS 2-19%</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>MDS, unclassifiable (MDS-U)</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>None or any</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 776\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>BM &lt;5%</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(835, 'Pathology', 'PM1460. Bone Marrow Changes in Myelodysplastic Syndrome (MDS)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The myelodysplastic syndrome can lead to dysplasia of the erythroid series, myeloid series, and megakaryocytes.</p>\n<p>Dysplasia of erythroid series:</p>\n<ul>\n<li><strong>Megaloblastoid maturation&nbsp;</strong>- Abnormally large erythroid cells</li>\n<li><strong>Nuclear budding abnormalities&nbsp;</strong>- Nucleus with abnormal shape</li>\n<li><strong>Ring sideroblasts&nbsp;</strong>- Erythroblasts with stainable iron in the cytoplasm&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5a79f916cf5b46d2a1ad0f781dddef8dx798x599.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p>Dysplasia of myeloid series:</p>\n<ul>\n<li>Neutrophils with a decreased number of secondary granules</li>\n<li class=\p1\><strong>Pseudo-Pelger-Hüet cells</strong>- neutrophils with only <strong>two nuclear lobes</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8fff2b32c6624e1da540ca3d292db163x359x512.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p class=\p1\>&nbsp;</p>\n<p class=\p1\>Dysplasia of the megakaryocytes:</p>\n<ul>\n<li class=\p1\>Megakaryocyte with single nuclear lobe</li>\n<li class=\p1\><strong>Pawn ball megakaryocytes</strong>- cells with multiple separate nuclei</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/bc059ad7c9c0487cad202d46105ccdafx512x465.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>If only one lineage is affected, then it is called single lineage dysplasia. If multiple lineages are affected, then it is called multilineage dysplasia. If the percentage of ring sideroblasts is more than 15% it is called MDS with ring sideroblasts (MDS-RS).</p></div><!---->\n      <!---->\n    </div><!---->'),
(836, 'Pathology', 'PM1451. Blood Transfusion Reactions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\4\><span><strong>Immunological Transfusion Reactions</strong>&nbsp;&nbsp;&nbsp;&nbsp;</span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Reaction<br></strong></span><span><strong>(Onset)</strong></span></p>\n</td>\n<td><span><strong>Mechanism</strong></span></td>\n<td><span><strong>Presentation</strong></span></td>\n<td><span><strong>Management</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Anaphylactic transfusion reaction</strong></span></p>\n<p><span>(Seconds-minutes)</span></p>\n</td>\n<td>\n<p><span>Common in<strong> IgA</strong> deficient recipients&nbsp;</span></p>\n</td>\n<td>\n<p><span>Shock, respiratory distress, angioedema</span></p>\n</td>\n<td>\n<p>Stop transfusion immediately, give epinephrine</p>\n<p><span>Prevention – using IgA deficient plasma and washed cellular blood components</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Allergic/ Urticarial transfusion reaction</strong></span></p>\n<p><span>(Within 2-3 hours)</span></p>\n</td>\n<td>\n<p><span>Recipient <strong>IgE</strong> against donor components causing mast cell activation</span></p>\n</td>\n<td>\n<p><span>Urticaria, flushing, pruritus</span></p>\n</td>\n<td>\n<p><span>Stop transfusion immediately, aggressively manage with IV fluids</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Febrile non-hemolytic transfusion reaction</strong></span></p>\n<p><span>(within&nbsp;</span><span>6h)</span></p>\n<p>&nbsp;</p>\n<p><span><span>(Most common complication of blood transfusion)</span></span></p>\n</td>\n<td>\n<p><span>Antibodies against donor WBC and <strong>HLA</strong> antigens (sensitization)</span></p>\n<p><span>Cytokine accumulation during blood storage</span></p>\n<p><span>More common in multipally transfused patients and multiparous women</span></p>\n</td>\n<td>\n<p><span>Fever and chills sometimes with mild dyspnoea</span></p>\n</td>\n<td>\n<p><span>Antihistamines and antipyretics</span></p>\n<p><span>Transfusion can be stopped if symptoms are severe</span></p>\n<p>Prevention: Leukoreduced products</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Transfusion-related acute lung injury (TRALI)</strong></span></p>\n<p><span>(1-6 hours)</span></p>\n</td>\n<td>\n<p><span>Anti-HLA type 2 antibodies in donor plasma bind recipient WBCs, increase capillary permeability</span></p>\n</td>\n<td>\n<p><span>Hypoxia, non-cardiogenic pulmonary edema</span></p>\n<p><span>CXR: Bilateral interstitial infiltrates</span></p>\n</td>\n<td>\n<p><span>Stop transfusion immediately</span></p>\n<p><span>Supportive care</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Acute hemolytic transfusion reaction</strong></span></p>\n<p><span>(during transfusion to within 24h)</span></p>\n</td>\n<td>\n<p><span>ABO incompatibility</span></p>\n<p><span>(Type 2 hypersensitivity)</span></p>\n<p><span>Pre-existing high affinity IgM antibodies rapidly induce complement mediated lysis, intra-vascular hemolysis, and hemoglobinuria</span></p>\n</td>\n<td>\n<p><span>Fever, chills, flank/back pain</span></p>\n<p><span>Sense of impending doom</span></p>\n<p><span>Hemoglobinuria</span></p>\n<p><span>DIC, Renal failure</span></p>\n<p><span>Coomb’s test positive, pink plasma</span></p>\n</td>\n<td>\n<p><span>Stop transfusion immediately, aggressively manage with IV fluids</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Delayed hemolytic transfusion reaction</strong></span></p>\n<p><span>occurs after 24 hours ( usually 2 weeks )</span></p>\n</td>\n<td>\n<p><span>Recipients have prior exposure to RBC antigens. </span><span>After the transfusion, anamnestic response results in antibody production</span></p>\n<p><span>Typically caused by IgG antibodies to foreign protein antigens and are associated with laboratory features of hemolysis.</span></p>\n</td>\n<td>\n<p><span>Mild fever, hemolytic anemia</span></p>\n<p><span>Coomb’s test positive</span></p>\n<p><span>Screening for new antibodies positive</span></p>\n</td>\n<td>\n<p><span>Supportive care</span></p>\n<p><span>Additional transfusions if needed</span></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><span><strong>Non-immune</strong> mediated transfusion reactions are as follows:</span></p>\n<ul>\n<li><span>Transfusion-associated circulatory overload (TACO)</span></li>\n<li><span>Hypothermia</span></li>\n<li><span>Electrolyte abnormality- hyperkalemia, hypocalcemia</span></li>\n<li><span>Iron overload</span></li>\n<li><span>Transient hypotension</span></li>\n<li><span>Immunomodulation</span></li>\n<li><span>Blood-borne infections&nbsp;</span></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(837, 'Pathology,', 'PM1449. Summary of Laboratory findings in Hemostatic Disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Platelet count</strong></p>\n</td>\n<td>\n<p><strong>Bleeding time</strong></p>\n</td>\n<td>\n<p><strong>PT</strong></p>\n</td>\n<td>\n<p><strong>APTT</strong></p>\n</td>\n<td>\n<p><strong>Comments</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ITP</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Nomal</p>\n</td>\n<td>\n<p>Auto-Antibodies against IIb-IIIa or Ib-IX</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glanzmann thrombasthenia</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Defect in IIb/IIIa</p>\n<p>Autosomal recessive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bernard– Soulier syndrome</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Defect in Ib/IX</p>\n<p>Autosomal recessive</p>\n<p>Large platelets</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>von Willebrand disease</p>\n</td>\n<td>\n<p>Low or normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>3 subtypes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemophilia A and B</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>X-linked inheritance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Liver disease</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin K deficiency</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>DIC</p>\n</td>\n<td>\n<p>Decreased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increase in fibrin degradation products</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Aspirin</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Increased</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Warfarin</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>↑ (Even in</p>\n<p>low dose)</p>\n</td>\n<td>\n<p>↑ (Even in</p>\n<p>low dose)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>ITP:&nbsp;Immune thrombocytopenic purpura</p>\n<p>DIC: Disseminated intravasculation coagulation</p></div><!---->\n      <!---->\n    </div><!---->'),
(838, 'Pathology,', 'PM1440. Causes of Megaloblastic Anemia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Vitamin B12 Deficiency causes:</strong></p>\n<ul>\n<li><strong>Decreased Intake</strong>\n<ul>\n<li>Inadequate diet</li>\n<li>Vegetarianism</li>\n</ul>\n</li>\n<li><strong>Impaired Absorption</strong>\n<ul>\n<li>Intrinsic factor deficiency</li>\n<li>Pernicious anemia</li>\n<li>Gastrectomy</li>\n<li>Malabsorption states</li>\n<li>Diffuse intestinal disease (e.g., lymphoma, systemic sclerosis)</li>\n<li>Ileal resection</li>\n<li>Ileitis</li>\n</ul>\n</li>\n<li><strong>Competitive parasitic uptake</strong>\n<ul>\n<li>Fish tapeworm infestation</li>\n<li>Bacterial overgrowth in blind loops and diverticula of bowel</li>\n</ul>\n</li>\n</ul>\n<p><strong>Folic Acid Deficiency causes:</strong></p>\n<ul>\n<li><strong>Decreased Intake</strong>\n<ul>\n<li>Inadequate diet</li>\n<li>Alcoholism</li>\n<li>Infancy</li>\n</ul>\n</li>\n<li><strong>Impaired Absorption</strong>\n<ul>\n<li>Malabsorption states</li>\n<li>Intrinsic intestinal disease</li>\n<li>Anticonvulsants</li>\n<li>Oral contraceptives</li>\n</ul>\n</li>\n<li><strong>Increased Loss</strong>\n<ul>\n<li>Hemodialysis</li>\n</ul>\n</li>\n<li><strong>Increased Requirement</strong>\n<ul>\n<li>Pregnancy, infancy</li>\n<li>Disseminated cancer</li>\n<li>Markedly increased hematopoiesis</li>\n</ul>\n</li>\n<li><strong>Impaired Utilization</strong>\n<ul>\n<li>Folic acid antagonists</li>\n<li>Unresponsive to vitamin B12 or folic acid therapy</li>\n<li>Metabolic inhibitors of DNA synthesis and/or folate metabolism</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(839, 'Pathology,', 'PM1273. Classification of acquired Immune Hemolytic Anemias', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Clinical setting </strong></p>\n</td>\n<td>\n<p><strong>Warm autoimmune hemolysis </strong></p>\n</td>\n<td>\n<p><strong>Cold autoimmune hemolysis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Antibody (optimal temperature)</p>\n</td>\n<td>\n<p>IgG (37<sup>0</sup> C)</p>\n</td>\n<td>\n<p>IgM (4-30<sup>0</sup>C)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Secondary to viral infection</p>\n</td>\n<td>\n<p>HIV</p>\n<p>Viral vaccines</p>\n</td>\n<td>\n<p>EBV</p>\n<p>CMV</p>\n<p>others</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Secondary to other infection</p>\n</td>\n<td>&nbsp;</td>\n<td>\n<p>Mycoplasma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Associated with</p>\n</td>\n<td>\n<p>SLE</p>\n<p>Chronic lymphocytic leukemia</p>\n<p>Inflammatory bowel disease</p>\n<p>Post allogenic HSCT</p>\n</td>\n<td>\n<p>Waldenstroms Disease</p>\n<p>Lymphoma</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(840, 'Pathology,', 'PM1268. Features of Peripheral Blood Smear in Different Anemias', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Type of anemia </strong></p>\n<p><strong>Microcytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thalassemia trait</p>\n</td>\n<td>\n<p>Basophilic stippling, target cells&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iron-deficiency</p>\n</td>\n<td>\n<p>Elliptocytes, target cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sideroblastic anemia</p>\n</td>\n<td>\n<p>Pappenheimer bodies, RBC dimorphism, ringed sideroblasts (Perl’s stain)&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Macrocytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Myelodysplastic syndrome</p>\n</td>\n<td>\n<p>Hypogranular or hypolobulated neutrophils, blast cells, giant or hypogranular platelets, Pappenheimer bodies</p>\n<p>Minor population of hypochromic / microcytic cells (dimorphic), poikilocytosis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Megaloblastic anemia</p>\n</td>\n<td>\n<p>Hypersegmented neutrophils (&gt;5 lobes), ovalocytes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemolysis</p>\n</td>\n<td>\n<p>Polychromasia (purple reticulocyte) +/- spherocytes&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic liver disease</p>\n</td>\n<td>\n<p>Target cells&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Normocytic anemia</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Diagnosis</strong></p>\n</td>\n<td>\n<p><strong>Peripheral blood smear</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Haemolytic anemia&nbsp;</p>\n</td>\n<td>\n<p>Anisocytosis, poikilocytosis, polychromasia, nucleated red cells&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hereditary spherocytosis</p>\n</td>\n<td>\n<p>RBC lack central zone of pallor, reticulocytosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucose-6-Phosphate-Dehydrogenase (G6PD) deficiency&nbsp;</p>\n</td>\n<td>\n<p>Heinz bodies (revealed by special staining),‘Bite’ cells</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(841, 'Pathology,', 'PM1247. Classification of Hemolytic Anemias', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Hemolytic anemias can be classified in 2 ways:</p>\n<p>1. Based on the <strong>type of defect</strong>:</p>\n<table width=\595\>\n<tbody>\n<tr>\n<td><strong>Type&nbsp;</strong></td>\n<td><strong>Intracorpuscular Defects</strong></td>\n<td><strong>Extracorpuscular Factors</strong></td>\n</tr>\n<tr>\n<td>Hereditary</td>\n<td>\n<p>Hemoglobinopathies</p>\n<p>Enzymopathies</p>\n<p>Membrane-cytoskeletal defects</p>\n</td>\n<td>Familial (atypical) hemolytic uremic syndrome</td>\n</tr>\n<tr>\n<td>Acquired</td>\n<td>Paroxysmal nocturnal hemoglobinuria (PNH)</td>\n<td>\n<p>Mechanical destruction (microangiopathic)</p>\n<p>Toxic agents</p>\n<p>Drugs</p>\n<p>Infectious</p>\n<p>Autoimmune</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>2. Based on the <strong>sites</strong> of <strong>hemolysis:</strong></p>\n<p><strong>Intravascular&nbsp;</strong>hemolysis<strong>:</strong></p>\n<ul>\n<li><span class=\TextRun SCXW225898103\ lang=\EN-GB\><span class=\NormalTextRun SCXW225898103\>Mechanical injury</span></span>\n<ul>\n<li aria-setsize=\-1\>Trauma caused by cardiac valves&nbsp;</li>\n<li aria-setsize=\-1\>Microangiopathic&nbsp;hemolytic&nbsp;anemias&nbsp;(hemolytic&nbsp;uremic syndrome,&nbsp;disseminated intravascular coagulation,&nbsp;thrombotic thrombocytopenic&nbsp;purpura)&nbsp;</li>\n<li aria-setsize=\-1\>Repetitive physical trauma</li>\n</ul>\n</li>\n<li><span class=\TextRun SCXW46333709\ lang=\EN-GB\><span class=\NormalTextRun SCXW46333709\>Complement fixation (antibody-mediated destruction)</span></span>\n<ul>\n<li aria-setsize=\-1\>Hemolytic&nbsp;disease of the&nbsp;newborn&nbsp;</li>\n<li aria-setsize=\-1\>Transfusion reaction&nbsp;&nbsp;</li>\n<li aria-setsize=\-1\>Drug-induced&nbsp;</li>\n</ul>\n</li>\n<li><span class=\TextRun SCXW127641793\ lang=\EN-GB\><span class=\NormalTextRun SCXW127641793\>Infections&nbsp;of red blood cells&nbsp;</span></span>\n<ul>\n<li><span class=\TextRun SCXW127641793\ lang=\EN-GB\><span class=\NormalTextRun SCXW127641793\>Malaria</span></span></li>\n<li><span class=\TextRun SCXW127641793\ lang=\EN-GB\><span class=\NormalTextRun SCXW127641793\>B</span></span><span class=\TextRun SCXW127641793\ lang=\EN-GB\><span class=\SpellingError SCXW127641793\>abesiosis</span></span></li>\n</ul>\n</li>\n<li><span class=\EOP SCXW127641793\><span class=\TextRun SCXW261552469\ lang=\EN-GB\><span class=\NormalTextRun SCXW261552469\>Exogenous toxic factors&nbsp;- c</span></span></span><span class=\EOP SCXW127641793\><span class=\TextRun SCXW261552469\ lang=\EN-GB\><span class=\SpellingError SCXW261552469\>lostridial</span></span><span class=\TextRun SCXW261552469\ lang=\EN-GB\><span class=\NormalTextRun SCXW261552469\>&nbsp;sepsis</span></span></span></li>\n</ul>\n<div class=\ng-scope\>\n<div class=\ng-scope\>\n<p class=\ng-binding\><strong>Extravascular&nbsp;</strong>hemolysis<strong>:</strong></p>\n<ul>\n<li>Hereditary spherocytosis</li>\n<li>Thalassemia</li>\n<li>Sickle cell anemia</li>\n</ul>\n<p><strong>Both</strong>&nbsp;intravascular and extravascular hemolysis:</p>\n<ul>\n<li>G6PD deficiency</li>\n<li>Autoimmune hemolytic anemia</li>\n</ul>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(842, 'Medicine,', 'PM1244. WHO classification of Acute Myeloid Leukemia (AML)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The 5th edition of WHO (2022) classification classifies&nbsp;acute myeloid&nbsp;leukemia (AML) as follows:</p>\n<p><strong>AML with defining genetic abnormalities&nbsp;(gene or chromosome changes):</strong></p>\n<ul>\n<li aria-level=\1\>Acute promyelocytic leukemia with PML::RARA fusion</li>\n<li aria-level=\1\>AML with RUNX1::RUNX1T1 fusion</li>\n<li aria-level=\1\>AML with CBFB::MYH11 fusion</li>\n<li aria-level=\1\>AML with DEK::NUP214 fusion</li>\n<li aria-level=\1\>AML with RBM15::MRTFA fusion</li>\n<li aria-level=\1\>AML with BCR::ABL1 fusion</li>\n<li aria-level=\1\>AML with KMT2A rearrangement<sup>*</sup></li>\n<li aria-level=\1\>AML with MECOM rearrangement</li>\n<li aria-level=\1\>AML with NUP98 rearrangement</li>\n<li aria-level=\1\>AML with NPM1 mutation</li>\n<li aria-level=\1\>AML with CEBPA mutation</li>\n<li aria-level=\1\>AML, myelodysplasia-related<sup>#</sup></li>\n<li aria-level=\1\>AML with other defined genetic alterations</li>\n</ul>\n<p>&nbsp;<strong>AML, defined by differentiation:</strong></p>\n<ul>\n<li>AML with minimal differentiation</li>\n<li>AML without maturation</li>\n<li>AML with maturation</li>\n<li>Acute basophilic leukaemia</li>\n<li>Acute myelomonocytic leukaemia</li>\n<li>Acute monocytic leukaemia</li>\n<li>Acute erythroid leukaemia</li>\n<li>Acute megakaryoblastic leukemia</li>\n</ul>\n<p>Most AML with defining&nbsp;genetic abnormalities are diagnosed with &lt; 20% blasts except AML with BCR: ABL1 and AML with CEBPA mutation that require at least 20% blasts for diagnosis.</p>\n<p><span>*AML with KMT2A rearrangement is the new term that replaces “AML with t(9;11)(p22;q23); KMT2A-MLLT3</span></p>\n<p><span>#AML with myelodysplasia-related changes has been renamed as AML, myelodysplasia-related (AML-MR).</span></p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(843, 'Pathology', 'PM1235. Cytogenetic Translocation and Associated Oncogenes Often Seen in Lymphoid Malignancies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\686\>\n<thead>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Cytogenetic Abnormality</strong></p>\n</td>\n<td>\n<p><strong>Oncogene</strong></p>\n</td>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>\n<p>CLL/small lymphocytic lymphoma</p>\n</td>\n<td>t(14;19)(q32;q13)</td>\n<td>&nbsp;—</td>\n</tr>\n<tr>\n<td>\n<p>MALT lymphoma</p>\n</td>\n<td>\n<p>t(11;18)(q21;q21)</p>\n</td>\n<td>\n<p>API2/MALT, BCL-10</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Precursor B cell acute lymphoid leukemia</strong></p>\n</td>\n<td>\n<p>t(9;22)(q34;q11) or variant</p>\n<p>t(4;11)(q21;q23)</p>\n</td>\n<td>\n<p>BCR/ABL</p>\n<p>AF4, ALLI</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Precursor acute lymphoid leukemia</strong></p>\n</td>\n<td>\n<p><strong>t(9;22)</strong></p>\n<p><strong>t(1;19)</strong></p>\n<p><strong>t(17;19)</strong></p>\n<p><strong>t(5;14)</strong></p>\n</td>\n<td>\n<p><strong>BCR, ABL</strong></p>\n<p><strong>E2A, PBX</strong></p>\n<p><strong>HLF, E2A</strong></p>\n<p><strong>HOX11L2, CTIP2</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mantle cell lymphoma</p>\n</td>\n<td>\n<p>t(11;14)(q13;q32)</p>\n</td>\n<td>\n<p>BCL-1, IgH</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Follicular lymphoma</p>\n</td>\n<td>\n<p>t(14;18)(q32;q21)</p>\n</td>\n<td>\n<p>BCL-2, IgH</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse large cell lymphoma</p>\n</td>\n<td>\n<p>t(3;-)(q27;-)<em><sup>a</sup></em></p>\n<p>t(17;-)(p13;-)</p>\n</td>\n<td>\n<p>BCL-6</p>\n<p>p53</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Burkitts lymphoma, Burkitts leukemia</p>\n</td>\n<td>\n<p>t(8;14)(q24;32)</p>\n</td>\n<td>\n<p>C-MYC</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CD30+ Anaplastic large cell lymphoma</p>\n</td>\n<td>\n<p>t(2;5)(p23;q35)</p>\n</td>\n<td>\n<p>ALK</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lymphoplasmacytoid lymphoma</p>\n</td>\n<td>\n<p>t(9;14)(p13;q32)</p>\n</td>\n<td>\n<p>PAX5, IgH</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(844, 'Pathology', 'PM1207. Prognostic Factors in Acute Myeloid Leukemia (AML)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Good prognosis&nbsp;</strong></td>\n<td><strong>Poor prognosis&nbsp;&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Age &lt;40 years&nbsp;</td>\n<td>Age &lt;2 years or &gt;55 years&nbsp;</td>\n</tr>\n<tr>\n<td>M2,M3,M4 forms of AML&nbsp;&nbsp;</td>\n<td>M0, M6, M7 forms of AML&nbsp;</td>\n</tr>\n<tr>\n<td>TLC &lt; 25 × 10<sup>9</sup>/L&nbsp;</td>\n<td>TLC &gt; 100 × 10<sup>9</sup>/L&nbsp;</td>\n</tr>\n<tr>\n<td>Blast cell with Auer rods&nbsp;</td>\n<td>Deletions 5q, 7q, 20q&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>t(8;21); RUNX1/ ETO fusion gene&nbsp;</p>\n<p>t(15;17); PML/ RARA fusion gene&nbsp;</p>\n<p>t(16;16) or&nbsp;inv&nbsp;16; CBF1/ MYH1 fusion gene&nbsp;</p>\n</td>\n<td>\n<p>t(11q23;v) with diverse MLL fusion genes&nbsp;</p>\n<p>t(6;9)</p>\n<p>Inversion 3</p>\n</td>\n</tr>\n<tr>\n<td>Rapid response to therapy&nbsp;</td>\n<td>Delayed response to therapy&nbsp;</td>\n</tr>\n<tr>\n<td>Leukemia&nbsp;without preceding MDS&nbsp;</td>\n<td>AML with preceding MDS or anticancer drug exposure&nbsp;</td>\n</tr>\n<tr>\n<td>Normal karyotyping with&nbsp;mutated NPM</td>\n<td>Complex karyotypes&nbsp;</td>\n</tr>\n<tr>\n<td>Biallelic&nbsp;mutation in CEBPA</td>\n<td>Activating mutation in FLT3</td>\n</tr>\n</tbody>\n</table>\n<p>TLC: Total leukocyte count</p>\n<p>MDS: Myelodysplastic syndrome</p></div><!---->\n      <!---->\n    </div><!---->'),
(845, 'Pathology', 'PM1193. Cytochemistry of Acute Leukemias', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Stain</strong></td>\n<td><strong>AML</strong></td>\n<td><strong>ALL</strong></td>\n</tr>\n<tr>\n<td>Myeloperoxidase</td>\n<td>+</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Sudan black</td>\n<td>+</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Non-specific esterase</td>\n<td>\n<p>Strongly +ve: M4, M5</p>\n<p>Weakly +ve: M3, M7</p>\n</td>\n<td>_</td>\n</tr>\n<tr>\n<td>Periodic acid Schiff</td>\n<td>+ve in AML M6</td>\n<td>+</td>\n</tr>\n<tr>\n<td>Acid phosphatase</td>\n<td>-</td>\n<td>+ (T-cell)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(846, 'Pathology', 'PM1190. Immunophenotyping of Acute Lymphocytic Leukemia (ALL)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Type of ALL&nbsp;</td>\n<td>Immunophenotype&nbsp;</td>\n</tr>\n<tr>\n<td>Early&nbsp;Pre-B ALL&nbsp;</td>\n<td>TdT, DR, CD19, CD24&nbsp;</td>\n</tr>\n<tr>\n<td>Pre B ALL&nbsp;</td>\n<td>TdT, DR, CD10, CD19, CD20, CD24,&nbsp;Cy&nbsp;Ig&nbsp;</td>\n</tr>\n<tr>\n<td>Common ALL&nbsp;</td>\n<td>CD19+,  CD10+/CALLA+&nbsp;</td>\n</tr>\n<tr>\n<td>Mature&nbsp;B&nbsp;&nbsp;ALL&nbsp;</td>\n<td>DR, CD19, CD20, CD24,&nbsp;Surface Ig&nbsp;</td>\n</tr>\n<tr>\n<td>Pro-T ALL&nbsp;&nbsp;</td>\n<td>CD3, CD7&nbsp;</td>\n</tr>\n<tr>\n<td>Pre-T ALL&nbsp;</td>\n<td>TdT,&nbsp;CD2,&nbsp;CD3, CD4, CD5, CD7, CD8, CD34&nbsp;</td>\n</tr>\n<tr>\n<td>Mature T ALL&nbsp;</td>\n<td>CD2, CD7,&nbsp;Tdt&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(847, 'Pathology', 'PM1188. Panel of monoclonal antibodies for classification of leukemias', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p>Haematopoetic</p>\n<p>precursors&nbsp;</p>\n</td>\n<td>CD34,Tdt, HLA-DR&nbsp;</td>\n</tr>\n<tr>\n<td>Myeloid&nbsp;</td>\n<td>CD13, CD33, CD15, MPO, CD117&nbsp;</td>\n</tr>\n<tr>\n<td>B cell&nbsp;</td>\n<td>CD19, CD20, CD22,&nbsp;CD79 a&nbsp;</td>\n</tr>\n<tr>\n<td>T cell&nbsp;</td>\n<td>CD2, CD3, CD5, CD7&nbsp;</td>\n</tr>\n<tr>\n<td>Monocytic&nbsp;</td>\n<td>CD11b, CD14&nbsp;</td>\n</tr>\n<tr>\n<td>Megakaryoblastic&nbsp;</td>\n<td>CD41, CD42, CD61&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(848, 'Pathology', 'PM1187. FAB classification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\281\>\n<tbody>\n<tr>\n<td><strong>FAB classification</strong></td>\n<td><strong>High-Yield points</strong></td>\n</tr>\n<tr>\n<td>M0-minimal differentiation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M1-without maturation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M2 - with maturation</td>\n<td>\n<ul>\n<li>Most common</li>\n<li>t(8,21)</li>\n<li>Chloromas</li>\n<li>Good prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M3 - promyelocytic</td>\n<td>\n<ul>\n<li>Young-good prognosis</li>\n<li>t(15,17)-intermediate</li>\n<li>Auer rods</li>\n<li>DIC</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M4 - myelomonocytic</td>\n<td>\n<ul>\n<li>inv 16</li>\n<li>t(16,16)</li>\n<li>Eosinophilia</li>\n<li>Gingival hyperplasia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>M5a - monoblastic</p>\n<p>M5b - monocytic</p>\n</td>\n<td>\n<ul>\n<li>Organ infiltration</li>\n<li>Gingival hyperplasia</li>\n<li>Increased WBC count, fever</li>\n<li>Sweet syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M6 - erythroid</td>\n<td>\n<ul>\n<li>Therapy related</li>\n<li>Erythemic myelosis, Di&nbsp;Guglielmo disease</li>\n<li>Poor prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M7 - megakaryocytic</td>\n<td>\n<ul>\n<li>CD 41/61</li>\n<li>Bad prognosis</li>\n<li>Down syndrome (good prognosis)</li>\n<li>Bone marrow fibrosis (increased PDGF)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(849, 'Pathology', 'PM1179. Morphological Characteristics of Blasts Cells in Acute Lymphoblastic Leukemia vs. Acute Myeloid Leukemia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Lymphoblasts&nbsp;</strong></td>\n<td><strong>Myeloblasts</strong>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Blast population</strong></td>\n<td>Homogeneous</td>\n<td>Heterogeneous,&nbsp;with the exception of&nbsp;the undifferentiated form&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Size</strong></td>\n<td>Variable, mainly small&nbsp;</td>\n<td>Variable, mainly large&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Nucleus</strong></td>\n<td>Central, mainly round; sometimes indented.&nbsp;<br>&nbsp;</td>\n<td>Eccentric, round, oval, or angulated; sometimes convoluted, particularly in the form with a monocytic component&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Chromatin</strong></td>\n<td>Fine, with dispersed condensation.&nbsp;<br>Very condensed in small&nbsp;lymphoblasts&nbsp;</td>\n<td>Fine, granular, delicately dispersed&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Nucleoli</strong></td>\n<td>Absent in small&nbsp;lymphoblasts.&nbsp;<br>Sometimes indistinct&nbsp;</td>\n<td>Present. Often large and prominent,&nbsp;double or triple&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Cytoplasm</strong></td>\n<td>Scanty and basophilic.<br>Sometimes with a single long projection (hand-mirror cell)&nbsp;</td>\n<td>Variable.&nbsp;<br>Abundant in&nbsp;monoblasts,&nbsp;<br>with protrusions in erythroblasts and&nbsp;megakaryoblasts&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Granules</strong></td>\n<td>Rarely present. Negative for peroxidase,&nbsp;esterases, and toluidine blue&nbsp;</td>\n<td>Present&nbsp;in forms with differentiation and positive with cytochemical stains\n<ul>\n<li>Peroxidase in the neutrophil and&nbsp;eosinophil&nbsp;lineages</li>\n<li>Nonspecific esterase in the monocyte lineage&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Auer rods</strong></td>\n<td>Absent&nbsp;</td>\n<td>Can be present.&nbsp;<br>Typically present in the hyper granular promyelocytic form&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Vacuoles</strong></td>\n<td>Can&nbsp;be present</td>\n<td>Can be present.&nbsp;<br>Almost always present in forms with a monocytic component&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>The image given below shows lymphoblasts.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/602336fa8d4c493297f9396f1c0723d3x720x820.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The image given below shows myeloblasts.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b1dfcd5c07f949719ccdce6583872615x250x364.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(850, 'Pathology', 'PM1178. Prognostic Factors in Acute Lymphoblastic Leukemia (ALL)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Good prognostic markers&nbsp;</strong></td>\n<td><strong>Bad prognostic markers&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Age between 2 and 10 years&nbsp;</td>\n<td>\n<p>Age younger than 2 years&nbsp;</p>\n<p>Presentation in adolescence or adulthood</p>\n</td>\n</tr>\n<tr>\n<td>Low white cell count&nbsp;</td>\n<td>Peripheral blood blast counts greater than 100,000,</td>\n</tr>\n<tr>\n<td>Female&nbsp;</td>\n<td>Male&nbsp;</td>\n</tr>\n<tr>\n<td>Hyperdiploidy&nbsp;</td>\n<td><span class=\TextRun SCXW19478924\ lang=\EN-GB\><span class=\NormalTextRun SCXW19478924\>Hypodiploidy</span></span><span class=\EOP SCXW19478924\>&nbsp;</span>&nbsp;</td>\n</tr>\n<tr>\n<td>Trisomy of chromosomes 4, 7, 10 &amp; 17</td>\n<td> Pseudodiploidy&nbsp;or t (9;22)&nbsp;&nbsp;or t (8;14) or t (4;11)&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;<span class=\TextRun SCXW77923760\ lang=\EN-GB\><span class=\NormalTextRun SCXW77923760\>t (12;21)<span class=\EOP SCXW77923760\>&nbsp;</span></span></span></td>\n<td><em>MLL</em> gene rearrangements&nbsp;</td>\n</tr>\n<tr>\n<td>Early precursor B cell phenotype</td>\n<td>&nbsp;T cell phenotype</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(851, 'Pathology', 'PM1175. Predisposing Factors for Acute Lymphocytic Leukemia (ALL)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Genetic&nbsp;</strong></td>\n<td><strong>Environmental&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Bloom Syndrome&nbsp;</td>\n<td>Ionizing radiation&nbsp;</td>\n</tr>\n<tr>\n<td>Fanconi anemia&nbsp;</td>\n<td>Alkylating agents&nbsp;</td>\n</tr>\n<tr>\n<td>Ataxia–telangiectasia&nbsp;</td>\n<td>Benzene exposure&nbsp;</td>\n</tr>\n<tr>\n<td>Shwachman&nbsp;syndrome&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Down syndrome&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Type I NF1&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Severe combined immunodeficiency (SCID)</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Paroxysmal nocturnal hemoglobinuria (PNH)&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Li–Fraumeni syndrome&nbsp;</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(852, 'Pathology', 'PM0694. Immunosecretory Disorders and Corresponding Neoplasms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Clinical syndrome</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Neoplasm</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Multiple myeloma</p>\n</td>\n<td width=\231\>\n<p>Plasma cell myeloma</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Primary AL amyloidosis</p>\n</td>\n<td width=\231\>\n<p>Plasma cell myeloma</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Light chain deposition disease</p>\n</td>\n<td width=\231\>\n<p>Plasma cell myeloma</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>POEMS syndrome</p>\n</td>\n<td width=\231\>\n<p>Osteosclerotic myeloma</p>\n<p>Multicentric Castleman’s disease</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Waldenstom Macroglobulinemia</p>\n</td>\n<td width=\231\>\n<p>Lymphoplasmacytic lymphoma</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Gamma heavy chain disease</p>\n</td>\n<td width=\231\>\n<p>Lymphoplasmacytic lymphoma</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Mu heavy chain disease</p>\n</td>\n<td width=\231\>\n<p>CLL</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Alpha heavy chain disease</p>\n</td>\n<td width=\231\>\n<p>MALT lymphoma</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(853, 'Pathology', 'PM0691. Prognostic Factors in Myeloma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Poor prognosis</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Good prognosis</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>t(4;14), MAF translocations t(14;16) and t(14;20), del(17p), aneuploidy, hypodiploidy</p>\n</td>\n<td width=\231\>\n<p>Hyperdiploid, t(11;14), t(6;14), cyclin D1 or D3 positive</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Elevated beta-2 microglobulin, lactate dehydrogenase, C- reactive protein, plasma-cell proliferation, or bone marrow infiltration</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Plasmablastic morphology</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Abnormalities by conventional cytogenetics</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Plasma labelling index &gt;3%</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Serum creatinine level &gt;2mg/dL</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Bone marrow biopsy: Diffuse&nbsp;and prominent angiogenesis</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Low serum albumin</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(854, 'Pathology', 'PM0690. WHO Classification of Plasma Cell Neoplasms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Plasma cell neoplasms and variants</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Plasma cell myeloma</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Non secretory: No secretion of Ig, No M component.</li>\n</ul>\n<ul>\n<li>Smoldering: M protein in serum ≥ 3g/dL and/or ≥10% clonal plasma cells in bone marrow, and&nbsp;no related organ or tissue impairment.</li>\n</ul>\n<ul>\n<li>Plasma-cell leukemia: &gt;20% plasma cells in the peripheral blood or Absolute plasma cell count of &gt;2 X 10<sup>9</sup>/L.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Plasmacytoma</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Solitary plasmacytoma: Localized tumour of monoclonal plasma cells with no clinical features of plasma cell myeloma.</li>\n</ul>\n<ul>\n<li>Extramedullary(extraosseous) plasmacytoma: Localized plasma cell neoplasms that arise in tissues other than bone.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Monoclonal immunoglobulin deposition diseases</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Primary amyloidosis: Tumor secreting light chains that are deposited as beta-pleated sheet structure (amyloid light chain).</li>\n</ul>\n<ul>\n<li>Systemic light and heavy chain diseases: Secrete abnormal light or heavy chain or both, which do not form beta pleated sheet, stain Congo Red or contain amyloid P component.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 239\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Plasma cell neoplasms with associated paraneoplastic syndrome</strong></p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>POEMS syndrome- Polyneuropathy,&nbsp;organomegaly, Endocrinopathy, Monoclonal gammopathy, Skin changes.</p>\n<div class=\page\ title=\Page 239\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>TEMPI syndrome&nbsp;</p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(855, 'Pathology', 'PM0674. Lymphomas and Chromosomal Translocations', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lymphoid neoplasm</strong></p>\n</td>\n<td>\n<p><strong>Most characteristic translocation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mantle-cell lymphoma</p>\n</td>\n<td>\n<p>t (11;14)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Follicular lymphoma</p>\n</td>\n<td>\n<p>t (14;18)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse large B-cell lymphoma&nbsp;</p>\n</td>\n<td>\n<p>t (14;18)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>t (8:14), t (2;8), t (8;22)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>MALT lymphoma</p>\n</td>\n<td>\n<p>t (11;18)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(856, 'Pathology', 'PM0671. Origin of leukemia / lymphoma and their immunophenotypes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>B cell precursors</strong></td>\n<td><strong>Derived lymphomas/leukemia</strong></td>\n<td><strong>Immunophenotype</strong></td>\n</tr>\n<tr>\n<td>Pro-B cell</td>\n<td>Pro-B cell ALL</td>\n<td>CD34,&nbsp;CD19, CD79a</td>\n</tr>\n<tr>\n<td>Pre-B cell</td>\n<td>Pre-B cell ALL</td>\n<td>CD19, CD79a,&nbsp;CD10, Tdt</td>\n</tr>\n<tr>\n<td>Mature B cell</td>\n<td>CLL/SLL</td>\n<td>\n<p>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD 23, CD5</p>\n</td>\n</tr>\n<tr>\n<td>Mantle zone</td>\n<td>Mantle zone lymphoma</td>\n<td>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD5</td>\n</tr>\n<tr>\n<td>Germinal center/Follicular center</td>\n<td>\n<p>Follicular lymphoma</p>\n<p>&nbsp;</p>\n<p>Diffuse large B-cell lymphoma</p>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>CD 79a, CD 19, CD20, CD21,CD22, CD10, CD 23, Bcl-2</p>\n<p>CD10, Cd23, Bcl-6</p>\n<p>CD19, CD20, CD22, CD79a, CD10, Bcl-6</p>\n</td>\n</tr>\n<tr>\n<td>Memory B cells</td>\n<td>Extranodal marginal zone lymphoma</td>\n<td>CD19, CD79a,CD 20, surface Ig</td>\n</tr>\n</tbody>\n</table>\n<p>CLL:&nbsp;Chronic lymphocytic leukemia&nbsp;</p>\n<p>SLL:&nbsp;Small lymphocytic lymphoma</p></div><!---->\n      <!---->\n    </div><!---->'),
(857, 'Pathology', 'PM0669. Lymphomas with Etiology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Etiological factor</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Lymphoid neoplasm</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><em>Helicobacter pylori</em></p>\n</td>\n<td width=\231\>\n<p>Gastric MALToma</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>EBV</p>\n</td>\n<td width=\231\>\n<p>Burkitts lymphoma</p>\n<p>Post–organ transplant lymphoma</p>\n<p>Primary CNS diffuse large B cell lymphoma</p>\n<p>Hodgkins disease (Mixed cellularity and lymphocyte depleted)</p>\n<p>Extranodal NK/T cell lymphoma, nasal type</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>HIV</p>\n</td>\n<td width=\231\>\n<p>Diffuse large B cell lymphoma</p>\n<p>Burkitts lymphoma</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Hepatitis C</p>\n</td>\n<td width=\231\>\n<p>Lymphoplasmacytic lymphoma (Waldenstroms macroglobulinemia)</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>HHV 8</p>\n</td>\n<td width=\231\>\n<p>Primary effusion lymphoma</p>\n<p>Kaposi sarcoma</p>\n<p>Multicentric Castlemans disease</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Gluten sensitivity / Celiac disease</p>\n</td>\n<td width=\231\>\n<p>Enteropathy-associated T-cell lymphoma (small intestine)</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Severe T-cell deficiency</p>\n</td>\n<td width=\231\>\n<p>B-cell lymphomas</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>HTLV-1</p>\n</td>\n<td width=\231\>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>EBV:&nbsp;Epstein–Barr virus</p>\n<p>HHV 8: Human herpesvirus-8</p>\n<p>HTLV:&nbsp;Human T-cell leukemia/lymphoma virus&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(858, 'Pathology', 'PM0668. Lymphoid Neoplasms with their Cell of Origin', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/02222251e8bf4380b0c5210a9e3be106x939x699.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\page\ title=\Page 597\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>CLP, Common lymphoid precursor; BLB, pre-B lymphoblast; DN, CD4/CD8 double-negative pro-T cell; DP, CD4/CD8 double-positive pre-T cell; GC, germinal-center B cell; MC, mantle B cell; MZ, marginal zone B cell; NBC, naive B cell; PTC, peripheral T cell.</p>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(859, 'Pathology', 'PM0608. Pathological Cells/Bodies in Multiple Myeloma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Dutcher bodies -</strong>&nbsp;pale-staining, PAS-positive&nbsp;<strong>intranuclear inclusions</strong> within plasma cells containing Ig, which are more common in <strong>IgA myeloma </strong>(Image below).&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/97ef33b0c64f414f9c6629a62fe310bax1279x1152.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Russell bodies -&nbsp;</strong>They are globular intracellular accumulations of immunoglobulins (Ig). Russell bodies are distended endoplasmic reticulum. Plasma cells filled with multiple Russell bodies are called <strong>Mott cells.</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/be2826017fa044f9a0f46c9a305d9baex1279x1199.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Flame cells</strong> - Plasma cells with fiery red cytoplasm due to vermillion-staining, glycogen-rich IgA in cytoplasmic projections</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(860, 'Pathology,', 'PM0604. Difference between B12 and Folic acid Deficiency', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\154\>\n<p><strong>Laboratory Tests</strong></p>\n</td>\n<td width=\154\>\n<p><strong>Pernicious Anemia (B12 Deficiency)</strong></p>\n</td>\n<td width=\154\>\n<p><strong>Folic Acid Deficiency</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Serum B12 level</p>\n</td>\n<td width=\154\>\n<p>Decreased</p>\n</td>\n<td width=\154\>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Serum folic acid level</p>\n</td>\n<td width=\154\>\n<p>Normal</p>\n</td>\n<td width=\154\>\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Serum LDH level</p>\n</td>\n<td width=\154\>\n<p>Increased</p>\n</td>\n<td width=\154\>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Achlorhydria</p>\n</td>\n<td width=\154\>\n<p>Present</p>\n</td>\n<td width=\154\>\n<p>Absent</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Schilling Test</p>\n</td>\n<td width=\154\>\n<p>Positive</p>\n</td>\n<td width=\154\>\n<p>Negative</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Methyl malonyl CoA in urine</p>\n</td>\n<td width=\154\>\n<p>Present</p>\n</td>\n<td width=\154\>\n<p>Absent</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Neurological signs</p>\n</td>\n<td width=\154\>\n<p>Present</p>\n</td>\n<td width=\154\>\n<p>Absent</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(861, 'Pathology,', 'PM0317. Parameters of the coagulation pathway and its uses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>&nbsp;Parameters of the coagulation pathway and its uses</strong></p>\n<table border=\1\>\n<tbody>\n<tr>\n<td><strong>Parameter </strong></td>\n<td><strong>Uses</strong></td>\n</tr>\n<tr>\n<td>Prothrombin Time (PT)</td>\n<td>It is used to monitor the functioning of the extrinsic and the common coagulation pathways. Normal PT is 12–16 seconds.</td>\n</tr>\n<tr>\n<td>Activated partial thromboplastin time (aPTT)</td>\n<td>It is used to monitor the functioning of the intrinsic and the common coagulation pathways. Normal aPTT is 26–34 seconds. A relatively rare cause of prolonged aPTT is the&nbsp;presence of antibodies against coagulation plasma proteins called inhibitors. It can be seen due to the following reasons: Hemophilia A and B patients receiving clotting factors to control their bleeding episodes, Pregnancy, Autoimmune diseases, Malignancies (lymphoma, prostate cancer), and Dermatologic conditions.</td>\n</tr>\n<tr>\n<td>Thrombin time (TT)</td>\n<td>It is used for testing the conversion of fibrinogen into fibrin and depends on adequate fibrinogen levels.&nbsp;</td>\n</tr>\n<tr>\n<td>Bleeding time (BT)</td>\n<td>It is the time taken for a standardized skin puncture to stop bleeding. It tests the ability of blood vessels to constrict and platelets to form a hemostatic plug.&nbsp;</td>\n</tr>\n<tr>\n<td>Fibrin degradation products (FDPs)</td>\n<td>They are used to assess the fibrinolytic activity, and they are increased in disseminated intravascular coagulation (DIC).&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(862, 'Pathology', 'PM0273. Malignancies Associated With Paraneoplastic Polycythemia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Renal cell carcinoma</li>\n<li>Hepatoma</li>\n<li>Cerebellar hemangioma</li>\n<li>Adrenal cortical tumors</li>\n<li>Pheochromocytomas</li>\n<li>Virilizing ovarian tumors</li>\n<li>Wilms’ tumor</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(863, 'Pathology', 'PM0261. Malignancies, Translocations and Affected Genes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Malignancy </strong></p>\n</td>\n<td>\n<p><strong>Translocation</strong></p>\n</td>\n<td>\n<p><strong>Affected Genes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CLL/ Small lymphocytic lymphoma</p>\n</td>\n<td>\n<p>t(14;19)</p>\n</td>\n<td>\n<p><em>-</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic myelogenous leukemia (CML)</p>\n</td>\n<td>\n<p>t(9;22)</p>\n</td>\n<td>\n<p><em>ABL </em>9q34</p>\n<p><em>BCR </em>22q11</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acute myeloid leukemia (AML)</p>\n</td>\n<td>\n<p>t(8; 21), t(15; 17)</p>\n</td>\n<td>\n<p><em>AML1 21</em>q22</p>\n<p><em>ETO 8</em>q22</p>\n<p><em>PML </em>15q22</p>\n<p><em>RARA </em>17q21</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Precursor B cell ALL</p>\n</td>\n<td>\n<p>t(9;22), t(4;11)</p>\n</td>\n<td>&nbsp;\n<p>BCR/ABL</p>\n<p>AF4, ALLI</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>t(8; 14), t(2;8) t(8;22)</p>\n</td>\n<td>\n<p><em>c-myc&nbsp;</em>8q24</p>\n<p><em>IGH </em>14q32</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mantle cell lymphoma</p>\n</td>\n<td>\n<p>t(11; 14)</p>\n</td>\n<td>\n<p><em>CCND1 </em>11q13</p>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL1</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Follicular lymphoma</p>\n</td>\n<td>\n<p>t(14; 18)</p>\n</td>\n<td>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL2 </em>18q21</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ewing sarcoma</p>\n</td>\n<td>\n<p>t(11; 22)</p>\n</td>\n<td>\n<p><em>FLI1 </em>11q24</p>\n<p><em>EWSR1 </em>22q12</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic adenocarcinoma</p>\n</td>\n<td>\n<p>t(7; 21), t(17; 21)</p>\n</td>\n<td>\n<p><em>TMPRSS2 </em>(21q22.3)</p>\n<p><em>ETV1</em> (7p21.2)</p>\n<p><em>ETV4 </em>(17q21)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse large B-cell lymphoma</p>\n</td>\n<td>&nbsp;t(14;18)</td>\n<td>&nbsp;\n<p><em>BCL-6</em>,&nbsp;p53</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>MALT lymphoma</p>\n</td>\n<td>t(11;18)</td>\n<td><em>API2/MALT</em>, <em>BCL-10</em></td>\n</tr>\n<tr>\n<td>\n<p>CD30+ Anaplastic large cell lymphoma</p>\n</td>\n<td>t(2;5)</td>\n<td><em>ALK</em></td>\n</tr>\n<tr>\n<td>\n<p>Lymphoplasmacytoid lymphoma</p>\n</td>\n<td>t(9;14)</td>\n<td><em>PAX5, IGH</em></td>\n</tr>\n<tr>\n<td>\n<p>Synovial sarcoma</p>\n</td>\n<td>t(X;18)(p11;q11)&nbsp;</td>\n<td>&nbsp;\n<p><em>SS18-SSX2</em></p>\n<p><em>SS18-SSX4</em></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Alveolar soft-part sarcoma</td>\n<td>&nbsp;t(X;17)(p11.2;q25)</td>\n<td>&nbsp;<em>TFE3-ASPL</em></td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(864, 'Pathology', 'PM0119. Important Features of the Different Types of Hodgkins Lymphoma (HL)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8f432ebab66e464e8027d857e46694c8x827x650.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Classic subtypes</strong></p>\n<ul>\n<li>Nodular sclerosis&nbsp;</li>\n<li>Mixed cellularity&nbsp;</li>\n<li>Lymphocyte-rich</li>\n<li>Lymphocyte depletion</li>\n</ul>\n<p><strong>Non-Classical subtype</strong></p>\n<ul>\n<li>Lymphocyte predominant</li>\n</ul>\n<p>Note: <strong>Mixed cellularity</strong> is most commonly associated with HIV due to its high incidence.&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(865, 'Pathology', 'PM0117. Variants of Reed Sternberg Cells', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Variant Reed–Sternberg cells and the corresponding subtype of Hodgkins Lymphoma</strong></p>\n<ul>\n<li><strong>Lacunar Variant:</strong>&nbsp;Nodular Sclerosis</li>\n<li><strong>Mononuclear variant:</strong>&nbsp;Mixed cellularity and Lymphocyte rich&nbsp;</li>\n<li><strong>Pleomorphic/Necrotic/Mummified Variant:</strong>&nbsp;Lymphocyte depleted&nbsp;</li>\n<li><strong>L&amp;H/Lymphohistiocytic/Popcorn Variant:</strong>&nbsp;Lymphocyte predominant</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(866, 'Pathology', 'PM0116. Hodgkin v/s Non-Hodgkin Lymphoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Features</strong></td>\n<td><strong>Hodgkin Lymphoma&nbsp;</strong></td>\n<td><strong>Non-Hodgkin&nbsp;Lymphoma</strong></td>\n</tr>\n<tr>\n<td>Lymph nodes&nbsp;</td>\n<td>Single axial group of lymph nodes</td>\n<td>Multiple peripheral lymph nodes&nbsp;</td>\n</tr>\n<tr>\n<td>Spread</td>\n<td>Contiguous</td>\n<td>Non-contiguous</td>\n</tr>\n<tr>\n<td>Mesenteric nodes and Waldeyer ring&nbsp;</td>\n<td>Rarely involved</td>\n<td>Commonly involved</td>\n</tr>\n<tr>\n<td>Extra-nodal involvement</td>\n<td>Uncommon</td>\n<td><strong>&nbsp;</strong>Common</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(867, 'Pathology', 'PM2482. Histological Features of CNS Tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Pilocytic Astrocytomas:</strong></p>\n<ul>\n<li>Biphasic architecture - loose microcystic component and dense fibrillary areas</li>\n<li>Bipolar cells (tumor cells): thin, long hairlike processes that are <strong>GFAP - positive</strong>.&nbsp;</li>\n<li><strong>Rosenthal fibers:&nbsp;</strong>eosinophilic corkscrew - shaped inclusions</li>\n<li>Eosinophilic granular bodies: mulberry - like inclusions&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/bc359017eb704f43b484326ad42d8425x510x497.GIF\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Medulloblastoma:</strong></p>\n<ul>\n<li>Very densely cellular, with sheets of small primitive appearing <strong>small blue cells</strong></li>\n<li>Individual tumor cells have scant&nbsp;cytoplasm and hyperchromatic nuclei that are frequently elongated&nbsp;or crescent-shaped</li>\n<li>Tumor cells form <strong>Homer - Wright&nbsp;rosettes&nbsp;</strong>(pseudorosettes) with a central <strong>neuropil</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/87aa6870c5d24984abea60df064d335ex510x525.GIF\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Ependymoma:</strong></p>\n<ul>\n<li><strong>Ependymal rosettes:</strong>&nbsp;gland - like round or elongated structures that resemble the embryologic ependymal canal, with long, delicate processes extending into the lumen&nbsp;</li>\n<li><strong>Perivascular pseudorosettes:</strong>&nbsp;perivascular nuclear - free zone consisting of thin ependymal processes radiating toward the central blood&nbsp;vessel</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/853ce0f481a746afb1f174bfc80f840fx510x497.GIF\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Oligodendroglioma:</strong></p>\n<ul>\n<li><strong>Fried - egg appearance:</strong>&nbsp;sheets of regular cells with spherical nuclei containing finely granular&nbsp;chromatin (similar to normal oligodendrocytes) surrounded by&nbsp;a clear halo of vacuolated cytoplasm.&nbsp;</li>\n<li><strong>Chicken - wire capillaries:&nbsp;</strong>a delicate network of anastomosing capillaries</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9c3dea0295f741f0aadb9e4bbdd51726x510x525.GIF\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Retinoblastoma:</strong>&nbsp;</p>\n<ul>\n<li>Composed of collections of <strong>small, round cells</strong> with hyperchromatic nuclei</li>\n<li><strong>Flexner - Wintersteiner&nbsp;rosettes:&nbsp;</strong>arrangements of a single layer of tumor cells around an apparent lumen</li>\n<li><strong>Homer - Wright rosettes:</strong>&nbsp;a ring of cells with an eosinophilic fibrillary center</li>\n<li><strong>Fleurettes:</strong>&nbsp;retinoblastoma cells that have undergone greater photoreceptor differentiation and group together as a bouquet. Fleurettes lack mitosis or necrosis.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8da2904e5dce4629b6d8253bc0f768f8x510x525.GIF\><!---->\n      </div><!---->\n    </div><!---->'),
(868, 'Pathology,', 'PM1570. Manifestations of systemic sclerosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Organ</strong></p>\n</td>\n<td>\n<p><strong>Manifestations</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Skin</p>\n</td>\n<td>\n<p>Endothelial injury and microvascular disease causing chronic ischemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alimentary Tract</p>\n</td>\n<td>\n<p>Affected in approximately 90% of patients.</p>\n<p>Progressive atrophy and collagenous fibrous replacement of the muscular is most severe in the esophagus.</p>\n<p><strong>The lower two-thirds of the esophagus often develops a rubber-hose–like an inflexibility. </strong></p>\n<p>Gastroesophageal reflux and Barrett metaplasia and strictures.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Musculoskeletal System</p>\n</td>\n<td>\n<p>Hypertrophy and hyperplasia of the synovial soft tissues</p>\n<p><strong>Joint destruction is not common</strong> in systemic sclerosis.</p>\n<p>Inflammatory myositis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kidneys.</p>\n</td>\n<td>\n<p><strong>The most prominent are the vascular lesions.</strong></p>\n<p>Interlobular arteries show intimal thickening as a result of deposition of mucinous or finely collagenous material</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lungs.</p>\n</td>\n<td>\n<p>The lungs are involved in more than 50% of individuals</p>\n<p>Pulmonary hypertension and interstitial fibrosis</p>\n<p>Pulmonary fibrosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heart</p>\n</td>\n<td>\n<p>Pericarditis with effusion, myocardial fibrosis, and thickening of intramyocardial arterioles</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e40a46c6a08c44e7ad65d4cdb56db86cx1280x853.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(869, 'Pathology,', 'PM1569. Characteristic Findings in Systemic Lupus Erythematosus (SLE)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>System</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Characteristic findings</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Blood Vessels</p>\n</td>\n<td width=\231\>\n<p>Acute necrotizing vasculitis with fibrinoid necrosis</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Kidney</p>\n</td>\n<td width=\231\>\n<p><strong>\Wire-loop\ lesions</strong></p>\n<p>Tubulointerstitial lesions</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Skin</p>\n</td>\n<td width=\231\>\n<p>Vacuolar degeneration of the basal layer of the epidermis</p>\n<p><strong>Vasculitis with fibrinoid necrosis</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Joints</p>\n</td>\n<td width=\231\>\n<p><strong>Non-erosive arthritis</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Cardiovascular system</p>\n</td>\n<td width=\231\>\n<p>Fibrinous pericarditis</p>\n<p><strong>Libman–Sacks endocarditis</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Spleen</p>\n</td>\n<td width=\231\>\n<p>Splenomegaly</p>\n<p>Capsular thickening</p>\n<p>Follicular hyperplasia</p>\n<p><strong>Onion-skin lesions of arteries</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Lungs</p>\n</td>\n<td width=\231\>\n<p>Pleuritis, pleural effusion, chronic interstitial fibrosis and secondary pulmonary hypertension</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Bone marrow</p>\n</td>\n<td width=\231\>\n<p><strong>Hematoxylin bodies</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Lymph nodes</p>\n</td>\n<td width=\231\>\n<p>Lymphadenopathy with hyperplastic follicles</p>\n<p>Necrotizing lymphadenitis</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>The image below shows</strong>&nbsp;<strong>hematoxylin bodies in systemic lupus erythematosus (SLE)-associated lymphadenopathy.</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1da1c0f61e29410c9f97bd2143e58b53x1280x1052.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><!---->'),
(870, 'Pathology,', 'PM0954. Important Vasculitis with Features', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vasculitis</strong></p>\n</td>\n<td>\n<p><strong>Predominant vessel involved</strong></p>\n</td>\n<td>\n<p><strong>Inflammatory cells</strong></p>\n</td>\n<td>\n<p><strong>Other features</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Temporal arteritis</strong></p>\n<p><strong>(Large vessel vasculitis)</strong></p>\n</td>\n<td>\n<p>Temporal, vertebral and ophthalmic arteries, aorta</p>\n</td>\n<td>\n<p>Lymphocytes, and macrophages</p>\n</td>\n<td>\n<p>&gt;40 years old, polymyalgia rheumatica, granulomas, giant cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Takayasu Arteritis</strong></p>\n<p><strong>(Large vessel vasculitis)</strong></p>\n</td>\n<td>\n<p>(Medium-sized and large arteries) Aortic arch, great vessels, pulmonary artery, coronary and renal arteries</p>\n</td>\n<td>\n<p>Lymphocytes, macrophages, neutrophils, granulomas, giant cells</p>\n</td>\n<td>\n<p>Pulseless disease</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Polyarteritis Nodosa</strong></p>\n</td>\n<td>\n<p>Small or medium-sized muscular arteries, typically involving renal and visceral vessels</p>\n</td>\n<td>\n<p>Neutrophils, eosinophils, and mononuclear cells,</p>\n</td>\n<td>\n<p>Spares pulmonary vessels, 30% of patients with&nbsp; chronic hepatitis B</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Microscopic polyangiitis</strong></p>\n</td>\n<td>\n<p>Capillaries, small arterioles, venules</p>\n</td>\n<td>\n<p>Neutrophils, eosinophils, and mononuclear cells,</p>\n</td>\n<td>\n<p>Necrotizing glomerulonephritism (90% of patients) and pulmonary capillaritis leukocytoclastic vasculitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Churg-Strauss&nbsp;</strong><strong>Syndrome</strong></p>\n</td>\n<td>\n<p>Medium and small arteries</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Eosinophils (required), lymphocytes, macrophages, neutrophils</p>\n</td>\n<td>\n<p>Associated with asthma, allergic rhinitis, lung infiltrates, peripheral hypereosinophilia, and extravascular necrotizing granulomata.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(871, 'Pathology', 'PM0953. Primary Forms of Vasculitis with Sites of Involvement', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Giant cell arteritis</strong></td>\n<td>\n<p><strong>Granulomatosis with polyangiitis</strong></p>\n<p><strong>(Wegeners granulomatosis)</strong></p>\n</td>\n<td><strong>Churg Strauss syndrome</strong></td>\n<td><strong>PAN</strong></td>\n<td><strong>Leukocytoclastic vasculitis</strong></td>\n<td><strong>Buergers disease</strong></td>\n<td><strong>Behcet disease</strong></td>\n</tr>\n<tr>\n<td><strong>Aorta</strong></td>\n<td>+</td>\n<td>-</td>\n<td>-</td>\n<td>-</td>\n<td>-</td>\n<td>-</td>\n<td>-</td>\n</tr>\n<tr>\n<td><strong>Medium-sized arteries</strong></td>\n<td>+</td>\n<td>+</td>\n<td>+</td>\n<td>+</td>\n<td>-</td>\n<td>+</td>\n<td>+</td>\n</tr>\n<tr>\n<td><strong>Small-sized arteries</strong></td>\n<td>-</td>\n<td>+</td>\n<td>+</td>\n<td>+</td>\n<td>+</td>\n<td>+</td>\n<td>+</td>\n</tr>\n<tr>\n<td><strong>Capillaries</strong></td>\n<td>-</td>\n<td>+/-</td>\n<td>+/-</td>\n<td>-</td>\n<td>+</td>\n<td>_</td>\n<td>+</td>\n</tr>\n<tr>\n<td><strong>Veins</strong></td>\n<td>-</td>\n<td>-</td>\n<td>-</td>\n<td>-</td>\n<td>+</td>\n<td>+</td>\n<td>+</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(872, 'Pathology,', 'PM0952. Classification of vasculitis - Modified Chapel Hill classification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f4180d76d84f4ec58afa5b626909b08cx1280x1443.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(873, 'Pathology', 'PM0950. Classification of Vasculitis based on Pathogenesis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Direct infection</strong></td>\n<td>\n<p>Bacterial</p>\n<p>Rickettsial</p>\n<p>Fungal</p>\n<p>Viral</p>\n<p>Spirochetes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Immunologic</strong></td>\n<td>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Immune complex-mediated</strong></p>\n<p>Henoch-Schönlein Purpura (HSP)</p>\n<p>Systemic lupus erythematosus (SLE); Rheumatoid arthritis, serum sickness</p>\n<p>Drugs (penicillin)</p>\n<p>Cryoglobulin vasculitis</p>\n<p>Polyarteritis nodosa</p>\n<p><strong>Antineutrophil cytoplasmic antibodies (ANCA) mediated </strong></p>\n<p>Wegner’s granulomatosis</p>\n<p>Churg–Strauss syndrome</p>\n<p>Microscopic polyangiitis°</p>\n<p><strong>Directed antibody mediated</strong></p>\n<p>Goodpasture-syndrome (anti-GBMAb°</p>\n<p>Kawasaki’s disease (anti-endothelial antibodies°)</p>\n<p><strong>Cell-mediated </strong></p>\n<p>Organ Rejection</p>\n<p>Inflammatory bowel disease</p>\n<p>Giant-cell arteritis</p>\n</td>\n</tr>\n</tbody>\n</table>\n</td>\n</tr>\n<tr>\n<td><strong>Unkown</strong></td>\n<td>\n<p>Takayasu arteritis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(874, 'Pathology,', 'PM0546. Classification of Gout', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\161\>\n<p><strong>Clinical Category</strong></p>\n</td>\n<td width=\162\>\n<p><strong>Uric Acid Production</strong></p>\n</td>\n<td width=\162\>\n<p><strong>Uric Acid Excretion</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\161\>\n<p><strong>Primary Gout (90%)</strong></p>\n</td>\n<td width=\162\>&nbsp;</td>\n<td width=\162\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\161\>\n<p>Unknown enzyme defects</p>\n<p>(85%-90%)</p>\n</td>\n<td width=\162\>\n<p>↑ (majority)</p>\n<p>↑↑ (minority)</p>\n<p>Normal</p>\n</td>\n<td width=\162\>\n<p>Normal</p>\n<p>↑</p>\n<p>↓</p>\n</td>\n</tr>\n<tr>\n<td width=\161\>\n<p><strong>Secondary Gout (10%)</strong></p>\n</td>\n<td width=\162\>&nbsp;</td>\n<td width=\162\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\161\>\n<p>Increased nucleic acid turnover (e.g., leukemia)</p>\n</td>\n<td width=\162\>\n<p>↑↑</p>\n</td>\n<td width=\162\>\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td width=\161\>\n<p>Chronic renal disease</p>\n</td>\n<td width=\162\>\n<p>Normal</p>\n</td>\n<td width=\162\>\n<p>↓</p>\n</td>\n</tr>\n<tr>\n<td width=\161\>\n<p>Congenital (e.g., Lesch-Nyhan syndrome HGPRT deficiency)</p>\n</td>\n<td width=\162\>\n<p>↑↑</p>\n</td>\n<td width=\162\>\n<p>↑</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>HGPRT: Hypoxanthine-guanine phosphoribosyltransferase</p></div><!---->\n      <!---->\n    </div><!---->'),
(875, 'Pathology,', 'PM0049. Radiosensitive and Radioresistant Tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Highly radiosensitive tumors</strong> :</p>\n<ul>\n<li aria-level=\1\>Lymphoma</li>\n<li aria-level=\1\>Seminoma</li>\n<li aria-level=\1\>Myeloma</li>\n<li aria-level=\1\>Ewing’s sarcoma</li>\n<li aria-level=\1\>Wilms tumor</li>\n</ul>\n<p>&nbsp;<strong>Highly radioresistant tumors :</strong></p>\n<ul>\n<li aria-level=\1\>Melanoma</li>\n<li aria-level=\1\>Osteosarcoma</li>\n<li aria-level=\1\>Pancreatic carcinoma</li>\n<li aria-level=\1\>Hepatic carcinoma</li>\n<li aria-level=\1\>Renal cell carcinoma</li>\n<li aria-level=\1\>glioblastoma</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(876, 'Medicine,', 'PM2026. Modified Dukes criteria for diagnosis of infective endocarditis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\page\ title=\Page 2415\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Diagnosis of Infective endocarditis is by Dukes Criteria, which requires either:</p>\n</div>\n</div>\n</div>\n</div>\n<ol>\n<li>Pathologic criteria</li>\n<li>Clinical criteria</li>\n</ol>\n<p>If clinical criteria are used, definitive endocarditis is defined by the presence of&nbsp;<strong>2 major </strong>or&nbsp;<strong>1 major + 3 minor </strong>or&nbsp;<strong>5 minor criteria.</strong></p>\n<p>The presence of single pathological criteria is definitive of infective endocarditis.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/186ed21749ed4d3ab7e43344abb39a78x1200x2770.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Note:&nbsp;The diagnosis of endocarditis is rejected if an alternative diagnosis is established either when:</p>\n<ul class=\p-rich_text_list p-rich_text_list__bullet\>\n<li>Symptoms resolve and do not recur with &lt;4 days of antibiotic therapy OR</li>\n<li>If surgery or autopsy yields no pathologic or macroscopic evidence of endocarditis in &lt;4 days of antimicrobial therapy.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(877, 'Pathology,', 'PM1981. One-liners on Hypertrophic Cardiomyopathy (HCM)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Autosomal dominant</li>\n<li>Missense mutation</li>\n<li>Most common mutation: Beta-chain of myosin</li>\n<li>Myofibre disarray on histology</li>\n<li>Asymmetric septal hypertrophy</li>\n<li>Diastolic dysfunction</li>\n<li>Systolic function normal</li>\n<li>On Echocardiography:\n<ol>\n<li>Left ventricular wall thickness &gt;15 mm</li>\n<li>Systolic anterior motion of left leaflet</li>\n<li>Banana shaped left ventricle</li>\n</ol>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(878, 'Pathology,', 'PM1977. Causes of CorPulmonale', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\365\>\n<tbody>\n<tr>\n<td><strong>CAUSES OF COR PULMONALE</strong></td>\n</tr>\n<tr>\n<td><strong>Diseases of the Pulmonary Parenchyma</strong></td>\n</tr>\n<tr>\n<td>\n<p>Chronic obstructive pulmonary disease</p>\n<p>Diffuse pulmonary interstitial fibrosis</p>\n<p>Pneumoconioses</p>\n<p>Cystic fibrosis</p>\n<p>Bronchiectasis</p>\n</td>\n</tr>\n<tr>\n<td><strong>Disorders of Chronic (Alveolar) Hypoxia</strong></td>\n</tr>\n<tr>\n<td>\n<p>Obesity hypoventilation syndrome</p>\n<p>Central hypoventilation syndrome</p>\n<p>Neuromuscular respiratory failure</p>\n<p>Chest wall disorders - kyphoscoliosis&nbsp;</p>\n<p>Chronic exposure to high altitude</p>\n</td>\n</tr>\n<tr>\n<td><strong>Diseases of the Pulmonary Vasculature</strong></td>\n</tr>\n<tr>\n<td>\n<p>Pulmonary arterial hypertension (PAH)</p>\n<ul>\n<li>Idiopathic</li>\n<li>Heritable</li>\n<li>Drug and toxin-induced</li>\n<li>Veno-occlusive disease</li>\n</ul>\n<p>Chronic thromboembolic pulmonary hypertension</p>\n<p>Pulmonary tumor thrombotic microangiopathy</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(879, 'Pathology,', 'PM0951. ANCA Antibodies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The antineutrophil cytoplasmic antibodies (<strong>ANCA</strong>) are the antibodies that are targeted against the specific proteins present in <strong>neutrophils</strong> and <strong>monocytes.</strong> They can be further classified as:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Cytoplasmic ANCA (cANCA)</p>\n</td>\n<td>Perinuclear ANCA (pANCA)</td>\n</tr>\n<tr>\n<td>\n<p>Directed against</p>\n</td>\n<td>\n<p>Proteinase 3 (PR3)</p>\n</td>\n<td>Myeloperoxidase (MPO)</td>\n</tr>\n<tr>\n<td>\n<p>Predominantly positive in</p>\n</td>\n<td>\n<p>Granulomatosis with polyangiitis (Wegener granulomatosis)</p>\n</td>\n<td>\n<p>Microscopic polyangiitis</p>\n<p>Churg–Strauss syndrome&nbsp;</p>\n<p>Crescentic glomerulonephritis</p>\n<p>Inflammatory Bowel Disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Staining pattern</p>\n</td>\n<td>\n<p>Granular cytoplasmic staining</p>\n</td>\n<td>\n<p>Perinuclear or nuclear staining</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(880, 'Pathology,', 'PM0949. Genetic Syndromes associated with the Aortic Aneurysmal Disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Syndrome</strong></p>\n</td>\n<td>\n<p><strong>Gene mutated</strong></p>\n</td>\n<td>\n<p><strong>Aneurysm</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Marfan syndrome (MFS)</strong></p>\n</td>\n<td>\n<p><em>FBN1</em></p>\n</td>\n<td>\n<p><strong>Dilatation and aneurysm of the aortic root,</strong> dilatation of the pulmonary artery, and dilatation or dissection of the descending thoracic or abdominal aorta</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Ehlers-Danlos syndrome (EDS)</strong></p>\n</td>\n<td>\n<p><em>COL5A1</em>, <em>COL5A2</em>, and <em>COL3A1</em></p>\n</td>\n<td>\n<p><strong>Arterial mid-sized rupture, specially involving thoracic or abdominal vessels</strong>. Frequently descending and abdominal aorta</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Loeys-Dietz syndrome (LDS)</strong></p>\n</td>\n<td>\n<p><em>TGFBR1</em> and <em>TGFBR2</em></p>\n</td>\n<td>\n<p>Premature and aggressive aneurysms and dissections. <strong>Aneurysms distal to the aortic root</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Familial aortic aneurysm and/or dissection syndromes (FAAD)</strong></p>\n</td>\n<td>\n<p><em>TGFBR2</em>, <em>MYH11</em>, and <em>ACTA2</em></p>\n</td>\n<td>\n<p>Ascending aorta aneurysm and dissection</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Bicuspid aortic valve (BAV)</strong></p>\n</td>\n<td>\n<p>Unknown</p>\n</td>\n<td>\n<p><strong>Aortic dilation typically involves the aortic root</strong> and ascending aorta whereas it is not present in the descending and abdominal aorta</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Autosomal dominant polycystic kidney disease (ADPKD)</strong></p>\n</td>\n<td>\n<p><em>PKD1</em> and <em>PKD2</em></p>\n</td>\n<td>\n<p>Dilatation of the aortic root and dissection of the thoracic aorta</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Turners syndrome</strong></p>\n</td>\n<td>\n<p>45X</p>\n</td>\n<td>\n<p><strong>Thoracic aortic aneurysms and dissections</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Neurofibromatosis</strong></p>\n</td>\n<td>\n<p><em>NF1</em></p>\n</td>\n<td>\n<p>Aneurysmal arterial disease affecting the <strong>abdominal aorta</strong></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(881, 'Pathology,', 'PM0948. Risk Factors for Atherosclerosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Nonmodifiable </strong>(constitutional):</p>\n<ul>\n<li>Genetic abnormalities</li>\n<li>Family history</li>\n<li>Increasing age</li>\n<li>Male gender</li>\n</ul>\n<p><strong>Modifiable:</strong></p>\n<ul>\n<li>Hyperlipidemia</li>\n<li>Hypertension</li>\n<li>Cigarette smoking</li>\n<li>Diabetes</li>\n</ul>\n<p><strong>Additional risk factors:</strong></p>\n<ul>\n<li>Inflammation&nbsp;</li>\n<li>Hyperhomocysteinemia</li>\n<li>Metabolic syndrome</li>\n<li>Lipoprotein a [Lp(a)]&nbsp;</li>\n<li>Elevated plasminogen activator inhibitor 1</li>\n<li>Type A personality</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(882, 'Pathology,', 'PM0947. Causes of Secondary Hypertension', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\346\>\n<p><strong>Renal</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Acute glomerulonephritis</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Chronic renal disease</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Polycystic disease</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Renal artery stenosis</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Renal vasculitis</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Renin-producing tumors</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p><strong>Endocrine</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Adrenocortical hyperfunction (Cushing syndrome, primary aldosteronism,&nbsp;congenital adrenal hyperplasia, licorice ingestion)</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Pheochromocytoma</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Acromegaly</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Hypothyroidism (myxedema)</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Hyperthyroidism (thyrotoxicosis)</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Pregnancy-induced</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p><strong>Cardiovascular</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Coarctation of aorta</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Polyarteritis nodosa</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Increased intravascular volume</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Increased cardiac output</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Rigidity of the aorta</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p><strong>Neurologic</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Psychogenic</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Increased intracranial pressure</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Sleep apnea</p>\n</td>\n</tr>\n<tr>\n<td width=\346\>\n<p>Acute stress, including surgery</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(883, 'Pathology,', 'PM0842. Difference between Acute and Subacute Endocarditis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td valign=\middle\>\n<p><strong>Acute</strong></p>\n</td>\n<td valign=\middle\>\n<p><strong>Subacute</strong></p>\n</td>\n</tr>\n<tr>\n<td valign=\middle\>\n<p><em>Staphylococcus aureus</em></p>\n</td>\n<td valign=\middle\>\n<p><em>Streptococcus viridans</em>, Enterococci</p>\n</td>\n</tr>\n<tr>\n<td valign=\middle\>\n<p>Stormy onset</p>\n</td>\n<td valign=\middle\>\n<p>Insidious onset</p>\n</td>\n</tr>\n<tr>\n<td valign=\middle\>\n<p>Necrotizing, ulcerative, invasive valvular</p>\n<p>infection on a previously normal valve</p>\n</td>\n<td valign=\middle\>\n<p>Protracted course on a previously damaged valve</p>\n</td>\n</tr>\n<tr>\n<td valign=\middle\>\n<p>Difficult to cure with antibiotics alone, and</p>\n<p>usually, require surgery.</p>\n</td>\n<td valign=\middle\>\n<p>Cures can be achieved with antibiotics</p>\n</td>\n</tr>\n<tr>\n<td valign=\middle\>\n<p>Destructive valvular lesions</p>\n</td>\n<td valign=\middle\>\n<p>Less destruction of valves</p>\n</td>\n</tr>\n<tr>\n<td valign=\middle\>\n<p>Histopathology: Fibrin, inflammatory cells, and bacteria</p>\n</td>\n<td valign=\middle\>\n<p>Histopathology: Granulation tissue at base indicative of healing</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(884, 'Medicine,', 'PM0821. Causes of Myocarditis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Causes of myocarditis include:</p>\n<ul>\n<li>Infections:\n<ol>\n<li>Viruses (e.g., coxsackievirus, ECHO, influenza, HIV, cytomegalovirus)</li>\n<li>Chlamydiae (e.g., &nbsp;<em>Chlamydophila psittaci</em>)</li>\n<li>Rickettsiae (e.g., <em>Rickettsia typhi</em>, typhus fever)</li>\n<li>Bacteria (e.g., <em>Corynebacterium diphtheriae</em>, <em>Neisseria meningococcus</em>)</li>\n<li>Borrelia (Lyme disease)</li>\n<li>Fungi (e.g., <em>Candida </em>spp.)</li>\n<li>Protozoa (e.g., <em>Trypanosoma cruzi</em>&nbsp;[Chagas disease], toxoplasmosis)</li>\n<li>Helminths (e.g., trichinosis)</li>\n<li>Poststreptococcal (rheumatic fever)</li>\n<li>Immune-Mediated Reactions</li>\n<li>Systemic lupus erythematosus</li>\n</ol>\n</li>\n<li>Drug hypersensitivity (e.g., methyldopa, sulfonamides)</li>\n<li>Transplant rejection</li>\n<li>Sarcoidosis</li>\n<li>Giant cell myocarditis</li>\n<li>Unknown</li>\n</ul>\n<p>Morphology:</p>\n<p>The heart in myocarditis may appear normal or dilated. Some hypertrophy may be present depending on disease duration. Mural thrombi may be present. Active myocarditis is characterized by an interstitial inflammatory infiltrate associated with focal myocyte necrosis.&nbsp;<strong>Endomyocardial </strong><strong>biopsies are diagnostic in some cases, </strong>but <strong>not</strong> when the inflammation is <strong>focal or patchy.</strong></p>\n<p>The morphological pattern of myocarditis in certain conditions:</p>\n<ul>\n<li><strong>Hypersensitivity myocarditis: </strong>Interstitial infiltrates with a high proportion of eosinophils</li>\n<li><strong>Giant-cell myocarditis:</strong>&nbsp;Multinucleate giant cells (fused macrophages)</li>\n<li><strong>Chagas disease:</strong>&nbsp;Scattered myofibers by trypanosomes.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(885, 'Pathology,', 'PM0820. Cardiac Biomarkers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\479\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Time to initial elevation</strong></td>\n<td><strong>Mean time to peak elevation</strong></td>\n<td><strong>Time to return to normal range</strong></td>\n</tr>\n<tr>\n<td>Myoglobin</td>\n<td>1- 4 h</td>\n<td>12 h</td>\n<td>24 h</td>\n</tr>\n<tr>\n<td>CK-MB</td>\n<td>4-8 h</td>\n<td>24 h</td>\n<td>48-72 h</td>\n</tr>\n<tr>\n<td>cTnI</td>\n<td>3-12 h</td>\n<td>24 h</td>\n<td>7-10 d</td>\n</tr>\n<tr>\n<td>cTnT</td>\n<td>3-12 h</td>\n<td>12h – 2d</td>\n<td>7-10 d&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>CK-MB: Creatine kinase-MB; CTnI: Cardiac-specific troponin I; CTnT: Cardiac-specific troponin T&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/af5c41b3daaa4572985768e9c8081561x1280x1144.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(886, 'Pathology', 'PM0819. The Temporal Evolution of the Morphologic Changes in Acute MI', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table class=\t1\ width=\530\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Time</strong></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Gross Features</strong></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Microscopy features</strong></p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ colspan=\3\ valign=\top\>\n<p class=\p1\><strong>Reversible Injury</strong></p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>0-1/2 hr</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>None</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>EM</strong>: Relaxation of myofibrils; glycogen loss; mitochondrial swelling</p>\n<p class=\p1\><strong>LM</strong>: None</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ colspan=\3\ valign=\top\>\n<p class=\p1\><strong>Irreversible Injury&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>1/2-4 hr</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>None</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>EM</strong>: Sarcolemmal disruption; mitochondrial amorphous densities</p>\n<p class=\p1\><strong>LM</strong>: Usually none; variable waviness of fibers at border</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>4-12 hr</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Dark mottling (occasional)</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>LM</strong>: Early coagulation necrosis, edema, hemorrhage</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>12-24 hr</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Dark mottling</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>LM</strong>: Ongoing coagulation necrosis, pyknosis of nuclei, myocyte hypereosinophilia, marginal contraction band necrosis, early neutrophilic infiltrate</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>1-3 days</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Mottling with yellow-tan infarct center</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>LM</strong>: Coagulation necrosis, with loss of nuclei and striations, brisk interstitial infiltrate of neutrophils</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>3-7 days</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Hyperemic border, central yellow-tan softening</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>LM</strong>: Begining disintegration of dead myofibres, with dying neutrophils, early phagocytosis of dead cells by macrophages at the infarct border</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>7-10 days</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Maximally yellow-tan and soft with depressed red-tan margins</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>LM</strong>: Well-developed phagocytosis of dead cells; granulation tissue at margins</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>10-14 days</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Red-grey depressed infarct borders</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>LM</strong>: Well-established granulation tissue with new blood vessels and collagen deposition</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>2-8 wk</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Grey-white scar, progressive from the&nbsp; border towards the core of the infarct</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>LM</strong>: increased collagen deposition, with decreased cellularity</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>&gt;2 mo</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Scarring complete</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>LM</strong>: Dense collagenous scar</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>EM: Electron microscopy</p>\n<p>LM: Light microscopy</p></div><!---->\n      <!---->\n    </div><!---->'),
(887, 'Pathology', 'PM0817. Approximate Time of onset of Key Events in Ischemic Cardiac Myocytes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Feature</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Time</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Onset of ATP depletion</p>\n</td>\n<td width=\231\>\n<p>Seconds</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Loss of contractility</p>\n</td>\n<td width=\231\>\n<p>&lt;2 minutes</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>ATP reduced</p>\n<p>to 50% of normal</p>\n<p>to 10% of normal</p>\n</td>\n<td width=\231\>\n<p>&nbsp;</p>\n<p>10 minutes</p>\n<p>40 minutes</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Irreversible cell injury</p>\n</td>\n<td width=\231\>\n<p>20-40 minutes</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Microvascular injury</p>\n</td>\n<td width=\231\>\n<p>&gt;1 hour</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(888, 'Pathology', 'PM0815. Changes in the Aging Heart', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\92\>\n<p><strong>Chambers</strong></p>\n</td>\n<td width=\92\>\n<p><strong>Valves</strong></p>\n</td>\n<td width=\92\>\n<p><strong>Epicardial Coronary Arteries</strong></p>\n</td>\n<td width=\92\>\n<p><strong>Myocardium</strong></p>\n</td>\n<td width=\92\>\n<p><strong>Aorta</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\92\>\n<p><strong>Increased left atrial cavity size</strong></p>\n</td>\n<td width=\92\>\n<p>Aortic valve calcific deposits</p>\n</td>\n<td width=\92\>\n<p>Tortuosity</p>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\92\>\n<p>Decreased mass</p>\n</td>\n<td width=\92\>\n<p>Dilated ascending aorta with rightward shift</p>\n</td>\n</tr>\n<tr>\n<td width=\92\>\n<p><strong>Decreased left ventricular cavity size</strong></p>\n</td>\n<td width=\92\>\n<p>Mitral valve annular calcific deposits</p>\n</td>\n<td width=\92\>\n<p>Diminished compliance</p>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\92\>\n<p>Increased subepicardial fat</p>\n</td>\n<td width=\92\>\n<p>Elongated (tortuous) thoracic aorta</p>\n</td>\n</tr>\n<tr>\n<td width=\92\>\n<p><strong>Sigmoid-shaped ventricular septum</strong></p>\n</td>\n<td width=\92\>\n<p>Fibrous thickening of leaflets</p>\n</td>\n<td width=\92\>\n<p>Calcific deposits</p>\n</td>\n<td width=\92\>\n<p>Brown atrophy</p>\n</td>\n<td width=\92\>\n<p>Sinotubular junction calcific deposits</p>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\92\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\92\>\n<p>Lambl excrescences</p>\n</td>\n<td width=\92\>\n<p>Atherosclerotic plaque</p>\n</td>\n<td width=\92\>\n<p>Lipofuscin deposition</p>\n</td>\n<td width=\92\>\n<p>Elastic fragmentation and collagen accumulation</p>\n</td>\n</tr>\n<tr>\n<td width=\92\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\92\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\92\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\92\>\n<p>Basophilic degeneration</p>\n</td>\n<td width=\92\>\n<p>Atherosclerotic plaque</p>\n</td>\n</tr>\n<tr>\n<td width=\92\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\92\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\92\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\92\>\n<p>Amyloid deposits</p>\n</td>\n<td width=\92\>\n<p><strong>&nbsp;</strong></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Small filiform processes form the closure lines of aortic and mitral valves, probably resulting from the organization of small thrombi - Lambl excrescences</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(889, 'Pathology', 'PM0803. Gene Defects Associated with Congenital Heart Disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Syndrome</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Cardiac defects</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Char syndrome</p>\n</td>\n<td width=\231\>\n<p>Patent ductus arteriosus (PDA)</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Alagille syndrome</p>\n</td>\n<td width=\231\>\n<p>Pulmonary artery stenosis or tetralogy of Fallot</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>CHARGE syndrome</p>\n</td>\n<td width=\231\>\n<p>Atrial septal defect (ASD), ventricular septal defect (VSD), PDA, or hypoplastic&nbsp;right side of the heart</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Noonan syndrome</p>\n</td>\n<td width=\231\>\n<p>Pulmonary valve stenosis, VSD, or Hypertrophic cardiomyopathy</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>DiGeorge syndrome</p>\n</td>\n<td width=\231\>\n<p>ASD, VSD, or outflow tract obstruction</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Holt-Oram syndrome</p>\n</td>\n<td width=\231\>\n<p>ASD, VSD, or conduction defect</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(890, 'Medicine,', 'PM0440. Granulomatosis with polyangiitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Granulomatosis with polyangiitis&nbsp;(previously called Wegener’s granulomatosis) is a&nbsp;<strong>necrotising</strong> vasculitis of small arteries and veins along with <strong>granuloma</strong> formation.</p>\n<p>It presents as a triad of&nbsp;upper and lower respiratory tract involvement with glomerulonephritis.</p>\n<p>Important organs involved are:</p>\n<ul>\n<li><strong>Upper respiratory tract- </strong>Presents with&nbsp;paranasal sinus pain, serous otitis media, nasal septal perforation.</li>\n<li><strong>Lower respiratory tract- </strong>Presents with cough, hemoptysis, and multiple bilateral cavitary nodular infiltrates.</li>\n<li><strong>Renal- </strong>Presents with rapidly progressive renal failure, crescentic glomerulonephritis.</li>\n<li>Eye- Presents with conjunctivitis, scleritis, episcleritis and dacryocystitis</li>\n<li>Skin<strong>- </strong>Papules, vesicles, palpable purpura and subcutaneous nodules.</li>\n</ul>\n<p>Histopathology shows&nbsp;<strong>necrotizing vasculitis</strong> of small arteries and vein with<strong> granuloma </strong>formation.</p>\n<p>The important laboratory features are elevated ESR,&nbsp;<strong>positive cANCA&nbsp;</strong> antibodies and mild elevation of rheumatoid factor.</p>\n<p>Treatment:</p>\n<ul>\n<li>Induction phase- Cyclophosphamide combined with steroids</li>\n<li>Remission phase- Methotrexate/Azathioprine</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(891, 'Pathology,', 'PM2286. Types of Cystitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Type of cystitis</strong></td>\n<td><strong>Etiology</strong></td>\n<td><strong>Characteristic features</strong></td>\n</tr>\n<tr>\n<td>Interstitial cystitis</td>\n<td>Idiopathic</td>\n<td>Hunners ulcer</td>\n</tr>\n<tr>\n<td>Polypoid cystitis</td>\n<td>Catheterization of bladder</td>\n<td>Mimics malignancy</td>\n</tr>\n<tr>\n<td>Malakoplakia</td>\n<td>Defective phagocytosis</td>\n<td>Michaelis– Gutmann bodies</td>\n</tr>\n<tr>\n<td>Eosinophilic cystitis</td>\n<td>Systemic allergic disorders</td>\n<td>Submucosal eosinophils</td>\n</tr>\n<tr>\n<td>Emphysematous cystitis</td>\n<td><em>Clostridium perfringens</em></td>\n<td>Associated with Diabetes</td>\n</tr>\n<tr>\n<td>Follicular cystitis</td>\n<td>Prolonged urinary retention, intravesicular chemotherapy or BCG</td>\n<td>Lymphoid follicles within bladder mucosa</td>\n</tr>\n<tr>\n<td>Hemorrhagic cystitis</td>\n<td>\n<p>Cyclo-phosphamide, BK virus, Adenovirus</p>\n</td>\n<td>Prophylactic administration of mesna reduces the incidence</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(892, 'Pathology,', 'PM2285. Nephrotic and nephritic syndromes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table class=\t1\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p3\>&nbsp;</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Nephrotic Syndrome</strong></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Nephritic Syndrome</strong> (Glomerulonephritis)</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Primary pathology</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Damage and dysfunction of glomerular filtration barrier, causing significant leakage of plasma proteins without much glomerular inflammation</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Significant inflammatory injury of the glomerulus resulting in passage of RBCs, inflammatory cells &amp; plasma proteins</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>The principal site of glomerular injury</p>\n</td>\n<td class=\td1\ valign=\top\>Visceral epithelial cell (Podocyte)</td>\n<td class=\td1\ valign=\top\>Endothelial cells, glomerular basement membrane (GBM), Mesangial cells, Parietal epithelial cells (&gt;Crescents)</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Clinical features</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Hallmark: </strong></p>\n<p class=\p1\><strong>Heavy Proteinuria: 3.5 g</strong>/24 h or Urine protein:creatinine ratio &gt;3)<span class=\Apple-converted-space\>&nbsp; </span></p>\n<p class=\p1\>Hypoalbuminemia,<span class=\Apple-converted-space\>&nbsp;</span></p>\n<p class=\p1\>Edema</p>\n<p class=\p1\>Lipiduria, Hyperlipidemia</p>\n<p class=\p1\>Microscopic hematuria</p>\n<p class=\p1\>Hypertension</p>\n<p class=\p1\>Hypercoagulability<span class=\Apple-converted-space\>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</span></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Hallmark: </strong></p>\n<p class=\p1\><strong>Hematuria</strong> (RBC casts/dysmorphic RBCs)</p>\n<p class=\p1\>Varying degrees of proteinuria and pyuria</p>\n<p class=\p1\>Renal dysfunction</p>\n<p class=\p1\>Hypertension</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Associated Glomerular pathology</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p>Minimal change disease (Primary and secondary)</p>\n<p>Focal segmental glomerulosclerosis (FSGS) (Primary and secondary)</p>\n<p>Membranous-nephropathy (Primary and secondary)</p>\n<p>Diabetic nephropathy</p>\n<p>Amyloidosis</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p>Acute post-streptococcal glomerulonephritis</p>\n<p>Rapidly progressive glomerulonephritis (crescentic)</p>\n<p>IgA nephropathy (Berger disease)</p>\n<p>Membranoproliferative glomerulonephritis</p>\n<p>Alport syndrome</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p class=\p1\>These syndromes, however, are <strong>not mutually exclusive</strong>. Some glomerular diseases <strong>may progress from one pattern to another</strong> or&nbsp;may present with considerable<strong> overlap</strong> between them, as&nbsp;a <strong>nephritic–nephrotic syndrome;</strong>&nbsp;features of nephrotic syndrome can concurrently occur with any form of nephritic syndrome but are most commonly seen with diffuse proliferative glomerulonephritis (seen in systemic lupus erythematosus) and membranoproliferative glomerulonephritis.</p></div><!---->\n      <!---->\n    </div><!---->'),
(893, 'Pathology', 'PM2279. Seminomatous germ-cell tumors (GCTs) vs Non-seminomatous GCT', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Features</strong></td>\n<td><strong>Seminoma</strong></td>\n<td><strong>Non- seminomatous GCT</strong></td>\n</tr>\n<tr>\n<td><strong>Age</strong></td>\n<td>2<sup>nd</sup> or 3<sup>rd</sup> decade (Never seen in prepubertal children)</td>\n<td>Occur at any age</td>\n</tr>\n<tr>\n<td><strong>Presentation</strong></td>\n<td>Localized to the testis for a&nbsp;long time</td>\n<td>Aggressive tumors; present&nbsp;at an advanced clinical stage</td>\n</tr>\n<tr>\n<td><strong>Spread</strong></td>\n<td>Lymphatic</td>\n<td>Hematogenous</td>\n</tr>\n<tr>\n<td><strong>Macroscopy</strong></td>\n<td>Homogenous</td>\n<td>Variegated</td>\n</tr>\n<tr>\n<td><strong>Cell type</strong></td>\n<td>Composed of primordial germ cells</td>\n<td>Composed of undifferentiated cells</td>\n</tr>\n<tr>\n<td><strong>Tumor marker</strong></td>\n<td>Placental alkaline phosphatase</td>\n<td>AFP, HCG</td>\n</tr>\n<tr>\n<td><strong>Radio-therapy</strong></td>\n<td>Radiosensitive</td>\n<td>Radioresistant</td>\n</tr>\n<tr>\n<td><strong>Prognosis</strong></td>\n<td>Better</td>\n<td>Poor</td>\n</tr>\n</tbody>\n</table>\n<p>AFP:&nbsp;Alpha-fetoprotein&nbsp;</p>\n<p>HCG: Human Chorionic Gonadotropin</p></div><!---->\n      <!---->\n    </div><!---->'),
(894, 'Pathology,', 'PM2277. WHO 2016 classification of testicular tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\page\ title=\Page 182\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>I. Germ-cell tumors (GCTs) derived from germ-cell neoplasia in situ</strong></p>\n<ul>\n<li>Germ-cell neoplasia in situ</li>\n<li>Seminoma</li>\n<li>Non-seminomatous GCTs\n<ul>\n<li>Embryonal carcinoma</li>\n<li>Yolk sac tumor, postpubertal-type</li>\n<li>Choriocarcinoma</li>\n<li>Teratoma, post-pubertal type</li>\n</ul>\n</li>\n<li>Mixed germ-cell tumors</li>\n</ul>\n<p><strong>II. Germ-cell tumors unrelated to germ-cell neoplasia in situ</strong></p>\n<ul>\n<li>Spermatocytic tumour</li>\n<li>Teratoma, prepubertal type</li>\n<li>Yolk sac tumor, prepubertal type</li>\n<li>Mixed</li>\n</ul>\n<p><strong>III. Sex cord stromal tumors</strong></p>\n<ul>\n<li>Leydig cell tumor</li>\n<li>Sertoli cell tumor</li>\n<li>Granulosa cell tumor</li>\n<li>Fibroma–thecoma</li>\n</ul>\n<p><strong>IV. Tumor containing both germ-cell and sex cord-stromal elements</strong></p>\n<ul>\n<li>Gonadoblastoma</li>\n</ul>\n<p><strong>V. Hematolymphoid tumors</strong></p>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(895, 'Pathology', 'PM2274. WHO 2016 Classification of Renal Cell Tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Clear-cell renal cell carcinoma</li>\n<li>Multilocular cystic renal neoplasm of low malignant potential</li>\n<li>Papillary renal cell carcinoma</li>\n<li>Hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinoma</li>\n<li>Chromophobe renal cell carcinoma</li>\n<li>Collecting duct carcinoma</li>\n<li>Renal medullary carcinoma</li>\n<li>MiT family translocation renal cell carcinoma</li>\n<li>Succinate dehydrogenase-deficient renal cell carcinoma</li>\n<li>Mucinous tubular and spindle cell carcinoma</li>\n<li>Tubulocystic renal cell carcinoma</li>\n<li>Acquired cystic disease-associated renal cell carcinoma</li>\n<li>Clear-cell papillary renal cell carcinoma</li>\n<li>Renal cell carcinoma, unclassified</li>\n<li>Papillary adenoma</li>\n<li>Oncocytoma</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(896, 'Pathology,', 'PM2272. Syndromic Associations of Wilms Tumor', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\544\>\n<tbody>\n<tr>\n<td><strong>Syndrome</strong></td>\n<td><strong>Mutation</strong></td>\n<td><strong>Features</strong></td>\n</tr>\n<tr>\n<td><strong>WAGR Syndrome</strong></td>\n<td>\n<ul>\n<li aria-level=\1\>WT1 and PAX6 deletion on Chr11p</li>\n<li aria-level=\1\>Genetic basis- two-hit hypothesis</li>\n</ul>\n</td>\n<td>\n<ul>\n<li aria-level=\1\><strong>W</strong>ilms tumor</li>\n<li aria-level=\1\><strong>A</strong>niridia</li>\n<li aria-level=\1\><strong>G</strong>enital anomalies</li>\n<li aria-level=\1\>Mental <strong>r</strong>etardation</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Denys–Drash Syndrome</strong></td>\n<td>\n<ul>\n<li aria-level=\1\>Dominant-negative missense mutation of WT1 protein</li>\n</ul>\n<ul>\n<li aria-level=\1\>Genetic basis- two-hit hypothesis</li>\n</ul>\n</td>\n<td>\n<ul>\n<li aria-level=\1\>Gonadal dysgenesis (male pseudo hermaphroditism)</li>\n<li aria-level=\1\>Early-onset nephropathy</li>\n<li aria-level=\1\>Gonadoblastoma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Beckwith– Wiedemann Syndrome</strong></td>\n<td>\n<ul>\n<li aria-level=\1\>IGF-2 overexpression onWT2 region</li>\n<li aria-level=\1\>Genetic basis- genomic imprinting</li>\n</ul>\n</td>\n<td>\n<ul>\n<li aria-level=\1\>Organomegaly</li>\n<li aria-level=\1\>Macroglossia</li>\n<li aria-level=\1\>Hemihypertrophy</li>\n<li aria-level=\1\>Omphalocele</li>\n<li aria-level=\1\>Adrenal cytomegaly</li>\n<li aria-level=\1\>Hepatoblastoma</li>\n<li aria-level=\1\>Pancreato-blastoma</li>\n<li aria-level=\1\>Adrenocortical tumors</li>\n<li aria-level=\1\>Rhabdomyosarcoma</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Note:&nbsp;<strong>Wilms tumor 1 (WT1)&nbsp;</strong>protein is a transcriptional activator of genes involved in normal renal and gonadal development. Therefore,&nbsp;<strong>genitourinary abnormalities</strong>&nbsp;are commonly associated with <em>WT1</em> gene mutations.</p></div><!---->\n      <!---->\n    </div><!---->'),
(897, 'Pathology,', 'PM2271. Sites of Deposits in Glomerular diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\271\>\n<tbody>\n<tr>\n<td><strong>Subepithelial</strong></td>\n<td>\n<ul>\n<li>Membranous nephropathy (epimembranous)</li>\n<li>PSGN</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Intramembranous</strong></td>\n<td>\n<ul>\n<li>Dense deposit disease (MPGN type II)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Subendothelial</strong></td>\n<td>\n<ul>\n<li>MPGN Type I</li>\n<li>Lupus nephritis class III and IV</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Mesangial</strong></td>\n<td>\n<ul>\n<li>IgA nephropathy</li>\n<li>Henoch–Schonlein Purpura</li>\n<li>RPGN&nbsp;</li>\n<li>Lupus nephritis classes I and II</li>\n<li>Resolving postinfectious&nbsp; glomerulonephritis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>No deposits</strong></td>\n<td>\n<ul>\n<li>Minimal change disease</li>\n<li>FSGS</li>\n<li>Alport syndrome</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>MPGN: Membranoproliferative glomerulonephritis</p>\n<p>PSGN: Poststreptococcal glomerulonephritis&nbsp;</p>\n<p>FSGS: Focal segmental glomerulosclerosis</p>\n<p>RPGN: Rapidly progressive glomerulonephritis&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7a297a03f6db49959196ff715d59b609x1280x1685.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(898, 'Pathology', 'PM2270. Inherited causes of nephrotic syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Gene involved</strong></p>\n</td>\n<td>\n<p><strong>Protein</strong></p>\n</td>\n<td>&nbsp;<strong>Disease Phenotype</strong></td>\n<td><strong>Inheritance Pattern</strong></td>\n</tr>\n<tr>\n<td>\n<p><em>NPHS1</em>&nbsp; (Ch.19q)</p>\n</td>\n<td>\n<p><strong>Nephrin</strong></p>\n</td>\n<td>\n<p>Congenital Nephrotic syndrome (Finnish Type)&nbsp;</p>\n</td>\n<td>\n<p>Autosomal recessive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>NPHS2</em>&nbsp; (Ch.1q)</p>\n</td>\n<td>\n<p><strong>Podocin</strong></p>\n</td>\n<td>Steroid resistant nephrotic syndrome</td>\n<td>Autosomal recessive&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><em>TRPC6</em></p>\n</td>\n<td>\n<p>Transient receptor potential cation channel 6</p>\n</td>\n<td>Adult onset FSGS</td>\n<td>Autosomal dominant&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><em>ACTN4</em></p>\n</td>\n<td>\n<p>Alpha-actinin 4</p>\n</td>\n<td>FSGS</td>\n<td>Autosomal dominant &nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>FSGS: Focal segmental glomerulosclerosis</p>\n<p>NOTE: <strong>Inherited</strong> forms of&nbsp;<strong>nephrotic syndrome</strong> are invariably resistant to immunosuppressants (<strong>steroid resistant</strong>)</p></div><!---->\n      <!---->\n    </div><!---->'),
(899, 'Pathology,', 'PM2176. Types of endometrial carcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Characteristics</strong></td>\n<td><strong>Type 1</strong></td>\n<td><strong>Type 2</strong></td>\n</tr>\n<tr>\n<td>Age</td>\n<td>55–65 yr</td>\n<td>65–75 yr</td>\n</tr>\n<tr>\n<td>Clinical setting</td>\n<td><strong>Unopposed estrogen</strong><br>Obesity<br>Hypertension<br>Diabetes</td>\n<td>Atrophy<br>Thin physique</td>\n</tr>\n<tr>\n<td>Morphology</td>\n<td><strong>Endometrioid</strong></td>\n<td><strong>Serous</strong><br>Clear Cell<br>Mixed mullerian tumor</td>\n</tr>\n<tr>\n<td>Precursor</td>\n<td><strong>Atypical hyperplasia</strong></td>\n<td><strong>Serous endometrial</strong><br><strong>intraepithelial carcinoma</strong></td>\n</tr>\n<tr>\n<td>\n<p>Mutated genes/genetic&nbsp;</p>\n<p>abnormalities</p>\n</td>\n<td><em><strong>PTEN</strong></em><br><em>ARID1A</em> (regulator of&nbsp;chromatin)<br><em>PIK3CA</em> (PI3K)<br>KRAS<br><em>FGF2</em> (growth factor)<br>MSI<br><em>CTNNB1</em> (Wnt&nbsp;signaling)<br><em>TP53</em></td>\n<td><em>TP53</em><br>Aneuploidy<br><em>PIK3CA</em> (PI3K)<br><em>FBXW7</em> (regulator of MYC,&nbsp;cyclin E)<br><em>CHD4</em> (regulator of&nbsp;chromatin)<br><em>PPP2R1A</em> (PP2A)</td>\n</tr>\n<tr>\n<td>Behavior</td>\n<td><strong>Indolent</strong><br>Spreads via lymphatics</td>\n<td><strong>Aggressive</strong><br>Intraperitoneal and<br>lymphatic spread</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(900, 'Pathology', 'PM2174. Human Papilloma Virus (HPV) and Associated Lesions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>HPV serotype</strong></td>\n<td><strong>Lesions</strong></td>\n</tr>\n<tr>\n<td>HPV 1,2,3,4</td>\n<td>\n<div class=\page\ title=\Page 566\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li>Common warts (verruca vulgaris, plantar wart)</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>HPV 6 and 11</td>\n<td>\n<ul>\n<li>Condyloma acuminatum (genital warts)</li>\n<li>Sinonasal papilloma</li>\n<li>Squamous papilloma of the larynx</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HPV 16</td>\n<td>\n<ul>\n<li>LSIL, HSIL, carcinoma cervix</li>\n<li>Vulval carcinoma</li>\n<li>Bowen disease (Carcinoma in situ of male external genitalia)</li>\n<li>Oropharyngeal squamous cell carcinoma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HPV 18</td>\n<td>\n<ul>\n<li>LSIL, HSIL, Carcinoma of the cervix</li>\n<li>Carcinoma of the anogenital region</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HPV 5 and 8</td>\n<td>\n<ul>\n<li>Squamous cell carcinoma of the skin in epidermodysplasia verruciformis patients</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>LSIL: Low-grade squamous intraepithelial lesion</p>\n<p>HSIL: High-grade squamous intraepithelial lesion&nbsp;&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(901, 'Pathology,', 'PM2068. Etiological Factors for Bladder Carcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>Histological subtype</td>\n<td>Risk factors</td>\n</tr>\n<tr>\n<td>Transitional cell carcinoma (urothelial)</td>\n<td><strong>Smoking</strong><br>Exposure to <strong>aniline dyes</strong><br><strong>Cyclophosphamide</strong><br>Pelvic irradiation</td>\n</tr>\n<tr>\n<td>Squamous cell carcinoma</td>\n<td><strong>Schistosomiasis&nbsp;</strong>(S. haematobium)<br>Chronic irritation caused by stone disease<br>Bladder diverticula<br>Chronic UTI<br>Smoking</td>\n</tr>\n<tr>\n<td>Adenocarcinoma</td>\n<td>\n<p>Persistent urachus or trigone of the bladder<br>Congenital bladder exstrophy</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Inherited cancer syndromes:</p>\n<ul>\n<li>Lynch syndrome</li>\n<li>Hereditary retinoblastoma</li>\n<li>Costello syndrome</li>\n</ul>\n<p>Acquired genetic mutations:</p>\n<ul>\n<li>Gain of function mutation in <em>FGFR3</em></li>\n<li>Activating mutations in <em>RAS and PI-3 kinase</em></li>\n<li>Disruption of p<em>53</em>&nbsp;and <em>RB</em> genes in muscle-invasive cancers</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(902, 'Pathology', 'PM2067. WHO Classification of Tumors of the Urothelial Tract (2016)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>1) Urothelial (transitional) tumors (most common)</strong></p>\n<ul>\n<li>Invasive</li>\n<li>Non-invasive\n<ul>\n<li>Carcinoma in situ</li>\n<li>Urothelial&nbsp;papilloma</li>\n<li>Inverted urothelial papilloma</li>\n<li>Papillary urothelial neoplasms of low malignant potential</li>\n<li>Low-grade and high-grade papillary urothelial cancers</li>\n</ul>\n</li>\n</ul>\n<div class=\page\ title=\Page 2980\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>2) Squamous cell carcinoma</strong></p>\n<p>3) Glandular neoplasms</p>\n<ul>\n<li><strong>Adenocarcinoma</strong></li>\n</ul>\n<p>4) Urachal carcinoma</p>\n<p>5) Tumors of mullerian type</p>\n<div class=\page\ title=\Page 2980\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li>Clear-cell carcinoma</li>\n<li>Endometrioid carcinoma</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n<p>6) Neuroendocrine tumors</p>\n<ul>\n<li>Small- and large-cell neuroendocrine tumor</li>\n</ul>\n<p>7) Melanocytic&nbsp;tumors</p>\n<p>8) Mesenchymal&nbsp;tumors</p>\n<p>9) Hematopoietic and lymphoid&nbsp;tumors</p>\n<p>10) Miscellaneous tumors</p>\n<ul>\n<li>Tumors arising from the bladder diverticulum</li>\n</ul>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n<div class=\page\ title=\Page 2975\>&nbsp;</div></div><!---->\n      <!---->\n    </div><!---->'),
(903, 'Pathology,', 'PM1900. Grades of cervical dysplasia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>A comparison of various naming systems based on cytology (Bethesda) and biopsy (CIN grade)</p>\n<table>\n<tbody>\n<tr>\n<td><strong>WHO grade</strong></td>\n<td><strong>Bethesda</strong></td>\n<td><strong>CIN grade</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>Mild Dysplasia</td>\n<td>LSIL</td>\n<td>CIN I</td>\n<td>Dysplastic cells in basal 1/3 of cervical epithelium</td>\n</tr>\n<tr>\n<td>Moderate Dysplasia</td>\n<td rowspan=\3\>HSIL</td>\n<td>CIN II</td>\n<td>Dysplastic cells in basal 2/3 of cervical epithelium</td>\n</tr>\n<tr>\n<td>Severe dysplasia</td>\n<td>CIN III</td>\n<td>Dysplastic cells in &gt;2/3 of the cervical epithelium</td>\n</tr>\n<tr>\n<td>Carcinoma in situ</td>\n<td>Carcinoma in situ</td>\n<td>Dysplastic cells in full-thickness of cervical epithelium but basement membrane is intact</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table width=\420\>\n<tbody>\n<tr>\n<td><strong>LSIL</strong></td>\n<td><strong>HSIL</strong></td>\n</tr>\n<tr>\n<td>Atypia confined to the basal one-third of the epithelium</td>\n<td>Atypia involving upper two-third of the epithelium</td>\n</tr>\n<tr>\n<td>80% of LSILs are associated with high-risk HPVs, mostly HPV-16</td>\n<td>100% of HSILs are associated with high-risk HPVs, mostly HPV-16</td>\n</tr>\n<tr>\n<td>60% regress spontaneously; only 10% progress to HSIL.</td>\n<td>30% regress spontaneously; 10% progress to carcinoma</td>\n</tr>\n<tr>\n<td>Not a premalignant lesion</td>\n<td>Premalignant lesion</td>\n</tr>\n<tr>\n<td>Next step - Colposcopic directed biopsy</td>\n<td>Next step -&nbsp;Colposcopic directed biopsy + Endocervical curettage</td>\n</tr>\n</tbody>\n</table>\n<p>Abbreviations:</p>\n<p>CIN: Cervical Intra-epithelial neoplasia</p>\n<p>LSIL: Low Squamous Intra-epithelial Lesion</p>\n<p>HSIL: High&nbsp;Squamous Intra-epithelial Lesion</p></div><!---->\n      <!---->\n    </div><!---->'),
(904, 'Pathology', 'PM1568. Classification of Lupus Nephritis (International Society of Nephrology and Renal Pathology Society)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Class&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>Findings</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Minimal mesangial lupus nephritis (class I)</p>\n</td>\n<td>\n<p><strong>Immune complex deposition</strong> in&nbsp;the mesangium without structural changes by light microscopy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mesangial proliferative lupus nephritis (class II)</p>\n</td>\n<td>\n<p><strong>Mesangial cell proliferation</strong> with mesangial immune deposits</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Focal lupus nephritis (class III)</p>\n</td>\n<td>\n<p>Focal, segmental <strong>glomerulonephritis</strong> involving <strong>less than 50%</strong> of all glomeruli.</p>\n<p>Focal subendothelial deposits with or without mesangial changes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse lupus nephritis (class IV)</p>\n</td>\n<td>\n<p>The most common and severe form of lupus nephritis</p>\n<p>Diffuse&nbsp;<strong>glomerulonephritis</strong> involving <strong>more than 50%</strong> of all glomeruli</p>\n<p>Diffuse subendothelial deposits with or without mesangial changes<strong>. “Wire loop”</strong> structures on light microscopy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranous lupus nephritis (class V)</p>\n</td>\n<td>\n<p>Global or segmental&nbsp;<strong>subepithelial</strong> immune deposits with or without mesangial proliferation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Advanced sclerosing lupus nephritis (class VI)</p>\n</td>\n<td>\n<p><strong>Sclerosis</strong> of <strong>more than 90%</strong> of the glomeruli&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li>Focal- Involves only a few glomeruli</li>\n<li>Diffuse- Involves almost all the glomeruli</li>\n<li>Segmental- Involves only a part of glomerulus</li>\n<li>Global- Involves entire glomerulus</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b83e16725c9e4acbae2e0ff8275ec1a5x1279x911.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(905, 'Medicine,', 'PM1406. Cystic Diseases of the Kidney', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Features&nbsp;</strong></td>\n<td><strong>Adult PKD</strong></td>\n<td><strong>Childhood PKD</strong></td>\n</tr>\n<tr>\n<td><strong>Mode of inheritance</strong></td>\n<td>Autosomal dominant</td>\n<td>Autosomal recessive</td>\n</tr>\n<tr>\n<td><strong>Mutation in genes</strong></td>\n<td>PKD1, PKD2</td>\n<td>PKHD1</td>\n</tr>\n<tr>\n<td><strong>Proteins produced</strong></td>\n<td>Polycystin 1, polycystin 2</td>\n<td>Fibrocystin</td>\n</tr>\n<tr>\n<td><strong>Chromosomes involved</strong></td>\n<td>16p, 4q</td>\n<td>6p</td>\n</tr>\n<tr>\n<td><strong>Extrarenal manifestations&nbsp;</strong></td>\n<td>\n<p>Multiple cysts in the <strong>liver</strong> (most common), pancreas, spleen</p>\n<p>Berry aneurysms in the circle of Willis - SAH</p>\n<p>Colonic diverticuli</p>\n<p>Mitral valve prolapse</p>\n</td>\n<td><strong>Congenital hepatic fibrosis</strong></td>\n</tr>\n</tbody>\n</table>\n<p>Other cystic diseases:</p>\n<p><strong>Medullary sponge kidney</strong> -&nbsp;</p>\n<ul>\n<li aria-level=\1\>Sporadic in origin</li>\n<li aria-level=\1\>Characterized by medullary cysts</li>\n<li aria-level=\1\>Associated with hematuria, recurrent renal stones, and normal renal function</li>\n</ul>\n<p><strong>Multicystic renal dysplasia</strong> -&nbsp;</p>\n<ul>\n<li aria-level=\1\>Characterized by irregular, enlarged, multicystic kidneys</li>\n<li aria-level=\1\>Associated with ureteropelvic obstruction, ureteral agenesis, or atresia&nbsp;</li>\n<li aria-level=\1\>Bilateral multicystic renal dysplasia&nbsp; is associated with renal failure</li>\n</ul>\n<p><strong>Simple renal cysts</strong> -&nbsp;</p>\n<ul>\n<li aria-level=\1\>Characterized by single or multiple cysts with normal-sized kidney</li>\n<li aria-level=\1\>Associated with microscopic hematuria</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(906, 'Pathology', 'PM1404. Causes of Papillary Necrosis in the Kidney', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Diabetes mellitus</strong></p>\n</td>\n<td>\n<p><strong>Analgesic nephropathy</strong></p>\n</td>\n<td>\n<p><strong>Sickle cell disease</strong></p>\n</td>\n<td>\n<p><strong>Obstruction</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Male:female ratio</strong></p>\n</td>\n<td>\n<p>1:3</p>\n</td>\n<td>\n<p>1:5</p>\n</td>\n<td>\n<p>1:1</p>\n</td>\n<td>\n<p>9:1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Time course</strong></p>\n</td>\n<td>\n<p>10 years</p>\n</td>\n<td>\n<p>7 years</p>\n</td>\n<td>\n<p>Variable</p>\n</td>\n<td>\n<p>Variable</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Infection</strong></p>\n</td>\n<td>\n<p>80%</p>\n</td>\n<td>\n<p>25%</p>\n</td>\n<td>\n<p>Variable</p>\n</td>\n<td>\n<p>90%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Calcification</strong></p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n<td>\n<p>Frequent</p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n<td>\n<p>Frequent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Number of papillae affected</strong></p>\n</td>\n<td>\n<p>Several; all of the same stage</p>\n</td>\n<td>\n<p>Almost all; all in different</p>\n<p>stages of necrosis</p>\n</td>\n<td>\n<p>Few</p>\n</td>\n<td>\n<p>Variable</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2f5f5862005f47ea9dae3e9a023bfc13x1280x1142.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><!---->'),
(907, 'Pathology', 'PM1399. EM findings in Renal Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<p>Alport syndrome</p>\n</td>\n<td>\n<p><strong>Basketweave appearance</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Postinfectious glomerulonephritis</p>\n</td>\n<td>\n<p>Primarily <strong>subepithelial humps;</strong> subendothelial deposits in early disease stages.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Goodpasture syndrome</p>\n</td>\n<td>\n<p>Disruptions in GBM</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranous nephropathy</p>\n</td>\n<td>\n<p><strong>Subepithelial deposits</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Minimal change disease</p>\n</td>\n<td>\n<p><strong>Effacement of foot processes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Focal segmental glomerulosclerosis</p>\n</td>\n<td>\n<p>Loss of foot processes, epithelial denudation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranoproliferative glomerulonephritis (MPGN) type I</p>\n</td>\n<td>\n<p><strong>Subendothelial deposits</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dense-deposit disease (MPGN type II)</p>\n</td>\n<td>\n<p>Dense deposits</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IgA nephropathy</p>\n</td>\n<td>\n<p>Mesangial and paramesangial dense deposits</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(908, 'Pathology,', 'PM1395. Causes of Nephrotic Syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Primary Glomerular Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranous nephropathy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Minimal-change disease (Most common cause in children)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Focal segmental glomerulosclerosis (Most common cause in adults)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranoproliferative glomerulonephritis and dense deposit disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Other proliferative glomerulonephritides (focal, “pure mesangial,” IgA nephropathy)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Systemic Diseases</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diabetes mellitus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Amyloidosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Systemic lupus erythematosus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Drugs (nonsteroidal anti-inflammatory, penicillamine, heroin)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Infections (malaria, syphilis, hepatitis B and C, HIV)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Malignant disease (carcinoma, lymphoma)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Miscellaneous (bee-sting allergy, hereditary nephritis)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(909, 'Pathology', 'PM1391. Glomerular Pathology in Renal Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td><strong>Light microscopy</strong></td>\n<td><strong>Fluorescence microscopy</strong></td>\n<td>\n<p><strong>Electron microscopy</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\4\>\n<p>Nephritic syndrome:</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Postinfectious glomerulo-nephritis</p>\n</td>\n<td>\n<div class=\page\ title=\Page 915\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Diffuse endocapillary proliferation; leukocytic infiltration</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 915\>\n<div class=\page\ title=\Page 915\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Granular IgG and C3 in glomerular basement membrane and mesangium,&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\page\ title=\Page 915\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Granular IgA in some cases</p>\n</div>\n</div>\n</div>\n</div>\n&nbsp;</td>\n<td>\n<p><strong>Subepithelial humps </strong>Subendothelial deposits in early disease stages</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Goodpasture syndrome</p>\n</td>\n<td>Extracapillary proliferation with <strong>crescents</strong>; necrosis</td>\n<td>&nbsp;<strong>Linear </strong>IgG and C3; fibrin in crescents</td>\n<td>\n<p><strong>Linear deposits</strong><strong><strong>&nbsp;</strong></strong>along the basement membrane.&nbsp;</p>\n<p><strong>Disruptions in GBM</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IgA nephropathy (Berger disease)</p>\n</td>\n<td>Focal mesangial proliferative glomerulo-nephritis; mesangial widening</td>\n<td>&nbsp;<strong>IgA</strong> ± IgG, IgM, and C3 in mesangium</td>\n<td><strong>Mesangial </strong>and paramesangial dense deposits&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Alport syndrome</p>\n</td>\n<td>Normal</td>\n<td>Negative</td>\n<td><strong>Basket-weave appearance </strong>of GBM</td>\n</tr>\n<tr>\n<td colspan=\4\>\n<p>Nephrotic syndrome:</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranous&nbsp; nephropathy</p>\n</td>\n<td>\n<div class=\page\ title=\Page 915\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Diffuse capillary wall thickening</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 915\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Granular IgG and C3; diffuse</p>\n</div>\n</div>\n</div>\n</div>\n&nbsp;</td>\n<td>\n<p><strong>Subepithelial deposits </strong>(epimembranous spikes),&nbsp;effacement of podocyte&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Minimal change disease</p>\n</td>\n<td>\n<div class=\page\ title=\Page 915\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Normal; lipid in tubules</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Negative&nbsp;</td>\n<td>\n<p>No deposits.</p>\n<p>Effacement of podocyte&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Focal segmental glomerulo-sclerosis&nbsp; (FSGS)</p>\n</td>\n<td>\n<div class=\page\ title=\Page 915\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Glomerular hyalinosis and sclerosis</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Occasional C3 and IgM deposits in the sclerotic areas and the mesangium.</td>\n<td>\n<p>No deposits.</p>\n<p>Effacement of podocyte&nbsp;</p>\n<p>Epithelial denudation.</p>\n</td>\n</tr>\n<tr>\n<td colspan=\4\>\n<p>Nephrito-nephrotic syndrome:&nbsp;&nbsp;&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membrano-proliferative glomerulo-nephritis</p>\n<p>(MPGN) type I</p>\n</td>\n<td>\n<div class=\page\ title=\Page 915\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Mesangial proliferative pattern of proliferation; GBM thickening; splitting</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 915\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C3, C1q, C4 deposits&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\nIgG deposits</td>\n<td>\n<p><strong>Subendothelial deposits</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dense-deposit disease (MPGN type II)</p>\n</td>\n<td>\n<div class=\page\ title=\Page 915\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Mesangial proliferative&nbsp; pattern of proliferation; GBM thickening; splitting</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 915\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C3 deposits;</p>\n<p>No C1q and C4 deposits</p>\n<p>No IgG deposits</p>\n</div>\n</div>\n</div>\n</div>\n&nbsp;</td>\n<td>\n<p><strong>Intramembranous </strong>Dense deposits</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fibrillary glomerulo-nephritis</p>\n</td>\n<td>&nbsp;\n<div class=\page\ title=\Page 931\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Membrano-proliferative or mesangio-proliferative patterns</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>IgG4 and C3&nbsp;</td>\n<td>Fibrillar deposits in the mesangium and capillary walls</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>Note:</p>\n<ul>\n<li>Anionic antigens form subendothelial deposits.</li>\n<li>Cationic antigens form subepithelial deposits.</li>\n<li>Neutral antigens form mesangial deposits.</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(910, 'Pathology', 'PM1390. Immunoflouresence  in Renal Lesions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Renal lesion</strong></p>\n</td>\n<td>\n<p><strong>Immunoflouresence</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Goodpasture syndrome</p>\n</td>\n<td>\n<p>Smooth, diffuse, linear IgG and C3; fibrin in crescents</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranous nephropathy</p>\n</td>\n<td>\n<p>Granular IgG and C3; Diffuse</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Post-streptococcal GN</p>\n</td>\n<td>\n<p>Granular IgG and C3 in GBM and mesangium</p>\n<p>Granular IgA in some cases</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Minimal change disease</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic glomerulonephritis</p>\n</td>\n<td>\n<p>Granular or negative</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>FSGS</p>\n</td>\n<td>\n<p>Focal; IgM + C3 in many cases</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>MPGN type I</p>\n</td>\n<td>\n<p>IgG, C3, C1q, C4</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dense deposit disease(MPGN Type II)</p>\n</td>\n<td>\n<p>C3; no C1q or C4</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IgA nephropathy</p>\n</td>\n<td>\n<p>IgA, IgG, IgM, and C3 in mesangium</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/39e04eb05d9f450c9fd517524c7b12edx512x454.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Image – Linear, smooth diffuse pattern of staining for IgG in Goodpasture syndrome.</p></div><!---->\n      <!---->\n    </div><!---->'),
(911, 'Pathology', 'PM1389. Types of Rapidly Progressive Glomerulonephritis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type I (Anti-GBM Antibody)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Renal limited</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Goodpasture syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Immunofluorescence:&nbsp;</p>\n<p>Linear GBM deposits of IgG and C3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type II (Immune Complex)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Idiopathic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Post-streptococcal glomerulonephritis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranoproliferative glomerulonephritis</p>\n</td>\n</tr>\n<tr>\n<td>Crescentic glomerulonephritis</td>\n</tr>\n<tr>\n<td>\n<p>Lupus nephritis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Henoch–Schönlein purpura</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IgA nephropathy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Others:&nbsp;Cryoglobulinemia,&nbsp;Bacterial endocarditis, sepsis,&nbsp;acute pancreatitis/advanced liver disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Immunofluorescence:&nbsp;Granular pattern of staining</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type III (Pauci-Immune)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ANCA-associated</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Idiopathic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Granulomatosis with polyangiitis (formerly Wegener granulomatosis)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Microscopic polyangiitis</p>\n</td>\n</tr>\n<tr>\n<td>Immunofluorescence:&nbsp;No immunoglobulin or complement deposits</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>Image: Crescentic glomerulonephritis (PAS stain) with the crescent-shaped mass of proliferating parietal epithelial cells and leukocytes internal to Bowman capsule.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/bc82f88b949d4f94bfd60049ae235674x800x533.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1da539adb07347789a398d272db0f337x1279x1112.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(912, 'Pathology', 'PM1388. Complement Levels in Renal Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Low complement (</strong><strong>Renal)</strong></p>\n</td>\n<td>\n<p><strong>Low complement GN (</strong><strong>Systemic)</strong></p>\n</td>\n<td>\n<p><strong>Normal complement GN (</strong><strong>Systemic)</strong></p>\n</td>\n<td>\n<p><strong>Normal complement GN (Renal)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Post-infectious GN</p>\n</td>\n<td>\n<p>Shunt nephritis</p>\n</td>\n<td>\n<p>Hypersensitivity vasculitis</p>\n</td>\n<td>\n<p>IgA nephropathy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dense-deposit disease&nbsp;</p>\n<p>(MPGN II)</p>\n</td>\n<td>\n<p>SLE</p>\n</td>\n<td>\n<p>HSP</p>\n</td>\n<td>\n<p>RPGN</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p>Endocarditis</p>\n</td>\n<td>\n<p>ANCA-associated&nbsp;glomerulonephritis</p>\n</td>\n<td>\n<p>Anti-GBM disease</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p>Cryoglobulinemia</p>\n</td>\n<td>\n<p>Goodpasture syndrome</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>GN: Glomerulonephritis</p>\n<p>MPGN: Membranoproliferative<em>&nbsp;</em>glomerulonephritis</p>\n<p>SLE: Systemic lupus erythematosus</p>\n<p>HSP: Henoch–Schonlein purpura</p>\n<p>GBM: Glomerular basement membrane</p>\n<p>RPGN:&nbsp;Rapidly progressive glomerulonephritis</p></div><!---->\n      <!---->\n    </div><!---->'),
(913, 'Pathology,', 'PM1384. Cytohormonal study of the vaginal epithelium', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Layer </strong></td>\n<td><strong>Cell characteristics</strong></td>\n<td><strong>Hormones</strong></td>\n<td><strong>Age of the woman</strong></td>\n</tr>\n<tr>\n<td><strong>Parabasal and basal</strong></td>\n<td>Small, round and basophilic with large nuclei</td>\n<td>Lack of hormonal activity</td>\n<td>\n<p><strong>Childhood</strong> until puberty</p>\n<p><strong>Menopause</strong> with atrophy</p>\n</td>\n</tr>\n<tr>\n<td><strong>Intermediate cells</strong></td>\n<td>\n<p>Transparent and basophilic (blue-green) with vesicular nuclei</p>\n</td>\n<td>Progesterone, Androgen, Corticosteroid&nbsp;</td>\n<td>\n<p><strong>Pregnancy</strong></p>\n<p>At an early transition of&nbsp; menopause</p>\n</td>\n</tr>\n<tr>\n<td><strong>Superficial cells</strong></td>\n<td>Large cells with a pyknotic nucleus, acidophilic on staining</td>\n<td>Estrogen</td>\n<td>\n<p><strong>Reproductive period </strong></p>\n<p>Preovulatory phase</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Note: Malignant cells contain less cytoplasm, and hyperchromatic nuclei which are variable in size.</p></div><!---->\n      <!---->\n    </div><!---->'),
(914, 'Obstetrics & Gynaecology,', 'PM0449. Tumor Markers in Testicular Germ Cell Tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\116\>\n<p>&nbsp;</p>\n</td>\n<td width=\116\>\n<p>AFP</p>\n</td>\n<td width=\116\>\n<p>b-hCG</p>\n</td>\n<td width=\116\>\n<p>LDH</p>\n</td>\n</tr>\n<tr>\n<td width=\116\>\n<p>Seminoma</p>\n</td>\n<td width=\116\>\n<p>&nbsp;-</p>\n</td>\n<td width=\116\>\n<p>+</p>\n</td>\n<td width=\116\>\n<p>++</p>\n</td>\n</tr>\n<tr>\n<td width=\116\>\n<p>Yolk sac tumor</p>\n</td>\n<td width=\116\>\n<p>+++</p>\n</td>\n<td width=\116\>\n<p>+</p>\n</td>\n<td width=\116\>\n<p>+</p>\n</td>\n</tr>\n<tr>\n<td width=\116\>\n<p>Choriocarcinoma</p>\n</td>\n<td width=\116\>\n<p>&nbsp;-</p>\n</td>\n<td width=\116\>\n<p>+++</p>\n</td>\n<td width=\116\>\n<p>+</p>\n</td>\n</tr>\n<tr>\n<td width=\116\>\n<p>Embryonal carcinoma</p>\n</td>\n<td width=\116\>\n<p>+</p>\n</td>\n<td width=\116\>\n<p>+</p>\n</td>\n<td width=\116\>\n<p>++</p>\n</td>\n</tr>\n<tr>\n<td width=\116\>\n<p>Teratoma</p>\n</td>\n<td width=\116\>\n<p>&nbsp;-&nbsp;</p>\n</td>\n<td width=\116\>\n<p>&nbsp;-</p>\n</td>\n<td width=\116\>\n<p>&nbsp;-</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;Note:</p>\n<p><strong>&nbsp;Alpha-fetoprotein AFP</strong>: Raised in</p>\n<ul>\n<li>Embryonal carcinoma</li>\n<li>Yolk sac tumor</li>\n<li>Teratocarcinoma</li>\n<li>Mixed germ cell tumor</li>\n</ul>\n<p>AFP is never raised in pure seminomas or pure choriocarcinoma</p>\n<p><strong>Human chorionic gonadotropin (HCG):&nbsp;</strong>Only the β subunit is measured by the most commonly available serum assays. Can be raised in</p>\n<ul>\n<li>Choriocarcinoma</li>\n<li>Embryonal carcinoma</li>\n<li>Teratocarcinoma</li>\n<li>Seminoma (only in about 15% Seminomas)</li>\n<li>Mixed germ-cell tumors</li>\n</ul>\n<p>&nbsp;<strong>Lactate dehydrogenase (</strong><strong>LDH):</strong></p>\n<ul>\n<li>LDH has limited sensitivity and specificity for seminoma, but LDH levels &gt;2000 U/L are more consistent with bulky disease, and rising levels are an accurate indicator of recurrence.</li>\n<li>&nbsp;In non-seminomatous germ-cell tumors (NSCGT), LDH is directly related to tumor burden.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(915, 'Pathology,', 'PM2267. Pharyngo-esophageal diverticula', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1e9857b4eeb94317b4d080511e386194x600x536.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Diverticula</strong></span></td>\n<td><span><strong>Weak space</strong></span></td>\n<td><span><strong>Site</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Zenker</strong> diverticulum</span></td>\n<td><span>Killian triangle/ Killian dehiscence</span></td>\n<td>\n<div class=\page\ title=\Page 1043\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><span><strong>Above</strong> the upper esophageal sphincter</span></p>\n<p><span>Between the oblique fibers of the thyropharyngeus muscle and the horizontal fibers of the cricopharyngeus muscle</span></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Laimers</strong> diverticulum</span></td>\n<td><span>Laimer’s triangle/ Laimer–Hackermann’s area</span></td>\n<td>\n<p><span><strong>Posteriorly</strong> below cricopharyngeus and above longitudinal muscle layer of the&nbsp;esophagus</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Killian– Jamieson</strong> Diverticulum</span></td>\n<td><span>Killian–Jamieson area</span></td>\n<td>\n<div class=\t m0 xd h3 y8c ff2 fs0 fc0 sc0 lsa ws75\>\n<div class=\t m0 xd h3 y8c ff2 fs0 fc0 sc0 lsa ws75\><span>&nbsp;</span></div>\n</div>\n<div class=\t m0 xd h3 y8c ff2 fs0 fc0 sc0 lsa ws75\><span><strong>Laterally</strong> between the oblique and transverse fibers of the cricopharyngeus</span></div>\n<div class=\t m0 xd h3 y8c ff2 fs0 fc0 sc0 lsa ws75\><span>at its attachment to the cricoid cartilage</span></div>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(916, 'Pathology,', 'PM2264. Types of autoimmune hepatitis (AIH)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Type I AIH</strong></td>\n<td><strong>Type II AlH</strong></td>\n</tr>\n<tr>\n<td>Characteristic antibodies</td>\n<td>Anti-SMA (F-actin), ANA, pANCA,&nbsp;anti-SLA/LP, anti-AMA antibodies</td>\n<td>Anti-LKM1,&nbsp;anti-liver cytosol 1</td>\n</tr>\n<tr>\n<td>Age of onset</td>\n<td>Bimodal, peaks at 10–20 years and 45–70 years</td>\n<td>2–14 years</td>\n</tr>\n<tr>\n<td>Gender distribution</td>\n<td>78% female</td>\n<td>89% female</td>\n</tr>\n<tr>\n<td>lgG increase</td>\n<td>Pronounced</td>\n<td>Moderate</td>\n</tr>\n<tr>\n<td>lgA decrease</td>\n<td>Absent</td>\n<td>Occasional</td>\n</tr>\n<tr>\n<td>Association with HLA&nbsp;haplotypes</td>\n<td>B8, DR3, DR4</td>\n<td>B14, DR3</td>\n</tr>\n</tbody>\n</table>\n<div class=\page\ title=\Page 2746\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Type III autoimmune hepatitis does not appear to represent a distinct category but, instead, is part of the spectrum of type I autoimmune hepatitis</p>\n<ul>\n<li>ANA: Anti-nuclear antibodies</li>\n<li>anti-SMA:&nbsp;Anti–smooth muscle actin antibodies</li>\n<li>anti-SLA/LP: Anti–soluble liver antigen/liver–pancreas antigen</li>\n<li>AMA: Anti-mitochondrial antibodies</li>\n<li>anti-LKM: Liver–kidney microsomal antibodies</li>\n<li>pANCA:&nbsp;Perinuclear anti-neutrophil cytoplasmic antibodies</li>\n</ul>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(917, 'Medicine,', 'PM2257. Acute Hepatitis vs. Chronic Hepatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Histological features of acute hepatitis</strong></td>\n<td><strong>Histological features of chronic hepatitis</strong></td>\n</tr>\n<tr>\n<td>Ballooning degeneration</td>\n<td>Ductular reaction</td>\n</tr>\n<tr>\n<td>Apoptosis of hepatocytes - <strong>Councilman bodies&nbsp;</strong></td>\n<td>Bridging fibrosis&nbsp;</td>\n</tr>\n<tr>\n<td>Confluent necrosis</td>\n<td>Bridging necrosis</td>\n</tr>\n<tr>\n<td>Spotty necrosis or lobular<strong> hepatitis&nbsp;</strong></td>\n<td>Interface hepatitis&nbsp;</td>\n</tr>\n<tr>\n<td>Bridging necrosis in severe acute hepatitis</td>\n<td>Dense, mononuclear portal infiltration&nbsp;</td>\n</tr>\n<tr>\n<td>Portal inflammation is absent&nbsp;</td>\n<td><strong>Chronic viral hepatitis</strong></td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Ground glass hepatocytes&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Lymphoid aggregates or fully formed lymphoid follicles</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Fatty change of scattered hepatocytes</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ed3b8d201aea404fbad0181756978b57x1280x3480.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(918, 'Medicine,', 'PM2254. The most commons in hepatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>CAUSE</strong></td>\n<td><strong>ETIOLOGICAL AGENT</strong></td>\n</tr>\n<tr>\n<td>Most common cause of viral hepatitis</td>\n<td>HepB</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis in children</td>\n<td>HepA</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis in adults</td>\n<td>HepE</td>\n</tr>\n<tr>\n<td>Most common&nbsp;cause of viral hepatitis in pregnancy</td>\n<td>HepB</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis related mortality in pregnancy</td>\n<td>HepE</td>\n</tr>\n<tr>\n<td>Most common cause of acute liver failure (Western countries)</td>\n<td>Paracetamol poisoning</td>\n</tr>\n<tr>\n<td>Most common cause of acute liver failure in India</td>\n<td>&nbsp;Viral hepatitis (B and E)</td>\n</tr>\n<tr>\n<td>Most common cause of viral fulminant hepatitis</td>\n<td>&nbsp;HepE</td>\n</tr>\n<tr>\n<td>Highest risk of progresion from acute viral hepatitis to fulminant hepatitis</td>\n<td>HepD&nbsp;</td>\n</tr>\n<tr>\n<td>Most common cause of chronic hepatitis (prevalence)</td>\n<td>HepB (450 million)</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis, leading to chronic<br>hepatitis (prevalence)</td>\n<td>&nbsp;HepC (150 million)</td>\n</tr>\n<tr>\n<td>Maximum risk and max potential of chronicity</td>\n<td>HepC</td>\n</tr>\n<tr>\n<td>Most common cause of carrier State</td>\n<td>HepB</td>\n</tr>\n<tr>\n<td>Most common cause of cirrhosis</td>\n<td>Alcohol</td>\n</tr>\n<tr>\n<td>Most common viral cause of cirrhosis</td>\n<td>HepC</td>\n</tr>\n<tr>\n<td>Most common cause of viral hepatocellular carcinoma</td>\n<td>HepB</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(919, 'Pathology', 'PM2241. Microvesicular Steatosis vs. Macrovesicular Steatosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Microvesicular Steatosis</strong></p>\n</td>\n<td>&nbsp;<strong>Macrovesicular Steatosis</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Acute fatty liver of pregnancy</li>\n<li>Reyes syndrome</li>\n<li>Alcoholic foamy degeneration</li>\n<li>Drug- and toxin-induced injury (valproic acid, salicylates, parenteral tetracycline, hypoglycin A)</li>\n<li>Congenital metabolic conditions\n<ul>\n<li>Urea cycle disorders,</li>\n<li>Defects in fatty acid metabolism,</li>\n<li>Deficiencies in lysosomal acid lipases</li>\n</ul>\n</li>\n</ul>\n</td>\n<td>\n<p><strong>Centrilobular predominant (zone III)</strong></p>\n<ul>\n<li>Obesity, Nonalcoholic steatohepatitis (NASH)</li>\n<li>Late alcoholic liver disease</li>\n<li>Diabetes mellitus</li>\n</ul>\n<p><strong>Periportal predominant (zone I)</strong></p>\n<ul>\n<li>Total parenteral nutrition (TPN)</li>\n<li>Aquired immunodeficiency syndrome (AIDS)</li>\n<li>Phosphorus poisoning</li>\n<li>Exogenous steroids</li>\n<li>Starvation</li>\n<li>Chronic hepatitis C</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(920, 'Pathology', 'PM2209. The most commons in GIT', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Most common</strong></td>\n<td><strong>Structure/Conditions</strong></td>\n</tr>\n<tr>\n<td>Congenital intestinal atresia</td>\n<td>Imperforate anus</td>\n</tr>\n<tr>\n<td>True diverticulum</td>\n<td>Meckels diverticulum</td>\n</tr>\n<tr>\n<td>Site of ischemia</td>\n<td>Colon</td>\n</tr>\n<tr>\n<td>Site of fistulization</td>\n<td>Esophagus</td>\n</tr>\n<tr>\n<td>Site of GI polyp</td>\n<td>Colorectum</td>\n</tr>\n<tr>\n<td>Malignancy of GI tract</td>\n<td>Adenocarcinoma colon</td>\n</tr>\n<tr>\n<td>Cause of esophagitis</td>\n<td>Acid reflux</td>\n</tr>\n<tr>\n<td>Benign tumor of the esophagus</td>\n<td>Leiomyoma</td>\n</tr>\n<tr>\n<td>Esophageal cancer in India and worldwide</td>\n<td>Squamous cell carcinoma</td>\n</tr>\n<tr>\n<td>Esophageal cancer in Western countries</td>\n<td>Adenocarcinoma</td>\n</tr>\n<tr>\n<td>Type of chronic gastritis</td>\n<td>Type B gastritis (<em>Helicobacter pylori</em> gastritis)</td>\n</tr>\n<tr>\n<td>Malignancy of the stomach</td>\n<td>Adenocarcinoma</td>\n</tr>\n<tr>\n<td>Site of extranodal lymphoma</td>\n<td>Stomach</td>\n</tr>\n<tr>\n<td>Mesenchymal&nbsp;tumor of the stomach</td>\n<td>Gastrointestinal stromal tumor (GIST)</td>\n</tr>\n<tr>\n<td>Tumor of small intestine/appendix</td>\n<td>Carcinoid</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(921, 'Pathology', 'PM2184. Precursor Lesions of Hepatocellular Carcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Hepatocellular adenoma</strong></td>\n<td><strong>Small-cell change</strong></td>\n<td><strong>Large-cell change</strong></td>\n<td><strong>Low-grade dysplastic nodule</strong></td>\n<td><strong>High-grade dysplastic nodule</strong></td>\n</tr>\n<tr>\n<td><strong>Premalignant</strong></td>\n<td>Yes</td>\n<td>Yes</td>\n<td>In some HBV</td>\n<td>Uncertain</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td><strong>Associated with cirrhosis</strong></td>\n<td>Rare</td>\n<td>Yes</td>\n<td>Yes</td>\n<td>Yes</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td><strong>Commonly associated diseases</strong></td>\n<td>\n<ul>\n<li>NAFLD</li>\n<li>Oral contraceptive pills</li>\n<li>Anabolic steroids</li>\n<li>Glycogen storage disorders</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>HBV, HCV</li>\n<li>Alcohol</li>\n<li>NAFLD</li>\n<li>α1-antitrypsin deficiency</li>\n<li>Hereditary hemochromatosis</li>\n<li>Primary biliary cirrhosis</li>\n</ul>\n</td>\n<td>Same as in small- cell change</td>\n<td>Same as in small-cell change</td>\n<td>Same as in small-cell change</td>\n</tr>\n</tbody>\n</table>\n<p>NAFLD: Non-alcoholic fatty liver disease</p>\n<p>HBV: Hepatitis B virus</p></div><!---->\n      <!---->\n    </div><!---->'),
(922, 'Pathology,', 'PM1482. Hereditary Hyperbilirubinemias', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Inheritance</strong></td>\n<td><strong>Defects in bilirubin metabolism</strong></td>\n<td><strong>Clinical course</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Unconjugated Hyperbilirubinemia</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type I</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Absent UGT1A1 activity</p>\n</td>\n<td>\n<p>Fatal in the neonatal period</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type II</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Generally mild,</p>\n<p>occasional kernicterus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gilbert syndrome</p>\n</td>\n<td>\n<p>AR (common)</p>\n<p>AD (occasional)</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Conjugated Hyperbilirubinemia</strong></p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Dubin-Johnson syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Impaired biliary excretion of bilirubin glucuronides due to a mutation in canalicular multidrug resistance protein 2 (MRP2)</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rotor syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased hepatic uptake and storage</p>\n<p>Decreased biliary excretion</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(923, 'Medicine,', 'PM1481. Hyperbilirubinemia- Causes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\425\>&nbsp;<strong>Predominantly Unconjugated Hyperbilirubinemia&nbsp;</strong></td>\n<td width=\425\><strong>Conjugated hyperbilirubinemia</strong></td>\n</tr>\n<tr>\n<td width=\425\>\n<p>Excess production of bilirubin</p>\n</td>\n<td width=\425\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\425\>\n<p>Hemolytic anemias</p>\n</td>\n<td width=\425\>\n<p>Biliary tract obstruction</p>\n</td>\n</tr>\n<tr>\n<td width=\425\>\n<p>Resorption of blood from internal hemorrhage (e.g., alimentary tract bleeding, hematomas)</p>\n</td>\n<td width=\425\>\n<p>&nbsp;Biliary tract diseases like primary biliary cirrhosis and primary sclerosing cholangitis</p>\n</td>\n</tr>\n<tr>\n<td width=\425\>\n<p>Ineffective erythropoiesis (e.g., pernicious anemia, thalassemia)</p>\n</td>\n<td width=\425\>\n<p>Dubin Johnson syndrome</p>\n</td>\n</tr>\n<tr>\n<td width=\425\>\n<p>Reduced hepatic uptake</p>\n</td>\n<td width=\425\>\n<p>Rotor syndrome</p>\n</td>\n</tr>\n<tr>\n<td width=\425\>\n<p>Drug interference with membrane carrier systems</p>\n</td>\n<td width=\425\>Benign recurrent intrahepatic cholestasis</td>\n</tr>\n<tr>\n<td width=\425\>\n<p>Some cases of Gilbert syndrome</p>\n</td>\n<td width=\425\>Progressive familial intrahepatic cholestasis</td>\n</tr>\n<tr>\n<td width=\425\>\n<p>Impaired bilirubin conjugation</p>\n</td>\n<td width=\425\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\425\>\n<p>Physiologic jaundice of the newborn (decreased UGT1A1 activity, decreased excretion)</p>\n</td>\n<td width=\425\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\425\>\n<p>Breast milk jaundice (β-glucuronidases in milk)</p>\n</td>\n<td width=\425\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\425\>\n<p>Genetic deficiency of UGT1A1 activity (Crigler-Najjar syndrome types I and II)</p>\n</td>\n<td width=\425\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\425\>\n<p>Gilbert syndrome</p>\n</td>\n<td width=\425\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\425\>\n<p>Diffuse hepatocellular disease (e.g., viral or drug-induced hepatitis, cirrhosis)</p>\n</td>\n<td width=\425\>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(924, 'Pathology', 'PM1480. Patterns of Drug- and Toxin-Induced Hepatic Injury', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p>Pathology/Pattern</p>\n</td>\n<td width=\231\>\n<p>Causative agent</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Cholestatic pattern</p>\n</td>\n<td width=\231\>\n<p>Contraceptive and anabolic steroids,</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Spotty hepatocyte necrosis</p>\n</td>\n<td width=\231\>\n<p>Methyldopa, phenytoin</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Massive necrosis</p>\n</td>\n<td width=\231\>\n<p>Acetaminophen, halothane</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Chronic hepatitis</p>\n</td>\n<td width=\231\>\n<p>Isoniazid</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Large and small droplet fat</p>\n</td>\n<td width=\231\>\n<p>Ethanol, Methotrexate, Total parenteral nutrition</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>Microvesicular steatosis</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Valproate, tetracycline, aspirin (Reye&nbsp;</strong><strong>syndrome), HAART</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Steatohepatitis with Mallory-Denk bodies</p>\n</td>\n<td width=\231\>\n<p>Ethanol, amiodarone</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Fibrosis and cirrhosis</p>\n</td>\n<td width=\231\>\n<p>Alcohol, methotrexate, enalapril, vitamin A and other retinoids</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Noncaseating epithelioid granulomas</p>\n</td>\n<td width=\231\>\n<p>Sulfonamides, amiodarone, isoniazid</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Fibrin ring granulomas</p>\n</td>\n<td width=\231\>\n<p>Allopurinol</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Budd-Chiari syndrome</p>\n</td>\n<td width=\231\>\n<p>Oral contraceptives</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(925, 'Pathology,', 'PM1473. Laboratory Evaluation of Liver Disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Test Category</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Serum measurement</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Hepatocyte integrity</p>\n</td>\n<td width=\231\>\n<p><strong>Cytosolic hepatocellular enzymes</strong></p>\n<p>Serum aspartate aminotransferase (AST)</p>\n<p>Serum alanine aminotransferase (ALT)</p>\n<p>Serum lactate dehydrogenase (LDH)</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Biliary excretory function</p>\n</td>\n<td width=\231\>\n<p><strong>Substances normally secreted in bile</strong></p>\n<p>Serum bilirubin</p>\n<ul>\n<li>Total: unconjugated plus conjugated</li>\n<li>Direct: conjugated only</li>\n</ul>\n<p>Urine bilirubin</p>\n<p>Serum bile acids</p>\n<p><strong>Plasma membrane enzymes (from damage to bile canaliculus)</strong></p>\n<p>Serum alkaline phosphatase</p>\n<p>Serum γ-glutamyl transpeptidase (GGT)</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Hepatocyte synthetic function</p>\n</td>\n<td width=\231\>\n<p><strong>Proteins secreted into the blood</strong></p>\n<p>Serum albumin</p>\n<p>Coagulation factors:</p>\n<p>Prothrombin (PT) and partial thromboplastin time (PTT) (fibrinogen, prothrombin, factors V, VII, IX, and X)</p>\n<p><strong>Hepatocyte metabolism</strong></p>\n<p>Serum ammonia</p>\n<p>Aminopyrine breath test (hepatic demethylation)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(926, 'Surgery,', 'PM1438. Types of Gallstones', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Cholesterol gallstones</strong></p>\n</td>\n<td>\n<p><strong>Black pigment</strong></p>\n</td>\n<td>\n<p><strong>Brown pigment</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Demography</p>\n</td>\n<td>\n<p>Western countries</p>\n</td>\n<td>\n<p>Non-western countries</p>\n</td>\n<td>\n<p>Non-western countries</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Location</p>\n</td>\n<td>\n<p>Gallbladder, ducts</p>\n</td>\n<td>\n<p>Gallbladder, ducts</p>\n</td>\n<td>\n<p>Ducts</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Risk factors</p>\n</td>\n<td>\n<ul>\n<li>Advancing age</li>\n<li>Female</li>\n<li>Oral contraceptives and pregnancy</li>\n<li>Obesity and insulin resistance</li>\n<li>Rapid weight reduction</li>\n<li>Gallbladder stasis</li>\n<li>Dyslipidemia syndromes</li>\n</ul>\n</td>\n<td>&nbsp;\n<ul>\n<li>Chronic hemolysis&nbsp;</li>\n<li>Ileal&nbsp;resection</li>\n<li>Cystic fibrosis with pancreatic insufficiency</li>\n</ul>\n</td>\n<td>&nbsp;Chronic biliary infection</td>\n</tr>\n<tr>\n<td>\n<p>Appearance</p>\n</td>\n<td>\n<p>Pale yellow, round to ovoid, finely granular, hard external surface</p>\n<p>Transection: glistening radiating crystalline palisade</p>\n</td>\n<td>\n<p>&gt; 1.5 cm in diameter,&nbsp;friable speculated and molded</p>\n</td>\n<td>\n<p>Large, brown, laminated and soft</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Constituents</p>\n</td>\n<td>\n<p>Cholesterol, phospholipids, bile salts</p>\n</td>\n<td>\n<p>Calcium bilirubinate</p>\n<p>Calcium bicarbonate</p>\n<p>Calcium phosphate</p>\n</td>\n<td>\n<p>Calcium bilirubinate</p>\n<p>Palmitate</p>\n<p>Cholesterol</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Consistency</p>\n</td>\n<td>\n<p>Crystalline with nucleus</p>\n</td>\n<td>\n<p>Hard</p>\n</td>\n<td>\n<p>Soft, friable</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>% of radio-opaque stones</p>\n</td>\n<td>\n<p>15%</p>\n</td>\n<td>\n<p>60%</p>\n</td>\n<td>\n<p>0%</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(927, 'Pathology,', 'PM1133. Types of Gastric  Adenocarcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Intestinal type </strong></p>\n</td>\n<td width=\231\>\n<p><strong>Diffuse type</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Male-to-female ratio, 2:1</p>\n</td>\n<td width=\231\>\n<p>Equal frequency in males and females</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Bulky masses</p>\n</td>\n<td width=\231\>\n<p>Diffusely infiltrative growth</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Glandular structures</p>\n</td>\n<td width=\231\>\n<p>Signet-ring cells</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Increased signaling via WNT pathway</p>\n</td>\n<td width=\231\>\n<p>Loss of E-cadherin</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Precursor lesions are flat dysplasia and adenomas.</p>\n</td>\n<td width=\231\>\n<p>No identified precursor lesions</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c510f583046a46f79413dee3af77b375x954x324.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(928, 'Pathology', 'PM1130. Polyposis Syndromes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Hereditary</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Non-hereditary</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Familial adenomatous polyposis syndrome (FAPS)</p>\n<p>Classic FAP</p>\n<p>Attenuated FAP</p>\n<p>Gardner syndrome</p>\n<p>Turcot syndrome</p>\n</td>\n<td width=\231\>\n<p>Serrated polyposis syndrome (SPS), also known as hyperplastic polyposis syndrome</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Bannayan–Riley–Ruvalcaba syndrome</p>\n</td>\n<td width=\231\>\n<p>Cronkhite- Canada syndrome</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Cowden syndrome</p>\n</td>\n<td width=\231\>\n<p>Juvenile polyposis syndrome</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Peutz-Jeghers syndrome</p>\n</td>\n<td width=\231\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Tuberous sclerosis</p>\n</td>\n<td width=\231\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Juvenile polyposis syndrome</p>\n</td>\n<td width=\231\>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(929, 'Pathology,', 'PM1077. Gastrointestinal Stromal Tumor (GIST)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>M/C mesenchymal tumor</strong> of GIT arising from <strong>interstitial cells of Cajal</strong> (pacemaker cells of GIT). <strong>Stomach is the m/c site.</strong></p>\n<p>Almost all GISTs express:</p>\n<ul>\n<li><strong>c-KIT (CD117)</strong></li>\n<li><strong>PDGF receptor A</strong></li>\n<li><strong>CD34</strong></li>\n</ul>\n<p>Clinical Features:</p>\n<ul>\n<li>Peaks at 60 years of age.</li>\n<li>M/C symptom: Upper GI<strong> bleeding</strong></li>\n<li>Other symptoms: Pain, lump, perforation, incidental finding</li>\n<li><strong>Carneys Triad:</strong>&nbsp;Sporadic GIST, Paraganglioma, Pulmonary chondroma</li>\n</ul>\n<p>Management:</p>\n<ul>\n<li>IOC for <strong>primary </strong>GIST:<strong>&nbsp;CECT </strong>abdomen</li>\n<li>IOC for <strong>recurrent </strong>GIST:<strong>&nbsp;PET-CT</strong></li>\n<li><strong>IHC&nbsp;</strong>markers:&nbsp;<strong>CD117/C-KIT </strong>(M/C), <strong>DOG 1</strong> (most specific), CD 34</li>\n<li>Route of metastasis: Hematogenous</li>\n</ul>\n<p>The following image shows microscopy of GIST composed of spindle-shaped tumor cells:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/303296bfa2ad4afcbbed1a6e4a12a671x1280x1033.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Fletchers</strong> classification (<strong>Tumor size</strong> &amp; <strong>No. of mitotic figures</strong>) is used to classify the tumors according to their malignancy risk.</li>\n<li><strong>Prognosis</strong> is determined by: Mitotic index, tumor size &amp; location of tumor (Stomach GISTs are less aggressive).</li>\n<li><strong>Complete surgical resection</strong>&nbsp;is the mainstay treatment. For <strong>unresectable</strong>, recurrent, or <strong>metastatic</strong> GISTs,&nbsp;<strong>imatinib</strong>, a tyrosine kinase inhibitor, can be used.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(930, 'Pathology,', 'PM2288. Types of lung cancer', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Features</strong></td>\n<td><strong>Adeno-carcinoma</strong></td>\n<td><strong>Squamous cell carcinoma</strong></td>\n<td><strong>Small cell carcinoma</strong></td>\n</tr>\n<tr>\n<td><strong>Association with smoking</strong></td>\n<td>Present, but most common type of lung cancer in non smokers</td>\n<td>Strong</td>\n<td>Strongest association</td>\n</tr>\n<tr>\n<td><strong>Common genetic alterations</strong></td>\n<td>EGFR and TP53</td>\n<td>TP53,&nbsp; CDKN2A</td>\n<td>RB, TP53, MYC</td>\n</tr>\n<tr>\n<td><strong>Location</strong></td>\n<td>Peripheral</td>\n<td>Central/hilar</td>\n<td>Anywhere</td>\n</tr>\n<tr>\n<td><strong>Precursor lesions</strong></td>\n<td>Atypical adenomatous hyperplasia, Adeno-carcinoma in situ</td>\n<td>Squamous dysplasia, Carcinoma in situ</td>\n<td>None</td>\n</tr>\n<tr>\n<td><strong>Histology</strong></td>\n<td>\n<p>Glandular differentiation, mucin production, Lepidic growth pattern</p>\n</td>\n<td>Keratinization, squamous pearls, intercellular bridges</td>\n<td>Small cells, scant cytoplasm, salt and pepper chromatin, Azzopardi effect</td>\n</tr>\n<tr>\n<td><strong>IHC</strong></td>\n<td>Mucin, TTF-1, Napsin-A</td>\n<td>p40, p63</td>\n<td>\n<div class=\page\ title=\Page 724\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Chromogranin, Synaptophysin, and CD56</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(931, 'Pathology,', 'PM2287. Types of emphysema', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Emphysema</strong> is classified according to its anatomic distribution within the lobule.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Area involved</strong></td>\n<td><strong>Other features</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Centriacinar (most common)</strong></p>\n</td>\n<td>\n<ul>\n<li>Central part of acinus (respiratory bronchiole)</li>\n<li>Upper lobes of lung</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Commonly seen in<strong> smokers</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Panacinar</strong></td>\n<td>\n<ul>\n<li>Entire acinus (respiratory bronchiole + alveoli)</li>\n<li>Lower lobes of lung</li>\n</ul>\n</td>\n<td>\n<ul>\n<li aria-level=\1\>Commonly seen in young <strong>non-smokers</strong></li>\n<li aria-level=\1\>Associated with <strong>α-1 antitrypsin deficiency</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Paraseptal</strong></td>\n<td>\n<ul>\n<li>Distal part of acinus (alveoli)</li>\n<li>Subpleural region</li>\n</ul>\n</td>\n<td>\n<ul>\n<li aria-level=\1\>Commonly seen in young adults&nbsp;</li>\n<li aria-level=\1\>Increased risk for <strong>spontaneous pneumothorax&nbsp;</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Irregular</strong></td>\n<td>\n<ul>\n<li>Focal and irregular involvement of acinus</li>\n<li>Areas of the lung near scar tissue&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Not usually seen in COPD</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a93fe0d6352f4bddb79cbafb63f956e0x1280x3586.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(932, 'Pathology,', 'PM2217. Some common pneumoconiosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\page\ title=\Page 695\>\n<table><colgroup><col><col><col></colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Agent</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Disease</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Exposure</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Mineral Dusts</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Coal dust</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Anthracosis<br>Macules</p>\n<p>Progressive massive fibrosis</p>\n<p>Caplan syndrome</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Coal mining (particularly hard coal)</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Silica</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Silicosis</p>\n<p>Caplan syndrome</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Metal casting work, sandblasting, hard rock mining, stone cutting, others</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Asbestos</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Asbestosis<br>Pleural plaques<br>Caplan syndrome<br>Mesothelioma</p>\n<p>Carcinoma of the lung, larynx, stomach, colon</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Mining, milling, manufacturing, and installation and removal of insulation</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Beryllium</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Acute berylliosis</p>\n<p>Beryllium granulomatosis</p>\n<p>Lung carcinoma (?)</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Mining, manufacturing</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Iron oxide</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Siderosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Welding</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Barium sulfate</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Baritosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Mining</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Tin oxide</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Stannosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Mining</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Organic Dusts</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Moldy hay</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Farmer’s lung</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Farming &nbsp;</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Bagasse</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Bagassosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Manufacturing wallboard, paper</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Bird droppings</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Bird-breeder’s lung</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Bird handling</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Cotton, flax, hemp</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Byssinosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Textile manufacturing</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(933, 'Medicine,', 'PM0150. Typical Pneumonia  v/s  Atypical Pneumonia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Typical pneumonia</strong>&nbsp;</span></td>\n<td><span><strong>Atypical pneumonia&nbsp;</strong></span></td>\n</tr>\n<tr>\n<td><span>Extracellular organism&nbsp;</span></td>\n<td><span>Intracellular organism</span></td>\n</tr>\n<tr>\n<td><span>Alveolar exudates in air spaces </span></td>\n<td><span>Interstitial involvement</span><br><br></td>\n</tr>\n<tr>\n<td><span>Neutrophilic in nature</span></td>\n<td><span>Lymphocytic in nature</span></td>\n</tr>\n<tr>\n<td><span>High-grade fever</span></td>\n<td><span>Low-grade fever</span></td>\n</tr>\n<tr>\n<td><span>Productive cough</span></td>\n<td>\n<p><span>Dry cough</span><br><span>hemoptysis &nbsp;&nbsp;</span><span>scanty sputum</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Pleuritic chest pain </span></td>\n<td><span>Extrapulmonary manifestation</span></td>\n</tr>\n<tr>\n<td><span>X-Ray shows large areas of consolidation</span></td>\n<td><span>X-Ray shows an interstitial pattern of involvement.</span></td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<ul>\n<li><span>The most common cause of <strong>Community-acquired Pneumonia</strong>- <em>Streptococcus pneumoniae.</em></span></li>\n<li><span>The most common cause of <strong>Atypical Pneumonia</strong>- <em>Mycoplasma&nbsp;pneumoniae.</em></span></li>\n<li><span>The most common&nbsp;cause of <strong>Nosocomial Pneumonia</strong>-</span>\n<ul>\n<li><span>Overall- gram-negative bacilli (implicated as a group)</span></li>\n<li><span>The single most common agent-&nbsp;<em>Staphylococcus aureus</em> (i.e.,&nbsp;gram-positive cocci)</span></li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/788eb4488f054109ae5a0d183c4128c5x1280x732.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(934, 'Pathology,', 'PM0149. HRCT Findings in Interstitial Lung Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Idiopathic interstitial lung diseases</p>\n<ul>\n<li aria-level=\1\><strong>Idiopathic pulmonary fibrosis / Usual interstitial pneumonia</strong><br>\n<ul>\n<li><strong>Honeycombing</strong></li>\n<li>Reticular shadows</li>\n<li aria-level=\1\>Traction bronchiectasis</li>\n<li aria-level=\1\>Complete loss of lung architecture</li>\n<li aria-level=\1\>Absence of other nonspecific findings (ground-glass opacities, nodules, cysts, consolidations)</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4689091fe1e944fbb126cdfdbbeab7ddx246x157.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Non-specific interstitial pneumonia</strong>\n<ul>\n<li aria-level=\1\>Extensive <strong>ground-glass opacities</strong></li>\n<li aria-level=\1\>Sub pleural sparing (specific, but not seen always)</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c2cc0129f166436b80cdc78eadefca46x706x644.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li aria-level=\1\><strong>Cryptogenic organizing pneumonia (COP)</strong></li>\n<ul>\n<li aria-level=\2\>Patchy consolidation with air bronchogram</li>\n<li aria-level=\2\><strong>Reverse halo</strong>/ <strong>Atoll sign</strong>: Ground glass area surrounded by peripheral consolidation (as shown below in red arrows)</li>\n</ul>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/14a2b8cf78af4d09ae90a48b8fcf2a25x598x445.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Lymphocytic interstitial pneumonia (LIP)</strong>\n<ul>\n<li aria-level=\1\><strong>Thin-walled cysts</strong> (shown below in red arrows)</li>\n<li aria-level=\1\>Centrilobular nodules&nbsp;</li>\n<li aria-level=\1\>Ground glass opacities</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/df68360574724c508e6cacf09f3feb6ex663x606.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>&nbsp;<strong>Respiratory bronchiolitis related interstitial lung disease</strong>\n<ul>\n<li>Centrilobular ground-glass nodules</li>\n<li>Bronchial wall thickening</li>\n</ul>\n</li>\n<li><strong>Acute interstitial pneumonia</strong>\n<ul>\n<li>Diffuse patchy ground-glass opacities</li>\n</ul>\n</li>\n<li><strong>Desquamated interstitial pneumonia</strong>\n<ul>\n<li>Patchy ground-glass opacities&nbsp;</li>\n</ul>\n</li>\n</ul>\n<p>Other forms of ILDs</p>\n<ul>\n<li><strong>Lymphangioleiomyomatosis (LAM)</strong>\n<ul>\n<li>Regular thin-walled cysts</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/57506149be7c44bfb863865b2ebefaf4x1126x962.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Pulmonary alveolar proteinosis (PAP)</strong>\n<ul>\n<li aria-level=\1\>Ground-glass opacification with superimposed septal thickening, known as “<strong>crazy paving</strong>”</li>\n<li aria-level=\1\>It is characteristic but not diagnostic</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b2c5317c962f4d16b1416ece31e7f352x1279x970.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Pulmonary Langerhans cell histiocytosis (PLCH)</strong>\n<ul>\n<li aria-level=\1\>Bilateral irregular shaped cysts with nodules, predominantly in the upper lobe.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/31564146821e4b5faa1b5305d8445724x1280x819.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(935, 'Pathology,', 'PM2185. Molecular classification of breast cancer', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Molecular subtypes&nbsp;</strong></td>\n<td>\n<p><strong>Receptor status </strong></p>\n</td>\n<td><strong>Histological subtypes</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Luminal A type&nbsp;</strong></p>\n<p><strong>(most common,&nbsp;</strong>best prognosis)</p>\n<p>Mutated gene-&nbsp;BRCA 2</p>\n</td>\n<td>\n<p>ER/PR-&nbsp;+ve</p>\n<p>Her2- -ve</p>\n<p><strong>Ki-67-&nbsp;</strong></p>\n<p><strong>&lt;14% (low)</strong></p>\n</td>\n<td>\n<div class=\page\ title=\Page 1069\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Lobular carcinoma</p>\n<p>Mucinous carcinoma</p>\n<p>Tubular carcinoma</p>\n<p>Papillary carcinoma</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Luminal B type (HER2/neu negative)</strong></p>\n<p>Mutated gene-&nbsp;BRCA 2&nbsp;</p>\n</td>\n<td>\n<p>ER/PR-&nbsp;+ve</p>\n<p>Her2- -ve</p>\n<p><strong>Ki-67-&nbsp;</strong></p>\n<p><strong>&gt;14% (high)</strong></p>\n</td>\n<td>\n<div class=\page\ title=\Page 1064\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Poorly differentiated, lobular-carcinoma</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Luminal B type (HER2 positive)</strong></p>\n</td>\n<td>\n<p>ER/PR-&nbsp;+ve</p>\n<p>Her2- +ve</p>\n<p><strong>Ki-67-&nbsp;</strong></p>\n<p><strong>variable</strong></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>HER2 enriched</strong></p>\n<p>Mutated gene-&nbsp;TP53</p>\n</td>\n<td>\n<p>ER/PR-&nbsp;-ve</p>\n<p>Her2- +ve</p>\n<p><strong>Ki-67-&nbsp;</strong></p>\n<p><strong>High&nbsp;</strong></p>\n</td>\n<td>\n<p>Apocrine carcinoma</p>\n<p>Micro-papillary carcinoma</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Basal type&nbsp;</strong><strong>(Triple-negative)</strong></p>\n<p>Mutated gene-&nbsp;BRCA 1</p>\n</td>\n<td>\n<p>ER/PR-&nbsp;-ve</p>\n<p>Her2- -ve</p>\n<p><strong>Ki-67-&nbsp;</strong></p>\n<p><strong>High</strong></p>\n</td>\n<td>\n<div class=\page\ title=\Page 1064\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Medullary carcinoma</p>\n<p>Adenoid cystic carcinoma</p>\n<p>Secretory carcinoma</p>\n<p>Metaplastic carcinoma</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n<p>*Update: <strong>Claudin low-molecular subtype</strong>&nbsp;is a triple-negative breast cancer with low expression of E-cadherin, with a poor prognosis. It is frequently associated with lymphocyte infiltration.</p>\n<p>Almost all breast malignancies are adenocarcinomas and based on the expression of estrogen receptor and HER2 can be divided into three major biologic subgroups:</p>\n<ul>\n<li><strong>ER-positive HER2-negative tumors&nbsp;</strong>(50% to 65% of tumors) – range from well-differentiated cancers with low proliferative rates and few chromosomal changes to poorly differentiated cancers with high proliferative rates and large numbers of chromosomal rearrangements. All of these cancers express ER.</li>\n<li><strong>HER2-positive cancers - </strong>10% to 20% of tumors, which may either be ER-positive or ER-negative.</li>\n<li><strong>ER-negative, HER2-negative carcinomas&nbsp;</strong>(triple-negative or basal-like)- are characterized by genomic instability, a high proliferative rate, and expression of many proteins typical of myoepithelial cells (e.g., basal keratins).</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Defining Features</strong></p>\n</td>\n<td>\n<p><strong>ER-positive, HER2- negative</strong></p>\n&nbsp;&nbsp;</td>\n<td>&nbsp;</td>\n<td>\n<p><strong>HER2- Positive (ER- positive or negative)</strong></p>\n</td>\n<td>\n<p><strong>ER- negative</strong></p>\n<p><strong>HER2- negative</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Frequency</p>\n</td>\n<td>\n<p>~40-55% (Low proliferation)</p>\n</td>\n<td>\n<p>~10% (High proliferation)</p>\n</td>\n<td>\n<p>~20%</p>\n</td>\n<td>\n<p>~15%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Included special histologic types</p>\n</td>\n<td>\n<p>Well or moderately differentiated lobular, tubular, mucinous</p>\n</td>\n<td>\n<p>Poorly differentiated lobular</p>\n</td>\n<td>\n<p>Some apocrine</p>\n</td>\n<td>\n<p>Medullary, adenoid cystic, secretory, metaplastic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Typical patient groups</p>\n</td>\n<td>\n<p>Older women, men, cancers detected by mammographic screening</p>\n</td>\n<td>\n<p><em>BRCA2</em> mutation carriers</p>\n</td>\n<td>\n<p>Young women, non-white women, <em>TP53</em> mutation carrier (ER-positive)</p>\n</td>\n<td>\n<p>Young women, <em>BRCA1 </em>mutation carriers, African American and Hispanic women</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(936, 'Surgery,', 'PM2122. Follicular thyroid malignancy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It is more common in <strong>iodine-deficient areas. </strong>It is associated with p53, PTEN, PAX/PPAR-gamma, RAS, miRNA (miR-197 and miR-346).</p>\n<p>It commonly presents as <strong>solitary thyroid nodules </strong>and the mean age of presentation is <strong>50 years.&nbsp;</strong>It can also occur in long-standing cases of multinodular goitre.</p>\n<p>FNAC&nbsp;is unable to distinguish between benign and malignant follicular lesions as <strong>malignancy</strong> is defined by <strong>capsular</strong> and <strong>vascular invasion. </strong>Hence, <strong>Trucut</strong> biopsy is required to confirm malignancy.</p>\n<p>Histological findings:</p>\n<ul>\n<li>Encapsulated</li>\n<li>Uniform microfollicles&nbsp;or sheets of cells devoid of colloid</li>\n<li>Capsular and vascular invasion indicates malignancy</li>\n<li>Tumour thrombus within middle thyroid/ jugular veins may be seen at the time of surgery</li>\n</ul>\n<p><strong>Vascular</strong> (hematogenous) dissemination is common, with metastases to bone, lungs, liver, and elsewhere. The prognosis depends largely on the extent of invasion and stage at presentation.</p>\n<p>Serum <strong>thyroglobulin</strong> levels are used for monitoring tumour recurrence, as they are undetectable after complete treatment.</p></div><!---->\n      <!---->\n    </div><!---->'),
(937, 'Surgery,', 'PM2118. Papillary thyroid carcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Papillary carcinoma is the <strong>most common</strong> thyroid carcinoma. It is most common in <strong>iodine sufficient areas</strong>, <strong>children</strong> and in those exposed to <strong>ionizing</strong>&nbsp;<strong>radiation.</strong>&nbsp;</p>\n<p>The mean age of presentation is<strong> 3rd-4th</strong> decade and is more common in <strong>women</strong> than men (2:1).&nbsp;<strong>Dysphagia</strong>, <strong>dysphonia</strong> and <strong>dyspnea</strong> are associated with local invasion.</p>\n<p>It usually presents as a&nbsp;<strong>cold nodule </strong>on the scan. Histological findings include:</p>\n<ul>\n<li>Branching&nbsp;papillae&nbsp;</li>\n<li>Follicles with the fibrovascular stalk</li>\n<li><strong>Psammoma bodies</strong></li>\n<li>Nuclear changes-&nbsp;\n<ul>\n<li>Optically clear -&nbsp;Ground glass&nbsp;or&nbsp;<strong>Orphan Annie eye nuclei</strong></li>\n<li>Pseudo-inclusions</li>\n<li>Nuclear grooves.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Lymph</strong> node metastasis is common.&nbsp;<strong>Lateral aberrant thyroid</strong> denotes a cervical lymph node invaded by papillary carcinoma. The most common sites of metastasis : <strong>lung</strong> &gt; liver &gt; bone &gt; brain.</p>\n<p>It has an <strong>excellent prognosis</strong>, with a 10-year survival rate in excess of 95%.</p></div><!---->\n      <!---->\n    </div><!---->'),
(938, 'Surgery,', 'PM1878. Comparison between BRCA 1 and BRCA 2:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\panel-body ng-scope\>\n<p>Both <em>BRCA1</em> and <em>BRCA2</em> are <strong>tumor suppressor genes.</strong></p>\n<p>Carcinoma breast <strong>occurs at an earlier age</strong> and is <strong>bilateral and multicentric in </strong>inherited forms compared to sporadic cases.</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>BRCA 1</strong></td>\n<td><strong>BRCA 2</strong></td>\n</tr>\n<tr>\n<td>Location</td>\n<td>Long arm of <strong>chromosome 17</strong>&nbsp;</td>\n<td>Long arm of <strong>chromosome 13</strong></td>\n</tr>\n<tr>\n<td>Differentiation</td>\n<td>Poorly differentiated</td>\n<td>Well-differentiated</td>\n</tr>\n<tr>\n<td>Hormone receptor status</td>\n<td>ER/PR- Negative, Her-2 negative – triple negative</td>\n<td>ER/PR- Positive</td>\n</tr>\n<tr>\n<td>Associated Cancers</td>\n<td>Breast, ovarian, colon, and prostate (lesser extent), Pancreas (lesser extent)&nbsp; cancers</td>\n<td>Breast, ovarian, colon, prostate, pancreas, gall bladder, stomach cancers, and melanoma</td>\n</tr>\n<tr>\n<td>Male breast carcinoma</td>\n<td>Low risk</td>\n<td><strong>Increased risk</strong></td>\n</tr>\n<tr>\n<td>Fanconi’s anemia</td>\n<td>Not associated</td>\n<td>Associated</td>\n</tr>\n<tr>\n<td>Medullary carcinoma</td>\n<td>Associated</td>\n<td>Not associated</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(939, 'Pathology,', 'PM1419. Causes of Adrenocortical Insufficiency', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Primary</strong><strong>&nbsp;adrenal insufficiency:</strong></p>\n<ul>\n<li>Anatomical destruction of gland</li>\n<li>Autoimmune (Addisons disease)</li>\n<li>Isolated autoimmune adrenalitis (polygenic)</li>\n<li>Infections -&nbsp;HIV, tuberculosis, fungi</li>\n<li>Surgical removal</li>\n<li>Acute hemorrhagic necrosis (Waterhouse-Friderichsen syndrome)</li>\n<li>Amyloidosis, sarcoidosis, hemochromatosis</li>\n<li>Metastatic carcinoma</li>\n<li>Cytotoxic agents – mitotane</li>\n<li>Enzyme inhibitors – metyrapone, ketoconazole</li>\n<li>Congenital adrenal hypoplasia</li>\n<li>Autoimmune polyendocrinopathy syndrome type 1 (AIRE1 gene on 21q22)</li>\n<li>Autoimmune polyendocrinopathy syndrome type 2 (polygenic)</li>\n<li>X-linked adrenal hypoplasia (DAX1 gene on Xp21)</li>\n<li>Adrenoleukodystrophy (ALD gene on Xq28)</li>\n</ul>\n<p><strong>Secondary adrenal insufficiency:</strong></p>\n<p>Hypopituitarism due to hypothalamic or pituitary disease</p>\n<ul>\n<li>Neoplasm</li>\n<li>Infiltration (sarcoidosis)</li>\n<li>Infection (tuberculosis, pyogenic, fungal)</li>\n</ul>\n<p>Suppression of HPA axis</p>\n<ul>\n<li>By endogenous steroids from tumor</li>\n<li>By exogenous steroids</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(940, 'Medicine,', 'PM1415. Pancreatic Endocrine Neoplasms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Endocrine neoplasm</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Clinical features</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Glucagonoma</p>\n</td>\n<td width=\231\>\n<p>Mild diabetes mellitus, a characteristic skin rash (necrolytic migratory erythema), and anemia</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Insulinoma</p>\n</td>\n<td width=\231\>\n<p>Clinically significant hypoglycemia</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Gastrinoma</p>\n</td>\n<td width=\231\>\n<p>Peptic ulceration often unresponsive to therapy and in unusual locations such as the jejunum</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Somatostatinoma</p>\n</td>\n<td width=\231\>\n<p>Diabetes mellitus, cholelithiasis, steatorrhea, and hypochlorhydria</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>VIPoma</p>\n</td>\n<td width=\231\>\n<p>Watery diarrhea, hypokalemia, achlorhydria, or WDHA syndrome</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Pancreatic polypeptide-secreting endocrine tumors</p>\n</td>\n<td width=\231\>\n<p>Present as mass lesions as even high plasma levels of this hormone fail to cause symptoms</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Islet hyperplasia (previously known as nesidioblastosis) is seen in maternal diabetes, Beckwith–Wiedemann syndrome , and rare mutations in the β-cell K+-channel protein or sulfonylurea receptor.</p>\n<p>In maternal diabetes, the fetal islets respond to hyperglycemia by increasing their size and number. In the postnatal period, these hyperactive islets may be responsible for serious episodes of hypoglycemia.</p></div><!---->\n      <!---->\n    </div><!---->'),
(941, 'Pathology,', 'PM1409. Classification of Pituitary Adenomas with Associated Syndromes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The various types of pituitary tumors are listed in decreasing order of frequency:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Adenoma cell origin</strong></p>\n</td>\n<td>\n<p><strong>Hormone</strong></p>\n</td>\n<td>\n<p><strong>Clinical features</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lactotroph</p>\n</td>\n<td>\n<p>Prolactin</p>\n</td>\n<td>\n<p>Galactorrhea and amenorrhea (in females)</p>\n<p>Sexual dysfunction, infertility</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gonadotroph</p>\n</td>\n<td>FSH, LH subunits</td>\n<td>\n<p>Hypogonadism, mass effects, and hypopituitarism</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Somatotroph&nbsp;</p>\n</td>\n<td>\n<p>GH</p>\n</td>\n<td>\n<p>Gigantism (children)</p>\n<p>Acromegaly (adults)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Corticotroph</p>\n</td>\n<td>ACTH</td>\n<td>\n<p>Cushings disease</p>\n<p>Nelsons syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mammosomatotroph</p>\n</td>\n<td>\n<p>Prolactin, GH</p>\n</td>\n<td>\n<p>Hypogonadism, galactorrhea, acromegaly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thyrotroph&nbsp;</p>\n</td>\n<td>\n<p>TSH</p>\n</td>\n<td>\n<p>Hyperthyroidism</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>GH: Growth hormone</p>\n<p>ACTH:&nbsp;Adrenocorticotropic hormone</p>\n<p>TSH:&nbsp;Thyroid-stimulating hormone</p>\n<p>FSH:&nbsp;Follicle-stimulating hormone</p>\n<p>LH:&nbsp;Luteinizing hormone&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(942, 'Pathology,', 'PM1305. Gene alterations in thyroid cancer', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\526\>\n<tbody>\n<tr>\n<td><strong>Type of Thyroid Carcinoma</strong></td>\n<td><strong>&nbsp;Mutations</strong></td>\n</tr>\n<tr>\n<td><strong>Papillary Carcinoma</strong></td>\n<td>\n<p><strong>BRAF</strong> mutation</p>\n<p><strong>RET/PTC</strong> rearrangement</p>\n<p><strong>MET</strong></p>\n<p>NTRK1 fusion gene</p>\n<p>GDNF - glial derived neurotropic factor</p>\n</td>\n</tr>\n<tr>\n<td><strong>Follicular carcinoma</strong></td>\n<td>&nbsp;\n<p><strong>RAS</strong> mutation</p>\n<p>PIK3CA mutation</p>\n<p><strong>PTEN</strong> mutation</p>\n<p><strong>PAX8/PPAR1</strong> fusion gene</p>\n</td>\n</tr>\n<tr>\n<td><strong>Medullary carcinoma</strong></td>\n<td>&nbsp;<strong>RET</strong> mutation</td>\n</tr>\n<tr>\n<td><strong>Follicular adenoma</strong></td>\n<td>&nbsp;\n<p>TSH-R mutation</p>\n<p>Gsα (GNAS) mutation</p>\n<p><strong>Ras</strong> mutation (&lt;20% cases)</p>\n<p>PAX8/PPARγ1 fusion (&lt;10% cases)</p>\n<p>PTEN</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;<strong>Anaplastic carcinoma</strong></td>\n<td>&nbsp;\n<p><strong>CTNNB1</strong> (β-catenin)</p>\n<p><strong>TP53</strong> inactivation</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(943, 'Pathology,', 'PM1138. MEN 4 Syndrome Features', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It is associated with CDKN1B gene on&nbsp;chromosome 12.</p>\n<p>Associated conditions:</p>\n<ul>\n<li>Parathyroid adenoma</li>\n<li>Pituitary adenoma</li>\n<li>Reproductive organ tumors like testicular cancer, neuroendocrine cervical carcinoma</li>\n<li>Adrenal and renal tumors</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(944, 'Pathology,', 'PM1137. MEN 2 Syndrome Features', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>MEN 2A</strong></p>\n<ul>\n<li>Known as <strong>Sipple’s</strong> syndrome</li>\n<li>Chromosome <strong>10</strong> / <strong>RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Parathyroid adenoma (10–25%)</li>\n</ul>\n</li>\n</ul>\n<p><strong>MEN 2B</strong></p>\n<ul>\n<li>Known commonly as<strong> MEN 3</strong></li>\n<li>Chromosome<strong> 10/ RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (&gt;90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Other associated abnormalities include: (40–50%)\n<ul>\n<li>Mucosal neuromas</li>\n<li>Marfanoid habitus</li>\n<li>Medullated corneal nerve fibers</li>\n<li>Megacolon</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a01742751e314b5fb189a29264e911d3x1280x1061.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(945, 'Medicine,', 'PM1136. MEN 1 Syndrome Features', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Chromosome <strong>11q13 / MEN1 </strong>gene</p>\n<p>Also known as <strong>Wermer’s syndrome</strong></p>\n<p>Characteristic tumors seen in:</p>\n<ul>\n<li>Parathyroid adenoma – 90 % - Most common overall</li>\n<li>Entero pancreatic tumors - Most common functioning tumor is gastrinoma (most common site is duodenum)</li>\n<li>Pituitary adenoma – Most common is prolactinoma</li>\n<li><strong>Mnemonic</strong> – Par Pan Pit – in decreasing order of frequency</li>\n</ul>\n<p>Associated tumors are:</p>\n<ul>\n<li>Angiofibroma</li>\n<li>Collagenomas</li>\n<li>Adrenal cortical tumors</li>\n<li>Lipoma</li>\n<li>Neuroendocrine tumors - gastric, thymic, lungs</li>\n<li>Meningioma</li>\n<li>Pheochromocytoma</li>\n<li>Carcinoid tumors, usually of the foregut</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/95f7c4eac7794f728806926c4f50bbb2x1280x1061.JPEG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(946, 'Pathology', 'PM0396. Epithelial Lesions and Risk of Malignancy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\225\>\n<p><strong>Pathologic Lesions and Relative Risk of Malignancy</strong></p>\n</td>\n<td width=\225\>\n<p><strong>Examples&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\225\>\n<p><strong>Non-proliferative Breast Changes / Fibrocystic changes</strong></p>\n<p>(RR = 1)</p>\n</td>\n<td width=\225\>\n<ul>\n<li>Duct ectasia</li>\n<li>Cysts</li>\n<li>Apocrine change</li>\n<li>Mild hyperplasia</li>\n<li>Adenosis</li>\n<li>Fibroadenoma without complex features</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\225\>\n<p><strong>Proliferative Disease Without Atypia</strong></p>\n<p>(RR = 1.5 to 2)</p>\n</td>\n<td width=\225\>\n<ul>\n<li>Moderate or florid hyperplasia</li>\n<li>Sclerosing adenosis</li>\n<li>Papilloma</li>\n<li>Complex sclerosing lesion (radial scar)</li>\n<li>Fibroadenoma with complex features</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\225\>\n<p><strong>Proliferative Disease with Atypia</strong></p>\n<p>(RR = 4 to 5)</p>\n</td>\n<td width=\225\>\n<ul>\n<li>Atypical ductal hyperplasia (ADH)</li>\n<li>Atypical lobular hyperplasia (ALH)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\225\>\n<p><strong>Carcinoma in situ</strong></p>\n<p>(RR = 8 to 10)</p>\n</td>\n<td width=\225\>\n<ul>\n<li>Lobular carcinoma in situ (LCIS)</li>\n<li>Ductal carcinoma in situ (DCIS)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(947, 'Pathology,', 'PM0395. Anatomic Origins of Common Breast Lesions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b52f182ae9ef4e41a63d4c52bf8469dbx1280x1413.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(948, 'Pathology,', 'PM0299. BRCA 1 and BRCA 2', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong><em>BRCA1</em> and <em>BRCA2</em></strong></p>\n<p><strong>BRCA1 </strong></p>\n<ul>\n<li>Tumor suppressor gene at <strong>17q21</strong></li>\n<li>Tumor suppressor, transcriptional regulation, repair of double-stranded DNA breaks</li>\n<li><em><strong>BRCA1</strong></em><strong>-associated breast cancers are commonly poorly differentiated, have “medullary features” (a syncytial growth pattern with pushing margins and a lymphocytic response).</strong></li>\n<li>Biologically similar to ER-negative/HER2-negative breast cancers identified as “basal-like”.</li>\n<li>Other associated neoplasms are ovarian, male breast cancer (but lower than BRCA2), prostate, pancreas, fallopian tube.</li>\n</ul>\n<p><strong>BRCA2</strong></p>\n<ul>\n<li>Mapped on chromosome <strong>13q12.3</strong></li>\n<li>Associated neoplasms are those of the ovary, male breast, prostate, pancreas, stomach, melanoma, gallbladder, bile duct, and pharynx.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(949, 'Pathology,', 'PM2329. Summary of Bone Tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Bone tumor</strong></td>\n<td><strong>Most common site</strong></td>\n<td><strong>Age</strong></td>\n</tr>\n<tr>\n<td>Simple bone cyst</td>\n<td>Proximal Humeral Metaphysis</td>\n<td>&lt;20years</td>\n</tr>\n<tr>\n<td>Enchondroma</td>\n<td>\n<p>Hand bones</p>\n<p>(Metaphysis of small bones of hand)</p>\n</td>\n<td>\n<p>4<sup>th</sup>&nbsp;&amp; 5<sup>th</sup></p>\n<p>Decade</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteochondroma</p>\n<p>(Exostosis)</p>\n</td>\n<td>Distal Femoral Metaphysis</td>\n<td>&lt;18years</td>\n</tr>\n<tr>\n<td>Osteoid osteoma</td>\n<td>Diaphysis of Femur</td>\n<td>\n<p>2<sup>nd</sup>&nbsp;&amp; 3<sup>rd</sup></p>\n<p>decade</p>\n</td>\n</tr>\n<tr>\n<td>Osteoblastoma</td>\n<td>Posterior column of vertebra</td>\n<td>\n<p>2<sup>nd</sup>&nbsp;&amp; 3<sup>rd</sup></p>\n<p>decade</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteoclastoma (GCT)</p>\n</td>\n<td>Distal femoral epiphysis</td>\n<td>\n<p>2<sup>nd</sup> -4<sup>th</sup></p>\n<p>Decade</p>\n</td>\n</tr>\n<tr>\n<td>Aneurysmal Bone Cyst</td>\n<td>Long bone Metaphysis</td>\n<td>&lt;18years</td>\n</tr>\n<tr>\n<td>Osteosarcoma</td>\n<td>Distal Femoral Metaphysis</td>\n<td>\n<p>BIMODAL</p>\n<p>Primary- 2<sup>nd</sup> Decade Secondary-6<sup>th</sup> and 7<sup>th</sup> Decade</p>\n</td>\n</tr>\n<tr>\n<td>Ewings sarcoma</td>\n<td>Diaphysis of Femur</td>\n<td>5-25 years</td>\n</tr>\n<tr>\n<td>Chondrosarcoma</td>\n<td>Any site in the bone - mc in proximal femur</td>\n<td>3<sup>rd</sup>-5<sup>th</sup> decade</td>\n</tr>\n<tr>\n<td>Clear cell chondrosarcoma</td>\n<td>Proximal femoral epiphysis</td>\n<td>&nbsp;3<sup>rd</sup>-5<sup>th</sup> decade</td>\n</tr>\n<tr>\n<td>Adamantinoma</td>\n<td>Diaphysis of Tibia</td>\n<td>&nbsp;20-40 years</td>\n</tr>\n<tr>\n<td>&nbsp;Fibrous dysplasia</td>\n<td>&nbsp;The upper end of femur &gt; tibia</td>\n<td>&nbsp;1st to 3rd decade</td>\n</tr>\n<tr>\n<td>&nbsp;Chordoma</td>\n<td>&nbsp;Sacrum</td>\n<td>&nbsp;5th to 7th decade</td>\n</tr>\n<tr>\n<td>Multiple myeloma</td>\n<td>Vertebrae</td>\n<td>5th to 7th decade</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(950, 'Pathology,', 'PM2299. Variant forms of melanocytic nevi', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\page\ title=\Page 1146\>\n<table><colgroup><col><col><col><col> </colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Nevus Variant</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Diagnostic Features</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Cytologic Features</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Clinical Significance</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Congenital nevus</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Deep dermal and sometimes subcutaneous growth around adnexa, neurovascular bundles, and blood vessel walls</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Identical to ordinary acquired nevi</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Present at birth; large variants have increased melanoma risk</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Blue nevus</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Non-nested dermal infiltration, often with associated fibrosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Highly dendritic, <strong>heavily pigmented</strong> nevus cells</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Black-blue nodule; often <strong>confused with melanoma</strong> clinically</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Spitz nevus</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Fascicular growth</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Large, plump cells with pink-blue cytoplasm; spindle to epithelioid cells</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Common in children; red-pink nodule; often <strong>confused with hemangioma</strong> clinically</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Halo nevus</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Lymphocytic infiltration</strong> surrounding nevus cells</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Identical to ordinary acquired nevi</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Host immune response against nevus cells and surrounding normal melanocytes</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Dysplastic nevus</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Coalescent intraepidermal nests</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Cytologic atypia</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Potential marker or <strong>precursor of melanoma</strong></p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(951, 'Pathology,', 'PM2296. Subtypes of Osteogenesis imperfecta', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\page\ title=\Page 1187\>\n<p>&nbsp;</p>\n<table width=\671\>\n<tbody>\n<tr>\n<td><strong>Subtypes</strong></td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Clinical features</strong></p>\n</div>\n</div>\n</td>\n<td><strong>Inheritance and Prognosis</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Subtype I-</strong></p>\n<p>Decreased synthesis of pro-α1(1) chain</p>\n<p>Abnormal pro-α1(1) or pro-α2(1) chains</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Blue sclera</p>\n<p>Normal stature</p>\n<p>Skeletal fragility</p>\n<p>Dentinogenesis imperfecta</p>\n<p>Hearing impairment</p>\n<p>Joint laxity</p>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Inheritance-&nbsp;</strong></p>\n</div>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Autosomal dominant</p>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\column\>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Prognosis-&nbsp;</strong></p>\n</div>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Compatible with survival</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Subtype II-&nbsp;</strong></p>\n<p>Abnormally short pro-α1(1) chain Unstable triple helix Abnormal or insufficient pro-α2(1)</p>\n</td>\n<td>\n<p>Death in utero or within days of birth</p>\n<p>Skeletal deformity with excessive fragility and multiple fractures</p>\n<p>Blue sclera</p>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Inheritance-&nbsp;</strong></p>\n</div>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Most are autosomal recessive Few are autosomal dominant</p>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\column\>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Prognosis-&nbsp;</strong></p>\n</div>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Perinatal<strong> lethal</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Subtype III-</strong></p>\n<p>Altered structure of pro-peptides of pro-α2(1)</p>\n<p>Impaired formation of triple helix</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Growth retardation</p>\n<p>Multiple fractures</p>\n<p>Progressive kyphoscoliosis</p>\n<p>Blue sclera at birth that become white</p>\n<p>Hearing impairment</p>\n<p>Dentinogenesis imperfecta</p>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Inheritance-&nbsp;</strong></p>\n</div>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Autosomal dominant (75%) Autosomal recessive (25%)</p>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\column\>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Prognosis-&nbsp;</strong></p>\n</div>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Progressive, deforming</p>\n</div>\n</div>\n<p>&nbsp;</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Subtype IV-</strong></p>\n<p>Short pro-α2(1) chain Unstable triple helix</p>\n</td>\n<td>\n<p>Postnatal fractures</p>\n<p>normal sclerae</p>\n<p>Moderate skeletal fragility</p>\n<p>Short stature</p>\n<p>Sometimes dentinogenesis imperfecta</p>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Inheritance-&nbsp;</strong></p>\n</div>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Autosomal dominant</p>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\column\>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Prognosis-&nbsp;</strong></p>\n</div>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Compatible with survival</p>\n</div>\n</div>\n</div>\n</div>\n&nbsp;</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(952, 'Orthopaedics,', 'PM1944. Types of metastasis(osteoblastic or osteolytic) and their primary:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><span><strong>Predominantly osteoblastic:</strong></span></p>\n<ul>\n<li><span>Prostate cancer</span></li>\n<li><span>Osteosarcoma&nbsp;</span></li>\n<li><span>Medullary carcinoma thyroid</span></li>\n</ul>\n<p><span><strong>Mixed osteoblastic and osteolytic:</strong></span></p>\n<ul>\n<li><span>Breast cancer(preponderance toward osteolytic)</span></li>\n<li><span>Lymphoma</span></li>\n<li><span>Urothelial carcinoma&nbsp;</span></li>\n<li><span>Lung cancer</span></li>\n</ul>\n<p><span><strong>Predominantly osteolytic:</strong></span></p>\n<ul>\n<li><span>Renal cell carcinoma</span></li>\n<li><span>Multiple myeloma&nbsp;</span></li>\n<li><span>Thyroid carcinoma(except medullary carcinoma thyroid)</span></li>\n<li><span>Gastrointestinal tract carcinoma</span></li>\n<li><span>Malignant melanoma</span></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(953, 'Orthopaedics,', 'PM1909. Most common sites of primary bone tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>EPIPHYSEAL :</strong></p>\n<ul>\n<li>Chondroblastoma&nbsp;</li>\n<li>Giant cell tumor in adults</li>\n<li>Articular osteochondroma (trevor’s disease)</li>\n<li>Clear cell chondrosarcoma&nbsp;</li>\n</ul>\n<p><strong>DIAPHYSEAL:</strong></p>\n<ul>\n<li>Round cell lesions-Ewing’s sarcoma&nbsp;</li>\n<li>Lymphoma</li>\n<li>Multiple myeloma</li>\n<li>Adamantinoma</li>\n<li>Osteoid osteoma</li>\n<li>Fibrous dysplasia</li>\n<li>Histiocytosis</li>\n<li>Osteoblastoma</li>\n</ul>\n<p><strong>METAPHYSEAL:</strong></p>\n<ul>\n<li>Chondrosarcoma (Note:Clear cell chondrosarcoma is epiphyseal)</li>\n<li>Enchondroma</li>\n<li>Osteochondroma</li>\n<li>Bone cyst</li>\n<li>Osteosarcoma</li>\n<li>Giant cell tumor in children</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(954, 'Pathology,', 'PM1901. Sarcolemmal proteins and diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><!---->'),
(955, 'Pathology,', 'PM0540. Bone Formation and Bone Resorption Markers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\406\>\n<tbody>\n<tr>\n<td>\n<p><strong>Bone Formation Markers</strong></p>\n</td>\n<td colspan=\2\>\n<p><strong>Bone Resorption Markers</strong></p>\n&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Blood</strong></p>\n</td>\n<td>\n<p><strong>Blood</strong></p>\n</td>\n<td>\n<p><strong>Urine</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Procollagen type I propeptides</p>\n</td>\n<td>&nbsp;Tartrate-resistant acid phosphatase&nbsp;(TRACP)</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Osteocalcin&nbsp;(OC)</p>\n</td>\n<td>\n<p>Cross-linked C-telopeptide of<strong> type I collagen</strong></p>\n</td>\n<td>\n<p>Hydroxyproline&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Total alkaline phosphate</p>\n<p>Bone isoform of alkaline phosphatase (BALP)</p>\n</td>\n<td>\n<p>C- telopeptide of <strong>pro</strong>collagen cross- links and&nbsp;</p>\n<p>N-telopeptide of <strong>pro</strong>collagen cross-links&nbsp;</p>\n</td>\n<td>\n<p>Free and total pyridinolines,&nbsp;</p>\n<p>Free and total deoxypyridinoline</p>\n<p>(PYD and DPD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Aminoterminal propeptide of type I collagen&nbsp;</p>\n<p>(PINP)</p>\n</td>\n<td>\n<p>Cathepsin K</p>\n</td>\n<td>\n<p>N-telopeptide of <strong>collagen</strong> cross-links and&nbsp;C-telopeptide of <strong>collagen</strong> cross-links&nbsp;(CTX, ICTP, NTX)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carboxyterminal propeptide of type I collagen&nbsp;</p>\n<p>(PICP)</p>\n</td>\n<td>\n<p>Matrix metalloproteinases (MMPs)</p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(956, 'Pathology', 'PM0538. Proteins of Bone Matrix', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\484\>\n<p><strong>Osteoblast- Derived Proteins</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\484\>\n<ul>\n<li>Type I collagen</li>\n<li>Calcium- binding proteins\n<ul>\n<li>Osteonectin, bone sialoprotein</li>\n</ul>\n</li>\n<li>Cell adhesion proteins\n<ul>\n<li>Osteopontin, fibronectin, thrombospondin</li>\n</ul>\n</li>\n<li>Cytokines\n<ul>\n<li>IL-1, IL-6, RANKL</li>\n</ul>\n</li>\n<li>Enzymes\n<ul>\n<li>Collagenase, alkaline phosphatase</li>\n</ul>\n</li>\n<li>Growth factors\n<ul>\n<li>IGF-1, TGF- b. PDGF</li>\n</ul>\n</li>\n<li>Proteins involved in mineralization\n<ul>\n<li>Osteocalcin</li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\484\>\n<p><strong>Proteins Concentrated from Serum</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\484\>\n<p>Albumin</p>\n</td>\n</tr>\n<tr>\n<td width=\484\>\n<p>β<sub>2 </sub>microglobulin</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(957, 'Pathology', 'PM0533. Skeletal Disease with Genetic Defects', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\121\>\n<p><strong>Disorder</strong></p>\n</td>\n<td width=\121\>\n<p><strong>Gene Symbol</strong></p>\n</td>\n<td width=\121\>\n<p><strong>Clinical Phenotype</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ width=\484\>\n<p><strong>Defects in transcriptions factors producing abnormalities in mesenchymal condensation and related cell differentiation</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\121\>\n<p>Cleidocranial dysplasia</p>\n</td>\n<td width=\121\>\n<p><em>RUNX2</em></p>\n</td>\n<td width=\121\>\n<p>Abnormal clavicles, Wormian bones, supernumerary teeth</p>\n</td>\n</tr>\n<tr>\n<td width=\121\>\n<p>Holt-Oram syndrome</p>\n</td>\n<td width=\121\>\n<p><em>TBX5</em></p>\n</td>\n<td width=\121\>\n<p>Congenital abnormalities, forelimb anomalies</p>\n</td>\n</tr>\n<tr>\n<td width=\121\>\n<p>Nail- patella syndrome</p>\n</td>\n<td width=\121\>\n<p><em>LMX1B</em></p>\n</td>\n<td width=\121\>\n<p>Hypoplastic nails, hypolastic or aplastic patellas, dislocated radial head, progressive nephropathy</p>\n</td>\n</tr>\n<tr>\n<td width=\121\>\n<p>Waardenburg syndrome types 1 and 3</p>\n</td>\n<td width=\121\>\n<p><em>PAX3</em></p>\n</td>\n<td width=\121\>\n<p>Hearing loss, abnormal pigmentation, craniofacial abnormalities</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(958, 'Pathology,', 'PM0442. Microscopic polyangiitis v/s  granulomatosis with polyangiitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Both microscopic polyangiitis and granulomatosis with polyangiitis are small vessel vasculitides that are mainly caused due to antineutrophil cytoplasmic antibodies (<strong>ANCA). </strong>Therefore, they share common clinical features with some differences.</p>\n<table>\n<tbody>\n<tr>\n<td>Features</td>\n<td>Microscopic polyangiitis</td>\n<td>Granulomatosis with polyangiitis</td>\n</tr>\n<tr>\n<td>Vessels affected</td>\n<td>Small and medium vessel vasculitis</td>\n<td>Small vessel vasculitis</td>\n</tr>\n<tr>\n<td>Principal organs involved</td>\n<td>\n<p>Lungs (hemoptysis)</p>\n<p>Kidney</p>\n<p>GIT</p>\n<p>Skin (cutaneous vasculitis)</p>\n<p>Nerves (Mononeuritis multiplex)</p>\n</td>\n<td>\n<p>Upper respiratory tract</p>\n<p>Lungs (hemoptysis)</p>\n<p>Kidney</p>\n<p>Eye</p>\n<p>Skin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Upper airway involvement</p>\n</td>\n<td>Less common</td>\n<td>\n<p>More common</p>\n<p>(Sinusitis, otitis media, hearing loss, septal perforation)</p>\n</td>\n</tr>\n<tr>\n<td>Nodular cavities in the lungs</td>\n<td><strong>Absent</strong></td>\n<td><strong>Present</strong></td>\n</tr>\n<tr>\n<td>ANCA</td>\n<td><strong>pANCA (mainly)</strong></td>\n<td><strong>cANCA(mainly)</strong></td>\n</tr>\n<tr>\n<td>Granuloma</td>\n<td><strong>Absent</strong></td>\n<td><strong>Present</strong></td>\n</tr>\n<tr>\n<td>Necrosis</td>\n<td>Present</td>\n<td>Present</td>\n</tr>\n<tr>\n<td>Kidney</td>\n<td>Glomerulonephritis</td>\n<td>Glomerulonephritis</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(959, 'Surgery,', 'PM0391. Clinical Findings suggestive of Melanoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The <strong>ABCDE of melanoma</strong> consists of the rules for the <strong>examination of a nevus</strong> to assess its malignant potential:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0ed26d31e9e545f382b79820c1440f1fx800x557.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>A</strong> : <strong>A</strong>symmetry</p>\n<ul>\n<li>Melanoma lesions are irregular, or not symmetrical, in shape</li>\n</ul>\n<p><strong>B </strong>: <strong>B</strong>order irregular</p>\n<ul>\n<li>Melanoma lesions usually have irregular borders that are ill-defined</li>\n</ul>\n<p><strong>C</strong> :&nbsp;<strong>C</strong>olor variation</p>\n<ul>\n<li>The presence of multiple colors (blue, black, brown, tan, etc.) or the uneven distribution of color</li>\n</ul>\n<p><strong>D </strong>: <strong>D</strong>iameter &gt;6 mm</p>\n<ul>\n<li>Melanoma lesions are often greater than 6 millimeters in diameter (approximately the size of a pencil eraser)</li>\n</ul>\n<p><strong>E : E</strong>volution</p>\n<ul>\n<li>There is a change in the size, shape, symptoms (such as itching or tenderness), surface (especially bleeding), or color of a mole</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(960, 'Dermatology,', 'PM0390. Main Prognostic Factors for Primary Melanoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The following are the prognostic factors for primary melanoma (predictive value from *** high to * low):</p>\n<ul>\n<li>Thickness <strong>(Breslow index)</strong>***</li>\n<li><strong>Sentinel node</strong> status***</li>\n<li><strong>Ulceration</strong>**</li>\n<li><strong>Mitotic</strong> <strong>rate</strong>** (negative value especially in thin tumours)</li>\n<li>Regression* (underestimation of Breslow)</li>\n<li>Age* (negative for older age)</li>\n<li>Sex* (negative for males)</li>\n<li>Location* (negative for head and neck)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(961, 'Dermatology,', 'PM0224. Vesiculobullous Disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>Clinical Manifestations</strong></td>\n<td><strong>Histology</strong></td>\n<td><strong>Immuno-pathology</strong></td>\n<td><strong>Autoantigens</strong></td>\n</tr>\n<tr>\n<td>Pemphigus vulgaris <strong>&nbsp;</strong> <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Flaccid blisters, denuded skin,oro-mucosal lesions</td>\n<td>Acantholytic blister formed in&nbsp;<strong>suprabasal layer</strong> of epidermis&nbsp;</td>\n<td>Cell surface deposits of IgG on keratinocytes- fish net pattern</td>\n<td><strong>Dsg3, Dsg1</strong> in patients with skin involvement</td>\n</tr>\n<tr>\n<td>Pemphigus foliaceus <strong>&nbsp;</strong> <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Crusts and shallow erosions on the scalp, central face, upper chest, and back</td>\n<td>Acantholytic blister formed in&nbsp;<strong>superficial layer</strong> of epidermis&nbsp;</td>\n<td>Cell surface deposits of IgG onkeratinocytes</td>\n<td><strong>Dsg1</strong></td>\n</tr>\n<tr>\n<td>Bullous pemphigoid <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Large tense blisters on flexor surfaces and trunk&nbsp;</td>\n<td><strong>Subepidermal </strong>blister with <strong>eosinophil-rich</strong> infiltrate</td>\n<td>Linear band of IgG and/or C3 in epidermal BMZ&nbsp;</td>\n<td><strong>BPAG1, BPAG2</strong></td>\n</tr>\n<tr>\n<td>Dermatitis herpetiformis<strong>&nbsp;</strong> <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Extremely pruritic small papules and vesicles on elbows, knees, buttocks, and posterior neck</td>\n<td><strong>Subepidermal </strong>blister with <strong>neutrophils </strong>in dermal papillae&nbsp;</td>\n<td>Granular deposits of IgA at the tips of dermal papillae</td>\n<td><strong>Epidermal trans-glutaminase</strong></td>\n</tr>\n<tr>\n<td>Linear IgA disease <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Pruritic small papules on extensor surfaces; occasionally larger, arciform blisters&nbsp;</td>\n<td><strong>Subepidermal </strong>blister with <strong>neutrophil</strong>-rich infiltrate&nbsp;</td>\n<td>Linear band of IgA in epidermalBMZ</td>\n<td><strong>BPAG2</strong></td>\n</tr>\n<tr>\n<td><strong>Epidermo-lysis bullosa acquisita</strong></td>\n<td>Tense bullae and erosions&nbsp;</td>\n<td>Subepidermal blister&nbsp;</td>\n<td>IgG and C3 DEJ – Continous and linear&nbsp;</td>\n<td><strong>Type VII collagen</strong></td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;The images below shows clinical pictures of pemphigus patients.</p>\n<ul>\n<li>Image A - oral erosions in a patient with <strong>pemphigus vulgaris</strong></li>\n<li>Image B - heavily clotted and crusted lesions around the mouth in a patient with <strong>paraneoplastic pemphigus</strong></li>\n<li>Image C - skin lesions found on the trunk in a patient with <strong>pemphigus vulgaris</strong></li>\n<li>Image D - skin lesions on the trunk in a patient with <strong>pemphigus foliaceus</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9f91eeb50e144e818c6d6e857996c593x443x358.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(962, 'Pathology', 'PM0208. Ehler–Danlos Syndrome (EDS)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\526\>\n<tbody>\n<tr>\n<td><strong>EDS Type</strong></td>\n<td><strong>Clinical Findings</strong></td>\n<td><strong>Inheritance</strong></td>\n<td><strong>Gene defects</strong> &nbsp;</td>\n<td><strong>Collagen Type</strong></td>\n</tr>\n<tr>\n<td>Classic&nbsp; or type(I/II)</td>\n<td>Skin and joint hypermobility, atrophic scars, easy bruising&nbsp;</td>\n<td>Autosomal dominant&nbsp;</td>\n<td><em>COL5A1</em>, <em>COL5A2</em>&nbsp; &nbsp;</td>\n<td>Collagen type 5</td>\n</tr>\n<tr>\n<td>Hypermobility or type (III)</td>\n<td>Joint hypermobility, pains, dislocations</td>\n<td>Autosomal dominant</td>\n<td>Unknown</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Vascular or type(IV)</td>\n<td>Thin skin, arterial or uterine rupture, bruising, small-joint hyperextensibility&nbsp;</td>\n<td>Autosomal dominant</td>\n<td><em>COL3A1</em></td>\n<td>Collagen type 3</td>\n</tr>\n<tr>\n<td>Kyphoscoliosis or type (VI)</td>\n<td>Hypotonia, joint laxity, congenital scoliosis, ocular fragility</td>\n<td>Autosomal recessive</td>\n<td>PLOD1</td>\n<td><strong>lysyl hydroxylase-1</strong></td>\n</tr>\n<tr>\n<td>Arthrochalasia or type (VII a, b)</td>\n<td>Severe joint hypermobility, skin changes (mild), scoliosis, bruising</td>\n<td>Autosomal dominant</td>\n<td><em>COL1A1</em>, <em>COL1A2</em> &nbsp;</td>\n<td>Collagen type 1</td>\n</tr>\n<tr>\n<td>Dermatosparaxis or type (VII c)</td>\n<td>Severe skin fragility, cutis laxa, bruising&nbsp;</td>\n<td>Autosomal recessive&nbsp;</td>\n<td>ADAMTS2</td>\n<td>&nbsp;Procollagen&nbsp;<em>N-</em> peptidase</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(963, 'Pathology,', 'PM0185. Antibodies in Dermatomyositis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Anti-Mi2 antibodies</strong> (directed against a helicase implicated in nucleosome remodeling) show a strong association with prominent Gottron papules and heliotrope rash.</li>\n<li><strong>Anti-Jo1 antibodies</strong> (directed against the enzyme histidyl t-RNA synthetase) are associated with interstitial lung disease, nonerosive arthritis, and a skin rash described as “mechanic’s hands.”</li>\n<li><strong>Anti-P155/P140 antibodies</strong> (directed against several transcriptional regulators) are associated with paraneoplastic and juvenile cases of dermatomyositis.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(964, 'Pathology', 'PM2321. Classification and  WHO Grading of Brain tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Astrocytomas</strong></td>\n<td><strong>WHO Grade</strong></td>\n</tr>\n<tr>\n<td>Pilocytic astrocytoma</td>\n<td>1</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse astrocytoma-</p>\n<p>IDH Mutant</p>\n<p>IDH Wild &nbsp;&nbsp;</p>\n<p>NOS</p>\n</td>\n<td>2</td>\n</tr>\n<tr>\n<td>\n<p>Anaplastic astrocytoma-</p>\n<p>IDH Mutant</p>\n<p>IDH Wild &nbsp;&nbsp;&nbsp;&nbsp;</p>\n<p>NOS</p>\n</td>\n<td>3</td>\n</tr>\n<tr>\n<td>\n<p>Glioblastoma -</p>\n<p>IDH Mutant &nbsp;</p>\n<p>IDH Wild</p>\n</td>\n<td>4</td>\n</tr>\n</tbody>\n</table>\n<div dir=\ltr\>\n<table>\n<tbody>\n<tr>\n<td>\n<p dir=\ltr\><strong>Oligodendroglioma</strong></p>\n</td>\n<td>\n<p dir=\ltr\><strong>WHO grade</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\>Oligodendroglioma-</p>\n<p dir=\ltr\>IDH Mutant</p>\n<p dir=\ltr\>NOS</p>\n</td>\n<td>\n<p dir=\ltr\>2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\>Anaplastic oligodendroglioma-IDH Mutant</p>\n<p dir=\ltr\>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; NOS</p>\n</td>\n<td>\n<p dir=\ltr\>3</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<div dir=\ltr\>\n<table><colgroup><col width=\312\><col width=\80\></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\ltr\><strong>Miscellaneous&nbsp;gliomas</strong></p>\n</td>\n<td>\n<p dir=\ltr\><strong>WHO grade</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\>Subependymal giant</p>\n<p dir=\ltr\>cell astrocytoma</p>\n</td>\n<td>\n<p dir=\ltr\>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\>Pleomorphic xanthoastrocytoma</p>\n</td>\n<td>\n<p dir=\ltr\>2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\>Anaplastic pleomorphic xanthoastrocytoma</p>\n</td>\n<td>\n<p dir=\ltr\>3</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<div dir=\ltr\>\n<table><colgroup><col width=\312\><col width=\106\></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\ltr\><strong>Ependymal Tumors</strong></p>\n</td>\n<td>\n<p dir=\ltr\><strong>WHO grade</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\>Subependymoma</p>\n</td>\n<td>\n<p dir=\ltr\>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\>Myxopapillary ependymoma</p>\n<p dir=\ltr\>Ependymoma</p>\n</td>\n<td>\n<p dir=\ltr\>2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\>Rela fusion positive ependymoma</p>\n<p dir=\ltr\>Supratentorial ependymoma</p>\n</td>\n<td>\n<p dir=\ltr\>2 OR 3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\ltr\>Anaplastic ependymoma</p>\n</td>\n<td>\n<p dir=\ltr\>3</p>\n</td>\n</tr>\n</tbody>\n</table>\n<table>\n<tbody>\n<tr>\n<td><strong>Meningiomas</strong></td>\n<td><strong>WHO grade</strong></td>\n</tr>\n<tr>\n<td>Meningioma</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Atypical meningioma</td>\n<td>2</td>\n</tr>\n<tr>\n<td>Anaplastic meningioma</td>\n<td>3</td>\n</tr>\n</tbody>\n</table>\n<table>\n<tbody>\n<tr>\n<td><strong>Embryonal tumors</strong></td>\n<td><strong>WHO grade</strong></td>\n</tr>\n<tr>\n<td>medulloblastomas(all subtypes)</td>\n<td>4</td>\n</tr>\n<tr>\n<td>Atypical teratoid/rhabdoid&nbsp;</td>\n<td>4</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(965, 'Pathology,', 'PM2319. Most commons of Brain tumours', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Most common tumor of the brain -&nbsp;<strong>Metastasis</strong>&nbsp;secondary to <strong>lungs</strong> &gt; breast</p>\n<p>Most common<strong> primary</strong> CNS tumor -&nbsp;<strong>glioma&nbsp;</strong>&gt; meningioma</p>\n<p>Most common <strong>primary</strong> CNS tumor in <strong>children</strong> -&nbsp;<strong>pilocytic astrocytoma</strong></p>\n<p>Most common <strong>primary</strong> CNS tumor in<strong> adults</strong> -&nbsp;<strong>astrocytoma</strong></p>\n<p>Most common primary <strong>malignant</strong> tumor of the brain in<strong> children</strong> -&nbsp;<strong>medulloblastoma</strong></p>\n<p>Most common primary <strong>malignant</strong> tumor of the brain in <strong>adults&nbsp;</strong>-&nbsp;<strong>glioblastoma</strong><br><br></p></div><!---->\n      <!---->\n    </div><!---->'),
(966, 'Pathology', 'PM2316. Synucleinopathies and tauopathies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div dir=\ltr\><span><strong>Synucleinopathies:</strong></span></div>\n<ul>\n<li dir=\ltr\><span>Parkinson’s disease</span></li>\n<li dir=\ltr\><span>Dementia with Lewy bodies</span></li>\n<li dir=\ltr\><span>Multiple system atrophy</span></li>\n<li dir=\ltr\><span>REM behavioral disorder</span></li>\n<li dir=\ltr\><span>Pure autonomic failure</span>&nbsp;</li>\n</ul>\n<div dir=\ltr\><span><strong>Tauopathies:</strong></span></div>\n<ul>\n<li dir=\ltr\><span>Alzheimer’s disease</span></li>\n<li dir=\ltr\><span>Down syndrome</span></li>\n<li dir=\ltr\><span>Progressive supranuclear palsy</span></li>\n<li dir=\ltr\><span>Corticobasal degeneration</span></li>\n<li dir=\ltr\><span>Pick’s disease/frontotemporal dementia</span></li>\n<li dir=\ltr\><span>Chronic traumatic encephalopathy/punch drunk syndrome/dementia pugilistica</span></li>\n<li dir=\ltr\><span>Postencephalitic parkinsonism</span></li>\n<li dir=\ltr\><span>Pantothenate kinase-associated degeneration</span></li>\n<li dir=\ltr\><span>Niemann Pick disease type C</span></li>\n<li dir=\ltr\><span>Subacute sclerosing panencephalitis</span></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(967, 'Pathology', 'PM2315. CNS infections and regions commonly affected', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>INFECTION</strong></td>\n<td><strong>REGION COMMONLY AFFECTED</strong></td>\n</tr>\n<tr>\n<td>Tubercular meningitis</td>\n<td>Basal part of the brain</td>\n</tr>\n<tr>\n<td>Tubercular encephalitis</td>\n<td>Intra parenchymal granulomas</td>\n</tr>\n<tr>\n<td>Meningovascular Neurosyphilis</td>\n<td>Base of the brain and meninges covering the cerebral convexities</td>\n</tr>\n<tr>\n<td>Paretic neurosyphilis</td>\n<td>Frontal lobe</td>\n</tr>\n<tr>\n<td>Tabes dorsalis(syphilis)</td>\n<td>Dorsal column of spinal cord</td>\n</tr>\n<tr>\n<td>HSV encephalitis</td>\n<td>Temporal and frontal lobes</td>\n</tr>\n<tr>\n<td>Varicella-zoster infection</td>\n<td>Dorsal root ganglia, Trigeminal ganglia</td>\n</tr>\n<tr>\n<td>Cytomegalovirus</td>\n<td>Choroid plexus and paraventricular subependymal regions</td>\n</tr>\n<tr>\n<td>Poliomyelitis</td>\n<td>Anterior horn cells of spinal cord</td>\n</tr>\n<tr>\n<td>JC virus</td>\n<td>Oligodendrocytes</td>\n</tr>\n<tr>\n<td>Rabies</td>\n<td>Hippocampus cerebellum</td>\n</tr>\n<tr>\n<td>HIV</td>\n<td>Subcortical regions</td>\n</tr>\n<tr>\n<td>Aspergillosis/ Mucormycosis</td>\n<td>Blood vessel walls, Intraparenchymal abscesses or granulomas</td>\n</tr>\n<tr>\n<td>Cryptococcosis</td>\n<td>Intra parenchymal abscesses or granulomas(soap bubble appearance)</td>\n</tr>\n<tr>\n<td>Toxoplasmosis</td>\n<td>Cerebral cortex(near grey matter-white matter junction)</td>\n</tr>\n<tr>\n<td>Cerebral malaria</td>\n<td>Blood vessels of brain</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(968, 'Pathology,', 'PM1746. Chromosomal abnormalities and syndromes associated with brain tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Syndrome </strong></td>\n<td><strong>Gene defect </strong></td>\n<td><strong>Tumor </strong></td>\n</tr>\n<tr>\n<td>Neurofibromatosis type 1</td>\n<td>Neurofibromin (chr 17q)</td>\n<td>\n<div class=\page\ title=\Page 1239\>\n<div class=\page\ title=\Page 1239\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Neurofibromas,</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\page\ title=\Page 1239\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>malignant peripheral nerve sheath tumors, optic nerve gliomas,</p>\n<p>hamartomatous lesions, pheochromocytomas.</p>\n</div>\n</div>\n</div>\n</div>\n<p class=\p1\>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Neurofibromatosis type 2</td>\n<td>Schwannomin (chr 22q)</td>\n<td>\n<div class=\page\ title=\Page 1239\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Bilateral eighth nerve schwannomas, multiple meningiomas,</p>\n<p>ependymomas of the spinal cord</p>\n</div>\n</div>\n</div>\n</div>\n<p class=\p1\>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Cowdens disease</td>\n<td>PTEN (chr 10)</td>\n<td>\n<p class=\p1\>Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease),</p>\n<p class=\p1\>meningioma, astrocytoma</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;VHL&nbsp;</td>\n<td>&nbsp;VHL gene (Chr 3p)&nbsp;</td>\n<td>\n<p class=\p1\>Hemangioblastomas, Retinal angiomas</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;MEN 1</td>\n<td>Menin ( chr 11q)&nbsp;</td>\n<td>\n<p class=\p1\>Pituitary adenoma, malignant schwannomas</p>\n</td>\n</tr>\n<tr>\n<td>Li-Fraumeni syndrome</td>\n<td>p53 (chr 17p)</td>\n<td>\n<p class=\p1\>Gliomas, medulloblastomas</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(969, 'Dermatology,', 'PM2060. Paraneoplastic dermatoses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Cutaneous markers and their commonly associated internal malignancy:</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td><strong>Skin condition</strong></td>\n<td><strong>Most commonly associated malignancy</strong></td>\n</tr>\n<tr>\n<td>Acanthosis nigricans</td>\n<td>Gastric adenocarcinoma</td>\n</tr>\n<tr>\n<td>Acanthosis palmaris</td>\n<td>Bronchial carcinoma</td>\n</tr>\n<tr>\n<td>Sign of LeserTrélat</td>\n<td>Gastrointestinal adenocarcinoma</td>\n</tr>\n<tr>\n<td>Acquired-ichthyosis</td>\n<td>Hodgkin disease</td>\n</tr>\n<tr>\n<td>Pityriasis rotunda</td>\n<td>Hepatocellular carcinoma</td>\n</tr>\n<tr>\n<td>Paraneoplastic pigmentation</td>\n<td>Small cell bronchial carcinoma</td>\n</tr>\n<tr>\n<td>Acrokeratosis paraneoplastica</td>\n<td>Squamous cell carcinoma of the upper respiratory or gastrointestinal<br>tracts</td>\n</tr>\n<tr>\n<td>Erythema gyratum-repens</td>\n<td>Lung cancer</td>\n</tr>\n<tr>\n<td>Necrolytic migratory erythema</td>\n<td>Glucagon secreting<br>pancreatic islet cell adenoma</td>\n</tr>\n<tr>\n<td>Dermatomyositis</td>\n<td>Lung cancer in men, breast and gynaecological tumours in women and&nbsp;colorectal cancers in both sexes</td>\n</tr>\n<tr>\n<td>Scleroderma‐like skin changes</td>\n<td>Carcinoid syndrome</td>\n</tr>\n<tr>\n<td>Paraneoplastic pemphigus</td>\n<td>B‐cell proliferations and thymoma or thymoma‐like neoplasms; specifically Non Hodgkins lymphoma (42%)</td>\n</tr>\n<tr>\n<td>Dermatitis herpetiformis</td>\n<td>Lymphoma</td>\n</tr>\n<tr>\n<td>Porphyria cutanea- tarda and variegate porphyrias</td>\n<td>Hepatocellular Carcinoma</td>\n</tr>\n<tr>\n<td>Erythroderma and exfoliative dermatitis</td>\n<td>Mycosis fungoides or&nbsp;Sézary syndrome</td>\n</tr>\n<tr>\n<td>Pyoderma gangrenosum</td>\n<td>Hematological malignancy</td>\n</tr>\n<tr>\n<td>Sweet syndrome</td>\n<td>Hematological malignancy</td>\n</tr>\n<tr>\n<td>Migratory thrombo-phlebitis (Trousseaus syndrome)</td>\n<td>Carcinoma Pancreas</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(970, 'Pathology', 'PM1670. Differentiation of Mesothelioma from Adenocarcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Immunohistochemical Results</td>\n<td>\n<p><strong>Mesothelioma</strong></p>\n</td>\n<td>\n<p><strong>Adenocarcinoma</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Calretinin</strong>, WT-1, CK 5/6, D2-40 (Podoplanin)</td>\n<td>\n<p>Positive</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n</tr>\n<tr>\n<td><strong>TTF-1</strong></td>\n<td>\n<p>Negative</p>\n</td>\n<td>\n<p>Positive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carcinoembryonic Antigen</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n<td>\n<p>Positive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vimentin</p>\n</td>\n<td>\n<p>Positive</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Low molecular weight cytokeratins&nbsp;</p>\n</td>\n<td>\n<p>Positive</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Electron microscopic features</strong></p>\n</td>\n<td>\n<p>Long, sinuous villi</p>\n</td>\n<td>\n<p>Short, straight villi with fuzzy glycocalyx</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(971, 'Pathology', 'PM0011. Types of Bone sequestra seen in chronic osteomyelitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Types of Bone sequestra seen in chronic osteomyelitis:</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Disease</strong></td>\n</tr>\n<tr>\n<td>Tubular</td>\n<td>Pyogenic</td>\n</tr>\n<tr>\n<td>Ring</td>\n<td>External fixator</td>\n</tr>\n<tr>\n<td>Black/coke</td>\n<td>Actinomycosis</td>\n</tr>\n<tr>\n<td>Coralliform</td>\n<td>Perthes disease</td>\n</tr>\n<tr>\n<td>Feathery</td>\n<td>Tuberculosis</td>\n</tr>\n<tr>\n<td>Sandy- coarse</td>\n<td>Tuberculosis</td>\n</tr>\n<tr>\n<td>Sandy- fine</td>\n<td>Viral</td>\n</tr>\n<tr>\n<td>Ivory</td>\n<td>Syphilis</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(972, 'Community Medicine', 'PM2224. Health Data', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Vital statistics</strong></td>\n<td><strong>Last Update on</strong></td>\n</tr>\n<tr>\n<td colspan=\2\>&nbsp;<strong>Crude Birth Rate (per 1000 mid-year population)</strong></td>\n<td rowspan=\12\>&nbsp;SRS - 2022</td>\n</tr>\n<tr>\n<td>&nbsp;India&nbsp;</td>\n<td>&nbsp;19.5</td>\n</tr>\n<tr>\n<td>&nbsp;Highest - Bihar</td>\n<td>&nbsp;25.5</td>\n</tr>\n<tr>\n<td>&nbsp;Lowest - Andaman &amp; Nicobar</td>\n<td>&nbsp;10.8</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Crude Death Rate&nbsp;(per 1000 mid-year population)</strong></td>\n</tr>\n<tr>\n<td>&nbsp;India&nbsp;</td>\n<td>&nbsp;6.0</td>\n</tr>\n<tr>\n<td>&nbsp;Highest -&nbsp;Chhattisgarh</td>\n<td>&nbsp;7.9</td>\n</tr>\n<tr>\n<td>&nbsp;Lowest - Delhi</td>\n<td>&nbsp;3.6</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Infant Mortality Rate (per 1000 live births)</strong></td>\n</tr>\n<tr>\n<td>&nbsp;India&nbsp;</td>\n<td>&nbsp;28</td>\n</tr>\n<tr>\n<td>&nbsp;Highest -&nbsp;Madhya Pradesh</td>\n<td>&nbsp;43</td>\n</tr>\n<tr>\n<td>&nbsp;Lowest -&nbsp; Mizoram</td>\n<td>&nbsp;3</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Total Fertility rate (children per woman in reproductive age)</strong></td>\n<td rowspan=\2\>&nbsp;NFHS -5</td>\n</tr>\n<tr>\n<td>India&nbsp;</td>\n<td>2.0</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Crude Birth Rate (per 1000 mid-year population)</strong></td>\n<td rowspan=\4\>&nbsp;SRS - 2022</td>\n</tr>\n<tr>\n<td>India</td>\n<td>20.0</td>\n</tr>\n<tr>\n<td>Highest - Bihar</td>\n<td>26.2</td>\n</tr>\n<tr>\n<td>Lowest - Andaman &amp; Nicobar</td>\n<td>11.2</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Crude Death Rate</strong>&nbsp;<strong>(per 1000 mid-year population)</strong></td>\n<td rowspan=\4\>&nbsp;SRS - 2022</td>\n</tr>\n<tr>\n<td>India</td>\n<td>6.2</td>\n</tr>\n<tr>\n<td>Highest - Chhattisgarh</td>\n<td>8.0</td>\n</tr>\n<tr>\n<td>Lowest - Delhi</td>\n<td>3.3</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Infant Mortality Rate (per 1000 live births)</strong></td>\n<td rowspan=\4\>&nbsp;SRS - 2022&nbsp; &nbsp;</td>\n</tr>\n<tr>\n<td>India</td>\n<td>28</td>\n</tr>\n<tr>\n<td>Highest - Chattisgarh and&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Uttar Pradesh&nbsp;</td>\n<td>38</td>\n</tr>\n<tr>\n<td>Lowest - Mizoram</td>\n<td>3</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Natural Growth Rate&nbsp;(per 1000 mid-year population)&nbsp;</strong></td>\n<td rowspan=\4\>&nbsp;SRS - 2022</td>\n</tr>\n<tr>\n<td>India&nbsp;</td>\n<td>13.5&nbsp;</td>\n</tr>\n<tr>\n<td>Highest -&nbsp;Bihar&nbsp;</td>\n<td>20</td>\n</tr>\n<tr>\n<td>Lowest - Goa and Kerala</td>\n<td>6.2</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Maternal Mortality Ratio (per 1 lac live births)&nbsp;&nbsp;</strong></td>\n<td rowspan=\4\>&nbsp;SRS - 2022</td>\n</tr>\n<tr>\n<td>&nbsp;India</td>\n<td>97</td>\n</tr>\n<tr>\n<td>Highest - Assam</td>\n<td>195</td>\n</tr>\n<tr>\n<td>Lowest - Kerala</td>\n<td>19</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Neonatal Mortality Rate (per 1000 live births)</strong></td>\n<td rowspan=\2\>&nbsp;SRS - 2022</td>\n</tr>\n<tr>\n<td>India</td>\n<td>20</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Total Fertility rate (children per woman of reproductive age)</strong></td>\n<td rowspan=\2\>&nbsp;NFHS -5</td>\n</tr>\n<tr>\n<td>India&nbsp;</td>\n<td>2.0</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Life expectancy at birth</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Male</td>\n<td>69.7 years</td>\n<td rowspan=\2\>&nbsp;2022</td>\n</tr>\n<tr>\n<td>Female</td>\n<td>72.2 years</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(973, 'Community Medicine', 'PM2044. Crude death rate', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Crude death rate:</strong></p>\n<ul>\n<li>The crude death rate is the <strong>simplest measure</strong> of mortality.</li>\n<li>It is the number of deaths (from all causes) per 1000 estimated mid-year population in one year, in a given place.</li>\n<li><strong>Crude death rate</strong> = &nbsp;(Number of deaths per year)/(Mid-year population) x 1000</li>\n<li>Disadvantage: lacks <strong>comparability</strong> for communities with populations that differ in age, sex, race, etc.</li>\n<li>Currently, the crude death rate in India is <strong>6.0.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(974, 'Community Medicine', 'PM1700. Neonatal Mortality Rate', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Neonatal deaths</strong> are those that occur during the neonatal period, commencing at birth and ending at 28 completed days after birth.</li>\n<li><strong>NMR = Number of deaths of children under 28 days of age in a year x 1000/Total live births in the same year</strong></li>\n<li>Main causes of neonatal death are <strong>prematurity&nbsp;</strong>(leading cause), birth asphyxia, intrapartum-related complications, sepsis, pneumonia, congenital anomalies, tetanus, diarrhea, etc.</li>\n<li>India’s NMR&nbsp; is<strong>&nbsp;20 per 1000 live births&nbsp;</strong>(SRS 2020)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(975, 'Community Medicine', 'PM1699. Perinatal Mortality Rate', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The term ‘perinatal mortality’ includes both<strong> late fetal death</strong> (stillbirths) and<strong> early neonatal deaths</strong>.</li>\n<li>Babies chosen for inclusion in perinatal statistics should be <strong>above a minimum birth weight</strong> (1000g at birth). If the birth weight is not available, a <strong>gestation period of at least 28 weeks</strong> should be used (as the weight at 28 weeks corresponds to 1000g). If both are not available, then <strong>crown to heel length of at least 35cm</strong> should be used.</li>\n<li>Generally, the <strong>PMR</strong> = Late fetal deaths and early neonatal deaths weighing over 1000g at birth x 1000/Total births(live+dead) weighing over 1000g at birth.</li>\n<li>The PMR is the yard-stick of obstetric and pediatric care before and around the time of birth.</li>\n<li>The PMR of India (2016) is 24 per 1000 births.</li>\n<li>The main causes of perinatal mortality are intrauterine and birth asphyxia, low birth weight, birth trauma, and intrauterine/neonatal infections.</li>\n</ul>\n<p>Please note that the <strong>actual perinatal period commences from the 22nd week of life, but at that time the fetus weighs only about 500g.</strong></p>\n<p>Therefore, <strong>only for statistical calculations and international comparisons, to calculate the perinatal mortality rate, the period from the 28th week</strong> of life is taken, as then the baby weighs about <strong>1000g</strong>. As mentioned, babies included in the perinatal <strong>statistics</strong> must weigh above <strong>1000g</strong>.</p></div><!---->\n      <!---->\n    </div><!---->'),
(976, 'Community Medicine', 'PM1698. Maternal Mortality Ratio', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Maternal death</strong> is defined as the death of a woman <strong>while pregnant or within 42 days of termination of pregnancy</strong>, irrespective of the duration and site of pregnancy, from <strong>any cause related to or aggravated by the pregnancy</strong> or its management but not from accidental or incidental causes.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/19493f9439a24b529b7a098cbbce594cx1280x644.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The main global causes of maternal deaths are <strong>severe bleeding, indirect causes</strong> (anemia, malaria, heart diseases), <strong>infections, unsafe abortions, eclampsia, obstructed labor,</strong> and other direct causes like ectopic pregnancy, anesthesia-related complications, etc.</p>\n<p>In India, the most common causes of maternal deaths are hemorrhage (leading cause), sepsis, obstructed labor, hypertensive disorders, etc.</p></div><!---->\n      <!---->\n    </div><!---->'),
(977, 'Community Medicine', 'PM0138. Socio-Economic Indicators of Health', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;Mnemonic: <strong>H – FLAGGED<br> <br> </strong></p>\n<ul>\n<li><strong>H</strong>ousing [number of persons per room]</li>\n<li><strong>F</strong>amily size</li>\n<li><strong>L</strong>iteracy rate [especially female literacy rate]</li>\n<li><strong>A</strong>vailability of per capita ‘calorie’</li>\n<li><strong>G</strong>NP per capita</li>\n<li><strong>G</strong>rowth rate of population</li>\n<li>Un<strong>E</strong>mployment level</li>\n<li><strong>D</strong>ependency ratio</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(978, 'Community Medicine', 'PM0137. Disability Adjusted Life Year (DALY)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/68a5647564a1454282a4026c51022dd2x1200x394.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(979, 'Community Medicine', 'PM0136. QALY vs. DALY', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>QALY and DALY are disability indicators used as measures of health in a population.</p>\n<table>\n<tbody>\n<tr>\n<td width=\308\>\n<p><strong>QALY </strong>(Quality Adjusted Life Years)</p>\n</td>\n<td width=\308\>\n<p><strong>DALY&nbsp;</strong>(Disability Adjusted Life Years)</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>&nbsp;</p>\n<p>Measures <strong>quality of life</strong> in health gain</p>\n</td>\n<td width=\308\>\n<p>&nbsp;</p>\n<p>Measures <strong>health loss</strong> in quality of life</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>&nbsp;</p>\n<p>Indicator of <strong>cost-effectiveness</strong> of intervention</p>\n</td>\n<td width=\308\>\n<p>&nbsp;</p>\n<p>Indicator of overall <strong>burden of disease</strong> in a population</p>\n</td>\n</tr>\n<tr>\n<td width=\308\>\n<p>&nbsp;</p>\n<p>Expressed as 1 or 0 where,</p>\n<p>1 = Perfect health</p>\n<p>0 = Death</p>\n<p>&nbsp;</p>\n</td>\n<td width=\308\>\n<p>&nbsp;</p>\n<p>Expressed as 0 or 1 where,</p>\n<p>0 = Perfect health</p>\n<p>1 = Death</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->'),
(980, 'Community Medicine', 'PM0134. HDI vs. PQLI', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Human Development Index&nbsp;</strong><strong>(HDI)</strong></p>\n</td>\n<td><strong>Physical Quality of Life Index (PQLI)</strong></td>\n</tr>\n<tr>\n<td><strong>Components</strong></td>\n<td>\n<p>Longevity (Life expectancy at birth)</p>\n<p>A decent standard of living (Real GNI per capita in PPP US$)</p>\n<p>Knowledge (mean years of schooling and expected years of schooling)</p>\n</td>\n<td>\n<p>Life expectancy at 1 year of age&nbsp;</p>\n<p>Infant Mortality rate</p>\n<p>Literacy rate</p>\n</td>\n</tr>\n<tr>\n<td><strong>Range</strong></td>\n<td>0 to +1</td>\n<td>0 to 100</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(981, 'Community Medicine,', 'PM1691. National Immunization Schedule (India)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\5\><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-&nbsp;Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy&nbsp;<br>within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\5\><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until one&nbsp;year of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br>1 month<br>age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - Birth&nbsp;Dose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td>&nbsp;Intra-muscular</td>\n<td>Antero-lateral&nbsp;side of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible within&nbsp;the first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent&nbsp;1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntra·muscular</td>\n<td>Antero-lateral&nbsp;side of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5&nbsp;drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Three fractional doses at 6, 14 weeks and 9 months of age</p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal 3 fractional dose</td>\n<td>Intra-dermal: right&nbsp;Upper arm (at 6, 14 weeks);<br>left upper arm (at 9 months)</td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra·muscular</td>\n<td>Antero-lateral&nbsp;side of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br>(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br>(1st dose)</td>\n<td>\n<p>At&nbsp;9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\5\><strong>For Children&nbsp;</strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateral&nbsp;side of mid-thigh &nbsp;</td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm &nbsp;</td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>16–24 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm&nbsp;</td>\n</tr>\n<tr>\n<td>Vitamin A***<br>(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>16–18 months, followed by&nbsp;one dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2&nbsp;mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>5–6 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 1–5 years old during biannual rounds, in collaboration with ICDS.</p></div><!---->\n      <!---->\n    </div><!---->'),
(982, 'Paediatrics,', 'PM0701. Contraindications to Vaccines', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\319\>\n<p><strong>Vaccine</strong></p>\n</td>\n<td width=\319\>\n<p><strong>Contraindications</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>All</p>\n</td>\n<td width=\319\>\n<p>Anaphylactic reaction to previous dose</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Live vaccines (MMR, BCG, yellow fever,Varicella)</p>\n</td>\n<td width=\319\>\n<p>Pregnancy</p>\n<p>Radiation therapy</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Yellow fever</p>\n</td>\n<td width=\319\>\n<p>Egg allergy</p>\n<p>Immunodeficiency</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>BCG</p>\n</td>\n<td width=\319\>\n<p>Symptomatic HIV infection</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Influenza, yellow fever</p>\n</td>\n<td width=\319\>\n<p>Egg allergy</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Pertussis-containing vaccines</p>\n</td>\n<td width=\319\>\n<p>Evolving neurological disorders</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(983, 'Paediatrics,', 'PM0700. Adverse Events following Immunization', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\151\>\n<p><strong>Vaccine</strong></p>\n</td>\n<td width=\204\>\n<p><strong>Common, Minor Reactions</strong></p>\n</td>\n<td width=\235\>\n<p><strong>Rare, Serious Reactions</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\151\>\n<p>BCG</p>\n</td>\n<td width=\204\>\n<p>Local pain and swelling</p>\n</td>\n<td width=\235\>\n<p>Suppurative lymphadenitis</p>\n<p>BCG osteitis</p>\n<p>Disseminated BCG infection</p>\n</td>\n</tr>\n<tr>\n<td width=\151\>\n<p>Hepatitis B</p>\n</td>\n<td width=\204\>\n<p>Local reaction, fever</p>\n</td>\n<td width=\235\>\n<p>Anaphylaxis</p>\n</td>\n</tr>\n<tr>\n<td width=\151\>\n<p>Inactivated influenza</p>\n</td>\n<td width=\204\>\n<p>Local reaction</p>\n</td>\n<td width=\235\>\n<p>Guillain-Barre syndrome (GBS)</p>\n<p>Oculo-respiratory syndrome</p>\n<p>Anaphylaxis</p>\n</td>\n</tr>\n<tr>\n<td width=\151\>\n<p>JE vaccine</p>\n</td>\n<td width=\204\>\n<p>Local reaction, low-grade fever, myalgia</p>\n</td>\n<td width=\235\>\n<p>Neurologic events like encephalitis</p>\n</td>\n</tr>\n<tr>\n<td width=\151\>\n<p>Measles/MMR</p>\n</td>\n<td width=\204\>\n<p>Local reactions, fever, malaise, irritability</p>\n</td>\n<td width=\235\>\n<p>Febrile seizures, arthralgia, thrombocytopenia</p>\n</td>\n</tr>\n<tr>\n<td width=\151\>\n<p>Yellow fever</p>\n</td>\n<td width=\204\>\n<p>Headache, flu like symptoms, local reactions</p>\n</td>\n<td width=\235\>\n<p>Vaccine-associated viscerotropic disease</p>\n</td>\n</tr>\n<tr>\n<td width=\151\>\n<p>Oral Polio</p>\n</td>\n<td width=\204\>\n<p>None</p>\n</td>\n<td width=\235\>\n<p>Vaccine associated paralytic poliomyelitis</p>\n</td>\n</tr>\n<tr>\n<td width=\151\>\n<p>DPT</p>\n</td>\n<td width=\204\>\n<p>Local reaction, fever</p>\n</td>\n<td width=\235\>\n<p>Neurologic events like encephalitis, seizures, HHE (hypotonic hyporesponsive episode), anaphylaxis, persistent inconsolable screaming</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(984, 'Community Medicine', 'PM0698. Vaccine Vial Monitors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Vaccine vial monitors</strong> are used to monitor heat exposure of vaccines.</li>\n<li>It is a chemical indicator that records the cumulative heat exposure through a gradual change in color.</li>\n<li>If the color of the <strong>inner square</strong> is the <strong>same color or darker</strong> than the <strong>outer circle</strong>, it indicates that the vaccine has been exposed to too much heat and it must be <strong>discarded</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3914a3eb19cf43ec9273112090e7b3f6x600x1199.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Currently, there are <strong>four types</strong> of VVMs (VVM2, VVM7, VVM14, and VVM30). They are chosen to match the heat sensitivity of the vaccine.</li>\n<li>The VVM can be located on the label of the vaccine or on the neck or cap of the ampule/vial.</li>\n<li>VVMs also help in <strong>reduction of vaccine wastage</strong> by indicating which batch of vaccines can be used first.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(985, 'Community Medicine', 'PM0697. Open Vial Policy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Open vial policy allows for reuse of partially used <strong>multidose vials</strong> of applicable vaccines under the Universal Immunization Programme in subsequent sessions up to&nbsp;<strong>4&nbsp;weeks</strong> subject to certain conditions and thereby reducing vaccine wastage.</p>\n<p>It is applicable only for <strong>DPT, TT, hepatitis B vaccine, OPV, liquid pentavalent vaccine, rotavirus vaccine(new version with the VVM on the side), and JE vaccines (inactivated). </strong>It is not applicable to <strong>BCG and measles vaccines.&nbsp;</strong></p>\n<p>Vaccine vials opened in session-site can be used in more than one session up to four weeks if <strong>expiry date has not passed, if storage and transport was appropriate, no contamination has occurred in vial septum, asepsis in withdrawing was practiced and if vaccine vial monitor has not reached discard point.</strong></p>\n<p>Open vials should <strong>not</strong> be submerged in water. All open vials should have a record of&nbsp;<strong>date and time of opening</strong>. At the end of a session, all vaccines should be returned to the cold chain point and segregated as re-usable and non-reusable. All open vials of BCG, measles must be destroyed after 48 hours or before next session, whichever is earlier.</p>\n<p>In case of any <strong>adverse events following immunization</strong>, all open vials should not be discarded until investigation is complete. All vials must be transported in zipper bags in the vaccine carrier and recorded in stock register. Ice packs used should be well sealed.</p></div><!---->\n      <!---->\n    </div><!---->'),
(986, 'Community Medicine', 'PM0696. Cold Chain Equipment', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Cold chain equipment :&nbsp;</strong></p>\n<p><strong>Storage :&nbsp;</strong></p>\n<ul>\n<li>Walk in cooler (WIC)</li>\n<li>Walk in freezer (WIF)</li>\n<li>Ice lined refrigerator (ILR)</li>\n<li>Deep freezer&nbsp;</li>\n<li>Domestic refrigerator&nbsp;</li>\n</ul>\n<p>Solar :</p>\n<ul>\n<li>Solar Refrigerator Battery drive</li>\n<li>Solar Refrigerator Direct drive</li>\n</ul>\n<p>Non electrical :</p>\n<ul>\n<li>Cold box</li>\n<li>Vaccine carrier</li>\n</ul>\n<p><strong>Transportation :&nbsp;</strong></p>\n<ul>\n<li>Refrigerator vaccine van</li>\n<li>Insulated vaccine van</li>\n<li>Cold box&nbsp;</li>\n<li>Vaccine carrier</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/549c3f139636430fa5c659529a31d432x1280x1489.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p>Electrical Cold Chain Equipment:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Component</strong></p>\n</td>\n<td>\n<p><strong>Temperature (degree Celsius)</strong></p>\n</td>\n<td>\n<p><strong>Level</strong></p>\n</td>\n<td>\n<p><strong>Other Comments</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Walk in Freezers (WIF)</p>\n</td>\n<td>\n<p><strong>-15 to -25&nbsp; </strong></p>\n</td>\n<td>\n<p>National, State and Regional vaccine stores</p>\n</td>\n<td>\n<p>Used for bulk storage of <strong>OPV </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Walk in Coolers (WIC)</p>\n</td>\n<td>\n<p><strong>+2 to +8</strong></p>\n</td>\n<td>\n<p>Government Medical Store Depot (GMSD), State and Regional vaccines stores</p>\n</td>\n<td>\n<p>Used for bulk storage of most vaccines in UIP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Deep Freezer (DF)</p>\n</td>\n<td>\n<p><strong>-15 to -25&nbsp; </strong></p>\n</td>\n<td>\n<p>District and Sub-district vaccines stores</p>\n</td>\n<td>\n<p>Used for bulk storage of <strong>OPV</strong> and ice packs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ice Line Refrigerator (ILR)</p>\n</td>\n<td>\n<p><strong>+2 to +8</strong></p>\n</td>\n<td>\n<p>District and Sub-district vaccines stores, <strong>PHCs</strong></p>\n</td>\n<td>\n<p>Has different <strong>temperature zones </strong>for different vaccines</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Front Load Refrigerator (Domestic)</p>\n</td>\n<td>\n<p><strong>+2 to +8</strong></p>\n</td>\n<td>\n<p>Sub-district levels, hospitals. dispensaries and nursing homes</p>\n</td>\n<td>\n<p>Used for all vaccines</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(987, 'Community Medicine', 'PM0693. Temperature Sensitivity of Vaccines', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Heat sensitivity</strong> in order of <strong>decreasing</strong> sensitivity:&nbsp;</p>\n<table width=\791\>\n<tbody>\n<tr>\n<td>Group</td>\n<td>Vaccines</td>\n</tr>\n<tr>\n<td>A</td>\n<td>OPV</td>\n</tr>\n<tr>\n<td>B</td>\n<td>Influenza</td>\n</tr>\n<tr>\n<td>C</td>\n<td>\n<p>IPV</p>\n<p>Japanese encephalitis(live)</p>\n<p>Measles, mumps, rubella</p>\n</td>\n</tr>\n<tr>\n<td>D</td>\n<td>\n<p>Cholera</p>\n<p>DTaP</p>\n<p>Pentavalent</p>\n<p>Rotavirus</p>\n<p>Hib(liquid)</p>\n<p>Yellow fever</p>\n<p>Measles</p>\n<p>Rubella</p>\n</td>\n</tr>\n<tr>\n<td>E</td>\n<td>\n<p>BCG</p>\n<p>HPV</p>\n<p>Japanese encephalitis(inactivated)</p>\n<p>Tetanus, TD, Td</p>\n</td>\n</tr>\n<tr>\n<td>F</td>\n<td>\n<p>Hepatitis B</p>\n<p>Hib(freeze-dried)</p>\n<p>Meningococcal A</p>\n<p>Pneumococcal</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Vaccine <strong>sensitivity to freezing</strong>:</p>\n<p><strong>Rotavirus(liquid)</strong>&lt; T,DT,dT&lt; IPV &lt; Hib(liquid)&lt; HepB &lt; Pentavalent &lt;<strong>DTaP</strong></p>\n<p>Vaccines not damaged by freezing:</p>\n<ul>\n<li>Yellow fever</li>\n<li>BCG</li>\n<li>Hib</li>\n<li>Japanese encephalitis(live and inactivated)</li>\n<li>Measles, mumps, rubella</li>\n<li>OPV</li>\n<li>Rabies</li>\n<li>Rotavirus(Freeze-dried)</li>\n<li>Varicella zoster</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c7bd80ca927b42bcb0956bc12ae146b7x956x717.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(988, 'Community Medicine', 'PM0688. Herd Immunity', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Herd immunity is the <strong>level of protection of a community</strong> against a particular disease brought about by vaccination or immunization.</li>\n<li>It refers to group protection beyond what is afforded by the protection of immunized individuals.</li>\n<li>It is difficult to maintain the chain of infection if a large portion of the population is immune to a certain disease.</li>\n<li>Elements which contribute to herd immunity are:\n<ul>\n<li><strong>Occurrence</strong> of clinical and sub-clinical infection in the herd</li>\n<li><strong>Immunization</strong> of the herd</li>\n<li>Herd <strong>structure</strong></li>\n</ul>\n</li>\n<li>The <strong>herd structure</strong> not only includes the primary species but also the presence and distribution of alternative animal hosts, vectors and other environmental/social factors that are related to disease spread.</li>\n<li>It is <strong>not possible or necessary</strong> to achieve 100% herd immunity in a population.</li>\n<li>The proportion of immune individuals above which a disease may no longer spread is called <strong>herd immunity threshold</strong>.</li>\n<li>This threshold depends upon the virulence of the disease, efficacy of the vaccine and contact parameter for the population.</li>\n<li>Herd immunity is determined by <strong>serological surveys.</strong></li>\n<li>Herd immunity doesn’t offer protection against diseases like tetanus.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(989, 'Community Medicine', 'PM0507. Investigation of an Epidemic', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>A) <strong>Steps</strong></p>\n<ul>\n<li><strong>Verification</strong> of diagnosis</li>\n<li>Confirmation of <strong>existence</strong> of epidemic</li>\n<li>Defining the <strong>population at risk</strong>\n<ul>\n<li>Obtaining a map of the area</li>\n<li>Counting the population</li>\n</ul>\n</li>\n<li>Rapid <strong>search</strong> for all the cases\n<ul>\n<li>Medical survey</li>\n<li>Epidemiological case sheets</li>\n<li>Searching for more cases</li>\n</ul>\n</li>\n<li><strong>Data analysis</strong> on the basis of time, place and person</li>\n<li>Formulation of <strong>hypothesis</strong></li>\n<li><strong>Testing </strong>of hypothesis</li>\n<li><strong>Evaluation </strong>of ecological factors</li>\n<li>Further investigation of population at risk</li>\n<li>Writing the <strong>report</strong></li>\n</ul>\n<p>B) <strong>Final Epidemic Report</strong></p>\n<ul>\n<li><strong>Background</strong> including geography, climate, demography, socio-economic groups, health service organization, surveillance data and normal disease prevalence</li>\n<li><strong>Historical data</strong> including previous occurrences of the epidemic, occurrence of any related diseases and discovery of the primary case in present outbreak</li>\n<li><strong>Methodology of investigations</strong> including case definition, epidemiological questionnaires, collection and laboratory techniques</li>\n<li><strong>Analysis of data</strong> including clinical and epidemiological data, modes of transmission, laboratory data and all their interpretations</li>\n<li><strong>Control measures</strong> including strategy definitions, methodology of implementation, evaluation methods and preventive measures</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(990, 'Community Medicine', 'PM0357. Uses of Epidemiology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>To study the <strong>rise and fall</strong> of disease in populations</li>\n<li><strong>Community diagnosis</strong></li>\n<li><strong>Planning</strong> and <strong>evaluation</strong></li>\n<li>Evaluation of individual’s <strong>risks and chances</strong></li>\n<li><strong>Syndrome</strong> identification</li>\n<li>Completing the <strong>natural history</strong> of disease</li>\n<li>Searching for <strong>causes and risk factors</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(991, 'Community Medicine', 'PM0350. Meta-analysis in Research', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Meta-analysis</strong> is a set of <strong>statistical techniques</strong> for combining <strong>quantitative results</strong> from multiple studies to produce a summary <strong>of empirical knowledge</strong> on a given topic.</li>\n<li>It refers to a method of systematic review.</li>\n<li>It is one of the most relevant methods in evidence-based medicine and ranks high on the evidence pyramid.</li>\n<li>Limitations\n<ul>\n<li>When testing is done before hypothesis generation, spurious results are found.</li>\n<li>Sample size may be misrepresentative.</li>\n<li>Publication bias due to suppression of some important information leading to <strong>file drawer effect</strong>.</li>\n<li>Heterogeneity of studies may force mashing together of disparate effects and lead to selection bias. This is also called <strong>apples and oranges effect.</strong></li>\n<li>Dissimilarities in control groups.</li>\n<li>Its <strong>validity</strong> is dependent on the <strong>quality of the systematic review</strong> and the original data used.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(992, 'Community Medicine', 'PM0349. Systematic Review in Research', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>A <strong>systematic review</strong> is the process of <strong>locating and synthesizing</strong> the research on a <strong>particular question</strong> using organized, transparent, and replicable procedures.</li>\n<li>It ranks <strong>high</strong> in the hierarchy of <strong>evidence</strong> in medicine.</li>\n</ul>\n<p><strong>Steps of a Systematic Review</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8250c0995fa04120bc2944ae1b5d75fax1280x781.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The research <strong>question</strong> formulated is always <strong>focussed</strong>.</li>\n<li>The <strong>literature on studies</strong> is always found and appraised after criteria of eligibility are established.</li>\n<li>Meta-analysis is usually done in a systematic review but <strong>not always</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(993, 'Community Medicine', 'PM0348. Evidence Pyramid in Research', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The <strong>evidence pyramid</strong> gives the hierarchy or ranking of evidence from different types of methods used in research.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0b73c37494284c61abab265d4c8b9acax1280x1603.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Animal research ranks the lowest, while <strong>meta-analysis</strong> ranks the highest and gives the best evidence.</p></div><!---->\n      <!---->\n    </div><!---->'),
(994, 'Community Medicine', 'PM0301. Randomized Controlled Trials', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Randomized controlled trials</strong> are a type of <strong>experimental studies</strong>.</p>\n<p><strong>Types</strong></p>\n<ul>\n<li>Clinical trials</li>\n<li>Preventive trials</li>\n<li>Risk factor trials</li>\n<li>Cessation experiments</li>\n<li>Trial of etiological agents</li>\n<li>Evaluation of health services</li>\n</ul>\n<p><strong>General Design of an RCT</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b18b067a5846405b95d6bb11b2e1546fx1280x1482.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Steps of an RCT</strong></p>\n<ul>\n<li>Drawing up a <strong>protocol</strong></li>\n<li>Selecting <strong>reference and experimental</strong> population</li>\n<li><strong>Randomization</strong></li>\n<li>Manipulation or <strong>intervention</strong></li>\n<li><strong>Follow-up</strong></li>\n<li><strong>Assessment</strong> of outcome.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(995, 'Community Medicine', 'PM0300. Blinding in Epidemiology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Blinding</strong> is done in epidemiology to <strong>reduce</strong> the possibility of <strong>bias</strong>.</li>\n<li><strong>Types:</strong>\n<ul>\n<li>In <strong>single blind trials</strong>, only the <strong>participants or group members</strong> are not aware of the group allocation.</li>\n<li>In <strong>double blind trials</strong>, both the <strong>group members </strong>and the<strong> observers</strong> are not aware of the group allocation.</li>\n<li>In <strong>triple blind trials</strong>, the <strong>group members, the observers </strong>and the <strong>analyzers</strong> are unaware of the group allocation.</li>\n</ul>\n</li>\n<li>The <strong>most commonly</strong> used type of blinding is <strong>double blinding.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(996, 'Community Medicine', 'PM0269. Relative and Attributable Risk', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Relative Risk:</p>\n<ul>\n<li>Ratio of incidence of disease or death among exposed to that among the non-exposed is called <strong>relative risk (RR).</strong></li>\n<li>It is also called <strong>risk ratio</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f8f2d7bcf01a465699a42d1a750c87b8x1280x704.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>It is the direct measure of the&nbsp;<strong>strength of association</strong> between suspected cause and effect in <strong>cohort studies</strong>.</li>\n<li>RR &lt; 1 indicates inverse association(protective effect)</li>\n<li>RR = 1 indicates no association.</li>\n<li>RR &gt; 1 indicates positive association.</li>\n<li>RR of 2 indicates a 100% increase in risk.</li>\n<li>Relative risk calculation (RR) = [ a/(a+b) ]/ [ c/(c+d) ] where,&nbsp;</li>\n</ul>\n<table width=\237\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td colspan=\3\>Cancer</td>\n</tr>\n<tr>\n<td rowspan=\3\>Exposure</td>\n<td>&nbsp;</td>\n<td>yes</td>\n<td>no</td>\n</tr>\n<tr>\n<td>yes</td>\n<td>a</td>\n<td>b</td>\n</tr>\n<tr>\n<td>no</td>\n<td>c</td>\n<td>d</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>Attributable Risk:</p>\n<ul>\n<li><strong>Attributable risk (AR)</strong> is the <strong>difference</strong> in incidence rates or proportions of disease or death between an exposed and non-exposed group.</li>\n<li>It is expressed in <strong>percentage</strong> and gives the extent to which the disease can be attributed to the exposure in a <strong>cohort study.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e22f0ba149fb4a2786d73446fd23c180x902x260.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(997, 'Community Medicine', 'PM0268. Cohort Study', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>A <strong>cohort study</strong> progresses from <strong>cause</strong> (exposure) <strong>to effect</strong> (disease).</li>\n<li>It is also known as <strong>forward-looking </strong>study, <strong>incidence </strong>study,<strong> prospective </strong>study, and<strong> longitudinal </strong>study.</li>\n<li><strong>Design of a cohort study:</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2ea236bdd083460eaa50179f47f0948dx1280x1373.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<ul>\n<li><strong>Types of cohort study:</strong>\n<ul>\n<li>Prospective (concurrent) cohort studies</li>\n<li>Retrospective (historical) cohort studies</li>\n<li>Combination cohort studies</li>\n</ul>\n</li>\n<li><strong>Steps of cohort study:</strong>\n<ul>\n<li>Selection of study subjects</li>\n<li>Obtaining data on exposure</li>\n<li>Selection of comparison groups</li>\n<li>Follow-up</li>\n<li>Analysis in terms of incidence rates and estimation of risk</li>\n</ul>\n</li>\n<li><strong>Advantages of cohort study:</strong>\n<ul>\n<li>Incidence can be calculated</li>\n<li>Several possible outcomes related to exposure can be studied at the same time</li>\n<li>Provides direct estimate of relative risk</li>\n<li>Calculation of dose-response ratio</li>\n<li>Minimization of certain biases</li>\n</ul>\n</li>\n<li><strong>Disadvantages of cohort study:</strong>\n<ul>\n<li>Cannot use for uncommon diseases</li>\n<li>Expensive, requires a large population and&nbsp;longer time</li>\n<li>Many common administrative and ethical problems</li>\n<li>High attrition and selection of subjects is difficult</li>\n<li>Dynamism of diagnostics is difficult to incorporate</li>\n<li>Tends to alter the behaviour of subjects known as&nbsp;<strong>Hawthorne effect</strong>.</li>\n</ul>\n</li>\n</ul>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(998, 'Community Medicine', 'PM0267. Odds Ratio', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Odds ratio is a measure of the <strong>strength of association</strong> between<strong> risk factor</strong> and <strong>outcome</strong> in case control studies.</li>\n<li>Odds ratio can be arrived at from <strong>case control studies</strong>.</li>\n<li>It is also known as <strong>cross product ratio</strong>.</li>\n<li>A representation of the odds ratio <strong>(OR) </strong>is given in the picture below:</li>\n</ul>\n<p>Calculation of odds ratio (OR) = (a/b)/(c/d) = ad/bc where,&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td colspan=\3\>Cancer</td>\n</tr>\n<tr>\n<td rowspan=\3\>Exposure</td>\n<td>&nbsp;</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Yes</td>\n<td>a</td>\n<td>b</td>\n</tr>\n<tr>\n<td>No</td>\n<td>c</td>\n<td>d</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>OR &lt; 1</strong> indicates <strong>possible protection</strong>&nbsp;(<strong>negative</strong> association) as the frequency of exposure is lower among cases than controls.</li>\n<li><strong>OR = 1&nbsp;</strong>indicates <strong>no association</strong> of risk with exposure, or that the event is equally likely in both groups.</li>\n<li><strong>OR &gt; 1</strong> indicates <strong>increased risk</strong>&nbsp;(<strong>positive</strong> association) as the frequency of exposure is greater among cases than controls.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(999, 'Community Medicine', 'PM0266. Bias in Epidemiological Studies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Type of Bias</strong></td>\n<td><strong>Definition</strong></td>\n<td><strong>Methods to reduce it</strong></td>\n</tr>\n<tr>\n<td>Observer bias</td>\n<td>Differential ability to observe. A <strong>subjective</strong> bias.</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Interviewers bias</td>\n<td>Interviewer asking <strong>leading questions</strong> to the subjects. Or interviewing cases thoroughly than the controls.</td>\n<td>&nbsp;Double blinding</td>\n</tr>\n<tr>\n<td>Memory/ <strong>Recall</strong> bias</td>\n<td>Differential ability of cases and controls <strong>to recall</strong> a certain detail. An <strong>objective</strong> bias.</td>\n<td>Decrease time from exposure to follow-up</td>\n</tr>\n<tr>\n<td>Surveillance bias</td>\n<td>Active surveillance leads to an <strong>increased chance</strong> of <strong>identifying</strong> the event.</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Reporting/ notification bias</td>\n<td>Diseases associated with <strong>stigma</strong> are <strong>reported less.</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Berkesonian</strong> bias</td>\n<td><strong>Hospital-based case-control studies.</strong> Occurs due to differential hospital admission rates.</td>\n<td>\n<p>Randomization or Matching&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Selection bias</td>\n<td>A <strong>sampling bias.</strong> Non-random allocation of subjects that do not represent the population</td>\n<td>Randomization or Matching</td>\n</tr>\n<tr>\n<td><strong>Hawthorne</strong> bias</td>\n<td><strong>Change</strong> in <strong>attitude/</strong> actions of the subjects under <strong>observation</strong></td>\n<td>Use placebo group</td>\n</tr>\n<tr>\n<td><strong>Confounding</strong> bias</td>\n<td><strong>Factors related</strong> to <strong>both exposure</strong> and <strong>outcome</strong> distort the effect of exposure on outcome</td>\n<td>Matching, cross-over studies, randomization, or stratification</td>\n</tr>\n<tr>\n<td>Attrition bias</td>\n<td>Participants <strong>lost to follow-up</strong> have a different prognosis than those who complete the study.</td>\n<td>Randomization</td>\n</tr>\n<tr>\n<td>Pygmalion bias</td>\n<td><strong>Researchers</strong> high <strong>expectations</strong> in the efficacy of the treatment <strong>change</strong> the <strong>outcome</strong> of that treatment.</td>\n<td>Blinding</td>\n</tr>\n<tr>\n<td><strong>Neymans/</strong> Prevalence-Incidence bias&nbsp;</td>\n<td>Occurs due to the <strong>selective survival</strong> in <strong>prevalent cases</strong> usually seen in <strong>fatal diseases.</strong> Very sick patients are automatically excluded because of their early death.</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Neyman’s</strong> bias or prevalence-incidence bias example: a case-control study is carried out to study the relationship between tobacco smoking and acute myocardial infarction (AMI). The cases are interviewed one week after the coronary attack. If smoker patients with AMI die more frequently, the living cases will show a lower frequency of smoking, undervaluing the association between smoking and AMI. It has been shown that the bias occurs only if the risk factor influences mortality from the disease being studied.</p>\n<p><strong>Ecological fallacy</strong> results when characteristics of the group are assigned inappropriately to individuals.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1000, 'Community Medicine', 'PM0265. Case Control Study', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>In a <strong>case-control</strong> study, progression is from <strong>effect </strong>(disease) to<strong> cause</strong>&nbsp;(exposure) as the outcome or disease has already occurred. It is also called a&nbsp;<strong>retrospective</strong> study.</p>\n<p><strong>Design </strong>of case-control study:</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/54361314f5e0423d9bef0e4acae144a0x1280x1242.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Steps of case control study:</strong>\n<ul>\n<li>Selection of cases and controls</li>\n<li>Matching</li>\n<li>Measurement of exposure</li>\n<li>Analysis in the form of exposure rates, risk ratio, and odds ratio</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Advantages of case control study:</strong>\n<ul>\n<li>Easy to carry out, rapid and inexpensive</li>\n<li>Requires few subjects, no risk to subjects</li>\n<li>Used to investigate rare diseases</li>\n<li>Different etiological factors can be studied and risk factors can be identified</li>\n<li>No attrition problems, minimal ethical problems</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Disadvantages&nbsp;of case control study:</strong>\n<ul>\n<li>Relies on memory or past records giving rise to bias</li>\n<li>Selection of appropriate control groups is difficult</li>\n<li>Incidence cannot be measured</li>\n<li>Does not distinguish between causes and associated factors</li>\n<li>Not suited for evaluation of therapy or prophylaxis</li>\n<li>Representativeness of the cases and controls is often inadequate</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1001, 'Community Medicine', 'PM0254. Levels of Prevention', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Level</strong></p>\n</td>\n<td>\n<p><strong>Primordial</strong></p>\n</td>\n<td>\n<p><strong>Primary</strong></p>\n</td>\n<td>\n<p><strong>Secondary</strong></p>\n</td>\n<td>\n<p><strong>Tertiary</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Phase of disease</strong></p>\n</td>\n<td>\n<p>Underlying socio-economic &amp; environmental conditions leading to causation</p>\n</td>\n<td>\n<p>Specific causal or risk factors</p>\n</td>\n<td>\n<p>Early stage of disease</p>\n</td>\n<td>\n<p>Late stage of disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Aim</strong></p>\n</td>\n<td>\n<p>Establish and maintain conditions that minimize hazards to health</p>\n</td>\n<td>\n<p>Reduce the incidence of disease</p>\n</td>\n<td>\n<p>Reduce prevalence by shortening duration</p>\n</td>\n<td>\n<p>Reduce number and impact of complications</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Actions</strong></p>\n</td>\n<td>\n<p>Inhibition of emergence of socio-economic, environmental and behavioural conditions</p>\n</td>\n<td>\n<p>Protection of personal and community health by eliminating risks</p>\n</td>\n<td>\n<p>Early detection and intervention to minimize disability</p>\n</td>\n<td>\n<p>Soften the impact of long-term disease and disability, minimize suffering</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Modes of Intervention</strong></p>\n</td>\n<td>\n<p>Health education</p>\n</td>\n<td>\n<p>Health promotion and specific protection</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Diagnosis and treatment</p>\n</td>\n<td>\n<p>Disability limitation and rehabilitation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Targets</strong></p>\n</td>\n<td>\n<p>Total population or select groups</p>\n</td>\n<td>\n<p>Total population or high risk individuals/groups</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Individuals/ Patients</p>\n</td>\n<td>\n<p>Patients</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1002, 'Community Medicine', 'PM0253. Sentinel  Surveillance', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Sentinel surveillance</strong> is used to augment the notification systems used in surveillance of diseases.</li>\n<li>It detects the total case load and is used to identify the missing cases that are not notified among the old and new cases.</li>\n<li><strong>Sentinel data</strong> from the same is extrapolated to the entire population and the prevalence can be commented on.</li>\n<li>Advantages: <strong>Bias </strong>in reporting is <strong>minimized</strong> and the <strong>feedback</strong> is simplified.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1003, 'Community Medicine', 'PM0252. Monitoring vs. Surveillance in Disease Control', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\301\>\n<p><strong>Monitoring</strong></p>\n</td>\n<td width=\301\>\n<p><strong>Surveillance</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\301\>\n<p>Performance and analysis of routine measurements aimed at detecting changes in environment or health status of a population.</p>\n</td>\n<td width=\301\>\n<p>Continuous scrutiny of the factors that determine the occurrence and distribution of disease and other conditions of ill-health.</p>\n</td>\n</tr>\n<tr>\n<td width=\301\>\n<p>One-time <strong>linear activity</strong></p>\n</td>\n<td width=\301\>\n<p><strong>Continuous cycle</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\301\>\n<p><strong>No feedback</strong> present</p>\n</td>\n<td width=\301\>\n<p>Feedback present</p>\n</td>\n</tr>\n<tr>\n<td width=\301\>\n<p>No inbuilt action component present</p>\n</td>\n<td width=\301\>\n<p><strong>Inbuilt action</strong> component present</p>\n</td>\n</tr>\n<tr>\n<td width=\301\>\n<p>Stops once disease is eliminated or eradicated</p>\n</td>\n<td width=\301\>\n<p><strong>Continuous</strong> even after disease is eliminated or eradicated</p>\n</td>\n</tr>\n<tr>\n<td width=\301\>\n<p>Smaller concept</p>\n</td>\n<td width=\301\>\n<p>Broader concept</p>\n</td>\n</tr>\n<tr>\n<td width=\301\>\n<p>It is a&nbsp;<strong>part of surveillance</strong>.</p>\n</td>\n<td width=\301\>\n<p>It is not a part of monitoring.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1004, 'Community Medicine', 'PM0234. Epidemics and its Types', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>An epidemic is an occurrence in a community or region of cases of an illness that is clearly in <strong>excess of normal expectancy</strong>. Its types include:</p>\n<p><strong>Common source epidemics</strong></p>\n<ul>\n<li>Single exposure or point source epidemics</li>\n<li>Multiple or continuous exposure epidemics</li>\n</ul>\n<p><strong>Propagated or progressive epidemics</strong></p>\n<ul>\n<li>Person to person</li>\n<li>Arthropod vector</li>\n<li>Animal reservoir</li>\n</ul>\n<p><strong>Slow or modern epidemics</strong></p>\n<ul>\n<li>Non-communicable diseases</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1005, 'Community Medicine', 'PM0233. Descriptive Epidemiology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Descriptive Epidemiology</strong></p>\n<ul>\n<li>Descriptive studies are used to describe a disease of <strong>unknown etiology</strong>.</li>\n<li><strong>Steps</strong>\n<ul>\n<li>Defining the <strong>population</strong> to be studied</li>\n<li>Defining the <strong>disease</strong> to be studied</li>\n<li>Describing the disease by <strong>time, place, and person</strong>\n<ul>\n<li><strong>Measurement</strong> of the disease by <strong>cross sectional or longitudinal study</strong></li>\n<li><strong>Comparing</strong> with known <strong>indices</strong></li>\n<li>Formulation of an <strong>etiological</strong> <strong>hypothesis</strong></li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Uses</strong>\n<ul>\n<li>Provides data of <strong>magnitude</strong> of disease load in community</li>\n<li>Provides <strong>clues to disease etiology</strong></li>\n<li>Provides background data for <strong>health planning</strong></li>\n<li>Contributes to <strong>research</strong> by describing the disease</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1006, 'Community Medicine', 'PM0231. Types of Epidemiological Study Designs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Types of Epidemiological Study Designs</strong></p>\n<p>The flow chart below gives a glance into the types of epidemiological study designs and where they are generally used.</p>\n<p><strong>Note:</strong>&nbsp;<strong>Descripitve study</strong> is used to <strong>formulate</strong> aetiological hypothesis of a disease. Whereas <strong>analytical study</strong> is used to <strong>test</strong> the hypothesis (i.e to accept or reject the hypothesis).</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8bf47c838ad64276ab706c700cc1758cx1280x2995.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1007, 'Community Medicine', 'PM0230. Morbidity Measurements in Epidemiology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5e17c2ec999e4412beacae58dadc5ea4x1280x1933.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1008, 'Community Medicine', 'PM0228. Incidence and Prevalence', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Incidence</strong>&nbsp;<strong>in Epidemiology:</strong></li>\n</ul>\n<p><strong>Incidence</strong> is the number of <strong>new</strong> <strong>cases</strong> occurring in a defined population during a period of time. The incidence rate is expressed in <strong>person-time</strong> units, usually per 1000 per year.&nbsp;It is given by the following formula:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/95992ed7fcdb46f682474bb07d7e3dcfx501x77.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It is generally used for <strong>acute illnesses.&nbsp;</strong>It provides insight into the <strong>effectiveness of health services and programs.&nbsp;</strong>Incidence can be determined from <strong>cohort studies and longitudinal studies.</strong></p>\n<p>The incidence rate of <strong>spells of sickness</strong> = &nbsp;(Number of spells of sickness starting in the specified period/Mean number of people exposed to that risk in the specified time) x <strong>1000.</strong></p>\n<p>Special types of incidence rates:</p>\n<p>1.<strong> Attack rate: </strong>It is used when there is a risk for a limited period of time.</p>\n<p>2.<strong> Secondary attack rate: </strong>It is the number of exposed persons developing the disease within the range of incubation period following exposure to a primary case.</p>\n<ul>\n<li><strong>Prevalence in Epidemiology:</strong></li>\n</ul>\n<p>Prevalence is the proportion of all cases, <strong>old and new</strong>, of a particular disease at a given point in time or over a period of time in a given population. It is a <strong>proportion,</strong> not a rate or ratio.&nbsp;Prevalence is always expressed in <strong>percentage.</strong></p>\n<p>It is given by the formula:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6746ce2989d64d339e4454605f41cde0x520x80.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It is useful to determine the <strong>magnitude </strong>of health problems.&nbsp;It can be determined from <strong>cross-sectional studies.</strong></p>\n<p>Types:</p>\n<p>1. <strong>Point </strong>prevalence is the prevalence at a point in time. Usually, prevalence is point prevalence unless <strong>otherwise specified</strong>.</p>\n<p>2. <strong>Period</strong> prevalence is the prevalence over a period of time.</p>\n<p><strong>Relationship</strong> between<strong> Incidence</strong> and<strong> Prevalence:</strong></p>\n<p>Prevalence depends upon <strong>incidence and duration</strong>.</p>\n<p><strong>Prevalence</strong> = <strong>Incidence x Mean Duration</strong></p>\n<p><strong>Longer the duration</strong> of the disease, the greater the prevalence.</p>\n<p>Few examples:</p>\n<ul>\n<li>In acute diseases, because of rapid recovery/death prevalence will be relatively&nbsp;<strong>lower</strong> than incidence. This is because, in some diseases (eg. food poisoning), the disease is so short-lived, there are no \old cases\.</li>\n<li>In chronic diseases like TB, prevalence will be <strong>higher</strong> than incidence.</li>\n<li>If a new treatment for a disease is effective, incidence does not change but <strong>prevalence decreases</strong> as the duration of disease decreases.</li>\n<li>If the treatment only prevents death but doesn’t cure the disease, it may cause a <strong>paradoxical increase</strong> in prevalence.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1009, 'Community Medicine', 'PM0225. Standardization of Rates in Epidemiology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p class=\heading\>Standardization of rates is done to allow for comparison of health statuses of two populations after adjustments for age, sex, etc. using a <strong>standard population.</strong></p>\n<p><strong>A) Direct Standardization:</strong></p>\n<ul>\n<li>Direct method uses <strong>actual age-specific</strong> death rates on <strong>standard population</strong>.</li>\n<li><strong>Concept</strong> is summarized by the given diagram:</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/70dcfc8c37c74afdb6759c7cb7ee6f17x1280x1097.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>It is feasible only if actual specific rates in subgroups of the observed population are available, along with number of people in each subgroup.</li>\n</ul>\n<p>B) <strong>Indirect Standardization</strong></p>\n<ul>\n<li>Indirect method uses <strong>standard age-specific</strong> death rates on <strong>actual population.</strong></li>\n<li><strong>Concept </strong>is summarized by the given diagram:</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8f7182d47ddc46d99cd8bed41f711368x1280x1373.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>One form of this is called the&nbsp;<strong>Standardized Mortality Ratio</strong>.\n<ul>\n<li>It is a ratio of the total number of deaths that occur in the study group to the number of deaths that would have been expected to occur if that study group had experienced the death rates of a standard population.</li>\n<li>It is given as&nbsp;<strong>x 100</strong>.</li>\n<li>If the value is <strong>&gt;100</strong>, then greater mortality risk and if the value is <strong>&lt;100</strong>, lesser risk.</li>\n<li>It does not need known specific rates for adjustment, unlike the direct method.</li>\n<li>It can be used if the event of interest is the occurrence of disease rather than death.</li>\n</ul>\n</li>\n<li>Other indirect methods are <strong>life table analysis, regression techniques and multivariate analysis.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1010, 'Community Medicine', 'PM0216. Case Fatality Rate', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Case fatality rate </strong>=&nbsp;&nbsp;(Total number of deaths due to a particular disease)/(Total number of cases due to the same disease)x 100</li>\n<li>It is a good indicator of <strong>severity or killing power</strong> of a disease.</li>\n<li>It is used mostly in <strong>acute and infectious diseases.</strong></li>\n<li>No time interval is used.</li>\n<li>Case fatality rate is closely related to <strong>virulence</strong>.</li>\n<li>Limitation of CFR is that its usefulness for chronic diseases is limited because the period from onset to death is variable.</li>\n<li>It is expressed in <strong>percentage</strong>.</li>\n<li>CFR is an <strong>incidence proportion</strong> and not a true rate.</li>\n<li>CFR may vary for the same disease in different epidemics.</li>\n<li>\n<p><strong>Case fatality of a few diseases:</strong></p>\n<ul>\n<li>Rabies - 100% especially after symptoms manifest</li>\n<li>Ebola - 25 to 90%, average - 50%&nbsp;</li>\n<li>Yellow fever - 15 to 50%</li>\n<li>Chicken pox - 0.001%</li>\n</ul>\n</li>\n<li>Diseases with a high case fatality rate: Tetanus, Rabies, Botulism, Ebola.</li>\n<li>Diseases with a low case fatality rate: Leprosy, Trachoma, Lymphatic filariasis.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1011, 'Community Medicine', 'PM0213. Mortality and morbidity indicators in epidemiology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Mortality Indicators</strong></p>\n</td>\n<td>\n<p><strong>Morbidity Indicators</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Universal indicators:</p>\n<ul>\n<li>Crude death rate</li>\n<li>Life expectancy</li>\n<li>Age-specific death rates</li>\n<li>Disease-specific mortality rate</li>\n<li>Proportional mortality rate</li>\n<li>Case fatality rate</li>\n<li>Years of potential life lost</li>\n<li>Adult mortality rate</li>\n</ul>\n<p>Maternal and child-related indicators:</p>\n<ul>\n<li>Infant mortality rate</li>\n<li>Child death rate</li>\n<li>Under-5 proportionate mortality rate</li>\n<li>Maternal mortality rate</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Incidence and Prevalence</li>\n<li>Notification rates</li>\n<li>Attendance rates at OPD</li>\n<li>Admission, discharge &amp; re-admission rates</li>\n<li>Duration of stay in hospital</li>\n<li>Spells of sickness or absence from work or school</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/be7a147091124fdc8afea68390904d96x1280x2327.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1012, 'Community Medicine', 'PM0212. WHO Format for International Death Certificate', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/fb295bd091194819a13f5d892b2e51a3x1280x1444.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1013, 'Community Medicine', 'PM0211. Rate, Ratio and Proportion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Rate</strong>:\n<ul>\n<li>It measures the occurrence of a particular event in a population in a given time.</li>\n<li>It consists of a <strong>numerator, denominator, time specification</strong> and <strong>multiplier</strong>.</li>\n<li>Numerator is often part of the denominator.</li>\n<li>Examples: Crude death rate, incidence rate.</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Ratio:</strong>\n<ul>\n<li>It expresses a relation in size between two random quantities.</li>\n<li>It consists of only <strong>numerator and denominator </strong>and no time specification.</li>\n<li>The numerator is <strong>not</strong> part of the denominator.</li>\n<li>Examples: sex ratio, doctor-population ratio.</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Proportion:</strong>\n<ul>\n<li>It is a ratio that indicates the relation in magnitude of a part of a whole.</li>\n<li>The numerator is <strong>always</strong> part of the denominator.</li>\n<li>Proportions are usually expressed as <strong>percentage</strong> and it is often measured at a <strong>point in time.</strong></li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e92a84967e2547a5bd4cc7edb66c6097x1258x1128.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1014, 'Community Medicine', 'PM2387. Cut-off points in diagnostic tests', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/77956c061f8a417f980dc92fa3b56592x1199x1136.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Highly <strong>sensitive</strong> test, when <strong>negative</strong>, <strong>rules out</strong> a disease. <strong>(Screening test)</strong></li>\n<li>Highly <strong>specific</strong> test, when <strong>positive</strong>, <strong>rules in</strong> a disease. <strong>(Confirmatory test)</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/fd3edf675b3f4e30a140e2ff769dc087x1200x1109.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/94e48ae863c74fbea0b8bfed13733accx1280x1199.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Sensitivity</strong> (True-positive rate): High sensitivity indicates low false-negative rate.</p>\n<p><strong>Specificity</strong>&nbsp;(True-negative rate): High specificity indicates low false-positive rate.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1015, 'Community Medicine', 'PM0362. Repeatability of a Screening Test', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Repeatability</strong> is an attribute of an ideal screening test. It is also called <strong>reliability, precision, or reproducibility.&nbsp;</strong>It implies that the test must give consistent results when repeated on the same individual or material, under the same conditions.</p>\n<p>It depends upon three factors:</p>\n<p><strong>A</strong>. <strong>Observer variation</strong></p>\n<ul>\n<li>All observations are subjected to variations.</li>\n<li><strong>Intra-observer </strong>variations or within-observer variations are when a single observer takes <strong>two measurements</strong> in the <strong>same subject,</strong> at the same time and obtained <strong>two different results</strong>.</li>\n<li><strong>Inter-observer </strong>variations or between-observer variations are when <strong>two different observers</strong> obtain <strong>different results</strong> on the <strong>same subject</strong> or material.</li>\n<li>They are minimized by <strong>standardization</strong> of procedures, intensive <strong>training</strong> of observers, and making use of <strong>more observers</strong>.</li>\n</ul>\n<p><strong>B. Biological variation</strong></p>\n<ul>\n<li>It is also called <strong>subject</strong> variation.</li>\n<li>They are due to <strong>changes&nbsp;in the parameters</strong> observed, variations in the <strong>perceptions of symptoms</strong> by patients, and <strong>regression to the mean </strong>where there is a tendency of values to be at either extreme of the distribution.</li>\n</ul>\n<p><strong>C</strong>. Errors relating to <strong>technical methods </strong>is&nbsp;due to the following:</p>\n<ul>\n<li>Defective instruments</li>\n<li>Erroneous calibration</li>\n<li>Faulty reagents</li>\n<li>Incorrect methods</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1016, 'Community Medicine', 'PM0361. Lead Time in Screening', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Lead time is the period between the <strong>first possible</strong> <strong>time</strong> of detection and the <strong>usual time</strong> of diagnosis.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b6e8bf826a364c7abb0006bc098eef63x1280x1020.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Lead time is the advantage gained by screening. It helps in the early diagnosis and treatment of disease. Early treatment reduces the severity by reversing the disease process.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1017, 'Community Medicine', 'PM0358. Validity of a Screening Test', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Validity/ accuracy </strong>of a screening test depends upon the <strong>sensitivity, specificity,</strong> and<strong> predictive accuracy</strong> of the test.</li>\n<li>It represents the closeness to a true value/ actual value.</li>\n<li>These are the <strong>inherent properties</strong> of a screening test.</li>\n<li>P<strong>P</strong>V and N<strong>P</strong>V are <strong>dependent</strong> on the <strong>P</strong>revalence of disease.</li>\n<li>Sensitivity &amp; Specificity are independent of prevalence of disease.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/62275b1d441443bc92db11bb3add523ex1280x959.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Formulae</strong>&nbsp;</td>\n</tr>\n<tr>\n<td><span>Sensitivity</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;<strong>TP</strong>&nbsp; &nbsp;&nbsp;</span></span><br><span><strong>TP</strong> + FN</span></td>\n</tr>\n<tr>\n<td><span>Specificity</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;<strong>TN&nbsp; &nbsp;&nbsp;</strong></span><sub><br></sub>FP + <strong>TN</strong></span></td>\n</tr>\n<tr>\n<td><span>Predictive value of a positive test (<strong>P</strong>PV)</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;T<strong>P&nbsp; &nbsp;&nbsp;</strong></span><sub><br></sub>T<strong>P</strong> + F<strong>P</strong></span></td>\n</tr>\n<tr>\n<td><span>Predictive value of a negative test (<strong>N</strong>PV)</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;T<strong>N&nbsp; &nbsp;&nbsp;</strong>&nbsp;</span><sub><br></sub>T<strong>N</strong> + F<strong>N</strong></span></td>\n</tr>\n<tr>\n<td><span>Percentage of false positives</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;FP&nbsp; &nbsp; &nbsp;</span><sub><br></sub>FP + TN</span></td>\n</tr>\n<tr>\n<td><span>Percentage of false negatives</span></td>\n<td><span><span>&nbsp; &nbsp; &nbsp;FN&nbsp; &nbsp; &nbsp;</span><sub><br></sub>TP + FN</span></td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li><strong>PPV</strong> varies <strong>directly</strong> with prevalence</li>\n<li><strong>NPV</strong> varies <strong>inversely</strong> with prevalence</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1018, 'Community Medicine', 'PM0356. Hills Criteria for Causal Association', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>It is also called <strong>Bradford Hill criteria.</strong></li>\n<li>It was established in 1965 by English epidemiologist, <strong>Sir Austin Bradford Hill.</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td width=\163\>\n<p><strong>Criteria</strong></p>\n</td>\n<td width=\357\>\n<p><strong>Brief Description</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\163\>\n<p><strong>Temporality</strong></p>\n</td>\n<td width=\357\>\n<p>Suspected cause precedes observed effect.</p>\n</td>\n</tr>\n<tr>\n<td width=\163\>\n<p><strong>Strength</strong></p>\n</td>\n<td width=\357\>\n<p>Larger the relative risk, the more likely it is causal.</p>\n</td>\n</tr>\n<tr>\n<td width=\163\>\n<p><strong>Consistency</strong></p>\n</td>\n<td width=\357\>\n<p>If the association is observed repeatedly under the same or various conditions, then more likely it is causation.</p>\n</td>\n</tr>\n<tr>\n<td width=\163\>\n<p><strong>Specificity</strong></p>\n</td>\n<td width=\357\>\n<p>When exposure is associated with a specific outcome only, then it is more likely to be causal.</p>\n</td>\n</tr>\n<tr>\n<td width=\163\>\n<p><strong>Plausibility</strong></p>\n</td>\n<td width=\357\>\n<p>A biologically plausible mechanism between cause and effect can be support for causation.</p>\n</td>\n</tr>\n<tr>\n<td width=\163\>\n<p><strong>Coherence</strong></p>\n</td>\n<td width=\357\>\n<p>A causal conclusion should not seriously conflict with the present substantive knowledge of the outcome.</p>\n</td>\n</tr>\n<tr>\n<td width=\163\>\n<p><strong>Analogy</strong></p>\n</td>\n<td width=\357\>\n<p>Other established cause-effect relationships may be used in analogies to support this causal relationship.</p>\n</td>\n</tr>\n<tr>\n<td width=\163\>\n<p><strong>Gradient</strong></p>\n</td>\n<td width=\357\>\n<p>It is called dose-response or response curve. It refers to the existence of an exposure-response relationship.</p>\n</td>\n</tr>\n<tr>\n<td width=\163\>\n<p><strong>Experiment</strong></p>\n</td>\n<td width=\357\>\n<p>To check if the condition can be or has been changed, weakened or prevented by experimental approach.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1019, 'Medicine,', 'PM2303. NACO ART Guidelines- 2021', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table class=\t1\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>ART regimen</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>First-line for:</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Tenofovir + Lamivudine + Dolutegravir</p>\n</td>\n<td class=\td1\ valign=\top\>\n<ul>\n<li>All PLHIV who are<strong> age &gt;10 years and body weight &gt;30 kg&nbsp;</strong>with <strong>HIV-1, HIV-2, HIV 1&amp;2 co-infection</strong>&nbsp;who have not received any ART&nbsp;</li>\n<li aria-level=\1\>Those with <strong>HIV-TB and HIV hepatitis co-infections</strong></li>\n<li aria-level=\1\><strong>Pregnant women</strong>, pregnant women presenting in <strong>active labour</strong> and <strong>breastfeeding women</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Abacavir + Lamivudine + Efavirenz</p>\n</td>\n<td class=\td1\ valign=\top\>\n<ul>\n<li aria-level=\1\>All PLHIV with <strong>abnormal serum creatinine</strong> values&nbsp;</li>\n<li aria-level=\1\>All PLHIV with <strong>bodyweight less &lt;30 kg</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Tenofovir + Lamivudine + Efavirenz /Lopinavir /Ritonavir</p>\n</td>\n<td class=\td1\ valign=\top\>\n<ul>\n<li>Women of childbearing age group who do not wish to take Dolutegravir</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li class=\p1\>All PLHIV who were on the previous recommended regime&nbsp;(Tenofovir+Lamivudine+Efavirenz) to be counselled to switch to new regime. Continue older regime if response is good</li>\n<li class=\p1\>Women in child-bearing age group to be counselled about Dolutegravir with opt-out option before switching to new regime</li>\n</ul>\n<p>*PLHIV: People living with HIV</p></div><!---->\n      <!---->\n    </div><!---->'),
(1020, 'Medicine,', 'PM2302. Opportunistic Infections/HIV related conditions and ART initiation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>Clinical scenario</td>\n<td>Action&nbsp;</td>\n</tr>\n<tr>\n<td>Any undiagnosed active infection with fever</td>\n<td>Diagnose and treat first; start Anti-Retroviral Therapy (ART) when stable</td>\n</tr>\n<tr>\n<td>Tuberculosis (TB)</td>\n<td>Start TB treatment first; start ART as soon as possible after 2 weeks and before 2 months. For those with CD4 less than 50/cmm, start ART within 2 weeks Caution is needed for PLHIV with TB meningitis, since immediate ART is associated with more severe adverse events than initiating ART 2 months after the start of TB treatment</td>\n</tr>\n<tr>\n<td>\n<p>Pneumocystis pneumonia (PCP)</p>\n</td>\n<td>Treat PCP first; start ART when PCP treatment is completed</td>\n</tr>\n<tr>\n<td>Invasive fungal diseases: Oesophageal candidiasis, penicilliosis, histoplasmosis</td>\n<td>Start treatment for oesophageal candidiasis first; start ART as soon as the patient can swallow comfortably. Treat penicilliosis, and histoplasmosis first; start ART when the patient is stabilized or opportunistic infection treatment is completed.</td>\n</tr>\n<tr>\n<td>Cryptococcal meningitis</td>\n<td>Treat cryptococcal meningitis. ART initiation should be deferred until there is evidence of sustained clinical response to anti-fungal therapy and after 4 weeks of induction and consolidation treatment with amphotericin B containing regimen.</td>\n</tr>\n<tr>\n<td>Bacterial pneumonia</td>\n<td>Treat pneumonia first; start ART when treatment is completed</td>\n</tr>\n<tr>\n<td>Malaria</td>\n<td>Treat malaria first; start ART when treatment is completed</td>\n</tr>\n<tr>\n<td>Acute diarrhoea which may reduce absorption of ART</td>\n<td>Diagnose the cause and treat diarrhoea first; start ART when diarrhoea is stabilized or controlled</td>\n</tr>\n<tr>\n<td>Non-severe anaemia (Hb&lt; 9 g/dl)</td>\n<td>Start ART if no other causes for anaemia are found (HIV is often the cause of anaemia)&nbsp;</td>\n</tr>\n<tr>\n<td>Skin conditions such as PPE and seborrhoeic dermatitis, psoriasis, HIV-related exfoliative dermatitis</td>\n<td>Start ART (ART may resolve these problems)&nbsp;</td>\n</tr>\n<tr>\n<td>Suspected Mycobacterium Avium Complex (MAC), Cryptosporidiosis and Microsporidiosis</td>\n<td>Start ART (ART may resolve these problems)</td>\n</tr>\n<tr>\n<td>Cytomegalovirus retinitis</td>\n<td>Start treatment for CMV urgently and start ART after 2 weeks of CMV treatment&nbsp;</td>\n</tr>\n<tr>\n<td>Toxoplasmosis</td>\n<td>Treat toxoplasmosis; start ART after 6 weeks of treatment and when the patient is stabilized</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1021, 'Community Medicine', 'PM2192. Measles vaccine', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Measles vaccine:&nbsp;</p>\n<ul>\n<li>\n<p>Type: Live attenuenated, lyophilized (freeze dried), vaccine (Tissue culture vaccine- chick embryo or Human diploid cell line).</p>\n</li>\n<li>\n<p>Strains used: 1. Edmonston Zagreb strain (most common).&nbsp;</p>\n</li>\n</ul>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2. Schwartz strain.</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 3. Moraten strain.</p>\n<ul>\n<li>\n<p>Dose: 0.5ml.</p>\n</li>\n<li>\n<p>Route: Subcutaneous.</p>\n</li>\n<li>\n<p>Site: Right arm (usually).</p>\n</li>\n<li>\n<p>Age of administration in National immunization schedule (India): 9 months (can be lowered to 6-9 months in epidemics and malnutrition) and 16-24 months.</p>\n</li>\n<li>\n<p>Diluent for reconstitution: Distilled water or sterile water. (To be used within 4 hours after reconstitutuion).</p>\n</li>\n<li>\n<p>Measles (and MMR) vaccine can lead to Toxic shock syndrome.</p>\n</li>\n<li>\n<p>Measles vaccine is contraindicated in pregnancy.</p>\n</li>\n<li>\n<p>Cold chain temperature for storage: +2 to +8 degree Celcius.</p>\n</li>\n<li>\n<p>Protective efficacy: &gt;90% with one dose; &gt;99% with two doses.</p>\n</li>\n<li>\n<p>Duration of protection: Life long.</p>\n</li>\n<li>\n<p>IP of vaccine induced measles: 7 days.</p>\n</li>\n<li>\n<p>Ideal gap between two successive doses: 6 months.</p>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1022, 'Community Medicine', 'PM2084. Malarial parameters', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Malarial parameters:</p>\n<table>\n<tbody>\n<tr>\n<td>Parameter</td>\n<td>Formula</td>\n</tr>\n<tr>\n<td>Annual Parasite Incidence</td>\n<td>\n<p>Confirmed cases in one year</p>\n<p>-----------------------------------×1000<br>Population under surveillance</p>\n</td>\n</tr>\n<tr>\n<td>Annual Blood Examination Rate</td>\n<td>\n<p>Number of slides examined</p>\n<p>-----------------------------------×100 <br>&nbsp; &nbsp; &nbsp; Population</p>\n</td>\n</tr>\n<tr>\n<td>Slide positivity Rate</td>\n<td>Percentage of slides found positive irrespective of species</td>\n</tr>\n<tr>\n<td>Slide Falciparum Rate</td>\n<td>Percentage of slides positive for <em>P. falciparum</em></td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1023, 'Community Medicine', 'PM2045. Periods of Isolation for Selected Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong class=\ng-binding\> Periods of Isolation for Selected Diseases</strong></p>\n<div class=\panel-body ng-scope\>\n<p class=\ng-binding ng-scope\>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td width=\211\>\n<p><strong>Disease</strong></p>\n</td>\n<td width=\379\>\n<p><strong>Duration of Isolation</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>Chickenpox</p>\n</td>\n<td width=\379\>\n<p>Until all lesions are crusted – usually about 6 days after onset of rash.</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>Measles</p>\n</td>\n<td width=\379\>\n<p>From the onset of symptoms (catarrhal stage) to 4 days after the appearance of the rash</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>Cholera</p>\n</td>\n<td width=\379\>\n<p>Until 3 days of tetracycline therapy.</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>Diphtheria&nbsp;</p>\n</td>\n<td width=\379\>\n<p>Until 48 hours of antibiotics.</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>Shigellosis and salmonellosis</p>\n</td>\n<td width=\379\>\n<p>Until 3 consecutive negative stool cultures.</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>Hepatitis A</p>\n</td>\n<td width=\379\>\n<p>3 weeks.</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>Influenza</p>\n</td>\n<td width=\379\>\n<p>3 days after onset.</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>Polio</p>\n</td>\n<td width=\379\>\n<p>2 weeks in adult; 6 weeks in children.</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>Tuberculosis (sputum +)</p>\n</td>\n<td width=\379\>\n<p>Until 3 weeks of effective chemotherapy.</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>Herpes zoster</p>\n</td>\n<td width=\379\>\n<p>6 days after onset of rash.</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>Mumps</p>\n</td>\n<td width=\379\>\n<p>Until the swelling subsides.</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>Pertussis</p>\n</td>\n<td width=\379\>\n<p>4 weeks or until paroxysms cease.&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>Meningococcal meningitis</p>\n</td>\n<td width=\379\>\n<p>Until the first 24 hours of effective antibiotic therapy.</p>\n</td>\n</tr>\n<tr>\n<td width=\211\>\n<p>Streptococcal pharyngitis</p>\n</td>\n<td width=\379\>\n<p>Until the first 6 hours of effective antibiotic therapy.</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n</div></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1024, 'Ophthalmology,', 'PM1899. WHO classification of trachoma (FISTO)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>WHO grading of trachoma</strong></p>\n<ul>\n<li>TF = trachomatous inflammation (<strong>follicular</strong>): <strong>five or more follicles</strong> (&gt;0.5 mm) on the superior tarsal conjunctiva.</li>\n<li>TI = trachomatous inflammation (<strong>intense</strong>): <strong>diffuse involvement</strong> of the tarsal conjunctiva,<strong> obscuring 50% or more</strong> of the normal deep tarsal vessels; <strong>papillae</strong> are present</li>\n<li>TS = trachomatous conjunctival <strong>scarring</strong>: easily visible fibrous <strong>white tarsal bands</strong></li>\n<li>TT = trachomatous<strong> trichiasis</strong>: at least <strong>one lash</strong> touching the globe</li>\n<li>CO = <strong>corneal opacity</strong> sufficient to blur details of at least part of the pupillary margin</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1025, 'Community Medicine', 'PM1779. Ending Cholera—A Global Roadmap to 2030', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>In October 2017, the <strong>WHO</strong> - <strong>Global Task Force on Cholera Control (GTFCC)</strong> has released, <strong>Ending Cholera—A Global Roadmap to 2030.</strong></p>\n<p>By implementing the strategy between 2017 and 2030, the GTFCC partners will support countries to <strong>reduce cholera deaths by 90 percent</strong>.</p>\n<p>The key points of the strategy include:</p>\n<ol>\n<li><strong>Early detection and quick response</strong> to contain outbreaks</li>\n<li>A targeted <strong>multi-sectoral approach</strong> to prevent cholera recurrence which includes:\n<ul>\n<li><strong>Water, Sanitation &amp; Hygiene: </strong>Implementation of adapted long-term sustainable WASH solutions for populations most at risk of cholera.</li>\n<li><strong>Leadership and Coordination:</strong> &nbsp;Inter-sectoral collaboration and building of a strong preparedness and response strategy.</li>\n<li><strong>Health Care System Strengthening: </strong>Enhanced readiness for cholera outbreaks through capacity building for staff, and prepositioning of resources for diagnostics, patient care, and emergency WASH intervention.</li>\n<li><strong>Surveillance &amp; Reporting: </strong>Implementation of effective routine surveillance and laboratory capacity at the peripheral level to confirm suspected cases, inform the response, and track progress towards control and elimination.</li>\n<li><strong>Use of Oral Cholera Vaccine (OCV): </strong>Large-scale use of OCV is recommended to immediately reduce disease burden while longer-term cholera control strategies are put in place.</li>\n<li><strong>Community Engagement: </strong>By enhancing the communication on cholera control strategies, hygiene promotion, and cholera risk, by mobilizing community leaders as agents of change.</li>\n</ul>\n</li>\n<li>An effective mechanism of <strong>coordination for technical support</strong>, advocacy, <strong>resource mobilization</strong>, and <strong>partnership</strong> at local and global levels.</li>\n</ol></div><!---->\n      <!---->\n    </div><!---->'),
(1026, 'Community Medicine', 'PM1775. Recommendations - WHO Guidelines for preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>WHO </strong>has recently in September 2017 has proposed guidelines for preventive chemotherapy (<strong>deworming</strong>) to control soil-transmitted helminth infections in at-risk population groups.</p>\n<p>The main soil-transmitted helminths includes the roundworm (<strong>Ascaris</strong> <strong>lumbricoides</strong>), the whipworm (<strong>Trichuris</strong> <strong>trichiura</strong>) and the hookworms (<strong>Ancylostoma</strong> <strong>duodenale</strong> and <strong>Necator</strong> <strong>americanus</strong>).</p>\n<p>The following table shows various <strong>recommendations:</strong></p>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Risk group</strong></td>\n<td><strong>Prevalence</strong></td>\n<td><strong>Frequency</strong></td>\n<td><strong>Drugs and Dosage</strong></td>\n</tr>\n<tr>\n<td rowspan=\2\>Young children, preschool and school-age children</td>\n<td>Any soil-transmitted infection ≥ 20%</td>\n<td>Annual</td>\n<td rowspan=\2\>\n<p>Single-dose albendazole (400&nbsp;mg)</p>\n<p>Or</p>\n<p>mebendazole (500&nbsp;mg).&nbsp;</p>\n<p><strong>Note</strong>: A half-dose of albendazole (i.e. 200 mg) is recommended for children 12–23 months of age.</p>\n</td>\n</tr>\n<tr>\n<td>Any soil-transmitted infection &gt; 50%l</td>\n<td>Biannual</td>\n</tr>\n<tr>\n<td rowspan=\2\>Non-pregnant adolescent girls and non-pregnant women of reproductive age</td>\n<td>Any soil-transmitted infection ≥ 20%</td>\n<td>Annual</td>\n<td rowspan=\2\>\n<p>Single-dose albendazole (400&nbsp;mg)</p>\n<p>Or</p>\n<p>mebendazole (500&nbsp;mg).&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Any soil-transmitted infection &gt; 50%</td>\n<td>Biannual</td>\n</tr>\n<tr>\n<td>Pregnant women</td>\n<td>\n<p>Hookworm and/or T. trichiura infection ≥20%&nbsp;</p>\n<p><strong>And</strong></p>\n<p>Anemia ≥ 40%&nbsp;</p>\n</td>\n<td>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</td>\n<td>\n<p>Single-dose albendazole (400 mg)</p>\n<p>or</p>\n<p>mebendazole(500 mg)</p>\n<p>in second or third trimester</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1027, 'Community Medicine', 'PM1726. Flea Indices', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>They are useful in measurements of density of fleas.</p>\n<p>They include:&nbsp;</p>\n<ul>\n<li><strong>Total flea index</strong> – it is the average number of fleas of all species per rat</li>\n<li><strong>Cheopis index</strong> - it is the average number of <em>Xenopsylla cheopis</em> species per rat,hence it is a <strong>specific flea index</strong>. It indicates the <strong>maximum explosiveness</strong> of the situation</li>\n</ul>\n<ul>\n<li><strong>Specific percentage of fleas</strong> – it is a precentage of different species of fleas that are found on rats.</li>\n<li><strong>Burrow index</strong> – It is the average&nbsp; number of free living flea per species per rodent burrow.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1028, 'Community Medicine', 'PM1725. Rabies vaccines and immunoglobulins schedules', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>According to the Ministry of Health and Family Welfare, Government of India:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f49dfa01d9bd424db725e4ebf600cb98x1280x3397.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>WHO category <strong>II</strong> or <strong>III</strong> exposures should receive&nbsp;<strong>post-exposure prophylaxis&nbsp;</strong>(PEP)<strong>&nbsp;immediately.</strong></p>\n<p>One <strong>intradermal&nbsp;</strong>(ID)&nbsp;dose is <strong>0.1 mL</strong> of vaccine and one <strong>intramuscular</strong> (IM) dose is an <strong>entire vial</strong> of vaccine, irrespective of the vial size.</p>\n<p>Should a vaccine dose be delayed for any reason, the PEP schedule should be resumed (not restarted).</p>\n<p><strong>Rabies Immunoglobulin(RIG):&nbsp;</strong></p>\n<ul>\n<li>Passive immunization</li>\n<li><strong>Single-dose</strong>; after initiation of PEP and not beyond 7 days after the first dose of vaccine</li>\n<li>Max dose: <strong>hRIG - 20IU/kg ,&nbsp;</strong><strong>eRIG</strong><strong>&nbsp;- 40IU/kg </strong>body weight</li>\n<li>Vaccines should never be withheld regardless of the availability of RIG.</li>\n<li><strong>Alternatives</strong> for RIG- WHO recommends&nbsp;<strong>m</strong><strong>onoclonal antibodies&nbsp;</strong>(mAb)&nbsp;as a cocktail containing at least <strong>two antibodies</strong> against the rabies virus.</li>\n</ul>\n<p>Administration of RIG:</p>\n<ul>\n<li>RIG should be administered&nbsp;<strong>into</strong> or <strong>around</strong> the <strong>wound site</strong> or sites.</li>\n<li>The&nbsp;<strong>remaining</strong> RIG, if any, should be injected <strong>IM</strong> at a site <strong>distant</strong> from the <strong>site</strong> of vaccine administration.</li>\n<li>RIG may be diluted to a volume sufficient for all wounds to be effectively and safely infiltrated.</li>\n</ul>\n<p>Prioritization&nbsp;of RIG allocation (numbered according to priority order):</p>\n<ol>\n<li>Multiple bites</li>\n<li>Deep wounds</li>\n<li>Bites to head, neck, and hands</li>\n<li>Patients with severe immunodeficiency</li>\n<li>Confirmed/probable rabies in biting animal</li>\n<li>Bites, scratches, and exposure of mucous membranes caused by a bat</li>\n</ol>\n<p><strong>Pre-exposure prophylaxis&nbsp;(PrEP)</strong></p>\n<p>PrEP is considered in the following conditions:</p>\n<ul>\n<li>High-risk groups- laboratory staff, wildlife wardens, veterinarians, animal handlers, and travelers to endemic regions.</li>\n<li>Remote, rabies-endemic areas where access to PEP is difficult</li>\n<li>Areas where&nbsp;dog bite incidence is &gt;5% per year</li>\n<li>Areas where vampire bat rabies is known to be present.</li>\n</ul>\n<p>Pre-exposure rabies vaccination consists of <strong>3&nbsp;intramuscular (IM) or 3 intradermal (ID)</strong>&nbsp;doses. These are given on <strong>days 0, 7 and 21 or 28.</strong></p>\n<ul>\n<li>Adults - the vaccine should always be administered in the deltoid area of the arm</li>\n<li>Young children (under 1 year of age)- Administration into the anterolateral area of the thigh is recommended.</li>\n<li><strong>Rabies vaccine </strong>should<strong> never</strong> be administered in the<strong> gluteal area.</strong>&nbsp;Administration in this manner will result in <strong>lower neutralizing antibody titers.</strong></li>\n</ul>\n<p>For exposed or re-exposed patients who can document previous completion of PEP or PrEP the following guidelines would be applicable:</p>\n<ul>\n<li>Proper wound management should be done.</li>\n<li>There is no need for the administration of RIG.</li>\n<li>One site ID or IM vaccine administration on days 0 and 3.</li>\n</ul>\n<p>Only adequate wound washing would be required in case of re-exposure where the animal bite victim has documented proof of complete PEP&nbsp;<strong>within the last three months.</strong></p>\n<p>The following cases are treated as fresh cases and given full PEP:</p>\n<ul>\n<li>Those who have previously received full post-exposure treatment with neural tissue vaccines (NTV) or vaccines of unproven potency</li>\n<li>Those who cannot document complete PEP or PrEP treatment&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1029, 'Community Medicine', 'PM1724. Classification of Zoonoses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Classification <strong>based on their reservoir hosts</strong> into:</p>\n<ul>\n<li>Anthropozoonoses</li>\n<li>Zoo-anthroponoses</li>\n<li>Amphixenoses</li>\n</ul>\n<p><strong>Classification based on life cycle if infecting agent is:</strong></p>\n<table width=\726\>\n<tbody>\n<tr>\n<td width=\168\>\n<p><strong>Category</strong></p>\n</td>\n<td width=\348\>\n<p><strong>Mode</strong></p>\n</td>\n<td width=\210\>\n<p><strong>Example</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\168\>\n<p><strong>Direct zoonoses</strong></p>\n</td>\n<td width=\348\>\n<p><strong>Direct contact/fomite/mechanical vector</strong></p>\n<p>No essential developmental/ propagative changes during transmission.</p>\n</td>\n<td width=\210\>\n<p>Rabies , Trichinosis, Brucellosis</p>\n</td>\n</tr>\n<tr>\n<td width=\168\>\n<p><strong>Cyclo-zoonoses</strong></p>\n</td>\n<td width=\348\>\n<p>More than one <strong>vertebrate</strong> host is needed to complete the developmental cycle. Invertebrate hosts will not suffice.</p>\n</td>\n<td width=\210\>\n<p>&nbsp;Human taeniasis, Echinococcosis, Pentastomid infections</p>\n</td>\n</tr>\n<tr>\n<td width=\168\>\n<p><strong>Meta-zoonoses</strong></p>\n</td>\n<td width=\348\>\n<p><strong>Transmitted by invertebrate vectors. </strong>Inside the invertebrate, the infective agent <strong>develops / multiplies. </strong>After an extrinsic period of incubation, the infective agent is transmitted to another vertebrate host.</p>\n</td>\n<td width=\210\>\n<p><strong>Arboviral infections, Plague and Schistosomiasis</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\168\>\n<p><strong>Sapro-zoonoses</strong></p>\n</td>\n<td width=\348\>\n<p>Has <strong>both</strong> a vertebrate host and a non-animal (food, soil/ plants)developmental site/reservoir.</p>\n</td>\n<td width=\210\>\n<p>Various forms of larva migrants and mycoses</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1030, 'Community Medicine', 'PM1719. Classification of TB Patients Based on History of Treatment', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>New case</strong> is defined as a TB patient who had</p>\n<ul>\n<li><strong>Never taken</strong> ATT previously or</li>\n<li>Taken ATT for <strong>&lt; 1 month</strong></li>\n</ul>\n<p><strong>Previously treated Case :&nbsp;</strong>Patients who have <strong>received 1 month or more</strong> of Anti TB drugs in the past. These include:</p>\n<ol>\n<li><strong>Recurrent TB:&nbsp;</strong>A TB patient who <strong>had completed course of treatment</strong> <strong>/ declared cured</strong> and now presenting as microbiologically confirmed case</li>\n<li><strong>Treatment after failure:&nbsp;</strong>Patients who had been treated for TB and <strong>their treatment failed</strong> at the end of most recent course of treatment</li>\n<li><strong>Treatment after loss to follow up:&nbsp;</strong>A TB patient who had <strong>been treated &gt; 1 month on ATT</strong> and registered as l<strong>ost to follow up</strong> and now presenting as microbiologically confirmed case of TB</li>\n<li><strong>Other previously treated patients:&nbsp;</strong>Patients who had been previously treated but whose <strong>outcome is now unknown/undocumented</strong></li>\n</ol>\n<p><strong>Transferred in:&nbsp;</strong>A TB patient who has been received in a TB unit after having registered in another TB unit for treatment.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1031, 'Community Medicine,', 'PM1718. Diagnostic algorithm for Pulmonary TB – National Tuberculosis Elimination Programme (NTEP) 2020 Guidelines', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Any case of&nbsp;<strong>presumptive pulmonary TB</strong>&nbsp;should undergo <strong>sputum examination + chest X-ray + CB-NAAT</strong></p>\n<ul>\n<li>If sputum and chest X-ray normal:<strong> rule out TB and refer</strong></li>\n<li>If sputum is positive and CB NAAT is positive:<strong>&nbsp;microbiologically confirmed case of TB</strong></li>\n</ul>\n<p>The following protocol is used for <strong>CB-NAAT testing:</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e8d17e5087654b588b4b519b350acb71x1280x2558.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1032, 'Community Medicine', 'PM1713. Ridleys logarithmic scale in determining Bacterial Index', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Bacterial Index(BI) indicates the density of the leprosy bacilli in smears and includes both living and dead bacilli.</p>\n<p>According to Ridleys logarithmic scale, the range is from 0 to 6+ and is based on the number of bacilli seen in an average microscopic field of the smear using an oil-immersion objective.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>0</p>\n</td>\n<td>\n<p>No bacilli in any of the 100 oil-immersion field</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1+</p>\n</td>\n<td>\n<p>1-10 bacilli, on average, in 100 oil-immersion field</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2+</p>\n</td>\n<td>\n<p>1-10 bacilli, on average, in 10 oil-immersion field</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3+</p>\n</td>\n<td>\n<p>1-10 bacilli, on average, in each oil-immersion field</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>4+</p>\n</td>\n<td>\n<p>10-100 bacilli, on average, in each oil-immersion field</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5+</p>\n</td>\n<td>\n<p>100-1000 bacilli, on average, in each oil-immersion field&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>6+</p>\n</td>\n<td>\n<p>More than 1000 bacilli, on average, in each oil-immersion field&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>BI is calculated by adding up the index from each site examined and dividing the total by the number of sites examined.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1033, 'Dermatology,', 'PM1710. Important sexually transmitted pathogens and the diseases caused by them', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Pathogen </strong></p>\n</td>\n<td>\n<p><strong>Disease or syndrome </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neisseria gonorrhoeae</p>\n</td>\n<td>\n<p>Gonorrhea, urethritis, cervicitis, epididymitis, salpingitis, PID, neonatal conjunctivitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Treponema pallidum</p>\n</td>\n<td>\n<p>Syphillis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Haemophilus ducreyi</p>\n</td>\n<td>\n<p>Chancroid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chlamydia trachomatis</p>\n</td>\n<td>\n<p>LGV, urethritis, cervicitis, proctitis, epididymis, infant pneumonia, Reiters syndrome, PID, neonatal conjunctivitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Klebsiella granulomatis (prev called Calymmatobacterium)</p>\n</td>\n<td>\n<p>Donovanosis (granuloma inguinale)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Herpes simplex virus</p>\n</td>\n<td>\n<p>Genital herpes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis B virus</p>\n</td>\n<td>\n<p>Acute and chronic hepatitis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human papillomaviruses&nbsp;</p>\n</td>\n<td>\n<p>Genital and anal warts</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HIV</p>\n</td>\n<td>\n<p>AIDS</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Molluscum contagiosum</p>\n</td>\n<td>\n<p>Genital molluscum contagiosum</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Candida albicans</p>\n</td>\n<td>\n<p>Vaginitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trichomonas vaginalis</p>\n</td>\n<td>\n<p>Vaginitis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1034, 'Community Medicine', 'PM0495. Biological Transmission in Vector-Borne Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>1. Propagative</strong></p>\n<ul>\n<li>The disease agent only multiplies in the vector and there is no change in form.</li>\n<li>E.g., Plague bacilli in rat fleas.</li>\n</ul>\n<p><strong>2. Cyclo-propagative</strong></p>\n<ul>\n<li>The agent changes in form and in number.</li>\n<li>E.g., Malarial parasites in mosquitoes.</li>\n</ul>\n<p><strong>3. Cyclo-developmental</strong></p>\n<ul>\n<li>The agent undergoes only developmental changes and not multiplication.</li>\n<li>E.g., Microfilaria in mosquitoes.</li>\n</ul>\n<p><strong>4. Transovarial</strong></p>\n<ul>\n<li>Infectious agent is transmitted vertically in the vector, from parent to progeny.</li>\n<li>E.g., Rickettsia rickettsii in ticks.</li>\n</ul>\n<p><strong>5. Transstadial</strong></p>\n<ul>\n<li>The infectious agent stays with the vector from one stage of its life cycle to the next.</li>\n<li>E.g., Borrelia burgdorferi in ticks.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1035, 'Community Medicine', 'PM0491. Modes of Transmission of Communicable Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\222\>\n<p><strong>Direct</strong></p>\n</td>\n<td width=\282\>\n<p><strong>Indirect</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\222\>\n<p>Direct contact</p>\n<p>Droplet infection</p>\n<p>Contact with soil</p>\n<p>Inoculation into skin or mucosa</p>\n<p>Vertical (transplacental)</p>\n</td>\n<td width=\282\>\n<p>Vehicle-borne</p>\n<p>Vector borne – mechanical or biological</p>\n<p>Air borne – droplet nuclei or dust</p>\n<p>Fomite borne</p>\n<p>Unclean hands and finger</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1036, 'Medicine,', 'PM0039. Period of communicability of important diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table width=\498\>\n<tbody>\n<tr>\n<td>Disease</td>\n<td>Period of communicability</td>\n</tr>\n<tr>\n<td>Chicken pox</td>\n<td>&nbsp;1-2 days before to 4-5 days after appearance of rash</td>\n</tr>\n<tr>\n<td>Hepatitis B</td>\n<td>One month before the appearance of Jaundice till the disappearance of HbsAg</td>\n</tr>\n<tr>\n<td>Measles</td>\n<td>4 days before to 4 days after appearance of rash</td>\n</tr>\n<tr>\n<td>Rubella</td>\n<td>7 days before to 7 days after the rash</td>\n</tr>\n<tr>\n<td>Mumps</td>\n<td>4-6 days before to 7 days after symptoms onset</td>\n</tr>\n<tr>\n<td>Pertussis</td>\n<td>7 days before to 3 weeks after the onset of paroxysms</td>\n</tr>\n<tr>\n<td>Diphtheria</td>\n<td>Up to 4 weeks after disease onset</td>\n</tr>\n<tr>\n<td>Meningococcal meningitis</td>\n<td>Till meningococci are absent from nasal/throat swabs</td>\n</tr>\n<tr>\n<td>Influenza</td>\n<td>1 to 2 days before and 1 to 2 days after onset of symptoms</td>\n</tr>\n<tr>\n<td>Tetanus</td>\n<td>Not communicable</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1037, 'Community Medicine', 'PM2160. Indicators for Body fat', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>The indicators for body fat are:</strong></p>\n<p><strong>Body weight</strong>: +3SD (standard deviations) from the median weight for height as a cut-off point for obesity. For adults, some people calculate various other indicators such as:</p>\n<ul>\n<li><strong>Body mass index (Quetelets index)</strong>: Weight (kg) / Square of height in metres</li>\n<li><strong>Ponderal index</strong>: Height(cm) / cube root of body weight (kg)</li>\n<li>Corpulence index: Actual weight /desirable weight.(Should not exceed 1.2)</li>\n</ul>\n<p><strong>Brocas index</strong>&nbsp;= Height (cm) - 100 .&nbsp;</p>\n<p><strong>Lorentzs formula</strong>&nbsp;<br>Ht (cm) - 100 - [ (Ht (cm) - 150) / 2 for women or 4 for men ]</p>\n<p><strong>Skinfold thickness:</strong>&nbsp;Four sites mid-triceps, biceps, subscapular and suprailiac regions. The sum of the measurements should be less than 40 mm in boys and 50 mm in girls.</p>\n<p><strong>Waist circumference and waist-hip ratio</strong>: At the mid point between the lower border of the rib cage and the iliac crest. There is an increased risk of metabolic complications for men with a waist circumference~ 102 cm, and women with a waist circumference~ 88 cm. A high WHR (&gt; 1.0 in men and&gt; 0.85 in women) indicates abdominal fat accumulation.</p>\n<p><strong>Total body water</strong></p>\n<p><strong>Total body potassium</strong></p>\n<p><strong>Body density&nbsp;</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1038, 'Medicine,', 'PM2065. Body mass index', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Recent update for Asian population:</p>\n<table>\n<tbody>\n<tr>\n<td>Classification</td>\n<td>Global population (kg/m<sup>2</sup>)&nbsp;&nbsp;</td>\n<td>\n<p>Indian population</p>\n<p>(kg/m<sup>2</sup>)</p>\n</td>\n</tr>\n<tr>\n<td>Underweight</td>\n<td>&lt;18.5</td>\n<td>\n<p>&lt;18.5</p>\n</td>\n</tr>\n<tr>\n<td>Normal&nbsp;</td>\n<td>18.5-24.99</td>\n<td>18.5-22.99</td>\n</tr>\n<tr>\n<td>Overweight</td>\n<td>25-29.99</td>\n<td>23-24.99 (and At risk)</td>\n</tr>\n<tr>\n<td>Obesity</td>\n<td><span>&gt;</span>30</td>\n<td><span>&gt;</span>25</td>\n</tr>\n<tr>\n<td>Class I obesity</td>\n<td>30.0-34.9</td>\n<td>&nbsp;25- 29.9</td>\n</tr>\n<tr>\n<td>Class II Obesity</td>\n<td>35.0 to 39.9</td>\n<td>&nbsp;<span>&gt;</span>30</td>\n</tr>\n<tr>\n<td>Class III Obesity (severe, extreme, massive)</td>\n<td>≥40</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>Note:</p>\n<p>Lethal BMI:</p>\n<p class=\p1\>BMI Value of 13 is considered as “Lethal” in men.</p>\n<p class=\p1\>Females withstand and survive even at lower BMI rate upto 11.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1039, 'Community Medicine,', 'PM2024. Syndromic Management of Sexually Transmitted Infections', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9e7908befff94f9a85b4a7b751999821x1280x1742.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Partner Management when <strong>asymptomatic</strong> is not required for <strong>Gardenella vaginalis, Candida and Herpes infections</strong>.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/60da7b1257d04ca5938ef3340533e6b9x1280x2974.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1040, 'Community Medicine', 'PM1778. HIV and AIDS (Prevention and Control) Act, 2017', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The Govt. of India on 21<sup>st</sup> April 2017, enacted the human immunodeficiency virus and acquired immune deficiency syndrome (prevention and control) act, 2017</p>\n<p><strong>Key highlights of the HIV and AIDS (Prevention and Control) Act, 2017</strong></p>\n<ul>\n<li><strong>Prohibition of discrimination against HIV positive persons: </strong>The Bill sets various grounds on which discrimination against HIV positive persons is prohibited.&nbsp; These include the denial, termination, discontinuation or unfair treatment with regard to employment, educational establishments, health care services, residing or renting property, among others.</li>\n<li><strong>Informed consent and disclosure of HIV status: </strong>The Bill requires that no HIV test, medical treatment, or research will be conducted on a person without his informed consent.</li>\n<li><strong>Role of the Union and State Governments: </strong>The Union and State Governments shall take measures to prevent the spread of HIV or AIDS, provide anti-retroviral therapy and infection management for persons with HIV or AIDS, and facilitate their access to welfare schemes especially for women and children, and others.</li>\n<li><strong>Role of the Ombudsman: </strong>An ombudsman shall be appointed by each state government to inquire into complaints related to the violation of the Act and the provision of health care services.</li>\n<li><strong>Guardianship: </strong>A person between the age of 12 to 18 years who has sufficient maturity in understanding and managing the affairs of his HIV or AIDS affected family shall be competent to act as a guardian of another sibling below 18 years of age.</li>\n<li><strong>Shared residence: </strong>Every protected HIV positive person has the right to reside in a shared household, and enjoy the facilities of the household.</li>\n<li><strong>Court proceedings: </strong>Cases relating to HIV positive persons shall be disposed of by the court on a priority basis.&nbsp; In any legal proceeding, if an HIV infected or affected person is a party, the court may pass orders that the proceedings be conducted (a) by suppressing the identity of the person, (b) in camera, and (c) to restrain any person from publishing information that discloses the identity of the applicant.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1041, 'Community Medicine', 'PM1682. Malaria in the National Vector Borne Disease Control Programme (NVBDCP)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>National Framework for Malaria Elimination in India (2016-2030)</strong></p>\n<ul>\n<li><strong>Goals:</strong> To eliminate malaria and maintain malaria-free status.</li>\n<li><strong>Objectives:</strong>\n<ul>\n<li>By 2022, transmission of malaria interrupted and zero indigenous cases.</li>\n<li>By 2024, incidence of malaria to be reduced to &lt;1 case per 1000 population.</li>\n<li>By 2030, malaria to be eliminated throughout the country.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Classification of states/UTs according to the Annual Parasite Index (API):</strong></p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Category</strong>&nbsp;</td>\n<td><strong>Criteria&nbsp;</strong></td>\n<td><strong>Major measures:</strong></td>\n</tr>\n<tr>\n<td>Category 0&nbsp;</td>\n<td>States/UTs with zero indigenous cases&nbsp;</td>\n<td>Detect re-introduced cases and notify and maintain malaria-free status.&nbsp;</td>\n</tr>\n<tr>\n<td>Category 1&nbsp;</td>\n<td><strong>Elimination phase –</strong> States/UTs with API &lt;1 and all their districts reporting API &lt;1&nbsp;</td>\n<td>Interruption of local transmission.</td>\n</tr>\n<tr>\n<td>Category 2&nbsp;</td>\n<td><strong>Pre-elimination phase –</strong> States/UTs with API &lt;1 but some districts reporting API&nbsp;≥1.&nbsp;</td>\n<td>\n<p>Screening.&nbsp;</p>\n<p>Setting up one-stop mobile centres/clinics.&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Category 3&nbsp;</td>\n<td><strong>Intensified control phase –</strong> States/UTs with API&nbsp;≥1.&nbsp;</td>\n<td>&nbsp;Same as category 2</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<ul>\n<li>The <strong>National Strategic Plan (NSP) for Malaria Elimination&nbsp;</strong>(2017-22) was launched by the Ministry of Health and Family Welfare under NVBDCP, which is based on the <strong>National Framework for Malaria Elimination </strong>(2016 – 2030).</li>\n<li>The <strong>NSP</strong> focuses mainly on the <strong>districts</strong> which function as the <strong>operational units.</strong></li>\n</ul>\n<p>Accordingly, all the districts are classified into the following <strong>four</strong> categories:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Category of districts</strong></td>\n<td><strong>Definition</strong></td>\n</tr>\n<tr>\n<td><strong>Category 0</strong>: Prevention of re-establishment phase</td>\n<td>&nbsp;Includes all districts in which no incidence of malaria was reported in the last 3 years.</td>\n</tr>\n<tr>\n<td><strong>Category 1:</strong> Elimination phase</td>\n<td>&nbsp;Districts with API &lt;1 per 1000 population.</td>\n</tr>\n<tr>\n<td><strong>Category 2: </strong>Pre elimination phase</td>\n<td>&nbsp;Districts with API in between 1-2 per 1000 population.</td>\n</tr>\n<tr>\n<td><strong>Category 3:</strong> Intensified control phase</td>\n<td>&nbsp;Districts with API &gt;2 per 1000 population.</td>\n</tr>\n</tbody>\n</table>\n<p>The above classification is more operational than the classification mentioned in the <strong>NFME</strong> which is <strong>state</strong> focussed.</p>\n<p>The goal of&nbsp;<strong>NSP strategy </strong>is the phased elimination of malaria in India. The National Framework for Malaria Elimination (<strong>NFME</strong>) in India has set <strong>2030</strong> as the goal for eliminating malaria, and the goals of NSP in consonance with overall goals.</p>\n<p><strong>The goals of NSP 2017 – 2022 are:</strong></p>\n<ul>\n<li>Eliminate malaria in <strong>category 1</strong> (API &lt; 1) districts by <strong>2020</strong>, and <strong>category 2</strong> (API 1-2) districts by <strong>2022</strong>.</li>\n<li>Reduce transmission in <strong>category 3</strong> districts to stabilize API at&nbsp;<strong>&lt;1 </strong>by <strong>2022</strong>.</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1042, 'Community Medicine,', 'PM0341. WHO proposed Multi Drug Therapy (MDT) for the treatment of Leprosy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>WHO proposed Multi-Drug Therapy (MDT) for the treatment of Leprosy</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Age group</strong></p>\n</td>\n<td>\n<p><strong>Drug</strong></p>\n</td>\n<td>\n<p><strong>Duration of Treatment</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Adult</p>\n</td>\n<td>\n<p><strong>Rifampicin 600 mg</strong> once a month</p>\n<p>+</p>\n<p><strong>Clofazimine 300 mg</strong> once a month and <strong>50 mg daily</strong></p>\n<p>+</p>\n<p><strong>Dapsone 100 mg</strong> daily</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>12 months (MB)</p>\n<p>6 months (PB)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Children (10–14 years)</p>\n</td>\n<td>\n<p>Rifampicin <strong>450 mg</strong> once a month</p>\n<p>+</p>\n<p>Clofazimine <strong>150 mg</strong> once a month and 50 mg <strong>alternate days</strong>.</p>\n<p>+</p>\n<p>Dapsone <strong>50 mg</strong> daily&nbsp;</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>\n</td>\n<td>&nbsp;\n<p>12 months (MB)</p>\n<p>6 months (PB)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Children &lt;10 years old or &lt;40 kg</p>\n</td>\n<td>\n<p>Rifampicin <strong>10 mg/kg</strong> once a month</p>\n<p>+</p>\n<p>Clofazimine <strong>100mg</strong> once a month, 50mg <strong>twice weekly</strong></p>\n<p>+</p>\n<p>Dapsone <strong>2 mg/kg</strong> daily</p>\n</td>\n<td>\n<p>12 months (MB)</p>\n<p>6 months (PB)</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1043, 'Community Medicine', 'PM0166. Health Planning Committees of India', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\85\>\n<p><strong>Year</strong></p>\n</td>\n<td width=\168\>\n<p><strong>Name</strong></p>\n</td>\n<td width=\337\>\n<p><strong>Concepts and Programmes</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p>1946</p>\n</td>\n<td width=\168\>\n<p>Bhore committee</p>\n</td>\n<td width=\337\>\n<ul>\n<li>Also called Health Survey and <strong>Development</strong> Committee</li>\n<li>1 PHC for 40,000 population</li>\n<li><strong>3 million plan</strong></li>\n<li>3 months training in PSM for physicians</li>\n<li>Preventive and curative services at all administrative levels&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p>1962</p>\n</td>\n<td width=\168\>\n<p>Mudaliar committee</p>\n</td>\n<td width=\337\>\n<ul>\n<li>Also known as Health Survey and <strong>Planning</strong> Committee</li>\n<li>District hospitals to have specialists</li>\n<li>1 PHC for not more than 40,000 people</li>\n<li>Constitution of <strong>All India Health Service</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p>1963</p>\n</td>\n<td width=\168\>\n<p>Chadah committee</p>\n</td>\n<td width=\337\>\n<ul>\n<li>Outlined responsibility of PHCs in the National Malaria Eradication Programme</li>\n<li>One <strong>basic health worker</strong> for 10,000 population&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p>1965</p>\n</td>\n<td width=\168\>\n<p>Mukerji committee</p>\n</td>\n<td width=\337\>\n<ul>\n<li>Delinked malaria activities from family planning activities.</li>\n<li><strong>Family planning assistants</strong> were for family planning work and basic health workers for other activities.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p>1966</p>\n</td>\n<td width=\168\>\n<p>Mukerji committee</p>\n</td>\n<td width=\337\>\n<ul>\n<li>Also called committee of Health Secretaries.</li>\n<li>Detailed the <strong>Basic Health Service</strong> to be given at block level&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p>1967</p>\n</td>\n<td width=\168\>\n<p>Jungalwalla committee</p>\n</td>\n<td width=\337\>\n<ul>\n<li>Also called <strong>Committee on Integration of Health Services</strong></li>\n<li>Ban of private practice by government doctors</li>\n<li>Equal pay for equal work and special pay for specialized work</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p>1973</p>\n</td>\n<td width=\168\>\n<p>Kartar Singh committee</p>\n</td>\n<td width=\337\>\n<ul>\n<li>Also called <strong>Committee on Multipurpose Workers under Health and Family Planning</strong></li>\n<li>Recommended <strong>male and female health workers</strong></li>\n<li>1 PHC for 50,000 population</li>\n<li>Each PHC to have 16 sub-centres</li>\n<li>Each sub-centre to have one male and one female health worker</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p>1975</p>\n</td>\n<td width=\168\>\n<p>Shrivastav committee</p>\n</td>\n<td width=\337\>\n<ul>\n<li>Also called <strong>Group on Medical Education and Support Manpower</strong></li>\n<li>Referral Services Complex</li>\n<li>Rural Health Infrastructure of&nbsp;Sub centre, PHC and CHC</li>\n<li><strong>ROME</strong> scheme – Reorientation of health education</li>\n<li><strong>Establishment of Medical and Health Education Commission</strong></li>\n<li><strong>Village Health Guide scheme</strong></li>\n<li>Bands of semi–professional and Para-professional Health workers&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p>1983</p>\n</td>\n<td width=\168\>\n<p>Krishnan committee</p>\n<p>&nbsp;</p>\n</td>\n<td width=\337\>\n<ul>\n<li><strong>Urban Revamping Scheme</strong></li>\n<li>Integration of PHC &nbsp; &nbsp; &nbsp;<strong>&nbsp;</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\85\>\n<p>1986</p>\n</td>\n<td width=\168\>\n<p>Bajaj committee</p>\n</td>\n<td width=\337\>\n<ul>\n<li><strong>Formulation</strong> of National Medical and Health Education Policy.</li>\n<li>Formulation of National Manpower Policy.</li>\n<li>Health Manpower cells</li>\n<li>Education commission.</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1044, 'Community Medicine', 'PM0163. Management Methods in Health Programmes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\564\>\n<tbody>\n<tr>\n<td width=\210\>\n<p><strong>Methods based on behavioral sciences</strong></p>\n</td>\n<td width=\354\>\n<p><strong>Quantitative methods</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\210\>\n<p>Organisational design</p>\n<p>Personnel management</p>\n<p>Communication</p>\n<p>Information systems</p>\n<p>Management by objectives(MBO)</p>\n</td>\n<td width=\354\>\n<p>Cost–Benefit analysis</p>\n<p>Cost-Effective analysis</p>\n<p>Cost–Accounting</p>\n<p>Input–Output analysis</p>\n<p>Model</p>\n<p>Systems analysis</p>\n<p>Network analysis- Includes Programme Evaluation and Review Technique(PERT) and Critical Path Method(CPM)</p>\n<p>Planning–Programming–Budgeting System (PPBS)</p>\n<p>Work sampling</p>\n<p>Decision making</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1045, 'Community Medicine', 'PM0162. The Planning Cycle', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The planning cycle for health programmes consists of:</p>\n<ol>\n<li>Analysis of the health situation</li>\n<li>Establishment of objectives and goals</li>\n<li>Assessment of resources</li>\n<li>Fixing priorities</li>\n<li>Write up of formulated plan</li>\n<li>Programming and implementation</li>\n<li>Monitoring</li>\n<li>Evaluation</li>\n</ol>\n<p>The planning cycle has been summarized in the following image:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b369b2910cee4095990b201b988f7f5ex1280x2558.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1046, 'Community Medicine', 'PM0155. Levels of Healthcare System in India', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e039424256924d55891c73b8e1a95878x1280x1130.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1047, 'Community Medicine', 'PM2505. Sex Ratio', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>It is the number of<strong> females per 1000 males</strong>.</li>\n<li>According to NFHS-5 (2019-21), the sex ratio in India was <strong>1020&nbsp;females</strong> per <strong>1000 males.</strong></li>\n<li>As per Census 2011, India had a sex ratio of 940 females per 1000 males. Hence, we can see the sex ratio has improved.</li>\n<li><strong>Kerala</strong> was the only state to hold a favourable sex ratio in the last census. It currently holds a sex ratio of <strong>1121 females per 1000 males. </strong>(NFHS-5 data)</li>\n<li><strong>Puducherry</strong> was the only union territory that had a favourable sex ratio in the last census. It currently has a sex ratio of <strong>1112 females per 1000 males</strong>. (NFHS-5 data)</li>\n<li>The sex composition of the population is affected by <strong>the differentials in mortality conditions of males and females</strong>, sex-selective migration and the sex ratio at birth.</li>\n<li>A very low sex ratio indicates male-child favoritism.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1048, 'Community Medicine', 'PM1715. Pearl index and couple protection rate:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Pearl Index</strong>&nbsp;is defined as the <strong>number </strong>of <strong>contraceptive failures</strong> per 100 woman-years of exposure (<strong>HWY).</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/da0fc9aa2dee499fb8ab86afa8cbe537x1280x667.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>In this formula, the total accidental pregnancies that are used as the numerator must include every known conception, irrespective of its outcome.</li>\n<li>In the denominator, total months of exposure is obtained by deducting, 10 months for full-term deliveries and 4 months for abortion, from the total period under review.</li>\n</ul>\n<p><strong>Couple Protection Rate:</strong></p>\n<ul>\n<li>It is an indicator of <strong>couple protection practice</strong> in the community.</li>\n<li>It is defined as the percentage of <strong>eligible couples</strong> effectively <strong>protected against childbirth</strong> by one or the other approved methods of family planning.</li>\n<li>Attaining a <strong>60% CPR</strong> would mean <strong>restricting all third </strong>or<strong> higher-order births.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1049, 'Community Medicine', 'PM1709. Fertility Indicators', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Crude birth rate</strong></p>\n<ul>\n<li>It is the simplest measure of fertility although its usage is unsatisfactory</li>\n<li><strong>India</strong>, as per SRS bulletin 2018, had a birth rate of <strong>20.0 per 1000 population</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/56282516aed8445b855f1227e904dba9x1280x668.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>General Fertility Rate</strong></p>\n<ul>\n<li>It is a better indicator of fertility than crude birth rate</li>\n<li>The demerit of this indicator is that not all women in the denominator are exposed to childbirth</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1a03fb429f244ed28e11d9e749e7d723x1280x674.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Age-specific fertility rates&nbsp;</strong>is a more precise measure of fertility and is also a <strong>sensitive indicator of family planning achievement.</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/344c26b2f7a9496b821ea2b178f3b854x1280x675.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Total Fertility Rate</strong></p>\n<ul>\n<li>It is the <strong>sum of all age-specific fertility rates multiplied by 5</strong></li>\n<li>This measure gives the <strong>approximate magnitude of completed family size</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e752fa3ff9314abbb882901d561c2e27x1280x738.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Gross Reproductive Rate&nbsp;</strong>is the average number of girls that would be born to a woman if she experiences the current fertility pattern throughout her reproductive span, assuming no mortality.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e95dc4384c834ee68605f26b4ca7211bx1280x738.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Net Reproduction Rate</strong></p>\n<ul>\n<li>It is a <strong>demographic indicator</strong></li>\n<li>NRR of <strong>1</strong> is equivalent to approximately the <strong>2 child norm</strong></li>\n<li>If the NRR is less than 1, then the reproductive performance of the population is said to be inadequate</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8264d886076a4266a5770f584eb6262ax1280x775.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1050, 'Community Medicine', 'PM1708. Literacy Rates', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Literacy rate</strong></p>\n<ul>\n<li>The <strong>literacy rate</strong> in<strong> India</strong> currently is <strong>74.04%</strong></li>\n<li>According to the 2011 census, <strong>Kerala</strong> has the <strong>highest literacy rate</strong> among Indian states with a value of <strong>93.91%</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/16f8b8c520db4932a79c6b0e9e97d6a2x1280x644.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c55fba561be84e539cf235587b80a15ax1280x644.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1051, 'Community Medicine', 'PM1707. Dependency Ratio', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Persons 65 years and above and children from 0 – 14 years are considered as dependents.</li>\n<li>The <strong>total dependency ratio</strong> is the ratio of the combined dependent population to those in the age group of 15 – 65 years.</li>\n<li><strong>Total dependency ratio</strong> = (children 0-14 years age + population above 65 years age) x 100/Total population in the age group of 15 – 64).</li>\n<li>It is also called <strong>societal dependency ratio.</strong></li>\n<li>The total dependency ratio can also be divided into <strong>young age dependency ratio</strong> and <strong>old age dependency ratio.</strong></li>\n<li>The term <strong>demographic bonus</strong> denotes the decline in dependency ratio due to declining <strong>fertility.</strong></li>\n<li>The term <strong>demographic burden</strong> is used to denote the increase in total dependency ratio during any period of time mostly caused by <strong>increased old age dependency ratio .</strong></li>\n<li>As of 2016, the dependency ratio of <strong>India </strong>is <strong>52%.</strong></li>\n<li><strong>Potential support ratio</strong> is the number of persons aged 15 to 64 per one older person aged 65 or more. This is the inverse of the <strong>old age dependency ratio.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1052, 'Community Medicine', 'PM1703. Sex Ratio', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>It is the number of<strong> females per 1000 males</strong>.</li>\n<li>According to NFHS-5 (2019-21), the sex ratio in India was <strong>1020&nbsp;females</strong> per <strong>1000 males.</strong></li>\n<li>As per Census 2011, India had a sex ratio of 940 females per 1000 males. Hence, we can see the sex ratio has improved.</li>\n<li><strong>Kerala</strong> was the only state to hold a favourable sex ratio in the last census. It currently holds a sex ratio of <strong>1121 females per 1000 males. </strong>(NFHS-5 data)</li>\n<li><strong>Puducherry</strong> was the only union territory that had a favourable sex ratio in the last census. It currently has a sex ratio of <strong>1112 females per 1000 males</strong>. (NFHS-5 data)</li>\n<li>The sex composition of the population is affected by <strong>the differentials in mortality conditions of males and females</strong>, sex-selective migration and the sex ratio at birth.</li>\n<li>A very low sex ratio indicates male-child favoritism.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1053, 'Community Medicine', 'PM1702. Demographic Aspects of India', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>UN Data (2021) </strong></p>\n<ul>\n<li>India’s <strong>population</strong>&nbsp;was <strong>1,393,409,000&nbsp;</strong>(1.39 Billion)&nbsp;</li>\n<li>In 2021, India ranked&nbsp;<strong>2<sup>nd</sup> </strong>in the list of countries with the highest population</li>\n<li>Almost <strong>34.5%</strong> of India’s population is <strong>urban</strong></li>\n<li>The population <strong>growth rate</strong> was&nbsp;<strong>1%</strong></li>\n</ul>\n<p><strong>SRS Statistical Report (2020)<br></strong></p>\n<p>Vital statistics according to&nbsp;the Sample Registration System data released by the Registrar General of India:</p>\n<ul>\n<li>Infant mortality rate (<strong>IMR</strong>) in India -<strong> 28 per 1000 live births</strong></li>\n<li>The crude birth rate (<strong>CBR</strong>) - <strong>19.5</strong></li>\n<li>The crude death rate (<strong>CDR</strong>) was<strong> 6.0</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1054, 'Community Medicine', 'PM1701. Population Pyramid', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The <strong>age or population pyramid</strong> is used to represent the age/sex structure of a population.</li>\n<li>Below is the <strong>age pyramid of India</strong> (2017).</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/fe5271a4a221480f809114549d9e0b7dx800x600.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The age pyramid of India has a <strong>broad base</strong> and a <strong>tapering top</strong>, as it is with <strong>most developing countries</strong>.</li>\n<li>As a nation develops the lower portion of the pyramid will start constricting and the upper portion will start increasing.&nbsp;</li>\n<li><strong>Developed countries</strong> usually will have a <strong>bulge in the middle with a narrow base</strong>, as shown below in the age pyramid of <strong>Switzerland.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9f72b363d41241e49d64b0341554818fx610x425.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1055, 'Community Medicine', 'PM1694. Demographic Process and Cycle', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Stages </strong>of the<strong> demographic cycle</strong> include:</p>\n<ul>\n<li><strong>Stage 1 - High stationary</strong>&nbsp;\n<ul>\n<li><strong>High birth rates </strong>and <strong>high death rates</strong> render the population <strong>stationary</strong></li>\n<li>Narrow demographic gap</li>\n</ul>\n</li>\n<li><strong>Stage 2 - Early expanding&nbsp;</strong>\n<ul>\n<li>The <strong>death rate declines</strong> and the&nbsp;<strong>birth rate</strong> remains<strong> unchanged</strong></li>\n<li>The <strong>demographic gap</strong> starts <strong>increasing </strong>and becomes<strong> maximum</strong></li>\n</ul>\n</li>\n<li><strong>Stage 3 - Late expanding</strong>\n<ul>\n<li><strong>Death rate</strong> <strong>declines </strong>further and <strong>birth rate falls</strong></li>\n<li><strong>India</strong> is in this stage, currently</li>\n<li>The <strong>demographic gap</strong> starts <strong>declining</strong></li>\n</ul>\n</li>\n<li><strong>Stage 4 - Low stationary</strong>&nbsp;\n<ul>\n<li><strong>Low birth rate</strong> and <strong>low death rate </strong>renders the population <strong>stationary</strong></li>\n<li>Narrow demographic gap</li>\n</ul>\n</li>\n<li><strong>Stage 5 - Declining&nbsp;</strong>\n<ul>\n<li>The <strong>population </strong>begins to<strong> decline</strong> as the birth rate is lower than the death rate</li>\n<li>The<strong> demographic gap</strong> is <strong>negative</strong></li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/195bd20c6832444caf57ca79ed76b70dx1280x1145.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1056, 'Community Medicine', 'PM2152. Integrated child development services (ICDS)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Integrated child development services (ICDS): </strong>Package of services provided include:</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td><strong>Beneficiary</strong></td>\n<td><strong>Services</strong></td>\n</tr>\n<tr>\n<td><strong>Pregnant women</strong></td>\n<td>\n<ul>\n<li>Health check up</li>\n<li>Tetanus immunization</li>\n<li>Supplementary nutrition</li>\n<li>Nutrition and health education</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Nursing mothers</strong></td>\n<td>\n<ul>\n<li>Health check up</li>\n<li>Supplementary nutrition</li>\n<li>Nutrition and health education</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Other women 15-45 years</strong></td>\n<td>\n<ul>\n<li>Nutrition and health education</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Children &lt;3 years</strong></td>\n<td>\n<ul>\n<li>Supplementary nutrition</li>\n<li>Immunization</li>\n<li>Health check up</li>\n<li>Referral services</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Children 3-6 years of age</strong></td>\n<td>\n<ul>\n<li>Supplementary nutrition</li>\n<li>Immunization</li>\n<li>Health check up</li>\n<li>Referral services</li>\n<li>Non formal education &nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Adolescent girls 11 -18 years</strong></td>\n<td>\n<ul>\n<li>Nutrition programme for adolescent girls</li>\n<li>Kishori shakti yojana</li>\n<li>Nutrition and &nbsp;heath education</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>The logo of the ICDS is given below:&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9cf9277a541c4877b367ef7957dd0d74x720x697.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1057, 'Paediatrics,', 'PM1884. Comparison between low-osmolar oral rehydration solution and ReSoMal', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Composition</strong></td>\n<td><span><strong>Low-osmolar ORS&nbsp;</strong></span>(mmol/L)</td>\n<td><strong><span>ReSoMal</span>&nbsp;</strong>(mmol/L)</td>\n</tr>\n<tr>\n<td>Glucose</td>\n<td>&nbsp;75</td>\n<td>125</td>\n</tr>\n<tr>\n<td>Sodium</td>\n<td>&nbsp;75</td>\n<td>&nbsp;45</td>\n</tr>\n<tr>\n<td>Potassium</td>\n<td>&nbsp;20</td>\n<td>&nbsp;40</td>\n</tr>\n<tr>\n<td>Chloride</td>\n<td>&nbsp;65</td>\n<td>&nbsp;70</td>\n</tr>\n<tr>\n<td>Citrate</td>\n<td>&nbsp;10</td>\n<td>&nbsp;7</td>\n</tr>\n<tr>\n<td>Magnesium</td>\n<td>&nbsp;---</td>\n<td>&nbsp;3</td>\n</tr>\n<tr>\n<td>Zinc</td>\n<td>&nbsp;---</td>\n<td>0.3</td>\n</tr>\n<tr>\n<td>Copper</td>\n<td>&nbsp;---</td>\n<td>0.045</td>\n</tr>\n<tr>\n<td><span><strong>Osmolarity</strong>&nbsp;(mOsmol/L)</span></td>\n<td><span><strong>245</strong></span></td>\n<td><span><strong>300</strong></span></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1058, 'Community Medicine,', 'PM1785. Methods of contraceptions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\ width=\304\>\n<tbody>\n<tr>\n<td><strong>Methods</strong></td>\n<td><strong>Advantages</strong></td>\n<td><strong>Disadvantages</strong></td>\n</tr>\n<tr>\n<td><strong>Barrier</strong></td>\n<td>\n<ul>\n<li>Prevents STD, HIV</li>\n<li>The incidence of Ca cervix reduced</li>\n<li>Effective if used properly</li>\n<li>No contraindication use</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Cumbersome</li>\n<li>&nbsp;Coital dependent</li>\n<li>&nbsp;Short term</li>\n<li>&nbsp;High failure rate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Lactation</strong></td>\n<td>\n<ul>\n<li>Beneficial to the newborn</li>\n<li>Contraceptive action (non-ovulatlon) 6 months</li>\n</ul>\n</td>\n<td>Short-term benefit</td>\n</tr>\n<tr>\n<td><strong>IUCD</strong></td>\n<td>\n<ul>\n<li>Long-term use</li>\n<li>Effective</li>\n<li>Coital Independent</li>\n</ul>\n</td>\n<td>Side effects<br>• Failure rate 1-3%<br>• Contraindicated In few</td>\n</tr>\n<tr>\n<td><strong>Hormones</strong></td>\n<td>Effective 99-100% long-term use of beneficial effects<br>of OC coital independent</td>\n<td>Side effects<br>• Not used during lactation<br>• Contraindicated In few<br>• Requires Surgery for implantation</td>\n</tr>\n<tr>\n<td><strong>Surgery</strong></td>\n<td>Permanent and effective</td>\n<td>Surgical complications surgery required.<br>• Not suited in low parity women</td>\n</tr>\n<tr>\n<td><strong>Postcoital</strong></td>\n<td>Effective 95-98% short-term use</td>\n<td>Failure in 1-5%<br>Not used as contraceptives</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1059, 'Obstetrics & Gynaecology,', 'PM1784. Failure rate of contraceptives', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Type of contraception </strong></td>\n<td><strong>Failure rate (%)</strong></td>\n</tr>\n<tr>\n<td>Lactation for 6 months</td>\n<td>0.5-1.5</td>\n</tr>\n<tr>\n<td>Coitus interruptus</td>\n<td>25</td>\n</tr>\n<tr>\n<td>Diaphragm</td>\n<td>4-6</td>\n</tr>\n<tr>\n<td>Intrauterine devices</td>\n<td>0-3</td>\n</tr>\n<tr>\n<td>Progesterone only minipill</td>\n<td>2-3</td>\n</tr>\n<tr>\n<td>Condom</td>\n<td>10-14</td>\n</tr>\n<tr>\n<td>Combined Pill</td>\n<td>0.1</td>\n</tr>\n<tr>\n<td>Vasectomy</td>\n<td>0.15</td>\n</tr>\n<tr>\n<td>Tubal ligation</td>\n<td>0.4</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1060, 'Paediatrics,', 'PM1776. World Health Organization (WHO) classification of nutritional status of infants and children', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Nutritional status</strong></span></div>\n</td>\n<td>\n<div><span><strong>Criteria </strong>(from birth to 5 years)</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Obese</span></p>\n</td>\n<td>\n<p><span><strong>Weight-for-height</strong>/length&nbsp;&gt;3 SD</span></p>\n<p><span><strong>BMI-for-</strong>age &gt;3 SD</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Overweight</span></td>\n<td>\n<p><span><strong>Weight-for-height</strong>/length&nbsp;&gt;2 SD and ≤3 SD</span></p>\n<p><span><strong>BMI-for-age</strong> &gt;2 SD and ≤3 SD</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Moderately underweight</span></td>\n<td><span><strong>Weight-for-age</strong> &lt;–2 SD and ≥–3 SD</span></td>\n</tr>\n<tr>\n<td><span>Severely underweight</span></td>\n<td><span><strong>Weight-for-age</strong> &lt;–3 SD</span></td>\n</tr>\n<tr>\n<td><span>Moderate acute malnutrition</span></td>\n<td>\n<p><span><strong>Weight-for-height</strong>/length&nbsp;≤–2 SD and ≥–3 SD</span></p>\n<p><span><strong>BMI-for-age</strong> ≤–2 SD and ≥–3 SD</span></p>\n<p><span><strong>Mid-upper arm circumference</strong> ≥115&nbsp;mm and &lt;125&nbsp;mm</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Severe acute malnutrition</span></td>\n<td>\n<p><span><strong>Weight-for-height</strong>/length&nbsp;&lt;– 3 SD</span></p>\n<p><span><strong>BMI-for-age</strong> &lt;– 3 SD</span></p>\n<p><span><strong>Mid-upper arm circumference</strong> &lt;115 mm</span></p>\n<p><span>Bilateral pitting edema</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Moderately stunted (or) moderate chronic malnutrition</span></td>\n<td><span><strong>Height/Length-for-age</strong> ≤–2 SD and ≥–3 SD</span></td>\n</tr>\n<tr>\n<td><span>Severely stunted (or) severe chronic malnutrition</span></td>\n<td><span><strong>Height/Length-for-age</strong> &lt;–3 SD</span></td>\n</tr>\n<tr>\n<td><span>Moderately wasted</span></td>\n<td><span><strong>Weight-for-height</strong>/length ≤–2 SD and ≥–3 SD</span></td>\n</tr>\n<tr>\n<td><span>Severely wasted</span></td>\n<td><span><strong>Weight-for-height</strong>/length &lt;-3 SD</span></td>\n</tr>\n</tbody>\n</table>\n<p><span><strong>SD</strong> - Standard deviation (from the median)</span></p></div><!---->\n      <!---->\n    </div><!---->'),
(1061, 'Community Medicine,', 'PM1773. Baby-friendly hospital initiative (revised 2018)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><h2 class=\module_title\><span>Ten steps to successful breastfeeding (Revised 2018)</span></h2>\n<table width=\59\>\n<tbody>\n<tr>\n<td>\n<h2 class=\module_title\><span>Critical management procedures</span></h2>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>1&nbsp; a.</strong>&nbsp;Comply fully with the&nbsp;<strong>International Code of Marketing of Breast-milk Substitutes</strong>&nbsp;and relevant World Health Assembly resolutions.</p>\n<p><strong>&nbsp; &nbsp; b.</strong>&nbsp;Have a <strong>written infant feeding policy</strong> that is routinely communicated to staff and parents.</p>\n<p><strong>&nbsp; &nbsp; c.</strong>&nbsp;Establish ongoing monitoring and data-management systems.</p>\n<p><strong>2.</strong>&nbsp;Ensure that <strong>staff has sufficient knowledge, competence, and skills</strong> to support breastfeeding.</p>\n<table width=\5\>\n<tbody>\n<tr>\n<td>\n<h2 class=\module_title\><span>Key clinical practices</span></h2>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>3.</strong>&nbsp;<strong>Discuss</strong> the importance and management of breastfeeding with pregnant women and their families.</p>\n<p><strong>4.</strong>&nbsp;Facilitate immediate and uninterrupted <strong>skin-to-skin contact</strong> and support mothers to initiate <strong>breastfeeding as soon as possible</strong> after birth.</p>\n<p><strong>5.</strong>&nbsp;Support mothers to <strong>initiate and maintain breastfeeding</strong> and manage common difficulties.</p>\n<p><strong>6.&nbsp;Do not provide</strong> breastfed newborns <strong>any food or fluids other than breast milk</strong>, unless medically indicated.</p>\n<p><strong>7.</strong>&nbsp;Enable mothers and their infants to remain together and to practice <strong>rooming-in</strong> 24 hours a day.</p>\n<p><strong>8.</strong>&nbsp;Support mothers to <strong>recognize and respond to their infants’ cues</strong> for feeding.</p>\n<p><strong>9.</strong>&nbsp;<strong>Counsel mothers</strong> on the use and risks of <strong>feeding bottles, teats, and pacifiers</strong>.</p>\n<p><strong>10.</strong>&nbsp;<strong>Coordinate discharge</strong> so that parents and their infants have timely access to ongoing support and care.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1062, 'Paediatrics,', 'PM1685. Composition of reduced osmolarity Oral Rehydration Solution (ORS)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The composition of reduced-osmolarity oral rehydration solution (ORS) is as follows:</p>\n<table width=\207\>\n<tbody>\n<tr>\n<td><strong>Reduced- osmolarity ORS</strong></td>\n<td><strong>mmol/L</strong></td>\n</tr>\n<tr>\n<td>Sodium&nbsp;</td>\n<td>75&nbsp;</td>\n</tr>\n<tr>\n<td>Chloride</td>\n<td>65</td>\n</tr>\n<tr>\n<td>Glucose (anhydrous)</td>\n<td>75</td>\n</tr>\n<tr>\n<td>Potassium</td>\n<td>20</td>\n</tr>\n<tr>\n<td>Citrate</td>\n<td>10</td>\n</tr>\n<tr>\n<td>Total Osmolarity</td>\n<td><strong>245</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1063, 'Paediatrics,', 'PM1456. Secondary attack rate of viral infections', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Viral infection&nbsp;</strong></span></td>\n<td><span><strong>Secondary attack rate&nbsp;</strong></span></td>\n</tr>\n<tr>\n<td>Chickenpox</td>\n<td>≈85% (61%–100%)</td>\n</tr>\n<tr>\n<td>Measles</td>\n<td>≥90%</td>\n</tr>\n<tr>\n<td>Mumps</td>\n<td>86%</td>\n</tr>\n<tr>\n<td>Rubella</td>\n<td>90%</td>\n</tr>\n<tr>\n<td>Erythema&nbsp;infectiosum</td>\n<td>10-60%</td>\n</tr>\n<tr>\n<td>Infectious mononucleosis</td>\n<td>10-20%</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1064, 'Obstetrics & Gynaecology,', 'PM1385. Recommendation for total weight gain during pregnancy by pre-pregnancy BMI', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Category (BMI)</strong></td>\n<td><strong>Total weight gain range [kg(lb)]</strong></td>\n</tr>\n<tr>\n<td>Underweight (&lt;18.5)</td>\n<td>12.5 - 18 (28-40 lb)</td>\n</tr>\n<tr>\n<td>Normal weight (BMI 18.5-24.9)</td>\n<td>11.5 - 16 (25-35 lb)</td>\n</tr>\n<tr>\n<td>Overweight (BMI 25-29.9)</td>\n<td>7 – 11.5 (15-25 lb)</td>\n</tr>\n<tr>\n<td>Obese (BMI more than equal to 30)</td>\n<td>5 - 9.1 (11-20 lb)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1065, 'Community Medicine,', 'PM1383. The Recommended Daily Allowance in Pregnancy and Lactation:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Nutrient </strong></td>\n<td><strong>Nonpregnant woman </strong></td>\n<td><strong>Pregnant woman </strong></td>\n<td><strong>Lactation (0-6 months)</strong></td>\n</tr>\n<tr>\n<td>Net energy (Kcal/day) moderate work</td>\n<td>2230</td>\n<td>2230 + 350</td>\n<td>2230 + 600</td>\n</tr>\n<tr>\n<td>Protein (g/d)</td>\n<td>55</td>\n<td>78</td>\n<td>74</td>\n</tr>\n<tr>\n<td>Visible fat (g/d)</td>\n<td>25</td>\n<td>30</td>\n<td>30</td>\n</tr>\n<tr>\n<td>Calcium (mg/d)</td>\n<td>600</td>\n<td>1200</td>\n<td>1200</td>\n</tr>\n<tr>\n<td>Iron (mg/d)</td>\n<td>21</td>\n<td>35</td>\n<td>21</td>\n</tr>\n<tr>\n<td>Zinc (mg/d)</td>\n<td>10</td>\n<td>10</td>\n<td>12</td>\n</tr>\n<tr>\n<td>Magnesium (mg/d)</td>\n<td>310</td>\n<td>310</td>\n<td>310</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1066, 'Community Medicine', 'PM2372. Food adulteration diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table dir=\ltr\ border=\1\ cellspacing=\0\ cellpadding=\0\><colgroup><col width=\50\><col width=\106\><col width=\91\><col width=\67\></colgroup>\n<tbody>\n<tr>\n<td><strong>Food</strong></td>\n<td><strong>Adulterant</strong></td>\n<td><strong>Toxin</strong></td>\n<td><strong>Disease</strong></td>\n</tr>\n<tr>\n<td>Dal</td>\n<td>Khesari dal (<em>Lathyrus sativus</em>)</td>\n<td>BOAA*</td>\n<td>Lathyrism</td>\n</tr>\n<tr>\n<td>Oil</td>\n<td><em>Argemone mexicana</em> (oil)</td>\n<td>Sanguinarine</td>\n<td>Epidemic dropsy</td>\n</tr>\n<tr>\n<td>Millet</td>\n<td>Crotalaria seeds (Jhunjhunia)</td>\n<td>Pyrrolizidine alkaloids<br>(Hepatotoxic)</td>\n<td>Endemic ascites&nbsp;</td>\n</tr>\n<tr>\n<td>Bajra, wheat</td>\n<td><em>Claviceps purpurea</em></td>\n<td>Clavine alkaloids</td>\n<td>Ergotism</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;* BOAA-Beta Oxalyl Amino Alanine</p></div><!---->\n      <!---->\n    </div><!---->'),
(1067, 'Obstetrics & Gynaecology,', 'PM2210. Prophylactic Iron and Folic Acid (IFA) Supplementation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>According to the&nbsp;<strong>Anemia Mukt Bharat 2018 scheme,</strong>&nbsp;giving<strong> IFA</strong> to children, adolescents, women of reproductive age, and pregnant women,&nbsp;irrespective of their anemia status, is a key intervention.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Age group</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Frequency</strong></td>\n<td><strong>Tablet Color</strong></td>\n</tr>\n<tr>\n<td><span>Children</span><br><span>6-59 months of age</span></td>\n<td>\n<p>&nbsp;</p>\n<p>1 mL iron and folic acid syrup</p>\n<p>Each mL contains&nbsp;<strong>20 mg</strong> elemental<strong> iron </strong>+<strong> 100 mcg</strong> of<strong> folic&nbsp;acid</strong></p>\n</td>\n<td>\n<p>Bi-weekly</p>\n</td>\n<td>&nbsp;Syrup</td>\n</tr>\n<tr>\n<td><span>Children </span><br><span>5-9 years of age</span></td>\n<td>\n<p>&nbsp;</p>\n<p>1 Iron and folic&nbsp;acid tablet</p>\n<p><strong>45 mg</strong> elemental iron +<strong> 400 mcg</strong> folic acid,</p>\n<p>Sugar-coated</p>\n</td>\n<td>Weekly&nbsp;</td>\n<td>&nbsp;Pink</td>\n</tr>\n<tr>\n<td>\n<p><span>School-going adolescent girls and Boys</span><br><span>10-19 years of age</span></p>\n<p><span>Out-of-school adolescent girls</span><br><span>10-19 years of age</span></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>1 iron and folic acid tablet</p>\n<p><strong>60&nbsp;mg&nbsp;</strong>elemental iron +<strong> 500 mcg </strong>folic acid,&nbsp;</p>\n<p>Sugar-coated</p>\n</td>\n<td>Weekly&nbsp;</td>\n<td>&nbsp;Blue</td>\n</tr>\n<tr>\n<td>\n<p><span>Women of reproductive age (non-pregnant, non-lactating) </span><br><span>20-49 years</span></p>\n<p><span>(Under Mission Parivar Vikas)</span></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>1 iron and folic acid tablet</p>\n<p><strong>60</strong>&nbsp;<strong>mg</strong> elemental iron +<strong> 500 mcg </strong>folic acid,&nbsp;</p>\n<p>Sugar-coated&nbsp;</p>\n</td>\n<td>Weekly&nbsp;</td>\n<td>&nbsp;Red</td>\n</tr>\n<tr>\n<td><span>Pregnant Women and Lactating Mothers </span><br><span>of 0-6 months child</span></td>\n<td>\n<p>&nbsp;</p>\n<p>1 iron and folic acid tablet starting from the <strong>fourth month</strong> of pregnancy is continued throughout pregnancy (minimum 180 days). It should also be continued for 180 days post-partum.</p>\n<p><strong>60</strong>&nbsp;<strong>mg </strong>elemental iron +<strong> 500 mcg </strong>folic acid,</p>\n<p>Sugar-coated and red color</p>\n</td>\n<td>Daily&nbsp;</td>\n<td>Red&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>Note 1:<strong> Prophylaxis with iron</strong> should be <strong>withheld</strong> in case of <strong>acute illness</strong> (fever, diarrhea, pneumonia, etc.) and in a known case of <strong>thalassemia major</strong>/ history of <strong>repeated blood transfusion</strong>. In cases of children with severe acute malnutrition (SAM), IFA supplementation should be continued as per the SAM management protocol.</p>\n<p>Note 2: All women in the reproductive age group in the pre-conception period and up to the first trimester of the pregnancy are advised to have 400 mcg of folic acid tablets, daily, to reduce the incidence of neural tube defects in the fetus.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1068, 'Community Medicine', 'PM2154. Assessment of Protein', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Protein quality:</strong> Assessed by comparing with reference protein i.e egg protein.</p>\n<ul>\n<li><strong>Amino acid score:</strong></li>\n<li><strong>Net protein utilization</strong></li>\n</ul>\n<p><strong>A) Amino acid score:</strong> It is a measure of the concentration of each essential amino acid in the protein to be tested, expressed as a percentage of that amino acid in the reference protein.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0b4e7dcfe93b45d092ec9cb664abb9d2x526x67.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>&nbsp;Digestible indispensable amino acid score (DIAAS)</strong><strong>&nbsp;</strong>is the best indicator of protein quality. It is defined as follows:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4a461fa26e594449a1301fcd005bfd23x615x86.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>B) Net protein utilization: </strong>It is a product of digestibility coefficient and biological value divided by 100.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e300cf9fb0a547f4a1f7297c86959dc4x308x55.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Protein quantity: </strong>It is assessed by<strong> protein energy ratio.</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/35ee644cb5e942318b40300a6022b371x343x62.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1069, 'Community Medicine,', 'PM1940. Vitamin-A supplementation & treatment of Vitamin-A deficiency', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\3\>\n<div><strong>Vitamin A supplementation</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Target group</strong></div>\n</td>\n<td>\n<div>6 to 11 months age</div>\n</td>\n<td>\n<div>12 to 59 month of age (1yr to 5yr)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Dose</strong></div>\n</td>\n<td>\n<div>100,000 IU (oral)</div>\n</td>\n<td>\n<div>200,000 IU (oral)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Frequency</strong></div>\n</td>\n<td>\n<div>Once</div>\n</td>\n<td>\n<div>Every 4–6 months</div>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>Note</strong>: A total dose of&nbsp;<strong>17 lakh IU</strong> given as per the following schedule:</p>\n<ul>\n<li>100,000 IU is given with measles vaccine at 9 months</li>\n<li>200,000 IU is given with DPT booster at 15–18 months</li>\n<li>200,000 IU is given every 6 months (till 5years of age)</li>\n</ul>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\4\><strong>Treatment </strong>of vitamin A<strong> deficiency</strong></td>\n</tr>\n<tr>\n<td><strong>Age</strong></td>\n<td>&lt; 6 months</td>\n<td>6-12 months</td>\n<td>&gt; 1 year</td>\n</tr>\n<tr>\n<td><strong>Dose</strong></td>\n<td>50,000 IU</td>\n<td>100,000 IU</td>\n<td>200,000 IU</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>Note:</strong> Route of administration is <strong>oral</strong>, in the form of retinyl palmitate.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1070, 'Community Medicine', 'PM1706. RDA Of Important Minerals', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>These values are specific for the <strong>Recommended Daily Allowances (RDA)</strong>:</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;&nbsp; <strong>Mineral</strong></td>\n<td><strong>Recommended intake (per day)</strong></td>\n</tr>\n<tr>\n<td>Folic acid&nbsp;\n<ul>\n<li aria-setsize=\-1\>Children</li>\n<li aria-setsize=\-1\>Adult male</li>\n<li aria-setsize=\-1\>Adult female&nbsp;</li>\n<li>Pregnancy</li>\n<li>Lactation&nbsp;&nbsp;&nbsp;</li>\n</ul>\n</td>\n<td>\n<p>&nbsp;</p>\n<ul>\n<li>120-170 mcg&nbsp;</li>\n<li aria-setsize=\-1\>300 mcg</li>\n<li aria-setsize=\-1\>220 mcg</li>\n<li aria-setsize=\-1\>570 mcg&nbsp;</li>\n<li aria-setsize=\-1\>330 mcg&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Iron&nbsp;\n<ul>\n<li aria-setsize=\-1\>Adult male&nbsp;</li>\n<li aria-setsize=\-1\>Adult female&nbsp;&nbsp;</li>\n<li aria-setsize=\-1\>Pregnancy&nbsp;&nbsp;</li>\n<li aria-setsize=\-1\>Lactation&nbsp;&nbsp;</li>\n</ul>\n</td>\n<td>&nbsp;\n<ul>\n<li aria-setsize=\-1\>19 mg&nbsp;</li>\n<li aria-setsize=\-1\>29 mg&nbsp;</li>\n<li aria-setsize=\-1\>27 mg&nbsp;</li>\n<li aria-setsize=\-1\>23 mg&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Calcium&nbsp;\n<ul>\n<li aria-setsize=\-1\>Adult male&nbsp;</li>\n<li aria-setsize=\-1\>Adult female&nbsp;</li>\n<li aria-setsize=\-1\>Pregnancy&nbsp;</li>\n<li aria-setsize=\-1\>Lactation&nbsp;</li>\n<li aria-setsize=\-1\>Elderly</li>\n</ul>\n</td>\n<td>&nbsp;\n<ul>\n<li aria-setsize=\-1\>1000 mg&nbsp;</li>\n<li aria-setsize=\-1\>1000 mg&nbsp;</li>\n<li aria-setsize=\-1\>1000 mg&nbsp;</li>\n<li aria-setsize=\-1\>1200 mg&nbsp;</li>\n<li aria-setsize=\-1\>1200 mg</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iodine</p>\n<ul>\n<li>Infant(0- 6m)</li>\n<li>Infant(7–12m)</li>\n<li>Children (1-9yrs)</li>\n<li>Children (9-16yrs)</li>\n<li>Adult male</li>\n<li>Adult female</li>\n<li>Pregnancy</li>\n<li>Lactation&nbsp;</li>\n</ul>\n</td>\n<td>\n<p>&nbsp;</p>\n<ul>\n<li>100 mcg</li>\n<li>130 mcg</li>\n<li>90-120 mcg</li>\n<li>150 mcg</li>\n<li>150 mcg</li>\n<li>150 mcg</li>\n<li>250 mcg</li>\n<li>280 mcg&nbsp;</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Mineral</strong></td>\n<td>\n<p><strong>Recommended intake</strong></p>\n<p><strong> (per day)</strong></p>\n</td>\n</tr>\n<tr>\n<td>Phosphorous&nbsp;</td>\n<td>1000 mg</td>\n</tr>\n<tr>\n<td>Sodium&nbsp;</td>\n<td>2000 mg</td>\n</tr>\n<tr>\n<td>Potassium&nbsp;</td>\n<td>3500 mg&nbsp;</td>\n</tr>\n<tr>\n<td>Copper&nbsp;</td>\n<td>2 mg</td>\n</tr>\n<tr>\n<td>Manganese&nbsp;</td>\n<td>4 mg</td>\n</tr>\n<tr>\n<td>Chromium&nbsp;</td>\n<td>50 mcg</td>\n</tr>\n<tr>\n<td>Selenium</td>\n<td>40 mcg</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1071, 'Community Medicine', 'PM1705. Recommended Dietary Allowances For Energy And Protein For Indians', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Category</strong></td>\n<td><strong>EAR - Energy(Kcal/D)&nbsp;</strong></td>\n<td><strong>&nbsp;RDA - Protein (g/D)&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Man</td>\n<td>\n<ul>\n<li aria-setsize=\-1\>Sedentary work&nbsp;</li>\n<li aria-setsize=\-1\>Moderate work&nbsp;</li>\n<li aria-setsize=\-1\>Heavy work&nbsp;&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li aria-setsize=\-1\>2110&nbsp;</li>\n<li aria-setsize=\-1\>2710&nbsp;</li>\n<li aria-setsize=\-1\>3470&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li aria-setsize=\-1\>54</li>\n<li aria-setsize=\-1\>54</li>\n<li aria-setsize=\-1\>54</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Woman&nbsp;</td>\n<td>\n<ul>\n<li>Sedentary work&nbsp;</li>\n<li aria-setsize=\-1\>Moderate work&nbsp;</li>\n<li aria-setsize=\-1\>Heavy work&nbsp;</li>\n<li aria-setsize=\-1\>Pregnancy&nbsp;<br><br><br></li>\n<li aria-setsize=\-1\>Lactation (0-6m)&nbsp;</li>\n<li aria-setsize=\-1\>Lactation (6-12m)&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>1660</li>\n<li>2130</li>\n<li>2720&nbsp;</li>\n<li>+340 (2nd trimester)<br>+452 (3rd trimester)</li>\n<li aria-setsize=\-1\>+600&nbsp;</li>\n<li aria-setsize=\-1\>+520&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>46</li>\n<li aria-setsize=\-1\>46</li>\n<li aria-setsize=\-1\>46</li>\n<li aria-setsize=\-1\>+9.5(2nd trimester)<br>+22 (3rd trimester)<br><br></li>\n<li aria-setsize=\-1\>+17 &nbsp;</li>\n<li aria-setsize=\-1\>+13&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Infant</td>\n<td>\n<ul>\n<li>0-6 months</li>\n<li>6-12 months</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>530</li>\n<li>660</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>8.0</li>\n<li>10.5</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Dietary Reference Intakes</strong></p>\n<ul>\n<li>Recommended Dietary Allowance (RDA) - The average daily dietary intake that is sufficient to meet the requirements of almost all individuals in a group</li>\n<li>Estimated Average Requirement (EAR) - A nutrient intake value that is estimated to meet the requirements of half the individuals in a group</li>\n</ul>\n<p>The EAR for an <strong>elderly male </strong>(&gt;60 years) is <strong>1700 Kcal/D</strong> and for an <strong>elderly female </strong>(&gt;60 years) is <strong>1500 Kcal/D</strong>.</p>\n<p>Note: There is no RDA for energy. The EAR is equivalent to Estimated Energy Requirement (EER).</p></div><!---->\n      <!---->\n    </div><!---->'),
(1072, 'Community Medicine', 'PM1704. Reference Indian Man and  Woman', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Parameters </strong></td>\n<td><strong>Reference Indian adult man&nbsp;&nbsp;</strong></td>\n<td><strong>Reference Indian adult&nbsp;woman&nbsp; - non pregnant, non lactating</strong></td>\n</tr>\n<tr>\n<td>Age</td>\n<td>19-39 years&nbsp;&nbsp;</td>\n<td>19-39 years&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Weight&nbsp;</td>\n<td>65kg&nbsp;</td>\n<td>55 kg&nbsp;</td>\n</tr>\n<tr>\n<td>Height&nbsp;</td>\n<td>1.77m&nbsp;</td>\n<td>1.62m&nbsp;</td>\n</tr>\n<tr>\n<td>BMI&nbsp;</td>\n<td>20.75</td>\n<td>20.95</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1073, 'Community Medicine,', 'PM1478. Malnutrition Universal Screening Tool (MUST)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Malnutrition Universal Screening Tool</strong>, ‘MUST’ is a five-step screening tool to identify adults, who are malnourished, at risk of malnutrition (undernutrition), or obese. It also includes management guidelines which can be used to develop a care plan.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c7bc13b83c2647d2a56f3129a3f74cd5x1280x2757.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1074, 'Ophthalmology,', 'PM1463. WHO grading of Vitamin A deficiency', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The term xerophthalmia is reserved to cover all the ocular manifestations of vitamin A deficiency.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Features</strong></td>\n<td><strong>Pathophysiology</strong></td>\n</tr>\n<tr>\n<td><strong>XN</strong></td>\n<td>Night blindness</td>\n<td>Lack of rhodopsin</td>\n</tr>\n<tr>\n<td><strong>X1A</strong></td>\n<td>Conjunctival Xerosis</td>\n<td>Conjunctival epithelial alteration, loss of goblet cells</td>\n</tr>\n<tr>\n<td><strong>X1B</strong></td>\n<td><strong>Bitot’s spots</strong></td>\n<td>Conjunctival keratinization and plaque formation</td>\n</tr>\n<tr>\n<td><strong>X2</strong></td>\n<td>Corneal xerosis</td>\n<td>Corneal epithelial alteration</td>\n</tr>\n<tr>\n<td><strong>X3A</strong></td>\n<td>Corneal ulceration/ Keratomalacia affecting &lt;1/3<sup>rd</sup> of the corneal surface</td>\n<td>Liquefaction of corneal stroma</td>\n</tr>\n<tr>\n<td><strong>X3B</strong></td>\n<td>Corneal ulceration/ Keratomalacia affecting &gt;1/3<sup>rd</sup> of the corneal surface</td>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</td>\n</tr>\n<tr>\n<td><strong>XS</strong></td>\n<td>Corneal scar</td>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</td>\n</tr>\n<tr>\n<td><strong>XF</strong></td>\n<td>Xerophthalmic fundus</td>\n<td>Degeneration of the retinal pigment epithelium</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>The first symptom</strong>&nbsp;of xerophthalmia is&nbsp;<strong>nyctalopia.</strong></p>\n<p><strong>The first sign of</strong>&nbsp;xerophthalmia<strong>&nbsp;is&nbsp;conjunctival xerosis.</strong></p>\n<p>The&nbsp;<strong>pathognomonic</strong>&nbsp;feature of<strong>&nbsp;xerophthalmia</strong>&nbsp;is the appearance of&nbsp;<strong>Bitots spots.</strong></p>\n<p><strong>Note: </strong></p>\n<p>Up to Stage X2, the manifestations are <strong>reversible</strong> if treated with vitamin A supplements. Active conjunctival xerosis and Bitot’s spots begin to resolve within 2—5 days after supplementation. Most will disappear within 2 weeks, although a significant proportion of temporal lesions may persist in shrunken form and may therefore not be&nbsp;completely reversible.</p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1075, 'Ophthalmology,', 'PM1462. Ophthalmic manifestation in vitamin deficiency', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Vitamin deficiency</strong></td>\n<td><strong>Ophthalmic manifestation</strong></td>\n</tr>\n<tr>\n<td><strong>A</strong></td>\n<td>\n<ul>\n<li>Xerophthalmia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>B1</strong></td>\n<td>\n<ul>\n<li>Corneal anesthesia</li>\n<li>Conjunctival and corneal dystrophy</li>\n<li>Acute retrobulbar neuritis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>B2</strong></td>\n<td>\n<ul>\n<li>Photophobia</li>\n<li>Burning sensation</li>\n<li>Vascularization of the cornea</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>B12</strong></td>\n<td>\n<ul>\n<li>Bilateral centrocecal scotoma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>C</strong></td>\n<td>\n<ul>\n<li>Hemorrhage in eye</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>D</strong></td>\n<td>\n<ul>\n<li>Zonular cataract</li>\n<li>Papilledema</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1076, 'Community Medicine', 'PM0853. Economics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Gross National Income (GNI)</strong>:\n<ul>\n<li>It is also known as the&nbsp;<strong>gross national product (GNP). </strong>It is the <strong>gross income</strong> generated from <strong>within the country</strong> as well as the income received <strong>from abroad</strong>. It is expressed as either ‘<strong>at current prices’</strong> or ‘<strong>at constant prices</strong>’.</li>\n</ul>\n</li>\n<li><strong>Per capita income</strong>:\n<ul>\n<li>It is arrived at by dividing the GNP by the total population of a country. It is a general indicator of national wealth.</li>\n</ul>\n</li>\n<li><strong>Gross Domestic Product (GDP):</strong>\n<ul>\n<li>It is the gross income generated only from <strong>within the country</strong>. It doesn’t include income from abroad.</li>\n</ul>\n</li>\n<li><strong>Net National Product (NNP):</strong>\n<ul>\n<li>It is the <strong>market value </strong>of all final goods and services in a country during a year after depreciation has been allowed for.</li>\n</ul>\n</li>\n<li><strong>Net Domestic Product (NDP):</strong>\n<ul>\n<li>It is <strong>gross domestic product (GDP) minus the depreciation</strong> of a country’s capital goods.</li>\n</ul>\n</li>\n<li><strong>Purchasing Power Parity (PPP):</strong>\n<ul>\n<li>It is an economic theory that <strong>compares the currencies of different countries</strong> through a <strong>market basket of goods</strong> approach. According to this concept, two currencies are in equilibrium when a market basket of goods is priced the same in both countries.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1077, 'Community Medicine', 'PM0850. The Art of Intervieweing', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Interviews</strong> are methods used widely in investigations and in research. A proper interview technique must be employed to achieve the objective.</li>\n<li><strong>Aims </strong>of an interview\n<ul>\n<li>To secure information usually through face to face association and to understand the individual/group being interviewed.</li>\n<li>To form a hypothesis.</li>\n<li>To collect personal data for quantitative purposes.</li>\n<li>To collect data from secondary sources of information.</li>\n</ul>\n</li>\n<li>Types of interviews\n<ul>\n<li>A <strong>direct</strong> or <strong>structured interview </strong>consists of predetermined questions and sequence.</li>\n<li>A <strong>non-directive</strong> or <strong>unstructured interview</strong> doesn’t have any sequence of questions set beforehand. The interviewer listens and allows the speaker to narrate his/her own experiences or opinions.</li>\n<li>A <strong>focused interview</strong> is usually used to study effects of mass communications like radio broadcasts or film. In this, the interviewer/researcher focuses on a particular aspect on the problem and draws responses from people.</li>\n<li>A <strong>repetitive interview</strong> is used to note the gradual influence of some social or psychological process. A record is maintained to understand the changes.</li>\n</ul>\n</li>\n<li><strong>Technique</strong> of interviewing\n<ul>\n<li>Establishing <strong>contact</strong></li>\n<li><strong>Starting</strong> an interview</li>\n<li>Securing <strong>rapport</strong></li>\n<li><strong>Recall</strong></li>\n<li><strong>Probe</strong> questions</li>\n<li><strong>Encouragement</strong></li>\n<li><strong>Guiding</strong> the interview</li>\n<li><strong>Recording</strong></li>\n<li><strong>Closing</strong> the interview</li>\n<li><strong>Report</strong></li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1078, 'Community Medicine', 'PM0849. Socio-Economic Status and the modified Kuppuswamy’s Socio-economic Status Scale, 2017', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Socio-Economic Status:</strong></p>\n<ul>\n<li>The <strong>socio-economic status (SES)</strong> is a person’s position in the <strong>societal hierarchy, </strong>which in turn is an important <strong>determinant of health</strong>.</li>\n<li>SES may be inherited but in most situations, it is achieved on the basis of <strong>occupation, income, type of housing, neighbourhood, material possessions, etc.</strong></li>\n<li>Many <strong>composite scales</strong> have been developed to classify SES. Some of them are listed below:</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Scale </strong></p>\n</td>\n<td>\n<p><strong>Used for:</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>BG Prasad scale</p>\n</td>\n<td>\n<p>Urban and rural areas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kuppuswamy scale</p>\n</td>\n<td>\n<p>Urban and peri-urban areas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Uday Pareek</p>\n</td>\n<td>\n<p>Rural areas</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Some other scales that have been used are Radhukar scale, Jalota scale, Shirvastava scale, Bharadwaj scale, Kulshestra scale and the Hollingshead scale.</p>\n<p>&nbsp;</p>\n<p><strong>The Kuppuswamy scale:</strong></p>\n<p>The Kuppuswamy scale was designed to classify the socio-economic status in <strong>urban and peri-urban areas</strong>.</p>\n<p>It was devised in <strong>1976</strong> by <strong>Kuppuswamy </strong>and was later <strong>modified</strong> to be called the Modified Kuppuswamy Scale.</p>\n<p>This scale uses the following components:</p>\n<ul>\n<li><strong>Education of head </strong>of the family</li>\n<li><strong>Occupation of the head of the family</strong></li>\n<li><strong>Monthly income</strong> of the family</li>\n</ul>\n<p>Each indicator is given a score and the final score from <strong>3–29</strong> reveals the Socio-Economic Score and class of the person.</p>\n<p>The scale requires regular upgrades owing to the changing value of the currency and for this, the changes are based on the <strong>Consumer Price Index</strong> for industrial workers (CPI IW) with the year 2001 as the base year.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Modified Kuppuswamy scale</strong>(2019):</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/829da5deee834df1b908cdf5bc01ad88x1280x2274.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1079, 'Community Medicine', 'PM0828. Intelligence Quotient', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The <strong>intelligence quotient</strong> is a score that can be obtained from several standardized tests to assess human intelligence.</li>\n<li>Historically, <strong>IQ = Mental age x 100/ Chronological age</strong></li>\n<li>Here, the mental age is obtained from <strong>intelligence tests</strong>.</li>\n<li>Higher the IQ, the more brilliant is the person.</li>\n<li>Classification of IQ according to <strong>Levine and Marks (1928)</strong> is as follows:</li>\n</ul>\n<table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>IQ Range</strong></p>\n</td>\n<td>\n<p><strong>Classification</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>0–24</p>\n</td>\n<td>\n<p>Idiots</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>25–49</p>\n</td>\n<td>\n<p>Imbeciles</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>50–74</p>\n</td>\n<td>\n<p>Morons</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>75–84</p>\n</td>\n<td>\n<p>Borderline</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>85–94</p>\n</td>\n<td>\n<p>Dull</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>95–104</p>\n</td>\n<td>Average</td>\n</tr>\n<tr>\n<td>\n<p>105-114</p>\n</td>\n<td>\n<p>Bright</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>115-124</p>\n</td>\n<td>\n<p>Very bright</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>125-149</p>\n</td>\n<td>\n<p>Superior</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>150-174</p>\n</td>\n<td>\n<p>Very superior</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>175 and over</p>\n</td>\n<td>\n<p>Precocious</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<ul>\n<li>Classification of<strong>&nbsp;Intellectual Disability</strong>&nbsp;based on IQ levels:</li>\n</ul>\n<table border=\1\ width=\448\>\n<tbody>\n<tr>\n<td>\n<p><strong>IQ</strong></p>\n</td>\n<td>\n<p><strong>Mental Status</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Above 70</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>50–69</p>\n</td>\n<td>\n<p>Mild&nbsp;intellectual disability</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>35–49</p>\n</td>\n<td>\n<p>Moderate intellectual disability</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>20–34</p>\n</td>\n<td>\n<p>Severe intellectual disability</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Below 20</p>\n</td>\n<td>\n<p>Profound&nbsp;intellectual disability</p>\n</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li>&nbsp;<strong>Wechsler’s</strong> <strong>Scale</strong> according to IQ:<strong>&nbsp;</strong></li>\n</ul>\n<table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>IQ</strong></p>\n</td>\n<td>\n<p><strong>Classification</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>65 and below</p>\n</td>\n<td>\n<p>Defective</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>66–79</p>\n</td>\n<td>\n<p>Borderline</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>80–90</p>\n</td>\n<td>\n<p>Dull normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>91–110</p>\n</td>\n<td>\n<p>Average</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>111–119</p>\n</td>\n<td>\n<p>Bright normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>120–127</p>\n</td>\n<td>\n<p>Superior</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>128 and above</p>\n</td>\n<td>\n<p>Very superior</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1080, 'Community Medicine', 'PM0827. Learning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Learning </strong>is any relative or permanent change in behaviour as a result of practice or experience.</li>\n<li>It includes acquiring <strong>knowledge and skills</strong>, formation of <strong>habits</strong> and development of <strong>perception</strong>.</li>\n<li>The conditions that affect learning are as follows:\n<ul>\n<li>Intelligence</li>\n<li>Age</li>\n<li>Learning situation</li>\n<li>Motivation</li>\n<li>Physical and mental health</li>\n</ul>\n</li>\n<li>Types of learning:\n<ul>\n<li><strong>Cognitive</strong> learning – <strong>knowledge</strong></li>\n<li><strong>Affective</strong> learning – <strong>attitudes</strong></li>\n<li><strong>Psychomotor</strong> learning – <strong>skills</strong></li>\n</ul>\n</li>\n<li>Theories of learning:\n<ul>\n<li>Learning by conditioned reflex</li>\n<li>Trial and error</li>\n<li>Learning by observation and imitation</li>\n<li>Learning by doing</li>\n<li>Learning by remembering</li>\n<li>Learning by insight</li>\n<li>Demonstration</li>\n<li>Field experience</li>\n<li>Problem solving</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1081, 'Psychiatry,', 'PM0826. Maslows Hierarchy of Needs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d605ecbad0a849fba1bac4535a12df61x1280x1216.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1082, 'Community Medicine', 'PM0823. Acculturation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Acculturation </strong>is the process by which there is diffusion of <strong>cultures between two culturally different groups of people.</strong></li>\n<li>This can happen by the following ways:\n<ul>\n<li>Trade and commerce</li>\n<li>Industrialization</li>\n<li>Religious propagation</li>\n<li>Education</li>\n<li>Conquest</li>\n</ul>\n</li>\n<li>This phenomenon is also known as <strong>culture contact.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1083, 'Community Medicine', 'PM0818. The Spaulding Classification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>The Spaulding classification</strong> classifies medical devices according to the degree of risk of infection if they are contaminated.</p>\n<table>\n<tbody>\n<tr>\n<td width=\160\>\n<p><strong>Device</strong></p>\n</td>\n<td width=\160\>\n<p><strong>Description</strong></p>\n</td>\n<td width=\160\>\n<p><strong>Examples</strong></p>\n</td>\n<td width=\160\>\n<p><strong>Disinfection</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p><strong>Non-critical device</strong></p>\n</td>\n<td width=\160\>\n<p>Lower risk of infection as the device comes in contact with intact or normal skin.</p>\n</td>\n<td width=\160\>\n<p>Stethoscope, walls, furniture, BP cuff, etc.</p>\n</td>\n<td width=\160\>\n<p><strong>Intermediate/low-level</strong> disinfectant.</p>\n<p>Clean, dry and store for future use.</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p><strong>Semi-critical devices</strong></p>\n</td>\n<td width=\160\>\n<p>Lower risk of infection as these devices come in contact with mucosa and do not penetrate into sterile areas of the body.</p>\n</td>\n<td width=\160\>\n<p>Fiber-optic endoscopes, laryngoscopes, bronchoscopes, cystoscopes, vaginal specula, etc.</p>\n</td>\n<td width=\160\>\n<p><strong>High-level </strong>disinfectant to be used after proper cleaning or sterilization by heat.</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p><strong>Critical devices</strong></p>\n</td>\n<td width=\160\>\n<p>High risks of infection as these devices come in contact with sterile areas of the body like blood.</p>\n</td>\n<td width=\160\>\n<p>Needles, cardiac catheters, implants, intrauterine devices, urinary catheters, etc.</p>\n</td>\n<td width=\160\>\n<p><strong>High-level </strong>disinfectant is indicated with sterilization with heat, ethylene oxide, etc.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1084, 'Community Medicine', 'PM1686. Insecticides', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Contact poisons</strong></p>\n<ul>\n<li><strong>Natural</strong>: Pyrethrum, rotenone, derris, nicotine, mineral oils</li>\n<li><strong>Synthetic:</strong>\n<ul>\n<li><strong>Organo-chlorine compounds</strong>: DDT, methoxychlor, HCH, lindane, chlordane, heptachlor, dieldrin, aldrin, toxaphene, kepone, mirex.</li>\n<li><strong>Repellants</strong>: Benzyl benzoate, indalone, meta-diethyltoluamide, dimethyl phthalate, ethyl hexanediol.</li>\n<li><strong>Organo-phosphorus compounds</strong>: Chlorthion (aryl), diazinon (aryl), demethoate, malathion (alkyl), fenthion, parathion (aryl), trichlorfon (alkyl), runnel, abale, naled, chlorpyrifos, fenitrothion, dicapthon.</li>\n<li><strong>Carbamates</strong>: Carbaryl, dimetilan, propoxur, pyrolan.</li>\n<li><strong>Synthetic pyrethroids</strong>: Prothrin, resmethrin, bioresmethrin, permethrin, proparthin, tetramethrin</li>\n</ul>\n</li>\n<li><strong>Stomach poisons</strong>: Paris green, sodium fluoride.</li>\n<li><strong>Fumigants</strong>: Hydrogen cyanide, methyl bromide, sulphur dioxide, carbon disulphide.</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Specific Insecticides</strong></td>\n<td><strong>Comments</strong></td>\n</tr>\n<tr>\n<td><strong>DDT </strong>(Dichloro-diphenyl-thrichloroethane)</td>\n<td>Insecticidal properties were discovered by Swiss scientist, <strong>Paul Muller</strong>. Most widely used insecticide. Attacks nerves of insects but doesn’t cause immediate death. White amorphous powder. Contains 70 – 80% of <strong>para-para isomers</strong>, which is the most active fraction of DDT. Has residual action up to 18 months. Used as a <strong>residual spray</strong>.Least toxic organo-chlorine compound.</td>\n</tr>\n<tr>\n<td><strong>HCH</strong> (hexachlorocyclo-hexane)</td>\n<td>Synthesized by <strong>Michael Faraday.</strong> Normal HCH contains 13 – 16% of gamma isomer. Gamma-HCH or <strong>lindane</strong> has 99% gamma isomer.Short residual action – 3 months.</td>\n</tr>\n<tr>\n<td><strong>Malathion</strong></td>\n<td><strong>Least toxicity</strong> of all <strong>organophosphorus</strong> compounds. Used as an <strong>ultra-low volume spray.</strong></td>\n</tr>\n<tr>\n<td><strong>Fenthion</strong></td>\n<td>Also called <strong>baytex.</strong> Used as a <strong>residual spray</strong>.</td>\n</tr>\n<tr>\n<td><strong>Pyrethrum</strong></td>\n<td>Vegetable origin – <strong>Chrysanthemum cinerariafolium.</strong> Nerve poison and is excellent as a <strong>space spray.</strong>No residual action.Synergistic action with DDT as space spray.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1085, 'Community Medicine', 'PM1684. Ticks', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The two types of ticks are <strong>hard ticks</strong> and <strong>soft ticks.</strong></li>\n<li>The general morphology of ticks includes an oval-shaped body, four pairs of legs, and no antennae.</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Hard tick</strong></td>\n<td><strong>Soft tick</strong></td>\n</tr>\n<tr>\n<td>Scutum</td>\n<td>A chitinous shield that covers the entire back in males. Females have a small portion in the front.</td>\n<td>Absent.</td>\n</tr>\n<tr>\n<td>Head</td>\n<td>Situated at the anterior end.</td>\n<td>Lies on the underside of the body (ventrally). Not visible from above.</td>\n</tr>\n<tr>\n<td>Eggs</td>\n<td>Several hundreds or thousands laid at once</td>\n<td>Laid in batches of 20 – 100 over a long period</td>\n</tr>\n<tr>\n<td>Nymphal stages</td>\n<td>One</td>\n<td>Five</td>\n</tr>\n<tr>\n<td>Habits</td>\n<td>Cannot withstand starvation; feed night and day.</td>\n<td>Can withstand starvation for more than a year.</td>\n</tr>\n<tr>\n<td>Vectors for</td>\n<td>Tick typhus, viral encephalitis, viral fevers, tularemia, Kyasanur forest disease, babesiosis, tick paralysis. Ixodes type transmits Lyme disease.</td>\n<td>Soft tick is a reservoir for Q fever and a vector for relapsing fever.</td>\n</tr>\n<tr>\n<td>Life span</td>\n<td>Short</td>\n<td>Longer</td>\n</tr>\n<tr>\n<td>Habits</td>\n<td>Always found on their hosts.</td>\n<td>They hide in cracks and crevices during the day and come out to feed during the night.</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li><strong>Insecticidal control</strong> of ticks includes <strong>DDT, chlordane, dieldrin, lindane, malathion, and toxaphene.</strong> Environmental control and protection of workers must also be done to prevent disease transmission from ticks.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4d145a93c39f4987bdc6815eb5c9c257x1280x760.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1086, 'Community Medicine', 'PM1683. Rat Fleas', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Rat fleas (<em>Xenopsylla cheopis</em>) belong to the genus <strong>Xenopsylla.</strong></li>\n<li>Their morphology includes <strong>a conical head</strong>, absent neck, a thorax with 3 segments, and an abdomen with 10 segments. They have <strong>three pairs of legs</strong> and no wings.</li>\n<li>The <strong>four stages</strong> in their life cycle are egg, larva, pupa, and adult.</li>\n<li>They cannot fly but can <strong>leap</strong> up to <strong>6 inches horizontally</strong>.</li>\n<li>They transmit diseases by<strong> biting</strong>, mechanical transmission, and <strong>feces.</strong></li>\n<li><strong>Flea indices</strong> that are used in flea surveys are the&nbsp;<strong>general flea index, specific flea index, percentage incidence of flea species,&nbsp;</strong>and <strong>rodent infestation rate.</strong></li>\n<li>Rat fleas are vectors for <strong>endemic typhus</strong> (murine typhus), <strong>chiggerosis</strong>, <strong>bubonic plague,</strong> and <strong>Hymenolepis diminuta</strong>.</li>\n<li>Insecticidal control is mainly by&nbsp;<strong>10% DDT.</strong></li>\n<li>Resistance to DDT, gamma-HCH, and dieldrin has been recorded.</li>\n<li>Repellants like <strong>diethyltoluamide</strong> and <strong>benzyl benzoate </strong>are efficient.</li>\n<li>Rodent control also aims to reduce flea infestation.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c23f2bce0b4c483d9cd264b0bd9c3cc4x1024x940.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1087, 'Community Medicine', 'PM1681. Lice', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>There are 3 kinds of lice. They are:\n<ul>\n<li><strong>Head lice</strong> (Pediculus capitis)</li>\n<li><strong>Body lice</strong> (Pediculus corporis)</li>\n<li><strong>Crab louse</strong> (pubic louse – Phthirus pubis).</li>\n</ul>\n</li>\n<li>Their morphology consists of a <strong>head</strong> with a pair of antennae, <strong>three pairs of legs</strong> attached to the <strong>thorax,</strong> and a <strong>segmented abdomen</strong>.</li>\n<li>The stages in their life cycle are <strong>eggs</strong> (nits), <strong>larva</strong> (nymph), and the <strong>adult</strong>, which live for 30 to 50 days.</li>\n<li>They are spread by direct or indirect contact.</li>\n<li>They are vectors for <strong>epidemic typhus</strong>, <strong>relapsing fever</strong>, <strong>trench fever,&nbsp;</strong>and <strong>pediculosis</strong>.</li>\n<li>Insecticidal control of lice is mainly by <strong>malathion</strong> in the form of lotion or powder.</li>\n<li>There are reports of <strong>resistance to DDT </strong>and<strong> HCH</strong>.</li>\n<li><strong>Personal hygiene</strong> is of utmost importance to prevent infestation.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d2254675e404485d8801b46ced1c8ad1x1280x760.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1088, 'Community Medicine', 'PM1676. Sandfly', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>They are also referred to as <strong>Phlebotomus.</strong></li>\n<li>They transmit diseases such as <strong>kala-azar</strong> (visceral leishmaniasis), Oriental sore, sandfly fever, and Oroya fever.</li>\n<li>They are generally smaller than mosquitoes and are <strong>hairy insects.</strong></li>\n<li>They like to dwell in cracks and crevices in walls during the daytime. They are active during the night (<strong>nocturnal pests</strong>).</li>\n<li>They do not fly for more than <strong>50 yards.</strong></li>\n<li>They can be <strong>controlled by insecticides&nbsp;</strong>and also by proper sanitation.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e7a4a6340edf44ae8550e78a19029e0fx1280x864.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1089, 'Community Medicine', 'PM1669. Mosquito Control Measures', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Anti-larval measures</strong>\n<ul>\n<li><strong>Environmental control</strong>\n<ul>\n<li>This is done by <strong>source reduction</strong> by <strong>eliminating breeding places</strong> through appropriate methods for the different species.</li>\n<li><strong>Intermittent irrigation</strong> is also a method of environmental control</li>\n</ul>\n</li>\n<li><strong>Chemical control</strong>\n<ul>\n<li><strong>Mineral oils</strong>: Oldest known larvicidal method. Oils that are used are diesel oil, kerosene, crude oil fractions. Disadvantage is that it kills fish.</li>\n<li><strong>Paris green</strong>: Copper acetoarsenite is an emerald green, micro-crystalline powder and is insoluble in water. It is a <strong>stomach poison</strong> to larvae. It is not harmful to man or animals. Very effective against Anopheles as they are surface feeders.</li>\n<li><strong>Synthetic insecticides</strong>: Organo-phosphorous compounds like fenthion, chlorpyrifos and abate are larvicidal. Abate is least toxic.</li>\n</ul>\n</li>\n<li><strong>Biological control</strong>\n<ul>\n<li>The fish species <strong>Gambusia affinis</strong> and <strong>Lebister reticulatus</strong> (Barbados millions) feed on mosquito larvae.</li>\n<li>These are used in conjunction with other methods.</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Anti-adult measures</strong>\n<ul>\n<li><strong>Residual sprays</strong>\n<ul>\n<li>Adult mosquitoes can be controlled by spraying with residual insecticides like <strong>DDT, Malathion, propoxur</strong> and<strong> gamma-HCH (lindane)</strong></li>\n<li><strong>Resistance</strong> to <strong>DDT</strong> has been shown by mosquitoes</li>\n</ul>\n</li>\n<li><strong>Space sprays</strong>\n<ul>\n<li>Space sprays are those in which <strong>insecticides</strong> are <strong>sprayed</strong> into the atmosphere in the form of a <strong>mist or fog</strong>.</li>\n<li><strong>Pyrethrum</strong> is a <strong>contact</strong>, <strong>nerve poison</strong> and is the most common insecticide used as a space spray. Its active principle is pyrethrin.</li>\n<li><strong>Ultra-low volume</strong> space spraying (ULV) is done with <strong>Malathion and fenitrothion.</strong></li>\n</ul>\n</li>\n<li><strong>Genetic control</strong> by sterile male technique, cytoplasmic incompatibility, sex distortion, etc.</li>\n</ul>\n</li>\n<li><strong>Protection against bites</strong>\n<ul>\n<li>Usage of <strong>mosquito nets</strong>, building screens and <strong>repellants </strong>like diethyltoluamide (deet), indalone, dimethylphthalate, dimethyl carbate, etc.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1090, 'Community Medicine', 'PM1668. The Mosquito', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>The mosquito as a vector:</strong></p>\n<ul>\n<li>Mosquitoes are <strong>global in distribution</strong></li>\n<li>The main species of mosquitoes include the <strong>Anopheles, Culex, Aedes,&nbsp;</strong>and <strong>Mansonia</strong></li>\n<li><strong>Flight range</strong> varies up to <strong>11 km,&nbsp;</strong>except Aedes for which it is 100 meters</li>\n<li>The life span of mosquitoes is around <strong>8 to 34 days</strong></li>\n<li>Their morphology consists of a head with a <strong>proboscis</strong>, a pair of <strong>palpi,</strong> and a pair of <strong>antennae</strong>; a thorax and an abdomen</li>\n<li>The larval stage lasts for 5 to 7 days</li>\n</ul>\n<p>Characteristics:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Characteristics</strong></td>\n<td><strong>Anopheles</strong></td>\n<td><strong>Culex</strong></td>\n<td><strong>Aedes</strong></td>\n<td><strong>Mansonia</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Eggs:</strong> 100-250.&nbsp;</p>\n</td>\n<td><strong>Laid singly</strong>.&nbsp;Boat-shaped with lateral floats.</td>\n<td>Laid in clusters or rafts.</td>\n<td>Laid singly.</td>\n<td>Laid in star-shaped clusters.</td>\n</tr>\n<tr>\n<td>\n<p><strong>Larval stage</strong></p>\n</td>\n<td>\n<p><strong>No siphon tube</strong>.</p>\n<p><strong>Lies parallel</strong> to the undersurface of water.</p>\n</td>\n<td>\n<p>Has siphon tube.</p>\n<p>Lies in water with head faced downwards.</p>\n</td>\n<td>\n<p>Has siphon tube.</p>\n<p>Lies in water with head faced downwards.</p>\n</td>\n<td>\n<p>Has siphon tube.</p>\n<p>Lies in water with head faced downwards.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Adults</strong></td>\n<td>Wings spotted.</td>\n<td>Wings unspotted.</td>\n<td>Wings unspotted. Striped body.</td>\n<td>Wings unspotted.</td>\n</tr>\n<tr>\n<td><strong>Breeding areas</strong></td>\n<td>Clean water</td>\n<td>Dirty and polluted water</td>\n<td>Artificial collections of water</td>\n<td>Water bodies containing aquatic vegetation</td>\n</tr>\n<tr>\n<td><strong>Diseases</strong></td>\n<td>Malaria, filaria</td>\n<td>Bancroftian filariasis, Japanese encephalitis, West Nile fever, viral arthritis.</td>\n<td>Yellow fever, dengue, DHF, chikungunya, rift valley fever, filariasis, Zika virus</td>\n<td>Malayan filariasis</td>\n</tr>\n<tr>\n<td><strong>Comments</strong></td>\n<td>Anopheline mosquitoes tend to sit with their heads low and their rear ends raised high, especially when feeding.&nbsp;</td>\n<td>\n<p>Called Nuisance mosquitoes</p>\n<p>These&nbsp;culicine female mosquitoes keep their bodies horizontal while feeding.</p>\n</td>\n<td>\n<p>Called&nbsp;<strong>tiger mosquitoes</strong></p>\n<p><strong>Day biters</strong></p>\n<p>They get the tigers name from the white stripes on its legs.</p>\n</td>\n<td>Big, black, or brown mosquitoes with sparkling wings and legs.&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Culex</strong> mosquito keeps their bodies <strong>horizontal</strong> while feeding.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/757c2c3ffa7b49d683b56627fa39f325x350x243.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;<strong>Anopheles</strong> mosquito tends to <strong>sit at an angle</strong>, with their heads low and their rear ends raised high.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/63efb6787d7b418b9c0acd907790fc3bx347x269.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Aedes</strong> mosquito has a&nbsp;<strong>striped&nbsp;</strong>body pattern.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/783a69fcdd7545f5a6a6166f8c0a73edx700x470.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1091, 'Community Medicine', 'PM1666. Oxidation Ponds', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>They are also called <strong>waste stabilization ponds</strong> or <strong>redox ponds</strong> or <strong>sewage lagoons.</strong></li>\n<li>They have become a popular method of purifying sewage for small communities.</li>\n<li>It is usually an open, shallow pool of around 1 – 1.5m depth with an inlet and outlet.</li>\n<li>To qualify as an oxidation pond, there needs to be <strong>algae</strong>, certain types of <strong>saprophytic bacteria</strong> and <strong>sunlight.</strong></li>\n<li>All of the above factors help in the treatment of sewage waste through aerobic and anaerobic processes</li>\n<li>The effluent formed can be used for land irrigation or can be forwarded for further treatment</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1092, 'Community Medicine', 'PM1664. Modern Sewage Treatment', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5e8bcf86dbd547028895f0d2057dab2ex1280x2066.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Primary treatment:</strong></p>\n<ul>\n<li><strong>Screening</strong>\n<ul>\n<li>A <strong>large metal screen</strong> is used to intercept large floating objects like dead animals, wood, rags, etc., so as to <strong>prevent clogging</strong></li>\n</ul>\n</li>\n<li><strong>Grit chamber</strong>\n<ul>\n<li>It is also called <strong>detritus chamber</strong></li>\n<li>It allows for the <strong>settlement</strong> of <strong>heavier solids</strong> like gravel or sand and permits the organic matter to flow through</li>\n<li>The <strong>grit</strong> that is collected at the bottom is then disposed of</li>\n</ul>\n</li>\n<li><strong>Primary sedimentation</strong>\n<ul>\n<li>In a <strong>primary sedimentation tank</strong>, sewage is allowed to flow slowly so that <strong>suspended matter</strong>&nbsp;that&nbsp;<strong>sediments</strong> form <strong>sludge</strong> which is then removed</li>\n<li>Biological action takes place here and breaks down complex organic solids</li>\n<li><strong>Scum</strong> in the form of grease and fat collects on top of the tank</li>\n<li>Sometimes, chemicals like lime are added to the <strong>effluent </strong>to enhance precipitation</li>\n</ul>\n</li>\n</ul>\n<p><strong>Secondary treatment:</strong></p>\n<p>The effluent from the primary sedimentation tank is subjected to aerobic oxidation by trickling filter method or activated sludge process.</p>\n<ul>\n<li><strong>Trickling filter method</strong>\n<ul>\n<li>The trickling or percolating filter is a <strong>bed of crushed stones or clinker</strong></li>\n<li>&nbsp;Effluent from the primary sedimentation tank is spread over the filter bed and as it percolates through it, it gets <strong>oxidized by bacterial flora</strong>. There is <strong>no actual filtration</strong> that occurs.</li>\n<li>The oxidized sewage forms a light green material called <strong>humus</strong>. It is then led into secondary sedimentation tanks.</li>\n</ul>\n</li>\n<li><strong>Activated sludge process</strong><br>\n<ul>\n<li>The <strong>heart</strong> of the activated sludge process is the <strong>aeration tank</strong></li>\n<li>In these tanks, the effluent from primary sedimentation is <strong>mixed with activated or return sludge</strong> (sludge from the final settling tank) and is then exposed to <strong>aeration for 6 to 8 hours.</strong></li>\n<li>During aeration, <strong>organic matter is oxidized</strong> into carbon dioxide, nitrates and water with the help of aerobic bacteria in the activated sludge.</li>\n</ul>\n</li>\n<li><strong>Secondary sedimentation</strong>\n<ul>\n<li>From the trickling filters or aeration tanks, the oxidized sewage is allowed into a <strong>secondary sedimentation tank</strong> where it is held for 2 – 3 hours</li>\n<li>Here, <strong>aerated sludge </strong>or <strong>activated sludge </strong>is formed, part of which is pumped back into an aeration tank</li>\n</ul>\n</li>\n<li><strong>Sludge digestion</strong>\n<ul>\n<li>Sludge digestion can be done by incubating it under favourable conditions to allow <strong>anaerobic auto-digestion</strong>. This is done in <strong>sludge digestion tanks</strong>.</li>\n<li>Disposal of sludge is also done by <strong>sea disposal</strong></li>\n<li>Sludge can also be disposed of by <strong>composting</strong> with solid refuse</li>\n</ul>\n</li>\n<li><strong>Disposal of effluent</strong>\n<ul>\n<li>Disposal of effluent can be done by <strong>dilution</strong> in water bodies which has to then be <strong>chlorinated</strong></li>\n<li><strong>Disposal on land</strong> is possible if the effluent can be used for <strong>irrigation purposes</strong></li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1093, 'Community Medicine', 'PM1662. Strength of Sewage', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The strength of sewage is expressed by the following.</p>\n<ul>\n<li><strong>Biochemical oxygen demand (BOD):</strong><br>\n<ul>\n<li>It is the <strong>standard test</strong> which is an indicator of the <strong>organic content</strong> of sewage</li>\n<li>It is defined as the <strong>amount of oxygen</strong> <strong>absorbed</strong> by a sample of sewage during a specified period (generally 5 days), at a specified temperature (generally 20 deg.C) for the <strong>aerobic destruction </strong>or use of organic matter&nbsp;by living microorganisms.</li>\n<li>A <strong>high BOD (300 mg/l)</strong> indicates a high content of easily degradable, organic material while a <strong>low BOD (100mg/l)</strong> indicates the presence of content that is not easily degradable, low volume of organic matter or measurement problems.</li>\n</ul>\n</li>\n<li><strong>Chemical oxygen demand (COD):</strong>\n<ul>\n<li>This test measures the <strong>oxygen equivalent</strong> of that portion of the organic matter in a sample that is susceptible to oxidation by a strong chemical oxidizer</li>\n<li>This is mostly used when sewage contains <strong>toxic wastes</strong></li>\n</ul>\n</li>\n<li><strong>Suspended solids:</strong>\n<ul>\n<li>The amount of <strong>suspended solids</strong> in sewage may vary from <strong>100 to 500 ppm</strong> (mg/litre)</li>\n<li>If the level of suspended solids is <strong>100 ppm</strong>, then sewage is <strong>weak</strong> and if it is <strong>more than 500 ppm</strong>, sewage is <strong>strong.</strong></li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1094, 'Community Medicine', 'PM1661. Septic Tank', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>It is a <strong>water-tight tank</strong> into which household sewage is admitted for treatment.</li>\n<li>Septic tanks are <strong>not recommended for large communities</strong>.</li>\n<li>Design features:\n<ul>\n<li>There are <strong>single and double chambered</strong> septic tanks.</li>\n<li>The usual minimum <strong>capacity </strong>recommended of a septic tank is <strong>500 gallons</strong> for a household.</li>\n<li>The <strong>length of a septic tank is twice its breadth</strong>.</li>\n<li>The <strong>depth of a septic tank</strong> is usually <strong>1.5 to 2m</strong>.</li>\n<li>The recommended <strong>depth of liquid</strong> is <strong>1.2m</strong>.</li>\n<li>The tank has an <strong>inlet and outlet pipe</strong> along with a concrete cover.</li>\n<li>Septic tanks are usually designed to have a <strong>retention period of 24 hours</strong>.</li>\n</ul>\n</li>\n<li><strong>Working</strong>:\n<ul>\n<li><strong>Sludge settles down</strong> and <strong>scum</strong> is formed at the <strong>surface</strong></li>\n<li><strong>Liquid</strong> called <strong>effluent</strong> passes out through the outlet pipe from time to time</li>\n<li><strong>Anaerobic digestion</strong> takes place <strong>in the tank</strong> and reduces the solid waste which is followed by <strong>aerobic oxidation</strong> <strong>outside the tank</strong></li>\n<li>By these processes, sewage is purified</li>\n</ul>\n</li>\n<li>Operation and maintenance:\n<ul>\n<li><strong>Soap water and phenols must not be used</strong></li>\n<li><strong>Desludging</strong> must be done at least once a year</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Below is an image of a double-chambered septic tank.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/704440c10215487f8b538b881b6068e8x1200x1280.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1095, 'Community Medicine', 'PM1660. RCA Latrines', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>This is a <strong>water-seal type latrine</strong> and has been adopted widely in India.</li>\n<li>It was designed by the <strong>Research-cum-Action Projects</strong> in Environment Sanitation of Ministry of Health, Government of India.</li>\n<li>Water-seals aid in preventing flies and other organisms from reaching the waste and also prevent odours and other forms of contamination.</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Location</strong></td>\n<td>More than 15m away from water source.</td>\n</tr>\n<tr>\n<td><strong>Squatting plate</strong></td>\n<td>Should be impervious and should allow for drainage of water.</td>\n</tr>\n<tr>\n<td><strong>Pan</strong></td>\n<td>It receives the nightsoil, urine and wash water.</td>\n</tr>\n<tr>\n<td><strong>Trap</strong></td>\n<td>It holds the water and provides the <strong>water-seal.</strong> A good trap has an effective seal of around 2 – 2.5 cms.</td>\n</tr>\n<tr>\n<td><strong>Connecting pipe</strong></td>\n<td>Present in indirect type and absent in direct type.</td>\n</tr>\n<tr>\n<td><strong>Dug well</strong></td>\n<td>Has to be changed after it is filled.</td>\n</tr>\n<tr>\n<td><strong>Superstructure</strong></td>\n<td>Built for privacy and shelter.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1096, 'Community Medicine', 'PM1659. Methods of Excreta Disposal', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Unsewered areas</strong></p>\n<ul>\n<li><strong>Service type latrines</strong> (Conservancy system)\n<ul>\n<li>In this, nightsoil is collected manually from pail or bucket type latrines and then disposed by burying or composting.</li>\n</ul>\n</li>\n<li><strong>Non-service type latrines</strong> (sanitary latrines)\n<ul>\n<li>Bore hole latrine</li>\n<li>Dug well or pit latrine</li>\n<li>Water-seal latrines – P.R.A.I. type, R.C.A. type and Sulabh shauchalaya</li>\n<li>Septic tanks</li>\n<li>Aqua privy</li>\n</ul>\n</li>\n<li>Latrines for <strong>camps and temporary use</strong>\n<ul>\n<li>Shallow and deep trench latrine</li>\n<li>Pit latrine</li>\n<li>Bore hole latrine</li>\n</ul>\n</li>\n</ul>\n<p><strong>Sewered areas</strong></p>\n<ul>\n<li>Water carriage system and sewage treatment\n<ul>\n<li><strong>Primary treatment </strong>– Screening, removal of grit and plain sedimentation.</li>\n<li><strong>Secondary treatment </strong>– Trickling filters, activated sludge process</li>\n<li><strong>Other methods</strong> – sea and river outfalls, sewage farming, oxidation ponds.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1097, 'Community Medicine', 'PM1658. Composting', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>It is a method of combined disposal of refuse and nightsoil.</li>\n<li>In this process, organic matter is broken down by <strong>bacterial action and heat</strong> into <strong>compost,</strong> which has manure value and few or no disease causing pathogens.</li>\n<li><strong>Bangalore method</strong>\n<ul>\n<li>This is also called <strong>hot fermentation process </strong>and is an anaerobic method.</li>\n<li><strong>Trenches</strong> with depth of <strong>not more than 90cm</strong> are used for this.</li>\n<li>Method – First layer of refuse is spread at bottom of trench (15cm thick) à Next layer, nightsoil is added (5cm thick) à Then, alternatively layers of refuse and nightsoil are added till heap rises to 30cm above ground level à The heap is then covered with <strong>excavated earth</strong>.</li>\n<li>At the end of 4 – 6 months, decomposition will be complete</li>\n</ul>\n</li>\n<li><strong>Mechanical composting</strong>\n<ul>\n<li>This is an <strong>aerobic process</strong></li>\n<li>In this method, compost is prepared on a <strong>large scale</strong> in a controlled environment.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1098, 'Community Medicine', 'PM1657. Controlled Tipping', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>It is the most<strong> satisfactory method of refuse disposal</strong> in available land</li>\n<li>Waste materials are placed in a trench, compacted and covered with Earth at the end of the day</li>\n<li>This method is also called as <strong>sanitary landfill</strong></li>\n<li>Methods used for controlled tipping are the <strong>trench method</strong>, the <strong>ramp method</strong> and the <strong>area method</strong></li>\n<li>Chemical, bacteriological and physical changes occur in the buried refuse with temperatures rising to over 60 degrees Celsius within 7 days.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1099, 'Community Medicine', 'PM1654. Effects of Noise Exposure', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Auditory effects</strong>\n<ul>\n<li><strong>Auditory fatigue</strong> appears at <strong>90 dB </strong>and is greatest at <strong>4000 Hz.</strong> Whistling and buzzing in ear occurs with auditory fatigue.</li>\n<li><strong>Temporary deafness</strong> or hearing loss occurs after a single exposure to a noise, usually at a frequency range of 4000 – 6000 Hz. It disappears after 24 hours following noise exposure.</li>\n<li><strong>Permanent hearing loss</strong> can result after continuous or repeated exposure to noises <strong>around 100 dB</strong>. It occurs commonly as <strong>occupational hearing loss.</strong></li>\n<li>Exposure to noise <strong>above 160 dB</strong> may <strong>rupture</strong> the <strong>tympanic membrane</strong> and cause permanent hearing loss.</li>\n</ul>\n</li>\n<li><strong>Non-auditory effects</strong>\n<ul>\n<li><strong>Interference with speech</strong> occurs when sound has a <strong>frequency of 300 – 500 Hz</strong></li>\n<li><strong>Annoyance</strong> is a psychological response to noise which can greatly affect <strong>efficiency and concentration</strong></li>\n<li>Noise has also been known to cause some physiological changes like increased blood pressure, intracranial pressure, increased sweating, etc.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1100, 'Community Medicine', 'PM1653. Properties of Sound and Noise', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>I)</strong>&nbsp;<strong>Loudness</strong></p>\n<ul>\n<li>Loudness or intensity depends upon the amplitude of vibrations and it is measured in <strong>decibels (dB).</strong></li>\n<li>The daily exposure of up to <strong>85 dB</strong> is the limit that people can tolerate without substantial damage to hearing. This limit is the maximum acceptable noise limit.</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Normal conversation</strong></td>\n<td>60 – 65 dB</td>\n</tr>\n<tr>\n<td><strong>Whispering</strong></td>\n<td>20 – 30 dB</td>\n</tr>\n<tr>\n<td><strong>Heavy street traffic</strong></td>\n<td>60 – 80 dB</td>\n</tr>\n<tr>\n<td><strong>Boiler factories</strong></td>\n<td>120 dB</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Acceptable noise levels </strong>are expressed in terms of unit <strong>dBA</strong>, which is decibels conform to a weighting curve called <strong>curve A.</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Area</strong></td>\n<td><strong>Place in area</strong></td>\n<td><strong>Acceptable noise levels (dBA)</strong></td>\n</tr>\n<tr>\n<td>Residential</td>\n<td>Bed room</td>\n<td>25</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Living room</td>\n<td>40</td>\n</tr>\n<tr>\n<td>Commercial</td>\n<td>Office</td>\n<td>35 – 45</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Conference</td>\n<td>40 – 45</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Restaurants</td>\n<td>40 – 60</td>\n</tr>\n<tr>\n<td>Industrial</td>\n<td>Workshop</td>\n<td>40 – 60</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Laboratory</td>\n<td>40 – 50</td>\n</tr>\n<tr>\n<td>Educational</td>\n<td>Classroom</td>\n<td>30 – 40</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Library</td>\n<td>35 – 40</td>\n</tr>\n<tr>\n<td>Hospitals</td>\n<td>Wards</td>\n<td>20 – 35</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>II)</strong> <strong>Frequency</strong></p>\n<ul>\n<li>It is expressed in <strong>Hertz (Hz.)</strong> and <strong>1 Hertz</strong> is equal to <strong>one wave per second</strong></li>\n<li>The human ear can hear frequencies from about <strong>20 to 20,000 Hz</strong></li>\n<li><strong>Below 20 Hz.</strong> the vibrations are <strong>infra-audible </strong>and <strong>above 20,000 Hz.</strong> they are <strong>ultra-sonic</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1101, 'Community Medicine', 'PM1652. Lighting Standards', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The following standards have been recommended by the <strong>Illuminating Engineer Society.</strong></li>\n</ul>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Visual Task</strong></td>\n<td><strong>Illumination in lux</strong></td>\n</tr>\n<tr>\n<td><strong>Casual reading</strong></td>\n<td>100</td>\n</tr>\n<tr>\n<td><strong>General office work</strong></td>\n<td>400</td>\n</tr>\n<tr>\n<td><strong>Fine assembly</strong></td>\n<td>900</td>\n</tr>\n<tr>\n<td><strong>Very severe tasks</strong></td>\n<td>1300 – 2000</td>\n</tr>\n<tr>\n<td><strong>Watch making</strong></td>\n<td>2000 – 3000</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1102, 'Community Medicine', 'PM1651. Daylight Factor', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Daylight factor (D.F.)</strong> is the ratio of the illumination at a given point to the illumination at a point exposed to the whole hemisphere of the sky (taken as 500 foot candles) excluding direct sunlight.</li>\n<li><strong>D.F. </strong>= <strong>Instantaneous illumination indoors x 100/ Simultaneously occurring illumination outdoors</strong></li>\n<li>The D.F. is used for measurement of daylight and is determined by a modified photo-electric meter called <strong>Daylight Factor Meter.</strong></li>\n<li>In living rooms, daylight factor should be at least 8% and in kitchens it should be 10%.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1103, 'Community Medicine', 'PM1650. Measurement of Light', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Quantity Measured</strong></td>\n<td><strong>Description</strong></td>\n<td><strong>SI Unit</strong></td>\n<td><strong>Other Units Used</strong></td>\n</tr>\n<tr>\n<td><strong>Luminous intensity</strong></td>\n<td>Power of light source</td>\n<td><strong>Candela</strong></td>\n<td>Candle power</td>\n</tr>\n<tr>\n<td><strong>Luminous flux</strong></td>\n<td>Flow of light</td>\n<td><strong>Lumen</strong></td>\n<td>_____</td>\n</tr>\n<tr>\n<td><strong>Illumination</strong> (Illuminance)</td>\n<td>Amount of light reaching a surface</td>\n<td><strong>Lux</strong> (per unit area)</td>\n<td>Foot candle or <strong>phot</strong> Lumen/cm<sup>2</sup></td>\n</tr>\n<tr>\n<td><strong>Luminance </strong>(brightness)</td>\n<td>Amount of light reflected from a surface</td>\n<td><strong>Lambert</strong></td>\n<td>Foot lambertCandles/cm<sup>2</sup></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1104, 'Community Medicine', 'PM1643. Overcrowding', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Overcrowding</strong> is considered to exist if <strong>2 persons</strong> over <strong>9 years of age</strong>, not <strong>husband and wife</strong>, of <strong>opposite sexes</strong> are obliged to sleep in the same room.</p>\n<p>The <strong>accepted standards</strong> against overcrowding are as follows.</p>\n<table>\n<tbody>\n<tr>\n<td>No of rooms</td>\n<td>&nbsp;No of persons</td>\n</tr>\n<tr>\n<td>1 room</td>\n<td>2 persons</td>\n</tr>\n<tr>\n<td>2 rooms</td>\n<td>3 persons</td>\n</tr>\n<tr>\n<td>3 rooms</td>\n<td>5 persons</td>\n</tr>\n<tr>\n<td>4 rooms</td>\n<td>7 persons</td>\n</tr>\n<tr>\n<td>5 rooms</td>\n<td>10 persons (1 rooms for every 2 additional persons)</td>\n</tr>\n</tbody>\n</table>\n<p>The <strong>floor space standards</strong> against overcrowding are as follows.</p>\n<table>\n<tbody>\n<tr>\n<td>Area</td>\n<td>No of persons</td>\n</tr>\n<tr>\n<td>110 sq. ft. and more</td>\n<td>2 persons</td>\n</tr>\n<tr>\n<td>90 – 100 sq. ft.</td>\n<td>1 ½ persons (Children from 1 – 10 are counted as a half unit)</td>\n</tr>\n<tr>\n<td>70 – 90 sq. ft.</td>\n<td>1 person</td>\n</tr>\n<tr>\n<td>50 – 70 sq. ft.</td>\n<td>½ person</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1105, 'Community Medicine', 'PM1638. Non-Rural Housing Standards in India', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Housing parameters</strong></td>\n<td>\n<p><strong>Description</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Site</strong></td>\n<td>\n<p><strong>Elevated</strong> to protect from rains and floods.</p>\n<p>Independent access to street.</p>\n<p>Away from vector breeding sites and other pollutants like smoke, noise, dust.</p>\n<p>Soil on which it is founded must be dry and safe.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Floor</strong></td>\n<td>A <strong>pucca floor</strong> that is impermeable, easy to clean, free from cracks, damp-proof. <strong>Height of plinth</strong> must be <strong>2 – 3 feet</strong>.</td>\n</tr>\n<tr>\n<td><strong>Walls</strong></td>\n<td><strong>9 inch </strong>thick, strong, low heat capacity, weather resistant, unsuitable for harbourage of rats/vermin.</td>\n</tr>\n<tr>\n<td><strong>Roof</strong></td>\n<td><strong>Height not less than 10 feet</strong> (3m).</td>\n</tr>\n<tr>\n<td><strong>Rooms</strong></td>\n<td>Number of rooms must be according to size of family but <strong>basic number</strong> is <strong>two.</strong></td>\n</tr>\n<tr>\n<td><strong>Floor area</strong></td>\n<td>A living room should have at least <strong>120 sq. ft.</strong> of area for <strong>occupancy of more than 1 person</strong> and 100 sq. ft. for occupancy of only one person. <strong>50 -100</strong> <strong>sq. ft.</strong> <strong>floor area per person is optimum</strong> in a living room.</td>\n</tr>\n<tr>\n<td><strong>Cubic space</strong></td>\n<td><strong>500 – 1000</strong> cubic feet of air space per capita.</td>\n</tr>\n<tr>\n<td><strong>Windows</strong></td>\n<td>At least <strong>2 windows per room</strong> with one opening into an open space. Windows must be at a <strong>height </strong>of not more than <strong>3 feet</strong> above ground. Window area must be 1/5<sup>th</sup> of floor area.</td>\n</tr>\n<tr>\n<td><strong>Lighting</strong></td>\n<td>Daylight factor should be <strong>&gt;1% over half the floor area.</strong></td>\n</tr>\n<tr>\n<td><strong>Sanitary privy</strong></td>\n<td>It is a <strong>must in every house.</strong></td>\n</tr>\n<tr>\n<td><strong>Others</strong></td>\n<td>Proper facilities for garbage disposal, bathing and washing and a good water supply.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1106, 'Community Medicine', 'PM1631. Types of Ventilation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Types of Ventilation</strong></p>\n<ul>\n<li><strong>Natural ventilation:</strong>\n<ul>\n<li><strong>Perflation </strong>is the ventilation of a space achieved by <strong>allowing wind to blow through it</strong> and removing the obstacles for this to happen (e.g., opening windows and doors).</li>\n<li><strong>Aspiration</strong> occurs when there is an obstruction as wind bypasses it and creates a suction action</li>\n<li><strong>Diffusion</strong> is the passage of air through small spaces or openings</li>\n<li><strong>Cross-ventilation</strong> is when air is allowed a natural path through the space by providing openings at appropriate places, like opposite to each other.</li>\n<li>The<strong> drawback</strong> of natural ventilation is that regulation of <strong>air quality is not possible</strong>.</li>\n</ul>\n</li>\n<li><strong>Mechanical Ventilation</strong>\n<ul>\n<li><strong>Exhaust ventilation</strong> utilizes <strong>exhaust fans </strong>which run on electricity and are placed high up near the roof on the external walls. A vacuum is created by which fresh air enters the ventilated space.</li>\n<li><strong>Plenum ventilation</strong> uses <strong>centrifugal fans</strong> to blow fresh air into the room and create a positive pressure, by which vitiated air is pushed out.</li>\n<li><strong>Balanced ventilation</strong> is the combination of both <strong>exhaust and plenum </strong>methods of ventilation.</li>\n<li><strong>Air conditioning</strong> is the simultaneous control of all or at least three factors that influence air quality in a confined room or space. These factors include temperature, humidity, air movement, distribution, dust, bacteria, odors and toxic gases.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1107, 'Community Medicine', 'PM1624. Greenhouse Effect', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Greenhouse gases</strong> (GHGs) or radiatively active gases (RAGs) are gases in the atmosphere that absorb some of the upward-going, long-wave radiation after they have left the Earth’s surface. They then emit the radiation<strong>&nbsp;</strong>in all directions, some of it back towards the Earth’s surface. This raises the earths temperature.</p>\n<p>In this entire process, the earth acts as an effective insulator and the overall process is known as the&nbsp;<strong>greenhouse effect.&nbsp;</strong>The greenhouse effect has a role in <strong>global warming </strong>which is the average rise in global temperature leading to change in climate patterns.</p>\n<p>The most important <strong>natural</strong> <strong>GHGs </strong>are:</p>\n<ul>\n<li>Water vapor</li>\n<li>Carbon dioxide</li>\n<li>Methane</li>\n<li>Tropospheric ozone (Stratospheric ozone is not harmful)</li>\n<li>Nitrous oxide</li>\n</ul>\n<p><strong>Non-natural</strong> GHGs include chlorofluorocarbons (<strong>CFCs</strong>).</p>\n<p>International protocols on climate change:</p>\n<ul>\n<li><strong>Kyoto Protocol:</strong>\n<ul>\n<li>Linked to the United Nations Framework Convention on Climate Change</li>\n<li>Set internationally binding <strong>emission reduction</strong> targets for the concerned parties</li>\n<li>Parties aimed to reduce GHGs by <strong>18%&nbsp;</strong>from&nbsp;<strong>2013-2020.</strong></li>\n</ul>\n</li>\n<li><strong>Paris Agreement:</strong>\n<ul>\n<li>Aims to strengthen the global response to climate change</li>\n<li>Aims to maintain the global temperature rise in this century &lt; 2°C above pre-industrial levels</li>\n<li>Aims to pursue efforts to limit the temperature increase even further to 1.5°C.</li>\n<li>It deals with <strong>greenhouse</strong> gas<strong> emissions mitigation, adaptation,</strong> and<strong> finance</strong> starting in the year <strong>2020.</strong></li>\n</ul>\n</li>\n<li><strong>Montreal Protocol:</strong>\n<ul>\n<li>Related to the <strong>depletion of the atmospheric ozone layer</strong>, which is protective.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1108, 'Community Medicine', 'PM1623. Air Pollution', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The <strong>vertical diffusion of pollutants</strong> depends upon the <strong>temperature gradient</strong>. When there is <strong>rapid cooling of the lower atmospheric layers</strong> – which is called <strong>temperature inversion </strong>- due to little vertical diffusion, pollutants and water&nbsp;vapor get <strong>trapped in the lower levels of the atmosphere.</strong></p>\n<p><strong>Air pollutants:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Pollutant</strong></td>\n<td><strong>Comments</strong></td>\n</tr>\n<tr>\n<td><strong>Carbon monoxide</strong></td>\n<td>Incomplete combustion of carbon-containing materials like fuel combustion, vehicles, industries, etc.</td>\n</tr>\n<tr>\n<td><strong>Sulfur dioxide</strong></td>\n<td>\n<p>Colorless gas <br>Sharp odor<br>Combustion of sulfur-containing fossil fuels, smelting of ores, etc<br>Main components of acid rain.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Lead</strong></td>\n<td>Usually occupational and environmental sources</td>\n</tr>\n<tr>\n<td><strong>Carbon dioxide</strong></td>\n<td>Increase in a global concentration above natural levels can increase temperature and affect climate adversely.</td>\n</tr>\n<tr>\n<td><strong>Hydrocarbons</strong></td>\n<td>Cause photochemical smog</td>\n</tr>\n<tr>\n<td><strong>Cadmium</strong></td>\n<td>From volcanic action, waste incineration, zinc production, smoking, etc</td>\n</tr>\n<tr>\n<td><strong>Hydrogen sulfide</strong></td>\n<td>Waste-water treatment plants, wood pulp production, coke production, etc</td>\n</tr>\n<tr>\n<td><strong>Ozone</strong></td>\n<td>Ground-level ozone is one of the main constituents of photochemical smog.</td>\n</tr>\n<tr>\n<td><strong>Oxides of nitrogen</strong></td>\n<td>Most common form is nitric oxide<br>From coal burning, road traffic, and electricity generation<br> Affects the lungs adversely</td>\n</tr>\n<tr>\n<td><strong>Polyaromatic hydrocarbons </strong>(PAH)</td>\n<td>Incomplete burning of wood or coal, vehicle exhausts, smoking, etc<br>Carcinogenic and mutagenic</td>\n</tr>\n<tr>\n<td><strong>Particulate matter</strong></td>\n<td>Mixture of solid and liquid, organic and inorganic matter<br> Major components are sulfates, nitrates, sodium chloride, mineral dust, black carbon, and water.</td>\n</tr>\n<tr>\n<td><strong>Common indoor air pollutants</strong></td>\n<td>\n<p>From coal or fuel combustion</p>\n<p>Include CO, PAHs, nitrogen and sulfur oxides, pesticides, and other biological pollutants</p>\n<p><br> Radon, lead, asbestos are formed from construction materials, paints, and demolition</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Effects</strong> of<strong> indoor</strong> air<strong> pollution:</strong></p>\n<ul>\n<li>Lung infections including pneumonia, tuberculosis, ALRI</li>\n<li>Stroke</li>\n<li>Ischemic heart disease</li>\n<li>COPD</li>\n<li>Lung, laryngeal, nasopharyngeal cancers</li>\n<li>Pregnancy problems like low birth weight</li>\n</ul>\n<p><strong>Indicators</strong> of air<strong> pollution:</strong></p>\n<ul>\n<li><strong>Sulfur dioxide</strong>&nbsp;- one of the best indicator of air pollution</li>\n<li><strong>Smoke </strong>or <strong>soiling index</strong>: A known volume of air is filtered through a white filter paper under specified conditions and the stain is measured by a photoelectric meter</li>\n<li><strong>Grit</strong> and<strong> dust measurement&nbsp;</strong></li>\n<li>The<strong> co-efficient of haze</strong> - assessment of the amount of smoke or other aerosols in the air</li>\n<li><strong>Air pollution index -</strong>&nbsp;measure of pollution severity</li>\n<li>Suspended particle matter (<strong>SPM</strong>)&nbsp;</li>\n</ul>\n<p>In India, <strong>National Air Quality Programme</strong> sponsored by the Central Pollution Control Board (<strong>CPCB</strong>) is the main mode of monitoring air pollution.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1109, 'Community Medicine', 'PM1620. Humidity', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Absolute humidity </strong>is the <strong>weight of water vapor </strong>in a <strong>unit volume of air</strong> and it is expressed as g/kg of air or g/m<sup>3</sup> of air.</p>\n<p><strong>Relative humidity (RH)</strong>:</p>\n<ul>\n<li>It is the <strong>ratio</strong> of the<strong>&nbsp;</strong>actual water vapor content to the maximum water vapor content&nbsp;in the air required for saturation of air at a given temperature and pressure. It is expressed as a percentage.</li>\n<li><strong>RH = Actual water vapor content x 100/ Total water vapor content</strong></li>\n<li>Very low RH can cause skin problems, irritation of the mucous membranes of the nose and throat, and precipitation of infections.&nbsp;</li>\n</ul>\n<p><strong>Dew point</strong> is the temperature to which air has to be cooled to achieve saturation given the pressure and constant moisture content</p>\n<p><strong>Measurement of humidity:</strong></p>\n<ul>\n<li>Dry and wet hygrometers -&nbsp;most widely used instrument</li>\n<li>Sling or whirling psychrometers</li>\n</ul>\n<p>The following image depicts a whirling psychrometer:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/29634098e945435586ab66cf88c8bd6bx1280x966.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The following image depicts an Assmann psychrometer:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/798c7dccb97244f49f38ac585717ebf4x442x1049.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The following image depicts a dry and wet hygrometer:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/037e621b5ecf4599927a14c00559f352x160x538.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1110, 'Community Medicine', 'PM1619. Heat Stress', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Heat stress </strong>is the <strong>load of heat </strong>that must be <strong>dissipated from the body </strong>if it is to remain in thermal equilibrium.</li>\n<li><strong>Factors</strong> which <strong>affect heat stress </strong>are <strong>metabolic rate, air temperature, humidity, air movement</strong> and <strong>radiant temperature</strong>.</li>\n<li>Heat stress <strong>indices</strong>:\n<ul>\n<li><strong>Equatorial comfort index</strong></li>\n<li><strong>Heat stress index (HSI)</strong> – Values of HIS are as given below</li>\n</ul>\n</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>HSI</strong></td>\n<td><strong>Thermal stress</strong></td>\n<td><strong>Work and effects</strong></td>\n</tr>\n<tr>\n<td>0</td>\n<td>No thermal strain</td>\n<td>No work impairment</td>\n</tr>\n<tr>\n<td>10 – 30</td>\n<td>Moderate to mild heat strain</td>\n<td>Minimal work impairment</td>\n</tr>\n<tr>\n<td>40 – 60</td>\n<td>Severe heat strain</td>\n<td>Threat to health and greatly impaired work</td>\n</tr>\n<tr>\n<td>70 – 90</td>\n<td>Very severe heat strain</td>\n<td>Only few who are fit and acclimatized can sustain work</td>\n</tr>\n<tr>\n<td>100</td>\n<td>Upper limit of heat tolerance</td>\n<td>Only fit and acclimatized can sustain work, although with impairment</td>\n</tr>\n<tr>\n<td>&gt;100</td>\n<td>Exceeds tolerable limits</td>\n<td>Varying degrees of heat stress and effects can pursue</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li><strong>Predicted four-hour sweat rate (P<sub>4</sub>SR)</strong>\n<ul>\n<li><strong>Effects</strong> of heat stress include heat<strong> stroke</strong>, heat<strong> hyperpyrexia</strong>, heat <strong>exhaustion</strong>, heat <strong>cramps</strong> and heat <strong>syncope</strong></li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1111, 'Community Medicine', 'PM1618. Measurement of Air Temperature', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>A number of <strong>thermometers</strong> that employ <strong>mercury or alcohol</strong> are used for measuring air temperature.</p>\n<p>These thermometers are <strong>mounted</strong> on a <strong>special screen</strong> called <strong>Stevenson screen</strong> as air should have free access to their bulbs and they must be protected from radiant heat.</p>\n<p>The instruments used to measure air temperature are:</p>\n<p>1)&nbsp;<strong>Dry bulb thermometers</strong>:</p>\n<p>These are <strong>ordinary mercury thermometers</strong> mounted on a Stevenson screen at about 1.20 to 1.80 metres above sea level</p>\n<p>2)<strong> Wet bulb thermometers:</strong></p>\n<p>These are just like the dry bulb variants but the bulb is kept wet by a <strong>muslin cloth</strong> that is fed with water from a bottle through a wick.</p>\n<p>3)<strong> Maximum thermometer</strong></p>\n<p>This is a <strong>mercury thermometer</strong> that has a very fine constriction near the neck of the bulb</p>\n<p>4)<strong> Minimum thermometer</strong></p>\n<p>The liquid in this thermometer is a spirit that has a dumb-bell shaped index immersed in it</p>\n<p>5) <strong>Six’s maximum-minimum thermometer</strong></p>\n<ul>\n<li>This thermometer has both <strong>mercury</strong> and<strong> alcohol</strong></li>\n<li>It measures the <strong>maximum and minimum air temperatures</strong> reached over a <strong>period of time</strong></li>\n<li>A mercury-free variant of this thermometer is available</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/2402ec51a0e14d0aa1737c2ead8456c7x198x198.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>5)<strong> Globe thermometer</strong>:</p>\n<ul>\n<li>It is used for the direct measurement of the <strong>mean radiant temperature</strong> of the surroundings.</li>\n<li>It has a <strong>hollow metal globe</strong> (6 inches diameter) that has&nbsp;<strong>matte black paint</strong> which absorbs radiant heat. A <strong>specially calibrated mercury bulb thermometer</strong> is kept inside.</li>\n<li>The <strong>difference</strong> between the<strong> readings</strong> of the <strong>globe</strong> thermometer and the <strong>bulb</strong> thermometer is the measure of the <strong>radiant</strong> heat.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/098706b6dbe24a5e825395b288bb22c7x1280x1714.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>7)<strong> Kata thermometers:</strong></p>\n<ul>\n<li>It is an <strong>alcohol thermometer</strong> and consists of a <strong>wet kata</strong> and a <strong>dry kata.</strong></li>\n<li>A <strong>wet kata reading</strong> of <strong>20 and above</strong> and a <strong>dry kata reading </strong>of 6 and above were taken as <strong>indices of thermal comfort</strong>.</li>\n<li>It was <strong>originally used</strong> to measure the <strong>cooling power of the air </strong>(air temperature, humidity and air movement) but <strong>currently</strong> it is used only as an anemometer to measure <strong>low</strong> <strong>air velocities.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e570a479ca8b41a7b3a5680cd52d147ex1280x1588.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1112, 'Community Medicine', 'PM1617. Indices of Thermal Comfort', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Air temperature</strong>\n<ul>\n<li>This was used as an index of thermal comfort before it was realized that it was <strong>not adequate on its own</strong>.</li>\n</ul>\n</li>\n<li><strong>Air temperature and humidity</strong>\n<ul>\n<li>Humidity was included with air temperature as an index for thermal comfort but this was also <strong>inadequate</strong>.</li>\n</ul>\n</li>\n<li><strong>Cooling power</strong>\n<ul>\n<li><strong>Air temperature, humidity and air movement</strong> were collectively expressed as the <strong>cooling power of air</strong>.</li>\n<li>A <strong>kata thermometer</strong> (dry and wet) was used to <strong>measure the cooling power of air</strong></li>\n<li>These measurements were also <strong>regarded as unreliable</strong></li>\n</ul>\n</li>\n<li><strong>Effective temperature</strong>\n<ul>\n<li>This <strong>arbitrary index of thermal comfort</strong> combines into a <strong>single value</strong> the effect of <strong>temperature, humidity and movement of internal air</strong> on the sensation of warmth or cold felt in the human body.</li>\n<li>It <strong>ignores the effects of radiation</strong> from surrounding structures</li>\n</ul>\n</li>\n<li><strong>Corrected Effective Temperature</strong>\n<ul>\n<li>This <strong>widely used</strong> index of thermal comfort deals with all four factors namely, <strong>air temperature, humidity, air movement or velocity and mean radiant heat</strong>.</li>\n<li>For this, a <strong>globe thermometer</strong> is used</li>\n</ul>\n</li>\n<li><strong>McArdle’s Maximum Allowable Sweat Rate</strong>\n<ul>\n<li><strong>4.5 litres of sweat excreted in four hours</strong> was taken as then <strong>maximum allowable sweat rate</strong> that was compatible with the normal physiological reaction of acclimatized, healthy young men for repeated exposures to heat.</li>\n<li>A chart was prepared from which the <strong>predicted four-hour sweat rate (P<sub>4</sub>SR)</strong> can be obtained from readings of air and mean radiant temperature and air velocity under different work intensities.</li>\n<li>A <strong>P<sub>4</sub>SR value of 3</strong> is considered as the <strong>upper limit of comfort zones</strong>.</li>\n</ul>\n</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Zone of comfort</strong></td>\n<td><strong>Predicted</strong> <strong>P<sub>4</sub>SR</strong></td>\n</tr>\n<tr>\n<td>Comfort zone</td>\n<td>1 – 3 litres</td>\n</tr>\n<tr>\n<td>Just tolerable</td>\n<td>3 – 4.5 litres</td>\n</tr>\n<tr>\n<td>Intolerable</td>\n<td>4.5 + litres</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1113, 'Community Medicine', 'PM1612. Hardness of Water', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Hardness is the <strong>soap destroying power of water</strong> or the <strong>amount of dissolved calcium and magnesium</strong> in water.</li>\n<li>It is most commonly caused by <strong>bicarbonates and sulphates </strong>of <strong>calcium </strong>and<strong> magnesium</strong>, but their nitrates and chlorides can also cause hardness.</li>\n<li><strong>Temporary </strong>(carbonate)<strong>&nbsp;</strong>hardness&nbsp;is due to <strong>bicarbonates</strong> of calcium and magnesium.&nbsp;</li>\n<li><strong>Permanent </strong>(non-carbonate)&nbsp;hardness&nbsp;is due to&nbsp;<strong>sulphates</strong>,<strong> chlorides </strong>and<strong> nitrates</strong>.</li>\n<li><strong>1 mEq/L</strong>&nbsp;of an ion that produces hardness is equal to <strong>50 mg CaCO<sub>3</sub></strong> (50 ppm) in <strong>1 litre of water</strong>.</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Classification</strong></td>\n<td><strong>Level of hardness (mEq/l)</strong></td>\n<td><strong>Amount of ion producing hardness (mg/l)</strong></td>\n</tr>\n<tr>\n<td>Soft water</td>\n<td>Less than 1</td>\n<td>Less than 50</td>\n</tr>\n<tr>\n<td>Moderately hard</td>\n<td>1 – 3</td>\n<td>50 – 150</td>\n</tr>\n<tr>\n<td>Hard water</td>\n<td>3 – 6</td>\n<td>150 – 300</td>\n</tr>\n<tr>\n<td>Very hard water</td>\n<td>Over 6</td>\n<td>More than 300</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li><strong>Drinking water</strong> must be <strong>moderately hard</strong></li>\n<li><strong>Softening of water</strong> is recommended when the <strong>hardness exceeds 3 mEq/L (150 mg/litre)</strong></li>\n<li><strong>Removal of hardness:</strong>\n<ul>\n<li><strong>Boiling:&nbsp;</strong>\n<ul>\n<li>This <strong>removes</strong> <strong>temporary hardness</strong> by <strong>expelling carbon dioxide</strong> and <strong>precipitating </strong>insoluble<strong> calcium carbonate</strong>. It would be expensive to do this on a large scale.</li>\n</ul>\n</li>\n<li><strong>Addition of lime:&nbsp; </strong>\n<ul>\n<li>This <strong>removes</strong> <strong>temporary hardness</strong> and also <strong>reduces magnesium</strong>. Lime <strong>absorbs carbon dioxide</strong> and <strong>precipitates </strong>insoluble<strong> calcium carbonate</strong>. In <strong>Clark’s method</strong> of softening water, <strong>lime</strong> is used.</li>\n</ul>\n</li>\n<li><strong>Addition of sodium carbonate </strong>(soda ash): <strong>removes</strong> both <strong>temporary </strong>and<strong> permanent </strong>hardness.</li>\n<li><strong>Base exchange process:</strong>\n<ul>\n<li>This <strong>removes</strong> <strong>permanent </strong>and<strong> temporary </strong>hardness and can be used on a large scale. In this method, <strong>permutit</strong> is used. <strong>Sodium permutit</strong> is a complex compound of <strong>sodium, aluminium and silica</strong>. When hard water is passed through this permutit, the calcium and magnesium ions are removed by<strong> base exchange</strong> and is converted into <strong>calcium and magnesium permutit</strong>. This process reduces water to <strong>zero hardness</strong>, which is corrosive and thus it is then mixed with a part of raw water.</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1114, 'Community Medicine', 'PM1611. WHO Guidelines for Drinking Water Quality, 2017', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>WHO Guidelines for Drinking Water Quality, 2017</strong></p>\n<p><strong>I)&nbsp;Physical parameters:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp;</strong></td>\n<td><strong>Guideline values</strong></td>\n<td><strong>Comments</strong></td>\n</tr>\n<tr>\n<td><strong>Turbidity</strong></td>\n<td>Ideally, no visible turbidity but permissible standard is <strong>&lt; 1.0 NTU </strong>(nephelometric turbidity units) for household drinking water.&nbsp;</td>\n<td>\n<p>It describes the <strong>cloudiness of water</strong>.</p>\n<ul>\n<li><strong>&gt;4 NTU </strong>– cloudiness visible to naked eye.</li>\n<li><strong>&lt;4 NTU</strong> – measured only by instruments.&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Color</strong></td>\n<td>Ideally, no visible color but permissible standard is <strong>&lt;15 TCU </strong>(true color units).</td>\n<td>&nbsp;<strong>&gt;15 TCU </strong>is detectable by the naked eye.&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Taste, odor and t</strong><strong>emperature</strong></p>\n</td>\n<td><strong>No health based guideline values</strong></td>\n<td>It may be indicative of contamination and pollution.&nbsp;High water temperature may enhance growth of microorganisms and influence taste, odor and color.</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>II)&nbsp;Chemical parameters:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp;</strong></td>\n<td><strong>Guideline values</strong></td>\n</tr>\n<tr>\n<td><strong>Ammonia</strong></td>\n<td>\n<p><strong>No health based guideline value</strong>.</p>\n<p>Natural levels in <strong>surface </strong>and<strong> ground water</strong> is <strong>0.2 mg/l</strong>. <strong>Anaerobic groundwater</strong> may have up to <strong>3 mg/l</strong>.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Aluminium</strong></td>\n<td>up to<strong> 0.9 mg/l</strong></td>\n</tr>\n<tr>\n<td><strong>Arsenic</strong></td>\n<td>\n<p>up to<strong> 0.01 mg/l</strong></p>\n<p>Levels in natural water range from 1 to 2 µg/l.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Chloride</strong></td>\n<td>\n<p><strong>250 mg/l</strong>, as above this a detectable taste appears.</p>\n<p>Maximum permissible level is <strong>600 mg/l. Sodium thiosulphate</strong> can be used to dechlorinate drinking water or tap water.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Copper</strong></td>\n<td>\n<p>up to<strong> 2 mg/l.</strong></p>\n<p>Excess copper in water can have gastrointestinal effects.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Fluoride</strong></td>\n<td>\n<p>up to<strong> 1.5 mg/l.&nbsp;</strong>Above this, there is risk of <strong>dental</strong>&nbsp;and <strong>skeletal</strong> <strong>fluorosis</strong>.</p>\n<p><strong>Artificial fluoridation </strong>range is <strong>0.5 to 1.0 mg/l</strong>.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Hydrogen sulphide</strong></td>\n<td>\n<p>Taste and odor threshold is between 0.05 and 0.1 mg/litre.</p>\n<p>A <strong>rotten egg</strong> smell of water indicates hydrogen sulphide.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Nitrates</strong></td>\n<td><strong>50 mg/l</strong> as nitrate ion, to prevent&nbsp;<strong>methaemoglobinaemia</strong> and <strong>thyroid effects</strong></td>\n</tr>\n<tr>\n<td><strong>Nitrites</strong></td>\n<td><strong>3 mg/l</strong> as nitrite ion, to prevent&nbsp;<strong>methemoglobinemia</strong> in bottle-fed infants and general population.</td>\n</tr>\n<tr>\n<td><strong>pH</strong></td>\n<td>Acceptable pH is in the range of <strong>6.5 – 8.5</strong>.</td>\n</tr>\n<tr>\n<td><strong>Lead</strong></td>\n<td>\n<p>up to<strong> 0.01 mg/l</strong></p>\n<p>The concentration of lead must be kept as low as possible. It is the most undesirable metal in drinking water.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Mercury</strong></td>\n<td>\n<p><strong>0.006 mg/l</strong> for inorganic mercury</p>\n<p>It is nephrotoxic</p>\n</td>\n</tr>\n<tr>\n<td><strong>Polyaromatic hydrocarbons (PAH)</strong></td>\n<td>\n<p><strong>Benzo(a)pyrene</strong> up to&nbsp;<strong>0.0007 mg/l</strong></p>\n<p>They are to be kept in traces as they are carcinogenic/mutagenic</p>\n</td>\n</tr>\n<tr>\n<td><strong>Sodium</strong></td>\n<td><strong>Above 200 mg/l</strong> may give an unacceptable taste.</td>\n</tr>\n<tr>\n<td><strong>Total Dissolved Solids (TDS)</strong></td>\n<td>\n<p><strong>Less than 600 mg/l</strong> is generally considered palatable.</p>\n<p>TDS consists of inorganic salts and small amounts of organic matter dissolved in water. Water is completely <strong>unpalatable above 1200mg/l</strong>.</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>III)&nbsp;Biological indicators:</strong></p>\n<ul>\n<li><strong>Total coliform bacteria:</strong>\n<ul>\n<li>They are the <strong>primary bacterial indicators</strong> for drinking water.</li>\n<li>Total coliforms are <strong>good indicators </strong>of water<strong> disinfection</strong> because they are <strong>abundant </strong>in the<strong> human intestine</strong> and are <strong>foreign to potable water</strong>.</li>\n<li><strong>E. coli</strong> is considered the <strong>best indicator of fecal contamination </strong>of water when resources for supplementary microbiological examination<strong>&nbsp;</strong>are limited.</li>\n<li>Guidelines state that <strong>coliforms must not be detectable in 100ml of sample water</strong>.&nbsp;</li>\n<li><strong>Multiple tubes method:</strong>\n<ul>\n<li>This is a test of bacteriological surveillance of drinking water for coliforms and thereby fecal contamination.</li>\n<li>This test is based on the <strong>most probable number (MPN) </strong>of coliform organisms.</li>\n<li><strong>Acid and gas production</strong> from fermentation due to coliforms are observed for in multiple tubes and a <strong>presumptive coliform count </strong>is arrived at.</li>\n<li>Confirmation of E. coli can be done by testing for <strong>indole formation at 44-45 degrees Celsius</strong> or by another test called <strong>Eijkman test.</strong></li>\n</ul>\n</li>\n<li><strong>Faecal streptococci:&nbsp;</strong>Their presence in water indicates <strong>recent contamination with feces </strong>and are regarded as<strong> specific indicators </strong>of human faecal pollution.</li>\n<li><strong>Clostridium perfringens:&nbsp;</strong>They are <strong>spore-forming organisms</strong> that are resistant to many disinfection methods.&nbsp;They are used as an <strong>indicator of protozoa</strong> in water and also of <strong>remote/intermittent </strong>fecal contamination.&nbsp;Their <strong>spores</strong> are also indicators of the <strong>effectiveness of filtration </strong>processes.</li>\n<li><strong>Viruses</strong> like <strong>enteric viruses</strong> can also be used as <strong>indicators of the disinfection </strong>process.</li>\n<li><strong>Heterotrophic plate counts</strong>&nbsp;measure a wide range of heterotrophic organisms including bacteria and fungi.</li>\n<li><strong>Coliphages </strong>and <strong>Bacteroides fragilis phages </strong>are evidence of fecal contamination of water.&nbsp;</li>\n</ul>\n</li>\n</ul>\n<p><strong>IV)</strong>&nbsp;<strong>Radiological aspects:</strong></p>\n<ul>\n<li>The proposed guidelines for gross <strong>alpha</strong> activity is <strong>0.5 Bq/litre </strong>and for gross <strong>beta</strong> activity,<strong>&nbsp;</strong>it<strong>&nbsp;</strong>is <strong>1.0 Bq/litre</strong> of drinking water.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1115, 'Community Medicine', 'PM1610. Horrock’s Apparatus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Horrock’s Apparatus</strong> is used to estimate the <strong>chlorine demand</strong> of water.</li>\n<li>This is widely used in the&nbsp;<strong>disinfection of wells</strong> to find out <strong>how much</strong> <strong>bleaching powder is required</strong>.</li>\n<li><strong>Contents</strong> of this water-testing apparatus:\n<ul>\n<li><strong>6 white cups</strong> of 200 ml each and <strong>one black cup</strong> with a circular mark</li>\n<li>2 metal spoons (each holds 2g of bleaching powder)</li>\n<li>7 glass stirring rods and 1 special pipette</li>\n<li>Two droppers</li>\n<li><strong>Starch-iodide indicator solution</strong></li>\n</ul>\n</li>\n<li><strong>Procedure:</strong>\n<ul>\n<li>Use 2g of bleaching powder to create a thin paste in the black cup. It is now called the&nbsp;<strong>Chlorine stock solution</strong>.</li>\n<li>The six white cups are filled with the water to be tested</li>\n<li>Add one drop of the stock solution to the 1<sup>st</sup> cup, two drops to the 2<sup>nd</sup> cup, three drops to the 3<sup>rd</sup> cup, and so on till adding six drops to the 6<sup>th</sup> cup.</li>\n<li>Stir the cups and wait for half an hour.</li>\n<li>Add 3 drops of starch-iodide indicator to each cup</li>\n<li>Development of <strong>blue color</strong> in the apparatus indicates <strong>free residual chlorine</strong>.&nbsp;</li>\n<li>The first cup which develops this color gives an estimate of the amount of bleaching powder needed to disinfect<strong> 455 Litres</strong> of the sample water.</li>\n</ul>\n</li>\n<li><strong>Chlorine demand</strong> or the&nbsp;<strong>dose of bleaching powder</strong> required is given by <strong>(n x 2) g</strong>&nbsp;for<strong> 455 liters of water, </strong>i.e., (n x 2) g of bleaching powder is required to disinfect 455 liters of water. Here, <strong>n</strong> represents the<strong> position of the cup</strong> (1, 2, 3, etc.) that was <strong>first to show a distinct blue color</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/bed65d5582c142b8ab4533128373dcabx383x287.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1116, 'Community Medicine', 'PM1604. Membrane Processes used in Treatment of Water', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Membrane processes</strong> are used in the treatment of water and are now employed in large scales.</li>\n<li>They are <strong>high-pressure processes</strong> and <strong>lower-pressure processes</strong>.</li>\n<li><strong>High-pressure processes:</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Operating Pressures</td>\n<td>Membrane pore sizes</td>\n<td>Notes</td>\n</tr>\n<tr>\n<td><strong>Reverse Osmosis</strong></td>\n<td>15 – 50 bar</td>\n<td>&lt; 0.002 µm</td>\n<td>Rejects monovalent ions and organics of molecular weight &gt; 50 Daltons. Most common used for desalination of seawater.</td>\n</tr>\n<tr>\n<td><strong>Nanofiltration</strong></td>\n<td>About 5 bar</td>\n<td>0.001 – 0.01 µm</td>\n<td>Allows monovalent ions such as sodium or potassium to pass but rejects a high proportion of divalent ions like calcium and magnesium and some higher molecular weight organics.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Lower-pressure processes:</strong></li>\n</ul>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Operating pressure</td>\n<td>Membrane pore sizes</td>\n<td>Comments</td>\n</tr>\n<tr>\n<td><strong>Ultrafiltration</strong></td>\n<td>Less than 5 bar</td>\n<td>0.002 – 0.03 µm.</td>\n<td>Rejects organic molecules of molecular weight &gt; 800 daltons.</td>\n</tr>\n<tr>\n<td><strong>Microfiltration</strong></td>\n<td>1 – 2 bar</td>\n<td>0.01 – 12 µm.</td>\n<td>Reject colloidal and suspended material. They do not separate molecules. Used before reverse osmosis usually.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1117, 'Community Medicine', 'PM1598. Chlorination of Water', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Chlorination is widely used for the&nbsp;<strong>large-scale purification</strong>&nbsp;of<strong>&nbsp;drinking water.</strong></li>\n<li>It is bactericidal and moderately virucidal but not <strong>sporicidal</strong>, except in high doses.</li>\n<li>It oxidizes<strong>&nbsp;iron, manganese, and hydrogen sulphide</strong>. It also destroys some taste and odour&nbsp;producing components. It <strong>controls algae and slime</strong> organisms and <strong>aids in coagulation</strong>.</li>\n<li><strong>The action of chlorine:</strong>\n<ul>\n<li><strong>Hydrochloric acid and hypochlorous acid </strong>are formed when chlorine is added to water. <strong>Hypochlorous acid</strong> ionizes to form <strong>hydrogen and hypochlorite ions.</strong></li>\n<li>H<sub>2</sub>O + Cl<sub>2</sub> → HCl + HOCl<br> HOCl → H + OCl</li>\n<li>The disinfecting action of chlorine is predominantly due to <strong>hypochlorous acid</strong>. <strong>Hypochlorous acid</strong>&nbsp;is&nbsp;the most<strong>&nbsp;effective</strong> form of chlorine and it is <strong>almost 70 – 80 times</strong>&nbsp;more effective than<strong>&nbsp;hypochlorite ions</strong>.</li>\n<li>Chlorine acts best in <strong>water</strong> that has a <strong>pH of around 7</strong>.</li>\n</ul>\n</li>\n<li><strong>Principles of chlorination:</strong>\n<ul>\n<li>The water to be disinfected must be <strong>clear of turbidity</strong> as turbidity <strong>impedes efficient chlorination</strong>.</li>\n<li>The <strong>chlorine demand</strong> of water is the <strong>difference between the amount of chlorine added to the water</strong> and the <strong>amount of residual chlorine</strong> remaining at the end of a specific period of contact (usually 60 minutes) at a given temperature and pH of the water. This has to&nbsp;be estimated<strong> before&nbsp;</strong>chlorination is done.</li>\n<li>The <strong>point</strong>&nbsp;at which<strong>&nbsp;the chlorine demand </strong>of&nbsp;water&nbsp;is met is called the <strong>breakpoint</strong>. It is beyond this that<strong> residual free chlorine</strong> begins to appear.</li>\n<li><strong>Contact period</strong>&nbsp;of free chlorine for at least<strong>&nbsp;one hour</strong> is required to kill bacteria and viruses.</li>\n<li>&nbsp;<strong>Minimum recommended concentration</strong>&nbsp;of free chlorine is<strong>&nbsp;0.5 mg/litre</strong>&nbsp;for<strong>&nbsp;one hour</strong>. Free residual chlorine provides a margin of <strong>safety</strong> against <strong>microbial contamination</strong> that occurs in storage or transport.</li>\n<li>The <strong>sum</strong> of the <strong>chlorine demand</strong> of the specific water plus <strong>free residual chlorine</strong>&nbsp;of 0.5<strong> mg/litre</strong> constitutes the <strong>correct dose of chlorine</strong> to be applied.</li>\n</ul>\n</li>\n<li><strong>Methods of chlorination:</strong>\n<ul>\n<li><strong>Chlorine gas</strong>: It is the <strong>first choice</strong> as it is <strong>cheap, quick and efficient</strong> in action, and easy to apply. Special <strong>chlorinating equipments</strong> like <strong>Paterson’s chloronome</strong> are used for the application of chlorine gas.</li>\n<li><strong>Chloramines</strong>: These<strong>&nbsp;loose compounds of chlorine and ammonia</strong> give more persistent forms of residual chlorine. They have <strong>slow action</strong> and thus are not widely used.</li>\n<li><strong>Perchloron</strong> or <strong>high test hypochlorite (H.T.H.)</strong>: It is a <strong>calcium compound</strong> that has <strong>60 – 70% of available chlorine</strong>.</li>\n</ul>\n</li>\n<li><strong>Break point chlorination:</strong>\n<ul>\n<li>The point at which the <strong>chlorine demand of water</strong>&nbsp;is met is called<strong>&nbsp;the breakpoint. </strong></li>\n<li><strong>Free chlorine</strong> (HOCl and OCl) appears when <strong>chlorine is added beyond the breakpoint</strong>.</li>\n<li>In other words, at the breakpoint, if chlorine is added, then <strong>all the combined chlorines</strong>&nbsp;would have been completely<strong>&nbsp;destroyed</strong> and <strong>free residual chlorines </strong>begin to&nbsp;<strong>appear</strong>.</li>\n<li>This corresponding dosage to achieve the appearance of free residual chlorine is called <strong>breakpoint dosage</strong> and this method is called <strong>breakpoint chlorination</strong>.</li>\n<li>It is also called <strong>controlled superchlorination</strong></li>\n<li><strong>Superchlorination </strong>followed by <strong>dechlorination </strong>is used to disinfect highly polluted waters whose quality fluctuates greatly.</li>\n</ul>\n</li>\n<li><strong>Orthotolidine (OT) test:</strong>\n<ul>\n<li>It is a <strong>test for chlorination</strong> and determines <strong>free and combined chlorine</strong> in water, rapidly and accurately.</li>\n<li>The reagent used is <strong>analytical grade Orthotolidine</strong> dissolved in a 10% solution of hydrochloric acid.</li>\n<li>When added to water that contains chlorine, it turns <strong>yellow</strong> with varying intensity. This is <strong>faster</strong> in the presence of <strong>free chlorine</strong> and <strong>slower</strong> in the presence of <strong>combined chlorine</strong>.</li>\n</ul>\n</li>\n<li><strong>Orthotolidine - arsenite (OTA) test:</strong>\n<ul>\n<li>This is a <strong>modification of the OT test</strong> which <strong>nullifies the errors</strong>&nbsp;due to interfering substances<strong>&nbsp;</strong>like <strong>iron, nitrites, manganese</strong>, etc.</li>\n<li>It determines <strong>free</strong>&nbsp;and<strong>&nbsp;combined chlorine separately.</strong></li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1118, 'Community Medicine', 'PM1596. Rapid Sand Filters', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>They are also called <strong>mechanical filters</strong> and are another method of <strong>large scale </strong>purification of water.</li>\n<li>The two types of rapid sand filters are <strong>gravity type </strong>(e.g. Paterson’s filter) and <strong>pressure type</strong> (e.g. Candy’s filter).</li>\n<li>Steps in the purification of water by rapid sand filters are:\n<ul>\n<li><strong>Coagulation</strong> – Raw water is first treated with a <strong>chemical coagulant like alum</strong>.</li>\n<li><strong>Rapid mixing</strong> – The treated water then undergoes <strong>violent agitation</strong> in a <strong>mixing chamber</strong> which allows <strong>complete dissemination of alum</strong> throughout the bulk of the water.</li>\n<li><strong>Flocculation</strong> – <strong>Slow </strong>and<strong> gentle mixing</strong> of water in a <strong>flocculation chamber</strong> is done for <strong>30 minutes</strong>.&nbsp;This results in a thick, copious flocculate of<strong> aluminium hydroxide</strong>.</li>\n<li><strong>Sedimentation</strong> – The coagulated water is moved into <strong>sedimentation tanks</strong> where detaining it for 2 – 6 hours will result in the <strong>settling down </strong>of the <strong>flocculent</strong> along with <strong>impurities</strong> and <strong>bacteria</strong>. This is to be removed before the filtration takes place.</li>\n<li><strong>Filtration</strong> – The partly purified water is then subjected to rapid sand filtration.\n<ul>\n<li><strong>Filter beds</strong>:&nbsp;The <strong>effective size</strong> of the sand particles/grains is about <strong>0.4 to 0.7 mm</strong>. The <strong>depth</strong> of the sand bed is about <strong>1 metre</strong> and has graded gravel below it.</li>\n<li>As the filtration is done, the alum-floc which has not precipitated is held back by the sand bed. This forms a layer which adsorbs bacteria and other impurities. When the <strong>loss of head</strong> in a rapid sand filter approaches <strong>7 – 8 feet</strong>, the <strong>filter needs to be cleaned</strong> by a process known as <strong>backwashing</strong>.</li>\n<li><strong>Backwashing</strong> is done by <strong>reversing </strong>the<strong> flow of water </strong>through the sand bed. It dislodges the impurities and cleans the bed. <strong>Skilled labor </strong>is needed for this purpose.</li>\n</ul>\n</li>\n<li><strong>Advantages</strong> of rapid sand filter:\n<ul>\n<li>Rapid sand filter <strong>does not need storage </strong>of water before it is treated.</li>\n<li>It occupies <strong>less space</strong> when compared to slow sand filters.</li>\n<li>Filtration is much<strong> more rapid</strong> than slow sand filters.</li>\n<li>It is <strong>easy </strong>to wash and clean.</li>\n<li>There is more <strong>flexibility</strong> in its operation.</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1119, 'Community Medicine', 'PM1595. Slow Sand Filters', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>These are also called <strong>biological filters</strong>.</li>\n<li>They are accepted as the <strong>standard method </strong>of<strong> large scale </strong>water purification.</li>\n<li>Essentially, elements of a slow sand filter include\n<ul>\n<li>Supernatant (raw) water</li>\n<li>Bed of graded sand</li>\n<li>Under-drainage system</li>\n<li>System of filter control valves</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/57efa9f1e6a34873a4a4b8c5996958c9x800x449.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Supernatant water:</strong>\n<ul>\n<li>It lies <strong>above </strong>the<strong> sand bed</strong> and its depth varies from <strong>1 – 1.5 metres</strong>.</li>\n<li>The <strong>level of supernatant or raw water</strong> is always kept <strong>constant</strong> and this helps in <strong>overcoming </strong>the<strong> resistance </strong>of filter bed, promoting the downward flow of water through the sand bed.</li>\n<li>It also provides for a<strong> waiting period</strong> during which the water undergoes <strong>partial purification</strong> by sedimentation, oxidation and particle agglomeration.</li>\n</ul>\n</li>\n<li><strong>Sand bed:</strong>\n<ul>\n<li>This is the <strong>most important part</strong> of a slow sand filter.</li>\n<li>Its <strong>thickness</strong> is generally around <strong>1 metre</strong>.</li>\n<li>The <strong>sand grains</strong> must be <strong>rounded</strong> and have an effective diameter of <strong>0.2 – 0.3 mm</strong>. They must be clean and free from organic matter.</li>\n<li>A layer of <strong>supporting, graded gravel</strong>, <strong>30 – 40 cm deep</strong>, prevents the grains from being carried into drainage pipes.</li>\n<li>The sand bed filters the water as it percolates slowly through it through processes like mechanical straining, oxidation, sedimentation and adsorption.</li>\n<li><strong>Vital layer</strong>: In a new filter, the bed merely acts as a mechanical strainer. But over time the sand bed get covered with a <strong>Schmutzdecke</strong>/<strong>vital layer/zoogleal layer/biological layer</strong>. This is a <strong>slimy </strong>and<strong> gelatinous layer</strong> that contains algae, diatoms and plankton. The <strong>formation</strong> of such a layer is the <strong>ripening</strong> of the filter and this layer is the <strong>heart of a slow sand filter</strong>. It removes organic matter, prevents bacteria from flowing through and oxidizes ammoniacal nitrogen into nitrates, thus rendering the water<strong> bacteria-free</strong>.</li>\n</ul>\n</li>\n<li><strong>Under-drainage system:</strong>\n<ul>\n<li>A system of <strong>porous and perforated pipes</strong>, at the bottom of the filter bed, is part of the under-drainage system.</li>\n<li>They provide an <strong>outlet </strong>for the<strong> filtered water</strong> and a support to the filter medium above.</li>\n<li>The <strong>under-drainage system</strong> along with the <strong>supernatant water</strong> and sand <strong>bed</strong> is kept in a<strong> filter box</strong>, which is usually <strong>2.5 to 4 metres</strong>.</li>\n</ul>\n</li>\n<li><strong>Filter control:</strong>\n<ul>\n<li>The <strong>outlet-pipe system</strong> is provided with <strong>valves </strong>and other devices which maintain a constant rate of filtration.</li>\n<li>The <strong>Venturi meter</strong> measures the <strong>bed resistance</strong> or the <strong>loss of head</strong>.</li>\n<li>When the resistance builds up, the operator opens the <strong>regulatory valve</strong> to maintain a steady-state of filtration.</li>\n<li>When the loss of head <strong>exceeds 1.5 metres </strong>(4 feet), it is <strong>uneconomical</strong> to run the filter.</li>\n<li>If the regulatory <strong>valve has to be kept fully open</strong> as the <strong>bed resistance is very high</strong>, the <strong>filter needs to be cleaned</strong>.</li>\n<li>This is done by <strong>scraping</strong> the <strong>sand bed</strong>, which doesn’t need to be done by skilled labor. After several years of operation (say 20 to 30 scrappings) the sand bed can be changed as it would have diminished in size.</li>\n</ul>\n</li>\n<li><strong>Advantages</strong> of slow sand filters:\n<ul>\n<li><strong>Simple </strong>to construct and operate.</li>\n<li>Cost of construction is<strong> cheap</strong> compared to rapid sand filters.</li>\n<li>Physical, chemical and bacteriological <strong>quality</strong> of the water is <strong>very high</strong> which is partially owed to the <strong>long duration</strong> taken for filtration.</li>\n<li>Bacteria are cleared <strong>more effectively</strong> than rapid filters.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1120, 'Community Medicine', 'PM1594. Purification of Water', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Purification of water can be done on a <strong>large scale</strong> or <strong>small scale.</strong></p>\n<p>I)&nbsp;Purification of water on a <strong>large scale </strong>is done by one or more of the following measures:</p>\n<ul>\n<li><strong>Storage</strong></li>\n<li><strong>Filtration:</strong>\n<ul>\n<li>Slow sand filters</li>\n<li>Rapid sand filters</li>\n</ul>\n</li>\n<li><strong>Disinfection:</strong>\n<ul>\n<li>Chlorination</li>\n<li>Ozonation</li>\n<li>UV radiation</li>\n<li>Membrane processes like <strong>reverse osmosis</strong>,<strong> nanofiltration</strong>,<strong> ultrafiltration </strong>and<strong> microfiltration</strong>.</li>\n</ul>\n</li>\n</ul>\n<p>II)&nbsp;Purification of water on a <strong>small scale:</strong></p>\n<ul>\n<li><strong>Household</strong> purification of water:\n<ul>\n<li>Boiling</li>\n<li>Chemical disinfection using <strong>bleaching powder</strong>, chlorine solution, <strong>high test hypochlorite</strong>, chlorine tablets, iodine and potassium permanganate.</li>\n<li>Filtration using <strong>Pasteur Chamberland </strong>filter,<strong> Berkefeld </strong>filters or<strong> Katadyn </strong>filters.</li>\n<li>UV radiation</li>\n<li>Multi-stage reverse osmosis</li>\n</ul>\n</li>\n<li><strong>Disinfection of wells</strong> with bleaching powder</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1121, 'Community Medicine', 'PM1593. Wells', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Wells </strong>are a source of <strong>ground water</strong> and are widely used across India.</li>\n<li>The two main types of wells are the <strong>shallow</strong> and <strong>deep wells</strong>, the difference between which are:</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Shallow Wells</strong></td>\n<td><strong>Deep Wells</strong></td>\n</tr>\n<tr>\n<td>Description</td>\n<td>They tap subsoil water, i.e., water from above the first impervious layer in the ground</td>\n<td>They tap water from the water-bearing stratum which is below the first impervious layer of the ground</td>\n</tr>\n<tr>\n<td>Chemical quality</td>\n<td>Moderately hard water</td>\n<td>Very hard water</td>\n</tr>\n<tr>\n<td>Contamination</td>\n<td>Very often grossly contaminated and liable to pollution</td>\n<td>Low contamination levels and purer than water from shallow wells</td>\n</tr>\n<tr>\n<td>Yield</td>\n<td>Generally dry in summer</td>\n<td>Provides constant water supply</td>\n</tr>\n<tr>\n<td>Prevalence in India</td>\n<td>Very common</td>\n<td>Less common than shallow wells</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li>An <strong>artesian well</strong> is a type of <strong>deep well</strong> in which the <strong>water rises to the surface</strong> due to the <strong>pressure</strong> with which it is held between <strong>two impervious/impermeable layers</strong>. There is <strong>no pump or other manual methods</strong> needed to bring the water to the surface. These are not common in India.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/757cd3b056ba491baacf879379998e83x734x425.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Wells can also be classified according to the method of <strong>construction</strong> as <strong>dug wells </strong>and<strong> tube wells</strong>.</li>\n</ul>\n<p><strong>i)&nbsp;</strong><strong>Dug wells:</strong></p>\n<ul>\n<li>They are the <strong>most common type</strong> of wells in India.</li>\n<li>In rural India, two types of dug wells exist, namely the <strong>unlined katcha wells</strong> and the <strong>masonry or pucca wells</strong>.</li>\n<li>The <strong>katcha wells </strong>are just big holes dug into the sand.</li>\n<li>The <strong>pucca wells</strong> are well built with walls or linings made of brick or stones.</li>\n<li><strong>Step wells </strong>are types of <strong>pucca dug wells</strong> that have steps. These steps can be used by people to descend into the well and come in contact with water. This increases the risk of water contamination.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>ii)&nbsp;Tube wells:</strong></p>\n<ul>\n<li><strong>Shallow tube wells</strong> are also called <strong>driven wells</strong> and&nbsp;<strong>deep tube wells</strong> are called <strong>bore wells</strong>.</li>\n<li>They are safer sources of water compared to other wells, relatively cheaper to build and maintain.</li>\n<li>Tube wells use <strong>strainers at the bottom</strong> and <strong>hand pumps at the top</strong> attached by a <strong>pipe</strong> in between.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The following are the considerations for building a safe and sanitary well:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Location</strong></td>\n<td>Must be at least 15 m away from sources of contamination. Must not be &gt;100 m from households.</td>\n</tr>\n<tr>\n<td><strong>Lining</strong></td>\n<td>Must be made of brick or stones set in cement to a depth of 6 m, so that water enters from bottom and not sides. Height of lining above ground level must be 60 – 90 cm.</td>\n</tr>\n<tr>\n<td><strong>Parapet Wall</strong></td>\n<td>Must be at least 70 – 75 cm (28 inches) from the ground level.</td>\n</tr>\n<tr>\n<td><strong>Platform</strong></td>\n<td>Should stretch at least 1 m around the well in all directions.</td>\n</tr>\n<tr>\n<td><strong>Drain</strong></td>\n<td>It should be a pucca drain to carry spilled water to a public drain beyond the <strong>cone of filtration </strong>of the well.</td>\n</tr>\n<tr>\n<td><strong>Covering</strong></td>\n<td>There should be a cement concrete covering over the well.</td>\n</tr>\n<tr>\n<td><strong>Hand-pump</strong></td>\n<td>Should be able to withstand rough handling.</td>\n</tr>\n<tr>\n<td><strong>Consumer responsibility</strong></td>\n<td>Consumers must practice basic precautions before handling the well.</td>\n</tr>\n<tr>\n<td><strong>Quality</strong></td>\n<td>The water standards in terms of quality must be conformed to.</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1122, 'Community Medicine', 'PM1592. Sources of Water', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>i) Rain</strong></p>\n<p><strong>ii) Surface water</strong></p>\n<ul>\n<li>Impounding reservoirs</li>\n<li>Rivers and streams</li>\n<li>Tanks, ponds and lakes</li>\n</ul>\n<p><strong>iii)&nbsp;Ground water</strong></p>\n<ul>\n<li>Shallow wells</li>\n<li>Deep wells</li>\n<li>Springs</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1123, 'Community Medicine', 'PM1590. Adequate Intake of Water for Different Age Groups (WHO)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Age Group</strong></td>\n<td><strong>Daily Adequate Water Intake (Litres/Day)</strong></td>\n</tr>\n<tr>\n<td><strong>0 – 6 months</strong>&nbsp;</td>\n<td>0.7, assumed to be from <strong>human milk.</strong></td>\n</tr>\n<tr>\n<td><strong>7 – 12 months</strong>&nbsp;&nbsp;</td>\n<td>0.8, assumed to be from human milk and complementary foods and beverages</td>\n</tr>\n<tr>\n<td><strong>1 – 3 years</strong>&nbsp;</td>\n<td>1.3</td>\n</tr>\n<tr>\n<td><strong>3 – 8 years</strong>&nbsp;</td>\n<td>1.7</td>\n</tr>\n<tr>\n<td>\n<p><strong>9 – 13 years</strong></p>\n<p>Boys</p>\n<p>Girls&nbsp;</p>\n</td>\n<td>\n<p>2.4</p>\n<p>2.1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>14 – 18 years</strong></p>\n<p>Boys</p>\n<p>Girls&nbsp;</p>\n</td>\n<td>\n<p>3.3</p>\n<p>2.3&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>19 – 70+ years</strong></p>\n<p>Men</p>\n<p>Women&nbsp;</p>\n</td>\n<td>\n<p>3.7</p>\n<p>2.7</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1124, 'Dermatology,', 'PM0366. Difference between classic and neonatal scabies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Classic scabies</strong></td>\n<td><strong>Neonatal scabies</strong></td>\n</tr>\n<tr>\n<td>Site of involvement</td>\n<td>Interdigital webs, trunk, genitals, flexors, sparing of palms and soles, and skin above neck</td>\n<td>Face, scalp, palm, and soles</td>\n</tr>\n<tr>\n<td>Morphology of Lesion</td>\n<td>Papules, pustules, excoriation, eczematization, burrow</td>\n<td>Vesicles, pustules, bullae, erosions, and ulcerations</td>\n</tr>\n<tr>\n<td>Burrows</td>\n<td>Present</td>\n<td>Usually absent</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1125, 'Community Medicine', 'PM2444. Biomedical Waste (BMW) Management -COVID 19', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>In addition to the current BMW Management rules, the following measures are proposed</p>\n<ul>\n<li>To report opening/operation of COVID 19 Ward/ICU/Lab/Collection Centre to <strong>SPCB</strong> (State Pollution Control Board) and <strong>CBWTF</strong> (Common Biomedical Waste Treatment Facility) in that area</li>\n<li>Dedicated sanitation workers deputed only to collect COVID 19 BMW</li>\n<li>It is mandatory for all BMW bags and containers from COVID 19 areas to carry <strong>\COVID 19 WASTE\</strong> label</li>\n<li>Keep separate colour coded bins with <strong>foot operated lids</strong></li>\n<li>The inner and outer surfaces of these containers must be disinfected daily with <strong>1% sodium hypochlorite</strong> solution</li>\n<li>To ensure no leaks, <strong>double layers&nbsp;</strong>(2 bags) are used</li>\n</ul>\n<table width=\433\>\n<tbody>\n<tr>\n<td><strong>COLOUR OF THE BIN</strong></td>\n<td><strong>PERSONAL PROTECTIVE EQUIPMENT(PPE)</strong></td>\n<td><strong>OTHER WASTE</strong></td>\n</tr>\n<tr>\n<td><strong>Red Bin</strong></td>\n<td>\n<ul>\n<li>Goggles</li>\n<li>Face shield&nbsp;</li>\n<li>Splash-proof apron</li>\n<li>Plastic coverall</li>\n<li>Hazmat suit</li>\n<li>Nitrile gloves</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Used gloves</li>\n</ul>\n<p><strong>Laboratory waste</strong></p>\n<ul>\n<li>Pre-treated viral transport media</li>\n<li>Plastic vials and cryovials</li>\n<li>Vacutainers</li>\n<li>Eppendorf tubes</li>\n<li>Pipette tips</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Yellow Bin</strong></td>\n<td>\n<ul>\n<li>Used mask(triple layer mask, N95 mask)</li>\n<li>Head cover/Cap, Shoe cover</li>\n<li>Disposable linen gown&nbsp;</li>\n<li>Non-plastic/Semi-plastic coverall</li>\n</ul>\n</td>\n<td>\n<p>&nbsp;</p>\n<ul>\n<li>Diapers with feces of immobile COVID 19 patients&nbsp;</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1126, 'Community Medicine', 'PM0128. Triage Colour Coding', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/515d17fd0b684f8b9cd1fd57ef97b7e6x454x304.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;<strong>Triage system </strong>consists of <strong>four colour codes:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Color code</strong></td>\n<td><strong>Type of patients</strong></td>\n<td><strong>Examples</strong></td>\n</tr>\n<tr>\n<td><span>Red (High priority)<br></span></td>\n<td>\n<p>Need for<strong> immediate resuscitation or surgery</strong> in the next<strong> 6 hours</strong> or transfer.</p>\n<p>May survive if timely medical intervention can be given</p>\n</td>\n<td>\n<ul>\n<li>Tension pneumothorax</li>\n<li>Airway obstruction</li>\n<li>Hemothorax</li>\n<li>Cardiac tamponade</li>\n<li>Acute circulatory arrest</li>\n<li>Major intra-abdominal bleed etc.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Yellow (Medium priority)<br></span></td>\n<td>\n<p>Possible <strong>resuscitation or surgery</strong> in the <strong>next 24 hours</strong>.</p>\n<p>Likely to survive if prompt treatment is given.</p>\n</td>\n<td>\n<ul>\n<li>Compound fractures</li>\n<li>Degloving injuries</li>\n<li>Pelvic fracture</li>\n<li>Spinal injuries</li>\n<li>Moderate head injury</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Green (Low priority)<br></span></td>\n<td>\n<p><strong>Ambulatory patients</strong> or minor illnesses.</p>\n<p>Likely to survive if treatment is slightly delayed.</p>\n</td>\n<td>\n<ul>\n<li>Simple fractures</li>\n<li>Minor lacerations etc.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Black (Least priority)</td>\n<td>\n<p><strong>Dead or moribund</strong> patients.</p>\n</td>\n<td>\n<ul>\n<li>Severe brain injury</li>\n<li>Major damage / disruption to chest wall and abdominal structures</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1127, 'Community Medicine', 'PM2488. Post-exposure management of healthcare personnel in Hepatitis B exposure', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td rowspan=\2\>\n<div class=\page\ title=\Page 214\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Healthcare personnel status</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td colspan=\2\>\n<div class=\page\ title=\Page 214\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Post-exposure testing</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td colspan=\2\>\n<div class=\page\ title=\Page 214\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Post-exposure prophylaxis</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><strong>Post-vaccination serological testing</strong></td>\n</tr>\n<tr>\n<td><strong>Source</strong><br><strong>patient (HbsAg)</strong></td>\n<td><strong>HCP testing (anti-HBs)</strong></td>\n<td>\n<div class=\page\ title=\Page 214\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>HBIG</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 214\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Vaccination</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Documented<br>responder (after 3 doses)</td>\n<td colspan=\5\>No action needed</td>\n</tr>\n<tr>\n<td rowspan=\2\>Documented non-responder (after 6 doses)</td>\n<td>Positive/&nbsp;<br>Unknown</td>\n<td>&nbsp;</td>\n<td>\n<p>HBIG x 2 <br>1 month apart</p>\n</td>\n<td>&nbsp;</td>\n<td>No&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 214\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Negative</p>\n</div>\n</div>\n</div>\n</td>\n<td colspan=\4\>No action needed</td>\n</tr>\n<tr>\n<td rowspan=\3\>\n<div class=\page\ title=\Page 214\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Response unknown (after 3 doses)</p>\n</div>\n</div>\n</div>\n</td>\n<td>Positive/<br>Unknown</td>\n<td>\n<div class=\page\ title=\Page 214\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>&lt;10 mIU/ml</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>HBIG x 1</td>\n<td rowspan=\2\>Initiate re-<br>vaccination</td>\n<td rowspan=\2\>Yes</td>\n</tr>\n<tr>\n<td>Negative</td>\n<td>&lt;10 mIU/ml</td>\n<td>None</td>\n</tr>\n<tr>\n<td>Any result</td>\n<td>≥10 mIU/ml</td>\n<td colspan=\3\>No action needed</td>\n</tr>\n<tr>\n<td rowspan=\2\>Unvaccinated/ incompletely vaccinated or vaccine refusers</td>\n<td>Positive/<br>Unknown</td>\n<td>&nbsp;</td>\n<td>HBIG x 1</td>\n<td>Complete&nbsp;<br>vaccination</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Negative</td>\n<td>&nbsp;</td>\n<td>None</td>\n<td>Complete&nbsp;<br>vaccination</td>\n<td>Yes&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1128, 'Community Medicine', 'PM2165. The Factories act, 1948 and The Maternity Act, 2017', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>The Factories act</strong>,<strong>1948</strong></p>\n<p>The act defines a factory as an establishment employing 10 or more workers where power is used, and 20 or more workers where power is not used.&nbsp;</p>\n<p>Provisions in the age of employment are:</p>\n<ul>\n<li>Children <strong>&lt;14 years</strong> are <strong>prohibited</strong> from working.</li>\n<li>Adolescents between <strong>15-18</strong> years:\n<ul>\n<li>Can be employed only in certain industries.</li>\n<li>They can work only between <strong>6 AM – 7 PM</strong>.</li>\n<li>They should not be made to work for more than <strong>four and a half hours.</strong></li>\n<li>They are allowed to take <strong>leave once</strong> every <strong>15 days</strong> and have an <strong>accumulated</strong> leave of up to <strong>40</strong> days.</li>\n</ul>\n</li>\n</ul>\n<p>For adults, the&nbsp;<strong>maximum</strong> hours of work for an industrial worker should be not more than <strong>48 hours</strong> <strong>per week</strong>, not exceeding 9 hours a day. If working <strong>overtime,</strong> then it should be no more than <strong>60 hours</strong> <strong>per week</strong> including overtime.</p>\n<p><strong>Per capita space</strong> availability: For factories established&nbsp;after 1948 – min 500cuft / person</p>\n<p>Safety and welfare measures include the provision of the following:</p>\n<ul>\n<li>&gt; 1000 Workers – Safety officer</li>\n<li>&gt; 500 Workers – Welfare officer</li>\n<li>&gt; 250 Workers – Canteen</li>\n<li>&gt; 50 employees - Crèche</li>\n</ul>\n<p><strong>The Maternity Act, 2017</strong> is a landmark law that has enhanced the&nbsp;duration of paid maternity leave:</p>\n<ul>\n<li>Working mothers -&nbsp;12-26 weeks</li>\n<li>Working mothers, with 2 surviving children - 12 weeks</li>\n<li>Adopting mother and commissioning mothers-&nbsp;12 weeks from the date on which the child is being handed over to the mother.</li>\n</ul>\n<p>According to <strong>Indian Maternity Benefit (Amendment) Act, 2017</strong>: Effective as of the 1st of July 2017, mandatory <strong>crèche</strong> (daycare) facilities for every establishment employing <strong>50 or more employees&nbsp;</strong>(inclusive of <strong>men</strong> and <strong>women</strong>).</p></div><!---->\n      <!---->\n    </div><!---->'),
(1129, 'Community Medicine', 'PM0022. ESI ACT, 1948', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Employees State Insurance Act, 1948 (Revised in 2019)</strong></p>\n<p><strong>Scope:</strong> It is applicable to all factories in India <strong>excluding</strong>:</p>\n<ul>\n<li>Defence&nbsp;</li>\n<li>Railway&nbsp;&nbsp;</li>\n<li>Mines&nbsp;</li>\n</ul>\n<p><strong>Finance Contribution</strong></p>\n<ul>\n<li>It covers all employees getting income up to Rs.21,000/- per month.</li>\n<li>Employee –<strong> 0.75%</strong> of his daily wage.</li>\n<li>Employer –<strong> 3.25%</strong> of the employees daily wage.</li>\n<li>Medical benefit – 1/8th by the state government and 7/8th by the ESI Corporation.</li>\n</ul>\n<p><strong>Benefits</strong></p>\n<p><strong>To the Employees</strong></p>\n<ul>\n<li><strong>Medical</strong> Benefit- full medical care is provided free of cost in case of sickness, employment injury, and maternity.</li>\n<li><strong>Sickness</strong> Benefit- is given at <strong>70%</strong> of average daily wages for a duration of <strong>91 days</strong> in one year.&nbsp;In order to qualify for sickness benefit, the worker is required to contribute for 78 days in a period of 6 months.\n<ul>\n<li><strong>Extended</strong> sickness benefit – <strong>80%</strong> of the daily wages for a duration of<strong> 2 years,</strong> for 34 specified diseases such as TB, leprosy, malignant diseases, diabetes, Parkinsons, myasthenia gravis, glaucoma, coronary artery disease, etc.</li>\n<li><strong>Enhanced</strong> sickness benefit – at <strong>full</strong> <strong>wages</strong> for sterilization procedure; for a duration of 7 days post-vasectomy and 14 days post tubectomy.&nbsp;</li>\n<li>The total amount payable is double the standard sickness benefit rate, that is, equal to full wages.</li>\n</ul>\n</li>\n<li><strong>Maternity</strong> Benefit&nbsp;– benefit is payable at full wages for 26 weeks (6.5 months) for pregnancy, 6 weeks following a miscarriage, and 30 days for sickness arising out of pregnancy. It also covers the premature birth of a child born to an insured woman.</li>\n<li><strong>Dependance</strong> Benefit– in case of death, as a result of employment injury, the dependents of an insured person are eligible for periodical payments. Pension at the rate of <strong>90%</strong> of the wages is payable, shared by dependants in a fixed ratio, on monthly basis in accordance with the prescribed share. An eligible son or daughter is entitled to the dependants benefit up to the age of 18; the benefit is withdrawn if the daughter marries earlier.</li>\n<li><strong>Disablement</strong> Benefits–\n<ul>\n<li>Temporary disability- at 90% daily wages as long as the person is disabled.</li>\n<li>Permanent disability- lifetime pension. It also covers occupational diseases.</li>\n</ul>\n</li>\n<li><strong>Funeral</strong> Benefit&nbsp;– a maximum of Rs.15,000/-.</li>\n<li><strong>Rehabilitation</strong> Benefit- on payment of Rs.10, the insured person and his/her family continue to get medical treatment after permanent disablement or retirement.</li>\n</ul>\n<p><strong>To the Employers</strong></p>\n<ul>\n<li>Exemption from Workman Compensation Act.</li>\n<li>Exemption from Maternity Benefit Act.</li>\n<li>Income tax rebate on the amount contributed towards the scheme.</li>\n<li>Exemption from payment of medical allowance to employees and their dependants, or arranging for their medical care.</li>\n<li>Healthy-work force.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1130, 'Community Medicine', 'PM0021. Notifiable occupational diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;There are 29 diseases notifiable to the government under the Indian Factories Act 1948, some important ones are:</p>\n<ul>\n<li>Anthracosis</li>\n<li>Asbestosis</li>\n<li>Byssinosis</li>\n<li>Noise induced hearing loss</li>\n<li>Occupational dermatitis</li>\n<li>Occupational cancers</li>\n<li>Silicosis</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1131, 'Community Medicine', 'PM0019. Consequences of different dust particle sizes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Size</strong></td>\n<td><strong>Consequence</strong></td>\n</tr>\n<tr>\n<td>&gt; 10 microns</td>\n<td>Settles down</td>\n</tr>\n<tr>\n<td>&lt;10 microns</td>\n<td>Suspended in air</td>\n</tr>\n<tr>\n<td>5-10 microns</td>\n<td>Trapped at upper respiratory tract</td>\n</tr>\n<tr>\n<td>3-5 microns</td>\n<td>Trapped in the mid respiratory tract</td>\n</tr>\n<tr>\n<td>1-3 microns</td>\n<td>Settles in alveoli</td>\n</tr>\n<tr>\n<td>&lt; 1micron</td>\n<td>Shows Brownian movement</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1132, 'Community Medicine', 'PM0174. Methods of Health Communication', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/48ba5eb0215744d389fb6f353dbe3813x538x361.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1133, 'Community Medicine', 'PM0173. Principles of Health Education', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>(Mnemonic: <strong>PLS, G</strong>ood <strong>F</strong>riend, <strong>CLICK MoRe</strong>!)</p>\n<ul>\n<li><strong>P</strong>articipation</li>\n<li><strong>L</strong>earning by doing</li>\n<li><strong>S</strong>etting an example</li>\n<li><strong>G</strong>ood human relations</li>\n<li><strong>F</strong>eedback</li>\n<li><strong>C</strong>redibility</li>\n<li><strong>L</strong>eaders</li>\n<li><strong>I</strong>nterest</li>\n<li><strong>C</strong>omprehension</li>\n<li><strong>K</strong>nown to unknown</li>\n<li><strong>M</strong>otivation</li>\n<li><strong>R</strong>einforcement</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1134, 'Community Medicine', 'PM0167. Evaluation of a Health Program', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Steps of evaluation:</strong></p>\n<ol>\n<li>Determine what is to be evaluated:<strong>&nbsp;</strong>structure, process or outcome</li>\n<li>Establish standards and criteria</li>\n<li>Plan the methodology to be applied</li>\n<li>Gather information</li>\n<li>Analyze the results</li>\n<li>Take action</li>\n<li>Re-evaluate</li>\n</ol>\n<p><strong>Components of evaluation</strong></p>\n<p>(Mnemonic: <strong>R</strong>yan <strong>A</strong>lways <strong>A</strong>te <strong>A</strong>n <strong>E</strong>gg <strong>E</strong>very <strong>E</strong>vening)</p>\n<ul>\n<li><strong>R</strong>elevance</li>\n<li><strong>A</strong>dequacy</li>\n<li><strong>A</strong>ccessibility</li>\n<li><strong>A</strong>cceptability</li>\n<li><strong>E</strong>ffectiveness</li>\n<li><strong>E</strong>fficiency</li>\n<li><strong>E</strong>ffect or impact</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1135, 'Community Medicine', 'PM0164. Network Analysis in Health Management', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>A network is a <strong>graphic plan</strong> of all events and activities to be completed in order to reach an end objective.<br> <br> Two types of network analysis: <strong>PERT </strong>and <strong>CPM</strong></p>\n<p>1. Programme Evaluation and Review Technique (PERT)</p>\n<ul>\n<li>An arrow diagram of all events in logical sequence is drawn.</li>\n<li>Time to finish each activity can be calculated and critical activities can be identified.</li>\n<li>It aids in planning, scheduling and monitoring of the project.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/173aa5799bb5492e8a01d82bdda0f6d2x1280x1447.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>2. Critical Path Method (CPM)</p>\n<ul>\n<li>The longest path of the network is called the critical path.</li>\n<li>A delay in the critical path will cause a delay in the entire project.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1136, 'Community Medicine', 'PM0845. The Family as a Social Organization', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>A family is a group of biologically related individuals living together under the same roof and eating from a common kitchen.</li>\n<li>It is the most primary and basic unit of all societies.</li>\n<li>The basic and arbitrary model of a family cycle has six phases:</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td width=\66\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\167\>\n<p><strong>Phase</strong></p>\n</td>\n<td width=\146\>\n<p><strong>Beginning</strong></p>\n</td>\n<td width=\138\>\n<p><strong>End</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\66\>\n<p>1</p>\n</td>\n<td width=\167\>\n<p>Formation</p>\n</td>\n<td width=\146\>\n<p>Marriage</p>\n</td>\n<td width=\138\>\n<p>Birth of 1<sup>st</sup> child</p>\n</td>\n</tr>\n<tr>\n<td width=\66\>\n<p>2</p>\n</td>\n<td width=\167\>\n<p>Extension</p>\n</td>\n<td width=\146\>\n<p>Birth of 1<sup>st</sup> child</p>\n</td>\n<td width=\138\>\n<p>Birth of last child</p>\n</td>\n</tr>\n<tr>\n<td width=\66\>\n<p>3</p>\n</td>\n<td width=\167\>\n<p>Complete extension</p>\n</td>\n<td width=\146\>\n<p>Birth of last&nbsp;child</p>\n</td>\n<td width=\138\>\n<p>1<sup>st</sup> child leaves home</p>\n</td>\n</tr>\n<tr>\n<td width=\66\>\n<p>4</p>\n</td>\n<td width=\167\>\n<p>Contraction</p>\n</td>\n<td width=\146\>\n<p>1<sup>st</sup> child leaves home</p>\n</td>\n<td width=\138\>\n<p>Last child leaves parental home</p>\n</td>\n</tr>\n<tr>\n<td width=\66\>\n<p>5</p>\n</td>\n<td width=\167\>\n<p>Completed contraction</p>\n</td>\n<td width=\146\>\n<p>Last child leaves parental home</p>\n</td>\n<td width=\138\>\n<p>Death of 1<sup>st</sup> spouse</p>\n</td>\n</tr>\n<tr>\n<td width=\66\>\n<p>6</p>\n</td>\n<td width=\167\>\n<p>Dissolution</p>\n</td>\n<td width=\146\>\n<p>Death of 1<sup>st</sup> spouse</p>\n</td>\n<td width=\138\>\n<p>Death of survivor</p>\n</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li><strong>Types </strong>of families:\n<ul>\n<li>A <strong>nuclear family</strong> or <strong>elementary family</strong> consists of only the married couple and their offspring while they are dependants.</li>\n<li>The term <strong>new family</strong> is applied when nuclear families <strong>are younger than 10 years</strong> and consist of parents and children.</li>\n<li>A <strong>joint</strong> family or <strong>extended family</strong> consists of a number of married couples and their children who live together in the same household with usually the men being related by blood. All <strong>property</strong> in joint families is <strong>held in common</strong> with the family income going into a common pocket. A <strong>senior male member</strong> is usually the <strong>head of the family</strong> who makes decisions.</li>\n<li>A <strong>three generation family</strong> is one where there are representatives from three different generations in one house.</li>\n<li>A <strong>communal family</strong> is one in which all the <strong>members play a part</strong> in its <strong>management</strong>.</li>\n</ul>\n</li>\n<li><strong>Functions </strong>of the family:\n<ul>\n<li>Residence (patrilocal and matrilocal)</li>\n<li>Division of labour</li>\n<li>Reproduction and raising children</li>\n<li>Socialization and social care</li>\n<li>Economic functions</li>\n</ul>\n</li>\n<li><strong>Problems families</strong> are those that <strong>lag behind</strong> the rest of the community in terms of standard and quality of life of its members.</li>\n<li><strong>Broken families </strong>are those in which the parental or family system has been disrupted by separation, divorce or death.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1137, 'Community Medicine', 'PM0172. Health Education vs. Propaganda', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Health education&nbsp;</strong></td>\n<td><strong>Health propaganda</strong></td>\n</tr>\n<tr>\n<td>Knowledge</td>\n<td>Actively acquired</td>\n<td>Instilled in the mind</td>\n</tr>\n<tr>\n<td>Skills</td>\n<td>Actively acquired</td>\n<td>Instilled</td>\n</tr>\n<tr>\n<td>Primitive desires</td>\n<td>Disciplined</td>\n<td>Aroused</td>\n</tr>\n<tr>\n<td>Action</td>\n<td>Reflective behaviour; trained to use judgement before acting</td>\n<td>Reflexive behaviour;Aims at impulsive action&nbsp;</td>\n</tr>\n<tr>\n<td>Emotion&nbsp;</td>\n<td>Does not appeal to emotion but appeals to reason</td>\n<td>Appeals to emotion</td>\n</tr>\n<tr>\n<td>Behaviour</td>\n<td>Process is behaviour centered</td>\n<td>&nbsp;Process is information centered</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1138, 'Community Medicine', 'PM0160. Responsibilities of Health Workers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\594\>\n<tbody>\n<tr>\n<td width=\289\>\n<p><strong>Female Health Worker</strong></p>\n</td>\n<td width=\305\>\n<p><strong>Male Health Worker</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\289\>\n<p>Maternal and child health services</p>\n<p>Family planning services and registers</p>\n<p>Medical Termination of Pregnancy</p>\n<p>Universal Immunization Program</p>\n<p>Detection of non communicable diseases</p>\n<p>Dai training</p>\n<p>Treatment of minor ailments</p>\n<p>Participate in team activities</p>\n</td>\n<td width=\305\>\n<p>National Health Programmes</p>\n<p>Malaria slides and surveillance</p>\n<p>Leprosy follow-up</p>\n<p>Identification and follow-up cases of blindness</p>\n<p>Reproductive and child health services</p>\n<p>RNTCP</p>\n<p>Expanded Immunization Program</p>\n<p>Environmental sanitation including chlorination of water and proper waste disposal</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\594\>\n<p><strong>Common Responsibilities</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\594\>\n<p>Nutrition</p>\n<p>Distribution of contraceptives</p>\n<p>Work on communicable diseases like DOTS activities</p>\n<p>Record and report vital events</p>\n<p>Record keeping and maintaining registers</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1139, 'Community Medicine', 'PM0159. Community Health Centre Human Resources', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\174\>\n<p><strong>Personnel</strong></p>\n</td>\n<td width=\150\>\n<p><strong>Strength (Essential)</strong></p>\n</td>\n<td width=\234\>\n<p><strong>Desirable Qualifications</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Block Medical Officer</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n<td width=\234\>\n<p>Senior most specialist</p>\n</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Public Health Specialist</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n<td width=\234\>\n<p>MD/MBA/MPH/DPH</p>\n</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Public Health Nurse</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n<td width=\234\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>General surgeon</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n<td width=\234\>\n<p>MS/DNB</p>\n</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Physician</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n<td width=\234\>\n<p>MD/DNB</p>\n</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>OG-cian</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n<td width=\234\>\n<p>MD/DNB/DGO</p>\n</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Paediatrician</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n<td width=\234\>\n<p>MD/DNB/DCH</p>\n</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Anesthetist</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n<td width=\234\>\n<p>MD/DNB/DA/LSAS trained MO</p>\n</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Dental surgeon</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n<td width=\234\>\n<p>BDS</p>\n</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>General Duty MO</p>\n</td>\n<td width=\150\>\n<p>2</p>\n</td>\n<td width=\234\>\n<p>MBBS</p>\n</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>AYUSH Medical Officer</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n<td width=\234\>\n<p>Graduate in AYUSH</p>\n</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Ophthalmologist</p>\n</td>\n<td width=\150\>\n<p>1 for 5 CHCs</p>\n</td>\n<td width=\234\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Staff Nurse</p>\n</td>\n<td width=\150\>\n<p>10</p>\n</td>\n<td width=\234\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Pharmacist</p>\n</td>\n<td width=\150\>\n<p>2</p>\n</td>\n<td width=\234\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Lab. Technician</p>\n</td>\n<td width=\150\>\n<p>2</p>\n</td>\n<td width=\234\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Radiographer</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n<td width=\234\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Assistants</p>\n</td>\n<td width=\150\>\n<p>2</p>\n</td>\n<td width=\234\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Cold Chain assistant</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n<td width=\234\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>OT technician</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n<td width=\234\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Counselor</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n<td width=\234\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Rehabilitation worker</p>\n</td>\n<td width=\150\>\n<p>1</p>\n</td>\n<td width=\234\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Other admin staff</p>\n</td>\n<td width=\150\>\n<p>6</p>\n</td>\n<td width=\234\>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\174\>\n<p>Group D staff</p>\n</td>\n<td width=\150\>\n<p>7</p>\n</td>\n<td width=\234\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\174\>\n<p><strong>Total</strong></p>\n</td>\n<td width=\150\>\n<p>46</p>\n</td>\n<td width=\234\>\n<p>Ophthalmologist not included</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1140, 'Community Medicine', 'PM0158. Primary Health Centres-PHC', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>HWC-PHCs</strong>: Population of <strong>30000</strong> in plains,<strong> 20000</strong> in hilly/tribal areas</li>\n<li>Urban HWC-PHCs: Population of <strong>50000</strong></li>\n<li>Specialist UPHC/Polyclinic (urban): Population of <strong>2.5- 3 lakh</strong></li>\n</ul>\n<p>PHC’s and UPHC’s can be further extended to <strong>24X7 PHC’s/UPHC’s</strong></p>\n<h4>Bed distribution:&nbsp;</h4>\n<table>\n<tbody>\n<tr>\n<td><strong>HWC-PHC</strong></td>\n<td><strong>HWC-UPHC</strong></td>\n<td><strong>24X7 HWC-PHC/UPHC</strong></td>\n</tr>\n<tr>\n<td>Essential: <strong>2 beds</strong></td>\n<td>Essential: <strong>2 daycare beds</strong></td>\n<td>Essential: <strong>6</strong>&nbsp;<strong>beds</strong></td>\n</tr>\n<tr>\n<td>Desirable: <strong>4 beds</strong></td>\n<td>Desirable: <strong>4 daycare beds</strong></td>\n<td>Desirable: <strong>4&nbsp;beds</strong></td>\n</tr>\n</tbody>\n</table>\n<p><strong>Note</strong>: The desirable will be over and above the essential beds.</p>\n<h4>The twelve packages envisaged under Comprehensive Primary Healthcare services (CPHC):&nbsp;</h4>\n<ol>\n<li>Care in Pregnancy and Childbirth&nbsp;</li>\n<li>Neonatal and Infant Health Care Services</li>\n<li>Childhood and Adolescent Health Care Services</li>\n<li>Family Planning, Contraceptive Services, and other Reproductive Health Care Services</li>\n<li>Management of Communicable Diseases: National Health Programmes</li>\n<li>General Out-patient Care for Acute Simple Illnesses and Minor Ailments</li>\n<li>Screening, Prevention, Control and Management of Non-communicable Diseases</li>\n<li>Care for Common Ophthalmic and ENT Problems</li>\n<li>Basic Oral Health Care</li>\n<li>Elderly and Palliative Health Care Services</li>\n<li>Emergency Medical Services including Burns and Trauma</li>\n<li>Screening and Basic Management of Mental Health Ailments.</li>\n</ol>\n<h4>IPHS 2022 normal for manpower at PHC:</h4>\n<p>Essential manpower for:</p>\n<p>1) PHC: 12&nbsp; &nbsp;2) UPHC: 16&nbsp; &nbsp;3) Polyclinic: 22&nbsp; &nbsp;4) 24x7 PHC: 23&nbsp; &nbsp;5) 24X7 UPHC: 27</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/fe811e66de5f481990c752327f6b6882x1280x3272.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1141, 'Community Medicine', 'PM0157. Sub-centre vs. PHC vs. CHC', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>HWC-Sub centre</td>\n<td>HWC-Primary Health Centre (PHC)</td>\n<td>Community Health Centre (CHC)</td>\n</tr>\n<tr>\n<td>Healthcare level</td>\n<td>Primary</td>\n<td>Primary</td>\n<td>Secondary</td>\n</tr>\n<tr>\n<td>\n<p>Population norm</p>\n<p>Plain areas</p>\n<p>Hilly or remote areas</p>\n<p>Urban areas</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>1 per 5000</p>\n<p>1 per 3000</p>\n<p>UHWC- 1 per 15000-20000</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>1 per 30,000</p>\n<p>1 per 20,000</p>\n<p>1 per 50,000, 1 per 2.5-3 lakh (polyclinic)</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>1 per 1,20,000</p>\n<p>1 per 80,000</p>\n<p>1 per 5 lakh (metro cities), 1 per 2.5 lakh (non-metro cities)</p>\n</td>\n</tr>\n<tr>\n<td>Total essential staff</td>\n<td>\n<p>HWC-SHC- 4 (including 1 ASHA)</p>\n<p>UHWC- 6 (including 1 ASHA)</p>\n</td>\n<td>\n<p>PHC: 12</p>\n<p>UPHC:16</p>\n<p>24X7 PHC: 23</p>\n<p>24X7 UPHC: 27</p>\n<p>Polyclinic: 22</p>\n</td>\n<td>\n<p>Non-FRU CHC: 33</p>\n<p>FRU CHC: 52 (30 beds), 56 (50 beds)</p>\n<p>FRU-UCHC: 55 (50 beds), 72 (100 beds)</p>\n</td>\n</tr>\n<tr>\n<td>Number of beds</td>\n<td>0</td>\n<td>\n<p>HWC-PHC- 2HWC UPHC: 2 (daycare)</p>\n<p>24X7 HWC-PHC/UPHC: 6</p>\n</td>\n<td>\n<p>Non-FRU CHC: 30</p>\n<p>FRU CHC: 30/50</p>\n<p>FRU-UCHC: 50/100</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>HWC- Health and wellness centre</p>\n<p>FRU- First referral unit</p></div><!---->\n      <!---->\n    </div><!---->'),
(1142, 'Community Medicine', 'PM0154. Suggested Norms for Health Workforce', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Health Personnel</strong></p>\n</td>\n<td>\n<p><strong>Norm Suggested</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Doctor</p>\n</td>\n<td>\n<p>1 per 1000 population</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Health worker (Male and female)</p>\n</td>\n<td>\n<p>1 per 5000 in plains</p>\n<p>1 per 3000 remote or hilly areas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Health assistant (Male and female)</p>\n</td>\n<td>\n<p>1 per 30,000 in plains</p>\n<p>1 per 20,000 in remote or hilly areas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pharmacist</p>\n</td>\n<td>\n<p>1 per 10,000</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lab technician</p>\n</td>\n<td>\n<p>1 per 10,000</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Auxillary Nurse Midwife</p>\n</td>\n<td>\n<p>1 per 10,000</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Urban Social Health Activist</p>\n</td>\n<td>\n<p>1 per 1000-2500</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Accredited Social Health Activist (ASHA)</p>\n</td>\n<td>\n<p>1 per 1000 (a village, 200-500 households)</p>\n<p>1 per habitation in remote or hilly areas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trained Dais or Trained Birth Attendant</p>\n</td>\n<td>\n<p>1 per 1000 (a village)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Village health guide (VHG)</p>\n</td>\n<td>\n<p>1 per 1000 (a village)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anganwadi worker (AWW)</p>\n</td>\n<td>\n<p>1 per 400 to 800 in plains</p>\n<p>1 per 300 to 800 in remote or hilly areas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nurse</p>\n</td>\n<td>\n<p>1 per 5000</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mahila Arogya Samiti</p>\n</td>\n<td>\n<p>1 per 250-500 (50-100 households)</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1143, 'Community Medicine', 'PM0153. Elements and Principles of Primary Health Care', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>A. Elements of Primary Health Care</strong></p>\n<p>(Mnemonic: <strong>ELEMENTS</strong>)</p>\n<ul>\n<li><strong>E</strong>ducation about health problems and their prevention and control</li>\n<li><strong>L</strong>ocally endemic diseases – prevention and control</li>\n<li><strong>E</strong>ssential drugs</li>\n<li><strong>M</strong>aternal and child health care</li>\n<li><strong>E</strong>xpanded programme of immunization against vaccine preventable diseases</li>\n<li><strong>N</strong>utrition and proper food supply</li>\n<li><strong>T</strong>reatment of common diseases and injuries</li>\n<li><strong>S</strong>afe water and sanitation</li>\n</ul>\n<p><strong>B. Principles/Pillars of Primary Health Care</strong></p>\n<ul>\n<li>Equitable distribution</li>\n<li>Community participation</li>\n<li>Intersectoral coordination</li>\n<li>Appropriate technology</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1144, 'Community Medicine', 'PM2208. Organizations and their Headquarters', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/711a91acb3c244ec80d64252f8ba6ce1x468x435.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/28903e978b2744c7b00bed32612fe153x720x454.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1145, 'Community Medicine', 'PM1820. Health-related International Declarations:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ol>\n<li><strong>Declaration of Alma-Ata (1978): </strong>Identified <strong>primary health care</strong> as the key to the attainment of the <strong>goal of Health for All.</strong></li>\n<li><strong>Ottawa&nbsp;Charter&nbsp;for&nbsp;Health&nbsp;Promotion (1986):&nbsp;</strong>The&nbsp;aim&nbsp;of&nbsp;the&nbsp;conference&nbsp;was&nbsp;to&nbsp;continue to&nbsp; achieve&nbsp;the&nbsp;<strong>objectives&nbsp;of&nbsp;the&nbsp;World&nbsp;Health Organization&nbsp;(WHO)&nbsp;Health&nbsp;for&nbsp;all by&nbsp;the&nbsp;year 2000</strong>.</li>\n</ol></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>3.&nbsp;<strong>Declaration of Oslo (1970): </strong>Related to<strong> therapeutic abortion.</strong></p>\n<p>4.&nbsp;<strong>Declaration of Tokyo (1975): </strong>Guidelines for medical doctors concerning <strong>torture </strong>and other cruel, inhuman or degrading treatment or punishment in relation to detention and imprisonment. (<strong>T </strong>– <strong>T</strong>okyo – <strong>T</strong>orture)</p>\n<p>5.&nbsp;<strong>Declaration of Helsinki (1975): </strong>Related to<strong> human experimentation. (H</strong> – <strong>H</strong>elsinki – <strong>H</strong>uman experimentation)</p>\n<p>6.&nbsp;<strong>Declaration of Geneva (1948): </strong>Most <strong>recent amendment</strong> was done on <strong>October 14, 2017 in Chicago. </strong> It gives the <strong>modern version of the 2500-year-old Hippocratic Oath</strong> which laid down the <strong>fundamental principles of medical ethics</strong> that any physician should follow.</p>\n<p>7.&nbsp;<strong>Declaration of Malta (1991, revised in 1992): Related to hunger strikes.</strong></p>\n<p>8.&nbsp;<strong>Declaration of Lisbon: </strong>Related to<strong> rights of the patients like right to information, confidentiality, dignity, freedom of choice etc.</strong></p>\n<p>9.&nbsp;<strong>Declaration of Sydney on human death: </strong> <strong>It </strong>stated that the <strong>determination of death</strong> “will be <strong>based on clinical judgment, supplemented if necessary by a number of diagnostic aids</strong>”, emphasising the <strong>EEG</strong>. Nonetheless, it asserted that “the <strong>overall judgment of the physician” could not be replaced by any ancillary test.</strong></p>\n<p>The statement also recommended that <strong>two or more physicians should make the diagnosis of death</strong> when organs were removed for <strong>transplantation.</strong></p>\n<p>10.&nbsp;<strong>Declaration of Istanbul: </strong>To address the urgent and growing problems of <strong>organ sales, transplant tourism and trafficking in organ donors</strong> in the context of the global shortage of organs.</p>\n<p>11.&nbsp;<strong>Declaration of Taipei</strong>: Related to ethical considerations regarding health databases and biobanks.</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1146, 'Community Medicine', 'PM0151. Diseases of International Significance', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>TDR (Tropical diseases) Strategy by the WHO</strong></p>\n</td>\n<td><strong>International Surveillance Diseases (WHO)</strong></td>\n</tr>\n<tr>\n<td>\n<p>Chagas disease</p>\n<p>Dengue</p>\n<p>Ebola</p>\n<p>Helminthiasis</p>\n<p>Leishmaniasis</p>\n<p>Leprosy</p>\n<p>Lymphatic filariasis</p>\n<p>Malaria</p>\n<p>Onchocerciasis</p>\n<p>Schistosomiasis</p>\n<p>Trypanosomiasis</p>\n<p>Tuberculosis</p>\n</td>\n<td>\n<p><strong><u><br> </u></strong>Avian Influenza</p>\n<p>Cholera</p>\n<p>MERS-CoV and SARS</p>\n<p>Ebola and Hendra virus infection</p>\n<p>Influenza</p>\n<p>Leptospirosis and Meningitis</p>\n<p>Nipah virus infection and Rift Valley fever</p>\n<p>Plague and Smallpox</p>\n<p>Tularaemia</p>\n<p>Hemorrhagic fevers (Lassa, Marburg, etc)</p>\n<p>Yellow fever</p>\n<p>Zika virus</p>\n<p>Louse borne typhus</p>\n<p>Malaria and Salmonellosis</p>\n<p>Relapsing fever and Paralytic polio</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>IHR(International Health regulations) notifiable diseases</strong></p>\n</td>\n<td>\n<p><strong>Diseases warranting isolation and quarantine</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><u></u>Smallpox</p>\n<p>Poliomyelitis due to wild type poliovirus</p>\n<p>Human influenza by a new subtype</p>\n<p>Severe acute respiratory syndrome (SARS)</p>\n<p>Cholera</p>\n<p>Pneumonic plague</p>\n<p>Yellow fever</p>\n<p>Viral hemorrhagic fever</p>\n<p>West Nile fever</p>\n</td>\n<td>\n<p>Cholera</p>\n<p>Diphtheria</p>\n<p>Infectious tuberculosis</p>\n<p>Plague</p>\n<p>Smallpox</p>\n<p>Yellow fever</p>\n<p>Viral hemorrhagic fevers</p>\n<p>SARS</p>\n<p>Flu that can cause a pandemic</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1147, 'Community Medicine', 'PM0148. GOBI–FFF Strategy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>This strategy was proposed by the United Nations Children’s Fund (UNICEF)</p>\n<ul>\n<li><strong>G </strong>– Growth monitoring with growth charts</li>\n<li><strong>O </strong>– Oral rehydration therapy for diarrhoea and dehydration</li>\n<li><strong>B</strong> – Breastfeeding</li>\n<li><strong>I</strong> – Immunization of children</li>\n<li><strong>F</strong> – Family planning and birth spacing</li>\n<li><strong>F </strong>– Food supplementation</li>\n<li><strong>F </strong>­– Female literacy promotion</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1148, 'Community Medicine', 'PM2399. Evaluation of diagnostic tests', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Different ways of asking the following parameters:</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Sensitivity</strong> (True positive rate)&nbsp;</p>\n<ul>\n<li>Percentage of <strong>diseased individuals</strong> who are <strong>correctly identified</strong> (as diseased).</li>\n<li>Proportion of all people <strong>with the disease</strong> who test <strong>positive.</strong></li>\n<li>Probability that when the <strong>disease is present</strong>, the test is <strong>positive.</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Specificity</strong> (True negative rate)&nbsp;</p>\n<ul>\n<li>Percentage of <strong>healthy individuals</strong> who are <strong>correctly identified</strong> (as healthy).</li>\n<li>Proportion of all people <strong>without the disease</strong> who test <strong>negative.</strong></li>\n<li>Probability that when the <strong>disease is absent</strong>, the test is <strong>negative.</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Positive</strong> <strong>predictive value&nbsp;</strong></p>\n<ul>\n<li>Probability that a person who has a <strong>positive test</strong> result actually <strong>has the disease</strong>.</li>\n<li>If the test is <strong>positive,</strong> what is the probability that the patient <strong>has the disease</strong>?</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Negative predictive value&nbsp;</strong></p>\n<ul>\n<li>Probability that a person who has a <strong>negative test</strong> result actually <strong>does not have the disease</strong>.</li>\n<li>If the test is <strong>negative,</strong> what is the probability that the patient <strong>does not have the disease</strong>?</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1149, 'Community Medicine', 'PM2138. Scales of data measurement', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Data can be <strong>quantitative</strong> (numerical values) or <strong>qualitative</strong> (types, labels).</p>\n<p>Quantitative data can be <strong>discrete variables </strong>or<strong> continuous variables.</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p>Description</p>\n</td>\n<td>\n<p>Example</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Discrete data</strong></p>\n</td>\n<td>\n<p>Can take&nbsp;<strong>certain values and none in between</strong></p>\n</td>\n<td>\n<p>Number of cancer patients in a hospital.&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Continuous data</strong></p>\n</td>\n<td>\n<p>Can <strong>take any value </strong>usually in between limits or a range.&nbsp;</p>\n</td>\n<td>\n<p>Most biomedical data is continuous.</p>\n<p>Height, weight, blood pressure, etc.</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>Data always forms one of four <strong>scales of measurement</strong> – <strong>nominal, ordinal, interval, or ratio</strong> scales (mnemonic: <strong>NOIR):</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><strong>Nominal Scale Data</strong></p>\n</td>\n<td>\n<p><strong>Ordinal Scale Data</strong></p>\n</td>\n<td>\n<p><strong>Interval Scale Data</strong></p>\n</td>\n<td>\n<p><strong>Ratio Scale Data</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Example</p>\n</td>\n<td>\n<p>Male/female; red/green; sub-urban/rural</p>\n</td>\n<td>\n<p>Students ranked 1st/2nd/3rd in their class.&nbsp;</p>\n<p>A customer feedback survey using terms like very good, good, poor and very poor or the <strong>Likert Scale.</strong></p>\n<p>Severity of a disease as mild, moderate, severe</p>\n<p>&nbsp;</p>\n</td>\n<td>Measurements on the celsius scale.</td>\n<td>Pulse rate;&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Notes</p>\n</td>\n<td>\n<p>Have <strong>no quantitative value</strong>.</p>\n<p>They have no order or ratio.&nbsp;</p>\n</td>\n<td>\n<p>Arranged in a <strong>meaningful order.</strong></p>\n<p><strong>No size interval is defined</strong></p>\n</td>\n<td>\n<p>Arranged in a <strong>meaningful order </strong>with a<strong> well defined size interval</strong>.</p>\n<p>Example: Temperature in Celsius. If temperature in A is 40 deg Celsius and that in B is 20 deg Celsius, then A is 20 deg Celsius hotter than B (taking difference)</p>\n<p><strong>Does not have an absolute zero.</strong></p>\n<p>For example, Celsius scale has no such thing as “no temperature”. So the value cannot be zero.</p>\n</td>\n<td>\n<p>Arranged in a <strong>meaningful order </strong>with a<strong> well defined size interval</strong>.</p>\n<p>Eg: A pulse rate has well defined intervals and is meaningful in comparison. A 100/min pulse is exactly twice of 50 beats/min.</p>\n<p>&nbsp;</p>\n<p><strong>Has an absolute zero.</strong></p>\n<p>Eg: There can be a value of zero for pulse.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type</p>\n</td>\n<td>\n<p><strong>Qualitative</strong></p>\n</td>\n<td>\n<p><strong>Qualitative</strong></p>\n</td>\n<td>\n<p><strong>Quantitative</strong></p>\n</td>\n<td>\n<p><strong>Quantitative</strong></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1150, 'Community Medicine', 'PM1150. Box and Whisker Plot', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>A box and whisker plot is used to show <strong>variation in a set of data</strong>.</li>\n<li>They can summarize data from various sources and display it in a single graph.</li>\n<li>A box and whisker plot is usually based on <strong>median, quartiles and percentiles</strong>.</li>\n<li>It is also called a <strong>box plot.</strong></li>\n<li>In the box plot as shown in the image, a simple box is divided into two by the <strong>median value</strong>. Above and below it are the <strong>whiskers</strong>. The top and bottom ends of the whiskers are the <strong>highest and lowest value of that group</strong>.&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>A box plot can help in identifying <strong>outliers</strong> and the <strong>interquartile range (IQR), </strong>as shown in the image below.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/557efa950e5f407ca148010054728d60x314x146.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1151, 'Community Medicine', 'PM1149. Forest Plot', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>A <strong>forest plot</strong> is used to present the results of a <strong>meta-analysis.</strong></li>\n<li>It is also called <strong>blobbogram.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/01f09b9b2dbb44fc90c6a6bb84df981ax1125x727.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Interpretation of forest plots:&nbsp;</p>\n<ul>\n<li aria-level=\1\>The <strong>rectangles</strong> represent the single studies</li>\n<li aria-level=\1\>The <strong>size of the rectangle</strong> is proportional to the sample size</li>\n<li aria-level=\1\>The <strong>horizontal line on either side</strong> - confidence interval, the longer the lines, the wider the confidential interval, the less reliable the study results</li>\n<li aria-level=\1\>The <strong>vertical solid line</strong> - the “line of no effect\, which represents the odds ratio or relative risk. If it is the odds ratio, then the vertical line would be at 1. No difference between the intervention and the placebo (i.e., <strong>a risk ratio of 1</strong>).&nbsp;</li>\n<li aria-level=\1\>The <strong>location of the result</strong> - whether it favours the intervention (the statin drug) or not</li>\n<li aria-level=\1\>A <strong>diamond</strong> shows the overall pooled result where all the individual studies are combined together and averaged</li>\n<li aria-level=\1\><strong>Lateral corners</strong> of the diamond represent the confidence interval, if these corners do not cross the line of no effect, then there is an overall statistically significant effect. If the diamond touches the vertical line, the overall result is not statistically significant.</li>\n<li>The <strong>vertical dashed line</strong> represents the <strong>overall pooled estimate</strong> which represents the <strong>meta-analysed measure of effect</strong>.</li>\n</ul>\n<p>Lets understand with an example -&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5b5dee4fbd514313a94da59b6f5366a4x1280x1200.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li aria-level=\1\>For <strong>study A</strong>- it has a wide horizontal line that crosses the line of null effect with a black box that is to the right of the vertical line. This most likely demonstrates a small scale study with few participants where the point estimate result favours the control used in the study. But because the study contains the null value in its 95% confidence interval, it is likely to have a p-value &gt;0.05 and not be statistically significant.</li>\n<li aria-level=\1\>For <strong>study B</strong>- it has quite a narrow line that does not cross the line of null effect with a black box that is to the left of the vertical line and is bigger than study A. This most likely demonstrates a larger study with more participants compared to study A, where the result favours the intervention used. Because the 95% confidence interval does not contain the null value, this study is likely to have a p-value &lt;0.05 and hence the differences observed in the study can be regarded as statistically significant.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1152, 'Community Medicine', 'PM1148. Funnel Plots', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>A <strong>funnel plot</strong> is basically a <strong>scatter plot of individual studies</strong> which are used in <strong>systematic reviews and meta-analysis</strong>. It plots their <strong>precisions and results</strong>.</li>\n<li>In a funnel plot, <strong>each dot represents an individual study</strong>.</li>\n<li>The <strong>y-axis</strong> is usually the <strong>standard error or another estimate of precision</strong> and the <strong>x-axis is the outcome</strong>, usually the <strong>odds ratio</strong>.</li>\n<li><strong>Higher powered studies</strong> are placed towards the <strong>top</strong> and the <strong>lower powered</strong> ones towards the <strong>bottom</strong> such that the plot resembles <strong>an inverted funnel or a pyramid</strong>.</li>\n<li>This shape is expected as different studies have different standard errors and other estimates.</li>\n<li>A symmetrical funnel plot is shown in Fig. A. in the image below.</li>\n<li>These funnel plots are used in meta-analysis to check for bias like publication bias or other reporting bias.</li>\n<li>In the case of <strong>bias being present</strong>, an <strong>asymmetrical funnel plot</strong> results, as shown in Fig. B. of the image below.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/21720e796dc64464b128ea514020d1edx1280x1746.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1153, 'Community Medicine', 'PM1147. Stem-and-Leaf Displays', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>A stem-and-leaf plot is used to <strong>graphically display small to moderate sized data</strong>.</li>\n<li>In this type of representation, the values of the data are separated into two parts, the <strong>stem and the leaf</strong>.</li>\n<li>Usually, the <strong>stem</strong> represents the <strong>tens, hundreds, thousandth digits</strong>, etc. and the <strong>leaf part</strong> represents the remainders of the digits.</li>\n<li>For example, if a set of data containing marks of students of out 100 is 94, 90, 84, 87, 89, 85, 83, 79, 72, 70, 72, 68, 69, 65, 53. Then the stem-and-leaf for this set of data would be as shown in the image.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1154, 'Community Medicine', 'PM1146. Sampling', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>1. Simple random sampling</strong></p>\n<ul>\n<li>In simple random sampling, samples are drawn in such a way that <strong>every element in a population has equal chances</strong> of being included.</li>\n<li>Randomness refers to the <strong>method of picking the sample</strong> and not the outcome.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/eab4b31aa4f24e689e44c4ccf3abf443x1280x1225.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>2. Stratified random sampling</strong></p>\n<ul>\n<li>In stratified random sampling, the <strong>population is first divided into homogeneous groups</strong>, or <strong>strata</strong>. From these <strong>strata,</strong> random samples are drawn.</li>\n<li>For example, dividing a population into the strata of men, women, and children and then picking samples randomly from these strata.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c86c4e0efdea496487723728f004de8ex1280x1523.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>3. Cluster sampling</strong></p>\n<ul>\n<li>In cluster sampling, the <strong>population is divided into internally heterogeneous groups.</strong>&nbsp;Then a <strong>simple random sampling is done of these clusters</strong> and taken as the samples.</li>\n<li>In other words, the <strong>clusters</strong> are the <strong>sampling unit.</strong></li>\n<li>This is usually done when large-scale simple random sampling or stratified sampling is laborious or expensive.</li>\n<li>This is the method used in assessing the&nbsp;<strong>immunization status of children</strong>.</li>\n<li>Cluster sampling involves a&nbsp;<strong>design effect</strong>, which is an adjustment to allow for design structure. It aids in the correlation between clusters.</li>\n<li><strong>Multistage sampling</strong> is a form of cluster sampling, where sampling clusters are chosen from the already divided clusters.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/711b7580f9604a5d8a05eab99ce199ebx1280x1225.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>4. Systematic random sampling</strong></p>\n<ul>\n<li>In systematic sampling, there is a <strong>systematic pattern</strong> to selecting the elements of a sample.</li>\n<li>For example, every 3<sup>rd</sup> baby to be born can be selected.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6e085576b4f04e5784a9a2773def8601x1280x978.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1155, 'Community Medicine', 'PM1142. Regression', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>When <strong>two variables</strong> are <strong>correlated</strong>, the value of<strong> one </strong>of the<strong> variables </strong>can be<strong> predicted&nbsp;</strong>from the value of the other using <strong>regression techniques.</strong></p>\n<ul>\n<li><strong>Independent variable:</strong>&nbsp;The <strong>variable from which</strong> the other variable is calculated.</li>\n<li><strong>Dependent variable: </strong>The&nbsp;variable for which the <strong>value is calculated</strong>.</li>\n</ul>\n<p>Types of regression:</p>\n<p><strong>1. Simple linear regression</strong></p>\n<ul>\n<li>In this,&nbsp;the <strong>value </strong>of <strong>one</strong> variable<strong> (y)</strong> is used to<strong> predict</strong> the value of another variable<strong>&nbsp;(x)</strong>.</li>\n<li>The<strong> regression equation </strong>is used for this purpose. It gives a <strong>straight-line</strong> relationship&nbsp;between the two variables.</li>\n<li>It is given by the equation<strong>&nbsp;y = a + bx</strong>, where,&nbsp;a is a constant called the intercept constant and b is the regression coefficient.</li>\n<li>The intercept constant is the point where the Y-axis is intercepted by the regression line.&nbsp;</li>\n</ul>\n<p>&nbsp;<strong>2. Multiple linear regression</strong></p>\n<ul>\n<li>In this, <strong>more than one </strong>variable is used to <strong>predict </strong>the expected <strong>value </strong>of another variable<strong> (y)</strong>.</li>\n<li>Here, the expected value of <strong>y = a + b<sub>1</sub>x<sub>1</sub> + b<sub>2</sub>x<sub>2</sub>…..b<sub>n</sub>x<sub>n&nbsp;</sub></strong>where b<sub>1</sub> and b<sub>2</sub>…..b<sub>n</sub> represent different regression coefficients and x<sub>1</sub>, x<sub>2</sub>…….x<sub>n</sub> represents the known variables.</li>\n</ul>\n<p>&nbsp;<strong>3. Logistic regression</strong></p>\n<ul>\n<li>&nbsp;In some situations, we are <strong>not interested in a numerical outcome</strong> (like risk, etc) but we want a<strong> nominal or categorical one</strong> (like death/survival, developing a disease/not developing a disease)</li>\n<li>Here, the relationship between the variables will <strong>not be a linear</strong> one as the outcome from survival to death in relationship with the risk factor can change suddenly. Thus <strong>these outcomes</strong> are represented by <strong>0 and 1.</strong></li>\n<li>Using a mathematical <strong>logistic function</strong> we can transform linear regression data, such that the values of a variable y are limited to the range of 0 to 1, which would give us the <strong>probability of y occurring for the given values of</strong> variable <strong>x</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1156, 'Community Medicine', 'PM1139. Correlation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Correlation</strong> expresses the <strong>strength</strong> and <strong>direction</strong> of the relationship between two variables in terms of a <strong>correlation coefficient</strong>. It is represented by&nbsp;<strong>r</strong>.</p>\n<ul>\n<li>Values of r vary from <strong>-1</strong> (perfect negative correlation) to <strong>+1</strong> (perfect positive correlation).</li>\n<li>Value (size) of the coefficient: Indicates the strength of relationship</li>\n<li>Sign of the coefficient: Indicates direction of relationship</li>\n</ul>\n<p>Coefficients between ±0.5 and 1 are regarded as strong whereas those between ±0.5 and 0 are regarded as weak.</p>\n<p>The data is plotted in a <strong>scattergram</strong> as shown in the examples given below</p>\n<p>Examples:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/333f39128051444e8f62260f161639ebx1280x2998.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Types of correlation coefficients</strong></p>\n<ol>\n<li>Pearson coefficient</li>\n<li>Spearman coefficient</li>\n</ol></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/69ce1962b6b64f638b91fe579a829ac4x1280x1675.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Coefficient of Determination (CD) =&nbsp;&nbsp;r<sup>2</sup></strong></p>\n<p>It is simply the percentage variability in one factor due to change in another variable.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1157, 'Community Medicine', 'PM1104. Tests of Significance', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>How to choose which test to use?</strong></p>\n<ul>\n<li>See the <strong>variable</strong>. Are the variables <strong>quantitative</strong> or <strong>qualitative</strong>?\n<ul>\n<li>If the variables are <strong>qualitative&nbsp;</strong>(<strong>nominal</strong>), then <strong>Chi square test</strong> is used.</li>\n<li>If the variables are <strong>quantitative</strong>, then see whether <strong>2 groups or more than 2 groups&nbsp;</strong>.\n<ul>\n<li>If <strong>2 groups </strong>are being tested, then <strong>T tests</strong> are used. In that, if the same group is tested before and after, paired T test is used. Otherwise, unpaired T test is used.</li>\n<li>If <strong>more than 2 groups</strong> are being tested, then use <strong>ANOVA</strong>.</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>1. T Tests</strong></p>\n<ul>\n<li><strong>Unpaired t tests</strong>\n<ul>\n<li>Also known as the <strong>student’s t test, independent t test, two-samples t test</strong>.</li>\n<li>Its the <strong>most commonly used t test</strong>&nbsp;and it tests the difference between two groups (the means of 2 groups)<strong> independent</strong> of each other<strong>&nbsp;</strong>and indicates how significant the differences are<strong>.</strong></li>\n</ul>\n</li>\n<li><strong>Paired t tests</strong>\n<ul>\n<li>\Pairs <strong>before</strong>&nbsp;marriage are not the same <strong>after!\</strong></li>\n<li>So remember the&nbsp;<strong>paired</strong> test is mainly used in the comparison of a&nbsp;<strong>before and after scenario</strong>&nbsp;</li>\n<li>Also known as<strong> correlated t test,</strong>&nbsp;<strong>dependent samples t test</strong>.</li>\n<li>It is mainly used on dependent samples.<strong>&nbsp;</strong>For example, the cholesterol level of a person before and after using a specific drug.</li>\n<li>It can also be used when you put the <strong>same condition</strong> under <strong>test</strong> <strong>using different items</strong> or things. For example, same crash safety tests for different cars.</li>\n</ul>\n</li>\n<li><strong>T scores</strong>&nbsp;\n<ul>\n<li>The t score is referred to as the <strong>ratio </strong>of<strong>&nbsp;</strong>the difference between two groups and the difference within the groups.</li>\n<li>The <strong>smaller </strong>the t score, the <strong>more similarity</strong> there is between two groups and vice versa.</li>\n</ul>\n</li>\n</ul>\n<p>&nbsp;</p>\n<p><strong>2</strong>. <strong>Analysis of Variance (ANOVA)</strong></p>\n<ul>\n<li>The analysis of variance test (<strong>ANOVA)</strong> is used to test the difference between two or usually<strong> more than two groups (means) </strong>and here the inferences are made by analyzing the variances.</li>\n</ul>\n<p>&nbsp;</p>\n<p><strong>3</strong>. <strong>Chi-Square Test</strong></p>\n<ul>\n<li>The <strong>Chi-Square test (χ<sup>2</sup>)</strong> is a <strong>non-parametric(non-numeric) test</strong> and it is used to test hypotheses in relation to <strong>nominal scale data or categorical data.</strong></li>\n<li>It is a <strong>test of proportions and associations.</strong></li>\n<li>A Chi-square distribution is usually<strong> positively skewed</strong> but it approaches a normal distribution as its degrees of freedom increases.</li>\n<li>If the <strong>frequency of any of the cells of the categorical table</strong> is&nbsp;<strong>&lt;5</strong>, then&nbsp;<strong>Fisher’s exact test</strong> is used.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1158, 'Community Medicine', 'PM1103. Degrees of Freedom', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>In general, <strong>degrees of freedom</strong> (<strong>df</strong>) is equal to the <strong>number of values minus the numbers of parameters estimated</strong> on the way to the obtaining a particular estimate. For example, if we want to estimate the variance between the heights of two people A and B, we would use the values of 2 heights to estimate 1 parameter. Thus, the degrees of freedom in this case would be 2 – 1 = 1.</li>\n<li>For a Chi-square contingency table, the <strong>df = (r-1) (c-1)</strong>, where <strong>r </strong>is the <strong>number of rows</strong> and <strong>c</strong> is the <strong>number of columns</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1159, 'Community Medicine', 'PM1098. Concepts in Hypothesis Testing', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Probability value (</strong><em>p</em><strong> value)</strong></p>\n<ul>\n<li>A&nbsp;<strong>probability value</strong>&nbsp;is the&nbsp;<strong>probability of an outcome given the hypothesis</strong>.</li>\n<li>It is not the probability of the hypothesis given the outcome, although the probability of the given hypothesis is not ignored.</li>\n<li>If the&nbsp;<strong>probability of an outcome is sufficiently low</strong>, we have&nbsp;<strong>evidence that the hypothesis is false</strong>.</li>\n<li>It is also called the&nbsp;<em>p</em><strong> value</strong>.</li>\n</ul>\n<p><strong>The Null Hypothesis and Alternative Hypothesis</strong></p>\n<ul>\n<li>The <strong>hypothesis that an apparent effect or outcome is only due to chance is a null hypothesis</strong>.</li>\n<li>In other words, a null hypothesis is one where there is <strong>no difference between the specified sample and population</strong> and any observed difference is due to chance or some other error.</li>\n<li>A null hypothesis is represented by <strong>H<sub>0</sub></strong>.</li>\n<li>If the <strong>null hypothesis</strong> is <strong>rejected</strong> as false, then there is an <strong>alternative</strong> or <strong>experimental hypothesis (H<sub>A</sub>)</strong>, which is logically accepted.</li>\n</ul>\n<p><strong>Criterion or Significance Level</strong> <strong>(α) </strong></p>\n<ul>\n<li>If the probability value of an outcome is sufficiently low, then the null hypothesis is rejected.</li>\n<li>This <strong>point below which we would define the probability value as being low enough</strong> to reject the null hypothesis is called the <strong>criterion</strong> or <strong>significance level </strong>or<strong> α (alpha) level</strong>.</li>\n<li>When the null hypothesis is rejected, the effect or outcome is said to be <strong>statistically significant</strong>.</li>\n<li>By <strong>convention</strong> (but not always), the <strong>level of α is 0.05</strong>, i.e., if the probability value of an outcome is <strong>less than or equal to 0.05 (</strong><em>p</em><strong> value ≤ 0.05)</strong>, then the null hypothesis is <strong>rejected</strong>.</li>\n<li>If it is <strong>greater than 0.05</strong>, then the null hypothesis is <strong>accepted</strong>.</li>\n<li>Although by convention the level of <strong>α is 0.05</strong>, it can be lower but cannot be any higher.</li>\n</ul>\n<p><strong>Type I Error</strong></p>\n<ul>\n<li>The interpretation of <strong><em>p</em> value ≤ 0.05 </strong>is that an investigator can be 95% sure that the result was not obtained by chance.</li>\n<li>It also means that there is a 5% probability that the result was obtained by chance.</li>\n<li>From this, we can deduce that the <strong>null hypothesis might indeed be true even though we rejected it</strong>.</li>\n<li>This is <strong>a type I error</strong>. In other words, <strong>when an alternative hypothesis is accepted even when it is false and the null hypothesis is true</strong>, it is a <strong>type I error</strong> or <strong>false positive error</strong>.</li>\n<li>It is also called an <strong>alpha (α) error</strong> as it is <strong>related to the criterion α</strong>.</li>\n<li>The <strong>lower the α level</strong>, the <strong>lower the rate of a type I error</strong> being made.</li>\n<li>Thus, it can be said that <strong>α is the maximum tolerable probability that a type I error is being made</strong> and that the <strong>p value is the probability that a significant difference is declared when there is none</strong>.</li>\n</ul>\n<p><strong>Type II Error</strong></p>\n<ul>\n<li>The error that is made by <strong>rejecting an alternative hypothesis when it is true</strong> or <strong>failing to reject a null hypothesis when it is false</strong> is called a <strong>type II error</strong>.</li>\n<li>It is also called a <strong>false negative error </strong>and more commonly, as a <strong>beta (β) error</strong>.</li>\n<li>If the null hypothesis is false, then the <strong>probability of a type II error</strong> is <strong>β</strong>.</li>\n<li>The <strong>power of a statistical test</strong> is indicated by <strong>1–β.</strong></li>\n</ul>\n<p><strong>Power of a Test</strong></p>\n<ul>\n<li>The <strong>power of a test</strong> is the <strong>ability</strong> of a statistical test to <strong>avoid a type II error</strong>, which depends on its <strong>ability to detect a false null hypothesis</strong>.</li>\n<li>It is <strong>equal to 1–β</strong>, which is the <strong>probability that a false null hypothesis will be rejected</strong>.</li>\n<li>By <strong>convention</strong>, a test is required to have a <strong>power of 0.8</strong> (or a <strong>β of 0.2</strong>) to be <strong>acceptable</strong>. This is to say that a study that has less than 80% chance of detecting a false null hypothesis is unacceptable.</li>\n<li><strong>Type I errors are easily reduced by reducing the criterion α</strong>.</li>\n<li>A <strong>tests power will increase</strong> in the following conditions:\n<ul>\n<li>If <strong>α increases</strong>, but this will increase the chance of a type I error.</li>\n<li>If the <strong>difference between </strong>the <strong>sample mean </strong>and<strong> hypothesized mean increases</strong>. This is also called <strong>effect size</strong>.</li>\n<li>If <strong>sampling error decreases</strong>.</li>\n<li>If the <strong>sample size (n) increases</strong>.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1160, 'Community Medicine', 'PM1090. Confidence Limits and Interval', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Confidence limits</strong> are the upper and lower limits of standard errors within which a parameter value is expected to lie.</p>\n<p>Generally, 95% confidence limits are used and they are approximately equal to the sample mean plus or minus two standard errors, i.e., <strong>95% confidence limits =</strong> <strong>Sample mean</strong> <strong>(</strong><strong>x̄) ± 2 standard errors.</strong></p>\n<p>The <strong>general formula </strong>is <strong>confidence limits = x̄ ± z</strong><strong>σ </strong><strong><sub>x̄</sub></strong><strong>.&nbsp;</strong></p>\n<ul>\n<li>Where z is 3 for 99.7% Cl</li>\n<li>z is 2 for 95% Cl</li>\n<li>z is 1 for 68% Cl</li>\n</ul>\n<p>The <strong>difference </strong>between<strong> upper</strong> and <strong>lower confidence limits </strong>is called the <strong>confidence interval.&nbsp;</strong>Since the standard error will decrease in proportion to the square root of the sample size, the<strong> width </strong>of the<strong> confidence interval </strong>will also <strong>decrease</strong> in <strong>proportion </strong>to the<strong> square root </strong>of the<strong> sample size.</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1161, 'Community Medicine', 'PM1089. The Standard Error and Related Aspects', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ol>\n<li><strong>Sampling Errors:&nbsp;</strong>They refer to <strong>natural, expected, random variations</strong> in the data. They are not errors per se. Hence, the mean of the sample always differs from the mean of the total population.&nbsp;<strong>For example</strong>, consider a population with a mean weight of 75. If we take a sample of 500 people from this population, the mean weight of this sample will not be exactly 75.</li>\n<li><strong>Random Sampling Distribution of Means</strong> (or Sampling Distribution):\n<ul>\n<li aria-level=\1\>This refers to the distribution formed when <strong>all possible sample means from a population</strong> are plotted in a <strong>frequency distribution.</strong></li>\n<li aria-level=\1\>Sampling distributions provide information into how <strong>different the samples are from each other and from the population mean.</strong></li>\n</ul>\n<strong>For example,</strong> the hemoglobin levels of 100 randomly selected women in a city are measured and their sample mean is calculated. This is done every day for a year with the same sample size but different women each time.&nbsp;<strong>If all the sample means</strong> of hemoglobin levels of all women are plotted on frequency distribution, the resulting distribution would be called the <strong>sampling distribution</strong>. It would resemble a <strong>normal distribution.</strong></li>\n<li><strong>Central Limit Theorem:&nbsp;</strong>According to this theorem, as the <strong>sample size increases:</strong>\n<ul>\n<li>The sampling distribution tends towards a <strong>normal distribution</strong> curve (bell curve)\n<ol>\n<li>Regardless of the populations actual distribution shape</li>\n<li>Assuming all samples are identical in size</li>\n</ol>\n</li>\n<li>The <strong>sample mean</strong> and standard deviations become <strong>closer</strong> to the <strong>population mean</strong> and standard deviations&nbsp;</li>\n</ul>\n</li>\n<li><strong>Standard Error of Mean</strong> (SE or σ x̄ ):\n<ul>\n<li aria-level=\1\>The standard error is a <strong>measure</strong> of the<strong> extent</strong> to which the <strong>sample means deviate</strong> from the true <strong>population mean</strong>. It is nothing but the standard deviation of the sampling distribution.</li>\n<ol>\n<li aria-level=\2\>Sample means closer to the population mean lead to a lower SE and a narrower and thinner distribution curve&nbsp;</li>\n<li aria-level=\2\>More variation in sample means leads to a higher SE and a broader curve&nbsp;</li>\n</ol>\n</ul>\nSE = Standard deviation / √Sample size</li>\n</ol>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; σ x̄ = σ/√n</p>\n<p>Hence, <strong>SE</strong> is <strong>inversely related</strong> to <strong>√sample size.&nbsp;</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1162, 'Community Medicine', 'PM1088. Coefficient of Variation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The coefficient of variation (<strong>CV</strong>) is a statistical measure of the relative dispersion of data points in a data series around the mean.</li>\n<li>It is done to measure of relative variability and it is also known as <strong>relative standard deviation (RSD).</strong></li>\n<li>It is expressed as a <strong>percentage of the mean</strong> and its formulas are given in the image below:</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/09cf5addc297429fa827684838f1e096x173x192.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>where&nbsp;σ and s = standard deviation; and μ and x = mean</p>\n<ul>\n<li>In simpler terms, <strong>coefficient of variation (CV) = standard deviation x 100/mean</strong>.</li>\n<li>CV usually gives an idea into the performance of a test or method. A CV of 5% gives the general idea that the method is good in its performance but a CV of more than 10% gives an idea that the method isn’t very good.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1163, 'Community Medicine', 'PM1087. Inferential Statistics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>One of the most common problems faced in research is using information gathered by researching a <strong>sample</strong> and then drawing conclusions about the <strong>population</strong> from which the sample is drawn.</li>\n<li>In these situations, only the <strong>sample statistics</strong>, i.e., <strong>sample mean (</strong><strong>x̄) and sample standard deviation (s) are known and the population parameters, i.e., population mean (µ) and population standard deviation (σ) are unknown.</strong></li>\n<li>This is where inferential statistics is used. Inferential statistical methods are used to draw conclusions about the population parameters from sample statistics.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1164, 'Community Medicine', 'PM1086. Z Scores', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Z score</strong>&nbsp;indicates the <strong>position </strong>of any<strong> element</strong> in a distribution in terms of how many <strong>standard deviations </strong>it lies<strong> from </strong>the<strong> mean </strong>of the distribution.</li>\n<li>It is also called the <strong>standard score.</strong></li>\n<li>If it lies <strong>above</strong> the <strong>mean</strong>, its <strong>z score</strong> will be <strong>positive</strong> and if it lies <strong>below</strong> it, the z score will be <strong>negative</strong>.</li>\n<li>For example, if an element lies 1.5 standard deviations below the mean, its z score will be <strong>-1.5 </strong>and if it lies 0.5 standard deviations above the mean, its z score will be <strong>+0.5.</strong></li>\n<li>The formula for calculating <strong>z scores </strong>is <strong>z = (X- µ)/σ</strong>, where x is the element’s value, µ is the mean and σ is the standard deviation. From this, we can also calculate the actual value of the element.</li>\n<li>Some of the z-values for commonly used percentiles:</li>\n</ul>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td width=\96\>\n<p><strong>Percentile</strong></p>\n</td>\n<td width=\85\>\n<p><strong>Z value</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>1<sup>st</sup></p>\n</td>\n<td width=\85\>\n<p>-2.326</p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>2.5<sup>th</sup></p>\n</td>\n<td width=\85\>\n<p>-1.960</p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>5<sup>th</sup></p>\n</td>\n<td width=\85\>\n<p>-1.645</p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>10<sup>th</sup></p>\n</td>\n<td width=\85\>\n<p>-1.282</p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>25<sup>th</sup></p>\n</td>\n<td width=\85\>\n<p>-0.675</p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>50<sup>th</sup></p>\n</td>\n<td width=\85\>\n<p>0</p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>75<sup>th</sup></p>\n</td>\n<td width=\85\>\n<p>0.675</p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>90<sup>th</sup></p>\n</td>\n<td width=\85\>\n<p>1.282</p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>95<sup>th</sup></p>\n</td>\n<td width=\85\>\n<p>1.645</p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>97.5<sup>th</sup></p>\n</td>\n<td width=\85\>\n<p>1.960</p>\n</td>\n</tr>\n<tr>\n<td width=\96\>\n<p>99<sup>th</sup></p>\n</td>\n<td width=\85\>\n<p>2.326</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1165, 'Community Medicine', 'PM1085. Quantiles', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Quantiles </strong>are elements in a distribution that divide it into <strong>equal groups</strong>.</p>\n<ul>\n<li>They are also referred to as <strong>fractiles</strong>.</li>\n<li>Quantiles are used for <strong>continuous, quantitative data.</strong></li>\n<li>The <strong>median </strong>is also considered a<strong> quantile</strong> as it divides a distribution into <strong>two equal parts.</strong> The median is also the same as the <strong>50<sup>th</sup> percentile </strong>and<strong>&nbsp;second</strong><strong>&nbsp;quartile.</strong></li>\n</ul>\n<p>Types of quantiles:</p>\n<ol>\n<li>Tertiles divide a distribution into 3&nbsp;equal groups</li>\n<li><strong>Quartiles</strong> divide it into <strong>4 equal</strong> parts or quarters</li>\n<li>Quintiles divide a distribution into 5 equal groups</li>\n<li>Deciles&nbsp;divide a distribution into 10 equal parts</li>\n<li>Vigintiles divide it into 20 equal groups</li>\n<li><strong>Centiles:</strong></li>\n</ol>\n<ul>\n<li>They are also called <strong>percentiles</strong> and are commonly used, especially for ranking marks in an exam.</li>\n<li>They divide a distribution into <strong>100 equal parts. </strong>Here, the <strong>median </strong>is the same as the <strong>50<sup>th</sup></strong> percentile.</li>\n<li>The formula to arrive at the rank order of a value is <strong>R</strong> = <strong>P/100 x (n + 1)</strong>, where R is the <strong>rank </strong>of the desired observation, P is the <strong>percentile desired</strong> and <strong>n</strong> is the <strong>number</strong> of <strong>variables</strong> in the data.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1166, 'Community Medicine', 'PM1011. The Range in Biostatistics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>The range</strong> is the <strong>simplest measure</strong> of <strong>variability </strong>or dispersion. It is the <strong>difference between the highest and lowest scores</strong> in the data distribution.</li>\n<li>The main advantage of the range is that it is <strong>easy to compute</strong>.</li>\n<li>The disadvantage of the range is that it is <strong>sensitive to extreme values</strong>.</li>\n<li>Examples: For a set of values: 9, 15, 25, 30, 40 – the range = 40 – 9 = 31. But for a set of values: 9, 20, 30, 40, 500 – the range = 500 – 9 = 491.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1167, 'Community Medicine', 'PM1007. Normal Distribution', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>The normal distribution </strong>curve is the most <strong>common </strong>shape taken by<strong> continuous data </strong>distributions. It is also called <strong>bell curve </strong>(bell-shaped) or <strong>Gaussian distribution</strong> after mathematician Karl Friedrich Gauss.</p>\n<p>The following is an image of three different normal distribution curves.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/99fb903f13594e838e63dcee222ccc82x479x387.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Salient features of the&nbsp;<strong>standard normal distribution</strong>:</p>\n<ul>\n<li>Defined by two parameters:&nbsp;the<strong>&nbsp;mean&nbsp;</strong>and the&nbsp;<strong>standard deviation</strong></li>\n<li>Has<strong> mean</strong> of<strong> 0</strong> and a<strong> standard deviation</strong> of<strong> 1</strong></li>\n<li><strong>Mean = median = mode</strong></li>\n<li><strong>Symmetric</strong>&nbsp;and have&nbsp;<strong>bell</strong>-shaped <strong>curves</strong>&nbsp;with a single peak</li>\n<li>Total<strong> area under the curve </strong>is<strong> 1</strong></li>\n<li><strong>Frequency of values</strong>&nbsp;is <strong>more around the center</strong> and <strong>less around the tails</strong></li>\n<li><strong>No skew </strong>in the curve</li>\n<li>Data like blood pressure, heights, IQ scores, etc. form a normal distribution</li>\n<li>The <strong>empirical rule</strong> of a normal distribution:\n<ul>\n<li>Approximately <strong>68%</strong> of the distribution falls within <strong>one</strong> standard deviation of the mean (<strong>mean ± 1 SD</strong>)</li>\n<li>Approximately <strong>95%</strong> of the distribution falls within <strong>two </strong>standard deviations of the mean (<strong>mean ± 2 SD</strong>)</li>\n<li>Approximately <strong>99.7%</strong> of the distribution falls within <strong>three </strong>standard deviations of the mean (<strong>mean ± 3 SD</strong>)</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9b2acfa7a0024a73895e0113ce912fbcx1280x1219.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1168, 'Community Medicine', 'PM0999. Variance, Deviation Scores and Standard Deviation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Deviation Scores:&nbsp;</strong>\n<ul>\n<li><strong>The deviation score </strong>of an element in distribution is the <strong>difference </strong>between the<strong> mean </strong>of the distribution and the<strong> element </strong>itself, i.e., subtracting the distribution’s mean from the element.</li>\n<li>Denoted by the letter <strong>x</strong></li>\n<li>For example, if <strong>29 </strong>and<strong> 15 </strong>are <strong>elements</strong> in a distribution that has a <strong>mean </strong>of<strong> 22</strong>, the deviation score of 29 would be (29 – 22) = <strong>7</strong>&nbsp;and the deviation score of 15 would be (15 – 22) = <strong>- 7</strong>.</li>\n<li><strong>Sum </strong>of all the<strong> deviation scores</strong> of elements in distribution will be <strong>zero</strong></li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Variance </strong>(also called mean square)&nbsp;\n<ul>\n<li>The <strong>mean </strong>of the<strong> squares </strong>of all the<strong> deviation scores</strong> of the distribution</li>\n<li>Used to <strong>measure </strong>how far<strong> data </strong>is <strong>spread out</strong></li>\n<li>If the&nbsp;<strong>variance</strong> is<strong> zero</strong>, it indicates that all the elements in the distribution are the same and that there is <strong>no variability</strong>.</li>\n<li>Population variance (<strong>σ<sup>2</sup></strong>) is calculated as:\n<ul>\n<li>Find the<strong> deviation score </strong>of<strong> each element </strong>in the distribution</li>\n<li><strong>Square&nbsp;</strong>each of the deviation <strong>scores.</strong></li>\n<li>Obtain the <strong>mean </strong>of all these <strong>squared</strong> deviation<strong> scores</strong></li>\n</ul>\n</li>\n</ul>\n</li>\n<li></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/7dc49e32bffe441a8e1cff5735b49425x268x112.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<ul>\n<li><strong>Sample variance</strong> (<strong>s<sup>2</sup></strong>):&nbsp;\n<ul>\n<li><strong>more commonly used</strong> in statistics than population variance</li>\n<li>The <strong>denominator</strong> is <strong>n-1</strong> (and not <strong>N </strong>as it is in population variance)</li>\n<li>For small samples, it is better to use<strong>&nbsp;n-1</strong>&nbsp;in the&nbsp;<strong>denominator</strong>.</li>\n<li>For a very&nbsp;<strong>large sample</strong>, like a population,<strong>&nbsp;</strong>subtracting 1 from a huge number will not make much of a significant correction. Hence, we may choose to&nbsp;<strong>ignore subtracting 1</strong>.</li>\n</ul>\n</li>\n</ul>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/84c56eba8e094f5ba405b6e6051f3af7x284x129.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Standard Deviation (SD)</strong></li>\n<ul>\n<li>It is the <strong>square root of variance.</strong></li>\n<li>The standard deviation of a <strong>population</strong>&nbsp;is denoted by&nbsp;<strong>σ</strong> and the standard deviation of a <strong>sample</strong> is denoted by just <strong>s</strong>.</li>\n<li>The formula for the standard deviation of a sample (usually &lt;30):</li>\n</ul>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/9c1bab370e1a4e3381792ddaca531f1bx259x194.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<ul>\n<li>For a population (large sample), the denominator would be replaced by just <strong>N</strong>.</li>\n<li>It is particularly useful for normal distributions but can be used in&nbsp;<strong>skewed distributions</strong></li>\n<li>It is used to calculate&nbsp;the <strong>proportion </strong>of the<strong> population</strong> within the given SD</li>\n<li>A low SD means that the data are close to the mean but a high SD would mean that the data are more spread out.</li>\n<li>The <strong>empirical rule</strong> of a normal distribution states that:\n<ul>\n<li>Approximately <strong>68%</strong> of the distribution falls within <strong>one</strong> standard deviation of the mean.</li>\n<li>Approximately <strong>95%</strong> of the distribution falls within <strong>two</strong> standard deviations of the mean.</li>\n<li>Approximately <strong>99.7%</strong> of the distribution falls within <strong>three</strong> standard deviations of the mean.</li>\n</ul>\n</li>\n</ul>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/39dff3335b964a29962407c305219e50x1280x1219.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1169, 'Community Medicine', 'PM0978. The Geometric Mean', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The geometric mean or average is defined as the <strong>nth root of the product of all the values in the distribution</strong>, where n is the number of elements in the distribution.</li>\n<li>It is given by the formula:</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/8d8fdfd0621547f3b2cc24aa70ded9c0x377x124.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>where n is the number of elements in the distribution; a1 is the first value, a2 the second and so on. The symbol <strong>π</strong> is representative of multiplication.</p>\n<ul>\n<li><strong>The geometric mean</strong> basically instructs to <strong>multiply</strong> instead of add like in the <strong>arithmetic mean.</strong></li>\n<li>The <strong>geometric mean</strong> of a set of data is always <strong>less than the arithmetic mean</strong> <strong>except</strong> if all values in the <strong>data are the same</strong>. Example, take data containing values 5, 5, 5. The arithmetic mean would be 15/3 = 5. The geometric mean would be = 5.</li>\n<li>Geometric mean has a wide range of application in areas like growth rates of population, estimating gastric emptying times and water quality standards.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1170, 'Community Medicine', 'PM0972. Mean, Median, Mode in Different Distribution Shapes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The relationship between the mean, median and mode depends upon the distribution.</li>\n<li>In a <strong>unimodal symmetrical </strong>distribution like a <strong>normal distribution</strong>, all the <strong>three measures</strong> are approximately the<strong> same</strong>, as shown in Figure (b) in the following image, i.e., <strong>mean = median = mode.</strong></li>\n<li>Figure (c) in the following image shows a <strong>positively skewed</strong> distribution in which the <strong>longer tail </strong>is towards the<strong> positive direction</strong>. In this, the mean will be larger than the median and mode, i.e., <strong>mean &gt; median &gt; mode.</strong></li>\n<li>Figure (a) in the following image shows a <strong>negatively skewed</strong> distribution in which the <strong>longer tail </strong>is towards the<strong> negative direction</strong>. In this, the mean will be smaller than the median, i.e., <strong>mean &lt; median &lt; mode.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d79321686162499ca8b9174d58e8f7aex1280x2893.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\264\>\n<p>Unimodal <strong>symmetrical distribution</strong></p>\n</td>\n<td width=\192\>\n<p><strong>Mean = Median = Mode</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\264\>\n<p><strong>Positively (right) skewed</strong> distribution</p>\n</td>\n<td width=\192\>\n<p><strong>Mean &gt; Median &gt; Mode</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\264\>\n<p><strong>Negatively (left) skewed</strong> distribution</p>\n</td>\n<td width=\192\>\n<p><strong>Mean &lt; Median &lt; Mode</strong></p>\n</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li>As seen in the figures above, in any distribution curve, the <strong>mode </strong>is generally the<strong> highest point</strong>. The <strong>mean</strong> will be pulled up or down <strong>based </strong>on the<strong> values</strong> in the distribution. The <strong>median </strong>will lie<strong> between</strong> the <strong>mode</strong> and <strong>mean</strong> and <strong>divide</strong> the distribution in two<strong> equal halves</strong> under the curve.</li>\n<li>A <strong>bimodal distribution</strong> will have <strong>two high</strong> points as shown in the image below.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/25c3b8cb808949c2891e9d098cd1ab54x1280x1007.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Mathematically, the relationship between mode, median and mean in <strong>asymmetrical</strong> distributions can be given as:<br> <strong>Mode = 3 median – 2 mean</strong> (or) <strong>Mean = ½ (3 median – mode).</strong></li>\n<li><strong>Outlier </strong>is the statistical term used for an <strong>observation </strong>or value that is<strong> very distant </strong>from<strong> other </strong>observations in the distribution.</li>\n<li>In a distribution with <strong>outliers</strong>, <strong>preferred </strong>measure of central tendency is the&nbsp;<strong>median</strong>.</li>\n<li><strong>Mode </strong>is <strong>least </strong>affected<strong> by outliers</strong> but <strong>mean </strong>is the <strong>most</strong> affected out of all the measures of location.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1171, 'Community Medicine', 'PM0971. The Mode in Biostatistics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The <strong>mode</strong> is most <strong>frequently </strong>occurring<strong> observed value</strong> in a distribution.</li>\n<li>A distribution with a <strong>single mode</strong> is called <strong>unimodal</strong>.</li>\n<li>If <strong>two values </strong>occur with the <strong>highest frequency</strong>, then the distribution is <strong>bimodal</strong>.</li>\n<li>If <strong>more </strong>than<strong> two values </strong>occur with the<strong> highest frequency</strong>, then the distribution is <strong>multimodal</strong>.</li>\n<li>The <strong>mode </strong>is the <strong>preferred</strong> measure of central tendency for <strong>nominal data.</strong></li>\n<li>It is sometimes symbolized by <strong>Mo</strong>.</li>\n<li>Mode can be arrived at from all data scales, i.e., <strong>nominal, ordinal, ratio </strong>and<strong> interval.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1172, 'Community Medicine', 'PM0970. The Median in Biostatistics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The <strong>median</strong> is the <strong>central element</strong> in a distribution when all the elements are arranged in<strong> order</strong>.</li>\n<li>In a distribution that has an <strong>odd </strong>number of<strong> elements</strong>, the median is the<strong> middle value</strong>.</li>\n<li>In a distribution that has an <strong>even </strong>number of <strong>elements</strong>, the median is the<strong> average </strong>of the<strong> middle values</strong>, i.e., the arithmetic mean of the two middle values.</li>\n<li>The median is <strong>not sensitive</strong> to extreme values, i.e., <strong>outliers</strong> and thus it is <strong>preferred</strong> measure of location for very<strong> skewed </strong>distributions.</li>\n<li>The drawback of the median is that it <strong>doesn’t respond </strong>to the<strong> actual values</strong> of the elements but <strong>only to</strong> the <strong>number of values</strong> above or below it.</li>\n<li>The median is the same as the<strong> 50<sup>th</sup></strong> <strong>centile</strong>.</li>\n<li>It is sometimes symbolized by <strong>Mdn</strong>.</li>\n<li>The median can be arrived at in <strong>ordinal, interval </strong>and <strong>ratio </strong>data scales.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1173, 'Community Medicine', 'PM0968. The Mean (Arithmetic) in Biostatistics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The <strong>mean</strong> is also called the <strong>average</strong> or <strong>arithmetic mean.</strong></li>\n<li>It is the<strong> sum </strong>of all<strong> elements</strong> in the distribution <strong>divided </strong>by the <strong>number </strong>of all the<strong> elements</strong> in it.</li>\n<li>It is usually denoted by <strong>μ</strong> in a population and by <strong>x̄ (x-bar) </strong>in a sample.</li>\n<li>The formula for sample mean is given as:</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/7f24605f12374f8cb503addde3b9bff4x179x128.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>where the sigma sign denotes summation and n is the total number of elements.</p>\n<ul>\n<li>The arithmetic mean <strong>responds </strong>to the<strong> exact value </strong>of every<strong> element</strong> in the distribution.</li>\n<li>This makes it <strong>over-sensitive</strong> to extreme values, i.e.,&nbsp;<strong>outliers</strong> thus making it an <strong>inappropriate </strong>measure for <strong>skewed distributions.</strong></li>\n<li>The advantage of the arithmetic mean is that if <strong>repeated samples</strong> are taken from the same populations, they will have very <strong>similar means</strong>, i.e., the measure of central tendency that best<strong> resists </strong>the influence of<strong> fluctuation</strong> between samples is the <strong>mean</strong>.</li>\n<li>The mean can be calculated only on <strong>quantitative</strong> data on an <strong>interval </strong>or a <strong>ratio scale.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1174, 'Community Medicine', 'PM0967. Measures in Statistics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table class=\t1\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Measures used in statistics</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Definition</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Examples</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Measures of Location </strong>or <strong>Central Tendency</strong></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>These measures summarize the data by defining the <strong>centre or the middle</strong>.</p>\n<p class=\p1\>An entire distribution can be <strong>characterized</strong> by these measures <strong>which represent all the observations</strong>.</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Mean, median, mode</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Measures of Dispersion </strong>or <strong>Variability </strong>or <strong>Spread</strong></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>These measures help in determining the <strong>extent to which data is stretched or squeezed</strong>.</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Range, interquartile range, variance, standard deviation</p>\n</td>\n</tr>\n<tr>\n<td class=\td1\ valign=\top\>\n<p class=\p1\><strong>Measures of Position</strong></p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>These measures give the <strong>position of specific data</strong> in relation to other data in the set.</p>\n</td>\n<td class=\td1\ valign=\top\>\n<p class=\p1\>Percentiles, quartiles, centiles,&nbsp; z scores</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1175, 'Community Medicine', 'PM0932. Graphical Representation of Data', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>1.<strong> Histogram</strong></p>\n<ul>\n<li>A histogram, by definition, is a <strong>graphical representation </strong>of frequency distribution that contains rectangles and shows the underlying <strong>frequency</strong> of a set of <strong>continuous,</strong> <strong>quantitative data.</strong></li>\n<li>The <strong>X or horizontal axis</strong> is called the <strong>abscissa</strong> which usually has the group scores or class intervals of the variables/data and the <strong>Y or vertical axis</strong> is called the <strong>ordinate</strong> which usually shows the <strong>frequencies </strong>at which these variables appear.</li>\n<li>The following image shows a histogram.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4a7878d951f54990a67a0c8de11a1bb7x563x438.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>2. <strong>Bar Chart</strong></p>\n<ul>\n<li>It is also called a <strong>bar graph.</strong></li>\n<li>It is used mainly for <strong>nominal or ordinal scale data</strong> as they are not quantitative and usually <strong>qualitative</strong>.</li>\n<li>The difference between a bar graph and a histogram is that the rectangles are separated by spaces representing data that forms <strong>discrete categories</strong> instead of continuous groups.</li>\n<li>Bar graphs can be <strong>simple, multiple or component</strong> bar graphs.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8f58ed9550a74b54a669177f5cf4d95ex320x320.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>3. Pie Charts</strong></p>\n<ul>\n<li>Pie charts are also used for <strong>nominal or ordinal data.</strong></li>\n<li>The categorical data are represented as <strong>segments of a circle.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/50e3eef6a816413fa1848c834d7bad36x556x516.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>4. Frequency polygons</strong></p>\n<ul>\n<li>Frequency polygons are used for mainly ratio and interval scale data.</li>\n<li>In a frequency polygon, the mid-points of each class interval are joined together by straight lines.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/094f9b92f79940e4a3f57c4f9a732b58x590x424.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>5. Ogive</strong></p>\n<ul>\n<li>A frequency polygon which is drawn to represent cumulative frequency distributions form a typical S-shaped curve which is called an ogive. It referred to as a cumulative frequency diagram.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5444b851ed95409bb25a180767a73d91x1280x740.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>6. Line chart</strong></p>\n<ul>\n<li>It is also called a <strong>line diagram or line graph.</strong></li>\n<li>Its best use is to show the <strong>trend of events</strong> or <strong>change over passage of time</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/515d36ccf06c4781960d8bc846ce5063x412x430.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1176, 'Community Medicine', 'PM0926. Probability', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Expressed as a <strong>decimal fraction</strong> never as a percentage. Denoted by <strong>p</strong></li>\n<li>Must lie between <strong>0 (zero probability) </strong>and <strong>1 (absolute certainty)</strong>.</li>\n<li>Probability of an event <strong>cannot be negative</strong>.</li>\n<li>The probability of an event <strong>not occurring (q)</strong> is q= 1-p</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td width=\213\>\n<p><strong>Rule</strong></p>\n</td>\n<td width=\213\>\n<p><strong>Description</strong></p>\n</td>\n<td width=\213\>\n<p><strong>Example</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>The <strong>Addition Rule</strong></p>\n</td>\n<td width=\213\>\n<p>(p)&nbsp;<strong>of any one of several particular events</strong> occurring =&nbsp;<strong>the sum of their individual probabilities</strong>, provided the events cannot both happen and are <strong>mutually exclusive</strong>.</p>\n</td>\n<td width=\213\>\n<p>Probability of picking a heart card from a deck is 0.25 and that of picking a club is 0.25. Thus the <strong>p (hearts or clubs)</strong> is 0.25 + 0.25 = 0.50.</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>The <strong>Multiplication Rule</strong></p>\n</td>\n<td width=\213\>\n<p>(p)<strong> of two or more statistically independent events</strong> <strong>all occurring</strong> is =&nbsp;<strong>product of their individual probabilities</strong>.</p>\n</td>\n<td width=\213\>\n<p>If the lifetime probability of a person developing a lung neoplasm is 0.25 and the life time probability of developing dementia is 0.01, then the <strong>p (lung neoplasm and dementia) </strong>is 0.25 x 0.01 = 0.0025.</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>The <strong>Binomial Distribution</strong></p>\n<p>&nbsp;</p>\n</td>\n<td width=\213\>\n<p>(p) of the occurrence of a <strong>specific combination of mutually exclusive independent events.</strong></p>\n<p>The events for which binomial distribution is used have only two outcomes like yes or no, tall or short, male or female, etc.</p>\n<p>&nbsp;</p>\n</td>\n<td width=\213\>\n<p>Widely used in <strong>genetic counseling</strong>.</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1177, 'Community Medicine', 'PM0141. Hardy-Weinberg Law', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The Hardy-Weinberg Law is related to <strong>population genetics</strong>.</li>\n<li>It is based on the principle founded by G.H. Hardy and Wilhelm Weinberg.</li>\n<li>The law states that the relative <strong>frequencies of each gene allele</strong>&nbsp;tends to remain <strong>constant</strong> from generation to generation in the absence of other evolutionary influences.</li>\n<li>It is also called the Hardy-Weinberg<strong> equilibrium</strong> or principle.</li>\n<li>It is only applicable for <strong>infinitely large, static</strong> populations which <strong>randomly mate</strong>.</li>\n<li>This law fails in the following conditions:\n<ul>\n<li>Small and dynamic populations</li>\n<li>Non random or assortative mating</li>\n<li>Mutations</li>\n<li>Gene outflow and genetic drift</li>\n<li>Migration</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1178, 'Community Medicine', 'PM1688. Pesticide Toxicity Labels', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Extremely toxic</strong></td>\n<td>Bright <strong>red</strong></td>\n</tr>\n<tr>\n<td><strong>Highly toxic</strong></td>\n<td>Bright <strong>yellow</strong></td>\n</tr>\n<tr>\n<td><strong>Moderately toxic</strong></td>\n<td>Bright <strong>blue</strong></td>\n</tr>\n<tr>\n<td><strong>Slightly toxic</strong></td>\n<td>Bright <strong>green</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/ba1415f5a3b84d668208be25942661aax278x267.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1179, 'Community Medicine', 'PM2503. Rabies vaccines and immunoglobulins schedules', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>According to the Ministry of Health and Family Welfare, Government of India:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f49dfa01d9bd424db725e4ebf600cb98x1280x3397.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>WHO category <strong>II</strong> or <strong>III</strong> exposures should receive&nbsp;<strong>post-exposure prophylaxis&nbsp;</strong>(PEP)<strong>&nbsp;immediately.</strong></p>\n<p>One <strong>intradermal&nbsp;</strong>(ID)&nbsp;dose is <strong>0.1 mL</strong> of vaccine and one <strong>intramuscular</strong> (IM) dose is an <strong>entire vial</strong> of vaccine, irrespective of the vial size.</p>\n<p>Should a vaccine dose be delayed for any reason, the PEP schedule should be resumed (not restarted).</p>\n<p><strong>Rabies Immunoglobulin(RIG):&nbsp;</strong></p>\n<ul>\n<li>Passive immunization</li>\n<li><strong>Single-dose</strong>; after initiation of PEP and not beyond 7 days after the first dose of vaccine</li>\n<li>Max dose: <strong>hRIG - 20IU/kg ,&nbsp;</strong><strong>eRIG</strong><strong>&nbsp;- 40IU/kg </strong>body weight</li>\n<li>Vaccines should never be withheld regardless of the availability of RIG.</li>\n<li><strong>Alternatives</strong> for RIG- WHO recommends&nbsp;<strong>m</strong><strong>onoclonal antibodies&nbsp;</strong>(mAb)&nbsp;as a cocktail containing at least <strong>two antibodies</strong> against the rabies virus.</li>\n</ul>\n<p>Administration of RIG:</p>\n<ul>\n<li>RIG should be administered&nbsp;<strong>into</strong> or <strong>around</strong> the <strong>wound site</strong> or sites.</li>\n<li>The&nbsp;<strong>remaining</strong> RIG, if any, should be injected <strong>IM</strong> at a site <strong>distant</strong> from the <strong>site</strong> of vaccine administration.</li>\n<li>RIG may be diluted to a volume sufficient for all wounds to be effectively and safely infiltrated.</li>\n</ul>\n<p>Prioritization&nbsp;of RIG allocation (numbered according to priority order):</p>\n<ol>\n<li>Multiple bites</li>\n<li>Deep wounds</li>\n<li>Bites to head, neck, and hands</li>\n<li>Patients with severe immunodeficiency</li>\n<li>Confirmed/probable rabies in biting animal</li>\n<li>Bites, scratches, and exposure of mucous membranes caused by a bat</li>\n</ol>\n<p><strong>Pre-exposure prophylaxis&nbsp;(PrEP)</strong></p>\n<p>PrEP is considered in the following conditions:</p>\n<ul>\n<li>High-risk groups- laboratory staff, wildlife wardens, veterinarians, animal handlers, and travelers to endemic regions.</li>\n<li>Remote, rabies-endemic areas where access to PEP is difficult</li>\n<li>Areas where&nbsp;dog bite incidence is &gt;5% per year</li>\n<li>Areas where vampire bat rabies is known to be present.</li>\n</ul>\n<p>Pre-exposure rabies vaccination consists of <strong>3&nbsp;intramuscular (IM) or 3 intradermal (ID)</strong>&nbsp;doses. These are given on <strong>days 0, 7 and 21 or 28.</strong></p>\n<ul>\n<li>Adults - the vaccine should always be administered in the deltoid area of the arm</li>\n<li>Young children (under 1 year of age)- Administration into the anterolateral area of the thigh is recommended.</li>\n<li><strong>Rabies vaccine </strong>should<strong> never</strong> be administered in the<strong> gluteal area.</strong>&nbsp;Administration in this manner will result in <strong>lower neutralizing antibody titers.</strong></li>\n</ul>\n<p>For exposed or re-exposed patients who can document previous completion of PEP the following guidelines would be applicable:</p>\n<ul>\n<li>Proper wound management should be done.</li>\n<li>There is no need for the administration of RIG.</li>\n<li>One site ID or IM vaccine administration on days 0 and 3.</li>\n</ul>\n<p>Only adequate wound washing would be required in case of re-exposure where the animal bite victim has documented proof of complete PEP&nbsp;<strong>within the last three months.</strong></p>\n<p>The following cases are treated as fresh cases and given full PEP:</p>\n<ul>\n<li>Those who have previously received full post-exposure treatment with neural tissue vaccines (NTV) or vaccines of unproven potency</li>\n<li>Those who cannot document complete PEP or PrEP treatment&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1180, 'Community Medicine', 'PM2502. GOBI–FFF Strategy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>This strategy was proposed by the United Nations Children’s Fund (UNICEF)</p>\n<ul>\n<li><strong>G </strong>– Growth monitoring with growth charts</li>\n<li><strong>O </strong>– Oral rehydration therapy for diarrhoea and dehydration</li>\n<li><strong>B</strong> – Breastfeeding</li>\n<li><strong>I</strong> – Immunization of children</li>\n<li><strong>F</strong> – Family planning and birth spacing</li>\n<li><strong>F </strong>– Food supplementation</li>\n<li><strong>F </strong>­– Female literacy promotion</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1181, 'Community Medicine', 'PM1144. Survival Analysis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Survival analysis </strong>is a technique used to analyze data about binomial or dichotomous outcomes, like death vs. survival, etc.</li>\n<li>One of the simplest methods used in survival analysis is the <strong>life table analysis</strong>.</li>\n<li>Another is the <strong>Kaplan-Meier</strong> analysis which involves calculating the <strong>survival function</strong> which is given as, <strong>survival function at time t = Number of patients surviving longer than times t / Total number of patients.</strong></li>\n<li>Life tables and survival functions are graphically represented in a <strong>Kaplan-Meier plot or curve</strong>.</li>\n<li>Tests which are used to compare the <strong>survival curves</strong> or <strong>Kaplan-Meier curves</strong> are <strong>Mantel-Haenszel test </strong>or <strong>log rank test</strong> and the <strong>Cox regression</strong> or <strong>Cox proportional hazards analysis.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1182, 'Forensic Medicine', 'PM0059. Medico-legal importance of age', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\430\>\n<tbody>\n<tr>\n<td>Age&nbsp;</td>\n<td>Medico-legal importance</td>\n</tr>\n<tr>\n<td><strong>7 months period of gestation</strong></td>\n<td>Attainment of viability by fetus – <strong>infanticide</strong> can’t be charged if fetus is proved to be less than 7 months of age.</td>\n</tr>\n<tr>\n<td><strong>&gt;5 years</strong></td>\n<td>Criminal responsibility as per <strong>railways act</strong>. &nbsp;</td>\n</tr>\n<tr>\n<td><strong>&lt;7 years</strong></td>\n<td>No criminal responsibility as per <strong>Section 82 IPC</strong>. &nbsp; &nbsp; &nbsp;</td>\n</tr>\n<tr>\n<td><strong>10 years</strong></td>\n<td>Abducting a child below 10 years for the sake of moveable property amounts to <strong>kidnap</strong> (369 IPC)</td>\n</tr>\n<tr>\n<td><strong>7 – 12 years</strong></td>\n<td>Criminal responsibility if he/she is of sufficient maturity to understand and judge the nature and consequences of the act <strong>(Section 83 IPC)</strong>.</td>\n</tr>\n<tr>\n<td><strong>&lt;12 years</strong></td>\n<td>\n<p><strong>Consent</strong> by the <strong>parent</strong> or <strong>guardian</strong> is needed before examination of the patient.</p>\n<p>Not punishable under the <strong>Railway Act</strong>.</p>\n</td>\n</tr>\n<tr>\n<td><strong>&lt;14 years </strong></td>\n<td>Cannot be employed in factory jobs.&nbsp;(<strong>Factory Act</strong>)</td>\n</tr>\n<tr>\n<td><strong>14 – 15 years</strong></td>\n<td>Can be employed in nonhazardous factory jobs in the daytime.</td>\n</tr>\n<tr>\n<td><strong>&gt;15 years</strong></td>\n<td>Can be employed in any job</td>\n</tr>\n<tr>\n<td><strong>&lt;16 years</strong></td>\n<td>Taking away a <strong>boy</strong> without consent of parent or guardian amounts to&nbsp;<strong>kidnapping</strong></td>\n</tr>\n<tr>\n<td><strong>&lt;18 years</strong></td>\n<td>\n<ul>\n<li>Juvenile (boy and girl)&nbsp;</li>\n<li>Taking away a <strong>girl </strong>without consent of parent or guardian amounts to<strong>&nbsp;kidnapping</strong></li>\n<li>Sexual intercourse with a girl with or without her consent amounts to rape (<strong>Section 375 IPC</strong>)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>&gt;/=18 years</strong>&nbsp;</td>\n<td>\n<ul>\n<li>Attainment of <strong>majority</strong>&nbsp;</li>\n<li>Can give <strong>valid consent</strong> to suffer any harm not known to cause death or grievous hurt.&nbsp;</li>\n<li>Valid consent given by a girl for <strong>sexual intercourse.</strong>&nbsp;</li>\n<li>Can make <strong>valid will</strong>.&nbsp;</li>\n<li>Legal age of <strong>marriage for girls</strong>.</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1183, 'Forensic Medicine', 'PM0058. Ossification centres appearing before birth', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>7 weeks in utero - Tibial Shaft</li>\n<li>8 weeks in utero - Femoral &amp; Fibular Shaft</li>\n<li>9 weeks in utero - metatarsals</li>\n<li>6 months in utero – Calcaneum</li>\n<li>7 months in utero – talus</li>\n<li>9 months in utero– Cuboid</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1184, 'Forensic Medicine', 'PM0057. Appearance of ossification centres of carpal bones', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Capitate – 2 months (1-3 months)</li>\n<li>Hamate – 3 months (2-4 months)</li>\n<li>Triquetrum – 3 years</li>\n<li>Lunate, Scaphoid, trapezoid, Trapezium –&nbsp;4 years in females and 5 years in males</li>\n<li>Pisiform –&nbsp;9 or 10 years in females and 12 years in males</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1185, 'Forensic Medicine', 'PM0056. Fusion of skull sutures and closure of fontanelles', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Fusion of skull sutures and closure of fontanelles:</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td>Lateral &amp; occipital&nbsp;fontanelles&nbsp;</td>\n<td>&lt;2months</td>\n</tr>\n<tr>\n<td>Posterior&nbsp;fontanelles</td>\n<td>6-8 weeks</td>\n</tr>\n<tr>\n<td>Anterior&nbsp;fontanelles</td>\n<td>1.5-2 years</td>\n</tr>\n<tr>\n<td>Metopic suture</td>\n<td>9 Months</td>\n</tr>\n<tr>\n<td>Basiocciput with basisphenoid</td>\n<td>18-21 years</td>\n</tr>\n<tr>\n<td>Sagittal suture:<br>\n<ul>\n<li>Posterior 1/3rd</li>\n<li>Anterior 1/3rd</li>\n<li>Middle 1/3rd</li>\n</ul>\n</td>\n<td>30-40 years<br>40-50 Years<br>50-60 years</td>\n</tr>\n<tr>\n<td>Coronal suture:<br>\n<ul>\n<li>Lower half</li>\n<li>Upper half</li>\n</ul>\n</td>\n<td>40-50 years<br>50-60years</td>\n</tr>\n<tr>\n<td>Lambdoid suture</td>\n<td>45 years</td>\n</tr>\n<tr>\n<td>Squamous temporal suture</td>\n<td>&gt;80 years</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1186, 'Forensic Medicine', 'PM0055. Permanent dentition', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>First molar - 6 years</li>\n<li>Central incisor - 7 years</li>\n<li>Lateral incisor - 8 years</li>\n<li>First premolar - 9 years</li>\n<li>Second premolar -10 years</li>\n<li>Canine - 11&nbsp; years</li>\n<li>Second molar -12-14 years</li>\n<li>Third molar -17-25 years</li>\n</ul>\n<p>&nbsp;</p>\n<p>Mnenomic: Mumma Is In Pain, Paapa Can Make Medicine</p></div><!---->\n      <!---->\n    </div><!---->'),
(1187, 'Forensic Medicine', 'PM0054. Temporary dentition', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Lower central incisor - 6 months</li>\n<li>Upper central incisor - 7 months</li>\n<li>Upper lateral incisor - 8 months</li>\n<li>Lower lateral incisor&nbsp; - 9 months</li>\n<li>First molar-1 year</li>\n<li>Canine- 1 ½&nbsp;years</li>\n<li>Second molar– 2 years</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1188, 'Forensic Medicine', 'PM0053. Indices for determination of race and sex of an individual', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>To determine the sex of an individual -</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6c5339f818154bd5a2224da77db2ecc7x377x228.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Krogmans degree of accuracy in sexing adult skeletal remains:</p>\n<ul>\n<li>Entire skeleton – 100%</li>\n<li>Pelvis alone – 95%</li>\n<li>Skull alone – 90%</li>\n<li>Pelvis plus skull – 98%</li>\n<li>Long bones alone – 80%</li>\n</ul>\n<p>&nbsp;</p>\n<p>To determine the race of an individual -&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/149e51cb37a046d5b49316bbc90fcb6fx435x252.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1189, 'Forensic Medicine', 'PM0050. Cephalic index', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Type of skull</strong></td>\n<td><strong>Cephalic Index</strong></td>\n<td><strong>Race</strong></td>\n</tr>\n<tr>\n<td>Dolicocephalic</td>\n<td>70-75</td>\n<td>Pure aryans, Aborigines, Negroes</td>\n</tr>\n<tr>\n<td>Mesaticephalic</td>\n<td>75-80</td>\n<td>Europeans &amp; Chinese</td>\n</tr>\n<tr>\n<td>Brachycephalic</td>\n<td>80-85</td>\n<td>Mongolians</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1190, 'Forensic Medicine', 'PM2391. Contributory negligence', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Contributory negligence</strong> occurs when a <strong>patient</strong> or his <strong>personal attendant</strong> shows unreasonable conduct or absence of ordinary care, which when combined with the negligence of the doctor, has contributed to the injury. In this case, the patient’s or attendant’s negligence should be the direct, proximate cause and without which the injury would not have occurred.</p>\n<p>So, contributory negligence occurs when <strong>both the doctor and patient are negligent</strong>. The direct or proximate cause of the injury should be the patient’s negligence, which means that if the patient was not negligent, the injury could have been prevented.</p>\n<p>Contributory negligence usually occurs when the doctor is negligent and the<strong> patient:</strong></p>\n<ul>\n<li>Fails to give an accurate medical history, and as a result, the doctor may misdiagnose or mistreat the patient.</li>\n<li>Fails to follow the doctor’s instructions</li>\n<li>Refuses to take the treatment</li>\n<li>Leaves the hospital against doctor’s advice</li>\n<li>Does not inform the doctor or seek further medical assistance if the symptoms persist or worsens.</li>\n</ul>\n<p><strong>Contributory negligence is a defence </strong>for doctor’s negligence in civil cases. However, from case to case, the liability of a doctor may vary from complete non-liability to substantial liability for the damages. Under the <strong>doctrine of comparative negligence</strong>, the court has the right to hold both parties liable for their negligent actions.</p>\n<p><strong>Limitations / Exceptions to contributory negligence:</strong></p>\n<p><strong>A. The doctor will be held guilty in the following conditions:</strong></p>\n<p><strong>1. The doctor failed to provide proper instructions to the patient</strong></p>\n<ul>\n<li><span><strong>Ex: </strong>Doctor applies a tight plaster cast (<strong>doctor is</strong> <strong>negligent</strong>) to the patient’s leg and did not tell the patient to inform if he develops any numbness (<strong>no</strong> <strong>proper</strong> <strong>instruction</strong>). The patient develops numbness and has not informed the doctor (<strong>patient is negligent</strong>). After few days patient developed a permanent injury.</span></li>\n</ul>\n<p>&nbsp;2.&nbsp;<strong>Last clear chance doctrine: </strong>It is applicable when the doctor fails to take necessary action to prevent damage due to a negligent act of the patient, even after getting a clear chance to take such action.</p>\n<ul>\n<li><span><strong>Ex: </strong>Doctor applies a tight plaster cast (<strong>doctor is</strong> <strong>negligent</strong>) to the patient’s leg and told the patient to inform if he develops any numbness (<strong>gave proper</strong> <strong>instruction</strong>). The patient developed numbness and has not informed the doctor (<strong>patient is</strong> <strong>negligent</strong>). Next day patient informed the doctor, but the doctor did not remove the cast and said he was busy (<strong>There was a clear last chance, but the doctor neglected again</strong>). After few days patient developed a permanent injury.</span></li>\n</ul>\n<p><strong>B. The doctor/person will not be held guilty in the following conditions:</strong></p>\n<p>1.&nbsp;<strong>Avoidable consequences rule: </strong>It occurs when an injury is caused due to doctor’s negligence, and the patient has done a negligent act, which further aggravated the injury caused by the doctor, and the patient could have avoided the consequence by not doing such act. In such cases, the<strong> doctor need not pay anything</strong>, and the<strong> patient will be held guilty</strong>.</p>\n<ul>\n<li><span><strong>Ex:</strong> A patient had a lacerated wound. The doctor examined the patient and had not done any dressing or provided any antibiotics (the doctor is negligent). However, the doctor instructed the patient to avoid contamination and asked him to visit the clinic next week. When the patient went home, he applied cow dung on his wound every day thinking that the wound would heal faster and didnt visit the doctor after one week. The wound got infected and developed pus and aggravated the injury.</span></li>\n<li><span>Here, <strong>despite the doctor being negligent </strong>in the first instance, the <strong>patient is responsible for his injury</strong> as he <strong>performed an unnecessary, avoidable act</strong>, which aggravated the injury. The doctor need not pay anything.</span></li>\n</ul>\n<p>2.&nbsp;<strong>Good Samaritan doctrine: </strong>A person who assists another person who is in serious danger cannot be charged with contributory negligence. unless such assistance is reckless or rash.</p>\n<ul>\n<li><span><strong>Ex:</strong> A person was travelling on a road and saw a car accident, where the victim was unconscious and was stuck inside the car. He called the ambulance. The paramedical staff instructed him not to mobilize the victim until they arrived. Meanwhile, the car was caught in fire (<strong>serious danger</strong>), and the person tried to remove the victim carefully out of the car <strong>(assisted the victim and was not reckless)</strong>. However, the victim already had a cervical bone fracture due to the accident, which got mobilized while he was being removed out of the car and as a result, suffered an injury to the spine that led to paralysis (<strong>victim’s injury was aggravated</strong>). In such a case, the good samaritan doctrine would apply and the person who tried to help, <strong>will not be charged under contributory negligence.</strong></span></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1191, 'Forensic Medicine,', 'PM2131. Medical Termination of Pregnancy Act - MTP Act 1971', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>MTP Act with 2021 amendments&nbsp;</strong></p>\n<p><strong>Indications:</strong></p>\n<ul>\n<li><strong>Therapeutic </strong>- to save the life of the mother</li>\n<li><strong>Eugenic </strong>- to prevent the&nbsp;risk of the child being born with serious mental or physical abnormality i.e. first-trimester viral infections, teratogenic drug intake, radiation exposure</li>\n<li><strong>Humanitarian </strong>-&nbsp;pregnancy resulted from rape or incest</li>\n<li><strong>Social </strong>-&nbsp;pregnancy resulted from failure of contraceptives&nbsp;</li>\n</ul>\n<p><strong>Rules:</strong></p>\n<ul>\n<li>Only a <strong>registered medical practitioner</strong> who is qualified (one who has assisted in the performance of 25 cases of MTP in a recognized hospital) can terminate a pregnancy.</li>\n<li>MTP should be carried out in a government or <strong>government-recognized hospital</strong>.&nbsp;Private hospitals may take up MTP if they obtain a license from the chief medical officer of the district.</li>\n<li>The termination of pregnancy by a person, who is not a registered medical practitioner (the person concerned), or in an unrecognised hospital (administrative head) shall be punished with rigorous imprisonment for a term not less than <strong>2 years</strong>, but which may extend to 7 years.&nbsp;</li>\n</ul>\n<p><strong>Consent</strong>:</p>\n<p>The consent of the woman is required for conducting an abortion. The written consent of the guardian is required if the woman is minor or mentally ill. Consent of the husband or partner is not necessary.&nbsp;</p>\n<p>If the woman is not willing, abortion cannot be performed at the request of the husband alone. The woman need not produce proof of her age.&nbsp;It is enough for the woman to say that she was raped, and it is not necessary that a complaint was lodged with the police.</p>\n<p><strong>Opinion of doctors:</strong></p>\n<ul>\n<li>Till 20 weeks - 1 doctors opinion</li>\n<li>20 to 24 weeks - 2 doctors opinion</li>\n<li>For substantial fetal anomalies - approval from the medical board consisting of obstetrician, paediatrician, radiologist and a person appointed by the state</li>\n</ul>\n<p><strong>Upper limit of MTP:</strong></p>\n<ul>\n<li>Up to <strong>24 weeks</strong> of gestation in victims of <strong>rape</strong> and incest, fetal anomalies, or congenital malformations</li>\n<li>Up to <strong>20 weeks</strong> in case of <strong>contraception failure</strong> (any female with her partner)</li>\n<li>At <strong>any gestational age</strong> for substantial <strong>fetal anomalies</strong> decided by the medical board</li>\n</ul>\n<p><strong>Confidentiality:</strong></p>\n<p>A <strong>register</strong> for recording the details of MTP must be kept for at least <strong>5 years</strong>. The patients name must not be entered, only the reference number is used.&nbsp;Unlawful disclosure of patients details is punishable with 1-year imprisonment&nbsp;± fine.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1192, 'Forensic Medicine,', 'PM2059. IPC Sec 84, MNaghtens rule', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>MNaghtens rule,&nbsp;Section 84 IPC:&nbsp;</strong>&nbsp;Criminal responsibility of the insane.</p>\n<p>It states that an accused is not criminally responsible if he was suffering from:</p>\n<ul>\n<li><strong>Defect of reason and </strong><strong>unsoundness of mind:&nbsp;</strong>the law&nbsp;recognizes only those diseases which impair the thinking abilities of the mind. So, not all medically insane people are legally insane, as emotional disturbances that affect the mind are not considered if they do not directly affect cognition.</li>\n<li><strong>That he did not know the nature and the quality of the act he is doing:&nbsp;</strong>&nbsp;the law needs the unsoundness of mind to exist at the time of the act to such a degree that the person is not aware of what he is doing and whether it is right or wrong to do. Absence of a motive or forethought is also considered as a criteria for determining unsoundness of mind.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1193, 'Forensic Medicine', 'PM1027. Sexual Offences', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>IPC section</strong></p>\n</td>\n<td>\n<p><strong>Section it deals with</strong></p>\n</td>\n<td>\n<p><strong>Punishment</strong></p>\n</td>\n<td>\n<p><strong>Type of offense</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>375</p>\n</td>\n<td>\n<p>Definition of Rape</p>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td rowspan=\3\>\n<p>376</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>376A</p>\n</td>\n<td>\n<p>Punishment for Rape</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Rigorous imprisonment of not less than 10 years which may extend to imprisonment for life.</p>\n</td>\n<td>\n<p>Cognizable; non-bailable</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Persons committing the offense of rape on a woman under 16 years of age</p>\n</td>\n<td>\n<p>Rigorous imprisonment of not be less than 20 years which may extend to imprisonment for life.</p>\n</td>\n<td>\n<p>Cognizable; Non-Bailable</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>The person committing&nbsp;an offense of rape and inflicting injury which causes death or causes the woman to be in a persistent vegetative state.</p>\n</td>\n<td>\n<p>Rigorous imprisonment of not less than 20 years may extend to imprisonment for life or with death.&nbsp;</p>\n</td>\n<td>\n<p>Cognizable; non-bailable</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>376AB</p>\n</td>\n<td>\n<p>The person committing an offense of rape on a woman under 12 years of age</p>\n</td>\n<td>\n<p>Rigorous imprisonment of not less than 20 years but which may extend to imprisonment for life with fine or with death</p>\n</td>\n<td>\n<p>Cognizable; Non-Bailable</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>376B</p>\n</td>\n<td>Sexual intercourse by the husband upon his wife during separation</td>\n<td>\n<p>Imprisonment for not less than 2 years but which may extend to 7 years and with a fine.</p>\n</td>\n<td>\n<p>Cognizable(only on a complaint of the victim); Bailable</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>376C</p>\n</td>\n<td>\n<p>Sexual intercourse by a person in authority (police officer, public servant, member of armed forces, management or staff of a jail, remand home or other places of custody and management or staff of a hospital) who&nbsp;<strong>induces or seduces</strong> any female inmate of such jail, remand home, place, or institution to have sexual intercourse with him, such sexual intercourse not amounting to the offense of rape.</p>\n</td>\n<td>\n<p>Rigorous imprisonment for not less than 5 years but which may extend to 10 years and with a fine.</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Cognizable; non-bailable</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>376D</p>\n</td>\n<td>\n<p>Gang Rape</p>\n</td>\n<td>\n<p>Rigorous imprisonment for not less than 20 years which may extend to imprisonment for life with fine</p>\n</td>\n<td>\n<p>Cognizable; non-bailable</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>376DA</p>\n</td>\n<td>\n<p>Gang rape on a woman under 16 years of age</p>\n</td>\n<td>\n<p>Rigorous imprisonment for life and with fine</p>\n</td>\n<td>\n<p>Cognizable; Non-Bailable</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>376DB</p>\n</td>\n<td>\n<p>Gang rape on a woman under 12 years of age</p>\n</td>\n<td>\n<p>Imprisonment for life with fine or with death</p>\n</td>\n<td>Cognizable; Non-Bailable</td>\n</tr>\n<tr>\n<td>\n<p>376E</p>\n</td>\n<td>\n<p>Repeat offenders</p>\n</td>\n<td>\n<p>Imprisonment for life or with death</p>\n</td>\n<td>Cognizable; Non-Bailable&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>354</p>\n</td>\n<td>Indecent assault /Outrage of modesty</td>\n<td>Imprisonment for up to 2 years, or with fine.</td>\n<td>Cognizable; Non-Bailable&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<div>&nbsp;</div>\n<p>The above sections are in accordance with The Criminal Law (Amendment) Bill, 2018.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1194, 'Forensic Medicine', 'PM1025. Doctor and The Court', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\0\>\n<tbody>\n<tr>\n<td>\n<p><strong>IPC section</strong></p>\n</td>\n<td>\n<p><strong>Deals with</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>191</p>\n</td>\n<td>\n<p>Giving false evidence (perjury)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>192</p>\n</td>\n<td>\n<p>Fabricating false evidence</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>193</p>\n</td>\n<td>\n<p>Punishment for false evidence</p>\n<ul>\n<li>Judicial proceedings: up to 7 yrs of imprisonment and fine</li>\n<li>Any other case: up to 3 yrs of imprisonment and fine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>196</p>\n</td>\n<td>\n<p>Using evidence known to be false</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>197</p>\n</td>\n<td>\n<p>Issuing or signing a false certificate</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>201</p>\n</td>\n<td>\n<p>Causing disappearance of evidence of offense or giving false information to screen offender</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1195, 'Forensic Medicine', 'PM1024. Consent', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>IPC Section</strong></p>\n</td>\n<td>\n<p><strong>Provisions under the Act</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>87</p>\n</td>\n<td>\n<p>Act not intended and not known to be likely to cause death or grievous hurt, done by consent is not an offense.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>88</p>\n</td>\n<td>\n<p>An act done by consent in good faith for a person’s benefit is not an offense.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>89</p>\n</td>\n<td>\n<p>An act done in good faith for the benefit of a child under 12 years of age or an insane person, with the consent of a parent or guardian is not an offense.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>90</p>\n</td>\n<td>\n<p>Consent is invalid if</p>\n<ul>\n<li>Given under fear or misconception.</li>\n<li>Given by an insane person</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>92</p>\n</td>\n<td>\n<p>The act is done in good faith without consent in&nbsp;the following situations:</p>\n<ul>\n<li>Emergency (No need to take consent during emergencies)</li>\n<li>The person is incapable of giving consent</li>\n<li>The person has no guardian to give consent</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>95</p>\n</td>\n<td>\n<p>Act causing slight harm is not an offense</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1196, 'Forensic Medicine', 'PM1023. Criminal Responsibilities', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>IPC Section</strong></p>\n</td>\n<td>\n<p><strong>Deals with</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>82</p>\n</td>\n<td>\n<p>A child under 7 years is not liable for the act.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>83</p>\n</td>\n<td>\n<p>Child of 7–12 years if not attained proper mental maturity is not liable for the act.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>84 &nbsp;</p>\n</td>\n<td>\n<p><strong>McNaughtens rule -&nbsp;</strong>A person of unsound mind is not liable for the act.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>85</p>\n</td>\n<td>\n<p>A person who under involuntary intoxication has commited an act is not liable for the act.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>86</p>\n</td>\n<td>\n<p>A person who under voluntary intoxication commits an act is liable for the act.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1197, 'Forensic Medicine', 'PM2132. Hyperthermic disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\408\>\n<tbody>\n<tr>\n<td>Hyperthermic disorders</td>\n<td>Mechanisms</td>\n</tr>\n<tr>\n<td>Heat edema</td>\n<td>Cutaneous vasodilation and pooling of interstitial fluid leads to swelling of hands, feet, and ankles</td>\n</tr>\n<tr>\n<td>Heat syncope</td>\n<td>Vasodilation and volume depletion(from sweating) following exercise or prolonged standing&nbsp;with consequent systemic and cerebral hypotension</td>\n</tr>\n<tr>\n<td>Heat cramps</td>\n<td>Deficiency of sodium, potassium, and water at an intracellular level, leading to intermittent, painful, and involuntary spasmodic contractions of skeletal muscles</td>\n</tr>\n<tr>\n<td>Heat exhaustion</td>\n<td>\n<p>Results from prolonged strenuous activity. There is water or salt depletion, but thermoregulatory mechanisms are maintained.&nbsp;Temperature &lt;&nbsp;40.5° C</p>\n</td>\n</tr>\n<tr>\n<td>Heatstroke</td>\n<td>\n<p>Thermoregulatory mechanisms are lost</p>\n<p>Temperature &gt; 40.5° C</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1198, 'Forensic Medicine', 'PM0761. Difference between ante mortem and post-mortem abrasion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Trait</td>\n<td>Ante mortem wounds &nbsp;</td>\n<td>Post-mortem wounds</td>\n</tr>\n<tr>\n<td>Site</td>\n<td>Anywhere on the body</td>\n<td>Usually over bony prominences &nbsp;</td>\n</tr>\n<tr>\n<td>Colour</td>\n<td>Bright reddish brown</td>\n<td>Yellowish, translucent, Parchment like&nbsp;</td>\n</tr>\n<tr>\n<td>Exudation</td>\n<td>More</td>\n<td>Less&nbsp;</td>\n</tr>\n<tr>\n<td>Microscopic</td>\n<td>Intravital reaction and congestion seen</td>\n<td>\n<p>No intravital reaction</p>\n<p>No congestion&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1199, 'Forensic Medicine', 'PM0074. Order of Putrefaction', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Larynx and trachea – first organ to putrify</strong>&nbsp; &nbsp;</li>\n<li>Stomach, intestine, and spleen</li>\n<li>Liver and lungs</li>\n<li>Brain</li>\n<li>Heart</li>\n<li>Kidney and bladder</li>\n<li>Prostate and uterus – virgin uterus resists putrefaction whereas uterus soon after delivery putrefies rapidly.</li>\n<li>Skin, muscle, tendon</li>\n<li>Bones</li>\n</ul>\n<p><br><strong>NOTE</strong>: This is only a generalised order of putrefaction, as each case must be assessed as per the attending factors, both endogenous and exogenous.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1200, 'Forensic Medicine', 'PM0073. Difference between Cadaveric Rigidity (Rigor mortis) and Cadaveric Spasm (Instantaneous rigor)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Trait</strong></td>\n<td><strong>Cadaveric rigidity</strong></td>\n<td><strong>Cadaveric spasm</strong></td>\n</tr>\n<tr>\n<td><strong>Production</strong></td>\n<td>Freezing and exposure to a temperature above 65<sup>0</sup>C will produce rigor</td>\n<td>Cannot be produced by any method after death</td>\n</tr>\n<tr>\n<td><strong>Mechanism</strong></td>\n<td>Reduction of ATP</td>\n<td>Not clear</td>\n</tr>\n<tr>\n<td><strong>Predisposing factors</strong></td>\n<td>Nil</td>\n<td>Sudden death, excitement, fear, etc</td>\n</tr>\n<tr>\n<td><strong>Time of onset</strong></td>\n<td>1 – 2 hours after death</td>\n<td>Instantaneous</td>\n</tr>\n<tr>\n<td><strong>Muscles involved</strong></td>\n<td>All muscles – both voluntary and involuntary</td>\n<td>Single group of voluntary muscles</td>\n</tr>\n<tr>\n<td><strong>Muscle stiffening</strong></td>\n<td>Not marked: can be overcome by moderate force</td>\n<td>Marked: Great force is required to overcome</td>\n</tr>\n<tr>\n<td><strong>Molecular death</strong></td>\n<td>Occurs</td>\n<td>Doesnt occur</td>\n</tr>\n<tr>\n<td><strong>Body heat</strong></td>\n<td>Cold</td>\n<td>Warm</td>\n</tr>\n<tr>\n<td><strong>Electrical stimuli</strong></td>\n<td>Muscles do not respond</td>\n<td>Muscles respond</td>\n</tr>\n<tr>\n<td><strong>Muscular reaction</strong></td>\n<td>Acidic</td>\n<td>Alkaline</td>\n</tr>\n<tr>\n<td><strong>Medicolegal importance</strong></td>\n<td>Indicates the time of death</td>\n<td>Indicates manner of death</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1201, 'Forensic Medicine', 'PM0072. Color of Postmortem Hypostasis in Various Conditions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Poisoning/Condition</strong></td>\n<td><strong>Postmortem staining</strong></td>\n</tr>\n<tr>\n<td>\n<p>Carbon monoxide&nbsp; &nbsp;</p>\n</td>\n<td>\n<p>Cherry red</p>\n</td>\n</tr>\n<tr>\n<td>Cyanides &nbsp; &nbsp;&nbsp;</td>\n<td>\n<p>Brick red/dark pink</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Potassium chlorate</p>\n</td>\n<td>Chocolate brown&nbsp;</td>\n</tr>\n<tr>\n<td>Phosphorous&nbsp;</td>\n<td>Dark brown&nbsp;</td>\n</tr>\n<tr>\n<td>Nitrites &nbsp;&nbsp;</td>\n<td>\n<p>Red-brown</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hydrogen sulphide</p>\n</td>\n<td>\n<p>Bluish-green</p>\n</td>\n</tr>\n<tr>\n<td>Opium&nbsp;</td>\n<td>Greyish/black</td>\n</tr>\n<tr>\n<td>Asphyxia</td>\n<td>Dark purple</td>\n</tr>\n<tr>\n<td>Hypothermia</td>\n<td>Bright pink</td>\n</tr>\n<tr>\n<td>Septic abortion (Cl. Perfringens infection)</td>\n<td>Pale bronze</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1202, 'Forensic Medicine', 'PM0071. Tests for Confirming Cessation of Breathing', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The recommended method is thorough auscultation for breath sounds by a stethoscope. <strong>No audible breath sounds</strong> on continuous auscultation of upper part of chest and in front of or on the larynx <strong>for minimum of 5 minutes</strong>, confirms cessation of breathing.</p>\n<p>Other tests: &nbsp; &nbsp;</p>\n<ul>\n<li><strong>Feather test </strong>– no movement of a feather held in front of the nose. &nbsp; &nbsp;&nbsp;</li>\n<li><strong>Mirror test </strong>– mirror held in front of the nose does not turn dim due to any moisture of breath. &nbsp;&nbsp;</li>\n<li><strong>Winslow’s test </strong>– no movement of surface of water in bowl kept on the chest.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1203, 'Forensic Medicine', 'PM0070. Tests for Confirming Cessation of Circulation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>No audible heart sounds</strong> on continuous auscultation on precordial area of chest for a <strong>minimum of 5 minutes</strong>&nbsp;is suggestive of cessation of circulation and a <strong>flat ECG recording for 5 minutes</strong> confirms this.</p>\n<p><strong>Other tests:</strong>&nbsp; &nbsp;</p>\n<ul>\n<li><strong>Magnus’s test (Ligature test)—</strong>fingers fail to show congestion distal to a ligature applied at their base. &nbsp; &nbsp;</li>\n<li><strong>Diaphanous test (Transillumination test)</strong>—Failure to show redness in the web space between the fingers on transillumination from behind. &nbsp; &nbsp; &nbsp;</li>\n<li><strong>Icard’s test</strong>—fluorescent dye on being injected at a given site in a dead body fails to produces any discolouration.</li>\n<li><strong>Fingernail test</strong>—no blanching and filling of blood in the fingernail on application of pressure and release.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1204, 'Forensic Medicine', 'PM0069. Suspended animation and its causes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Suspended animation </strong>is a condition where<strong> signs of life are absent as functions are interrupted for sometime or are reduced to minimum.</strong></p>\n<p>It can be produced voluntarily by yoga practitioners. &nbsp; &nbsp; &nbsp; &nbsp;</p>\n<p><strong>It is seen in following conditions</strong></p>\n<ul>\n<li>After anaesthesia</li>\n<li>Cholera</li>\n<li>Concussion</li>\n<li>Drowning</li>\n<li>Electrocution</li>\n<li>Hypothermia</li>\n<li>Insanity</li>\n<li>Newborn</li>\n<li>Narcotics</li>\n<li>Shock</li>\n<li>Sunstroke</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1205, 'Forensic Medicine', 'PM0068. Harvard criteria for brain death', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Unreceptivity and unresponsivity &nbsp; &nbsp; &nbsp;</li>\n<li>No movements &nbsp; &nbsp;</li>\n<li>Apnoea &nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Absence of elicitable reflexes &nbsp; &nbsp; &nbsp;</li>\n<li>Isoelectric EEG (confirmatory)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1206, 'Forensic Medicine', 'PM1458. Autopsy Techniques', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Virchows</strong>&nbsp;<strong>technique</strong>: Organs are removed <strong>one by one</strong> from the body to be examined. Here the cranial cavity is opened first, then the spinal cord, followed by thoracic, cervical, and abdominal organs in that order.</li>\n<li><strong>Ghons technique</strong>: Here the organs are removed<strong> en bloc</strong>. The thoracic, cervical, pelvic, and abdominal organs are removed as organ blocks.</li>\n<li><strong>Rokitanskys technique</strong>: This is characterized by <strong>in situ</strong> dissection in part combined with<strong><em> en bloc</em>&nbsp;</strong>removal like Ghons technique. The dissection begins at the neck and slowly works its way down the body and the organ is removed as a bloc. A cut is first made at the larynx to separate the esophagus from the pharynx. The larynx and trachea are pulled downward and using a scalpel, the chest organs are cut. The diaphragm is cut to expose the abdominal organs. Other organs like the bladder and rectum are separated from the body by using a scalpel to cut the pelvic ligaments.</li>\n<li><strong>Letulles technique</strong>: Thoracic, cervical, abdominal, and pelvic organs are removed <strong>en masse</strong> meaning as one big organ block. It allows the body to be made available for examination in less than 30 minutes as the process of removing the organs is much quicker.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1207, 'Forensic Medicine', 'PM1457. Autopsy: Types Of Incision', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Type of incision</strong></td>\n<td><strong>Procedure</strong></td>\n<td><strong>Indication</strong></td>\n<td><strong>Advantage</strong></td>\n</tr>\n<tr>\n<td><strong>I-Shaped Incision</strong></td>\n<td>Extends from <strong>symphysis menti to symphysis pubis</strong>, taking a curve towards the left around the umbilicus.</td>\n<td>It is used routinely in practice</td>\n<td>It is <strong>simple and convenient</strong>.</td>\n</tr>\n<tr>\n<td><strong>Y-Shaped Incision</strong></td>\n<td>Commences at the <strong>anterior axillary fold</strong> on the chest on either side, runs downwards and anteriorly <strong>beneath the breasts</strong> as to meet at the xiphisternum and then run downwards as in the \I\-shaped incision&nbsp;&nbsp;</td>\n<td>Preferred in <strong>females</strong></td>\n<td>It <strong>prevents cutting of the chest</strong> skin in the midline.</td>\n</tr>\n<tr>\n<td><strong>Modified Y-Shaped Incision</strong></td>\n<td>Commences at the <strong>angle of mandible</strong> on either side, brought forwards, downwards to meet at the suprasternal notch and then run downwards as in the “I” shaped incision.&nbsp;</td>\n<td>Preferred when a <strong>detailed study of neck structures</strong> required, e.g. asphyxial death due to neck compression.&nbsp;</td>\n<td>It has better exposure and allows the study of neck structures.&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Elongated X-shaped Incision</strong></td>\n<td>Used to dissect out <strong>subcutaneous structures</strong> in the back to identify and evaluate the extent of blunt injuries.&nbsp;</td>\n<td>Should be practiced in cases of custodial death.&nbsp;</td>\n<td>Helpful in the&nbsp;<strong>reconstruction of events</strong> prior to death.&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b50f95de210f4d069f005b0844c8e10ex1264x1306.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/49bf2290516345ddbf128a1ea88ec8e3x1267x1297.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f798ddeaaa0f45c292cb0be7ab3f3a40x1262x1293.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e036f4fc17f1412ca5f8b027908a66a8x1261x1287.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1208, 'Forensic Medicine', 'PM2193. Differences between antemortem and postmortem burns', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p class=\p1\>&nbsp;</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td><strong>Characteristics</strong></td>\n<td><strong>Antemortem burns</strong></td>\n<td><strong>Postmortem burns</strong></td>\n</tr>\n<tr>\n<td>Line of redness</td>\n<td>Present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Vital sign</td>\n<td>Present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Vesication / Blister</td>\n<td>Present and true, contains serous fluid</td>\n<td>\n<p class=\p1\>Present but are false, contains PM gases +/- thin clear fluid</p>\n</td>\n</tr>\n<tr>\n<td>Reparative process</td>\n<td>Present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Internal organs</td>\n<td>Congested</td>\n<td>\n<p class=\p1\>Usually burnt+emits peculiar odor</p>\n</td>\n</tr>\n<tr>\n<td>Blood colour</td>\n<td>Cherry red due to CO</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>Curling’s ulcer</td>\n<td>Present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Inflamed Payer’s patches</td>\n<td>Present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\>Carbon/ soot particles in the trachea, bronchus</p>\n</td>\n<td>Present</td>\n<td>&nbsp;Absent</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\>Peripheral zone of burn&nbsp;</p>\n</td>\n<td>Shows an increase in enzyme reaction</td>\n<td>Does not show an increase in enzyme reaction</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1209, 'Forensic Medicine', 'PM2129. Most common injuries in a Road Traffic Accident', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Scenario</strong></td>\n<td><strong>Injury</strong></td>\n</tr>\n<tr>\n<td><strong>Unrestrained driver</strong></td>\n<td>\n<p>Face and head injury</p>\n<p>Cervical spine injury</p>\n<p>Steering wheel impact - Thoracic injuries</p>\n<p>Pelvic fracture</p>\n<p>Leg fracture</p>\n</td>\n</tr>\n<tr>\n<td><strong>Seatbealt injury</strong></td>\n<td>\n<p>Bruising</p>\n<p>Rupture of the mesentery or small intestine</p>\n<p>Abdominal aorta injury</p>\n<p>Lumbar spine fracture</p>\n</td>\n</tr>\n<tr>\n<td><strong>Airbag injury</strong></td>\n<td>\n<p>Facial bruising</p>\n<p>Amputation of fingers</p>\n<p>Fractures arms</p>\n<p>Cervical spine and head injury</p>\n</td>\n</tr>\n<tr>\n<td><strong>Front-seat passenger&nbsp;</strong></td>\n<td>\n<p>The pattern of injuries is similar to that of the driver, but this position in the car is even more dangerous.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Rear-seat passenger</strong></td>\n<td>The injuries occurring are more fatal compared to front-seat passengers</td>\n</tr>\n<tr>\n<td><strong>Motorcyclist&nbsp;</strong></td>\n<td>\n<p>Basal skull fracture - Hinge fracture</p>\n<p>Brush abrasions</p>\n<p>Tailgating</p>\n</td>\n</tr>\n<tr>\n<td><strong>Pedestrian</strong></td>\n<td>\n<p>Lower limb injuries</p>\n<p>Head injuries</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1210, 'Radiology,', 'PM2128. Diffuse Axonal Injury', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The mechanism of diffuse axonal injury (DAI) is primarily a non-impact rotational acceleration-deceleration injury. This leads to the deformation of the axons by stretching them.</p>\n<p>Pathology of DAI:</p>\n<ul>\n<li>Changes in permeability of the axolemma</li>\n<li>Axonal swelling</li>\n<li>Intracellular calcium accumulation</li>\n<li>Proteolysis</li>\n<li>The collapse of the cytoskeleton</li>\n<li><strong>Retraction balls</strong> or globes - bulbous and clubbed axons. Seen earliest at 12-18 hours.&nbsp;The number of retraction balls begins to decrease<strong> after 2-3 weeks after injury</strong> and a cluster of microglial cells appears followed by astrocytosis and demyelination.</li>\n<li>Immuno-histochemistry shows beta-amyloid precursor protein - the <strong>most reliable</strong> indicator of axon damage. Seen earliest at 2-3 hours.&nbsp;</li>\n</ul>\n<p>Image shows scattered axonal retraction balls stained with Congo Red:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cf55a5006e2e477ebb43d97d7e373764x1280x1139.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1211, 'Forensic Medicine', 'PM1808. Types of bullets:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>1. Ricochet bullet: </strong>Bullet first strikes an <strong>intermediate object</strong> and then after being <strong>reflected strikes the target.</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/c162353ba8714028bacb6d2cd96989b4x304x191.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>2.</strong>&nbsp;<strong>Yawning bullet: </strong>Travels in an <strong>irregular fashion</strong> and produces a key<strong> hole entry wound</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/56007c1b13db447580f082614e2dd2b0x300x81.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>3.</strong>&nbsp;<strong>Tandem (Piggy Back) Bullet Effect: Two bullets are ejected one after the other</strong>; first bullet failed to leave the barrel and is ejected by subsequently fired bullet. This occurs due to <strong>defect in the weapon</strong> or due to <strong>faulty ammunition</strong> or with <strong>loaded firearms unused for several years.&nbsp;</strong><strong>Tandem cartridge</strong> (also called duplex cartridge) is a single cartridge containing two bullets.&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/09c02e2f5842489795a6ea1a2aaa411ex312x135.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>4.</strong>&nbsp;<strong>Frangible bullet: Fragments </strong>on hitting the target.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/bcc46f8a8a87488594e05754d8eed4f0x290x152.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>5.</strong>&nbsp;<strong>Dum Dum bullet: Tip is chiseled out, fragments extensively on impact.</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/3b142ec1047d4358a842fef7639d67e4x283x152.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>6.</strong>&nbsp;<strong>Tumbling bullet: &nbsp;Rotates end on end </strong>during its motion.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/5850c87b5a6c4dbea3d9b14ac43e01e4x290x130.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>7.</strong>&nbsp;<strong>Souvenir bullet: &nbsp;</strong>Bullet <strong>left in the body</strong> for a long time and <strong>covered with dense fibrous connective tissue.</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/61f5ab7bf3924308b3122719651e4919x290x138.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>8.</strong>&nbsp;<strong>Tracer bullet: </strong>This type of bullet <strong>leaves a visible mark or trace </strong>while in flight so that the gunner can observe the strike of shot. Rear portion of bullet is filled with <strong>mixture of barium nitrate, strontium nitrate and powdered magnesium </strong>which is ignited by the burning powder. Mixture burns and sheds red sparks which makes the projectile visible to naked eye which enables shooter to make aiming corrections.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3cbe6e1a20774317b382f79f78bfa917x1280x697.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>9.</strong>&nbsp;<strong>Incendiary bullet: </strong>It is filled with<strong> white phosphorous </strong>and<strong> ignites the target.</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>From left to right : Blank with frangible wooden bullet, ball, tracer and incendiary bullets</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/376e0233099242b9a43903052e22c60fx800x600.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1212, 'Forensic Medicine,', 'PM1185. Whiplash Injury (Cervical Acceleration-Deceleration Injuries)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Mechanism of injury</strong>:&nbsp;Collision causing the occupant’s body to be forced against the car seat, while the head flips backwards causing&nbsp;<strong>hyperextension</strong> and then recoil into&nbsp;<strong>flexion</strong>.&nbsp;</p>\n<p><strong>Clinical features</strong>: Neck pain and stiffness are common symptoms. Less commonly,&nbsp;headache, dizziness, blurring of vision, paraesthesia in the arms, temporomandibular discomfort and tinnitus.</p>\n<p><strong>Examination findings</strong>: Tenderness of neck muscles, restriction of neck movements.&nbsp;</p>\n<p>Clinical presentation can be <strong>graded</strong> using the&nbsp;<strong>Quebec Task Force</strong> grading system:</p>\n<ul>\n<li>0 - No neck symptoms or signs</li>\n<li>1 - Neck pain, stiffness and tenderness</li>\n<li>2 - Neck symptoms and musculoskeletal signs</li>\n<li>3 - Neck symptoms and neurological signs</li>\n<li>4 - Neck symptoms and fracture or dislocation</li>\n</ul>\n<p><strong>Investigations</strong>: X-ray may be normal or show loss of cervical lordosis due to muscle spasm. <strong>MRI&nbsp;</strong>is done if there are neurological signs.&nbsp;</p>\n<p><strong>Treatment</strong>: Simple pain-relieving measures, including NSAIDs during the first few weeks.&nbsp;Graded exercises and isometric strengthening exercises after the pain subsides.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b9d35b51d252478a87c2f5659b58de31x1158x622.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1213, 'Forensic Medicine', 'PM0980. Kronlein Shot', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>This is a condition wherein a large portion of the brain is thrown out (herniated) of the exit wound but still intact/attached to the wound</strong>.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/0029452971af49589763aec2e12a6726x623x417.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1214, 'Forensic Medicine', 'PM0979. Types of Blast Injuries', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td width=\150\>\n<p><strong>Blast injury type</strong></p>\n</td>\n<td width=\150\>\n<p><strong>Mechanism of injury</strong></p>\n</td>\n<td width=\245\>\n<p><strong>Health impact</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p><strong>Primary</strong></p>\n</td>\n<td width=\150\>\n<p>Rapid crushing over pressure</p>\n</td>\n<td width=\245\>\n<p>Tympanic membrane (<strong>most common), </strong>Lung (2<sup>nd</sup> most common), eyes, GIT</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p><strong>Secondary</strong></p>\n</td>\n<td width=\150\>\n<p>Flying debris</p>\n</td>\n<td width=\245\>\n<p><strong>MARSHAL’s triad </strong>(triad of abrasions, contuisions, lacerations)</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p><strong>Tertiary</strong></p>\n</td>\n<td width=\150\>\n<p>Blast wind</p>\n</td>\n<td width=\245\>\n<p>Victim is thrown in air and strikes other objects leading to fracture and blunt trauma</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p><strong>Quaternary</strong></p>\n</td>\n<td width=\150\>\n<p>Any complicating factor not in the other three categories</p>\n</td>\n<td width=\245\>\n<p>Burns, histotoxicanoxia, and crush injuries</p>\n</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li>The specific pulmonary injury of air blast is known as blast lung.</li>\n<li>When the explosion is in the water the pressure changes are called underwater blast. <strong>Intestinal damage</strong> is very common in underwater blast injuries.</li>\n<li>Solid blast refers to the wave of energy that spreads through the rigid structure when an explosive is detonated near it and people in contact with its structure can be injured.</li>\n<li>Caecum is most sensitive to intestinal blast injury.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1215, 'Forensic Medicine', 'PM0977. Rayalaseema Phenomenon', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>This is an <strong>artifact</strong>.</li>\n<li>Here, a victim <strong>was first killed by stab injury</strong> and then to mislead the investigating officer, the <strong>criminal stuffed the stab wound with a bullet manually</strong>.</li>\n<li>This was <strong>unraveled only after a meticulous autopsy examination</strong>.</li>\n<li>Since the <strong>whole incident occurred in the Rayalaseema, a geographic region of Andhra Pradesh State</strong> in India, the terminology for the phenomenon was coined accordingly.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1216, 'Forensic Medicine', 'PM0976. Difference between Wound of Entry and Exit', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\154\>\n<p><strong>Characteristics</strong></p>\n</td>\n<td width=\154\>\n<p><strong>Wound of entry</strong></p>\n</td>\n<td width=\154\>\n<p><strong>Wound of exit</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Size</p>\n</td>\n<td width=\154\>\n<p>Smaller than the diameter of the bullet.</p>\n<p>In close discharge, skin is torn, hence size is increased.</p>\n</td>\n<td width=\154\>\n<p>Bigger than the diameter of the bullet.</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Margin</p>\n</td>\n<td width=\154\>\n<p>Inverted</p>\n</td>\n<td width=\154\>\n<p>Everted</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Soiling of wound</p>\n</td>\n<td width=\154\>\n<p>+ve</p>\n</td>\n<td width=\154\>\n<p>-ve</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Abrasion collar</p>\n</td>\n<td width=\154\>\n<p>+ve</p>\n</td>\n<td width=\154\>\n<p>-ve</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Contusion collar</p>\n</td>\n<td width=\154\>\n<p>+ve</p>\n</td>\n<td width=\154\>\n<p>-ve</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Grease collar</p>\n</td>\n<td width=\154\>\n<p>+ve</p>\n</td>\n<td width=\154\>\n<p>-ve</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Bleeding</p>\n</td>\n<td width=\154\>\n<p>Less</p>\n</td>\n<td width=\154\>\n<p>More</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Foreign bodies</p>\n</td>\n<td width=\154\>\n<p>+ve</p>\n</td>\n<td width=\154\>\n<p>-ve</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Dispersion of pallets (shotgun)</p>\n</td>\n<td width=\154\>\n<p>+ve</p>\n</td>\n<td width=\154\>\n<p>-ve</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Protrusion of fat</p>\n</td>\n<td width=\154\>\n<p>-ve</p>\n</td>\n<td width=\154\>\n<p>+ve</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Bright red (Carboxy Hb)</p>\n</td>\n<td width=\154\>\n<p>+ve (Near shot)</p>\n</td>\n<td width=\154\>\n<p>-ve</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>X-ray Metallic Ring</p>\n</td>\n<td width=\154\>\n<p>+ve</p>\n</td>\n<td width=\154\>\n<p>-ve</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Muzzle impression</p>\n</td>\n<td width=\154\>\n<p>+ve (contact shot)</p>\n</td>\n<td width=\154\>\n<p>-ve</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Blast effect</p>\n</td>\n<td width=\154\>\n<p>+ve (contact shot)</p>\n</td>\n<td width=\154\>\n<p>-ve</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1217, 'Forensic Medicine', 'PM0975. Summary of Wound of entry for Rifled Firearm at different Ranges', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Characteristics</strong></p>\n</td>\n<td>\n<p><strong>Contact shot</strong></p>\n</td>\n<td>\n<p><strong>Close shot</strong></p>\n</td>\n<td>\n<p><strong>Near shot</strong></p>\n</td>\n<td>\n<p><strong>Distant shot</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Range</p>\n</td>\n<td>\n<p>In-touch with skin</p>\n</td>\n<td>\n<p>2.5-7.5 cm</p>\n</td>\n<td>\n<p>30-60 cm</p>\n</td>\n<td>\n<p>&gt;60 cm</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Size</p>\n</td>\n<td>\n<p><strong>Largest size</strong></p>\n</td>\n<td>\n<p>Bullet size</p>\n</td>\n<td>\n<p>Smaller</p>\n</td>\n<td>\n<p>Smallest</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Shape</p>\n</td>\n<td>\n<p>Stellate</p>\n</td>\n<td>\n<p>Circular</p>\n</td>\n<td>\n<p>Circular</p>\n</td>\n<td>\n<p>Circular</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Muzzle end imprint</p>\n</td>\n<td>\n<p><strong>Positive </strong></p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Edge eversion</p>\n</td>\n<td>\n<p><strong>Positive</strong></p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Blackening</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n<td>\n<p><strong>Positive</strong></p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tattooing</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n<td>\n<p><strong>Positive</strong></p>\n</td>\n<td>\n<p><strong>Positive</strong></p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Singeing</p>\n</td>\n<td>\n<p>Positive</p>\n</td>\n<td>\n<p><strong>Positive</strong></p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Abrasion collar</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n<td>\n<p><strong>Positive</strong></p>\n</td>\n<td>\n<p><strong>Positive</strong></p>\n</td>\n<td>\n<p><strong>Positive</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Grease collar</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n<td>\n<p><strong>Positive</strong></p>\n</td>\n<td>\n<p><strong>Positive</strong></p>\n</td>\n<td>\n<p><strong>Positive</strong></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Contact shot:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/60d9c33411084d6ebb4206179e5ab21fx453x432.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>This is a contact gunshot entrance wound. Since the barrel contacts the skin, the gases released by the fired round go into the subcutaneous tissue and cause the star-shaped laceration. Note also the grey-black discoloration from the soot, as well as the faint abrasion ring.</p>\n<p><strong>Close shot:</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/74a1ae8e4ced4b14ab1c3e64fc3c1f86x515x509.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>The wound has been washed and there is stippling. This indicates a close-range gunshot wound because both stippling and fouling are present.</li>\n</ul>\n<p><strong>Distant shot:</strong></p>\n<ul>\n<li>Distant range entrance gunshot wound with eccentric abrasion rim.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/e6ba1b7acac54301a1df10c6d5639536x551x413.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1218, 'Forensic Medicine', 'PM0974. Products of firing and their effects', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Components</strong></p>\n</td>\n<td>\n<p><strong>Distance traveled</strong></p>\n</td>\n<td>\n<p><strong>Effects produced</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gun flame</p>\n<p>Gunsmoke</p>\n</td>\n<td>\n<p>15 cm (6”)</p>\n</td>\n<td>\n<p>Heat combustion effect-&nbsp;</p>\n<p>Burning and singeing</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Soot Particles/</p>\n<p>Gunpowder</p>\n</td>\n<td>\n<p>30 cm (12”)</p>\n&nbsp;</td>\n<td>Blackening/\n<p>Smudging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fine or coarse particles</p>\n</td>\n<td>\n<p>90 cm (36”)</p>\n</td>\n<td>\n<p>Tattooing/peppering/ powder stippling-&nbsp;</p>\n<p>Become impregnated into the skin and cannot be washed or scrubbed off.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gases</p>\n</td>\n<td>\n<p>Contact shot</p>\n</td>\n<td>\n<p>Blast effects</p>\n<p>Facial distortion</p>\n<p>Cherry red discoloration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bullet</p>\n</td>\n<td>\n<p>Variable</p>\n</td>\n<td>\n<p>Abrasion collar</p>\n<p>Grease collar</p>\n<p>Wound of entry</p>\n<p>Wound of exit</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Medicolegal importance</p>\n<ul>\n<li>Smudging and tattooing effects can help to assess the range of firing, as below\n<ul>\n<li>If both are present, the range of firing is close or near shot.</li>\n<li>If both are absent, the range of firing is a distant shot.</li>\n<li>If both are found deeper, i.e. on the inner aspect of the wound, the range is contact shot.</li>\n<li>If only tattooing is present, the range is near shot.</li>\n</ul>\n</li>\n<li>Thus as the range increases, blackening fades first, followed by tattooing, the reason being their causative agents cannot travel beyond a fixed distance.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1219, 'Forensic Medicine', 'PM0973. Products of Firing and its Effects', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Flame and hot air</strong></p>\n</td>\n<td>\n<p><strong>Smoke/soot (completely burnt powder)</strong></p>\n</td>\n<td>\n<p><strong>Partially burnt and unburnt powder particle</strong></p>\n</td>\n<td>\n<p><strong>Bullet</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Scorching</p>\n<p>Burning and singeing</p>\n</td>\n<td>\n<p>Blackening /smudging</p>\n</td>\n<td>\n<p><strong>Tattooing</strong>/peppering/powder strippling</p>\n</td>\n<td>\n<p>Wound of entry</p>\n<p>Grease collar</p>\n<p>Abrasion collar</p>\n<p>Wound of exit</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Soiling of the Wound:</p>\n<p>Smudging/blackening:</p>\n<ul>\n<li>It is due to the deposition of smoke particles, lead or metal of which the missile is made of.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/b541a09e4730441aac9449fb519c0ad4x408x416.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Tattooing/peppering</p>\n<ul>\n<li><strong>It is due to deposition of fine or coarse gunpowder particles, which become truly impregnated into and mark the skin, and cannot be washed or scrubbed off</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/fd70e021746945e6860ffe7cf9af61c5x387x390.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Medicolegal importance</p>\n<ul>\n<li>Smudging and tattooing effects can help to assess the range of firing, as below\n<ul>\n<li>If both are present, the range of firing is close or near shot.</li>\n<li>If both are absent, the range of firing is a distant shot.</li>\n<li>If both are found deeper, i.e. on the inner aspect of the wound, the range is contact shot.</li>\n<li>If only tattooing is present, the range is near shot.</li>\n</ul>\n</li>\n<li>Thus as the range increases, blackening fades first, followed by tattooing, the reason being their causative agents cannot travel beyond a fixed distance.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1220, 'Forensic Medicine', 'PM0969. Various types of gunpowder', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Smokeless powder:</strong>\n<ul>\n<li>Nitrocellulose (single base)</li>\n<li>Nitrocellulose &amp; Nitroglycerine (double base)</li>\n<li>Nitrocellulose, Nitroglycerine, and Nitroguanidine (triple base)</li>\n</ul>\n</li>\n<li><strong>Smoke producing powders contain</strong><strong>&nbsp;</strong><strong>Black Powder:</strong>\n<ul>\n<li>Potassium nitrate</li>\n<li>Charcoal</li>\n<li>Sulphur</li>\n</ul>\n</li>\n<li><strong>Semi-smokeless powder</strong>:\n<ul>\n<li>Mixture of 80% black and 20% of the smokeless powder</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1221, 'Forensic Medicine', 'PM0966. Difference between Epidural Hematoma due to Burns and Blunt Force', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Trait </strong></p>\n</td>\n<td>\n<p><strong>Epidural hematoma due to burns</strong></p>\n</td>\n<td>\n<p><strong>Epidural hematoma due to blunt force </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cause</p>\n</td>\n<td>\n<p>Charring of skull due to intense heat</p>\n</td>\n<td>\n<p>Blunt force to the head</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Situation</p>\n</td>\n<td>\n<p>Anywhere usually bilateral</p>\n</td>\n<td>\n<p>Usually adjacent to Sylvian fissure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Distribution</p>\n</td>\n<td>\n<p>Diffuse</p>\n</td>\n<td>\n<p>Localised</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Characters</p>\n</td>\n<td>\n<p>Thin, granular, soft friable clot of light chocolate color honeycomb appearance; evenly distributed or sickle-shaped</p>\n</td>\n<td>\n<p>Discoid shape, localized more rubbery in consistency, reddish purple</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Skull</p>\n</td>\n<td>\n<p>Maybe fractured</p>\n</td>\n<td>\n<p>Associated fracture in temporal area</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CNS</p>\n</td>\n<td>\n<p>No injury</p>\n</td>\n<td>\n<p>Frequently injured</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carboxyhaemoglobin</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n<td>\n<p>Absent</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1222, 'Forensic Medicine', 'PM0965. Difference between Ante-mortem Burns and Post-mortem Burns', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\154\>\n<p>Trait</p>\n</td>\n<td width=\154\>\n<p>Ante-mortem burns</p>\n</td>\n<td width=\154\>\n<p>Post-mortem burns</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Line of redness</p>\n</td>\n<td width=\154\>\n<p>Present</p>\n</td>\n<td width=\154\>\n<p>Absent</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Blister</p>\n</td>\n<td width=\154\>\n<p>Contains serous fluid with proteins and chlorides</p>\n<p>Base is inflamed</p>\n</td>\n<td width=\154\>\n<p>Contains air only</p>\n<p>Base is dry, hard and yellow.</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Vital reaction</p>\n</td>\n<td width=\154\>\n<p>Present</p>\n</td>\n<td width=\154\>\n<p>Absent</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Enzymes</p>\n</td>\n<td width=\154\>\n<p>Peripheral zone of burn shows increase in enzyme reaction</p>\n</td>\n<td width=\154\>\n<p>Peripheral zone of burn does not show increase in enzyme reaction</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1223, 'Forensic Medicine', 'PM0829. Types of impact injuries', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Primary impact injuries:</strong></p>\n<ul>\n<li>It is caused due <strong>to initial impact b/w vehicle and pedestrian</strong>. These are seen on the part of the body facing the vehicle and help in identifying the offending vehicle.</li>\n</ul>\n<p><strong>Secondary impact injuries:</strong></p>\n<ul>\n<li>It is caused due to <strong>subsequent second impact of same vehicle</strong>. These injuries are also seen on the same side as the primary impact injuries.</li>\n</ul>\n<p><strong>Tertiary impact injuries/secondary injuries</strong></p>\n<ul>\n<li>It is caused<strong> by person violently falling on ground or on other stationary objects</strong>. Found on parts opposite to primary impact <strong>or on head<em>.</em></strong></li>\n</ul>\n<p><strong>Rolling/Run over/degloving injuries:</strong></p>\n<ul>\n<li>It is caused by wheel of vehicle running or rolling over the victim. Children are often involved.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Types of impact injuries on pedestrian</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3df0f261ba824803a86e21445237a218x386x335.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1224, 'Forensic Medicine', 'PM0822. Types of skull vault fracture', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Diastatic</strong> fracture/ <strong>sutural</strong> fracture - It involves the separation of sutures due to blow with a blunt weapon or from cerebral edema.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ba0902e972ff42d08d29c34cc50c1f54x327x150.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Fissured</strong> fracture/ <strong>linear</strong> fracture:</p>\n<ul>\n<li>They are breaks in the bone that traverse the full thickness of the skull from the outer to inner table.</li>\n<li>They are usually fairly straight with no bone displacement.</li>\n<li>The common cause of injury is blunt force trauma where the impact energy transferred over a wide area of the skull.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Pond</strong> fracture/ <strong>indented</strong> fracture - It occurs in children due to elasticity of bones.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ed4f9a37343641e59bcc73eda4ecffd1x167x176.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Depressed</strong> fracture/ <strong>signature</strong> fracture - It is caused by a heavy weapon with a small striking surface. Its shape indicates the type of weapon which is produced (signature fracture).</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b493f5278c3d460d906209a6d1462fbex1200x797.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Comminuted</strong> fracture/ <strong>spider-web</strong> fracture - It has a stellate appearance where there is no displacement of the fracture.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2090d8cd7b744d2d9e9136e65cdd7069x526x382.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Ring</strong> fracture - It is usually caused due to a fall from height landing on feet.&nbsp;These occur in the&nbsp;posterior fossa&nbsp;around the&nbsp;foramen magnum.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cfbc6a495f5f47f6b1be0a6dc8651bd3x1279x1477.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1225, 'Forensic Medicine', 'PM0763. Difference between incised, lacerated and stab wound', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Trait</strong></td>\n<td><strong>Incised wound</strong></td>\n<td><strong>Lacerated wound</strong></td>\n<td><strong>Stabwound</strong></td>\n</tr>\n<tr>\n<td><strong>Manner of production </strong></td>\n<td>By sharp objects or weapons</td>\n<td>By blunt&nbsp; objects or weapons&nbsp;</td>\n<td>By pointed sharp or blunt weapons</td>\n</tr>\n<tr>\n<td><strong>Site </strong></td>\n<td>Anywhere</td>\n<td>Usually over the bony prominences</td>\n<td>Anywhere, usually chest and abdomen</td>\n</tr>\n<tr>\n<td><strong>margins</strong></td>\n<td>Smooth, even, clean cut and everted</td>\n<td><strong>Irregular and often undermined</strong></td>\n<td>Cleancut, parallel edges, lacerated if weapon is blunt pointed</td>\n</tr>\n<tr>\n<td><strong>Abrasion and edges </strong></td>\n<td>Absent</td>\n<td>Usually present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td><strong>Bruising </strong></td>\n<td>No adjacent bruising of soft tissues</td>\n<td>Bruising of surrounding and underlying tissue</td>\n<td>rare</td>\n</tr>\n<tr>\n<td><strong>shape</strong></td>\n<td>Linear or spindle shaped</td>\n<td>Varies usually irregular</td>\n<td>Linear or irregular</td>\n</tr>\n<tr>\n<td><strong>Depth of wound</strong></td>\n<td>Structures cleanly cut to the depth of the wound</td>\n<td>Small strands of tissue at the bottom bridge across margins</td>\n<td>Structures cleanly cut</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1226, 'Forensic Medicine', 'PM0762. Age of bruise and abrasion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Age and color change of bruise/contusion</strong>:</p>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Colour</strong></td>\n<td><strong>Due to</strong></td>\n<td><strong>Duration &nbsp;</strong></td>\n</tr>\n<tr>\n<td>Red</td>\n<td>Haemoglobin (fresh blood)</td>\n<td>Fresh <em>&nbsp;</em></td>\n</tr>\n<tr>\n<td>Blue</td>\n<td>Deoxygenated haemoglobin</td>\n<td>Few hours to 3 days<em>&nbsp;</em></td>\n</tr>\n<tr>\n<td>Bluish black/ brown</td>\n<td>Hemosiderin</td>\n<td>4<sup>th</sup> day &nbsp;</td>\n</tr>\n<tr>\n<td>Green</td>\n<td>Hematoidin</td>\n<td>5 to 6 days&nbsp;</td>\n</tr>\n<tr>\n<td>Yellow</td>\n<td>Bilirubin</td>\n<td>7 to 12 days&nbsp;</td>\n</tr>\n<tr>\n<td>Normal colour</td>\n<td>Pigment removed by phagocytes&nbsp;</td>\n<td>2 weeks</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>The image given below shows the age and colour change of bruise:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/108b99181eaa4f5d8900121410157a90x1280x3975.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Age of abrasion</strong>:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Colour of scab</strong></td>\n<td><strong>Duration </strong></td>\n</tr>\n<tr>\n<td>Bright red</td>\n<td>12-24 hrs</td>\n</tr>\n<tr>\n<td>Reddish brown</td>\n<td>2-3 days</td>\n</tr>\n<tr>\n<td>Dark brown to brownish black</td>\n<td>4-7 days</td>\n</tr>\n<tr>\n<td>Scab dries shrinks and falls off</td>\n<td>After 7 days</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1227, 'Forensic Medicine,', 'PM0487. Degrees of Burns', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>First-degree</strong></td>\n<td><strong>Second-degree (superficial partial thickness)</strong></td>\n<td><strong><strong>Second-degree (deep </strong></strong><strong>partial thickness)</strong></td>\n<td>\n<p><strong>Third-degree&nbsp;</strong><strong>(full thickness)</strong></p>\n</td>\n<td><strong><strong>Fourth-degree&nbsp;</strong></strong><strong>(full thickness)</strong></td>\n</tr>\n<tr>\n<td>Depth</td>\n<td>Epidermis</td>\n<td>Epidermis + superficial dermis</td>\n<td>Epidermis + most of the dermis (most skin appendages destroyed)</td>\n<td>Entire dermis + subcutaneous tissue</td>\n<td>Involves connective tissue, muscle, possibly bone</td>\n</tr>\n<tr>\n<td>Colour/texture</td>\n<td>Red</td>\n<td>Red, edematous, and blistered</td>\n<td>Pale, mottled</td>\n<td>Hard, leathery</td>\n<td>Pale, dry, charred</td>\n</tr>\n<tr>\n<td>Blanchable (capillary refill)&nbsp;</td>\n<td>Yes</td>\n<td>Yes</td>\n<td>No</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Pain</td>\n<td>Painful</td>\n<td>Painful</td>\n<td>Painful (only on pinprick)</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Healing</td>\n<td>5-10 days; no scar</td>\n<td>10-14 days; no or minimal scar</td>\n<td>&nbsp;4-8 weeks, often with scarring and contractures</td>\n<td>Prolonged, with scarring and contractures, requires skin grafting</td>\n<td>Requires skin grafting or even amputation.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/280163e3ef8a49199158cdd221a8c725x1280x2560.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1228, 'Forensic Medicine,', 'PM0467. Wallaces rule of 9', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>&nbsp;</strong></p>\n<table width=\640\>\n<tbody>\n<tr>\n<td width=\160\>\n<p><strong>Body part </strong></p>\n</td>\n<td width=\160\>\n<p><strong>%TBSA </strong></p>\n</td>\n<td width=\160\>\n<p><strong>Body part </strong></p>\n</td>\n<td width=\160\>\n<p><strong>%TBSA </strong></p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>Head/neck</p>\n</td>\n<td width=\160\>\n<p>9%</p>\n</td>\n<td width=\160\>\n<p>Lower back</p>\n</td>\n<td width=\160\>\n<p>9%</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>R-UL</p>\n</td>\n<td width=\160\>\n<p>9%</p>\n</td>\n<td width=\160\>\n<p>R- thigh</p>\n</td>\n<td width=\160\>\n<p>9%</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>L-UL</p>\n</td>\n<td width=\160\>\n<p>9%</p>\n</td>\n<td width=\160\>\n<p>L-thigh</p>\n</td>\n<td width=\160\>\n<p>9%</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>Anterior chest</p>\n</td>\n<td width=\160\>\n<p>9%</p>\n</td>\n<td width=\160\>\n<p>R- leg</p>\n</td>\n<td width=\160\>\n<p>9%</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>Upper back</p>\n</td>\n<td width=\160\>\n<p>9%</p>\n</td>\n<td width=\160\>\n<p>L- leg</p>\n</td>\n<td width=\160\>\n<p>9%</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>Anterior abdomen</p>\n</td>\n<td width=\160\>\n<p>9%</p>\n</td>\n<td width=\160\>\n<p>Genitals</p>\n</td>\n<td width=\160\>\n<p>1%</p>\n</td>\n</tr>\n<tr>\n<td width=\160\>\n<p>Total</p>\n</td>\n<td width=\160\>\n<p>54%</p>\n</td>\n<td width=\160\>&nbsp;</td>\n<td width=\160\>\n<p>46%</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5169280b55754776a636343f435aba19x723x781.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1229, 'Forensic Medicine', 'PM2150. Difference between freshwater and seawater drowning.', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\360\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Freshwater drowning</strong></td>\n<td><strong>Seawater drowning</strong></td>\n</tr>\n<tr>\n<td><strong>Mechanism of death</strong></td>\n<td>Disruption of surfactant - causes surfactant denaturation</td>\n<td>Disruption of surfactant - causes dilution of surfactant</td>\n</tr>\n<tr>\n<td><strong>Fluid and electrolyte changes</strong></td>\n<td>\n<p>Hypervolemia</p>\n<p>Hyponatremia</p>\n<p>Hyperkalemia</p>\n</td>\n<td>\n<p>Hypovolemia</p>\n<p>Hypernatremia</p>\n</td>\n</tr>\n<tr>\n<td><strong>Time to death</strong></td>\n<td>\n<p>Lesser (4-5 minutes)</p>\n</td>\n<td>\n<p>More (8-12 minutes)</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1230, 'Forensic Medicine', 'PM1454. Differentiating features between Antemortem amd Postmortem drowning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Antemortem drowning </strong></td>\n<td><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Postmortem drowning</strong></td>\n</tr>\n<tr>\n<td>Froth/ foam at nostrils or mouth</td>\n<td>Present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Cadaveric spasm</td>\n<td>Present</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Lungs</td>\n<td>\n<p>Emphysema aquosum</p>\n<p>Edema aquosum(seen in unconscious)&nbsp;</p>\n<p>Lungs are voluminous, bulky, water-logged and over-inflated</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>Passive collection of water in the lungs</p>\n</td>\n</tr>\n<tr>\n<td>Presence of foreign bodies (fluid, debris, weeds, vegetation, etc)</td>\n<td>Present in bronchi and bronchioles</td>\n<td>Passively collected only in upper respiratory passage</td>\n</tr>\n<tr>\n<td>Demonstration of diatoms&nbsp;</td>\n<td>Present in the lungs, liver, brain, bone marrow, etc.</td>\n<td>\n<p>Present only in the lungs</p>\n<p>Not spread to distant organs because of absence of circulation</p>\n</td>\n</tr>\n<tr>\n<td>Stomach contents&nbsp;</td>\n<td>\n<p>Water</p>\n<p>Foreign material like sand, weed, dirt etc&nbsp; (swallowed while struggling for life)</p>\n</td>\n<td>\n<p>Water (lesser quantity)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1231, 'Forensic Medicine', 'PM1102. Difference between strangulation by Ligature and Hanging', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\0\>\n<tbody>\n<tr>\n<td width=\154\>\n<p><strong>Trait</strong></p>\n</td>\n<td width=\154\>\n<p><strong>Hanging</strong></p>\n</td>\n<td width=\154\>\n<p><strong>Strangulation by ligature</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Nature of death</p>\n</td>\n<td width=\154\>\n<p>Mostly suicidal</p>\n</td>\n<td width=\154\>\n<p>Mostly homicidal</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Face</p>\n</td>\n<td width=\154\>\n<p>Usually pale and petechiae are rare</p>\n</td>\n<td width=\154\>\n<p>Congested, livid, and marked with petechiae</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Tongue</p>\n</td>\n<td width=\154\>\n<p>Swelling and protrusion is less marked</p>\n</td>\n<td width=\154\>\n<p>Swelling and protrusion is more marked</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Bleeding</p>\n</td>\n<td width=\154\>\n<p>Bleeding from the nose, mouth, and ears is not common</p>\n</td>\n<td width=\154\>\n<p>Bleeding from the nose, mouth, and ears may be found</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Saliva</p>\n</td>\n<td width=\154\>\n<p>Often dribbles out of the mouth</p>\n</td>\n<td width=\154\>\n<p>Dribbling of saliva is very rare</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Ligature mark</p>\n</td>\n<td width=\154\>\n<p>Oblique, non-continuous, placed high up in the neck between the chin and the larynx.&nbsp;</p>\n<p>The subcutaneous tissue underneath the mark is usually hard, white, and glistening</p>\n</td>\n<td width=\154\>\n<p>Horizontal or transverse, continuous around the neck, low down in the neck below or across the thyroid.&nbsp; &nbsp;</p>\n<p>Subcutaneous tissue underneath may be ecchymosed</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Abrasions and</p>\n<p>ecchymoses</p>\n</td>\n<td width=\154\>\n<p>Rare</p>\n</td>\n<td width=\154\>\n<p>Common</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Injury to muscles of</p>\n<p>neck</p>\n</td>\n<td width=\154\>\n<p>Rare</p>\n</td>\n<td width=\154\>\n<p>Common</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Carotid arteries</p>\n</td>\n<td width=\154\>\n<p>Internal coats are usually ruptured in violent cases of a long drop (Amussats sign)</p>\n</td>\n<td width=\154\>\n<p>Damage to the internal coat is rare</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Hyoid bone fracture</p>\n</td>\n<td width=\154\>\n<p>Less common</p>\n</td>\n<td width=\154\>\n<p>Less common (common in manual strangulation)</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Thyroid cartilage fracture</p>\n</td>\n<td width=\154\>\n<p>Less common</p>\n</td>\n<td width=\154\>\n<p>More common</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Cervical vertebrae fracture or dislocation</p>\n</td>\n<td width=\154\>\n<p>Common in judicial hanging</p>\n</td>\n<td width=\154\>\n<p>Rare</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1232, 'Forensic Medicine', 'PM1101. Difference between Ante mortem and Post-mortem Hanging', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Characteristics</strong></td>\n<td><strong>Antemortem</strong></td>\n<td><strong>Post-mortem</strong></td>\n</tr>\n<tr>\n<td>Salivary dribbling mark at the angle<br>of mouth, the opposite side of the knot</td>\n<td>+ve</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td>Fecal/ urinary discharge</td>\n<td>Not very common</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td colspan=\3\>Ligature mark</td>\n</tr>\n<tr>\n<td>Direction</td>\n<td>Oblique</td>\n<td>Circular</td>\n</tr>\n<tr>\n<td>Continuous/not</td>\n<td>Noncontinuous</td>\n<td>Continuous</td>\n</tr>\n<tr>\n<td>Level in the neck</td>\n<td>High up above the level<br>thyroid cartilage</td>\n<td>Low, below<br>the level of the thyroid cartilage</td>\n</tr>\n<tr>\n<td>Parchmentisation</td>\n<td>+ve</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td>VItal reaction</td>\n<td>+ve</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td>Knot</td>\n<td>Single, simple, on<br>one of the side of neck/ rarely on<br>chin the or occiput</td>\n<td>More than one, granny or reef<br>type on occiput/chin</td>\n</tr>\n<tr>\n<td>Tongue may or may not be&nbsp;<br>protruded out, bitten at the tip</td>\n<td>+ve</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td>Injuries&nbsp;Imprint abrasion/ Bruise</td>\n<td>Always +ve and with vital&nbsp;reaction</td>\n<td>+ ve/ -ve and if +ve no vital reaction</td>\n</tr>\n<tr>\n<td>Elongation of neck</td>\n<td>+ve</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td colspan=\3\>PM staining</td>\n</tr>\n<tr>\n<td>Above ligature mark</td>\n<td>+ve</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td>In lower limbs</td>\n<td>+ve</td>\n<td>+ve</td>\n</tr>\n<tr>\n<td>Glove-stocking like distribution</td>\n<td>+ve</td>\n<td>Independent parts of body<br>at the time of death<br>and position at death</td>\n</tr>\n<tr>\n<td>Lung Surface<br>Emphysematous bulla</td>\n<td>- ve</td>\n<td>+ve</td>\n</tr>\n<tr>\n<td colspan=\3\>Evidence of Injury</td>\n</tr>\n<tr>\n<td>Self-infliction</td>\n<td>+ve</td>\n<td>-ve &nbsp;</td>\n</tr>\n<tr>\n<td>Struggle evidence</td>\n<td>+ve &nbsp;</td>\n<td>-ve</td>\n</tr>\n<tr>\n<td>Tear of carotid artery intima</td>\n<td>+ve</td>\n<td>-ve &nbsp;</td>\n</tr>\n<tr>\n<td>Fracture of hyoid</td>\n<td>\n<p>+ve</p>\n</td>\n<td>+ve</td>\n</tr>\n<tr>\n<td>Cyanosis</td>\n<td>\n<p>Deeply+ ve</p>\n</td>\n<td>- ve/ faintly +ve</td>\n</tr>\n<tr>\n<td>Point of suspension</td>\n<td>\n<p>Compatible with antemortem&nbsp;<br>self-suspension</p>\n</td>\n<td>Not so</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1233, 'Forensic Medicine', 'PM2133. Tests to detect seminal and blood stains', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Tests for seminal stains</strong></p>\n<ul>\n<li>Barberios test</li>\n<li>Florence test</li>\n<li>Acid phosphatase test</li>\n<li>Creatine phosphokinase test</li>\n<li>Immunological test to detect Prostate Specific Antigen</li>\n</ul>\n<p><strong>Tests for blood stains &nbsp;</strong></p>\n<ul>\n<li>Benzidine test</li>\n<li>Phenophthalein (Kastle Meyer) test</li>\n<li>Takayama hemochromogen crystal test</li>\n<li>Teichmann’s hemin crystal test</li>\n<li>Spectroscopic test</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1234, 'Forensic Medicine', 'PM1106. New update regarding Sexual Intercourse with Minor Wife', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>On 11.10.2017 Supreme Court has passed a judgment regarding sexual intercourse with minor wife.</p>\n<ul>\n<li><strong>Section 375 of the Indian penal code</strong> says sex with a girl who is below 18 years is rape (now an offense) but it had an exception which allowed a man to have sex with his underage wife, 15 or above, even without her consent.</li>\n<li>Age of consent for sexual intercourse\n<ul>\n<li>Unmarried female-18 years</li>\n<li>Married female -18years (if female of 15-18 years is not complaining against the husband it does not make the act lawful)</li>\n</ul>\n</li>\n<li>The wife (15-18 years) should file a complaint within 1 year from the incident.</li>\n<li>Marital rape is not punishable in India (court has not commented on this).</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1235, 'Forensic Medicine,', 'PM2135. Radiological features of  Intrauterine Death', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Roberts sign</strong> - The presence of a gas shadow within the chambers of the heart or the greater vessels like aorta, in cases of foetal death in utero</li>\n<li><strong>Spalding sign</strong> - Loss of alignment and over-riding of bones of cranial vault and overlapping of skull bones due to shrinkage of brain after death</li>\n<li><strong>Deuel’s halo sign</strong> – Increased pericranial fat</li>\n<li>Hyperflexion of spine and crowding of ribs</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/dab0944e00f746b6a80031f212c83ebcx1280x1159.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0a3e099b8ec74c27872703c00ee16e68x1280x1181.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1236, 'Forensic Medicine', 'PM1330. Internal Findings of Starvation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>General</strong> – Fat is absent from subcutaneous tissues and muscles.</li>\n<li><strong>Brain</strong> – is pale and soft with congested meningeal vessels (at times).</li>\n<li><strong>Heart</strong> – is smaller due to brown atrophy. Heart chambers are usually empty, pale and collapsed, and show hypostatic congestion.</li>\n<li><strong>Gastro intestinal tract</strong>: Stomach is small, contracted, and empty. Mucous membrane of stomach and upper part of intestine is stained with bile. Large intestine has hard fecal matter.</li>\n<li><strong>Gall bladder</strong> - is unusually distended. It contains dark and filled with dry and inspissated bile.</li>\n<li><strong>Liver </strong>- shows necrosis</li>\n<li><strong>Spleen, kidneys and pancreas</strong>&nbsp;are small and shrunken</li>\n<li><strong>Urinary bladder</strong> - is empty</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1237, 'Forensic Medicine', 'PM1326. Hydrostatic Test/Floatation Test/Raygats Test', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It is based on the lung changes in a fetus after respiration.</p>\n<p><strong>Principle: </strong>Respired air remains in the lungs as residual air which cannot be removed after death. Hence lung floats in water.</p>\n<p><strong>False-negative </strong>test in:</p>\n<ul>\n<li>Atelectasis</li>\n<li>Pulmonary edema</li>\n<li>Pneumonia</li>\n<li>Congenital syphilis</li>\n<li>Air absorbed from air passages if circulation continued for long time after cessation of respiration</li>\n<li>More air exhaled from the lungs compared to air entering during inspiration</li>\n<li>Obstruction by alveolar duct membrane</li>\n</ul>\n<p><strong>False-positive</strong> test in:</p>\n<ul>\n<li>Putrefied foetus</li>\n<li>Artificial inflation</li>\n</ul>\n<p>Hydrostatic test is <strong>not required </strong>when:</p>\n<ul>\n<li>Fetus is monstrous</li>\n<li>Fetus is macerated or mummified</li>\n<li>Fetus is born before 180 days of gestation</li>\n<li>Stomach contains milk</li>\n<li>Umbilical cord has separated and scar has been formed</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1238, 'Forensic Medicine', 'PM1325. Important Changes in Maceration', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Earliest sign – reddening of the skin with peeling (12 hours)</li>\n<li>Skull bones—loss of alignment and over-riding of bones of cranial vault and overlapping which is seen on a radiograph, called&nbsp;<strong>Spaldings sign</strong>, due to shrinkage of the brain after death; seen within a few days of the death of the fetus.</li>\n<li>Emits a rancid odor</li>\n<li>The body is soft and pliable and flattens out when placed on an even surface.</li>\n<li>Skin—sodden and coppery red/purplish (never greenish as with putrefaction) with blisters, and cuticle peeling.</li>\n<li>Abdomen - distended</li>\n<li>Umbilical cord - thick, red smooth, soft.</li>\n<li>Joints - abnormally mobile or flexible</li>\n<li>Body cavity presents reddish serum</li>\n<li>Organs/viscera—soft and oedematous, lose their morphology, but lungs and uterus remain unaffected for long period.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1239, 'Psychiatry,', 'PM2115. Common names of Drugs of abuse', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Drug of abuse</strong></td>\n<td><strong>Common name</strong></td>\n</tr>\n<tr>\n<td>Cocaine</td>\n<td>White lady, Coke, Blow, Snow</td>\n</tr>\n<tr>\n<td>Cannabis</td>\n<td>Weed, Pot, Reefer, Ganja, Mary Jane, Hash, Indian hemp</td>\n</tr>\n<tr>\n<td>Heroin</td>\n<td>Smack, Dope, Brown sugar, Snowball</td>\n</tr>\n<tr>\n<td>Ketamine</td>\n<td>Vitamin K, Special K, Super K</td>\n</tr>\n<tr>\n<td>LSD</td>\n<td>Acid</td>\n</tr>\n<tr>\n<td>Methamphetamine</td>\n<td>Ice, Meth, Crystal,</td>\n</tr>\n<tr>\n<td>MDMA</td>\n<td>Ecstasy</td>\n</tr>\n<tr>\n<td>Phencyclidine</td>\n<td>Angel dust</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>Forms of cannabis:</p>\n<p><strong>Bhang:&nbsp;</strong>Decoction prepared from dried leaves and fruit shoot</p>\n<p><strong>Majoon:</strong>&nbsp;Sweet prepared from bhang</p>\n<p><strong>Ganja:</strong>&nbsp;Prepared from flower tops of female plant and smoked</p>\n<p><strong>Hashish/Charas:</strong>&nbsp;Most potent; resin exudate from leaves and stem thats smoked</p></div><!---->\n      <!---->\n    </div><!---->'),
(1240, 'Forensic Medicine', 'PM2111. Mechanism of action of corrosives', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\811\>\n<tbody>\n<tr>\n<td>Corrosive</td>\n<td>Mechanism of Action</td>\n<td>Type of necrosis</td>\n</tr>\n<tr>\n<td>Strong acids</td>\n<td>Hydrogen ions penetrate tissues and lead to cell death and&nbsp;<strong>eschar formation.&nbsp;</strong>This prevents further hydrogen ion penetration and protects against deeper injury.</td>\n<td>Coagulation necrosis</td>\n</tr>\n<tr>\n<td>Carbolic acid</td>\n<td>Same as other strong acids, but also hardens the GI mucosa. Produces a&nbsp;<strong>leather bottle stomach</strong> and anesthetizes the nerve endings. This&nbsp;<strong>allows for gastric lavage.</strong></td>\n<td>Coagulation necrosis&nbsp;</td>\n</tr>\n<tr>\n<td>Oxalic acid</td>\n<td>Same as other strong acids, but also scavenges calcium ions, leading to&nbsp;<strong>hypocalcemia&nbsp;</strong>and&nbsp;<strong>Calcium oxalate renal stones.&nbsp;</strong></td>\n<td>Coagulation necrosis</td>\n</tr>\n<tr>\n<td>Hydrofluoric acid</td>\n<td>Fluoride ions scavenge intracellular cations, such as calcium and magnesium and inhibit Na/K ATPase, <strong>disrupting cell membranes</strong>. This leads to&nbsp;<strong>hypocalcemia</strong>&nbsp;and<strong> hypomagnesemia.</strong></td>\n<td>Liquefactive necrosis</td>\n</tr>\n<tr>\n<td>Strong alkalis</td>\n<td>Hydroxide ions easily penetrate tissues, leading to the <strong>dissolution of cell membranes</strong>. It is associated with deep tissue injury.</td>\n<td>Liquefactive necrosis</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1241, 'Forensic Medicine', 'PM2108. Identification of Poisonous Snakes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Snake</strong></td>\n<td><strong>Identification</strong></td>\n</tr>\n<tr>\n<td><strong>&nbsp;</strong>Common Cobra</td>\n<td><strong>&nbsp;</strong>Hooded with spectacle mark</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f111e65c3f5d4b33abde23e678339914x1280x960.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>King cobra</td>\n<td>Hooded without spectacle mark</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0a28a5dbd66340018aed58401c2718e3x1024x766.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Common krait</td>\n<td>Single/double white bands on body</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/87b896b98ddb475288814df3072a8fe9x694x449.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Russell viper</td>\n<td>\n<table>\n<tbody>\n<tr>\n<td>Three rows of diamond shape black/brown spots.&nbsp;</td>\n</tr>\n</tbody>\n</table>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c87be92ff110497181d44eadbe1d44bfx1200x780.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1242, 'Forensic Medicine', 'PM2107. Mechanism of action of snake venom', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Snake</strong></td>\n<td><strong>Toxicity</strong></td>\n<td><strong>Main features</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Viperidae</strong></p>\n<ul>\n<li>Pit viper</li>\n<li>Saw-scaled viper</li>\n</ul>\n</td>\n<td>Vasculotoxic</td>\n<td>\n<ul>\n<li>Local reaction:\n<ul>\n<li>Severe</li>\n<li>Edema and necrosis</li>\n</ul>\n</li>\n<li>Anticoagulant effect: widespread bleeding</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Elapidae</strong></p>\n<ul>\n<li>Cobra</li>\n<li>Krait</li>\n</ul>\n</td>\n<td>Neurotoxic</td>\n<td>\n<ul>\n<li><strong>Local reaction:</strong>\n<ul>\n<li>Mild</li>\n</ul>\n</li>\n<li>Neurotoxicity leads to muscle paralysis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hydrophidae&nbsp;</strong>(sea snakes) are now considered a subfamily of <strong>Elapidae</strong></p>\n</td>\n<td>Myotoxic</td>\n<td>Generalized rhabdomyolysis</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Saw scaled viper:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/49672c9f8ef84b07a2b81c0b23f0e9e0x468x351.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Green pit viper:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/35d711ca8cd14f47ac29c4a37f8b82afx468x347.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Common krait:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cc2199ff9e5441faad2b819d721828acx299x449.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>King cobra:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/163a5f1d6a2d4a28b5369f7c6084d0b5x468x350.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Sea snake:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1fe0c8dfd6d84371b75db991c4ac2183x468x403.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1243, 'Forensic Medicine', 'PM2106. Plant poisons', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Datura stramonium (Jimsonweed) : Flower and fruit are poisonous</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2eaede053909497389cac1e1b0c4d530x1280x960.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Ricinus communis : Seed is poisonous</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7180cc0b0cf94045b876f6cbdb0ebd6dx1280x1706.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Digitalis purpurea&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a517f2827afa4cdcad5aaf1327a7b82bx1280x1786.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Atropa belladonna</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5aad720936ff44a697c2504ece8f5fa0x1280x1052.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Calotropis gigantea</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0bd879b96af64132a731d35608addbeax1280x1065.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1244, 'Forensic Medicine', 'PM2105. Common names for plant poisons', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\386\>\n<tbody>\n<tr>\n<td>Plant poison</td>\n<td>Common name</td>\n</tr>\n<tr>\n<td>Conium maculatum</td>\n<td>Poison hemlock</td>\n</tr>\n<tr>\n<td>Digitalis purpurea</td>\n<td>Foxglove</td>\n</tr>\n<tr>\n<td>Nerium odorum</td>\n<td>White oleander</td>\n</tr>\n<tr>\n<td>Ricinus communis</td>\n<td>Castor bean</td>\n</tr>\n<tr>\n<td>Abrus precatorius</td>\n<td>Rosary pea</td>\n</tr>\n<tr>\n<td>Aconite</td>\n<td>Monks hood</td>\n</tr>\n<tr>\n<td>Atropa belladona</td>\n<td>Deadly nightshade</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1245, 'Forensic Medicine', 'PM2103. Phosphorus poisoning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\476\>\n<tbody>\n<tr>\n<td>Features</td>\n<td>\n<p>Phosphorus</p>\n</td>\n</tr>\n<tr>\n<td>Chemistry</td>\n<td>\n<p>2 forms - White and Red Phosphorus</p>\n<p>White Phosphorus is toxic, Red Phosphorus is not.</p>\n</td>\n</tr>\n<tr>\n<td>Mechanism of action</td>\n<td>Protoplasmic irritant poison</td>\n</tr>\n<tr>\n<td>Organs affected</td>\n<td>\n<p>Liver</p>\n<p>Bone</p>\n<p>Kidneys</p>\n</td>\n</tr>\n<tr>\n<td>Characteristic clinical findings</td>\n<td>\n<p>Smoky stool syndrome</p>\n<p>Luminescent stools</p>\n<p>Garlicky odor</p>\n<p>Liver necrosis</p>\n<p>Phossy jaw</p>\n</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>\n<p>Symptomatic therapy</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1246, 'Forensic Medicine', 'PM2101. Lead Poisoning/Plumbism/Saturnism', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Lead Toxicity</strong></td>\n</tr>\n<tr>\n<td>Source of exposure</td>\n<td>\n<p>Occupational exposure</p>\n<p>Lead paint</p>\n</td>\n</tr>\n<tr>\n<td>Route of absorption</td>\n<td>\n<p>Children - GI tract</p>\n<p>Adults - Respiratory tract</p>\n</td>\n</tr>\n<tr>\n<td>Mechanism of action</td>\n<td>\n<ul>\n<li>Binds to sulfhydryl groups and inhibits\n<ul>\n<li>ALA dehydratase</li>\n<li>Ferrochelatase</li>\n</ul>\n</li>\n<li>Inhibits pyrimidine 5 nucleotidase</li>\n<li>Competes with <strong>calcium</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Organs affected <strong>(acute</strong> toxicity)</td>\n<td>\n<p>GI tract, Bone marrow, Peripheral nerves</p>\n</td>\n</tr>\n<tr>\n<td>Organs affected <strong>(chronic</strong> toxicity)</td>\n<td>\n<p>CNS, Kidney</p>\n</td>\n</tr>\n<tr>\n<td>Characteristic clinical findings</td>\n<td>\n<p><strong>A - </strong>Anemia with basophilic stippling</p>\n<p><strong>B - </strong>Burtonian line (blue stippled line on gums)</p>\n<p><strong>C - </strong>Constipation and colic (abdominal pain)</p>\n<p><strong>D - </strong>Drop (wrist and foot drop) due to neuropathy</p>\n<p><strong>E - </strong>Encephalopathy-&nbsp;<strong>Mostly seen in infants</strong> presenting with severe ataxia, vomiting, lethargy, stupor, convulsions, and coma</p>\n<p><strong>F - Facial pallor (Earliest sign)</strong></p>\n</td>\n</tr>\n<tr>\n<td>Diagnosis</td>\n<td>Blood lead levels</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>Calcium EDTA; succimer(DMSA)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1247, 'Forensic Medicine', 'PM2100. Mercury Poisoning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Features</td>\n<td>\n<p>Mercury</p>\n</td>\n</tr>\n<tr>\n<td>Source of exposure</td>\n<td>\n<p>Thermometers (elemental mercury)</p>\n<p>Industries (inorganic mercury)</p>\n<p>Fish (organic mercury)&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Route of absorption</td>\n<td>\n<p>Elemental - Respiratory tract (negligible through GI unless the mucosa is damaged)&nbsp;</p>\n<p>Inorganic - GI tract</p>\n<p>Organic - GI tract</p>\n</td>\n</tr>\n<tr>\n<td>Mechanism of action</td>\n<td>\n<p>binds to sulhydryl groups of enzymes and affects</p>\n<ul>\n<li>glutathione metabolism</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Organs affected (acute toxicity)</td>\n<td>\n<p>Respiratory tract (elemental mercury)</p>\n<p>GI tract (inorganic mercury)</p>\n<p>Respiratory + GI tract (organic mercury)</p>\n</td>\n</tr>\n<tr>\n<td>Organs affected (chronic toxicity)</td>\n<td>\n<p>CNS, Renal (elemental mercury)</p>\n<p>Renal (inorganic mercury)</p>\n<p>CNS (organic mercury)</p>\n</td>\n</tr>\n<tr>\n<td>Characteristic clinical findings</td>\n<td>\n<p>&nbsp;</p>\n<p><strong>Mnemonic: MEATS</strong></p>\n<p><strong>M</strong> -</p>\n<ul>\n<li>Mercuria lentis</li>\n<li>Membranous colitis (diphtheria like)</li>\n<li>Minimata disease</li>\n<li>Membranous glomerulopathy</li>\n</ul>\n<p><strong>E-</strong>Erethism (personality disturbance, insomnia, and loss of memory)</p>\n<p><strong>A</strong>-Acrodynia (Pink disease)</p>\n<p><strong>T-</strong>Tremors (Coarse tremors) - Include Danbury tremors, hatter’s or Glass blower’s shakes</p>\n<p><strong>S-</strong>Salivation (excessive salivation)</p>\n</td>\n</tr>\n<tr>\n<td>Diagnosis</td>\n<td>Blood and/or 24 hour urine mercury level</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>BAL; succimer(DMSA)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1248, 'Forensic Medicine', 'PM2099. Arsenic poisoning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Summary of Arsenic poisoning</p>\n<p><strong>Source of exposure</strong>:&nbsp;Arsenic-containing pesticides, natural sources - drinking water and soil</p>\n<p><strong>Route of absorption</strong>:&nbsp;GI tract</p>\n<p><strong>Mechanism of action</strong>:&nbsp;binds to sulfhydryl groups and inhibits pyruvate dehydrogenase, gluconeogenesis, glutathione metabolism</p>\n<p>Characteristic clinical findings are as follows: Mnemonic-ARSENIC</p>\n<p><strong>A-&nbsp;</strong>Aldrich mees lines</p>\n<p><strong>R-&nbsp;</strong>raindrop pigmentation, rash,&nbsp;red velvety mucosa</p>\n<p><strong>S-&nbsp;</strong>subendocardial haemorrhage</p>\n<p><strong>E-&nbsp;</strong>Excessive pigmentation- Blackfoot&nbsp;disease</p>\n<p><strong>N-&nbsp;</strong>Neuritis</p>\n<p><strong>I-&nbsp;</strong>Iron oxide + BAL –treatment</p>\n<p><strong>C-&nbsp;</strong>Cholera like illness</p>\n<p><strong>Diagnosis</strong>:&nbsp;24-hour urine arsenic</p>\n<p><strong>Treatment</strong>:&nbsp;BAL; succimer(DMSA)</p>\n<p>Clinicopathological findings in acute and chronic arsenic poisoning:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>System</strong></p>\n</td>\n<td>\n<p><strong>Acute</strong></p>\n</td>\n<td>\n<p><strong>Chronic</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Skin</p>\n</td>\n<td>\n<p>Delayed hair loss (alopecia)</p>\n</td>\n<td>\n<p>Melanosis, Bowen’s disease facial edema, hyperkeratosis, cutaneous cancer, hyperpigmentation.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nails</p>\n</td>\n<td>\n<p>Mees’s lines in 2-3 weeks post ingestion.</p>\n</td>\n<td>\n<p><strong>Mees lines</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neurologic</p>\n</td>\n<td>\n<p>Hyperpyrexia, convulsions, tremors, coma</p>\n</td>\n<td>\n<p>Encephalopathy, polyneuropathy, tremors, axonal degeneration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GI tract</p>\n</td>\n<td>\n<p>Abdominal pain, dysphagia, vomiting, bloody or rice water diarrhea, mucosal erosions.</p>\n</td>\n<td>\n<p>Nausea, vomiting, diarrhea, anorexia, weight loss</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Liver</p>\n</td>\n<td>\n<p>Fatty infiltration</p>\n</td>\n<td>\n<p>Hepatomegaly, jaundice, cirrhosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kidney</p>\n</td>\n<td>\n<p>Tubular and glomerular changes – oliguria and uremia</p>\n</td>\n<td>\n<p>Nephritic finding</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Haemetologic</p>\n</td>\n<td>\n<p>thrombocytopenia, impaired folate metabolism</p>\n</td>\n<td>\n<p>Bone marrow hypoplasia, anemia, leukopenia, basophilic stippling, and karyorrhexis.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cardiovascular</p>\n</td>\n<td>\n<ul>\n<li>S-T wave abnormalities,</li>\n<li>prolonged QT interval</li>\n<li>ventricular fibrillation</li>\n<li>atypical ventricular tachycardia&nbsp;</li>\n</ul>\n</td>\n<td>\n<p>There is platelet activation and hypercoagulability of blood in peripheral arteries leading to blackfoot disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reproductive system</p>\n</td>\n<td>\n<p>Maternal ingestion of inorganic</p>\n<p>Arsenic crosses the placental barrier and infant death shortly after birth.</p>\n</td>\n<td>\n<p>-Nil-</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1249, 'Forensic Medicine', 'PM2094. Poisoning - Modalities of General Management', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;Management</td>\n<td>Examples</td>\n</tr>\n<tr>\n<td>Gastrointestinal decontamination</td>\n<td>\n<p>Orogastric Lavage</p>\n<p>Activated Charcoal</p>\n<p>Whole Bowel Irrigation</p>\n</td>\n</tr>\n<tr>\n<td>Enhanced elimination</td>\n<td>\n<p>Multidose activated charcoal</p>\n<p>Urinary alkalinization</p>\n<p>Extracorporeal removal(Hemodialysis, Hemoperfusion)</p>\n</td>\n</tr>\n<tr>\n<td>Administration of antidote</td>\n<td>\n<p>Mechanical Antidotes</p>\n<p>Chemical Antidotes</p>\n<p>Physiological Antidotes</p>\n<p>Pharmacological Antidotes</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1250, 'Forensic Medicine', 'PM0900. Signs and Symptoms of Strychnine Poisoning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The clinical features of&nbsp;strychnine poisoning are:</p>\n<ul>\n<li>Convulsions - clonic-tonic type</li>\n<li>Reflex increased</li>\n<li>Awful taste</li>\n<li>Mind is conscious</li>\n<li>Pupils dilated</li>\n<li>Opisthotonos: arching back</li>\n<li>Emprosthotonos: arching forward</li>\n<li>Pleurothotonus: bending sideward</li>\n<li>Risus Sardonicus&nbsp;-<strong>&nbsp;</strong>fixed contraction of the facial muscles resulting in a peculiar distorted grin.</li>\n</ul>\n<p>Strychnine poisoning case may resemble tetanus.</p>\n<p>Although a poison, in relatively low doses it can be used as a medical stimulant for respiration.</p>\n<p><strong>Strychnine plant</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d8690926df9547d79adc83295934d6b3x615x600.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Strychnine seeds</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5af4813b6ca74316a15d06f04cfd67b6x1280x910.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1251, 'Forensic Medicine', 'PM0899. Toxic manifestations of Datura', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Mnemonic: \hot as a hare, blind as a bat, dry as a bone, red as a beet, and mad as a hatter\</li>\n<li>Also, remember <strong>the Ds of Datura</strong>\n<ul>\n<li><strong>D</strong>ry hot skin (Temp rises upto 42 C, a scarlet rash may also be appreciated).</li>\n<li><strong>D</strong>ilatation of pupils along with loss of accommodation</li>\n<li><strong>D</strong>iplopia</li>\n<li><strong>D</strong>ryness of the mouth and throat, unquenchable thirst</li>\n<li><strong>D</strong>ysphagia</li>\n<li><strong>D</strong>ilatation of cutaneous blood vessels</li>\n<li><strong>D</strong>ysarthria (Difficulty in talking)</li>\n<li><strong>D</strong>runken gait</li>\n<li><strong>D</strong>elirium</li>\n<li><strong>D</strong>rowsiness</li>\n<li><strong>D</strong>eath due to respiratory or cardiac failure</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1252, 'Forensic Medicine', 'PM0898. Difference between Poisonous and Non- Poisonous Snakes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\495\>\n<tbody>\n<tr>\n<td width=\165\>\n<p>&nbsp;</p>\n</td>\n<td width=\165\>\n<p><strong>Poisonous snake</strong></p>\n</td>\n<td width=\165\>\n<p><strong>Non poisonous snake</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\165\>\n<p>Belly scales</p>\n</td>\n<td width=\165\>\n<p><strong>Large and it covers the entire belly</strong></p>\n</td>\n<td width=\165\>\n<p>Small and do not cover the entire belly</p>\n</td>\n</tr>\n<tr>\n<td width=\165\>\n<p>Head scales</p>\n</td>\n<td width=\165\>\n<p><strong>Small</strong></p>\n</td>\n<td width=\165\>\n<p>Large</p>\n</td>\n</tr>\n<tr>\n<td width=\165\>\n<p>Fang</p>\n</td>\n<td width=\165\>\n<p>Long and canalised</p>\n</td>\n<td width=\165\>\n<p>Short and solid</p>\n</td>\n</tr>\n<tr>\n<td width=\165\>\n<p>Tail</p>\n</td>\n<td width=\165\>\n<p><strong>Compressed </strong></p>\n</td>\n<td width=\165\>\n<p>Not markedly compressed</p>\n</td>\n</tr>\n<tr>\n<td width=\165\>\n<p>Habits</p>\n</td>\n<td width=\165\>\n<p><strong>Nocturnal</strong></p>\n</td>\n<td width=\165\>\n<p>Not so</p>\n</td>\n</tr>\n<tr>\n<td width=\165\>\n<p>Bite</p>\n</td>\n<td width=\165\>\n<p><strong>Two fang marks</strong></p>\n</td>\n<td width=\165\>\n<p>A number of small teeth marks in a row</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6cab6f8345e14069980e9050a74e2923x448x480.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a0406e65d06544ef8873500c09037370x472x480.PNG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1253, 'Forensic Medicine', 'PM0895. Cardiac Poisons', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Mnemonic: Don has a queen</strong>.\n<ul>\n<li><strong>D</strong><em> -</em>Digitalis</li>\n<li><strong>O</strong> -Oleander</li>\n<li><strong>N </strong>-Nicotine</li>\n<li><strong>Has</strong> -Hydrocyanic acid</li>\n<li><strong>A </strong>-Aconite</li>\n<li><strong>Queen</strong> –Quinine</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1254, 'Forensic Medicine', 'PM0892. Presentation of Plumbism/Saturnism/Chronic Lead Poisoning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Mnemonic-ABCDEF</strong></p>\n<ul>\n<li><strong>A - </strong>Anemia with basophilic stippling</li>\n<li><strong>B - </strong>Burtonian line (blue stippled line on gums)</li>\n<li><strong>C - </strong>Constipation and colic (abdominal pain)</li>\n<li><strong>D - </strong>Drop (wrist and foot drop) due to neuropathy</li>\n<li><strong>E - </strong>Encephalopathy (<strong>Mostly seen in infants</strong> presenting with severe ataxia, vomiting, lethargy, stupor, convulsions, and coma)</li>\n<li><strong>F - </strong>Facial pallor <strong>(Earliest sign)</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1255, 'Forensic Medicine', 'PM0891. Clinical presentations of Mercury Poisoning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Mnemonic: MEATS</strong></p>\n<ul>\n<li>M - Mercuria lentis\n<ul>\n<li>Membranous colitis (diphtheria like)</li>\n<li>Minimata disease</li>\n<li>Membranous glomerulopathy</li>\n</ul>\n</li>\n<li><strong>E-</strong>Erethism (personality disturbance, insomnia, and loss of memory)</li>\n<li><strong>A</strong>-Acrodynia (Pink disease)</li>\n<li><strong>T-</strong>Tremors (Coarse tremors)\n<ul>\n<li>Also called Danbury tremors, hatter’s Or Glass blower’s shakes</li>\n</ul>\n</li>\n<li><strong>S-</strong>Salivation (excessive salivation)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1256, 'Forensic Medicine', 'PM0890. Typical appearance of Stomach Mucosa in some Poisoning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong> Poison</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Appearance of Gastric Mucosa</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>Arsenic</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Red velvety mucosa</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>H2SO4</p>\n</td>\n<td width=\231\>\n<p>Brown or black with erosion perforation and Carbolization</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Carbolic acid</p>\n</td>\n<td width=\231\>\n<p>Grey leathery and thickened mucosa</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>HNO3</p>\n</td>\n<td width=\231\>\n<p>Yellow</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>HCN</p>\n</td>\n<td width=\231\>\n<p>Pink</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>KCN</p>\n</td>\n<td width=\231\>\n<p>Brick red to brown</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Phosphorous</p>\n</td>\n<td width=\231\>\n<p>Yellow or grey white</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1257, 'Forensic Medicine', 'PM0889. Clinicopathological findings in Acute and Chronic Arsenic Poisoning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\154\>\n<p><strong>System</strong></p>\n</td>\n<td width=\154\>\n<p><strong>Acute</strong></p>\n</td>\n<td width=\154\>\n<p><strong>Chronic</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Skin</p>\n</td>\n<td width=\154\>\n<p>Delayed hair loss (alopecia)</p>\n</td>\n<td width=\154\>\n<p>Melanosis, Bowen’s disease facial edema, hyperkeratosis, cutaneous cancer, hyperpigmentation.</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Nails</p>\n</td>\n<td width=\154\>\n<p>Mees’s lines in 2-3 weeks post ingestion.</p>\n</td>\n<td width=\154\>\n<p><strong>Mees lines</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Neurologic</p>\n</td>\n<td width=\154\>\n<p>Hyperpyrexia, convulsions, tremors, coma</p>\n</td>\n<td width=\154\>\n<p>Encephalopathy, polyneuropathy, tremors, axonal degeneration</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>GI tract</p>\n</td>\n<td width=\154\>\n<p>Abdominal pain, dysphagia, vomiting, bloody or rice water diarrhea, mucosal erosions.</p>\n</td>\n<td width=\154\>\n<p>Nausea, vomiting, diarrhea, anorexia, weight loss</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Liver</p>\n</td>\n<td width=\154\>\n<p>Fatty infiltration</p>\n</td>\n<td width=\154\>\n<p>Hepatomegaly, jaundice, cirrhosis</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Kidney</p>\n</td>\n<td width=\154\>\n<p>Tubular and glomerular changes – oliguria and uremia</p>\n</td>\n<td width=\154\>\n<p>Nephritic finding</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Haemetologic</p>\n</td>\n<td width=\154\>\n<p>thrombocytopenia, impaired folate metabolism</p>\n</td>\n<td width=\154\>\n<p>Bone marrow hypoplasia, anemia, leukopenia, basophilic stippling, and karyorrhexis.</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Cardiovascular</p>\n</td>\n<td width=\154\>\n<p>Heart will show S-T wave abnormalities, prolonged QT interval, ventricular fibrillation, atypical ventricular tachycardia with humic acid in Southwest coast of Taiwan</p>\n</td>\n<td width=\154\>\n<p><strong>Blackfoot disease due to platelet activation and hypercoagulability of blood in peripheral arteries </strong>is observed in endemic areas of arsenicism,</p>\n</td>\n</tr>\n<tr>\n<td width=\154\>\n<p>Reproductive system</p>\n</td>\n<td width=\154\>\n<p>Maternal ingestion of inorganic</p>\n<p>Arsenic crosses the placental barrier and infant death shortly after birth.</p>\n</td>\n<td width=\154\>\n<p>-Nil-</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1258, 'Forensic Medicine', 'PM0888. Clinical features of Arsenic Poisoning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Mnemonic-ARSENIC</strong>\n<ul>\n<li><strong>A-</strong>Aldrich mees lines</li>\n<li><strong>R-</strong>rain drop pigmentation, rash<strong>,</strong> red velvety mucosa</li>\n<li><strong>S-</strong>sub endocardial hemorrhage</li>\n<li><strong>E-</strong>Excessive pigmentation</li>\n<li><strong>N-</strong>Neuritis</li>\n<li><strong>I-</strong>Iron oxide + BAL –treatment</li>\n<li><strong>C-</strong>mimics cholera</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1259, 'Forensic Medicine', 'PM0883. Characteristic Odor of Toxins', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\ width=\388\>\n<tbody>\n<tr>\n<td width=\169\>\n<p><span><strong>Odor</strong></span></p>\n</td>\n<td width=\169\>\n<p><span><strong>Toxins</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Garlic odor</span></p>\n<p><span>&nbsp;</span></p>\n</td>\n<td>\n<p><span>Arsenic, phosphorous, malathion, thallium carbonate</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Odorless</span></p>\n</td>\n<td>\n<p><span>Thallium sulfate (most common),&nbsp;thallium oxide</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Garlic odor or rotten fish</span></p>\n</td>\n<td>\n<p><span>Zinc phosphide</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Odor of burnt rope</span></p>\n</td>\n<td>\n<p><span>Cannabis</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Phenolic odor</span></p>\n</td>\n<td>\n<p><span>Carbolic acid</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Smell of bitter almonds</span></td>\n<td><span>Cyanide</span></td>\n</tr>\n<tr>\n<td><span>Fruity odor</span></td>\n<td><span>Ethyl alcohol</span></td>\n</tr>\n<tr>\n<td><span>Rotten egg</span></td>\n<td><span>Hydrogen sulphide</span></td>\n</tr>\n<tr>\n<td><span>Smell of kerosene</span></td>\n<td><span>Organophosphorous</span></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1260, 'Forensic Medicine', 'PM0882. Urine Color caused by certain Toxins', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Urine colours</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Causes</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>Olive green colour urine on standing</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Carbolic acid</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Grey-black</p>\n</td>\n<td width=\231\>\n<p>Phenols, cresols</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Opaque appearance which settles on standing</p>\n</td>\n<td width=\231\>\n<p>Primidone crystals</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Orange or orange-red</p>\n</td>\n<td width=\231\>\n<p>Rifampicin, iron (especially after giving desferrioxamine)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1261, 'Forensic Medicine', 'PM0871. Cannabis Forms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Bhang:&nbsp;</strong>Decoction prepared from dried leaves and fruit shoot</li>\n<li><strong>Majoon:</strong>&nbsp;Sweet prepared from bhang</li>\n<li><strong>Ganja:</strong>&nbsp;Prepared from flower tops of female plant and smoked</li>\n<li><strong>Charas:</strong>&nbsp;Most potent; resin exudate from leaves and stems thats smoked</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1262, 'Forensic Medicine', 'PM0868. Drugs used in Organophosphorus Poisoning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Symptoms</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Drug used for treatment</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Muscarinic symptoms and CNS effects</p>\n</td>\n<td width=\231\>Atropine</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Nicotinic symptoms</p>\n</td>\n<td width=\231\>Pralidoxime</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Nicotinic &gt;muscarinic and CNS effects</p>\n</td>\n<td width=\231\>Diacetyl monoxime-specific cholinesterase reactivator</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Convulsions</p>\n</td>\n<td width=\231\>IV diazepam</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Pulmonary oedema, bronchospasm</p>\n</td>\n<td width=\231\>Oxygen, atropine, intubation, positive pressure ventilation</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1263, 'Forensic Medicine', 'PM0864. List of Hard and Soft Drugs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Hard drugs</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Soft drugs </strong>(ABCD)</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p><strong>Opium</strong></p>\n<p><strong>Heroin</strong></p>\n<p><strong>Cocaine</strong></p>\n<p>Methedrine</p>\n</td>\n<td width=\231\>\n<p>Amphetamine</p>\n<p>Barbiturates</p>\n<p><strong>Cannabis</strong></p>\n<p>LSD</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1264, 'Forensic Medicine', 'PM0863. Difference between Drug Addiction and Drug Habituation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Traits</strong></p>\n</td>\n<td>\n<p><strong>Drug addiction </strong></p>\n</td>\n<td>\n<p><strong>Drug habituation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Dependence </strong></p>\n</td>\n<td>\n<p>Psychological and physical</p>\n</td>\n<td>\n<p><strong>Some degree of psychological but no physical</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Compulsion</p>\n</td>\n<td>\n<p>Present</p>\n</td>\n<td>\n<p>Desire present but no compulsion</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dose</p>\n</td>\n<td>\n<p>Tendency to increase</p>\n</td>\n<td>\n<p>No tendency to increase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Withdrawal symptoms</p>\n</td>\n<td>\n<p>Characteristic withdrawal symptoms present</p>\n</td>\n<td>\n<p>None or Mild withdrawal symptoms</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Harm</p>\n</td>\n<td>\n<p>Both to individual and society</p>\n</td>\n<td>\n<p>If any primarily to the individual</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1265, 'Forensic Medicine', 'PM0862. Contraindications of Pharmacological Antidote', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\231\>\n<p><strong>Pharmacological antidote</strong></p>\n</td>\n<td width=\231\>\n<p><strong>Contraindicated in</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>BAL</p>\n</td>\n<td width=\231\>\n<p>Liver damage</p>\n<p>G6PD deficient patient</p>\n<p>Iron and cadmium toxicity</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>EDTA</p>\n</td>\n<td width=\231\>\n<p>Mercury</p>\n</td>\n</tr>\n<tr>\n<td width=\231\>\n<p>Pencillamine</p>\n</td>\n<td width=\231\>\n<p>Arsenic</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1266, 'Forensic Medicine', 'PM0859. Classification of Poisons', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\342\>\n<tbody>\n<tr>\n<td><strong>Corrosives</strong></td>\n<td>Examples</td>\n</tr>\n<tr>\n<td>Inorganic acids</td>\n<td>\n<p>Sulphuric acid</p>\n<p>Nitric acid</p>\n</td>\n</tr>\n<tr>\n<td>Organic acids</td>\n<td>\n<p>Carbolic acid</p>\n<p>Oxalic acid</p>\n</td>\n</tr>\n<tr>\n<td>Alkalies</td>\n<td>\n<p>Sodium hydroxide</p>\n<p>Potassium carbonate</p>\n<p>Ammonia</p>\n</td>\n</tr>\n<tr>\n<td>Metallic salts</td>\n<td>\n<p>Zinc chloride</p>\n<p>Copper sulphate</p>\n<p>Silver nitrate</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Irritants</strong></td>\n<td>Examples</td>\n</tr>\n<tr>\n<td>Inorganic - Metallic</td>\n<td>\n<p>Lead</p>\n<p>Copper</p>\n<p>Arsenic</p>\n</td>\n</tr>\n<tr>\n<td>Inorganic - Non-metallic</td>\n<td>\n<p>Phosphorus</p>\n<p>Halogens</p>\n</td>\n</tr>\n<tr>\n<td>Organic - Vegetable</td>\n<td>\n<p>Abrus</p>\n<p>Croton</p>\n<p>Castor</p>\n</td>\n</tr>\n<tr>\n<td>Organic - Animal</td>\n<td>\n<p>Snake venom</p>\n<p>Insect bites</p>\n</td>\n</tr>\n<tr>\n<td>Mechanical</td>\n<td>\n<p>Diamond dust</p>\n<p>Glass powder</p>\n<p>Pins</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table width=\365\>\n<tbody>\n<tr>\n<td><strong>Systemic Poisons</strong></td>\n<td>Examples</td>\n</tr>\n<tr>\n<td>CNS- Somniferous</td>\n<td>Opiates</td>\n</tr>\n<tr>\n<td>CNS- Inebriants</td>\n<td>\n<p>Alcohol</p>\n<p>Sedatives, Hypnotics</p>\n</td>\n</tr>\n<tr>\n<td>CNS- Deliriants</td>\n<td>\n<p>Datura</p>\n<p>Cannabis</p>\n<p>Cocaine</p>\n</td>\n</tr>\n<tr>\n<td>CNS - Spinal</td>\n<td>\n<p>Strychnine</p>\n<p>Gelsemium</p>\n</td>\n</tr>\n<tr>\n<td>Peripheral</td>\n<td>\n<p>Curare</p>\n<p>Conium maculatum</p>\n</td>\n</tr>\n<tr>\n<td>Cardiovascular</td>\n<td>\n<p>Oleander</p>\n<p>Aconite</p>\n</td>\n</tr>\n<tr>\n<td>Asphyxiants</td>\n<td>\n<p>Carbon monoxide</p>\n<p>Cyanogen gas</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1267, 'Forensic Medicine', 'PM0648. Specific antidotes for poisoning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>ANTIDOTE</strong></td>\n<td><strong>POISONING</strong></td>\n</tr>\n<tr>\n<td><strong>4-methyl pyrazole</strong></td>\n<td>Methanol and ethylene glycol</td>\n</tr>\n<tr>\n<td><strong>100% oxygen </strong></td>\n<td>Carbon monoxide, cyanide, methemoglobinemia</td>\n</tr>\n<tr>\n<td><strong>Ammonium chloride </strong></td>\n<td>Phencyclidine, amphetamine</td>\n</tr>\n<tr>\n<td><strong>Amyl nitrate </strong></td>\n<td>Cyanide, hydrogen sulphide</td>\n</tr>\n<tr>\n<td><strong>Atropine</strong></td>\n<td>Carbamate and organophosphorus poisoning</td>\n</tr>\n<tr>\n<td><strong>Bupropion</strong></td>\n<td>Nicotine</td>\n</tr>\n<tr>\n<td><strong>Calcium disodium edetate</strong></td>\n<td>Cadmium, chromium, cobalt, copper, lead, magnesium, nickel, uranium, zinc</td>\n</tr>\n<tr>\n<td><strong>Calcium gluconate </strong></td>\n<td>Precipitates fluorides, magnesium and oxalates</td>\n</tr>\n<tr>\n<td><strong>Chlorpromazine</strong></td>\n<td>Amphetamine</td>\n</tr>\n<tr>\n<td><strong>Deferoxamine</strong></td>\n<td>Iron, aluminium</td>\n</tr>\n<tr>\n<td><strong>Diazepam</strong></td>\n<td>Amphetamine, chloroquine, alcohol withdrawal</td>\n</tr>\n<tr>\n<td><strong>Dicobalt edetate</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Dimercaprol (BAL)</strong></td>\n<td>Antimony, arsenic, copper, lead, mercury, nickel and gold</td>\n</tr>\n<tr>\n<td><strong>Diphenhydramine</strong></td>\n<td>Phenothiazines and related drugs</td>\n</tr>\n<tr>\n<td><strong>Disodium calcium edetate</strong></td>\n<td><strong>&nbsp;</strong>Lead</td>\n</tr>\n<tr>\n<td><strong>DMPS *, (Unithiol)</strong></td>\n<td><strong>&nbsp;</strong>Mercury</td>\n</tr>\n<tr>\n<td><strong>DMSA ** </strong></td>\n<td><strong>&nbsp;</strong>Lead</td>\n</tr>\n<tr>\n<td><strong>D-Penicillamine (Cuprimine) </strong></td>\n<td>Copper, lead, mercury, chromate, nickel, zinc, arsenic</td>\n</tr>\n<tr>\n<td><strong>Ethanol</strong></td>\n<td>Methanol and ethylene glycol</td>\n</tr>\n<tr>\n<td><strong>Fab fragment</strong></td>\n<td>Digoxin, digitoxin, oleander tea</td>\n</tr>\n<tr>\n<td><strong>Flumazenil</strong></td>\n<td>Benzodiazepine</td>\n</tr>\n<tr>\n<td><strong>Glucagon</strong></td>\n<td>Propranolol and other beta-blockers toxicity</td>\n</tr>\n<tr>\n<td><strong>Hydroxocobalamin</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Labetalol hydrochloride</strong></td>\n<td>Hypertensive crisis due to cocaine</td>\n</tr>\n<tr>\n<td><strong>Methionine</strong></td>\n<td>Paracetamol</td>\n</tr>\n<tr>\n<td><strong>Methylene blue</strong></td>\n<td>Methemoglobinemia</td>\n</tr>\n<tr>\n<td><strong>N-acetylcysteine </strong></td>\n<td>Paracetamol, acetaminophen toxicity</td>\n</tr>\n<tr>\n<td><strong>Nalorphine</strong></td>\n<td>Morphine</td>\n</tr>\n<tr>\n<td><strong>Naloxone (Naltrexone)</strong></td>\n<td>Narcotic, opiates, CNS depressants</td>\n</tr>\n<tr>\n<td><strong>Nicotinamide</strong></td>\n<td>Vacor poisoning, phenylurea pesticide toxicity</td>\n</tr>\n<tr>\n<td><strong>Pancuronium bromide</strong></td>\n<td>Neuromuscular blocking agents</td>\n</tr>\n<tr>\n<td><strong>Penicillamine</strong></td>\n<td>Copper</td>\n</tr>\n<tr>\n<td><strong>Physostigmine salicylate </strong></td>\n<td>Coma, convulsions from anticholinergics</td>\n</tr>\n<tr>\n<td><strong>Pralidoxime (2-PAM) </strong></td>\n<td>Organophosphorus insecticides, nerve agents</td>\n</tr>\n<tr>\n<td><strong>Propranolol</strong></td>\n<td>Cocaine intoxication, beta adrenergics</td>\n</tr>\n<tr>\n<td><strong>Protamine sulphate </strong></td>\n<td>Heparin overdose</td>\n</tr>\n<tr>\n<td><strong>Prussian blue</strong></td>\n<td>Thallium</td>\n</tr>\n<tr>\n<td><strong>Pyridoxine (Vit. B6) </strong></td>\n<td>Isoniazid, hydrazine toxicity</td>\n</tr>\n<tr>\n<td><strong>Sodium bicarbonate </strong></td>\n<td>Urinary alkalinisation for salicylates, phenobarbital</td>\n</tr>\n<tr>\n<td><strong>Sodium nitrite</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Sodium thiosulphate</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Vitamin K</strong></td>\n<td>Warfarin</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1268, 'Psychiatry,', 'PM0647. Specific effects of substance abuse', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Substance</strong></td>\n<td>\n<p>Associations</p>\n</td>\n</tr>\n<tr>\n<td><strong>Cocaine </strong></td>\n<td>\n<p>Magnan syndrome (cocaine bugs or tactile hallucinations)</p>\n<p>Mini packers syndrome</p>\n</td>\n</tr>\n<tr>\n<td><strong>Phencyclidine</strong></td>\n<td>Dissociative anaesthesia (Angel dust)</td>\n</tr>\n<tr>\n<td><strong>LSD</strong></td>\n<td>Bad trips, Flashbacks</td>\n</tr>\n<tr>\n<td><strong>Amphetamine</strong></td>\n<td>Paranoid hallucinatory syndrome</td>\n</tr>\n<tr>\n<td><strong>Alcohol&nbsp; </strong></td>\n<td>Mc Ewan’s sign, Morbid jealousy</td>\n</tr>\n<tr>\n<td><strong>Cannabis </strong></td>\n<td>Amotivational syndrome, Run amok</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1269, 'Forensic Medicine', 'PM0643. Certain specific clinical features diagnostic of poisons and poisoning', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Clinical features</strong></td>\n<td><strong>Possible causes</strong></td>\n</tr>\n<tr>\n<td>Pupillary constriction (Miosis)</td>\n<td>Barbiturates, caffeine, carbamates, carbolic acid (phenol), clonidine, methyl dopa, nicotine, opiates, organophosphates, parasympathomimetics.</td>\n</tr>\n<tr>\n<td>Pupillary dilatation (Mydriasis)</td>\n<td>Alcohol (constricted in coma), amphetamines, antihistamines, benzodiazepines, carbon monoxide, cocaine, cyanide, datura (atropine), ephedrine</td>\n</tr>\n<tr>\n<td><strong>Hippus (alternate constriction and dilatation of pupils)</strong></td>\n<td><strong>Aconite, alcohol, barbiturates.</strong></td>\n</tr>\n<tr>\n<td>Nystagmus</td>\n<td>Alcohol, barbiturates, carbamazepine, phencyclidine, phenytoin</td>\n</tr>\n<tr>\n<td>Pinpoint pupils, and reduced respiratory rate</td>\n<td>Opioids, cholinesterase inhibitors (organophosphorus or carbamate insecticides), clonidine, phenothiazines, Pontine hemorrhage</td>\n</tr>\n<tr>\n<td>Cyanosis</td>\n<td>Any CNS depressant or agent causing methemoglobinemia</td>\n</tr>\n<tr>\n<td>Needle tracks, pinpoint pupils, and reduced respiratory rate</td>\n<td>IV Opioids</td>\n</tr>\n<tr>\n<td>Dilated pupils or mid-point pupils, and reduced respiratory rate</td>\n<td>Benzodiazepines</td>\n</tr>\n<tr>\n<td>Dilated pupils, tachycardia</td>\n<td>\n<ul>\n<li>Tricyclic antidepressants – dry mouth, warm peripheries, may also be twitchy or have seizures</li>\n<li>Amphetamines, ecstasy, cocaine – may also be hallucinating or agitated</li>\n<li>Anticholinergic drugs such as benzhexol, benztropine – may also have hyperreflexia and myoclonus</li>\n<li>Antihistamines – may also be drowsy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Increased salivation</td>\n<td>Organophosphorus or carbamate insecticides</td>\n</tr>\n<tr>\n<td>\n<p>Hypothermia</p>\n<p>&nbsp;</p>\n</td>\n<td>Lithium, tricyclic antidepressants, anticholinergics, antihistamines</td>\n</tr>\n<tr>\n<td>\n<p>Hyperthermia</p>\n</td>\n<td>\n<ul>\n<li>Amphetamines, ecstasy, cocaine (also hypertension, tachycardia, agitation, rhabdomyolysis)</li>\n<li>Neuroleptic malignant syndrome (also confusion, fluctuating consciousness, rigidity, tremor, autonomic instability, sweating, rhabdomyolysis)</li>\n<li>Serotonin syndrome (also agitation, clonus, tremor, hyperreflexia, sweating, tachycardia)</li>\n<li>Salicylates including aspirin (also tachycardia, metabolic acidosis, restlessness, hyperventilation)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hypertension</td>\n<td>Amphetamine, ephedrine, cocaine, clonidine, MAO inhibitors, thyroid hormones</td>\n</tr>\n<tr>\n<td>Hypotension</td>\n<td>Cyanide, alcohol, digitalis, carbon monoxide, narcotics, barbiturates</td>\n</tr>\n<tr>\n<td>Abdominal cramps, diarrhea, tachycardia, restlessness, hallucinations</td>\n<td>Withdrawal from: Alcohol, benzodiazepines, opioids</td>\n</tr>\n<tr>\n<td>Bradycardia</td>\n<td>Beta-blockers, calcium antagonists (not dihydropyridines), digoxin, opioids, organophosphorus insecticides, centrally acting alpha agonists, e.g. clonidine</td>\n</tr>\n<tr>\n<td>Seizures</td>\n<td>Tricyclic antidepressants, theophylline, antihistamines, anticonvulsants, non-steroidal drugs, phenol, phenothiazines, isoniazid, cocaine, carbon monoxide, organophosphorus insecticides, strychnine</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1270, 'Forensic Medicine,', 'PM0417. Alcohol Withdrawal Syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\115\>\n<tbody>\n<tr>\n<td>\n<div><strong>Manifestation</strong></div>\n</td>\n<td>\n<div><strong>Symptoms/signs</strong></div>\n</td>\n<td>\n<div><strong>Onset since last drink (hours)</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Tremulousness</div>\n</td>\n<td>\n<div>Continuous tremor of &gt; 8 Hz (or)&nbsp;Bursts of tremor activity &lt; 8 Hz</div>\n</td>\n<td>\n<div>6–8</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Alcoholic hallucinosis/</div>\n<div>Psychotic and perceptual symptoms</div>\n</td>\n<td>\n<div>Visual, auditory or tactile; <strong>intact orientation</strong>; stable vital signs.&nbsp;</div>\n</td>\n<td>\n<div>8-12</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Seizures&nbsp;<strong>(rum</strong> <strong>fits)</strong></div>\n</td>\n<td>\n<div>Single or multiple generalized tonic-clonic</div>\n</td>\n<td>\n<div>12–24</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Delirium tremens</div>\n</td>\n<td>\n<div>Confusion, agitation, fever, tachycardia, hypertension, diaphoresis,&nbsp;<strong>impaired orientation</strong></div>\n</td>\n<td>\n<div>&lt; 72</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1271, 'Forensic Medicine,', 'PM0416. Substances of abuse', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Substance</strong></span></div>\n</td>\n<td>\n<div><span><strong>Withdrawal symptoms</strong></span></div>\n</td>\n<td>\n<div><span><strong>Intoxication features</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Alcohol</strong></span></div>\n</td>\n<td>\n<div><span>Tremors, delirium, seizures</span></div>\n</td>\n<td>\n<div><span>Blackouts, nystagmus and slurring of speech</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>BZD</strong></span></div>\n</td>\n<td>\n<div><span>Tremors,&nbsp;insomnia, anxiety</span></div>\n</td>\n<td>\n<div><span>Lethargy and drowsiness.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Opioid/ Heroin</strong></span></div>\n</td>\n<td>\n<div><span>Diarrhea,&nbsp;yawning, mydriasis,&nbsp;lacrimation, piloerection, cold turkey phenomenon</span></div>\n</td>\n<td>\n<div><span>Euphoria, depressed mental status, miosis, respiratory depression, constipation.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Nicotine/ Tobacco</strong></span></div>\n</td>\n<td>\n<div><span>Increased appetite</span></div>\n</td>\n<td>\n<div><span>Shows a biphasic pattern.&nbsp;</span></div>\n<div><span>Early stimulatory symptoms of vomiting, hypertension and tachycardia.&nbsp;</span><span>Later depressive symptoms of hypotension and bradycardia.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Cannabis</strong></span></div>\n</td>\n<td>\n<div><span>Irritability, sweating, tremors, decreased appetite</span></div>\n</td>\n<td>\n<div><span>Increased appetite, euphoria, conjunctival injection, dry mouth,&nbsp;</span><span>panic,&nbsp;</span><span>synesthesia, impaired time perception, amotivational&nbsp;syndrome, run amok and&nbsp;</span><span>flashbacks.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Amphetamine</strong></span></div>\n</td>\n<td>\n<div><span>Depressed mood, suicidal thoughts, unpleasant dreams</span></div>\n</td>\n<td>\n<div>\n<div><span>Acute:&nbsp;</span><span>Sympathetic&nbsp;</span><span>overactivity, paranoid hallucinatory syndrome, violent behavior, psychosis and diaphoresis.</span></div>\n</div>\n<div><span>Chronic: Runs &amp; crashes, choreiform movements, tooth decay. Can resemble schizophrenia.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Cocaine</strong></span></div>\n</td>\n<td>\n<div><span>Depressed mood, suicidal thoughts</span></div>\n</td>\n<td>\n<div><span>Acute: Sympathetic overactivity, agitation, euphoria, chest pain, seizures and mydriasis</span></div>\n<div><span>Chronic: Cocaine psychosis (Magnan sign) and black pigmentation of the tongue.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>LSD/ Haluccinogen</strong></span></div>\n</td>\n<td>\n<div><span>Nothing significant</span></div>\n</td>\n<td>\n<div>\n<div><span>Synesthesia, brisk tendon reflex, t</span>achycardia, hypertension, panic, ataxia, visual hallucinations, euphoria and dysphoria.</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Phencyclidine (PCP)</strong></span></div>\n</td>\n<td>\n<div><span>Nothing significant&nbsp;</span></div>\n</td>\n<td>\n<div>Tachycardia, hypertension, ataxia, hallucinations, violent behavior, dissociation, amnesia and nystagmus.</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1272, 'Forensic Medicine', 'PM0861. Post-mortem Staining in Poisonings', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\2\>\n<tbody>\n<tr>\n<td><strong>Poisoning</strong></td>\n<td><strong>Color of lividity</strong></td>\n</tr>\n<tr>\n<td>Carbon monoxide</td>\n<td>Cherry red</td>\n</tr>\n<tr>\n<td>Cyanide</td>\n<td>Brick red or Dark pink</td>\n</tr>\n<tr>\n<td>Phosphorous, acute copper poisoning</td>\n<td>Dark brown</td>\n</tr>\n<tr>\n<td>Opium</td>\n<td>Black</td>\n</tr>\n<tr>\n<td>Hydrogen sulphide</td>\n<td>Blue-green</td>\n</tr>\n<tr>\n<td>Nitrate, nitrite, aniline, potassium chlorate</td>\n<td>Red-brown&nbsp;or chocolate brown</td>\n</tr>\n<tr>\n<td>Potassium cyanide</td>\n<td>Deep blue</td>\n</tr>\n<tr>\n<td>Clostridium perfringens infection</td>\n<td>Bronze</td>\n</tr>\n<tr>\n<td>Hypothermia</td>\n<td>Bright pink</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1273, 'Ophthalmology', 'PM1887. Visual development', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Age </strong></div>\n</td>\n<td>\n<div><strong>Visual development</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>At birth</div>\n</td>\n<td>\n<div>Fixation at light held 8–10 inches away - momentarily</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>6–8 weeks</div>\n</td>\n<td>\n<div>Fixation at light and moving objects - more steadily</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3 months</div>\n</td>\n<td>\n<div><strong>Follows</strong> moving objects</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>5–6 months</div>\n</td>\n<td>\n<div><strong>Depth perception</strong>,&nbsp;<strong>color vision</strong>, and <strong>eye–body coordination </strong></div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1274, 'Ophthalmology', 'PM1240. Extraocular Muscles and Their Actions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0bb7d5876bda4f169609e47a0090c446x1280x3287.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1275, 'Ophthalmology', 'PM1014. Grades of binocular vision', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>I - Simultaneous perception&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p>\n<ul>\n<li>Ability to see two dissimilar objects simultaneously</li>\n</ul>\n<p><strong>II - Fusion</strong></p>\n<ul>\n<li>Ability to superimpose two incomplete but similar images</li>\n</ul>\n<p><strong>III - Stereopsis</strong></p>\n<ul>\n<li>Ability to perceive depth</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/39c446b2dd13447c8f788ae592bc965dx1280x3027.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1276, 'Ophthalmology', 'PM1013. Laws governing ocular movements', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><span><strong>Sherrington’s law of Reciprocal Innervation:</strong></span></p>\n<p>During ocular motility, an increased flow of innervation to the contracting muscle is accompanied by the&nbsp;decreased flow of innervation to the relaxing antagonist muscle. For example, during <strong>dextroversion</strong>, an <strong>increased innervation flow</strong> to the <strong>right lateral rectus (LR) and left medial rectus (MR)</strong> is accompanied by <strong>decreased flow</strong> to the <strong>right MR and left LR.</strong></p>\n<p><span><strong>Herring’s Law of Equal Innervation:</strong></span></p>\n<p>According to this law, equal and simultaneous innervation flows from the brain to the contralateral synergists and contralateral antagonists. For example, <strong>during convergence</strong>, <strong>both</strong> medial recti get <strong>equal</strong> innervation.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1277, 'Ophthalmology', 'PM0843. Axes of the Eye', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Axes</strong> of the eye:&nbsp;</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td><strong>Axis&nbsp;</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td><strong>Optic Axis</strong></td>\n<td>&nbsp;Line passing through the <strong>center of the cornea and</strong>&nbsp;<strong>centre of the lens</strong>&nbsp;to meet the<strong> retina</strong> on the nasal side of the fovea.</td>\n</tr>\n<tr>\n<td><strong>Visual Axis&nbsp;</strong></td>\n<td>&nbsp;Line joining the <strong>fixation point</strong> (object),&nbsp;<strong>nodal point</strong> (centre of the&nbsp;lens), and the <strong>fovea</strong></td>\n</tr>\n<tr>\n<td><strong>Fixation Axis&nbsp;</strong></td>\n<td>&nbsp;Line joining the <strong>fixation point</strong> (object) and the <strong>centre of rotation</strong></td>\n</tr>\n</tbody>\n</table>\n<p><strong>Angles</strong> of the eye:&nbsp;</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td><strong>&nbsp;</strong></td>\n<td><strong>Visual axis</strong></td>\n<td><strong>Line of sight</strong></td>\n<td><strong>Fixation axis</strong></td>\n</tr>\n<tr>\n<td><strong>Pupillary axis</strong></td>\n<td>Kappa (κ)</td>\n<td>Lambda (<span lang=\el\ title=\Greek-language text\>λ)</span></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Optic Axis</strong></td>\n<td>Alpha (α)</td>\n<td>&nbsp;</td>\n<td>Gamma (γ)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/498ff34f58ab407491ee3c1461fb1194x600x773.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1278, 'Ophthalmology', 'PM0800. Layers of the Tear Film', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Lipid layer</strong></p>\n<ul>\n<li>Outermost layer</li>\n<li>Secreted by the meibomian, Zeis glands</li>\n<li><strong>Prevents evaporation</strong> of tears</li>\n</ul>\n<p><strong>Aqueous layer</strong></p>\n<ul>\n<li>Middle layer</li>\n<li>Secreted by the lacrimal and accessory lacrimal glands</li>\n<li>Provides&nbsp;<strong>lubrication</strong></li>\n</ul>\n<p><strong>Mucin layer</strong> &nbsp;</p>\n<ul>\n<li>Innermost layer</li>\n<li>Secreted by the&nbsp;<strong>goblet cells of the conjunctiva</strong></li>\n<li>Help in <strong>spreading the tear film</strong> over the ocular surface</li>\n</ul>\n<p>The maximum <strong>density of the goblet cells</strong> is seen on the&nbsp;<strong>nasal bulbar conjunctiva</strong>.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7011380769e74ea39872d4ff8a3bbdb1x1280x1473.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1279, 'Medicine,', 'PM0790. Causes of small and dilated pupils', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Causes of <strong>small pupils </strong>include</p>\n<ul>\n<li>Pontine hemorrhage</li>\n<li>Horners syndrome</li>\n<li>Old age</li>\n<li>Argyll Robertson pupil</li>\n<li>Drugs and poisons (opiates, organophosphates)</li>\n</ul>\n<p>Causes of <strong>dilated pupils</strong> include</p>\n<ul>\n<li>Holmes–Adie (myotonic) pupil</li>\n<li>Third nerve palsy</li>\n<li>Atropine</li>\n<li>Carbon monoxide</li>\n<li>Ethylene glycol</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1280, 'Ophthalmology', 'PM0723. Surgical treatment of hypermetropia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\157\>\n<tbody>\n<tr>\n<td>\n<p><strong>Cornea based </strong><strong>procedures</strong></p>\n</td>\n<td>\n<p><strong>Lens-based procedure</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thermal laser keratoplasty <strong>(TLK)</strong></p>\n</td>\n<td>\n<p>Refractive lens exchange</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperopic photorefractive keratotomy</p>\n</td>\n<td>Phakic intraocular lens&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Conductive keratoplasty</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1281, 'Ophthalmology', 'PM0722. Grading of Hypermetropia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>American Optometric Association (AOA) has defined three grades of hypermetropia:</p>\n<ul>\n<li><strong>Low</strong> hypermetropia: error of&nbsp;<strong>+ 2D or less</strong></li>\n<li><strong>Moderate</strong> hypermetropia: error from<strong>&nbsp;+2.25D to + 5D&nbsp;</strong></li>\n<li><strong>High</strong> hypermetropia: error is <strong>&gt; + 5D</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1282, 'Ophthalmology', 'PM0721. Surgical correction of Myopia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\478\>\n<tbody>\n<tr>\n<td><strong>Cornea-based procedures</strong></td>\n<td><strong>Lens-based procedures</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Laser-based:</strong></p>\n<p>Photorefractive keratectomy (<strong>PRK</strong>)</p>\n<p>Laser in-situ keratomileusis (<strong>LASIK</strong>)(<strong>Most common</strong>)</p>\n</td>\n<td>\n<p>Refractive lens exchange</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Refractive lenticule extraction (<strong>ReLEx</strong>) (or)</p>\n<p>Small incision lenticule extraction (<strong>SMILE</strong>)</p>\n</td>\n<td>\n<p>Phakic intraocular lens</p>\n</td>\n</tr>\n<tr>\n<td>Intracorneal ring segment&nbsp;<strong>(ICRS) </strong>implantation</td>\n<td>\n<p>Clear lens extraction</p>\n</td>\n</tr>\n<tr>\n<td>Orthokeratology</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Radial keratotomy (obsolete)</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1283, 'Ophthalmology', 'PM0717. Grading of Myopia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>American Optometric Association (AOA) Grading of Myopia:</p>\n<ul>\n<li><strong>Low </strong>myopia, when the error is <strong>≤ –3D.</strong></li>\n<li><strong>Moderate</strong> myopia, when the error is between <strong>-3D to -6D.</strong></li>\n<li><strong>High </strong>myopia, when the error <strong>is ≥ –6D.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1284, 'Ophthalmology', 'PM0716. Causes of Myopia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Myopia</strong></p>\n</td>\n<td>\n<p><strong>Etiology</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Axial myopia</strong></p>\n<p><strong>(Most common</strong>)</p>\n</td>\n<td>\n<p>Increase in the&nbsp;<strong>anteroposterior length</strong> of the <strong>eyeball.</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Curvatural myopia</strong></p>\n</td>\n<td>\n<p><strong>Increased curvature</strong> of the <strong>cornea, lens,</strong> or both</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Positional myopia</strong></p>\n</td>\n<td>\n<p><strong>Anterior placement of the crystalline lens</strong> in the eye</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Index myopia</strong></p>\n</td>\n<td>\n<p><strong>Increase in the refractive index</strong> of crystalline <strong>lens</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Nocturnal myopia</strong></p>\n</td>\n<td>\n<p><strong>Due to spherical aberration and accomodation</strong></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1285, 'Ophthalmology', 'PM0345. Types of contact lens (based on the material)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>3 types of contact lens (based on the material) are:</p>\n<ul>\n<li><strong>Hard lenses:</strong>\n<ul>\n<li>Made of <strong>PMMA&nbsp;</strong>(polymethylmethacrylate)</li>\n<li>They are sparingly used because of poor patient compliance.</li>\n</ul>\n</li>\n<li><strong>Rigid gas permeable lenses/ semi soft lenses:</strong>\n<ul>\n<li>Made up of <strong>silicone acrylate</strong> and <strong>cellulose acetate butyrate</strong> (CAB)</li>\n</ul>\n</li>\n<li><strong>Soft lenses:</strong>\n<ul>\n<li>Made up of <strong>HEMA </strong>(hydroxy ethyl methyl acrylate)</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1286, 'Ophthalmology', 'PM0801. Tear film tests used for the diagnosis of dry eye', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Schirmer test</strong></p>\n<p>Inference&nbsp;</p>\n<ul>\n<li>15 mm: Normal</li>\n<li>5-10 mm: Moderate keratoconjunctivitis sicca (KCS)</li>\n<li>&lt; 5 mm: Severe KCS</li>\n</ul>\n<p><strong>Tear film break up test (TBUT)</strong></p>\n<p>Inference&nbsp;</p>\n<ul>\n<li>15-35 seconds: Normal</li>\n<li>&lt; 10 seconds: Unstable tear film</li>\n</ul>\n<p><strong>Rose Bengal staining</strong></p>\n<p>Inference</p>\n<ul>\n<li>A pattern: Confluent staining&nbsp;→ Severe KCS</li>\n<li>B pattern: Extensive staining → Moderate KCS</li>\n<li>C pattern: Fine punctate stains → Mild KCS</li>\n</ul>\n<p><strong>Tear osmolarity test</strong></p>\n<p>Abnormal osmolarity is defined by&nbsp;</p>\n<ul>\n<li>An elevated reading, &gt;300 mOsm/L, indicating loss of homeostasis, or<span class=\blockquote blue\><sup><br></sup></span></li>\n<li>When the inter-eye difference is &gt;8 mOsm/L, indicating instability of the tear film.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1287, 'Ophthalmology', 'PM0799. Surgical treatment of different types of ptosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\306\>\n<tbody>\n<tr>\n<td>\n<div><strong>Surgery</strong></div>\n</td>\n<td>\n<div><strong>Requisite Levator action</strong></div>\n</td>\n<td>\n<div><strong>Amount of ptosis that can be treated</strong></div>\n</td>\n<td>\n<div><strong>Indications</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Fasanella–Servat</strong></div>\n</td>\n<td>\n<div>Good</div>\n</td>\n<td>\n<div>&lt;2 mm</div>\n</td>\n<td>\n<div><strong>Horner Syndrome</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Levator Resection</strong><strong>–</strong>Anterior approach (Everbusch operation)</div>\n</td>\n<td>\n<div>Moderate</div>\n</td>\n<td>\n<div>Any</div>\n</td>\n<td>\n<div>Larger resection in ptosis</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Levator resection<strong>–</strong>Conjunctival approach (Blaskovics operation)</div>\n</td>\n<td>\n<div>Moderate</div>\n</td>\n<td>\n<div>Any</div>\n</td>\n<td>\n<div>Moderate resection in ptosis</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Levator resection with aponeurotic reinsertion</div>\n</td>\n<td>\n<div>Moderate</div>\n</td>\n<td>\n<div>Any</div>\n</td>\n<td>\n<div>Acquired ptosis</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Frontalis suspension</strong>–Fascia lata</div>\n</td>\n<td>\n<div>Poor</div>\n</td>\n<td>\n<div>&gt;2 mm</div>\n</td>\n<td>\n<div><strong>Congenital ptosis</strong>–Marcus<strong>–</strong>Gunn ptosis</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1288, 'Ophthalmology', 'PM0798. Surgical Modalities Used in Correcting Ectropion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Ectropion</strong></p>\n</td>\n<td>\n<p><strong>Procedure</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Involutional ectropion</p>\n</td>\n<td>\n<ul>\n<li><strong>Medial conjunctivoplasty</strong></li>\n<li>Horizontal lid shortening</li>\n<li><strong>Byron–Smith-modified Kuhnt–Szymanowski operation</strong></li>\n<li>Lateral tarsal strip technique</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Paralytic ectropion</p>\n</td>\n<td>\n<ul>\n<li>Horizontal lid tightening</li>\n<li><strong>Palpebral sling</strong> operation</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cicatricial ectropion</p>\n</td>\n<td>\n<ul>\n<li><strong>V-Y operation</strong></li>\n<li>Z-plasty (<strong>Elschnig’s operation</strong>)</li>\n<li>Excision of scar tissue and full-thickness skin grafting</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1289, 'Ophthalmology', 'PM0075. Trachoma Staging', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The four stages of trachoma according to <strong>McCallan</strong> are as follows:</p>\n<p><strong>Stage 1:</strong>&nbsp;<strong>Incipient&nbsp;</strong></p>\n<ul>\n<li>Immature follicles are present, but<strong> <strong>clinical symptoms are not obvious.</strong></strong></li>\n</ul>\n<p><strong><strong>Stage 2:&nbsp;<strong>Established</strong></strong></strong></p>\n<ul>\n<li>Typical trachomatous lesions<strong><strong><strong> <strong>without scarring.</strong></strong></strong></strong></li>\n</ul>\n<p><strong><strong><strong><strong>Stage 3:&nbsp;<strong>Cicatrising</strong></strong></strong></strong></strong></p>\n<ul>\n<li><strong><strong><strong><strong><strong>Scarring </strong></strong></strong></strong></strong>along with<strong><strong><strong><strong><strong> <strong>active</strong></strong></strong></strong></strong></strong> infection.</li>\n</ul>\n<p><strong>Stage 4:</strong>&nbsp;<strong>Healed</strong></p>\n<ul>\n<li><strong>O</strong>nly scarring, the&nbsp;disease is<strong> <strong>either cured or quiet</strong>.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1290, 'Ophthalmology', 'PM1919. Stromal Dystrophies and Staining', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Dystrophy</strong></td>\n<td><strong>Substance deposited</strong></td>\n<td><strong>Stain</strong> used</td>\n</tr>\n<tr>\n<td>Granular dystrophy</td>\n<td>Hyaline</td>\n<td>Massons trichrome</td>\n</tr>\n<tr>\n<td>Lattice dystrophy</td>\n<td>Amyloid</td>\n<td>Congo-red</td>\n</tr>\n<tr>\n<td>Avellino (Combination of both lattice and granular)</td>\n<td>Amyloid and hyaline</td>\n<td>Congo red and Masson trichrome</td>\n</tr>\n<tr>\n<td>Macular dystrophy</td>\n<td>Mucopolysaccharide</td>\n<td>Alcian blue</td>\n</tr>\n<tr>\n<td>Schnyders crystalline dystrophy</td>\n<td>Phospholipids</td>\n<td>Oil red-O</td>\n</tr>\n<tr>\n<td>Gelatinous drop-like dystrophy</td>\n<td>Amyloid</td>\n<td>Congo-red</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1291, 'Ophthalmology', 'PM1918. Causes of congenital opacities of the cornea', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Causes of congenital opacities of the cornea (<strong>STUMPED</strong>)</p>\n<p><strong>S</strong> -&nbsp;<strong>S</strong>clerocornea</p>\n<p><strong>T</strong> -&nbsp;<strong>T</strong>ears in the Descemet membrane secondary to birth trauma or congenital glaucoma</p>\n<p><strong>U</strong> -&nbsp;<strong>U</strong>lcer</p>\n<p><strong>M</strong> -&nbsp;<strong>M</strong>ucopolysaccharidosis</p>\n<p><strong>P</strong> -&nbsp;<strong>P</strong>eters anomaly</p>\n<p><strong>E</strong> -&nbsp;Congenital hereditary <strong>e</strong>ndothelial dystrophy</p>\n<p><strong>D</strong> - <strong>D</strong>ermoid</p></div><!---->\n      <!---->\n    </div><!---->'),
(1292, 'Ophthalmology', 'PM1908. Important investigations related to the cornea', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Pachymetry:</strong>&nbsp;To measure <strong>corneal thickness</strong></li>\n<li><strong>Keratometry:</strong>&nbsp;To measure <strong>corneal curvature </strong>(of the anterior surface)</li>\n<li><strong>Corneal</strong> <strong>topography:</strong>&nbsp;To measure corneal curvature, shape,&nbsp;and thickness</li>\n<li><strong>Specular microscopy:</strong>&nbsp;To assess the <strong>corneal endothelium</strong></li>\n<li>Anterior segment ocular coherence tomography: To assess different corneal layers</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1293, 'Ophthalmology', 'PM1907. Clinical differential diagnosis of corneal ulcer', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Bacterial</strong></td>\n<td><strong>Fungal</strong></td>\n<td><strong>Viral</strong></td>\n<td><strong>Parasitic</strong></td>\n</tr>\n<tr>\n<td><strong>Risk factors</strong></td>\n<td>\n<p>Contact lens wear</p>\n<p>Trauma</p>\n<p>Chronic steroid use</p>\n<p>Anesthetic cornea</p>\n<p>Dry eyes</p>\n<p>Exposure keratopathy</p>\n</td>\n<td>Trauma with<strong> vegetative matter</strong></td>\n<td>\n<p>Low immunity</p>\n<p>Recurrent attacks</p>\n</td>\n<td>\n<p>Contact lens wear</p>\n<p>Exposure to contaminated water (acanthamoeba)</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Clinical features</strong></td>\n<td>\n<p>Hypopyon is<strong> fluid and mobile</strong></p>\n<p><em><strong>Pseudomonas aeruginosa</strong> </em>is likely to have a <strong>rapid course,</strong> with deep corneal necrosis.</p>\n</td>\n<td>\n<p><strong>Less pain</strong> and watering compared to the extent of vision loss and signs.&nbsp;</p>\n<p>Tend to be <strong>indolent</strong> but <strong>progressive</strong></p>\n<p><strong>Hypopyon</strong> is <strong>thick</strong>, <strong>immobile.</strong></p>\n</td>\n<td>\n<p>Relatively <strong>more&nbsp;pain</strong> and watering compared to the extent of vision loss and signs.&nbsp;</p>\n<p><strong>Recurrences</strong> are characteristic.</p>\n</td>\n<td>\n<p><strong>Disproportionately severe pain</strong> is a characteristic feature.</p>\n<p><strong>Indolent course</strong> and in&nbsp;<strong>initial&nbsp;stages,&nbsp;</strong>often <strong>mistaken</strong> to be<strong>&nbsp;viral/ fungal infection,</strong> leading to a delay in diagnosis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1294, 'Ophthalmology', 'PM1723. Different types of keratic precipitates (KPs)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><strong>KPs</strong></div>\n</td>\n<td>\n<div><strong>Notable points</strong></div>\n</td>\n<td>\n<div><strong>Seen in</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Mutton-fat KPs</strong></div>\n</td>\n<td>\n<div>Composed of epithelioid cells and macrophages</div>\n</td>\n<td>\n<div>Granulomatous uveitis</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Granular KPs</strong></div>\n</td>\n<td>\n<div>Composed of lymphocytes</div>\n</td>\n<td>\n<div>Non-granulomatous uveitis</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Fine KPs </strong>or</div>\n<div><strong>Stellate/Star shaped KPs</strong></div>\n</td>\n<td>\n<div>Form endothelial dusting</div>\n</td>\n<td>\n<div>Fuchs heterochromic iridocyclitis</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Old KPs</strong></div>\n</td>\n<td>\n<div>Sign of healed uveitis</div>\n</td>\n<td>\n<div>&nbsp;--------</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Red KPs</strong></div>\n</td>\n<td>\n<div>\n<div>&nbsp;--------</div>\n</div>\n</td>\n<td>\n<div>Acute hemorrhagic uveitis</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/fcf3755a7a6541d9b6b3a59c0df0818ex1280x1308.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1295, 'Ophthalmology', 'PM0783. Vogts striae', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5a178f81ff1e49ca88241f617bdb5656x720x575.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The above image shows “<strong>Vogt’s Striae</strong>” which are characteristically seen in <strong>Keratoconus</strong>.</p>\n<ul>\n<li><strong>Vogts striae</strong> are <strong>vertical</strong> (rarely horizontal) fine, whitish lines in the deep/posterior stroma and Descemets membrane commonly found in patients with <strong>keratoconus</strong>.</li>\n<li>It may be asymmetric depending on the degree of keratoconus in each eye.</li>\n<li>It is considered that there is a positive correlation between the <strong>orientation of the lines</strong> with the <strong>steepest axis of the cornea</strong> and the mechanism is thought to be related to <strong>mechanical stress</strong> forces on collagen lamellae radiating from the cone apex.</li>\n<li>The striae can <strong>temporarily disappear</strong> with external pressure to the globe.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1296, 'Ophthalmology', 'PM0755. Corneal Preservation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Corneal preservation – </strong>They can be transplanted immediately or preserved in an eye bank by various preservation techniques for varying intervals.</p>\n<ul>\n<li><strong>Short-term </strong>preservation\n<ul>\n<li>In a&nbsp;<strong>moist </strong>chamber or McCarey–Kaufman medium (<strong>MK medium</strong>)</li>\n<li>Refrigerated at <strong>2-8 °C </strong></li>\n<li>Cornea to be used within <strong>48 to 72 hours</strong> (maximum 96 hours)</li>\n</ul>\n</li>\n<li><strong>Intermediate– term </strong>preservation\n<ul>\n<li>In medium containing <strong>chondroitin sulfate</strong></li>\n<li>Refrigerated at <strong>2-8 °C </strong>for 7 to 14 days</li>\n<li>Or maintained at <strong>37°C </strong>by <strong>organ culture</strong> methods</li>\n<li>Using modified Eagles medium extends this to <strong>30 days</strong></li>\n</ul>\n</li>\n<li><strong>Long-term </strong>preservation\n<ul>\n<li>By <strong>cryopreservation</strong> in <strong>liquid nitrogen</strong> or <strong>in glycerol</strong></li>\n<li>Is up to <strong>1 year</strong></li>\n<li>Loss of transparency of the tissue is a disadvantage.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1297, 'Ophthalmology', 'PM0754. Corneal Opacities', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Corneal opacity </strong>is formed when <strong>Bowmans layer (+/- deeper layer) is damaged.</strong></p>\n<p><strong>Nebular opacity </strong></p>\n<ul>\n<li>Faint white</li>\n<li>Only Bowmans layer&nbsp;is involved</li>\n<li>Causes more visual handicap&nbsp;than macular opacity due to the scattering of light</li>\n</ul>\n<p><strong>Macular opacity</strong></p>\n<ul>\n<li>White in color</li>\n<li>Bowmans layer + Half of stromal thickness&nbsp;involved</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2e555d1c14df456d89b7ce7b85f31b95x478x395.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Leucoma</strong></p>\n<ul>\n<li>White and opaque</li>\n<li>BM + half or more than half stromal thickness&nbsp;involved</li>\n</ul>\n<p><strong>Image</strong>: Leucomatous corneal opacity</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8a98801140e545068224194d50f61c74x262x244.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1298, 'Ophthalmology', 'PM0711. Types of Corneal Dystrophies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Epithelial</strong></p>\n<ul>\n<li>Epithelial basement membrane dystrophy (EBMD)</li>\n<li>Epithelial recurrent erosion dystrophy</li>\n<li>Meesman’s dystrophy</li>\n<li>Lisch’s epithelial dystrophy</li>\n<li>Gelatinous drop-like dystrophy</li>\n</ul>\n<p><strong>Bowman’s Membrane</strong></p>\n<ul>\n<li>Reis Buckler’s dystrophy</li>\n<li>Thiel-Behnke corneal dystrophy</li>\n<li>Grayson-Wilbrandt corneal dystrophy</li>\n</ul>\n<p><strong>Stromal Corneal Dystrophies</strong></p>\n<ul>\n<li>Lattice corneal dystrophy</li>\n<li>Granular dystrophy</li>\n<li>Macular corneal dystrophy</li>\n<li>Schnyder corneal dystrophy</li>\n<li>Fleck corneal dystrophy</li>\n<li>Posterior amorphous corneal dystrophy</li>\n<li>Central cloudy dystrophy of Francois</li>\n</ul>\n<p><strong>Descemet membrane and Endothelial corneal dystrophy</strong></p>\n<ul>\n<li>Fuchs endothelial&nbsp;corneal dystrophy</li>\n<li>Posterior polymorphous corneal dystrophy (PPCD)</li>\n<li>Congenital hereditary endothelial</li>\n<li>X-linked endothelial corneal dystrophy</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1299, 'Ophthalmology', 'PM0710. Ocular lesions of Herpes Simplex', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Primary herpes:</strong></p>\n<ul>\n<li>Cornea\n<ul>\n<li>Fine <strong>epithelial</strong> punctate keratitis</li>\n<li>Coarse <strong>epithelial</strong> punctate keratitis</li>\n<li><strong>Dendritic</strong> ulcer</li>\n</ul>\n</li>\n<li>Conjunctiva: acute follicular conjunctivitis</li>\n<li>Skin lesions</li>\n</ul>\n<p><strong> Recurrent herpes:</strong></p>\n<ul>\n<li>Active epithelial keratitis\n<ul>\n<li>Punctate <strong>epithelial</strong> keratitis</li>\n<li><strong>Dendritic</strong> ulcer</li>\n<li><strong>Geographica</strong>l ulcer</li>\n</ul>\n</li>\n<li>Stromal keratitis</li>\n<li><strong>Disciform</strong> keratitis</li>\n<li><strong>Diffuse</strong> stromal necrotic keratitis</li>\n<li>Trophic keratitis (meta-herpetic)</li>\n<li>Herpetic iridocyclitis</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a1db947bf72446dc836793b85945c4a9x1280x2341.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1300, 'Ophthalmology', 'PM2487. Early treatment diabetic retinopathy study (ETDRS) classification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Non-proliferative diabetic retinopathy (NPDR):</p>\n<ul>\n<li>Mild NPDR\n<ul>\n<li>At least one microaneurysm must be present</li>\n</ul>\n</li>\n<li>Moderate NPDR\n<ul>\n<li>Microaneurysms/intraretinal hemorrhage in 2 or 3 quadrants</li>\n<li>Early mild intraretinal microvascular abnormalities (IRMA)</li>\n<li>Hard exudates and cotton-wool spots may or may not be present</li>\n</ul>\n</li>\n<li>Severe NPDR - any one of the following (4-2-1 rule)\n<ul>\n<li>4 quadrants of microaneurysms and extensive intraretinal hemorrhages</li>\n<li>2 quadrants of venous beading</li>\n<li>1 quadrant of IRMA changes</li>\n</ul>\n</li>\n<li>Very severe NPDR - any two of the following (4-2-1)\n<ul>\n<li>4 quadrants of microaneurysms and extensive intraretinal hemorrhages</li>\n<li>2 quadrants of venous beading</li>\n<li>1 quadrant of IRMA changes</li>\n</ul>\n</li>\n</ul>\n<p>Proliferative diabetic retinopathy (PDR):</p>\n<ul>\n<li>PDR without high-risk characteristics (Early PDR)\n<ul>\n<li>Early neovascularization at the optic disc (NVD) or neovascularization elsewhere (NVE)</li>\n</ul>\n</li>\n<li>PDR with high-risk characteristics as follows\n<ul>\n<li>NVD &lt; 1/4 disc area with vitreous hemorrhage (VH) or preretinal hemorrhage (PRH)</li>\n<li>NVD 1/4 to 1/3 of disc area with or without VH&nbsp;or PRH</li>\n<li>NVE &gt; 1/2 disc area with VH or PRH</li>\n</ul>\n</li>\n</ul>\n<p>Clinically significant macular edema: 1&nbsp;of the following 3 criteria are present on&nbsp;slit-lamp examination with 90D lens</p>\n<ul>\n<li>Thickening of the retina at or within 500 micron of&nbsp;the center of the fovea.</li>\n<li>Hard exudates at or within 500 micron of the&nbsp;centre of fovea associated with adjacent retinal&nbsp;thickening.</li>\n<li>Development of a zone of retinal thickening one disc&nbsp;diameter or larger in size. At least a part of this should be within one disc diameter of the foveal center.</li>\n</ul>\n<p>Advanced diabetic eye disease:</p>\n<ul>\n<li>Persistent vitreous hemorrhage</li>\n<li>Tractional retinal detachment</li>\n<li>Neovascular glaucoma</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/92933781eb3d4b00998e69c7e0d4dcb9x1280x1359.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1301, 'Ophthalmology', 'PM1475. Causes of loss of vision', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Features </strong></td>\n<td><strong>Cause </strong></td>\n</tr>\n<tr>\n<td><strong>Sudden painless loss of vision</strong></td>\n<td>\n<ul>\n<li>Central retinal artery occlusion</li>\n<li>Massive vitreous hemorrhage</li>\n<li>Retinal detachment involving macula</li>\n<li>Ischemic central retinal vein occlusion</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Sudden painless onset of diminution of vision</strong></td>\n<td>\n<ul>\n<li>Central serous retinopathy</li>\n<li>Optic neuritis</li>\n<li>Methyl alcohol amblyopia</li>\n<li>Non-ischemic central retinal vein occlusion</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Sudden painful loss of vision</strong></td>\n<td>\n<ul>\n<li>Acute congestive glaucoma</li>\n<li>Acute iridocyclitis</li>\n<li>Injury to eyeball</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Gradual painless diminution of vision</strong></td>\n<td>\n<ul>\n<li>Corneal dystrophy</li>\n<li>Senile cataract</li>\n<li>Primary open angle glaucoma</li>\n<li>Optic atrophy</li>\n<li>ARMD</li>\n<li>Refractive error</li>\n<li>Diabetic retinopathy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Gradual painful diminution of vision</strong></td>\n<td>\n<ul>\n<li>Chronic iridocyclitis</li>\n<li>Corneal ulceration</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1302, 'Ophthalmology', 'PM0795. Classification of optic atrophy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Simple optic atrophy:</strong>&nbsp;(Primary) Image below\n<ul>\n<li>Pathology lies in portion&nbsp;of optic nerve behind lamina cribrosa.</li>\n<li>Causes are <strong>multiple sclerosis</strong>, neurosyphilis, and <strong>traumatic optic neuropathy.</strong></li>\n<li><strong>Well defined disc margin </strong>and <strong>chalky white</strong> in color.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/bc5b4bbd9fc048f7b804b41faea3dde4x1200x940.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Post-neuritic optic atrophy:</strong>&nbsp;(Secondary)</p>\n<ul>\n<li>Occurs after disc edema.</li>\n<li>Causes are <strong>Papillitis and papilledema</strong></li>\n<li><strong>Blurred disc margin </strong>and <strong>dirty white</strong> in color</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2977587bfbad40c7b30be07ab452511bx476x215.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Consecutive optic atrophy </strong>\n<ul>\n<li>Extensive pathology of retina.</li>\n<li>Causes are <strong>retinitis pigmentosa</strong> and any cause of diffuse chorioretinitis</li>\n<li><strong>Well defined disc margin </strong>and<strong> pale waxy disc.</strong></li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6c5ba6c450c84e93b5b7c8d8bbcbe1e6x434x313.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Glaucomatous optic atrophy/Cavernous optic atrophy:</strong>\n<ul>\n<li>100% cupping</li>\n<li>Bayonetting of vessels</li>\n<li>Laminar dot sign</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/60a87d653a694c73a9b7c53eab7accddx409x314.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->'),
(1303, 'Ophthalmology', 'PM0792. Foster–Kennedy Syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>It is characterized by the occurrence of:\n<ul>\n<li>Ipsilateral <strong>pressure optic atrophy</strong> and</li>\n<li>Contralateral <strong>papilledema</strong> (due to raised intracranial pressure).</li>\n</ul>\n</li>\n<li>It is associated with <strong>olfactory</strong> or sphenoidal meningiomata and <strong>frontal lobe tumors</strong>.</li>\n</ul>\n<p><strong>Pseudo-Foster–Kennedy syndrome:&nbsp;</strong>It is characterized by the occurrence of:</p>\n<ul>\n<li><strong>Pre-existing optic atrophy</strong> due to any cause on <strong>one eye</strong>.</li>\n<li><strong>Unilateral papilledema</strong> associated with <strong>raised intracranial pressure </strong>due to some other cause on the opposite side.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1304, 'Ophthalmology', 'PM0365. Layers of Retina', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Layers of Retina&nbsp;&nbsp;</strong>(inner to outer)</p>\n<ol>\n<li>Internal limiting membrane</li>\n<li>Nerve fibre layer</li>\n<li>Ganglion cell layer&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Inner plexiform layer</li>\n<li>Inner nuclear layer</li>\n<li>Outer plexiform layer&nbsp;</li>\n<li>Outer nuclear layer</li>\n<li>External limiting membrane</li>\n<li>Rods and cones</li>\n<li>Retinal pigment epithelium</li>\n</ol></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/441b0c4c46264c2a8e754af2303f2f40x1280x3064.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1305, 'Ophthalmology', 'PM0029. Important causes of cherry-red spots', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Commotio retinae</li>\n<li>Central retinal and cilioretinal artery occlusion</li>\n<li>Metabolic storage diseases\n<ul>\n<li>GM1 gangliosidosis</li>\n<li>Mucolipidosis type I (sialidosis)</li>\n<li>GM2 gangliosidosis (Tay-Sachs disease and Sandhoff disease)</li>\n<li>Farber disease</li>\n<li>Niemann–Pick disease</li>\n</ul>\n</li>\n<li>Retinotoxicity due to specific agents, including quinine, dapsone, gentamicin, carbon monoxide,&nbsp;and methanol</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/28a0aade2cc74ae8b0ca120ea25df7d5x600x448.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1306, 'Ophthalmology', 'PM2204. Fincham’s Test', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Also called<strong> Emsley–Fincham Test</strong></p>\n<p>It used for&nbsp;<strong>differentiating</strong> between the colored halos due to <strong>cataract and</strong>&nbsp;the colored halos in corneal edema due to <strong>glaucoma</strong>. It&nbsp;is performed by passing a stenopaic slit across the pupil and observing the halos.</p>\n<p><strong>Halos are broken</strong>&nbsp;up into segments which revolve as the slit moves&nbsp;→&nbsp;<strong>Lenticular</strong>&nbsp;halo</p>\n<p><strong>Intact halos</strong> but the intensity and brightness are diminished&nbsp;→&nbsp;<strong>Glaucomatous</strong>&nbsp;halo due to fluid accumulation in the corneal epithelium</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c4b3a08cf529448da10103793ec3fd6ex719x430.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The image shows a <strong>stenopaeic&nbsp;slit</strong></p>\n<p>It causes</p>\n<ul>\n<li><strong>Reduced</strong> size of <strong>blur circle</strong> in the <strong>meridian perpendicular</strong> to the slit.</li>\n<li><strong>No change</strong> in the blur circle in the <strong>meridian coincident</strong> with it.</li>\n</ul>\n<p>So, it can be used to <strong>determine the axis of the&nbsp;cylinder</strong> in astigmatism.</p>\n<p>In cases with <strong>corneal opacity</strong>, the&nbsp;optimal <strong>site for optical iridectomy</strong> is determined using a stenopaic slit.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1307, 'Ophthalmology', 'PM0707. Visual field Defects in Open-Angle Glaucoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ebfa7f51402942568a0f08d0e6cc1580x1280x3528.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1308, 'Ophthalmology', 'PM2181. Complications of cataract surgery', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Early postoperative complications</strong></p>\n<p>Occurs within the first few days to 4 weeks.</p>\n<ul>\n<li>Endophthalmitis</li>\n<li>Retained lens matter</li>\n<li>Corneal edema</li>\n<li>Wound leak and dehiscence</li>\n<li>Toxic anterior segment syndrome</li>\n</ul>\n<p><strong>Late postoperative complications</strong></p>\n<p>Occurs within months to years.</p>\n<ul>\n<li><strong>Posterior capsule opacification (most common)</strong></li>\n<li>Cystoid macular edema</li>\n<li>Secondary glaucoma</li>\n<li>Retinal detachment</li>\n<li>Intraocular lens malpositions:\n<ul>\n<li><strong>Windshield wiper syndrome</strong>— intraocular lens haptic rubs on the endothelium</li>\n<li><strong>Sunset syndrome—</strong>inferior subluxation</li>\n<li><strong>Sunrise syndrome—</strong>superior subluxation</li>\n<li><strong>Complete dislocation </strong>of the intraocular lens.</li>\n</ul>\n</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1309, 'Medicine,', 'PM2092. Horners syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Horners Syndrome</strong>:</p>\n<p>Horners syndrome occurring due to occulo-sympathetic paresis is characterized by the classic triad of:</p>\n<ul>\n<li>Mild <strong>ptosis</strong> (due to paralysis of Mullers muscle).</li>\n<li><strong>Miosis</strong> (due to paralysis of dilator pupillae).</li>\n<li>Reduced ipsilateral sweating (<strong>anhydrosis</strong>).</li>\n</ul>\n<p>Other features include:</p>\n<ul>\n<li>Mild enophthalmos,</li>\n<li>Loss of cilio-spinal reflex,</li>\n<li>Heterochromia, i.e., the ipsilateral iris is lighter in colour,</li>\n<li>Pupil is slow to dilate, and there occurs slight elevation of lower eyelid.</li>\n</ul>\n<p><strong>Cocaine test (2% to 4%)</strong>: Small pupils fail to dilate in Horners syndrome.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/25c677e2ab514f62ba98d38063d205fcx1280x1115.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>In <strong>congenital Horners syndrome</strong>, the additional features seen are <strong>heterochromia iridis </strong>and<strong> unilateral straight hair.</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1310, 'Ophthalmology', 'PM1722. Congenital anomailes of the uveal tract', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>\n<table>\n<tbody>\n<tr>\n<td><strong>Congenital anomaly</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td><strong>Heterochromia of iris</strong></td>\n<td>Variation in iris color</td>\n</tr>\n<tr>\n<td>Heterochromia <strong>iridum</strong></td>\n<td>Color of <strong>one iris</strong> differs from the other, i.e&nbsp;different color of the two iris</td>\n</tr>\n<tr>\n<td>Heterochromia <strong>iridis</strong></td>\n<td><strong>One sector of the iris</strong> differs from the other, i.e&nbsp;different color of sectors of the same iris</td>\n</tr>\n<tr>\n<td><strong>Corectopia</strong></td>\n<td>Abnormally <strong>eccentrically</strong> placed pupil</td>\n</tr>\n<tr>\n<td><strong>Polycoria</strong></td>\n<td><strong>More than one pupil</strong></td>\n</tr>\n<tr>\n<td><strong>Aniridia</strong></td>\n<td><strong>Absence</strong>&nbsp;of iris</td>\n</tr>\n<tr>\n<td><strong>Congenital coloboma</strong></td>\n<td>Absence of the tissue of iris, ciliary body, and choroid</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1311, 'Ophthalmology', 'PM0875. Maturation of Cortical Cataract', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>1. Stage of <strong>lamellar separation&nbsp;</strong></p>\n<p>2. Stage of <strong>incipient cataract- cuneiform</strong> and <strong>cupuliform</strong> patterns can be made out at this stage.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/98f893f1601a46219c2f54cddd4cb5fcx1280x2197.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p>3.<strong>&nbsp;Immature senile cataract:&nbsp;</strong></p>\n<ul>\n<li>The lens is <strong>greyish white.</strong></li>\n<li><strong>Clear cortex</strong> is still present, so <strong>iris shadow</strong> is <strong>visible<br></strong></li>\n<li>Untreated immature cataracts can <strong>progress</strong> and develop into <strong>intumescent cataracts</strong> as a result of&nbsp;<strong>swelling</strong> and <strong>congestion of the lens</strong> due to <strong>degeneration of lens proteins.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0f0ee83fdc4a47f6bff960693b22465ex265x379.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>4.&nbsp;Mature cortical cataract/ Ripe cataract&nbsp;</strong></p>\n<ul>\n<li>The <strong>opacification</strong> is <strong>complete</strong></li>\n<li>The lens is <strong>pearly white</strong></li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2ea3c22476864db293b757b52071f5b4x200x150.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p>5.<strong> Morgagnian hypermature cataract</strong></p>\n<ul>\n<li>The whole <strong>cortex liquefies</strong> and the lens is converted into a <strong>bag of milky fluid</strong>.</li>\n<li>The <strong>small, brownish nucleus</strong> settles at the <strong>bottom</strong>, <strong>altering its position</strong> with a change in the position of the head.</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/33749bf0e7344420af2d2dc2e29c22f4x239x175.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1312, 'Ophthalmology', 'PM0874. Types of Congenital Cataract', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Punctate cataract: </strong>Blue-dot cataract, most common congenital cataract</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ba8aed2ba0ca44e3863528de2692664dx512x336.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Zonular/Lamellar cataract</strong>: <strong>Most common</strong>&nbsp;<strong>congenital cataract</strong> <strong>with diminished vision</strong>; Spokes of a wheel appearance (<strong>Rider’s Cataract</strong>) A, B, and C</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/eb18bcb86b0b4e98ba703cddfe8c051ax1280x2620.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Fusiform/coralliform</strong>&nbsp;cataract: Anteroposterior spindle shaped appearance.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a1169db0e2d34323b948c8522f8ee409x512x336.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Nuclear cataract:&nbsp;</strong><strong>Most common</strong>&nbsp;type of cataract<strong> seen in congenital rubella syndrome</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/0003f0d7d35e4583b9802238823d9f00x426x279.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Coronary cataract:</strong> Appears as a corona of<strong> club-shaped opacities</strong> near the<strong> periphery</strong> of&nbsp;the lens.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a3238717f2b140ea88ad5575eda041a9x1280x1868.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Anterior polar cataract:&nbsp;</strong>May arise either due to delayed development of anterior chamber or due to corneal perforation</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/eecd5f444375498bb2a3265c37aba981x512x215.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Posterior polar cataract:&nbsp;</strong>Progressive form of posterior polar cataract, which typically shows an \onion whorl appearance\</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/616bd869a54e439da4ff2bbcf60ae5f6x368x712.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1313, 'Ophthalmology,', 'PM0407. Complications and contraindications of retrobulbar block', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Complications</strong>:</p>\n<ul>\n<li>Retrobulbar hemorrhage (most common complication)</li>\n<li>Subconjunctival hemorrhage</li>\n<li>Proptosis</li>\n<li>Perforation of the globe</li>\n<li>Optic nerve atrophy</li>\n<li>Oculocardiac reflex</li>\n<li>Accidental intravascular injection of the local anesthetic</li>\n<li>Trigeminal nerve block</li>\n<li>Respiratory arrest</li>\n<li>Acute neurogenic pulmonary edema (rarely)</li>\n</ul>\n<p><strong>Contraindications</strong>:</p>\n<ul>\n<li>\n<div>Bleeding disorders (because of the risk of retrobulbar hemorrhage)</div>\n</li>\n<li>\n<div>High myopia (if the axial length is greater than 25 mm, then sclera would be thin which could increase the risk of globe perforation)</div>\n</li>\n<li>\n<div>Open eye injury or penetrating eye injury: injection of local anesthetic behind the globe could increase the intraocular pressure which could lead to extrusion of the orbital contents.</div>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1314, 'Ophthalmology', 'PM1898. Lasers in Ophthalmology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Laser</strong></td>\n<td><strong>Wavelength (Nanometers)</strong></td>\n<td><strong>Clinical applications</strong></td>\n</tr>\n<tr>\n<td>Nd:YAG</td>\n<td>1064</td>\n<td>\n<ul>\n<li><strong>Posterior capsulotomy</strong></li>\n<li><strong>Iridotomy</strong></li>\n<li><strong>Hyloidotomy</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Frequency doubled Nd:YAG</td>\n<td>532</td>\n<td>\n<ul>\n<li>Retinal photocoagulation</li>\n<li>Cyclo photocoagulation</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Argon green</td>\n<td>514</td>\n<td>\n<ul>\n<li><strong>Trabeculoplasty</strong></li>\n<li>Iridoplasty</li>\n<li><strong>Pupillomydriasis</strong></li>\n<li>Retinal photo-coagulation</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Diode laser</td>\n<td>810</td>\n<td>\n<ul>\n<li>Retinal photo-coagulation</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Krypton red</td>\n<td>714</td>\n<td>\n<ul>\n<li>Retinal photo-coagulation</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Excimer (Argon fluoride)</td>\n<td>193</td>\n<td>\n<ul>\n<li>Photo-refractive keratectomy (<strong>PRK</strong>)</li>\n<li>Photo-therapeutic keratectomy (<strong>PTK</strong>)</li>\n<li><strong>LASIK</strong></li>\n<li><strong>LASEK</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Femtosecond laser (neodymium - glass)</td>\n<td>1053</td>\n<td>\n<ul>\n<li>Femtosecond laser-assisted <strong>refractive surgery </strong>and<strong>&nbsp;</strong>lamellar and full-thickness <strong>corneal transplants</strong></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1315, 'Ophthalmology', 'PM1479. Difference between direct and indirect ophthalmoscopy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\154\>\n<tbody>\n<tr>\n<td><strong>FEATURE</strong></td>\n<td><strong>DIRECT OPHTHALMOSCOPE&nbsp;</strong></td>\n<td><strong>INDIRECT OPHTHALMOSCOPE</strong></td>\n</tr>\n<tr>\n<td><strong>Condensing lens</strong></td>\n<td>Not required</td>\n<td>Required</td>\n</tr>\n<tr>\n<td><strong>Examination distance</strong></td>\n<td>As close to the patients eye as possible</td>\n<td>At an arms length</td>\n</tr>\n<tr>\n<td><strong>Image</strong></td>\n<td>Virtual, Erect</td>\n<td>Real, Inverted</td>\n</tr>\n<tr>\n<td><strong>Magnification</strong></td>\n<td>15 times</td>\n<td>4-5 times</td>\n</tr>\n<tr>\n<td><strong>Illumination</strong></td>\n<td>Not so bright, so not useful in hazy media</td>\n<td>Bright, so useful in hazy media</td>\n</tr>\n<tr>\n<td><strong>Area of the field in focus</strong></td>\n<td>About 2 disc diameter</td>\n<td>About 8 disc diameter</td>\n</tr>\n<tr>\n<td><strong>Stereopsis</strong></td>\n<td>Absent</td>\n<td>Present</td>\n</tr>\n<tr>\n<td><strong>Accessible fundus view</strong></td>\n<td>Slightly beyond equator</td>\n<td>Up to ora serrata</td>\n</tr>\n<tr>\n<td><strong>Examination through hazy media</strong></td>\n<td>Not possible</td>\n<td>Possible</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1316, 'Ophthalmology', 'PM1016. Cover tests in ophthalmology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Cover–uncover test</strong>:</p>\n<ul>\n<li>To detect the presence of <strong>heterophoria</strong>:<strong>&nbsp;Latent squint</strong></li>\n<li>One eye is covered with the occluder, and the other eye is made to fix an object.</li>\n<li>In the&nbsp;<strong>presence of heterophoria</strong>, the eye<strong> under the cover</strong> will <strong>deviate</strong>.</li>\n<li>When the cover is removed, the eye<strong> under the cover</strong>&nbsp;will return <strong>back to its normal</strong>.</li>\n<li>This movement is observed.</li>\n<li>The<strong> direction</strong> of movement determines the&nbsp;<strong>type</strong> of heterophoria.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/812d254abce441f2b5ad48055dfd9addx1280x5268.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Direct Cover test</strong>:</p>\n<ul>\n<li>Confirms the presence of <strong>manifest squint</strong>.</li>\n<li>Differentiates <strong>apparent squint</strong> from a&nbsp;<strong>manifest squint</strong>.</li>\n<li>The patient is asked to fixate on the&nbsp;point light.</li>\n<li>The normal-looking eye is covered.</li>\n<li><strong>In manifest squint</strong>, the uncovered eye <strong>will move</strong> in the opposite direction to take fixation.</li>\n<li><strong>In apparent squint</strong>, there will be <strong>no movement of the&nbsp;uncovered eye</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/86f737206d894a21821d9855aecf4deex1280x5149.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Alternate cover test</strong>:</p>\n<ul>\n<li>In the below image, the patient has right exotropia with left eye fixating.</li>\n<li>Both eyes move each time the cover alternates from one eye to the other.</li>\n<li>It reveals if the squint is <strong>unilateral</strong> or <strong>alternate</strong>.</li>\n<li>It <strong>differentiates</strong> between <strong>concomitant </strong>and <strong>paralytic</strong> squint.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/270efb6a725e49fc823c54a5442a5db0x1280x2207.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1317, 'Ophthalmology', 'PM1015. Classification of Strabismus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Pseudostrabismus—</strong>Apparent squint\n<ul>\n<li>Pseudo esotropia</li>\n<li>Pseduo exotropia</li>\n</ul>\n</li>\n<li><strong>Heterophoria—</strong>Latent squint\n<ul>\n<li><strong>Esophoria:</strong>&nbsp;Convergent</li>\n<li><strong>Exophoria:</strong>&nbsp;Divergent</li>\n<li>Hyperphoria<strong>:</strong> Deviation upwards</li>\n<li>Hypophoria<strong>:</strong> Deviation downwards</li>\n<li>Cyclophoria<strong>:</strong> Rotation around AP axis</li>\n</ul>\n</li>\n<li><strong>Heterotropia—</strong>Manifest squint</li>\n<li><strong>Concomitant</strong>\n<ul>\n<li>Amount of deviation <strong>remains constant</strong> in all directions of gaze.</li>\n<li><strong>Esotropia:</strong>&nbsp;Convergent\n<ul>\n<li>Infantile</li>\n<li>Accommodative</li>\n<li>Sensory</li>\n<li>Consecutive</li>\n</ul>\n</li>\n<li><strong>Exotropia:</strong>&nbsp;Divergent\n<ul>\n<li>Congenital</li>\n<li>Primary</li>\n<li>Secondary: Sensory deprived</li>\n<li>Consecutive</li>\n</ul>\n</li>\n<li><strong>Hypertropia:</strong>&nbsp;Vertical squint</li>\n</ul>\n</li>\n<li><strong>Incomitant</strong>\n<ul>\n<li>Amount of <strong>deviation varies</strong> in different directions of gaze\n<ul>\n<li><strong>Paralytic</strong> squint</li>\n<li><strong>Restrictive</strong> squint</li>\n<li><strong>A and V pattern </strong>heterotropia</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1318, 'Medicine,', 'PM1781. Signs in Grave’s ophthalmopathy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>\n<table>\n<tbody>\n<tr>\n<td><strong>Sign</strong></td>\n<td><strong>Feature</strong></td>\n</tr>\n<tr>\n<td>Dalrymples sign</td>\n<td>Retraction of the upper lids</td>\n</tr>\n<tr>\n<td>von Graefes sign</td>\n<td>Lid lag, i.e., when the globe is moved downward, the upper lid lags behind</td>\n</tr>\n<tr>\n<td>Griffith Sign</td>\n<td>Lower lid lag on upward gaze</td>\n</tr>\n<tr>\n<td>Enroths sign</td>\n<td>Fullness of the eyelids</td>\n</tr>\n<tr>\n<td>Stellwags sign</td>\n<td>Infrequent blinking</td>\n</tr>\n<tr>\n<td>Giffords sign</td>\n<td>Difficulty in eversion of the upper lid</td>\n</tr>\n<tr>\n<td>Mobius’ sign</td>\n<td>Convergence weakness</td>\n</tr>\n<tr>\n<td>Joffroy’s sign</td>\n<td>Lack of wrinkling of the forehead on superior gaze</td>\n</tr>\n<tr>\n<td>Jellineks Sign</td>\n<td>Abnormal pigmentation of the upper lid</td>\n</tr>\n</tbody>\n</table>\n<p>The image given below shows Dalrymples sign in the right eye.</p>\n</div></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0a484751a2e640e7906b3d75f752f5b5x450x224.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1319, 'Ophthalmology', 'PM1728. Uveitis Associated with HLA B-27-associated Arthritis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Ankylosing spondylitis</li>\n<li>Psoriatic arthritis</li>\n<li>Reiter’s syndrome</li>\n<li>Juvenile idiopathic arthritis (JIA) (previously known as juvenile rheumatoid arthritis)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1320, 'Paediatrics,', 'PM1469. Ocular manifestation in infections', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\178\>\n<tbody>\n<tr>\n<td><strong>Infections</strong></td>\n<td><strong>Ocular manifestation</strong></td>\n</tr>\n<tr>\n<td><strong>Measles</strong></td>\n<td>\n<ul>\n<li>Catarrhal conjunctivitis</li>\n<li>Corneal ulceration</li>\n<li>Optic neuritis</li>\n<li>Retinitis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Mumps</strong></td>\n<td>\n<ul>\n<li>Acute dacryoadenitis (most common)</li>\n<li>Conjunctivitis</li>\n<li>Keratitis</li>\n<li>Uveitis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Rubella</strong></td>\n<td>\n<ul>\n<li>Chorioretinitis—salt and pepper (most common)</li>\n<li>Congenital microphthalmos</li>\n<li>Cataract</li>\n<li>Glaucoma</li>\n<li>Optic atrophy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Whooping cough</td>\n<td>\n<ul>\n<li>Subconjunctival hemorrhage</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1321, 'Ophthalmology', 'PM0897. Diseases and Associated Cataracts - Images', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Wilsons Disease/Chalcosis: Sunflower Cataract</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f38ae9ec7610483cb46270495dbc44b0x826x499.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Diabetes mellitus</strong>:<strong> &nbsp;Snowflake cataract </strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0235d6510b5145419c408792a18dde31x595x395.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Blunt trauma</strong>: May present as rosette-shaped cataract</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f66a5f456ef84776a83894d96c1f9b96x381x394.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Myotonic dystrophy</strong> - Christmas tree cataract</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c10ec0ef6d6948249f32b3325209b9bcx720x677.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1322, 'Ophthalmology', 'PM0879. Diseases and Their Associated Cataracts', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\624\>\n<tbody>\n<tr>\n<td width=\312\>\n<p><strong>Disease</strong></p>\n</td>\n<td width=\312\>\n<p><strong>Type of cataract </strong></p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Myotonic dystrophy</p>\n</td>\n<td width=\312\>\n<p>Christmas tree cataract</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Wilson’s disease</p>\n<p>Copper deposition (Chalcosis)</p>\n<p>Penetrating trauma</p>\n</td>\n<td width=\312\>\n<p>Sunflower cataract</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Diabetes mellitus</p>\n</td>\n<td width=\312\>\n<p>Snowflake/ Snowstorm cataract</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Downs syndrome</p>\n</td>\n<td width=\312\>\n<p>Stellate/ Snowflake/ Snowstorm cataract</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Hypoparathyroidism (Hypocalcemia)</p>\n<p>Hypovitaminosis D</p>\n</td>\n<td width=\312\>\n<p>Congenital lamellar (zonular) cataract</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Atopic dermatitis</p>\n</td>\n<td width=\312\>\n<p>Shield cataract (anterior subcapsular)</p>\n<p>Posterior subcapsular cataract</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Congenital rubella</p>\n</td>\n<td width=\312\>\n<p>Nuclear cataract</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Galactosemia</p>\n</td>\n<td width=\312\>\n<p>Oil drop cataract</p>\n<p>(Reversible cataract)</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Complicated cataract</p>\n<p>(Iridocyclitis, high myopia)</p>\n</td>\n<td width=\312\>\n<p>Posterior subcapsular cataract</p>\n<p>Breadcrumb appearance</p>\n<p>Polychromatic lustre</p>\n<p>Rainbow cataract</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Blunt trauma</p>\n</td>\n<td width=\312\>\n<p>Vossius ring</p>\n<p>Rosette-shaped cataract</p>\n</td>\n</tr>\n<tr>\n<td width=\312\>\n<p>Steroid induced&nbsp;</p>\n</td>\n<td width=\312\>\n<p>Posterior subcapsular</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1323, 'Ophthalmology', 'PM0076. WHO Programme to Control Trachoma: SAFE Strategy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>S—</strong>Surgery: Trichiasis and entropion correction surgery&nbsp;→ 3°&nbsp;prevention.</li>\n<li><strong>A—</strong>Antibiotics: Oral azithromycin, topical <strong>1% tetracycline</strong>, topical 1% azithromycin&nbsp;→ 2° prevention</li>\n<li><strong>F—</strong>Facial hygiene&nbsp;→ 1° prevention.</li>\n<li><strong>E—</strong>Environmental cleanliness&nbsp;→ primordial prevention</li>\n</ul>\n<p>The strategy depends on the prevalence of trachoma follicle in children (aged 1–9 yrs)</p>\n<ul>\n<li aria-level=\1\>&gt;10% → Mass antibiotic treatment at the community level and FE measures</li>\n<li aria-level=\1\>5 to 10% → Targeted antibiotic treatment (affected families) and FE measures</li>\n<li aria-level=\1\>&lt; 5% → FE measures&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1324, 'Ophthalmology', 'PM0881. Different extracapsular cataract extraction (ECCE) techniques', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Conventional ECCE</strong></p>\n<ul>\n<li>Incision: 10 to 2 oclock</li>\n<li>Anterior capsulotomy\n<ul>\n<li>Can opener’s technique</li>\n<li>Envelope technique</li>\n<li>Continuous circular capsulorrhexis</li>\n</ul>\n</li>\n</ul>\n<p><strong>Manual SICS</strong></p>\n<ul>\n<li>Incision: 4-6 mm</li>\n<li>A self-sealing sclerocorneal tunnel incision is made.</li>\n</ul>\n<p><strong>Phacoemulsification</strong></p>\n<ul>\n<li>Incision:1.5–2.4 mm</li>\n<li>Phacoprobe and foldable IOL is used</li>\n<li>Sutureless surgery is possible with self-sealing sclerocorneal tunnel or clear corneal incision.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1325, 'Ophthalmology', 'PM0878. Important symptoms and their occurrence in cataract', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>\n<table width=\199\>\n<tbody>\n<tr>\n<td><strong>Symptom</strong></td>\n<td><strong>Condition</strong></td>\n</tr>\n<tr>\n<td>Monocular diplopia or polyopia</td>\n<td>Cortical cataract (Incipient stage)</td>\n</tr>\n<tr>\n<td>Color shift</td>\n<td>Nuclear cataract</td>\n</tr>\n<tr>\n<td>Index hypermetropia</td>\n<td>Cortical cataract</td>\n</tr>\n<tr>\n<td>Loss of ability to see objects in bright sunlight, blinded by the&nbsp;light of oncoming headlamps when driving at night</td>\n<td><strong>Posterior subcapsular cataract</strong> and&nbsp;Nuclear cataract</td>\n</tr>\n<tr>\n<td>Second sight/ Myopic shift/ Index myopia</td>\n<td>Nuclear cataract</td>\n</tr>\n<tr>\n<td>Fluctuating refractive error</td>\n<td>Diabetic cataract (due to fluctuating blood sugar levels)</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1326, 'Ophthalmology', 'PM0797. Surgical Modalities Used in Correcting Entropion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\206\>\n<p><strong>Cicatricial entropion</strong></p>\n</td>\n<td width=\206\>\n<p><strong>Senile entropion</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>Anterior lamellar resection</p>\n</td>\n<td width=\206\>\n<p>Transverse everting suture</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>Tarsal wedge resection</p>\n</td>\n<td width=\206\>\n<p><strong>Weiss</strong> operation</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>Transposition of the tarsoconjunctival wedge. (Modified <strong>Ketssey’s</strong> operation)</p>\n</td>\n<td width=\206\>\n<p>Plication of lower lid retractors (<strong>Jones operation</strong>).</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>Posterior lamellar graft</p>\n</td>\n<td width=\206\>\n<p><strong>Quickert</strong> procedure</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1327, 'Ophthalmology', 'PM2486. Early treatment diabetic retinopathy study (ETDRS) classification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Non-proliferative diabetic retinopathy (NPDR):</p>\n<ul>\n<li>Mild NPDR\n<ul>\n<li>At least one microaneurysm must be present</li>\n</ul>\n</li>\n<li>Moderate NPDR\n<ul>\n<li>Microaneurysms/intraretinal hemorrhage in 2 or 3 quadrants</li>\n<li>Early mild intraretinal microvascular abnormalities (IRMA)</li>\n<li>Hard exudates and cotton-wool spots may or may not be present</li>\n</ul>\n</li>\n<li>Severe NPDR - any one of the following (4-2-1 rule)\n<ul>\n<li>4 quadrants of microaneurysms and extensive intraretinal hemorrhages</li>\n<li>2 quadrants of venous beading</li>\n<li>1 quadrant of IRMA changes</li>\n</ul>\n</li>\n<li>Very severe NPDR - any two of the following (4-2-1)\n<ul>\n<li>4 quadrants of microaneurysms and extensive intraretinal hemorrhages</li>\n<li>2 quadrants of venous beading</li>\n<li>1 quadrant of IRMA changes</li>\n</ul>\n</li>\n</ul>\n<p>Proliferative diabetic retinopathy (PDR):</p>\n<ul>\n<li>PDR without high-risk characteristics (Early PDR)\n<ul>\n<li>Early neovascularization at the optic disc (NVD) or neovascularization elsewhere (NVE)</li>\n</ul>\n</li>\n<li>PDR with high-risk characteristics as follows\n<ul>\n<li>NVD &lt; 1/4 disc area with vitreous hemorrhage (VH) or preretinal hemorrhage (PRH)</li>\n<li>NVD 1/4 to 1/3 of disc area with or without VH&nbsp;or PRH</li>\n<li>NVE &gt; 1/2 disc area with VH or PRH</li>\n</ul>\n</li>\n</ul>\n<p>Clinically significant macular edema: 1&nbsp;of the following 3 criteria are present on&nbsp;slit-lamp examination with 90D lens</p>\n<ul>\n<li>Thickening of the retina at or within 500 micron of&nbsp;the center of the fovea.</li>\n<li>Hard exudates at or within 500 micron of the&nbsp;centre of fovea associated with adjacent retinal&nbsp;thickening.</li>\n<li>Development of a zone of retinal thickening one disc&nbsp;diameter or larger in size. At least a part of this should be within one disc diameter of the foveal center.</li>\n</ul>\n<p>Advanced diabetic eye disease:</p>\n<ul>\n<li>Persistent vitreous hemorrhage</li>\n<li>Tractional retinal detachment</li>\n<li>Neovascular glaucoma</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ddc4d7c4ed154be98790b03b3cdc44d8x1280x1308.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1328, 'Ophthalmology', 'PM2451. Clinical findings in keratoconus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><span><strong>External signs:</strong></span></p>\n<ul>\n<li><span><strong>Munson’s sign-&nbsp;</strong>V-shaped conformation of the lower lid produced by the ectatic cornea in downgaze&nbsp;</span></li>\n<li><span><strong>Rizzuti’s sign-</strong>&nbsp;sharply focused conical beam of light near the nasal limbus, produced by lateral illumination of the cornea from the temporal side</span></li>\n</ul>\n<p><span><strong>Slit-lamp signs:</strong></span></p>\n<ul>\n<li><span><strong>Vogt’s striae- </strong>fine&nbsp;<strong>vertical</strong>&nbsp;stress lines in the&nbsp;<strong>deep stroma,&nbsp;</strong>parallel to the steep axis of the cone.&nbsp;May&nbsp;<strong>disappear with external pressure</strong>&nbsp;on the globe.</span></li>\n<li><span><strong>Fleischer ring- </strong>deposition of&nbsp;<strong>iron</strong>&nbsp;in the epithelium in a ring shape at the base of the conical protrusion.</span></li>\n<li><span><strong>Corneal thinning-&nbsp;</strong>predominantly in the&nbsp;<strong>inferotemporal</strong>&nbsp;area.</span></li>\n<li><span><strong>Hydrops- </strong>an acute rupture in <strong>Descemet’s</strong> membrane causing imbibition of aqueous into the corneal stroma. It is a complication of long-standing keratoconus.</span></li>\n<li><span><strong>Prominent corneal nerves-</strong>&nbsp;increased visibility of the corneal nerve fibres.</span></li>\n<li><span><strong>Rupture in Bowman’s layer-</strong>&nbsp;irregular superficial <strong>opacities</strong> that develop due to breaks in Bowman’s layer.</span></li>\n</ul>\n<p><span><strong>Retroillumination signs:</strong></span></p>\n<ul>\n<li><span><strong>Scissoring reflex- </strong>during retinoscopy, two bands of the light beam reflexed from the retina, moves like the blades of the pair of scissors, towards and away from each other. This sign is diagnostic of keratoconus.</span></li>\n<li><span><strong>Oil droplet sign (“Charleaux” sign)-</strong>&nbsp;dark reflex in the area of the cone on observation of cornea in dilated pupil by distant direct ophthalmoscopy.</span></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1329, 'ENT', 'PM2222. Myringotomy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\page\ title=\Page 413\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<div class=\page\ title=\Page 413\><strong>Indications</strong>:</div>\n<ul>\n<li><strong>Acute suppurative otitis media</strong>:\n<ul>\n<li>Severe earache with the bulging tympanic membrane.</li>\n<li>Incomplete resolution with opaque drum and persistent conductive deafness.</li>\n<li>Complications of acute otitis media,e.g.facialparalysis, labyrinthitis or meningitis with the bulging tympanic membrane.</li>\n</ul>\n</li>\n<li><strong>Serous otitis media</strong>.</li>\n<li>Aero-otitis media (to drain fluid and “unlock” the eustachian tube).</li>\n<li>Atelectatic ear (grommet is often inserted for long-term aeration).</li>\n</ul>\n<div class=\page\ title=\Page 413\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Contraindication</strong>: Suspected intratympanic glomus tumor.</p>\n<p><strong>Incisions</strong>:&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<ul>\n<li>In <strong>acute suppurative otitis media</strong>, a <strong>circumferential </strong>incision is made in the <strong>posteroinferior</strong> quadrant of the tympanic membrane, midway between the handle of malleus and tympanic annulus, avoiding injury to the incudostapedial joint.</li>\n<li>In <strong>serous otitis media</strong>, a small <strong>radial</strong> incision is given in the<strong>&nbsp;anteroinferior</strong> quadrant and all the effusion is sucked out.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9ad20391e348495eb8316e0a318c0d79x1280x1521.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\page\ title=\Page 414\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Complications</strong>:</p>\n<ul>\n<li>Injury to incudostapedial joint or stapes.</li>\n<li>Injury to jugular bulb with profuse bleeding, if jugular bulb is high and floor of the middle ear dehiscent.</li>\n<li>Middle ear infection.</li>\n</ul>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1330, 'ENT', 'PM2205. Eagle syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Also called the<strong>&nbsp;kerato-stylohyoidal syndrome</strong>&nbsp;is characterized by an <strong>elongated styloid</strong> process or <strong>calcified stylohyoid</strong> ligament.</p>\n<p><strong>Etiology</strong>: Usually, this condition is seen&nbsp;<strong>post-tonsillectomy</strong> or <strong>post pharyngeal trauma.</strong>&nbsp;It is more common in Females (3:1).</p>\n<p><strong>Clinical Presentation</strong>:</p>\n<ul>\n<li>Commonly bilateral</li>\n<li>Presentation 1:<strong>&nbsp;Classic Eagle syndrome</strong>\n<ul>\n<li>Dull and persistent pharyngeal pain often referred to the ear.</li>\n<li>Pain exacerbated by rotation of the head.</li>\n<li>A <strong>palpable mass or a bulge</strong> in the tonsillar fossa.</li>\n<li>Other associated symptoms like dysphagia, foreign body sensation, <strong>tinnitus</strong> and cervicofacial pain may be seen.</li>\n</ul>\n</li>\n<li>Presentation 2:<strong>&nbsp;Stylocarotid syndrome</strong>\n<ul>\n<li>Compression of the internal or external carotid artery by medially or laterally rotated styloid process.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Treatment</strong>:&nbsp;<strong>Styloidectomy</strong> in those not responding to conservative treatment with <strong>analgesics.</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1331, 'ENT', 'PM1819. Auditory Brainstem Implant', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Used in case of <strong>bilateral acoustic neuroma</strong> where the auditory nerve has been destroyed by tumor or by surgery</li>\n<li>It <strong>bypasses auditory nerve </strong>and<strong> directly stimulates the cochlear nucleus</strong></li>\n<li>Placed in lateral recess of the<strong> fourth ventricle</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1332, 'ENT', 'PM1818. BAHA (Bone Anchored Hearing Aid)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It replaces the external auditory canal and middle ear and <strong>directly stimulates cochlea</strong>.</p>\n<p><strong>Indications</strong>:</p>\n<ul>\n<li>When air-conduction (AC) hearing aid cannot be used:\n<ul>\n<li><strong>Canal atresia</strong>, congenital or acquired, not amenable to treatment</li>\n<li>Chronic ear discharge, not amenable to treatment</li>\n<li>Excessive feedback and discomfort from air-conduction hearing aid</li>\n</ul>\n</li>\n<li><strong>Conductive or mixed hearing loss</strong>, e.g. otosclerosis and tympanosclerosis where surgery is contraindicated</li>\n<li><strong>Single-sided</strong> hearing loss</li>\n</ul>\n<p><strong>Eligibility</strong>:</p>\n<ul>\n<li><strong>Cochlea and nerve</strong> should be <strong>functional</strong></li>\n<li>BC threshold should be better than or equal to 45 dB on PTA</li>\n</ul>\n<p><strong>Components</strong>:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/b38dc43aae2c4e68ab9eb8c16749f4b6x357x249.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Mechanism of action</strong>:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/1dcc23247c584a25a6ff4276895b9741x292x229.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1333, 'ENT', 'PM1817. Cochlear implant', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>A cochlear implant <strong>replaces the organ of Corti</strong> i.e. when hair cells of the organ of Corti are severely damaged these implants bypass it and <strong>directly stimulate the auditory nerve</strong>.</p>\n<p><strong>Indication</strong>: Bilateral severe <strong>sensorineural hearing loss i.e. &gt; 70 dB</strong>.</p>\n<p><strong>Components</strong>:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/6b73504428414062b50a8d5d2a7c7f0fx599x465.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Preoperative</strong> investigation: Complete audiological evaluation and HRCT and MRI (to detect the structure of cochlea, cochlear nerve and CNS abnormalities).</p>\n<p><strong>Surgical</strong> <strong>approach</strong>: Two surgical techniques to approach the cochlea for implantation are the <strong>facial recess approach</strong> (via facial recess) and the <strong>pericanal technique</strong> (via EAC).</p>\n<p><strong>Postoperatively</strong>: Activation of the device after 3-4 weeks and evaluation is by HRCT (MRI is contraindicated).</p>\n<p><strong>Contraindications</strong>:</p>\n<ul>\n<li>Absence of cochlea (Michel aplasia)</li>\n<li>Deafness due to absent cochlear nerve, lesions of cochlear nerve or lesions of the central auditory pathway</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1334, 'ENT', 'PM1807. Inner Ear Abnormalities', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Anomaly </strong></span></td>\n<td><span><strong>Defect</strong></span></td>\n<td><span><strong>Notable features</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Scheibe dysplasia</strong> <strong>&nbsp;</strong></span></td>\n<td><span>Dysplasia of the <strong>cochlea and saccule</strong></span></td>\n<td>\n<p><span><strong>Most common</strong> inner ear anomaly</span></p>\n<p><span>Also called <strong>cochleosaccular</strong> dysplasia</span></p>\n<p><span><strong>Autosomal recessive </strong>nonsyndromic inheritance</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Alexander dysplasia</strong> <strong>&nbsp;</strong></span></td>\n<td><span>Dysplasia of the<strong> basal turn </strong>of the membranous<strong> cochlea</strong></span></td>\n<td><span>Hearing loss at&nbsp;<strong>high frequencies</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Bing- Siebenmann dysplasia</strong></span></td>\n<td><span>The complete absence of <strong>membranous labyrinth</strong></span></td>\n<td><span>Since the bony structures and vestibule are fully formed, it <strong>cannot be detected radiologically</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Michel aplasia</strong></span></td>\n<td>\n<p><span>A <strong>complete absence</strong> of bony and membranous labyrinth including the petrous apex is absent</span></p>\n</td>\n<td><span>Hearing aids or cochlear implantation <strong>does not help</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Mondini dysplasia</strong> <strong>&nbsp;</strong> <strong>&nbsp;</strong></span></td>\n<td>\n<p><span>The basal coil is present or<strong> cochlea is 1.5 turns</strong></span></p>\n</td>\n<td>\n<p><span>Condition is <strong>unilateral or bilateral</strong></span></p>\n<p><span>Seen in syndromes like:</span></p>\n<ul>\n<li><span>Pendred syndrome</span></li>\n<li><span>Waardenburg syndrome</span></li>\n<li><span>Branchio-oto-renal syndrome</span></li>\n<li><span>Treacher-Collins syndrome</span></li>\n<li><span>Wildervanck syndrome</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1335, 'ENT', 'PM1800. Tuning fork tests', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Tests</strong></td>\n<td><strong>Normal</strong></td>\n<td>\n<div><strong>Conductive</strong><strong>&nbsp;</strong></div>\n<div><strong>loss</strong></div>\n</td>\n<td>\n<div><strong>Sensorineural</strong></div>\n<div><strong>loss</strong></div>\n</td>\n</tr>\n<tr>\n<td><strong>Rinne</strong></td>\n<td>AC &gt; BC (Rinne +)</td>\n<td>BC &gt; AC (Rinne -)</td>\n<td>AC &gt; BC (Rinne +)</td>\n</tr>\n<tr>\n<td><strong>Weber</strong></td>\n<td>Center</td>\n<td>Lateralized to the affected ear</td>\n<td>Lateralized to the normal ear</td>\n</tr>\n<tr>\n<td><strong>Absolute bone conduction</strong></td>\n<td>Normal</td>\n<td>Normal</td>\n<td>Reduced</td>\n</tr>\n<tr>\n<td><strong>Schwabach</strong></td>\n<td>Normal</td>\n<td>Lengthened</td>\n<td>Shortened</td>\n</tr>\n<tr>\n<td><strong>Bing</strong></td>\n<td>Positive</td>\n<td>Negative</td>\n<td>Positive</td>\n</tr>\n<tr>\n<td><strong>Gelle</strong></td>\n<td>Positive</td>\n<td>Negative (ossicular lesions)</td>\n<td>Positive</td>\n</tr>\n</tbody>\n</table>\n<p>AC- Air conduction; BC- Bone conduction.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1336, 'ENT', 'PM1755. BERA (Brainstem Evoked Response Audiometry) or ABR (Auditory Brainstem Response)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It is an<strong>&nbsp;objective test </strong>that<strong> r</strong><strong>ecords electrical activity </strong>occurring in the auditory pathway.</p>\n<p>Normally, 7 waves are produced in the first 10ms.&nbsp;</p>\n<ul>\n<li>Wave I – distal part of the cochlear nerve</li>\n<li>Wave II –proximal part of the cochlear nerve</li>\n<li>Wave III – cochlear nucleus</li>\n<li>Wave IV – superior olivary complex</li>\n<li><strong>Wave V – lateral lemniscus</strong></li>\n<li>Wave VI &amp; VII – inferior colliculus</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1f9167544929446482f04a6b10c3109dx1280x851.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Findings:</p>\n<ul>\n<li>Conductive or cochlear pathology- delayed wave-I but inter-peak latency of I-V is normal</li>\n<li>Retrocochlear pathology- wave-I present, rest of the waves absent</li>\n<li><strong>Acoustic neuroma</strong> or vestibular schwannoma- increased inter-peak latency of wave I-V and increased inter-aural latency of wave <strong>V &gt; 0.2ms.</strong></li>\n</ul>\n<p>Uses:</p>\n<ul>\n<li>To objectively find hearing threshold- <strong>wave-V</strong> appears 10dB above the hearing level obtained through PTA</li>\n<li>Best audiometric test for:\n<ul>\n<li>Confirming <strong>hearing loss in infants</strong></li>\n<li>Diagnosing <strong>acoustic neuroma</strong></li>\n</ul>\n</li>\n<li>\n<ul>\n<li>Differentiating cochlear and retro-cochlear hearing loss</li>\n<li>Diagnosing non-organic hearing loss.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1337, 'ENT', 'PM1754. OAEs - Otoacoustic emissions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It is an <strong>objective test</strong> that records the low-intensity&nbsp;sounds produced by&nbsp;the<strong> outer hair cells</strong> of a<strong> normal cochlea</strong>.</p>\n<p>It is of two types:</p>\n<ul>\n<li><strong>Spontaneous </strong>type- it is generated spontaneously and is present in 50% of normal individuals.</li>\n<li><strong>Evoked </strong>types- also called<strong>&nbsp;</strong>Kemp echoes or cochlear echoes, are generated <strong>in response to sound stimulus</strong> and found in <strong>all individuals</strong> with<strong> normal hearing</strong>. The two subtypes are transient evoked and distortion product.</li>\n</ul>\n<p>The applications are as follows:</p>\n<ul>\n<li><strong>Screening test</strong> for<strong>&nbsp;neonates</strong>,<strong> infants</strong>,<strong>&nbsp;</strong>and <strong>small children</strong>&nbsp;for deafness due to inner ear causes.</li>\n<li>Helps to <strong>differentiate cochlear and retrocochlear hearing loss-</strong>&nbsp;normal OAE indicates normal cochlea and hence retrocochlear pathology in a patient with sensorineural deafness.</li>\n<li><strong>Early detection</strong> of<strong> noise-induced hearing loss</strong>-<strong>&nbsp;</strong>since it is generated by outer hair cells that are prone to damage by noise trauma.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1338, 'ENT', 'PM1753. Speech audiometry', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Consists of two components:</p>\n<ul>\n<li><strong>Speech reception threshold</strong>:&nbsp;The minimum intensity at which 50% of the words are repeated correctly by the patient.</li>\n<li><strong>Speech discrimination score</strong>: The patient’s ability to understand speech.\n<ul>\n<li>Percentage of phonetically balanced words delivered <strong>30dB above SRT</strong> which are identified correctly.</li>\n<li>In normal persons and those with conductive hearing loss, a high score of 90–100% can be obtained.</li>\n<li>It is reduced in cochlear lesions, very poor and out of proportion to hearing loss in retrocochlear hearing loss, and worst in cortical deafness.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Roll-over phenomenon:</strong></p>\n<ul>\n<li>Feature of <strong>retrocochlear hearing loss</strong>.</li>\n<li>When speech intensity is increased above a particular level, SDS falls instead of maintaining a plateau as in cochlear deafness.</li>\n</ul>\n<p>Uses:</p>\n<ul>\n<li>To differentiate organic from non-organic hearing loss.</li>\n<li>To differentiate cochlear from retrocochlear lesions.</li>\n<li>To find the intensity at which discrimination score is the best which is useful for <strong>fitting a hearing aid</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8e75c7e16b9045ad89595ed0ca1b4b06x1280x1416.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1339, 'ENT', 'PM1752. The differences between cochlear and retrocochlear hearing loss', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Test</strong></span></div>\n</td>\n<td>\n<div><span><strong>Cochlear hearing loss</strong></span></div>\n</td>\n<td>\n<div><span><strong>Retrocochlear hearing loss</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong><span>Recruitment </span></strong><span>(ABLB test)</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n<td>\n<div><span>Absent</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>*</span><strong><span>SISI score </span></strong><span>(Short Increment Sensitivity Index)</span></div>\n</td>\n<td>\n<div><span>70 – 100%</span></div>\n</td>\n<td>\n<div><span>0 – 20%&nbsp;</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong><span>Acoustic reflex threshold</span></strong></div>\n</td>\n<td>\n<div><span>Decreased due to recruitment</span></div>\n</td>\n<td>\n<div><span>Increased</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>**</span><strong><span>Tone decay </span></strong><span>(nerve fatigue)</span></div>\n</td>\n<td>\n<div><span>Absent</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong><span>Acoustic reflex decay </span></strong><span>(nerve fatigue)</span></div>\n</td>\n<td>\n<div><span>Absent</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong><span>OAEs</span></strong></div>\n</td>\n<td>\n<div><span>Absent</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong><span>BERA </span></strong><span>(Best test)</span></div>\n</td>\n<td>\n<div><span>Delayed wave-I, rest are normal</span></div>\n</td>\n<td>\n<div><span>Only wave-I is present, rest are absent or affected</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong><span>Speech discrimination score</span></strong></div>\n</td>\n<td>\n<div>\n<ul>\n<li><span>Reduced</span></li>\n<li><span>Roll over phenomenon absent</span></li>\n</ul>\n</div>\n</td>\n<td>\n<div>\n<ul>\n<li><span>Very poor</span></li>\n<li><span>Roll over phenomenon present</span></li>\n</ul>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n<p>*<strong>Short Increment Sensitivity Index</strong>: A normal ear can’t differentiate short increments of sound but a recruiting ear can. SISI test is started sound 20db above the hearing threshold of the patient and 20 increments of 1db are given every 5 seconds. The total number of increments heard by the patient is recorded. SISI score of <strong>70-100% is seen in cochlear deafness</strong> and of <strong>0-20% in retrocochlear deafness</strong>.</p>\n<p>** <strong>Threshold tone decay</strong>: It is a function of nerve fatigue. A Tone of 4000Hz is presented at 5dB above the patient’s threshold of hearing for 60 seconds. A normal ear can hear continuously for a minute but a patient with abnormal hearing stops hearing before 1 minute. Loudness is increased until the patient can hear the sound. If loudness has to be increased by <strong>more than 30dB, it indicates retrocochlear hearing loss</strong>.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1340, 'ENT', 'PM1750. Pure tone audiometry (PTA)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>A pure tone is the sound of a single frequency. An <strong>audiometer</strong> is a device that <strong>generates pure tones</strong> and its frequency can be increased or decreased by 5Hz.</p>\n<p>The&nbsp;<strong>threshold for air conduction&nbsp;</strong>(AC) of sound frequencies from 125-8000 Hz and the&nbsp;<strong>threshold for bone conduction&nbsp;</strong>(BC) of sound frequencies from 250-4000 Hz is measured and the result is plotted on an audiogram.</p>\n<div>Normal thresholds:</div>\n<div>\n<ul>\n<li>For&nbsp;<strong>AC</strong>:<strong>&nbsp;15 dB</strong></li>\n<li>For&nbsp;<strong>BC</strong>:<strong>&nbsp;25 dB</strong></li>\n</ul>\n</div>\n<p><strong>Symbols</strong> used in pure tone audiometry:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/08e1a8592af442298a505488323105bex1280x1116.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>Findings in PTA audiogram</strong></td>\n</tr>\n<tr>\n<td>Conductive hearing loss</td>\n<td>AC abnormal, BC normal, air-bone gap present</td>\n</tr>\n<tr>\n<td>Sensorineural hearing loss</td>\n<td>Both AC and BC are abnormal and no air-Bone gap</td>\n</tr>\n<tr>\n<td>Mixed hearing loss</td>\n<td>Both AC and BC abnormal and air-bone gap present</td>\n</tr>\n<tr>\n<td>Presbycusis, ototoxicity, noise-induced hearing loss (higher frequencies affected first)</td>\n<td>Downsloping or descending audiogram&nbsp;</td>\n</tr>\n<tr>\n<td>Early stages of Menieres disease (lower frequencies affected first)</td>\n<td>Upsloping or ascending audiogram</td>\n</tr>\n<tr>\n<td>Congenital hearing loss and cochlear otosclerosis (mid-frequency hearing loss)</td>\n<td>U-shaped or trough-shaped or cookie bite shaped audiogram</td>\n</tr>\n<tr>\n<td>Early cases of noise-induced hearing loss</td>\n<td>\n<p>Acoustic dip - characteristic dip in both AC and BC at 4000 Hz</p>\n</td>\n</tr>\n<tr>\n<td>Otosclerosis</td>\n<td>&nbsp;Carharts notch- dip at 2000 Hz in BC curve</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1341, 'ENT', 'PM1749. Natural resonance and efficiency of auditory apparatus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>External auditory canal - 3000 Hz</p>\n<p>Tympanic membrane - 800–1600 Hz</p>\n<p>Middle ear - 800 Hz</p>\n<p>Ossicular chain - 500–2000 Hz</p></div><!---->\n      <!---->\n    </div><!---->'),
(1342, 'ENT,', 'PM1417. Radiographic views of temporal bone', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/faab4d9568ab46429ea2965f1bd7ff4ax1280x2076.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ed5393f78f8949db975815b967d2b4dex1280x2076.JPEG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1343, 'ENT', 'PM0835. Meniere’s disease vs. Otosclerosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Meniere’s Disease</strong></p>\n</td>\n<td>\n<p><strong>Otosclerosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Middle age (M&gt;F)</p>\n</td>\n<td>\n<p>Middle age (F&gt;&gt;M)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Unilateral</p>\n</td>\n<td>\n<p>Bilateral</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sensory </strong>neural hearing loss</p>\n</td>\n<td>\n<p><strong>Conductive</strong> Hearing loss</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cochlear pathology (endolymphatic system)</p>\n</td>\n<td>\n<p>Middle ear pathology (stapes footplate)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1344, 'ENT', 'PM0760. Signs in Glomus Tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Sign</strong></div>\n</td>\n<td>\n<div><strong>Seen on</strong></div>\n</td>\n<td>\n<div><strong>What is seen</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Rising sun</strong></div>\n</td>\n<td>\n<div>Otoscopy</div>\n</td>\n<td>\n<div>Tumor arising from floor</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Brown sign</strong></div>\n</td>\n<td>\n<div>Otoscopy</div>\n</td>\n<td>\n<div>On increasing the ear canal pressure, tumor pulsates and then blanches</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Phelp sign</strong></div>\n</td>\n<td>\n<div>CT</div>\n</td>\n<td>\n<div>Loss of carotico-jugular crest</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1345, 'ENT', 'PM0758. Common sites of ear tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Tumor</strong></p>\n</td>\n<td>\n<p><strong>Most common site</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sebaceous cyst</p>\n</td>\n<td>\n<p>Post auricular sulcus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dermoid cyst</p>\n</td>\n<td>\n<p>Post auricular area</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Keloid</p>\n</td>\n<td>\n<p>Pinna around the piercing site</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cutaneous horn</p>\n</td>\n<td>\n<p>Helix</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acoustic neuroma</p>\n</td>\n<td>\n<p>Vestibular Nerve</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Squamous cell Carcinoma</p>\n</td>\n<td>\n<p>Helix</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Basal cell Carcinoma</p>\n</td>\n<td>\n<p>Helix &amp; tragus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Malignant Melanoma</p>\n</td>\n<td>\n<p>Anywhere</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1346, 'ENT', 'PM0678. Fractures of temporal bone', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\496\>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Fracture pattern</strong></span></div>\n</td>\n<td>\n<div><span><strong>Longitudinal </strong></span></div>\n</td>\n<td>\n<div><span><strong>Transverse</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Incidence</strong></span></div>\n</td>\n<td>\n<div><span>80%</span></div>\n</td>\n<td>\n<div><span>20%</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Incidence of facial nerve injury</strong></span></div>\n</td>\n<td>\n<div><span>20%</span></div>\n</td>\n<td>\n<div><span>50%</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Onset</strong></span></div>\n</td>\n<td>\n<div><span>Delayed</span></div>\n</td>\n<td>\n<div><span>Immediate</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Segment involved</strong></span></div>\n</td>\n<td>\n<div><span>Tympanic</span></div>\n</td>\n<td>\n<div><span>Meatal/ labyrinthine</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Type of injury</strong></span></div>\n</td>\n<td>\n<div><span>Parietal blow</span></div>\n</td>\n<td>\n<div><span>Occipital blow</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Structures injured</strong></span></p>\n</td>\n<td>\n<p><span>Tympanic membrane - ear bleed</span></p>\n<p><span>Tegmen - CSF otorrhoea</span></p>\n<p><span>Ossicles - Conductive hearing loss</span></p>\n</td>\n<td>\n<p><span>Labyrinth - Vertigo</span></p>\n<p><span>8<sup>th</sup> nerve - Sensorineural hearing loss</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1347, 'ENT', 'PM0672. Eponyms of the ear', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Eponym</strong></p>\n</td>\n<td>\n<p><strong>Description</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Boxer’s/ Cauliflower ear</p>\n</td>\n<td>\n<p>Organized hematoma of pinna</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Surfer’s ear</p>\n</td>\n<td>\n<p>Exostosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Swimmer’s ear</p>\n</td>\n<td>\n<p>Diffuse otitis externa</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1348, 'ENT', 'PM0670. Congenital anomalies of pinna', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Condition</strong></p>\n</td>\n<td>\n<p><strong>Abnormality</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Microtia</strong></p>\n</td>\n<td>\n<p>Small pinna</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Anotia</strong></p>\n</td>\n<td>\n<p>Absent pinna and stenosis of outer EAC</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Bat ear</strong></p>\n</td>\n<td>\n<p>Absent anti-helix</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mozart ear</strong></p>\n</td>\n<td>\n<p>Fusion of helix &amp; antihelix</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Wildermuth ear</strong></p>\n</td>\n<td>\n<p>Absent helix</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Macrotia</strong></p>\n</td>\n<td>\n<p>Large pinna</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1349, 'ENT', 'PM0548. Parasympathetic/ secretomotor (general visceral efferent) innervation of glands', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Nervus intermedius, also called the nerve of Wrisberg, is the sensory &amp; secretomotor component of the facial nerve.</li>\n<li>The main trunk of the facial nerve, as it exits the brainstem, only carries motor fibers.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\ width=\343\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><span><strong>LACRIMAL GLANDS</strong></span></td>\n<td><span><strong>SUBMANDIBULAR GLAND</strong></span><br><span><strong>SUBLINGUAL GLAND</strong></span></td>\n<td><span><strong>PAROTID GLANDS</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Nucleus</strong></span></td>\n<td>\n<p><span>Lacrimatory nucleus</span></p>\n<p><span>Pons</span></p>\n</td>\n<td>\n<p><span>Superior salivatory&nbsp;nucleus</span></p>\n<p><span>Pons</span></p>\n</td>\n<td>\n<p><span>Inferior salivatory nucleus</span></p>\n<p><span>Pons</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Carried by</strong></span></td>\n<td>\n<div><span>Nervus intermedius</span></div>\n<div><span>Facial nerve (VII)</span></div>\n</td>\n<td>\n<div><span>Nervus intermedius</span></div>\n<div><span>Facial nerve (VII)</span></div>\n</td>\n<td>\n<div><span>Glossopharyngeal (IX)</span></div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Nerve</strong></span></td>\n<td><span>Greater superficial petrosal nerve</span></td>\n<td><span>Chorda tympani</span></td>\n<td><span>Lesser petrosal nerve</span></td>\n</tr>\n<tr>\n<td><span><strong>Formation</strong></span></td>\n<td><span>Branches at 1st genu/&nbsp;Geniculate ganglion</span></td>\n<td><span>Branches in vertical&nbsp;segment</span></td>\n<td><span>Formed over the promontory from&nbsp;tympanic plexus</span></td>\n</tr>\n<tr>\n<td><span><strong>Exits middle</strong></span><br><span><strong>ear through</strong></span></td>\n<td><span>Facial hiatus</span></td>\n<td><span>Petrotympanic fissure/&nbsp;</span><br><span>Canal of Huguier</span></td>\n<td><span>Hiatus for lesser petrosal nerve</span></td>\n</tr>\n<tr>\n<td><span><strong>Course</strong></span></td>\n<td><span>Traverses in middle cranial</span><br><span>fossa floor, exits through&nbsp;foramen lacerum and joins deep petrosal nerve in</span><br><span>foramen lacerum</span></td>\n<td><span>---</span></td>\n<td><span>Travels on the floor of</span><br><span>middle cranial fossa &amp;</span><br><span>exits via foramen ovale</span></td>\n</tr>\n<tr>\n<td><span><strong>Further course</strong></span></td>\n<td><span>Forms nerve of Pterygoid</span><br><span>canal/ Vidian nerve</span></td>\n<td><span>Enters infratemporal fossa and joins lingual nerve</span></td>\n<td><span>Enters infratemporal fossa</span></td>\n</tr>\n<tr>\n<td><span><strong>Ganglion</strong></span></td>\n<td><span>Pterygopalatine ganglion</span></td>\n<td><span>Submandibular ganglion</span></td>\n<td><span>Otic ganglion</span></td>\n</tr>\n<tr>\n<td><span><strong>Supplied by</strong></span></td>\n<td><span>Lacrimal branch of&nbsp;Ophthahnmic division (V<sub>1</sub>) of</span><br><span>Trigeminal nerve</span></td>\n<td><span>---</span></td>\n<td><span>Auriculotemporal branch&nbsp;of Mandibular nerve (V3)</span></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1350, 'ENT', 'PM0537. Inner ear fluids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Perilymph</strong></td>\n<td><strong>Endolymph</strong></td>\n</tr>\n<tr>\n<td><strong>Found in</strong></td>\n<td>Bony labyrinth</td>\n<td>Membranous labyrinth</td>\n</tr>\n<tr>\n<td><strong>Similar to</strong></td>\n<td>Extracellular fluid</td>\n<td>Intracellular fluid</td>\n</tr>\n<tr>\n<td><strong>Rich in</strong></td>\n<td>Na<sup>+</sup> ions</td>\n<td>K<sup>+</sup> ions</td>\n</tr>\n<tr>\n<td><strong>Formation</strong></td>\n<td>Filtrate of blood/ directly from CSF</td>\n<td>Produced by stria vascularis</td>\n</tr>\n<tr>\n<td><strong>Drainage</strong></td>\n<td>Into CSF via cochlear aqueduct</td>\n<td>Absorbed through endolymphatic sac</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1351, 'ENT', 'PM0504. Tympanic membrane', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cc5ed4afe3674efebb3e4fc14f9c6370x1280x1436.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Parts of the tympanic membrane</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<div><strong>Pars&nbsp;Tensa</strong></div>\n</td>\n<td>\n<div><strong>Pars&nbsp;Flaccida</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Taut</div>\n</td>\n<td>\n<div>Loose</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Middle fibrous layer is well organized</div>\n</td>\n<td>\n<div>Middle fibrous layer is not well organized</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Contains annulus tympanicus</div>\n</td>\n<td>Also called&nbsp;Shrapnell’s&nbsp;membrane</td>\n</tr>\n<tr>\n<td>\n<div>Transmits sound</div>\n</td>\n<td>\n<div>Does not transmit&nbsp;sound</div>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Layers of the tympanic membrane</strong></p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Outer</strong></td>\n<td><strong>Middle</strong></td>\n<td><strong>Inner</strong></td>\n</tr>\n<tr>\n<td><strong>Layer</strong></td>\n<td>Epithelium</td>\n<td>Fibrous</td>\n<td>Mucosa</td>\n</tr>\n<tr>\n<td><strong>Continuous with</strong></td>\n<td>Skin of EAC</td>\n<td>-</td>\n<td>Middle ear mucosa</td>\n</tr>\n<tr>\n<td><strong>Derived from</strong></td>\n<td><strong>Ectoderm</strong></td>\n<td><strong>Mesoderm</strong></td>\n<td><strong>Endoderm</strong></td>\n</tr>\n<tr>\n<td><strong>Made of</strong></td>\n<td>-</td>\n<td>Circular, radial &amp; parabolic fibers</td>\n<td>-</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1352, 'ENT', 'PM0456. Causes of ET Obstruction', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\>\n<div><span><strong>Mechanical</strong></span></div>\n</td>\n<td>\n<div><span><strong>Functional</strong></span></div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Extrinsic/ block at opening</strong></span></td>\n<td><span><strong>Intrinsic/ edema</strong></span></td>\n<td rowspan=\2\>\n<p><span>Cleft palate</span></p>\n<p><span>Down’s syndrome</span></p>\n<p><span>Neuromuscular disorders</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Adenoid hypertrophy</span></p>\n<p><span>Nasopharyngeal tumor</span></p>\n<p><span>DNS</span></p>\n<p><span>Sinonasal polyps</span></p>\n<p><span>Sinusitis</span></p>\n</td>\n<td>\n<p><span>URTI</span></p>\n<p><span>Allergy</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1353, 'ENT', 'PM0455. Valsalva vs. Toynbee', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><strong>Valsalva</strong></p>\n</td>\n<td>\n<p><strong>Toynbee</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Maneuver</strong></p>\n</td>\n<td>\n<p><strong>Blow</strong> with closed nose &amp; mouth</p>\n</td>\n<td>\n<p><strong>Swallow</strong> with closed nose &amp; mouth</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pressure build-up in the nasopharynx</strong></p>\n</td>\n<td>\n<p><strong>Positive</strong></p>\n</td>\n<td>\n<p><strong>Negative</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Test of</strong></p>\n</td>\n<td>\n<p>ET patency</p>\n</td>\n<td>\n<p>ET function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Result on TM</strong></p>\n</td>\n<td>\n<p>TM moves out</p>\n</td>\n<td>\n<p>TM moves inwards/ retracts</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Contraindications</strong></p>\n</td>\n<td>\n<p>Atrophic TM</p>\n<p>Acute infections in the nose and pharynx</p>\n</td>\n<td>\n<p>Atrophic TM</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1354, 'ENT', 'PM0434. Austins classification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Based on the&nbsp;presence or absence of <strong>malleus handle</strong> (M) and&nbsp;<strong>stapes suprastructure</strong> (S) assuming<strong> incus is absent </strong>in all cases.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type</strong></p>\n</td>\n<td>\n<p><strong>Malleus handle</strong></p>\n</td>\n<td>\n<p><strong>Stapes superstructure</strong></p>\n</td>\n<td>\n<p><strong>Reconstruction</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A</p>\n</td>\n<td>\n<p>M +</p>\n</td>\n<td>\n<p>S +</p>\n</td>\n<td>\n<p>PORP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B</p>\n</td>\n<td>\n<p>M +</p>\n</td>\n<td>\n<p>S -</p>\n</td>\n<td>\n<p>TORP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C</p>\n</td>\n<td>\n<p>M -</p>\n</td>\n<td>\n<p>S +</p>\n</td>\n<td>\n<p>PORP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>D</p>\n</td>\n<td>\n<p>M -</p>\n</td>\n<td>\n<p>S -</p>\n</td>\n<td>\n<p>TORP</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>PORP</strong>: Partial Ossicular Reconstruction Prosthesis; <strong>TORP</strong>: Total Ossicular Reconstruction Prosthesis</p></div><!---->\n      <!---->\n    </div><!---->'),
(1355, 'ENT', 'PM0433. Zollner and Wullstein’s classification/ Types of tympanoplasty', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Findings</strong></td>\n<td><strong>Procedure</strong><br><strong>Graft placed over</strong></td>\n</tr>\n<tr>\n<td><strong>Type I&nbsp;</strong>(or) Myringoplasty</td>\n<td>All ossicles are intact</td>\n<td>Over/ under remnant TM over the handle of malleus</td>\n</tr>\n<tr>\n<td><strong>Type II</strong></td>\n<td>Malleus eroded</td>\n<td>Over the remnant malleus/ incus</td>\n</tr>\n<tr>\n<td><strong>Type III </strong>(or)<strong>&nbsp;</strong>Columella (or) Myringostapediopexy</td>\n<td>Malleus &amp; incus absent</td>\n<td>Over stapes superstructure</td>\n</tr>\n<tr>\n<td><strong>Type IV (</strong>or) Cavum minor</td>\n<td>All ossicles eroded</td>\n<td>Over ET and the round&nbsp;window, leaving mobile&nbsp;footplate exposed</td>\n</tr>\n<tr>\n<td><strong>Type V</strong> (or) Fenestration surgery</td>\n<td>Fixed footplate</td>\n<td>An opening made in the lateral semicircular canal (an alternative pathway)</td>\n</tr>\n<tr>\n<td><strong>Type VI </strong>(or)<strong>&nbsp;</strong>Sono-Inversion</td>\n<td>---</td>\n<td>The round window is left&nbsp;exposed and receives sound and the oval window is&nbsp;covered (reversed pathway)</td>\n</tr>\n</tbody>\n</table>\n<p>Type III is called columella because it resembles the middle ear of birds. They have a single ossicle. Type VI is not part of the original Zollner-Wullstein classification. It is a recent addition.</p>\n<p>Image showing different types of tympanoplasty:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b3551577d5db4681a219a079fd77d451x1280x2266.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>SCC: Semicircular canal.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1356, 'ENT', 'PM0429. Signs of impending complication in attico-antral disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\175\>\n<p><strong>Sign</strong></p>\n</td>\n<td width=\463\>\n<p><strong>Complication</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\175\>\n<p><strong>Pain</strong></p>\n</td>\n<td width=\463\>\n<p>Extradural, Perisinus, Brain abscess</p>\n</td>\n</tr>\n<tr>\n<td width=\175\>\n<p><strong>Vertigo</strong></p>\n</td>\n<td width=\463\>\n<p>Labyrinthine fistula, Labyrinthitis</p>\n</td>\n</tr>\n<tr>\n<td width=\175\>\n<p><strong>Persistent headache</strong></p>\n</td>\n<td width=\463\>\n<p>Intracranial complication</p>\n</td>\n</tr>\n<tr>\n<td width=\175\>\n<p><strong>Facial weakness</strong></p>\n</td>\n<td width=\463\>\n<p>Facial Paralysis</p>\n</td>\n</tr>\n<tr>\n<td width=\175\>\n<p><strong>Fever</strong></p>\n</td>\n<td width=\463\>\n<p>Intracranial Complication</p>\n</td>\n</tr>\n<tr>\n<td width=\175\>\n<p><strong>Nausea/Vomiting</strong></p>\n</td>\n<td width=\463\>\n<p>Intracranial Complication</p>\n</td>\n</tr>\n<tr>\n<td width=\175\>\n<p><strong>Neck rigidity</strong></p>\n</td>\n<td width=\463\>\n<p>Meningitis</p>\n</td>\n</tr>\n<tr>\n<td width=\175\>\n<p><strong>Diplopia</strong></p>\n</td>\n<td width=\463\>\n<p>Gradenigo’s syndrome/ Petrous apecitis</p>\n</td>\n</tr>\n<tr>\n<td width=\175\>\n<p><strong>Ataxia</strong></p>\n</td>\n<td width=\463\>\n<p>Labyrinthitis, Cerebellar abscess</p>\n</td>\n</tr>\n<tr>\n<td width=\175\>\n<p><strong>Abscess around ear</strong></p>\n</td>\n<td width=\463\>\n<p>Mastoiditis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1357, 'ENT', 'PM0428. Types of tympanic membrane perforation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3d2a5a97af904fdc978dff0fb940ae59x1280x2082.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1358, 'ENT', 'PM0427. Microbiology of the middle ear', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p>&nbsp;</p>\n</td>\n<td>\n<div><strong>ASOM</strong></div>\n</td>\n<td>\n<div><strong>CSOM</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Aerobic organisms</strong></div>\n</td>\n<td>\n<div><strong><em>Streptococcus pneumoniae</em></strong><span> (30%)</span></div>\n<div>&nbsp;</div>\n<div><em>H. influenzae</em> (20%)</div>\n<div>&nbsp;</div>\n<div><em>M. catarrhalis</em> (12%)</div>\n<div>&nbsp;</div>\n<div><em>Strep. pyogenes</em></div>\n<div>&nbsp;</div>\n<div><em>Staph. aureus</em></div>\n<div>&nbsp;</div>\n<div><em>Pseudomonas aeruginosa</em></div>\n</td>\n<td>\n<div>\n<div><strong>Mixed growth <br></strong><span>(</span><span>Most common)</span></div>\n</div>\n<div>&nbsp;</div>\n<div><em>Pseudomonas aeruginosa</em></div>\n<div>&nbsp;</div>\n<div><em>Proteus</em></div>\n<div>&nbsp;</div>\n<div><em>E. coli</em></div>\n<div>&nbsp;</div>\n<div><em>Staph. aureus</em></div>\n<div>&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Anaerobic organisms</strong></div>\n</td>\n<td>\n<div>---</div>\n</td>\n<td>\n<div><em>Bacteriodes fragilis</em></div>\n<div>&nbsp;</div>\n<div>Anaerobic Streptococci</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1359, 'ENT', 'PM0425. Classification of CSOM', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>\n<table>\n<tbody>\n<tr>\n<td><span>&nbsp;</span></td>\n<td><span><strong>Tubo-tympanic</strong></span></td>\n<td><span><strong>Attico-antral</strong></span></td>\n</tr>\n<tr>\n<td><span>Old name</span></td>\n<td><span><strong>Safe</strong> type</span></td>\n<td><span><strong>Unsafe</strong> ear</span></td>\n</tr>\n<tr>\n<td><span>Recent name</span></td>\n<td><span><strong>Mucosal</strong> variant</span></td>\n<td><span><strong>Squamosal</strong> disease</span></td>\n</tr>\n<tr>\n<td><span>Discharge</span></td>\n<td>\n<p><span>Profuse</span></p>\n<p><span>Mucoid</span></p>\n<p><span>Non-foul smelling</span></p>\n<p><span>Non-blood stained</span></p>\n</td>\n<td>\n<p><span>Scanty</span></p>\n<p><span>Purulent</span></p>\n<p><span>Foul-smelling</span></p>\n<p><span>May be blood stained</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Site</span></td>\n<td><span>Mostly in the <strong>pro-tympanum,</strong> i.e., part of middle ear around the Eustachian tube orifice</span></td>\n<td><span>Mostly involves the epi-tympanum/<strong>attic</strong> and involves the <strong>mastoid antrum</strong> via the aditus</span></td>\n</tr>\n<tr>\n<td><span>Perforation</span></td>\n<td><span><strong>Central </strong>(most common: Antero-inferior quadrant)</span></td>\n<td>\n<p><span><strong>Attic </strong>(Pars flaccida) or</span></p>\n<p><span><strong>Marginal</strong> (most common: Postero-superior)</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Granulations</span></td>\n<td><span>Uncommon</span></td>\n<td><span><strong>Common</strong></span></td>\n</tr>\n<tr>\n<td><span>Polyp</span></td>\n<td><span>Pale, rare</span></td>\n<td><span>Fleshy<strong> red, common</strong></span></td>\n</tr>\n<tr>\n<td><span>Cholesteatoma</span></td>\n<td><span>Absent</span></td>\n<td><span><strong>Present</strong></span></td>\n</tr>\n<tr>\n<td><span>Complications</span></td>\n<td><span>Rare</span></td>\n<td><span><strong>Common</strong></span></td>\n</tr>\n<tr>\n<td><span>Treatment</span></td>\n<td><span>Medical/ surgical (Tympanoplasty)</span></td>\n<td><span>Always&nbsp;surgical (Mastoidectomy)</span></td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1360, 'ENT', 'PM0424. Classification and theories for origin of cholesteatoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div class=\abstr\>\n<div class=\\>\n<p><span><strong>Classification</strong>:</span></p>\n<p><span><strong>Congenital</strong> cholesteatoma is that which has its nidus of trapped squamous epithelium present at birth.</span></p>\n<p><span><strong>Primary acquired</strong> cholesteatoma is associated with a defect in the pars flaccida.&nbsp;</span></p>\n<p><span><strong>Secondary acquired</strong> cholesteatoma is associated with a defect in the pars tensa.</span></p>\n<div class=\abstr\>\n<div class=\\>\n<p><strong>Tertiary acquired</strong> cholesteatoma is defined as that which occurs behind a normal-appearing tympanic membrane as the result of implantation of an antecedent middle ear inflammation.</p>\n</div>\n</div>\n<div class=\aux\>&nbsp;</div>\n</div>\n</div>\n<table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Type</strong></span></div>\n</td>\n<td>\n<div><span><strong>Theory</strong></span></div>\n</td>\n<td>\n<div><span><strong>Description</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Congenital Cholesteatoma</strong></span></div>\n</td>\n<td>\n<div><span>Congenital <strong>cell rests</strong></span></div>\n</td>\n<td>\n<div><span>The presence of congenital <strong>epithelial cell rests</strong> within the middle ear cleft/ temporal bone.</span></div>\n</td>\n</tr>\n<tr>\n<td rowspan=\3\>\n<div><span><strong>Primary Acquired Cholesteatoma</strong></span></div>\n</td>\n<td>\n<div><span><strong>Wittmaack’s</strong> theory of retraction pockets</span></div>\n</td>\n<td>\n<div><span><strong>Negative middle ear pressure</strong> leads to the formation of <strong>retraction pockets</strong> (usually in the posterosuperior part of pars tensa and the pars flaccida) which <strong>accumulates keratin debris</strong>.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Ruedi’s</strong> theory of basal cell hyperplasia</span></div>\n</td>\n<td>\n<div><span>The basal cell layer of the&nbsp;<strong>germinal layer of skin proliferates</strong> in response to infection &amp; other stimuli.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Sade’s</strong> Metaplasia theory</span></div>\n</td>\n<td>\n<div><span>Repeated infections (<strong>Otitis media with effusion</strong>) lead to metaplasia of middle ear epithelium into squamous type.</span></div>\n</td>\n</tr>\n<tr>\n<td rowspan=\2\>\n<div><span><strong><span>Secondary Acquired Cholesteatoma</span></strong></span></div>\n</td>\n<td>\n<div><span><strong>Habermann’s</strong> theory of epithelial invasion</span></div>\n</td>\n<td>\n<div><span><strong>Marginal perforation</strong> leads to <strong>ingrowth</strong> of squamous epithelium of the meatus or outer surface of the tympanic membrane into middle ear.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Sade’s</strong> Metaplasia theory</span></div>\n</td>\n<td>\n<div><span>Repeated infections (<strong>ASOM</strong>/<strong>CSOM</strong>) lead to metaplasia of middle ear epithelium into squamous type.</span></div>\n</td>\n</tr>\n</tbody>\n</table>\n<p>ASOM: Acute suppurative otitis media; CSOM: Chronic suppurative otitis media.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1361, 'ENT,', 'PM0344. Signs of base of skull fracture', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Signs of Base of Skull Fracture</strong></p>\n<ul>\n<li>Bilateral periorbital haematoma (<strong>raccoon eyes</strong>)</li>\n<li>Battle’s sign (bruising over mastoid)</li>\n<li>CSF rhinorrhoea or otorrhoea</li>\n<li>Haemotympanum or bleeding from ear</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1362, 'ENT', 'PM0326. Diseases of the middle ear - Terminologies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Disease</strong></span></td>\n<td><span><strong>Pathology&nbsp;</strong></span></td>\n<td><span><strong>Duration</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span>Otitis media with effusion (OME)</span></p>\n<p><span>aka. Glue ear/secretory/serous/ mucoid otitis media&nbsp;</span></p>\n</td>\n<td>\n<p><span>Fluid </span><span>in the </span><span>middle ear&nbsp;</span></p>\n</td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute suppurative otitis media (ASOM)&nbsp;</span></p>\n<p><span>aka.&nbsp;Acute otitis media (AOM)</span></p>\n</td>\n<td>\n<p><span>Pyogenic inflammation </span><span>of middle ear cleft&nbsp;</span></p>\n</td>\n<td><span>≤ 6 weeks</span></td>\n</tr>\n<tr>\n<td><span>Chronic suppurative otitis media (CSOM)&nbsp;</span></td>\n<td>\n<p><span>Pyogenic inflammation of middle ear </span><span>cleft </span><span>with </span><span>perforation of&nbsp;</span><span>the tympanic&nbsp;</span><span>membrane&nbsp;</span></p>\n</td>\n<td><span>&gt; 6 weeks</span></td>\n</tr>\n<tr>\n<td><span>Recurrent otitis media&nbsp;</span></td>\n<td><span>Pyogenic inflammation of middle ear cleft&nbsp;</span></td>\n<td><span>&nbsp;≥3 episodes within 6 months or ≥4 episodes within 12 months</span></td>\n</tr>\n<tr>\n<td><span>Aero-otitis media /Otitic barotrauma</span></td>\n<td><span>Barotrauma to the middle ear&nbsp;</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1363, 'ENT', 'PM0316. Light house sign', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Pulsatile discharge</strong> through a pin-hole perforation.</li>\n<li>It suggests a <strong>reservoir of infection</strong> in the mastoid and middle ear.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1364, 'ENT', 'PM0315. Stages of acute suppurative otitis media', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Stage</strong></span></div>\n</td>\n<td>\n<div><span><strong>Pathology</strong></span></div>\n</td>\n<td>\n<div><span><strong>Symptoms</strong></span></div>\n</td>\n<td>\n<div><span><strong>Signs</strong></span></div>\n</td>\n<td>\n<div><span><strong>Treatment</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Tubal occlusion</strong></span></div>\n</td>\n<td>\n<div><span>ET block &gt; retraction of TM</span></div>\n</td>\n<td>\n<div><span>Mild earache, deafness</span></div>\n</td>\n<td>\n<div><span>Retracted TM</span></div>\n<div><span>CHL</span></div>\n</td>\n<td>\n<div><span>Decongestants</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Pre suppuration</strong></span></div>\n</td>\n<td>\n<div><span>Invasion of microbes</span></div>\n</td>\n<td>\n<div><span>Throbbing pain, deafness. fever</span></div>\n</td>\n<td>\n<div><span>Cartwheel TM</span></div>\n<div><span>CHL</span></div>\n</td>\n<td>\n<div><span>Add antibiotics</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Suppuration</strong></span></div>\n</td>\n<td>\n<div><span>Exudation</span></div>\n<div><span>and</span></div>\n<div><span>pus formation</span></div>\n</td>\n<td>\n<div><span>Excruciating earache, deafness, high fever</span></div>\n</td>\n<td>\n<div><span>Bulging TM with pus</span></div>\n<div><span>CHL</span></div>\n</td>\n<td>\n<div><span>Add myringotomy to drain the pus</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Resolution</strong></span></div>\n</td>\n<td>\n<div><span>TM ruptures and pus drains</span></div>\n</td>\n<td>\n<div><span>Ear discharge and patient starts to feel better</span></div>\n</td>\n<td>\n<div><span>Perforation in AI quadrant</span></div>\n<div><span>CHL improves</span></div>\n</td>\n<td>\n<div><span>Ear mopping with the decongestants and antibiotics</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Complication</strong></span></div>\n</td>\n<td>\n<div><span>Virulent organism/poor immunity</span></div>\n</td>\n<td colspan=\3\>\n<div><span>Mastoiditis/ Infratemporal/ Intracranial complications</span></div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><span><strong>ET</strong>: Eustachian tube; <strong>TM</strong>: Tympanic Membrane; <strong>CHL</strong>: Conductive Hearing Loss; <strong>AI</strong>: Antero-Inferior quadrant</span></p></div><!---->\n      <!---->\n    </div><!---->'),
(1365, 'ENT', 'PM0227. Types of curves in tympanogram', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6b4b5cb4346c46c897b05917cdbf8c21x1280x3090.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1366, 'ENT,', 'PM2086. Radiographic views of paranasal sinuses and mastoid', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/26c5041ba2364f75aa278cad0885db67x1280x5194.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1367, 'ENT', 'PM1472. Esthesioneuroblastoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Esthesioneuroblastoma is known as <strong>olfactory neuroblastoma</strong> or <strong>olfactory placode tumor.</strong></p>\n<p>It arises from the <strong>olfactory epithelium</strong> in the upper 1/3 rd of the nose. It has a <strong>bimodal</strong> age distribution (10-20 and 50-60 years)</p>\n<p>Clinical features:</p>\n<ul>\n<li aria-level=\1\><strong>Unilateral nasal obstruction</strong></li>\n<li aria-level=\1\><strong>Epistaxis</strong>&nbsp;</li>\n<li aria-level=\1\>Friable<strong> cherry-red</strong>, <strong>vascular</strong> polypoidal mass in the upper third of the nasal cavity</li>\n</ul>\n<p>Investigation of choice is <strong>biopsy after</strong> appropriate <strong>imaging</strong> showing the extent of the tumor.</p>\n<p>The tumor may be <strong>low grade</strong> with <strong>pseudorosettes</strong> or <strong>high grade</strong> with <strong>nuclear pleomorphism</strong>. Lymph node metastasis can occur in 10-15% cases.</p>\n<p>Treatment is <strong>surgery</strong> which can be combined with <strong>preoperative chemotherapy</strong> or <strong>radiotherapy.</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1368, 'ENT', 'PM1471. Inverted Papilloma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Inverted papilloma is also known as <strong>transitional cell papilloma</strong> or <strong>Ringertz tumor</strong> or <strong>Schneiderian papilloma</strong>. It&nbsp;is&nbsp;a common benign tumour of the paranasal sinuses.<strong>&nbsp;</strong>It is a <strong>premalignant</strong> condition with 10-15% chances of turning malignant.</p>\n<p>Etiology:<strong> Human papillomavirus</strong> has been implicated in its etiology.</p>\n<p>Origin: Arises from the <strong>lateral wall of the nose</strong> from the non-olfactory epithelium of the nose</p>\n<p>Clinical features:</p>\n<ul>\n<li aria-level=\1\>More common in <strong>men</strong>.</li>\n<li aria-level=\1\>Predominance between 40-70 years.</li>\n<li aria-level=\1\><strong>Unilateral nasal obstruction</strong>, nasal <strong>discharge</strong>, and epistaxis are the main presenting symptoms</li>\n<li aria-level=\1\>It is a <strong>locally invasive</strong> tumor and can invade orbit and paranasal sinuses.</li>\n<li aria-level=\1\>Proptosis, diplopia, and lacrimation can result from <strong>orbital invasion</strong></li>\n</ul>\n<p>Findings: It is seen as a<strong> pale polypoidal mass</strong> resembling a simple nasal polyp.</p>\n<p>Investigations: A <strong>biopsy</strong> is needed for diagnosis.</p>\n<p>Treatment: <strong>Medial maxillectomy</strong> via <strong>l</strong><strong>ateral rhinotomy</strong> or <strong>midfacial degloving approach.&nbsp;Radiotherapy</strong> can lead to <strong>malignancy.</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1369, 'ENT', 'PM1430. Functions of the paranasal sinuses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Air-conditioning of the inspired air</strong> by providing large surface area over which the air is humidified and warmed</li>\n<li>To provide <strong>resonance to voice</strong></li>\n<li>To act as <strong>thermal insulators</strong> to protect the delicate structures in the orbit and the cranium from variations of intranasal temperature</li>\n<li>To<strong> lighten the skull bones</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1370, 'ENT', 'PM1421. Indications of FESS', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Indications</strong></p>\n<ul>\n<li>Chronic bacterial sinusitis unresponsive to adequate medical treatment.</li>\n<li>Recurrent acute bacterial sinusitis</li>\n<li>Polypoid rhinosinusitis (diffuse nasal polyposis)</li>\n<li>Fungal sinusitis with fungal ball or nasal polypi</li>\n<li>Antrochoanal polyp</li>\n<li>Mucocele of frontoethmoid or sphenoid sinus</li>\n<li>Control of epistaxis by endoscopic cautery.</li>\n<li>Removal of foreign body from the nose or sinus</li>\n<li>Endoscopic septoplasty</li>\n</ul>\n<p><strong>Advanced nasal endoscopic techniques</strong></p>\n<ul>\n<li>Removal of benign tumours, e.g. inverted papillomas or angiofibromas.</li>\n<li>Orbital abscess or cellulitis management.</li>\n<li>Dacryocystorhinostomy</li>\n<li>Repair of CSF leak</li>\n<li>Pituitary surgery</li>\n<li>Optic nerve decompression</li>\n<li>Orbital decompression for Graves’ disease</li>\n<li>Control of posterior epistaxis (endoscopic clipping of sphenopalatine artery)</li>\n<li>Choanal atresia.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1371, 'ENT', 'PM1416. Radiographic view of sinuses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/f44b95684808454dabf4beb9418b646bx561x267.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/6785a2f95c644527b35544760f9145bfx564x715.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1372, 'ENT', 'PM1413. Symptoms of Sinusitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Symptoms of <strong>maxillary sinusitis</strong>:</p>\n<ul>\n<li><strong>Pain</strong> over the upper jaw, aggravated by stooping, coughing &amp; chewing</li>\n<li>Constitutional symptoms like malaise and fever</li>\n<li><strong>Headache</strong> in the frontal region</li>\n<li>Nasal and postnasal <strong>discharge</strong></li>\n<li>Redness and edema of cheeks</li>\n<li><strong>Tenderness</strong> on pressing over the anterior wall of the antrum</li>\n</ul>\n<p>Symptoms of <strong>frontal sinusitis</strong>:</p>\n<ul>\n<li><strong>Frontal headache</strong>/ office headache with characteristic <strong>periodicity</strong> i.e. starts early morning and gradually increases and reaches its&nbsp;peak by about mid-day&nbsp;and then starts subsiding</li>\n<li><strong>Tenderness</strong> on pressing on the floor of the frontal sinus, just above the medial canthus</li>\n<li>Nasal <strong>discharge</strong></li>\n<li><strong>Edema</strong> of the upper eyelid</li>\n</ul>\n<p>Symptoms of <strong>ethmoid sinusitis</strong>:</p>\n<ul>\n<li><strong>Pain</strong> over the bridge of the nose and deep to the eye that is <strong>aggravated by the movements of the eyeball</strong></li>\n<li><strong>Edema of both eyelids</strong>,</li>\n<li>Nasal <strong>discharge</strong></li>\n</ul>\n<p>Symptoms of <strong>sphenoid sinusitis</strong>:</p>\n<ul>\n<li><strong>Headache</strong> localized to <strong>occiput or vertex</strong></li>\n<li>Postnasal discharge</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1373, 'ENT', 'PM1324. Midline lethal granuloma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Associated with EBV</li>\n<li>Also called:&nbsp;Non-healing midline granuloma (or) midline granulomas reticulosis (or)&nbsp;Stewart’s granuloma (or) nasal T-cell lymphoma</li>\n<li><strong>Nasal obstruction and epistaxis</strong> are the presenting features</li>\n<li>It is <strong>locally invasive</strong> causing destruction of midfacial structures</li>\n<li>Histologically polymorphic lymphoid tissue with angiocentric and angioinvasive features is seen</li>\n<li>Cells express <strong>T cell markers</strong> like<strong> CD56</strong></li>\n<li>Localized T-cell lymphoma is treated by <strong>radiation</strong> while a disseminated disease requires <strong>chemotherapy</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1374, 'ENT', 'PM1314. Nasal Features in Different Stages of Syphilis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Stage&nbsp;</strong></td>\n<td><strong>Feature&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Early congenital syphilis</td>\n<td>Snuffles</td>\n</tr>\n<tr>\n<td>Late congenital syphilis</td>\n<td>Gumma on the nasal septum</td>\n</tr>\n<tr>\n<td>Primary syphilis</td>\n<td>Primary chancre of the vestibule of nose</td>\n</tr>\n<tr>\n<td>Secondary syphilis</td>\n<td>Simple rhinitis with crusting and fissuring&nbsp;in the nasal vestibule</td>\n</tr>\n<tr>\n<td>Tertiary form of acquired syphilis</td>\n<td>Gumma on the nasal septum</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1375, 'ENT', 'PM1310. Nasal glioma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>It is a portion that nipped off of the <strong>encephalocele</strong> during embryonic development</li>\n<li><strong>60% are extranasal</strong>, 30% are intranasal, and 10% are both intranasal and extranasal</li>\n<li>Usually presents as a firm, subcutaneous swelling causing <strong>nasal obstruction</strong></li>\n<li><strong>Furstenbergs test</strong> is negative</li>\n<li><strong>CT scan </strong>reveals<strong> bony details</strong></li>\n<li><strong>MRI </strong>reveals<strong> soft tissue details</strong></li>\n<li>Its communication with the cranial cavity is cut off, so there will be <strong>no CSF leak</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->'),
(1376, 'ENT', 'PM1308. Choanal atresia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It is due to the&nbsp;<strong>persistence of bucconasal membrane</strong> which separates primitive oropharynx from the primitive nasopharynx. It has the following features:</p>\n<ul>\n<li><strong>30% of cases are bony </strong>and 70% are mixed</li>\n<li>Unilateral &gt; bilateral</li>\n<li>Unilateral cases may be asymptomatic and present in adult life</li>\n<li><strong>Bilateral cases</strong> are <strong>life-threatening</strong> and present with <strong>respiratory distress</strong></li>\n<li>Associated with <strong>CHARGE</strong> syndrome\n<ul>\n<li><strong>C</strong>- Coloboma of the eye</li>\n<li><strong>H</strong>- Heart defects</li>\n<li><strong>A</strong>- Atresia of choana</li>\n<li><strong>R</strong>- Retarded growth and development</li>\n<li><strong>G</strong>- Genital anomalies</li>\n<li><strong>E</strong>- Ear anomalies and hearing loss.</li>\n</ul>\n</li>\n</ul>\n<p><strong>CT scan</strong> is the investigation of choice</p>\n<p>Image:&nbsp;Membranous, bilateral choanal atresia in a newborn</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/dff547f2da0c4b1fba7b0b4222c897f8x799x472.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Immediate management involves placing a feeding nipple with a large hole at the mouth to force the baby to mouth-breathe -&nbsp;<strong>McGoverns technique.</strong></p>\n<p>Definitive treatment consists of correction of atresia by a&nbsp;<strong>trans-nasal </strong>or<strong> trans-palatal </strong>approach.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1377, 'ENT', 'PM1297. Antrochoanal Polyp', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Main etiological factors:&nbsp;<strong>Infection </strong>and<strong> allergy</strong></li>\n<li>Usually affects <strong>children</strong></li>\n<li>Site of origin: Mucosa of the&nbsp;<strong>maxillary antrum</strong></li>\n<li>Clinical features: <br>\n<ul>\n<li>Usually single and <strong>unilateral</strong></li>\n<li>Unilateral nasal obstruction which becomes bilateral when it <strong>grows posteriorly</strong> and obstructs opposite choana</li>\n<li>Mucoid nasal discharge</li>\n<li><strong>Hyponasal voice</strong></li>\n</ul>\n</li>\n<li>Findings: <br>\n<ul>\n<li>Grows posteriorly and usually missed on anterior rhinoscopy</li>\n<li>Posterior rhinoscopy: Globular mass filling the choana or nasopharynx</li>\n</ul>\n</li>\n<li>Investigation:<strong>&nbsp;</strong><strong>Nasal endoscopy:&nbsp;</strong>Shows nasal polyps that are pale, gelatinous and pedunculated. <strong>NonContrast CT scan: </strong>Gives exquisite bony detail of the paranasal sinus anatomy. It is the primary diagnostic imaging modality.</li>\n<li>Treatment of choice: <strong>FESS</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1378, 'ENT', 'PM1296. Ethmoidal polyps', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Main etiological factor is <strong>allergy</strong></li>\n<li>Usually affects the <strong>middle-aged</strong></li>\n<li>Site of origin: <strong>Lateral wall</strong> of the nose</li>\n<li>Clinical features: Nasal stuffiness, headache (due to sinusitis), sneezing, watery nasal discharge, anosmia/ hyposmia, mass protruding from the nasal cavity</li>\n<li>Findings: <br>\n<ul>\n<li>Anterior rhinoscopy: <strong>Multiple</strong>, <strong>bilateral</strong> polypi that are smooth, glistening, grape-like masses often pale in color</li>\n<li>They may be sessile or pedunculated, <strong>insensitive to probing</strong> and do not bleed on touch</li>\n</ul>\n</li>\n<li>Investigation of choice: <strong>NCCT</strong></li>\n<li>Treatment of choice:&nbsp;<strong>FESS</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1379, 'ENT', 'PM1293. Septal Haematoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Septal hematoma is a collection of blood <strong>under the perichondrium or periosteum</strong> of the nasal septum</li>\n<li>Causes: Trauma, septal surgery and bleeding disorders</li>\n<li>Clinical features: Bilateral nasal <strong>obstruction</strong> (most common presenting feature), frontal headache</li>\n<li>Treatment: <br>\n<ul>\n<li><strong>Aspiration</strong> of small hematomas</li>\n<li><strong> Incision and drainage</strong> of large hematomas followed by nasal packing</li>\n<li>Systemic antibiotics to prevent abscess formation</li>\n</ul>\n</li>\n<li>Complications: Septal <strong>abscess</strong>, depression of dorsum, permanently thickened septum</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1380, 'ENT', 'PM1275. Clinical Features of Atrophic Rhinitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Atrophic rhinitis is more common in <strong>females</strong>&nbsp;and usually <strong>starts at puberty.&nbsp;</strong>It is a <strong>bilateral condition.</strong></p>\n<ul>\n<li>Symptoms: <br>\n<ul>\n<li><strong>Foul smell</strong> from the nose</li>\n<li><strong>Nasal</strong> <strong>obstruction</strong> in spite of roomy chambers due to large crusts filling nasal cavity</li>\n<li><strong>Epistaxis</strong> on removing of the crusts</li>\n<li>Anosmia due to degeneration of nerve elements (<strong>merciful anosmia</strong>).</li>\n</ul>\n</li>\n<li>Signs: <br>\n<ul>\n<li>Greenish or greyish black dry crusts covering the turbinates and septum</li>\n<li>After removal of crusts, nasal cavities appear <strong>roomy</strong> with <strong>atrophy</strong> <strong>of turbinates</strong></li>\n<li>Nasal mucosa appears <strong>pale.</strong></li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1381, 'ENT', 'PM1274. Etiology of atrophic rhinitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Etiology of <strong>primary atrophic rhinitis</strong>:</p>\n<ul>\n<li>Hereditary- Involves more than one member of a family</li>\n<li>Endocrinal- More common in females, starts at puberty and regresses after menopause</li>\n<li>Racial- More common in mongoloid and caucasian races</li>\n<li>Nutritional deficiency- Vitamin A, D, iron deficiencies</li>\n<li>Autoimmune- Antigens of the nasal mucosa</li>\n<li>Organism- Klebsiella ozaenae</li>\n</ul>\n<p>Etiology of <strong>secondary atrophic rhinitis</strong>:</p>\n<ul>\n<li>Specific infections like syphilis, lupus, leprosy and, rhinoscleroma</li>\n<li>Long-standing purulent sinusitis</li>\n<li>Radiotherapy to nose</li>\n<li>Excessive surgical removal of turbinates</li>\n<li>Diphtheroids, Proteus vulgaris, Escherichia coli, staphylococci and streptococci</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1382, 'ENT', 'PM0946. Le-Forts classification of Maxillary Fracture', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div><strong>Le-Fort I</strong>&nbsp;is a&nbsp;<strong>transverse fracture of the maxilla</strong></div>\n<ul>\n<li>Fracture line passes through the lower part of nasal septum, maxillary antra and the pterygoid plates</li>\n<li>It separates palate from the rest of the face leading to <strong>floating teeth or palate</strong></li>\n<li>Also called<strong> Guerin’s fracture.</strong>&nbsp;</li>\n</ul>\n<div><strong>Le-Fort II </strong>is a<strong> pyramidal fracture</strong></div>\n<ul>\n<li>Fracture line passes through the root of the nose, lacrimal bone, floor of the orbit, upper part of the maxillary sinus and pterygoid plates</li>\n<li>X-ray or CT appears like <strong>hanging maxilla</strong></li>\n<li>It is associated with <strong>CSF rhinorrhea.</strong></li>\n</ul>\n<div><strong>Le-Fort III </strong>is<strong> craniofacial dysjunction</strong>&nbsp;i.e., facial skeleton completely disconnected from its cranial attachment</div>\n<ul>\n<li>Fracture line passes through the root of the nose, ethmo-frontal junction, superior orbital fissure, lateral wall of the orbit, fronto-zygomatic and temporo-zygomatic sutures and the upper part of pterygoid plates</li>\n<li>It is also associated with <strong>CSF rhinorrhea.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7eb9c177d2f6496e9495eb0cf7a80430x1280x1597.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1383, 'ENT', 'PM0942. Features of CSF rhinorrhea', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Reservoir sign </strong>- In CSF rhinorrhea, the fluid which had collected in the sinuses, particularly sphenoid, empties into the nose.</li>\n<li><strong>Double ring sign </strong>or<strong>&nbsp;halo sign </strong>or<strong>&nbsp;target sign</strong>&nbsp;-<em>&nbsp;</em>CSF is mixed with blood and collected on a piece of filter paper. It shows <strong>a central red spot </strong>(blood) and a<strong> peripheral lighter halo</strong>.</li>\n</ul>\n<p>The image below shows the double ring sign in CSF rhinorrhoea:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/56e07b5ce2ae4838a27d1b747bf7ceccx1280x1269.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>CSF<strong> can’t be sniffed back</strong>.</li>\n<li>CSF<strong> doesn’t stiffen </strong>the handkerchief.</li>\n</ul>\n<p>&nbsp;</p>\n<p>Note: The repeated reappearance of pus immediately after cleaning, in the external auditory canal of patients with acute mastoiditis/coalescent mastoiditis is also referred to as Reservoir sign.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1384, 'Paediatrics,', 'PM1799. Acute Stridor/ Noisy breathing', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Stridor indicates an upper airway problem. Look for a history of foreign body aspiration and signs of toxicity.</p>\n<p>Important differentials:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Condition</strong></td>\n<td><strong>&nbsp;Findings</strong></td>\n</tr>\n<tr>\n<td><strong>Croup</strong></td>\n<td>\n<p>Non-toxic, viral prodrome, barking cough</p>\n<p>X-ray neck shows <strong>steeple sign</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Epiglottitis</strong></td>\n<td>\n<p>Toxic child, drooling saliva</p>\n<p>Lateral X-ray neck shows <strong>thumb sign</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Diphtheria</strong></td>\n<td>Unimmunized child, cervical lymph nodes (bull neck), dirty grey/ white membrane</td>\n</tr>\n<tr>\n<td><strong>Foreign body aspiration</strong></td>\n<td>Choking, decreased air entry, unilateral hyperinflation</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1385, 'ENT,', 'PM1690. Plunging ranula', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>It is a form of mucous retention cyst that can arise from both <strong>sublingual</strong> and <strong>submandibular </strong>salivary glands and presents as <strong>dumb-bell</strong>-shaped swelling that is soft, fluctuant and painless in the submandibular or submental region of the neck.</p>\n<ul>\n<li>It shows <strong>cross fluctuation</strong> along the <strong>mylohyoid </strong></li>\n<li>Treatment is by&nbsp;<strong>removal of the&nbsp;sublingual gland</strong>&nbsp;and <strong>aspiration</strong> of the saliva out from the sac. The <strong>cervical approach</strong> which was previously used is now <strong>contraindicated</strong>.</li>\n<li>Conditions with cross fluctuation are :\n<ul>\n<li>Plunging ranula</li>\n<li>Bilocular hydrocele</li>\n<li>Compound palmar ganglion</li>\n<li>Psoas abscess</li>\n</ul>\n</li>\n</ul>\n<p>Note:</p>\n<p class=\p1\>The term ‘ranula’ is applied to a mucous extravasation cyst that arises from the sublingual gland.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1386, 'Anaesthesia,', 'PM1801. Child vs Adult airway', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/06e37d23253040d9a15882a1a6b4112ax1062x2301.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Feature</strong></div>\n</td>\n<td>\n<div><strong>Child</strong></div>\n</td>\n<td>\n<div><strong>Adults</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Position</strong></div>\n</td>\n<td>\n<div>Opposite C3-C4</div>\n</td>\n<td>\n<div>Opposite C5-C6</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Epiglottis</strong></div>\n</td>\n<td>\n<div>Omega-shaped</div>\n</td>\n<td>\n<div>Leaf-shaped</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Thyroid cartilage</strong></div>\n</td>\n<td>\n<div>Flat</div>\n</td>\n<td>\n<div>Angulated</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Larynx</strong></div>\n</td>\n<td>\n<div>Conical</div>\n</td>\n<td>\n<div>Cylindrical</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Narrowest part</strong></div>\n</td>\n<td>\n<div>Subglottis</div>\n</td>\n<td>\n<div>Subglottis (70%)</div>\n<div>Glottis (30%)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Submucosal tissue</strong></div>\n</td>\n<td>\n<div>More and loose</div>\n</td>\n<td>\n<div>Less and dense</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Laryngeal cartilages</strong></div>\n</td>\n<td>\n<div>Soft and collapsible</div>\n</td>\n<td>\n<div>Hard and ossified</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1387, 'ENT', 'PM1096. Sites and subsites of the larynx (AJCC Classification)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Sites</strong></p>\n</td>\n<td>\n<p><strong>Subsites</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\5\>\n<p>Supraglottis</p>\n</td>\n<td>\n<p>Suprahyoid epiglottis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Infrahyoid epiglottis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Arytenoids</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Aryepiglottic folds with the corniculate and cuneiform cartilages</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>False/Ventricular cords</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<p>Glottis</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<p>Subglottis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f03f3cdd32a146d491a76cbe67545db4x666x600.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Image :&nbsp;&nbsp;A top view of the larynx (seen with a mirror).</p></div><!---->\n      <!---->\n    </div><!---->'),
(1388, 'ENT', 'PM1094. Various Vocal Cord Palsies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Type of palsy</strong></span></td>\n<td><span><strong>U/L Abductor</strong></span></td>\n<td><span><strong>B/L Abductor</strong></span></td>\n<td><span><strong>U/L complete</strong></span></td>\n<td><span><strong>B/L complete</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Nerve</strong></span></td>\n<td><span>RLN (left)</span></td>\n<td><span>Both RLNs</span></td>\n<td><span>RLN+SLN (left)</span></td>\n<td><span>Both RLN+SLN</span></td>\n</tr>\n<tr>\n<td><span><strong>Cord position</strong></span></td>\n<td><span>Paramedian &nbsp; |</span></td>\n<td><span>Both in&nbsp; Paramedian &nbsp; ||</span></td>\n<td><span>Cadaveric &nbsp; [</span></td>\n<td><span>cadaveric (intermediate) position [[</span></td>\n</tr>\n<tr>\n<td><span><strong>Voice</strong></span></td>\n<td><span>Hoarse</span></td>\n<td><span>Good</span></td>\n<td><span>Hoarse</span></td>\n<td><span>Aphonia</span></td>\n</tr>\n<tr>\n<td><span><strong>Dyspnea</strong></span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td><span><strong>Aspiration</strong></span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td><span><strong>Treatment</strong></span></td>\n<td><span>Wait &amp; watch (palsy with least consequences)</span></td>\n<td><span>Tracheostomy, lateralization</span></td>\n<td><span>Wait &amp; watch, medialization</span></td>\n<td><span>Tracheostomy + Epiglottopexy</span></td>\n</tr>\n</tbody>\n</table>\n<p><span><strong>Guide:</strong> <strong></strong> is normal moving cord; <strong>|</strong> is paramedian;&nbsp;<strong>[</strong> is cadaveric.</span></p></div><!---->\n      <!---->\n    </div><!---->'),
(1389, 'ENT', 'PM1093. Positions of the Vocal Cord', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ac5dbf3b0d7449279efdc72a549df0a5x1280x1134.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>\n<table width=\120\>\n<tbody>\n<tr>\n<td><strong>Position</strong></td>\n<td><strong>Distance from median</strong></td>\n<td><strong>Seen in</strong></td>\n</tr>\n<tr>\n<td>Median</td>\n<td><strong>0</strong></td>\n<td>During speech/ swallowing</td>\n</tr>\n<tr>\n<td>Paramedian</td>\n<td><strong>1 mm</strong></td>\n<td>Recurrent laryngeal nerve palsy</td>\n</tr>\n<tr>\n<td>Intermediate/ Cadaveric</td>\n<td><strong>3 mm</strong></td>\n<td>Complete paralysis</td>\n</tr>\n<tr>\n<td>Slight abduction</td>\n<td><strong>7 mm</strong></td>\n<td>Normal respiration</td>\n</tr>\n<tr>\n<td>Full abduction</td>\n<td><strong>9 mm</strong></td>\n<td>Strained respiration</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1390, 'ENT', 'PM0931. Differences between adult and infant Larynx', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Feature</strong></p>\n</td>\n<td>\n<p><strong>Infants</strong></p>\n</td>\n<td>\n<p><strong>Adults</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Position</strong></p>\n</td>\n<td>\n<p>Opposite C3-C4</p>\n</td>\n<td>\n<p>Opposite C5-C6</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Epiglottis</strong></p>\n</td>\n<td>\n<p>Omega-shaped</p>\n</td>\n<td>\n<p>Leaf-shaped</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Thyroid cartilage</strong></p>\n</td>\n<td>\n<p>Flat</p>\n</td>\n<td>\n<p>Angulated</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Larynx</strong></p>\n</td>\n<td>\n<p>Conical</p>\n</td>\n<td>\n<p>Cylindrical</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Narrowest part</strong></p>\n</td>\n<td>\n<p>Subglottis</p>\n</td>\n<td>\n<p>Glottis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Submucosal tissue</strong></p>\n</td>\n<td>\n<p>More and loose</p>\n</td>\n<td>\n<p>Less and dense</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Laryngeal cartilages</strong></p>\n</td>\n<td>\n<p>Soft and collapsible</p>\n</td>\n<td>\n<p>Hard and ossified</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1391, 'ENT,', 'PM0403. Precautions during laser airway surgery', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Precautions taken before laser airway surgery-</strong></p>\n<ul>\n<li>Inspired oxygen concentration should be as low as possible</li>\n<li>Nitrous oxide supports combustion, hence avoided</li>\n<li>Endotracheal tube (ETT) cuffs are filled with <strong>saline</strong>&nbsp;instead of air to reduce the risk of fire&nbsp;</li>\n<li>Laser intensity and duration should be at minimum</li>\n<li>Saline-soaked pledgets are placed in the airway to limit the risk of ignition to ETT</li>\n<li>Source of water (eg, 60-mL syringe) should be immediately available in case of fire.</li>\n</ul>\n<p><strong>Management if an airway fire should occur- </strong></p>\n<ul>\n<li>Air/oxygen should immediately be <strong>turned off</strong> at the anaesthesia gas machine</li>\n<li>Airway checked and burning combustible material (eg, an ETT) should be removed</li>\n<li>The fire should be extinguished with <strong>saline.</strong></li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1392, 'ENT', 'PM1298. Laser Application in ENT', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><div>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Indications&nbsp;</strong></span></td>\n<td><span><strong>LASER</strong></span></td>\n</tr>\n<tr>\n<td colspan=\2\><span><strong>Ear</strong></span>&nbsp;</td>\n</tr>\n<tr>\n<td><span>Stapedotomy</span></td>\n<td><strong><span>CO2</span></strong></td>\n</tr>\n<tr>\n<td><span><span>Middle ear adhesion l</span></span><span>ysis</span></td>\n<td><strong><span>Argon</span></strong></td>\n</tr>\n<tr>\n<td colspan=\2\><strong><span>Nose</span>&nbsp;</strong></td>\n</tr>\n<tr>\n<td><span>Polyps</span></td>\n<td rowspan=\2\><strong><span>KTP</span>&nbsp;</strong></td>\n</tr>\n<tr>\n<td><span>Epistaxis</span></td>\n</tr>\n<tr>\n<td colspan=\2\>\n<div><strong><span>Larynx</span></strong></div>\n</td>\n</tr>\n<tr>\n<td><span>Laryngocele</span></td>\n<td rowspan=\5\><strong><span>CO2</span>&nbsp;&nbsp;&nbsp;&nbsp;</strong></td>\n</tr>\n<tr>\n<td><span>Laryngomalacia</span></td>\n</tr>\n<tr>\n<td><span>Stenosis</span></td>\n</tr>\n<tr>\n<td><span>Vocal fold polyps</span></td>\n</tr>\n<tr>\n<td><span>Reinkes edema</span></td>\n</tr>\n<tr>\n<td><span>LASER cordotomy for vocal cord paresis</span></td>\n<td><strong><span>CO2 &gt; KTP</span></strong></td>\n</tr>\n<tr>\n<td colspan=\2\><strong><span>Oral cavity</span></strong></td>\n</tr>\n<tr>\n<td><span>Premalignant (leukoplakia, erythroplakia)</span></td>\n<td rowspan=\4\><strong><span>CO2</span></strong></td>\n</tr>\n<tr>\n<td><span>Carcinoma (verrucous, superficial T1)</span></td>\n</tr>\n<tr>\n<td><span>Lymphangioma</span></td>\n</tr>\n<tr>\n<td><span>Lingual tonsils</span></td>\n</tr>\n<tr>\n<td colspan=\2\><span><strong>Oropharynx</strong></span></td>\n</tr>\n<tr>\n<td><span>Palatine tonsils</span></td>\n<td><strong><span>KTP &gt; CO2</span></strong></td>\n</tr>\n<tr>\n<td><span>T1 and T2 SCC</span></td>\n<td><strong><span>CO2</span></strong></td>\n</tr>\n<tr>\n<td><span>Sleep apnea</span></td>\n<td><strong><span>KTP</span></strong></td>\n</tr>\n<tr>\n<td colspan=\2\><span><strong>Trachea</strong></span></td>\n</tr>\n<tr>\n<td><span>Obstructing malignant lesions</span></td>\n<td><strong><span>Nd:YAG</span></strong></td>\n</tr>\n</tbody>\n</table>\n</div>\n<div>&nbsp;</div></div><!---->\n      <!---->\n    </div><!---->'),
(1393, 'ENT', 'PM2157. Types of Tracheostomy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>High tracheostomy</strong></p>\n<ul>\n<li>Done through the <strong>1<sup>st</sup> tracheal ring</strong></li>\n<li>An opening is made above the isthmus of the thyroid gland&nbsp;</li>\n<li>Done in case of <strong>malignancy</strong> of the larynx</li>\n<li>Increased risk of perichondritis and subglottic stenosis</li>\n</ul>\n<p><strong>Mid tracheostomy</strong></p>\n<ul>\n<li>Done through the <strong>2<sup>nd&nbsp;</sup>- 3<sup>rd</sup></strong> rings</li>\n<li><strong>Most commonly done</strong>&nbsp;tracheostomy</li>\n<li>Isthmus has to be retracted or divided</li>\n</ul>\n<p><strong>Low tracheostomy</strong></p>\n<ul>\n<li>Done through the <strong>4<sup>th&nbsp;</sup>- 5<sup>th</sup></strong> tracheal ring</li>\n<li>Done below the isthmus</li>\n<li>Done when the <strong>airway is blocked</strong> at an upper airway level</li>\n<li>Risk of injuring the great vessels of the neck</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1394, 'Anaesthesia,', 'PM2124. Drugs that should be discontinued prior to surgery', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Drugs that should be discontinued prior to surgery:</p>\n<table width=\834\>\n<tbody>\n<tr>\n<td><strong>Drug</strong></td>\n<td><strong>Duration before discontinuation</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Topical medications</strong></p>\n</td>\n<td>Discontinue on the day of surgery</td>\n</tr>\n<tr>\n<td>\n<p><strong>Diuretics</strong>&nbsp;(except thiazides)&nbsp;</p>\n</td>\n<td>\n<p>Discontinue on the day of surgery</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Oral hypoglycemic agents</strong>&nbsp;</p>\n</td>\n<td>\n<p>Discontinue on the day of surgery</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sildenafil</strong>&nbsp;</p>\n</td>\n<td>\n<p>Discontinue 24 hours before the day of surgery</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>NSAIDs</strong>&nbsp;</p>\n</td>\n<td>Discontinue 48 hours before the day of surgery</td>\n</tr>\n<tr>\n<td>\n<p><strong>Warfarin</strong>&nbsp;</p>\n</td>\n<td>\n<p>Discontinue 4 days before surgery (except for patients having cataract surgery without a bulbar block)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Short-acting&nbsp;Insulins</strong>&nbsp;</p>\n</td>\n<td>Discontinued (except when given by a continuous pump)</td>\n</tr>\n<tr>\n<td>\n<p><strong>Thienopyridines</strong> (e.g., clopidogrel, ticlopidine)&nbsp;</p>\n</td>\n<td>Discontinued (Except in cataract surgery, patients with metallic/drug-eluting stents)</td>\n</tr>\n<tr>\n<td>\n<p><strong>Aspirin</strong>&nbsp;</p>\n</td>\n<td>Discontinued 3 days before the surgery (except in patients with prior PCI, coronary artery disease and stroke)</td>\n</tr>\n<tr>\n<td>\n<p><strong>MAO Inhibitors</strong></p>\n</td>\n<td>Discontinued 2 weeks prior&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1395, 'Anaesthesia,', 'PM2093. Drugs that can be continued on the day of surgery', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ol>\n<li>Antihypertensive medications (Exceptions are&nbsp;ACE Inhibitors and ARB)<strong>&nbsp;</strong></li>\n<li>Cardiac medications (e.g., β-blockers, digoxin)</li>\n<li>Antidepressants, anxiolytics, and other psychiatric medications</li>\n<li>Thyroid medications</li>\n<li>Eye drops</li>\n<li>Heartburn or reflux medications</li>\n<li>Narcotic medications</li>\n<li>Anticonvulsants</li>\n<li>Asthma medications</li>\n<li>Steroids (oral and inhaled)</li>\n<li>Statins</li>\n<li>Levodopa</li>\n<li>Mono Amine Oxidase inhibitors are continued when:(1) Anesthesiologist is comfortable with use of MAO-safe procedures (2) Possibility of exacerbation or precipitation of depressive syndrome.&nbsp;</li>\n</ol>\n<div class=\page\ title=\Page 1127\>&nbsp;</div></div><!---->\n      <!---->\n    </div><!---->'),
(1396, 'Anaesthesia', 'PM0413. Samsoon & Youngs Modified Mallampati Classification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/817eb2ae07634a7b8ef86e6827beefbax1280x2145.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>Samsoon &amp; Youngs Modified Mallampati Classification is used to predict the ease of endotracheal intubation.</p>\n<ul>\n<li>Class I: soft palate, fauces, entire uvula, pillars;</li>\n<li>Class II: soft palate, fauces, the portion of uvula;</li>\n<li>Class III: soft palate, the base of uvula;</li>\n<li>Class IV: hard palate only.</li>\n</ul>\n<p>Initially, the Mallampatti scoring system (1985) had only 3 classes. This was modified by Samsoon and Young to include class 4. Later class 0 was also added.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1397, 'Anaesthesia', 'PM0412. Predictors of Difficult Airway', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Risk factors:</strong></p>\n<ol>\n<li>Obstructive sleep apnea</li>\n<li>History of snoring</li>\n<li>Obesity</li>\n<li>Facial and neck deformities from previous surgery</li>\n<li>Previous head and neck radiation</li>\n<li>Head and neck trauma</li>\n<li>Congenital abnormalities of the head and neck</li>\n<li>Rheumatoid arthritis</li>\n<li>Down syndrome</li>\n<li>Scleroderma</li>\n<li>Cervical spine disease or previous cervical spine surgery</li>\n</ol>\n<p><strong>Specific tests for assessment:</strong></p>\n<ol>\n<li>Mallampati scores (III and IV)</li>\n<li>Thyromental distance less than 6 cm</li>\n<li>Sterno-mental distance &lt;12.5 cm&nbsp;with head in maximum extension</li>\n<li>Increased neck circumference &gt;17 inches in men or &gt;16 inches in women</li>\n<li>Upper lip bite test:&nbsp;Inability to protrude the mandible or lower teeth in front of the upper teeth</li>\n<li>Cormack and Lehane (laryngoscopic view) - Grade III and IV</li>\n</ol>\n<p>Although the presence of these risk factors may not be sensitive in detecting difficult intubation, the absence of these findings indicates ease with intubation.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1398, 'Anaesthesia', 'PM0411. American Society of Anesthesiologists’ Physical Status Classification of Patients', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>American Society of Anesthesiologists Physical Status (<strong>ASA-PS</strong>) classification is used to define relative risk before conscious sedation and surgical anaesthesia&nbsp;and strongly correlates to perioperative risk.</p>\n<p>ASA-PS Classification:</p>\n<table class=\ul100\ border=\0\ width=\100%\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td valign=\top\><strong>Class</strong></td>\n<td valign=\top\><strong>Definition</strong></td>\n<td valign=\top\><strong>Examples, including, but not limited to:</strong></td>\n</tr>\n<tr>\n<td valign=\top\>I</td>\n<td valign=\top\>A normal healthy patient</td>\n<td valign=\top\>Healthy, non-smoking, no or minimal alcohol use</td>\n</tr>\n<tr>\n<td valign=\top\>II</td>\n<td valign=\top\>A patient with mild systemic disease</td>\n<td valign=\top\>Current smoker, well-controlled DM and HTN</td>\n</tr>\n<tr>\n<td valign=\top\>III</td>\n<td valign=\top\>A patient with severe systemic disease</td>\n<td valign=\top\>Poorly controlled DM or HTN, history (&gt;3 months) of MI, CVA, TIA, or CAD or stents.</td>\n</tr>\n<tr>\n<td valign=\top\>IV</td>\n<td valign=\top\>A patient with severe systemic disease that is a constant threat to life</td>\n<td valign=\top\>Recent (&lt; 3 months) MI, CVA, TIA, or CAD/stents</td>\n</tr>\n<tr>\n<td valign=\top\>V</td>\n<td valign=\top\>A moribund patient who is not expected to survive without the operation</td>\n<td valign=\top\>Ruptured abdominal, thoracic aneurysm, massive trauma, intracranial bleed with mass effect</td>\n</tr>\n<tr>\n<td valign=\top\>VI</td>\n<td valign=\top\>A declared brain-dead patient whose organs are being removed for donor purposes</td>\n<td valign=\top\>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1399, 'Anaesthesia', 'PM0186. Various capnography waveforms:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/077e3e46c9eb4180b297ccf7fcc81c5cx1280x4941.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>A</strong>- Obstructive airway or bronchospasm <br><strong>B</strong>- Expiratory valve malfunctioning <br><strong>C</strong>- Inspiratory valve malfunction <br><strong>D</strong>- Normal physiological variant seen in pregnant subjects under GA <br><strong>E</strong>- Curare cleft <br><strong>F</strong>- Rebreathing <br><strong>G</strong>- Esophageal intubation <br><strong>H</strong>- Spontaneous breathing <br><strong>I</strong>-Dual capnogram in one lung transplantation patient. The first peak in phase III is from the transplanted normal lung, whereas the second peak is from the native disease lung. A variation of dual capnogram (steeple sign capnogram – dotted line) is seen if there is a leak around the sidestream sensor port at the monitor <br><strong>J</strong>- Malignant hyperthermia<br><strong>K</strong>- Classic ripple effect during the expiratory pause showing cardiogenic oscillations <br><strong>L</strong>- Sudden rise of baseline and end-tidal PCO2 (PETCO2) due to contamination of the sensor with secretions or water vapor. <br>The gradual rise of baseline and PETCO2 occurs when soda lime is exhausted.  <br><strong>M</strong> -Intermittent mechanical ventilation (IMV) breaths in the midst of spontaneously breathing patient. <br><strong>N</strong> -Cardiopulmonary resuscitation: capnogram showing positive waveforms during each compression.  <br><strong>O</strong>-Capnogram showing rebreathing during inspiration. This is normal in rebreathing circuits such as Mapleson D or Bain circuit.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1400, 'Anaesthesia', 'PM0139. Stages of Anesthesia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>STAGE</td>\n<td>RESPIRATION</td>\n<td>EYE REFLEXES</td>\n<td>URT &amp;<br>RESPIRATORY<br>REFLEXES</td>\n</tr>\n<tr>\n<td>Analgesia</td>\n<td>Regular<br>Small volume</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Excitement</td>\n<td>Irregular</td>\n<td>Eyelash reflex absent</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td colspan=\4\>Anaesthesia</td>\n</tr>\n<tr>\n<td>Plane I</td>\n<td>Regular<br>Large volume</td>\n<td>Eyelid absent<br>Conjunctival&nbsp;depressed</td>\n<td>Pharyngeal &amp;<br>vomiting<br>depressed</td>\n</tr>\n<tr>\n<td>Plane II</td>\n<td>Regular<br>Large volume</td>\n<td>Corneal depressed</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Plane III</td>\n<td>Regular<br>Becoming&nbsp;Diaphragmatic<br>Small volume</td>\n<td>&nbsp;</td>\n<td>Laryngeal&nbsp;depressed</td>\n</tr>\n<tr>\n<td>Plane IV</td>\n<td>Irregular<br>Diaphragmatic<br>Small volume</td>\n<td>&nbsp;</td>\n<td>Carinal&nbsp;depressed</td>\n</tr>\n<tr>\n<td>Overdose</td>\n<td>Apnoea</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1401, 'Anaesthesia', 'PM2493. Basic Life Support (BLS) Algorithm', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/67cce4a491424e00abddb1e32b730ffbx1280x2542.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1402, 'Medicine,', 'PM2295. High quality CPR for adults', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Push hard:&nbsp;<strong>5-6cm </strong>depth</li>\n<li>Push fast:&nbsp;<strong>100-120/min</strong>&nbsp;frequency</li>\n<li>Allow for <strong>complete chest recoil</strong></li>\n<li>Minimize interruptions in compressions <strong>&lt;10 seconds</strong></li>\n<li>Avoid excessive ventilation</li>\n<li>Rotate compressor every<strong>&nbsp;2 min</strong>&nbsp;or earlier if fatigued</li>\n<li>If no advanced airway,&nbsp;<strong>30:2&nbsp;</strong>compression-ventilation ratio</li>\n</ul>\n<p><strong>Attempt to improve CPR quality if :</strong></p>\n<ul>\n<li>Quantitative waveform capnography -&nbsp;<strong>PETCO2 &lt;10mmHg</strong>,&nbsp;</li>\n<li>Intra-arterial pressure -&nbsp;If relaxation phase (<strong>diastolic) pressure &lt;20mmHg</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1403, 'Anaesthesia,', 'PM2290. Colloid solution', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\584\>\n<tbody>\n<tr>\n<td><strong>Properties</strong></td>\n<td><strong>Albumin (5%, 25%)</strong></td>\n<td><strong>Gelatin</strong></td>\n<td><strong>Dextran</strong></td>\n<td><strong>Hydroxy ethyl starch</strong></td>\n</tr>\n<tr>\n<td><strong>Molecular weight MW (kDa)</strong></td>\n<td>69</td>\n<td>35 (avg)</td>\n<td>\n<p>40 (Dextran40)</p>\n<p>70 (Dextran70)</p>\n</td>\n<td>\n<p>450 (high MW)</p>\n<p>200 (medium MW)</p>\n<p>70 (low MW)</p>\n</td>\n</tr>\n<tr>\n<td><strong>Oncotic pressure (mmHg)</strong></td>\n<td>\n<p>5% - 20</p>\n<p>25% - 70</p>\n</td>\n<td>&nbsp;</td>\n<td>40(Dextran40)</td>\n<td>30 (6% hetastarch)</td>\n</tr>\n<tr>\n<td><strong>Duration of effect (hr)</strong></td>\n<td>12</td>\n<td>&nbsp;</td>\n<td>6</td>\n<td>24 (6% hetastarch)</td>\n</tr>\n<tr>\n<td><strong>Advantages</strong></td>\n<td><strong>Natural colloid</strong>, hence fewer side effects</td>\n<td>\n<p>No interference with blood grouping and crossmatching</p>\n<p>Compatible with other IV fluids</p>\n</td>\n<td><strong>Dextran 40</strong> is used as <strong>antiaggregant in vascular surgeries</strong> to prevent thrombosis</td>\n<td>\n<p>Non-antigenic</p>\n<p>Anaphylaxis-rare</p>\n</td>\n</tr>\n<tr>\n<td><strong>Disadvantages</strong></td>\n<td>\n<p>Expensive</p>\n<p>Volume overload</p>\n<p>Fever (pyrogens)</p>\n</td>\n<td><strong>Highest incidence of anaphylactoid and severe anaphylactic reaction</strong></td>\n<td>\n<p>Anaphylaxis</p>\n<p>Interferes with crossmatching</p>\n<p>Coagulopathy</p>\n<p>Nephrotoxicity</p>\n<p>Maximum dose - 20ml/kg</p>\n</td>\n<td>\n<p>Coagulopathy</p>\n<p>Nephrotoxicity</p>\n<p>Hyperamylasemia</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1404, 'Paediatrics,', 'PM2289. Estimating maintenance fluid requirement - Holliday Segar formula', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table width=\412\>\n<tbody>\n<tr>\n<td><strong>Weight&nbsp;</strong></td>\n<td><strong>Rate</strong></td>\n</tr>\n<tr>\n<td>First 10 kgs</td>\n<td>4ml/kg/h</td>\n</tr>\n<tr>\n<td>Next 10 kgs</td>\n<td>Add 2ml/kg/h</td>\n</tr>\n<tr>\n<td>For each kg above 20 kgs</td>\n<td>Add 1 ml/kg/h</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Examples:&nbsp;</strong></p>\n<p>1. Maintenance fluid requirement for <strong>25 kg</strong> child:&nbsp;</p>\n<p>(10kg*4)+(10kg*2)+(5kg*1) = <strong>65ml/h</strong></p>\n<p>2. Maintenance fluid requirement for <strong>60kg</strong> man:</p>\n<p>(10kg*4)+(10kg*2)+(40kg*1) = <strong>100ml/h</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1405, 'Anaesthesia', 'PM2235. Different sizes of the Endotracheal tube', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Internal diameter(mm)</strong></td>\n<td><strong>Length(cm)</strong></td>\n</tr>\n<tr>\n<td>Full term infant</td>\n<td>3.5</td>\n<td>&nbsp; &nbsp;12</td>\n</tr>\n<tr>\n<td>Child</td>\n<td><span class=\TextRun SCX204806933\ lang=\EN-US\><span class=\NormalTextRun SCX204806933\>4</span></span><span class=\TextRun SCX204806933\ lang=\EN-US\><span class=\NormalTextRun SCX204806933\>&nbsp;&nbsp;</span></span><span class=\TextRun SCX204806933\ lang=\EN-US\><span class=\NormalTextRun SCX204806933\>+</span></span><span class=\TextRun SCX204806933\ lang=\EN-US\><span class=\NormalTextRun SCX204806933\>&nbsp;(</span></span><span class=\TextRun SCX204806933\ lang=\EN-US\><span class=\NormalTextRun SCX204806933\>Age</span></span><span class=\TextRun SCX204806933\ lang=\EN-US\><span class=\NormalTextRun SCX204806933\>/4)&nbsp;</span></span></td>\n<td>\n<p><span class=\TextRun SCX261922224\ lang=\EN-US\><span class=\NormalTextRun SCX261922224\>12</span></span><span class=\TextRun SCX261922224\ lang=\EN-US\><span class=\NormalTextRun SCX261922224\>&nbsp;</span></span><span class=\TextRun SCX261922224\ lang=\EN-US\><span class=\NormalTextRun SCX261922224\>+ (</span></span><span class=\TextRun SCX261922224\ lang=\EN-US\><span class=\NormalTextRun SCX261922224\>Age</span></span><span class=\TextRun SCX261922224\ lang=\EN-US\><span class=\NormalTextRun SCX261922224\>/2) [orotracheal]</span></span></p>\n<p><span class=\TextRun SCX261922224\ lang=\EN-US\><span class=\NormalTextRun SCX261922224\>14 + (Age/2)[nasotracheal]</span></span></p>\n</td>\n</tr>\n<tr>\n<td>Adult female</td>\n<td><span class=\TextRun SCX150009163\ lang=\EN-US\><span class=\NormalTextRun SCX150009163\>7.0</span></span><span class=\TextRun SCX150009163\ lang=\EN-US\><span class=\NormalTextRun SCX150009163\>&nbsp;- 7.5&nbsp;&nbsp;</span></span></td>\n<td>&nbsp;<span class=\TextRun SCX150009163\ lang=\EN-US\><span class=\NormalTextRun SCX150009163\>&nbsp; 20-22</span></span></td>\n</tr>\n<tr>\n<td>Adult male</td>\n<td><span class=\TextRun SCX247515821\ lang=\EN-US\><span class=\NormalTextRun SCX247515821\>7.5</span></span><span class=\TextRun SCX247515821\ lang=\EN-US\><span class=\NormalTextRun SCX247515821\>&nbsp; - 9&nbsp;</span></span></td>\n<td>&nbsp;<span class=\TextRun SCX247515821\ lang=\EN-US\><span class=\NormalTextRun SCX247515821\>&nbsp; 22-24</span></span></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1406, 'Anaesthesia', 'PM2234. Different sizes of the laryngeal mask airway', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Mask size</strong></td>\n<td><strong><span class=\TextRun SCX50814102\ lang=\EN-US\><span class=\NormalTextRun SCX50814102\>Patient Size&nbsp;</span></span></strong></td>\n<td><strong><span class=\TextRun SCX50814102\ lang=\EN-US\><span class=\NormalTextRun SCX50814102\>Weight (kg)</span></span></strong></td>\n<td><strong><span class=\TextRun SCX50814102\ lang=\EN-US\><span class=\NormalTextRun SCX50814102\>Cuff</span></span><span class=\TextRun SCX50814102\ lang=\EN-US\><span class=\NormalTextRun SCX50814102\>&nbsp;</span></span><span class=\TextRun SCX50814102\ lang=\EN-US\><span class=\NormalTextRun SCX50814102\>Volume (mL)</span></span></strong></td>\n</tr>\n<tr>\n<td>1</td>\n<td>Infant</td>\n<td>&lt;5</td>\n<td>2-4</td>\n</tr>\n<tr>\n<td>1.5</td>\n<td>Infant</td>\n<td>5-10</td>\n<td>upto 7</td>\n</tr>\n<tr>\n<td>2</td>\n<td>Child</td>\n<td>10-20</td>\n<td>upto 10</td>\n</tr>\n<tr>\n<td>2.5</td>\n<td>Child</td>\n<td>20-30</td>\n<td>upto 14</td>\n</tr>\n<tr>\n<td>3</td>\n<td>Small Adult</td>\n<td>30-50</td>\n<td>upto 20</td>\n</tr>\n<tr>\n<td>4</td>\n<td>Normal adult(women)</td>\n<td>50-70</td>\n<td>upto 30&nbsp;</td>\n</tr>\n<tr>\n<td>5</td>\n<td>Normal adult</td>\n<td>&gt;70</td>\n<td>30-40</td>\n</tr>\n<tr>\n<td>6</td>\n<td>Adults</td>\n<td>&gt;100</td>\n<td>50</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1407, 'Anaesthesia', 'PM2229. Signs of correct endotracheal intubation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>Detection of end-tidal CO<sub>2</sub> by capnography (Surest confirmation)</li>\n<li>Symmetric chest rise</li>\n<li>Bilateral breath sounds</li>\n<li>Absence of breath sounds in the epigastrium</li>\n<li>Visible condensation in the endotracheal tube</li>\n<li>Large exhaled tidal volumes</li>\n<li>Appropriate compliance of the reservoir bag during manual ventilation</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1408, 'Paediatrics,', 'PM2171. Color Coding of Intravenous Cannulae', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Size</strong></td>\n<td><strong>Color Coding</strong></td>\n<td><strong>Flow Rate</strong></td>\n<td><strong>Uses</strong></td>\n</tr>\n<tr>\n<td><span>14G</span></td>\n<td><strong><span>Orange</span></strong></td>\n<td>270ml/min</td>\n<td>Trauma Patients, Rapid, Large Volume replacement</td>\n</tr>\n<tr>\n<td>16G</td>\n<td><strong><span>Grey</span></strong></td>\n<td>236ml/min</td>\n<td>Trauma Patients, Major Surgery, Intra Partum/Post Partum, GI bleeds, Multiple blood transfers, High volume of Fluids</td>\n</tr>\n<tr>\n<td>17G</td>\n<td><strong>White</strong></td>\n<td>125ml/min</td>\n<td>Newly added</td>\n</tr>\n<tr>\n<td>18G</td>\n<td><span><strong><span>Green</span></strong></span></td>\n<td>103 ml/min</td>\n<td>Blood products, delivery of irritant medications, major surgery, contrast study</td>\n</tr>\n<tr>\n<td>20G</td>\n<td><strong><span>Pink</span></strong></td>\n<td>67ml/min</td>\n<td>General use IV maintenance, IV antibiotics, IV analgesics</td>\n</tr>\n<tr>\n<td>22G</td>\n<td><span><strong><span>Blue</span></strong></span></td>\n<td>42 ml/min</td>\n<td>Small or Fragile veins, Cytotoxic Therapy</td>\n</tr>\n<tr>\n<td>24G</td>\n<td><strong><span>Yellow</span></strong></td>\n<td>20ml/min</td>\n<td>For pediatric Usage</td>\n</tr>\n<tr>\n<td>26G</td>\n<td><span><strong><span>Violet</span></strong></span></td>\n<td>13ml/min</td>\n<td>Newly added</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1409, 'Medicine,', 'PM0503. Reversible Causes of Cardiac Arrest', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li>5 H’s:\n<ul>\n<li>Hypovolemia</li>\n<li>Hypoxia</li>\n<li>Hydrogen ion (acidosis)</li>\n<li>Hypokalemia or hyperkalemia</li>\n<li>Hypothermia</li>\n</ul>\n</li>\n<li>5 T’s:\n<ul>\n<li>Tension pneumothorax</li>\n<li>Tamponade (cardiac)</li>\n<li>Toxins</li>\n<li>Thrombosis (pulmonary)</li>\n<li>Thrombosis (coronary)</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1410, 'Anaesthesia,', 'PM0190. Adult Bradycardia with Pulse Algorithm', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p dir=\ltr\>When a patient is in <strong>bradyarrhythmia</strong> typically with a <strong>heart rate</strong> of <strong>&lt;50 bpm</strong> the initial intervention consists of identifying and treating the underlying cause. This includes:&nbsp;</p>\n<ul>\n<li dir=\ltr\ role=\presentation\>Maintaining a patent airway and assisting breathing as necessary</li>\n<li dir=\ltr\ role=\presentation\>Administering oxygen if hypoxemic</li>\n<li dir=\ltr\ role=\presentation\>Attaching cardiac monitor to identify rhythm; monitor blood pressure and oximetry</li>\n<li dir=\ltr\ role=\presentation\>IV access</li>\n<li dir=\ltr\ role=\presentation\>12-Lead ECG&nbsp;</li>\n</ul>\n<p>If the bradyarrhythmia is persisent causing<strong> hemodynamic instability</strong>, then the management is as depicted by the flowchart (based on the AHA guidelines) below:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ca90a6d0c948407698a4711a5cb0d095x1280x1558.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1411, 'Medicine,', 'PM0189. Adult Tachycardia with a Pulse Algorithm', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c6ee2010d37e4d4b89b3f56e0f5b9cb8x936x734.PNG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1412, 'Anaesthesia,', 'PM0188. Adult cardiac arrest algorithm (Updated as per 2020 guidelines)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p>The adult cardiac arrest algorithm is based on the AHA guidelines as shown below.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-2 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2bdbdbe380bd43f59ef07a42a15ff9bax1280x3518.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1413, 'Anaesthesia', 'PM0179. Indications and contraindications of Laryngeal mask airway (LMA)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Indication:</strong></p>\n<ul>\n<li>Difficult airway management during cardiopulmonary resuscitation.</li>\n<li>In emergency where intubation &amp; mask ventilation is not possible.&nbsp;</li>\n<li>For minor surgeries, where Anesthetist wants to avoid intubation.&nbsp;</li>\n<li>As a conduit for bronchoscopes, small size tubes, gum elastic bougies.</li>\n<li>Mouth opening &lt; 1.5cm</li>\n</ul>\n<p><strong>Contraindications:</strong></p>\n<ul>\n<li>Oropharyngeal abscess or mass</li>\n<li>Conditions with high risk of aspiration:<br>\n<ul>\n<li>Hiatus hernia</li>\n<li>Pregnancy</li>\n<li>Full stomach patients who are vulnerable to go in bronchospasm</li>\n<li>Low pulmonary compliance (eg. Obesity)</li>\n<li>Peak inspiratory pressure &gt; 30 cm of H<sub>2</sub>O.&nbsp;</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1414, 'Anaesthesia', 'PM0472. Definitions in pain management', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><ul>\n<li><strong>Allodynia</strong>- perception of ordinary non-noxious stimulus as pain</li>\n<li><strong>Analgesia</strong>- absence of pain perception</li>\n<li><strong>Anesthesia</strong>- absence of all sensation</li>\n<li><strong>Anesthesia Dolorosa</strong>- pain in area that lacks sensation</li>\n<li><strong>Dysesthesia</strong>-Unpleasant or abnormal sensation with or without a stimulus</li>\n<li><strong>Hypalgesia</strong>- diminished response to noxious stimulus</li>\n<li><strong>Hyperalgesia</strong>- increased response to noxious stimulation</li>\n<li><strong>Hyperesthesia</strong>- increased response to mild stimulation</li>\n<li><strong>Hyperpathia</strong>- presence of hyperesthesia, allodynia, hyperalgesia usually associated with over reaction, and persistence of the sensation after the stimulus</li>\n<li><strong>Hypoesthesia</strong>- reduced cutaneous sensation (e.g. light touch, pressure, temperature)</li>\n<li><strong>Neuralgia</strong>- pain in the distribution of nerve or a group of nerve</li>\n<li><strong>Paresthesia</strong>- Abnormal sensation perceived without an apparent stimulus</li>\n<li><strong>Radiculopathy</strong>- functional abnormality of one or more nerve root.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1415, 'Anaesthesia', 'PM0245. Muscle relaxants and their effects on autonomic ganglia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-2 ng-star-inserted\><p><strong>Muscle relaxants and their effects on autonomic ganglia:</strong></p>\n<p><strong>Stimulation:</strong></p>\n<p>Succinyl choline</p>\n<p><strong>Block:</strong></p>\n<ul>\n<li>d-TC(strong)</li>\n<li>Metocurine (weak)</li>\n<li>Alcuronium (weak)</li>\n</ul>\n<p><strong>No effect:</strong></p>\n<ul>\n<li>Atracurium</li>\n<li>Cisatracurium</li>\n<li>Mivacurium</li>\n<li>Vecuronium</li>\n<li>Pancuronium</li>\n<li>Rocuronium</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1416, 'Anaesthesia', 'PM2494. Basic Life Support (BLS) Algorithm', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/67cce4a491424e00abddb1e32b730ffbx1280x2542.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1417, 'Anaesthesia', 'PM0184. Safety profiles of drugs used in Porphyria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Contraindicated</strong></td>\n<td><strong>Safe</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Alcohol</li>\n<li>Barbiturates (Thiopentone)</li>\n<li>Carbamazapine</li>\n<li>Danazol</li>\n<li>Ergots</li>\n<li>Estrogens and progesterone</li>\n<li>Glutethimide</li>\n<li>Grisefulvin</li>\n<li>Meprobamate</li>\n<li>Mephenytoin</li>\n<li>Methyprylon</li>\n<li>Pyrazolones</li>\n<li>Succinimides</li>\n<li>Sulfonamides</li>\n<li>Valproic acid</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Narcotic analgesics</li>\n<li>Aspirin</li>\n<li>Acetaminophen</li>\n<li>Atropine</li>\n<li>Bromides</li>\n<li>Glucocorticoids</li>\n<li>Insulin</li>\n<li>Streptomycin</li>\n<li>Phenothiazines</li>\n<li>Pencillin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1418, 'Anaesthesia', 'PM0244. Dibucaine number', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>High</strong> dibucaine number (80) means the high quantity of normal and <strong>low quantity</strong> of <strong>atypical pseudocholinesterase</strong>: normal response to succinylcholine and mivacurium.</li>\n<li><strong>Low</strong> dibucaine number (&lt;30) means the low quantity of normal and <strong>high quantity</strong> of <strong>atypical pseudocholinesterase</strong>: prolonged succinylcholine and mivacurium block.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1419, 'Anaesthesia', 'PM0183. Malignant hyperthermia key features', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Pathophysiology:</strong></p>\n<ul>\n<li>Prolonged opening of functionally altered <strong>ryanodine receptors</strong>, leading to uncontrolled release of <strong>calcium</strong> from the sarcoplasmic reticulum resulting in sustained muscle contraction.</li>\n</ul>\n<p><strong>Drugs known to trigger malignant hyperthermia:</strong></p>\n<ul>\n<li><strong>Inhaled anesthetics: </strong>Halothane, Isoflurane, Sevoflurane, Desflurane, Ether, Methoxyflurane</li>\n<li><strong>Depolarising muscle relaxant:&nbsp;</strong>Succinylcholine</li>\n</ul>\n<p><strong>Clinical signs:</strong></p>\n<ul>\n<li><strong>Increased metabolism:</strong>&nbsp;Increased EtCO<sub>2</sub>, decreased SpO<sub>2</sub>, metabolic acidosis</li>\n<li><strong>Increased sympathetic activity:</strong>&nbsp;Tachycardia,&nbsp;hypertension, arrythmia</li>\n<li><strong>Muscle damage:</strong> Masseter spasm, generalised&nbsp;rigidity, hyperkalemia, rhabdomyolysis, myoglobinuria</li>\n<li><strong>Hyperthermia:</strong> Fever, sweating</li>\n</ul>\n<p>&nbsp;<strong>Treatment:&nbsp;</strong></p>\n<ul>\n<li>Discontinuation of all anesthetic agents</li>\n<li>Hyperventilation with 100% O<sub>2</sub></li>\n<li><strong>Dantrolene:</strong> 2.5 mg/kg intravenously every 5 min until the episode is terminated (upper limit - 10 mg/kg).</li>\n<li>Correction of acid-base, electrolyte abnormality&nbsp;</li>\n<li>Cooling the patient</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1420, 'Anaesthesia', 'PM2300. Factors affecting Minimum Alveolar Concentration (MAC)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Factors increasing MAC</strong></td>\n<td><strong>Factors decreasing MAC</strong></td>\n</tr>\n<tr>\n<td>Hyperthermia &gt;42°C</td>\n<td>Younger age (maximum at 6 months of age)&nbsp;</td>\n</tr>\n<tr>\n<td>Chronic alcohol abuse</td>\n<td>Hypothermia and hyperthermia up to 42°C</td>\n</tr>\n<tr>\n<td>Acute amphetamine use&nbsp;</td>\n<td>Older age (&gt;40 years, MAC decreases 6% per decade)</td>\n</tr>\n<tr>\n<td>Drugs: Cocaine, Ephedrine</td>\n<td>Chronic amphetamine abuse</td>\n</tr>\n<tr>\n<td>Hypernatremia&nbsp;</td>\n<td>Drugs: Opioids, Ketamine, Barbiturates, Benzodiazepines, Sympatholytics&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Hyponatremia, Hypercalcemia</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Hypotension</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Hypercarbia, Hypoxia, Metabolic acidosis</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Pregnancy&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Acute alcohol intoxication&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Note:&nbsp;</strong>Hyperthyroidism and hypothyroidism have no effect on MAC.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1421, 'Anaesthesia', 'PM2298. Minimum alveolar concentration (MAC)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong><span class=\topic-highlight\>Minimum alveolar concentration</span>&nbsp;(MAC)</strong> is the minimum concentration of an inhaled anesthetic at 1&nbsp;atm of pressure that<strong> prevents skeletal muscle movement</strong> in response to a<strong> surgical incision </strong>in<strong> 50% of patients.&nbsp;</strong></p>\n<p><strong>MAC of inhaled anesthetics</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Anesthetic Agents</strong></td>\n<td>\n<p><strong>MAC&nbsp;</strong><strong>(Potency)</strong></p>\n</td>\n<td>\n<p><strong>Blood-gas coefficient&nbsp;</strong><strong>(Solubility)</strong></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Halothane</strong></span></td>\n<td><strong>0.75</strong></td>\n<td>&nbsp;2.4</td>\n</tr>\n<tr>\n<td><span><strong>Isoflurane</strong></span></td>\n<td>1.2</td>\n<td>1.4&nbsp;</td>\n</tr>\n<tr>\n<td><span><strong>Enflurane</strong></span></td>\n<td>1.7</td>\n<td>1.9&nbsp;</td>\n</tr>\n<tr>\n<td><span><strong>Sevoflurane</strong></span></td>\n<td>2</td>\n<td>0.65&nbsp;</td>\n</tr>\n<tr>\n<td><span><strong>Desflurane</strong></span></td>\n<td>6</td>\n<td><strong>0.42</strong>&nbsp;</td>\n</tr>\n<tr>\n<td><span><strong>Nitrous oxide</strong></span></td>\n<td><strong>104</strong></td>\n<td>0.47&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>MAC is an indicator of potency. The <strong>lower</strong> the <strong>MAC,</strong>&nbsp;the <strong>higher</strong> is the <strong>potency.</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2b4742a236574d888df15bbc175acb5dx1280x1280.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1422, 'Anaesthesia', 'PM2273. Contraindications for Spinal anesthesia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Absolute</strong></p>\n<ul>\n<li>Infection at the site of injection</li>\n<li>Patient refusal</li>\n<li>Increased intracranial pressure</li>\n<li>Allergy to the anesthetic drugs</li>\n<li>Coagulopathy or other bleeding diathesis</li>\n<li>Severe hypovolemia</li>\n<li>Severe aortic stenosis</li>\n<li>Severe mitral stenosis</li>\n</ul>\n<p><strong>Relative</strong></p>\n<ul>\n<li>Sepsis</li>\n<li>Uncooperative patient</li>\n<li>Preexisting neurological deficits</li>\n<li>Demyelinating lesions</li>\n<li>Stenotic valvular heart lesions</li>\n<li>Left ventricular outflow obstruction (hypertrophic obstructive cardiomyopathy)</li>\n<li>Severe spinal deformity</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1423, 'Anaesthesia', 'PM2249. Color coding of Vaporisers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\ width=\357\>\n<tbody>\n<tr>\n<td><strong>Volatile Agent&nbsp;</strong></td>\n<td><strong>Color</strong></td>\n</tr>\n<tr>\n<td>Halothane</td>\n<td>Red</td>\n</tr>\n<tr>\n<td>Isoflurane</td>\n<td>Purple</td>\n</tr>\n<tr>\n<td>Sevoflurane</td>\n<td>Yellow</td>\n</tr>\n<tr>\n<td>Desflurane</td>\n<td>Blue</td>\n</tr>\n<tr>\n<td>Enflurane</td>\n<td>Orange</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/fdc7f380a095478e876f1db68b009ccfx1280x1644.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1424, 'Anaesthesia', 'PM2237. Identification of Maplesons circuits', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c8411e09764e400fb3baa0cc510e054ex1280x4494.442877291961.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Mapleson System</strong></p>\n</td>\n<td><strong>Fresh gas flow inlet</strong></td>\n<td><strong>APL valve location</strong></td>\n<td><strong>Reservoir bag</strong></td>\n<td><strong>Corrugated tubing</strong></td>\n<td><strong>Example and comments</strong></td>\n</tr>\n<tr>\n<td><strong>A</strong></td>\n<td>Near bag</td>\n<td>Near patient</td>\n<td>Present</td>\n<td>Present</td>\n<td>\n<p><strong>Magill</strong>;</p>\n<p><strong>Lack</strong> (co-axial)&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>B</strong></td>\n<td>Near patient</td>\n<td>Near patient</td>\n<td>Present</td>\n<td>Present</td>\n<td>Obsolete</td>\n</tr>\n<tr>\n<td><strong>C</strong></td>\n<td>Near patient</td>\n<td>Near patient</td>\n<td>Present</td>\n<td><strong>Absent</strong></td>\n<td>Obsolete; Still used in emergency resuscitation (AMBU bag)</td>\n</tr>\n<tr>\n<td><strong>D</strong></td>\n<td>Near patient</td>\n<td>Away from patient</td>\n<td>Present</td>\n<td>Present</td>\n<td><strong>Bain</strong> (co-axial)</td>\n</tr>\n<tr>\n<td><strong>E</strong></td>\n<td>Near patient</td>\n<td><strong>Absent</strong></td>\n<td><strong>Absent</strong></td>\n<td>Present</td>\n<td><strong>Ayres T piece</strong></td>\n</tr>\n<tr>\n<td><strong>F</strong></td>\n<td>Near patient</td>\n<td><strong>Absent</strong></td>\n<td>Present</td>\n<td>Present</td>\n<td><strong>Jackson Rees</strong> Modification for pediatric patients&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1425, 'Anaesthesia', 'PM2143. Inhalational anaesthetic agents', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Inhalational agent of choice:&nbsp;</p>\n<table width=\502\>\n<tbody>\n<tr>\n<td><strong>Indication</strong></td>\n<td><strong>Anesthetic gas</strong></td>\n</tr>\n<tr>\n<td>1. Induction&nbsp;</td>\n<td>Sevoflurane</td>\n</tr>\n<tr>\n<td>2. Daycare surgery</td>\n<td>Sevflurane&gt;Desflurane</td>\n</tr>\n<tr>\n<td>3. Elderly&nbsp;</td>\n<td>Desflurane</td>\n</tr>\n<tr>\n<td>4. Cardiac surgery</td>\n<td>Isoflurane</td>\n</tr>\n<tr>\n<td>5. Renal disease</td>\n<td>Desflurane</td>\n</tr>\n<tr>\n<td>6. Liver disease&nbsp;</td>\n<td>Sevoflurane &gt; Desflurane&nbsp;</td>\n</tr>\n<tr>\n<td>7. Neurosurgery&nbsp; &nbsp;</td>\n<td>Sevoflurane&gt;Isoflurane</td>\n</tr>\n<tr>\n<td>8. Asthmatics</td>\n<td>Sevoflurane</td>\n</tr>\n<tr>\n<td>9. Obese patients</td>\n<td>Desflurane</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>Drug</strong></td>\n</tr>\n<tr>\n<td>Most potent&nbsp; &nbsp; &nbsp;&nbsp;</td>\n<td>Methoxyflurane &gt; Halothane&nbsp;</td>\n</tr>\n<tr>\n<td>Least potent&nbsp; &nbsp;&nbsp;&nbsp;</td>\n<td>Nitrous oxide &gt; Desflurane&nbsp;</td>\n</tr>\n<tr>\n<td>Most epileptogenic&nbsp;&nbsp;</td>\n<td>Enflurane</td>\n</tr>\n<tr>\n<td>Most nephrotoxic</td>\n<td>Methoxyflurane&nbsp;</td>\n</tr>\n<tr>\n<td>Most hepatotoxic</td>\n<td>Halothane&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1426, 'Anaesthesia', 'PM0465. Mechanical Criteria for Weaning or Extubation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Inspiratory pressure: -20 to -30cm H2O</li>\n<li>Tidal volume: 4-6ml/kg</li>\n<li>Vital capacity: &gt;10 mL/kg</li>\n<li>Minute ventilation: 10L/min</li>\n<li>Rapid shallow breathing index: &lt;100</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1427, 'Anaesthesia', 'PM0307. Pin index safety system (PISS):', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b4558d677c5c41dbbe34006bd919cabdx1280x2768.51904090268.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Note:</p>\n<ul>\n<li>Mixtures of CO<sub>2</sub> and O<sub>2</sub>&nbsp;with more than 7% CO<sub>2</sub>: <strong>1,6</strong><sup class=\reference\></sup></li>\n<li>Mixtures of&nbsp;CO<sub>2</sub> and O<sub>2</sub>&nbsp;with less than 7% CO<sub>2</sub>: <strong>2,6</strong><sup class=\reference\></sup></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1428, 'Anaesthesia', 'PM0306. Pressure sections of Anaesthesia work station', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/97b9ee14d7b94c379575ec33b48f8d57x1280x2558.194640338505.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1429, 'Anaesthesia', 'PM0305. Coding of gas cylinders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>GAS</strong></td>\n<td><strong>SHOULDER COLOUR</strong></td>\n<td><strong>BODY COLOUR</strong></td>\n</tr>\n<tr>\n<td>Oxygen</td>\n<td>White</td>\n<td>Black</td>\n</tr>\n<tr>\n<td>Air</td>\n<td>White</td>\n<td>Grey</td>\n</tr>\n<tr>\n<td>Carbon dioxide</td>\n<td colspan=\2\>Grey</td>\n</tr>\n<tr>\n<td>Nitrous oxide</td>\n<td colspan=\2\>Blue</td>\n</tr>\n<tr>\n<td>Helium</td>\n<td colspan=\2\>Brown</td>\n</tr>\n<tr>\n<td>Nitrogen</td>\n<td colspan=\2\>Black</td>\n</tr>\n<tr>\n<td>Ethylene</td>\n<td colspan=\2\>Purple</td>\n</tr>\n<tr>\n<td>Cyclopropane</td>\n<td colspan=\2\>Orange</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1430, 'Anaesthesia', 'PM0304. Characteristics of medical gas cylinders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5db38c05b68a4790887718241b950ea9x1280x3405.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1431, 'Anaesthesia', 'PM0303. Composition of CO2 Absorbers in rebreathing system', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>SODA LIME</strong>:</p>\n<ul>\n<li><strong>Ca(OH)<sub>2&nbsp;</sub>- 80%</strong></li>\n<li><strong>NaOH - 3%</strong></li>\n<li>KOH - 2%</li>\n<li>Silica - 0.2%</li>\n<li>Moisture- &nbsp;14-19%</li>\n</ul>\n<p>Granule size is 4-8 mesh</p>\n<p>Absorbs up to 23L of CO2/100 g</p>\n<p>With Trilene, soda-lime forms neurotoxin dichloroacetylene and pulmonary irritant phosgene gas; hence contraindicated.</p>\n<p>Sevoflurane reacts with soda lime and produces Compound A</p>\n<p>Method of hardness- Silica</p>\n<p><strong>AMSORB:</strong></p>\n<ul>\n<li><strong>Ca(OH)<sub>2</sub></strong></li>\n<li><strong>Ca Cl<sub>2</sub></strong></li>\n<li>CaSO<sub>4</sub></li>\n</ul>\n<p>Causes less degradation of volatile anesthetics eg. Sevoflurane to Compound A or Desflurane to Carbon Monoxide</p>\n<p><strong>BARALYME:</strong></p>\n<ul>\n<li><strong>Ca(OH)<sub>2</sub> 80%</strong></li>\n<li><strong>Ba(OH)<sub>2</sub> 20%</strong></li>\n<li>KOH &lt;1%</li>\n</ul>\n<p>Absorbs up to 9-18L of CO2/100 g</p>\n<p>Desflurane can be broken down to CO by dry barium hydroxide lime.</p>\n<p>Method of hardness: water of crystallization.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1432, 'Anaesthesia', 'PM0302. Mapleson Classification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td rowspan=\2\><strong>Mapleson circuit</strong>&nbsp;</td>\n<td rowspan=\2\><strong>&nbsp;Other name</strong>&nbsp;</td>\n<td colspan=\2\><strong>Fresh gas flow rate</strong></td>\n</tr>\n<tr>\n<td><strong>Spontaneous ventilation</strong></td>\n<td>&nbsp;<strong>Controlled ventilation</strong></td>\n</tr>\n<tr>\n<td>A</td>\n<td>Magills</td>\n<td><strong>1</strong> minute ventilation (MV) i.e. 80 ml/kg/min</td>\n<td>Very high and difficult to predict</td>\n</tr>\n<tr>\n<td>B</td>\n<td>-</td>\n<td>2-3× (MV)</td>\n<td>2-2.5 × (MV)</td>\n</tr>\n<tr>\n<td>C</td>\n<td>Water’s to and fro</td>\n<td>2-3 × (MV)</td>\n<td>2-2.5 × (MV)</td>\n</tr>\n<tr>\n<td>D</td>\n<td>Bain circuit</td>\n<td>2-3 × (MV)</td>\n<td><strong>1-2</strong> × (MV)</td>\n</tr>\n<tr>\n<td>E</td>\n<td>Ayre’s t-piece</td>\n<td>2-3 × (MV)</td>\n<td>3 × (MV)</td>\n</tr>\n<tr>\n<td>F</td>\n<td>Jackson rees modification</td>\n<td>2-3 × (MV)</td>\n<td>2 × (MV)</td>\n</tr>\n</tbody>\n</table>\n<p dir=\ltr\>&nbsp;</p>\n<p dir=\ltr\>Note:</p>\n<p>The efficiency of Mapleson circuits in <strong>spontaneous</strong> ventilation is&nbsp;&nbsp;<strong>A &gt; DFE &gt; CB&nbsp;</strong>(A Dog Can Bite - Usually a spontaneous event)</p>\n<p>The efficiency of Mapleson circuits in <strong>controlled</strong> ventilation is&nbsp;<strong>DFE &gt; BC &gt; A&nbsp;</strong>(Dead Babies cant assist - controlled)</p>\n<p><br><br></p></div><!---->\n      <!---->\n    </div><!---->'),
(1433, 'Anaesthesia', 'PM2276. Differences between Spinal and Epidural anesthesia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Spinal (Subarachnoid, Intrathecal) anesthesia</strong></td>\n<td><strong>Epidural (Extradural) anesthesia</strong></td>\n</tr>\n<tr>\n<td><strong>Level</strong></td>\n<td>Below L1/L2, where the spinal cord ends</td>\n<td>At any level of the vertebral column (cervical to sacral)</td>\n</tr>\n<tr>\n<td><strong>Injection</strong></td>\n<td>Subarachnoid space i.e. puncture of dura mater</td>\n<td>Epidural space i.e. without the puncture of dura mater</td>\n</tr>\n<tr>\n<td><strong>Identification</strong></td>\n<td>CSF backflow</td>\n<td>Loss of resistance technique</td>\n</tr>\n<tr>\n<td><strong>Dose</strong></td>\n<td>Low (2.5-3.5 ml of 0.5% hyperbaric Bupivacaine)</td>\n<td>High (15-20 ml of plain Bupivacaine 0.1-0.5% depending on the desired effect)</td>\n</tr>\n<tr>\n<td><strong>Dosing</strong></td>\n<td>Single dosing</td>\n<td>With the catheter in situ, multiple dosing and continuous infusions possible</td>\n</tr>\n<tr>\n<td><strong>Onset of action</strong></td>\n<td>Rapid (2-5 minutes)</td>\n<td>Slow (15-20 minutes)</td>\n</tr>\n<tr>\n<td><strong>Density of block</strong></td>\n<td>More dense</td>\n<td>Less dense</td>\n</tr>\n<tr>\n<td><strong>Hypotension</strong></td>\n<td>Rapid</td>\n<td>Slow</td>\n</tr>\n<tr>\n<td><strong>Complications (specific)</strong></td>\n<td>\n<p>High spinal</p>\n<p>Cardiac arrest</p>\n<p>Post-dural&nbsp;puncture headache</p>\n</td>\n<td>\n<p>Local anesthesia toxicity</p>\n<p>Total spinal anesthesia</p>\n<p>Epidural hematoma</p>\n</td>\n</tr>\n<tr>\n<td><strong>Postoperative analgesia</strong></td>\n<td>No</td>\n<td>Yes (with epidural infusion through the catheter)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1434, 'Anaesthesia', 'PM2275. Complications of neuraxial (spinal and epidural) anesthesia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Adverse or exaggerated physiological response:</strong></p>\n<ul>\n<li>Urinary retention</li>\n<li>High block</li>\n<li>Total spinal anesthesia (with epidural)</li>\n<li>Cardiac arrest</li>\n<li>Anterior spinal artery syndrome</li>\n<li>Horners syndrome</li>\n</ul>\n<p><strong>Complication related to needle or catheter placement:</strong></p>\n<ul>\n<li>Backache</li>\n<li>Dural puncture/leak\n<ul>\n<li>Post dural&nbsp;puncture headache</li>\n<li>Diplopia (<strong>6th cranial nerve</strong> most commonly affected)</li>\n</ul>\n</li>\n<li>Neural injury\n<ul>\n<li>Nerve root/spinal cord damage</li>\n</ul>\n</li>\n<li>Bleeding\n<ul>\n<li>Intraspinal/epidural hematoma</li>\n</ul>\n</li>\n<li>Misplacement\n<ul>\n<li>Inadequate anesthesia</li>\n<li>subdural block</li>\n<li>intravascular injection</li>\n</ul>\n</li>\n<li>Inflammation&nbsp;\n<ul>\n<li>Arachnoiditis</li>\n</ul>\n</li>\n<li>Infection\n<ul>\n<li>Meningitis</li>\n<li>Epidural abscess</li>\n</ul>\n</li>\n</ul>\n<p><strong>Drug toxicity</strong></p>\n<ul>\n<li>Systemic local anesthesia toxicity (epidural &gt; spinal)</li>\n<li>Transient neurological symptoms (Lidocaine, chloroprocaine&nbsp;with preservative)</li>\n<li>Cauda equina syndrome (Lidocaine)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1435, 'Anaesthesia', 'PM2126. Factors affecting dermatomal spread of spinal anesthesia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\3\><strong>Factors affecting</strong> <strong>the dermatomal spread of spinal anesthesia</strong></td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td><strong>More important</strong></td>\n<td><strong>Less important</strong></td>\n</tr>\n<tr>\n<td rowspan=\4\><strong>Drug factor</strong></td>\n<td>Dose</td>\n<td>Volume</td>\n</tr>\n<tr>\n<td>Baricity</td>\n<td>Concentration</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Viscosity</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Additives</td>\n</tr>\n<tr>\n<td rowspan=\4\><strong>Patient factor</strong></td>\n<td>CSF volume</td>\n<td>Weight</td>\n</tr>\n<tr>\n<td>Advanced age</td>\n<td>Height</td>\n</tr>\n<tr>\n<td>Pregnancy</td>\n<td>Spinal anatomy</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Intra-abdominal pressure</td>\n</tr>\n<tr>\n<td rowspan=\3\><strong>Procedure factor</strong></td>\n<td>Patient position</td>\n<td>Level of injection</td>\n</tr>\n<tr>\n<td>Epidural injection post spinal</td>\n<td>Needle orifice direction</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Needle type</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1436, 'Anaesthesia', 'PM2113. Nerve fibres & Their Properties', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Fibre</strong></td>\n<td><strong>Diameter</strong> (micro m.)</td>\n<td><strong>Function</strong></td>\n</tr>\n<tr>\n<td>B&nbsp;</td>\n<td>1-3&nbsp;</td>\n<td>Sympathetic</td>\n</tr>\n<tr>\n<td>C</td>\n<td>0.3-1</td>\n<td>Pain, temperature</td>\n</tr>\n<tr>\n<td>A delta</td>\n<td>1-4</td>\n<td>Pain, temperature</td>\n</tr>\n<tr>\n<td>A gamma</td>\n<td>3-6</td>\n<td>Muscle spindle</td>\n</tr>\n<tr>\n<td>A beta</td>\n<td>5-12</td>\n<td>Touch, pressure</td>\n</tr>\n<tr>\n<td>A alpha</td>\n<td>12-20</td>\n<td>Motor, proprioception</td>\n</tr>\n</tbody>\n</table>\n<div class=\page\ title=\Page 281\>&nbsp;</div></div><!---->\n      <!---->\n    </div><!---->'),
(1437, 'Anaesthesia', 'PM0513. High Yield Points in Local Anaesthetics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Cocaine:&nbsp;</strong></p>\n<ul>\n<li>Naturally occurring</li>\n<li>Vasoconstrictor</li>\n<li>1<sup>st</sup>&nbsp;local anesthetic</li>\n</ul>\n<p><strong>Chloroprocaine:&nbsp;</strong>Intradural injections are contraindicated and may cause paraplegia</p>\n<p><strong>Prilocaine:&nbsp;</strong></p>\n<ul>\n<li>Safest</li>\n<li>Causes maximum methemoglobinemia</li>\n<li>Suitable for Bier’s IV block</li>\n<li>EMLA is a eutectic mixture of LA containing 2.5% lidocaine &amp; 2.5% prilocaine</li>\n</ul>\n<p><strong>Bupivacaine</strong></p>\n<ul>\n<li>Long-acting</li>\n<li>Most cardiotoxic</li>\n<li>Contraindicated in regional IV anesthesia</li>\n<li>Toxicity is treated with amiodarone, bretylium(for VT), vasopressors (for circulatory collapse), isoproterenol and benzodiazepines (sedative)</li>\n</ul>\n<p><strong>Procaine</strong></p>\n<ul>\n<li>LA of choice in malignant hyperthermia</li>\n<li>1<sup>st</sup> synthetic LA</li>\n<li>Metabolized to PABA, which have been associated with rare anaphylactic reactions</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1438, 'Anaesthesia', 'PM0510. Brachial Plexus Blocks', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>Name of Block</td>\n<td>Level of Block</td>\n<td>Adequate Analgesia Seen at</td>\n<td>Limitations</td>\n</tr>\n<tr>\n<td>Interscalene</td>\n<td>Superior and middle trunk</td>\n<td>Shoulder and upper arm. Most intense effect at C5-C7 dermatomes.</td>\n<td>Ulnar nerve (C8,T1) sparing</td>\n</tr>\n<tr>\n<td>Supraclavicular</td>\n<td>Distal trunk and proximal division</td>\n<td>Elbow, forearm and hand</td>\n<td>Axillary and suprascapular nerve sparing; Pneumothorax, phrenic nerve palsy</td>\n</tr>\n<tr>\n<td>Infraclavicular</td>\n<td>Cords</td>\n<td>Elbow, forearm and hand</td>\n<td>Intercostobrachial nerve sparing</td>\n</tr>\n<tr>\n<td>Axillary</td>\n<td>Terminal nerves</td>\n<td>\n<p>Forearm and hand.</p>\n<ul>\n<li>Most intense block in C7-T1 (Ulnar nerve) distribution</li>\n<li>Least intense in C5-C6 dermatome</li>\n<li>Most optimal for procedures from elbow to hand</li>\n</ul>\n<p>&nbsp;</p>\n</td>\n<td>Musculocutaneous, axillary, medial cutaneous nerve branches sparing; Inadvertent intravascular injection</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9a3610faac25490ab1c29c0b30472ab4x1064x1934.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1439, 'Anaesthesia', 'PM0475. Absolute contraindications for Epidural', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Patient refusal</li>\n<li>Bleeding diathesis</li>\n<li>Severe hypovolemia</li>\n<li>Raised ICT</li>\n<li>Infection at site of injection</li>\n<li>Severe stenotic valvular heart disease and fixed cardiac output states</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1440, 'Anaesthesia', 'PM0469. Test Dose given in Epidural', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>A test dose is designed to detect both subarachnoid and intravascular injection. The classic test dose combines local anesthetic and epinephrine, typically 3 mL of 1.5% lidocaine with 1:200,000 epinephrine (0.005 mg/mL).</li>\n<li>The 45 mg of lidocaine, if injected intrathecally, will produce spinal anesthesia that should be rapidly apparent.</li>\n<li>The 15 mcg dose of epinephrine, if injected intravascularly, should produce a noticeable increase in heart rate (20% or more), with or without hypertension.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1441, 'Anaesthesia', 'PM0468. High yield points in epidural anaesthesia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Epidural space lies between dura and ligamentum flavum</li>\n<li>Dura is <strong>not</strong> penetrated</li>\n<li>The site of action of epidural anesthesia is <strong>nerve roots</strong></li>\n<li>Methods to identify epidural space:\n<ul>\n<li>Loss of resistance technique</li>\n<li>Hanging drop technique – Gutierrezs sign (sudden sucking of a drop in epidural space)</li>\n</ul>\n</li>\n<li>Methods to confirm epidural anesthesia\n<ul>\n<li>Test dose with 3cc lidocaine with 15mcg adrenaline (1:2,00,000) - Intrathecal injection will produce spinal anesthesia (lidocaine) that should be rapidly apparent. Intravascular injection will produce significant tachycardia 20% above baseline (adrenaline).</li>\n<li>Durant’s sign – rapid injection of the drug in epidural space causes an increase in rate and depth of respiration</li>\n<li>Westpal sign – absence of knee-jerk after epidural anesthesia</li>\n</ul>\n</li>\n<li>Anesthetic of choice in epidural anesthesia <strong>during labor</strong> - <strong>Bupivacaine</strong></li>\n<li>Epidural narcotic preferred over epidural local anesthesia because of the absence of motor paralysis</li>\n<li>Drugs used for epidural analgesia- <strong>Morphine</strong>, <strong>Fentanyl</strong></li>\n<li>Epidural opioids act on dorsal horn substantia gelatinosa. It may cause pruritis and respiratory depression</li>\n<li>Drug <strong>not</strong> given in central neuraxial block or caudal block- Remifentanil</li>\n<li>Walking epidural- Ultra low dose epidural used especially for labor (only sensory blockade)</li>\n<li>Complication of Epidural anesthesia -Total spinal anesthesia</li>\n<li><strong>Not</strong> a complication of epidural anesthesia –DIC, Headache</li>\n<li>During epidural anesthesia- sudden hypotension is due to the drug entering subarachnoid space</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c5c48123b4a349b8a024e278ebe5d5e5x800x480.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The most commonly used needle for epidural analgesia is a&nbsp;<strong>Tuohy</strong> <strong>needle (16-18G)</strong>. It has a blunt bevel with a<strong> curve</strong> at the tip. The blunt bevel helps to<strong> push away</strong> the <strong>dura</strong> after passing through the ligamentum flavum instead of penetrating it. The <strong>curved tip</strong> decreases the incidences of <strong>dural puncture</strong>.&nbsp;The image below shows a Tuohy needle.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a2bfd1e3a39d40aabdd98a0e5ff9ff11x720x819.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1442, 'Anaesthesia', 'PM0448. High Yield Points in spinal anesthesia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>The normal extent of the spinal cord is the lower border of L1 in adults and the upper border of L3 in infants.</li>\n<li>First spinal anesthesia was given by <strong>Augustin Bier</strong>.</li>\n<li>It is injected into the space between <strong>L3-L4 in adults </strong>and<strong> L4-L5 in children.</strong></li>\n<li>The deposition of the drug is in the <strong>subarachnoid space.</strong></li>\n<li>The subarachnoid space <strong>ends at S2 in adults</strong> and <strong>S3 in children</strong>.</li>\n<li>Traumatic needle- <strong>Quincke</strong></li>\n<li>Atraumatic needle- <strong>Sprotte</strong></li>\n<li>Structures pierced- Ligamentum flavum, interspinous ligament, supraspinous ligament. (Posterior longitudinal ligament is NOT punctured)</li>\n<li>The <strong>first</strong> fibres to be <strong>blocked</strong>- <strong>Autonomic preganglionic</strong>.</li>\n<li>The <strong>last</strong> fibres to be <strong>blocked</strong>- <strong>Motor</strong>.</li>\n<li>The <strong>last</strong>&nbsp;fibres to <strong>recover</strong>- <strong>Preganglionic</strong> <strong>autonomic</strong>.</li>\n<li>Levels of anesthetic effect - Autonomic level is 2 segments above the sensory, which is 2 segments above the motor.</li>\n<li>The most common complication is hypotension.</li>\n<li><strong>Brewer</strong> <strong>Luckhardt</strong> <strong>reflex</strong>- Reflex hypotension due to parasympathetic stress at a different site.&nbsp;</li>\n<li>Paramedian spinal anesthesia prevents penetration of the supraspinous and interspinous ligaments.</li>\n<li>Anesthetics in a paravertebral block are least likely to diffuse into subarachnoid space.</li>\n<li>The <strong>lowest</strong> incidence of <strong>post</strong>-<strong>spinal</strong> <strong>headache</strong> is when a <strong>thin needle</strong> is used.</li>\n<li>A high level of spinal injection causes hypotension and bradycardia.</li>\n<li>The <strong>vasopressor of choice</strong> in hypotension produced during the subarachnoid block is <strong>phenylephrine</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1443, 'Anaesthesia', 'PM0447. Factors That Can Increase the Incidence of Headache After Spinal Puncture', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Age: Younger, more frequent</li>\n<li>Sex: Females &gt; males</li>\n<li>Needle size: Larger &gt; smaller</li>\n<li>Needle bevel: Less when the needle bevel is placed in the long axis of the neuraxis Orienting a needle bevel parallel with the axis of the spine, such that the longitudinal fibers of the dura would more likely be separated than cut, results in a lower incidence of postspinal puncture headache</li>\n<li>Pregnancy: More when pregnant</li>\n<li>Dural punctures: More with multiple punctures</li>\n</ul>\n<p><strong>Factors That Do Not Increase the Incidence of Headache After Spinal Puncture</strong></p>\n<ul>\n<li>Insertion and use of catheters for continuous spinal anesthesia</li>\n<li><strong>Timing&nbsp;of ambulation</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1444, 'Anaesthesia', 'PM0446. PDPH- Post-Dural Puncture Headache', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>May follow lumbar puncture, spinal anesthesia, wet epidural tap (in which epidural needle pierced dura).</li>\n<li>Onset 12-72hrs and last for 1-2 weeks.</li>\n<li>Aggravated by sitting and relieved by lying down.</li>\n<li>Incidence increases with the larger needle, cutting point (in comparison to pencil point) needle, young age, females, pregnancy.</li>\n<li>Prevention by thinner needle</li>\n</ul>\n<p><strong>Management:</strong></p>\n<ul>\n<li>Supine position</li>\n<li>IV fluids</li>\n<li>Caffeine and analgesia</li>\n<li>Epidural blood patch</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1445, 'Anaesthesia', 'PM0436. Order of block in spinal anaesthesia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Autonomic preganglionic sympathetic</li>\n<li>Temperature</li>\n<li>Pin prick</li>\n<li>Pain</li>\n<li>Touch</li>\n<li>Pressure</li>\n<li>Motor</li>\n</ul>\n<p>Regression of blockade (“recovery”) follows in the reverse order: motor function &gt; touch &gt; pinprick &gt; cold sensation &gt; autonomic.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1446, 'Anaesthesia', 'PM0492. Coarctation of Aorta in Pregnancy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Any anesthetic procedure that causes hypotension should be avoided.</li>\n<li>Regional anesthetic procedure such as spinal anesthesia and epidural anesthesia should be avoided.</li>\n<li>General anesthesia is the technique of choice.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1447, 'Anaesthesia', 'PM0485. High Yield Points in Pediatric Anesthesia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>The narrowest part of the larynx in the infant is at the cricoid level, in administering anesthesia this may lead to Laryngeal edema, trauma to sub epiglottic region, post-operative stridor.</li>\n<li>Neonatal circumcision is done under General anesthesia.</li>\n<li><strong>Oculocardiac reflex:</strong>\n<ul>\n<li>Trigemino-vagal-reflex</li>\n<li>Causes-strabismus surgery, cataract surgery, enucleation, ocular trauma, retinal detachment surgery.</li>\n<li>Manifestation-bradycardia (most common)</li>\n<li>Treatment-temporary cessation surgery until heart rate increases, IV Atropine.</li>\n</ul>\n</li>\n<li><strong>Duchenne muscular dystrophy :</strong>\n<ul>\n<li>High risk for malignant hyperthermia so succinyl choline and halothane should be avoided</li>\n<li>Choice of anesthesia is propofol, nitrous oxide for maintenance.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1448, 'Obstetrics & Gynaecology,', 'PM0484. Obstetric Anesthesia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>N2O is avoided in early pregnancy because of possible teratogenic effects</li>\n<li>Anesthesia is dangerous in all trimester but comparatively, 2nd trimester is the safest</li>\n<li>Supine hypotension syndrome: In 3rd-trimester circulatory collapse occurs due to diminished venous return because of the pressure of gravid uterus over IVC in the supine position.</li>\n<li>Best uterine relaxant is halothane, so uterine tetanic contractions are most rapidly treated by halothane.</li>\n<li>M.C. cause of death during GA in obstetrics is Mendelson’s syndrome. This is prevented by empty stomach, H2 blockers, SELLICKS maneuver i.e. backward pressure on the cartilage</li>\n<li>Contraindications:\n<ul>\n<li>Gallamine crosses the placenta.</li>\n<li>Morphine causes respiratory depression in mother and baby. For treatment naloxone, 0.01mg/kg is given through the umbilical vein.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1449, 'Obstetrics & Gynaecology,', 'PM0483. Obstetrics Indication for GA', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Fetal distress during 2nd stage of labour</li>\n<li>Tetanic uterine contractions</li>\n<li>Breech extraction</li>\n<li>Version and extraction</li>\n<li>Manual removal of a retained placenta</li>\n<li>Replacement of an inverted uterus</li>\n<li>Uncontrollable psychiatric patients</li>\n<li>LSCS in patients with rheumatic heart disease and mitral valve stenosis</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1450, 'Obstetrics & Gynaecology,', 'PM0482. Regional Anesthesia in Obstetrics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Pregnant patients display enhanced sensitivity to LA during regional anesthesia because of hormonal factors and engorgement of epidural venous plexus resulting in decreased epidural space and subarachnoid space (CSF volume).This enhances the cephalad spread of LA solution during spinal and epidural anesthesia.</li>\n<li>Lower doses of LA agents and pain relief drugs are used because of altered pharmacokinetics and pharmacodynamics during parturition as a result of hormonal and cardiovascular effects.</li>\n<li>Lignocaine is less protein bound and nerves are more sensitive to LA agents.</li>\n<li>NOT a cause of decreased anesthetic requirement during pregnancy Increased lumbar lordosis.</li>\n<li>The level of the block under spinal anesthesia is desirable upto T4.</li>\n<li>Lumbar epidural - The most preferred technique for painless labor.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1451, 'Anaesthesia', 'PM0405. Hypotensive Anesthesia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Defined as:</p>\n<ul>\n<li>Reduction of the <strong>systolic blood pressure to 80-90 mmHg, </strong>or<strong>&nbsp;</strong></li>\n<li>Reduction of mean arterial pressure <strong>(MAP) to 50-65 mmHg, </strong>or</li>\n<li>Reduction of<strong>&nbsp;MAP to 30% of baseline.</strong></li>\n</ul>\n<p>Controlled hypotension has been used to <strong>reduce bleeding</strong> and the need for blood transfusions, and provide a satisfactory bloodless surgical field.</p>\n<p>It has been indicated in Oro-maxillofacial surgery (mandibular osteotomy, facial repair), endoscopic sinus or middle ear microsurgery, spinal surgery and other neurosurgery (an aneurysm), major orthopedic surgery (hip or knee replacement, spinal), prostatectomy, cardiovascular surgery and liver transplant surgery.</p>\n<p><strong>Agents</strong> used successfully include <strong>inhalation anesthetics, sodium nitroprusside, nitroglycerin</strong>, trimethaphan camsilate, clonidine,&nbsp;<strong>phentolamine,</strong>&nbsp;beta blockers, <strong>remifentanil</strong>, and agents used in <strong>spinal anesthesia</strong> for orthopedic surgeries</p>\n<p>Newer hypotensive drugs, such as fenoldopam, adenosine, and alprostadil, are currently being evaluated.</p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1452, 'Anaesthesia', 'PM0398. Anesthetic Considerations in Patients with Aortic Stenosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Maintain normal sinus rhythm</li>\n<li>Avoid bradycardia or tachycardia</li>\n<li>Avoid hypotension</li>\n<li>Optimize intravascular fluid volume to maintain venous return and left ventricular filling</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1453, 'Anaesthesia', 'PM0534. Modified Bromage scale', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>0: No motor block</p>\n<p>1: Inability to raise the extended leg; Able to move knees and feet</p>\n<p>2: Inability to raise the extended leg and move knee; Able to move feet</p>\n<p>3: Complete block of motor limb</p></div><!---->\n      <!---->\n    </div><!---->'),
(1454, 'Anaesthesia', 'PM0494. Muscle Relaxant and Effect on Cardiac Muscarinic Receptors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Stimulation&nbsp;</strong>(leads to bradycardia):</p>\n<ul>\n<li>Succinyl choline&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</li>\n</ul>\n<p><strong>Block</strong>:</p>\n<ul>\n<li>Gallamine (strong)</li>\n<li>Rapacurium (moderate)</li>\n<li>Pancuronium (moderate)</li>\n<li>Rocuronium (weak)</li>\n<li>Alcuronium (weak)</li>\n</ul>\n<p><strong>No effect</strong>:</p>\n<ul>\n<li>d-TC</li>\n<li>Atracurium</li>\n<li>Cisatracurium</li>\n<li>Mivacurium</li>\n<li>Vecuronium</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1455, 'Anaesthesia', 'PM0471. Assessment of Pain', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Best scale to measure pain in children of 5 years of age is CHEOPS</li>\n<li>Visual analogue scale is the most widely used to measure Pain intensity</li>\n<li>CHEOPS for post-operative pain in children does NOT include Oxygen saturation</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1456, 'Anaesthesia', 'PM0464. Indications of Mechanical Ventilation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Direct measurement</strong>\n<ul>\n<li>Arterial oxygen tension &lt;50 mm Hg on room air</li>\n<li>Arterial CO 2 tension &gt;50 mm Hg in the absence of metabolic alkalosis</li>\n</ul>\n</li>\n<li><strong>Derived indices</strong>\n<ul>\n<li>Pa O 2 /F IO 2 ratio &lt;300 mm Hg</li>\n<li>PA–a o 2 gradient &gt;350 mm Hg</li>\n<li>V D /V T &gt;0.6</li>\n</ul>\n</li>\n<li><strong>Clinical indices</strong>\n<ul>\n<li>Respiratory rate &gt;35 breaths/min</li>\n</ul>\n</li>\n<li><strong>Mechanical indices</strong>\n<ul>\n<li>Tidal volume &lt;5 mL/kg</li>\n<li>Vital capacity &lt;15 mL/kg</li>\n<li>Maximum inspiratory Force &gt; −25 cm H 2 O</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1457, 'Anaesthesia', 'PM0432. Regarding Nerve Blockers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Site of phrenic nerve block -3 cm above clavicle at the posterior border of sternomastoid</li>\n<li>Site of block in thyroid surgery is Upper cervical ganglion</li>\n<li>Approach for inferior alveolar nerve block -Approached lateral to pterygomandibular raphe between buccinator and superior constrictor</li>\n<li>Nerves blocked in ankle block are Superficial peroneal nerve, deep peroneal nerve, saphenous nerve</li>\n<li>Block for injury at medial aspect of foot- Posterior tibial nerve</li>\n<li>Advantages of ilioinguinal block for an inguinal hernia -Postoperative analgesia, allows maneuvers, avoid hypotension, no risk of GA</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1458, 'Anaesthesia', 'PM0367. Safety Profile of Anesthetic Drugs used in Porphyria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Safe analgesics/others</strong></p>\n</td>\n<td>\n<p><strong>Safe anesthetics</strong></p>\n</td>\n<td>\n<p><strong>Contraindicated drugs</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alfentanyl</p>\n</td>\n<td>\n<p>Atropine</p>\n</td>\n<td>\n<p>Barbiturates</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Aspirin</p>\n</td>\n<td>\n<p>Bupivacaine</p>\n</td>\n<td>\n<p>Ketamine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Buprenorphine</p>\n</td>\n<td>\n<p>Diazepam</p>\n</td>\n<td>\n<p>Primidone</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fentanyl</p>\n</td>\n<td>\n<p>Desflurane</p>\n</td>\n<td>\n<p>Phenytoin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ibuprofen</p>\n</td>\n<td>\n<p>Isoflurane</p>\n</td>\n<td>\n<p>Valproic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Morphine</p>\n</td>\n<td>\n<p>Lignocaine</p>\n</td>\n<td>\n<p>Clonazepam</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Paracetamol</p>\n</td>\n<td>\n<p>Midazolam</p>\n</td>\n<td>\n<p>Alcohol</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pethidine</p>\n</td>\n<td>\n<p>Muscle relaxants</p>\n</td>\n<td>\n<p>Estrogen</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tramadol</p>\n</td>\n<td>\n<p>Neostigmine</p>\n</td>\n<td>\n<p>Progestrone</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gabapentin</p>\n</td>\n<td>\n<p>Nitrous oxide</p>\n</td>\n<td>\n<p>Pyrazinamide</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Glucocorticoids</p>\n</td>\n<td>\n<p>Prilocaine</p>\n</td>\n<td>\n<p>Ergots</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Insulin</p>\n</td>\n<td>\n<p>Propofol</p>\n</td>\n<td>\n<p>Rifampicin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ranitidine</p>\n</td>\n<td>\n<p>Remifentanil</p>\n</td>\n<td>\n<p>Sulphonamides</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Penicillin</p>\n</td>\n<td>\n<p>Suxamethonium</p>\n</td>\n<td>\n<p>Griseofulvin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Betablockers</p>\n</td>\n<td>\n<p>Chlorpromazine</p>\n</td>\n<td>\n<p>Calcium channel blockers</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1459, 'Dermatology', 'PM1875. Dermoepidermal Junction/Basement Membrane Zone', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>The <strong>junction</strong> between epidermis and dermis is called the <strong>basement membrane zone</strong> or <strong>dermoepidermal junction</strong> and consists of a number of <strong>extracellular macromolecules</strong>.</li>\n<li>As many of these components <strong>are glycoproteins</strong>, the BMZ can be recognized histologically by staining with <strong>PAS stain</strong>.</li>\n<li><strong>Ultrastructural examination</strong> by electron microscopy shows 2 different layers with different optical densities\n<ul>\n<li><strong>Lamina Lucida - upper, less electron dense layer</strong></li>\n<li><strong>Lamina Densa -&nbsp;lower, more electron dense layer</strong></li>\n</ul>\n</li>\n<li>This zone is composed of<strong> 3 </strong>components :<strong> 1. Hemidesmosome 2. Anchoring Filaments 3. Anchoring Fibrils.</strong></li>\n</ul>\n<p><strong>1.</strong><strong>HEMIDESMOSOME </strong></p>\n<ul>\n<li>Hemidesmosomes are <strong>multiprotein complexes </strong>that facilitate the stable adhesion <strong>of basal epithelial cells</strong> to the underlying <strong>basement membrane</strong>.</li>\n<li>The intermediate keratin filaments <strong>K5/K14</strong> present within the basal keratinocytes <strong>attach to the hemidesmosomes </strong>at the base of the cell.</li>\n<li>The <strong>major</strong> hemidesmosomal Protein is <strong>Bullous Pemphigoid Antigen-1 (BPAg1 or BP230) </strong>and this attaches to the transmembrane component protein <strong>BPAg2 (BP180) </strong>below.</li>\n<li>The other hemidesmosomal protein <strong>Plectin</strong> is attached to the transmembrane component protein called as <strong>α6</strong><strong>β4 integrin</strong> below.</li>\n</ul>\n<p><strong>2.</strong><strong>ANCHORING FILAMENTS/Lamina Lucida and Lamina Densa</strong></p>\n<ul>\n<li>The <strong>anchoring filaments</strong> form the <strong>Lamina Lucida</strong> layer.</li>\n<li>Anchoring filaments consist of<strong> Laminin5/332</strong> proteins that connect <strong>BPAg2 and </strong><strong>α6</strong><strong>β4 integrin </strong>above<strong> to Lamina Densa </strong>below<strong>.</strong></li>\n<li><strong>Lamina Densa</strong> consists mainly of <strong>type IV Collagen </strong>and other proteins like<strong>&nbsp;</strong><strong>Nidogen</strong>. &nbsp;</li>\n</ul>\n<p><strong>3.</strong><strong>ANCHORING FIBRILS</strong></p>\n<ul>\n<li>These are <strong>ultrastructurally U shaped</strong> structures that attach the Lamina Densa above to the <strong>underlying connective tissue below in dermis.</strong></li>\n<li><strong>Type VII Collagen</strong> is the major protein in anchoring fibrils.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/03e655f6657846aba5d84e988c5680f9x800x316.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Blistering disorders</strong> in the <strong>DEJ/BMZ</strong> arise due to defects or antibodies against any of the above mentioned proteins.</p>\n<p><strong>Image:</strong>&nbsp;Gene/protein systems within the cutaneous basement membrane zone that can harbour mutations and result in blistering of the skin in different forms of epidermolysis bullosa (EB). BP, bullous pemphigoid</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2f7aacb5ea474798a32ebbaf3d85d14ax683x509.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9feeabeb3d2b40be99d5a15a50098cc2x436x566.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1460, 'Dermatology,', 'PM2213. Benign findings in a newborn', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>1. Erythema toxicum</strong>&nbsp;– small, white papules on an erythematous base that usually present on the face, trunk, and extremities. They&nbsp;<strong>contain eosinophils</strong>&nbsp;and may persist for a week.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c93e405ca4644726849478ab2b791561x338x600.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>2. Mongolian spots</strong>&nbsp;– Slate-blue, demarcated areas of pigmentation seen over the buttocks and back. This is also called <strong>dermal melanocytosis.</strong>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2bfc8d5afdde4dc5b525cd000fa21b22x727x528.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>3. Pustular melanosis</strong>&nbsp;– Benign lesions seen predominantly in black neonates,&nbsp;<strong>contains neutrophils,</strong>&nbsp;and is present at birth as vesiculopustular eruption around the chin, neck, back, extremities, palms and soles.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3d692b2255f14c8488cf7e85c470e2e4x800x600.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>4. Sebaceous Hyperplasia</strong> - White-Yellow papules on nose of a newborn due to hyperplastic sebaceous glands</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5bdad07b94374b1bbc90cc7290db714ax1280x1180.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>5. Milia</strong> - Pearly opalescent white, epidermal inclusion cysts usually over the face.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c2ce65089d7e41e390572e8a5d93a3b6x512x384.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>6. Epstein Pearls</strong> -&nbsp;nests of epithelial cells, that appear as whitish/yellowish spots on hard palate. Usually, resolve by 3 months.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a509aebb9e6c4af98bd625d0effe03dex800x510.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>7. Cutis Marmorata</strong> - Transient lacy reticular vascular pattern of skin caused due to exaggerated physiologic vasomotor response on exposure to low environmental temperature.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f4888a3caa914c6998363ccf1b6af0cdx450x600.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>8. Sucking Blisters</strong> - Solitary or scattered superficial bullae present at birth on the upper limbs of infants, which are caused by vigorous sucking on the affected part in-utero.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/83349d1da8164953bf8db49131d38395x539x411.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>9. Salmon patch&nbsp;</strong>or&nbsp;<strong>naevus</strong>&nbsp;<strong>simplex</strong>&nbsp;- Small, ill-defined, pink-coloured macules commonly seen over glabella, eyelids, upper lip, and nuchal area, which develop due to vascular ectasia.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/65419641c8d244b988ae57573a4ffc68x800x494.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>10.</strong> <strong>Harlequin colour change</strong> - A transient, well-demarcated colour change, with one half of the body displaying erythema and the other half pallor, usually occurring between two and five days of age.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/398fb3ef431240139602c4f63a0695aax720x715.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>11. Vaginal bleeding in the newborn</strong>&nbsp;at 2–3 days of age and enlargement and secretion of the breasts in both sexes.</p>\n<p><strong>12. Hymenal tags</strong></p>\n<p><strong>13. Physiological phimosis</strong></p>\n<p><strong>14. Conjunctival hemorrhage</strong></p>\n<p><strong>15. Peeling of skin</strong> (especially in post terms)</p></div><!---->\n      <!---->\n    </div><!---->'),
(1461, 'Dermatology', 'PM1962. Flowchart for Quick Diagnosis using Tzanck Smear Results', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/482a78776b8b407b831713707c36295bx965x698.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1462, 'Dermatology', 'PM1961. Tzanck Smear in Dermatology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The Tzanck smear, introduced by the Frenchman Tzanck, is a simple to perform, inexpensive bed side cytological test that&nbsp;aids in the diagnosis of <strong>vesicular, pustular and bullous</strong> diseases, in particular herpes.</p>\n<p>The sensitivity of the Tzanck smear exceeds <strong>80%</strong>, and the specificity <strong>90%</strong> when the investigators are experienced.</p>\n<p><strong>Preparation of Tzanck smear</strong>:</p>\n<ul>\n<li><strong>Viral</strong> infections and&nbsp;<strong>Blistering</strong> disorders - <strong>fresh vesicle or intact blister</strong> is de-roofed and base is scraped&nbsp;</li>\n<li><strong>Suspected tumors -&nbsp;</strong>any crust should be removed from ulcerated tumors, and non-ulcerated tumors should be incised with a sharp, pointed scalpel and sample is then obtained with either a blunt scalpel or a small curette</li>\n<li>The smear should preferably be <strong>fixed immediately</strong> using <strong>Formol-Zenker solution</strong> since significant artifacts can result from drying.</li>\n<li>Tzanck smear can be stained by a variety of methods, most commonly by <strong>Giemsa stain</strong>.&nbsp;Other stains used are hematoxylin and eosin, Wright, methylene blue, Papanicolaou and toluidine blue.&nbsp;</li>\n</ul>\n<p><strong>Results in Tzanck Smear</strong>:</p>\n<p>A <strong>typical Tzanck cell<a href=\http://www.ijdvl.com/viewimage.asp?img=ijdvl_2005_71_4_295_16632_2.jpg\ target=\_blank\ rel=\noopener\></a>&nbsp;</strong>is a large round keratinocyte with a hypertrophic nucleus, hazy or absent nucleoli, and abundant basophilic cytoplasm. The <strong>basophilic staining is deeper peripherally</strong> on the cell membrane (<strong>\mourning edged\ cells</strong>) due to the cytoplasms tendency to get condensed at the periphery, leading to a perinuclear halo.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\>Immunobullous Disorders&nbsp;</td>\n</tr>\n<tr>\n<td>Pemphigus Vulgaris</td>\n<td>Multiple acantholytic cells (Tzanck cells)</td>\n</tr>\n<tr>\n<td>Staphylococcal Scalded Skin Syndrome (SSSS)</td>\n<td>Dyskeratotic acantholytic cells with <strong>very few inflammatory cells</strong></td>\n</tr>\n<tr>\n<td>Toxic Epidermal Necrolysis(TEN)</td>\n<td><strong>Necrotizing or degenerating basal cells</strong> with scattered inflammatory cells and fibroblasts&nbsp;</td>\n</tr>\n<tr>\n<td>Bullous pemphigoid (BP), Stevens-Johnson syndrome (SJS) and erosive lichen planus</td>\n<td><strong>No acantholytic cells</strong> ; Many leucocytes</td>\n</tr>\n</tbody>\n</table>\n</td>\n</tr>\n<tr>\n<td>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\>Cutaneous Infections&nbsp;</td>\n</tr>\n<tr>\n<td>Herpes simplex, varicella, herpes zoster</td>\n<td><strong>Ballooning degeneration and multinucleated</strong> giant cells are seen</td>\n</tr>\n<tr>\n<td>Molluscum contagiosum</td>\n<td>Diagnostic intracytoplasmic molluscum bodies <strong>(Henderson-Patterson bodies)</strong>, the largest known inclusion bodies (30-35 microns)</td>\n</tr>\n<tr>\n<td>Vaccinia, orf, milkers nodules and variola</td>\n<td>Acantholytic squamous keratinocytes ,&nbsp;eosinophilic cytoplasmic inclusion called a \<strong>Guarnieri body</strong>\</td>\n</tr>\n<tr>\n<td>&nbsp;Leishmaniasis</td>\n<td><strong>Leishman-Donovan (LD)</strong> bodiesgrouped together in a typical <strong>\swarm of bees\</strong> fashion, within large macrophages (Wrights cells)</td>\n</tr>\n<tr>\n<td>Bullous Impetigo</td>\n<td>Dyskeratotic acantholytic cells&nbsp;with abundant neutrophils and&nbsp;<strong>clusters of coccoid bacteria</strong></td>\n</tr>\n</tbody>\n</table>\n</td>\n</tr>\n<tr>\n<td>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\>Genodermatoses&nbsp;</td>\n</tr>\n<tr>\n<td>Hailey-Hailey disease</td>\n<td>Multiple acantholytic cells; Direct Immunofluorescence Negative</td>\n</tr>\n<tr>\n<td>Dariers Disease</td>\n<td><strong>\Corps ronds\</strong> are isolated keratinocytes with a round shape and an acidophilic cytoplasm. The <strong>corps grains</strong> are seen as small, hyaline, acidophilic ovoid bodies resembling pomegranate seeds.</td>\n</tr>\n</tbody>\n</table>\n</td>\n</tr>\n<tr>\n<td>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\>Cutaneous Tumours&nbsp;</td>\n</tr>\n<tr>\n<td>Squamous Cell Carcinoma</td>\n<td><strong>Atypical Squamous Cells</strong></td>\n</tr>\n<tr>\n<td>Basal Cell Carcinoma</td>\n<td><strong>Clusters of Basaloid cells</strong></td>\n</tr>\n</tbody>\n</table>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Image : Tzanck smear , showing <strong>three multinucleated giant cell</strong>s in center.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f4da4033d6d14c07a4f478bbd8ea8a4cx1280x1143.6953455571227.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1463, 'Dermatology', 'PM0260. Woods lamp examination', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Woods lamp examination</strong> is a <strong>diagnostic</strong> test&nbsp;wherein the <strong>skin</strong> or <strong>hair</strong> is examined under exposure to the <strong>black</strong> <strong>light</strong> emitted by the <strong>Wood</strong> <strong>lamp</strong>.</p>\n<p>Blacklight is invisible to the naked eye because it is in the ultraviolet spectrum, with a wavelength just shorter than the color violet. The lamp glows violet in a dark environment because it also emits some light in the violet part of the electromagnetic spectrum.</p>\n<p>A traditional Wood lamp is a low-output mercury arc covered by a <strong>Wood</strong> <strong>filter</strong> (<strong>barium</strong> <strong>silicate</strong> and <strong>9% nickel oxide</strong>) and emits light at&nbsp;<strong>wavelength</strong> <strong>320</strong>–<strong>450</strong> <strong>nm</strong> (<strong>peak</strong> <strong>365</strong> <strong>nm</strong>).</p>\n<p><strong>Table</strong>: Various diseases and their color on Wood’s lamp examination</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Colour on Wood’s Light</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tinea capitis</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><strong>Microsporum species</strong>: brilliant green (M. canis, M. audouinii, M. ferrugineum, M. distortum)</p>\n<p><strong>Trichophyton schoenleinii</strong>: dull blue</p>\n<p>Most&nbsp;<strong>Trichophyton&nbsp;</strong>species, with the exception of&nbsp;T. schoenleini<em>i</em>, are&nbsp;non-fluorescent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Erythrasma</p>\n</td>\n<td>\n<p>Coral pink</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pityriasis versicolor</p>\n</td>\n<td>\n<p>Faint yellow</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pseudomonas</p>\n</td>\n<td>\n<p>Green</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Scabies</p>\n</td>\n<td>\n<p>Fluorescein solution fills the burrows and fluoresces on Wood’s light.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Porphyria</p>\n</td>\n<td>\n<p>Urine, feces, blister fluid fluoresce red or pink</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitiligo</p>\n</td>\n<td>\n<p>Ivory or milky white</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2242a0f1720540909975b6853638f735x800x531.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1464, 'Dermatology', 'PM0257. Primary and Secondary Lesions of Skin', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Primary lesions of the skin include:</strong></p>\n<ul>\n<li>Papule</li>\n<li>Plaque</li>\n<li>Wheal</li>\n<li>Vesicle</li>\n<li>Bulla</li>\n<li>Nodule</li>\n<li>Macule</li>\n<li>Patch</li>\n<li>Purpura</li>\n<li>Pustule</li>\n</ul>\n<p>For mnemonic lovers, the following mnemonic might help!</p>\n<p><strong>P</strong>redatory <strong>P</strong>oisonous <strong>W</strong>asps <strong>V</strong>iciously <strong>B</strong>it on the <strong>N</strong>ose of <strong>M</strong>y <strong>P</strong>atient causing <strong>P</strong>urulent <strong>P</strong>us</p>\n<p>&nbsp;</p>\n<p><strong>Secondary lesions of the skin include:</strong></p>\n<p>Mnemonic-<strong>&nbsp;</strong><strong>LEAF SUCKS </strong>water</p>\n<ul>\n<li><strong>L </strong>—<strong>&nbsp;L</strong>ichenification</li>\n<li><strong>E </strong>—<strong> E</strong>rosion / <strong>E</strong>xcoriation</li>\n<li><strong>A </strong>—<strong> A</strong>trophy</li>\n<li><strong>F </strong>—<strong> F</strong>issure</li>\n<li><strong>S </strong>—&nbsp;<strong>S</strong>cale</li>\n<li><strong>U </strong>—&nbsp;<strong>U</strong>lcer</li>\n<li><strong>C </strong>—&nbsp;<strong>C</strong>rust</li>\n<li><strong>K </strong>—&nbsp;<strong>K</strong>ind-of-hard to feel (Induration)</li>\n<li><strong>S </strong>—&nbsp;<strong>S</strong>car</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1465, 'Dermatology', 'PM0256. Shapes of skin lesions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Shapes of Skin Lesions</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Shape</strong></p>\n</td>\n<td>\n<p><strong>Description</strong></p>\n</td>\n<td>\n<p><strong>Examples</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Discoid (nummular)</strong></p>\n</td>\n<td>\n<p>A filled circle</p>\n</td>\n<td>\n<p>Discoid eczema, Psoriasis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Petaloid</strong></p>\n</td>\n<td>\n<p>Discoid lesions which have merged together</p>\n</td>\n<td>\n<p>Seborrhoeic dermatitis on the trunk</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Arcuate</strong></p>\n</td>\n<td>\n<p>Incomplete circles</p>\n</td>\n<td>\n<p>Urticaria</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Annular</strong></p>\n</td>\n<td>\n<p>Open circles with different central skin compared with the rim</p>\n</td>\n<td>\n<p>Tinea corporis, granuloma annulare</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Polycyclic</strong></p>\n</td>\n<td>\n<p>Circles which have merged together</p>\n</td>\n<td>\n<p>Psoriasis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Livedo</strong></p>\n</td>\n<td>\n<p>Chicken‐wire criss‐cross pattern</p>\n</td>\n<td>\n<p>Erythema ab igne, polyarteritis nodosa</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Reticulate</strong></p>\n</td>\n<td>\n<p>Fine lace‐like pattern</p>\n</td>\n<td>\n<p>Oral lichen planus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Target</strong></p>\n</td>\n<td>\n<p>Multiple concentric rings</p>\n</td>\n<td>\n<p>Erythema multiforme</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Stellate</strong></p>\n</td>\n<td>\n<p>Star‐shaped</p>\n</td>\n<td>\n<p>Lesions of meningococcal septicaemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Linear</strong></p>\n</td>\n<td>\n<p>Straight line</p>\n</td>\n<td>\n<p>Koebner reaction to a scratch in lichen planus or psoriasis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Serpiginous</strong></p>\n</td>\n<td>\n<p>Snake‐like</p>\n</td>\n<td>\n<p>Cutaneous larva migrans</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Whorled</strong></p>\n</td>\n<td>\n<p>Swirling pattern</p>\n</td>\n<td>\n<p>Epidermal naevi, late‐stage incontinentia pigmenti</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1466, 'Dermatology', 'PM0255. Glossary of important skin lesions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Glossary of Important Skin Lesions</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Lesion</strong></p>\n</td>\n<td>\n<p><strong>Description</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Alopecia</strong></p>\n</td>\n<td>\n<p>Absence of hair from a normally hairy area</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Aphtha</strong></p>\n</td>\n<td>\n<p>A small ulcer of the mucosa</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Atrophy</strong></p>\n</td>\n<td>\n<p>Loss of tissue from one or more of the epidermis, dermis or subcutaneous tissues</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Burrow</strong></p>\n</td>\n<td>\n<p>A small tunnel in the skin that houses a parasite, such as the scabies acarus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Callus</strong></p>\n</td>\n<td>\n<p>A localized hyperplasia of the stratum corneum</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cellulitis</strong></p>\n</td>\n<td>\n<p>An inflammation of cellular tissue, particularly purulent inflammation of the deep dermis and subcutaneous tissue</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Comedo</strong></p>\n</td>\n<td>\n<p>A plug of keratin and sebum in a dilated pilosebaceous orifice</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Crusts </strong><strong>(scabs)</strong></p>\n</td>\n<td>\n<p>Crusts consist of dried serum and other exudates</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cyst</strong></p>\n</td>\n<td>\n<p>Any closed cavity or sac (normal or abnormal) with an epithelial, endothelial or membranous lining and containing fluid or semi‐solid material</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Ecchymosis</strong></p>\n</td>\n<td>\n<p>A macular area of hemorrhage more than 1 cm (bruise) in diameter</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Erosion</strong></p>\n</td>\n<td>\n<p>A loss of epidermis, which heals without scarring. It commonly follows a blister.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Erythema</strong></p>\n</td>\n<td>\n<p>Redness of the skin produced by vascular congestion or increased perfusion</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Excoriation</strong></p>\n</td>\n<td>\n<p>Loss of skin substance, specifically produced by scratching</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Exfoliation</strong></p>\n</td>\n<td>\n<p>The splitting off of the epidermal keratin in scales or sheets</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Fibrosis</strong></p>\n</td>\n<td>\n<p>The formation of excessive fibrous tissue</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Fissure</strong></p>\n</td>\n<td>\n<p>Any linear gap or slit in the skin surface</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Fistula</strong></p>\n</td>\n<td>\n<p>An abnormal passage from a deep structure, such as a hollow viscus, to the skin surface or between two structures</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Gangrene</strong></p>\n</td>\n<td>\n<p>Death of tissue, usually due to loss of blood supply</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Guttate lesions</strong></p>\n</td>\n<td>\n<p>Small round or oval lesions distributed as a ‘shower’ of droplets. Usually applied to a form of psoriasis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hematoma</strong></p>\n</td>\n<td>\n<p>A localized tumor‐like collection of blood</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Keratoderma</strong></p>\n</td>\n<td>\n<p>A horny thickening of the skin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Lichenification</strong></p>\n</td>\n<td>\n<p>Thickening of the epidermis (and to some extent also of the dermis) in response to prolonged rubbing</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Macule</strong></p>\n</td>\n<td>\n<p>A flat circumscribed, non‐palpable lesion that differs in color from the surrounding skin. It can be of any color or shape. A macule is &lt;1 cm in diameter, larger lesions are a patch.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Maculopapular</strong></p>\n</td>\n<td>\n<p>Rash consisting of both macules and papules</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Milium</strong></p>\n</td>\n<td>\n<p>A tiny white cyst containing lamellated keratin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Nodule*</strong></p>\n</td>\n<td>\n<p>A solid palpable lesion in the dermis or subcutis, which can be observed as an elevation or can be palpated. It is &gt;0.5 cm in diameter.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Papule</strong></p>\n</td>\n<td>\n<p>An elevated solid lesion that is &lt;1 cm in diameter.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Petechia</strong></p>\n</td>\n<td>\n<p>A punctate hemorrhagic spot, approximately 1–2 mm in diameter.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Plaque</strong></p>\n</td>\n<td>\n<p>An elevated circumscribed lesion &gt;1 cm diameter; its surface is usually flat. Plaques may form from coalesced papules.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Poikiloderma</strong></p>\n</td>\n<td>\n<p>The association of cutaneous pigmentation, and telangiectasia.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pustule</strong></p>\n</td>\n<td>\n<p>A circumscribed lesion that contains purulent material.&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pyoderma</strong></p>\n</td>\n<td>\n<p>Any purulent skin disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scale</strong></p>\n</td>\n<td>\n<p>Scale is a flat plate or flake-like lesion desquamated of stratum corneum.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Scar</strong></p>\n</td>\n<td>\n<p>Replacement by fibrous tissue of another tissue that has been destroyed by injury or disease</p>\n<p>An <strong>atrophic scar</strong> is thin and wrinkled.</p>\n<p>A <strong>hypertrophic scar</strong> is elevated, with excessive growth of fibrous tissue.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sclerosis</strong></p>\n</td>\n<td>\n<p>Diffuse or circumscribed induration of the subcutaneous tissues. It may also involve the dermis, when the overlying epidermis may be atrophic. It is characteristically seen in scleroderma.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sinus</strong></p>\n</td>\n<td>\n<p>A cavity or track with a blind ending</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Target lesions</strong></p>\n</td>\n<td>\n<p>These are &lt;3 cm in diameter and have three or more zones, usually a central area of dusky erythema or purpura, a middle paler zone of edema, and an outer ring of erythema with a well‐defined edge.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Tumor</strong></p>\n</td>\n<td>\n<p>Literally a swelling; the term is used to imply enlargement of the tissues by normal or pathological material, or cells that form a mass.&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Ulcer (of skin)</strong></p>\n</td>\n<td>\n<p>A loss of dermis and epidermis, often with loss of the underlying tissues</p>\n</td>\n</tr>\n<tr>\n<td><strong>Vesicles and Bullae</strong></td>\n<td>\n<p>&nbsp;A vesicle is a circumscribed elevation &lt;1 cm in diameter that contains fluid</p>\n<p>Bullae are &gt;1 cm in diameter</p>\n</td>\n</tr>\n<tr>\n<td><strong>Wheal</strong></td>\n<td>&nbsp;A transient elevation of the skin due to dermal and hypodermal, often pale centrally with an erythematous rim; it is the characteristic lesion of urticaria.</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;*While Rooks textbook of Dermatology,9th edition mention nodule as &gt;0.5 cm. Some authors define nodules as &gt;1 cm.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1467, 'Dermatology', 'PM0248. Key Chart to help differentiate lesions on face', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Key Chart to help Differentiate Lesions on face</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0a5140c64ee04126a3fec16990765703x1280x2116.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p>The following images show the findings in -</p>\n<ul>\n<li><strong>Melasma</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1b24d22d7e6a4de493c0d240ebd6ec77x512x379.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<ul>\n<li><strong>Rosacea</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0b3b7051b30c4603b4fc56b6170151f5x484x237.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<ul>\n<li>Butterfly-shaped malar rash in<strong> SLE&nbsp;</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/96558496ccf84739a55a7acab31585ffx512x584.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<ul>\n<li><strong>Acne</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/22d3e7b84f47471a8b58f938dc1a03f2x640x480.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8897f6677285496484b6281ce6100c65x640x427.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/20f4612e49014dcbb32ac3481718547fx640x480.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f248bc3b24f94e969561e2bf7be0b6b7x800x536.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<ul>\n<li><strong>Nevus of Ota</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0f16c38775234b8789ab421ee8988755x512x494.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<ul>\n<li><strong>Portwine stain</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2ff136c533da46809a1e8615c5c9afa2x1280x959.5486600846262.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<ul>\n<li><strong>Infantile hemangioma</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/828bdd67837445a583f2c34441ecc984x450x600.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1468, 'Dermatology', 'PM1917. Fox-Fordyce disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Fox Fordyce disease</strong>, also known as&nbsp;<strong>Apocrine</strong>&nbsp;<strong>Miliaria</strong>, is characterized by intensely&nbsp;<strong>pruritic</strong>, white pearly&nbsp;<strong>papules</strong>&nbsp;in&nbsp;<strong>apocrine areas</strong>. It most commonly involves<strong> axilla</strong>, then areolae. It is commonly seen in&nbsp;<strong>women&nbsp;</strong>(90%).</p>\n<p>The condition occurs as a result of apocrine sweat&nbsp;<strong>duct occlusion by aggregates of epithelial cells</strong>&nbsp;of the apocrine or apoeccrine secretory cells. The&nbsp;<strong>earliest pathological sign</strong>&nbsp;is a&nbsp;<strong>small vesicle in the apocrine duct</strong>.</p>\n<p>Later, the apocrine glands are seen to be enlarged, and as a consequence of repeated inflammatory events,&nbsp;<strong>perifollicular xanthomatosis with perifollicular foam cells</strong>&nbsp;expressing CD68 may develop.</p>\n<p>Treatment:</p>\n<p>First-line</p>\n<ul>\n<li>Topical or intralesional steroids</li>\n<li>Topical clindamycin lotion</li>\n<li>Topical retinoids</li>\n</ul>\n<p>Second line</p>\n<ul>\n<li>Ultraviolet light</li>\n<li>Oral retinoids</li>\n</ul>\n<p>Third line</p>\n<ul>\n<li>Surgery</li>\n</ul>\n<p>This should&nbsp;<strong>not</strong>&nbsp;be confused with&nbsp;<strong>Fordyce spots</strong>&nbsp;or Fordyce disease which is due to&nbsp;<strong>ectopic sebaceous glands</strong>.</p>\n<p><strong>Image:&nbsp;</strong>Fox-Fordyce disease of the axilla</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a884c646e44749c3a5600b80d0d72e9cx512x384.PNG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1469, 'Dermatology', 'PM1914. Different types of miliaria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Miliaria</strong>&nbsp;is a common acute or subacute skin condition that arises due to the&nbsp;<strong>occlusion</strong>&nbsp;or&nbsp;<strong>disruption</strong>&nbsp;of&nbsp;<strong>eccrine sweat ducts</strong>&nbsp;in hot humid conditions.</p>\n<p>Based on the <strong>level of blockade</strong> it is differentiated into</p>\n<ul>\n<li><strong>Miliaria Crystallina-&nbsp;</strong>Stratum corneum</li>\n<li><strong>Miliaria Rubra</strong>&nbsp;- Malpighian Layer</li>\n<li><strong>Miliaria profunda</strong>&nbsp;- Dermoepidermal junction</li>\n</ul>\n<p><strong>Pathophysiology:</strong></p>\n<ul>\n<li>The first event may be an<strong>&nbsp;increase in the skin flora</strong>, perhaps with Staphylococcus epidermidis being responsible for producing an extracellular polysaccharide substance or slime that&nbsp;<strong>blocks the lumen</strong>&nbsp;of the sweat duct.</li>\n<li>The&nbsp;<strong>parakeratotic plugs</strong>, a notable feature of the later stages of the disease, are not the primary cause of the obstruction but arise in the<strong>&nbsp;repair process</strong>, and further aggravate the obstruction.</li>\n<li><strong>Leakage of sweat into the epidermis</strong>&nbsp;is responsible for the final production of the lesions, and for their further aggravation.</li>\n<li>Miliaria crystallina occurs commonly in infants due to a delay in the development of patency in the sweat ducts.</li>\n</ul>\n<p><strong>Clinical features:</strong></p>\n<ul>\n<li><strong>Miliaria crystallina:</strong>&nbsp;<strong>Clear, thin‐walled vesicles, 1–2 mm</strong>&nbsp;in diameter&nbsp;<strong>without an inflammatory areola</strong>, are usually&nbsp;<strong>symptomless</strong>&nbsp;and develop in&nbsp;<strong>crops</strong>, mainly on the trunk. In persistent febrile illnesses, recurrent crops may occur. The vesicles soon rupture and are followed by&nbsp;<strong>superficial, branny desquamation</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/aa0deef4a0d14ef3bcfc937904ab0af5x600x413.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<ul>\n<li><strong>Miliaria rubra:</strong>&nbsp;Typical lesions develop on the body, especially in areas of<strong>&nbsp;friction with clothing, and in flexures</strong>. The lesions are uniformly&nbsp;<strong>minute erythematous papules</strong>, which may be present in very large numbers. Characteristically, the lesions produce intense discomfort in the form of an&nbsp;<strong>unbearable pricking sensation.</strong>&nbsp;Relief is often instantaneous when the stimulus to sweating is abolished by a cool shower. In infants, lesions commonly appear on the occluded skin of the neck, groins and axillae, but also occur elsewhere.</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/35d93e9e18cd4f19b2a0df77cb0c2896x448x496.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<ul>\n<li><strong>Miliaria profunda:</strong>&nbsp;This nearly always&nbsp;<strong>follows repeated attacks of miliaria rubra</strong>, and is common only in the tropics. The&nbsp;lesions are&nbsp;<strong>easily missed</strong>. The affected skin is covered with&nbsp;<strong>pale, firm papules 1–3 mm across</strong>, especially on the body, but sometimes also on the limbs. There is&nbsp;<strong>no itching or discomfort </strong>from the lesions.</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Treatment:</strong></p>\n<ul>\n<li><strong>First line</strong><br> • Control local environment (remove excess bedding, fans, air<br> conditioning)<br> • Cool the skin (damp compresses, cool showers)<br> • Avoid tight or excessive clothing</li>\n<li><strong>Second line</strong><br> • Menthol (e.g. 0.5% menthol in aqueous cream)<br> • Topical antibiotics if there is secondary infection<br> • Mild topical steroids</li>\n<li><strong>Third line</strong><br> • Removal to cooler climate<br> • Prophylactic oral vitamin C</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1470, 'Dermatology', 'PM1913. Fordyce Spots', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Fordyce spots/Fordyce granules:</strong></p>\n<ul>\n<li>The Fordyce spots are&nbsp;<strong>heterotopic&nbsp;sebaceous glands&nbsp;</strong>wherein&nbsp;the duct is connected&nbsp;<strong>directly</strong>&nbsp;to the overlying&nbsp;<strong>skin or mucosal surface&nbsp;</strong>unlike other sebum glands which open into the follicle.</li>\n<li>They are called&nbsp;<strong>ectopic/free-lying sebaceous glands</strong>.</li>\n<li>They occur commonly on the vermilion border of&nbsp;<strong>upper lip(m/c)</strong>,&nbsp;<strong>buccal mucosa</strong>,&nbsp;<strong>skin over penile shaft and areolar of the breast.</strong></li>\n<li>They are commonly&nbsp;<strong>multiple</strong>&nbsp;and appear as&nbsp;<strong>symmetrical discrete yellow papules.</strong></li>\n<li>Fordyce spots on penis are called&nbsp;<strong>Tyson glands.</strong></li>\n<li>They are&nbsp;<strong>asymptomatic</strong>.</li>\n<li><strong>Treatment ladder</strong>\n<ul>\n<li><strong>First line</strong>:<strong>&nbsp;</strong>Reassurance</li>\n<li><strong>Second line</strong>\n<ul>\n<li>Local destruction with superficial cautery or electrodessication</li>\n<li>Topical trichloracetic acid&nbsp;</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>Image:&nbsp;</strong>Fordyce spots on the&nbsp;vermilion border of both lips in A, upper lip in B, and buccal mucosa in&nbsp; C.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2759a4f8bc9e4098b54c8308c4a26e5ex512x108.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1471, 'Dermatology', 'PM0243. Global Alliance Algorithm for Acne Treatment', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Global Alliance Algorithm for Acne Treatment</strong></p>\n<p><strong>Image: </strong>Global Alliance Algorithm for Improving Outcomes in acne</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/d0c11e3325124df49bac9104eabccaebx686x530.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>BPO - Benzoyl peroxide</p></div><!---->\n      <!---->\n    </div><!---->'),
(1472, 'Dermatology', 'PM0240. Important Syndromes Related to Acne', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Important Syndromes Related to Acne</strong></p>\n<p><strong>I. SAPHO syndrome</strong></p>\n<ol>\n<li>Synovitis</li>\n<li>Acne</li>\n<li>Pustulosis</li>\n<li>Hyperostosis</li>\n<li>Osteitis</li>\n</ol>\n<p><strong>II. HAIR-AN syndrome</strong></p>\n<ol>\n<li>Hyperandrogenism (HA)</li>\n<li>Insulin Resistance (IR)</li>\n<li>Acanthosis Nigricans(AN)</li>\n</ol>\n<p><strong>III. SAHA syndrome</strong></p>\n<ol>\n<li>Seborrhoea</li>\n<li>Acne</li>\n<li>Hirsutism</li>\n<li>Androgenetic alopecia</li>\n</ol>\n<p><strong>IV. PAPA syndrome</strong></p>\n<ol>\n<li>Pyogenic Arthritis (PA)</li>\n<li>Pyoderma gangrenosum (P)</li>\n<li>Acne(A)</li>\n</ol></div><!---->\n      <!---->\n    </div><!---->'),
(1473, 'Dermatology', 'PM1897. Causes of scarring and non-scarring alopecia- Mnemonic', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Alopecia or hair loss can be classified as :</p>\n<ol>\n<li>Non-Scarring/Non-Cicatricial alopecia</li>\n<li>Scarring/Cicatricial alopecia&nbsp;</li>\n</ol>\n<p><strong>Mnemonic</strong> for causes of<strong> non-scarring </strong>alopecia<strong>: THATS STD!</strong></p>\n<ul>\n<li><strong>T</strong>inea capitis(Non-Inflammatory Type&nbsp; - grey patch and black dot types )</li>\n<li><strong>H</strong>ormonal - Hypothyroidism, Androgenetic alopecia</li>\n<li><strong>A</strong>nagen effluvium,&nbsp;<strong>A</strong>lopecia areata</li>\n<li><strong>T</strong>richotillomania</li>\n<li><strong>S</strong>econdary syphilis (moth-eaten alopecia)</li>\n<li><strong>S</strong>LE(predominantly causes non-scarring alopecia but also can cause scarring alopecia)</li>\n<li><strong>T</strong>elogen effluvium</li>\n<li><strong>D</strong>eficiency of Zinc, Iron&nbsp;</li>\n</ul>\n<p><strong>Mnemonic</strong> for causes of <strong>scarring</strong> alopecia: <strong>SF<sub>2</sub>L<sub>3</sub></strong></p>\n<ul>\n<li><strong>S</strong>cleroderma - Linear scalp morphea (en coup de sabre)</li>\n<li><strong>F</strong>avus and Kerion (Inflammatory Type of Tinea capitis)</li>\n<li><strong>F</strong>olliculitis decalvans</li>\n<li><strong>L</strong>ichen planopilaris</li>\n<li><strong>L</strong>upus vulgaris</li>\n<li><strong>L</strong>upus erythematosis - discoid (DLE)</li>\n<li>Pseudopelade of Brocq</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1474, 'Dermatology', 'PM0182. Hair Cycle', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Hair follicles</strong> undergo a repetitive sequence of growth and the rest is known as the <strong>hair cycle</strong>. Hair Cycle is usually described under <strong>three phases</strong>: Anagen, Catagen, and Telogen.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/4e7b67b1c3c646fda4224ac2fbca4337x936x718.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>1. Anagen</strong></p>\n<ul>\n<li>The <strong>period of active hair growth</strong> is known as <strong>anagen</strong> and the duration of this phase is responsible for determining the final length of the hair.</li>\n<li>The entry of a resting hair follicle into anagen is heralded by the <strong>onset of mitotic activity in epithelial cells</strong> overlying the dermal papilla at the base of the follicle (the secondary epithelial germ).</li>\n<li>Under normal circumstances, <strong>80–90% of hair follicles</strong> on the human scalp are in anagen at any one time.</li>\n<li>Anagen can continue for several years.</li>\n</ul>\n<p><strong>Fig 1.</strong>&nbsp;Scalp hair follicle in the anagen II stage of development</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/ee859cd3c39c47b4a7f639dfeb33f278x404x601.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Fig 2.</strong>&nbsp; Anagen hair bulb. <strong>Co</strong>, hair cortex; <strong>Cu</strong>, hair cuticle; <strong>DP</strong>, dermal papilla; <strong>DS</strong>, dermal sheath; <strong>He</strong>, Henle layer; <strong>HM</strong>, hair matrix; <strong>Hu</strong>, Huxley layer; <strong>IRSCu</strong>, inner root sheath cuticle; <strong>Me</strong>, melanocyte; <strong>ORS</strong>, outer root sheath</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/5231bb585714455d9ada9c1ddc365512x400x482.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>2. Catagen</strong></p>\n<ul>\n<li>At the end of anagen, <strong>epithelial cell division declines and ceases</strong>, and the follicle enters an <strong>involutionary phase</strong> known as <strong>catagen</strong>.</li>\n<li>During catagen, the proximal end of the <strong>hair shaft keratinizes</strong> to form a <strong>club-shaped structure</strong> and the lower part of the follicle involutes by apoptosis.</li>\n<li>The basement membrane surrounding the follicle becomes thickened and corrugated to form the ‘<strong>glassy membrane’</strong>.</li>\n<li>It lasts for about 10 days.</li>\n</ul>\n<p><strong>Fig 3.&nbsp; </strong>Human hair follicle in mid-catagen. There is a prominent glassy membrane surrounding the regressing epithelial column. The dermal papilla is rounded and condensed.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/c270087a4c224c20a09ed0369eddf177x400x600.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>3. Telogen</strong></p>\n<ul>\n<li>It is the time period between catagen and the next anagen.</li>\n<li>It lasts for about 3 months.</li>\n<li><strong>Club hair is eventually shed</strong> through an active process called <strong>exogen</strong>.</li>\n<li>In the human scalp, hair follicles may remain in a <strong>state of latency</strong>, also known as <strong>kenogen</strong>, for a pro­longed period after the club hair is shed.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1475, 'Dermatology,', 'PM0180. Nail findings and associated systemic conditions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Nail finding</strong></p>\n</td>\n<td><strong>Associated systemic condition</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Clubbing</strong></p>\n</td>\n<td>\n<ul>\n<li>Inflammatory bowel disease</li>\n<li><span>Lung cancer</span></li>\n<li>Idiopathic pulmonary fibrosis</li>\n<li><span>Complicated tuberculosis</span></li>\n<li><span>Suppurative lung disease (lung abscess, empyema, bronchiectasis, cystic fibrosis)</span></li>\n<li>Mesothelioma</li>\n<li>Cirrhosis</li>\n<li>Congenital heart disease, Endocarditis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Koilonychia</strong></p>\n</td>\n<td>\n<p>Iron-deficiency anemia, hemochromatosis, Raynaud’s disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Onycholysis</strong></p>\n</td>\n<td>\n<p>Psoriasis, onychomycosis, hyperthyroidism, sarcoidosis, trauma, amyloidosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Pitting</strong></p>\n</td>\n<td>\n<p>Psoriasis, Reiter’s syndrome, Alopecia areata</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Beau’s lines</strong></p>\n</td>\n<td>\n<p>Any severe systemic illness that disrupts nail growth, Raynaud’s disease, pemphigus, trauma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Yellow nail</strong></p>\n</td>\n<td>\n<p>Lymphedema, pleural effusion, immunodeficiency, bronchiectasis, sinusitis, rheumatoid arthritis, nephrotic syndrome, thyroiditis, tuberculosis, Raynaud’s disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Nail Pterygium</strong></p>\n</td>\n<td>\n<p>Dorsal: Lichen Planus</p>\n<p>Ventral: trauma, systemic sclerosis, Raynaud phenomenon, lupus erythematosus</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p class=\heading\>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Nail finding</strong></p>\n</td>\n<td>\n<p><strong>Associated systemic condition</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Terry’s (white) nails</strong></p>\n</td>\n<td>\n<p>Hepatic failure, cirrhosis, diabetes mellitus, CHF, hyperthyroidism, malnutrition</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Azure lunula</strong></p>\n</td>\n<td>\n<p>Hepatolenticular degeneration (Wilson’s disease), silver poisoning, quinacrine therapy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Half-and-half nails</strong></p>\n</td>\n<td>\n<p>Specific for renal failure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Muehrcke’s lines</strong></p>\n</td>\n<td>\n<p>Specific for hypoalbuminemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mees’ lines</strong></p>\n</td>\n<td>\n<p>Arsenic poisoning, Hodgkin’s disease, CHF, leprosy, malaria, chemotherapy, carbon monoxide poisoning, other systemic insults</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Dark longitudinal streaks</strong></p>\n</td>\n<td>\n<p>Melanoma, benign nevus, chemical staining, normal variant in darkly pigmented people</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Splinter hemorrhage</strong></p>\n</td>\n<td>\n<p>Subacute bacterial endocarditis, SLE, rheumatoid arthritis, antiphospholipid syndrome, peptic ulcer disease, malignancies, oral contraceptive use, pregnancy, psoriasis, trauma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Telangiectasia</strong></p>\n</td>\n<td>\n<p>Rheumatoid arthritis, SLE, dermatomyositis, scleroderma</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1476, 'Dermatology', 'PM1911. Algorithm for the differential diagnosis of Hypomelanosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/76d12e9fdf3e477fa5ca155bed1ddaacx657x456.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1477, 'Dermatology', 'PM1948. Erythema multiforme vs. Stevens-Johnson syndrome/Toxic epidermal necrolysis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Erythema multiforme major</strong></td>\n<td><strong>Stevens-Johnsons Syndrome</strong></td>\n<td><strong>Toxic Epidermal Necrolysis (Lyell syndrome)</strong></td>\n</tr>\n<tr>\n<td><strong>% Body Surface-area</strong></td>\n<td>\n<p>&lt;10%</p>\n</td>\n<td>&lt;10%</td>\n<td><strong>&gt;30%</strong></td>\n</tr>\n<tr>\n<td><strong>Causes</strong></td>\n<td><strong>Herpes simplex</strong>&gt; Mycoplasma infection</td>\n<td>Drug induced e.g. cephalosporins, sulfa drugs, allopurinol</td>\n<td>Drug induced e.g. cephalosporins, sulfa drugs, allopurinol</td>\n</tr>\n<tr>\n<td><strong>Associated Symptoms</strong></td>\n<td><strong>Less</strong> fever and other constitutional symptoms</td>\n<td>Fever, malaise and headache</td>\n<td>Fever, malaise and headache</td>\n</tr>\n<tr>\n<td><strong>Mucosal Lesions</strong></td>\n<td><strong>Milder</strong> mucosal lesions</td>\n<td>Severe mucosal involvement</td>\n<td>Severe mucosal involvement</td>\n</tr>\n<tr>\n<td><strong>Lesions</strong></td>\n<td>Erythematous papules, <strong>Target lesions</strong>, <strong>raised atypical target</strong> lesions, occasional bullous lesions</td>\n<td>\n<p>Vesicles on erythematous base, erosions, <strong>purpuric macules, Flat atypical target lesions</strong></p>\n<p>Nikolsky Sign Positive</p>\n</td>\n<td>\n<p>Diffuse, generalized epidermal detachment</p>\n<p><strong>TEN with spots</strong> - with widespread purpuric macules and flat atypical target lesions</p>\n<p><strong>TEN without spots</strong>-&nbsp;loss of large epidermal sheets without purpuric macules or target lesions</p>\n<p>&nbsp;Nikolsky Sign Positive</p>\n</td>\n</tr>\n<tr>\n<td><strong>Distribution</strong></td>\n<td><strong>Acral</strong> – distal extremities</td>\n<td><strong>Variable</strong> distribution</td>\n<td><strong>Extensive</strong> distribution</td>\n</tr>\n<tr>\n<td><strong>Histo-pathology</strong></td>\n<td><strong>Interface dermatitis</strong> – Basal cell vacuolization, apoptotic bodies and inflammatory cells at Dermo-epidermal junction</td>\n<td>Dermo-epidermal separation, Intense inflammatory cell infiltrates in dermis, some areas of epidermal detachment&nbsp;</td>\n<td><strong>Epidermal necrosis</strong>, Dermo-epidermal separation, minimal dermal inflammatory cell infiltrate, large areas of epidermal detachment.</td>\n</tr>\n<tr>\n<td><strong>Recurrence</strong></td>\n<td><strong>Common</strong>, related to Herpes infections</td>\n<td>Uncommon, drug-related</td>\n<td>Uncommon, drug-related</td>\n</tr>\n<tr>\n<td><strong>Mortality</strong></td>\n<td>Rare – recovery in 1 to 4 weeks</td>\n<td>Elevated mortality</td>\n<td><strong>Highest mortality</strong></td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>Note:&nbsp;<strong>Overlap SJS-TEN:</strong>&nbsp;There is detachment of <strong>10–30%</strong>&nbsp;body surface area, plus widespread purpuric macules or flat atypical targets.</p>\n<p><strong>Erythema Multiforme</strong> is regarded as a <strong>self‐limiting cytotoxic dermatitis</strong> resulting from cell‐mediated hypersensitivity most commonly to&nbsp;infection or drugs.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c83d335429494d2eb09a17fd553fe4c2x600x796.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1478, 'Dermatology', 'PM0232. Characteristic features of various types of Angioedema', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Characteristic Features of Various Types of Angioedema</strong></p>\n<table border=\all sides\ width=\671\>\n<tbody>\n<tr>\n<td colspan=\2\ width=\340\>\n<p><strong>Clinical Presentation</strong></p>\n</td>\n<td width=\85\>\n<p><strong>C4 Level</strong></p>\n</td>\n<td colspan=\2\ width=\95\>\n<p><strong>C1-INH Function by Chromogenic Assay</strong></p>\n</td>\n<td width=\76\>\n<p><strong>C1-INH Level</strong></p>\n<p><strong>&nbsp;</strong></p>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\76\>\n<p><strong>C1q Level</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\123\>\n<p><strong>Hereditary Angioedema (HAE)</strong></p>\n</td>\n<td colspan=\6\ width=\548\>\n<p><strong>Inherited defect in the gene for</strong> <strong>C1-esterase inhibitor. Autosomal dominant: patients have one normal, one abnormal gene</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\123\>\n<p><strong>Type I</strong></p>\n</td>\n<td rowspan=\2\ width=\217\>\n<p>Recurrent episodic angioedema and abdominal attacks without urticaria. Onset in childhood or young adulthood. 75% have family history. Note that attacks may be oestrogen dependent in this group as well as the Type III form.</p>\n</td>\n<td colspan=\4\ width=\255\>\n<p>Usually LOW</p>\n</td>\n<td rowspan=\3\ width=\76\>\n<p>NORMAL</p>\n</td>\n</tr>\n<tr>\n<td width=\123\>\n<p><strong>Type II</strong></p>\n</td>\n<td colspan=\3\ width=\180\>\n<p>Usually LOW</p>\n</td>\n<td width=\76\>\n<p>NORMAL or HIGH</p>\n</td>\n</tr>\n<tr>\n<td width=\123\>\n<p><strong>Type III</strong></p>\n</td>\n<td width=\217\>\n<p>Family history present in most cases, onset after childhood. Female patients predominate and attacks often appear to be estrogen-dependent.</p>\n</td>\n<td colspan=\4\ width=\255\>\n<p>NORMAL</p>\n</td>\n</tr>\n<tr>\n<td width=\123\>\n<p><strong>Acquired Angioedema (AAE)</strong></p>\n</td>\n<td colspan=\6\ width=\548\>\n<p><strong>Condition not inherited but due to other underlying disease. C1-esterase inhibitor is low due to consumption</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\123\>\n<p><strong>Type I</strong></p>\n</td>\n<td width=\217\>\n<p>Onset age variable; symptoms same as HAE. No family history, may be associated with underlying lymphoproliferative disease.</p>\n<p>&nbsp;</p>\n</td>\n<td colspan=\3\ rowspan=\2\ width=\180\>\n<p>Usually LOW</p>\n</td>\n<td width=\76\>\n<p>LOW</p>\n</td>\n<td rowspan=\2\ width=\76\>\n<p>Usually LOW, May be NORMAL</p>\n</td>\n</tr>\n<tr>\n<td width=\123\>\n<p><strong>Type II</strong></p>\n</td>\n<td width=\217\>\n<p>Onset at variable age; symptoms indistinguishable from HAE. No family history, often associated with an autoantibody that binds to C1-INH.</p>\n</td>\n<td width=\76\>\n<p>NORMAL</p>\n</td>\n</tr>\n<tr>\n<td width=\123\>\n<p><strong>Drug-induced Angioedema</strong></p>\n</td>\n<td colspan=\6\ width=\548\>\n<p><strong>Angioedema occurs through allergic mechanism and does not involve C1-INH.</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\123\>\n<p><strong>ACE Inhibitors</strong></p>\n</td>\n<td rowspan=\2\ width=\217\>\n<p>Pseudoallergic (NSAID) or non-allergic (ACE) inhibitors Angioedema may start at first use. Acute onset of well-demarcated subcutaneous non-pitting edema of the face or hands</p>\n</td>\n<td colspan=\4\ rowspan=\2\ width=\255\>\n<p>NORMAL</p>\n</td>\n<td rowspan=\2\ width=\76\>\n<p>NORMAL</p>\n</td>\n</tr>\n<tr>\n<td width=\123\>\n<p><strong>NSAIDs</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\123\>\n<p><strong>Angioedema with Urticaria</strong></p>\n</td>\n<td colspan=\6\ width=\548\>\n<p><strong>Angioedema is accompanied by urticaria. Does not usually involve C1-INH.</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\123\>\n<p><strong>Allergic AE</strong></p>\n</td>\n<td width=\217\>\n<p>Exposure to food, venom, latex, drug, or environmental allergen. May include anaphylaxis</p>\n</td>\n<td colspan=\2\ rowspan=\3\ width=\90\>\n<p>May be LOW or NORMAL</p>\n</td>\n<td colspan=\2\ rowspan=\3\ width=\165\>\n<p>NORMAL</p>\n<p>&nbsp;</p>\n</td>\n<td rowspan=\2\ width=\76\>\n<p>NORMAL OR LOW</p>\n</td>\n</tr>\n<tr>\n<td width=\123\>\n<p><strong>AE with Vasculitis</strong></p>\n</td>\n<td width=\217\>\n<p>Long-lasting urticaria with tenderness. Vascular Damage. With Hypocomplementemic Urticarial Vasculitis, the CH5O is usually LOW and so are classical pathway components.</p>\n</td>\n</tr>\n<tr>\n<td width=\123\>\n<p><strong>Idiopathic AE</strong></p>\n</td>\n<td width=\217\>\n<p>Frequently chronic and relapsing, often occurs with urticarial. Consider test for chronic urticarial (CD203c)</p>\n</td>\n<td width=\76\>\n<p>NORMAL</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1479, 'Dermatology', 'PM0206. UK refinement of Hanifin & Rajka’s diagnostic criteria of atopic dermatitis (eczema)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>In order to qualify as a case of <strong>atopic dermatitis</strong> (<strong>eczema</strong>) with the <strong>UK&nbsp; diagnostic criteria</strong>, the child <strong>must have</strong>&nbsp;<strong>an itchy skin condition</strong> (or parental report of scratching or rubbing in a child).</p>\n<p><strong>Plus three or more of the following:</strong></p>\n<ul>\n<li>Onset below age of 2 years (not used if child is under 4 years)</li>\n<li>History of skin crease involvement (including cheeks in children under 10 years)</li>\n<li>History of a generally dry skin</li>\n<li>Personal history of other atopic disease (or history of any atopic disease in a first-degree relative in children under 4 years)</li>\n<li>Visible flexural dermatitis (or dermatitis of cheeks/forehead and outer limbs in children under 4 years)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1480, 'Dermatology', 'PM1956. Koebner phenomenon', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Koebner or isomorphic Phenomenon</strong> is the development of new lesions <strong>along the line of trauma</strong> in a previously normal skin. The new lesions have iso (same) and morphic (morphology) as the existing lesions.</p>\n<p>The trauma may include mechanical trauma, thermal trauma, allergic or irritant reactants or any treatment procedures.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>True</strong> Koebners phenomenon</td>\n<td>In immune-mediated conditions</td>\n<td>\n<p>Psoriasis</p>\n<p>Vitiligo</p>\n<p>Lichen planus</p>\n</td>\n</tr>\n<tr>\n<td><strong>False</strong> Koebners phenomenon</td>\n<td>In infectious diseases</td>\n<td>\n<p>Viral warts</p>\n<p>Molluscum contagiosum</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Remote reverse</strong> Koebner phenomenon</td>\n<td>\n<p><strong>Spontaneous repigmentation</strong> of vitiligo patches <strong>distant</strong> from the autologous skin graft sites (trauma)</p>\n<p>Generalized granuloma annulare</p>\n</td>\n<td>\n<p>Vitiligo</p>\n<p>Psoriasis</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Some <strong>rare causes</strong> of True Koebner Phenomenon are : Dariers disease, Hailey-Hailey disease, Erythema multiforme, Kaposis Sarcoma and Lichen sclerosus.</p>\n<p><strong>Image:</strong>&nbsp;Koebner phenomenon with linear psoriasis patch on the abdomen</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d31270bf5e5f4b709adfe08cf50556d9x131x217.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1481, 'Dermatology', 'PM1954. Drug of choice for different types of psoriasis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Drug of choice</strong></td>\n</tr>\n<tr>\n<td>Chronic Plaque Psoriasis</td>\n<td>Methotrexate</td>\n</tr>\n<tr>\n<td>Erythrodermic Psoriasis</td>\n<td>Methotrexate&nbsp;</td>\n</tr>\n<tr>\n<td>Psoriatic Arthritis</td>\n<td>Methotrexate / Apremilast</td>\n</tr>\n<tr>\n<td>Pustular Psoriasis</td>\n<td>Acitretin</td>\n</tr>\n<tr>\n<td>Psoriasis in HIV patients</td>\n<td>Acitretin</td>\n</tr>\n<tr>\n<td>Impetigo Herpetiformis</td>\n<td>\n<p>1. Systemic Corticosteroids</p>\n<p>2. Cyclosporine</p>\n</td>\n</tr>\n<tr>\n<td>Erythrodermic Psoriasis in Pregnancy</td>\n<td>Systemic Corticosteroids&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1482, 'Dermatology', 'PM0294. Drugs Inducing or Exacerbating Psoriasis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Drugs Inducing or Exacerbating Psoriasis</strong></p>\n<p>The following drugs are implicated in the exacerbation of psoriasis:</p>\n<ul>\n<li><strong>Beta blockers</strong></li>\n<li>Synthetic antimalarials</li>\n<li>NSAIDS</li>\n<li><strong>Lithium</strong></li>\n<li><strong>ACE inhibitors </strong>&amp; angiotensin receptor blockers</li>\n<li></li>\n<li>Interferon alpha</li>\n<li>Tetracycline</li>\n<li>Terbinafine</li>\n<li>Gemfibrozil</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1483, 'Dermatology', 'PM0292. Papulosquamous Disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Lichen planus</li>\n<li>Psoriasis</li>\n<li>Parapsoriasis</li>\n<li>Pityriasis rubra pilaris</li>\n<li>Pityriasis rosea</li>\n<li>Seborrheic dermatitis</li>\n<li>Secondary Syphilis</li>\n<li>Drug Reactions</li>\n<li>Reiter’s disease</li>\n<li>Eczema</li>\n<li>Neoplasms (Mycosis fungoides, Squamous cell carcinoma, &nbsp;Bowen’s disease)</li>\n<li>Tinea infections</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1484, 'Dermatology', 'PM0259. Types of scales associated with dermatological conditions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Types of Scales and Associated Diseases</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type of Scale</strong></p>\n</td>\n<td>\n<p><strong>Associated Disease</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Collarette scale</p>\n</td>\n<td>\n<p>It is a fine, peripherally attached, and centrally detached scale at the edge of an inflammatory lesion. It is seen in <strong>pityriasis rosea</strong>.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fish-like scales</p>\n</td>\n<td>\n<p>They are seen in <strong>ichthyosis</strong> <strong>vulgaris</strong> (<em><strong>ichthyos</strong></em>&nbsp;-&nbsp;<strong>fish</strong>). Ichthyotic scales are large and polygonal.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Silvery scales</p>\n</td>\n<td>\n<p>They are characteristic of processes involving parakeratosis, especially <strong>psoriasis</strong>. The silvery color is due to the reflection of light at several air–keratin interfaces.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mica-like scales</p>\n</td>\n<td>\n<div class=\page\ title=\Page 659\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>They are seen in <strong>Pityriasis lichenoides.&nbsp;</strong>The lesions are polymorphic with some showing hemorrhagic crusting and adherent scales.</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Yellow / greasy scales</p>\n</td>\n<td>\n<p>Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Leaf-like scales</p>\n</td>\n<td>\n<p>Pemphigus foliaceous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Powdery, branny, fine scales</p>\n</td>\n<td>\n<p>Pityriasis versicolor</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b6af559a05704578a2cf494258896e78x1280x8136.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1485, 'Dermatology', 'PM2085. Differences between pemphigus vulgaris and bullous pemphigoid', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Pemphigus vulgaris</strong></td>\n<td><strong>Bullous pemphigoid</strong></td>\n</tr>\n<tr>\n<td>Age</td>\n<td>30-40 years</td>\n<td>70-80 years</td>\n</tr>\n<tr>\n<td>Antibody</td>\n<td>Anti-desmoglein</td>\n<td>Anti-hemidesmosome</td>\n</tr>\n<tr>\n<td>Location of target antigens</td>\n<td>Intraepidermal</td>\n<td>Subepidermal</td>\n</tr>\n<tr>\n<td>Immuno-fluorescence</td>\n<td>Fish-net pattern</td>\n<td>Linear, shoreline pattern</td>\n</tr>\n<tr>\n<td>Bullae</td>\n<td>Thin and fragile</td>\n<td>Deep and tense</td>\n</tr>\n<tr>\n<td>Mouth involved</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Nikolsky’s sign</td>\n<td>Positive</td>\n<td>Negative</td>\n</tr>\n<tr>\n<td>Symptom</td>\n<td>Painful</td>\n<td>Pruritic</td>\n</tr>\n<tr>\n<td>Severity</td>\n<td>Life threatening</td>\n<td>Resolves</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1486, 'Dermatology', 'PM0363. Classification of Vesiculobullous Disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>According to Pathology</strong></p>\n<ul>\n<li><strong>Immunobullous disorders/ Primary blistering disease: </strong>occur due to autoimmunity</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Intraepidermal</strong></p>\n</td>\n<td>\n<p><strong>Subepidermal</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pemphigus vulgaris</p>\n</td>\n<td>\n<p>Bullous pemphigoid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pemphigus foliaceous</p>\n</td>\n<td>Dermatitis herpetiformis</td>\n</tr>\n<tr>\n<td>\n<p>Pemphigus vegetans</p>\n</td>\n<td>Epidermolysis bullous acquisita</td>\n</tr>\n<tr>\n<td>&nbsp;Pemphigus erythematosus</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li><strong>Mechanobullous disorders:</strong> Due to defect in the structure of epidermis\n<ul>\n<li>Epidermolysis bullosa</li>\n<li>Bullous ichthyosiform erythroderma</li>\n</ul>\n</li>\n<li><strong>Other disorders</strong>\n<ul>\n<li>Infections - VZV, HSV, Bullous impetigo, SSSS</li>\n<li>Metabolic - Porphyria, Diabetes, Hemodialysis</li>\n<li>Drug eruptions - Fixed drug eruption, Steven Johnson Syndrome, Erythema Multiforme</li>\n</ul>\n</li>\n</ul>\n<p><strong>According to Site</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Intraepidermal</strong></p>\n</td>\n<td>\n<p><strong>Sub-epidermal (Dermo-epidermal)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>1. Subcorneal (granular layer)</strong></p>\n<ul>\n<li>Pemphigus foliaceous &amp; erythematosus</li>\n<li>Staphylococcal scalded skin syndrome</li>\n<li>Miliaria crystalina</li>\n<li>Bullous impetigo</li>\n<li>Friction blister</li>\n<li>Subcorneal pustular dermatosis</li>\n</ul>\n<p><strong>2. Spinous layer</strong></p>\n<ul>\n<li>Eczematous (atopic) dermatitis</li>\n<li>HSV/VZV infection</li>\n<li>Molluscum contagiosum</li>\n<li>Familial benign pemphigus (Hailey-hailey disease)</li>\n</ul>\n<p><strong>3. Suprabasal</strong></p>\n<ul>\n<li>Pemphigus vulgaris</li>\n<li>Darrier’s disease</li>\n</ul>\n<p><strong>4. Basal layer</strong></p>\n<ul>\n<li>Erythema multiforme</li>\n<li>Epidermolysis bullosa simplex</li>\n</ul>\n</td>\n<td>\n<p><strong>1. Junctional (at basal lamina)</strong></p>\n<ul>\n<li>Junctional epidermolysis bullosa</li>\n<li>Bullous pemphigoid</li>\n<li>Toxic epidermal necrolysis</li>\n</ul>\n<p><strong>2. Dermolytic (below basal lamina)</strong></p>\n<ul>\n<li>Epidermolysis bullosa acquisita</li>\n<li>Epidermolysis bullosa dystrophicans</li>\n<li>Deep burns</li>\n<li>Porphyria cutanea tarda</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1487, 'Dermatology', 'PM1995. Nail changes in lichen planus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Nail involvement in lichen planus</strong> occurs in up to<strong>&nbsp;</strong>10%&nbsp;of the cases but is usually a minor feature of the disease.</p>\n<p><strong>Dorsal Nail Pterygium&nbsp;</strong>is the<strong> most specific</strong>&nbsp;nail change in Lichen planus. The fusion<strong>&nbsp;of dorsal nail fold</strong>&nbsp;and&nbsp;<strong>nail bed</strong>&nbsp;leads to&nbsp;<strong>pterygium</strong>.</p>\n<p>The&nbsp;<strong>most frequent</strong>&nbsp;nail change is the exaggeration of longitudinal lines and linear depressions due to a slight&nbsp;<strong>thinning of the nail plate</strong>.</p>\n<p><strong>Pup-tent sign</strong>&nbsp;- elevation of nail in shape of tent</p>\n<p><strong>Trachyonychia</strong>&nbsp;- 20 nail dystrophy</p>\n<p><strong>Subungual Hyperkeratosis</strong>&nbsp;and Onycholysis</p>\n<p><strong>Longitudinal Melanonychia</strong>&nbsp;in Lichen Planus of the nail bed</p>\n<p><strong>Permanent destruction</strong>&nbsp;of several toenails with ulceration of soles (rare variant)</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3131aa9be4124cbe906d8d8975d39f08x800x533.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Image shows&nbsp; Nails in Lichen planus presented with irregular longitudinal grooves and ridges .</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7e2934a4486d4ac28a14dbccffc37ed9x512x476.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Image :&nbsp;<strong>Dorsal Nail Pterygium</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e7c66d7b46b5468b8850c33722e61737x512x478.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Image :&nbsp;<strong>Pup-tent sign</strong>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5775473480c84dc3939adb6d5b2b1d3cx512x287.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Image:&nbsp;<strong>Trachyonychia</strong></p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1488, 'Dermatology', 'PM1994. Nail changes in psoriasis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Nail changes in psoriasis</strong> are present in about<strong>&nbsp;40%&nbsp;</strong>of the cases at any point in time. Nail psoriasis is associated with more&nbsp;extensive&nbsp;psoriasis, longer disease duration,&nbsp;family history&nbsp;of psoriasis, and the presence of&nbsp;psoriatic arthritis.</p>\n<p><strong>Subungal oil drop sign or Salmon Patch</strong>&nbsp;is a<strong>&nbsp;highly specific&nbsp;</strong>pathognomonic sign seen in Nail psoriasis. It is a yellow-red discoloration in the nail bed resembling a drop of oil.</p>\n<p><strong>Nail pitting</strong>&nbsp;however is the most<strong>&nbsp;frequent sign.&nbsp;</strong>Individual pits are uniformly sized,&nbsp;<strong>deep and irregular</strong>&nbsp;in nature. These nail pits are also known as <strong>Thimble pits</strong>&nbsp;and are due to the involvement of the proximal nail matrix.</p>\n<p>Nail Bed disease also causes&nbsp;<strong>subungual hyperkeratosis</strong>,&nbsp;<strong>splinter hemorrhages,</strong>&nbsp;and&nbsp;<strong>distal onycholysis</strong>.</p>\n<p><strong>Leuconychia</strong>&nbsp;may also be present.</p>\n<p><strong>Trachonychia</strong>&nbsp;or Twenty Nail dystrophy may be present in severe cases.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f0da378ee7f743efbfc9081ff7287a61x512x340.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Image :&nbsp;&nbsp;Pitting is the commonest manifestation of nail psoriasis.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f09a662cc05e4c4f995a7ee68a24d4bbx512x334.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Image:&nbsp;oil drops visible in the nail bed.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3aa273571f484fe380d4efe7476efa4ex512x348.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Image:&nbsp;pitting and salmon patches in fingernails.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b553a94f74764bffb051362172637611x512x341.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Image:&nbsp;Leukonychia in a patient with psoriasis.</p>\n<p>&nbsp;</p>\n<p><strong>Features of Nail Psoriasis – Mnemonic</strong></p>\n<p>“Nail – <strong>POLISH</strong>”</p>\n<ul>\n<li><strong>P – P</strong>itting</li>\n<li><strong>O – O</strong>il drop sign<strong>, O</strong>nycholysis</li>\n<li><strong>L – L</strong>euconychia</li>\n<li><strong>I – I</strong>rregular pitting pattern</li>\n<li><strong>S – S</strong>plinter Hemorrhage</li>\n<li><strong>H – H</strong>yperkeratosis (Subungual)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1489, 'Dermatology', 'PM1971. Classification of cutaneous tuberculosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The classification of cutaneous tuberculosis is based on the mode of acquisition.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Pathophysiology</strong></td>\n<td><strong>AFB</strong></td>\n</tr>\n<tr>\n<td colspan=\3\>\n<p><strong>Exogenous</strong></p>\n<p>Through broken skin or mucosa</p>\n</td>\n</tr>\n<tr>\n<td>Tuberculous chancre</td>\n<td>Occurs in individuals with no previous sensitization to TB</td>\n<td>Multibacillary</td>\n</tr>\n<tr>\n<td>Tuberculosis verrucosa cutis</td>\n<td>Occurs in previously sensitized individuals with strong immunity</td>\n<td>Paucibacillary</td>\n</tr>\n<tr>\n<td colspan=\3\>\n<p><strong>Endogenous</strong></p>\n<p>Direct spread from a focus of infection</p>\n</td>\n</tr>\n<tr>\n<td>Scrofuloderma</td>\n<td>Contiguous spread from affected parts like lymph nodes, joints</td>\n<td>Multibacillary</td>\n</tr>\n<tr>\n<td>Periorificial tuberculosis</td>\n<td>Autoinoculation at mucocutaneous borders from infected secretions</td>\n<td>Multibacillary</td>\n</tr>\n<tr>\n<td colspan=\3\>\n<p><strong>Hematogenous</strong></p>\n<p>Spread from a distant primary focus of TB</p>\n</td>\n</tr>\n<tr>\n<td>Acute cutaneous miliary tuberculosis</td>\n<td>Occurs in severe disseminated TB</td>\n<td>Multibacillary</td>\n</tr>\n<tr>\n<td>Lupus vulgaris</td>\n<td>Occurs in previously sensitized individuals with strong immunity. Mostly hematogenous spread, sometimes exogenous.</td>\n<td>Paucibacillary</td>\n</tr>\n<tr>\n<td>Tuberculous gumma/ abscess</td>\n<td>Occurs in immunocompromised patients</td>\n<td>Multibacillary</td>\n</tr>\n<tr>\n<td colspan=\3\>\n<p><strong>Tuberculids</strong></p>\n<p>Hypersensitivity reaction</p>\n</td>\n</tr>\n<tr>\n<td>Lichen scrofulosorum (micropapular)</td>\n<td rowspan=\3\>Hematogenous spread of <em>M. tuberculosis </em>antigens to the skin causes type III hypersensitivity which triggers type IV reaction with granuloma formation</td>\n<td rowspan=\3\>Very rarely seen</td>\n</tr>\n<tr>\n<td>Papulonecrotic tuberculid</td>\n</tr>\n<tr>\n<td>Erythema induratum of Bazin (nodular)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1490, 'Dermatology', 'PM1967. Characteristics of Ridley Jopling Classification in Leprosy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>TT (Tuberculoid Leprosy)</strong></td>\n<td><strong>BT (Borderline Tuberculoid)</strong></td>\n<td><strong>BB (Borderline)</strong></td>\n<td><strong>BL(Borderline Lepromatous)</strong></td>\n<td><strong>LL (Lepromatous Leprosy)</strong></td>\n</tr>\n<tr>\n<td><strong>Number and Type of lesions</strong></td>\n<td><strong>1-3</strong> <strong>well</strong><br><strong>defined</strong>&nbsp;hypopigmented macule(s) or plaque(s) with elevated sloping borders&nbsp; -<strong>saucer right side up</strong> lesion. Asymmetrical distribution.</td>\n<td>\n<p>Hypopigmented macules or plaques, variable in number, up to <strong>10</strong>.</p>\n<p>Occasionally showing fingerlike extensions<br>(<strong>pseudopodia</strong>) or&nbsp;<strong>satellite lesions</strong></p>\n</td>\n<td>\n<p>Hypopigmented macules or plaques with annular, ‘<strong>swiss&nbsp;</strong><strong>cheese’</strong>&nbsp;/inverted saucer/punched out appearance</p>\n<p>Variable in number<br><strong>(10–30)</strong></p>\n</td>\n<td>\n<p><strong>Numerous</strong> hypopigmented macules, papules, plaques, and some nodules, lesions with&nbsp;<strong>swiss&nbsp;</strong><strong>cheese’</strong>&nbsp;/inverted saucer/punched out appearance&nbsp;<strong>almost symmetrical</strong> in<br>distribution</p>\n</td>\n<td>\n<p>Hypopigmented macules, plaques,<br>and nodular lesions</p>\n<p><strong>Innumerable</strong> lesions<br>showing&nbsp;<strong>perfect&nbsp; symmetrical&nbsp;</strong>distribution</p>\n</td>\n</tr>\n<tr>\n<td><strong>Size of Lesion</strong></td>\n<td>Variable size,<strong>usually</strong><br><strong>large</strong></td>\n<td>Variable size, some lesions are large</td>\n<td>Variable</td>\n<td>Variable, usually small</td>\n<td><strong>Small</strong></td>\n</tr>\n<tr>\n<td><strong>Surface of Lesion</strong></td>\n<td><strong>Dry, scaly and infiltrated</strong></td>\n<td>Dry, scaly infiltrated (but less than TT)</td>\n<td>Dry, scaly and slightly shiny</td>\n<td>Shiny (less than LL)</td>\n<td><strong>Shiny</strong></td>\n</tr>\n<tr>\n<td><strong>Sensations</strong></td>\n<td><strong>Absent.&nbsp;</strong></td>\n<td>Markedly diminished</td>\n<td>Moderately diminished</td>\n<td>Slightly diminished</td>\n<td><strong>May be normal</strong></td>\n</tr>\n<tr>\n<td><strong>Peripheral Nerves</strong></td>\n<td>\n<p><strong>Asymmetrical, single nerve</strong><br>enlargement.</p>\n<p>Nerve to patch may<br>be palpable</p>\n</td>\n<td>Asymmetrical enlargement of few nerves</td>\n<td>Asymmetrical involvement of several nerves</td>\n<td><strong>Increasingly symmetric</strong> enlargement of nerves</td>\n<td>\n<p><strong>Symmetrical</strong><br><strong>involvement</strong> of<br>nerve trunks with<br>‘<strong>glove and stocking</strong><br><strong>anesthesia’</strong>.</p>\n<p>Nerves may feel normal on<br>palpation or may be<br>thickened.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Hair</strong></td>\n<td><strong>Absent</strong></td>\n<td>Markedly diminished</td>\n<td>Moderately diminished</td>\n<td>Slightly diminished</td>\n<td><strong>Almost normal (initially)</strong></td>\n</tr>\n<tr>\n<td><strong>Bacteriology on Split Skin Smear</strong></td>\n<td><strong>Negative</strong></td>\n<td>Negative or Scanty Bacilli</td>\n<td>Moderate number of AFB present</td>\n<td>Large number of AFB&nbsp;</td>\n<td>Plenty of AFB including <strong>Globi</strong> are seen</td>\n</tr>\n<tr>\n<td><strong>Typical Lepra Reaction</strong></td>\n<td>Type 1</td>\n<td>Type 1</td>\n<td>Type 1/Type 2</td>\n<td>Type 1/Type 2</td>\n<td>Type 2</td>\n</tr>\n<tr>\n<td><strong>Lepromin Reactivity</strong></td>\n<td>\n<p><strong>Strongly Positive</strong></p>\n<p>(+++)</p>\n</td>\n<td>\n<p>Weakly Positive</p>\n<p>(+ or ++)</p>\n</td>\n<td>Negative/ Weakly positive</td>\n<td>Negative</td>\n<td><strong>Negative</strong></td>\n</tr>\n<tr>\n<td><strong>Histopathology</strong></td>\n<td>\n<p><strong>Dermal Tuberculoid granulomas</strong> (arranged around nerves)</p>\n<p><strong>No bacilli are seen</strong></p>\n</td>\n<td>\n<p>Fewer Tuberculoid granulomas</p>\n<p><strong>Grenz clear zone</strong> in upper papillary dermis <strong>starts to form</strong></p>\n<p>Nerves are<br>replaced by granulomas</p>\n<p>Fragmented<br>bacilli are seen with AFB stain</p>\n</td>\n<td>\n<p>Tuberculoid granulomas less prominent</p>\n<p>Grenz zone is more prominent</p>\n<p>Transverse section of the nerve shows&nbsp;<strong>cut onion appearance</strong></p>\n</td>\n<td>\n<p>Prominent foam cells</p>\n<p>Prominent Grenz zone</p>\n<p>Nerves show concentric perineural cell infiltration<br>and <strong>more conspicuous cut onion appearance</strong>.</p>\n<p>AFB are plentiful, including<br><strong>small globi</strong></p>\n</td>\n<td>\n<p><strong>Most prominent Grenz zone</strong></p>\n<p><strong>Expansive and loose granulomas</strong></p>\n<p>Plenty of macrophages<br>loaded with AFB- <strong>Virchow cells or Lepra cells</strong></p>\n<p>AFB are seen in endothelial cells and Schwann cells as clumps - <strong>globi</strong></p>\n<p>Nerves are minimally<br>involved.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1491, 'Dermatology', 'PM0342. Differentiating features between Tuberculoid Leprosy (TT) and Lepromatous Leprosy (LL)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Differentiating features between Tuberculoid Leprosy (TT) and Lepromatous Leprosy (LL)</strong></p>\n<table>\n<tbody>\n<tr>\n<td width=\150\>\n<p>&nbsp;</p>\n</td>\n<td width=\150\>\n<p><strong>Tuberculoid</strong></p>\n</td>\n<td width=\150\>\n<p><strong>Lepromatous</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p><strong>Number of lesions</strong></p>\n</td>\n<td width=\150\>\n<p>1 -10</p>\n</td>\n<td width=\150\>\n<p>Hundreds, confluent</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p><strong>Distribution</strong></p>\n</td>\n<td width=\150\>\n<p>Asymmetrical, anywhere</p>\n</td>\n<td width=\150\>\n<p>Symmetrical, avoiding ‘soared’ areas</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p><strong>Definition and clarity</strong></p>\n</td>\n<td width=\150\>\n<p>Defined edge, markedly hypopigmented</p>\n</td>\n<td width=\150\>\n<p>Vague edge, slight hypopigmented</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p><strong>Anaesthesia</strong></p>\n</td>\n<td width=\150\>\n<p>Early, marked, defined, localized to skin lesions or major peripheral nerve</p>\n</td>\n<td width=\150\>\n<p>Late, initially slight, ill- defined, but extensive, over ‘cool’ areas of body</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p><strong>Autonomic loss</strong></p>\n</td>\n<td width=\150\>\n<p>Early in skin and nerve lesions</p>\n</td>\n<td width=\150\>\n<p>Late, extensive as for anesthesia</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p><strong>Nerve enlargement</strong></p>\n</td>\n<td width=\150\>\n<p>Marked, in a few nerves</p>\n</td>\n<td width=\150\>\n<p>Slight but widespread</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p><strong>Mucosal and systemic</strong></p>\n</td>\n<td width=\150\>\n<p>Absent</p>\n</td>\n<td width=\150\>\n<p>Common, severe during type 2 reactions</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p><strong>Number of <em>Mycobacterium leprae</em></strong></p>\n</td>\n<td width=\150\>\n<p>Not detectable</p>\n</td>\n<td width=\150\>\n<p>Numerous in all affected tissue</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1492, 'Dermatology', 'PM2489. Cutaneous lesions of Tuberous sclerosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Tuberous sclerosis (TS)&nbsp;is also known as&nbsp;tuberous sclerosis complex&nbsp;or&nbsp;Bourneville disease. It is a neurocutaneous disorder (<strong>phakomatosis</strong>) characterized by the development of&nbsp;<strong>multiple benign tumors&nbsp;</strong>of the<strong>&nbsp;embryonic ectoderm</strong>&nbsp;(e.g. skin, eyes, and nervous system). It is an&nbsp;<strong>autosomal dominant&nbsp;</strong>condition.&nbsp;&nbsp;The mutations are involved in the&nbsp;<strong>TSC1</strong>&nbsp;gene that encodes&nbsp;<strong>hamartin</strong>&nbsp;on&nbsp;<strong>chromosome 9</strong>&nbsp;and the&nbsp;<strong>TSC2 gene&nbsp;</strong>that&nbsp;encodes a protein&nbsp;<strong>tuberin</strong>&nbsp;on&nbsp;<strong>chromosome 16.</strong></p>\n<p>Tuberous sclerosis presents in childhood with a triad (<strong>Vogt triad</strong>). The triad comprises of:</p>\n<ul>\n<li>Seizures</li>\n<li>Mental retardation</li>\n<li>Adenoma sebaceum</li>\n</ul>\n<p><strong>Skin lesions in tuberous sclerosis</strong>:</p>\n<p><strong>Shagreen patch</strong> consists of a roughened, raised lesion with an orange-peel consistency, located primarily in the lumbosacral region. Shagreen is shark skin used as a decorative material present in the right image given below.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0cee876a9f6240469fbeeec41caa125ex1280x523.0933333333334.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The typical <strong>hypomelanotic ash leaf–type macules</strong> on the trunk and extremities are&nbsp;seen in 90% of the patients. It is visualized by the use of a wood ultraviolet lamp.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/181f1c6703df48e0b459ef3224c79828x973x697.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Facial angiofibromas (<strong>adenoma sebaceum</strong>) develop between 4 and 6 years of age; they appear as tiny red nodules over the nose and cheeks and are sometimes confused with acne. Later, they enlarge, coalesce, and assume a fleshy appearance.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7dd9904adb764d4492cce469f6b0ce88x800x525.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Periungual fibroma</strong> are small fibromas or nodules of skin, which form around fingernails or toenails in some adolescent patients</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d7eeecb16bbf4cfaa451b24185d0ab43x569x629.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Confetti skin lesions</strong>&nbsp;are seen less commonly as a minor feature of tuberous sclerosis.</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1d30bdf16a3a42079eaa18cadb32ad7fx1280x521.892071952032.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1493, 'Dermatology,', 'PM2483. Skin rashes (Erythemas)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Erythema marginatum</strong>&nbsp;is an&nbsp;<span>evanescent</span>, non-pruritic rash over the trunk and extremities seen in&nbsp;<strong>rheumatic fever.</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/31d3dceee51b4984b72a7db26d7a909ax1280x960.0.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Erythema nodosum&nbsp;</strong>is an acute, nodular, erythematous, painful eruption, occurring probably due to a delayed hypersensitivity reaction to a variety of antigens. Lesions are usually seen over the extensor aspects of the legs. Its causes include infections (tuberculosis), autoimmune (IBD and&nbsp;<strong>sarcoidosis</strong>), idiopathic.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/25992b6578f94152a91386ff3bf217e0x800x562.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Erythema migrans</strong>&nbsp;has a bulls-eye appearance (central erythema and necrosis) and is seen in&nbsp;<strong>Lyme disease.</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/98f6b0c0b2ed4191ba8b8d02006ef8f6x1280x1881.077752117013.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Erythema multiforme&nbsp;</strong>lesions usually have a&nbsp;<strong>target appearance</strong>; it is mediated by the deposition of immune complexes in the superficial microvasculature of the skin and oral mucosal membrane. It is usually triggered by certain infections (<strong>herpes simplex virus</strong>) and drugs.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c2541fbf6c18417aaae813fd00078246x758x600.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1494, 'Dermatology,', 'PM0297. Types of Psoriatic Arthritis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Types of Psoriatic Arthritis - Mnemonic</strong></p>\n<p><strong>“SODA”</strong></p>\n<p><strong>S &nbsp;— &nbsp;S</strong>ymmetrical Polyarthritis</p>\n<p><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;S</strong>pondylitis<strong>/S</strong>acroiliits</p>\n<p><strong>O — &nbsp;O</strong>ligoarticular Asymmetrical&nbsp;</p>\n<p><strong>D — &nbsp;D</strong>IP(Distal Interphalangeal/Classic Type)</p>\n<p><strong>A — &nbsp;A</strong>rthritis Mutilans</p></div><!---->\n      <!---->\n    </div><!---->'),
(1495, 'Psychiatry', 'PM0353. Defense mechanisms that operate in various diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>OCD</strong> - reaction formation, undoing</li>\n</ul>\n<ul>\n<li><strong>Phobia</strong> - displacement</li>\n</ul>\n<ul>\n<li><strong>Neurosis</strong> - repression</li>\n</ul>\n<ul>\n<li><strong>Grief</strong> - denial</li>\n</ul>\n<ul>\n<li><strong>Borderline personality</strong> - Splitting</li>\n</ul>\n<ul>\n<li><strong>Schizophrenia</strong> - projection</li>\n</ul>\n<ul>\n<li><strong>Enuresis</strong> - Regression</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1496, 'Psychiatry', 'PM0346. Contributions by Sigmund Freud', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Contributions of Sigmund Freud to the field of psychiatry</strong></p>\n<ul>\n<li>Free association</li>\n<li>Interpretation of dreams</li>\n<li>Psychoanalysis</li>\n<li>Psycho-sexual development&nbsp;</li>\n<li>Psychodynamic theory&nbsp;</li>\n<li>Topographic theory of the mind-unconscious, preconscious, conscious</li>\n<li>Structural theory of mind- id, ego, superego</li>\n<li>Cocaine in psychiatry</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1497, 'Psychiatry', 'PM2384. Classification of disorders of thought', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5245e029dd5b4d2d8711bef5bf3b05eex1280x1809.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1498, 'Psychiatry', 'PM2383. Disorders of thought and perception', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><span><strong>DISORDERS OF THOUGHT</strong></span></p>\n<table width=\431\>\n<tbody>\n<tr>\n<td>\n<p><span><strong>DISORDER OF STREAM OF THOUGHT</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>(A) Disorder of tempo</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(i) Flight of Ideas</span></p>\n<p><span>Continuous flow of rapid speech that jumps from topic to topic</span></p>\n<ul>\n<li>\n<p><span>\I like mangoes, the weather is nice, India is great\</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(ii) Retardation of thinking</span></p>\n<p><span>Slow speed of speech and a prolonged latent period before a response</span></p>\n<ul>\n<li>\n<p><span>\I went to the market (pause)......... the shop was closed\</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iii) Circumstantialities</span></p>\n<p><span>Inclusion of irrelevant details and going on in a roundabout manner, but their thought ultimately reaches the answer</span></p>\n<ul>\n<li>\n<p><span>Doctor: \How did you get that bruise?\</span></p>\n</li>\n<li>\n<p><span>Patient: \I woke up and had a cup of coffee, read the newspaper and went for a walk. It was a wonderful day in the park. I returned home and watched the TV. I took a nap in the afternoon after lunch. I slipped and fell in the bathroom. The fall gave me this bruise.\</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iv) Clang associations</span></p>\n<p><span>Jumping from one word to another irrelevant rhyming word</span></p>\n<ul>\n<li>\n<p><span>I am Sam...I like jam...I travel in a tram\</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>(B) Disorder of continuity</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(i) Perseveration</span></p>\n<p><span>Repetition of out of context words, phrases, or ideas beyond the point of relevance.</span></p>\n<ul>\n<li>\n<p><span>Q1. Whats your name?: \Rahul\</span></p>\n</li>\n<li>\n<p><span>Q2. Where are you from?: \Rahul\</span></p>\n</li>\n<li>\n<p><span>Q3. How old are you?: \Rahul\</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(ii) Thought blocking</span></p>\n<p><span>A sudden disruption of thought or a break in the flow of ideas</span></p>\n<ul>\n<li>\n<p><span>\I went to the market (extreme silence)....................\</span></p>\n</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<table width=\429\>\n<tbody>\n<tr>\n<td>\n<p><span><strong>DISORDER OF FORM OF THOUGHT</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(i) Tangentiality</span></p>\n<p><span>In response to a question, the patient gives a reply that is appropriate to the general topic but does not answer the question exactly. The speech moves away from the actual answer.</span></p>\n<ul>\n<li><span>Doctor: \Have you had any trouble sleeping lately?\</span></li>\n<li><span>Patient: \I usually sleep in my bed, but now Im sleeping on the sofa\</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(ii) Derailment</span></p>\n<p><span>A breakdown in both the logical connection between ideas and the overall sense of goal-directedness. The words make sentences, but the sentences do not make sense.</span></p>\n<ul>\n<li><span>\Some people just dont understand why I had breakfast in America during the first world war\</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iii) Neologisms</span></p>\n<p><span>Bringing in new words that do not exist.</span></p>\n<ul>\n<li><span>The world is not gooder for people like me\</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iv) Desultory thoughts</span></p>\n<p><span>Speech is grammatically correct, however, sudden unrelated ideas force their way in from time to time.</span></p>\n<ul>\n<li><span>My actual problem is that the people never understand me and my stomach feels like an empty bucket\</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(v) Word salad</span></p>\n<p><span>Using a mixture of unintelligible meaningless words and sentences</span></p>\n<ul>\n<li><span>Tree bus rain food home car tiger\</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<table width=\430\>\n<tbody>\n<tr>\n<td>\n<p><span><strong>DISORDER OF POSSESSION OF THOUGHT</strong></span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>A. Thought alienation</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span>(i) Thought insertion</span></p>\n<p><span>Thoughts are being inserted into the patients mind and they recognize them as being foreign and coming from without any stimulus</span></p>\n<ul>\n<li>\n<p><span>\I have repeated thoughts of killing my neighbors and I believe aliens are putting these ideas into my head at night\</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(ii) Thought withdrawal</span></p>\n<p><span>Delusion that someone or something is removing from ones mind and the patient has no power over this.</span></p>\n<ul>\n<li>\n<p><span>\Lately, I am losing all my memories and I believe that the government agents are stealing them when I go to sleep\</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iii) Thought broadcasting</span></p>\n<p><span>Belief that ones thoughts are quietly escaping from ones mind and that other people might be able to access them and hear or see them.</span></p>\n<ul>\n<li>\n<p><span>\I believe my exact thoughts appear on the TV and the internet and I think I can broadcast them globally\&nbsp;</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iv) Thought echo</span></p>\n<p><span>Patient hears the echo of his own thoughts in the form of a voice after he has made the thought.</span></p>\n<ul>\n<li>\n<p><span>\I thought of making a sandwich in the morning and surprisingly a voice, from nowhere, told me to make a sandwich out loud\</span><span>&nbsp;</span></p>\n</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<table width=\430\>\n<tbody>\n<tr>\n<td>\n<p><span>&nbsp;<strong>B.&nbsp;</strong><strong>Obsessions and Compulsions</strong></span></p>\n<p><span>1. Obsessions</span></p>\n<p><span>Recurrent and persistent thoughts, impulses. or images that cause distress to oneself.</span></p>\n<ul>\n<li><span>Fear of dirt or contamination</span></li>\n<li><span>Fear of becoming ill</span></li>\n<li><span>Constant thoughts of a certain number</span></li>\n<li><span>Need for symmetry or exactness</span></li>\n<li><span>Worry about whether something has been done \right\</span></li>\n<li><span>Forbidden sexual or religious thoughts</span></li>\n</ul>\n<p><span>2. Compulsions</span></p>\n<p><span>Repetitive behaviors or actions that the person feels driven to perform in response to an obsession</span></p>\n<ul>\n<li><span>Washing hands</span></li>\n<li><span>Blinking eyes</span></li>\n<li><span>Counting items, such as currency</span></li>\n<li><span>Checking to see if doors are locked</span></li>\n<li><span>Arranging items in a certain way</span></li>\n<li><span>Requiring constant approval from people around them</span></li>\n</ul>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;<span><strong>DISORDER OF CONTENT OF THOUGHT</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span>(i) Phobias</span></p>\n<p><span>Persistent fear of an object or situation, typically disproportional to the actual danger posed, in which the sufferer goes to great lengths in avoiding it</span></p>\n<ul>\n<li>\n<div><span>Arachnophobia - fear of spider</span></div>\n</li>\n<li>\n<div><span>Barophobia - fear of gravity</span></div>\n</li>\n<li>\n<div><span>Cynophobia - fear of dogs</span></div>\n</li>\n<li>\n<div><span>Hemophobia - fear of blood</span></div>\n</li>\n<li>\n<div><span>Nosocomephobia - fear of hospitals</span></div>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(ii) Religious preoccupations</span></p>\n<p><span>Thoughts involving religious themes or subject matter.</span></p>\n<ul>\n<li>\n<p><span>\I get instructions from God on how to make my country great\</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iii) Ideas of hopelessness</span></p>\n<p><span>Thoughts of complete despair where the patient strongly believes that the circumstances will never get better for him.</span></p>\n<ul>\n<li>\n<p><span>\I am never going to pass my final exams, no matter how hard I study\</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(iv) Antisocial urges</span></p>\n<p><span>Thoughts of indulging in some behaviors or actions that harm or lack consideration for the well being of others.</span></p>\n<ul>\n<li>\n<p><span>\I have these urges to go rob a bank or blackmail my neighbors for their money\</span></p>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>(v) Delusions</span></p>\n<p><span>False beliefs that are strongly held and unchangeable in the face of refuting evidence and that are not consistent with the persons educational, social and cultural background.</span></p>\n<p><span>The three main criteria for a belief to be considered a delusion are:</span></p>\n<ul>\n<li>\n<div><span>Certainty (held with complete confidence)</span></div>\n</li>\n<li>\n<div><span>Incorrigibility (not changeable by proof to the contrary)</span></div>\n</li>\n<li>\n<div><span>Impossibility or falsity of content (implausible, bizarre or patently untrue)</span></div>\n</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<table width=\429\>\n<tbody>\n<tr>\n<td>&nbsp;<span><strong>DISORDERS OF PERCEPTIONS</strong></span></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>\n<p><span><strong>Illusion</strong>: Misinterpretation of real external stimuli.</span></p>\n</li>\n<li>\n<p><span><strong>Hallucination</strong>: False sensory perception, externally.</span></p>\n</li>\n<li>\n<p><span><strong>Pseudohallucination</strong>: False sensory perception from within and having an insight.</span></p>\n</li>\n<li>\n<p><strong><span>Depersonalization:</span></strong><span> Feeling as if one is disconnected from reality, feeling detached from ones own thoughts and ones own physical body.</span><strong><span><br></span></strong></p>\n<p><span>\I sometimes drift into a dream-like state where I lose contact with my own self\</span></p>\n</li>\n<li>\n<p><strong><span>Derealization: </span></strong><span>Alteration in the perception or experience of the external world so that it seems unreal.</span><strong><span><br></span></strong></p>\n<p><span>\The world and everything around is nothing but just a dream\</span></p>\n</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1499, 'Psychiatry', 'PM2323. ECT versus TMS', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\20\>\n<tbody>\n<tr>\n<td><span>&nbsp;</span></td>\n<td><span><strong>Electroconvulsive Therapy</strong></span></td>\n<td><span><strong>Transcranial Magnetic Stimulation</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Principle</strong></span></td>\n<td><span>Seizures are induced by applying an electric current</span></td>\n<td><span>Induction of eddy currents in the cortex by applying magnetic fields</span></td>\n</tr>\n<tr>\n<td><span><strong>Mechanism</strong></span></td>\n<td><span>Neuroplasticity; induced seizures promote new synapse formation</span></td>\n<td><span>Neuronal stimulation by eddy currents</span></td>\n</tr>\n<tr>\n<td><span><strong>Advantages</strong></span></td>\n<td>\n<div>\n<ul>\n<li><span>More effective</span></li>\n<li><span>Faster response</span></li>\n<li><span>Shorter treatment course</span></li>\n</ul>\n</div>\n</td>\n<td>\n<div>\n<ul>\n<li><span>Non-invasive</span></li>\n<li><span>Enables focal stimulation of cortical areas</span></li>\n<li><span>No significant memory loss</span></li>\n<li><span>Does not induce seizures</span></li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Disadvantages</strong></span></td>\n<td>\n<div>\n<ul>\n<li><span>Invasive</span></li>\n<li><span>Requires anesthesia</span></li>\n<li><span>Significant cognitive impairment</span></li>\n</ul>\n</div>\n</td>\n<td>\n<div>\n<ul>\n<li><span>Less effective</span></li>\n<li><span>Slower response</span></li>\n<li><span>Prolonged treatment course</span></li>\n</ul>\n</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1500, 'Psychiatry', 'PM2116. Neurotransmitters', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table width=\1103\>\n<tbody>\n<tr>\n<td><strong>Neuro-transmitters</strong></td>\n<td><strong>&nbsp;Major source</strong></td>\n<td><strong>&nbsp;Function</strong></td>\n<td><strong>&nbsp;Increased in</strong></td>\n<td><strong>&nbsp;Decreased in</strong></td>\n</tr>\n<tr>\n<td><strong>Serotonin</strong></td>\n<td><span>Midline Raphe Nucleus</span>&nbsp;</td>\n<td>\n<p><span><strong>Inhibitory</strong>:</span></p>\n<p><span>Regulation of mood, sleep, appetite, sexual behavior, decreases anxiety</span></p>\n<p><span>Inhibits the dopaminergic function</span></p>\n</td>\n<td><span>Serotonin syndrome</span></td>\n<td>\n<p><span>Depression</span></p>\n<p><span>OCD</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Dopamine</strong></td>\n<td>&nbsp;<span>Substantia Nigra</span></td>\n<td>\n<p><span><strong>Inhibitory</strong>:</span></p>\n<p><span>Motor movement and alertness</span></p>\n<p><span>Reward seeking, pleasure, motivation</span></p>\n<p><span>Major neurotransmitter in the basal ganglia</span></p>\n</td>\n<td>\n<p><span>Schizophrenia</span></p>\n<p><span>OCD</span></p>\n<p><span>Mania</span></p>\n<p><span>Delirium</span></p>\n</td>\n<td>\n<p><span>Parkinsons disease</span></p>\n<p><span>Depression</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Endorphins</strong></td>\n<td>&nbsp;<span>Pituitary gland</span></td>\n<td><span>Pain control, feelings of pleasure, stress reduction, \natural opium\</span></td>\n<td><span>Addiction</span></td>\n<td><span>Inability to combat pain</span></td>\n</tr>\n<tr>\n<td><strong>Acetylcholine</strong></td>\n<td>&nbsp;<span>Nucleus Basalis (of Meynert)</span></td>\n<td>\n<p><span><strong>Excitatory</strong>:</span></p>\n<p><span>Motor movement, learning and memory</span></p>\n</td>\n<td><span>Parkinsons disease</span></td>\n<td>\n<p><span>Alzheimers disease</span></p>\n<p><span>Delirium</span></p>\n<p><span>Dementia</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>GABA</strong></td>\n<td>&nbsp;\n<p>&nbsp;</p>\n</td>\n<td>\n<p><span><strong>Inhibitory</strong>:</span></p>\n<p><span>Decreases anxiety and reduces insomnia</span></p>\n<p><span>Interacts with dopamine, inhibits dopaminergic neurons</span></p>\n</td>\n<td>&nbsp;</td>\n<td>\n<p><span>Anxiety</span></p>\n<p><span>Seizure disorder</span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Norepinephrine</strong></td>\n<td><span>Locus ceruleus</span>&nbsp;</td>\n<td>\n<p><span><strong>Excitatory:</strong></span></p>\n<p><span>\Fight or flight\</span></p>\n</td>\n<td><span>Mania</span></td>\n<td><span>Lack of energy, anhedonia in Schizophrenia,&nbsp;</span><span>Depression</span></td>\n</tr>\n<tr>\n<td><strong>Glutamate</strong></td>\n<td>&nbsp;</td>\n<td>\n<p><span><strong>Excitatory</strong>:</span></p>\n<p><span>Links between neurons for learning and long term memory</span></p>\n</td>\n<td><span>Seizures</span></td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1501, 'Psychiatry', 'PM2046. The Mental Health Care Act, 2017 and The Mental Health Act, 1987', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The <strong>Mental Health Care Act</strong>, <strong>2017</strong>, was passed to provide for health care and services for persons with mental illness and to protect, promote and fulfill their rights during the delivery of mental health care.</p>\n<p>Its main provisions are:</p>\n<ul>\n<li><strong>Patient autonomy</strong>:<strong>&nbsp;</strong>The mentally ill patient has the right to make an advance directive about their treatment and their nominated representative.</li>\n<li>If the mental health professional/care-giver does not wish to follow the <strong>advance directive</strong> made by the patient, they can send an application to the Mental Health Board to review/alter/cancel the advance directive.</li>\n<li><strong>Decriminalization of suicide</strong>.</li>\n<li><strong>Mental Health Review Commission and Mental Health Authority&nbsp;</strong>set up.</li>\n</ul>\n<p>&nbsp;</p>\n<p><strong class=\ng-binding\>The Mental Health Act, 1987:</strong></p>\n<div class=\panel-body ng-scope\>\n<p class=\ng-binding ng-scope\>The&nbsp;Mental Health Act, 1987 deals with the care of the mentally ill, makes provisions with respect to their property and affairs and states the law for psychiatric hospitals .<sup class=\reference\></sup></p>\n<p>Important provisions under it for the diagnosis of mental illness are:</p>\n<ul>\n<li>For the diagnosis of mental illness, an individual can be kept in a psychiatric hospital for&nbsp;<strong>10 days</strong>.</li>\n<li>If the mental health professional needs further time, the magistrate can permit an extension of&nbsp;<strong>10 more days.</strong></li>\n<li>This extension can be permitted only&nbsp;<strong>twice</strong>.</li>\n<li>Thus, an individual can be detained in a psychiatric hospital for a maximum period of&nbsp;<strong>30 days only</strong>.</li>\n<li>If a mentally ill person is detained against these provisions, the responsible authority can be punished with an imprisonment of upto&nbsp;<strong>2 years.</strong></li>\n</ul>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1502, 'Psychiatry', 'PM1607. Tests for evaluating attention, concentration and memory', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Memory</strong>:</p>\n<p>Memory is of 3 types:</p>\n<ul>\n<li><strong>Immediate memory and recall</strong> are usually tested by digit span/ digit repetition test.\n<ul>\n<li><strong>Digit span test</strong>:<strong>&nbsp;</strong>Digits spelled at the rate of <strong>1 digit per second.&nbsp;</strong>It is of two types: Digit forward and Digit backward.</li>\n<li><strong>Digit forward</strong>:<strong>&nbsp;</strong>Reproduction of increasingly longer digits. E.g., Examiner says 2 - 4 –8 –1 –5 –7 - 9. The person has to repeat in the same order 2 – 4 – 8 –1 –5 –7 –9.</li>\n<li><strong>Digit backward</strong>:<strong>&nbsp;</strong>Reproduction of longer digits in the backward direction. Eg: Examiner says 2 - 4 –8 –1 –5 –7 - 9. The person has to repeat it backward. 9 -7 -5 -1 -8- 4- 2.</li>\n<li>The above tests should<strong> be stopped</strong> when there are <strong>2 successive failures</strong>. Hence <strong>2 skips are not allowed</strong>.</li>\n</ul>\n</li>\n<li><strong>Recent memory</strong>:&nbsp;Ask them how they reached the hospital or what they ate for breakfast.</li>\n<li><strong>Remote memory</strong>:&nbsp;Relevant questions from the past like close relatives birth dates.&nbsp;</li>\n</ul>\n<p><strong>Attention</strong>:</p>\n<ul>\n<li>Is the patients attention easily aroused and sustained?</li>\n<li><strong>Digit span </strong>test.</li>\n</ul>\n<p><strong>Concentration</strong>:</p>\n<ul>\n<li>Is the patient easily distractable or can they concentrate?</li>\n<li><strong>Serial subtraction test</strong>: Minimum of five subtractions done serially is taken into account</li>\n<li>Count backward from 20.</li>\n<li>Enumerate the months in reverse order.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1503, 'Psychiatry', 'PM0498. Key points on electroconvulsive therapy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Produces grand mal seizure in an anesthetized patient.</p>\n<p>Mechanism of action:</p>\n<ul>\n<li><strong>Neuroplasticity</strong>:<strong>&nbsp;</strong>Ability of the brain to form and reorganize synaptic connections.</li>\n<li>Increases levels of Brain-Derived Growth Factor and Vascular Endothelial Growth Factor</li>\n</ul>\n<p><strong>Indications</strong>:</p>\n<ul>\n<li>Treatment-resistant depression</li>\n<li>Severe depression with suicidal risk (most common indication)</li>\n<li>Depression with psychotic features</li>\n<li>Depressed suicidal pregnant women</li>\n<li>Refusal to eat or drink</li>\n<li>Imminent risk for suicide</li>\n<li>Neuroleptic malignant syndrome</li>\n<li>Catatonia and catatonic schizophrenia</li>\n<li>Severe agitated depression</li>\n</ul>\n<p>Electrode placement: <strong>Bifrontotemporal</strong>, <strong>right unilateral</strong>.</p>\n<p>Anesthetic agent: <strong>Methohexital</strong> (most common)</p>\n<p>Adverse effects:</p>\n<ul>\n<li>Retrograde amnesia (most common)</li>\n<li>Partial anterograde amnesia</li>\n<li>Disorientation</li>\n<li>Temporary headache</li>\n</ul>\n<p>Memory disturbances recover within 1-6 months. <strong>Safe in pregnancy</strong>.&nbsp;ECT can reverse extrapyramidal symptoms of neuroleptics.</p>\n<p>Contraindications: <strong>No absolute contraindication</strong> (raised intracranial tension is considered as a relative contraindication).</p>\n<p>Increased risk of adverse effects in:</p>\n<ul>\n<li>Severe cardiovascular disease, recent myocardial infarction</li>\n<li>Space occupying brain lesion</li>\n<li>Recent stroke, unstable aneurysm</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1504, 'Psychiatry', 'PM0397. Timeline in psychiatry', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Condition</strong></span></td>\n<td><span><strong>Duration</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Manic episode</strong></span></td>\n<td><span>At least 1 week</span></td>\n</tr>\n<tr>\n<td><span><strong>Hypomania</strong></span></td>\n<td><span>At least 4 consecutive days</span></td>\n</tr>\n<tr>\n<td><span><strong>Major depressive disorder</strong></span></td>\n<td>\n<p><span>Lasts 6 to12 months with episodes for 2 or more weeks</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Cyclothymia</strong></span></td>\n<td><span>At least 2 years</span></td>\n</tr>\n<tr>\n<td><span><strong>Dysthymia</strong></span></td>\n<td><span>At least 2 years</span></td>\n</tr>\n<tr>\n<td><span><strong>Maternal blues</strong></span></td>\n<td><span>Starts 2–3 days after delivery and usually resolves within 10 days</span></td>\n</tr>\n<tr>\n<td><span><strong>Postpartum mood disturbances</strong></span></td>\n<td><span>Onset within 4 weeks of delivery</span></td>\n</tr>\n<tr>\n<td><span><strong>Brief psychotic disorder</strong></span></td>\n<td><span>Lasts &lt; 1 month, usually stress-related</span></td>\n</tr>\n<tr>\n<td><span><strong>Schizophreniform disorder</strong></span></td>\n<td><span>Lasts 1-6 months</span></td>\n</tr>\n<tr>\n<td><span><strong>Schizophrenia</strong></span></td>\n<td><span>Lasts &gt; 6 months</span></td>\n</tr>\n<tr>\n<td><span><strong>Schizoaffective disorder</strong></span></td>\n<td><span>Lasts &gt; 2 weeks</span></td>\n</tr>\n<tr>\n<td><span><strong>Delusional disorder</strong></span></td>\n<td><span>Lasts &gt; 1 month</span></td>\n</tr>\n<tr>\n<td><span><strong>Panic disorder</strong></span></td>\n<td><span>An episode followed by 1 month of concern of additional attacks&nbsp;</span></td>\n</tr>\n<tr>\n<td><span><strong>Specific phobia</strong></span></td>\n<td><span>Lasts &gt; 6 months</span></td>\n</tr>\n<tr>\n<td><span><strong>Generalized anxiety disorder</strong></span></td>\n<td><span>Lasts &gt; 6 months&nbsp;</span></td>\n</tr>\n<tr>\n<td><span><strong>Acute stress disorder</strong></span></td>\n<td><span>Lasts between 3 days and 1 month&nbsp;</span></td>\n</tr>\n<tr>\n<td><span><strong>PTSD</strong></span></td>\n<td><span>Lasts &gt; 1 month&nbsp;</span></td>\n</tr>\n<tr>\n<td><span><strong>Adjustment disorder</strong></span></td>\n<td>\n<p><span>Symptoms occur within 3 months of the stressor and last &lt; 6 months</span></p>\n<p><span>May last &gt; 6 months in presence of chronic stressor</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Bulimia nervosa</strong></span></td>\n<td><span>At least 3 months</span></td>\n</tr>\n<tr>\n<td><span><strong>Somatic symptom disorder</strong></span></td>\n<td><span>Lasts &gt; 6 months</span></td>\n</tr>\n<tr>\n<td><span><strong>Separation anxiety disorder</strong></span></td>\n<td><span>Common onset at 7–9 years&nbsp;</span></td>\n</tr>\n<tr>\n<td><span><strong>Tourette syndrome</strong></span></td>\n<td>\n<p><span>Onset &lt; age 18 years</span></p>\n<p><span>Tics that persist for &gt; 1 year&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>ADHD</strong></span></td>\n<td><span>Symptoms for &gt; 6 months&nbsp;</span></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1505, 'Psychiatry', 'PM0264. Types of delusions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><span><strong>THE TYPES OF DELUSIONS</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Delusion&nbsp;of control</strong></span></p>\n<p><span>False belief that a person’s will, thoughts, or feelings are being controlled by external forces.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Delusion&nbsp;of grandeur </strong>or<strong> Megalomania</strong>&nbsp;</span></p>\n<p><span>Exaggerated conception of one’s importance, power, or identity.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Delusion&nbsp;of infidelity </strong>or morbid jealousy or <strong>Othello syndrome</strong></span></p>\n<p><span>False&nbsp;belief that one’s lover is unfaithful.&nbsp;Sometimes called pathological jealousy.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Delusion of love </strong>or<strong> erotomania</strong></span></p>\n<p><span>False belief that another person is in love with them. In<strong> De Clerambault</strong> syndrome, the woman believes that a man, frequently older and of higher status, is in love with her.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Delusion of misidentification</strong>&nbsp;</span></p>\n<p><span><strong>Capgras syndrome</strong>: Belief that a familiar person has been replaced by an exact double i.e. an <strong>impostor</strong>.</span></p>\n<p><span><strong>Fregoli syndrome</strong>: Person holds a delusional belief that different people are in fact a single person who changes his or her appearance or is in <strong>disguise</strong>.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Nihilistic delusion</strong>&nbsp;</span></p>\n<p><span>False belief that oneself, others or the world, is non-existent or about to end. When nihilistic delusion is accompanied by ideas concerning bodily function failure e.g. putrefaction of intestine etc, it is called <strong>Cotard syndrome.</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Delusion of infestation</strong>&nbsp;</span></p>\n<p><span>False belief that one is infested with small but visible organisms. As a monosymptomatic delusional disorder, this is called <strong>Ekbom syndrome.&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Delusion&nbsp;of persecution</strong></span></p>\n<p><span>The most<strong>&nbsp;common delusion</strong>.<strong>&nbsp;</strong>False&nbsp;belief of being harassed or persecuted.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Delusion&nbsp;of poverty</strong></span></p>\n<p><span>The person&nbsp;strongly believes they are financially incapacitated.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Delusion of reference</strong></span></p>\n<p><span>False belief that the behavior of others has a particular and unusual significance, usually of a negative nature. The person may falsely feel that others are talking about them (e.g. the people on television are talking to or about the person). &nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Delusion&nbsp;of self-accusation</strong></span></p>\n<p><span>False&nbsp;feeling of remorse and guilt.&nbsp;Seen in depression with psychotic features.</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1506, 'Psychiatry', 'PM0239. Tests for intelligence', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 277\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Omnibus Intellectual and Ability Tests:</p>\n</div>\n</div>\n</div>\n<ul>\n<li>Wechsler Adult Intelligence Scale (WAIS) - 16 yrs to 90 yrs</li>\n<li>Stanford-Binet test - 2 yrs to 89 yrs</li>\n<li>Binet-Kamat test of intelligence</li>\n<li>Bhatia’s battery test of intelligence</li>\n</ul>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Infant and Child Tests:</p>\n</div>\n</div>\n<div class=\ng-scope\>\n<div class=\ng-scope\>\n<div class=\ng-scope\>\n<ul>\n<li class=\ng-binding\>Gesell schedule - 1month to 36 months</li>\n<li>Bayley scale - 1 month to 42 months</li>\n<li>Mullen scale - 0 months to 68 months&nbsp;</li>\n</ul>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1507, 'Psychiatry', 'PM0237. Neuropsychological tests', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 1132\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>The neuropsychiatric evaluation combines information from neurological, neuropsychological testing, and mental status examinations.</p>\n<p>The following are some common neuropsychological screening tests and test batteries:&nbsp;</p>\n</div>\n</div>\n</div>\n<ul>\n<li>Wisconsin card sorting test</li>\n<li>Wechsler memory scale</li>\n<li>PGI memory scale</li>\n<li>Bender Gestalt test or&nbsp;BG test</li>\n<li>Benton visual retention test or&nbsp;BVRT</li>\n<li>Luria-Nebraska neuropsychological battery</li>\n<li>Halstead-Reitan neuropsychological test battery</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1508, 'Psychiatry', 'PM2377. The 5 stages of grief model by Kübler-Ross', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>D</strong>enial - Patients may become numb and dazed at the news of their own imminent death and refuse to accept the diagnosis.&nbsp;</li>\n<li><strong>A</strong>nger - Patients may get angry towards God or themselves.&nbsp;</li>\n<li><strong>B</strong>argaining - Patients may start to bargain with God or friends and doctors for a cure to buy some more time.</li>\n<li><strong>D</strong>epression - Patients may go into depression.</li>\n<li><strong>A</strong>cceptance - Patients finally accept that their death is inevitable and make further preparations (eg., making a will, etc).&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1509, 'Psychiatry', 'PM1861. Neurotransmitters in Psychiatry', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Neurotransmitter</strong></div>\n</td>\n<td>\n<div><strong>Source</strong></div>\n</td>\n<td>\n<div><strong>Disorder</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Dopamine</strong></div>\n&nbsp;</td>\n<td>\n<div>&nbsp;</div>\n<div>Substantia Nigra</div>\n&nbsp;</td>\n<td>\n<div><strong>Decrease</strong>:</div>\n<div>Parkinson’s disease</div>\n<div>\n<div><strong>Increase</strong>:&nbsp;</div>\n<div>Mania, Delirium</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Acetylcholine</strong></div>\n&nbsp;&nbsp;</td>\n<td>\n<div>Nucleus Basalis (of Meynert)</div>\n&nbsp;&nbsp;</td>\n<td>\n<div><strong>Decrease</strong>:</div>\n<div>Delirium, Dementia</div>\n<div>\n<div><strong>Increase</strong>:</div>\n<div>Parkinson’s disease</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Norepinephrine</strong></td>\n<td>Locus Coeruleus</td>\n<td>\n<div>\n<div>\n<div><strong>Decrease</strong>:</div>\n<div>Depression</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Serotonin</strong></td>\n<td>Midline Raphe nucleus</td>\n<td>\n<div>\n<div>\n<div>\n<div><strong>Decrease</strong>:</div>\n<div>Depression</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1510, 'Psychiatry', 'PM0528. Neuroleptic malignant syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Neuroleptic Malignant syndrome</strong></td>\n</tr>\n<tr>\n<td>Signs/ symptoms</td>\n<td>\n<p>Fever (sometimes &gt; 40<sup>o</sup> C)</p>\n<p>Mental status changes</p>\n<p>Motor symptoms:</p>\n<ul>\n<li><strong>Muscular rigidity </strong>(generalised)</li>\n<li>Dystonia</li>\n<li>Akinesia</li>\n</ul>\n<p>Autonomic symptoms: &nbsp; &nbsp;</p>\n<ul>\n<li>Tachycardia/arrhythmias</li>\n<li>Labile blood pressure &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</li>\n<li>Tachypnea</li>\n<li>Diaphoresis</li>\n</ul>\n<p>Mutism, obtundation, and agita­tion.</p>\n</td>\n</tr>\n<tr>\n<td>Precipitating factors</td>\n<td>\n<p>Antipsychotics (typical and atypical)</p>\n<p>Antiemetics (ex: Promethazine, Metoclopramide)&nbsp;</p>\n<p>Withdrawal of Antiparkinsonian drugs (dopamine agonists)&nbsp;</p>\n<p>Infection&nbsp;</p>\n<p>Surgery</p>\n</td>\n</tr>\n<tr>\n<td>Investigations</td>\n<td>\n<p><strong>Elevated WBC count,</strong> creatinine phosphokinase (<strong>CPK</strong>), myoglobin, and liver enzymes.</p>\n<p>Myoglobinuria may be seen in patients who develop acute renal failure.</p>\n</td>\n</tr>\n<tr>\n<td>Treatment&nbsp;</td>\n<td>\n<ul>\n<li>Stop neuroleptic agents and start dopaminergic agonists</li>\n<li>Supportive care (hydration, cooling)</li>\n<li>Dantrolene or Bromocriptine</li>\n<li>Amantadine may be used in some cases.</li>\n<li>Electroconvulsive therapy may also be used.&nbsp;</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1511, 'Psychiatry', 'PM0263. Difference between psychotic and neurotic illness', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Psychosis</strong></td>\n<td><strong>Neurosis</strong></td>\n</tr>\n<tr>\n<td>Insight absent</td>\n<td>Insight present</td>\n</tr>\n<tr>\n<td>Personality changed</td>\n<td>Personality maintained</td>\n</tr>\n<tr>\n<td>Impaired judgment</td>\n<td>Judgment normal</td>\n</tr>\n<tr>\n<td>Loss of contact with reality</td>\n<td>Contact with reality is present</td>\n</tr>\n<tr>\n<td>An organic cause may be present</td>\n<td>Absence of organic causative factor</td>\n</tr>\n<tr>\n<td>Hallucination, delusion present</td>\n<td>Not present</td>\n</tr>\n<tr>\n<td>Ex: Schizophrenia,&nbsp; acute psychotic disorder</td>\n<td>Ex: Anxiety, OCD, conversion disorder</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1512, 'Psychiatry', 'PM2172. Symptoms of schizophrenia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Positive symptoms</strong></td>\n<td><strong>Negative symptoms</strong></td>\n</tr>\n<tr>\n<td>\n<div>Hallucination</div>\n<div>Delusion</div>\n<div>Bizarre motor acts</div>\n</td>\n<td>\n<div>Flattening of affect</div>\n<div>Anhedonia</div>\n<div>Alogia</div>\n<div>Apathy</div>\n<div>Paucity of thought</div>\n<div>Poverty of speech</div>\n</td>\n</tr>\n<tr>\n<td>Common in <strong>acute schizophrenia</strong></td>\n<td>Common in <strong>chronic schizophrenia</strong></td>\n</tr>\n<tr>\n<td>Hyperactivity of the dopaminergic system in the <strong>mesolimbic</strong> system</td>\n<td>Hypoactivity of the dopaminergic system in the <strong>mesocortical</strong> system</td>\n</tr>\n<tr>\n<td>Respond to most&nbsp;<strong>typical and atypical</strong> antipsychotics</td>\n<td>Respond better to&nbsp;<strong>atypical</strong> antipsychotics</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1513, 'Psychiatry', 'PM0445. Psychiatric conditions and associated neurotransmitter activity', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Psychiatric Condition</strong></td>\n<td><strong>Associated Neurotransmitter Activity</strong></td>\n</tr>\n<tr>\n<td><strong>Depression</strong></td>\n<td>Decrease in serotonin, norepinephrine and dopamine</td>\n</tr>\n<tr>\n<td><strong>Mania</strong></td>\n<td>Increase in dopamine and decrease in GABA</td>\n</tr>\n<tr>\n<td><strong>Schizophrenia</strong></td>\n<td>Increase in dopamine and serotonin</td>\n</tr>\n<tr>\n<td><strong>Anxiety</strong></td>\n<td>Increase in norepinephrine and decrease in GABA ad serotonin</td>\n</tr>\n<tr>\n<td><strong>Alzheimers disease</strong></td>\n<td>Decrease in Norepinephrine and decrease&nbsp;in Acetylcholine</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1514, 'Psychiatry', 'PM0339. Clozapine treatment guidelines', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Clozapine treatment guidelines:</strong></p>\n<p>Indications:&nbsp; Treatment resistant schizophrenia, schizophrenia associated with suicidality.</p>\n<p>Adverse effects:&nbsp;</p>\n<ul>\n<li>Agranulocytosis</li>\n<li>Seizures</li>\n<li>Myocarditis</li>\n<li>Metabolic syndrome</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1515, 'Psychiatry', 'PM0336. Psychotic disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Differential diagnosis of DSM-5 psychotic disorders</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Psychotic disorder</strong></span></p>\n</td>\n<td><span><strong>Criteria for diagnosis</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Brief psychotic disorder</strong></span></td>\n<td>\n<p><span>Sudden onset and a full return to function</span></p>\n<p><span>Duration: &gt; 1 day and &lt; 1 month</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Schizophreniform disorder</strong></span></td>\n<td>\n<p><span>Same symptoms as schizophrenia and functional decline not required</span></p>\n<p><span>Duration: &gt; 1 month &amp; &lt; 6 months</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Schizophrenia</strong></span></td>\n<td>\n<p><span>Requires functional decline</span></p>\n<p><span>At least 6 months (includes at least 1 month of active symptoms, can include prodromal and residual periods)</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Schizoaffective disorder</strong></span></td>\n<td>\n<p><span>With concurrent mood episode.&nbsp;</span><span>Active-phase symptoms of schizophrenia with at least a 2 weeks of lifetime history of delusions or hallucinations in absence of prominent mood symptoms</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Delusional disorder</strong></span></td>\n<td>\n<p><span>One or more delusions for &gt; 1 month</span></p>\n<p><span>No other psychotic symptoms and normal functioning apart from the direct impact of delusions</span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Shared psychotic disorder (folie a deux)</strong></span></td>\n<td>\n<p><span>Development of delusions in a person who is in a close relationship (ex: spouse, child) with someone who has a delusional disorder (the inducer)</span></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1516, 'Psychiatry', 'PM0333. Prevalence of schizophrenia in specific population', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\15\>\n<tbody>\n<tr>\n<td>\n<p><strong>Populations</strong></p>\n</td>\n<td>\n<p><strong>Prevalence</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>General population</p>\n</td>\n<td>\n<p>1%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>One schizophrenic parent</p>\n</td>\n<td>\n<p>12%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Two schizophrenic parents</p>\n</td>\n<td>\n<p>40%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Monozygotic twin</p>\n</td>\n<td>\n<p>47%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dizygotic twin</p>\n</td>\n<td>\n<p>12%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>First-degree relative</p>\n</td>\n<td>\n<p>12%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Second-degree relative</p>\n</td>\n<td>\n<p>5–6%</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1517, 'Psychiatry', 'PM1864. Differential diagnosis of dementia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Condition</strong></span></td>\n<td><span><strong>Features</strong></span></td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Alzheimer’s disease</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Insidious onset</span></li>\n<li><strong><span>Short-term memory loss</span></strong></li>\n<li><span>Language deficits and spatial disorientation</span></li>\n<li><span>Later, personality changes</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Vascular Dementia</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Stepwise decline</span></li>\n<li><strong><span>Early executive dysfunction</span></strong></li>\n<li><span>Cerebral infarction &amp;/or deep white matter changes on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Frontotemporal dementia</strong></span></div>\n<div><span><strong>(Pick’s disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Early <strong>personality changes</strong></span></li>\n<li><span>Apathy, disinhibition &amp; compulsive behaviors</span></li>\n<li><span>Frontotemporal atrophy on neuroimaging</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Dementia with Lewy bodies</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span><strong>Visual Hallucination</strong></span></li>\n<li><span>Spontaneous parkinsonism</span></li>\n<li><span>Fluctuating cognition</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Normal-pressure hydrocephalus</strong></span></div>\n</td>\n<td>\n<ul>\n<li><span>Gait abnormalities&nbsp;</span></li>\n<li><span>Urinary Incontinence</span></li>\n<li><span>Dementia</span></li>\n<li><strong><span>Dilated ventricles on neuroimaging</span></strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Creutzfeldt-Jakob disease</strong></span></div>\n<div><span><strong>(Prion disease)</strong></span></div>\n</td>\n<td>\n<ul>\n<li><strong><span>Behavioral changes</span></strong></li>\n<li><span>Rapidly progressive</span></li>\n<li><span>Myoclonus and/or seizures</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1518, 'Psychiatry', 'PM1862. Clinical subtypes of delirium', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div class=\p1\><strong>Hyperactive Delirium</strong></div>\n</td>\n<td>\n<div><strong>Hypoactive Delirium</strong></div>\n</td>\n<td>\n<div><strong>Mixed delirium</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\p1\>Increased</div>\n<div class=\p1\>Psychomotor activities like restlessness, hyperarousal and increased speech</div>\n</td>\n<td>\n<div>Decreased Psychomotor activities like withdrawal, apathy and diminished speech&nbsp;</div>\n</td>\n<td>\n<div>Presence of both either simultaneously or sequentially</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\p1\>Easily identified</div>\n<div class=\p1\>due to dramatic symptoms</div>\n</td>\n<td>\n<div>Overlooked&nbsp; and often mistaken for depression</div>\n</td>\n<td>\n<div>Confusion in diagnosis due to varying presentations</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\p1\>Common in drug withdrawal/ intoxication</div>\n</td>\n<td>\n<div>Common in metabolic encephalopathies</div>\n</td>\n<td>\n<div>Multiple etiologies</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1519, 'Medicine,', 'PM0404. Alzheimer’s disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Alzheimer’s disease:</strong></p>\n<ul>\n<li>Age of onset &gt; 60 years</li>\n<li>Mini-mental state examination (MMSE) &lt; 24</li>\n<li>Diagnosis: Clinical\n<ul>\n<li>2 or more areas of cognitive deficits</li>\n<li>Progressive worsening of memory and other cognitive function</li>\n<li>No disturbance in consciousness</li>\n<li>Other systemic causes must be ruled out&nbsp;</li>\n</ul>\n</li>\n</ul>\n<p><strong>Risk Factors:</strong></p>\n<ul>\n<li>Most important risk factor: Old age</li>\n<li>Other risk factors – Family history, presenilin-1, presenilin-2, Apolipoprotein E4&nbsp;<strong><strong>(ApoE ε4 allele)</strong></strong>,&nbsp;Ubiquitin, Down syndrome and smoking.</li>\n</ul>\n<p><strong>Protective factors:</strong> NSAIDs and Apolipoprotein <strong>E2</strong></p>\n<p><strong>Causes: </strong>Decrease in <strong>acetylcholine</strong> causing depletion&nbsp;of the&nbsp;cholinergic neurons&nbsp;in the <strong>nucleus basalis of Meynert</strong> resulting in short-term memory defects.&nbsp;</p>\n<p><strong>Early findings:</strong></p>\n<ul>\n<li><strong>Anterograde</strong> memory loss (immediate recall affected, distant memories preserved)</li>\n<li><strong>Visuospatial deficits</strong> (lost in own neighborhood)</li>\n<li><strong>Language difficulties</strong> (difficulty finding words)</li>\n<li><strong>Cognitive impairment</strong> with a progressive decline</li>\n<li>Anosognosia&nbsp;</li>\n<li>Visual processing dysfunction (posterior cortical atrophy syndrome)</li>\n<li>Difficulties with naming and repetition (logopenic aphasia)</li>\n</ul>\n<p><strong>Late findings:</strong></p>\n<ul>\n<li>Psychotic symptoms: <strong>delusions</strong></li>\n<li><strong>Apraxia</strong>: Difficulty to perform learned motor tasks</li>\n<li><strong>Lack of insight</strong> regarding deficits</li>\n<li>Non-cognitive neurologic deficits: Pyramidal and extrapyramidal, myoclonus and seizures</li>\n<li>disrupted sleep - wake pattern.</li>\n<li><strong>Urinary incontinence.</strong></li>\n<li>Loss of procedural memory</li>\n</ul>\n<p><strong>Histopathology:</strong></p>\n<ul>\n<li><strong>Senile plaques</strong> (amyloid deposits), <strong>neurofibrillary tangles</strong> (composed of <strong>tau</strong> proteins), neuronal loss, synaptic loss, and granulovacuolar degeneration of neurons.</li>\n</ul>\n<p>The image below shows neurofibrillary tangles in&nbsp;Alzheimers disease.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e5db3b220b5c4a6fb0a82d0c724c68c5x640x784.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>CT/MRI:</strong></p>\n<ul>\n<li>Later stages: Cortical and subcortical atrophy prominent in parietal and temporal lobes, particularly <strong>hippocampus</strong>.&nbsp;</li>\n</ul>\n<p><strong>Treatment:</strong></p>\n<ul>\n<li>NMDA antagonist: <strong>memantine</strong></li>\n<li>Cholinesterase inhibitors: <strong>donepezil</strong>, <strong>galantamine</strong>, <strong>rivastigmine</strong>.</li>\n<li>Monoclonal antibody against the N-terminus of the Aβ peptide - <strong>aducanumab</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1520, 'Psychiatry', 'PM0401. Delirium vs Dementia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Features</strong></p>\n</td>\n<td>\n<p><span><strong>Delirium</strong></span></p>\n</td>\n<td>\n<p><span><strong>Dementia</strong></span></p>\n</td>\n</tr>\n<tr>\n<td><strong>Presentation</strong></td>\n<td>\n<p><span>Hallmark is impaired consciousness</span></p>\n</td>\n<td>\n<p><span>Loss of memory and intellectual abilities</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong><span>Commonly seen in&nbsp;</span></strong></p>\n</td>\n<td>\n<p><span>Children and elderly&nbsp;</span></p>\n</td>\n<td>\n<p><span>Elderly&nbsp;</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Associated physical findings</strong></span></p>\n</td>\n<td>\n<ul>\n<li><span>Acute medical illness&nbsp;</span></li>\n<li><span>Autonomic dysfunction</span></li>\n<li><span>Abnormal EEG&nbsp;</span></li>\n<li><span>Carphologia or&nbsp;floccillation&nbsp;(picking movements at cover-sheets and clothes)&nbsp;</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><span>No medical illness</span></li>\n<li><span>Little autonomic dysfunction</span></li>\n<li><span>Normal EEG&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Psychological findings</strong></span></p>\n</td>\n<td>\n<ul>\n<li><span>Impaired consciousness</span></li>\n<li><span>Illusion, delusion&nbsp;</span></li>\n<li><span>Sundowning (symptoms much worse at night)&nbsp;</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><span>Normal consciousness</span></li>\n<li><span>Depressed mood&nbsp;</span></li>\n<li><span>Personality changes in early stages in Pick’s disease&nbsp;<br></span></li>\n<li><span>Sundowning (symptoms much worse at night)&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Course</strong></span></p>\n</td>\n<td>\n<ul>\n<li><span>Develops quickly</span></li>\n<li><span>Fluctuating course with lucid intervals (waxing and waning)&nbsp;</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><span>Insidious-onset</span></li>\n<li><span>Progressive downhill course</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p><span><strong>Etiology</strong></span></p>\n</td>\n<td>\n<ul>\n<li><span>CNS disease (E.g: Huntington or Parkinson disease)</span></li>\n<li><span>CNS trauma</span></li>\n<li><span>CNS infection (E.g: Meningitis)</span></li>\n<li><span>Systemic disease (E.g., hepatic, cardiovascular)</span></li>\n<li><span>Substance abuse/withdrawal</span></li>\n<li><span>HIV infection</span></li>\n<li><span>Prescription drug overdose (E.g: atropine)&nbsp;</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><span>Alzheimers disease</span></li>\n<li><span>Vascular disease (15-30% of all dementias)</span></li>\n<li><span>CNS disease (E.g., Huntingtons or Parkinsons disease)</span></li>\n<li><span>CNS infection (HIV, Prion diseases)</span></li>\n<li><span>Lewy body dementia</span></li>\n<li><span>Picks disease (Frontotemporal dementia)&nbsp;</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p><span><strong>Treatment:</strong></span></p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><span>Treat the underlying medical cause</span></p>\n</td>\n<td>\n<p><span>Acetylcholinesterase inhibitors&nbsp;(donepezil, rivastigmine) and&nbsp;</span><span>NMDA antagonist (memantine)</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1521, 'Psychiatry', 'PM1983. Patterns of Mood Disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6ab1892272934b0792b8745017664ccfx1280x6841.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1522, 'Psychiatry', 'PM1904. Mania Vs Hypomania', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Mania</strong></td>\n<td><strong>Hypomania</strong></td>\n</tr>\n<tr>\n<td>Symptoms for at least 1 week</td>\n<td>Symptoms for at least 4 days</td>\n</tr>\n<tr>\n<td>Marked impairment in social or occupational functioning</td>\n<td>No impairment in social or occupational functioning</td>\n</tr>\n<tr>\n<td>May need hospitalization</td>\n<td>Doesnt need hospitalization</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1523, 'Psychiatry', 'PM0500. Treatment of acute manic episode', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>There is no single drug of choice for the treatment of acute mania.&nbsp;</p>\n<p>If the patient is <strong>on anti-depressants</strong>: Stop antidepressants.&nbsp;</p>\n<p>If the patient is <strong>already on anti-manic medication</strong>:&nbsp;</p>\n<ul>\n<li>If already on lithium or valproate: increase the dose of lithium or valproate and consider adding an antipsychotic.&nbsp;</li>\n<li>Consider adding short-term benzodiazepines for all patients.&nbsp;</li>\n</ul>\n<p>If the patient is <strong>not on anti-manic medication</strong>:</p>\n<ul>\n<li>Consider an antipsychotic if symptoms are severe and behavior is disturbed (or)</li>\n<li>Consider valproate, but avoid in women of reproductive age (or)</li>\n<li>Consider lithium if future adherence is likely&nbsp;</li>\n<li>Consider adding short-term benzodiazepines for all patients.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1524, 'Psychiatry', 'PM0499. Bipolar disorder', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong> Bipolar &amp; related disorders </strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Manic episode</strong></span></p>\n<ul>\n<li><span>Symptoms more <strong>severe</strong></span></li>\n<li><span><strong>1 week</strong> unless hospitalized</span></li>\n<li><span><strong>Marked impairment</strong> in social or occupational functioning or <strong>hospitalization</strong> necessary</span></li>\n<li><span>May have <strong>psychotic features</strong>; makes episode manic by definition</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Hypomanic episode</strong> &nbsp;</span></p>\n<ul>\n<li><span>Symptoms <strong>less severe</strong></span></li>\n<li><span><strong>4 days&nbsp;</strong>to less than 7 days</span></li>\n<li><span>Unequivocal, observable change in functioning from patients baseline</span></li>\n<li><span>Symptoms not severe enough to cause marked impairment or necessitate hospitalization</span></li>\n<li><span><strong>No psychotic features</strong></span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Bipolar I</strong></span></p>\n<ul>\n<li><span><strong>Manic episode(s)</strong></span></li>\n<li><span>Depressive episodes common (but not required for diagnosis)</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Bipolar II</strong></span></p>\n<ul>\n<li><span><strong>Hypomanic episode(s)</strong></span></li>\n<li><span>Major depressive episodes (required for diagnosis)</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Cyclothymic disorder</strong></span></p>\n<ul>\n<li><span>At least <strong>2 years</strong> of fluctuating, mild hypomanic &amp; depressive symptoms that </span><br><span>do not meet criteria for hypomanic episodes or major depressive episodes</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1525, 'Obstetrics & Gynaecology,', 'PM0497. Postpartum mood disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Disorders and features</strong></span></td>\n<td><span><strong>Incidence and timeline</strong></span></td>\n<td><span><strong>Harmful thoughts</strong></span></td>\n<td><span><strong>Treatment</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Postpartum blues</strong>:</span></p>\n<p><span>Depressed affect, tearfulness and fatigue</span></p>\n</td>\n<td>\n<p><span>30-75%</span></p>\n<p><span>Starts&nbsp;2-3 days after delivery. Resolves within 10 days.</span></p>\n</td>\n<td><span>No thoughts of harming the baby</span></td>\n<td><span>Support and follow up</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Postpartum depression</strong>:</span></p>\n<p><span>Depressed affect, anxiety, and poor concentration</span></p>\n</td>\n<td>\n<p><span>10-15%</span></p>\n<p><span>Starts within 4 weeks from delivery (DSM 5) or 6 weeks (ICD 11) and persists for ≥ 2 weeks.&nbsp;</span></p>\n</td>\n<td><span>Thoughts of harming the baby often present</span></td>\n<td><span>CBT and SSRIs&nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Postpartum psychosis</strong>:</span></p>\n<p><span>Mood-congruent delusions, hallucinations</span></p>\n</td>\n<td>\n<p><span>0.1-0.2%</span></p>\n<p><span>Onset within 4 weeks postpartum (DSM 5) or 6 weeks (ICD 11)</span></p>\n</td>\n<td><span>Thoughts of harming the baby or self</span></td>\n<td><span>Hospitalization, atypical antipsychotics and ECT for refractory cases</span></td>\n</tr>\n</tbody>\n</table>\n<p>Note: Zuranolone is the first-ever oral drug to be FDA-approved specifically for the treatment of postpartum depression. It is a neuroactive steroid that enhances the action of GABA in the brain and regulates mood.&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1526, 'Psychiatry', 'PM0496. Signs and symptoms of depression', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Mnemonic \<strong>SIGECAPS</strong>\</p>\n<p><strong>S</strong>leep disorder (increased or decreased)</p>\n<p><strong>I</strong>nterest deficit (anhedonia): loss of interest in previously pleasurable activities</p>\n<p><strong>G</strong>uilt (worthlessness, hopelessness, regret)</p>\n<p><strong>E</strong>nergy deficit</p>\n<p><strong>C</strong>oncentration deficit</p>\n<p><strong>A</strong>ppetite disorder (increased or decreased)</p>\n<p><strong>P</strong>sychomotor retardation or agitation</p>\n<p><strong>S</strong>uicidal tendency</p></div><!---->\n      <!---->\n    </div><!---->'),
(1527, 'Psychiatry', 'PM0418. Acute drug intoxication', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\3\>\n<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Acute Drug Intoxication</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Drug</strong></p>\n</td>\n<td>\n<p><strong>Class</strong></p>\n</td>\n<td>\n<p><strong>Clinical Features</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Phencyclidine (PCP)</strong></p>\n</td>\n<td>\n<p>Hallucinogen</p>\n</td>\n<td>\n<ul>\n<li>Tachycardia&nbsp;</li>\n<li>Hypertension</li>\n<li>Ataxia</li>\n<li>Hallucinations</li>\n<li>Violent behavior</li>\n<li>Dissociation</li>\n<li>Amnesia</li>\n<li><strong>Nystagmus</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>LSD</strong></p>\n</td>\n<td>\n<p>Hallucinogen</p>\n</td>\n<td>\n<ul>\n<li>Tachycardia&nbsp;</li>\n<li>Hypertension</li>\n<li>Ataxia</li>\n<li><strong>Visual hallucinations</strong></li>\n<li>Euphoria</li>\n<li>Dysphoric/panic</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cocaine</strong></p>\n</td>\n<td>\n<p>Stimulant&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Tachycardia</li>\n<li>Hypertension</li>\n<li>Agitation</li>\n<li>Euphoria</li>\n<li><strong>Chest pain</strong></li>\n<li><strong>Seizures</strong></li>\n<li>Mydriasis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;<strong>Methamphetamine</strong></p>\n</td>\n<td>\n<p>Stimulant</p>\n</td>\n<td>\n<ul>\n<li>Tachycardia</li>\n<li>Hypertension</li>\n<li>Violent behavior</li>\n<li>Psychosis</li>\n<li>Diaphoresis</li>\n<li>Choreiform movements</li>\n<li>Tooth decay</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;<strong>Marijuana (THC, Cannabis)</strong></p>\n</td>\n<td>\n<p>Psychoactive</p>\n</td>\n<td>\n<ul>\n<li><strong>Increased appetite</strong></li>\n<li>Euphoria</li>\n<li>Dysphoria/panic</li>\n<li><strong>Impaired time perception</strong></li>\n<li>Dry mouth</li>\n<li><strong>Conjunctival injection</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;<strong>Heroin</strong></p>\n</td>\n<td>\n<p>Opioid</p>\n</td>\n<td>\n<ul>\n<li>Euphoria</li>\n<li><strong>Depressed mental status</strong></li>\n<li><strong>Miosis</strong></li>\n<li><strong>Respiratory depression</strong></li>\n<li>Constipation</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1528, 'Psychiatry', 'PM2336. Differential diagnosis of Trauma and Stress related disorder', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><span>&nbsp;</span></div>\n</td>\n<td>\n<div><span><strong>PTSD</strong></span></div>\n</td>\n<td>\n<div><span><strong>Adjustment disorder</strong></span></div>\n</td>\n<td>\n<div><span><strong>Bereavement</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Stressor</strong></span></div>\n</td>\n<td>\n<div><span>Extreme traumatic events like rape or accident</span></div>\n</td>\n<td>\n<div><span>Financial/ Illness/ Relationship issues</span></div>\n</td>\n<td>\n<div><span>Death of a loved one</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Time</strong></span></div>\n</td>\n<td>\n<div>\n<div><span>Symptoms</span></div>\n</div>\n<div><span><strong>develop</strong><strong>&nbsp;within 6 months</strong> and persist more than 1 month</span></div>\n</td>\n<td>\n<div>\n<div><span>Symptoms</span></div>\n</div>\n<div><span><strong>develop</strong><strong>&nbsp;within 3 months</strong> and resolve in 6 months if stressor eliminated</span></div>\n</td>\n<td>\n<div><span>Symptoms <strong>develop within 2 months</strong> and resolve within 2 months</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Symptoms</strong></span></div>\n</td>\n<td>\n<div><span>Flashbacks and nightmares</span></div>\n</td>\n<td>\n<div><span>Mostly depressive and anxiety</span></div>\n</td>\n<td>\n<div><span>Mostly depressive</span></div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1529, 'Psychiatry', 'PM1874. Anxiety disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div>\n<table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Disorder&nbsp;</strong></span></div>\n</td>\n<td>\n<div><span><strong>Feature</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Panic disorder</strong></span></div>\n</td>\n<td>\n<div><span>1. Recurrent and unexpected panic attacks with ≥ 4 of the following:</span></div>\n<div>\n<ul>\n<li><span>Dyspnea</span></li>\n<li><span>Tachypnea</span></li>\n<li><span>Palpitations</span></li>\n<li><span>Sweating</span></li>\n<li><span>Dizziness</span></li>\n<li><span>Chest pain</span></li>\n<li><span>Tightness</span></li>\n<li><span>Paresthesias</span></li>\n<li><span>Emotional and cognitive</span><br><span>symptoms</span></li>\n<li><span>Feeling that something catastrophic is</span><br><span>about to happen.</span></li>\n</ul>\n</div>\n<div>\n<p>2. At least 1 attack followed by one or both of the following &gt; 1 month:</p>\n<ul>\n<li>Worry about an additional panic attack or consequences</li>\n<li>Changes in behaviour related to attacks (ex: avoidance)</li>\n</ul>\n<p>3. Panic attack not attributable to substance abuse or another medical condition.</p>\n<p>4. Panic attack not explained by another mental disorder.</p>\n</div>\n<div>\n<p>Treatment of Panic disorder:</p>\n<p>Immediate: Benzodiazepines <br>Long term: SSRI/ SNRI and or cognitive behavioural therapy</p>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Phobias</strong></span></div>\n</td>\n<td>\n<div><span>Exaggerated anxiety responses that occur</span><br><span>during exposure to relatively innocuous stimuli or situations.</span></div>\n<div><span>Specific phobias entail phobic responses to</span><br><span>particular stimuli or situations.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Social</strong></span><br><span><strong>anxiety disorder (Social phobia)</strong></span></div>\n</td>\n<td>\n<div><span>Phobic responses to specific social situations.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Generalized anxiety disorder</strong></span></div>\n</td>\n<td>\n<div><span>Excessive worry about</span><br><span>a variety of topics (job, health, finances, etc.) &gt; 6 months.</span></div>\n<div><span>&nbsp;</span></div>\n<div><span>3 or more of the following symptoms:</span></div>\n<div>\n<ul>\n<li><span>Restlessness</span></li>\n<li><span>Fatigue</span></li>\n<li><span>Difficulty concentrating</span></li>\n<li><span>Irritability</span></li>\n<li><span>Muscle tension</span></li>\n<li><span>Sleep disturbance</span></li>\n</ul>\n</div>\n<div>\n<p><span>Treatment:</span></p>\n<p><span>First line: CBT, SSRIs or SNRIs</span></p>\n<p><span>Second-line: Benzodiazepines, Buspirone</span></p>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<div><span>&nbsp;</span></div></div><!---->\n      <!---->\n    </div><!---->'),
(1530, 'Psychiatry', 'PM0552. Obsessive-compulsive disorder', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Key points:</p>\n<ul>\n<li>Most common:\n<ul>\n<li>Obsession: <strong>Contamination</strong></li>\n<li>Compulsion: <strong>Checking, cleaning</strong></li>\n</ul>\n</li>\n<li>Treatment: Exposure and Response prevention - 1st line, Cognitive Behavioural Therapy(CBT), CBT with ERP, Pharmacotherapy.</li>\n<li>Drug of choice:&nbsp;High dose <strong>SSRI</strong></li>\n<li>Treatment in nonresponsive patients:&nbsp;Clomipramine or antipsychotic augmentation</li>\n<li>Treatment of severe or refractory cases:&nbsp;<strong>Deep brain stimulation</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1531, 'Psychiatry', 'PM0550. Specific phobia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Present in 10% of the population.</p>\n<p>Clinical features:</p>\n<ul>\n<li><strong>Marked anxiety about a specific object</strong> or situation (the phobic stimulus) for &gt; 6 months</li>\n<li>Usually develops in childhood, can develop after a traumatic event</li>\n<li>Avoidance behavior</li>\n</ul>\n<p>Treatment:</p>\n<ul>\n<li><strong>Behavioral therapy</strong> (exposure-based, systematic desensitization) is the <strong>treatment of choice</strong></li>\n<li>Short-acting <strong>benzodiazepines</strong> may help acutely</li>\n</ul>\n<p>&nbsp;</p>\n<table width=\257\>\n<tbody>\n<tr>\n<td><strong>Phobia</strong></td>\n<td><strong>Object</strong></td>\n</tr>\n<tr>\n<td>Acarophobia</td>\n<td>Small objects</td>\n</tr>\n<tr>\n<td>Acrophobia</td>\n<td>High places</td>\n</tr>\n<tr>\n<td>Agoraphobia</td>\n<td>Open or crowded places, leaving familiar setting of home</td>\n</tr>\n<tr>\n<td>Aichmophobia</td>\n<td>Pointed objects</td>\n</tr>\n<tr>\n<td>Ailurophobia</td>\n<td>Cats</td>\n</tr>\n<tr>\n<td>Algophobia</td>\n<td>Pain</td>\n</tr>\n<tr>\n<td>Androphobia</td>\n<td>Men</td>\n</tr>\n<tr>\n<td>Astraphobia or astrapophobia</td>\n<td>Thunder and lightning</td>\n</tr>\n<tr>\n<td>Autophobia</td>\n<td>Being alone, or of self</td>\n</tr>\n<tr>\n<td>Bathophobia</td>\n<td>Depths</td>\n</tr>\n<tr>\n<td>Claustrophobia</td>\n<td>Closed or confined places</td>\n</tr>\n<tr>\n<td>Coprophobia</td>\n<td>Excreta</td>\n</tr>\n<tr>\n<td>Cynophobia</td>\n<td>Dogs</td>\n</tr>\n<tr>\n<td>Demophobia</td>\n<td>Crowds</td>\n</tr>\n<tr>\n<td>Erythrophobia</td>\n<td>Blushing</td>\n</tr>\n<tr>\n<td>Gynophobia</td>\n<td>Women</td>\n</tr>\n<tr>\n<td>Haphephobia</td>\n<td>Being touched</td>\n</tr>\n<tr>\n<td>Hematophobia</td>\n<td>Sight of blood</td>\n</tr>\n<tr>\n<td>Hydrophobia</td>\n<td>Water</td>\n</tr>\n<tr>\n<td>Hypnophobia</td>\n<td>Sleep</td>\n</tr>\n<tr>\n<td>Lalophobia or glossophobia</td>\n<td>Speaking</td>\n</tr>\n<tr>\n<td>Mysophobia</td>\n<td>Dirt, contamination</td>\n</tr>\n<tr>\n<td>Necrophobia</td>\n<td>Dead bodies</td>\n</tr>\n<tr>\n<td>Nyctophobia</td>\n<td>Darkness, night</td>\n</tr>\n<tr>\n<td>Panphobia</td>\n<td>Everything</td>\n</tr>\n<tr>\n<td>Pathophobia or nosophobia</td>\n<td>Disease, suffering</td>\n</tr>\n<tr>\n<td>Peccatophobia</td>\n<td>Sinning</td>\n</tr>\n<tr>\n<td>Pedophobia</td>\n<td>Children</td>\n</tr>\n<tr>\n<td>Phonophobia</td>\n<td>Speaking aloud</td>\n</tr>\n<tr>\n<td>Photophobia</td>\n<td>Strong light</td>\n</tr>\n<tr>\n<td>Sitophobia</td>\n<td>Eating</td>\n</tr>\n<tr>\n<td>Taphophobia</td>\n<td>Being buried alive</td>\n</tr>\n<tr>\n<td>Thanatophobia</td>\n<td>Death</td>\n</tr>\n<tr>\n<td>Toxophobia</td>\n<td>Being poisoned</td>\n</tr>\n<tr>\n<td>Xenophobia</td>\n<td>Strangers</td>\n</tr>\n<tr>\n<td>Zoophobia</td>\n<td>Animals</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1532, 'Psychiatry', 'PM0541. Panic disorder', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>DSM-5 criteria for panic disorder:</p>\n<p class=\p1\>1.Recurrent and unexpected panic attacks with ≥ 4 of the following:</p>\n<ul class=\ul1\>\n<li class=\li1\>Palpitation</li>\n<li class=\li1\>Sweating</li>\n<li class=\li1\>Trembling or shaking</li>\n<li class=\li1\>Shortness of breath of smothering sensation</li>\n<li class=\li1\>Choking sensation</li>\n<li class=\li1\>Chest pain or discomfort</li>\n<li class=\li1\>Nausea or abdominal distress</li>\n<li class=\li1\>Dizziness, light-headedness</li>\n<li class=\li1\>Chills or heat sensation</li>\n<li class=\li1\>Paraesthesia’s</li>\n<li class=\li1\>Derealisation or depersonalisation</li>\n<li class=\li1\>Fear of losing control or “going crazy”</li>\n<li class=\li1\>Fear of dying &nbsp;</li>\n</ul>\n<p class=\p1\>&nbsp;2.<strong>&nbsp;</strong>At least 1 attack followed by one or both of the following &gt; <strong>1 month:</strong></p>\n<ul class=\ul1\>\n<li class=\li1\>Worry about additional panic attack or consequences</li>\n<li class=\li1\>Changes in behaviour related to attacks (ex: avoidance)</li>\n</ul>\n<p class=\p1\>3. Panic attack not attributable to substance abuse or another medical condition.</p>\n<p class=\p1\>4. Panic attack not explained by another mental disorder.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p class=\p1\>Treatment of Panic disorder:</p>\n<ul class=\ul1\>\n<li class=\li1\><strong>Immediate</strong>: benzodiazepines&nbsp;</li>\n<li class=\li1\><strong>Long term</strong>: SSRI/ SNRI and or cognitive behavioural therapy</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1533, 'Psychiatry', 'PM0347. Normal vs abnormal grief', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;<strong>Normal vs abnormal grief</strong></p>\n<table>\n<tbody>\n<tr>\n<td width=\225\>\n<p><strong>Grief/bereavement</strong></p>\n</td>\n<td width=\225\>\n<p><strong>Pathological Grief/depression</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\225\>\n<p>Sadness, tearfulness, decreased sleep, decreased appetite, decreased interest in the world</p>\n</td>\n<td width=\225\>\n<p>Sadness, tearfulness, decreased sleep, decreased appetite, decreased interest in the world</p>\n</td>\n</tr>\n<tr>\n<td width=\225\>\n<p>Symptoms wax and wane</p>\n</td>\n<td width=\225\>\n<p>Symptoms pervasive and unremitting</p>\n</td>\n</tr>\n<tr>\n<td width=\225\>\n<p>Shame and guilt are less common</p>\n</td>\n<td width=\225\>\n<p>Shame and guilt are common</p>\n</td>\n</tr>\n<tr>\n<td width=\225\>\n<p>Threaten suicide less often</p>\n</td>\n<td width=\225\>\n<p>Threaten suicide more often</p>\n</td>\n</tr>\n<tr>\n<td width=\225\>\n<p>Symptoms can last up to 1 year</p>\n</td>\n<td width=\225\>\n<p>Symptoms continue for more than one year</p>\n</td>\n</tr>\n<tr>\n<td width=\225\>\n<p>Usually, return to baseline level of functioning within 2 months</p>\n</td>\n<td width=\225\>\n<p>Patients do not return to normal functioning</p>\n</td>\n</tr>\n<tr>\n<td width=\225\>\n<p>Treatment includes supportive psychotherapy</p>\n</td>\n<td width=\225\>\n<p>Treatment includes antidepressants</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1534, 'Psychiatry', 'PM0379. Personality Disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\>\n<p><span><strong>Key features of Personality disorders</strong></span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<p><span><strong>Cluster A (Odd, Weird, Eccentric)</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Paranoid</span></div>\n</td>\n<td>\n<div><span>Suspicious, distrustful, hypervigilant</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Schizoid</span></div>\n</td>\n<td>\n<div><span>Prefers to be loner, detached, unemotional</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Schizotypal</span></div>\n</td>\n<td>\n<div><span>Eccentric &amp; odd thoughts, perceptions &amp; behavior, magical thinking and beliefs</span></div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<p><span><strong>Cluster B (Dramatic, Emotional and Erratic)</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Antisocial</span></div>\n</td>\n<td>\n<div><span>Disregard for and violation of rights of others, illegal activities</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Borderline</span></div>\n</td>\n<td>\n<div><span>Chaotic relationships, sensitivity to abandonment, labile mood, impulsivity, inner emptiness, self-harm</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Histrionic</span></div>\n</td>\n<td>\n<div><span>Dramatic, superficial, attention-seeking</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Narcissistic</span></div>\n</td>\n<td>\n<div><span>Grandiosity, lack of empathy</span></div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<p><span><strong>Cluster C (Anxious, Fearful, Introvert)</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Avoidant</span></div>\n</td>\n<td>\n<div><span>Avoidance due to fears of criticism and rejection</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Dependent</span></div>\n</td>\n<td>\n<div><span>Submissive, clingy, needs to be taken care of</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Obsessive-compulsive/</span></div>\n<div><span>Anankastic</span></div>\n<div>&nbsp;</div>\n</td>\n<td>\n<div><span>Rigid, controlling, perfectionist</span></div>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1535, 'Psychiatry', 'PM0377. Conversion Disorder', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Conversion disorder</strong>: Also called functional neurological symptom disorder.</p>\n<p><strong>Common presenting symptoms</strong>:</p>\n<ul>\n<li>Weakness and/or paralysis</li>\n<li>Non-epileptic seizures</li>\n<li>Movement disorders</li>\n<li>Speech or visual impairment like mutism or blindness</li>\n<li>Swallowing difficulty</li>\n<li>Sensory disturbances</li>\n<li>Cognitive symptoms</li>\n</ul>\n<p><strong>Diagnostic criteria</strong>:</p>\n<ul>\n<li>Symptoms of altered neurological function-voluntary motor or sensory</li>\n<li>Often precipitated by a psychological stressor (the temporal relationship between stressor and symptoms is present)</li>\n<li>Not feigned or intentionally produced (as in factitious disorder or malingering)</li>\n<li>Findings incompatible with a recognized neurological condition</li>\n<li>Symptoms cause significant social or occupational impairment</li>\n</ul>\n<p><strong>Other important features</strong>:</p>\n<ul>\n<li><strong>Primary gain</strong> - Unconscious relief from stress&nbsp;as the focus of the patient shifts to&nbsp;the symptoms.</li>\n<li><strong>Secondary gain</strong> - Attention gained by the patient (from bystanders) as a result of the symptoms.</li>\n<li><strong>La-belle indifference </strong>-&nbsp;refers to an absence of concern towards one’s problem despite severe disability</li>\n<li><strong>Astasia abasia</strong> - Wildly ataxic, staggering gait accompanied by irregular, jerky truncal movements, thrashing and waving arm movements</li>\n</ul>\n<p><strong>Management options</strong>:</p>\n<ul>\n<li>First-line: Education and self-help technique</li>\n<li>Second-line: Cognitive-behavioral therapy</li>\n<li>Physical therapy for motor symptoms</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1536, 'Psychiatry', 'PM0238. Personality tests', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><span><strong>Minnesota&nbsp;Multiphasic&nbsp;Personality&nbsp;Inventory (MMPI-2)</strong></span></p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Uses</strong></span></td>\n<td><span><strong>Characteristics</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span>The most commonly used <strong>objective personality</strong> test.</span></p>\n<p><span>Useful for <strong>primary care physicians</strong> because no training is required for administration and scoring&nbsp;</span></p>\n<p><span><strong>Evaluating the attitude</strong> of the patient toward taking the test</span></p>\n</td>\n<td>\n<p><span><strong>Objective</strong> test</span></p>\n<p><span>Patients answer 567 true(T) or false(F) questions about themselves.</span></p>\n<p><span><strong>Clinical scales</strong> include depression, paranoia, schizophrenia, and hypochondriasis.</span></p>\n<p><span><strong>Validity scales</strong> identify trying to look ill (faking bad or malingering) or trying to look well (faking good)&nbsp;</span></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><span><strong>Rorschach Test</strong></span></p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Uses</strong></span></td>\n<td><span><strong>Characteristics</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span>The most commonly used <strong>projective personality</strong> test.&nbsp;</span></p>\n<p><span>Used to identify <strong>thought disorders </strong>and<strong> defense mechanisms</strong></span></p>\n</td>\n<td>\n<p><span><strong>Projective</strong>&nbsp;test&nbsp;</span></p>\n<p><span>Patients are asked to interpret 10 bilaterally symmetrical inkblot designs (e.g., Describe what you see in this figure)</span></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8c59dcc284dd44318126b291b695cafdx720x540.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><span><strong>Thematic&nbsp;Apperception Test (TAT)</strong></span></p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Uses</strong></span></td>\n<td><span><strong>Characteristics</strong></span></td>\n</tr>\n<tr>\n<td>\n<p><span>Stories are used to evaluate <strong>unconscious emotions and conflicts</strong></span></p>\n</td>\n<td>\n<p><span><strong>Projective</strong>&nbsp;test</span></p>\n<p><span>Patients are asked to <strong>create a verbal scenario</strong> based on 20 drawings depicting ambiguous situations (e.g., Using the picture, make up a story that has a beginning, a middle, and an end)</span></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>The image given below is the first card, drawn by Christiana D. Morgan. It is a recreation of a photograph taken by Samuel Lumiere of violinist,&nbsp;Yehudi Menuhin, in 1928.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ff77aa3cbbc04baea2ecb25be69ca81ex728x555.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><span><strong>Sentence&nbsp;Completion Test</strong></span></p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Uses</strong></span></td>\n<td><span><strong>Characteristics</strong></span></td>\n</tr>\n<tr>\n<td><span>Used to identify worries and problems using <strong>verbal associations</strong></span></td>\n<td>\n<p><span><strong>Projective</strong>&nbsp;test</span></p>\n<p><span>Patients <strong>complete sentences</strong> started by the examiner</span></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1537, 'Psychiatry', 'PM2334. Sleep Polysomnography', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Sleep polysomnography is a testing tool for the evaluation of <strong>sleep-disordered breathing</strong>.</p>\n<p>Such disorders include:</p>\n<ul>\n<li>obstructive sleep apnea (OSA) +/- Cheyne-stokes respiration</li>\n<li>central sleep apnea (CSA)&nbsp;+/- Cheyne-stokes respiration</li>\n<li>sleep-related hypoventilation</li>\n</ul>\n<p>Physiologic monitoring during polysomnography:</p>\n<ul>\n<li>Electroencephalography (EEG)</li>\n<li>Chin electromyography (EMG)</li>\n<li>Electrooculography (EOG)</li>\n<li>Electrocardiography (ECG)</li>\n<li>Measures of airflow</li>\n<li>Measures of respiratory effort</li>\n<li>Pulse oximetry</li>\n<li>Limb electromyography</li>\n<li>Snore volume</li>\n<li>Body position monitor</li>\n</ul>\n<p>The following table helps in identifying the state of wakefulness and sleep from the polysomnograph :</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><strong>EEG</strong></p>\n</td>\n<td>\n<p><strong>EOG</strong></p>\n</td>\n<td>\n<p><strong>EMG</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Active state</strong></p>\n</td>\n<td>\n<p>Fast</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>REM sleep</strong></p>\n</td>\n<td>\n<p>Mixed</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>_</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>NREM sleep</strong></p>\n</td>\n<td>\n<p>Slow</p>\n</td>\n<td>\n<p>_</p>\n</td>\n<td>\n<p>+</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1538, 'Psychiatry', 'PM1937. Classification of somatic symptom disorders: DSM-5 vs ICD-10', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>DSM-5</strong></p>\n<p><span>(S</span><span>omatic symptom and related disorders)</span></p>\n</td>\n<td>\n<p><strong>&nbsp;ICD-10</strong></p>\n<p><span>(Somatoform disorders)</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Somatic symptom disorder</span></td>\n<td>\n<p><span>Somatization disorder</span></p>\n<p><span>Undifferentiated somatoform disorder</span></p>\n<p><span>Persistent somatoform pain disorder</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Conversion disorder</span><span>&nbsp;</span><span>(functional neurological</span><span>&nbsp;</span><span>symptom disorder)</span></td>\n<td><span>Dissociative (conversion) disorder</span></td>\n</tr>\n<tr>\n<td><span>Illness anxiety disorder</span></td>\n<td><span>Hypochondriacal disorder</span></td>\n</tr>\n<tr>\n<td><span>Factitious disorder</span></td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td><span>Somatoform disorder NEC</span></td>\n<td>\n<p><span>Somatoform autonomic dysfunction</span></p>\n<p><span>Other somatoform disorders</span></p>\n<p><span>Somatoform disorder unspecified</span></p>\n<p><span>Neurasthenia (neurotic</span><br><span>disorders category)</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Psychological factors affecting another medical condition</span></td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1539, 'Psychiatry', 'PM0382. Eating Disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><span>&nbsp;</span></p>\n</td>\n<td>\n<p><span><strong>Anorexia nervosa</strong></span></p>\n</td>\n<td>\n<p><span><strong>Bulimia nervosa</strong></span></p>\n</td>\n<td>\n<p><span><strong>Binge-eating disorder</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Avoidance of food</strong></span></p>\n<p><span>(calorie deficit)</span></p>\n</td>\n<td>\n<p><span>+</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Binge eating</strong></span></p>\n</td>\n<td>\n<p><span>+/-</span></p>\n</td>\n<td>\n<p><span>+</span></p>\n</td>\n<td>\n<p><span>+</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Compensation</strong></span></p>\n<p><span>(purge/vomit)</span></p>\n</td>\n<td>\n<p><span>&nbsp;+/-</span></p>\n</td>\n<td>\n<p><span>+</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>BMI</strong></span></p>\n</td>\n<td>\n<p><span>LOW*</span></p>\n</td>\n<td>\n<p><span>NORMAL (</span><span>18.5–22.9)</span></p>\n</td>\n<td>\n<p><span>HIGH</span></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;*In <strong>atypical anorexia nervosa</strong>, all the features of anorexia nervosa will be present, but the patient will have normal BMI.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1540, 'Psychiatry', 'PM0381. Parasomnias', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td width=\71\>\n<p><strong>Disorder</strong></p>\n</td>\n<td width=\191\>\n<p><strong>Sleep stage and Characteristics</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\71\>\n<p><strong>Nightmares (dream anxiety disorder)</strong></p>\n</td>\n<td width=\191\>\n<p>REM</p>\n<p>Memory of the event upon awakening</p>\n<p>Treatment: Usually no treatment, REM suppressants&nbsp;(TCAs) may be used</p>\n</td>\n</tr>\n<tr>\n<td width=\71\>\n<p><strong>Night terror (sleep terror disorder)</strong></p>\n</td>\n<td width=\191\>\n<p>Stage 3 and 4</p>\n<p>Awakened by a scream or with intense anxiety</p>\n<p>No memory of the event the folowing day</p>\n<p>Seen more frequently in children</p>\n<p>More common in boys</p>\n<p>Runs in families</p>\n<p>Treatment: Rarely treatment is required. Benzodiazepines can be used</p>\n</td>\n</tr>\n<tr>\n<td width=\71\>\n<p><strong>Sleep talking</strong></p>\n</td>\n<td width=\191\>\n<p>All stages of sleep</p>\n<p>Common in children</p>\n<p>Usually, involves a few words</p>\n<p>May accompany night terrors and sleepwalking</p>\n<p>Treatment: No treatment is necessary</p>\n</td>\n</tr>\n<tr>\n<td width=\71\>\n<p><strong>Sleepwalking</strong></p>\n<p><strong>(Somnambulism)</strong></p>\n</td>\n<td width=\191\>\n<p>Stage 3 and 4</p>\n<p>Sequence of behaviors without full of consciousness</p>\n<p>May perform perseverative behaviors</p>\n<p>Usually, terminates in awakening followed by confusion</p>\n<p>May return to sleep without any memory of the event</p>\n<p>Begins at a young age</p>\n<p>More common in boys</p>\n<p>There may be a neurological condition</p>\n<p>Sleep deprivation exacerbates</p>\n<p>Treatment: Patient safety has to be ensured.</p>\n<p>Benzodiazepines to suppress stage 3 and 4.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1541, 'Psychiatry', 'PM0378. Dissociative Disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>DSM-5 Classification and characteristics of dissociative disorders:</p>\n<table width=\579\>\n<tbody>\n<tr>\n<td>\n<div><strong>Dissociative disorder</strong></div>\n</td>\n<td>\n<div><strong>Characteristic features</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Dissociative amnesia</strong>:</span></p>\n<p><span><strong>Failure to remember</strong> important information about oneself after a stressful event.</span></p>\n</td>\n<td>\n<p><span>Amnesia usually resolves in minutes or days but may last years. Retrograde amnesia &gt; antegrade amnesia</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Dissociative fugue</strong>:</span></p>\n<p><span>Amnesia combined with <strong>sudden wandering</strong> from home after a stressful event.</span></p>\n</td>\n<td>\n<p><span>Adoption of a different identity. The patient denies memory loss during the fugue state.</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Dissociative identity disorder</strong>:</span></p>\n<p><span>Previously called <strong>multiple personality disorder.</strong></span></p>\n<p><span>At least two distinct personalities (“alters”) in an individual.</span></p>\n</td>\n<td>\n<p><span>More common in women (particularly those sexually abused in childhood)</span></p>\n<p><span>In a forensic setting (Eg: jail), malingering and alcohol abuse must be considered and excluded</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Depersonalization disorder</strong>:</span></p>\n<p><span>Recurrent, persistent feelings of <strong>detachment from one’s own body</strong>, the social situation, or the environment (derealisation) when stressed.</span></p>\n</td>\n<td><span>Understanding that these perceptions are only feelings, i.e., normal reality testing.</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Dissociative disorder not otherwise specified</strong>:</span></p>\n<p><span>Dissociate symptom (Eg: trance-like state, memory loss) in -&nbsp;</span></p>\n</td>\n<td>\n<ul>\n<li><span>Persons exposed to intense coercive persuasion (Eg: brainwashing)</span></li>\n<li><span>Indigenous to particular locations or cultures (Eg: Amok in Indonesia)</span></li>\n</ul>\n<span>&nbsp;</span></td>\n</tr>\n</tbody>\n</table>\n<p>ICD-11 classifies Dissociative Disorders as:</p>\n<ul>\n<li>Dissociative Identity Disorder</li>\n<li>Partial Dissociative Identity Disorder</li>\n<li>Depersonalization-Derealization disorder</li>\n<li>Dissociative Amnesia</li>\n<li>Trance Disorder</li>\n<li>Possession Trance Disorder</li>\n<li>Dissociative Neurological symptom disorder</li>\n<li>Secondary Dissociative syndrome</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1542, 'Psychiatry', 'PM0376. Somatoform Disorder', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Somatoform Disorder</strong></td>\n<td>\n<p><strong>Key features of somatic symptom and related disorders</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Somatic symptom disorder</span></p>\n</td>\n<td>\n<p><span>Excessive anxiety and preoccupation with ≥1 unexplained symptom</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Illness anxiety disorder</span></p>\n<p><span>(hypochondriasis)</span></p>\n</td>\n<td>\n<p><span>Fear of having a serious illness despite few or no symptoms and consistently negative evaluations</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Conversion disorder</span></p>\n<p><span>(functional neurologic symptom disorder)</span></p>\n</td>\n<td>\n<p><span>Neurologic symptom&nbsp; incompatible with any known neurologic disease, often acute onset associated with stress</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Factitious disorder</span></p>\n</td>\n<td>\n<p><span>Intentional falsification or inducement of symptoms with a goal to assume the sick role</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Malingering</span></p>\n</td>\n<td>\n<p><span>Falsification or exaggeration of symptoms to obtain external incentives (secondary gain)</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1543, 'Psychiatry', 'PM2057. Psychiatric emergency: Fever with altered mental status', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>In a clinical setting of <strong>fever with altered mental status</strong>, it is important to differentiate between the following.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>&nbsp;Syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Neuroleptic malignant syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Serotonin syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Anticholinergic syndrome</strong></span></div>\n</td>\n<td>\n<div><span><strong>Malignant hyperthermia</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>&nbsp;Cause</strong></span></div>\n</td>\n<td>\n<div><span>Dysregulation of dopaminergic pathways</span></div>\n</td>\n<td>\n<div><span>Co-prescription of MAO-I and SSRIs leading to increased serotonin and norepinephrine levels</span></div>\n</td>\n<td>\n<div>\n<div><span>Anticholinergic i</span><span>ntoxication</span></div>\n</div>\n</td>\n<td>\n<div>\n<div><span>Halogenated anesthetics and succinylcholine leading to a</span></div>\n</div>\n<div><span>hypermetabolic response causing an increased intracellular calcium level</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Fever and altered mental status</strong></span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n<td>\n<div><span>Present</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Muscle tone</strong></span></div>\n</td>\n<td>\n<div><span>Rigid</span></div>\n</td>\n<td>\n<div><span>Rigid</span></div>\n</td>\n<td>\n<div><span><strong>Normal</strong></span></div>\n</td>\n<td>\n<div><span>Rigid</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Skin and mucosa</strong></span></div>\n</td>\n<td>\n<div><span>Wet</span></div>\n</td>\n<td>\n<div><span>Wet</span></div>\n</td>\n<td>\n<div><strong><span>Dry</span></strong></div>\n</td>\n<td>\n<div><span>Wet</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Pupils</strong></span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n<td>\n<div><span><strong>Dilated</strong></span></div>\n</td>\n<td>\n<div><span><strong>Dilated</strong></span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Bowel sounds</strong></span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n<td>\n<div><span>Increased</span></div>\n</td>\n<td>\n<div><span>Decreased</span></div>\n</td>\n<td>\n<div><span>Decreased</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Reflexes</strong></span></div>\n</td>\n<td>\n<div><span>Bradyreflexia</span></div>\n</td>\n<td>\n<div><span>Increased</span></div>\n</td>\n<td>\n<div><span>Normal</span></div>\n</td>\n<td>\n<div><span>Decreased</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Treatment</strong></span></div>\n</td>\n<td>\n<div><span>Stop antipsychotic;</span></div>\n<div><span>give dantrolene, bromocriptine and&nbsp;</span><span>monitor CPK levels</span></div>\n</td>\n<td>\n<div><span>Change the drug;&nbsp;</span></div>\n<div><span>give cyproheptadine</span></div>\n</td>\n<td>\n<div><span>Discontinue drug;</span></div>\n<div><span>give i.v. physostigmine</span></div>\n</td>\n<td>\n<div><span>Cooling, dantrolene, insulin, and glucose</span></div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1544, 'Psychiatry', 'PM1869. Paraphilic disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>DSM-5 includes eight specific paraphilic disorders:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>Exhibitionistic disorder</td>\n<td>Sexual arousal from exposing their genitals to a stranger</td>\n</tr>\n<tr>\n<td>Pedophilic disorder</td>\n<td>Sexual arousal to a prepubescent individual, generally 13&nbsp;years of age or younger</td>\n</tr>\n<tr>\n<td>Voyeuristic disorder</td>\n<td>Sexual arousal from observing others sexual&nbsp;activities</td>\n</tr>\n<tr>\n<td>Sexual sadism disorder</td>\n<td>Sexual arousal upon inflicting suffering or humiliation &nbsp;</td>\n</tr>\n<tr>\n<td>Frotteuristic disorder</td>\n<td>Sexual arousal by touching or rubbing against a non-consenting person</td>\n</tr>\n<tr>\n<td>Fetishistic disorder</td>\n<td>Sexual arousal from the use of inert objects, such as female<br>undergarments</td>\n</tr>\n<tr>\n<td>Transvestic disorder</td>\n<td>Sexual arousal from cross-dressing</td>\n</tr>\n<tr>\n<td>Sexual masochism</td>\n<td>Sexual arousal from being humiliated, beaten, bound, or made to suffer</td>\n</tr>\n</tbody>\n</table>\n<p>As per <strong>ICD-11</strong>, the first five are included under paraphilic disorders. Two other subclasses in addition to this are:</p>\n<ul>\n<li>Other paraphilic disorders involving non-consenting individuals (e.g., arousal patterns involving corpses or animals)</li>\n<li>Paraphilic disorders involving solitary behaviour or consenting individuals&nbsp;(e.g., asphyxophilia, fetishism, fetishistic transvestism).</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1545, 'Psychiatry', 'PM1866. Psychosexual factors determining sexuality', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Sexual Identity</strong></td>\n<td><strong>Gender Identity</strong></td>\n<td><strong>Gender Role</strong></td>\n</tr>\n<tr>\n<td>\n<div>A person’s<strong> biological </strong>sexual characters</div>\n</td>\n<td>\n<div>A person’s <strong>sense or feeling&nbsp;</strong>of maleness or femaleness</div>\n</td>\n<td>\n<div><strong>Acts</strong> which someone does to <strong>establish</strong> their <strong>status</strong> as a male or a female</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Determined <strong>at birth</strong></div>\n</td>\n<td>\n<div>Not present at birth&nbsp;</div>\n<div>(Established at 2-3 years of age)</div>\n</td>\n<td>\n<div>Not present at birth</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Based on <strong>chromosomes</strong>, gonads, genitalia, and secondary sexual characters</div>\n</td>\n<td>\n<div>Based on <strong>clues</strong>&nbsp;<strong>from experience</strong> with people</div>\n<div>&nbsp;</div>\n</td>\n<td>\n<div>Based on experience,</div>\n<div><strong>instructions and inculcation</strong> from others</div>\n<div>&nbsp;</div>\n</td>\n</tr>\n</tbody>\n</table>\n<div>&nbsp;</div></div><!---->\n      <!---->\n    </div><!---->'),
(1546, 'Psychiatry', 'PM0557. Sexual disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Phase</strong></span></div>\n</td>\n<td>\n<div><span><strong>Characteristics</strong></span></div>\n</td>\n<td>\n<div><span><strong>Disorder</strong></span></div>\n</td>\n<td>\n<div><span><strong>Treatment</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Desire</strong></span></div>\n</td>\n<td>\n<div><span>Focuses on the patients drives, motivation, and desires</span></div>\n</td>\n<td>\n<div><span><strong>Hypoactive sexual desire</strong>: Patients have a decrease or absence of sexual fantasies, desires, etc</span></div>\n<div>&nbsp;</div>\n<div><span><strong>Sexual aversion</strong>: A complete aversion to all sexual contact</span></div>\n</td>\n<td>\n<div><span>Address issues like feelings of guilt, poor self-esteem, homosexual impulses, etc</span></div>\n<div>&nbsp;</div>\n<div><span>Couples therapy may be indicated if due to marital conflict</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Arousal</strong></span></div>\n</td>\n<td>\n<div><span>Consists of a sense of sexual pleasure with accompanying physiologic changes</span></div>\n</td>\n<td>\n<div><span><strong>Female sexual arousal disorder:</strong> Persistent failure to achieve or maintain sufficient sexual interest or arousal&nbsp;during the sexual act</span></div>\n<div><span>&nbsp;</span></div>\n<div><span><strong>Impotence:</strong> Persistent or recurrent inability to attain or maintain an adequate erection until completion of the sexual act</span></div>\n</td>\n<td>\n<div><span>Address issues like guilt, anxiety, and fear</span></div>\n<div>&nbsp;</div>\n<div><span>Check for use of medications that cause vaginal dryness, like antihistamines or anticholinergics</span></div>\n<div>&nbsp;</div>\n<div><span>Relaxation techniques.</span></div>\n<div>&nbsp;</div>\n<div><span>Determine if organic or psychological.</span></div>\n<div>&nbsp;</div>\n<div><span>Consider plethysmography or postage stamp test</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Orgasm</strong></span></div>\n</td>\n<td>\n<div><span>Physiologic state in which sexual tension is released and contractions are produced in various organs</span></div>\n</td>\n<td>\n<div><span><strong>Female orgasmic disorder and delayed ejaculation:</strong> Recurrent or persistent inability to achieve orgasm either through masturbation or sexual intercourse</span></div>\n<div><span>&nbsp;</span></div>\n<div><span><strong>Premature ejaculation:</strong> Ejaculation before the man wishes to do so, before penetration or just after penetration</span></div>\n</td>\n<td>\n<p><span>Address issues of guilt, fear of impregnation, etc</span></p>\n<p><span>Use vibrators, education, and fantasy</span></p>\n<p><span>Behavioral techniques such as squeeze and stop-and-go</span></p>\n<p><span>Address issues of anxiety about the sexual act</span></p>\n<p><span>SSRIs to delay ejaculation</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Pain</strong></span></div>\n</td>\n<td>\n<div><span>Subjective sense of pain associated with the sexual act. Most likely due to dynamic factors</span></div>\n</td>\n<td>\n<div><span><strong>Genito-pelvic pain disorder:</strong> Pain associated with sexual intercourse in either male or female. Not diagnosed when the organic cause has been found or if due to vaginal lubrication.</span></div>\n<div><span>&nbsp;</span></div>\n<div><span><strong>Penetration disorder:</strong> Involuntary constriction of the outer one-third of the vagina that interferes with the sexual act.</span></div>\n</td>\n<td>\n<p><span>Help with issues of anxiety and tension about the sexual act</span></p>\n<p><span>Behavioral techniques, such as the use of dilators and relaxation</span></p>\n<p><span>Address issues of fear of impregnation, strict upbringing, religion, etc</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1547, 'Psychiatry', 'PM2342. Autism Spectrum Disorder', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>&nbsp;</strong></span></td>\n<td><span><strong>Autism</strong></span></td>\n<td><span><strong>Rett syndrome</strong></span></td>\n<td><span><strong>Asperger syndrome</strong></span></td>\n<td><span><strong>Heller syndrome</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Onset</strong></span></td>\n<td><span>Before 3 years</span></td>\n<td><span>After 5 months</span></td>\n<td><span>After 3 years</span></td>\n<td><span>After 2 years</span></td>\n</tr>\n<tr>\n<td><span><strong>Gender predilection</strong></span></td>\n<td><span>Boys</span></td>\n<td><span>Girls</span></td>\n<td><span>Boys</span></td>\n<td><span>Boys</span></td>\n</tr>\n<tr>\n<td><span><strong>Intellectual disability</strong></span></td>\n<td><span>Present in 30% of the cases</span></td>\n<td><span>Present</span></td>\n<td><span>Absent</span></td>\n<td><span>Present</span></td>\n</tr>\n<tr>\n<td><span><strong>Language</strong></span></td>\n<td><span>Mostly poor</span></td>\n<td><span>Mostly poor</span></td>\n<td><span>Normal</span></td>\n<td><span>Mostly poor</span></td>\n</tr>\n<tr>\n<td><span><strong>Remarks</strong></span></td>\n<td><span>---</span></td>\n<td>\n<p><span>Normal head circumference at birth.</span></p>\n<p><span>Regression of milestones</span></p>\n</td>\n<td><span>---</span></td>\n<td>\n<p><span>Normal head circumference at birth.</span></p>\n<p><span>Regression of milestones</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0fd179d1aaa7421ab241484cc63a4038x1279x1336.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>NOTE</strong>: Retts syndrome has been removed from DSM-5 because it was found to have a clear genetic basis.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span>&nbsp;</span></td>\n<td>\n<div><span><strong>DSM - 4</strong></span></div>\n</td>\n<td>\n<div><span><strong>DSM - 5</strong></span></div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Change in Classification&nbsp;</strong></span></td>\n<td>\n<div><span>Pervasive Developmental disorders</span></div>\n</td>\n<td>\n<div><span>Autistic Spectrum Disorder</span></div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Number of Domains</strong>&nbsp;</span></td>\n<td>\n<div><span>3 domains</span></div>\n</td>\n<td>\n<div><span>2 domains</span></div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Impairment in social interaction and communication</strong>&nbsp;</span></td>\n<td>\n<div>\n<div><span>&nbsp;</span></div>\n<div>\n<ul>\n<li>\n<p><span>Delay or total lack of development of spoken language</span></p>\n</li>\n<li>\n<p><span>Stereotyped and repetitive use of language</span></p>\n</li>\n<li>\n<p><span>Impairment in the use of multiple nonverbal behaviors</span></p>\n</li>\n<li>\n<p><span>Failure to develop peer relationships</span></p>\n</li>\n<li><span>Lack of social or emotional reciprocity</span></li>\n</ul>\n</div>\n</div>\n<div><span>&nbsp;</span></div>\n</td>\n<td>\n<div><span>&nbsp;</span></div>\n<div>\n<ul>\n<li>\n<p><span>Deficits in nonverbal communicative behaviors</span></p>\n</li>\n<li>\n<p><span>Deficits in developing, maintaining, and understanding relationships</span></p>\n</li>\n<li><span>Deficits in social-emotional reciprocity&nbsp;</span></li>\n</ul>\n</div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Repetitive and restricted</strong><br><strong>interests/behaviors</strong>&nbsp;</span></td>\n<td>\n<div><span>&nbsp;</span></div>\n<div>\n<ul>\n<li><span>Stereotyped and repetitive motor mannerisms</span></li>\n<li>\n<p><span>Inflexible adherence to specific, nonfunctional routines</span></p>\n</li>\n<li>\n<p><span>Persistent preoccupation with parts of an object</span></p>\n</li>\n</ul>\n</div>\n</td>\n<td>\n<div>\n<div><span>&nbsp;</span></div>\n<div>\n<ul>\n<li>\n<p><span>Stereotyped or repetitive motor movements</span></p>\n</li>\n<li>\n<p><span>Insistence on sameness, inflexible adherence to routines</span></p>\n</li>\n<li>\n<p><span>Highly restricted, fixated interests.</span></p>\n</li>\n<li>\n<p><span>Hyper- or hyporeactivity to sensory input</span></p>\n</li>\n</ul>\n</div>\n<span>&nbsp;</span></div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1548, 'Psychiatry', 'PM2030. Speech sound disorder Vs Neurological/Structural dysarthria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Criteria</strong></td>\n<td><strong>Neurological/ Structural Dysarthria</strong></td>\n<td><strong>Speech Sound Disorder</strong></td>\n</tr>\n<tr>\n<td><strong>Language development</strong></td>\n<td>Within normal limits</td>\n<td>Within normal limits</td>\n</tr>\n<tr>\n<td><strong>Examination</strong></td>\n<td>\n<p>Possible abnormalities of lips, tongue, or palate</p>\n<p>Muscular weakness</p>\n<p>Incoordination</p>\n<p>Disturbance of vegetative functions</p>\n</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td><strong>Rate of speech</strong></td>\n<td>Slow</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td><strong>Phonemes affected</strong></td>\n<td>Any phonemes</td>\n<td>r, sh, th, ch, dg, j, f, v, s, and z are most commonly affected</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1549, 'Radiology', 'PM0645. Investigation of choice in Neurology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Generally, <strong>MRI</strong> is considered the best imaging for the&nbsp;<strong>spinal cord and nerves</strong>.</p>\n<p>Conditions in which MRI is used include:</p>\n<ul>\n<li>Optic neuritis</li>\n<li>Vestibular schwannoma</li>\n<li>Multiple sclerosis</li>\n<li>Pituitary adenoma</li>\n<li>Spinal cord tumor</li>\n<li>Neurofibroma</li>\n<li>Viral encephalitis</li>\n<li>Hippocampal volumetry.</li>\n</ul>\n<p><strong>CT scan</strong> is preferred when the timing is critical. So, the investigation of choice for stroke is an <strong>NCCT</strong>. This helps to rule out <strong>hemorrhagic stroke</strong>.</p>\n<p>The investigation of choice for <strong>ischemic stroke</strong> is a <strong>diffusion-weighted MRI</strong>.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1550, 'Radiology', 'PM2501. Radionuclide agent and its uses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Radionuclide agent</strong></p>\n</td>\n<td>\n<p><strong>Use</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Medronate (MDP) (most common)</p>\n<p>Tc-99m Oxidronate (HMDP)</p>\n<p>Tc-99m HEDP</p>\n</td>\n<td>\n<p>Bone imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Apcitide</p>\n</td>\n<td>\n<p>Peptide imaging of DVT</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Arcitumomab</p>\n</td>\n<td>\n<p>Monoclonal antibody for colorectal cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m albumin colloid</p>\n</td>\n<td>\n<p>Imaging of RES (liver/spleen)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m bicisate (ECD)</p>\n<p>Tc-99m exametazine (HMPAO</p>\n</td>\n<td>\n<p>Cerebral perfusion imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Depreotide</p>\n</td>\n<td>\n<p>Somatostatin receptor-bearing pulmonary masses</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m disofenin (DISIDA)</p>\n</td>\n<td>\n<p>Hepatobiliary imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Glucepatate</p>\n<p>Tc-99m Meriatide</p>\n<p>Tc-99m Succimer (DMSA)</p>\n</td>\n<td>\n<p>Renal imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Human Serum Albumin(HAS)</p>\n</td>\n<td>\n<p>Imaging of cardiac chambers</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Lidofenin (HIDA)</p>\n<p>Tc-99m Mebrofenin</p>\n</td>\n<td>\n<p>Hepatobiliary imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m nofetumomab Merpentan NR-LU-10</p>\n</td>\n<td>\n<p>Monoclonal antibody Fab fragment for imaging small cell lung cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Pentetate (DTPA)</p>\n</td>\n<td>\n<p>Renal imaging and functional studies; radioaerosol ventilation imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Pyrophosphate (PYP)</p>\n</td>\n<td>\n<p>Avid infarct imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Red Blood Cells (RBCs)</p>\n</td>\n<td>\n<p>Imaging of GI bleeds, cardiac chambers</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Sestamibi</p>\n</td>\n<td>\n<p>Myocardial perfusion imaging; breast tumor imaging, parathyroid gland</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Sulfur colloid (SC)</p>\n</td>\n<td>\n<p>Imaging of RES( liver/spleen), gastric emptying, GI bleeds</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Teboroxime</p>\n<p>Tc-99m Tetrofosmin</p>\n</td>\n<td>\n<p>Myocardial perfusion imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><sup>68</sup>Gallium</p>\n</td>\n<td>\n<p>Binds to somatostatin receptors</p>\n<p>Detection of new neuroendocrine tumors</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1551, 'Radiology', 'PM2500. Radionuclide agent and its uses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Radionuclide agent</strong></p>\n</td>\n<td>\n<p><strong>Use</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Medronate (MDP) (most common)</p>\n<p>Tc-99m Oxidronate (HMDP)</p>\n<p>Tc-99m HEDP</p>\n</td>\n<td>\n<p>Bone imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Apcitide</p>\n</td>\n<td>\n<p>Peptide imaging of DVT</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Arcitumomab</p>\n</td>\n<td>\n<p>Monoclonal antibody for colorectal cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m albumin colloid</p>\n</td>\n<td>\n<p>Imaging of RES (liver/spleen)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m bicisate (ECD)</p>\n<p>Tc-99m exametazine (HMPAO</p>\n</td>\n<td>\n<p>Cerebral perfusion imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Depreotide</p>\n</td>\n<td>\n<p>Somatostatin receptor-bearing pulmonary masses</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m disofenin (DISIDA)</p>\n</td>\n<td>\n<p>Hepatobiliary imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Glucepatate</p>\n<p>Tc-99m Meriatide</p>\n<p>Tc-99m Succimer (DMSA)</p>\n</td>\n<td>\n<p>Renal imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Human Serum Albumin(HAS)</p>\n</td>\n<td>\n<p>Imaging of cardiac chambers</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Lidofenin (HIDA)</p>\n<p>Tc-99m Mebrofenin</p>\n</td>\n<td>\n<p>Hepatobiliary imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m nofetumomab Merpentan NR-LU-10</p>\n</td>\n<td>\n<p>Monoclonal antibody Fab fragment for imaging small cell lung cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Pentetate (DTPA)</p>\n</td>\n<td>\n<p>Renal imaging and functional studies; radioaerosol ventilation imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Pyrophosphate (PYP)</p>\n</td>\n<td>\n<p>Avid infarct imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Red Blood Cells (RBCs)</p>\n</td>\n<td>\n<p>Imaging of GI bleeds, cardiac chambers</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Sestamibi</p>\n</td>\n<td>\n<p>Myocardial perfusion imaging; breast tumor imaging, parathyroid gland</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Sulfur colloid (SC)</p>\n</td>\n<td>\n<p>Imaging of RES( liver/spleen), gastric emptying, GI bleeds</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Teboroxime</p>\n<p>Tc-99m Tetrofosmin</p>\n</td>\n<td>\n<p>Myocardial perfusion imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><sup>68</sup>Gallium</p>\n</td>\n<td>\n<p>Binds to somatostatin receptors</p>\n<p>Detection of new neuroendocrine tumors</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1552, 'Radiology', 'PM2380. Classification of iodinated contrast medias:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span>&nbsp;</span></td>\n<td colspan=\4\><span><strong>Iodinated contrast materials&nbsp;&nbsp;</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Types</strong></span></td>\n<td colspan=\2\><span>Ionic&nbsp;</span></td>\n<td colspan=\2\><span>Non-ionic</span></td>\n</tr>\n<tr>\n<td><span><strong>Subtypes&nbsp;</strong></span></td>\n<td><span>Monomer</span></td>\n<td><span>Dimer</span></td>\n<td><span>Monomer</span></td>\n<td><span>Dimer</span></td>\n</tr>\n<tr>\n<td><span><strong>Osmolarity</strong></span></td>\n<td>\n<p><span>1400- 1600 mOsm <span>(Not preferred due to high osmolarity)</span></span></p>\n</td>\n<td><span>600- 800 mOsm</span></td>\n<td><span>600- 800 mOsm</span></td>\n<td><span>300 mOsm</span></td>\n</tr>\n<tr>\n<td><span><strong>Iodine: particle ratio</strong></span></td>\n<td><span>3:2</span></td>\n<td><span>6:2 or 3:1</span></td>\n<td><span>3:1</span></td>\n<td><span>6:1</span></td>\n</tr>\n<tr>\n<td><span><strong>Examples&nbsp;</strong></span></td>\n<td>\n<p><span>Diatrizoate <span>(Urograffin)</span></span></p>\n<p><span>Iothalamate</span></p>\n</td>\n<td>\n<p><span>Ioxaglate</span></p>\n</td>\n<td>\n<p><span>Iohexol <span>(most commonly used</span></span><span>)</span></p>\n<p><span>Ioversol</span></p>\n<p><span>Iopamidol</span></p>\n</td>\n<td>\n<p><span>Iodixanol</span></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1553, 'Radiology', 'PM0644. T1 vs T2 MRI', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Structure</strong></div>\n</td>\n<td>\n<div><strong>T1 image</strong></div>\n</td>\n<td>\n<div><strong>T2 image</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Grey matter</strong></div>\n</td>\n<td>\n<div>Darker</div>\n</td>\n<td>Lighter</td>\n</tr>\n<tr>\n<td>\n<div><strong>White matter</strong></div>\n</td>\n<td>Lighter&nbsp;</td>\n<td>Darker</td>\n</tr>\n<tr>\n<td>\n<div><strong>CSF/ Fluids</strong></div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n<td>\n<div>Bright</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Fat</strong></div>\n</td>\n<td>\n<div>White</div>\n</td>\n<td>\n<div>Less white</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Air</strong></div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Cortical bone</strong></div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Tendons and ligaments</strong></div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Calcification</strong></div>\n</td>\n<td>Variable</td>\n<td>\n<div>Dark</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Flowing blood and hemosiderin</strong></div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n<td>\n<div>Dark</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1554, 'Radiology', 'PM0283. Radionuclide agents and their uses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Radionuclide agent</strong></p>\n</td>\n<td>\n<p><strong>Use</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Medronate (MDP) (most common)</p>\n<p>Tc-99m Oxidronate (HMDP)</p>\n<p>Tc-99m HEDP</p>\n</td>\n<td>\n<p>Bone imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Apcitide</p>\n</td>\n<td>\n<p>Peptide imaging of DVT</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Arcitumomab</p>\n</td>\n<td>\n<p>Monoclonal antibody for colorectal cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m albumin colloid</p>\n</td>\n<td>\n<p>Imaging of RES (liver/spleen)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m bicisate (ECD)</p>\n<p>Tc-99m exametazine (HMPAO</p>\n</td>\n<td>\n<p>Cerebral perfusion imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Depreotide</p>\n</td>\n<td>\n<p>Somatostatin receptor-bearing pulmonary masses</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m disofenin (DISIDA)</p>\n</td>\n<td>\n<p>Hepatobiliary imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Glucepatate</p>\n<p>Tc-99m Meriatide</p>\n<p>Tc-99m Succimer (DMSA)</p>\n</td>\n<td>\n<p>Renal imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Human Serum Albumin(HAS)</p>\n</td>\n<td>\n<p>Imaging of cardiac chambers</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Lidofenin (HIDA)</p>\n<p>Tc-99m Mebrofenin</p>\n</td>\n<td>\n<p>Hepatobiliary imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m nofetumomab Merpentan NR-LU-10</p>\n</td>\n<td>\n<p>Monoclonal antibody Fab fragment for imaging small cell lung cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Pentetate (DTPA)</p>\n</td>\n<td>\n<p>Renal imaging and functional studies; radioaerosol ventilation imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Pyrophosphate (PYP)</p>\n</td>\n<td>\n<p>Avid infarct imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Red Blood Cells (RBCs)</p>\n</td>\n<td>\n<p>Imaging of GI bleeds, cardiac chambers</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Sestamibi</p>\n</td>\n<td>\n<p>Myocardial perfusion imaging; breast tumor imaging, parathyroid gland</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Sulfur colloid (SC)</p>\n</td>\n<td>\n<p>Imaging of RES( liver/spleen), gastric emptying, GI bleeds</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Teboroxime</p>\n<p>Tc-99m Tetrofosmin</p>\n</td>\n<td>\n<p>Myocardial perfusion imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><sup>68</sup>Gallium</p>\n</td>\n<td>\n<p>Binds to somatostatin receptors</p>\n<p>Detection of new neuroendocrine tumors</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1555, 'Radiology', 'PM0048. Radioprotectors and Radiosensitizers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Radioprotectors</strong>:</p>\n<p>Radioprotectors are substances that protect normal tissues from the effect of radiation. These include:</p>\n<ul>\n<li>Zinc oxide</li>\n<li>Pentoxifylline</li>\n<li>Estramustine</li>\n<li>Amifostine</li>\n<li>Chlorhexidine (radiation-induced stomatitis)</li>\n<li>Potassium iodide (for thyroid against radioactive iodine)</li>\n<li>Melatonin</li>\n<li>Antioxidants</li>\n</ul>\n<p><strong>Radiosensitizers</strong>:</p>\n<p>Radiosensitizers make the tumor more susceptible to the action of radiotherapy. These include:</p>\n<ul>\n<li>Oxygen</li>\n<li>Cisplatin</li>\n<li>5 FU</li>\n<li>Gemcitabine</li>\n<li>Nitroimidazoles</li>\n</ul>\n<p><strong>Radiation potentiators</strong>:</p>\n<p>The following drugs potentiate the action of radiation when used in conjunction:&nbsp;</p>\n<ul>\n<li>Doxorubicin</li>\n<li>Dactinomycin</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1556, 'Radiology', 'PM0047. Important SI units for radiation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Quantity measured</strong></td>\n<td><strong>Old unit</strong></td>\n<td><strong>New Unit</strong></td>\n<td><strong>Conversion</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td><strong>Radioactivity</strong></td>\n<td>Curie</td>\n<td>Becquerel</td>\n<td>1 curie = 3.7 x 10<sup>10 </sup>becquerel</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Radiation exposure</strong></td>\n<td>Roentgen</td>\n<td>Coulumb/kg</td>\n<td>1 roentgen = 2.58 × 10<sup>-4&nbsp;</sup>C/Kg</td>\n<td>Amount of radiation absorbed in air. &nbsp;</td>\n</tr>\n<tr>\n<td><strong>Absorbed dose</strong></td>\n<td>Rad</td>\n<td>Gray (Gy)</td>\n<td>100 rad = 1 gray (or, 1 rad = 0.01 gray)</td>\n<td>&nbsp;Amount of radioactive energy absorbed per unit gram of tissue or material.</td>\n</tr>\n<tr>\n<td><strong>Dose equivalent</strong></td>\n<td>Rem</td>\n<td>Sievert (Sv)</td>\n<td>100 rem = 1 sievert</td>\n<td>&nbsp;Indicates potential danger to health.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1557, 'Radiology', 'PM0045. Ionising and penetrating ability of radiation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Penetration power</strong>: Gamma rays &gt; X-rays &gt; Beta particle &gt; Alpha particle (helium ion)</li>\n<li><strong>Ionising or tissue damaging ability</strong>: Alpha particle (helium ion) &gt; Beta particle &gt; X-ray &gt; Gamma ray</li>\n<li>Alpha waves have the <strong>highest molecular mass</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cf6ccc6f20ed4ebe82d52753f65929a6x260x817.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1558, 'Obstetrics & Gynaecology,', 'PM2262. Radiological Signs in Obstetrics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Bagel Sign</strong> (USG)</p>\n<p>It is seen in <strong>unruptured tubal ectopic pregnancy</strong>. It is also known as the <strong>tubal ring sign</strong> or the <strong>blob sign</strong>. It refers to the appearance of an anechoic gestational sac in the adnexa surrounded by a hyperechoic ring.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/65667801a0fb450ab1af9a1939e7ff8dx1280x1432.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Twin Peak Sign/ Lambda Sign</strong> (USG)</p>\n<p>Chorionicity of the placenta is best diagnosed by ultrasound at 10–13 weeks of gestation. In <strong>dichorionic twins</strong>, there is a thick triangular projection of placental tissue between the two gestational sacs. This is known as the lambda sign or twin peak sign.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/96f08dd9f0fa4fc694291835f3cd15b3x510x432.GIF\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>T Sign</strong> (USG)</p>\n<p>The T sign which is seen in <strong>monochorionic diamniotic gestation</strong> is thin and T-shaped because there is no extension of placental tissue or chorion in between the amniotic membranes.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8c59f243f5294b64ac000021835b7b5fx510x396.GIF\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Double Decidual Sac Sign</strong> (USG)</p>\n<p>It is seen in <strong>early intrauterine pregnancy</strong> as two concentric echogenic rings surrounding the gestational sac.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/41b99e48f08c46fbb6bafdd542c1891dx1280x955.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Lemon Sign</strong> (USG)</p>\n<p>At the level of the lateral ventricles, there is<strong> inward bowing or scalloping of frontal bones</strong>&nbsp;giving rise to the lemon sign. It is suggestive of <strong>spina bifida</strong>. It is also characteristically associated with <strong>Chiari II Malformation</strong>.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0ef0a805761c4ec987831c7a0197d01cx510x418.GIF\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Banana Sign</strong> (USG)</p>\n<p>Anterior curvature of the<strong> cerebellum</strong> with effacement of the <strong>cisterna magna</strong> in the posterior fossa is seen as banana sign.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5e04c4b1c58a44258a37864e5518899ax510x354.GIF\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Spalding sign</strong> (USG)</p>\n<p>It usually appears 7 days after <strong>intrauterine death</strong> and is caused by liquefaction of the brain matter and softening of the ligamentous structures supporting the vault, leading to<strong> irregular overlapping of the cranial bones</strong> on one another.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0eef8c33a1a143e38b966f4ec038a545x1076x711.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Frog Eye Sign</strong> (USG)</p>\n<p>It is seen in <strong>anencephaly</strong>. Due to the absence of calvaria, the <strong>orbits appear more prominent</strong>. This is known as the \frog-eye sign\.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/972403fa3d0e48a08e561ff4310101acx510x620.GIF\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Omphalocele</strong> (USG)</p>\n<p>It is a <strong>congenital midline abdominal wall defect</strong> at the base of the umbilical cord insertion, with <strong>herniation</strong> of the solid abdominal viscera and/or bowel out of the fetal abdomen&nbsp; (indicated with an asterisk). The extruded abdominal contents are <strong>covered in a sac</strong>.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/96660889c8b34a0f89ee373ebdb60f40x1280x1040.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Double Bubble Sign</strong> (USG)</p>\n<p>Dilatation of stomach and first part of duodenum due to <strong>duodenal atresia</strong>.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/91de267cb9594cb6ba98e16f4495780fx443x490.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><span><strong>Bunch of grapes sign&nbsp;</strong>or&nbsp;<strong>Snowstorm appearance&nbsp;</strong>(USG)&nbsp;</span></p>\n<p><span>The appearance of multiple cystic spaces or lesions in a <strong>complete mole</strong>.</span></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6353c90095d1471696dac8fa7bd2a3b3x676x568.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Ball sign</strong> (X-ray)</p>\n<p>It is due to the <strong>crumpled up spine</strong> of the fetus seen in case of <strong>intrauterine death</strong>.</p>\n<p>&nbsp;</p>\n<p><strong>Robert’s sign</strong> (X-ray)</p>\n<p>The presence of <strong>gas in the fetal great vessels</strong> in case of<strong> intrauterine fetal demise</strong> is known as Roberts sign.</p>\n<p>&nbsp;</p>\n<p><strong>Stuck twin sign</strong> (USG)</p>\n<p>Smaller twin is held in a fixed position along the uterine wall due to the severe oligohydramnios. It is seen in <strong>twin-twin transfusion syndrome</strong>.</p>\n<p>&nbsp;</p>\n<p><span><strong>Butterfly sign&nbsp;</strong>(USG)</span></p>\n<p><span>Normal appearance of the choroid plexuses on axial imaging of the fetal brain. An<strong> absence</strong>&nbsp;of this sign suggests <strong>holoprosencephaly</strong>.</span></p>\n<p>&nbsp;</p>\n<p><span><strong>Cloverleaf skull&nbsp;</strong>(USG)</span></p>\n<p><span>Seen in <strong>craniosynostosis</strong></span></p>\n<p>&nbsp;</p>\n<p><span><strong>Empty amnion sign&nbsp;</strong>(USG)</span></p>\n<p><span>Visualization of an amniotic sac without concomitant visualization of an embryo. It is an indicator of <strong>pregnancy failure</strong>.</span></p></div><!---->\n      <!---->\n    </div><!---->'),
(1559, 'Radiology,', 'PM2134. Congenital diaphragmatic hernias (CDH)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 959\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<div class=\page\ title=\Page 1892\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<div class=\page\ title=\Page 1892\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>It is due to<strong>&nbsp;</strong>the <strong>failure of the closure of the pleuroperitoneal canal</strong> in the developing fetus (Normally the pleuroperitoneal cavities separate by 8-10 weeks of gestation). <strong>Left-sided </strong>hernias are<strong>&nbsp;</strong>more <strong>common</strong>(80%).</p>\n<p>The two well-recognized congenital sites where abdominal viscera can herniate into the chest are:</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<ul>\n<li><strong>The foramen of Morgagni</strong>: a hernia in the <strong>anteromedial</strong>&nbsp;part of the diaphragm with a defect between the sternal and costal attachments. The most commonly involved viscus is the <strong>transverse colon.</strong></li>\n<li><strong>The foramen of Bochdalek</strong>: through the dome of the diaphragm<strong> posterolaterally</strong></li>\n</ul>\n<p>CDH causes <strong>pulmonary hypoplasia (bilateral) </strong>by compressing the developing lung. These lungs have smaller bronchi, with less bronchial branching and less alveolar surface area than lungs in normal infants. Pulmonary hypertension may also develop due to increased thickness of arteriolar smooth muscle and also by&nbsp;multiple local and systemic vasoactive factors.</p>\n<p><strong>Clinical features:</strong></p>\n<div class=\page\ title=\Page 1892\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li>respiratory distress at birth</li>\n<li>grunting respiration</li>\n<li>chest retractions</li>\n<li>dyspnea</li>\n<li>cyanosis</li>\n<li>scaphoid abdomen</li>\n<li>decreased breath sounds along with bowel sound over the chest with CDH</li>\n<li>shifting of heart sounds to the right (for left-sided CDH)</li>\n</ul>\n<div class=\section\>&nbsp;</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f4f1fdad64d24053b439a528cf873989x1280x1660.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1560, 'Radiology,', 'PM1988. Causes of lytic lesions in the skull', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Eosinophilic granuloma (geographic lytic lesions in the vault of skull with beveled edges)</li>\n<li>Multiple myeloma (punched out lytic lesion)</li>\n<li>Langerhans Cell Histiocytosis (permeative lesions)</li>\n<li>Hyperparathyroidism (salt and pepper skull)</li>\n<li>Metastasis</li>\n<li>Lymphoma</li>\n<li>Tuberculosis&nbsp;</li>\n<li>Osteomyelitis&nbsp;</li>\n<li>Radiation&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1561, 'Radiology,', 'PM1960. Radiological Features of Scurvy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Radiological features of scurvy:</p>\n<ul>\n<li>Generalised osteopenia</li>\n<li><strong>Pencil-point cortex</strong>: Cortical thinning</li>\n<li><strong>Periosteal</strong> <strong>reaction</strong> due to subperiosteal hemorrhage</li>\n<li><strong>Scorbutic rosary</strong>: Expansion of the costochondral junctions</li>\n<li><strong>Hemarthrosis</strong></li>\n<li><strong>Wimberger</strong> <strong>ring</strong>: Circular, opaque radiological shadow surrounding epiphyseal centers of ossification, which may result from bleeding</li>\n<li><strong>Frenkel line</strong>: Dense zone of provisional calcification&nbsp;</li>\n<li><strong>Trummerfeld</strong> <strong>zone</strong>: Lucent metaphyseal band underlying Frankel line</li>\n<li><strong>Pelken spur</strong>: Metaphyseal spurs which result in cupping of the metaphysis</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/78592172dff84017a824c47084b3f181x1024x906.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1562, 'Radiology,', 'PM1959. Radiological Features of Rickets', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Radiological features of rickets:</p>\n<ul>\n<li><strong>Loss of provisional zone of calcification: </strong>earliest radiological finding of rickets.&nbsp;</li>\n<li>Delayed appearance of the epiphysis</li>\n<li><strong>Widening of growth plate:&nbsp;</strong>normal width of growth is 2-4mm. It is increased in cases of rickets due to excessive accumulation of uncalcified osteoid at the growth plate.</li>\n<li><strong>Cupping of metaphysis:&nbsp;</strong>normally metaphysis meets epiphysis as a smooth line of sclerosis. But in rickets the line is absent and the metaphyseal ends appear irregular and the cartilage accumulating in the growth plate creates a depression in the metaphysis causing cupping.</li>\n<li><strong>Fraying</strong>:&nbsp;indistinct margins of the metaphysis</li>\n<li><strong>Bowing of diaphysis,&nbsp;</strong>with thinning of cortices</li>\n<li>In healing rickets, zone of calcification becomes denser.&nbsp;</li>\n</ul>\n<p>The above features are prominent at the growth plates where growth is greatest:</p>\n<ul>\n<li>Knee: distal femur, proximal tibia</li>\n<li>Wrist: especially the ulna</li>\n<li>Anterior rib ends: <strong>rachitic rosary</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3fb9e16daa324d32bc69ad013a616401x1280x1694.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The below image shows bowing of legs in rickets.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2540c743846448f9a7b302483397230ax256x406.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1563, 'Radiology,', 'PM1910. Classical Radiological Appearance of Bone Tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>RADIOLOGICAL APPEARANCE&nbsp;</strong></td>\n<td>\n<p><strong>TUMORS</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sunray appearance / Codman’s triangle</p>\n</td>\n<td>\n<p>Osteosarcoma (but can be seen in any malignant lesion)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Onion peel appearance&nbsp;</p>\n</td>\n<td>\n<p>Ewing’s sarcoma (but can be seen in any malignant lesion or chronic osteomyelitis)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Soap bubble appearance&nbsp;</p>\n</td>\n<td>\n<p>Giant cell tumor, adamantinoma&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ground glass appearance / Shepherds</p>\n<p>crook deformity&nbsp;</p>\n</td>\n<td>\n<p>Fibrous dysplasia&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Patchy calcification&nbsp;</p>\n</td>\n<td>\n<p>Chondrogenic tumors (chondrosarcoma and chondroblastoma)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Popcorn, punctate or comma-shaped calcification</p>\n</td>\n<td>\n<p>Chondrosarcoma&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stippled or Punctate calcification</p>\n</td>\n<td>\n<p>Chondroblastoma&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homogeneous calcification&nbsp;</p>\n</td>\n<td>\n<p>Osteogenic tumors (osteosarcoma)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fallen fragment / Trap door sign</p>\n</td>\n<td>\n<p>Simple bone cyst</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Double-density fluid levels and intra-lesional septation</p>\n</td>\n<td>\n<p>Aneurysmal bone cyst</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Winking owl sign</p>\n</td>\n<td>\n<p>Vertebral metastasis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Polka dot sign / Corduroy / Jailhouse sign</p>\n</td>\n<td>\n<p>Vertebral hemangioma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Moth eaten bone</p>\n</td>\n<td>\n<p>Multiple myeloma</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1564, 'Radiology,', 'PM1831. BIRADS - Breast Imaging Reporting and Data System', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Breast Imaging Reporting and Data System <strong>(BI-RADS)</strong> standardizes the reporting for mammography and ultrasonography and helps guide decision making:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Category</strong></td>\n<td><strong>Definition</strong></td>\n<td><strong>% Chances of Malignancy</strong></td>\n<td><strong>Follow-up</strong></td>\n</tr>\n<tr>\n<td>0</td>\n<td>Incomplete assessment</td>\n<td>Not applicable</td>\n<td>Additional imaging evaluation</td>\n</tr>\n<tr>\n<td>1</td>\n<td>Negative</td>\n<td>Essentially 0%</td>\n<td>Annual screening</td>\n</tr>\n<tr>\n<td>2</td>\n<td>Benign finding</td>\n<td>Essentially 0%</td>\n<td>Annual screening</td>\n</tr>\n<tr>\n<td>3</td>\n<td>Probably benign finding</td>\n<td>&gt;0% but ≤2%</td>\n<td>6 monthly mammograms for the next 2 years</td>\n</tr>\n<tr>\n<td>4\n<p>&nbsp;</p>\n</td>\n<td colspan=\2\>\n<p>4A: low level of suspicion for malignancy &gt;2% to ≤10%</p>\n<p>4B: moderate suspicion for malignancy &gt;10% to ≤50%</p>\n<p>4C: high suspicion for malignancy &gt;50% to &lt;95%</p>\n</td>\n<td>Biopsy</td>\n</tr>\n<tr>\n<td>5</td>\n<td>Highly suggestive of malignancy&nbsp;</td>\n<td>≥95%</td>\n<td>Appropriate action should be taken&nbsp;</td>\n</tr>\n<tr>\n<td>6</td>\n<td colspan=\2\>Known biopsy-proven malignancy</td>\n<td>Appropriate treatment</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1565, 'Radiology,', 'PM1827. Fetal Monitoring using Ultrasound', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul class=\ul1\>\n<li class=\li1\>The first definitive USG finding to suggest pregnancy is the visualization of the gestational sac.</li>\n<li class=\li1\>The first sign of intrauterine pregnancy is the presence of yolk sac within the gestational sac.</li>\n<li class=\li1\>Best time to assess gestational age by USG is 9-12 weeks(by CRL)</li>\n<li class=\li1\>CRL(mm)+42 = Days of pregnancy</li>\n<li class=\li1\>CRL(cm)+6.5 = Gestational age in weeks.</li>\n<li class=\li1\>The best indicator of fetal growth is the abdominal circumference.&nbsp;Abdominal circumference is the transverse measurement at the level of the stomach with the confluence of the umbilical vein and right portal vein.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1566, 'Surgery,', 'PM1804. Radiological findings in various GI disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Duodenal atresia:&nbsp;</strong>Double bubble sign</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a8e78c140797481eb09e4bcef9106cd8x720x910.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Jejunal and ileal atresia:&nbsp;</strong>Multiple air-fluid levels (plain erect X-ray abdomen) presenting as&nbsp;<strong>triple bubble sign.&nbsp;</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9513fa34bce3499088a9a4601ae434c4x834x1186.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Congenital hypertrophic pyloric stenosis: </strong>Single enlarged gastric gas bubble&nbsp;- <strong>single bubble</strong> sign</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/20dd99dfcb3e4ffa8728b296b69b5556x284x383.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Sigmoid volvulus:&nbsp;</strong>Coffee bean sign&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/81240b80138a476d8f5ca2b40d19c68bx490x600.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Achalasia cardia:&nbsp;</strong>Bird-beak sign</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/fdcc40d8b70549d4b0c489b623ab32c8x720x1526.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Small bowel obstruction</strong>: The obstructed bowel loops are central in location and show <strong>valvulae conniventes</strong> (mucosal folds that cross the entire diameter of the bowel) characteristic of jejunal involvement.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c32bbb60d2824af6b74fbd5585c9bb98x1279x1662.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Large bowel obstruction</strong>: The presence of <strong>haustrations</strong> is a feature of large bowel obstruction. Haustral folds are irregular and do not cross the entire diameter of the bowel. These are absent in the caecum.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6bf0090dbba54d08bf6d460f3f8c3a01x1279x1642.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Caecal volvulus</strong>: Presence of caecal dilatation, single air-fluid level extending into the left upper quadrant, and absence of gas in the distal colon. The colonic haustrations are well maintained.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cee8aa378b1148b198c0d8a7c9f23822x720x608.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Midgut volvulus</strong>: Corkscrew appearance showing the duodenum and jejunum spiraling around the mesenteric vessels in upper GI contrast studies.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/300e1080a96d4fe19194df39a503fef0x660x476.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Necrotizing enterocolitis (NEC)</strong>: Abdominal X-ray findings include pneumatosis intestinalis (air in the bowel wall).</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/13531a6af0434a64bf763df3a4c61fb8x479x600.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Cystic fibrosis</strong> (CF): Abdominal x-ray with contrast enema reveals a microcolon with several meconium plugs.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6d13f1689c1141ed93c2e447931546f0x512x683.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1567, 'Radiology', 'PM1737. Sites of normal intracranial calcification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Pineal gland</li>\n<li>Habenular commissure</li>\n<li>Choroid plexus</li>\n<li>The dura</li>\n<li>Ligaments (petroclinoid and interclinoid)</li>\n<li>Pacchionian bodies</li>\n<li>Basal ganglia - physiological only&nbsp;in a senile person</li>\n<li>Pituitary gland</li>\n<li>Arachnoid granulations</li>\n</ul>\n<p>NOTE: The lens (not intracranial) can also be seen as a calcified structure</p></div><!---->\n      <!---->\n    </div><!---->'),
(1568, 'Radiology', 'PM1733. Difference between Normal Radiography and Mammography', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Radiography</strong></td>\n<td><strong>Mammography</strong></td>\n</tr>\n<tr>\n<td><strong>Type of X rays</strong></td>\n<td>Bremsstrahlung reaction</td>\n<td>Characteristic radiation</td>\n</tr>\n<tr>\n<td><strong>Target</strong></td>\n<td>Tungsten</td>\n<td>Molybdenum</td>\n</tr>\n<tr>\n<td><strong>Exit Window</strong></td>\n<td>Glass</td>\n<td>Beryllium</td>\n</tr>\n<tr>\n<td><strong>Filter</strong></td>\n<td>Aluminum</td>\n<td>Molybdenum</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1569, 'Medicine,', 'PM1721. Radiological Signs of Hyperparathyroidism', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Rugger jersey spine</strong>: It refers to the prominent hyperdensities at the&nbsp;endplates of successive vertebrae, which mimics the striped&nbsp;appearance of a rugby jersey.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/666a460de5f9487294c804cd28a46d5bx720x1197.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Subperiosteal bone resorption</strong>: This is seen on the radial side of the proximal and middle phalanges of the index and middle fingers. It&nbsp;is the most consistent and specific finding of hyperparathyroidism and is virtually<strong> pathognomonic</strong> of the condition.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/49d4133d5b6e49a394882e929d8be212x1280x1246.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Brown tumors / Osteitis fribrosa cystica /&nbsp;Von Recklinghausens disease of bone</strong>: These are composed of pseudotumors that are made up of macrophages, blood, and connective tissue. They are seen as radiolytic areas due to the reduction in the bone trabeculae. &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/57436a7d9dac4a02a03a9d08d991b811x720x720.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Salt and pepper appearance of the skull</strong>:&nbsp; Refers to multiple tiny well-defined lucencies in the calvaria of the skull ( top part of the skull) due to resorption of the trabecular bone. Alternate areas of mineralization (salt-white) and decalcification (pepper-black)</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ea56ff526ee445e7ba55188fea556f7fx672x526.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Acral osteolysis</strong>: This is also known as the tufting of phalanges&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1570, 'Radiology,', 'PM1630. Radiological findings in Acute Pancreatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Radiographic findings of acute pancreatitis are non-specific.</p>\n<p>The&nbsp;<strong>sentinel loop</strong>&nbsp;is seen in an X-ray. It&nbsp;is a focal area of&nbsp;adynamic ileus&nbsp;close to an intra-abdominal inflammatory process. A sentinel loop in the upper abdomen indicates pancreatitis.</p>\n<p>The sentinel loop sign may aid in localizing the source of inflammation. For example, a sentinel loop in the upper abdomen may indicate pancreatitis, while one in the right lower quadrant may be due to appendicitis.</p>\n<p><strong>Colon cut-off sign:</strong> <strong>Functional spasm at the splenic flexure</strong> due to the extension of inflammation to phrenicocolic ligament via transverse mesocolon.</p>\n<p>The X-ray given below shows <strong>sentinel loop sign</strong>&nbsp;(marked as 1) and <strong>colon cut-off sign</strong>&nbsp;(marked as 2) in a patient with acute pancreatitis:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/51fba8412fcf4e6cba1d6b1304190a1ax1280x1503.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Renal halo sign:</strong>&nbsp;Edema around the kidney due to the involvement of paranephric fat resulting in:</p>\n<ul>\n<li>Obliteration of psoas shadow</li>\n<li>Localised ground-glass appearance</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1e91a2c0705b412da5c4e381216d902cx1280x1025.JPEG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1571, 'Radiology,', 'PM1520. Important radiological signs in OBG', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Sign</strong></span></div>\n</td>\n<td>\n<div><span><strong>Significance</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Bagel sign</strong></span></div>\n</td>\n<td>\n<div><span>Gestational sac in the adnexa with a hyperechoic ring.</span></div>\n<div><span>USG sign in <strong>tubal ectopic</strong>.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Ball Sign</strong></span></div>\n</td>\n<td>\n<div><span>X-ray shows a crumpled up spine of the fetus.</span></div>\n<div><span>Radiological sign of <strong>intrauterine fetal death</strong>.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Banana Sign</strong></span></div>\n</td>\n<td>\n<div><span>Abnormal anterior curvature of the cerebellum due to the associated <strong>Arnold-Chiari</strong> malformation.</span></div>\n<div><span>USG sign in <strong>open spina bifida</strong>.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Double decidual sac Sign</strong></span></div>\n</td>\n<td>\n<div><span>Two concentric echogenic rings separated by a hyperechoic space.</span></div>\n<div><span><strong>Normal</strong> USG appearance of an intrauterine gestational sac.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Lambda Sign</strong></span></div>\n</td>\n<td>\n<div><span>The chorionic tissue in between the two layers of the membrane between the twins.</span></div>\n<div><span>USG sign seen in <strong>di-chorionic pregnancies</strong>.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>‘T’ Sign</strong></span></div>\n</td>\n<td>\n<div><span>USG sign seen in <strong>monochorionic twins</strong>. As the intertwin membrane does not have any chorionic tissue it gives rise to ‘T’ sign in ultrasound.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Bunch of grapes sign</strong></span></div>\n</td>\n<td>\n<div><span>USG appearance of multiple cystic spaces or lesions in a <strong>complete mole</strong>.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Butterfly sign</strong></span></div>\n</td>\n<td>\n<div><span>Normal appearance of the choroid plexuses on axial imaging of the fetal brain. An<strong> absence</strong>&nbsp;of this sign suggests <strong>holoprosencephaly</strong>.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Cloverleaf skull</strong></span></div>\n</td>\n<td>\n<div><span>Seen in <strong>craniosynostosis</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Empty amnion sign</strong></span></div>\n</td>\n<td>\n<div><span>Visualization of an amniotic sac without concomitant visualization of an embryo. It is an indicator of <strong>pregnancy failure</strong>.</span></div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1572, 'Medicine,', 'PM0584. Chest X Ray signs in pulmonary embolism', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Westermarks sign:&nbsp;</strong>Focal area of oligemia (decreased vascular markings) distal to the embolism.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1320503c26a8431b903e7e15089c8ed4x720x655.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Hamptons hump:&nbsp;</strong>Peripherally placed wedge-shaped or dome-shaped opacity due to infarction of lung tissue.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5faac4b6986f4b6da649d4ca027f99b3x1063x874.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Pallas sign:&nbsp;</strong>Increased size of the right descending pulmonary artery with a sausage-like appearance.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9d6849e258104848bfc976a72abaae15x1069x804.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Fleishner sign</strong>: enlarged pulmonary artery.</p>\n<p><strong>Melting sign</strong>:&nbsp;an infarct shows rapid clearing in contrast to pneumonic consolidation.</p>\n<p><strong>McConnells</strong>&nbsp;<strong>sign</strong> (indirect sign of PE seen in transthoracic echo):&nbsp;<strong>hypokinesis</strong>&nbsp;of the right ventricular free wall with&nbsp;<strong>normal motion</strong>&nbsp;of the right ventricle apex.</p>\n<p><strong>Knuckle&nbsp;</strong>or<strong>&nbsp;sausage’ sign:&nbsp;</strong>dilatation of the pulmonary artery,&nbsp;proximal to the embolus with collapse or constriction of the distal arteries resulting in an abrupt tapering of these arteries. &nbsp;</p>\n<p>Note - A normal chest X-ray does not rule out pulmonary embolism in a patient with unexplained acute tachypnea or hypoxemia.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1573, 'Radiology', 'PM0369. Tram Track Appearance in Various Conditions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Tram tracks </strong>or<strong> tram track signs</strong> are medical signs that bear some resemblance to <strong>tramway tracks (Railway Track)</strong>.</p>\n<p><strong>1. Pulmonology</strong></p>\n<ul>\n<li>When found in the lungs, tram tracks are radiologic signs that are usually accompanied by <strong>pulmonary edema</strong> in cases of <strong>congestive heart failure</strong> and <strong>bronchiectasis</strong>.</li>\n<li><strong>Tram tracks</strong> are caused by <strong>bronchial</strong> <strong>wall</strong> <strong>thickening</strong>, and can be detected on a <strong>lateral chest X-ray</strong>.</li>\n</ul>\n<p><strong>2. Nephrology</strong></p>\n<ul>\n<li>The term \<strong>tram tracks</strong>\ is also used to describe the basement membrane duplication found on light microscopy that is characteristic of membranoproliferative glomerulonephritis<strong> (MPGN) type I</strong>.</li>\n<li>It is less commonly associated with types II and III.</li>\n</ul>\n<p><strong>3. Neurology</strong></p>\n<ul>\n<li>The term has also been used to describe findings associated with <strong>optic nerve sheath meningioma.</strong></li>\n<li><strong>Tram track-shaped calcifications</strong> in the cerebral cortex indicate <strong>Sturge-Weber syndrome</strong>.</li>\n</ul>\n<p><strong>4. Mammary glands:</strong></p>\n<ul>\n<li>Tram track appearance in mammography/USG indicates <strong>Duct Ectasia.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/005dd7f21675470cad600851cab9e990x1280x960.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1574, 'Radiology,', 'PM0284. Bone scan findings', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Causes of a hot spot</strong></p>\n</td>\n<td>\n<p><strong>Causes of a cold spot</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteomyelitis</p>\n<p><strong>Bone&nbsp;tumors and m</strong><strong>etastases</strong></p>\n<p><strong>Fibrous dysplasia</strong></p>\n<p>Trauma (fracture healing)</p>\n<p><strong>Avascular necrosis</strong></p>\n<p><strong>Perthes&nbsp;disease</strong></p>\n<p>Paget’s disease</p>\n<p>Hyperparathyroidism</p>\n</td>\n<td>\n<p><strong>Multiple myeloma</strong></p>\n<p>Fibrous cortical defect</p>\n<p>Pseudoarthrosis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1575, 'Radiology,', 'PM0251. Important radiological signs in cardiology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<div><strong>Sign</strong></div>\n</td>\n<td>\n<div><strong>Condition</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Flask</strong> shaped/ Pear shaped/ <strong>Leather bottle </strong>shaped/ <strong>Money-bag</strong> shaped heart</div>\n</td>\n<td>\n<div><strong>Pericardial effusion</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Boot shaped heart/ <strong>Coeur-en-sabot</strong></div>\n</td>\n<td>\n<div><strong>Fallot’s tetralogy</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Gooseneck sign</div>\n</td>\n<td>\n<div>Endocardial cushion defects</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Box-shaped heart</strong></div>\n</td>\n<td>\n<div><strong>Ebsteins anomaly</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Jug handle appearance</div>\n</td>\n<td>\n<div>Primary pulmonary artery hypertension</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>“3” like appearance of the aorta</div>\n</td>\n<td>\n<div>Coarctation of aorta</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Egg on string appearance</strong></div>\n</td>\n<td>\n<div><strong>Transposition of great vessels</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Egg in cup appearance, Pericardial calcification</div>\n</td>\n<td>\n<div>Constrictive pericarditis</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Snowman’s heart, Cottage loaf appearance, Figure of Eight appearance</strong></div>\n</td>\n<td>\n<div><strong>Total anomalous pulmonary venous circulation</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Scimitar</strong> sign</div>\n</td>\n<td>\n<div><strong>Partial anomalous pulmonary venous return</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Calcification in the heart wall</div>\n</td>\n<td>\n<div>Carcinoid syndrome</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Calcification of ascending aorta</div>\n</td>\n<td>\n<div>Atherosclerosis, Syphilis</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Hilar dance on fluoroscopy</div>\n</td>\n<td>\n<div>Atrial septal defect</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Batwing appearance</div>\n</td>\n<td>\n<div>Pulmonary edema</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>Pruned tree appearance of the pulmonary vasculature</div>\n</td>\n<td>\n<div>Pulmonary artery hypertension</div>\n</td>\n</tr>\n</tbody>\n</table>\n<div>&nbsp;</div></div><!---->\n      <!---->\n    </div><!---->'),
(1576, 'Radiology', 'PM0236. Causes of pathological basal ganglia calcification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Endocrinopathies\n<ul>\n<li>Hypoparathyroidism (primary or secondary)</li>\n<li>Pseudohypoparathyroidism</li>\n<li>Hyperparathyroidism</li>\n<li>Hypothyroidism</li>\n</ul>\n</li>\n<li>Vasculitis (e.g. SLE)</li>\n<li>Mitochondrial disorders (e.g. Mitochondrial myopathy)</li>\n<li>Infections\n<ul>\n<li>Brucellosis</li>\n<li>TORCH&nbsp;</li>\n<li>Epstein-Barr virus (EBV)</li>\n<li>HIV</li>\n</ul>\n</li>\n<li>Other inherited disorders\n<ul>\n<li>Neuroferritinonpathy</li>\n<li>Cockayne syndrome</li>\n</ul>\n</li>\n<li>Radiation</li>\n<li>Chemotherapy</li>\n<li>Carbon monoxide poisoning</li>\n<li>Lead poisoning</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1577, 'Paediatrics,', 'PM0193. Radiological findings in some congenital heart defects', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Boot shaped heart - Tetralogy of Fallot (TOF)</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b8d455f894f24e8e9c147e7c3a178428x510x558.GIF\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Egg on string appearance - Transposition of Great Arteries (TGA)</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ad3fe6b6422548c8856299317c3e47c5x510x522.GIF\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Snowmans heart appearance or figure of 8 appearance</strong> -&nbsp;<strong>Supracardiac TAPVC</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c4d273d1af7445fdad02e659555c9e69x510x494.GIF\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Box Shaped Heart - Ebsteins Anomaly</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d07d5041004645849e8cce1dd37bd092x510x640.GIF\><!---->\n      </div><!---->\n    </div><!---->'),
(1578, 'Radiology,', 'PM0124. Differences between the two types of endemic cretinism', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Neurological type</strong></td>\n<td><strong>Myxedematous type</strong></td>\n</tr>\n<tr>\n<td>Goiter&nbsp;</td>\n<td>No goiter (USG shows thyroid atrophy)</td>\n</tr>\n<tr>\n<td>Euthyroid&nbsp;</td>\n<td>Permanent hypothyroidism</td>\n</tr>\n<tr>\n<td>Intellectual disability, deaf-mutism, squint, proximal spasticity,&nbsp;and rigidity</td>\n<td>Intellectual disability, Deaf, coarse facial features, and myxedema.</td>\n</tr>\n<tr>\n<td>Normal pubertal development and adult stature</td>\n<td>Delayed skeletal maturation and sexual development, severe short stature</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1579, 'Radiology,', 'PM0111. Types of Intracranial Hemorrhage', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>1. Extradural hemorrhage/epidural hematoma (EDH)</strong></p>\n<ul>\n<li>Source: Arterial - <strong>middle meningeal artery&nbsp;</strong>(m/c)</li>\n<li>Cause: Trauma - fracture of the squamous part of the <strong>temporal bone</strong></li>\n<li><strong>Lens or lentiform</strong> shaped opacity</li>\n<li>Presence of a characteristic <strong>lucid interval</strong></li>\n<li>Treatment: Surgical evacuation of large/rapidly evolving EDH</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/507e530f4b3c4faba01eac509037b78bx784x963.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>2. Acute subdural hemorrhage&nbsp;</strong>(SDH)</p>\n<ul>\n<li>Source: Venous - bridging veins</li>\n<li>Cause: Trauma</li>\n<li>Common in <strong>old age</strong>, <strong>alcoholics</strong>, patients on <strong>anticoagulants</strong>, <strong>shaken baby syndrome</strong> (a form of child abuse seen in infants and toddlers)</li>\n<li>Clinical features: Acute SDH may be associated with a lucid interval; chronic SDH is associated with drowsiness, headache</li>\n<li>CT findings: <strong>Crescent</strong>&nbsp;opacity</li>\n<li>Treatment: May resolve spontaneously or require surgical drainage</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a7e5c451c38e4dedbdc912ca6a22c4dax1280x1026.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>3. Acute on chronic SDH</strong></p>\n<ul>\n<li>Source: Venous - bridging veins</li>\n<li>Cause: Usually, <strong>trivial trauma</strong> in old age or patients on anticoagulants</li>\n<li><strong>Crescent</strong>&nbsp;clots</li>\n<li>Presence of a history of headache, confusion, and <strong>being prone to falls</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/da30bfdd9fb343269e21219017fbda42x1280x1149.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>4. Subarachnoid hemorrhage</strong></p>\n<ul>\n<li>Source: Arterial</li>\n<li>Causes: <strong>Trauma</strong> (most common), <strong>berry aneurysm</strong> (2nd most common)</li>\n<li>M/c sites: Terminal ICA, MCA bifurcation, top of basilar artery</li>\n<li>Clinical features: Characteristic <strong>thunderclap headache</strong></li>\n<li><strong>CSF: Xanthochromia</strong></li>\n<li><strong>Hyperdensity</strong> in the subarachnoid space</li>\n<li>Treatment:&nbsp; <strong>T</strong><strong>riple H therapy</strong> (hypertension, hypervolemia, and hemodilution) to prevent vasospasm, Clipping/coiling of berry aneurysm</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d7cb2373c2794c4684e64759ca20c19ex647x745.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>5. Intra-parenchymal hemorrhage</strong></p>\n<ul>\n<li><strong>Most common</strong> type of intracranial hemorrhage</li>\n<li>Cause:<strong> Hypertension</strong> (most common cause)</li>\n<li>Hyperdensity within the brain parenchyma</li>\n<li>Site: <strong>P</strong><strong>utamen</strong> of the basal ganglia (most common)</li>\n<li>Treatment: Correction of any identified coagulopathy by infusing prothrombin complex concentrates, FFP, or fresh platelets as required; surgical evacuation for cerebellar hematoma &gt;3 cm in size</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/917c06cd8b0241e8995ff2379c1b42f0x831x977.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1580, 'Radiology,', 'PM0066. Investigation of Choice in Respiratory Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>Investigation of choice</strong></td>\n</tr>\n<tr>\n<td><strong>Interstitial lung disease</strong></td>\n<td>HRCT</td>\n</tr>\n<tr>\n<td><strong>Bronchiectasis</strong></td>\n<td>HRCT</td>\n</tr>\n<tr>\n<td><strong>Pulmonary embolism</strong></td>\n<td>CT Pulmonary Angiography &gt;&nbsp;Ventilation-Perfusion Scan</td>\n</tr>\n<tr>\n<td><strong>Calcification</strong></td>\n<td>CT</td>\n</tr>\n<tr>\n<td><strong>Solitary pulmonary nodule</strong></td>\n<td>CT &gt;&nbsp;PET</td>\n</tr>\n<tr>\n<td><strong>Lung Malignancy</strong></td>\n<td>CT scan</td>\n</tr>\n<tr>\n<td><strong>Superior sulcus tumor</strong></td>\n<td>MRI scan &gt; CT scan</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1581, 'Radiology', 'PM0065. Eggshell calcification of lymph node on chest X-ray', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Eggshell calcification refers to fine calcification seen at the periphery of a lymph node. Causes are -</p>\n<ul>\n<li><strong>Silicosis</strong> (most common)</li>\n<li>Sarcoidosis</li>\n<li>Post radiotherapy</li>\n<li>Post-irradiation lymphoma</li>\n<li>Histoplasmosis</li>\n<li>Blastomycosis</li>\n<li>Amyloidosis</li>\n<li>Tuberculosis</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4a4d813b4cc64ebbb0bdff38920873e8x1280x930.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1582, 'Radiology,', 'PM0064. Causes of miliary shadow in Chest X-ray', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Miliary shadow&nbsp;refers to innumerable, small&nbsp;(1-4 mm) pulmonary nodules&nbsp;scattered throughout the&nbsp;lungs. It is seen in -&nbsp;</p>\n<ul>\n<li><strong>Miliary tuberculosis</strong></li>\n<li>Histoplasmosis</li>\n<li><strong>Sarcoidosis</strong></li>\n<li>Pneumoconiosis – coal workers pneumoconiosis and silicosis</li>\n<li>Healed varicella</li>\n<li><strong>Long-standing MS</strong> – can lead to pulmonary hemosiderosis</li>\n<li>Alveolar microlithiasis</li>\n<li>Papillary and medullary Ca thyroid</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cd37e41e724146cd94276c610fdefbbcx720x568.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1583, 'Orthopaedics,', 'PM1339. Important radiosenstive and radioresistant bone tumours', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Radiosensitive</strong> tumors:</p>\n<ol>\n<li>Metastasis (except metastasis from renal cell carcinoma which is radioresistant)</li>\n<li>Ewings sarcoma</li>\n<li>Multiple myeloma</li>\n<li>Lymphoma</li>\n</ol>\n<p><strong>Radioresistant</strong> tumors:</p>\n<ol>\n<li>Osteosarcoma</li>\n<li>Chondrosarcoma</li>\n<li>Fibrosarcoma</li>\n<li>Malignant fibrous histiocytoma</li>\n</ol></div><!---->\n      <!---->\n    </div><!---->'),
(1584, 'Radiology', 'PM2445. Barium swallow', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Diffuse esophageal spasm</strong>: Corkscrew appearance</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d8236260ddee416fbac986f814ef6970x720x938.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Feline esophagus</strong>: Transient transverse bands seen in the mid and lower esophagus on a double-contrast barium swallow. It is seen in active gastroesophageal reflux, hiatus hernia, and eosinophilic esophagitis.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/270761a611f6405a961fcecfe050e5edx720x1107.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Achalasia</strong>: Dilated esophagus with a retained column of barium and bird beak sign.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9d0869506ae542e1bb72aa5e0c3cc94cx245x520.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Zenkers diverticulum: </strong>Posterior outpouching of the hypopharynx through a weakness in the muscle layer called Killian dehiscence.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/35c984e64ee642878526077ceef5e961x1080x1503.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Esophageal carcinoma</strong>: Irregular narrowing, mucosal destruction, and shouldered margins.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9c598150228f4315b254e5ba8af9b13fx1071x1024.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Schatzkis ring</strong>: Thin submucosal circumferential ring in the lower esophagus at the squamocolumnar junction.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f58822b0b33945d69d9a97c60e34bc24x720x996.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Esophageal web</strong> in a patient with Plummer Vinson syndrome. Esophageal webs are thin membranes of normal esophageal tissue consisting of mucosa and submucosa. Translucent part denotes esophageal web.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b37419089d4840df98207a1eaa0b6781x720x1339.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d9fbe2bf49d9490a91f5525c33acbb34x592x571.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Esophageal leiomyoma</strong>&nbsp;is the <strong>most common</strong>&nbsp;benign tumor of the esophagus. On barium swallow, it is seen as a discrete ovoid mass that is well outlined by barium (smooth submucosal mass). Its borders form slightly obtuse angles with the esophagal wall.</p>\n<p>The image below depicts a barium study showing the classic<strong> semilunar filling defect</strong>.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cc584152656442f6bcbb0fb47e97fc92x388x385.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1585, 'Radiology', 'PM2443. Barium Studies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Barium swallow:&nbsp;</strong>Used to assess the pharynx, esophagus, and stomach. (Barium paste is used)</p>\n<p>The image below is a barium swallow showing eosinophilic esophagitis and associated stricture:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b5bdec3be8214149b4321669d20ce417x323x461.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Barium meal: </strong>Used to assess stomach and duodenum. (95% BaSO4 is used)</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/26d315aabed64925a095dd613db26b5cx720x720.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Barium meal followthrough: </strong>Used to assess the small intestine (50% BaSO4 is used)</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2581dc5431c74171abcd83814d250beex484x698.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Barium enema: </strong>Used to assess the large intestine (25% BaSO4 is used)</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d548af6e9d5a4b16880804dd8b4d6cfax387x450.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1586, 'Medicine', 'PM2040. Conditions commonly associated with Klippel-Feil syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Condition&nbsp;</strong>&nbsp; &nbsp;</td>\n<td><strong>Description</strong>&nbsp; &nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Scoliosis&nbsp;</strong></td>\n<td>\n<p><strong>Most frequent</strong>&nbsp;orthopaedic complication</p>\n</td>\n</tr>\n<tr>\n<td><strong>Renal anomalies&nbsp;</strong></td>\n<td>\n<p>Usually asymptomatic</p>\n</td>\n</tr>\n<tr>\n<td><strong>Cardiovascular anomalies&nbsp;</strong></td>\n<td>\n<p>Ventricular septal defect most common&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Deafness&nbsp;</strong></td>\n<td>\n<p>Obtain audiometric testing</p>\n</td>\n</tr>\n<tr>\n<td><strong>Respiratory anomalies&nbsp;</strong></td>\n<td>\n<p>Restriction of lung function</p>\n</td>\n</tr>\n<tr>\n<td><strong>Sprengel deformity&nbsp;</strong></td>\n<td>\n<p>High placed scapula. Affects appearance and shoulder motion</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1587, 'Medicine', 'PM1233. Indications of Plasma exchange Therapy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Speciality</strong></p>\n</td>\n<td>\n<p><strong>Condition</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neurology</p>\n</td>\n<td>\n<p>Acute Guillain Barre syndrome</p>\n<p>Chronic inflammatory demyelinating polyneuropathy</p>\n<p>Myasthenia gravis</p>\n<p>Polyneuropathy associated with paraproteinaemias</p>\n<p>PANDAS</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hematology</p>\n</td>\n<td>\n<p>Thrombotic thrombocytopenic purpura</p>\n<p>Atypical hemolytic-uraemic syndrome</p>\n<p>Hyperviscosity syndromes</p>\n<p>Severe/symptomatic cryoglobulinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Renal</p>\n</td>\n<td>\n<p>Goodpasture’s syndrome</p>\n<p>Antineutrophil cytoplasmic antibody (ANCA)-associated rapidly progressive glomerulonephritis</p>\n<p>Recurrent focal segmental glomerular sclerosis</p>\n<p>Antibody-mediated renal transplant rejection</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Metabolic</p>\n</td>\n<td>\n<p>Familial hypercholesterolemia</p>\n<p>Fulminant Wilson’s disease</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1588, 'Medicine', 'PM0133. Important dates and events', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Some important days and dates:</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td><strong>Days</strong></td>\n<td><strong>Dates</strong></td>\n</tr>\n<tr>\n<td>World Leprosy eradication day</td>\n<td>January last Sunday</td>\n</tr>\n<tr>\n<td>World cancer day</td>\n<td>&nbsp;February 4</td>\n</tr>\n<tr>\n<td>&nbsp;International day of Zero Tolerance to Female Genital Mutilation</td>\n<td>&nbsp;February 6</td>\n</tr>\n<tr>\n<td>National deworming day (2019)</td>\n<td>\n<p>February 8 (first round) Feb 14 (Mop-up), August 8.</p>\n</td>\n</tr>\n<tr>\n<td>Sexual reproductive health awareness day</td>\n<td>February 12</td>\n</tr>\n<tr>\n<td>World Glaucoma week</td>\n<td>March 12 – 18</td>\n</tr>\n<tr>\n<td>World kidney day</td>\n<td>March Second Thursday</td>\n</tr>\n<tr>\n<td>Measles immunization day</td>\n<td>March 16</td>\n</tr>\n<tr>\n<td>World Oral health day</td>\n<td>March 20</td>\n</tr>\n<tr>\n<td>World Downs Syndrome day</td>\n<td>March 21</td>\n</tr>\n<tr>\n<td>World Water day</td>\n<td>March 22</td>\n</tr>\n<tr>\n<td><strong>World TB day</strong></td>\n<td>March 24</td>\n</tr>\n<tr>\n<td>World autism awareness day</td>\n<td>April 2</td>\n</tr>\n<tr>\n<td><strong>World health day</strong></td>\n<td>April 7</td>\n</tr>\n<tr>\n<td>World Hemophilia day</td>\n<td>April 17</td>\n</tr>\n<tr>\n<td>World Liver day</td>\n<td>April 19</td>\n</tr>\n<tr>\n<td><strong>World Malaria day</strong></td>\n<td>April 25</td>\n</tr>\n<tr>\n<td><strong>World Immunization week</strong></td>\n<td>April 24 - 30</td>\n</tr>\n<tr>\n<td>World Asthma day</td>\n<td>May first Tuesday</td>\n</tr>\n<tr>\n<td>World Red Cross day, World Thalassemia day</td>\n<td>May 8</td>\n</tr>\n<tr>\n<td>World Chronic Fatigue syndrome awareness day</td>\n<td>May 12</td>\n</tr>\n<tr>\n<td>National Dengue day</td>\n<td>May 16</td>\n</tr>\n<tr>\n<td>World MS day</td>\n<td>May last Wednesday</td>\n</tr>\n<tr>\n<td>International Womens health day</td>\n<td>May 28</td>\n</tr>\n<tr>\n<td><strong>World No Tobacco day</strong></td>\n<td>May 31</td>\n</tr>\n<tr>\n<td>World Brain Tumor day</td>\n<td>June 8</td>\n</tr>\n<tr>\n<td>World Blood donor day</td>\n<td>June 14</td>\n</tr>\n<tr>\n<td>Autistic Pride day</td>\n<td>June 18</td>\n</tr>\n<tr>\n<td>International day of Yoga</td>\n<td>June 21</td>\n</tr>\n<tr>\n<td>International day against Drug abuse and Illicit Trafficking</td>\n<td>June 26</td>\n</tr>\n<tr>\n<td><strong>World Population day</strong></td>\n<td>July 11</td>\n</tr>\n<tr>\n<td>World Hepatitis day</td>\n<td>July 28</td>\n</tr>\n<tr>\n<td>ORS day</td>\n<td>July 29</td>\n</tr>\n<tr>\n<td><strong>World Breast feeding week</strong></td>\n<td>August 1 - 7</td>\n</tr>\n<tr>\n<td>National Eye donation fortnight</td>\n<td>August 25 - September 8</td>\n</tr>\n<tr>\n<td>National Nutrition week</td>\n<td>September 1 - 7</td>\n</tr>\n<tr>\n<td>World Suicide Prevention day</td>\n<td>September 10</td>\n</tr>\n<tr>\n<td>World Alzheimers day</td>\n<td>September 21</td>\n</tr>\n<tr>\n<td>World day of Deaf</td>\n<td>September 30, 2019 (Last monday of september)</td>\n</tr>\n<tr>\n<td>World Rabies day</td>\n<td>September 28</td>\n</tr>\n<tr>\n<td>&nbsp;World Heart day&nbsp;</td>\n<td>&nbsp;September 29</td>\n</tr>\n<tr>\n<td>&nbsp;Breast cancer awareness month&nbsp;</td>\n<td>&nbsp;October&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;International day for the Elderly&nbsp;</td>\n<td>&nbsp;October 1</td>\n</tr>\n<tr>\n<td>&nbsp;National Anti-drug addiction day&nbsp;</td>\n<td>&nbsp;October 2</td>\n</tr>\n<tr>\n<td>World Cerebral Palsy day</td>\n<td>October first Wednesday</td>\n</tr>\n<tr>\n<td>World Sight day</td>\n<td>\n<p>October 11 for 2018</p>\n<p>(second thursday of October every year)</p>\n</td>\n</tr>\n<tr>\n<td>World Obesity day</td>\n<td>October 11</td>\n</tr>\n<tr>\n<td><strong>World Mental health day</strong></td>\n<td>October 10</td>\n</tr>\n<tr>\n<td>Global handwashing day</td>\n<td>October 15</td>\n</tr>\n<tr>\n<td>World Anesthesia day&nbsp;</td>\n<td>&nbsp;October 16&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;World Trauma day&nbsp;</td>\n<td>&nbsp;October 17</td>\n</tr>\n<tr>\n<td>&nbsp;World Iodine Deficiency day&nbsp;</td>\n<td>&nbsp;October 21</td>\n</tr>\n<tr>\n<td><strong>World Polio day</strong></td>\n<td>October 24</td>\n</tr>\n<tr>\n<td>World Stroke day</td>\n<td>October 29</td>\n</tr>\n<tr>\n<td>National cancer awareness day</td>\n<td>November 7</td>\n</tr>\n<tr>\n<td>World Immunization day</td>\n<td>November 10</td>\n</tr>\n<tr>\n<td>World Pneumonia day</td>\n<td>November 12</td>\n</tr>\n<tr>\n<td>World Antibiotic Awareness week</td>\n<td>November 13 - 19</td>\n</tr>\n<tr>\n<td><strong>World Diabetes day</strong></td>\n<td>November 14</td>\n</tr>\n<tr>\n<td>National Epilepsy day</td>\n<td>November 17</td>\n</tr>\n<tr>\n<td>World COPD day</td>\n<td>November 21 (in 2018) - variable</td>\n</tr>\n<tr>\n<td>Newborn care week</td>\n<td>November 15 - 21</td>\n</tr>\n<tr>\n<td><strong>World AIDS day</strong></td>\n<td>December 1</td>\n</tr>\n<tr>\n<td>International day of persons with disability</td>\n<td>December 3</td>\n</tr>\n<tr>\n<td>World patient safety day</td>\n<td>December 9</td>\n</tr>\n<tr>\n<td>Universal health coverage day</td>\n<td>December 12</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1589, 'Medicine,', 'PM1599. Causes of Hypercalcemia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Parathyroid</strong>-Related\n<ul>\n<li>Primary hyperparathyroidism\n<ul>\n<li>Adenoma(s)</li>\n<li>Multiple endocrine neoplasia</li>\n<li>Carcinoma</li>\n</ul>\n</li>\n<li>Lithium therapy</li>\n<li>Familial hypocalciuric hypercalcemia</li>\n</ul>\n</li>\n<li><strong>Malignancy</strong>-Related\n<ul>\n<li>Solid tumour with metastases (breast)</li>\n<li>Solid tumour with humoral mediation of hypercalcemia (lung, kidney)</li>\n<li>Hematologic malignancies (multiple myeloma, lymphoma, leukemia)</li>\n</ul>\n</li>\n<li><strong>Vitamin</strong> <strong>D</strong>–Related\n<ul>\n<li>Vitamin D intoxication</li>\n<li>↑ 1,25(OH)2D :\n<ul>\n<li>Sarcoidosis and other granulomatous diseases</li>\n<li>Impaired 1,25(OH)2D metabolism due to 24-hydroxylase deficiency</li>\n</ul>\n</li>\n<li>Associated with <strong>high bone turnover</strong>\n<ul>\n<li>Hyperthyroidism</li>\n<li>Immobilization</li>\n<li>Thiazides</li>\n<li>Vitamin A intoxication</li>\n<li>Fat necrosis</li>\n</ul>\n</li>\n<li>Associated with <strong>renal failure</strong>\n<ul>\n<li>Severe secondary hyperparathyroidism</li>\n<li>Aluminium intoxication</li>\n<li>Milk-alkali syndrome</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1590, 'Medicine', 'PM1589. Chronic Complications of Type2 DM', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\ width=\414\>\n<p><strong>Vascular</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p><strong>Microvascular</strong></p>\n</td>\n<td width=\208\>\n<p><strong>Macrovascular</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>Retinopathy</p>\n<p>Macular edema</p>\n</td>\n<td width=\208\>\n<p>Coronary heart disease</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>Nephropathy</p>\n</td>\n<td width=\208\>\n<p>Peripheral arterial disease</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p>Neuropathy</p>\n</td>\n<td width=\208\>\n<p>Cerebrovascular disease</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\414\>\n<p><strong>Non Vascular</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\414\>\n<p>Gastrointestinal (gastroparesis, diarrhea)</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\414\>\n<p>Genitourinary (uropathy/sexual dysfunction)</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\414\>\n<p>Dermatologic</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\414\>\n<p>Infectious</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\414\>\n<p>Cataracts</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\414\>\n<p>Glaucoma</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\414\>\n<p>Cheiroarthropathy</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\414\>\n<p>Periodontal disease</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ width=\414\>\n<p>Hearing loss</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1591, 'Medicine', 'PM1583. Treatment Goals for Adults with Diabetes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\177\>\n<p><strong>Index</strong></p>\n</td>\n<td width=\189\>\n<p><strong>Goal</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\177\>\n<p>HbA1c*</p>\n</td>\n<td width=\189\>\n<p>&lt; 7 %</p>\n</td>\n</tr>\n<tr>\n<td width=\177\>\n<p>Preprandial capillary plasma glucose</p>\n</td>\n<td width=\189\>\n<p>80–130 mg/dL</p>\n</td>\n</tr>\n<tr>\n<td width=\177\>\n<p>Peak postprandial capillary plasma glucose</p>\n</td>\n<td width=\189\>\n<p>&lt;180 mg/dL</p>\n</td>\n</tr>\n<tr>\n<td width=\177\>\n<p>Blood pressure<sup>+</sup></p>\n</td>\n<td width=\189\>\n<p>&lt; 140/80 mmHg</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>*Note that most diabetes associations recommend the target HbA1c must be individualized to the patient. A target of &lt;7% is reasonable in most individuals.</p>\n<p>+ Blood pressure: Harrisons 20th&nbsp; edition,(based on ADA) recommends the target blood pressure goal of &lt;140/90 mmHg for adults with diabetes. It further adds that for younger individuals the target blood pressure is &lt;130/80 mmHg. But the \AHA/SPRINT TRIAL recommendations\ recommend that the goal of blood pressure in patients with diabetes mellitus is less than <span class=\nowrap\>130/80</span> mmHg.</p>\n<p>Dyslipidemia: Although not a treatment goal, ADA recommends&nbsp;to intensify lifestyle therapy and optimize glycemic control for patients with elevated triglyceride levels (≥150 mg/dL [1.7 mmol/L]) and/or low HDL cholesterol (&lt;40 mg/dL for men, &lt;50 mg/dL&nbsp; for women). Treatment with statins would depend on the overall cardiovascular risk (ASCVD) rather than specific LDL/HDL cholesterol level.</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1592, 'Medicine', 'PM1582. Comparative Features of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\169\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\162\>\n<p><strong>DKA</strong></p>\n</td>\n<td width=\160\>\n<p><strong>HHS</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\169\>\n<p><strong>Seen in </strong></p>\n</td>\n<td width=\162\>\n<p>Type 1 DM</p>\n</td>\n<td width=\160\>\n<p>Type 2 DM</p>\n</td>\n</tr>\n<tr>\n<td width=\169\>\n<p><strong>Clinical features</strong></p>\n</td>\n<td width=\162\>\n<p>Abdominal pain</p>\n<p>Kussmaul respiration</p>\n<p>Fruity odour of breath</p>\n</td>\n<td width=\160\>\n<p>Altered sensorium</p>\n<p>Coma</p>\n</td>\n</tr>\n<tr>\n<td width=\169\>\n<p><strong>Glucose (mg/dL)</strong></p>\n</td>\n<td width=\162\>\n<p>250–600</p>\n</td>\n<td width=\160\>\n<p>600–1200</p>\n</td>\n</tr>\n<tr>\n<td width=\169\>\n<p><strong>Sodium</strong></p>\n</td>\n<td width=\162\>\n<p>120–125</p>\n</td>\n<td width=\160\>\n<p>135–145</p>\n</td>\n</tr>\n<tr>\n<td width=\169\>\n<p><strong>Osmolality </strong></p>\n</td>\n<td width=\162\>\n<p>300–320</p>\n</td>\n<td width=\160\>\n<p>330–380</p>\n</td>\n</tr>\n<tr>\n<td width=\169\>\n<p><strong>Plasma Ketones</strong></p>\n</td>\n<td width=\162\>\n<p>++++</p>\n</td>\n<td width=\160\>\n<p>+/-</p>\n</td>\n</tr>\n<tr>\n<td width=\169\>\n<p><strong>Serum Bicarbonate</strong></p>\n</td>\n<td width=\162\>\n<p>&lt; 15 meq/ L</p>\n</td>\n<td width=\160\>\n<p>Normal to slightly ↓</p>\n</td>\n</tr>\n<tr>\n<td width=\169\>\n<p><strong>Arterial pH </strong></p>\n</td>\n<td width=\162\>\n<p>6.8–7.3</p>\n</td>\n<td width=\160\>\n<p>&gt;7.3</p>\n</td>\n</tr>\n<tr>\n<td width=\169\>\n<p><strong>Arterial pCO<sub>2 </sub>(mmHg)</strong></p>\n</td>\n<td width=\162\>\n<p>20–30</p>\n</td>\n<td width=\160\>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td width=\169\>\n<p><strong>Anion Gap</strong></p>\n</td>\n<td width=\162\>\n<p><strong>↑</strong></p>\n</td>\n<td width=\160\>\n<p>Normal to slightly ↑</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1593, 'Medicine', 'PM1550. Initial Tests for Diagnosing Cushings Syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>These include two steps:</p>\n<p><strong>1. Tests to detect hypercortisolism</strong></p>\n<ul>\n<li><strong>Midnight salivary or serum cortisol</strong> (highly sensitive test):<strong>&nbsp;</strong>The presence of cortisol in the saliva or serum at midnight signifies loss of diurnal variation of cortisol</li>\n<li><strong>24-hour urinary free cortisol excretion</strong>:&nbsp;Increased three times the normal value</li>\n<li><strong>Overnight dexamethasone suppression test</strong> (DST):&nbsp;Plasma cortisol &gt;1.8 μg/dL at 8 a.m after overnight exposure to dexamethasone (1 mg given at 11 p.m)</li>\n<li><strong>Low dose DST</strong> (highly specific test):&nbsp;Plasma cortisol &gt;1.8 μg/dL at 8 a.m. on the third day after giving 0.5 mg dexamethasone every 6 hours for 2 days</li>\n</ul>\n<p><strong>2. Test </strong><strong>to rule out pseudo Cushings syndrome</strong></p>\n<ul>\n<li><strong>Low-dose DST + CRH stimulation test</strong>: Plasma cortisol levels are increased in true Cushing’s but remain unaffected in pseudo Cushings.&nbsp;Dexa-induced negative feedback is overcome by CRH in true Cushing’s.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1594, 'Medicine', 'PM1549. Causes of Cushings Syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Exogenous causes </strong>(iatrogenic)</p>\n<ul>\n<li>Prolonged administration of glucocorticoids (most common cause of Cushings)</li>\n</ul>\n<p><strong>Endogenous causes</strong></p>\n<ul>\n<li><strong>ACTH independent </strong>(primary hypercortisolism)\n<ul>\n<li>Adrenocortical adenoma&nbsp;</li>\n<li>Adrenocortical carcinoma&nbsp;</li>\n<li>Bilateral adrenal hyperplasia</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>ACTH dependent&nbsp;</strong>(secondary hypercortisolism)\n<ul>\n<li><strong>Cushing’s disease:&nbsp;</strong>ACTH secreting&nbsp;<strong>pituitary adenoma </strong>(most common cause of endogenous Cushings)</li>\n<li><strong>Paraneoplastic causes: </strong>Ectopic ACTH secreting tumors\n<ul>\n<li><strong>Small-cell lung carcinoma</strong></li>\n<li>Bronchial or pancreatic carcinoid tumors</li>\n<li>Medullary thyroid carcinoma</li>\n<li>Pheochromocytoma</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>Rare causes</strong></p>\n<ul>\n<li>Macronodular adrenal hyperplasia</li>\n<li>Primary pigmented nodular adrenal disease</li>\n<li>McCune <strong>–</strong> Albright syndrome</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1595, 'Medicine', 'PM1536. Water Deprivation test in Diabetes Insipidus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Procedure</strong>: Start the test at 4 am by checking the baseline urine osmolality. Deprive the patient of water till 12 pm (8 hours), and then re-check urine osmolality.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4fbb612d53a844a481418c1744026250x1200x1255.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Urine osmolality&nbsp;before water deprivation</td>\n<td>Urine osmolality after water deprivation</td>\n<td>Urine osmolality after desmopressin administration</td>\n</tr>\n<tr>\n<td>Normal&nbsp;</td>\n<td>Normal&nbsp;</td>\n<td>Increases</td>\n<td>No change</td>\n</tr>\n<tr>\n<td>Central DI</td>\n<td>Low</td>\n<td>No change</td>\n<td>&gt;50% increase from baseline</td>\n</tr>\n<tr>\n<td>Nephrogenic DI</td>\n<td>Low</td>\n<td>No change</td>\n<td>&lt;10% increase from baseline</td>\n</tr>\n<tr>\n<td>Primary polydipsia</td>\n<td>Low</td>\n<td>Increases</td>\n<td>No change</td>\n</tr>\n</tbody>\n</table>\n<p><br>Note: Normal urine osmolality- 500-850 mOsm/L<br><br></p></div><!---->\n      <!---->\n    </div><!---->'),
(1596, 'Medicine', 'PM1535. Causes of Nephrogenic DI', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>&nbsp;Drugs\n<ul>\n<li><strong>Lithium</strong></li>\n<li><strong>Amphotericin B</strong></li>\n<li>Demeclocycline</li>\n<li>Cisplatin</li>\n<li>Aminoglycosides</li>\n<li>Foscarnet</li>\n<li>Methoxyflurane</li>\n<li>Rifampin</li>\n</ul>\n</li>\n<li>&nbsp;Genetic\n<ul>\n<li>X-linked recessive (AVP receptor-2 gene)</li>\n<li>Autosomal recessive (AQP2 gene)</li>\n<li>Autosomal dominant (AQP2 gene)</li>\n</ul>\n</li>\n<li>&nbsp;Metabolic\n<ul>\n<li>Hypercalcemia, hypercalciuria</li>\n<li>Hypokalemia</li>\n<li>Hyperoxaluria</li>\n</ul>\n</li>\n<li>Sarcoidosis</li>\n<li>Sjogren syndrome</li>\n<li>Polycystic kidney disease</li>\n<li>Amyloidosis</li>\n<li>Vascular\n<ul>\n<li>Sickle cell disease and trait</li>\n<li>Ischemia (acute tubular necrosis)</li>\n</ul>\n</li>\n<li>Idiopathic</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1597, 'Medicine', 'PM1534. Causes of Central Diabetes insipidus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Neoplasms:<strong>&nbsp;</strong>\n<ul>\n<li aria-level=\2\><strong>Pituitary adenomas</strong> (most common)</li>\n<li aria-level=\2\>Meningioma</li>\n<li aria-level=\2\>Metastasis from lung and breast cancers</li>\n</ul>\n</li>\n<li>Infiltrative:&nbsp;\n<ul>\n<li>Sarcoidosis</li>\n<li>Langerhans cell histiocytosis</li>\n</ul>\n</li>\n<li>Genetic:&nbsp;\n<ul>\n<li>Wolfram syndrome</li>\n<li>Hand-Schuller-Christian disease&nbsp;</li>\n</ul>\n</li>\n<li>Infections:&nbsp;\n<ul>\n<li>Chronic meningitis</li>\n<li>Viral encephalitis</li>\n<li>Toxoplasmosis</li>\n</ul>\n</li>\n<li>&nbsp;Inflammatory:\n<ul>\n<li>Granulomatosis with polyangiitis</li>\n<li>Lupus erythematosus</li>\n<li>Scleroderma</li>\n</ul>\n</li>\n<li>&nbsp;Vascular:\n<ul>\n<li>Sheehan’s syndrome</li>\n<li>Aneurysm (internal carotid)</li>\n</ul>\n</li>\n<li>Head injury (closed and penetrating) including pituitary surgery</li>\n<li>Snakebite</li>\n<li>Lymphocytic hypophysitis</li>\n<li></li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1598, 'Medicine', 'PM1525. Tests for Acromegaly', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Screening test</strong>:</p>\n<p>The <strong>single</strong>&nbsp;best test for the diagnosis of acromegaly is the measurement of serum insulin-like growth factor-1 (<strong>IGF-1</strong>). A normal serum IGF-1 concentration is strong evidence that the patient does&nbsp;<strong>not</strong>&nbsp;have acromegaly.</p>\n<p><strong>Confirmatory test</strong>:</p>\n<p>GH suppression test:<strong>&nbsp;75 g</strong> of <strong>oral glucose</strong> (OGTT- oral glucose tolerance test) is administered to the patient. Blood GH levels are checked at 30, 60, 90, 120 min (i.e over 2 hours) after the glucose load.&nbsp;Normally, glucose suppresses GH and it falls to &lt;1 ng/mL. If GH <strong>&gt;1 ng/mL</strong>, it is diagnostic of acromegaly.</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1599, 'Medicine,', 'PM1524. Diagnostic tests in Zollinger Ellison Syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>To confirm the diagnosis of ZES,</p>\n<ul>\n<li><strong>Gastric pH &lt;2.5</strong> and</li>\n<li><strong>Serum gastrin &gt;1000pg/ml</strong> (normal &lt;100pg/ml)</li>\n</ul>\n<p>Provocative tests can be done like the <strong>secretin stimulation test</strong> when the diagnosis is in doubt. An <strong>increase in serum gastrin &gt;200pg/ml</strong> following an IV bolus of secretin (2U/kg) is diagnostic.</p>\n<p>Other tests:</p>\n<ul>\n<li><strong>BAO &gt;15mEq/h</strong> (or &gt;5mEq/h if they have had a procedure for peptic ulcer)</li>\n<li><strong>BAO: MAO ratio </strong>is <strong>increased </strong>(<strong>&gt;0.6</strong>)</li>\n</ul>\n<p>(BAO=Basal acid output; MAO=Maximal acid output)</p>\n<p>For localization</p>\n<ul>\n<li>Initial investigation - CT or MRI</li>\n<li>Best investigation - <strong>Endoscopic ultrasound</strong></li>\n<li>If the tumor is not localized - <strong>Somatostatin receptor scintigraphy</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1600, 'Medicine', 'PM1141. Rule of Tens in Pheochromocytoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Rule of 10s in Pheochromocytoma includes :</p>\n<ul>\n<li>10% are bilateral</li>\n<li>10% are extra- adrenal</li>\n<li>10% are malignant</li>\n<li>25-33 % are inherited.</li>\n</ul>\n<p>Note: Symptomatic patients do not follow the Rule of 10s</p>\n<div class=\section\>&nbsp;</div></div><!---->\n      <!---->\n    </div><!---->'),
(1601, 'Medicine', 'PM1140. Clinical features of Pheochromocytoma (By frequency of occurrence)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Classical triad of symptoms:\n<ul>\n<li>Headaches – most common symptom</li>\n<li>Profuse sweating</li>\n<li>Palpitations and tachycardia</li>\n</ul>\n</li>\n<li>Hypertension (sustained or intermittent) – most common&nbsp;sign</li>\n<li>Anxiety,&nbsp;panic attacks</li>\n<li>Hyperglycemia</li>\n<li>Hypercalcemia</li>\n<li>Pallor - due to&nbsp;alpha-1 mediated vasoconstriction</li>\n<li>Polyuria and polydipsia&nbsp;</li>\n<li>Orthostatic hypotension</li>\n<li>Dilated cardiomyopathy</li>\n<li>Erythrocytosis, high hematocrit (hemoconcentration)</li>\n<li>Constipation</li>\n<li>Abdominal pain</li>\n<li>Weakness</li>\n<li>Weight loss</li>\n<li>Nausea</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1602, 'Medicine', 'PM0992. Dawn Phenomenon and Somogyi Phenomenon', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\114\>\n<p>&nbsp;</p>\n</td>\n<td width=\188\>\n<p><strong>Dawn phenomenon</strong></p>\n</td>\n<td width=\255\>\n<p><strong>Somogyi phenomenon</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\114\>\n<p><strong>Features</strong></p>\n</td>\n<td width=\188\>\n<p>Early morning <strong>hyperglycaemia</strong></p>\n</td>\n<td width=\255\>\n<p>Early morning <strong>hyperglycaemia</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\114\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\188\>\n<p><strong>Normal blood glucose </strong>levels at 3 am</p>\n</td>\n<td width=\255\>\n<p><strong>Hypoglycaemia</strong> at 3 am</p>\n</td>\n</tr>\n<tr>\n<td width=\114\>\n<p><strong>Mechanism</strong></p>\n</td>\n<td width=\188\>\n<p>Early morning surge in growth hormone and cortisol which causes hyperglycemia</p>\n</td>\n<td width=\255\>\n<p>Excessive night basal insulin dose &gt; hypoglycemia in middle of night &gt; triggers the release of counterregulatory hormones which causes hyperglycemia.</p>\n</td>\n</tr>\n<tr>\n<td width=\114\>\n<p><strong>Treatment </strong></p>\n</td>\n<td width=\188\>\n<p><strong>Increase</strong> nighttime long-acting insulin dose</p>\n</td>\n<td width=\255\>\n<p><strong>Decrease</strong> night time long-acting insulin dose</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1603, 'Medicine', 'PM0990. Abnormal Glucose Homeostasis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Individuals without overt diabetes can have <strong>abnormal glucose homeostasis.&nbsp;</strong>It is also&nbsp;called <strong>prediabetes</strong> or intermediate hyperglycemia. These people are at an increased risk of developing diabetes<strong>&nbsp;</strong>mellitus. Three categories of abnormal glucose homeostasis have been defined:</p>\n<ul>\n<li class=\bulletIndent2\>Impaired glucose tolerance&nbsp;(IGT) –&nbsp;blood glucose levels between 140 and 199 mg/dL following an oral glucose challenge</li>\n<li class=\bulletIndent2\>Impaired fasting glucose&nbsp;(IFG) – fasting<strong>&nbsp;</strong>blood glucose 100 to 125&nbsp;<span class=\nowrap\>mg/dL</span>&nbsp;</li>\n<li class=\bulletIndent2\>HbA1c&nbsp;– 5.7-6.4%</li>\n</ul>\n<p class=\bulletIndent2\>Please&nbsp;note that impaired glucose tolerance and impaired fasting glucose are two distinct entities.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1604, 'Medicine', 'PM0989. ADA criteria for Diagnosis of Diabetes mellitus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Any one</strong> of the following:</p>\n<ul>\n<li><strong>Symptoms</strong> of diabetes <strong>plus</strong> Random Blood Glucose concentration <strong>≥</strong> <strong>200 mg/dL.</strong></li>\n<li><strong>Fasting plasma</strong> glucose <strong>≥</strong> <strong>126 </strong>mg/dL.&nbsp;Fasting is defined as no caloric intake for at least 8 hours.</li>\n<li>Haemoglobin <strong>A1c </strong><strong>≥6.</strong><strong>5%</strong></li>\n<li><strong>2-hour</strong> plasma <strong>glucose </strong><strong>≥</strong> <strong>200 mg/dL</strong> during an <strong>oral glucose tolerance test.</strong></li>\n</ul>\n<p>Note: In the absence of unequivocal hyperglycemia and acute metabolic decompensation, these criteria should be <strong>confirmed by repeat testing</strong> on a different day.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1605, 'Medicine', 'PM0988. Comparative Features between MODY and Type 2 DM', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\0\>\n<tbody>\n<tr>\n<td width=\206\>\n<p>&nbsp;</p>\n</td>\n<td width=\206\>\n<p><strong>Type 2 DM</strong></p>\n</td>\n<td width=\206\>\n<p><strong>MODY</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p><strong>Age of onset</strong></p>\n</td>\n<td width=\206\>\n<p>Predominantly middle to old age</p>\n</td>\n<td width=\206\>\n<p>Predominantly young (&lt; 25 years)</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p><strong>Pathology</strong></p>\n</td>\n<td width=\206\>\n<p>Beta cell dysfunction</p>\n<p>Insulin resistance</p>\n</td>\n<td width=\206\>\n<p>Only Beta cell dysfunction</p>\n<p>No insulin resistance</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p><strong>Family history</strong></p>\n</td>\n<td width=\206\>\n<p>Positive</p>\n<p>Inheritance - Polygenic&nbsp;</p>\n<p>Vertical transmission through <strong>successive generations</strong> is <strong>not essential </strong>for diagnosis</p>\n</td>\n<td width=\206\>\n<p>Positive</p>\n<p>Inheritance – Monogenic / <strong>Autosomal dominant</strong>&nbsp;</p>\n<p>Vertical transmission through at <strong>least two successive generation</strong> (ideally three) is <strong>essential</strong> for diagnosis</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p><strong>Insulin dependence</strong></p>\n</td>\n<td width=\206\>\n<p>Non-insulin dependent</p>\n</td>\n<td width=\206\>\n<p>Non-insulin dependent</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p><strong>Obesity</strong></p>\n</td>\n<td width=\206\>\n<p>Common</p>\n</td>\n<td width=\206\>\n<p>Uncommon</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p><strong>DKA</strong></p>\n</td>\n<td width=\206\>\n<p>Uncommon</p>\n</td>\n<td width=\206\>\n<p>Uncommon</p>\n</td>\n</tr>\n<tr>\n<td width=\206\>\n<p><strong>Serum insulin level</strong></p>\n</td>\n<td width=\206\>\n<p>High</p>\n</td>\n<td width=\206\>\n<p>Low</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1606, 'Medicine', 'PM0987. Comparative Features of Type I and Type II Diabetes mellitus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\155\>\n<p>&nbsp;</p>\n</td>\n<td width=\211\>\n<p><strong>Type 1 DM</strong></p>\n</td>\n<td width=\198\>\n<p><strong>Type 2 DM</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p><strong>Etiology</strong></p>\n</td>\n<td width=\211\>\n<p>Autoimmune</p>\n</td>\n<td width=\198\>\n<p>Insulin resistance which later leads to impaired insulin secretion</p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p><strong>Age at onset</strong></p>\n</td>\n<td width=\211\>\n<p>Usually young children</p>\n</td>\n<td width=\198\>\n<p>Adult</p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p><strong>HLA association</strong></p>\n</td>\n<td width=\211\>\n<p><strong>DR3, DR4</strong></p>\n</td>\n<td width=\198\>\n<p>No HLA association</p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p><strong>Body weight</strong></p>\n</td>\n<td width=\211\>\n<p>Normal / Underweight</p>\n</td>\n<td width=\198\>\n<p><strong>Obese</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p><strong>Family history</strong></p>\n</td>\n<td width=\211\>\n<p>May or may not be positive</p>\n</td>\n<td width=\198\>\n<p>Usually<strong> strongly positive</strong>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p><strong>Presentation</strong></p>\n</td>\n<td width=\211\>\n<p>Abrupt</p>\n</td>\n<td width=\198\>\n<p>Gradual or symptomatic</p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p><strong>Insulin requirement</strong></p>\n</td>\n<td width=\211\>\n<p>Absolute</p>\n</td>\n<td width=\198\>\n<p>Oral hypoglycemics, later insulin</p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p><strong>Serum insulin level / C peptide level</strong></p>\n</td>\n<td width=\211\>\n<p>Low</p>\n</td>\n<td width=\198\>\n<p>High</p>\n</td>\n</tr>\n<tr>\n<td width=\155\>\n<p><strong>&nbsp;</strong></p>\n<p><strong>Clinical Features</strong></p>\n</td>\n<td width=\211\>\n<p><strong>Diabetic ketoacidosis</strong> is common&nbsp;</p>\n<p>It is associated with other autoimmune diseases like:</p>\n<p><strong>Thyroid disorders</strong></p>\n<ul>\n<li>Addisons disease</li>\n<li>Rheumatoid arthritis</li>\n<li>Schmidt syndrome/ Polyglandular failure syndrome</li>\n</ul>\n</td>\n<td width=\198\>\n<p><strong>Non-ketotic hyperosmolar coma</strong> is common</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1607, 'Medicine', 'PM0986. Types of Diabetes mellitus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>I. <strong>Type 1 diabetes</strong>:<strong>&nbsp;</strong>Beta cell destruction, usually leading to absolute insulin deficiency</p>\n<ul>\n<li>Immune-mediated</li>\n<li>Idiopathic</li>\n</ul>\n<p>II. <strong>Type 2 diabetes</strong>: Insulin resistance with relative insulin deficiency</p>\n<p>III.&nbsp;<strong>Other specific types</strong> of diabetes</p>\n<ul>\n<li>Genetic defects of beta cell development or function\n<ul>\n<li><strong>MODY – </strong>Maturity Onset Diabetes of Young</li>\n</ul>\n</li>\n<li>Genetic defects in insulin action\n<ul>\n<li>Type A insulin resistance</li>\n<li>Leprechaunism</li>\n<li>Rabson-Mendenhall syndrome Lipodystrophy syndromes</li>\n</ul>\n</li>\n<li>Diseases of the exocrine pancreas\n<ul>\n<li>Pancreatitis</li>\n<li>Neoplasia</li>\n<li>Cystic fibrosis</li>\n<li>Hemochromatosis</li>\n</ul>\n</li>\n<li>Endocrinopathies\n<ul>\n<li>Acromegaly</li>\n<li>Cushing’s syndrome</li>\n<li>Glucagonoma</li>\n<li>Pheochromocytoma</li>\n<li>Hyperthyroidism</li>\n</ul>\n</li>\n<li>Infections\n<ul>\n<li>Congenital rubella</li>\n<li>Cytomegalovirus</li>\n<li>Coxsackievirus</li>\n</ul>\n</li>\n<li>Uncommon forms of immune-mediated diabetes\n<ul>\n<li>“Stiff-person” syndrome</li>\n<li>Anti-insulin receptor antibodies</li>\n</ul>\n</li>\n<li>Genetic syndromes sometimes associated with diabetes\n<ul>\n<li>Wolfram’s syndrome</li>\n<li>Down’s syndrome, Klinefelter’s syndrome, Turner’s syndrome</li>\n</ul>\n</li>\n</ul>\n<p>IV.<strong> Gestational diabetes mellitus (GDM)</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1608, 'Medicine,', 'PM0929. Causes of Male Infertility', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Pre-testicular causes:</strong></p>\n<p>Endocrine cause</p>\n<ul>\n<li>Gonadotropin deficiency</li>\n<li>Thyroid dysfunction</li>\n<li>Hyperprolactinemia</li>\n</ul>\n<p>Psychosexual</p>\n<ul>\n<li>Impotence</li>\n<li>Erectile dysfunction</li>\n</ul>\n<p>Drugs</p>\n<ul>\n<li>Antihypertensives</li>\n<li>Antipsychotics</li>\n</ul>\n<p>Genetics</p>\n<ul>\n<li>47XXY</li>\n<li>Y chromosome deletions</li>\n</ul>\n<p><strong>Testicular causes:</strong></p>\n<ul>\n<li>Immotile cilia syndrome</li>\n<li>Cryptorchidism</li>\n<li>Orchitis (mumps, Tb, gonorrhoea, traumatic)</li>\n<li>Toxins(Drugs,radiation)</li>\n<li>Primary testicular failure</li>\n<li>Sertoli cell-only syndrome</li>\n<li>Oligoasthenoteratozoospermia</li>\n</ul>\n<p><strong>Post-testicular causes:</strong></p>\n<p>Obstruction of efferent duct&nbsp;</p>\n<p>Congenital</p>\n<ul>\n<li>Absence of Vas deferens</li>\n<li>Youngs syndrome</li>\n</ul>\n<p>Acquired (Inflammatory block)</p>\n<ul>\n<li>Tuberculosis</li>\n<li>Gonorrhea</li>\n</ul>\n<p>Surgical</p>\n<ul>\n<li>Vasectomy</li>\n</ul>\n<p>Others</p>\n<ul>\n<li>Ejaculatory failure</li>\n<li>Bladder neck surgery</li>\n<li>Retrograde ejaculation&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1609, 'Medicine,', 'PM0786. Causes of Hypothyroidism', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Primary </strong></p>\n<p>(Low T3, T4 → Raised TSH levels)</p>\n</td>\n<td>\n<p><strong>Secondary</strong></p>\n<p><strong> </strong>(Low TSH levels → Low T3, T4)</p>\n</td>\n<td>\n<p><strong>Tertiary</strong></p>\n<p><strong> </strong>(Low TRH → Low TSH → Low T3,T4)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hashimoto’s thyroiditis</strong></p>\n<p>RAI therapy for Grave’s disease</p>\n<p>Post thyroidectomy</p>\n<p>Excessive iodine intake - Wolff Chiakoff effect</p>\n<p>Subacute thyroiditis</p>\n<p>Medications: Antithyroid drugs, lithium</p>\n<p>Iodine deficiency, dyshormonogenesis</p>\n</td>\n<td>\n<p><strong>Pituitary tumour</strong></p>\n<p>Pituitary resection or ablation</p>\n</td>\n<td>\n<p><strong>Hypothalamic insufficiency</strong></p>\n<p>Resistance to thyroid hormone</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1610, 'Surgery,', 'PM0784. Thyroid storm / Thyrotoxic crisis:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>It is an emergency caused by an acute exacerbation of hyperthyroidism.&nbsp;</p>\n<p>Precipitating factors:</p>\n<ul>\n<li>When a thyrotoxic patient has been<strong> inadequately prepared for thyroidectomy</strong></li>\n<li>Abrupt cessation of antithyroid medications</li>\n<li>Stress\n<ul>\n<li>Infection</li>\n<li>Thyroid or non-thyroid surgery</li>\n<li>Trauma in patients with untreated thyrotoxicosis</li>\n</ul>\n</li>\n<li>Acute iodine load\n<ul>\n<li>Amiodarone administration&nbsp;</li>\n<li>Exposure to iodinated contrast agents</li>\n<li>Following RAI therapy</li>\n</ul>\n</li>\n</ul>\n<p>Clinical features:</p>\n<ul>\n<li>Fever</li>\n<li>Tachycardia</li>\n<li>Altered mentation (delirium, psychosis, coma)</li>\n<li>GI symptoms (nausea, vomiting, diarrhoea)</li>\n<li><strong>Atrial fibrillation</strong> and <strong>cardiac failure</strong> - most common causes of death</li>\n</ul>\n<p>Treatment of thyroid storm:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Treatment modality</strong></td>\n<td><strong>Effect</strong></td>\n</tr>\n<tr>\n<td>IV Fluids, ice packs</td>\n<td>Rehydration and external cooling</td>\n</tr>\n<tr>\n<td><strong>Propylthiouracil</strong><br><strong>(DOC)</strong></td>\n<td>\n<p>Reduces peripheral T4 to T3 conversion</p>\n</td>\n</tr>\n<tr>\n<td>Propranolol</td>\n<td>\n<p>Block adrenergic effects</p>\n<p>Reduces peripheral T4 to T3 conversion</p>\n</td>\n</tr>\n<tr>\n<td>Corticosteroids</td>\n<td>\n<p>Inhibits the release of thyroid hormone from the gland</p>\n<p>Reduces peripheral T4 to T3 conversion</p>\n</td>\n</tr>\n<tr>\n<td>Lugol’s iodine/ sodium ipodate</td>\n<td>Inhibits the release of thyroid hormone from the gland</td>\n</tr>\n<tr>\n<td>Digoxin</td>\n<td>Controls the associated atrial fibrillation</td>\n</tr>\n<tr>\n<td>Diuretics and administration of oxygen</td>\n<td>\n<p>To manage cardiac failure</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1611, 'Medicine', 'PM0122. Antibodies seen in some autoimmune thyroid disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Antibody</strong></td>\n<td><strong>Disorder</strong></td>\n</tr>\n<tr>\n<td>TSH receptor-stimulating Immunoglobulins (TSI)</td>\n<td>Graves disease</td>\n</tr>\n<tr>\n<td>Anti TPO &amp; Anti Tg antibodies</td>\n<td>Chronic lymphocytic(Hashimoto) thyroiditis</td>\n</tr>\n<tr>\n<td>\n<p>TRBAb</p>\n<p>(maternal transmission)</p>\n</td>\n<td>Transient congenital hypothyroidism (maternal autoimmune thyroid disease)</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li>Anti TPO – Anti thyroperoxidase antibody</li>\n<li>Anti Tg – Antithyroglobulin antibody</li>\n<li>TRBAb – TSH receptor blocking antibodies</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1612, 'Medicine', 'PM2432. Maddrey score', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Maddrey score or DF score:</p>\n<ul>\n<li>DF =&nbsp;4.6 X (the prolongation of the prothrombin time above control [seconds]) + serum bilirubin (mg/dL)</li>\n<li>To assess the prognosis in alcoholic hepatitis.</li>\n<li>DF ≥ 32 is severe disease&nbsp; and is an indication for starting glucocorticoids.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1613, 'Medicine,', 'PM2163. Indications of liver transplantation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Adult</strong></p>\n</td>\n<td>\n<p><strong>Children</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Non-cholestatic (65%)</p>\n<ul>\n<li>Viral hepatitis B and C</li>\n<li>Alcoholic liver cirrhosis</li>\n<li>Cryptogenic</li>\n</ul>\n<p>Cholestatic (14%)</p>\n<ul>\n<li>Primary biliary cirrhosis</li>\n<li>Primary sclerosing cholangitis</li>\n</ul>\n<p>Autoimmune (5%)</p>\n<p>Malignant neoplasm (2%)</p>\n<p>Miscellaneous (14%)</p>\n</td>\n<td>\n<p>Biliary atresia (58%)</p>\n<p>Inborn errors of metabolism (11%)</p>\n<p>Cholestatic (9%)</p>\n<ul>\n<li>Primary sclerosing cholangitis</li>\n<li>Alagille syndrome</li>\n</ul>\n<p>Autoimmune (4%)</p>\n<p>Viral hepatitis (2%)</p>\n<p>Miscellaneous (16%)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1614, 'Medicine', 'PM2049. Serum Ascites Albumin Gradient  (SAAG)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The serum ascites albumin gradient is calculated as follows:</p>\n<p>SAAG = Serum albumin - Ascitic fluid albumin</p>\n<p>It can be used to determine the cause of ascites following ascitic fluid analysis.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/08ad7499e5e74b398f3c98a430c6af02x1200x1361.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1615, 'Medicine', 'PM2048. Causes of Portal Hypertension', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ba11a261470c410298f73941ff987a2fx1280x2190.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1616, 'Medicine', 'PM1985. Drugs causing acute Pancreatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp;Group</strong></td>\n<td><strong>&nbsp;Examples</strong></td>\n</tr>\n<tr>\n<td>Angiotensin-converting enzyme inhibitors</td>\n<td>\n<p>Captopril</p>\n<p>Lisinopril</p>\n<p>Enalapril</p>\n</td>\n</tr>\n<tr>\n<td>Angiotensin receptor inhibitor</td>\n<td>&nbsp;Losartan</td>\n</tr>\n<tr>\n<td>Antimicrobial</td>\n<td>\n<p>Erythromycin</p>\n<p>Isoniazid</p>\n<p>Metronidazole</p>\n<p>Sulfamethazine</p>\n<p>Sulfamethoxazole</p>\n<p>Tetracycline</p>\n<p>Dapsone</p>\n</td>\n</tr>\n<tr>\n<td>Antithyroid</td>\n<td>&nbsp;Carbimazole</td>\n</tr>\n<tr>\n<td>H2 blocker</td>\n<td>\n<p>Cimetidine</p>\n</td>\n</tr>\n<tr>\n<td>Antipsychotics</td>\n<td>&nbsp;Clozapine</td>\n</tr>\n<tr>\n<td>Antiepileptic</td>\n<td>\n<p>Valproic acid</p>\n</td>\n</tr>\n<tr>\n<td>Steroids&nbsp;</td>\n<td>\n<p>Dexamethasone</p>\n<p>Hydrocortisone</p>\n</td>\n</tr>\n<tr>\n<td>Diuretics&nbsp;</td>\n<td>\n<p>Furosemide</p>\n<p>Hydrochlorothiazide</p>\n</td>\n</tr>\n<tr>\n<td>Lipid-lowering drugs&nbsp;</td>\n<td>\n<ul>\n<li>Simvastatin</li>\n<li>Fluvastatin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hormones</td>\n<td>\n<ul>\n<li>Estrogen&nbsp;</li>\n<li>Stibogluconate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Anticancer drugs</td>\n<td>\n<ul>\n<li>5-Aminosalicylic acid compounds</li>\n<li>L-Asparaginase</li>\n<li>Azathioprine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Others</td>\n<td>\n<p>Acetaminophen</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1617, 'Medicine', 'PM1934. Differences between primary sclerosing cholangitis (PSC)  and primary biliary cholangitis (PBC)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Primary Biliary Cholangitis</strong></td>\n<td><strong>Primary Sclerosing Cholangitis</strong></td>\n</tr>\n<tr>\n<td>Antibodies</td>\n<td>\n<p>Antimitochondrial antibodies positive in most patients</p>\n<p>Antinuclear antibodies positive</p>\n</td>\n<td>\n<div class=\page\ title=\Page 860\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Antimitochondrial antibodies /AMA typically negative</p>\n</div>\n</div>\n</div>\n</div>\n<p><strong>p-ANCA</strong>-positive</p>\n</td>\n</tr>\n<tr>\n<td>Age group</td>\n<td>40–60 years</td>\n<td>30-45 years</td>\n</tr>\n<tr>\n<td>Gender predominance</td>\n<td>Females</td>\n<td>Males</td>\n</tr>\n<tr>\n<td>Site</td>\n<td>Intrahepatic&nbsp;bile ducts only</td>\n<td>Intra- and extrahepatic bile ducts</td>\n</tr>\n<tr>\n<td>&nbsp;Associated with</td>\n<td>\n<p>Sjogren syndrome</p>\n<p>Hashimotos thyroiditis&nbsp;</p>\n<p>CREST&nbsp;syndrome</p>\n<p>Rheumatoid arthritis</p>\n<p>Celiac disease</p>\n</td>\n<td><strong>Ulcerative colitis</strong></td>\n</tr>\n<tr>\n<td>Diagnosis</td>\n<td>Biopsy</td>\n<td>MRCP/ERCP-strictures&nbsp;</td>\n</tr>\n<tr>\n<td>Biopsy findings</td>\n<td>&nbsp;<strong>Florid duct lesion</strong> (granuloma)</td>\n<td>Concentric \<strong>onion-skin\</strong>&nbsp;fibrosis &nbsp; &nbsp;</td>\n</tr>\n<tr>\n<td>Long-term complication</td>\n<td>Cirrhosis</td>\n<td>\n<p>Cirrhosis</p>\n<p>Cholangiocarcinoma</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1618, 'Medicine', 'PM1931. Types of acute  liver failure', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Condition&nbsp;</strong></td>\n<td>\n<p><strong>Time</strong></p>\n</td>\n<td>\n<p><strong>Cerebral edema&nbsp;</strong></p>\n</td>\n<td><strong>Causes</strong></td>\n</tr>\n<tr>\n<td>Hyperacute liver failure</td>\n<td>&nbsp;7 days or less</td>\n<td>Common&nbsp;</td>\n<td>Viral<br>paracetamol</td>\n</tr>\n<tr>\n<td>Acute liver faliure</td>\n<td>&nbsp;8 to 28 days</td>\n<td>Common</td>\n<td>Cryptogenic<br>drugs</td>\n</tr>\n<tr>\n<td>Subacute liver failure</td>\n<td>&nbsp;4 to 24 weeks</td>\n<td>Uncommon</td>\n<td>Cryptogenic<br>drugs</td>\n</tr>\n</tbody>\n</table>\n<p><span>Time: onset of jaundice to&nbsp; encephalopathy</span></p></div><!---->\n      <!---->\n    </div><!---->'),
(1619, 'Medicine', 'PM1902. Extrahepatic Manifestations of Hepatitis B and C', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Hepatitis B</strong></td>\n<td><strong>Hepatitis C</strong></td>\n</tr>\n<tr>\n<td>Hematological</td>\n<td>\n<p>Aplastic anemia</p>\n</td>\n<td>\n<p>Essential mixed cryoglobulinemia</p>\n</td>\n</tr>\n<tr>\n<td>Renal</td>\n<td>\n<p>Membranous glomerulonephritis (hepatitis B &gt; C)</p>\n<p>Membranoproliferative glomerulonephritis</p>\n</td>\n<td>\n<p>Membranoproliferative glomerulonephritis</p>\n<p>Membranous glomerulonephritis &nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Vascular</td>\n<td>\n<p>Polyarteritis nodosa (hepatitis B&gt;C)</p>\n</td>\n<td>\n<p>Leukocytoclastic vasculitis</p>\n</td>\n</tr>\n<tr>\n<td>Dermatologic</td>\n<td>\n<p>Erythema multiforme (Hepatitis B&gt;C)</p>\n<p>Urticaria</p>\n<p>Serum sickness</p>\n<p>Infantile papular acrodermatitis (Gianotti–Crosti syndrome)</p>\n<p>Erythema nodosum</p>\n</td>\n<td>\n<p>Erythema multiforme</p>\n<p>Sporadic porphyria cutanea tarda</p>\n<p>Lichen planus</p>\n<p>Necrolytic acral erythema</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>Hepatitis C also increases the risk of:</p>\n<ul>\n<li>Non-Hodgkin’s lymphoma</li>\n<li>Idiopathic thrombocytopenic purpura</li>\n<li>Autoimmune hemolytic anemia</li>\n<li>Diabetes mellitus</li>\n<li>Autoimmune thyroiditis &nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1620, 'Medicine', 'PM1881. Rotor syndrome vs Dubin johnson syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Rotor syndrome</strong></td>\n<td><strong>Dubin Johnson syndrome</strong></td>\n</tr>\n<tr>\n<td>Inheritance</td>\n<td>Autosomal recessive</td>\n<td>Autosomal recessive</td>\n</tr>\n<tr>\n<td>Defect</td>\n<td>Organic anion transporting polypeptide &nbsp;defect.(OATP1B1,OATP1B3)</td>\n<td>Multi drug resistance protein (MRP )2 mutation</td>\n</tr>\n<tr>\n<td>Kernicterus</td>\n<td>Absent</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Biopsy</td>\n<td>Normal</td>\n<td>Black pigmentation</td>\n</tr>\n<tr>\n<td>Total Urinary &nbsp;coproporphyrin</td>\n<td>Elevated</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>Urinary &nbsp;coproporphyrin I</td>\n<td>&lt;70%</td>\n<td>&gt;80%</td>\n</tr>\n<tr>\n<td>Bromsulphalein clearance test</td>\n<td>Slow clearance</td>\n<td>No/Delayed clearance</td>\n</tr>\n<tr>\n<td>Gall bladder on oral cholangiography</td>\n<td>Visualized</td>\n<td>Not visualized</td>\n</tr>\n<tr>\n<td>Cholestasis</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Serum bile acids</td>\n<td>Normal</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>Jaundice</td>\n<td>Mild (TB&lt;4mg/dl)</td>\n<td>Mild (TB&lt;4mg/dl)</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\></div><!---->\n      <!---->\n    </div><!---->'),
(1621, 'Medicine', 'PM1855. Diagnostic criteria for Clostridium difficile infection', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p>The diagnosis of CDI is based on a combination of clinical criteria:</p>\n<p>1.Diarrhea (≥3 unformed stools per 24 h for ≥2 days) with no other recognized cause&nbsp; &nbsp; &nbsp;&nbsp;</p>\n<p>2.Detection of toxins A or B in the stool by PCR or culture</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>\n<p>&nbsp;Detection of pseudomembranes in the colon</p></div><!---->\n      <!---->\n    </div><!---->'),
(1622, 'Medicine', 'PM1854. Investigations in  Malabsorption Syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The following are the general tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Fat malabsorption</td>\n<td>\n<p>Quantitative: 24h fecal fat &gt;7g</p>\n<p>Qualitative: Sudan III staining</p>\n<p>C<sup>14</sup> Triolein breath test</p>\n<p>Fecal steatocrit</p>\n</td>\n</tr>\n<tr>\n<td>Carbohydrate malabsorption</td>\n<td>\n<p>D-xylose test</p>\n<p>Lactose hydrogen breath test</p>\n</td>\n</tr>\n<tr>\n<td>Protein malabsorption</td>\n<td>C<sup>13</sup> egg-white breath test</td>\n</tr>\n</tbody>\n</table>\n<p>The following are the specific tests for malabsorption:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Investigation</strong></td>\n</tr>\n<tr>\n<td>Celiac disease</td>\n<td>\n<p>Anti-tissue transglutaminase (anti-tTG)</p>\n<p>Anti-endomysial antibodies</p>\n<p>Mucosal biopsy showing villous atrophy, crypt hyperplasia, lamina propria infiltrates, and normal mucosal thickness.</p>\n</td>\n</tr>\n<tr>\n<td>Whipples disease</td>\n<td>Mucosal biopsy showing PAS +ve macrophages in lamina propria</td>\n</tr>\n<tr>\n<td>Pancreatic insufficiency</td>\n<td>\n<p>Fecal elastase</p>\n<p>Fecal chymotrypsin</p>\n</td>\n</tr>\n<tr>\n<td>Small intestinal bacterial overgrowth (SIBO)</td>\n<td>\n<p>Due to Enterobacter or Pseudomonas - jejunal aspirate&nbsp;&gt;10<sup>3</sup>&nbsp;CFU</p>\n<p>Due to other organisms - jejunal aspirate&nbsp;&gt;10<sup>5</sup> CFU</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1623, 'Medicine', 'PM1853. Types of Chronic gastritis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Type A and Type B</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Type B (90% cases)</strong></td>\n<td><strong>Type A (10% cases)</strong></td>\n</tr>\n<tr>\n<td><strong>Association</strong></td>\n<td><em>Helicobacter&nbsp;pylori</em></td>\n<td>\n<p>Autoimmune disease</p>\n</td>\n</tr>\n<tr>\n<td><strong>Site</strong></td>\n<td>Antral Predominant</td>\n<td>Fundus and body with antral sparing</td>\n</tr>\n<tr>\n<td><strong>Acid Production</strong></td>\n<td>Normal to increased</td>\n<td>Decreased (<strong>achlorhydria)</strong></td>\n</tr>\n<tr>\n<td><strong>Gastrin</strong></td>\n<td>Normal to increased</td>\n<td>Increased <strong>(hypergastrinemia)</strong></td>\n</tr>\n<tr>\n<td><strong>HLA</strong></td>\n<td>No association</td>\n<td>HLA DR3, HLA B8</td>\n</tr>\n<tr>\n<td><strong>Serology</strong></td>\n<td>Antibodies to <em>H. pylori</em></td>\n<td>\n<p>Sensitive: Anti-parietal antibodies</p>\n<p>Specific: Anti-IF antibodies</p>\n</td>\n</tr>\n<tr>\n<td><strong>Cytokines involved</strong></td>\n<td>\n<p>IL-1, IL-8</p>\n</td>\n<td>No</td>\n</tr>\n<tr>\n<td><strong>Long term sequelae</strong></td>\n<td>\n<p>Non-atrophic pan gastritis- MALTOMA</p>\n<p>Atrophic pan gastritis-Adenocarcinoma</p>\n<p>Peptic ulcer</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<p>Diffuse atrophy,</p>\n<p>Pernicious anemia,</p>\n<p>Adenocarcinoma,</p>\n<p>Gastric carcinoid tumors</p>\n</td>\n</tr>\n<tr>\n<td><strong>Histology</strong></td>\n<td>\n<p>Intraepithelial neutrophils,</p>\n<p>Subepithelial plasma cells</p>\n</td>\n<td>Lymphocytes, plasma cells,&nbsp;and macrophages</td>\n</tr>\n<tr>\n<td><strong>Other associated lesion</strong></td>\n<td>\n<p>Hyperplastic/inflammatory polyps</p>\n</td>\n<td>Neuroendocrine hyperplasia</td>\n</tr>\n<tr>\n<td><strong>Association</strong></td>\n<td>Low socioeconomic&nbsp;status, poverty,&nbsp;residence in rural areas</td>\n<td>Autoimmune diseases like&nbsp;thyroiditis, diabetes&nbsp;mellitus, Graves disease</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1624, 'Medicine,', 'PM1852. Endoscopic Findings in Esophagitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Conditions</strong></td>\n<td><strong>Endoscopic findings</strong></td>\n</tr>\n<tr>\n<td>Infectious esophagitis</td>\n<td>Diffuse and involve the proximal esophagus &nbsp;</td>\n</tr>\n<tr>\n<td>HSV esophagitis</td>\n<td>Vesicles and small punched-out lesions (volcano ulcers)</td>\n</tr>\n<tr>\n<td>CMV&nbsp;esophagitis</td>\n<td>Serpiginous ulcers</td>\n</tr>\n<tr>\n<td>Peptic esophagitis</td>\n<td>Solitary and distal &nbsp;</td>\n</tr>\n<tr>\n<td>Eosinophilic esophagitis</td>\n<td>Multiple esophageal rings, linear furrows, or white punctate exudates (feline esophagus)</td>\n</tr>\n<tr>\n<td>Pill esophagitis</td>\n<td>Singular and deep at points of luminal narrowing with sparing of the distal esophagus</td>\n</tr>\n<tr>\n<td>Candida esophagitis</td>\n<td>White friable plaques, in advance form - adherent, grey-white pseudomembranes.</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>The image below shows the lesions of CMV esophagitis.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4d3459a16bb04e7db0a37697b70d64f3x358x327.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The image below shows the lesions of candida esophagitis.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/27753ea663e94016878e0fdfbfe7ab80x526x488.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The image below shows feline esophagus in eosinophilic esophagitis.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/fd7fb7a1bf14483f9405672cd6b522dex592x472.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The image below shows the erosive lesion of pill esophagitis.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b7d3184539ba462d8fa7bfd006f20927x512x399.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The image below shows the lesions of HSV esophagitis.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6b4e6f9f77b44981b91065e60457a1e6x388x439.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1625, 'Medicine', 'PM1848. Inlammatory Bowel Disease (IBD): General One-Liners', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>FEATURE</td>\n<td>CAUSE/PRESENTATION</td>\n</tr>\n<tr>\n<td>Most common ophthalmic manifestation of IBD</td>\n<td>Uveitis and episcleritis</td>\n</tr>\n<tr>\n<td>Most common ophthalmic manifestation correlate with relapse</td>\n<td>Episcleritis</td>\n</tr>\n<tr>\n<td>Feature of arthritis in IBD (LAMP-P)</td>\n<td>Lower limb-asymmetric- migrating- peripheral-pauci-articular</td>\n</tr>\n<tr>\n<td>Correlate with early complication in CD</td>\n<td><br>\n<h3 class=\r\><span>Anti-<em>Saccharomyces cerevisiae</em> antibodies </span></h3>\n</td>\n</tr>\n<tr>\n<td>Predict the response to surgery in CD</td>\n<td>Anti-I2</td>\n</tr>\n<tr>\n<td>No role in&nbsp; maintenance of IBD</td>\n<td>Steroids</td>\n</tr>\n<tr>\n<td>Fecal antigen used in IBD</td>\n<td>Lactoferrin, Calprotectin</td>\n</tr>\n<tr>\n<td>Gene involved in&nbsp; IBD</td>\n<td><em>NOD2</em>, Chr 16</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;CD- Crohns Disease</p>\n<p>IBD - Inflammatory Bowel Disease</p></div><!---->\n      <!---->\n    </div><!---->'),
(1626, 'Medicine', 'PM1847. Inflammatory Bowel Disease (IBD)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Crohns disease</strong></td>\n<td><strong>Ulcerative colitis</strong></td>\n</tr>\n<tr>\n<td><strong>Age of onset&nbsp;</strong></td>\n<td>2nd-4th decades &amp; 7th-9th decades</td>\n<td>2nd-4th decades &amp; 7th-9th decades&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Most common presentation</strong></td>\n<td>Ileocolitis&nbsp;with rectal sparing</td>\n<td>Proctitis (rectum)</td>\n</tr>\n<tr>\n<td><strong>Protective factors</strong></td>\n<td>&nbsp;None&nbsp;</td>\n<td>\n<p>Smoking&nbsp;</p>\n<p>Appendicectomy</p>\n</td>\n</tr>\n<tr>\n<td><strong>Risk factors</strong></td>\n<td>\n<p>OCP</p>\n<p>Smoking</p>\n<p>Antibiotic during first year of life&nbsp;</p>\n</td>\n<td>\n<p>α-Methyldopa</p>\n<p>Antibiotic during first year of life</p>\n</td>\n</tr>\n<tr>\n<td><strong>T cell involved</strong></td>\n<td>TH1&nbsp;</td>\n<td>TH2</td>\n</tr>\n<tr>\n<td><strong>Gross findings/ endoscopic findings</strong></td>\n<td>\n<p>Transmural involvement</p>\n<p>Segmental involvement</p>\n<p>Skip lesions</p>\n<p>Cobblestone appearance</p>\n<p>Creeping fat</p>\n<p>Longitudinal ulcers</p>\n</td>\n<td>\n<p>Mucosal and superficial submucosal involvement&nbsp;</p>\n<p>Continuous involvement</p>\n<p>Pseudopolyps&nbsp;</p>\n<p>Backwash ileitis&nbsp;</p>\n<p>Collar button ulcers</p>\n</td>\n</tr>\n<tr>\n<td><strong>Earliest finding</strong></td>\n<td>Aphthous ulcer</td>\n<td>Erythematous mucosa with a fine granular surface</td>\n</tr>\n<tr>\n<td><strong>Microscopic findings&nbsp;</strong></td>\n<td>\n<p class=\p1\>Deep, knife-like ulcers</p>\n<p>Granulomas</p>\n<p>Pyloric metaplasia&nbsp;&nbsp;</p>\n</td>\n<td>\n<p class=\p1\>Superficial, broad-based</p>\n<p>Cryptitis and crypt abscess&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Complications&nbsp;</strong></td>\n<td>\n<p>Fistulas&nbsp;</p>\n<p>Strictures</p>\n</td>\n<td>\n<p>Hemorrhage</p>\n<p>Toxic megacolon</p>\n</td>\n</tr>\n<tr>\n<td><strong>Recurrence after resection</strong></td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Uncommon, curative after resection</p>\n</td>\n</tr>\n<tr>\n<td><strong>Radiological findings&nbsp;</strong></td>\n<td>\n<p>Aphthous ulcer</p>\n<p>Rose thorn appearance</p>\n</td>\n<td>\n<p>Mucosal granularity</p>\n<p>Lead pipe appearance</p>\n</td>\n</tr>\n<tr>\n<td><strong>Extraintestinal manifestations</strong></td>\n<td colspan=\2\>\n<div class=\page\ title=\Page 807\>\n<div class=\page\ title=\Page 807\>\n<div class=\page\ title=\Page 807\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Episcleritis, uveitis&nbsp;</p>\n<p>Migratory polyarthritis</p>\n<p>Ankylosing spondylitis, sacroiliitis</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\page\ title=\Page 807\>\n<div class=\page\ title=\Page 807\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Erythema nodosum</p>\n<p>Pyoderma gangrenosum- MC in UC</p>\n<p>Primary sclerosing cholangitis- MC in UC</p>\n<p>Renal Calculi- MC in CD</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n<p><br><br></p></div><!---->\n      <!---->\n    </div><!---->'),
(1627, 'Medicine,', 'PM1802. Glasgow-Blatchford score For UGI bleed', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Total score ranges from <strong>0 to 23.</strong></li>\n<li>Hemoglobin value scores differs for men and women.</li>\n<li>Scores of <strong>6 or more</strong> were associated with a greater than <strong>50% risk of needing an intervention</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Factors</strong></td>\n<td><strong>Value</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td><strong>Systolic blood pressure</strong></td>\n<td>\n<p>100-109 mmHg</p>\n<p>90-99 mmHg</p>\n<p>&lt;90 mmHg</p>\n</td>\n<td>\n<p>1</p>\n<p>2</p>\n<p>3</p>\n</td>\n</tr>\n<tr>\n<td><strong>Blood urea nitrogen</strong></td>\n<td>\n<p><strong>6.5-7.9 mmol/L</strong></p>\n<p>8.0-9.9 mmol/L</p>\n<p>10.0-24.9 mmol/L</p>\n<p><strong>≥25 mmol/L</strong></p>\n</td>\n<td>\n<p><strong>2</strong></p>\n<p>3</p>\n<p>4</p>\n<p><strong>6</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Haemoglobin for men</strong></td>\n<td>\n<p>12.0-12.9 g/dl</p>\n<p><strong>10.0-11.9 g/dL</strong></p>\n<p><strong>10.0g/dL</strong></p>\n</td>\n<td>\n<p>1</p>\n<p><strong>3</strong></p>\n<p><strong>6</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Haemoglobin for women</strong></td>\n<td>\n<p>&lt;10.0-11.9 g/dL</p>\n<p>&lt;10.0 g/dL</p>\n<p>Pulse&nbsp;≥100 beats/min</p>\n</td>\n<td>\n<p>1</p>\n<p>6</p>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td><strong>Other variable at presentation</strong></td>\n<td>\n<p>Melena</p>\n<p>Syncope</p>\n<p>Hepatic disease</p>\n<p>Cardiac failure</p>\n</td>\n<td>\n<p>1</p>\n<p>2</p>\n<p>2</p>\n<p>2</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1628, 'Surgery,', 'PM1633. Ranson Prognostic Criteria for Acute Pancreatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\471\>\n<tbody>\n<tr>\n<td colspan=\3\><strong>Ransons prognostic criteria at presentation</strong></td>\n</tr>\n<tr>\n<td><strong>Parameter</strong></td>\n<td><strong>Non-gallstone pancreatitis</strong></td>\n<td><strong>Gallstone pancreatitis</strong></td>\n</tr>\n<tr>\n<td><strong>Age</strong></td>\n<td>&gt;55 years</td>\n<td>&gt;70 years</td>\n</tr>\n<tr>\n<td><strong>Blood glucose level</strong></td>\n<td>&gt;200 mg/dL</td>\n<td>&gt;220 mg/dL</td>\n</tr>\n<tr>\n<td><strong>White blood cell count</strong></td>\n<td>&gt;16,000 cells/mm<sup>3</sup></td>\n<td>&gt;18,000 cells/mm<sup>3</sup></td>\n</tr>\n<tr>\n<td><strong>Serum LDH level</strong></td>\n<td>&gt;350 IU/L</td>\n<td>&nbsp;&gt;400 IU/L</td>\n</tr>\n<tr>\n<td><strong>Serum Aspartate aminotransferase level</strong></td>\n<td>&nbsp;&gt;250 IU/L</td>\n<td>&nbsp;&gt;250 IU/L</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table width=\484\>\n<tbody>\n<tr>\n<td colspan=\3\><strong>Ransons prognostic criteria after 48 hours of admission</strong></td>\n</tr>\n<tr>\n<td><strong>Parameter</strong></td>\n<td><strong>Non-gallstone pancreatitis</strong></td>\n<td><strong>Gallstone pancreatitis&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Hematocrit fall<br></strong></td>\n<td>&gt;10%</td>\n<td>&gt;10%</td>\n</tr>\n<tr>\n<td><strong>Serum calcium level</strong></td>\n<td>&lt;8 mg/dL</td>\n<td>&lt;8 mg/dL</td>\n</tr>\n<tr>\n<td><strong>Base deficit</strong></td>\n<td>&gt;4 mEq/L</td>\n<td>&gt;5 mEq/L</td>\n</tr>\n<tr>\n<td><strong>Blood urea nitrogen level increase&nbsp;<br></strong></td>\n<td>\n<p>≥5 mg/dL despite IV fluid hydration</p>\n</td>\n<td>≥2 mg/dL despite IV fluid hydration</td>\n</tr>\n<tr>\n<td><strong>Fluid sequestration<br></strong></td>\n<td>&nbsp;&gt;6 L</td>\n<td>&nbsp;&gt;4 L</td>\n</tr>\n<tr>\n<td><strong>PaO<sub>2</sub></strong></td>\n<td>&nbsp;&lt;60 mm Hg</td>\n<td>&nbsp;Not available</td>\n</tr>\n</tbody>\n</table>\n<p>Ranson score<strong> ≥3</strong> defines <strong>severe pancreatitis</strong>.</p>\n<p><strong>Score Interpretation</strong></p>\n<ul>\n<li class=\half_rhythm\>\n<div>0 to 2 points: 0% to 3% mortality</div>\n</li>\n<li class=\half_rhythm\>\n<div>3 to 4 points: 15% mortality</div>\n</li>\n<li class=\half_rhythm\>\n<div>5 to 6 points: 40% mortality</div>\n</li>\n<li class=\half_rhythm\>\n<div>7 to 11: nearly 100% mortality</div>\n</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1629, 'Medicine,', 'PM1603. Revised Model for End-stage liver disease  (MELD) scoring system: MELD 3.0', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>MELD 3.0 score has the following components (Mnemonic <strong>F BASIC</strong>)</p>\n<ul>\n<li>Female sex</li>\n<li>Bilirubin</li>\n<li>Albumin</li>\n<li>Serum sodium (mEq/L)</li>\n<li>INR (International Normalized ratio)</li>\n<li>Creatinine</li>\n</ul>\n<p><strong>Uses:</strong></p>\n<ul>\n<li>Predict short-term prognosis in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) insertion</li>\n<li>Assess and <strong>prioritize patients</strong> awaiting <strong>liver transplantation</strong></li>\n<li>Assess prognosis in cirrhosis</li>\n</ul>\n<p class=\bulletIndent1\>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1630, 'Medicine,', 'PM1597. Difference between pyogenic and amebic liver abscess', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Clinical features</strong></p>\n</td>\n<td>\n<p><strong>Pyogenic abscess</strong></p>\n</td>\n<td>\n<p><strong>Amebic abscess</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Age</p>\n</td>\n<td>\n<p>&gt;50 years</p>\n</td>\n<td>\n<p>20–40 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Male:Female ratio</p>\n</td>\n<td>\n<p>1.5:1</p>\n</td>\n<td>\n<p>10:1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Solitary vs multiple</p>\n</td>\n<td>\n<p>Solitary 50%</p>\n</td>\n<td>\n<p>Solitary 80%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Location</p>\n</td>\n<td>\n<p>Right lobe</p>\n</td>\n<td>\n<p>Right lobe</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Travel to endemic area</p>\n</td>\n<td>\n<p>No</p>\n</td>\n<td>\n<p>Yes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alcohol</p>\n</td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Common</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Most common symptom</p>\n</td>\n<td>\n<p>Fever with chills</p>\n</td>\n<td>\n<p>Abdominal pain</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Most common lab abnormality</p>\n</td>\n<td>\n<p>Elevated ALP</p>\n</td>\n<td>\n<p>Elevated ALP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Jaundice and elevated bilirubin</p>\n</td>\n<td>\n<p>More common</p>\n</td>\n<td>\n<p>Less common</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diagnosis</p>\n</td>\n<td>\n<p>Positive blood culture</p>\n</td>\n<td>\n<p>Positive antiamebic antibodies</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;ALP: alkaline phophatase</p></div><!---->\n      <!---->\n    </div><!---->'),
(1631, 'Medicine', 'PM1591. Nazer’s Prognostic Index', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Nazer’s prognostic index</strong> for <strong>Wilson’s disease</strong></p>\n<ul>\n<li>Serum bilirubin</li>\n<li>Serum aspartate aminotransferase (AST)</li>\n<li>Prolongation of prothrombin time (sec)</li>\n</ul>\n<p>Interpretation of Scores :</p>\n<ul>\n<li>&lt; 7 – Medical therapy</li>\n<li>7–9 – Clinical judgement, Either medical / surgical treatment</li>\n<li>&gt; 9 – Liver transplantation</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1632, 'Medicine', 'PM1545. Causes of Hyperamylasemia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pancreatic Diseases</strong> <strong>&nbsp;</strong></td>\n<td><strong>&nbsp;&nbsp; Non-Pancreatic Disorders</strong></td>\n<td><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other Abdominal</strong> <strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disorders &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li><strong>Acute pancreatitis</strong></li>\n<li><strong>Pancreatic pseudocyst</strong></li>\n<li>Ascites caused by pancreatic duct disruption</li>\n<li>Pancreatic necrosis, trauma, carcinoma</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Renal insufficiency</li>\n<li>Salivary gland lesions\n<ul>\n<li><strong>Mumps</strong></li>\n<li>Calculus</li>\n<li>Irradiation sialadenitis</li>\n<li>Maxillofacial surgery</li>\n</ul>\n</li>\n<li>CA lung/esophagus/breast/ovary</li>\n<li>Macroamylasemia</li>\n<li>Burns</li>\n<li><strong>DKA</strong></li>\n<li>Pregnancy</li>\n<li>Renal transplantation</li>\n<li>Cerebral trauma</li>\n<li>Drugs: opiates</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Biliary<strong> tract disease:&nbsp;</strong>cholecystitis, choledocholithiasis</li>\n<li>Intraabdominal disease\n<ul>\n<li><strong>Perforated/penetrating peptic ulcer</strong></li>\n<li>Intestinal obstruction or inflammation</li>\n<li><strong>Ruptured ectopic pregnancy</strong></li>\n<li>Peritonitis</li>\n<li>Aortic aneurysm</li>\n<li>Postoperative</li>\n</ul>\n</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1633, 'Medicine', 'PM1539. Diagnostic Evaluation of the Bile Ducts', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Diagnostic Evaluation of the Bile Ducts</strong></p>\n<ul>\n<li><strong>Hepatobiliary ultrasound:</strong> Initial procedure of choice in investigating possible biliary tract obstruction</li>\n<li><strong>CT scan:</strong> Procedure of choice in investigating possible biliary obstruction if diagnostic limitations prevent HBUS</li>\n<li><strong>MRCP:</strong> Useful modality for visualizing pancreatic and biliary ducts</li>\n<li><strong>ERCP: Best visualisation of distal biliary tract</strong>\n<ul>\n<li>Endoscopic sphincterotomy and stone removal can also be done</li>\n</ul>\n</li>\n<li><strong>PTC(Percutaneous Transhepatic Cholangiography): Best visualisation of proximal biliary tract</strong>\n<ul>\n<li>Indicated when ERCP is contraindicated or failed</li>\n</ul>\n</li>\n<li><strong>EUS: </strong>Most sensitive method to <strong>detect ampullary stones</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1634, 'Medicine,', 'PM1538. Courvoisier’s Law', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Courvoisier’s Law</strong> states that the presence of a <strong>palpably enlarged gallbladder</strong> suggests that the <strong>biliary obstruction </strong>is secondary to an<strong> underlying malignancy </strong>rather than to calculous disease.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1635, 'Medicine,', 'PM1537. Diagnostic Evaluation of the Gall Bladder', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Gallbladder Ultrasound: </strong>Investigation of choice for <strong>detection of gall stones</strong></li>\n<li><strong>Abdominal X-ray: </strong>Useful in&nbsp;\n<ul>\n<li>Calcified gall stones</li>\n<li>Emphysematous cholecystitis</li>\n<li>Porcelain gallbladder</li>\n<li>Limey bile</li>\n<li>Gallstone ileus</li>\n</ul>\n</li>\n<li><strong>Radioisotope scans </strong>(HIDA/DIDA/DISIDA)\n<ul>\n<li>Indicated for <strong>confirmation of suspected acute cholecystitis</strong></li>\n<li>Useful in diagnosis of <strong>acalculous cholecystopathy</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Abbreviations:</strong></p>\n<ul>\n<li>HIDA: <strong>H</strong>epatobiliary <strong>I</strong>mino<strong>D</strong>iacetic <strong>A</strong>cid scan</li>\n<li>DIDA/DISDA: <strong>Di</strong>-i<strong>s</strong>opropyl <strong>I</strong>mino<strong>D</strong>iacetic <strong>A</strong>cid - Dynamic Tc99m DIDA Cholescintigraphy</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1636, 'Medicine', 'PM1532. Prerequisites for Medical Therapy in Cholelithiasis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Functioning gallbladder</strong></li>\n<li><strong>Radiolucent stones</strong></li>\n<li><strong>Stones &lt;10mm</strong></li>\n<li><strong>Cholesterol stones </strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1637, 'Surgery,', 'PM1528. Achalasia Cardia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 2599\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Achalasia cardia is a rare disease caused by the <strong>loss of ganglion cells</strong> within the esophageal myenteric plexus. <span>Their absence leads to </span><strong>increased tone of the lower esophageal sphincter</strong><span>,&nbsp;impaired relaxation of the lower&nbsp;esophageal sphincter (LES),&nbsp;and absent peristalsis.</span></p>\n<div class=\page\ title=\Page 2599\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Achalasia is the <strong>only true motility disorder</strong> of the&nbsp;esophagus.</p>\n<ul>\n<li><strong>Primary achalasia</strong> is due to ganglion cell degeneration and is thought to be due to an autoimmune process attributable to latent infection with human herpes simplex virus 1 (HSV1) combined with genetic susceptibility.</li>\n<li><strong>Secondary achalasia</strong> may arise in Chagas disease.</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<p>Clinical features:</p>\n<ul>\n<li><strong>Dysphagia</strong> <strong>(solid and liquid food)</strong></li>\n<li>Regurgitation</li>\n<li>Chest pain</li>\n<li>Weight loss</li>\n<li>Bronchitis, pneumonia, or lung abscess from aspiration</li>\n</ul>\n<p>Differential diagnosis: <strong>Diffuse esophageal spasm, pseudoachalasia</strong></p>\n<p>On barium swallow: <strong>Bird beak-appearance</strong></p>\n<p>Investigation of choice: <strong>Manometry (most sensitive)</strong></p>\n<p>Treatment: <strong>Pneumatic dilatation, Heller myotomy</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c90179ebbbca4cd090d07b3ae3029c74x319x598.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1638, 'Medicine,', 'PM1527. Zenker’s Diverticulum', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Zenkers diverticulum occurs due to <strong>herniation</strong> of mucosa and submucosa through the <strong>Killians triangle</strong>, which is a weak area between two&nbsp;parts of the <strong>inferior constrictor - </strong>(thyropharyngeus and cricopharyngeus)&nbsp;in the <strong>posterior pharyngeal wall.&nbsp;</strong>It is usually seen in elderly patients (&gt;60 years).</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f1d91adec7cf4043844cb02f3d29e3ffx600x1200.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Characteristics</strong> of Zenkers diverticulum:</p>\n<ul>\n<li aria-level=\1\>Hypopharyngeal</li>\n<li aria-level=\1\>False diverticula - doesnt have a muscle coat</li>\n<li aria-level=\1\>Acquired&nbsp;</li>\n<li aria-level=\1\>Pulsion diverticulum&nbsp;</li>\n</ul>\n<p><strong>Pathophysiology</strong>: Impaired relaxation and spasm of the cricopharyngeus muscle after swallowing can result in increased pressure within the distal pharynx, and cause the diverticulum.Clinical features:</p>\n<ul>\n<li aria-level=\1\>Dysphagia</li>\n<li aria-level=\1\>Regurgitation</li>\n<li aria-level=\1\>Halitosis</li>\n<li aria-level=\1\>Aspiration</li>\n<li aria-level=\1\>Gurgling sound during swallowing</li>\n</ul>\n<p>The investigation of choice is <strong>barium swallow</strong> (lateral X-ray).</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ae9cc93c02584eb8b4f68d0d17465135x515x727.GIF\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>It is treated with:</p>\n<ul>\n<li aria-level=\1\><strong>Cricopharyngeal myotomy</strong></li>\n<li aria-level=\1\>Surgical diverticulectomy</li>\n<li aria-level=\1\>Marsupialization</li>\n<li aria-level=\1\><strong>Dohlman’s procedure</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1639, 'Medicine,', 'PM1523. Types Of Gastric Ulcers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>This is the classification given in Harrisons 20th ed, Principles of Internal Medicine.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp; Type Of Ulcer</strong></td>\n<td><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Location</strong></td>\n<td><strong>Acid Production</strong></td>\n<td><strong>Surgical Management</strong></td>\n</tr>\n<tr>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Type I</td>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gastric body</td>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low</td>\n<td>Distal Gastrectomy Billroth Type 1</td>\n</tr>\n<tr>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Type II</td>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Antrum</td>\n<td>&nbsp; &nbsp;Low to Normal</td>\n<td>Distal Gastrectomy and Vagotomy/PPI</td>\n</tr>\n<tr>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Type III</td>\n<td>Within 3cm of the pylorus; Accompanied by duodenal ulcers</td>\n<td>&nbsp; &nbsp;Normal or High</td>\n<td>&nbsp;Distal Gastrectomy and Vagotomy/PPI&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Type IV</td>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cardia</td>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low</td>\n<td>&nbsp;Pouchet, Csendes Procedure</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>The other classification is Modified Johnsons Classification which is as follows:&nbsp;</p>\n<p><strong>Modified Johnson classification</strong> for gastric ulcer</p>\n<p>I. Lesser curve, incisura - Normal Acid secretion</p>\n<p>II. Body of stomach, incisura + duodenal ulcer (active or healed) - Increased Acid secretion</p>\n<p>III. Prepyloric - Increased Acid secretion</p>\n<p>IV. High on lesser curve - Normal acid secretion</p>\n<p>V. Medication induced (NSAID/ acetylsalicylic acid), anywhere in stomach</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/bf5c4629d1994c429b07e815b3065147x1280x2177.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1640, 'Medicine', 'PM0774. ROME IV Diagnostic criteria for IBS', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p class=\bulletIndent1\>According to the Rome IV criteria, IBS is defined as recurrent <strong>abdominal pain </strong>for&nbsp;at least <strong>1 day per week</strong> in the last <strong>3 months</strong>. It must be associated with <strong>2 or more</strong> of the following criteria:</p>\n<ul>\n<li class=\bulletIndent2\>Related to defecation&nbsp;(improvement or worsening)</li>\n<li class=\bulletIndent2\>Associated with a change in stool frequency</li>\n<li class=\bulletIndent2\>Associated with a change in stool form (appearance)</li>\n</ul>\n<p>The above criteria must be fulfilled for <strong>3 months</strong> with&nbsp;<strong>onset</strong>&nbsp;of some symptoms at least <strong>6 months</strong> before diagnosis.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1641, 'Medicine', 'PM0419. Precipitating factors of Hepatic Encephalopathy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Common precipitating factors of Hepatic Encephalopathy are</strong>:</p>\n<ul>\n<li><strong>Increased Nitrogen load:</strong>\n<ul>\n<li>GI bleeding</li>\n<li>Excess dietary protein</li>\n<li>Azotemia</li>\n<li>Constipation</li>\n</ul>\n</li>\n<li><strong>Drugs</strong>\n<ul>\n<li>Narcotics</li>\n<li>Sedatives</li>\n<li>Excess diuretics</li>\n</ul>\n</li>\n<li><strong>Electrolytic imbalance</strong>:\n<ul>\n<li>Hypokalemia</li>\n<li>Alkalosis</li>\n<li>Hypoxia</li>\n<li>Hyponatremia</li>\n<li>Hypovolemia</li>\n</ul>\n</li>\n<li><strong>Miscellaneous</strong>\n<ul>\n<li>Infection</li>\n<li>Surgery</li>\n<li>Superimposed liver disease</li>\n<li>Shunts</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1642, 'Medicine', 'PM2428. Autoantibodies Seen in Autoimmune Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\469\>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Autoantibody</strong></td>\n<td><strong>Associated disease</strong></td>\n</tr>\n<tr>\n<td>Antinuclear (ANA)</td>\n<td>\n<p>SLE (non-specific)</p>\n</td>\n</tr>\n<tr>\n<td>Anticardiolipin, lupus anticoagulant</td>\n<td>SLE, APLA syndrome</td>\n</tr>\n<tr>\n<td>Anti-ds DNA, anti-Smith</td>\n<td>SLE</td>\n</tr>\n<tr>\n<td>Anti-histone</td>\n<td>Drug-induced Lupus</td>\n</tr>\n<tr>\n<td>Anti-U1 RNP</td>\n<td>Mixed connective tissue disease</td>\n</tr>\n<tr>\n<td>Rheumatoid factor, anti-CCP</td>\n<td>Rheumatoid arthritis</td>\n</tr>\n<tr>\n<td>Anti-Ro/SSA, Anti-La/SSB</td>\n<td>Sjögren’s syndrome</td>\n</tr>\n<tr>\n<td>Anti-Scl-70 (anti-DNA topoisomerase)</td>\n<td>Diffuse scleroderma</td>\n</tr>\n<tr>\n<td>Anticentromere</td>\n<td>CREST syndrome</td>\n</tr>\n<tr>\n<td>Anti-SRP,&nbsp;Anti-Mi-2, Anti-Jo-1</td>\n<td>Polymyositis, Dermatomyositis</td>\n</tr>\n<tr>\n<td>p-ANCA/MPO</td>\n<td>Churg Strauss syndrome</td>\n</tr>\n<tr>\n<td>c-ANCA</td>\n<td>Wegener (Granulomatosis with polyangiitis)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1643, 'Orthopaedics,', 'PM2038. The most commons of rheumatoid arthritis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Feature of RA</strong></td>\n<td><strong>Most common&nbsp;</strong>&nbsp;</td>\n</tr>\n<tr>\n<td>Involved joints</td>\n<td>MCP, Wrist, PIP(DIP spared)&nbsp;</td>\n</tr>\n<tr>\n<td>Spine involvement</td>\n<td>Cervical spine</td>\n</tr>\n<tr>\n<td>Extra-articular manifestation</td>\n<td>Subcutaneous nodules (mostly extensor surface)</td>\n</tr>\n<tr>\n<td>Cardiac manifestation</td>\n<td>Pericarditis</td>\n</tr>\n<tr>\n<td>Valvular abnormality</td>\n<td>Mitral regurgitation</td>\n</tr>\n<tr>\n<td>Pulmonary manifestation</td>\n<td>Pleuritis</td>\n</tr>\n<tr>\n<td>Hematological manifestation</td>\n<td>Normochromic normocytic anemia</td>\n</tr>\n<tr>\n<td>Neurological manifestation</td>\n<td>Compression neuropathies (mostly carpal tunnel syndrome)</td>\n</tr>\n<tr>\n<td>Ocular manifestation</td>\n<td>&nbsp;Keratoconjunctivitis sicca</td>\n</tr>\n<tr>\n<td>Lymphoma</td>\n<td>Diffuse large B-cell lymphoma</td>\n</tr>\n<tr>\n<td>Cause of death</td>\n<td>Cardiovascular disease (coronary artery disease)</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1644, 'Medicine', 'PM1947. Diffuse Cutaneous Systemic Sclerosis  Versus Limited Cutaneous Systemic Sclerosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\556\>\n<tbody>\n<tr>\n<td><strong>Characteristic feature</strong></td>\n<td><strong>Diffuse cutaneous systemic sclerosis</strong></td>\n<td><strong>Limited cutaneous systemic sclerosis</strong></td>\n</tr>\n<tr>\n<td>Skin involvement</td>\n<td>\n<p>Rapid progression</p>\n<p>Involvement of the skin areas <strong>proximal</strong> <strong>to the knees or elbows</strong> or over the anterior chest, trunk, or abdomen</p>\n</td>\n<td>\n<p>Slow progression</p>\n<p>Limited to face and skin <strong>distal</strong> <strong>to the elbows and knees</strong></p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Raynaud’s phenomenon</td>\n<td>\n<p>Less severe</p>\n<p>&nbsp;</p>\n<p><strong>Short history</strong>&nbsp;</p>\n</td>\n<td>\n<p>More severe; commonly associated with critical limb ischemia.</p>\n<p><strong>Long history</strong>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Musculoskeletal</td>\n<td><strong>Severe arthralgia</strong>, carpal tunnel syndrome, and tendon friction rubs</td>\n<td><strong>Mild</strong> arthralgia</td>\n</tr>\n<tr>\n<td>Pulmonary manifestation</td>\n<td>Interstitial lung disease more common</td>\n<td>Pulmonary artery hypertension (PAH) is equal in both</td>\n</tr>\n<tr>\n<td>Scleroderma renal crisis</td>\n<td>Occurs usually &lt;4 years of disease onset</td>\n<td>Very rare</td>\n</tr>\n<tr>\n<td>Calcinosis cutis</td>\n<td>Less common</td>\n<td>More common &amp;&nbsp;prominent</td>\n</tr>\n<tr>\n<td>Auto-antibodies</td>\n<td>\n<p><strong>Anti-topoisomerase I</strong> (Scl-70)</p>\n<p>anti-RNA polymerase III</p>\n</td>\n<td><strong>Anti centromere</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/35bb13425bb64e78b9164796e0c2fc29x1280x2412.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1645, 'Medicine,', 'PM1921. Joint Involvement in Various Arthritis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>&nbsp;Joint Disorders</strong></td>\n<td><strong>Joints Commonly Involved</strong></td>\n<td>\n<p><strong>Joints Com</strong><strong>monly </strong><strong>Spared</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;<strong>Osteoarthritis</strong></p>\n</td>\n<td>\n<p>Cervical and lumbosacral spine, PIP, DIP,&nbsp;1st CMC, hip, knee,&nbsp;1st MTP,&nbsp;</p>\n</td>\n<td>\n<p>&nbsp;Elbow, Wrist, Ankle, MCP&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Rheumatoid Arthritis</strong></td>\n<td>Shoulder, Wrist, MCP, PIP, Knee, MTP&nbsp;</td>\n<td>DIP&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Ankylosing Spondylitis</strong></td>\n<td>Sacroiliac joint, intervertebral joints</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Psoriatic Arthritis</strong></td>\n<td>PIP,&nbsp;DIP</td>\n<td>Ray distribution*&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>*Ray distribution: Joint involvement tends to follow a pattern with all of the joints of one finger involved sparing the adjacent finger completely.</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1646, 'Medicine', 'PM1844. Auto antibodies in a few disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Auto-antibodies in <strong>myasthenia gravis</strong>:</p>\n<p>i)&nbsp;Anti-acetylcholine receptor (<strong>AChR</strong>) antibodies</p>\n<p>ii)&nbsp;Anti-muscle-specific kinase (<strong>MuSK</strong>) antibodies</p>\n<p>iii)&nbsp;Anti-low density lipoprotein receptor-related protein 4 (<strong>LRP4</strong>) antibodies</p>\n<p><strong>Anti-C1q antibodies</strong> are associated with <strong>systemic lupus erythematosus </strong>(SLE) and membrane proliferative glomerulonephritis (MPGN).&nbsp;</p>\n<p><strong>Anti-Smith</strong> antibodies (Anti-Sm) are associated with SLE.</p>\n<p>Anti-lysosome associated membrane protein-2 <strong>(LAMP-2)</strong> antibodies are associated with certain types of vasculitis.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1647, 'Medicine', 'PM1563. Deformities in rheumatoid arthritis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Boutonnière deformity: </strong>Flexion of the PIP joint with hyperextension of the DIP joint.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f0250f1148284de1bd77c8d6e470c56fx720x960.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Swan-neck deformity</strong>: Hyperextension of the PIP joint with flexion of the DIP joint.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/560c6a73ecfc46e7aed6682bc24af2a4x720x1017.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Z line deformity: </strong>Radial deviation of the wrist with ulnar deviation of digits.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c60e1966a5314bbf8fd6c20a5ed7f625x800x600.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Eversion at hindfoot (subtalar joint), hallux valgus (shown below), hammertoe.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/798b7febef7a44699a664b1f1a5363cdx720x919.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Windswept deformities of toes - Valgus deformities of toes in one foot and varus in the other foot.&nbsp;</p>\n<p><strong>Piano-key movement </strong>of the ulnar styloid.&nbsp;</p>\n<p><strong>Trigger finger</strong> due to flexor tendon synovitis.&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1648, 'Medicine,', 'PM1080. Difference between Gout and Pseudo-gout', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Finding</strong></p>\n</td>\n<td>\n<p><strong>Gout</strong></p>\n</td>\n<td>\n<p><strong>Pseudogout</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Crystal composition</p>\n</td>\n<td>\n<p>Monosodium urate</p>\n</td>\n<td>\n<p>Calcium pyrophosphate</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Shape</p>\n</td>\n<td>\n<p>Needle like</p>\n</td>\n<td>\n<p>Rhomboid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Birefringence pattern</p>\n</td>\n<td>\n<p>Negative</p>\n</td>\n<td>\n<p>Weak positive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Most commonly affected joint</p>\n</td>\n<td>\n<p>1<sup>st</sup> MTP</p>\n</td>\n<td>\n<p>Knee</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>X-ray findings</p>\n</td>\n<td>\n<p>Periarticular erosions with overhanging margins</p>\n</td>\n<td>\n<p>Chondrocalcinosis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1649, 'Medicine', 'PM0441. Churg Strauss', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Eosinophilic Granulomatosis with polyangiitis (Churg Strauss Syndrome) is a <strong>necrotising granulomatous</strong> vasculitis. It involves <strong>small</strong> and medium-sized muscular arteries, capillaries, veins, and venules.</li>\n<li>It presents as a combination of <strong>asthma</strong>, peripheral and tissue <strong>eosinophilia</strong>,&nbsp;extravascular <strong>granulomas</strong>,<strong>&nbsp;vasculitis</strong> of multiple organ systems.</li>\n<li>The characteristic histopathological shows granulomatous reaction that can be present in the tissue or even within the walls of the vessels.</li>\n<li>&nbsp;Common organs affected in this condition are:\n<ul>\n<li>Lung- presents with severe asthmatic attacks and pulmonary infiltrates</li>\n<li>Mononueritis multiplex</li>\n<li>Skin lesions- presents as purpura and subcutaneous nodules</li>\n<li>Renal involvement</li>\n</ul>\n</li>\n<li>Important laboratory findings seen are:\n<ul>\n<li><strong>Eosinophilia</strong> with levels of &gt; 1000 cells/µL</li>\n<li>Presence of <strong>pANCA</strong> antibodies</li>\n</ul>\n</li>\n<li>Treatment- Glucocorticoids and mepolizumab (anti-IL-5 antibody) have been found to effective.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1650, 'Paediatrics,', 'PM0191. Kawasaki disease criteria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Diagnostic criteria of Kawasaki disease</strong>:&nbsp;</p>\n<p><strong>Fever of five days or more</strong> duration <strong>plus four</strong> <strong>out of the following</strong> five criteria:</p>\n<ol>\n<li>Oropharyngeal changes (90% of cases)</li>\n<li>Changes in peripheral extremities (90% of cases)</li>\n<li>Cervical lymphadenopathy (~75% of cases)</li>\n<li>Polymorphous rash (95% of cases)</li>\n<li>Bilateral non-purulent conjunctival injection (90% of cases)</li>\n</ol></div><!---->\n      <!---->\n    </div><!---->'),
(1651, 'Medicine', 'PM2453. Treatment of Asthma based on severity of symptoms (GINA-2022)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Asthma management - GINA 2022</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3349e17dd3a64530b8cda3c9732af613x1280x3702.792665726375.JPEG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1652, 'Medicine', 'PM2392. Clinical prediction for pulmonary embolism: Well’s, Modified Well’s and Pulmonary Embolism Rule out Criteria (PERC)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Signs/symptoms</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Clinical signs of DVT</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Diagnosis other than pulmonary embolism is less likely</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Heart rate &gt;100 bpm</td>\n<td>1.5</td>\n</tr>\n<tr>\n<td>Immobilization for &gt;3 days or surgery in the last 4 weeks</td>\n<td>1.5</td>\n</tr>\n<tr>\n<td>Past history of DVT/pulmonary embolism</td>\n<td>1.5</td>\n</tr>\n<tr>\n<td>Hemoptysis</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Malignancy</td>\n<td>1</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Three-level score probability:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Wells criteria</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Low</td>\n<td>&lt;2</td>\n</tr>\n<tr>\n<td>Moderate</td>\n<td>2-6</td>\n</tr>\n<tr>\n<td>High</td>\n<td>&gt;6</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Two-level score probability:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Modified Wells criteria</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Pulmonary embolism unlikely</td>\n<td>≤4</td>\n</tr>\n<tr>\n<td>Pulmonary embolism likely</td>\n<td>&gt;4&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Pulmonary embolism rule out criteria (PERC):</strong></p>\n<p>This is a quick OPD/casualty tool to rule out pulmonary embolism in patients with low clinical probability. It comprises <strong>eight clinical variables</strong>. If the patient meets all eight criteria, there is no need for further investigations. The variables include:&nbsp;</p>\n<ol>\n<li aria-level=\1\>Age &lt;50 years</li>\n<li aria-level=\1\>Heart rate &lt;100 bpm</li>\n<li aria-level=\1\>SpO2 ≥95%</li>\n<li aria-level=\1\>No unilateral leg swelling</li>\n<li aria-level=\1\>No hemoptysis</li>\n<li aria-level=\1\>No recent trauma or surgery</li>\n<li aria-level=\1\>No history of venous thromboembolism</li>\n<li aria-level=\1\>No use of hormonal therapy.</li>\n</ol></div><!---->\n      <!---->\n    </div><!---->'),
(1653, 'Medicine', 'PM1879. Types of pleural effusion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Transudative Pleural effusion</strong></p>\n<ul>\n<li>Congestive heart failure (most common)</li>\n<li>Cirrhosis</li>\n<li>Nephrotic syndrome</li>\n<li>Myxedema&nbsp;</li>\n<li>Peritoneal dialysis</li>\n<li>Urinothorax</li>\n<li>Hypoalbuminemia</li>\n<li>Constrictive pericarditis</li>\n<li>Superior vena cava obstruction</li>\n</ul>\n<p><strong>Exudative Pleural effusion&nbsp;</strong></p>\n<ul>\n<li aria-level=\1\>Infections:&nbsp;Tuberculosis, pneumonia,&nbsp;intraabdominal abscess (like- liver abscess)</li>\n<li aria-level=\1\>Malignancy:&nbsp;Pleural mesothelioma,&nbsp;metastasis,&nbsp;lymphoma</li>\n<li aria-level=\1\>Connective tissue diseases:&nbsp;SLE,&nbsp;rheumatoid arthritis</li>\n<li aria-level=\1\>Drugs:&nbsp;Amiodarone,&nbsp;bromocriptine,&nbsp;dantrolene,&nbsp;dasatinib,&nbsp;methysergide,&nbsp;nitrofurantoin</li>\n<li aria-level=\1\>Others:\n<ul>\n<li aria-level=\1\>Pancreatitis</li>\n<li aria-level=\1\>Asbestosis</li>\n<li aria-level=\1\>Pulmonary embolism</li>\n<li aria-level=\1\>Hemothorax</li>\n<li aria-level=\1\>Chylothorax</li>\n<li aria-level=\1\>Meigs syndrome&nbsp;</li>\n<li aria-level=\1\>Dressler syndrome (post-myocardial infarction or cardiac surgery)</li>\n<li aria-level=\1\>Yellow nail syndrome&nbsp;</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1654, 'Medicine', 'PM1863. Types of Respiratory Failure', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td>Type</td>\n<td>Name</td>\n<td>Mechanism</td>\n<td>Associated conditions</td>\n</tr>\n<tr>\n<td>I</td>\n<td>Acute <strong>hypoxemic</strong> respiratory failure</td>\n<td>\n<p>Alveolar flooding and subsequent intrapulmonary shunt physiology.</p>\n<p>Low pO2</p>\n<p>Normal/ low pCO2</p>\n<p>High (pAO2-paO2)</p>\n</td>\n<td>\n<p>Sepsis</p>\n<p>Gastric aspiration</p>\n<p>Pneumonia</p>\n<p>Near-drowning</p>\n<p>Multiple blood transfusions</p>\n<p>Pancreatitis</p>\n</td>\n</tr>\n<tr>\n<td>II</td>\n<td>\n<p>Hypoxemia with <strong>hypercapnia</strong></p>\n</td>\n<td>\n<p>Results from the inability to eliminate carbon dioxide effectively.</p>\n<p>Low pO2</p>\n<p>High pCO2</p>\n<p>Normal (pAO2-paO2)</p>\n</td>\n<td>\n<p>Drug overdose</p>\n<p>Brainstem injury</p>\n<p>Sleep-disordered breathing</p>\n<p>Severe hypothyroidism</p>\n<p>Myasthenia gravis</p>\n<p>Guillain-Barre syndrome</p>\n<p>Amyotrophic lateral sclerosis</p>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td>Peri-operative respiratory failure</td>\n<td>Results from lung atelectasis.</td>\n<td>After general anesthesia.</td>\n</tr>\n<tr>\n<td>IV</td>\n<td>Shock</td>\n<td>Results from hypoperfusion of respiratory muscles in patients with shock</td>\n<td>Cardiogenic shock.</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>pO2- partial pressure of oxygen</p>\n<p>pCO2- partial pressure of carbon dioxide</p>\n<p>(pAO2-paO2)- alveolar- arterial oxygen gradient</p></div><!---->\n      <!---->\n    </div><!---->'),
(1655, 'Medicine', 'PM1845. Incidence of lung cancer according to histology', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/db74b9a5468642d5806deed4dfad448cx1280x1541.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1656, 'Medicine', 'PM1843. Lobes involved in various lung diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Mnemonic to easily remember the lobe of lung involved in CTD is:</p>\n<p>Upper Lobe - <strong>CHARTS</strong></p>\n<ul>\n<li><strong>C</strong>oal workers pneumoconiosis (CWP), silicosis, berylliosis</li>\n<li><strong>H</strong>istiocytosis X (LCH)</li>\n<li><strong>A</strong>nkylosing spondylitis, ABPA</li>\n<li><strong>R</strong>adiation</li>\n<li><strong>T</strong>uberculosis</li>\n<li><strong>S</strong>arcoidosis</li>\n</ul>\n<p>Lower lobes - <strong>RAIDS</strong></p>\n<ul>\n<li><strong>R</strong>heumatoid arthritis</li>\n<li><strong>A</strong>sbestosis</li>\n<li><strong>I</strong>diopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP)</li>\n<li><strong>D</strong>rugs: bleomycin, busulfan, amiodarone, methotrexate, nitrofurantoin</li>\n<li><strong>S</strong>cleroderma</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1657, 'Medicine', 'PM1840. Extrinsic vs Intrinsic asthma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Component</strong></td>\n<td><strong>Extrinsic asthma</strong></td>\n<td><strong>Intrinsic asthma</strong></td>\n</tr>\n<tr>\n<td>Other names</td>\n<td>Atopic/ allergic asthma</td>\n<td>Non-atopic/ non-allergic/ idiosyncratic asthma</td>\n</tr>\n<tr>\n<td>Associated with&nbsp;</td>\n<td>Atopy, drug or food allergy (past or family history)</td>\n<td>Samter’s triad (asthma + aspirin sensitivity + sinus disease with recurrent nasal polyps)</td>\n</tr>\n<tr>\n<td>Onset</td>\n<td>Childhood</td>\n<td>Adult</td>\n</tr>\n<tr>\n<td>Inflammation</td>\n<td>Eosinophil mediated</td>\n<td>Neutrophil mediated</td>\n</tr>\n<tr>\n<td>IgE levels</td>\n<td>↑ IgE (type 1 hypersensitivity)</td>\n<td>Normal IgE (negative skin prick test)</td>\n</tr>\n<tr>\n<td>Most common trigger</td>\n<td>Dermatophagoides (House mite)</td>\n<td>\n<p>Superantigen -&nbsp;<br><em>S. aureus</em> enterotoxin</p>\n</td>\n</tr>\n<tr>\n<td>Response to inhaled corticosteroids</td>\n<td>Responds well&nbsp;</td>\n<td>\n<p>Decreased short term response</p>\n</td>\n</tr>\n<tr>\n<td>Prognosis</td>\n<td>Good</td>\n<td>Bad</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1658, 'Medicine', 'PM1821. Evaluation of solitary pulmonary nodule', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Nodule size (a):</td>\n<td>Low-risk patient (b):</td>\n<td>High-risk patient (c):</td>\n</tr>\n<tr>\n<td>≤4 mm</td>\n<td>No follow-up needed (d)</td>\n<td>Follow-up at 12 months; if unchanged, no further follow-up</td>\n</tr>\n<tr>\n<td>&gt;4–6 mm</td>\n<td>Follow-up CT at 12 months; if unchanged, no further follow-up</td>\n<td>Follow-up CT at 6–12 months; then 18–24 months if no change</td>\n</tr>\n<tr>\n<td>&gt;6–8 mm</td>\n<td>Follow-up CT at 6–12 months; then 18–24 months if no change</td>\n<td>Follow-up CT at 3–6 months; then 9–12 and 24 months if no change</td>\n</tr>\n<tr>\n<td>&gt;8 mm</td>\n<td>Follow-up CT at 3, 9, and 24 months; dynamic contrast enhanced CT, PET, and/or biopsy</td>\n<td>Same as low-risk patient</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>(a) Average of largest and smallest axial diameters of the nodule</p>\n<p>(b) No smoking history and absence of other risk factors</p>\n<p>(c) Previous or current smoking history or other risk factors</p>\n<p>(d) Risk of malignancy (&lt;0.1%) is substantially lower than for an asymptomatic smoker</p></div><!---->\n      <!---->\n    </div><!---->'),
(1659, 'Medicine', 'PM1172. PFT for obstructive vs restrictive diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\150\>\n<p><strong>PFT</strong></p>\n</td>\n<td width=\150\>\n<p><strong>Obstructive disease</strong></p>\n</td>\n<td width=\150\>\n<p><strong>Restrictive disease</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>FVC</p>\n</td>\n<td width=\150\>\n<p>Decreased</p>\n</td>\n<td width=\150\>\n<p>Decreased (&lt;80% predicted)</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>FEV1</p>\n</td>\n<td width=\150\>\n<p>Decreased (&lt;80% predicted)</p>\n</td>\n<td width=\150\>Decreased</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>FEV1% (FEV1/FVC)</p>\n</td>\n<td width=\150\>\n<p>Decreased (&lt;0.7)</p>\n</td>\n<td width=\150\>\n<p>Normal/ increased (&gt;0.7)</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>FEF 25-75</p>\n</td>\n<td width=\150\>\n<p>&lt;50% predicted</p>\n</td>\n<td width=\150\>\n<p>Normal/ decreased</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>TLC</p>\n</td>\n<td width=\150\>\n<p>Normal/ increased</p>\n</td>\n<td width=\150\>\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>RV</p>\n</td>\n<td width=\150\>\n<p>Increased</p>\n</td>\n<td width=\150\>\n<p>Decreased</p>\n</td>\n</tr>\n<tr>\n<td width=\150\>\n<p>DLCO</p>\n</td>\n<td width=\150\>\n<ul>\n<li>Normal or increased in asthma</li>\n<li>Decreased in emphysema</li>\n</ul>\n</td>\n<td width=\150\>\n<ul>\n<li>Decreased in intrinsic restrictive disease</li>\n<li>Normal in neuromuscular or musculoskeletal restrictive disease</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>FVC: Forced Vital Capacity</p>\n<p>FEV1: Forced expiratory volume in 1 second</p>\n<p>FEF 25-75: Forced expiratory flow at 25-75% vital capacity</p>\n<p>TLC: Total lung capacity</p>\n<p>RV: Residual volume</p>\n<p>DLCO: Diffusion capacity of lung for Carbon monoxide.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1660, 'Medicine', 'PM1171. CURB-65 Criteria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>This is a score to determine the severity of pneumonia.</p>\n<p>The CURB-65 criteria include five variables(1 point for each variable):</p>\n<ul>\n<li><strong>C</strong>onfusion&nbsp;</li>\n<li>Blood <strong>U</strong>rea Nitrogen (BUN) &gt;7&nbsp;<span class=\nowrap\>mmol/L</span></li>\n<li><strong>R</strong>espiratory rate ≥30/min&nbsp;</li>\n<li><strong>B</strong>lood pressure, systolic ≤90 mmHg or diastolic ≤60 mmHg&nbsp;</li>\n<li>Age ≥<strong>65</strong> years.</li>\n</ul>\n<p>Management:</p>\n<p><span class=\medCalcFontOneBold\>0 point: Treat as an outpatient</span></p>\n<p><span class=\medCalcFontOneBold\>1 to 2 points: Admitted to the hospital</span></p>\n<p><span class=\medCalcFontOneBold\>≥3 points: ICU admission</span></p>\n<p><span class=\medCalcFontOneBold\><strong>Treatment of Community-Acquired Pneumonia</strong>&nbsp;</span></p>\n<p><span class=\medCalcFontOneBold\>Score - 0: The drug of choice is macrolides. </span></p>\n<p><span class=\medCalcFontOneBold\>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Azithromycin 500mg OD </span></p>\n<p><span class=\medCalcFontOneBold\>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; or </span></p>\n<p><span class=\medCalcFontOneBold\>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Clarithromycin&nbsp; 500mg BD </span></p>\n<p><span class=\medCalcFontOneBold\>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; or </span></p>\n<p><span class=\medCalcFontOneBold\>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Doxycycline&nbsp; 100mg BD.</span></p>\n<p><span class=\medCalcFontOneBold\>Score - 1: Treated with azithromycin&nbsp; 500mg OD + ceftriaxone 2gm OD.</span></p>\n<p><span class=\medCalcFontOneBold\>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Respiratory quinolones (Levofloxacin) are not preferred. </span></p>\n<p><span class=\medCalcFontOneBold\>Score - &gt;2: Azithromycin 500mg OD + Ceftriaxone 2gm IV OD and specific management.<br></span></p>\n<p>NOTE:- In a<strong> modified </strong>version of the CURB-65, the criteria of blood urea nitrogen has been removed.</p>\n<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;This elimination removes the need for lab testing.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1661, 'Medicine', 'PM1165. Types of Bronchiectasis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Cylindrical/Tubular</strong></td>\n<td><strong>Saccular/Varicose</strong></td>\n<td><strong>Cystic</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Mildest form of&nbsp;bronchiectasis</li>\n<li>Loss of&nbsp;normal airway tapering</li>\n<li>Bronchi have a uniform calibre, have parallel walls&nbsp;tram track sign and signet&nbsp;ring sign</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Further distortion of the&nbsp;airway wall along with&nbsp;more mucous and sputum&nbsp;production</li>\n<li>Beaded bronchi with interspersed sites of&nbsp;relative narrowing</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Most severe form of&nbsp;bronchiectasis and least common</li>\n<li>This form has large air spaces&nbsp;and a honeycombed&nbsp;appearance</li>\n<li>Air fluid levels present</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/11950d44a96e48f785aa4b59a074c06cx284x115.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1662, 'Medicine', 'PM0581. Causes of predominantly unilateral pleural effusion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Predominantly right-</strong><strong>sided pleural </strong><strong>effusion</strong></p>\n</td>\n<td>\n<p><strong>Predominantly </strong><strong>left-sided pleural </strong><strong>effusion</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cirrhosis of the liver</p>\n<p>(hepatic hydrothorax)</p>\n</td>\n<td>Acute pancreatitis</td>\n</tr>\n<tr>\n<td>\n<p>Amebic liver abscess</p>\n</td>\n<td>Aortic dissection</td>\n</tr>\n<tr>\n<td>&nbsp;Meig’s syndrome</td>\n<td>Esophageal rupture</td>\n</tr>\n<tr>\n<td>\n<p>Cardiac failure</p>\n<p>( B/L&gt;&gt;right-sided)</p>\n</td>\n<td>\n<p>Dressler’s syndrome</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1663, 'Medicine', 'PM0009. Named lung diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<p>Bagassosis</p>\n</td>\n<td>Pneumoconiosis due to sugarcane</td>\n</tr>\n<tr>\n<td>Byssinosis (brown lung disease/ Monday fever)</td>\n<td>Pneumoconiosis due to cotton fiber</td>\n</tr>\n<tr>\n<td>Farmer’s lung</td>\n<td>Pneumoconiosis due to Thermophilic actinomycetes</td>\n</tr>\n<tr>\n<td>Bird Fancier’s lung</td>\n<td>Hypersensitivity pneumonitis caused by bird droppings</td>\n</tr>\n<tr>\n<td>Chalicosis (flint disease)&nbsp;</td>\n<td>In stonecutters, due to inhalation of fine particles of stone</td>\n</tr>\n<tr>\n<td>Caplan’s syndrome</td>\n<td>&nbsp;RA + pneumoconiosis</td>\n</tr>\n<tr>\n<td>Lofgrens syndrome</td>\n<td>An acute presentation of sarcoidosis, consisting of arthritis, erythema nodosum, and bilateral hilar adenopathy</td>\n</tr>\n<tr>\n<td>Bornholm’s disease (epidemic pleurodynia)</td>\n<td>associated with Coxsackie B virus</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1664, 'Medicine', 'PM2427. Hemodialysis vs Peritoneal dialysis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Difference between Hemodialysis and Peritoneal dialysis</p>\n<table>\n<tbody>\n<tr>\n<td>Hemodialysis</td>\n<td>Peritoneal dialysis</td>\n</tr>\n<tr>\n<td>Comparatively difficult access</td>\n<td>Easy access</td>\n</tr>\n<tr>\n<td>Better clearance</td>\n<td>Good clearance</td>\n</tr>\n<tr>\n<td>Short time for treatment</td>\n<td>Longer time may be required</td>\n</tr>\n<tr>\n<td>Principle:<br><br>Solute removal through a semi-permeable membrane.</td>\n<td>\n<p>Principle:</p>\n<p>Solute removal through a peritoneal membrane</p>\n</td>\n</tr>\n<tr>\n<td>Must be done in hospital</td>\n<td>Can be done at home</td>\n</tr>\n<tr>\n<td>Complications:<br>\n<ul>\n<li>Hypotension</li>\n<li>Disequilibrium syndrome</li>\n<li>Muscle cramps</li>\n<li>Anaphylaxis reaction</li>\n</ul>\n</td>\n<td>\n<p>Complications :</p>\n<ul>\n<li>Peritonitis</li>\n<li>Catheter-associated non-peritoneal infections</li>\n<li>Weight gain</li>\n<li>Metabolic disturbances</li>\n<li>Residual uremia</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1665, 'Medicine', 'PM2381. Renal Tubular Syndromes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7e5e18bdaa4a442981637c52affb466fx1280x3492.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1666, 'Medicine', 'PM2212. Risk Factors of UTI', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Risk Factors for Urinary Tract Infection</strong></p>\n<p><strong>Demographic factors</strong></p>\n<ul>\n<li>Female Gender</li>\n<li>Male infants (UTI is Males&gt;females during infancy alone)</li>\n</ul>\n<p><strong>Structural</strong> factors - Any anatomical hindrance to drainage</p>\n<ul>\n<li>Vesicoureteral reflux (for pyelonephritis)</li>\n<li>Neuropathic Bladder</li>\n<li>Pregnancy</li>\n<li>Constipation</li>\n<li>Obstructive uropathy</li>\n<li>Uncircumcised male</li>\n</ul>\n<p><strong>Practices &amp; Procedures</strong>:</p>\n<ul>\n<li>Toilet training</li>\n<li>Voiding dysfunction</li>\n<li>Wiping from back to front in Females (not males)</li>\n<li>Tight clothing (underwear)</li>\n<li>Urethral instrumentation</li>\n</ul>\n<p><strong>Infective Factors</strong></p>\n<ul>\n<li>Pinworm infestation</li>\n<li>Infection of Bacteria with P fimbriae</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1667, 'Medicine', 'PM2110. Characteristics of renal tubular acidosis (RTA)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td rowspan=\2\>&nbsp;&nbsp;</td>\n<td colspan=\2\>Hypokalemic RTA&nbsp;</td>\n<td>Hyperkalemic RTA</td>\n</tr>\n<tr>\n<td>\n<p>Type 1 RTA</p>\n</td>\n<td>Type 2 RTA&nbsp;</td>\n<td>\n<p>Type 4 RTA</p>\n<p>Most Common</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary</p>\n<p>defect</p>\n</td>\n<td>\n<p>Impaired distal acidification</p>\n</td>\n<td>\n<p>Reduced proximal</p>\n<p>HCO<sub>3</sub>&nbsp;resorption</p>\n</td>\n<td>Decreased aldosterone secretion or aldosterone resistance</td>\n</tr>\n<tr>\n<td>\n<p>Plasma HCO3</p>\n<p>(mEq/L)</p>\n</td>\n<td>&nbsp;<span class=\symbol\>&lt;</span>15</td>\n<td>12 to 20</td>\n<td>&gt;17</td>\n</tr>\n<tr>\n<td>Plasma potassium</td>\n<td>\n<p>&nbsp; Low</p>\n<p>(normalizes with alkalinization)</p>\n</td>\n<td>\n<p>&nbsp;Low</p>\n<p>(Decreased further by alkalinization)</p>\n</td>\n<td>\n<p><strong>High</strong></p>\n<p>(correcting the hyperkalemia alone will improve the acidosis by increasing ammonium availability)</p>\n</td>\n</tr>\n<tr>\n<td>Urine pH</td>\n<td>&gt;5.5</td>\n<td>\n<p>&gt; 5.3 if the serum HCO<sub>3&nbsp;</sub>exceeds the tubules&nbsp;HCO<sub>3&nbsp;</sub></p>\n<p>reabsorptive threshold.</p>\n<p><strong>&lt; 5.3</strong> when the serum HCO<sub>3</sub>&nbsp;is reduced to levels that can be largely reabsorbed despite defective proximal tubule reabsorptive mechanisms.</p>\n</td>\n<td>&lt;5.5</td>\n</tr>\n<tr>\n<td>\n<p>Urine</p>\n<p>anion gap</p>\n</td>\n<td>Positive</td>\n<td>Negative</td>\n<td>Positive</td>\n</tr>\n<tr>\n<td>\n<p>Nephrolithiasis/ Nephrocalcinosis</p>\n</td>\n<td>&nbsp;Yes</td>\n<td>&nbsp;No</td>\n<td>&nbsp;No</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1668, 'Medicine', 'PM1891. Most Commons in Glomerulopathies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\>Most common cause of:</td>\n</tr>\n<tr>\n<td>Primary glomerulonephritis in the world</td>\n<td>IgA nephropathy</td>\n</tr>\n<tr>\n<td>Secondary glomerulonephritis in the&nbsp;world</td>\n<td>Diabetic nephropathy</td>\n</tr>\n<tr>\n<td>Nephrotic syndrome&nbsp;in adults</td>\n<td>Focal segmental glomerulosclerosis &gt; membranous nephropathy</td>\n</tr>\n<tr>\n<td>Nephrotic syndrome&nbsp;in&nbsp;children</td>\n<td>Minimal change disease</td>\n</tr>\n<tr>\n<td>Glomerulopathy in colon cancer or lung cancer</td>\n<td>Membranous nephropathy</td>\n</tr>\n<tr>\n<td>Renal pathology in leprosy</td>\n<td>Membranoproliferative glomerulonephritis</td>\n</tr>\n<tr>\n<td>Renal pathology in syphillis</td>\n<td>Membranous nephropathy</td>\n</tr>\n<tr>\n<td>Renal pathology in hepatitis C</td>\n<td>Cryoglobulinemic glomerulonephritis</td>\n</tr>\n<tr>\n<td>Renal pathology in hepatitis B</td>\n<td>&nbsp;Membranous nephropathy</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1669, 'Medicine', 'PM1885. Urinary Casts and Their Significance', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8ce4f74ab9824f42b8cb05ac3433314cx1280x3456.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1670, 'Medicine', 'PM1877. Color of urine  in different conditions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Normal color of urine is <strong>pale straw</strong> due to presence of <strong>urochrome.</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Cause</strong></td>\n</tr>\n<tr>\n<td>Smokey or cloudy</td>\n<td>\n<ul>\n<li>AGN</li>\n<li>Nephrotic syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Gross blood</td>\n<td>\n<ul>\n<li>Urological causes&nbsp; &nbsp; &nbsp;</li>\n<li>Nephro causes</li>\n<li>Hematological causes, e.g. PNH</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Red without blood [brownish tinge]</td>\n<td>\n<ul>\n<li>Rhabdomyolysis&nbsp; &nbsp;</li>\n<li>Beetroot ingestion&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Tea- or cola-colored urine</td>\n<td>Hemoglobinuria</td>\n</tr>\n<tr>\n<td>High-colored urine</td>\n<td>Bilirubinuria</td>\n</tr>\n<tr>\n<td>Darkens on standing</td>\n<td>Alkaptonuria</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>&nbsp;Due to Drugs:&nbsp;</p>\n<table width=\251\>\n<tbody>\n<tr>\n<td><strong>Abnormality&nbsp;</strong></td>\n<td><strong>Drugs&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Orange</td>\n<td>\n<ul>\n<li>Rifamycins (rifampicin, rifabutin, rifapentine)</li>\n<li>B-complex&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Blue</td>\n<td>\n<ul>\n<li>Amitriptyline</li>\n<li>Methylene blue</li>\n<li>Copper poisoning</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Brown</td>\n<td>\n<ul>\n<li>Chloroquine</li>\n<li>Quinine</li>\n<li>Primaquine</li>\n<li>Nitrofurantoin&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Yellow</td>\n<td>Tetracycline&nbsp;</td>\n</tr>\n<tr>\n<td>Pinkish</td>\n<td>Deferoxamine</td>\n</tr>\n<tr>\n<td>Green</td>\n<td>Triamterene</td>\n</tr>\n<tr>\n<td>Darkens on standing</td>\n<td>\n<ul>\n<li>Metronidazole</li>\n<li>Methyldopa</li>\n<li>Imipenem-cilastin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1671, 'Medicine', 'PM2441. Supraventricular tachycardias', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with narrow QRS complex:</strong></p>\n<ul>\n<li><strong>Narrow QRS with regular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp;Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Sinus tachycardia</strong></td>\n<td>Normal P wave, normal ECG features except for the rate</td>\n</tr>\n<tr>\n<td><strong>Focal atrial tachycardia</strong></td>\n<td>A single type of abnormal p wave morphology is seen</td>\n</tr>\n<tr>\n<td><strong>Junctional tachycardia</strong></td>\n<td>No p waves. Heart rate is 100- 200/ min</td>\n</tr>\n<tr>\n<td><strong>AV nodal reentry tachycardia</strong></td>\n<td>No p waves. Pseudo R waves may be seen. Heart rate is 150-250/ min</td>\n</tr>\n<tr>\n<td><strong>Atrioventricular reentry tachycardia</strong></td>\n<td>P wave always follows QRS. RP interval&lt; PR interval</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter</strong></td>\n<td>Sawtooth shaped flutter waves are seen</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<ul>\n<li><strong>Narrow QRS with irregular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp; &nbsp; &nbsp;<strong>Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Atrial fibrillation</strong></td>\n<td>No distinct p waves seen</td>\n</tr>\n<tr>\n<td><strong>Multifocal atrial tachycardia</strong></td>\n<td>More than 3 different abnormal p wave morphologies are seen</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter/tachycardia with variable block</strong></td>\n<td>ECG features of heart block are seen.</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with wide QRS complex:</strong></p>\n<ul>\n<li>Antidromic AVRT (atrioventricular reentry tachycardia)</li>\n<li>Supraventricular tachycardias with bundle branch block</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1672, 'Medicine', 'PM2440. ECG patterns of various ventricular arrhythmias', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Ventricular tachycardia</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/097b95729fa14ac68da475ce6288a968x1088x570.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p>Polymorphic ventricular tachycardia associated with QTc prolongation- Torsades de pointes</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a8ebe0b5757c4efca4f5dd15c6d24e99x1268x324.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p>Ventricular flutter</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/666962cd0f424000b7e84123f719f120x502x282.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p>Ventricular fibrillation</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/25067efa869941baa6a40b54599b371ax1049x213.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1673, 'Medicine', 'PM2439. Wolff Parkinson White Syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Wolff Parkinson White Syndrome</strong>&nbsp;(WPW) is characterized by an abnormal accessory pathway in the heart leading to arrhythmias.</p>\n<p><strong>Pathology</strong>- Born with an accessory pathway, the bundle of Kent which connects the atria and ventricle. The electrical impulses from the SA node reach the ventricles earlier via the accessory pathway as there is no AV nodal delay in this pathway. This leads to the preexcitation of the ventricle and initiation of ventricular contraction. This ventricular contraction is prolonged when the impulse via the AV nodal pathway reaches the ventricles.</p>\n<p><strong>Most common location</strong> of the accessory pathway-&nbsp;between the left atrium and free wall of the left ventricle</p>\n<p><strong>ECG changes</strong>:</p>\n<p><strong>Shortened PR interval</strong>- because of the early initiation of ventricular depolarization</p>\n<p><strong>Prolonged QRS duration</strong>- because of the AV nodal impulse reaching the ventricles after the aberrant impulse.</p>\n<p><strong>Delta waves</strong>- slurred upstroke of QRS complex</p>\n<p>The given ECG shows delta waves marked with red arrows:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b00a7f28fc9540629f591281df010cf4x791x183.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Treatment:</strong></p>\n<ul>\n<li><strong>Catheter ablation</strong>&nbsp;is the treatment of choice.</li>\n<li>Anti-arrhythmic drugs like procainamide, amiodarone, quinidine, propafenone, dofetilide are used in slowing conduction in the accessory pathway (prolong refractory period).</li>\n<li>IV procainamide is the drug of choice in a hemodynamically stable WPW presenting with atrial fibrillation.</li>\n<li>DC cardioversion is done in&nbsp;hemodynamically unstable patients.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1674, 'Surgery,', 'PM2291. Risk Factors for Venous Thromboembolism', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The risk factors for venous thromboembolism (pulmonary embolism and DVT) are as follows:</p>\n<ul>\n<li aria-level=\1\><strong>Major trauma</strong> like spinal cord injury or fracture of lower limb</li>\n<li aria-level=\1\><strong>Surgery</strong> like hip or knee replacement</li>\n<li aria-level=\1\><strong>Hospitalization</strong> for heart failure or atrial fibrillation/flutter within last 3 months</li>\n<li aria-level=\1\><strong>Myocardial infarction</strong>&nbsp;within last 3 months</li>\n<li aria-level=\1\><strong>Previous venous thromboembolism</strong></li>\n<li aria-level=\1\>Infections and inflammatory bowel disease</li>\n<li aria-level=\1\>Autoimmune diseases:\n<ul>\n<li aria-level=\1\>Antiphospholipid antibody (APLA)</li>\n<li aria-level=\1\>SLE</li>\n</ul>\n</li>\n<li aria-level=\1\>Inherited thrombophilias:\n<ul>\n<li aria-level=\1\>Factor V leiden mutation</li>\n<li aria-level=\1\>Deficiency of antithrombin III</li>\n<li aria-level=\1\>Deficiency of protein C or protein S</li>\n</ul>\n</li>\n<li>Hypercoagulable states:\n<ul>\n<li>Pregnancy and postpartum period</li>\n<li aria-level=\1\>COPD</li>\n<li aria-level=\1\>Nephrotic syndrome</li>\n<li aria-level=\1\>Polycythemia vera</li>\n<li aria-level=\1\>Malignancies</li>\n</ul>\n</li>\n<li aria-level=\1\>Iatrogenic:\n<ul>\n<li aria-level=\1\>OCPs</li>\n<li aria-level=\1\>Hormone replacement therapy</li>\n<li aria-level=\1\>Chemotherapeutic drugs</li>\n<li aria-level=\1\>Insertion of central venous lines</li>\n</ul>\n</li>\n<li aria-level=\1\>Varicose veins</li>\n<li aria-level=\1\>Prolonged car or air travel.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1675, 'Medicine,', 'PM2066. Revised Jones criteria for diagnosis of Acute Rheumatic Fever (ARF)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Revised Jones criteria for the diagnosis of rheumatic fever are as follows:</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\>Major criteria</td>\n</tr>\n<tr>\n<td><strong>Low-risk populations*</strong></td>\n<td><strong>Moderate- and high-risk populations*</strong></td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Carditis- Clinical or subclinical</td>\n<td>Carditis- Clinical or subclinical</td>\n</tr>\n<tr>\n<td>Arthritis- <strong>Polyarthritis only</strong></td>\n<td>Arthritis- <strong>P</strong><strong>olyarthritis/polyarthralgia/monoarthritis</strong></td>\n</tr>\n<tr>\n<td>Chorea</td>\n<td>Chorea</td>\n</tr>\n<tr>\n<td>Erythema marginatum</td>\n<td>Erythema marginatum</td>\n</tr>\n<tr>\n<td>Subcutaneous nodules</td>\n<td>Subcutaneous nodules</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td colspan=\2\>Minor criteria&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Polyarthralgia</strong></td>\n<td><strong>Monoarthralgia</strong></td>\n</tr>\n<tr>\n<td>Fever&nbsp;(≥38.5°C)</td>\n<td>Fever (≥38°C)</td>\n</tr>\n<tr>\n<td>ESR ≥60 mm in the first hour and/or CRP ≥3.0 mg/dL</td>\n<td>ESR ≥30 mm/hr and/or CRP ≥3.0 mg/dL</td>\n</tr>\n<tr>\n<td><strong>Prolonged PR interval</strong>, after accounting for age variability (unless carditis is a major criterion)</td>\n<td>Prolonged PR interval, after accounting for age variability (unless carditis is a major criterion)&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td colspan=\2\>For all patient populations with evidence of preceding Group A Streptococcal infection:(Increased ASLO/ anti-DNAse B titer or positive throat culture for group A streptococcus or positive rapid streptococcal carbohydrate antigen test)&nbsp;</td>\n</tr>\n<tr>\n<td>Diagnosis of initial ARF</td>\n<td>2 Major criteria or 1 major plus 2 minor criteria</td>\n</tr>\n<tr>\n<td>Diagnosis of recurrent ARF</td>\n<td>2 Major or 1 major and 2 minor or 3 minor criteria</td>\n</tr>\n</tbody>\n</table>\n<p>*Low-risk populations are those with ARF incidence ≤2 per 100 000 school-aged children or all-age rheumatic heart disease prevalence of ≤1 per 1000 population per year. If the incidence exceeds the given limit, then it is moderate-high risk populations.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1676, 'Medicine', 'PM1846. The causes of holosystolic murmur are:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp; 1. Mitral regurgitation</p>\n<ul>\n<li>Best heard at the apex</li>\n<li>Radiates to axilla or base</li>\n<li>Decreases in intensity with amyl nitrate</li>\n<li>A2 is not heard at the apex</li>\n</ul>\n<p>&nbsp; 2. Tricuspid regurgitation</p>\n<ul>\n<li>Best heard at lower left sternal border</li>\n<li>Radiates to the epigastrium and right sternal border</li>\n<li>Increases in intensity during inspiration</li>\n<li>Prominent c-v waves seen in JVP</li>\n</ul>\n<p>&nbsp; 3. Ventricular septal defect</p>\n<ul>\n<li>Beat heard over left 3<sup>rd</sup> and 4<sup>th</sup> intercostal space</li>\n<li>Radiates widely</li>\n<li>Palpable thrill present</li>\n<li>Decreases in intensity with amyl nitrate</li>\n<li>Wide splitting of S2 seen</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1677, 'Medicine', 'PM1834. Cardiac conditions requiring antibiotic prophylaxis for infective endocarditis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>High risk cardiac conditions for development of Infective endocarditis and require antibiotic prophylaxis are:</p>\n<ul>\n<li>Prosthetic valves</li>\n<li>History of infective endocarditis</li>\n<li>Few congenital heart diseases which include:<br>\n<ul>\n<li>Unrepaired cyanotic CHD, including palliative shunts and conduit</li>\n<li>Completely repaired congenital heart defect with prosthetic material or device, whether placed by surgery or by catheter intervention, during the first 6 months after the procedure</li>\n<li>Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device</li>\n</ul>\n</li>\n<li>Cardiac transplantation recipients with cardiac valvular disease</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1678, 'Medicine', 'PM1738. Revised 2017 ACC guidelines on Hypertension:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Systolic BP (mm Hg)</strong></td>\n<td><strong>Diastolic BP</strong> <strong>(mm Hg)</strong></td>\n<td><strong>Management</strong></td>\n</tr>\n<tr>\n<td><strong>Normal</strong></td>\n<td>&nbsp;&lt; 120</td>\n<td>&lt; 80</td>\n<td>Lifestyle modification</td>\n</tr>\n<tr>\n<td><strong>Elevated BP</strong></td>\n<td>120 -129</td>\n<td>&lt; 80</td>\n<td>Lifestyle modification</td>\n</tr>\n<tr>\n<td><strong>Stage 1 HT</strong></td>\n<td>130 -139 (or)</td>\n<td>80 -89</td>\n<td>\n<p>Lifestyle modification(Antihypertensive medication only if</p>\n<ul>\n<li>Previous stroke / CAD / Heart attack</li>\n<li>Diabetic</li>\n<li>CKD</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Stage 2 HT</strong></td>\n<td>&gt; 140 (or)</td>\n<td>&nbsp;&gt; 90</td>\n<td>Anti-hypertensive medication + Lifestyle modification</td>\n</tr>\n<tr>\n<td><strong>Hypertensive crisis</strong></td>\n<td>&gt; 180 (or)</td>\n<td>&gt;120</td>\n<td>Patients needing prompt changes in medication if there are no other indications of problems, or immediate hospitalization if there are signs of organ damage.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1679, 'Medicine', 'PM1679. CHADS2 VASc Score (Risk of stroke in AF)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>RISK FACTOR</strong></td>\n<td><strong>POINTS</strong></td>\n</tr>\n<tr>\n<td><strong>C</strong>- Congestive Heart Failure</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>H</strong>- Hypertension</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>A<sub>2</sub></strong><sub>-&nbsp;</sub>Age &gt;= 75 years</td>\n<td>2</td>\n</tr>\n<tr>\n<td><strong>D</strong>- Diabetes</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>S<sub>2</sub></strong>- Prior stroke or TIA</td>\n<td>2</td>\n</tr>\n<tr>\n<td><strong>V</strong>-&nbsp;Vascular disease&nbsp;</td>\n<td>&nbsp;1</td>\n</tr>\n<tr>\n<td><strong>A</strong>-&nbsp;Age 65–74 years</td>\n<td>&nbsp;1</td>\n</tr>\n<tr>\n<td><strong>S<sub>c</sub></strong>- Sex category (Female sex)</td>\n<td>&nbsp;1</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table width=\376\>\n<tbody>\n<tr>\n<td><strong>CHA<sub>2</sub>DS<sub>2</sub>-VASc Score</strong></td>\n<td><strong>Stroke rate per 100 Patient Years</strong></td>\n</tr>\n<tr>\n<td>0</td>\n<td>0</td>\n</tr>\n<tr>\n<td>1</td>\n<td>1.3</td>\n</tr>\n<tr>\n<td>2</td>\n<td>2.2</td>\n</tr>\n<tr>\n<td>3</td>\n<td>3.2</td>\n</tr>\n<tr>\n<td>4</td>\n<td>4.0</td>\n</tr>\n<tr>\n<td>5</td>\n<td>6.7</td>\n</tr>\n<tr>\n<td>6</td>\n<td>9.8</td>\n</tr>\n<tr>\n<td>7</td>\n<td>\n<p>9.6</p>\n</td>\n</tr>\n<tr>\n<td>8</td>\n<td>6.7</td>\n</tr>\n<tr>\n<td>9</td>\n<td>15.2</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1680, 'Medicine,', 'PM1655. Prophylaxis for DVT', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Mechanical prophylaxis</strong></td>\n</tr>\n<tr>\n<td>Early ambulation</td>\n<td>\n<p>Acts by activating the calf pump mechanism</p>\n</td>\n</tr>\n<tr>\n<td>Pneumatic compression stocking</td>\n<td>\n<p>Prevents stasis by periodically compressing the calves</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Pharmacological prophylaxis</strong></td>\n</tr>\n<tr>\n<td>\n<p>Low molecular weight heparin (LMWH) - Enoxaparin</p>\n<p>Fondaparinux</p>\n</td>\n<td>Prevent thrombus formation by inhibiting factor Xa</td>\n</tr>\n<tr>\n<td>\n<p>Apixaban</p>\n<p>Rivaroxaban&nbsp;</p>\n</td>\n<td>&nbsp;Oral factor Xa inhibitors</td>\n</tr>\n<tr>\n<td>\n<p>Unfractionated heparin (UFH)</p>\n</td>\n<td>\n<p>Prevents action of factors VIII - XII and production of thrombin/fibrin.</p>\n<p>Used in renal insufficiency</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Warfarin</p>\n</td>\n<td>\n<p>Inhibits hepatic production of factors II, VII, IX and X</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1681, 'Medicine', 'PM1227. Management of Hypertensive Emergency', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9addcf0641a14be88a24f231435de7ebx883x489.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1682, 'Medicine', 'PM1226. Target BP in hypertensive patients- European Society of Cardiology guidelines 2018', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\672\>\n<tbody>\n<tr>\n<td><strong>Age group</strong></td>\n<td><strong>Hypertension</strong></td>\n<td><strong>Coexisting diabetes</strong></td>\n<td><strong>Coexisting chronic kidney disease</strong></td>\n<td><strong>Coexisting coronary artery disease</strong></td>\n<td><strong>Coexisting stroke/ TIA</strong></td>\n</tr>\n<tr>\n<td>\n<p>18-65 years</p>\n<p>(Target systolic range- if tolerated)</p>\n</td>\n<td>\n<p class=\p1\>120-130 mmHg</p>\n</td>\n<td>\n<p class=\p1\>120-130 mmHg</p>\n</td>\n<td>\n<p class=\p1\>130-140 mmHg</p>\n</td>\n<td>\n<p class=\p1\>120-130 mmHg</p>\n</td>\n<td>\n<p class=\p1\>120-130 mmHg</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>65-79 years</p>\n<p>(Target systolic range- if tolerated)</p>\n</td>\n<td>\n<p class=\p1\>130-139 mmHg</p>\n</td>\n<td>\n<p class=\p1\>130-139 mmHg</p>\n</td>\n<td>\n<p class=\p1\>130-139 mmHg</p>\n</td>\n<td>\n<p class=\p1\>130-139 mmHg</p>\n</td>\n<td>\n<p class=\p1\>130-139 mmHg</p>\n</td>\n</tr>\n<tr>\n<td>Office diastolic measurement</td>\n<td>70-79mmHg</td>\n<td>70-79mmHg</td>\n<td>70-79mmHg</td>\n<td>&nbsp;70-79mmHg</td>\n<td>&nbsp;70-79mmHg</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1683, 'Medicine', 'PM1223. European society of cardiology guidelines for treatment of hypertension', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\489\>\n<tbody>\n<tr>\n<td width=\149\>\n<p><strong>Indication</strong></p>\n</td>\n<td width=\339\>\n<p><strong>Initial treatment of choice&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Hypertension alone or hypertension with diabetes/ cerebrovascular disease</p>\n</td>\n<td width=\339\>\n<p>ACEi/ARB + CCB/diuretic (A+C or A+D)</p>\n</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Hypertension with coronary artery disease</p>\n</td>\n<td width=\339\>\n<p>ACEi/ ARB + beta blocker/CCB (A+B or A+C)</p>\n<p>or</p>\n<p>beta-blocker + diuretic (B+D)</p>\n<p>or&nbsp;</p>\n<p>CCB+ diuretic/ beta-blocker (C+B or C+D)</p>\n</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Hypertension with chronic kidney disease</p>\n</td>\n<td width=\339\>\n<p>ACEi/ARB + CCB/diuretic (A+C or A+D)</p>\n</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Hypertension with heart failure and reduced ejection fraction</p>\n</td>\n<td width=\339\>\n<p>ACEI/ ARB + diuretic + beta-blocker (A+D+B)</p>\n</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Pregnancy</p>\n</td>\n<td width=\339\>\n<p>Labetalol, Nifedipine, methyldopa</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>ACEi – Angiotensin-converting enzyme inhibitors</p>\n<p>ARB – Angiotensin II receptor blockers</p>\n<p>CCB – Calcium Channel Blockers</p></div><!---->\n      <!---->\n    </div><!---->'),
(1684, 'Medicine', 'PM1222. American Heart Association (AHA) 2019 guidelines for hypertension management', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>According to the AHA hypertension guidelines, 2019, pharmacologic treatment for hypertension is recommended</p>\n<ul>\n<li>In patients who&nbsp;have <strong>≥10% estimated 10year ASCVD risk,&nbsp;</strong>when&nbsp;<strong>BP ≥ 130/80 mmHg</strong>&nbsp;</li>\n<li>In patients who have <strong>&lt;10%&nbsp;estimated 10year ASCVD risk&nbsp;</strong>when<strong>&nbsp;</strong><strong>BP ≥ 140/90</strong> <strong>mmHg</strong>&nbsp;</li>\n</ul>\n<p>&nbsp;ASCVD - Atherosclerotic cardiovascular disease</p>\n<p>ASCVD risk is calculated using a calculator provided by the American Heart Association.</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Lifestyle modifications in the management of hypertension</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Intervention</strong></td>\n<td><strong>Goal</strong></td>\n<td><strong>Impact on BP</strong></td>\n</tr>\n<tr>\n<td>1. Weight reduction</td>\n<td>The best goal is ideal body weight</td>\n<td>-5 mmHg</td>\n</tr>\n<tr>\n<td>2. Dietary sodium restriction</td>\n<td>\n<ul>\n<li>Total sodium - &lt;1.5g/day (AHA 2019 guidelines)</li>\n<li>Total NaCl (salt) intake - &lt;6g/day</li>\n</ul>\n</td>\n<td>-5/6 mmHg</td>\n</tr>\n<tr>\n<td>3. Enhanced potassium intake</td>\n<td>3.5 - 5g/day</td>\n<td>-4/5 mmHg</td>\n</tr>\n<tr>\n<td>4. DASH dietary pattern&nbsp;</td>\n<td>high in vegetables, fruits, low-fat dairy products, whole grains, poultry, fish, and nuts and low in sweets, sugar-sweetened beverages, red meats, and saturated and total fat.</td>\n<td>-11 mmHg</td>\n</tr>\n<tr>\n<td>5. Physical activity</td>\n<td>Aerobic exercise, dynamic resistance and isometric resistance</td>\n<td>-4-8 mmHg</td>\n</tr>\n<tr>\n<td>6. Moderation in alcohol consumption</td>\n<td><span class=\Y0NH2b CLPzrc\>In individuals who drink alcohol - ≤</span> 2 drinks/ day for men and <span class=\Y0NH2b CLPzrc\>≤</span> 1 drink/ day for women</td>\n<td><span class=\Y0NH2b CLPzrc\>-4 mmHg</span></td>\n</tr>\n</tbody>\n</table>\n<p>DASH – Dietary Approaches to Stop Hypertension</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Target BP in hypertensives:</strong></p>\n<table width=\658\>\n<tbody>\n<tr>\n<td><strong>Clinical condition</strong></td>\n<td><strong>BP Goal, mm Hg</strong></td>\n</tr>\n<tr>\n<td>Clinical CVD or&nbsp;10 year ASCVD risk&nbsp; &gt; 10%</td>\n<td>&lt;130/80</td>\n</tr>\n<tr>\n<td>No clinical CVD and 10 year ASCVD risk &lt; 10%</td>\n<td>&lt;130/80</td>\n</tr>\n<tr>\n<td>Adults with CKD</td>\n<td>&lt;130/80</td>\n</tr>\n<tr>\n<td>Adults with Type 2 DM&nbsp;</td>\n<td>&lt;130/80</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1685, 'Medicine', 'PM1221. Causes of Secondary Hypertension', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\149\>\n<p>Renal parenchymal</p>\n</td>\n<td width=\329\>\n<p>Glomerulonephritis, renal cysts, renal tumors</p>\n</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Renovascular</p>\n</td>\n<td width=\329\>\n<p>Renal artery stenosis,<strong>&nbsp;</strong>arteriosclerotic, fibromuscular dysplasia</p>\n</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Adrenal</p>\n</td>\n<td width=\329\>\n<p>Primary aldosteronism, Cushing’s syndrome, pheochromocytoma</p>\n</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Aortic coarctation</p>\n</td>\n<td width=\329\>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Obstructive sleep apnea</p>\n</td>\n<td width=\329\>&nbsp;</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Pre-eclampsia/ eclampsia</p>\n</td>\n<td width=\329\>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Neurogenic</p>\n</td>\n<td width=\329\>\n<p>Psychogenic, polyneuritis (acute porphyria, lead poisoning), acute increased ICP, acute spinal cord section</p>\n</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Endocrine</p>\n</td>\n<td width=\329\>\n<p>Hypothyroidism, hyperthyroidism, hypercalcemia, acromegaly</p>\n</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Medications</p>\n</td>\n<td width=\329\>\n<p>High-dose estrogens, adrenal steroids, appetite suppressants, cyclosporine, tricyclic antidepressants, MAO inhibitors, NSAIDS</p>\n</td>\n</tr>\n<tr>\n<td width=\149\>\n<p>Mendelian forms</p>\n</td>\n<td width=\329\>\n<p>Liddle’s syndrome, Gordon’s syndrome, MEN 2A &amp; 2B</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1686, 'Medicine', 'PM1219. Classification of Hypertension', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\144\>\n<p><strong>Types</strong></p>\n</td>\n<td width=\293\>\n<p><strong>Features</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p>Primary/ Essential/ Idiopathic Hypertension</p>\n</td>\n<td width=\293\>\n<p>Most common&nbsp;type</p>\n<p>Cause is unknown</p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p>Secondary hypertension</p>\n</td>\n<td width=\293\>\n<p>Usually correctable</p>\n<p>Has definitive cause</p>\n<p>Usually develops before 30yrs or after 55yrs</p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p>Isolated systolic hypertension</p>\n</td>\n<td width=\293\>\n<p><span class=\nowrap\>≥140/&lt;90</span> mmHg</p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p>Isolated diastolic hypertension</p>\n</td>\n<td width=\293\>\n<p><span class=\nowrap\>&lt;130/≥80 mmHg</span></p>\n</td>\n</tr>\n<tr>\n<td width=\144\>\n<p>Whitecoat hypertension</p>\n</td>\n<td width=\293\>\n<ul>\n<li>The office blood pressure is ≥140/90 mm Hg on ≥3 separate office visits</li>\n<li>≥2 blood pressure measurements taken outside the office are &lt;140/90 mm Hg, frequently using home blood pressure monitoring; and</li>\n<li>There is no evidence of hypertensive target organ damage.</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1687, 'Medicine', 'PM1218. Classification of blood pressure for adults - European Society of Cardiology guidelines - 2018', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Classification of Office blood pressure</strong></p>\n</td>\n<td>\n<p><strong>SBP (mmHg)</strong></p>\n</td>\n<td>\n<p><strong>DBP (mmHg)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Optimal&nbsp;</p>\n</td>\n<td>\n<p>&lt;120 and</p>\n</td>\n<td>\n<p>&lt;80</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>120-129 and/or</p>\n</td>\n<td>\n<p>80-84</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>High normal</p>\n</td>\n<td>\n<p>130-139 and/or</p>\n</td>\n<td>\n<p>85-89</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Grade 1 hypertension</p>\n</td>\n<td>\n<p>140-159 and/or</p>\n</td>\n<td>\n<p>90-99</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Grade 2 hypertension</p>\n</td>\n<td>\n<p>160-179 and/or</p>\n</td>\n<td>\n<p>100-109</p>\n</td>\n</tr>\n<tr>\n<td>Grade 3 hypertension</td>\n<td>≥180 and/or</td>\n<td>≥110</td>\n</tr>\n<tr>\n<td>Isolated systolic hypertension</td>\n<td>≥140 and</td>\n<td>&lt;90</td>\n</tr>\n</tbody>\n</table>\n<p>Note: Whenever hypertension can be classified into two different categories based on values of SBP and DBP, then the higher category is considered as the classification of hypertension.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1688, 'Medicine', 'PM1214. Classification of Congenital Heart Disease in Adults', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Simple</strong></p>\n</td>\n<td>\n<p><strong>Intermediate complexity</strong></p>\n</td>\n<td>\n<p><strong>Complex </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&nbsp;</p>\n<ul>\n<li>Uncomplicated small ASD</li>\n<li>Uncomplicated Small VSD</li>\n<li>Mild pulmonic stenosis</li>\n<li>Occluded or ligated ductus arteriosus</li>\n<li>Repaired VSD without residue</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Ostium primum or sinus venous ASD</li>\n<li>AV canal defects</li>\n<li>Coarctation of Aorta</li>\n<li>Pulmonic valve stenosis</li>\n<li>PDA non closed</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Cyanotic congenital heart disease</li>\n<li>Ebstein anomaly</li>\n<li>Eisenmenger’s syndrome</li>\n<li>TOF</li>\n<li>Truncus arteriosus</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1689, 'Medicine', 'PM1212. Localisation of MI based on ST elevations in different leads', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Extensive anterior - I, aVL, V1-V6</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a0d690cfd571427cabfe3625fec7aea2x720x446.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Lateral - I, aVL</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/544634fa03c146d38f02014738cc9ffdx1280x791.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Inferior - II, III, aVF</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ecf1b037017145409598613d151004afx1280x808.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Anteroseptal - V1-V4</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/92955d71dfdd400ca4f634e482ddf9d8x1280x849.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Anterolateral - I, aVL, V3-V6</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e2aaee158f5b4111b131cce1219c5afax1280x791.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Posterior - ST depression and tall R in V1-V4</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/dda0e5b11d9340808ac18534d35fd867x1280x803.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1690, 'Medicine', 'PM1208. Classification of Pulmonary Hypertension & its Causes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Based on underlying mechanisms, the World Health Organization has classified pulmonary hypertension into five groups.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Classification</strong></p>\n</td>\n<td>\n<p><strong>Causes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Group 1</strong></p>\n<p><strong>Pulmonary arterial hypertension (PAH)</strong></p>\n</td>\n<td>\n<p>Idiopathic PAH</p>\n<p>Hereditary PAH - BMPR2 gene (most common mutation)</p>\n<p>Drug or toxin-induced PAH</p>\n<p>PAH associated with</p>\n<ul>\n<li>Connective tissue disorder (limited systemic sclerosis)</li>\n<li>Portal hypertension</li>\n<li>HIV</li>\n<li>Schistosomiasis</li>\n<li>Congenital heart diseases</li>\n</ul>\n<p>PAH long-term responders to calcium channel blockers</p>\n<p>PAH with overt features of a pulmonary veno-occlusive disease or pulmonary capillary hemangiomatosis</p>\n<p>Persistent pulmonary hypertension of the newborn syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Group 2</strong></p>\n<p><strong>Pulmonary hypertension associated with left heart disease </strong></p>\n</td>\n<td>\n<p>Left ventricular systolic or diastolic dysfunction</p>\n<p>Valvular heart disease</p>\n<p>Congenital cardiomyopathies</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Group 3</strong></p>\n<p><strong>Pulmonary hypertension associated with lung</strong> <strong>disease</strong></p>\n</td>\n<td>\n<p>Chronic obstructive pulmonary disease</p>\n<p>Interstitial lung disease</p>\n<p>Sleep-disordered breathing</p>\n<p>Alveolar hypoventilation disorders</p>\n<p>Chronic exposure to high altitude</p>\n<p>Developmental lung disorders</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Group 4</strong></p>\n<p><strong>Chronic thromboembolic pulmonary hypertension</strong></p>\n</td>\n<td>\n<p>Chronic thromboembolic pulmonary hypertension</p>\n<p>Congenital pulmonary artery stenosis</p>\n<p>Pulmonary arteritis</p>\n<p>Pulmonary angiosarcoma&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Group 5</strong></p>\n<p><strong>Pulmonary hypertension with unclear and/or multifactorial mechanisms</strong></p>\n</td>\n<td>\n<p>Hematological disorders (chronic hemolytic anemias)</p>\n<p>Metabolic disorders (glycogen storage diseases)</p>\n<p>Systemic disorders (sarcoidosis)</p>\n<p>Others (tumor obstruction, fibrosing mediastinitis)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1691, 'Medicine', 'PM1205. Indication for Pacemaker in AV Conduction Defects', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\479\>\n<ul>\n<li>In any patient with symptomatic bradycardia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\479\>\n<ul>\n<li>Irreversible second- or third-degree AV bloc</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\479\>\n<ul>\n<li>Pacing in patients with asymptomatic AV block should be individualized</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\479\>\n<p>With acquired CHB</p>\n</td>\n</tr>\n<tr>\n<td width=\479\>\n<p>Left ventricular dysfunction and</p>\n</td>\n</tr>\n<tr>\n<td width=\479\>\n<p>Waking heart rates 40 beats/min.</p>\n</td>\n</tr>\n<tr>\n<td width=\479\>\n<ul>\n<li>Asymptomatic second-degree AV block of either type, if the block is demonstrated to be intra- or infra-His or is associated with a wide QRS complex</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td width=\479\>\n<ul>\n<li>Neuromuscular diseases having a predilection for the conduction system, such as myotonic dystrophy and other muscular dystrophies, and Kearns-Sayre syndrome</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1692, 'Medicine', 'PM1204. Types of Heart block', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/321f89fee89642ff8d4791a7741dd90ax1280x1311.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1693, 'Medicine', 'PM1203. Etiology of Torsade De Pointes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Acquired prolongation of QT interval</strong></p>\n<p><strong>Electrolyte abnormalities</strong></p>\n<ul>\n<li>Hypokalemia</li>\n<li>Hypomagnesemia</li>\n<li>Hypocalcemia</li>\n</ul>\n<p><strong>Drugs</strong></p>\n<ul>\n<li><strong>Antiarrhythmic drugs</strong>\n<ul>\n<li>Class IA: Quinidine, disopyramide, procainamide</li>\n<li>Class III: Sotalol, amiodarone (QT prolongation common but torsade ventricular tachycardia is rare), ibutilide, dofetilide, almokalant</li>\n</ul>\n</li>\n<li><strong>Antibiotics</strong>\n<ul>\n<li>Macrolides: Erythromycin, clarithromycin, azithromycin</li>\n<li>Fluoroquinolones: Levofloxacin, moxifloxacin, gatifloxacin</li>\n<li>Trimethoprim-sulfamethoxazole</li>\n<li>Clindamycin</li>\n<li>Pentamidine</li>\n<li>Chloroquine</li>\n<li>Antifungals: Ketoconazole, itraconazole</li>\n<li>Antivirals</li>\n<li>Antipsychotics</li>\n<li>Antihistamines</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1694, 'Medicine', 'PM1202. Difference between VT and SVT with aberrancy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>An ECG with a wide QRS complex can be seen in both VT and in SVT with aberrancy (the presence of a block or WPW syndrome). These two can be differentiated by the features given below:</p>\n<table>\n<tbody>\n<tr>\n<td width=\131\>\n<p><strong>Features </strong></p>\n</td>\n<td width=\158\>\n<p><strong>VT</strong></p>\n</td>\n<td width=\154\>\n<p><strong>SVT with aberrancy</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\131\>\n<p><strong>QRS duration</strong></p>\n</td>\n<td width=\158\>\n<p>&gt;0.14sec</p>\n</td>\n<td width=\154\>\n<p>0.12 – 0.14 sec</p>\n</td>\n</tr>\n<tr>\n<td width=\131\>\n<p><strong>Fusion beats</strong></p>\n</td>\n<td width=\158\>\n<p>+</p>\n</td>\n<td width=\154\>\n<p>-</p>\n</td>\n</tr>\n<tr>\n<td width=\131\>\n<p><strong>Capture beats</strong></p>\n</td>\n<td width=\158\>\n<p>+</p>\n</td>\n<td width=\154\>\n<p>unusual</p>\n</td>\n</tr>\n<tr>\n<td width=\131\>\n<p><strong>AV dissociation</strong></p>\n</td>\n<td width=\158\>\n<p>+</p>\n</td>\n<td width=\154\>\n<p>-</p>\n</td>\n</tr>\n<tr>\n<td width=\131\>\n<p><strong>Independent P waves</strong></p>\n</td>\n<td width=\158\>\n<p>+/-</p>\n</td>\n<td width=\154\>\n<p>-</p>\n</td>\n</tr>\n<tr>\n<td width=\131\>\n<p><strong>QRS pattern</strong></p>\n</td>\n<td width=\158\>\n<p>Does not resemble RBBB / LBBB</p>\n</td>\n<td width=\154\>\n<p>Resemble RBBB/ LBBB</p>\n</td>\n</tr>\n<tr>\n<td width=\131\>\n<p><strong>Axis</strong></p>\n</td>\n<td width=\158\>\n<p>Left axis deviation</p>\n</td>\n<td width=\154\>\n<p>Normal or right</p>\n</td>\n</tr>\n<tr>\n<td width=\131\>\n<p><strong>QRS morphology in V1</strong></p>\n</td>\n<td width=\158\>\n<p>Monophasic or biphasic</p>\n</td>\n<td width=\154\>\n<p>Triphasic</p>\n</td>\n</tr>\n<tr>\n<td width=\131\>\n<p><strong>R/S ratio in V6</strong></p>\n</td>\n<td width=\158\>\n<p>&lt;1</p>\n</td>\n<td width=\154\>\n<p>&gt;1</p>\n</td>\n</tr>\n<tr>\n<td width=\131\>\n<p><strong>Vagal manuvers</strong></p>\n</td>\n<td width=\158\>\n<p>No effect</p>\n</td>\n<td width=\154\>\n<p>Slowing / termination</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1695, 'Medicine', 'PM1201. Recommendations on use of Antithrombotics based on CHADS2 Score', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\163\>\n<p><strong>CHADS2 score</strong></p>\n</td>\n<td width=\280\>\n<p><strong>Antithrombotics </strong></p>\n</td>\n</tr>\n<tr>\n<td width=\163\>\n<p>0</p>\n</td>\n<td width=\280\>\n<p>Aspirin or no antithrombotics</p>\n</td>\n</tr>\n<tr>\n<td width=\163\>\n<p>1</p>\n</td>\n<td width=\280\>\n<p>Aspirin or oral anticoagulant</p>\n</td>\n</tr>\n<tr>\n<td width=\163\>\n<p>&gt;1</p>\n</td>\n<td width=\280\>\n<p>Oral anticoagulant</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1696, 'Medicine', 'PM1200. CHA2DS2-VASC scoring for risk of stroke  & need for oral anticoagulation in AF', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\441\>\n<tbody>\n<tr>\n<td>\n<p><strong>Components</strong></p>\n</td>\n<td>\n<p><strong>Points</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C – Congestive heart failure</p>\n</td>\n<td>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>H - Hypertension</p>\n</td>\n<td>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A – Age &gt; 75 years</p>\n</td>\n<td>\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>D – Diabetes Mellitus</p>\n</td>\n<td>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>S – Stroke/TIA/TE</p>\n</td>\n<td>\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\>VASc-Vascular disease (prior MI, Peripheral Arterial Disease,</p>\n<p class=\p1\>or aortic plaque)</p>\n</td>\n<td>&nbsp;1</td>\n</tr>\n<tr>\n<td>&nbsp;A- Age 65–74 years</td>\n<td>&nbsp;1</td>\n</tr>\n<tr>\n<td>&nbsp;S- sex category (i.e., female sex)</td>\n<td>&nbsp;1</td>\n</tr>\n</tbody>\n</table>\n<p class=\p1\>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td width=\163\>\n<p><strong>CHADS2 score</strong></p>\n</td>\n<td width=\280\>\n<p><strong>Antithrombotics </strong></p>\n</td>\n</tr>\n<tr>\n<td width=\163\>\n<p>0</p>\n</td>\n<td width=\280\>\n<p>Aspirin or no antithrombotics</p>\n</td>\n</tr>\n<tr>\n<td width=\163\>\n<p>1</p>\n</td>\n<td width=\280\>\n<p>Aspirin or oral anticoagulant</p>\n</td>\n</tr>\n<tr>\n<td width=\163\>\n<p>&gt;1</p>\n</td>\n<td width=\280\>\n<p>Oral anticoagulant</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1697, 'Medicine', 'PM1199. Treatment algorithm in PSVT', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3a21d597731d4ecdb43cd7e97f553095x563x438.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1698, 'Medicine', 'PM1198. Management of AR', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Stages of aortic regurgitation (AR):<br><br></p>\n<table>\n<tbody>\n<tr>\n<td>Stage</td>\n<td>Valve abnormalities</td>\n<td>Hemodynamic changes</td>\n</tr>\n<tr>\n<td><strong>A</strong><br>(At risk of AR)</td>\n<td>\n<p>BAV<br><br>Valve sclerosis<br><br>Diseases of aortic sinus/ascending aorta<br><br>Rheumatic fever history/ RHD<br><br>IE</p>\n</td>\n<td>Not seen&nbsp;<br><br>Absent/trace aortic regurgitation</td>\n</tr>\n<tr>\n<td><strong>B</strong><br>(Pro-gressive AR)</td>\n<td>BAV<br><br>Valve calcification- mild/moderate<br><br>Dilated aortic sinuses<br><br>Rheumatic valve changes<br><br>IE</td>\n<td>LV systolic function- normal<br><br>LV dilatation- absent/mild</td>\n</tr>\n<tr>\n<td><strong>C</strong><br>(Asympto-matic severe AR)</td>\n<td>BAV<br><br>Calcific valve disease<br><br>Dilated aortic sinuses/ascending aorta<br><br>Rheumatic valve changes<br><br>IE with abnormal leaflet closure/perforation</td>\n<td><br><br>Stage C1-&nbsp;<br>LVEF- normal (&gt;55%)<br>LV dilatation- mild/moderate<br><br>Stage C2-<br>LVEF- decreased (≤55%)<br>LV dilatation- severe</td>\n</tr>\n<tr>\n<td>\n<p><strong>D</strong><br>(Sympto-matic severe AR)</p>\n</td>\n<td>BAV<br><br>Calcific valve disease<br><br>Dilated aortic sinuses/ascending aorta<br><br>Rheumatic valve changes<br><br>IE with abnormal leaflet closure/perforation</td>\n<td>LVEF may be:<br>normal (&gt;55%)<br>Mild-moderate (40-55%)<br>severe (&lt;40%)<br><br>LV dilatation-moderate to severe</td>\n</tr>\n</tbody>\n</table>\n<p><br>BAV- Bicuspid aortic valve<br>IE- Infective endocarditis<br>RHD- Rheumatic heart disease<br>LV- Left ventricle<br>LVEF- Left ventricle ejection fraction<br><br></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/65bfb35ee79f4a61af02c85b37ca6a5cx1280x2284.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1699, 'Medicine', 'PM1197. Mitral Regurgitation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Stages of mitral regurgitation:<br><br></p>\n<table>\n<tbody>\n<tr>\n<td>Stage</td>\n<td>Valve prolapse and coaptation</td>\n<td>Hemodynamic changes</td>\n</tr>\n<tr>\n<td><strong>A</strong><br>(At risk of MR)</td>\n<td>Prolapse- Mild<br>Coaptation- Normal</td>\n<td>Not seen&nbsp;</td>\n</tr>\n<tr>\n<td><strong>B</strong><br>(Progressive MR)</td>\n<td>Prolapse- Moderate to severe<br>Coaptation- Normal</td>\n<td>LA enlargement- mild<br>LV&nbsp;enlargement- absent<br>Pulmonary hypertension- not seen</td>\n</tr>\n<tr>\n<td><strong>C</strong><br>(Asymptomatic severe MR)</td>\n<td>Prolapse- Severe<br>Coaptation- Lost/ flail leaflets</td>\n<td>LA enlargement- moderate to severe<br>LV&nbsp;enlargement- present<br>Pulmonary hypertension- +/- at rest<br><br>Stage C1-&nbsp;<br>LVEF- &gt;60%<br>LVESD- &lt;40 mm<br><br>Stage C2-<br>LVEF- ≤60%<br>LVESD-&nbsp;≥ 40 mm</td>\n</tr>\n<tr>\n<td>\n<p><strong>D</strong><br>(Symptomatic severe MR)</p>\n</td>\n<td>Prolapse- Severe<br>Coaptation- Lost/ flail leaflets</td>\n<td>LA enlargement- moderate to severe<br>LV&nbsp;enlargement- present<br>Pulmonary hypertension- present&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f37fde7867ea48c4a5b5179596ca69fcx1280x2458.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1700, 'Medicine', 'PM1196. Management of MS', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c13058822c034779954adb0e9ea5c6f7x892x531.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>PCWP – Pulmonary capillary wedge pressure: PMBC – Percutaneous mitral balloon commissurotomy.</strong></li>\n<li><strong>MVR - Mitral valve surgery (repair/ replacement): T1/2 – Pressure halftime: MVA – Mitral valve area.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1701, 'Medicine', 'PM1195. Different signs in Aortic Regurgitation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\158\>\n<p><strong>Sign</strong></p>\n</td>\n<td width=\320\>\n<p><strong>Description</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\158\>\n<p><strong>De Mussets sign</strong></p>\n</td>\n<td width=\320\>&nbsp;Head nodding with each heartbeat</td>\n</tr>\n<tr>\n<td width=\158\>\n<p><strong>Collapsing/Water Hammer/Corrigan pulse</strong></p>\n</td>\n<td width=\320\>\n<p>&nbsp;It is a bounding pulse with rapid upstroke&nbsp; and descent</p>\n</td>\n</tr>\n<tr>\n<td width=\158\>\n<p><strong>Lighthouse sign</strong></p>\n</td>\n<td width=\320\>&nbsp;Alternate flushing &amp; blanching of the forehead</td>\n</tr>\n<tr>\n<td width=\158\>\n<p><strong>Landolfi’s sign</strong></p>\n</td>\n<td width=\320\>&nbsp;Alternating constriction and dilation of the pupil</td>\n</tr>\n<tr>\n<td width=\158\>\n<p><strong>Becker’s sign</strong></p>\n</td>\n<td width=\320\>&nbsp;Retinal artery pulsations</td>\n</tr>\n<tr>\n<td width=\158\>\n<p><strong>Quincke’s pulse</strong></p>\n</td>\n<td width=\320\>\n<p>&nbsp;Alternate flushing and paling of the skin at the root of the nail while pressure is applied to the tip of the nail</p>\n</td>\n</tr>\n<tr>\n<td width=\158\><strong>Rosenbach’s sign</strong></td>\n<td width=\320\>&nbsp;Pulsation of liver</td>\n</tr>\n<tr>\n<td width=\158\><strong>Gerhardt’s sign</strong></td>\n<td width=\320\>&nbsp;Pulsation over the spleen, detected in the presence of splenomegaly</td>\n</tr>\n<tr>\n<td width=\158\>\n<p><strong>Traube’s sign</strong></p>\n</td>\n<td width=\320\>\n<p>&nbsp;A pistol shot sound over femoral arteries</p>\n</td>\n</tr>\n<tr>\n<td width=\158\>\n<p><strong>Durozeiz’s sign</strong></p>\n</td>\n<td width=\320\>\n<p>&nbsp;To-and-fro murmur over the femoral artery when lightly compressed with a stethoscope</p>\n</td>\n</tr>\n<tr>\n<td width=\158\>\n<p><strong>Hill’s sign</strong></p>\n</td>\n<td width=\320\>\n<p>&nbsp;The systolic blood pressure of the lower limb exceeds that of the upper limb at least by 20mm Hg</p>\n</td>\n</tr>\n<tr>\n<td width=\158\>\n<p><strong>Muller’s sign</strong></p>\n</td>\n<td width=\320\>\n<p>Systolic pulsation of the uvula</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1702, 'Medicine', 'PM1194. Grading of Aortic Stenosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\222\>\n<p><strong>Grading of stenosis</strong></p>\n</td>\n<td width=\221\>\n<p><strong>Area of aortic valve</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\222\>\n<p>Mild</p>\n</td>\n<td width=\221\>\n<p>1.5 – 2 sq cm</p>\n</td>\n</tr>\n<tr>\n<td width=\222\>\n<p>Moderate</p>\n</td>\n<td width=\221\>\n<p>1 – 1.5 sq cm</p>\n</td>\n</tr>\n<tr>\n<td width=\222\>\n<p>Severe</p>\n</td>\n<td width=\221\>\n<p>&lt; 1 sq cm</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1703, 'Medicine', 'PM1191. Causes of Valvular Heart Disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\176\>\n<p>Stenosis</p>\n</td>\n<td width=\302\>\n<p>Rheumatic fever</p>\n<p>Congenital</p>\n<p>Degenerative disease</p>\n<p>SLE</p>\n</td>\n</tr>\n<tr>\n<td width=\176\>\n<p>Regurgitation</p>\n</td>\n<td width=\302\>\n<p>Rheumatic fever</p>\n<p>Congenital</p>\n<p>Infective endocarditis</p>\n<p>Syphilitic Aortitis</p>\n<p>Trauma</p>\n<p>Myxomatous</p>\n<p>Marfan’s Syndrome</p>\n<p>HOCM</p>\n<p>Tumor</p>\n<p>Hypertension</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1704, 'Medicine', 'PM0653. Dynamic auscultation of murmurs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Bedside Manoeuvre</strong></td>\n<td><strong>Effect</strong></td>\n</tr>\n<tr>\n<td>\n<p>Inspiration</p>\n<p>(↑venous return to right atrium)</p>\n</td>\n<td>\n<ul>\n<li>↑ intensity of right-sided sounds</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Handgrip</p>\n<p>(↑afterload )</p>\n</td>\n<td>\n<ul>\n<li>↑ intensity of MR, AR, and VSD murmurs</li>\n<li>↓ hypertrophic cardiomyopathy and AS murmurs</li>\n<li>MVP: delayed onset of click/murmur</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Valsalva-Phase II, standing up</p>\n<p>(↓ preload)</p>\n</td>\n<td>\n<ul>\n<li>↓ intensity of most murmurs (including AS)</li>\n<li>↑&nbsp;intensity of hypertrophic cardiomyopathy murmur</li>\n<li>MVP: earlier onset of click /murmur</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rapid squatting</p>\n<p>(↑venous return,↑preload,<br>↑ afterload)</p>\n</td>\n<td>\n<ul>\n<li>↓intensity of hypertrophic cardiomyopathy murmur</li>\n<li>↑&nbsp;intensity of AS, MR, and VSD murmurs</li>\n<li>MVP: later onset of click/murmur</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1705, 'Medicine', 'PM0652. Risk Factors for Sudden Death in HCM', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Risk factors for sudden death in HCM:</p>\n<ul>\n<li>History of cardiac arrest or spontaneous sustained ventricular tachycardia</li>\n<li>Syncope</li>\n<li>Family history of sudden cardiac death</li>\n<li>Spontaneous nonsustained ventricular tachycardia</li>\n<li>LV thickness &gt; 30mm</li>\n<li>Abnormal blood pressure response to exercise</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1706, 'Medicine', 'PM0646. Definitions of Heart Failure According to EF (ESC HF guidelines 2016)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\374\>\n<p><strong>Newer definitions</strong></p>\n</td>\n<td width=\163\>\n<p><strong>Ejection fraction</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\374\>\n<p>Heart failure with reduced Ejection Fraction (HFrEF)</p>\n</td>\n<td width=\163\>\n<p>≤40%</p>\n</td>\n</tr>\n<tr>\n<td width=\374\>\n<p><strong>Heart failure with preserved Ejection Fraction (HFpEF)</strong></p>\n</td>\n<td width=\163\>\n<p>≥50%</p>\n</td>\n</tr>\n<tr>\n<td width=\374\>\n<p>Heart failure with midrange Ejection Fraction (HFmrEF)</p>\n</td>\n<td width=\163\>\n<p>40-49%</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1707, 'Medicine', 'PM0607. Signs in Pericardial Effusion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\454\>\n<tbody>\n<tr>\n<td width=\114\>\n<p><strong>Sign</strong></p>\n</td>\n<td width=\340\>\n<p><strong>Description</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\114\>\n<p>Auenbrugger’s sign</p>\n</td>\n<td width=\340\>\n<p>Bulging of the epigastrium in severe pericardial effusion</p>\n</td>\n</tr>\n<tr>\n<td width=\114\>\n<p>Moschcowitz’s sign</p>\n</td>\n<td width=\340\>\n<p>In pericardial effusion, the transition on percussion from the lungs to the right heart border is abrupt</p>\n</td>\n</tr>\n<tr>\n<td width=\114\>\n<p>Dressler’s sign</p>\n</td>\n<td width=\340\>\n<p>Dullness to percussion of the lower half of the sternum, seen In pericardial effusion.</p>\n</td>\n</tr>\n<tr>\n<td width=\114\>\n<p>Ewarts sign</p>\n</td>\n<td width=\340\>\n<p>In large pericardial effusion, compression of the base of the left lung by the pericardial fluid produces dullness and increased vocal fremitus beneath the angle of the left scapula.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1708, 'Medicine', 'PM0598. American Heart Association (AHA) recommendation for duration of secondary prophylaxis of rheumatic fever', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\454\>\n<tbody>\n<tr>\n<td width=\227\>\n<p><strong>Category</strong></p>\n</td>\n<td width=\227\>\n<p><strong>Duration after the last attack</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\227\>\n<p>Rheumatic fever without carditis</p>\n</td>\n<td width=\227\>&nbsp;\n<p>5 years or until 21 years of age (whichever is longer)</p>\n</td>\n</tr>\n<tr>\n<td width=\227\>\n<p>Rheumatic fever with carditis but no residual heart disease (no valvular disease)</p>\n</td>\n<td width=\227\>&nbsp;10 years or until 21 years of age (whichever is longer)</td>\n</tr>\n<tr>\n<td width=\227\>\n<p>Rheumatic fever with carditis and residual heart disease (persistent valvular disease)</p>\n</td>\n<td width=\227\>\n<p>10 years or until 40 years of age (whichever is longer), sometimes lifelong prophylaxis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1709, 'Medicine', 'PM0564. Causes of Pulsus Paradoxus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\177\>\n<p>Physiological causes</p>\n</td>\n<td width=\262\>\n<p>Obesity</p>\n<p>Pregnancy</p>\n</td>\n</tr>\n<tr>\n<td width=\177\>\n<p>Cardiovascular causes</p>\n</td>\n<td width=\262\>\n<p>Cardiac tamponade – most common cause</p>\n<p>Constrictive pericarditis ( in 1/3<sup>rd</sup> cases )</p>\n<p>Massive pulmonary embolism</p>\n<p>Severe CCF</p>\n<p>Hypovolemic shock</p>\n</td>\n</tr>\n<tr>\n<td width=\177\>\n<p>Respiratory causes</p>\n</td>\n<td width=\262\>\n<p>Severe obstructive lung disease</p>\n<p>Acute severe asthma</p>\n<p>Severe emphysema</p>\n<p>Tension pneumothorax</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1710, 'Medicine', 'PM0555. Vascular diseases – Gender differences', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>More common in males</strong></td>\n<td><strong>More common in females</strong></td>\n</tr>\n<tr>\n<td>\n<p>Aortic aneurysm</p>\n<p>Aortic dissection</p>\n<p>Thromboangitis obliterans</p>\n<p>Erythromelalgia</p>\n</td>\n<td>\n<p>Fibromuscular</p>\n<p>Dysplasia</p>\n<p>Raynaud’s phenomenon</p>\n<p>Acrocyanosis</p>\n<p>Livedo reticularis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1711, 'Medicine', 'PM0544. Source of microorganisms causing infective endocarditis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\419\>\n<tbody>\n<tr>\n<td width=\210\>\n<p><strong>Microorganism </strong></p>\n</td>\n<td width=\209\>\n<p><strong>Source </strong></p>\n</td>\n</tr>\n<tr>\n<td width=\210\>\n<p>Streptococcus viridans</p>\n</td>\n<td width=\209\>\n<p>Oral cavity</p>\n</td>\n</tr>\n<tr>\n<td width=\210\>\n<p>Staphylococcus aureus</p>\n</td>\n<td width=\209\>\n<p>Skin</p>\n</td>\n</tr>\n<tr>\n<td width=\210\>\n<p>HACEK organisms</p>\n</td>\n<td width=\209\>\n<p>Upper respiratory tract</p>\n</td>\n</tr>\n<tr>\n<td width=\210\>\n<p>Streptococcus gallolyticus</p>\n</td>\n<td width=\209\>\n<p>GIT (Colon )</p>\n</td>\n</tr>\n<tr>\n<td width=\210\>\n<p>Enterococci</p>\n</td>\n<td width=\209\>\n<p>Genitourinary tract</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1712, 'Medicine', 'PM2434. CSF findings in meningitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Glucose&nbsp;</strong><br><strong>(mg/dL)</strong></td>\n<td><strong>Protein</strong><br><strong>(mg/dL)</strong></td>\n<td><strong>WBC (per&nbsp;μL)</strong></td>\n</tr>\n<tr>\n<td><strong>Normal</strong></td>\n<td>40-85</td>\n<td>15-45</td>\n<td>\n<p>&lt;5</p>\n<p>60-70% lymphocytes, ≤30% monocytes / macrophages</p>\n</td>\n</tr>\n<tr>\n<td><strong>Bacterial</strong></td>\n<td>&lt;40</td>\n<td>&gt;100</td>\n<td>\n<p>&gt;1000</p>\n<p>↑↑PMNs (≥80%)</p>\n</td>\n</tr>\n<tr>\n<td><strong>Viral</strong></td>\n<td>Normal</td>\n<td>20-80</td>\n<td>\n<p>25-500</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Tuberculous</strong></td>\n<td>&lt;50 <br>in 75% cases</td>\n<td>100-200</td>\n<td>\n<p>25-100</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Fungal</strong></td>\n<td>↓ to normal</td>\n<td>150-300</td>\n<td>\n<p>40-600</p>\n<p>Lymphocytes or PMNs, depending on specific organism</p>\n</td>\n</tr>\n<tr>\n<td><strong>Parasitic</strong></td>\n<td>Normal</td>\n<td>50-200&nbsp;</td>\n<td>\n<p>150-2000</p>\n<p>↑↑ Eosinophils (≥50%)</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1713, 'Medicine', 'PM2431. West haven criteria for grading of mental status', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Grade 1</strong></td>\n<td>Trivial lack of awareness; euphoria or anxiety; shortened attention span; impaired performance of addition or subtraction.&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Grade 2</strong></td>\n<td>&nbsp;Lethargy or apathy; minimal disorientation for time or place; subtle personality change; inappropriate behaviour with easily detectable flapping tremors.</td>\n</tr>\n<tr>\n<td><strong>Grade 3</strong></td>\n<td>&nbsp;Somnolence to semi stupor, but responsive to verbal stimuli; confusion; gross disorientation.</td>\n</tr>\n<tr>\n<td><strong>Grade 4&nbsp;</strong></td>\n<td>Coma.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1714, 'Medicine', 'PM2083. Neurological Manifestations in Deficiency Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div class=\page\ title=\Page 1551\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Neurological</strong><br><strong> manifestations</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><strong>Associated nutritional deficiencies</strong></td>\n</tr>\n<tr>\n<td>Dementia,&nbsp;encephalopathy</td>\n<td>Vitamin B12, nicotinic acid, thiamine, folate&nbsp;</td>\n</tr>\n<tr>\n<td>Seizures</td>\n<td>Pyridoxine</td>\n</tr>\n<tr>\n<td>Myelopathy</td>\n<td>Vitamin B12, vitamin E, folate, copper</td>\n</tr>\n<tr>\n<td>Myopathy</td>\n<td>Vitamin D, vitamin E</td>\n</tr>\n<tr>\n<td>Peripheral neuropathy</td>\n<td>Thiamine, vitamin B12, and many others</td>\n</tr>\n<tr>\n<td>Optic neuropathy</td>\n<td>Thiamine, vitamin B12, and many others</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1715, 'Medicine', 'PM2077. Neuropathic Disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Hereditary neuropathic disorders&nbsp;</p>\n<ul>\n<li>Charcot-Marie-Tooth disease (Most common hereditary neuropathy)</li>\n<li>Tangier disease</li>\n<li>Friedreich’s ataxia</li>\n<li>Familial Amyloid Polyneuropathy</li>\n<li>Hereditary Neuropathy with Liability to Pressure Palsies (HNPP)</li>\n<li>Hereditary Neuralgic Amyotrophy (HNA)</li>\n<li>Hereditary Sensory and Autonomic Neuropathy (HSAN)</li>\n<li>Fabry’s disease (angiokeratoma corporis diffusum)</li>\n<li>Refsum’s disease</li>\n</ul>\n<p>Causes of&nbsp;acquired&nbsp;neuropathies</p>\n<ul>\n<li>Primary or AL amyloidosis</li>\n<li>Diabetic neuropathy</li>\n<li>Hypothyroidism</li>\n<li>Sjögren’s syndrome</li>\n<li>Rheumatoid arthritis (RA)</li>\n<li>Scleroderma, Sarcoidosis</li>\n<li>Infectious (VZV,CMV,EBV,Hepatitis, HIV, Diphtheria, Leprosy)&nbsp;</li>\n<li>Inflammatory bowel disease</li>\n<li>Critical illness polyneuropathy (CIP)</li>\n</ul>\n<div class=\page\ title=\Page 3595\>&nbsp;</div></div><!---->\n      <!---->\n    </div><!---->'),
(1716, 'Medicine', 'PM2076. Conditions causing sensorimotor neuropathy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Conditions causing sensorimotor neuropathy&nbsp;</p>\n<ul>\n<li>Diabetes mellitus</li>\n<li>Uremia</li>\n<li>Porphyria</li>\n<li>Cryoglobulinemia</li>\n<li>Drugs (Amiodarone,&nbsp;Isoniazid, Metronidazole)</li>\n<li>Toxins (Arsenic<strong>,</strong>&nbsp;Diphtheria toxin, Organophosphates)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1717, 'Medicine', 'PM2075. Sensory Loss In peripheral Neuropathies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Symmetrical Sensory Loss</p>\n<ul>\n<li>Cryptogenic or idiopathic sensory polyneuropathy (CSPN)</li>\n<li>Diabetes mellitus and other metabolic disorders</li>\n<li>Drugs and toxins</li>\n<li>Familial (HSAN), CMT, amyloidosis</li>\n<li>Inflammatory demyelinating polyneuropathy (GBS and CIDP)&nbsp;</li>\n</ul>\n<p>Asymmetrical Sensory Loss</p>\n<ul>\n<li>Cancer (paraneoplastic)</li>\n<li>Sjögren’s syndrome</li>\n<li>Idiopathic sensory neuronopathy (possible GBS variant)</li>\n<li>Cisplatin and other chemotherapeutic agents</li>\n<li>Vitamin B6 toxicity</li>\n<li>Multifocal CIDP, vasculitis, cryoglobulinemia, amyloidosis, sarcoid, infectious (leprosy, Lyme, hepatitis B, C, or E, HIV, CMV), tumor infiltration&nbsp;</li>\n<li>Compressive mononeuropathy, plexopathy, or radiculopathy</li>\n<li>Polyradiculopathy or plexopathy due to diabetes mellitus</li>\n<li>Cryptogenic or idiopathic sensory polyneuropathy (CSPN)</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1718, 'Medicine', 'PM2073. Peripheral Neuropathies Without Sensory Loss', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>With Symmetrical Weakness</p>\n<ul>\n<li>Spinal muscular atrophy</li>\n<li>Hereditary motor neuropathy (“distal” spinal muscular atrophy) or atypical&nbsp;Charcot–Marie–Tooth disease (CMT)</li>\n</ul>\n<p>With Asymmetrical weakness &nbsp;</p>\n<ul>\n<li>Motor neuron disease</li>\n<li>Progressive muscular atrophy</li>\n<li>Juvenile monomelic amyotrophy (Hirayama’s&nbsp; disease)</li>\n<li>\n<div>Multifocal motor neuropathy</div>\n</li>\n<li>\n<div>Multifocal acquired motor axonopathy</div>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1719, 'Medicine', 'PM2072. Neuropathies associated with prominent autonomic dysfunction', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 3593\>\n<ul>\n<li>Hereditary sensory and autonomic neuropathy</li>\n<li>Amyloidosis (familial and acquired)</li>\n<li>Diabetes mellitus</li>\n<li>Idiopathic pandysautonomia (may be a variant of Guillain-Barré syndrome)</li>\n<li>Porphyria</li>\n<li>HIV-related autonomic neuropathy</li>\n<li>Vincristine and other chemotherapeutic agents</li>\n</ul>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1720, 'Medicine', 'PM2051. Difference between various causes of ataxia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<p><strong>Friedreichs&nbsp;</strong><strong>ataxia</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;Tabes&nbsp;</strong><strong>dorsalis</strong></p>\n</td>\n<td><strong>&nbsp;SACD</strong></td>\n</tr>\n<tr>\n<td>Tract&nbsp;</td>\n<td>\n<p>Posterior column</p>\n<p>Pyramidal&nbsp;</p>\n<p>Spinocerebellar tracts&nbsp;</p>\n</td>\n<td>\n<p>Posterior column</p>\n</td>\n<td>\n<p>Posterior column</p>\n<p>Pyramidal&nbsp;</p>\n<p>Peripheral nerves</p>\n</td>\n</tr>\n<tr>\n<td>Vibration sense</td>\n<td>\n<p>Absent</p>\n</td>\n<td>Absent</td>\n<td>Absent&nbsp;</td>\n</tr>\n<tr>\n<td>Proprioception</td>\n<td>\n<p>Absent</p>\n</td>\n<td>Absent</td>\n<td>Absent</td>\n</tr>\n<tr>\n<td>Pain/Temperature</td>\n<td>\n<p>Present</p>\n</td>\n<td>Present</td>\n<td>Present</td>\n</tr>\n<tr>\n<td>Deep tendon reflex</td>\n<td>\n<p>Absent</p>\n</td>\n<td>Absent</td>\n<td>Present. Maybe lost later.</td>\n</tr>\n<tr>\n<td>Babinski sign</td>\n<td>\n<p>Present</p>\n</td>\n<td>Not Present</td>\n<td>Present</td>\n</tr>\n<tr>\n<td>Features</td>\n<td>\n<p>Cardiomyopathy</p>\n<p>Optic atrophy</p>\n<p>Diabetes mellitus</p>\n</td>\n<td>\n<p>Argyll Robertson pupil</p>\n<p>Bladder disturbance</p>\n</td>\n<td>\n<p>Vitamin B12 deficiency</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>SACD-subacute combined degeneration</p></div><!---->\n      <!---->\n    </div><!---->'),
(1721, 'Medicine', 'PM2019. Parkinson plus syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Condition</strong></td>\n<td colspan=\2\><strong>Lesion</strong></td>\n</tr>\n<tr>\n<td>MSA/Shy dragger syndrome</td>\n<td rowspan=\5\>\n<p>Parkinson disease +</p>\n</td>\n<td>Dysautonomia&nbsp;</td>\n</tr>\n<tr>\n<td>MSAc</td>\n<td>Cerebellar symptoms</td>\n</tr>\n<tr>\n<td>MSAp</td>\n<td>Pyramidal symptoms&nbsp;</td>\n</tr>\n<tr>\n<td>Progressive supranuclear palsy</td>\n<td>Supranuclear palsy</td>\n</tr>\n<tr>\n<td>Lewy body dementia</td>\n<td>Early dementia&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>MSA - Multi System Atrophy</p>\n<p>Parkinson plus syndrome</p>\n<ul>\n<li>Faster progress of disease</li>\n<li>Poor response to levodopa</li>\n<li>Poor prognosis</li>\n<li>Increased mortality</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1722, 'Medicine', 'PM2018. Brain lesions and disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td><strong>&nbsp;Area of lesion</strong></td>\n<td><strong>Description</strong></td>\n<td><strong>Disease</strong></td>\n</tr>\n<tr>\n<td>Dominant parietal cortex</td>\n<td>Agraphia, acalculia, finger agnosia, left-right disorientation</td>\n<td>Gerstmann syndrome</td>\n</tr>\n<tr>\n<td>Non-dominant parietal cortex</td>\n<td>Agnosia of the contralateral side of the world</td>\n<td>Hemispatial neglect syndrome</td>\n</tr>\n<tr>\n<td>Mammillary bodies<br>(bilateral)</td>\n<td>Confusion, Ataxia, Nystagmus, Ophthalmoplegia,<br>memory loss (anterograde and retrograde<br>amnesia), confabulation, personality changes.</td>\n<td>Wernicke-Korsakoff syndrome</td>\n</tr>\n<tr>\n<td>Amygdala (bilateral)</td>\n<td>hyperphagia, hypersexuality, hyperorality</td>\n<td>Klüver-Bucy syndrome</td>\n</tr>\n<tr>\n<td>Superior colliculus</td>\n<td>Paralysis of conjugate<br>vertical gaze (rostral interstitial nucleus also<br>involved)</td>\n<td>Parinaud syndrome</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1723, 'Medicine', 'PM2003. Trigeminal Autonomic Cephalalgia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Types of trigeminal autonomic cephalalgia:</strong></p>\n<ul>\n<li>Cluster headache</li>\n<li>Paroxysmal hemicranias</li>\n<li>Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT)</li>\n<li>Short-lasting unilateral neuralgiform&nbsp;<em>headache</em>&nbsp;attacks with cranial autonomic features (SUNA)</li>\n<li>Hemicrania continua</li>\n</ul>\n<table border=\1\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>&nbsp;Cluster headache</strong></td>\n<td><strong>Paroxysmal hemicrania&nbsp;</strong></td>\n<td><strong>&nbsp;SUNCT/SUNA</strong></td>\n</tr>\n<tr>\n<td>Gender&nbsp;</td>\n<td>Males&gt;females</td>\n<td>Female=Males</td>\n<td>Female=Males</td>\n</tr>\n<tr>\n<td>Character of pain&nbsp;</td>\n<td>Stabbing /boring</td>\n<td>Throbbing pain&nbsp;/stabbing /boring</td>\n<td>Burning /stabbing/sharp</td>\n</tr>\n<tr>\n<td>Severity of pain&nbsp;</td>\n<td>Excruciating&nbsp;</td>\n<td>Excruciating</td>\n<td>Severe to excruciating</td>\n</tr>\n<tr>\n<td>Site of pain&nbsp;</td>\n<td>Orbit, temple</td>\n<td>Orbit, temple</td>\n<td>Periorbital</td>\n</tr>\n<tr>\n<td>Attack frequency&nbsp;</td>\n<td>1-8 /day</td>\n<td>1-20/day</td>\n<td>3-200/day</td>\n</tr>\n<tr>\n<td>Duration</td>\n<td>15min-3 hours</td>\n<td>2-30 min</td>\n<td>5-240seconds</td>\n</tr>\n<tr>\n<td>Migraneous feature&nbsp;</td>\n<td>Yes&nbsp;</td>\n<td>Yes&nbsp;</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Alcohol trigger&nbsp;</td>\n<td>Yes</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Cutaneous trigger</td>\n<td>No</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Response to indomethacin</td>\n<td>No</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Abortive treatment</td>\n<td>\n<p>100% oxygen</p>\n<p>Sumatriptan injection</p>\n</td>\n<td>\n<p>No effective treatment</p>\n</td>\n<td>\n<p>IV lidocaine&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Prophylaxis</td>\n<td>\n<p>Chronic cluster</p>\n<ul>\n<li>Lithium</li>\n<li>Verapamil</li>\n<li>Methysergide</li>\n</ul>\n<p>Episodic cluster&nbsp;</p>\n<ul>\n<li>Steroids&nbsp;</li>\n<li>Verapamil</li>\n<li>Methysergide</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Indomethacin</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n<li>Topiramate</li>\n<li>Gabapentin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li><strong>Indomethacin</strong> is effective in paroxysmal hemicrania,hemicrania continuum, and primary sexual/ exercise headache</li>\n<li>Cutaneous trigger is also seen in trigeminal neuralgia, however, <strong>trigeminal neuralgia</strong> is a <strong>separate entity </strong>and not a part of trigeminal autonomic cephalalgia&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1724, 'Medicine', 'PM1996. Simplified diagnostic criteria for migraine', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Repeated attacks of headache lasting 4-72 h in patients with a normal physical examination with no other reasonable cause for the headache, and</p>\n<p><strong>At least 2 of the following features:</strong></p>\n<ul>\n<li>Unilateral pain</li>\n<li>Throbbing pain</li>\n<li>Aggravation by movement</li>\n<li>Moderate or severe intensity</li>\n</ul>\n<p><strong>Plus at least 1 of the following features:</strong></p>\n<ul>\n<li>Nausea/vomiting</li>\n<li>Photophobia and phonophobia</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1725, 'Medicine', 'PM1989. Inflammatory myopathy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Dermatomyositis</strong></td>\n<td><strong>Polymyositis</strong></td>\n<td><strong>Inclusion Body Myositis</strong></td>\n</tr>\n<tr>\n<td>Age of onset</td>\n<td>Adulthood and childhood</td>\n<td>&gt;18 years</td>\n<td>&gt;50 years &nbsp;</td>\n</tr>\n<tr>\n<td>Familial Association</td>\n<td>No</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Skin Manifestation</td>\n<td>Yes</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Muscle involvement</td>\n<td>\n<p>Symmetric</p>\n</td>\n<td>\n<p>Symmetric</p>\n</td>\n<td>\n<p>Asymmetric</p>\n</td>\n</tr>\n<tr>\n<td>Histopathological Findings</td>\n<td>\n<p><strong>Perimysial</strong>&nbsp;<strong>CD4+</strong>&nbsp;cellular infiltrates</p>\n<p>Perivascular infiltrates and <strong>perifascicular atrophy</strong></p>\n</td>\n<td>\n<p><strong>Endomysial</strong>&nbsp;<strong>CD8+</strong>&nbsp;cellular infiltrates&nbsp;</p>\n<p>Perivascular infiltrates&nbsp;&nbsp;</p>\n</td>\n<td>\n<p><strong>Endomysial</strong>&nbsp;<strong>CD8+</strong>&nbsp;cellular infiltrates</p>\n<p>Perivascular infiltrates with amyloid inclusion bodies and rimmed vacuoles &nbsp;&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Association with connective tissue disease</td>\n<td>Scleroderma and mixed connective tissue only</td>\n<td>Yes</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Association with other autoimmune diseases</td>\n<td>Infrequent</td>\n<td>Frequent</td>\n<td>&nbsp;Infrequent</td>\n</tr>\n<tr>\n<td>Association with malignancy</td>\n<td>Yes (most common- ovarian malignancy)</td>\n<td>&nbsp;Yes (incidence much lesser than dermatomyositis)</td>\n<td>&nbsp;No</td>\n</tr>\n<tr>\n<td>Immunotherapy</td>\n<td>&nbsp;Responsive</td>\n<td>&nbsp;Responsive</td>\n<td>&nbsp;Resistant</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1726, 'Medicine', 'PM1980. Antibodies seen in Guillian Barre syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Antibody</strong></td>\n</tr>\n<tr>\n<td>AIDP</td>\n<td>Anti GM1</td>\n</tr>\n<tr>\n<td>AMAN</td>\n<td>Anti GD1a</td>\n</tr>\n<tr>\n<td>AMSAN</td>\n<td>Anti GD1a</td>\n</tr>\n<tr>\n<td>Miller Fisher syndrome</td>\n<td>Anti GQ1b</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li>AIDP-Acute inflammatory demyelinating polyneuropathy&nbsp;</li>\n<li>AMAN-Acute motor axonal neuropathy&nbsp;</li>\n<li>AMSAN-Acute motor sensory axonal neuropathy&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1727, 'Medicine', 'PM1930. Grading of hepatic encephalopathy - West Haven Criteria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Clinical grade</strong></td>\n<td><strong>Clinical signs</strong></td>\n<td><strong>Category</strong></td>\n</tr>\n<tr>\n<td><strong>Minimal&nbsp;</strong></td>\n<td>\n<p>Abnormal psychometric or neurophysiological tests</p>\n<p>No clinical manifestations</p>\n</td>\n<td>\n<p>Covert HE</p>\n</td>\n</tr>\n<tr>\n<td><strong>Grade 1</strong></td>\n<td>\n<p>Altered sleep pattern</p>\n<p>Changes in behavior</p>\n<p>Slurred speech</p>\n<p>Mild confusion</p>\n</td>\n<td>\n<p>Covert HE</p>\n</td>\n</tr>\n<tr>\n<td><strong>Grade 2</strong></td>\n<td>\n<p>Disoriented</p>\n<p>Lethargic</p>\n<p>Inappropriate behavior</p>\n<p>Asterixis</p>\n</td>\n<td>\n<p>&nbsp;Overt HE</p>\n</td>\n</tr>\n<tr>\n<td><strong>Grade 3</strong></td>\n<td>\n<p>Stuporous</p>\n<p>Responds to pain and voice</p>\n<p>Gross disorientation</p>\n</td>\n<td>Overt HE</td>\n</tr>\n<tr>\n<td><strong>Grade 4</strong>&nbsp;</td>\n<td>\n<p>Unresponsive to voice or pain</p>\n<p>Comatose</p>\n</td>\n<td>\n<p>Overt HE</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1728, 'Medicine', 'PM1814. Stroke syndromes with visual symptoms', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\162\>\n<p><strong>Disease</strong></p>\n</td>\n<td width=\198\>\n<p><strong>Site of lesion</strong></p>\n</td>\n<td width=\241\>\n<p><strong>Clinical features</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\162\>\n<p>Anton’s syndrome</p>\n</td>\n<td width=\198\>\n<p>B/L infarction in the distal PCAs</p>\n</td>\n<td width=\241\>\n<p>Cortical blindness, with denial or unawareness of blindness</p>\n</td>\n</tr>\n<tr>\n<td width=\162\>\n<p>Balint’s syndrome</p>\n</td>\n<td width=\198\>\n<p>Low flow in the “watershed region” between distal PCA and MCA territories</p>\n</td>\n<td width=\241\>\n<p>Palinopsia</p>\n<p>Asimultanagnosia</p>\n<p>Optic ataxia</p>\n<p>Ocular apraxia</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\162\>\n<p>Weber’s syndrome</p>\n</td>\n<td width=\198\>\n<p>Midbrain</p>\n</td>\n<td width=\241\>\n<p>I/L CN III palsy</p>\n<p>C/L hemiplegia</p>\n</td>\n</tr>\n<tr>\n<td width=\162\>\n<p>Parinaud’s syndrome</p>\n</td>\n<td width=\198\>\n<p>Dorsal midbrain</p>\n</td>\n<td width=\241\>\n<p>Tetrad of symptoms:</p>\n<p>Loss of upgaze</p>\n<p>Light-near dissociation</p>\n<p>Convergence – retraction nystagmus</p>\n<p>Lid retraction</p>\n</td>\n</tr>\n<tr>\n<td width=\162\>\n<p>Benedikt syndrome</p>\n</td>\n<td width=\198\>\n<p>Midbrain</p>\n</td>\n<td width=\241\>\n<p>Ipsilateral oculomotor nerve palsy</p>\n<p>Contralateral hemiparesis</p>\n<p>Contralateral cerebellar ataxia</p>\n<p>Holmes tremor</p>\n<p>Choreoathetosis</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1729, 'Medicine', 'PM1813. ABCD2 Score', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The risk of stroke <strong>following TIAs</strong> is determined by <strong>ABCD<sup>2</sup> score:</strong></p>\n<table width=\475\>\n<tbody>\n<tr>\n<td><strong>Risk factors</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td><strong>A</strong>ge&nbsp;<span>&gt;</span> 60&nbsp;</td>\n<td>1</td>\n</tr>\n<tr>\n<td>S<strong>B</strong>P&gt;140 mmHg or D<strong>B</strong>P &gt;90 mmHg</td>\n<td>1</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>C</strong>linical symptoms:</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Unilateral weakness</li>\n</ul>\n</td>\n<td>2</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Speech disturbances without&nbsp;weakness</li>\n</ul>\n</td>\n<td>1</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>D</strong>uration:</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>&gt;60 minutes</li>\n</ul>\n</td>\n<td>2</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>10 - 59 minutes</li>\n</ul>\n</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>D</strong>iabetes</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>Total score</strong></td>\n<td><strong>Sum each score</strong></td>\n</tr>\n<tr>\n<td>ABCD2 Score Total</td>\n<td>3-months Rate of stroke (%)</td>\n</tr>\n<tr>\n<td>0</td>\n<td>0</td>\n</tr>\n<tr>\n<td>1</td>\n<td>2</td>\n</tr>\n<tr>\n<td>2</td>\n<td>3</td>\n</tr>\n<tr>\n<td>3</td>\n<td>3</td>\n</tr>\n<tr>\n<td>4</td>\n<td>8</td>\n</tr>\n<tr>\n<td>5</td>\n<td>12</td>\n</tr>\n<tr>\n<td>6</td>\n<td>17</td>\n</tr>\n<tr>\n<td>7</td>\n<td>22</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1730, 'Medicine', 'PM1805. The Medical Research Council scale for grading the muscle strength is :', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Grade</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>Grade 0</td>\n<td>No contraction</td>\n</tr>\n<tr>\n<td>Grade 1</td>\n<td>Flicker or trace of contraction</td>\n</tr>\n<tr>\n<td>Grade 2</td>\n<td>Active movement with gravity eliminated</td>\n</tr>\n<tr>\n<td>Grade 3</td>\n<td>Active movement against gravity</td>\n</tr>\n<tr>\n<td>Grade 4&nbsp;</td>\n<td>Active movement against gravity and resistance</td>\n</tr>\n<tr>\n<td>Grade 5</td>\n<td>Normal Power</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1731, 'Medicine', 'PM1790. Mesial Temporal Lobe Epilepsy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Mesial temporal lobe epilepsy</strong> shows a <strong>familial inheritance</strong> and begins in childhood. It presents as&nbsp;<strong>focal seizures&nbsp;</strong>with a remitting and relapsing course. It is associated with:</p>\n<ul>\n<li>Aura</li>\n<li>Complex automatism</li>\n<li>Post-ictal confusion</li>\n<li>Anterograde amnesia</li>\n</ul>\n<p>EEG findings include <strong>temporal spikes</strong>, and MRI shows <strong>hippocampal sclerosis</strong>. Management includes <strong>anteromedial resection</strong> of the <strong>temporal lobe</strong>.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/515b5573b7c34b1f9289e3b434b67a4ex1280x1669.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1732, 'Medicine', 'PM1788. Indications and Contraindications of thrombolysis in Ischemic Stroke', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Indications for thrombolysis in stroke</strong>&nbsp;</p>\n<ul>\n<li>Clinical diagnosis of stroke</li>\n<li>Onset of symptoms to time of drug administration &lt;3 hours/<strong>4.5</strong> hours</li>\n<li>Age ≥ 18 years</li>\n<li>CT scan showing no haemorrhage or edema of &gt;1/3<sup>rd</sup> of the MCA territory&nbsp;</li>\n</ul>\n<p><strong>Contraindications of thrombolysis in stroke&nbsp;</strong></p>\n<ul>\n<li>Sustained BP &gt;185/110 mmHg despite treatment</li>\n<li>Bleeding diathesis</li>\n<li>Recent head injury or Intracerebral hemorrhage</li>\n<li>Major surgery in preceding 14 days</li>\n<li>Minor stroke symptoms</li>\n<li>Gastrointestinal bleeding in preceding 21 days</li>\n<li>Recent myocardial infarction</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1733, 'Medicine', 'PM1780. Revised criteria for the clinical diagnosis of probable and possible dementia with Lewy bodies (DLB)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Essential for a diagnosis of <strong>DLB </strong>is<strong> dementia</strong>, defined as a progressive cognitive decline of sufficient magnitude to interfere with normal social or occupational functions, or with usual daily activities.</li>\n<li>Prominent or persistent memory impairment may not necessarily occur in the early stages but is usually evident with progression.</li>\n<li>Deficits on tests of attention, executive function, and visuoperceptual ability may be especially prominent and occur early.</li>\n</ul>\n<p><strong>Core clinical features (The first 3 typically occur early and may persist throughout the course.)</strong></p>\n<ul>\n<li><strong>Fluctuating cognition</strong> with pronounced variations in attention and alertness.</li>\n<li><strong>Recurrent visual hallucinations</strong> that are typically well formed and detailed.</li>\n<li><strong>REM sleep behavior disorder</strong>, which may precede cognitive decline.</li>\n<li>One or more spontaneous <strong>cardinal features of Parkinsonism</strong>: these are bradykinesia (defined as slowness of movement and decrement in amplitude or speed), rest tremor, or rigidity.</li>\n</ul>\n<p><strong>Supportive clinical features:</strong></p>\n<ul>\n<li>Severe sensitivity to antipsychotic agents; postural instability; repeated falls; syncope or other transient episodes of unresponsiveness; severe autonomic dysfunction, e.g., constipation, <strong>orthostatic</strong> <strong>hypotension</strong>, urinary incontinence; hypersomnia; hyposmia; hallucinations in other modalities; systematized delusions; apathy, anxiety, and depression.</li>\n</ul>\n<p><strong>Indicative biomarkers</strong></p>\n<ul>\n<li>Reduced dopamine transporter uptake in basal ganglia demonstrated by SPECT or PET.</li>\n<li>Abnormal (low uptake) <sup>123</sup>iodine-MIBG myocardial scintigraphy.</li>\n<li>Polysomnographic confirmation of REM sleep without atonia.</li>\n</ul>\n<p><strong>Supportive biomarkers</strong></p>\n<ul>\n<li>Relative preservation of medial temporal lobe structures on CT/MRI scan.</li>\n<li>Generalized low uptake on SPECT/PET perfusion/metabolism scan with reduced occipital activity ± the cingulate island sign on FDG-PET imaging.</li>\n<li>Prominent posterior slow-wave activity on EEG with periodic fluctuations in the pre-alpha/ theta range.</li>\n</ul>\n<p><strong>A. Probable DLB can be diagnosed if:</strong></p>\n<ul>\n<li>Two or more core clinical features of DLB are present, with or without the presence of indicative biomarkers, or</li>\n<li>Only one core clinical feature is present, but with one or more indicative biomarkers</li>\n</ul>\n<p><strong>Note</strong>: Probable DLB should not be diagnosed on the basis of biomarkers alone</p>\n<p><strong>B. Possible DLB can be diagnosed if:</strong></p>\n<ul>\n<li>Only one core clinical feature of DLB is present, with no indicative biomarker evidence, or</li>\n<li>One or more indicative biomarkers is present but there are no core clinical features.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1734, 'Medicine', 'PM1677. Intracranial Hypertension', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Definition</strong></p>\n<p>Intracranial hypertension is pressure within the cranium above normal. Normal range of ICP is 5-15mm Hg. Levels above 20-25mm Hg are usually treated.&nbsp;</p>\n<p><strong>Causes</strong>: Intracranial haemorrhage, brain tumors, head injury, meningitis, brain abscess, etc.&nbsp;</p>\n<p><strong>Symptoms of raised ICT</strong></p>\n<ul>\n<li><strong>Cushing’s triad</strong> – hypertension, bradycardia and respiratory depression</li>\n<li>Headache, visual blurring due to papilloedema and abducent nerve palsy&nbsp;</li>\n<li>Focal symptoms may arise due to the local effects in patients with mass lesions or due to herniation.</li>\n<li>Seizures</li>\n<li>Stroke</li>\n</ul>\n<p><strong>Investigations</strong></p>\n<ul>\n<li>CT brain or MRI brain with gadolinium to rule out ICSOL&nbsp;</li>\n<li><strong>Lumbar puncture is contraindicated</strong> in the presence of raised ICT due to the risk of coning.</li>\n<li>Papilledema (as an indicator of ICT) should be ruled out before lumbar puncture.</li>\n</ul>\n<p><strong>Treatment</strong></p>\n<ul>\n<li>Dexamethasone</li>\n<li>Ventriculotomy to remove CSF or ventriculoperitoneal shunt</li>\n<li>Decompressive craniectomy</li>\n<li>Surgical resection of ICSOL – by craniotomy or stereotactic radiosurgery</li>\n<li>Whole brain radiation for multiple metastases causing raised ICT</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1735, 'Medicine', 'PM1673. Signs that distinguish the origin of muscle weakness', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Sign</strong></td>\n<td><strong>Upper Motor Neuron</strong></td>\n<td><strong>Lower&nbsp;Motor Neuron</strong></td>\n<td><strong>Myopathic</strong></td>\n<td><strong>Psychogenic</strong></td>\n</tr>\n<tr>\n<td>Atrophy</td>\n<td>None</td>\n<td>Severe</td>\n<td>Mild</td>\n<td>None</td>\n</tr>\n<tr>\n<td>Fasciculation</td>\n<td>None</td>\n<td>Common</td>\n<td>None</td>\n<td>None</td>\n</tr>\n<tr>\n<td>Tone</td>\n<td>Spastic</td>\n<td>Decreased</td>\n<td>Normal/ Decreased</td>\n<td>Variable/ paratonia</td>\n</tr>\n<tr>\n<td>Distribution of weakness</td>\n<td>Pyramidal/ regional</td>\n<td>\n<p>Distal/ segmental</p>\n</td>\n<td>Proximal</td>\n<td>Variable/ Inconsistent with daily activities</td>\n</tr>\n<tr>\n<td>Muscle stretch reflexs</td>\n<td>Hyperactive</td>\n<td>Hypoactive/ Absent</td>\n<td>Normal/ hypoactive</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>Babinski sign</td>\n<td>Present</td>\n<td>Absent</td>\n<td>Absent</td>\n<td>Absent</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1736, 'Medicine', 'PM1672. The 2017 Revised McDonald Diagnostic Criteria for Multiple Sclerosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Clinical</strong><br><strong>(Attacks)</strong></td>\n<td><strong>Objective</strong><br><strong>Lesions</strong></td>\n<td><strong>Additional requirements to make the diagnosis</strong></td>\n</tr>\n<tr>\n<td>2 or more</td>\n<td>2 or more</td>\n<td>None*</td>\n</tr>\n<tr>\n<td>2 or more</td>\n<td>1</td>\n<td>None*</td>\n</tr>\n<tr>\n<td>2 or more</td>\n<td>1</td>\n<td>Dissemination in space demonstrated by an additional clinical attack implicating a different CNS site or by MRI</td>\n</tr>\n<tr>\n<td>&nbsp;1&nbsp;</td>\n<td>2 or more</td>\n<td>\n<p>Dissemination in time demonstrated by an additional clinical attack or by MRI</p>\n<p>or demonstration of CSF-specific oligoclonal bands</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;1<br><br></td>\n<td>1</td>\n<td>\n<p>Dissemination in space demonstrated by an additional clinical attack implicating a different CNS site or by MRI</p>\n<p><strong>AND</strong></p>\nDissemination in time demonstrated by an additional clinical attack or by MRI&nbsp;<strong>OR</strong> demonstration of CSF-specific oligoclonal bands</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>* No additional test needed. MRI considered in all cases. Spinal cord MRI or CSF examination in patients with insufficient clinical diagnosis</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table border=\1\>\n<tbody>\n<tr>\n<td><strong>Definition of MRI evidence of</strong><br><strong>dissemination in space</strong></td>\n<td>T2 lesion in at least 2 of 4 MS-typical regions (peri-ventricular, juxtocortical, infratentorial,<br>or spinal cord)<br>Note: Gd-enhancing lesions are not required</td>\n</tr>\n<tr>\n<td><strong>Definition of MRI evidence of</strong><br><strong>dissemination in time</strong></td>\n<td>The simultaneous presence of Gd-enhancing and non-enhancing MRI lesions at any time<br>New T2 and/or Gd-enhancing lesion(s) on follow-up MRI</td>\n</tr>\n</tbody>\n</table>\n<p>Gd, gadolinium; MS, multiple sclerosis</p></div><!---->\n      <!---->\n    </div><!---->'),
(1737, 'Medicine', 'PM1671. Initial Symptoms In Multiple Sclerosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 3580\>&nbsp;</div>\n<div class=\page\ title=\Page 3580\>\n<div class=\page\ title=\Page 3580\>\n<table><colgroup><col><col><col><col> </colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>&nbsp;Symptom</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>&nbsp;</p>\n<p>Percentage of Cases</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Symptom</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Percentage of Cases</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Sensory loss</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>37</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Lhermitte</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>3</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Optic neuritis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>36</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Pain</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>3</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Weakness</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>35</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Dementia</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>2</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Paresthesias</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>24</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Visual loss</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>2</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Diplopia</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>15</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Facial palsy</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>1</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ataxia</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>11</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Impotence</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>1</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Vertigo</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>6</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Myokymia</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>1</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Paroxysmal attacks</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>4</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Epilepsy</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>1</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Bladder</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>4</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Falling</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>1</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1738, 'Medicine', 'PM1665. Nerve Fiber Types And Sensory Neuropathies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Depending on the nerve fibers involved (Large or Small), the sensory neuropathies are classified as follows:</p>\n<p><strong>A. Small fiber</strong> (Painful neuropathies: dissociated sensory loss)</p>\n<ul>\n<li>Lepromatous leprosy</li>\n<li>Amyloidosis</li>\n<li>Diabetic small fiber neuropathy</li>\n<li>HIV and antiretroviral therapy neuropathy</li>\n</ul>\n<p><strong>B. Large fiber </strong>(Ataxic neuropathies)</p>\n<ul>\n<li>Sjogren’s syndrome</li>\n<li>Vitamin B12 neuropathy</li>\n<li>Pyridoxine toxicity</li>\n<li>Cisplatin neuropathy</li>\n</ul>\n<p><strong>C. Mixed </strong>(small &amp; large fiber) (Global sensory loss)</p>\n<ul>\n<li>Diabetic sensory neuropathy</li>\n<li>Hereditary sensory neuropathies</li>\n<li>Carcinomatous sensory neuropathy</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1739, 'Medicine', 'PM1637. Patterns of Neuropathic Disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\253\>\n<p><strong>Pattern</strong></p>\n</td>\n<td width=\363\>\n<p><strong>Consideration</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\253\>\n<p>Symmetric proximal and distal weakness with sensory loss</p>\n</td>\n<td width=\363\>\n<p>Inflammatory demyelinating polyneuropathy (GBS and CIDP)</p>\n</td>\n</tr>\n<tr>\n<td width=\253\>\n<p>Symmetric distal sensory loss with or without distal weakness</p>\n</td>\n<td width=\363\>\n<p>Cryptogenic or idiopathic sensory polyneuropathy (CSPN)</p>\n<p>Diabetes mellitus and other metabolic disorders</p>\n<p>Drugs, toxins, familial (HSAN)</p>\n<p>Charcot-Marie-Tooth disease</p>\n<p>Amyloidosis, and others</p>\n</td>\n</tr>\n<tr>\n<td width=\253\>\n<p>Symmetric sensory loss and distal areflexia with upper motor neuron findings</p>\n</td>\n<td width=\363\>\n<p>Vitamin B12, vitamin E, and copper deficiency with combined system degeneration with peripheral neuropathy, hereditary leukodystrophies (e.g., adrenomyeloneuropathy)</p>\n</td>\n</tr>\n<tr>\n<td width=\253\>\n<p>Asymmetric proprioceptive sensory loss without weakness</p>\n</td>\n<td width=\363\>\n<p>Causes of a sensory neuronopathy &nbsp;(ganglionopathy):</p>\n<p>Cancer (paraneoplastic)</p>\n<p>Sjögren’s syndrome</p>\n<p>Idiopathic sensory neuronopathy (possible GBS variant)</p>\n<p>Cisplatin and other chemotherapeutic agents</p>\n<p>Vitamin B6 toxicity</p>\n<p>HIV-related sensory neuronopathy</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\2\ width=\253\>\n<p>Asymmetric distal weakness with sensory loss</p>\n<p>&nbsp;</p>\n</td>\n<td width=\363\>\n<p><strong>With involvement of multiple nerves:</strong></p>\n<p>Multifocal CIDP</p>\n<p>Vasculitis</p>\n<p>Cryoglobulinemia</p>\n<p>Amyloidosis, sarcoid</p>\n<p>Infectious (leprosy, Lyme, hepatitis B, C, or E, HIV, CMV), HNPP, tumor infiltration</p>\n</td>\n</tr>\n<tr>\n<td width=\363\>\n<p><strong>With involvement of single nerves/regions:</strong></p>\n<p>May be any of the above but also could be compressive mononeuropathy, plexopathy, or radiculopathy</p>\n</td>\n</tr>\n<tr>\n<td width=\253\>\n<p>Asymmetric proximal and distal weakness with sensory loss</p>\n</td>\n<td width=\363\>\n<p>Polyradiculopathy or plexopathy due to diabetes mellitus</p>\n<p>Meningeal carcinomatosis or lymphomatosis</p>\n<p>Hereditary plexopathy (HNPP, HNA), idiopathic</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1740, 'Medicine', 'PM1628. Mechanism of Immunopathogenesis of Guillain-Barre Syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The following sequence of events, takes into consideration, the development of Guillain-Barre syndrome (GBS) associated with <em>Campylobacter jejuni</em><strong> infection</strong>.</p>\n<ol>\n<li><strong>B cells</strong> recognize glycoconjugates on <strong> jejuni (Cj)</strong> that cross-react with <strong>ganglioside</strong> present on <strong>Schwann cell surface</strong> and <strong>subjacent peripheral nerve myelin</strong>.</li>\n<li>Most of the B cells are activated via a partially T cell–dependent route and secrete primarily <strong>IgG autoantibodies</strong>. Some B cells, activated via a T cell–independent mechanism, secrete primarily IgM</li>\n<li><strong>The</strong> <strong>activated B cells</strong> escape from Peyer’s patches into regional lymph nodes.</li>\n<li><strong>Activated T cells</strong> also function to assist in the opening of the blood-nerve barrier, facilitating penetration of pathogenic autoantibodies.</li>\n<li>The earliest changes in myelin consist of <strong>edema between myelin lamellae</strong> and <strong>vesicular disruption</strong> of the outermost myelin layers.</li>\n<li>These effects are associated with activation of the <strong>C5b-C9 membrane attack complex</strong> and mediated by <strong>calcium entry</strong>; it is possible that the macrophage cytokine tumor necrosis factor (TNF) also participates in <strong>myelin damage</strong>.</li>\n</ol></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b40cb513616a452c90a928eb9e4fc6d7x1280x1987.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1741, 'Medicine', 'PM0908. Aphasias and Related Conditions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\0\ width=\320\ cellspacing=\0\ cellpadding=\0\><colgroup><col span=\5\ width=\64\> </colgroup>\n<tbody>\n<tr>\n<td class=\xl63\ height=\80\>&nbsp;</td>\n<td class=\xl65\><strong>Comprehension</strong></td>\n<td class=\xl65\><strong>Repetition of Spoken language</strong></td>\n<td class=\xl65\><strong>Naming</strong></td>\n<td class=\xl65\><strong>Fluency</strong></td>\n</tr>\n<tr>\n<td class=\xl65\ height=\40\><strong>Wernickes</strong></td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Preserved</td>\n</tr>\n<tr>\n<td class=\xl65\ height=\40\><strong>Brocas</strong></td>\n<td class=\xl64\>Preserved</td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Decreased</td>\n</tr>\n<tr>\n<td class=\xl65\ height=\40\><strong>Global</strong></td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Decreased</td>\n</tr>\n<tr>\n<td class=\xl65\ height=\40\><strong>Conduction</strong></td>\n<td class=\xl64\>Preserved</td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Preserved</td>\n</tr>\n<tr>\n<td class=\xl65\ height=\100\><strong>Anterior (nonfluent) transcortical</strong></td>\n<td class=\xl64\>Preserved</td>\n<td class=\xl64\>Preserved</td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Impaired</td>\n</tr>\n<tr>\n<td class=\xl65\ height=\80\><strong>Posterior (fluent) transcortical</strong></td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Preserved</td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Preserved</td>\n</tr>\n<tr>\n<td class=\xl65\ height=\80\><strong>Isolation</strong></td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Echolalia</td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>No purposeful speech</td>\n</tr>\n<tr>\n<td class=\xl65\ height=\100\><strong>Anomic</strong></td>\n<td class=\xl64\>Preserved</td>\n<td class=\xl64\>Preserved</td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Preserved except for word finding pauses</td>\n</tr>\n<tr>\n<td class=\xl65\ height=\80\><strong>Pure Word Deafness</strong></td>\n<td class=\xl64\>Impaired only for spoken language</td>\n<td class=\xl64\>Impaired</td>\n<td class=\xl64\>Preserved</td>\n<td class=\xl64\>Preserved</td>\n</tr>\n<tr>\n<td class=\xl65\ height=\60\><strong>Pure Alexia</strong></td>\n<td class=\xl64\>Impaired only for reading</td>\n<td class=\xl64\>Preserved</td>\n<td class=\xl64\>Preserved&nbsp;</td>\n<td class=\xl64\>Preserved</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c1cb9177ba6f447ead67de336cd40692x1280x1590.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1742, 'Medicine', 'PM1999. Prognostic factors in ALL', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Prognostic factors in ALL</p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp;Prognostic factors</strong></td>\n<td><strong>Good</strong></td>\n<td><strong>Bad</strong></td>\n</tr>\n<tr>\n<td>Age</td>\n<td>2-9 years</td>\n<td>&lt;1 year or &gt;10 years</td>\n</tr>\n<tr>\n<td>Sex</td>\n<td>Female</td>\n<td>Male</td>\n</tr>\n<tr>\n<td>Race</td>\n<td>White</td>\n<td>Black</td>\n</tr>\n<tr>\n<td>CNS leukemia</td>\n<td>Absent</td>\n<td>Overt</td>\n</tr>\n<tr>\n<td>Hepatosplenomegaly, Lymphadenopathy</td>\n<td>Absent</td>\n<td>Massive</td>\n</tr>\n<tr>\n<td>Mediastinal mass</td>\n<td>Absent</td>\n<td>Present</td>\n</tr>\n<tr>\n<td>Testicular involvement</td>\n<td>Absent</td>\n<td>Present</td>\n</tr>\n<tr>\n<td>WBC count</td>\n<td>&lt;50,000/mm<sup>3</sup></td>\n<td>&gt;50,000/mm<sup>3</sup></td>\n</tr>\n<tr>\n<td>FAB Type</td>\n<td>L1</td>\n<td>L2,L3</td>\n</tr>\n<tr>\n<td>Cytogenetics</td>\n<td>Hyperdiploidy</td>\n<td>Hypodiploidy</td>\n</tr>\n<tr>\n<td>Immunophenotype</td>\n<td>B-cell, early pre-B</td>\n<td>T cell</td>\n</tr>\n<tr>\n<td>Translocation</td>\n<td>T(12,21),Notch 1,HOX 11</td>\n<td>t(9,22),t(4,11)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1743, 'Medicine', 'PM1964. Blood components', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Component</strong></td>\n<td><strong>Volume&nbsp; &nbsp; &nbsp;(1 unit)</strong></td>\n<td><strong>Content</strong></td>\n<td><strong>Clinical response, increase in&nbsp;</strong></td>\n<td><strong>Storage temperature</strong></td>\n<td><strong>Shelf-life</strong></td>\n</tr>\n<tr>\n<td>Whole blood</td>\n<td>450 ml</td>\n<td>RBCs, platelets, plasma</td>\n<td>Hb and plasma volume</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Packed red blood cells (PRBCs)</td>\n<td>300-350 ml</td>\n<td>RBCs</td>\n<td>\n<p>Hb by 1 g/dl</p>\n<p>Hematocrit by 3%</p>\n</td>\n<td>\n<p>1° to 6°C</p>\n</td>\n<td>\n<p>ACD/CPD-21 days, CPD-A-35 days, additive-42 days</p>\n</td>\n</tr>\n<tr>\n<td>Random donor platelets (RDP)</td>\n<td>50-70 ml</td>\n<td>Platelets</td>\n<td>platelet count by 5000-10,000/µL</td>\n<td rowspan=\2\>20 to 24°C</td>\n<td rowspan=\2\>5 days</td>\n</tr>\n<tr>\n<td>Single donor apheretic platelets (SDP*)</td>\n<td>200-400 ml</td>\n<td>Platelets</td>\n<td>platelet count by 30,000/µL</td>\n</tr>\n<tr>\n<td>Fresh frozen plasma (FFP)</td>\n<td>200-250 ml</td>\n<td>Coagulation factors, protein C, protein S, anti thrombin</td>\n<td>coagulation factors by 2%</td>\n<td>-18 to -30°C</td>\n<td>1 year</td>\n</tr>\n<tr>\n<td>Cryoprecipitate</td>\n<td>10-15 ml</td>\n<td>fibrinogen, factor VIII, VWF</td>\n<td>80 IU Factor VIII</td>\n<td>-30 °C</td>\n<td>1 year</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1b1f01af443f48ec90792074de2e9c37x1280x1063.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>*SDP is obtained by collecting multiple units of platelets from a single donor using apheretic technology.&nbsp;</p>\n<p>1 SDP = 6 RDP</p></div><!---->\n      <!---->\n    </div><!---->'),
(1744, 'Medicine', 'PM1955. Coagulation Pathways and its Abnormalities', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0fedd76b578148fc8ed55da37e66574cx1280x1995.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Test results</strong></td>\n<td><strong>Inherited causes</strong></td>\n<td><strong>Acquired causes</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged PT&nbsp;</strong></p>\n<p>Evaluates extrinsic pathway factors</p>\n<p>Normal PT - 12-16 seconds</p>\n</td>\n<td>Factor VII deficiency&nbsp;</td>\n<td>\n<p>Mild vitamin K deficiency</p>\n<p>Liver disease</p>\n<p>Warfarin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Prolonged aPTT </strong></p>\n<p>Evaluates intrinsic pathway factors</p>\n<p>Normal aPTT - 26-34 seconds</p>\n</td>\n<td>\n<p>Factors VIII, IX, XI deficiency</p>\n<p>Factor XII, prekallikrein, or HMW kininogen deficiency</p>\n<p>von Willebrand disease</p>\n</td>\n<td>Heparin, lupus anticoagulant, acquired von Willebrand disease</td>\n</tr>\n<tr>\n<td>\n<p>Prolonged PT + prolonged aPTT</p>\n<p>Evaluates common pathway factors</p>\n</td>\n<td>\n<p>Prothrombin (II), fibrinogen (I), factors V and factor X deficiencies</p>\n</td>\n<td>\n<p>Disseminated intravascular coagulation (DIC)</p>\n<p>Severe liver disease</p>\n<p>Severe vitamin K deficiency</p>\n<p>Direct thrombin inhibitor-argatroban, dabigatran</p>\n<p>Direct factor Xa inhibitor-rivaroxaban, apixaban, edoxaban</p>\n<p>Fondaparinux</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1745, 'Medicine,', 'PM1313. Idiopathic/Immune thrombocytopenic purpura (ITP)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>It is characterized by</p>\n<ul>\n<li>Isolated thrombocytopenia—the<strong>&nbsp;</strong>presence of antibody against platelet membrane glycoprotein and subsequent destruction in reticuloendothelial system</li>\n<li>Normal bone marrow—normal or even increased number of megakaryocytes</li>\n<li>Absence of other causes of thrombocytopenia.<strong>&nbsp;</strong></li>\n</ul>\n<p><strong>Types:</strong></p>\n<p>Acute (&lt;6 months) and chronic (&gt;6 months)<strong>&nbsp;</strong>idiopathic/immune thrombocytopenic purpura (ITP)</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Features</strong></p>\n</td>\n<td>\n<p><strong>Acute ITP</strong></p>\n</td>\n<td>\n<p><strong>Chronic ITP</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Peak incidence</p>\n</td>\n<td>\n<p>2<strong>–</strong>6 years</p>\n</td>\n<td>\n<p>20<strong>–</strong>40 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sex predilection</p>\n</td>\n<td>\n<p><strong>None</strong></p>\n</td>\n<td>\n<p><strong>female: male ratio of 3:1&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Antecedent infection</p>\n</td>\n<td>\n<p><strong>Common 1 to&nbsp;</strong><strong>3 weeks before</strong></p>\n</td>\n<td>\n<p><strong>Unusual</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Onset of bleeding</p>\n</td>\n<td>\n<p>Abrupt</p>\n</td>\n<td>\n<p>Insidious</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Platelet count</p>\n</td>\n<td>\n<p>&lt;20000/microlitre</p>\n</td>\n<td>\n<p>30<strong>–</strong>80000/microlitre</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Eosinophilia/lymphocytosis</p>\n</td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Duration</p>\n</td>\n<td>\n<p>2<strong>–</strong>6 weeks</p>\n</td>\n<td>\n<p>Months or years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Spontaneous remission</strong></p>\n</td>\n<td>\n<p><strong>80% of cases</strong></p>\n</td>\n<td>\n<p><strong>Uncommon</strong></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1746, 'Medicine', 'PM1238. Abnormal Hemoglobins with their Clinical Effects', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\731\>\n<tbody>\n<tr>\n<td>\n<p><strong>Designation</strong></p>\n</td>\n<td>\n<p><strong>Population</strong></p>\n</td>\n<td>\n<p><strong>Main Clinical Effects</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sickle or S</p>\n</td>\n<td>\n<p>African</p>\n</td>\n<td>\n<p>Anemia, ischemic infarcts</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C</p>\n</td>\n<td>\n<p>African</p>\n</td>\n<td>\n<p>Mild anemia; interacts with HbS</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>E</p>\n</td>\n<td>\n<p>Southeast Asian&nbsp;</p>\n</td>\n<td>\n<p>Microcytic anemia, splenomegaly, thalassemic phenotype&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Köln</p>\n</td>\n<td>\n<p>Sporadic</p>\n</td>\n<td>\n<p>Hemolytic anemia, Heinz bodies when splenectomized</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Yakima</p>\n</td>\n<td>\n<p>Sporadic</p>\n</td>\n<td>\n<p>Polycythemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kansas</p>\n</td>\n<td>\n<p>Sporadic</p>\n</td>\n<td>\n<p>Mild anemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>M. Iwata</p>\n</td>\n<td>\n<p>Sporadic</p>\n</td>\n<td>\n<p>Methemoglobinemia</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1747, 'Medicine', 'PM1232. Differences between TTP and HUS', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Features</strong></p>\n</td>\n<td>\n<p><strong>TTP</strong></p>\n</td>\n<td>\n<p><strong>HUS</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Causative agent</p>\n</td>\n<td>\n<p>A deficiency of, or antibodies to the metalloprotease ADAMTS13</p>\n</td>\n<td>\n<p>E. coli (O157: H7)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GI prodrome</p>\n</td>\n<td>\n<p>Uncommon</p>\n</td>\n<td>\n<p>Often</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Age group affected</p>\n</td>\n<td>\n<p>Adults</p>\n</td>\n<td>\n<p>Children</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sex affected</p>\n</td>\n<td>\n<p>Females</p>\n</td>\n<td>\n<p>No sex predilection</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Relapses</p>\n</td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Renal impairment</p>\n</td>\n<td>\n<p>Usually mild</p>\n</td>\n<td>\n<p>Often severe</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Severe thrombocytopenia</p>\n</td>\n<td>\n<p>Often</p>\n</td>\n<td>\n<p>Rare</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Pentad of TTP and triad of HUS</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f1004c9ccec548288509c1eaed783d3fx1280x1840.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1748, 'Medicine', 'PM1230. Characteristics of Inherited Coagulation Disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<thead>\n<tr>\n<td rowspan=\2\>\n<p><strong>Clotting Factor Deficiency</strong></p>\n</td>\n<td rowspan=\2\>\n<p><strong>Inheritance</strong></p>\n</td>\n<td colspan=\3\>\n<p><strong>Laboratory Abnormality&nbsp;</strong></p>\n</td>\n<td rowspan=\2\>\n<p><strong>Treatment</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>aPTT</strong></p>\n</td>\n<td>\n<p><strong>PT</strong></p>\n</td>\n<td>\n<p><strong>TT</strong></p>\n</td>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>\n<p>Fibrinogen</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>Cryoprecipitate</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prothrombin</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>–</p>\n</td>\n<td>\n<p>FFP/PCC</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor V</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+/–</p>\n</td>\n<td>\n<p>+/–</p>\n</td>\n<td>\n<p>–</p>\n</td>\n<td>\n<p>FFP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor VII</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>–</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>–</p>\n</td>\n<td>\n<p>FFP/PCC</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor VIII</p>\n</td>\n<td>\n<p>X-linked</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>–</p>\n</td>\n<td>\n<p>–</p>\n</td>\n<td>\n<p>FVIII concentrates</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor IX</p>\n</td>\n<td>\n<p>X-linked</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>–</p>\n</td>\n<td>\n<p>–</p>\n</td>\n<td>\n<p>FIX concentrates</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor X</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+/–</p>\n</td>\n<td>\n<p>+/–</p>\n</td>\n<td>\n<p>–</p>\n</td>\n<td>\n<p>FFP/PCC</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor XI</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>–</p>\n</td>\n<td>\n<p>–</p>\n</td>\n<td>\n<p>FFP</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Factor XII</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>+</p>\n</td>\n<td>\n<p>–</p>\n</td>\n<td>\n<p>–</p>\n</td>\n<td>\n<p><strong>No </strong>risk of bleeding; treatment not indicated</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>*FFP: Fresh frozen plasma</p>\n<p>PCC: Prothrombin complex concentrate</p></div><!---->\n      <!---->\n    </div><!---->'),
(1749, 'Medicine', 'PM2058. WHO clinical staging of HIV', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\635\>\n<tbody>\n<tr>\n<td><strong>Selected conditions &amp; respective clinical stages in HIV &nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Clinical stage 1</strong>\n<ul>\n<li>Asymptomatic</li>\n<li>Persistent generalized lymphadenopathy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Clinical stage 2 (Mild Symptoms)</strong>\n<ul>\n<li>Moderate unexplained weight loss (&lt;10% ofpresumed or measured body weight)&nbsp;</li>\n<li>Recurrent respiratory tract infections (sinusitis,tonsillitis, otitis media, pharyngitis)&nbsp;</li>\n<li>Herpes zoster&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Angular cheilitis&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Recurrent oral ulceration&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Papular pruritic eruption&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Fungal nail infections&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Seborrhoeic dermatitis&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Unexplained persistent hepatosplenomegaly*&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Extensive wart virus infection*&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Extensive molluscum contagiosum*&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Unexplained persistent parotid enlargement*</li>\n</ul>\n<p>&nbsp;*In Children</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Clinical stage 3 &amp; 4 represent Advanced &amp; Severe illness respectively</strong></p>\n<p>For complete staging, please refer WHO guidelines.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1750, 'Medicine', 'PM2409. Acid-Base Balance - Normal Values', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Component</td>\n<td>Normal Range</td>\n<td>Optimal Value</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>7.35 - 7.45</td>\n<td>7.4</td>\n</tr>\n<tr>\n<td>HCO<sub>3</sub><sup>-</sup>&nbsp;</td>\n<td>22 - 28 mEq/L&nbsp;</td>\n<td>&nbsp;24 mEq/L</td>\n</tr>\n<tr>\n<td>pCO<sub>2</sub></td>\n<td>35 - 45 mmHg</td>\n<td>40 mmHg&nbsp;</td>\n</tr>\n<tr>\n<td>Anion gap</td>\n<td>6 - 12 mEq/L</td>\n<td>&lt;10 mEq/L</td>\n</tr>\n<tr>\n<td>O<sub>2</sub> saturation</td>\n<td colspan=\2\>&gt; 95%</td>\n</tr>\n<tr>\n<td>pO<sub>2</sub></td>\n<td colspan=\2\>75 - 100 mmHg&nbsp;&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1751, 'Medicine', 'PM2098. Expected compensation in acid-base disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Primary disorder</td>\n<td>Expected compensation</td>\n</tr>\n<tr>\n<td>Metabolic acidosis</td>\n<td>\n<p>Expected PaCO<sub>2</sub> = [1 .5 X HCO<sub>3</sub><sup>-</sup>] + 8 ± 2; or</p>\n<p>↓ PaCO2 = 1.25 x ΔHCO3</p>\n</td>\n</tr>\n<tr>\n<td>Metabolic alkalosis</td>\n<td>Increase in PaCO<sub>2 </sub>= 0.75 x ΔHCO<sub>3</sub><sup>-</sup></td>\n</tr>\n<tr>\n<td colspan=\2\>\n<p>Respiratory acidosis</p>\n</td>\n</tr>\n<tr>\n<td>Acute</td>\n<td>\n<p>Increase in HCO<sub>3</sub><sup>- </sup>= 0.1 x Δ PaCO<sub>2</sub></p>\n<p>↓ pH = 0.008 x ΔPaCO2</p>\n</td>\n</tr>\n<tr>\n<td>Chronic</td>\n<td>\n<p>Increase in HCO<sub>3</sub><sup>- </sup>= 0.4 x Δ PaCO<sub>2</sub></p>\n<p>↓ pH = 0.003 x ΔPaCO2</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<p>Respiratory alkalosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acute</p>\n</td>\n<td>\n<p>Decrease in HCO<sub>3</sub><sup>- </sup>= 0.2 x Δ PaCO<sub>2</sub></p>\n<p>↑ pH = 0.008 x ΔPaCO2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic</p>\n</td>\n<td>\n<p>Decrease in HCO<sub>3</sub><sup>- </sup>= 0.4 x Δ PaCO<sub>2</sub></p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1752, 'Medicine', 'PM1521. Causes of Metabolic Acidosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>High Anion-Gap Metabolic Acidosis (MUDPILES)</td>\n<td>Normal Anion-Gap Metabolic Acidosis (FUSED CAR)</td>\n</tr>\n<tr>\n<td><strong>M</strong>ethanol</td>\n<td><strong>F</strong>istula pancreatic</td>\n</tr>\n<tr>\n<td><strong>U</strong>remia (Renal failure - Acute or Chronic)</td>\n<td><strong>U</strong>reterosigmoidostomy</td>\n</tr>\n<tr>\n<td><strong>D</strong>iabetic ketoacidosis</td>\n<td><strong>S</strong>mall bowel fistula</td>\n</tr>\n<tr>\n<td><strong>P</strong>araldehyde</td>\n<td><strong>E</strong>xtra chloride (Hyperalimentation)</td>\n</tr>\n<tr>\n<td><strong>I</strong>ron tablets, INH</td>\n<td><strong>D</strong>iarrhea</td>\n</tr>\n<tr>\n<td><strong>L</strong>actic acidosis</td>\n<td><strong>C</strong>arbonic anhydrase inhibitor (acetazolamide)</td>\n</tr>\n<tr>\n<td><strong>E</strong>thylene glycol</td>\n<td><strong>A</strong>ddisons disease</td>\n</tr>\n<tr>\n<td><strong>S</strong>alicylates</td>\n<td><strong>R</strong>enal tubular acidosis</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1753, 'Medicine', 'PM1343. Interpretation of Acid-Base Disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p>pH&lt;7.35 is acidosis</p>\n<p>pH&gt;7.45 is alkalosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A primary change in HCO<sub>3</sub><sup>-</sup> is termed metabolic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>If the change in HCO<sub>3</sub><sup>-</sup>&nbsp;is in keeping with the pH (i.e. if there are acidosis and HCO<sub>3</sub><sup>-</sup>&nbsp;is decreased) the problem is metabolic.</p>\n<p>If the change in HCO<sub>3</sub><sup>-</sup>&nbsp;is opposite with the pH (i.e. if there is acidosis and HCO<sub>3</sub><sup>-</sup>&nbsp;is increased or normal) the problem is compensatory metabolic.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A primary change in CO<sub>2 </sub>is termed as respiratory</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>If the change in CO<sub>2 </sub>keeping in line with the pH (if in acidosis CO2 is raised) the problem is termed respiratory</p>\n<p>If the change in CO<sub>2</sub> is in the opposite direction of that of the pH (i.e. if there&nbsp;are acidosis and CO<sub>2</sub> is decreased or normal ) the problem is termed compensatory respiratory</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1754, 'Medicine', 'PM1341. Causes of Acid-Base Disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Metabolic acidosis</strong></p>\n</td>\n<td>\n<p><strong>Metabolic alkalosis</strong></p>\n</td>\n<td>\n<p><strong>Respiratory acidosis</strong></p>\n</td>\n<td>\n<p><strong>Respiratory alkalosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ketoacidosis</p>\n<p>Lactic acidosis</p>\n<p>Chronic renal failure</p>\n<p>Salicylate intoxication</p>\n<p>Methanol/formaldehyde intoxication</p>\n<p>Ethylene glycol intoxication</p>\n<p>Diarrhoea</p>\n<p>Renal tubular acidosis</p>\n</td>\n<td>\n<p>Vomiting</p>\n<p>Hyperaldosteronism</p>\n<p>Loop or thiazide diuretics</p>\n</td>\n<td>\n<p>Opiates, sedatives, anesthesia</p>\n<p>Guillain- Barre syndrome, Polio, ALS, multiple sclerosis</p>\n<p>Airway obstruction</p>\n<p>Adult respiratory distress syndrome, COPD</p>\n</td>\n<td>\n<p>Pneumonia, pulmonary embolism</p>\n<p>High altitude</p>\n<p>Psychogenic</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1755, 'Medicine', 'PM0556. Sodium Channelopathies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Mutation in</strong></td>\n<td><strong>Disease</strong></td>\n</tr>\n<tr>\n<td>SCN1A</td>\n<td>Familial hemiplegic migraine type 3</td>\n</tr>\n<tr>\n<td>SCN4A</td>\n<td>\n<p>Hyperkalemic periodic paralysis</p>\n<p>Potassium aggravated myotonia</p>\n<p>Hypokalemic periodic paralysis type 2</p>\n<p>Paramyotonia congenita</p>\n<p>Congenital myasthenic syndrome</p>\n</td>\n</tr>\n<tr>\n<td>SCN5A</td>\n<td>\n<p>Brugada syndrome</p>\n<p>Long QT syndrome type 3</p>\n</td>\n</tr>\n<tr>\n<td>SCN9A</td>\n<td>Erythromelalgia</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1756, 'Medicine', 'PM2496. Simplified diagnostic criteria for migraine', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Repeated attacks of headache lasting 4-72 h in patients with a normal physical examination with no other reasonable cause for the headache, and</p>\n<p><strong>At least 2 of the following features:</strong></p>\n<ul>\n<li>Unilateral pain</li>\n<li>Throbbing pain</li>\n<li>Aggravation by movement</li>\n<li>Moderate or severe intensity</li>\n</ul>\n<p><strong>Plus at least 1 of the following features:</strong></p>\n<ul>\n<li>Nausea/vomiting</li>\n<li>Photophobia and phonophobia</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1757, 'Surgery', 'PM2498. Suture materials', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Suture</strong></td>\n<td><strong>Types</strong></td>\n<td><strong>Uses</strong></td>\n</tr>\n<tr>\n<td colspan=\3\>\n<p class=\p1\><strong>Absorbable&nbsp;</strong><strong>suture materials</strong></p>\n</td>\n</tr>\n<tr>\n<td>Catgut</td>\n<td>Plain/Chromic</td>\n<td>\n<p class=\p1\>Ligate superficial vessels</p>\n<p class=\p1\>Suture subcutaneous tissues, stomas and other tissues that heal rapidly</p>\n</td>\n</tr>\n<tr>\n<td>Polyglactin (Vicryl)</td>\n<td>Braided multifilament</td>\n<td>\n<p class=\p1\>Gut and biliary anastomoses</p>\n<p class=\p1\>Vascular ligatures</p>\n<p class=\p1\>Kidney and ureter surgeries.</p>\n<p class=\p1\>Subcuticular wound</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\>Polydioxanone</p>\n</td>\n<td>\n<p class=\p1\>Monofilament</p>\n<p class=\p1\>Dyed or&nbsp;undyed</p>\n</td>\n<td>\n<p class=\p1\>Used in tissues where slightly longer wound support is required</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\>Poliglecaprone (Monocryl)</p>\n</td>\n<td>Monofilament</td>\n<td>\n<p class=\p1\>Subcuticular suturing of skin</p>\n<p class=\p1\>Soft tissue ligation</p>\n<p class=\p1\>Gastrointestinal and muscle surgery</p>\n</td>\n</tr>\n<tr>\n<td colspan=\3\><strong>Non-absorbable suture materials</strong></td>\n</tr>\n<tr>\n<td>Silk</td>\n<td>\n<p class=\p1\>Braided or twisted multifilament</p>\n<p class=\p1\>Coated (with wax or silicon) or uncoated</p>\n</td>\n<td>\n<p class=\p1\>Ligation and suturing when long-term tissue support is necessary</p>\n<p class=\p1\>e.g., for securing drains externally, two-layer bowel anastomoses</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\>Surgical steel</p>\n</td>\n<td>\n<p class=\p1\>Monofilament or multifilament</p>\n</td>\n<td>\n<p class=\p1\>Closure of sternotomy wounds</p>\n</td>\n</tr>\n<tr>\n<td>Nylon</td>\n<td>\n<p class=\p1\>Monofilament or braided multifilament</p>\n</td>\n<td>\n<p class=\p1\>Skin closure</p>\n<p class=\p1\>Abdominal wall closure</p>\n<p class=\p1\>Hernia repair</p>\n<p class=\p1\>Neurosurgery</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\>Polybutester</p>\n</td>\n<td>\n<p class=\p1\>Monofilament</p>\n</td>\n<td>\n<p class=\p1\>Exhibits elasticity. Favoured&nbsp;for use in plastic surgery</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p class=\p1\>Polypropylene (Prolene)</p>\n</td>\n<td>Monofilament&nbsp;</td>\n<td>&nbsp;\n<p class=\p1\>Cardiovascular surgery and vascular anastomosis&nbsp;</p>\n<p class=\p1\>Plastic surgery</p>\n<p class=\p1\>General surgical subcuticular skin closure</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1758, 'Surgery', 'PM2459. Suture materials', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Suture</strong></td>\n<td><strong>Types</strong></td>\n<td><strong>Uses</strong></td>\n</tr>\n<tr>\n<td colspan=\3\>\n<p class=\p1\><strong>Absorbable&nbsp;</strong><strong>suture materials</strong></p>\n</td>\n</tr>\n<tr>\n<td>Catgut</td>\n<td>Plain/Chromic</td>\n<td>\n<p class=\p1\>Ligate superficial vessels</p>\n<p class=\p1\>Suture subcutaneous tissues, stomas and other tissues that heal rapidly</p>\n</td>\n</tr>\n<tr>\n<td>Polyglactin (Vicryl)</td>\n<td>Braided multifilament</td>\n<td>\n<p class=\p1\>Gut and biliary anastomoses</p>\n<p class=\p1\>Vascular ligatures</p>\n<p class=\p1\>Kidney and ureter surgeries.</p>\n<p class=\p1\>Subcuticular wound</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\>Polydioxanone</p>\n</td>\n<td>\n<p class=\p1\>Monofilament</p>\n<p class=\p1\>Dyed or&nbsp;undyed</p>\n</td>\n<td>\n<p class=\p1\>Used in tissues where slightly longer wound support is required</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\>Poliglecaprone (Monocryl)</p>\n</td>\n<td>Monofilament</td>\n<td>\n<p class=\p1\>Subcuticular suturing of skin</p>\n<p class=\p1\>Soft tissue ligation</p>\n<p class=\p1\>Gastrointestinal and muscle surgery</p>\n</td>\n</tr>\n<tr>\n<td colspan=\3\><strong>Non-absorbable suture materials</strong></td>\n</tr>\n<tr>\n<td>Silk</td>\n<td>\n<p class=\p1\>Braided or twisted multifilament</p>\n<p class=\p1\>Coated (with wax or silicon) or uncoated</p>\n</td>\n<td>\n<p class=\p1\>Ligation and suturing when long-term tissue support is necessary</p>\n<p class=\p1\>For securing drains externally, two-layer bowel anastomoses</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\>Surgical steel</p>\n</td>\n<td>\n<p class=\p1\>Monofilament or multifilament</p>\n</td>\n<td>\n<p class=\p1\>Closure of sternotomy wounds</p>\n</td>\n</tr>\n<tr>\n<td>Nylon</td>\n<td>\n<p class=\p1\>Monofilament or braided multifilament</p>\n</td>\n<td>\n<p class=\p1\>Skin closure</p>\n<p class=\p1\>Abdominal wall closure</p>\n<p class=\p1\>Hernia repair</p>\n<p class=\p1\>Neurosurgery</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\p1\>Polybutester</p>\n</td>\n<td>\n<p class=\p1\>Monofilament</p>\n</td>\n<td>\n<p class=\p1\>Exhibits elasticity. Favoured&nbsp;for use in plastic surgery</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p class=\p1\>Polypropylene (Prolene)</p>\n</td>\n<td>Monofilament&nbsp;</td>\n<td>&nbsp;\n<p class=\p1\>Cardiovascular surgery and vascular anastomosis&nbsp;</p>\n<p class=\p1\>Plastic surgery</p>\n<p class=\p1\>General surgical subcuticular skin closure</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1759, 'Surgery', 'PM2294. Ankle–brachial Pressure Index (ABPI)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The <strong>ankle-brachial Pressure Index (ABPI)</strong> is the <strong>ratio of systolic pressure at the ankle to that in the arm.</strong></p>\n<p>The numerator is the highest pressure in the dorsalis pedis, posterior tibial, or peroneal artery and the denominator is the highest brachial systolic pressure.</p>\n<table>\n<tbody>\n<tr>\n<td>ABPI Reading</td>\n<td>Interpretation</td>\n</tr>\n<tr>\n<td>&gt;0.9 to &lt;1.4</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>&lt;0.9</td>\n<td>Diagnostic of occlusive arterial disease&nbsp;in patients with symptoms of claudication or other signs of ischemia</td>\n</tr>\n<tr>\n<td>0.5 to 0.9</td>\n<td>Arterial obstruction often associated with claudication</td>\n</tr>\n<tr>\n<td>&lt;0.4</td>\n<td>Critical limb ischemia (multilevel obstruction i.e any combination of iliac, femoral or tibial vessel disease and may be associated with non-healing ulcerations, ischemic rest pain, or pedal gangrene.</td>\n</tr>\n<tr>\n<td>&gt;1.4</td>\n<td>Signifies poor compressibility of the arteries. Mostly due to calcification because of increased age, diabetes etc.</td>\n</tr>\n</tbody>\n</table>\n<p>Note:&nbsp;A fall in the resting ABPI of more than 20% after exercise is indicative of arterial disease.<br><br></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a4a28e64a1194038b7da810b44d924cbx1280x1892.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1760, 'Surgery', 'PM2292. CEAP Classification of Chronic Lower Extremity Venous Disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 1027\>\n<table><colgroup><col><col><col> </colgroup>\n<tbody>\n<tr>\n<td colspan=\3\>\n<div class=\layoutArea\>\n<div class=\column\>\n<div class=\page\ title=\Page 995\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>CEAP (Clinical-Etiology-Anatomy-Pathophysiology)</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Clinical&nbsp;classification (C)*</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C0</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>No visible or palpable signs of venous disease</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C1</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Telangiectases or reticular veins</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C2</p>\n<p>C2r</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Varicose veins</p>\n<p>Recurrent varicose veins</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C3</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Edema</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C4</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Changes in skin and subcutaneous tissue secondary</p>\n<p>to chronic venous disease</p>\n<p>C4a-Pigmentation or eczema</p>\n</div>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C4b-Lipodermatosclerosis or atrophie blanche</p>\n<p>C4c-Corona phlebectatica</p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C5</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Healed ulcer</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C6</p>\n<p>C6r</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Active ulcer</p>\n<p>Recurrent active venous ulcer</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>S</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>With symptoms attributable to venous disease</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>A</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Absence of&nbsp;symptoms attributable to venous disease</p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Etiological</strong>&nbsp;<strong>classification (E)</strong></p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ec</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Congenital (Klippel-Trenaunay syndrome)</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ep</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Primary</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Es</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Secondary (postthrombotic syndrome, trauma)</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Esi</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Secondary (intravenous)</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ese</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Secondary (extravenous)</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ec</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Congenital</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>En</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>No venous cause identified</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Anatomic</strong>&nbsp;<strong>classification</strong> <strong>(A)</strong></p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>As</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Superficial</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ad</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Deep</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ap</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Perforator</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>An</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>No venous location identified</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Patho-physiologic&nbsp;classification (P)</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Pr</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Reflux</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Po</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Obstruction, thrombosis</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Pr,o</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Reflux and obstruction</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Pn</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>No venous pathophysiology identified</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n<div class=\page\ title=\Page 1027\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Note:</strong></p>\n<ul>\n<li>The descriptor A (asymptomatic) or S (symptomatic) is placed after the C clinical class.</li>\n<li aria-level=\1\>Telengiactesia refers to tiny intradermal venules &lt;1 mm in diameter.</li>\n<li aria-level=\1\>Reticular veins refer to small dilated subdermal blue veins of 1 to 2.9 mm</li>\n<li aria-level=\1\>Varicose veins refer to dilated tortuous veins &gt;3 mm in diameter</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1761, 'Surgery', 'PM2166. Complications of total parenteral nutrition', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>A. Related to nutrient deficiency</strong></p>\n<ul>\n<li>Hypoglycemia/hypocalcaemia/hypophosphatemia/hypomagnesaemia (<strong>refeeding syndrome</strong>)</li>\n<li>Chronic deficiency syndromes (essential fatty acids,&nbsp;<strong>zinc</strong>, mineral and trace elements)</li>\n</ul>\n<p><strong>B. Related to overfeeding</strong></p>\n<ul>\n<li><strong>Excess glucose:</strong>&nbsp;Hyperglycemia, hyperosmolar dehydration, hepatic steatosis, hypercapnia, increased sympathetic activity, fluid retention, electrolyte abnormalities</li>\n<li><strong>Excess fat:</strong>&nbsp;Hypercholesterolemia and formation of lipoprotein X, hypertriglyceridemia, hypersensitivity reactions</li>\n<li><strong>Excess amino acids:</strong>&nbsp;Hyperchloremic metabolic acidosis, hypercalcemia, aminoacidemia, uremia</li>\n</ul>\n<p><strong>C. Related to sepsis</strong></p>\n<ul>\n<li>Catheter-related sepsis</li>\n<li>Possible increased predisposition to systemic sepsis</li>\n</ul>\n<p><strong>D. Related to IV line</strong></p>\n<ul>\n<li><strong>On insertion:</strong>&nbsp;Pneumothorax, damage to adjacent artery, air embolism, thoracic duct damage, cardiac perforation or tamponade, pleural effusion, hydro mediastinum</li>\n<li><strong>Long-term use:</strong>&nbsp;Occlusion, venous thrombosis</li>\n</ul>\n<p><strong>E. Related to motility</strong></p>\n<ul>\n<li>Cholestasis</li>\n<li><strong>Gallstones</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1762, 'Surgery', 'PM2147. Modified Gilberts classification of hernia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Type 1</strong> <strong>Indirect</strong> hernia with&nbsp;peritoneal sac passing through an intact internal ring that will not admit 1 fingerbreadth (ie,&lt;1 cm.); the posterior wall is intact.</p>\n<p><strong>Type 2 Indirect</strong> hernia (the most common indirect hernia) with peritoneal sac coming through a 1-fingerbreadth internal ring (ie, ≤2 cm.); the posterior wall is intact.</p>\n<p><strong>Type 3 Indirect</strong> hernia with peritoneal sac coming through a 2-fingerbreadth or wider internal ring (ie, &gt;2 cm.).They are frequently complete and often have a <strong>sliding</strong> component. They begin to break down a portion of the posterior wall just medial to the internal ring.</p>\n<p><strong>Type 4 Direct</strong> hernia with full floor posterior wall breakdown or multiple defects in the posterior wall. The internal ring is intact, and there is no peritoneal sac.</p>\n<p><strong>Type 5 Direct</strong> hernia with a <strong>diverticular</strong> defect. There is no peritoneal sac and the internal ring remains intact.</p>\n<p><strong>Type 6</strong>&nbsp;Both <strong>direct and indirect</strong> inguinal hernia (a <strong>pantaloon</strong> hernia)</p>\n<p><strong>Type 7</strong>&nbsp; <strong>Femoral</strong> hernia.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1763, 'Surgery', 'PM2142. Complications of enteral nutrition', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>1.&nbsp;<strong>Tube-related </strong>(most common)<strong>:</strong></p>\n<ul>\n<li>Malposition</li>\n<li>Displacement</li>\n<li>Blockage</li>\n<li>Breakage/leakage</li>\n<li>Local complications (e.g. erosion of skin/mucosa)</li>\n</ul>\n<p>2. <strong>Gastrointestinal:</strong></p>\n<ul>\n<li>Diarrhoea</li>\n<li>Bloating, nausea, vomiting</li>\n<li>Abdominal cramps</li>\n<li>Aspiration</li>\n<li>Constipation</li>\n</ul>\n<p>3. <strong>Metabolic/biochemical:</strong></p>\n<ul>\n<li>Electrolyte disorders</li>\n<li>Vitamin, mineral, trace element deficiencies</li>\n<li>Drug interactions</li>\n</ul>\n<p>4. <strong>Infective:</strong></p>\n<ul>\n<li>Exogenous (handling contamination)</li>\n<li>Endogenous (patient)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1764, 'Surgery', 'PM2120. Brilliantly Transilluminating Swellings', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Vaginal hydrocele</li>\n<li>Epididymal cyst</li>\n<li>Cystic hygroma</li>\n<li>Ranula</li>\n<li>Meningocele</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1765, 'Surgery', 'PM2114. Types of transplants', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>&nbsp;Definition</strong></td>\n</tr>\n<tr>\n<td><strong>Orthotopic</strong></td>\n<td>\n<p class=\p1\>Organ implanted in the same anatomic location in the recipient as it was in the donor.&nbsp;Diseased organ is removed. Eg: heart, lung, liver, intestine</p>\n</td>\n</tr>\n<tr>\n<td><strong>Heterotopic</strong></td>\n<td>\n<p class=\p1\>Organ implanted in a different anatomic location. Diseased organ is left in place. Eg: Kidney, pancreas</p>\n</td>\n</tr>\n<tr>\n<td><strong>Auxiliary transplantation</strong></td>\n<td>Partial tissue from the donor is used which acts as temporary support for the recipients injured organ, which remains in place. Eg: left lobe of liver</td>\n</tr>\n<tr>\n<td><strong>Autotransplant&nbsp;</strong></td>\n<td>Transfer of cells/tissues/organs within the same person.&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Allotransplant</strong></td>\n<td>Transfer of cells/tissues/organs within the same species.&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Xenotransplant</strong></td>\n<td>Transfer of cells/tissues/organs in a different species.</td>\n</tr>\n<tr>\n<td><strong>Isograft</strong></td>\n<td>Transfer of organ or tissue within genetically identical individuals. Eg: Identical twins</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1766, 'Surgery', 'PM2087. Lasers used in various specialities', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\520\>\n<tbody>\n<tr>\n<td><strong>Laser</strong></td>\n<td><strong>Major indications</strong></td>\n</tr>\n<tr>\n<td>Nd:YAG</td>\n<td>\n<p><strong>Ophthalmology</strong></p>\n<ul>\n<li>Posterior capsulotomy</li>\n<li>Iridotomy</li>\n<li>Vitreolysis</li>\n</ul>\n<p><strong>Urology</strong></p>\n<ul>\n<li>Bladder cancer</li>\n</ul>\n<p><strong><strong>GIT</strong></strong></p>\n<ul>\n<li>Fragmentation of gall stones</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Holmium YAG</td>\n<td>\n<p><strong>Urology</strong></p>\n<ul>\n<li>Lithotripsy</li>\n<li>Benign prostatic hyperplasia</li>\n<li>Urethral stricture</li>\n</ul>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Carbon dioxide&nbsp;</td>\n<td>\n<p><strong>ENT</strong></p>\n<ul>\n<li>Stapedectomy</li>\n<li>Tympanomastoid surgery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Excimer (argon fluoride)</td>\n<td>\n<p><strong>Ophthalmology</strong></p>\n<ul>\n<li>LASIK</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Argon green</td>\n<td>\n<p><strong>Ophthalmology</strong></p>\n<ul>\n<li>Retinal photocoagulation</li>\n</ul>\n<p><strong>ENT</strong></p>\n<ul>\n<li>Middle ear surgery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Pulsed dye laser (PDL)</td>\n<td>\n<p><strong>Dermatology</strong></p>\n<ul>\n<li>Port-wine stain</li>\n<li>Strawberry birthmarks</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1767, 'Surgery', 'PM2082. Damage Control Surgery', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><h3>Five stages of damage control surgery:</h3>\n<ol>\n<li>Patient selection</li>\n<li>Control of haemorrhage and control of contamination</li>\n<li>Resuscitation continued in the intensive care unit</li>\n<li>Deﬁnitive surgery</li>\n<li>Abdominal closure</li>\n</ol>\n<h3>Indications for damage control surgery:</h3>\n<h4>Anatomical</h4>\n<ul>\n<li>Inability to achieve haemostasis</li>\n<li>Complex abdominal injury, e.g. liver and pancreas</li>\n<li>Combined vascular, solid and hollow organ injury, e.g. aortic or caval injury</li>\n<li>Inaccessible major venous injury, e.g. retrohepatic vena cava</li>\n<li>Demand for non-operative control of other injuries, e.g. fractured pelvis</li>\n<li>Anticipated need for a time-consuming procedure</li>\n</ul>\n<h4>Physiological (decline of physiological reserve)</h4>\n<ul>\n<li>Temperature &lt;34ºC</li>\n<li>pH &lt;7.2</li>\n<li>Serum lactate &gt;5 mmol/L (normal is &lt;2.5 mmol/L)</li>\n<li>Prothrombin time (PT) &gt;16 s</li>\n<li>Partial thromboplastin time (PTT) &gt;60 s</li>\n<li>Blood transfusion approaching 15 units</li>\n<li>Systolic blood pressure &lt;90 mmHg for &gt;60 min</li>\n</ul>\n<h4>Environmental</h4>\n<ul>\n<li>Operating time &gt;60 min</li>\n<li>Inability to approximate the abdominal incision</li>\n<li>Desire to reassess the intra-abdominal contents (directed relook)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1768, 'Surgery', 'PM1953. Diathermy/Cautery:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Features</strong></td>\n<td><strong>Monopolar</strong></td>\n<td><strong>Bipolar</strong></td>\n</tr>\n<tr>\n<td>Flow of current</td>\n<td>\n<p>Cautery pencil –&gt; tissue –&gt; cautery pad –&gt; machine/ground</p>\n<p>Hence <strong>more</strong> chance of burns</p>\n</td>\n<td>\n<p>Only between tips of the instrument</p>\n<p>Hence <strong>less</strong> chance of burns</p>\n</td>\n</tr>\n<tr>\n<td>Modes</td>\n<td>\n<p><strong>Cutting</strong> – Low voltage, high amplitude, continuous waveforms</p>\n<p><strong>Coagulation</strong> – Alternate waveforms (Bursts)</p>\n<p><strong>Dessication</strong> – Low power</p>\n<p><strong> Fulguration</strong> – High power</p>\n</td>\n<td>Only coagulation</td>\n</tr>\n<tr>\n<td>Dissipation</td>\n<td>\n<p>More thermal dissipation of current</p>\n<p>Hence can cause <strong>damage</strong> to nerves and other vital structures</p>\n</td>\n<td>\n<p>Less lateral dissipation of current</p>\n<p>Hence<strong> safer</strong> in procedures closer to vital structures</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1a2ad85d0c4b467ba6f98641c22ef684x554x1180.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1769, 'Surgery', 'PM1769. Trauma Scoring Systems', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Revised Trauma Score&nbsp; </strong>- Total score 0-12 :</p>\n<ul>\n<li>Glasgow coma scale</li>\n<li>Respiratory rate</li>\n<li>Systolic BP</li>\n</ul>\n<p><strong>Glasgow coma scale&nbsp; -</strong> Total score 3-15 :</p>\n<ul>\n<li>Eye-opening</li>\n<li>Verbal response</li>\n<li>Motor response</li>\n</ul>\n<p><strong>Abbreviated Injury Scale:&nbsp;</strong>AIS severity code – 1(minimal severity) to 6 (presumably fatal)</p>\n<p><strong>Injury Severity Score –</strong> Total score 3 to 75. Calculated summing the squares of the AIS severity codes for the three most severely injured body regions</p>\n<table width=\199\>\n<tbody>\n<tr>\n<td>Score</td>\n<td>Severity of injury</td>\n</tr>\n<tr>\n<td>3-8</td>\n<td>Minor</td>\n</tr>\n<tr>\n<td>9-16</td>\n<td>Moderate</td>\n</tr>\n<tr>\n<td>16-24</td>\n<td>Serious</td>\n</tr>\n<tr>\n<td>&gt;25</td>\n<td>Severe/ Critical</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;&nbsp;</p>\n<p><strong>Mangled Extremity Severity score: </strong>Mnemonic -<strong> ELiSA</strong></p>\n<ul>\n<li><strong>E</strong>nergy that caused the injury, skeletal and soft tissue injury</li>\n<li><strong>Li</strong>mb ischemia</li>\n<li><strong>S</strong>hock</li>\n<li>Patient’s <strong>a</strong>ge</li>\n</ul>\n<p><strong>TRISS (Trauma</strong><strong> and Injury Severity Score</strong><strong>) : </strong>Mnemonic - <strong>IRMA</strong></p>\n<ul>\n<li><strong>I</strong>njury Severity Score</li>\n<li><strong>R</strong>evised Trauma Score</li>\n<li><strong>M</strong>echanism of Injury (blunt/penetrating)</li>\n<li><strong>A</strong>ge</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1770, 'Surgery', 'PM1768. Response to surgical stress / trauma :', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Factors that are altered in cases of trauma or surgical stress:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Increased levels</strong></td>\n<td><strong>Decreased levels</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li><strong>ACTH</strong></li>\n<li>Cortisol</li>\n<li>Adrenaline</li>\n<li>Glucagon</li>\n<li><strong>GH</strong></li>\n<li><strong>TNF α</strong></li>\n<li>IL-1</li>\n<li>IL-6</li>\n<li>IL-8</li>\n</ul>\n</td>\n<td>\n<ul>\n<li><strong>Insulin (ebb phase)</strong></li>\n<li>IGF-1</li>\n<li>Testosterone</li>\n<li>T3</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Metabolic changes seen include:</strong></p>\n<ul>\n<li>↑ Adipocyte lipolysis</li>\n<li>↑ Hepatic gluconeogenesis</li>\n<li>↑ Skeletal muscle protein degradation</li>\n<li>↑ Hepatic acute phase protein synthesis</li>\n<li>Pyrexia</li>\n<li>Hypermetabolism</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1771, 'Surgery', 'PM1716. Classification of Kaposi sarcoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Classic</strong></p>\n<ul>\n<li>Older men of eastern European and Meditteranean origin</li>\n<li>Not associated with HIV</li>\n<li>Skin plaques and nodules</li>\n</ul>\n<p><strong>Endemic African</strong></p>\n<ul>\n<li>Seen in HIV seronegative individuals</li>\n<li>Predominant lymph node and visceral involvement</li>\n</ul>\n<p><strong>Transplant associated</strong></p>\n<ul>\n<li>Solid organ transplant recipients</li>\n<li>Involves lymph nodes, mucosa, and viscera</li>\n<li>Cutaneous lesions may be absent</li>\n</ul>\n<p><strong>AIDS-associated epidemic KS</strong></p>\n<ul>\n<li>HIV infected individuals</li>\n<li>Involves lymph nodes</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1772, 'Surgery', 'PM1615. Triads in Surgery', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Triad</strong></p>\n</td>\n<td>\n<p><strong>Seen in</strong></p>\n</td>\n<td>\n<p><strong>Components</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Borchardt’s Triad</p>\n</td>\n<td>\n<p>Gastric Volvulus</p>\n</td>\n<td>\n<p>Epigastric pain + Inability to vomit + Inability to pass a nasogastric tube</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cushing’s Triad</p>\n</td>\n<td>\n<p>Intracranial hypertension</p>\n</td>\n<td>\n<p>Hypertension&nbsp;+ Bradycardia + Irregular respiration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dieulafoy’s Triad</p>\n</td>\n<td>\n<p>Acute appendicitis</p>\n</td>\n<td>\n<p>Hypersensitiveness of skin + Reflex muscular contraction + Tenderness at Mc Burney’s point</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Galezias Triad</p>\n</td>\n<td>&nbsp;</td>\n<td>\n<p>Dupuytren’s contracture + Retroperitoneal fibrosis + Peyronie’s disease of the penis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hutchison’s Triad</p>\n</td>\n<td>\n<p>Congenital syphilis</p>\n</td>\n<td>\n<p>Hutchison’s teeth (notched upper incisors) + Interstitial keratitis + Nerve deafness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mackler’s Triad</p>\n</td>\n<td>\n<p>Boerhaave’s syndrome</p>\n</td>\n<td>\n<p>Thoracic pain + Vomiting + Cervical subcutaneous emphysema</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Quinckes Triad</p>\n</td>\n<td>\n<p>Hemobilia</p>\n</td>\n<td>\n<p>Gastrointestinal hemorrhage + Biliary colic + Jaundice</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rigler’s Triad</p>\n</td>\n<td>\n<p>Gallstone ileus</p>\n</td>\n<td>\n<p>Small bowel obstruction + Pneumobilia + Ectopic gallstone</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Saints Triad</p>\n</td>\n<td>&nbsp;</td>\n<td>\n<p>Hiatus hernia + Gallstones+ Colonic diverticulosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tillaux’s Triad</p>\n</td>\n<td>\n<p>Mesenteric cyst</p>\n</td>\n<td>\n<p>Soft fluctuant swelling in umbilical region + Freely mobile perpendicular to mesentery + Zone of resonance all around</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trotter’s Triad</p>\n</td>\n<td>\n<p>Nasopharyngeal Carcinoma</p>\n</td>\n<td>\n<p>Conductive hearing loss + Immobility of homolateral soft palate + Trigeminal neuralgia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Virchow’s Triad</p>\n</td>\n<td>\n<p>Thrombosis</p>\n</td>\n<td>\n<p>Hypercoagulability + Stasis + Endothelial injury</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Whipple’s Triad</p>\n</td>\n<td>\n<p>Insulinoma</p>\n</td>\n<td>\n<p>Symptoms of hypoglycemia + Serum&nbsp;glucose &lt;50 mg/dL + Symptomatic relief on glucose ingestion</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1773, 'Surgery', 'PM1600. Indications and contraindications of puncture, aspiration, injection, and re-aspiration (PAIR) in hydatid cyst', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Indications:</strong></p>\n<ul>\n<li>Relapse cyst, infected cyst, cyst &gt;5 cm in different liver segments</li>\n<li>Patients who refuse surgery or where surgery is contraindicated</li>\n<li>Pregnant women, children &lt; 3 years of age</li>\n<li>WHO - type CE1 and type CE3a (transitional cyst)</li>\n</ul>\n<p><strong>Contraindications:</strong></p>\n<ul>\n<li>Cysts in lung</li>\n<li>Cysts communicating with bile duct</li>\n<li>Cysts with multiple septae—honeycomb cysts</li>\n<li>Inaccessible cysts</li>\n<li>Hyperechogenic cysts</li>\n<li>Calcified cysts</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1774, 'Surgery', 'PM1512. Identification of Surgical Retractors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Deavers Retractor:</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1bdb9c3f1d64405eb0ba5d6b7f14c373x800x600.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Doyens retractor:</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ba4b0fd005ca49eb9e1bd9f3a014a99dx1280x960.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Morris retractor:</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/20f77217c4f6464189079798ee63679fx714x340.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Czerny’s retractor:</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f080538ebecb4e22bb229bfcafd32caax720x390.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1775, 'Surgery,', 'PM1500. Gurds criteria for diagnosing fat embolism syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\ng-scope\><strong>Major criteria</strong></div>\n<div class=\ng-scope\>\n<ul>\n<li>Petechial rash</li>\n<li>Respiratory symptoms with radiographic changes</li>\n<li>CNS depression.</li>\n</ul>\n</div>\n<div class=\ng-scope\>\n<div class=\ng-scope\>\n<p class=\ng-binding\><strong>Minor criteria</strong></p>\n<ul>\n<li>Tachycardia</li>\n<li>Pyrexia</li>\n<li>Retinal changes (fat or petechiae)</li>\n<li>Renal abnormalities (oliguria, anuria, or lipiduria)</li>\n<li>Acute thrombocytopenia</li>\n<li>Acute decrease in hemoglobin</li>\n<li>Fat globules in sputum</li>\n<li>Increased ESR</li>\n</ul>\n<p><strong>2 major criteria</strong> OR <strong>one major criteria</strong> + <strong>four minor criteria</strong> suggest a diagnosis of fat embolism syndrome.</p>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1776, 'Surgery', 'PM1492. Complications of a Massive Transfusion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Massive transfusion (MT)</strong>&nbsp;is defined as the replacement by transfusion of <strong>10 units of pRBCs</strong>&nbsp;in <strong>24 hours&nbsp;</strong>or more than <strong>4 units of pRBCs</strong> in <strong>one hour</strong>.</p>\n<p>Complications from massive transfusion include:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Complication</strong></td>\n<td><strong>Mechanism</strong></td>\n</tr>\n<tr>\n<td>Hypothermia</td>\n<td>As blood products are normally stored between 1°C and 6°C</td>\n</tr>\n<tr>\n<td>Coagulopathy</td>\n<td>\n<p>MT with PRBCs alone causes a <strong>dilutional coagulopathy&nbsp;</strong>(vs&nbsp;consumptive coagulopathy caused by&nbsp;massive hemorrhage)</p>\n<p>Can be prevented by starting early transfusion of FFP, platelets, pRBCs in a <strong>1:1:1 ratio</strong></p>\n</td>\n</tr>\n<tr>\n<td>Acidosis/ Alkalosis</td>\n<td>\n<p>Mild acidosis - increased CO2 levels in stored blood by 21-35 days</p>\n<p>Metabolic alkalosis -&nbsp;citrate gets metabolized to bicarbonate</p>\n<p>Metabolic acidosis - due to tissue hypoperfusion</p>\n</td>\n</tr>\n<tr>\n<td>Hyperkalemia/ Hypokalemia</td>\n<td>\n<p>Initially - Hyperkalemia, as stored blood has high K+ levels due to inactivated Na/K/ATPase pump</p>\n<p>Later - Hypokalemia, due to intracellular potassium uptake and metabolic alkalosis</p>\n</td>\n</tr>\n<tr>\n<td>Hypocalcemia</td>\n<td>Stored blood is anticoagulated with citrate, which binds calcium.</td>\n</tr>\n<tr>\n<td>Hypomagnesemia</td>\n<td>Infusion of large volumes of magnesium-poor fluids and&nbsp;binding of magnesium to citrate</td>\n</tr>\n<tr>\n<td>Impaired O2-carrying capacity of hemoglobin</td>\n<td>Decreased 2, 3 DPG</td>\n</tr>\n<tr>\n<td>Volume overload</td>\n<td>Due to massive transfusion</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1777, 'Surgery', 'PM1486. Classification of hemorrhagic shock', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table class=\scrollable bordered\ border=\0\ cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<th class=\rowsep\>Parameters</th>\n<th class=\rowsep\>Class I</th>\n<th class=\rowsep\>Class II</th>\n<th class=\rowsep\>Class III</th>\n<th class=\rowsep\>Class IV</th>\n</tr>\n<tr>\n<td>Blood loss in %</td>\n<td>&lt;15</td>\n<td>15–30</td>\n<td>30–40</td>\n<td>&gt;40</td>\n</tr>\n<tr>\n<td>Pulse rate</td>\n<td>&lt;100</td>\n<td>100–120</td>\n<td>120–140</td>\n<td>&gt;140</td>\n</tr>\n<tr>\n<td>Blood pressure</td>\n<td>Normal</td>\n<td>Normal</td>\n<td>Decreased</td>\n<td>Greatly decreased</td>\n</tr>\n<tr>\n<td>Pulse pressure</td>\n<td>Normal or increased</td>\n<td>Decreased</td>\n<td>Decreased</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td>Respiratory rate</td>\n<td>14–20</td>\n<td>20–30</td>\n<td>30–40</td>\n<td>&gt;35</td>\n</tr>\n<tr>\n<td>Mental status</td>\n<td>Slightly anxious</td>\n<td>Mildly anxious</td>\n<td>Anxious, confused</td>\n<td>Confused, lethargic</td>\n</tr>\n<tr>\n<td>Urine output (mL/hr)</td>\n<td>&gt;30</td>\n<td>20–30</td>\n<td>5–15</td>\n<td>Minimal</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1778, 'Surgery', 'PM1112. Marjolin’s Ulcer', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Low-grade squamous cell carcinoma</strong> arising from:\n<ol>\n<li>Long-standing ulcers like a venous ulcer</li>\n<li>Post-burn scar</li>\n<li>Chronic osteomyelitis</li>\n<li>Post-radiation ulcer</li>\n</ol>\n</li>\n<li><strong>Slow growing</strong> since it is relatively <strong>avascular</strong></li>\n<li><strong>Painless</strong> due to the <strong>absence of nerves</strong> in scar tissue</li>\n<li><strong>No secondary deposits</strong> since there are <strong>no lymphatics</strong> in scar tissue</li>\n<li><strong>Radioresistant</strong> due to avascularity</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1779, 'Surgery', 'PM1047. The triangle of pain/Electrical hazard zone:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>The triangle of pain</strong>/Electrical hazard zone:</p>\n<p>It is bounded</p>\n<ul>\n<li>Superio-medially by gonadal vessels</li>\n<li>Laterally by peritoneum</li>\n<li>Inferio-laterally by the iliopubic tract</li>\n</ul>\n<p>Contents:</p>\n<ul>\n<li>Lateral femoral cutaneous nerve</li>\n<li>Anterior femoral cutaneous nerve</li>\n<li>Femoral branch of the genitofemoral nerve</li>\n<li>Femoral nerves</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/833ca430d54d417da2cf19e702148c98x1280x1369.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1780, 'Surgery', 'PM0794. Types of microcalcification indicating malignancy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>In decreasing order of risk of malignancy-</p>\n<ul>\n<li>Cluster microcalcification (maximum risk)</li>\n<li>Linear microcalcification</li>\n<li>Segmental microcalcification</li>\n<li>Diffuse microcalcification (minimum risk)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1781, 'Surgery', 'PM0787. Clinical signs and symptoms of phaeochromocytoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>Prevalance</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Hypertension</strong></p>\n<ul>\n<li>Paroxysmal<br><br></li>\n<li>Continuous</li>\n</ul>\n</td>\n<td>\n<p>80–90</p>\n<p>50–60</p>\n<p>30</p>\n</td>\n</tr>\n<tr>\n<td><strong>Headache</strong></td>\n<td>60–90</td>\n</tr>\n<tr>\n<td>Sweating</td>\n<td>50–70</td>\n</tr>\n<tr>\n<td>Palpitation</td>\n<td>50–70</td>\n</tr>\n<tr>\n<td>Pallor</td>\n<td>40–45</td>\n</tr>\n<tr>\n<td>Weight loss</td>\n<td>20–40</td>\n</tr>\n<tr>\n<td>Hyperglycaemia</td>\n<td>40</td>\n</tr>\n<tr>\n<td>Nausea</td>\n<td>20–40</td>\n</tr>\n<tr>\n<td>Psychological effects</td>\n<td>20–40</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1782, 'Surgery', 'PM0478. Surgical wound classifications as defined by ACS NSOP', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Clean</strong>:&nbsp;Uninfected operative wounds in which no inflammation is encountered and the respiratory, alimentary, genital, and uninfected urinary tracts are not entered</li>\n<li><strong>Clean/Contaminated</strong>:&nbsp;Operative wounds in which the respiratory, alimentary, genital, or urinary tract is entered under controlled conditions and without unusual contamination</li>\n<li><strong>Contaminated</strong>:&nbsp;Open, fresh, accidental wounds; operations with major breaks insterile technique or gross spillage from the gastrointestinal tract and incisions in which acute, nonpurulent inflammation is encountered</li>\n<li><strong>Dirty</strong>:&nbsp;Old traumatic wounds with retained devitalized tissue and wounds that involve existing clinical infection or perforated viscera</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1783, 'Surgery', 'PM0476. Staging of Pressure Sores', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td>\n<div class=\page\ title=\Page 50\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Description</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>1</td>\n<td><strong>Non-blanchable erythema</strong> without a breach in the epidermis</td>\n</tr>\n<tr>\n<td>2</td>\n<td>\n<p><strong>Partial thickness skin loss</strong> involving the epidermis and dermis</p>\n</td>\n</tr>\n<tr>\n<td>3</td>\n<td>\n<p><strong>Full thickness skin loss</strong> extending into the subcutaneous tissue but <strong>not</strong> through underlying <strong>fascia</strong></p>\n</td>\n</tr>\n<tr>\n<td>4</td>\n<td><strong>Full thickness skin loss</strong> through fascia with extensive tissue destruction, maybe involving <strong>muscle, bone, tendon or joint</strong></td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5101f11adf164ca39aa80464ba864044x1280x4990.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1784, 'Surgery', 'PM0466. Causes of Burns and their Likely Depth', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\455\>\n<tbody>\n<tr>\n<td><strong>Cause of burn</strong></td>\n<td><strong>Probable depth of burn</strong></td>\n</tr>\n<tr>\n<td>Scald</td>\n<td>Superficial, but with deep dermal patches in the absence of good first aid. Will be deep in a young infant</td>\n</tr>\n<tr>\n<td>Fat burns</td>\n<td>Deep dermal</td>\n</tr>\n<tr>\n<td>Flame burns</td>\n<td>Mixed deep dermal and full thickness</td>\n</tr>\n<tr>\n<td>Alkali burns, including cement</td>\n<td>Often deep dermal or full thickness</td>\n</tr>\n<tr>\n<td>Acid burns</td>\n<td>Weak concentrations superficial; strong concentration deep dermal</td>\n</tr>\n<tr>\n<td>Electrical contact burn</td>\n<td>Full thickness</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1785, 'Surgery', 'PM0457. White cell peaks during wound healing', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\213\>\n<tbody>\n<tr>\n<td><strong>Cell</strong></td>\n<td><strong>Peak (day)</strong></td>\n</tr>\n<tr>\n<td>Neutrophils</td>\n<td>2</td>\n</tr>\n<tr>\n<td>Macrophages</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Lymphocytes</td>\n<td>7</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1786, 'Surgery', 'PM0192. Important Tumor Classifications', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Name of classification</strong>&nbsp;</td>\n<td><strong>Associated tumors</strong></td>\n</tr>\n<tr>\n<td>Bloom–Richardson grading</td>\n<td>Carcinoma breast</td>\n</tr>\n<tr>\n<td>Butchart staging</td>\n<td>Mesothelioma</td>\n</tr>\n<tr>\n<td>Chang staging</td>\n<td>Medulloblastoma</td>\n</tr>\n<tr>\n<td>Duke staging</td>\n<td>Colorectal carcinoma</td>\n</tr>\n<tr>\n<td>Gleason</td>\n<td>Prostate</td>\n</tr>\n<tr>\n<td>Jackson</td>\n<td>Carcinoma penis</td>\n</tr>\n<tr>\n<td>Masaoka staging</td>\n<td>Thymoma</td>\n</tr>\n<tr>\n<td>Noguchi</td>\n<td>Adenocarcinoma lung</td>\n</tr>\n<tr>\n<td>Nevine staging</td>\n<td>Carcinoma gall bladder</td>\n</tr>\n<tr>\n<td>Robson staging</td>\n<td>Renal cell carcinoma</td>\n</tr>\n<tr>\n<td>\n<div>Reiss and Ellsworth classification</div>\n<div>Esson prognostic index</div>\n</td>\n<td>Retinoblastoma</td>\n</tr>\n<tr>\n<td>Shimda index</td>\n<td>Neuroblastoma</td>\n</tr>\n<tr>\n<td>Sullivan modification of Macfarlane system</td>\n<td>Adrenocortical carcinoma</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1787, 'Surgery', 'PM0161. Important tumor classifications', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;<strong>Important tumor classifications:</strong></p>\n<table>\n<tbody>\n<tr>\n<td>Bloom Richardson grading</td>\n<td>Carcinoma breast</td>\n</tr>\n<tr>\n<td>Butchart staging</td>\n<td>Mesothelioma</td>\n</tr>\n<tr>\n<td>Chang staging</td>\n<td>Medulloblastoma</td>\n</tr>\n<tr>\n<td>Duke staging</td>\n<td>Colorectal carcinoma</td>\n</tr>\n<tr>\n<td>Gleason</td>\n<td>Prostate</td>\n</tr>\n<tr>\n<td>Jackson</td>\n<td>Carcinoma penis</td>\n</tr>\n<tr>\n<td>Masaoka staging</td>\n<td>Thymoma</td>\n</tr>\n<tr>\n<td>Noguchi</td>\n<td>Adenocarcinoma lung</td>\n</tr>\n<tr>\n<td>Nevins staging</td>\n<td>Carcinoma gall bladder</td>\n</tr>\n<tr>\n<td>Robson staging</td>\n<td>Renal cell carcinoma</td>\n</tr>\n<tr>\n<td>\n<p>Reiss and Ellsworth classification</p>\n<p>Esson prognostic index</p>\n</td>\n<td>Retinoblastoma</td>\n</tr>\n<tr>\n<td>Shimada index</td>\n<td>Neuroblastoma</td>\n</tr>\n<tr>\n<td>Sullivan modification of Macfarlane system&nbsp;</td>\n<td>Adrenocortical carcinoma</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->'),
(1788, 'Surgery', 'PM2218. Characteristics of in situ ductal (DCIS) and lobular (LCIS) carcinoma of the breast', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 548\>\n<table border=\1\><colgroup><col><col><col> </colgroup>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>LCIS</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>DCIS</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Age (years)</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>44–47</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>54–58</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Incidence</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>2%–5%</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>5%–10%</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Clinical signs</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Mostly incidental finding.</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Usually asymptomatic but mass, pain, nipple discharge may also be seen.</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Mammographic signs</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>None</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Microcalcifications</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Premenopausal</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>2/3</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>1/3</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Incidence of synchronous invasive carcinoma</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>5%</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>2%–46%</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Multicentricity</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>60%–90%</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>40%–80%</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Bilaterality</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>50%–70%</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>10%–20%</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Axillary metastasis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>1%</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>1%–2%</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\3\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Subsequent carcinomas:</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li>Incidence</li>\n</ul>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>25%–35%</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>25%–70%</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li>Laterality</li>\n</ul>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Bilateral</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ipsilateral</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li>Interval to diagnosis</li>\n</ul>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>15–20 y</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>5–10 y</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li>Histologic type</li>\n</ul>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ductal</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ductal</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1789, 'Surgery', 'PM2216. Discharge from the Nipple', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>From the surface:</strong></p>\n<ul>\n<li>Paget’s disease</li>\n<li>Skin diseases (eczema, psoriasis)</li>\n<li>Rare causes (e.g., chancre)</li>\n</ul>\n<p><strong>From a single duct:</strong></p>\n<ul>\n<li><strong>Blood-stained:</strong>\n<ul>\n<li>Intraductal papilloma (M/C cause)</li>\n<li>Intraductal carcinoma</li>\n<li>Duct ectasia</li>\n</ul>\n</li>\n<li><strong>Serous (any colour):</strong>\n<ul>\n<li>Fibrocystic disease</li>\n<li>Duct ectasia</li>\n<li>Carcinoma</li>\n</ul>\n</li>\n</ul>\n<p><strong>From multiple ducts:</strong></p>\n<ul>\n<li><strong>Blood-stained:</strong>\n<ul>\n<li>Carcinoma (M/C cause)</li>\n<li>Ectasia</li>\n<li>Fibrocystic disease</li>\n</ul>\n</li>\n<li><strong>Black or green:</strong>\n<ul>\n<li>Duct ectasia</li>\n</ul>\n</li>\n<li><strong>Purulent:</strong>\n<ul>\n<li>Infection</li>\n</ul>\n</li>\n<li><strong>Serous:</strong>\n<ul>\n<li>Fibrocystic disease (M/C cause)</li>\n<li>Duct ectasia</li>\n<li>Carcinoma</li>\n</ul>\n</li>\n<li><strong>Milk:</strong>\n<ul>\n<li>Lactation</li>\n<li>Rare causes (hypothyroidism, pituitary tumour)</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1790, 'Surgery', 'PM1850. Newer drugs in chemotherapy for metastatic breast cancer', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Treatment of metastatic breast cancer by targeting PI3k/AKT/mTOR pathways has led to newer chemotherapeutic drugs, which are as follows:</p>\n<p><strong>Cyclin-dependent kinase 4/6 inhibitor</strong></p>\n<ul>\n<li><strong>Palbociclib:</strong>&nbsp;Approved for use with aromatase inhibitor (Letrozole) or SERD (Fulvestrant)</li>\n<li>Ribociclib: Approved for use with aromatase inhibitor (Letrozole)</li>\n<li>Abemaciclib: Approved for use with SERD (Fulvestrant)</li>\n</ul>\n<p><strong>mTOR pathway inhibitors</strong></p>\n<ul>\n<li><strong>Everolimus:</strong>&nbsp; Approved for treatment of advanced/metastatic hormone receptor–positive, HER-2-negative breast cancer</li>\n</ul>\n<p><strong>Phophatidyl-inositol 3 kinase (PI3k) inhibitors</strong></p>\n<ul>\n<li><strong>Buparlisib – </strong>Not approved, but trials are underway for treatment of metastatic breast carcinoma</li>\n</ul>\n<p><strong>AKT (Protein kinase B) inhibitors</strong></p>\n<ul>\n<li><strong>Ipatasertib:</strong>&nbsp;Not approved, but found beneficial for metastatic triple-negative breast cancer&nbsp;<strong>&nbsp;</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1791, 'Surgery', 'PM1849. Newer molecular tests in breast cancer', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Newer molecular tests for breast cancer have been developed, which help in predicting the advantage of adding <strong>chemotherapy</strong>.&nbsp;These are:</p>\n<ul>\n<li>Oncotype Dx (21-geneassay)</li>\n<li>Mammaprint (70-gene assay)</li>\n<li>EndoPredict (12-gene assay)</li>\n<li>PAM50 (50-gene assay)</li>\n</ul>\n<p><strong>Oncotype Dx </strong>can only be used in<strong> hormone (ER, PR) receptor-positive&nbsp;cancers, </strong>while <strong>mammaprint </strong>can be used in<strong> both </strong>hormone receptor (ER, PR) positive&nbsp;and hormone receptor-negative&nbsp;cancers.&nbsp;</p>\n<p>These tests are used for T<sub>1,2 </sub>N<sub>0</sub> M<sub>0</sub> breast cancers – (<strong>node-negative, metastasis-negative</strong>). Using these molecular tests, a <strong>recurrence score</strong> (0 – 100) is calculated.</p>\n<ul>\n<li>If the score is <strong>low</strong>, then there <strong>is no advantage</strong> of adding chemotherapy</li>\n<li>If the score is <strong>high</strong>, then chemotherapy should be <strong>added</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1792, 'Surgery', 'PM0885. Indications and contraindications for radical mastectomy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Indications:</strong></p>\n<ul>\n<li>Large, bulky tumor involving pectoralis major muscle and fascia.</li>\n<li>Axillary lymph node involvement</li>\n<li>Interpectoral lymph node involvement</li>\n</ul>\n<p><strong>Contraindications:</strong></p>\n<ul>\n<li>Non-palpable or small tumors</li>\n<li>Advanced disease with distant metastasis</li>\n<li>Patients who need improved cosmetic result</li>\n<li>Patients who need reconstructive surgery</li>\n<li>Coexisting severe systemic diseases like DM, CHF, CRF</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1793, 'Surgery', 'PM0884. Contraindications for Breast Conservative Surgery', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Absolute contraindications:</strong></p>\n<ul>\n<li>1st-trimester pregnancy</li>\n<li>Diffuse microcalcifications</li>\n<li>Persistently positive pathologic margin</li>\n<li>Multicentric tumor</li>\n</ul>\n<p><strong>Relative contraindications:</strong></p>\n<ul>\n<li>Connective tissue disorders like systemic lupus erythematosus (SLE),&nbsp; scleroderma and&nbsp;rheumatoid arthritis</li>\n<li>Large lump-to-breast ratio, i.e., a big lump in small breast</li>\n<li>Lump beneath the nipple-areola complex</li>\n<li>Multifocal&nbsp;tumor</li>\n<li>History of therapeutic radiation exposure to the chest wall</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>NOTE : Some authorities do not consider Rheumatoid Arthritis as a relative contraindication as the data on radiation toxicity in RA is sparse.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1794, 'Surgery', 'PM0880. Important surgeries for breast cancer', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Tylectomy:&nbsp;Excision of lump</li>\n<li><strong>Breast conservation surgery (BCS)/WLE (wide local excision)</strong>: Tumour removal with a 3D clearance of a 1 mm margin of normal tissue</li>\n<li><strong>Simple mastectomy:</strong>&nbsp;Palpable extent of breast +&nbsp;Nipple–areola complex + overlying skin.</li>\n<li>Extended simple mastectomy: Simple mastectomy + removal of level I axillary lymph nodes.</li>\n<li>Skin-sparing mastectomy: Mastectomy with breast envelope preservation and nipple-areola complex removal</li>\n<li>Skin+ nipple/areola-sparing mastectomy: Mastectomy with breast envelope and nipple-areola complex preservation</li>\n<li><strong>Total mastectomy:</strong>&nbsp;All breast tissue + Nipple–areola complex + skin.</li>\n<li><strong>Level I oncoplasty (volume displacement surgery):</strong> Tumour excision with wide margins followed by defect repair via dual-plane mobilisation of the breast parenchyma to maintain shape and symmetry</li>\n<li><strong>Level II oncoplasty (volume replacement surgery):</strong> Skin excision and glandular mobilisation involving &gt;20% resection of breast volume</li>\n<li><strong>Modified radical mastectomy:</strong>&nbsp; Entire breast tissue + Nipple–areola complex + skin + axillary lymph nodes (levels I + II ± III) dissection\n<ul>\n<li><strong>Patey’s:</strong> Pectoralis minor is removed</li>\n<li><strong>Scanlon’s</strong>: Pectoralis minor incised</li>\n<li><strong>Auchincloss</strong>: Pectoralis minor only retracted</li>\n</ul>\n</li>\n<li><strong>Halsted’s radical mastectomy:</strong>&nbsp;Entire breast tissue + Nipple–areola complex + skin + Levels I + II+ III Axillary lymph nodes + Pectoralis major and minor</li>\n<li>Extended radical (Urban) - Halsted’s + internal mammary lymph nodes dissection</li>\n<li>Extended radical (Dahl-Iverson) mastectomy: Halsted’s + internal mammary and supraclavicular lymph nodes dissection</li>\n<li>Super radical mastectomy: Halsted’s + internal mammary, supraclavicular and mediastinal lymph nodes dissection.</li>\n</ul>\n<p>*Dual-plane mobilisation of breast parenchyma: Mobilisation of the dermoglandular plane and plane between breast parenchyma and pectoralis muscle.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1795, 'Surgery', 'PM0877. TNM Staging of Carcinoma Breast', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Tumor (T)</strong></td>\n<td>\n<p><strong>Description</strong></p>\n</td>\n</tr>\n<tr>\n<td>Tx</td>\n<td>\n<p>Primary tumor cannot be assessed</p>\n</td>\n</tr>\n<tr>\n<td>T0</td>\n<td>\n<p>No evidence of primary tumor</p>\n</td>\n</tr>\n<tr>\n<td><strong>Tis (DCIS)</strong></td>\n<td>Ductal carcinoma in situ</td>\n</tr>\n<tr>\n<td><strong>Tis (Paget)</strong></td>\n<td>Paget disease not associated with invasive carcinoma or DCIS</td>\n</tr>\n<tr>\n<td>T1</td>\n<td>\n<p><strong>≤</strong><strong>2 cm</strong> in greatest dimension</p>\n<p><strong>1mic</strong>&nbsp;≤ 0.1 cm</p>\n<p>1a &gt;0.1 to 0.5 cm</p>\n<p>1b &gt;0.5 to 1 cm</p>\n<p>1c &gt;1 to 2 cm</p>\n</td>\n</tr>\n<tr>\n<td>T2</td>\n<td><strong>&gt;2 but ≤5 cm</strong> in greatest dimension</td>\n</tr>\n<tr>\n<td>T3</td>\n<td><strong>&gt;5 cm</strong> in greatest dimension</td>\n</tr>\n<tr>\n<td>T4</td>\n<td>\n<p>Tumor of<strong> any size&nbsp;</strong>and -</p>\n<p><strong>4a</strong> – chest wall involvement (except pectoralis major)<strong>#</strong>&nbsp;</p>\n<p><strong>4b </strong>– skin involvement in the form of ulceration, peau d’orange, satellite nodules &nbsp;</p>\n<p><strong>4c </strong>– 4a + 4b &nbsp;</p>\n<p><strong>4d</strong> – Inflammatory breast carcinoma (typical skin changes involving <span>&gt;</span>1/3rd of breast)<strong>*</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Nodes (N)</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>N1 mic</td>\n<td>Refers to micrometastasis to Lymph node</td>\n</tr>\n<tr>\n<td>N1</td>\n<td>Ipsilateral <strong>mobile</strong> axillary lymph nodes</td>\n</tr>\n<tr>\n<td>N2A</td>\n<td>Ipsilateral<strong> fixed or matted</strong> axillary lymph nodes</td>\n</tr>\n<tr>\n<td>N2B</td>\n<td>Ipsilateral internal mammary <strong>without axillary lymph node</strong> involvement</td>\n</tr>\n<tr>\n<td>N3A</td>\n<td>Ipsilateral infraclavicular lymph nodes</td>\n</tr>\n<tr>\n<td>N3B</td>\n<td>Ipsilateral internal mammary and axillary lymph nodes</td>\n</tr>\n<tr>\n<td>N3C</td>\n<td>Ipsilateral supraclavicular lymph nodes</td>\n</tr>\n<tr>\n<td><strong>Distant metastasis (M)</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>M0</td>\n<td>Metastasis absent</td>\n</tr>\n<tr>\n<td>M1</td>\n<td>Metastasis present</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stages</strong></td>\n<td><strong>T, N</strong></td>\n<td>&nbsp;<strong>M</strong></td>\n</tr>\n<tr>\n<td>Stage 0</td>\n<td>T<sub>is</sub>N<sub>0</sub></td>\n<td>M<sub>0</sub></td>\n</tr>\n<tr>\n<td>Stage IA</td>\n<td>T<sub>1</sub>N<sub>0</sub></td>\n<td>M<sub>0</sub></td>\n</tr>\n<tr>\n<td>Stage IB</td>\n<td>T<sub>0,1</sub>N<sub>1mic</sub></td>\n<td>M<sub>0</sub></td>\n</tr>\n<tr>\n<td>Stage IIA</td>\n<td>T<sub>0,1</sub>N<sub>1</sub> (or) T<sub>2</sub>N<sub>0</sub></td>\n<td>M<sub>0</sub></td>\n</tr>\n<tr>\n<td>Stage IIB</td>\n<td>T<sub>2</sub>N<sub>1</sub> (or) T<sub>3</sub>N<sub>0</sub></td>\n<td>M<sub>0</sub></td>\n</tr>\n<tr>\n<td>Stage IIIA</td>\n<td>T<sub>0,1,2,3</sub>N<sub>2 </sub>(or) T<sub>3</sub>N<sub>1</sub></td>\n<td>M<sub>0</sub></td>\n</tr>\n<tr>\n<td>Stage IIIB</td>\n<td><strong>T</strong><sub><strong>4</strong>&nbsp;</sub>N<sub>0,1,2</sub></td>\n<td>M<sub>0</sub></td>\n</tr>\n<tr>\n<td>Stage IIIC</td>\n<td>\n<p>Any T,<strong> N<sub>3</sub></strong></p>\n</td>\n<td>M<sub>0</sub></td>\n</tr>\n<tr>\n<td>Stage IV</td>\n<td>\n<p>Any T, Any N</p>\n</td>\n<td><strong>M<sub>1</sub></strong></td>\n</tr>\n</tbody>\n</table>\n<p><strong>#&nbsp;</strong>Chest wall includes Serratus anterior, Intercostal muscles, Ribs.&nbsp;Pectoralis muscle is <strong>not</strong> a part of the chest wall.</p>\n<p><strong>*&nbsp;</strong>Inflammatory breast carcinoma (stage 4d) is characterized by the skin changes of&nbsp;<strong>brawny induration, erythema</strong> with a raised edge, and edema (<strong>peaud’orange</strong>) involving <span>&gt;</span>1/3rd of the breast.</p>\n<p>Note: LCIS (lobular carcinoma in situ) is considered a benign condition and not included under Tis.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2202ec4c95df457eb86eaf658395ea5dx1280x943.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Prefixes for TNM staging:</p>\n<ul>\n<li><strong>c:</strong>&nbsp;clinical staging (e.g. cT1b)</li>\n<li><strong>p:</strong>&nbsp;pathological (histological) staging</li>\n<li><strong>y:</strong>&nbsp;stage following systemic or radiation therapy (either prior to surgery or as a primary treatment)</li>\n<li><strong>r:</strong>&nbsp;staging at the time of retreatment or recurrence for disease progression</li>\n</ul>\n<p>Suffix for TNM staging:</p>\n<ul>\n<li><strong>m:</strong>&nbsp;multiple primary tumours of the same histology in the same organ, e.g. T2(m) or T2(5), the latter meaning that there are five primary tumours</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1796, 'Surgery', 'PM0872. Relative risk of invasive breast carcinoma based on pathological examination of benign breast tissue', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>No increased risk </strong></p>\n<ul>\n<li>Adenosis, sclerosing or florid</li>\n<li>Apocrine metaplasia</li>\n<li>Cysts, macro and/or micro</li>\n<li>Duct ectasia</li>\n<li>Fibroadenoma</li>\n<li>Fibrosis</li>\n<li>Hyperplasia</li>\n<li>Mastitis (inflammation)</li>\n<li>Periductal mastitis</li>\n<li>Squamous metaplasia</li>\n</ul>\n<p><strong>Slightly increased risk (1.5–2 times)</strong></p>\n<ul>\n<li><strong>Hyperplasia</strong>, moderate or <strong>florid, solid, or papillary</strong></li>\n<li><strong>Papilloma</strong> with a fibrovascular core</li>\n</ul>\n<p><strong>Moderately increased risk (5 times)</strong></p>\n<ul>\n<li>Atypical hyperplasia (ductal or lobular)</li>\n</ul>\n<p><strong>Insufficient data to assign a risk</strong></p>\n<ul>\n<li>Solitary papilloma of lactiferous sinus</li>\n<li>Radial scar lesion</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1797, 'Surgery', 'PM0870. Breast Cancer Screening', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Breast Cancer Screening</strong></p>\n<p>Individuals are encouraged to conduct a <strong>risk assessment by 25 years of age</strong>. This helps classify them into <strong>average risk</strong> or <strong>increased risk groups</strong>.</p>\n<p>Recommendations<strong>:</strong>&nbsp;</p>\n<ol>\n<li aria-level=\1\><strong>Average-risk</strong>&nbsp;(no known genetic or family history of breast cancer)</li>\n<ul>\n<li aria-level=\1\>25-39 years of age: clinical breast examination every 1-3 years;&nbsp;</li>\n<li aria-level=\2\>≥ 40 years of age: clinical breast examination and mammogram annually</li>\n</ul>\n<li aria-level=\1\><strong>High-risk </strong>(positive family or genetic history of breast cancer)</li>\n<ul>\n<li aria-level=\2\>Consult a healthcare professional&nbsp;every <strong>6-12 months</strong> <strong>after 21 years of age</strong></li>\n<li aria-level=\2\><strong>Annual mammogram or MRI</strong> from 25 years of age or 10 years prior to the age at which the youngest family member was diagnosed with breast cancer (whichever is earliest)</li>\n</ul>\n<li aria-level=\1\><strong>Asymptomatic women</strong> with <strong>previously treated breast cancer</strong></li>\n<ul>\n<li aria-level=\2\>Consult a healthcare professional&nbsp;every <strong>6-12 months</strong></li>\n<li aria-level=\2\><strong>Annual mammogram</strong></li>\n<li aria-level=\2\>Annual MRI to be considered</li>\n</ul>\n<li aria-level=\1\>Mammogram and USG are&nbsp;<strong>not contraindicated</strong> in <strong>pregnant and breastfeeding</strong> women</li>\n</ol>\n<p><strong>High-risk patients</strong> for breast cancer:</p>\n<ol>\n<li aria-level=\1\>Women (or a first-degree relative) with a known BRCA1 or BRCA2 mutation or TP53 or PTEN genes</li>\n<li aria-level=\1\>Two first-degree relatives with breast cancers with or without gene mutations</li>\n<li aria-level=\1\>Women with a history of chest irradiation between the ages of 10 and 30</li>\n<li aria-level=\1\>Women with previously biopsy-proven breast cancer</li>\n<li aria-level=\1\>Women with ≥ 20% lifetime risk for breast cancer based on breast cancer risk models</li>\n</ol>\n<p>*According to <strong>NCCN 2022 guidelines</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1798, 'Surgery', 'PM0869. Risk Factors and Protective Factors for Breast Carcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Risk factors:</strong></p>\n<ul>\n<li>Age: Incidence increases with increasing age.</li>\n<li>Sex: more common in females.</li>\n<li>Family history of breast cancer</li>\n<li>Race, ethnicity (white women have increased risk compared to women of other races)</li>\n<li>History of radiation exposure</li>\n<li>Mammographically dense breast</li>\n<li>Genetic factors:</li>\n<li>Mutations in tumor suppressor genes:\n<ul>\n<li><em><strong>BRCA 1</strong></em></li>\n<li><em><strong>BRCA 2</strong></em></li>\n<li><em>TP53</em></li>\n<li><em>CHEK2</em></li>\n</ul>\n</li>\n<li>Hereditary syndromes:\n<ul>\n<li>Li Fraumeni syndrome</li>\n<li>Cowden’s syndrome</li>\n<li>HNPCC syndrome</li>\n<li>Peutz-Jegher’s syndrome</li>\n<li>Ataxia telangiectasia</li>\n</ul>\n</li>\n<li>Hormonal factors (hyperestrogenemia is the risk factor):\n<ul>\n<li>Early menarche</li>\n<li>Late menopause</li>\n<li>First full-term pregnancy &gt;30 years</li>\n<li>Nulliparity</li>\n<li>Obesity (postmenopausal)</li>\n</ul>\n</li>\n<li>Higher socioeconomic status, high fat diet, alcohol intake</li>\n</ul>\n<p><strong>Protective factors:</strong></p>\n<ul>\n<li>Early age at first pregnancy</li>\n<li>Multiparity</li>\n<li>Breastfeeding</li>\n<li>Oophorectomy</li>\n<li>Exercise</li>\n<li>Tamoxifen and Aromatase inhibitors</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1799, 'Surgery', 'PM0802. Relative risk of invasive breast carcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Relative risk of invasive breast carcinoma based on pathological examination of benign breast tissue (American College of Pathologists Consensus Statement):</p>\n<ul>\n<li><strong>No increased risk</strong>\n<ul>\n<li>Adenosis, sclerosing or florid</li>\n<li>Apocrine metaplasia</li>\n<li>Cysts, macro and/or micro</li>\n<li>Duct ectasia</li>\n<li>Fibroadenoma</li>\n<li>Fibrosis</li>\n<li>Hyperplasia</li>\n<li>Mastitis (inflammation)</li>\n<li>Periductal mastitis</li>\n<li>Squamous metaplasia</li>\n</ul>\n</li>\n<li><strong>Slightly increased risk (1-5 - 2times)</strong>\n<ul>\n<li>Hyperplasia, moderate or florid, solid or papillary</li>\n<li>Papilloma with a fibrovascular core</li>\n</ul>\n</li>\n<li><strong>Moderately increased risk (5 times)</strong>\n<ul>\n<li>Atypical hyperplasia (ductal or lobular)</li>\n</ul>\n</li>\n<li><strong>Insufficient data to assign a risk</strong>\n<ul>\n<li>Solitary papilloma of lactiferous sinus</li>\n<li>Radial scar lesion</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1800, 'Surgery', 'PM0796. Differentiating features of benign and malignant breast lump on USG', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\403\>\n<tbody>\n<tr>\n<td><strong>Benign lump</strong></td>\n<td><strong>Malignant lump</strong></td>\n</tr>\n<tr>\n<td>Hyper echoic</td>\n<td>Hypo echoic</td>\n</tr>\n<tr>\n<td>Oval, well circumscribed lump</td>\n<td>Lump will be taller than wider</td>\n</tr>\n<tr>\n<td>Thin echogenic pseudocapsule</td>\n<td>Ill defined echogenic halo</td>\n</tr>\n<tr>\n<td>Peripheral vascularity</td>\n<td>Central vascularity</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li>Most sensitive and most common finding of malignancy on USG – Lump will be taller than wider.</li>\n<li><strong>Most specific finding</strong> of malignancy on USG – <strong>Central vascularity</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1801, 'Surgery', 'PM0194. Breast Lump Evaluation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7c86e5c970864792a60c24c28018aec0x1280x2445.JPEG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1802, 'Surgery', 'PM2223. TNM staging of oral cavity cancer -  AJCC 8th edition', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\ width=\708\>\n<tbody>\n<tr>\n<td colspan=\2\>Primary Tumour (T)</td>\n</tr>\n<tr>\n<td>TX</td>\n<td>Cannot be assessed</td>\n</tr>\n<tr>\n<td>Tis</td>\n<td>Carcinoma in situ</td>\n</tr>\n<tr>\n<td>T1</td>\n<td>\n<p>Tumor ≤2 cm,&nbsp;<strong>depth of invasion (DOI)&nbsp;&nbsp;</strong><strong>≤5 mm</strong> (DOI is depth of invasion and not tumor thickness)</p>\n</td>\n</tr>\n<tr>\n<td>T2</td>\n<td>\n<p>Tumor ≤2 cm, DOI &gt;5 mm and ≤10 mm;</p>\n<p>or tumor &gt;2 cm but ≤4 cm, and ≤10 mm DOI</p>\n</td>\n</tr>\n<tr>\n<td>T3</td>\n<td>Tumor &gt;4 cm or any tumor &gt;10 mm DOI</td>\n</tr>\n<tr>\n<td>T4</td>\n<td>Moderately advanced or very advanced local disease</td>\n</tr>\n<tr>\n<td><strong>T4a</strong></td>\n<td>\n<p><strong>Moderately advanced local disease</strong>:</p>\n<p>Tumor&gt; 4 cms with DOI &gt;10 mm</p>\n<p>or tumor invades adjacent structures only (through cortical bone of the mandible or maxilla or involves the maxillary sinus or skin of the face.</p>\n<p>Note that superficial erosion of bone/tooth socket (alone) by a gingival primary is not sufficient to classify a tumor as T4</p>\n</td>\n</tr>\n<tr>\n<td><strong>T4b</strong></td>\n<td><strong>Very advanced local disease</strong>; tumor invades the masticator space, pterygoid plates, or skull base and/or encases the internal carotid artery</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table class=\table article-section__table\ border=\1\>\n<tbody>\n<tr>\n<td class=\right-bordered-cell left-aligned\ colspan=\2\>\n<div class=\page\ title=\Page 785\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Regional lymph nodes (N) - Clinical</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td class=\right-bordered-cell left-aligned\>NX</td>\n<td class=\left-aligned\>Cannot be assessed</td>\n</tr>\n<tr>\n<td class=\right-bordered-cell left-aligned\>N0</td>\n<td class=\left-aligned\>No regional lymph node metastasis</td>\n</tr>\n<tr>\n<td class=\right-bordered-cell left-aligned\>N1</td>\n<td class=\left-aligned\>Single ipsilateral, <span>&lt;</span>3 cm and <strong><strong>ENE (</strong></strong><strong>extranodal extension)‐</strong>negative</td>\n</tr>\n<tr>\n<td class=\right-bordered-cell left-aligned\>N2</td>\n<td class=\left-aligned\>&nbsp;Single ipsilateral lymph node larger than 3 cms but not greater than 6 cms, ENE - negative;&nbsp;Multiple ipsilateral lymph nodes, &lt;6 cm and ENE ‐negative ;&nbsp;&nbsp;Bilateral or contralateral lymph nodes, &lt;6 cm and ENE‐negative</td>\n</tr>\n<tr>\n<td class=\right-bordered-cell left-aligned\>N2a</td>\n<td class=\left-aligned\>Single ipsilateral lymph node larger than 3 cms but not greater than 6 cms, ENE - negative</td>\n</tr>\n<tr>\n<td class=\right-bordered-cell left-aligned\>N2b</td>\n<td class=\left-aligned\>Multiple ipsilateral lymph nodes, &lt;6 cm and ENE ‐negative</td>\n</tr>\n<tr>\n<td class=\right-bordered-cell left-aligned\>N2c</td>\n<td class=\left-aligned\>Bilateral or contralateral lymph nodes, &lt;6 cm and ENE‐negative</td>\n</tr>\n<tr>\n<td class=\right-bordered-cell left-aligned\>N3</td>\n<td class=\left-aligned\>\n<p>Metastasis in a lymph node larger than 6 cms and ENE -negative or metastasis in any lymph node and clinically over ENE +positive</p>\n</td>\n</tr>\n<tr>\n<td class=\right-bordered-cell left-aligned\>N3a</td>\n<td class=\left-aligned\>Metastasis in a lymph node &gt;6 cms and ENE‐negative</td>\n</tr>\n<tr>\n<td class=\right-bordered-cell left-aligned\>N3b</td>\n<td class=\left-aligned\>\n<p>Metastasis in any lymph node(s) and clinically overt ENE +positive.</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><br>Note:<br>ENE is as determined by physical examination (e.g., invasion of the skin, infiltration of musculature/dense tethering to adjacent structures, or dysfunction of a cranial nerve, the brachial plexus, the sympathetic trunk, or the phrenic nerve) and supported by radiological evidence, should be present to assign a status of ENE‐positive.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1803, 'Surgery', 'PM2183. Indications for splenectomy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 1206\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Trauma (most common)</strong></p>\n<ul>\n<li>Accidental</li>\n<li>Operative</li>\n</ul>\n<p><strong>Oncological</strong></p>\n<ul>\n<li>Part of en bloc resection</li>\n<li>Diagnostic</li>\n<li>Therapeutic</li>\n</ul>\n<p><strong>Haematological</strong></p>\n<ul>\n<li>Spherocytosis</li>\n<li>Purpura (idiopathic/immune thrombocytopenic purpura)</li>\n<li>Hypersplenism</li>\n</ul>\n<p><strong>Portal hypertension</strong></p>\n<ul>\n<li>Variceal surgery</li>\n</ul>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1804, 'Surgery', 'PM2153. TNM staging of Gallbladder Carcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>TNM staging of gallbladder carcinoma according to the AJCC guidelines, 8<sup>th</sup> edition</strong></td>\n</tr>\n<tr>\n<td colspan=\2\><strong>T: Primary tumor</strong></td>\n</tr>\n<tr>\n<td><strong>T<sub>x</sub></strong></td>\n<td>Main tumor cannot be assessed</td>\n</tr>\n<tr>\n<td><strong>T<sub>0</sub></strong></td>\n<td>No sign of a primary tumor</td>\n</tr>\n<tr>\n<td><strong>T<sub>is</sub></strong></td>\n<td>Cancer is only in the epithelium and has not grown into deeper layers of the gallbladder</td>\n</tr>\n<tr>\n<td><strong>T<sub>1</sub></strong></td>\n<td>Tumor invades the lamina propria or the muscle layer (muscularis)</td>\n</tr>\n<tr>\n<td><strong>T<sub>1a</sub></strong></td>\n<td>\n<p>Tumor invades the lamina propria</p>\n</td>\n</tr>\n<tr>\n<td><strong>T<sub>1b</sub></strong></td>\n<td>Tumor invades the muscular layer</td>\n</tr>\n<tr>\n<td><strong>T<sub>2a</sub></strong></td>\n<td>Tumor invades the <strong>muscle layer</strong> into the <strong>fibrous tissue on the side of the peritoneum</strong> (the lining of the abdominal cavity)</td>\n</tr>\n<tr>\n<td><strong>T<sub>2b</sub></strong></td>\n<td>Tumor invades&nbsp;the <strong>muscle layer</strong> into the <strong>fibrous tissue on the side of the liver</strong>&nbsp;but has not invaded the liver</td>\n</tr>\n<tr>\n<td><strong>T<sub>3</sub></strong></td>\n<td>Tumor invades the serosa and/or it has grown directly into the liver and/or one nearby structure like the stomach, duodenum, colon, pancreas, or bile ducts outside the liver.</td>\n</tr>\n<tr>\n<td><strong>T<sub>4</sub></strong></td>\n<td>Tumor invades&nbsp;the main blood vessels leading into the liver (portal vein or hepatic artery) or it has grown into 2 or more structures outside the liver</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>N: Lymph nodes involvement&nbsp;&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>N<sub>X</sub></strong></td>\n<td>Regional lymph nodes cannot be assessed&nbsp;</td>\n</tr>\n<tr>\n<td><strong>N<sub>0</sub></strong></td>\n<td>No spread to nearby lymph nodes&nbsp;</td>\n</tr>\n<tr>\n<td><strong>N<sub>1</sub></strong></td>\n<td>Spread to <span>&lt;</span> 3 nearby lymph nodes</td>\n</tr>\n<tr>\n<td><strong>N<sub>2</sub></strong></td>\n<td>Spread to <span>&gt;</span>4 nearby lymph nodes&nbsp;</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>M: Distant metastasis&nbsp;&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>M<sub>0</sub></strong></td>\n<td>No spread to distant sites</td>\n</tr>\n<tr>\n<td><strong>M<sub>1</sub></strong></td>\n<td>Tumor spread to distant sites such as the liver, peritoneum, or the lungs</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table width=\347\>\n<tbody>\n<tr>\n<td><strong>AJCC Stage</strong></td>\n<td><strong>Stage grouping</strong></td>\n</tr>\n<tr>\n<td>0</td>\n<td>TisN0M0</td>\n</tr>\n<tr>\n<td>I</td>\n<td>T1N0M0</td>\n</tr>\n<tr>\n<td>IIA</td>\n<td>T2aN0M0</td>\n</tr>\n<tr>\n<td>IIB</td>\n<td>T2bN0M0</td>\n</tr>\n<tr>\n<td>IIIA</td>\n<td>T3N0M0</td>\n</tr>\n<tr>\n<td>IIIB</td>\n<td>T1-3N1M0</td>\n</tr>\n<tr>\n<td>IVA</td>\n<td>T4N0 or N1M0</td>\n</tr>\n<tr>\n<td>IVB</td>\n<td>Any TN2M0&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1805, 'Surgery', 'PM2148. Lauren Classification System of gastric carcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\366\>\n<tbody>\n<tr>\n<td>\n<div class=\page\ title=\Page 1241\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Intestinal(type l)</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><strong>Diffuse (type ll)</strong></td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 1241\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Environmental</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Familial</td>\n</tr>\n<tr>\n<td>\n<p>Gastric atrophy, intestinal metaplasia</p>\n</td>\n<td>&nbsp;Blood type A</td>\n</tr>\n<tr>\n<td>Men &gt; women</td>\n<td>Women &gt; Men</td>\n</tr>\n<tr>\n<td>Increasing incidence with age</td>\n<td>Younger age group</td>\n</tr>\n<tr>\n<td>Gland formation</td>\n<td>Poorly differentiated, signet ring cells&nbsp;</td>\n</tr>\n<tr>\n<td>Hematogenous spread</td>\n<td>Transmural, lymphatic spread</td>\n</tr>\n<tr>\n<td>\n<p>Microsatellite instability</p>\n<p>APC gene mutations</p>\n</td>\n<td>Decreased E-cadherin</td>\n</tr>\n<tr>\n<td>p53, p16 inactivation</td>\n<td>p53, p16 inactivation</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1806, 'Surgery', 'PM1963. Indication for Cholecystectomy in Gallbladder Polyp', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>All symptomatic patients</li>\n<li>All asymptomatic patients &gt;50 years</li>\n<li>Polyp of size &gt;10 mm</li>\n<li>Evidence of polyp growth on serial ultrasonography</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1807, 'Surgery', 'PM1924. Liver tumors - commons', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Most common tumor overall: Metastatic&nbsp;tumor</li>\n<li>Most common <strong>primary benign</strong> tumor: Cavernous hemangioma</li>\n<li>Most common <strong>primary malignant</strong> tumor: Hepatocellular carcinoma</li>\n<li>Most common <strong>primary malignant</strong> liver tumor of early <strong>childhood</strong>: Hepatoblastoma</li>\n<li>Most common tumor associated with <strong>arsenic / vinyl chloride</strong>: Angiosarcoma</li>\n<li>Most common tumor associated with <strong>oral contraceptive / anabolic steroid</strong>: Hepatic adenoma</li>\n<li>Most common tumor rupture spontaneously causing <strong>hemoperitoneum</strong>: Hepatic adenoma</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1808, 'Surgery', 'PM1803. Rockall score for risk stratificatison of UGI bleed:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>NOTE:</p>\n<ul>\n<li>The total Rockall score amounts to <strong>0 to 11</strong></li>\n<li>The Rockall score has both clinical and complete scores</li>\n<li>The factors like Age, shock and coexisting illness are combined together as <strong>CLINICAL ROCKALL SCORE (Age + Shock + Coexisting illness)</strong></li>\n<li>When the endoscopic features are taken into consideration along with CLINICAL SCORE, then it is called as <strong>COMPLETE ROCKALL SCORE (Clinical score + endoscopic features)</strong></li>\n<li>A score of less than 3 carries good prognosis but total score more than 8 carries a high risk of mortality</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Factors</td>\n<td>Value</td>\n<td>Score</td>\n</tr>\n<tr>\n<td><strong>Age</strong></td>\n<td>\n<p>&lt;60 y</p>\n<p>60-79 y</p>\n<p>≥80 y</p>\n</td>\n<td>\n<p>0</p>\n<p>1</p>\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td><strong>Shock</strong></td>\n<td>\n<p>Heart rate &gt;100 beats/min</p>\n<p>Systolic blood pressure &lt;100 mm Hg&nbsp;</p>\n</td>\n<td>\n<p>1</p>\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td><strong>Coexisting Illness</strong></td>\n<td><strong>Ischemic heart disease, heart disease, congestive heart failure, other major illness</strong></td>\n<td>\n<p>2</p>\n<p>3</p>\n</td>\n</tr>\n<tr>\n<td><strong>Endoscopic diagnosis</strong></td>\n<td>\n<p>No lesions observed, Mallory-Weiss syndrome</p>\n<p>Peptic ulcer, erosive disease, esophagitis</p>\n<p>Cancer of the upper GI tract</p>\n</td>\n<td>\n<p>0</p>\n<p>1</p>\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td><strong>Endoscopic stigmata of recent haemorrhage</strong></td>\n<td>\n<p>Clean base ulcer, flat pigmented spot</p>\n<p><strong>Blood in upper GI tract, active bleeding, visible vessels, clot</strong></p>\n</td>\n<td>\n<p>0</p>\n<p>2</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1809, 'Surgery', 'PM1772. Physiological Consequences of Increased Intra-abdominal Pressure', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Decreased :</strong></p>\n<ul>\n<li>Cardiac output</li>\n<li><strong>Venous return</strong></li>\n<li><strong>Visceral blood ﬂow</strong></li>\n<li>Renal blood ﬂow</li>\n<li>Glomerular filtration</li>\n</ul>\n<p><strong>Increased :</strong></p>\n<ul>\n<li><strong>Cardiac rate</strong></li>\n<li>Pulmonary capillary wedge pressure</li>\n<li>Peak inspiratory pressure</li>\n<li><strong>Central venous pressure</strong></li>\n<li>Intrapleural pressure</li>\n<li><strong>Systemic vascular resistance</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1810, 'Surgery', 'PM1771. Criteria for evaluation of peritoneal lavage fluid', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Positive</strong></td>\n<td>&nbsp;<strong>Intermediate<br></strong></td>\n<td>&nbsp;<strong>Negative</strong></td>\n</tr>\n<tr>\n<td><strong><br> </strong>\n<ul>\n<li>&gt; <strong>100,000 red cells/μL<br> &gt; 500 white cells/μL<br> = 175 units amylase/dL</strong></li>\n<li>Bacteria on Gram-stained smear</li>\n<li><strong>Bile</strong></li>\n<li>Food particles</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Pink fluid on free aspiration</li>\n<li><strong>50,000–100,000 red</strong> cells/μL in blunt trauma</li>\n<li>100–500 white cells/μL</li>\n<li>75–175 units amylase/dL</li>\n</ul>\n</td>\n<td><strong><br> </strong>\n<ul>\n<li>Clear aspirate</li>\n<li>&lt; 100 white cells/μL</li>\n<li>&lt; 75 units amylase/dL</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1811, 'Surgery', 'PM1646. Tests for Exocrine Pancreas', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Directly measuring<strong> pancreatic secretion </strong>in response to a standardized<strong> stimulus</strong>.\n<ul>\n<li>The stimulus to secretion can be\n<ul>\n<li><strong>Physiological, </strong>e.g., ingestion of a test meal, as in the <strong>Lundh test</strong></li>\n<li><strong>Pharmacological, </strong>e.g., intravenous injection of a hormone, such <strong>as secretin or cholecystokinin&nbsp;(CCK).</strong></li>\n<li><strong>Duodenal intubation</strong> has to be performed with a triple-lumen tube so that the gastric and duodenal juices can be aspirated, and a non-absorbable marker, such as polyethylene glycol, is used to assess the completeness of the aspiration.</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p>&nbsp;</p>\n<ul>\n<li>The<strong> nitroblue tetrazolium–para-aminobenzoic acid (NBT–PABA) test </strong>provides an <strong>indirect measure</strong> of pancreatic function\n<ul>\n<li>The substance is administered orally and degraded in the gut by a pancreatic enzyme, and the breakdown product (PABA) is absorbed by the intestine and excreted in the urine; its urinary level is measured.</li>\n</ul>\n</li>\n</ul>\n<p>&nbsp;</p>\n<ul>\n<li>The <strong>pancreolauryl test</strong> works on a similar principle.\n<ul>\n<li>These tests are <strong>cheap and easy to perform</strong>, but are <strong>non-specific</strong>, especially following gastrectomy and in conditions that may alter gastrointestinal transit and intestinal absorptive capacity.</li>\n</ul>\n</li>\n</ul>\n<p>&nbsp;</p>\n<ul>\n<li><strong>Measurement of the fecal elastase 1 in the stool</strong> is simple, specific, and now widely used.\n<ul>\n<li>Interpretation:\n<ul>\n<li>Above 200 μg/g feces is normal</li>\n<li>Between 100 and 200 μg/g:&nbsp;mild to moder­ate pancreatic insufficiency</li>\n<li>Below 100 μg/g: establishes the diagnosis of severe pancreatic exocrine insufficiency</li>\n</ul>\n</li>\n<li>The <strong>fecal fat and weight estimation test </strong>measures the stool content of fat after a nutritional intake of 100 g of fat per day during 3 days. If the stool fat content exceeds 7 g/day, the diag­nosis of steatorrhea is established.</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1812, 'Surgery', 'PM1634. Glasgow scale for assessment of severity of acute pancreatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Within 48 hours</strong></p>\n<ul>\n<li>Age &gt;55 years</li>\n<li>White blood cell count &gt;15 × 10<sup>9</sup>/L</li>\n<li>Blood glucose &gt;10 mmol/L (no history of diabetes)</li>\n<li>Serum urea &gt;16 mmol/L (no response to intravenous fluids)</li>\n<li>Arterial oxygen saturation (<em>P</em>aO2) &lt;8 kPa (60 mmHg)</li>\n<li>Serum calcium &lt;2.0 mmol/L</li>\n<li>Serum albumin &lt;32 g/L</li>\n<li>LDH &gt;600 units/L</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1813, 'Surgery', 'PM1621. Differentiating features between hepatocellular carcinoma (HCC) and fibrolamellar carcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Parameter</strong></p>\n</td>\n<td>\n<p><strong>HCC</strong></p>\n</td>\n<td>\n<p><strong>Fibrolamellar carcinoma</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Male-to-female ratio</p>\n</td>\n<td>\n<p>2:1&nbsp; to&nbsp;8:1</p>\n</td>\n<td>\n<p>No gender predilection</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Median age</p>\n</td>\n<td>\n<p>55 years</p>\n</td>\n<td>\n<p>25 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tumor&nbsp;</p>\n</td>\n<td>\n<p>Invasive</p>\n</td>\n<td>\n<p>&nbsp;Well circumscribed</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Resectability</p>\n</td>\n<td>\n<p>&lt;25%</p>\n</td>\n<td>\n<p>50%–75%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cirrhosis</p>\n</td>\n<td>\n<p>90%</p>\n</td>\n<td>\n<p>5%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>AFP positive</p>\n</td>\n<td>\n<p>80%</p>\n</td>\n<td>\n<p>5%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis B positive</p>\n</td>\n<td>\n<p>65%</p>\n</td>\n<td>\n<p>5%</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>AFP: alpha-fetoprotein&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1814, 'Surgery', 'PM1614. Classification of Choledochal Cysts', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type</strong></p>\n</td>\n<td>\n<p><strong>Feature</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type I</p>\n</td>\n<td>\n<p>The most common choledochal cyst type; it involves only the extrahepatic biliary tree and is generally a fusiform dilation.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type II</p>\n</td>\n<td>\n<p>Saccular diverticulum off the common bile duct and may be mistaken for an accessory gallbladder.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type III</p>\n</td>\n<td>\n<p>A cystic dilation of the intramural common bile duct, within the wall of the duodenum, known as choledochoceles.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type IV</p>\n</td>\n<td>\n<p>Type IVa: Cysts involving the intrahepatic and extrahepatic biliary tree</p>\n<p>Type IVb: Multiple cysts limited to the extrahepatic biliary tree.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type V</p>\n</td>\n<td>\n<p>Also known as Caroli disease, involve the intrahepatic ducts only.</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cb8a9fd06ff049cf8d8471ff68af11dcx1280x6315.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1815, 'Surgery', 'PM1609. Complications following Pancreaticoduodenectomy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\239\>\n<p><strong>Complication</strong></p>\n</td>\n<td width=\239\>\n<p><strong>Frequency (%)</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Delayed gastric emptying</p>\n</td>\n<td width=\239\>\n<p>18</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Pancreas fistula</p>\n</td>\n<td width=\239\>\n<p>12</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Wound infection</p>\n</td>\n<td width=\239\>\n<p>7</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Intra-abdominal abscess</p>\n</td>\n<td width=\239\>\n<p>6</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Cardiac events</p>\n</td>\n<td width=\239\>\n<p>3</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Bile leak</p>\n</td>\n<td width=\239\>\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Overall reoperation</p>\n</td>\n<td width=\239\>\n<p>3</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1816, 'Surgery', 'PM1608. Presenting symptoms of periampullary tumors of pancreas', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\239\>\n<p><strong>Presenting symptom</strong></p>\n</td>\n<td width=\239\>\n<p><strong>Frequency (%)</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p><strong>Jaundice</strong></p>\n</td>\n<td width=\239\>\n<p><strong>75</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Weight loss</p>\n</td>\n<td width=\239\>\n<p>51</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Abdominal pain</p>\n</td>\n<td width=\239\>\n<p>39</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Nausea/vomiting</p>\n</td>\n<td width=\239\>\n<p>13</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Pruritus</p>\n</td>\n<td width=\239\>\n<p>11</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Fever</p>\n</td>\n<td width=\239\>\n<p>3</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Gastrointestinal bleeding</p>\n</td>\n<td width=\239\>\n<p>1</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1817, 'Surgery', 'PM1602. Child-Turcotte-Pugh Score', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The Child–Turcotte–Pugh (CTP) score was originally developed to <strong>evaluate the risk of portocaval shunt procedures </strong>performed for<strong> portal hypertension.</strong>&nbsp;It is also useful in predicting the surgical risks of other intra-abdominal operations performed in cirrhotic patients.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Variable</strong></p>\n</td>\n<td>\n<p><strong>1 Point</strong></p>\n</td>\n<td>\n<p><strong>2 Points</strong></p>\n</td>\n<td>\n<p><strong>3 Points</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bilirubin level</p>\n</td>\n<td>\n<p>&lt;2 mg/dL</p>\n</td>\n<td>\n<p>2–3 mg/dL</p>\n</td>\n<td>\n<p>&gt;3 mg/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albumin level</p>\n</td>\n<td>\n<p>&gt;3.5 g/dL</p>\n</td>\n<td>\n<p>2.8–3.5 g/dL</p>\n</td>\n<td>\n<p>&lt;2.8 g/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prothrombin time (increased seconds)</p>\n<p>International normalized ratio</p>\n</td>\n<td>\n<p>1–3</p>\n<p>&lt;1.7</p>\n</td>\n<td>\n<p>4–6</p>\n<p>1.7–2.3</p>\n</td>\n<td>\n<p>&gt;6</p>\n<p>&gt;2.3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Encephalopathy</p>\n</td>\n<td>\n<p>None</p>\n</td>\n<td>\n<p>Controlled</p>\n</td>\n<td>\n<p>Uncontrolled</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascites</p>\n</td>\n<td>\n<p>None</p>\n</td>\n<td>\n<p>Controlled</p>\n</td>\n<td>\n<p>Uncontrolled</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Child-Turcotte-Pugh class and overall surgical mortality rates:</strong></p>\n<ul>\n<li>Class A = 5–6 points - Well-compensated - 10% mortality</li>\n<li>Class B = 7–9 points - Decompensated and significant&nbsp; functional compromise - 30% mortality</li>\n<li>Class C = 10–15 points - Severerly decompensated - 75-80% mortality</li>\n</ul>\n<p><strong>Prognosis of the various CTP classes:</strong></p>\n<table width=\429\>\n<tbody>\n<tr>\n<td><strong>Class</strong></td>\n<td><strong>1-year survival rate &nbsp;%</strong></td>\n<td><strong>2-year survival rate %</strong></td>\n</tr>\n<tr>\n<td>A</td>\n<td>100</td>\n<td>85</td>\n</tr>\n<tr>\n<td>B</td>\n<td>80</td>\n<td>60</td>\n</tr>\n<tr>\n<td>C</td>\n<td>45</td>\n<td>35</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1818, 'Surgery', 'PM1588. Barium studies in GI tuberculosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Earliest feature </strong>is <strong>spasm </strong>and <strong>hypermotility,&nbsp;</strong>with <strong>edema of the valve.</strong></li>\n<li><strong>Thickening of the valve lips,&nbsp;</strong>with <strong>narrowing </strong>of the <strong>terminal ileum:&nbsp;</strong><strong>Fleischner </strong>or <strong>inverted</strong>&nbsp;<strong>umbrella sign </strong>is <strong>characteristic of TB</strong>.</li>\n<li>In advance disease, the characteristic deformity includes <strong>symmetric, annular, napkin-ring stenosis </strong>and obstruction or shortening and pouch formation.</li>\n<li><strong>The cecum is</strong>&nbsp;<strong>shrunken </strong>and <strong>retracts&nbsp;</strong>out of the iliac fossa due to contraction of the mesocolon: <strong>Pulled-up cecum</strong></li>\n<li><strong>Loss of ileocecal angle </strong>with <strong>dilated terminal ileum:</strong>&nbsp;<strong>Gooseneck deformity </strong></li>\n<li><strong>Narrowing of the terminal ileum </strong>due to irritability, along with shortened rigid cecum: <strong>Sterlein sign</strong></li>\n<li><strong>Persistent narrow stream </strong>of <strong>barium </strong>in the bowel indicates stenosis:&nbsp;<strong>String sign</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->'),
(1819, 'Surgery', 'PM1586. Factors Preventing Spontaneous Fistula Closure', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>High output (</strong><strong>&gt;</strong><strong>500 mL/24 hours)</strong></li>\n<li>Severe disruption of intestinal continuity (&gt;50% of bowel circumference)</li>\n<li>Active inflammatory bowel disease of bowel segment</li>\n<li>Cancer</li>\n<li>Radiation enteritis</li>\n<li><strong>Distal obstruction</strong></li>\n<li>Undrained abscess cavity</li>\n<li>Foreign body in the fistula tract</li>\n<li><strong>Fistula tract </strong><strong>&lt;2.5</strong><strong> cm long</strong></li>\n<li><strong>Epithelialization of fistula tract</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1820, 'Surgery', 'PM1585. Rule of two’s in Meckels diverticulum', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>2% prevalence</li>\n<li>2:1 male predominance</li>\n<li>Located approx 2 feet (60 cm) proximal to the ileocecal valve in adults</li>\n<li>Approx 2 inches in length</li>\n<li>Half of those who are symptomatic are under 2 years of age.</li>\n<li>2 types of heterotopic mucosa (gastric &amp; pancreatic)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1821, 'Surgery', 'PM1578. Replacement conduits after esophagectomy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Best conduit after esophagectomy – <strong>Stomach</strong></li>\n<li>Best conduit of choice after carcinoma esophagus resection – Stomach</li>\n<li>Best conduit of choice after benign disorders – Colon</li>\n<li>Best conduit of choice after short segment replacement – Jejunum</li>\n<li><strong>Gastric conduit </strong>is based on <strong>right gastric and gastroepiploic arteries</strong></li>\n<li>Left colon conduit is based on left colic artery</li>\n<li>The <strong>posterior mediastinal route</strong> is preferred for placement of conduit as it is the shortest route.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1822, 'Surgery', 'PM1576. Types of Fundoplication', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Types of fundoplication</strong></p>\n</td>\n<td>\n<p><strong>Degree of wrap</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>&nbsp;Dor</strong></p>\n</td>\n<td>\n<p>anterior 180–200° fundoplication</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thal</p>\n</td>\n<td>\n<p>270° anterior fundoplication</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lind</p>\n</td>\n<td>\n<p>300° posterior fundoplication</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Toupet</strong></p>\n</td>\n<td>\n<p>posterior 180 - 270°&nbsp;fundoplication</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Belsey Mark IV</p>\n</td>\n<td>\n<p><strong>270° anterior transthoracic</strong> fundoplication</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nissen</p>\n</td>\n<td>\n<p><strong>360°</strong> fundoplication</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Watson</p>\n</td>\n<td>\n<p>90<strong>°&nbsp;anterior </strong>fundoplication</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1823, 'Surgery', 'PM1575. Manometric classification of esophageal motility disorders', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\727\>\n<tbody>\n<tr>\n<td><strong>Types</strong></td>\n<td><strong>Definition</strong></td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Disorders of EGJ obstruction</strong></td>\n</tr>\n<tr>\n<td>Type I achalasia<br>(classic)</td>\n<td>Abnormal IRP<br>100% failed peristalsis</td>\n</tr>\n<tr>\n<td>Type II<br>(with panesophageal pressurization)</td>\n<td>Abnormal IRP<br>100% failed peristalsis<br>Panesophageal pressurization</td>\n</tr>\n<tr>\n<td>Type III<br>(spastic)</td>\n<td>Abnormal IRP<br>100% failed peristalsis<br>Spastic contractions<br>Panesophageal pressurization or normal presurization<br>DCI &gt; 450mmHg</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Disorders of peristalsis&nbsp;</strong></td>\n</tr>\n<tr>\n<td>DES (Diffuse esophageal spasm)</td>\n<td>Normal IRPN<br>Non-peristaltic (spastic) contractions or premature contractions.<br>DCI&gt;450mmHg</td>\n</tr>\n<tr>\n<td>Nutcracker’s esophagus</td>\n<td>Normal IRP<br>Increased duration of peristalsis<br>Normal peristalsis<br>DCI&gt;8000mmHg</td>\n</tr>\n</tbody>\n</table>\n<p class=\p1\><em>DCI (distal contractile integral) is an <strong>index of contractile vigor</strong>&nbsp;and is calculated as the product of amplitude, duration, and span of the distal esophageal contraction, (mmHg·s·cm).</em></p>\n<p><em>IRP (integrated relaxation pressure) corresponds to the <strong>mean pressure</strong>&nbsp;of greatest post deglutitive relaxation in a 10 seconds gap, triggered at the beginning of a swallow, (mmHg).</em></p></div><!---->\n      <!---->\n    </div><!---->'),
(1824, 'Surgery', 'PM1540. Charcot and Reynolds Triad', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Charcots triad - </strong>in <strong>acute cholangitis</strong></p>\n<ul>\n<li>Right upper quadrant pain</li>\n<li>Fever with chills</li>\n<li>Jaundice</li>\n</ul>\n<p><strong>Reynolds pentad - </strong>in<strong> acute suppurative cholangitis</strong></p>\n<ul>\n<li>Charcot’s triad + Altered mental status + Hypotension&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1825, 'Surgery', 'PM1530. Mirizzi’s syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Gallstone becomes impacted in the <strong>cystic duct or neck of the gallbladder</strong>&nbsp;producing&nbsp;<strong>CBD obstruction and jaundice.</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/e49b34e6f474441a9f74f858fa5cdb28x245x222.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<ul>\n<li><strong>ERCP, PTC, MRCP</strong> will usually demonstrate the characteristic extrinsic compression of the CBD.&nbsp;</li>\n<li>Surgery consists of <strong>removing the cystic duct, diseased gallbladder, and the impacted stone.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1826, 'Surgery', 'PM1374. Non-functioning Pancreatic Neuroendocrine Tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>These <strong>do not cause any clinical symptoms</strong>.</p>\n<p>Account for <strong>30-50%</strong> of all neuroendocrine tumors.</p>\n<p>Usually <strong>larger (&gt;5cm), solitary, mostly in head, malignant and metastatic</strong>.</p>\n<p>Diagnosis: Positive for Immunohistochemical markers such as <strong>synaptophysin, chromogranin A (CgA), and neuron-specific enolase.</strong></p>\n<p><strong>Chromogranin A – </strong>used as<strong> serum marker to monitor response to treatment and to detect recurrence.</strong></p>\n<p><strong>Treatment is mainly surgical - </strong>partial pancreaticoduodenectomy as well as the synchronous or metachronous resection of liver metastases<strong>.</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1827, 'Surgery', 'PM1373. Diagnosis of Zollinger Ellison syndrome/Gastrinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Gastric pH below 2.5 </strong>and a <strong>serum gastrin concentration above 1000 pg/mL</strong> (normal &lt;100 pg/mL) confirms the diagnosis of Zollinger Ellison syndrome.</p>\n<p><strong>BAO &gt;15 mEq/h or &gt;5 mEq/h</strong> if they have had a previous procedure for peptic ulcer.</p>\n<p>Provocative tests when diagnosis is in doubt:</p>\n<ul>\n<li><strong>Secretin stimulation test – </strong>Increase in serum gastrin &gt; 200pg/ml&nbsp;(over the pretreatment value ) following an IV bolus of secretin (2U/kg).</li>\n<li>Calcium stimulation test</li>\n<li>Secretin plus calcium stimulation test</li>\n<li>Bombesin test</li>\n<li>Protein meal test</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1828, 'Surgery', 'PM1372. Clinical features of gastrinoma (Zollinger-Ellison Syndrome)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Most common symptom: <strong>Abdominal pain</strong>.</p>\n<p><strong>Gastrin hypersecretion</strong> stimulates <strong>gastric acid secretion,</strong> leading to <strong>peptic ulcers </strong>that&nbsp;occur at atypical sites like the duodenum and jejunum and are&nbsp;<strong>refractory</strong> and <strong>multiple.</strong></p>\n<p>Diarrhea&nbsp;is due to</p>\n<ul>\n<li>Acid-induced injury to the small intestine mucosa</li>\n<li>Inability of the intestinal tract to absorb large volumes of fluids secreted by the stomach</li>\n<li>Inactivation of pancreatic lipase by low pH</li>\n<li>Precipitation of bile salts.</li>\n</ul>\n<p>The unique characteristic of <strong>acid-induced diarrhea</strong> is that it is controlled by <strong>nasogastric aspiration of gastric secretions.</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1829, 'Surgery', 'PM1368. American Association for the Surgery of Trauma (AAST) Spleen Injury Scale', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/304d125090cf41f5b2ac0b5561d350dfx1280x2558.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1830, 'Surgery', 'PM1320. Appendicular tumors and their characteristics', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\213\>\n<p><strong>Appendicular tumor</strong></p>\n</td>\n<td width=\213\>\n<p><strong>Characteristics</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Carcinoid</p>\n</td>\n<td width=\213\>\n<p>10 times more common than any other tumor of appendix</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Goblet cell carcinoid tumor</p>\n</td>\n<td width=\213\>\n<p>More aggressive</p>\n<p>Endocrine and glandular differentiation</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Primary adenocarcinoma</p>\n</td>\n<td width=\213\>\n<p>Usually of mucinous type</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Mucinous cystadenoma</p>\n</td>\n<td width=\213\>\n<p>Can present as pseudomyxoma peritonei</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1831, 'Surgery', 'PM1319. Complications of Appendicectomy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Wound infection</strong>:<strong> 5–10%</strong></li>\n<li>Intra-abdominal abscess: 8%</li>\n<li>Post operative ileus</li>\n<li>Respiratory complications</li>\n<li>Venous thrombo-embolism</li>\n<li>Portal pyemia- septicemia in portal venous system, can lead to hepatic abscess.</li>\n<li><strong>Adhesive intestinal obstruction</strong>:<strong> 1–3% (MC late post op complication)</strong></li>\n<li>Fecal fistula</li>\n<li>Port site hernias.</li>\n<li>Appendico-cutaneous fistula or appendico-vesical fistula: rare</li>\n<li>Mortality after appendicectomy is less than 1%</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1832, 'Surgery', 'PM1318. Oshner Sherren Regimen', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Principle</strong> :</p>\n<ul>\n<li>The inflammatory process is already localised and that inadvertent surgery is difficult and may be dangerous.</li>\n<li>It may be impossible to find the appendix and, occasionally, a faecal fistula may form.</li>\n<li>Antibiotic therapy should be given after performing CECT abdomen</li>\n<li>Abscess if present can be drained radiologically.</li>\n</ul>\n<p><strong>Outcome</strong> :</p>\n<ul>\n<li>Improvement in 24–48 h</li>\n<li>90% cases resolve</li>\n<li>Failure should raise suspicion of Crohn’s disease and carcinoma.&nbsp;</li>\n</ul>\n<p><strong>Criteria for stopping conservative treatment of Appendicular mass:</strong></p>\n<ul>\n<li>Rising pulse rate</li>\n<li>Increasing or spreading abdominal pain</li>\n<li>Increasing size of the mass</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1833, 'Surgery', 'PM1317. Alvarado Scoring System', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\319\>\n<p><strong>Findings</strong></p>\n</td>\n<td width=\78\>\n<p><strong>Points</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Migratory right iliac fossa pain</p>\n</td>\n<td width=\78\>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Anorexia</p>\n</td>\n<td width=\78\>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Nausea / vomiting</p>\n</td>\n<td width=\78\>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p><strong>Tenderness in right iiliac fossa</strong></p>\n</td>\n<td width=\78\>\n<p><strong>2</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Rebound tenderness right iliac fossa</p>\n</td>\n<td width=\78\>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Elevated temperature ≥ 37.3°C</p>\n</td>\n<td width=\78\>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p><strong>Leukocytosis ≥ </strong>10⨯10<sup>9</sup><strong> cells/L</strong></p>\n</td>\n<td width=\78\>\n<p><strong>2</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Shift to the left of neutrophils</p>\n</td>\n<td width=\78\>\n<p>1</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>A score of 4-5 or below&nbsp;rules out the diagnosis of acute appendicitis in children, and in adults, a score of 8-9 or higher&nbsp;rules in the diagnosis.</p>\n<p>If the score is 4-6, an&nbsp;an adjunctive CT scan would be recommended to confirm the diagnosis.</p>\n<p>If the score is 7 or higher, surgery is recommended.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1834, 'Surgery', 'PM1315. Signs in appendicitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\213\>\n<p><strong>Sign</strong></p>\n</td>\n<td width=\213\>\n<p><strong>Characteristic</strong></p>\n</td>\n<td width=\213\>\n<p><strong>Seen in</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Dunphy’s sign</p>\n</td>\n<td width=\213\>\n<p>Pain on coughing</p>\n</td>\n<td width=\213\>\n<p>Acute appendicitis</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p><strong>Rovsing sign</strong></p>\n</td>\n<td width=\213\>\n<p>&nbsp;</p>\n<p>Pain in the right lower quadrant during palpation of the left lower quadrant</p>\n</td>\n<td width=\213\>\n<p>Acute appendicitis</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Obturator sign</p>\n</td>\n<td width=\213\>\n<p>Pain on internal rotation of hip</p>\n</td>\n<td width=\213\>\n<p>Pelvic appendicitis</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Ilio-Psoas sign</p>\n</td>\n<td width=\213\>\n<p>Pain on extension of hip</p>\n</td>\n<td width=\213\>\n<p>Retrocaecal appendicitis</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Aaron sign</p>\n</td>\n<td width=\213\>\n<p>Pain or pressure in epigastrium or anterior chest with persistent firm pressure applied to McBurney’s point</p>\n</td>\n<td width=\213\>\n<p>Acute appendicitis</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Basseler sign</p>\n</td>\n<td width=\213\>\n<p>Sharp pain created by compressing appendix between abdominal wall and iliacus</p>\n</td>\n<td width=\213\>\n<p>Chronic appendicitis</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Blumberg’s sign</p>\n</td>\n<td width=\213\>\n<p>Transient abdominal wall rebound tenderness</p>\n</td>\n<td width=\213\>\n<p>Peritoneal inflammation</p>\n</td>\n</tr>\n<tr>\n<td width=\213\>\n<p>Ten Horn sign</p>\n</td>\n<td width=\213\>Pain caused by gentle traction of right testicle</td>\n<td>\n<p>Appendicitis</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1835, 'Surgery', 'PM1276. Chemotherapy for GI Tumours', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\0\>\n<tbody>\n<tr>\n<td width=\265\>\n<p><strong>GI malignancy</strong></p>\n</td>\n<td width=\408\>\n<p><strong>Chemotherapy</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\265\>\n<p>Esophageal carcinoma</p>\n</td>\n<td width=\408\>\n<p>ECF (Epirubicin + Cisplatin + 5-FU)</p>\n</td>\n</tr>\n<tr>\n<td width=\265\>\n<p>Gastric carcinoma</p>\n</td>\n<td width=\408\>\n<p>ECF (Epirubicin + Cisplatin + 5-FU)</p>\n</td>\n</tr>\n<tr>\n<td width=\265\>\n<p>Small intestine adenocarcinoma</p>\n</td>\n<td width=\408\>\n<p>5-FU</p>\n</td>\n</tr>\n<tr>\n<td width=\265\>\n<p>Colorectal carcinoma</p>\n</td>\n<td width=\408\>\n<p>FOLFOX-IV (5-FU + Leucovorin + Oxaliplatin)</p>\n</td>\n</tr>\n<tr>\n<td width=\265\>\n<p>Carcinoma of the anal canal</p>\n</td>\n<td width=\408\>\n<p>Nigro Regimen: Chemoradiation (5-FU + Mitomycin C) + Radiation</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1836, 'Surgery', 'PM1269. Parks classification of fistula–in–ano', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;Type of Fistula</strong></p>\n</td>\n<td>\n<p><strong>Arises due to&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>Begins from</strong></p>\n</td>\n<td>\n<p><strong>Track</strong></p>\n</td>\n<td>\n<p><strong>Ends in</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inter-sphincteric</strong></p>\n</td>\n<td>\n<p>Perianal abscess</p>\n</td>\n<td>\n<p>Dentate line</p>\n</td>\n<td>\n<p><strong>In inter-sphincteric space</strong></p>\n</td>\n<td>\n<p>Perianal skin or perineum</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trans- sphincteric</p>\n</td>\n<td>\n<p>Ischiorectal Fossa abscess</p>\n</td>\n<td>\n<p>Dentate line</p>\n</td>\n<td>\n<p>Crosses the internal and external sphincters&nbsp;</p>\n</td>\n<td>\n<p>Perineal skin or perineum</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Supra- sphincteric</p>\n</td>\n<td>\n<p>Supra-levator abscess</p>\n</td>\n<td>\n<p>Dentate line</p>\n</td>\n<td>\n<p>Penetrates the inter-sphincteric space, continues above puborectalis, and penetrates levator ani</p>\n</td>\n<td>\n<p>Perineal skin or perineum</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Extra- sphincteric</p>\n</td>\n<td>\n<p>Penetrating injury</p>\n<p>Crohn’s disease</p>\n<p>Carcinoma rectum</p>\n</td>\n<td>Rectum or sigmoid colon&nbsp;</td>\n<td>\n<p>Outside the external sphincter, penetrating the levator ani&nbsp;</p>\n</td>\n<td>Peri-anal skin via ischio-rectal&nbsp; fossa.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/42a24c416b354e1eb349609162b1dce0x1280x1480.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1837, 'Surgery', 'PM1267. Grading of hemorrhoids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\295\>\n<p><strong>GRADE</strong></p>\n</td>\n<td width=\295\>\n<p><strong>SYMPTOMS AND SIGNS</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\295\>\n<p>First degree</p>\n</td>\n<td width=\295\>\n<p>Bleeding; no prolapse</p>\n</td>\n</tr>\n<tr>\n<td width=\295\>\n<p>Second degree</p>\n</td>\n<td width=\295\>\n<p>Prolapse with spontaneous reduction</p>\n</td>\n</tr>\n<tr>\n<td width=\295\>\n<p>Third degree</p>\n</td>\n<td width=\295\>\n<p>Prolapse requiring manual reduction</p>\n</td>\n</tr>\n<tr>\n<td width=\295\>\n<p>Fourth degree</p>\n</td>\n<td width=\295\>\n<p>Prolapsed, cannot be reduced</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1838, 'Surgery', 'PM1266. Differences between internal and external hemorrhoids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Internal hemorrhoids</strong></td>\n<td><strong>External hemorrhoids</strong></td>\n</tr>\n<tr>\n<td>Located&nbsp;<strong>proximal</strong> to&nbsp;the dentate line</td>\n<td>\n<p>Located&nbsp;<strong>distal </strong>to the dentate line</p>\n</td>\n</tr>\n<tr>\n<td>Covered by&nbsp;<strong>transitional&nbsp;</strong>and&nbsp;<strong>columnar epithelium</strong></td>\n<td>Covered by richly innervated<strong>&nbsp;squamous epithelium</strong></td>\n</tr>\n<tr>\n<td>Caused by pressure on <strong>superior rectal veins</strong></td>\n<td>Caused by pressure on <strong>inferior rectal veins</strong></td>\n</tr>\n<tr>\n<td><strong>Painless,&nbsp;</strong>can be&nbsp;<strong>ligated</strong></td>\n<td><strong>Painful, not ligated</strong></td>\n</tr>\n<tr>\n<td><strong>Banding&nbsp;</strong>is&nbsp;<strong>preferred</strong></td>\n<td>Excision is done</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1839, 'Surgery', 'PM1264. Risk Factors for Colorectal Cancer', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The risk factors for colorectal cancer are:</p>\n<ul>\n<li><strong>Dietary: </strong>\n<ul>\n<li>High-animal-fat diet</li>\n<li>Low-fiber diet</li>\n<li>Alcohol</li>\n</ul>\n</li>\n<li><strong>Hereditary syndromes:</strong>\n<ul>\n<li>FAP</li>\n<li>HNPCC</li>\n</ul>\n</li>\n<li>Inflammatory bowel disease</li>\n<li>Cholecystectomy: increased right colon cancer due to exposure to bile acids</li>\n<li>Ureterosigmoidostomy</li>\n<li>Smoking</li>\n<li>Acromegaly</li>\n<li>Pelvic irradiation</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1840, 'Surgery', 'PM1263. Haggitt’s classification for polyps containing cancer according to the depth of invasion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Level 0:</strong> Carcinoma does not invade the muscularis mucosae (<strong>carcinoma in situ or intramucosal carcinoma</strong>)</li>\n<li><strong>Level 1</strong>: Carcinoma invades through the muscularis mucosae into the submucosa but is limited to the <strong>head</strong> of the polyp</li>\n<li><strong>Level 2</strong>: Carcinoma invades the level of the <strong>neck</strong> of the polyp (junction between the head and stalk)</li>\n<li><strong>Level 3</strong>: Carcinoma invades <strong>any part of the stalk</strong></li>\n<li><strong>Level 4</strong>: Carcinoma invades into the <strong>submucosa of the bowel wall below the stalk of the polyp but above the muscularis propria</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/81ca1351b12d443d9d4e991af0c4c62dx1280x1413.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1841, 'Surgery', 'PM1260. Peutz–Jeghers Syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Autosomal-dominant disease</li>\n<li>Germline defects in the <strong>tumor suppressor </strong>serine-threonine kinase 11 (<strong><em>STK11</em></strong>) gene on<strong> chromosome 19.</strong></li>\n</ul>\n<p><strong>Features</strong>:</p>\n<ul>\n<li><strong>Hyperpigmentation</strong> of the buccal mucosa, lips, and digits</li>\n<li><strong>Hamartomatous polyps</strong> of the intestinal tract</li>\n<li>Increased (2% to 10%) risk for <strong>cancer</strong> of the<strong> intestinal tract</strong>&nbsp;(stomach - rectum).</li>\n<li>Increased risk for <strong>extraintestinal malig­nant neoplasms</strong>, including cancer of the breast, ovary, cervix, fallopian tubes, thyroid, lung, gallbladder, bile ducts, pancreas, and testicles.</li>\n</ul>\n<p><strong>Screening</strong>:&nbsp;Baseline colonoscopy and upper endoscopy at age 20 years, followed by annual flexible sigmoidoscopy thereafter.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/eff8622ebbed495bb2c50bb2544cdb48x450x600.JPEG\><img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1160ec99452648149a62ef6cadaef74ex418x532.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Histologic image</strong> showing the characteristic arborizing network of connective tissue, smooth muscle, lamina propria, and glands lined by normal-appearing intestinal epithelium:</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e7f25b73d84249949d85119e7bd2cc28x1280x1863.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1842, 'Surgery', 'PM1259. Features of Familial Adenomatous Polyposis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Gastrointestinal manifestations</strong>:</p>\n<ul>\n<li><strong>Colon </strong>and<strong> rectum</strong>:<strong> Multiple adenomatous polyps</strong> usually <strong>&gt;100</strong></li>\n<li>Gastric and duodenal polyps are present</li>\n<li><strong>Gastric polyp: </strong>fundal gland polyp, gastric adenoma</li>\n<li><strong>Duodenal polyp</strong> usually in the<strong> ampullary </strong>region: Adenomatous and premalignant</li>\n</ul>\n<p><strong>Extraintestinal manifestations</strong></p>\n<ul>\n<li>Congenital hypertrophy of retinal pigment epithelium (<strong>CHRPE</strong>) is seen. It is detected by indirect ophthalmoscopy.</li>\n<li><strong>Epidermoid cysts</strong></li>\n<li><strong>Desmoid tumors </strong>in the abdomen</li>\n<li><strong>Osteoma </strong>in the skull, mandible, and tibia</li>\n<li><strong>Brain tumors</strong></li>\n<li>Tumors of the thyroid, adrenal, liver, pancreas, gallbladder, and bile duct</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1843, 'Surgery', 'PM1258. Characteristic features of colorectal carcinoma in Hereditary Non-polyposis Colorectal Cancer (HNPCC)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Onset of cancer at a <strong>relatively young age </strong>(mean, 44 years)</li>\n<li>Proximal distribution (70% of cancers located in the <strong>right colon)</strong></li>\n<li>Predominance of <strong>mucinous or poorly differentiated (signet cell) adenocarcinoma</strong></li>\n<li>Increased number of <strong>synchronous and metachronous cancers</strong></li>\n<li>Relatively <strong>good outcome after surgery</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1844, 'Surgery', 'PM1257. Types of Lynch syndromes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Lynch I syndrome</strong> is characterized by <strong>cancer of the proximal colon</strong> occurring at a relatively young age.</li>\n<li><strong>Lynch II syndrome</strong> is characterized by <strong>fami­lies at risk for both colorectal and extracolonic cancers</strong>, including cancers of endometrial, ovarian, gastric, small intestinal, pancre­atic, and ureteral and renal pelvic origin.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1845, 'Surgery', 'PM1256. Amsterdam Criteria II - Revised Criteria for HNPCC', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The <strong>diagnostic criteria for HNPCC</strong> are referred to as the <strong>Amsterdam criteria</strong><em>&nbsp;</em>or the <strong>3-2-1-0 rule</strong><em>.</em></p>\n<p>It includes the following:</p>\n<ul>\n<li><strong>Three or more relatives</strong> with HNPCC-associated cancer (colorectal cancer, endometrial cancer, cancer of the small bowel, ureter, or renal pelvis), <strong>one </strong>of whom is a<strong> first-degree relative of the other two</strong></li>\n<li>At least <strong>two successive generations</strong> affected</li>\n<li>At least <strong>one case </strong>diagnosed<strong> before </strong>the age of<strong> 50 years</strong></li>\n<li>Familial adenomatous polyposis excluded.</li>\n<li>Tumors verified by pathologic examination.</li>\n</ul>\n<p><strong>All of the above</strong> must be applicable for a presumptive diagnosis of HNPCC to be made in a family.</p>\n<p>&nbsp;</p>\n<p class=\p1\>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1846, 'Surgery', 'PM1254. Fearon-Vogelstein adenoma-carcinoma multistep model of colorectal neoplasia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/36a7ff35752b47cb923b911ff3c3e18bx1280x1486.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1847, 'Surgery', 'PM1253. Sites of carcinoma colon and rectum', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\319\>\n<p><strong>Site of carcinoma</strong></p>\n</td>\n<td width=\319\>\n<p><strong>Frequency</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p><strong>Rectum (most common)</strong></p>\n</td>\n<td width=\319\>\n<p><strong>38%</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p><strong>Sigmoid colon</strong></p>\n</td>\n<td width=\319\>\n<p><strong>21%</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p><strong>Caecum</strong></p>\n</td>\n<td width=\319\>\n<p><strong>12%</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Transverse colon</p>\n</td>\n<td width=\319\>\n<p>5.5%</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Ascending colon</p>\n</td>\n<td width=\319\>\n<p>5%</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Descending colon</p>\n</td>\n<td width=\319\>\n<p>4%</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Splenic flexure</p>\n</td>\n<td width=\319\>\n<p>3%</p>\n</td>\n</tr>\n<tr>\n<td width=\319\>\n<p>Hepatic flexure</p>\n</td>\n<td width=\319\>\n<p>2%</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/925f8d8fa9b34218846e9970ec217bbdx1280x1150.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1848, 'Surgery', 'PM1252. Virtual/CT Colonoscopy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>CT colonography (virtual colonoscopy)</strong></p>\n<p>It uses helical CT and three-dimensional reconstruction to detect <strong>intraluminal colonic lesions</strong>.</p>\n<p>Oral bowel preparation, oral and rectal contrast, and colon insufflation have been used to <strong>maximize sensitivity</strong>.</p>\n<p><strong>Advantages:</strong></p>\n<ul>\n<li>Noninvasive, less time consuming</li>\n<li>Sensitivity may be as good as colonoscopy</li>\n</ul>\n<p><strong>Disadvantages:</strong></p>\n<ul>\n<li>Requires bowel preparation</li>\n<li>Insensitive for small polyps</li>\n<li>Minimal experience and data</li>\n<li>Colonoscopy required for positive result</li>\n</ul>\n<p>False positive results from retained stool, diverticular disease, haustral folds, motion artifacts, and an inability to detect flat adenomas.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/65cd04b932ff460a940784e3636b0a2cx512x182.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1849, 'Surgery', 'PM1251. Dukes’ staging for colorectal cancer', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Stage A</strong> - Invasion of but <strong>not breaching the muscularis propria</strong></li>\n<li><strong>Stage B</strong> <strong>- Breaching the muscularis propria</strong> but not involving lymph nodes</li>\n<li><strong>Stage C - Lymph nodes involved</strong></li>\n</ul>\n<p>Dukes himself never described a <strong>stage D</strong>, but this is often used to describe <strong>metastatic disease</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1850, 'Surgery', 'PM1183. Cowden Disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Autosomal dominant</strong></p>\n<p>Mutation of <strong>PTEN</strong> gene on chromosome <strong>10q23.3</strong></p>\n<p>Components:</p>\n<ul>\n<li>Hamartomas of all three embryonal cell layers\n<ul>\n<li>Intestinal hamartomatous polyp – usually <strong>ectodermal</strong>, most common in <strong>colon</strong></li>\n</ul>\n</li>\n<li><strong>Facial trichilemmomas – most common feature.</strong></li>\n<li>Cancer of the\n<ul>\n<li>Breast (30–50%)</li>\n<li>Thyroid (10% - <strong>Mainly </strong><strong>FTC</strong>, rarely PTC and Hurthle cell tumors)</li>\n<li>Endometrium</li>\n</ul>\n</li>\n<li>CNS – 2<sup>nd</sup> most commonly involved system\n<ul>\n<li>Megalencephaly, ataxia, epilepsy, dysplastic gangliocytoma of cerebellum – <strong>Lhermitte Duclos syndrome.</strong></li>\n</ul>\n</li>\n<li><strong>Developmental anomalies – high arched palate</strong>, adenoid facies, prominent forehead, Hypoplastic mandible.</li>\n<li><strong>Skin disease – acral keratosis.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1851, 'Surgery', 'PM1177. Classification of colorectal polyps', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Colorectal polyps can be classified as:</p>\n<p><strong>Neoplastic </strong></p>\n<p>Adenomatous polyps:</p>\n<ul>\n<li>Tubular adenoma (Most common)</li>\n<li>Tubulovillous adenomas</li>\n<li>Villous adenoma (highest risk of malignancy)</li>\n</ul>\n<p><strong>Non-neoplastic: </strong></p>\n<ul>\n<li>Hyperplastic</li>\n<li>Hamartomatous\n<ul>\n<li>Juvenile polyp(solitary)-benign</li>\n<li>Juvenile polyposis syndromes (multiple)-premalignant</li>\n<li>Peutz-Jeghers syndrome- occasionally carcinoma may develop.</li>\n<li>Cronkite-Canada syndrome*</li>\n</ul>\n</li>\n<li>Inflammatory\n<ul>\n<li>Pseudopolyp</li>\n<li>Benign lymphoid polyp</li>\n</ul>\n</li>\n</ul>\n<p>Note:</p>\n<p>*Cronkite-Canada syndrome: Cancer occurs in the stomach, colon, and rectum, but it remains controversial whether these polyps&nbsp; possess malignant potential. As many as 15% of patients with Cronkite- Canada syndrome have a malignant tumor at the time of diagnosis</p></div><!---->\n      <!---->\n    </div><!---->'),
(1852, 'Surgery', 'PM1074. TNM staging of gastric carcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table class=\datatable xwidetable\>\n<tbody>\n<tr>\n<td colspan=\2\>\n<p><strong>Primary tumor (T)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>TX</p>\n</td>\n<td>\n<p>Primary tumor cannot be assessed</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T0</p>\n</td>\n<td>\n<p>No evidence of primary tumor</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tis</p>\n</td>\n<td>\n<p>Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T1</p>\n</td>\n<td>\n<p>Tumor invades lamina propria, muscularis mucosae, or submucosa</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T1a</p>\n</td>\n<td>\n<p>Tumor invades lamina propria or muscularis mucosae</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T1b</p>\n</td>\n<td>\n<p>Tumor invades submucosa</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T2</p>\n</td>\n<td>\n<p>Tumor invades muscularis propria</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T3</p>\n</td>\n<td>\n<p>Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T4</p>\n</td>\n<td>\n<p>Tumor invades serosa (visceral peritoneum) or adjacent structures</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T4a</p>\n</td>\n<td>\n<p>Tumor invades serosa (visceral peritoneum)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T4b</p>\n</td>\n<td>\n<p>Tumor invades adjacent structures</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<p><strong>Regional lymph nodes (N)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NX</p>\n</td>\n<td>\n<p>Regional lymph node(s) cannot be assessed</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>N0</p>\n</td>\n<td>\n<p>No regional lymph node metastasis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>N1</p>\n</td>\n<td>\n<p>Metastasis in 1-2 regional lymph nodes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>N2</p>\n</td>\n<td>\n<p>Metastasis in 3-6 regional lymph nodes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>N3</p>\n</td>\n<td>\n<p>Metastasis in seven or more regional lymph nodes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>N3a</p>\n</td>\n<td>\n<p>Metastasis in 7-15 regional lymph nodes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>N3b</p>\n</td>\n<td>\n<p>Metastasis in 16 or more regional lymph nodes</p>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<p><strong>Distant metastasis (M)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>M0</p>\n</td>\n<td>\n<p>No distant metastasis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>M1</p>\n</td>\n<td>\n<p>Distant metastasis</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1853, 'Surgery', 'PM1072. Borrmann’s classification of stomach cancer', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cdf8171797864909bcbfd5d019fc4ec6x1280x1766.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1854, 'Surgery', 'PM1070. Siewert-Stein classification of adenocarcinomas of the esophago-gastric junction', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Siewert</td>\n<td>Description</td>\n<td>Surgical approach</td>\n</tr>\n<tr>\n<td>I</td>\n<td>Tumour center located between 5 and 1 cm proximal to the anatomical cardia</td>\n<td>Approached as esophageal or EGJ cancer</td>\n</tr>\n<tr>\n<td>II</td>\n<td>Tumour center located between 1 cm proximal and 2 cm distal to the anatomical cardia</td>\n<td>Approached as esophageal or EGJ cancer</td>\n</tr>\n<tr>\n<td>III</td>\n<td>Tumour center located between 2 and 5 cm distal to the anatomical cardia</td>\n<td>Approached as gastric cancer</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/340014f8d74f4927a93edc2b769e8d7cx1279x1588.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1855, 'Surgery', 'PM1069. Most common site of gastric malignancies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Most common site of <strong>Ca. Stomach</strong> : <strong>Proximal Stomach (Western countries)</strong></p>\n<p>Most common site of <strong>Ca. Stomach in Pernicious anaemia</strong> :&nbsp;<strong>&nbsp;Fundus</strong></p>\n<p>Most common site of <strong>diffuse variety of&nbsp;Ca. Stomach</strong> :&nbsp;<strong>Fundus</strong></p>\n<p>Most common site of&nbsp;<strong>Gastric lymphoma</strong> :<strong> Antrum</strong></p>\n<p>Most common site of&nbsp;<strong>Burkitt’s lymphoma/EBV</strong> : <strong>Cardia / Body</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1856, 'Surgery', 'PM1068. Risk factors for carcinoma stomach', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Risk factors for carcinoma stomach:</strong></p>\n<ul>\n<li>Dietary\n<ul>\n<li>Low fat or protein consumption</li>\n<li>Consumption of <strong>salted meat</strong> or fish with <strong>high nitrate content</strong></li>\n<li>High complex carbohydrate consumption</li>\n<li>Smoking,&nbsp;<strong>alcohol </strong>consumption</li>\n<li>Spicy food, high salt diet</li>\n<li>Lack of fresh fruits and vegetables</li>\n<li>Dietary anti-oxidant deficiency</li>\n</ul>\n</li>\n<li><strong>Genetic and familial</strong>\n<ul>\n<li><strong>E cadherin</strong> – hereditary diffuse type of gastric cancer</li>\n<li><strong>Blood group A</strong></li>\n<li>FAP</li>\n<li>Li-Fraumeni syndrome</li>\n<li>HNPCC</li>\n<li>BRCA 2 mutation</li>\n</ul>\n</li>\n<li><strong>Premalignant lesions</strong>\n<ul>\n<li><strong>Chronic atrophic gastritis</strong></li>\n<li>Adenomatous polyp (FAP)</li>\n<li>Pernicious anemia</li>\n<li><strong>Intestinal metaplasia (H. pylori)</strong></li>\n<li><strong>Menetrier’s disease</strong></li>\n<li>Stump carcinoma from stomach remnants in Billroth II GJ or vagotomy GJ</li>\n</ul>\n</li>\n<li>Others\n<ul>\n<li>Low socioeconomic status</li>\n<li>Male gender</li>\n<li>Rubber and coal workers</li>\n<li><strong>EBV infection</strong></li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1857, 'Surgery', 'PM1067. Desmoid tumor', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Unencapsulated fibroma </strong>arising from<strong> musculoaponeurotic structures </strong>usually below the umbilicus.</li>\n<li>Females&gt;males</li>\n<li><strong>Extraabdominal (65%) </strong>&gt; abdominal (25%) &gt; intraabdominal (15%)</li>\n<li>Associated with FAP (Gardner syndrome)</li>\n<li>Infiltrates surrounding tissues but no metastasis and <strong>no sarcomatous change</strong>.</li>\n<li>Investigation of choice – <strong>MRI</strong></li>\n<li><strong>Treatment</strong>:\n<ul>\n<li>Wide local excision with negative margin</li>\n<li>More <strong>prone for recurrence</strong> – treated by surgery and radiotherapy</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1858, 'Surgery', 'PM1066. Moore’s classification of Omphalocele:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Type</td>\n<td>Diameter of defect</td>\n</tr>\n<tr>\n<td>Type I</td>\n<td>&nbsp;&lt;2.5cm</td>\n</tr>\n<tr>\n<td>Type II</td>\n<td>2.5 - 5 cm</td>\n</tr>\n<tr>\n<td>Type III</td>\n<td>&nbsp;&gt;5cm</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1859, 'Surgery', 'PM1057. Lumbar triangles and hernia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Acquired</strong>&gt;congenital</li>\n<li><strong>Left side</strong>&gt; right side</li>\n</ul>\n<p><strong>Superior lumbar triangle (Grynfelt triangle) -&nbsp;</strong>Bounded by the</p>\n<ul>\n<li>12th rib</li>\n<li>Paraspinal muscles</li>\n<li>Internal oblique muscle.</li>\n</ul>\n<p><strong>Inferior lumbar triangle (Petit triangle) -&nbsp;</strong>Bounded by the</p>\n<ul>\n<li>Iliac crest</li>\n<li>Latissimus dorsi muscle</li>\n<li>External oblique muscle.&nbsp;</li>\n</ul>\n<p>Dowd’s operation is done for lumbar hernia</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a6a8d905893446aab2c86694c553af86x1280x1211.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1860, 'Surgery', 'PM1054. Spigelian hernia/Hernia of linea semilunaris:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Occurs through the <strong>spigelian fascia</strong>, which is the aponeurosis of transversus abdominis.&nbsp;</li>\n<li>This aponeurotic layer is&nbsp; between the <strong>rectus muscle medially and semilunar line laterally</strong>.</li>\n<li>Occur <strong>at or above the arcuate line</strong>.</li>\n<li>Often <strong>interparietal</strong>, with the hernia sac dissecting <strong>pos­terior to the external oblique aponeurosis.</strong></li>\n<li>In subumbilical region and is due to defect in internal oblique.</li>\n<li><strong>Clinical feature:</strong>\n<ul>\n<li>Often present with <strong>localized pain in the area without a bulge</strong> because the hernia lies beneath the intact external oblique aponeurosis.&nbsp;</li>\n</ul>\n</li>\n<li><strong>Diagnosis: Ultrasound or CT of the abdomen.</strong></li>\n<li>Treatment – surgery</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1861, 'Surgery', 'PM1053. Variants of femoral hernia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Laugier’s femoral hernia:</strong></p>\n<ul>\n<li>Through a gap in <strong>lacunar (Gimbernat) ligament.</strong></li>\n<li>Always strangulated</li>\n</ul>\n<p><strong>Narath’s femoral hernia:</strong></p>\n<ul>\n<li>Seen in patients with <strong>congenital dislocation of hip</strong></li>\n<li>It is <strong>behind the femoral vessels</strong></li>\n</ul>\n<p><strong>Cloquet’s hernia</strong>:</p>\n<ul>\n<li>Sac lies <strong>under pectineus fascia.</strong></li>\n</ul>\n<p><strong>Hesselbach’s hernia:</strong></p>\n<ul>\n<li>Lateral to femoral artery</li>\n</ul>\n<p><strong>Serafinis hernia:</strong></p>\n<ul>\n<li>Behind the femoral vessels</li>\n</ul>\n<p><strong>Velpeau(Prevascular/Teales) hernia:</strong></p>\n<ul>\n<li>Infront of femoral vessels</li>\n</ul>\n<p><strong>Beclard’s hernia:</strong></p>\n<ul>\n<li>Through saphenous opening</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1862, 'Surgery', 'PM1052. Surgeries for femoral hernia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Lockwood’s low inguinal surgery</li>\n<li>McEvedy’s high inguinal surgery – preferred in emergency where risk of bowel infarction is high</li>\n<li>Lotheissen’s inguinal surgery</li>\n<li>Henry procedure – Mid abdominal Extraperitoneal Femoral Hernioplasty</li>\n<li>McVay – for both femoral and inguinal hernia</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1863, 'Surgery', 'PM1042. Types of indirect inguinal hernia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Bubonocele</strong> – Hernia limited to the <strong>inguinal canal.</strong></li>\n<li>Funicular – Hernia stops just above the testis.</li>\n<li>Complete/scrotal – Hernia reaches bottom of scrotum.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1cff780fee0d413389d14744a7f8ff0bx1280x1156.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1864, 'Surgery', 'PM1040. Nyhus classification of groin hernia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Type I - Indirect inguinal hernia: internal inguinal ring normal (e.g., pediatric hernia)</li>\n<li>Type II - Indirect inguinal hernia: internal inguinal ring dilated but posterior inguinal wall intact; inferior deep epigastric vessels not displaced</li>\n<li>Type III - Posterior wall defect\n<ul>\n<li>A- Direct inguinal hernia</li>\n<li>B - Indirect inguinal hernia: internal inguinal ring dilated, medially encroaching on or destroying the transversalis fascia of Hesselbach&nbsp;triangle (e.g., scrotal, sliding, or pantaloon hernia)</li>\n<li><strong>C - Femoral hernia</strong></li>\n</ul>\n</li>\n<li>Type IV - Recurrent hernia\n<ul>\n<li>A - Direct</li>\n<li>B - Indirect</li>\n<li>C - Femoral</li>\n<li>D - Combined</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1865, 'Surgery', 'PM0788. Pheochromocytoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Features:</strong></p>\n<ul>\n<li>When pheochromocytoma is associated with the MEN syndrome it is rarely malignant.</li>\n<li>Phaeochromocytomas are greyish-pink on the cut surface and are usually highly vascularised.</li>\n<li><strong>Zellbalen cells and nuclei with salt and pepper chromatin </strong>are seen.</li>\n</ul>\n<p><strong>Factors indicating more chances of malignancy:</strong></p>\n<ul>\n<li>An increased PASS (phaeochromocytoma of the adrenal gland scale score)</li>\n<li>High number of Ki-67-positive cells</li>\n<li>Vascular invasion or a breached capsule</li>\n</ul>\n<p><strong>Diagnosis:</strong></p>\n<ul>\n<li>Measurement of the plasma metanephrines is the most sensitive screening test.</li>\n<li><strong>MRI is the IOC.</strong></li>\n<li>Biopsy and CT Contrast scans are contraindicated in order to avoid a hypertensive crisis.</li>\n</ul>\n<p><strong>Treatment:</strong></p>\n<ul>\n<li><strong>Adrenalectomy i</strong>s preferred TOC.</li>\n<li>Size&lt;5 cm -&nbsp; Laparoscopic adrenalectomy</li>\n<li>Preop Alpha blockers should be given</li>\n<li>Mitotane should be started as adjuvant or palliative treatment</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1866, 'Surgery', 'PM0578. Early Dumping vs. Late Dumping', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\208\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\208\>\n<p><strong>Early dumping</strong></p>\n</td>\n<td width=\208\>\n<p><strong>Late dumping</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p><strong>Incidence</strong></p>\n</td>\n<td width=\208\>\n<p>5–10%</p>\n</td>\n<td width=\208\>\n<p>5%</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p><strong>Relation to meals</strong></p>\n</td>\n<td width=\208\>\n<p>Almost immediate</p>\n</td>\n<td width=\208\>\n<p>Second hour after meal</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p><strong>Duration of attack</strong></p>\n</td>\n<td width=\208\>\n<p>30–40 mins</p>\n</td>\n<td width=\208\>\n<p>30–40 mins</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p><strong>Relief</strong></p>\n</td>\n<td width=\208\>\n<p>Lying down</p>\n</td>\n<td width=\208\>\n<p>Food</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p><strong>Aggravated by</strong></p>\n</td>\n<td width=\208\>\n<p>More food</p>\n</td>\n<td width=\208\>\n<p>Exercise</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p><strong>Precipitating factor</strong></p>\n</td>\n<td width=\208\>\n<p>Carbohydrate-rich food</p>\n</td>\n<td width=\208\>\n<p>Carbohydrate-rich food</p>\n</td>\n</tr>\n<tr>\n<td width=\208\>\n<p><strong>Major symptoms</strong></p>\n</td>\n<td width=\208\>\n<p>Epigastric fullness, sweating, light headedness, tachycardia, colic, sometimes diarrhoea</p>\n</td>\n<td width=\208\>\n<p>Tremor, faintness, prostration</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1867, 'Anatomy,', 'PM0561. Abdominal muscles and their nerve supplies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\239\>\n<p><strong>Muscles</strong></p>\n</td>\n<td width=\239\>\n<p><strong>Nerve supply</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>External oblique and rectus abdominis</p>\n</td>\n<td width=\239\>\n<p>T7-11 intercostal nerves and subcostal nerve</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Internal oblique&nbsp;and transversus abdominis</p>\n</td>\n<td width=\239\>\n<p>T7-11 intercostal nerves, subcostal nerve and L1</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Pyramidalis</p>\n</td>\n<td width=\239\>\n<p>Subcostal nerve (the anterior division of T12)&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>Cremaster&nbsp; (efferent for cremasteric reflex)</p>\n</td>\n<td width=\239\>\n<p>Genital branch of genitofemoral nerve</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1868, 'Surgery', 'PM0312. Opacities on a Plain Abdominal Radiograph that may be Confused with Renal Calculus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Opacities on a plain abdominal radiograph that may be confused with renal calculus</strong></p>\n<ul>\n<li>Calcified Mesenteric Lymph Node</li>\n<li>Gallstones or concretion in the appendix</li>\n<li>Tablets or Foreign bodies in the Alimentary canal (e.g., cyclopenthiazide (Navidrex-K))</li>\n<li>Phleboliths - calcification in the walls of veins, especially in the veins</li>\n<li>Ossified tip of the 12th rib</li>\n<li>Calcified tuberculous lesion in the kidney</li>\n<li>Calcified adrenal gland</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1869, 'Surgery', 'PM1041. Difference between Direct and Indirect inguinal hernias:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Indirect hernia</strong></td>\n<td><strong>Direct hernia</strong></td>\n</tr>\n<tr>\n<td><strong>Age</strong></td>\n<td>Young</td>\n<td>Elderly</td>\n</tr>\n<tr>\n<td><strong>Herniation</strong></td>\n<td>Through the deep inguinal ring</td>\n<td>Through the posterior wall of the inguinal canal</td>\n</tr>\n<tr>\n<td><strong>Shape</strong></td>\n<td>Pyriform/oval</td>\n<td>Globular/round</td>\n</tr>\n<tr>\n<td><strong>Descent</strong></td>\n<td>Obliquely and downwards</td>\n<td>Directly forwards</td>\n</tr>\n<tr>\n<td><strong>Descent to scrotum</strong></td>\n<td>Complete – descends till the bottom of the scrotum</td>\n<td>Rarely complete</td>\n</tr>\n<tr>\n<td><strong>Neck</strong></td>\n<td>Narrow</td>\n<td>Wide</td>\n</tr>\n<tr>\n<td><strong>Sac</strong></td>\n<td>Lateral to the inferior epigastric artery</td>\n<td>Medial to the inferior epigastric artery</td>\n</tr>\n<tr>\n<td><strong>Zieman’s test</strong></td>\n<td>Cough impulse on the index finger</td>\n<td>Cough impulse on the middle finger</td>\n</tr>\n<tr>\n<td><strong>Invagination test</strong></td>\n<td>Tip of finger</td>\n<td>Pulp of finger</td>\n</tr>\n<tr>\n<td><strong>Ring occlusion test</strong></td>\n<td>Doesn’t bulge</td>\n<td>Bulges medial to occluding finger</td>\n</tr>\n<tr>\n<td><strong>Coverings</strong></td>\n<td>\n<p>Extraperitoneal tissue</p>\n<p>Internal spermatic fascia</p>\n<p>Cremasteric fascia</p>\n<p>External spermatic fascia</p>\n<p>Skin</p>\n</td>\n<td>\n<p>Extraperitoneal tissue</p>\n<p>Fascia transversalis</p>\n<p>Conjoint tendon</p>\n<p>External spermatic fascia</p>\n<p>Skin</p>\n</td>\n</tr>\n<tr>\n<td><strong>Obstruction/strangulation</strong></td>\n<td>Common</td>\n<td>Rare</td>\n</tr>\n<tr>\n<td><strong>Sac</strong></td>\n<td>Should be opened during surgery</td>\n<td>Not necessary</td>\n</tr>\n<tr>\n<td><strong>&nbsp;</strong></td>\n<td>Usually unilateral</td>\n<td>Usually bilateral</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1870, 'Surgery', 'PM2252. Causes of Hydronephrosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 1306\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<div class=\page\ title=\Page 1306\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Unilateral hydronephrosis</strong></p>\n</div>\n</div>\n</div>\n</div>\n<p><strong>Extramural obstruction</strong></p>\n<ul>\n<li>Tumor from adjacent structures, e.g., cervix, prostate, rectum, colon, or cecum</li>\n<li>Retrocaval ureter</li>\n<li aria-level=\1\>Aberrant renal vessels</li>\n<li aria-level=\1\>Idiopathic retroperitoneal fibrosis (Ormond’s disease)</li>\n</ul>\n<p><strong>Intramural obstruction</strong></p>\n<ul>\n<li><strong>Congenital PUJ obstruction</strong> - most common congenital cause</li>\n<li>Congenital stenosis</li>\n<li>Ureterocele</li>\n<li>Ureteric stricture - iatrogenic/ inflammatory</li>\n<li>Neoplasm of the ureter or bladder involving the ureteric orifice</li>\n</ul>\n<p><strong>Intraluminal obstruction</strong></p>\n<ul>\n<li><strong>Renal stones</strong> - most common acquired unilateral cause</li>\n<li>Sloughed papilla in papillary necrosis (especially, in patients with diabetes, analgesic abuse, or sickle cell disease)</li>\n</ul>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong><span><span>Bilateral hydronephrosis</span></span></strong></p>\n<p><strong><span><span>Congenital</span></span></strong></p>\n<ul>\n<li><span><span>Posterior urethral valves (associated with pulmonary hypoplasia)</span></span></li>\n<li><span><span>Urethral atresia</span></span></li>\n<li><span><span>PUJ obstruction</span></span></li>\n</ul>\n<p><strong>Acquired &nbsp; &nbsp;&nbsp;</strong></p>\n<ul>\n<li>Benign prostatic hypertrophy or carcinoma of the prostate</li>\n<li>Idiopathic retroperitoneal fibrosis <span><span>(Ormonds disease)</span></span></li>\n<li>Postoperative bladder neck scarring</li>\n<li>Urethral stricture</li>\n<li>Phimosis</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1871, 'Surgery', 'PM2238. American Association for the Surgery of Trauma (AAST) Kidney Injury Scale', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p class=\p1\>GRADE&nbsp;&nbsp;</p>\n</td>\n<td>INJURY</td>\n<td>DESCRIPTION</td>\n</tr>\n<tr>\n<td>I</td>\n<td>\n<p class=\p1\>Contusion</p>\n</td>\n<td>\n<p class=\p1\>Microscopic or gross hematuria, urologic studies normal</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Hematoma</td>\n<td>\n<p class=\p1\>Subcapsular, nonexpanding, without parenchymal laceration</p>\n</td>\n</tr>\n<tr>\n<td>II</td>\n<td>\n<p class=\p1\>Hematoma</p>\n</td>\n<td>\n<p class=\p1\>Nonexpanding perirenal hematoma confined to renal retroperitoneum</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Laceration</td>\n<td>\n<p class=\p1\>&nbsp;&lt;1 cm parenchymal depth of renal cortex without urinary extravasation</p>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td>\n<p class=\p1\>Laceration&nbsp;</p>\n</td>\n<td>\n<p class=\p1\>&gt;1 cm depth of renal cortex, without collecting system rupture or urinary extravasation</p>\n</td>\n</tr>\n<tr>\n<td>IV</td>\n<td>Laceration</td>\n<td>\n<p class=\p1\>Parenchymal laceration extending through the renal cortex, medulla, and collecting system</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Vascular</td>\n<td>\n<p class=\p1\>Main renal artery or vein injury, with contained hemorrhage</p>\n</td>\n</tr>\n<tr>\n<td>V</td>\n<td>Laceration</td>\n<td>Completely shattered kidney</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Laceration&nbsp;&nbsp;</td>\n<td>Avulsion of renal hilum, which devascularizes kidney</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7b401ef41a614376a0bf729998a717a5x1280x2560.JPEG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1872, 'Surgery', 'PM2149. TNM staging of testicular tumour: American Joint Committee on Cancer (AJCC) and Union Internationale Contre le Cancer (UICC)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 1175\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Primary tumor (T)</strong></p>\n<p>The extent of the primary tumor is usually classified after radical orchiectomy (except for pTis and pT4) and, for this reason, a pathologic (p) stage is assigned.</p>\n<p>pTx - Primary tumor cannot be assessed</p>\n<p>pT0 - No evidence of primary tumor (e.g., a histologic scar in testis)</p>\n<p>pTis -&nbsp; Germ-cell neoplasia in situ</p>\n<p>pT1 - Tumor limited to the testis and epididymis <strong>without</strong> <strong>vascular/lymphatic invasion</strong>; tumor may invade into tunica albuginea but <strong>not&nbsp;</strong><strong>tunica vaginalis</strong></p>\n<p>pT2 - Tumor limited to testis and epididymis <strong>with vascular/lymphatic invasion</strong> or tumor extending through the tunica albuginea, with the&nbsp;<strong>involvement of tunica vaginalis</strong></p>\n<p>pT3 - Tumor <strong>invades spermatic cord</strong> with or without vascular/lymphatic invasion</p>\n<p>pT4 - Tumor <strong>invades the scrotum</strong> with or without vascular/lymphatic invasion</p>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 1175\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Regional lymph nodes (N)</strong></p>\n<p>NX - Regional lymph nodes cannot be assessed</p>\n<p>N0 - No regional lymph node metastasis</p>\n<p>N1 - Metastasis with lymph node mass <strong>≤2 cm</strong> in greatest dimension; or multiple lymph nodes, none more than 2 cm in greatest dimension</p>\n<p>N2 - Metastasis with lymph node mass,&nbsp;<strong>2–5 cm</strong> in greatest dimension; or multiple lymph nodes, anyone mass &gt;2 cm but not more than 5 cm in greatest dimension</p>\n<p>N3 - Metastasis with lymph node mass <strong>&gt;5 cm</strong> in greatest dimension</p>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 1176\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Distant metastasis (M)</strong></p>\n<p>MX - Distant metastasis cannot be assessed</p>\n<p>M0 - No distant metastasis</p>\n<p>M1 - Distant metastasis</p>\n<p>M1a - Nonregional nodal or pulmonary metastasis</p>\n<p>M1b - Distant metastasis at site other than nonregional lymph nodes or lung</p>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 1176\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Serum tumor markers (S)</strong></p>\n<p>SX - Marker studies unavailable or not performed</p>\n<p>S0 - Marker study levels within normal limits</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>S1</td>\n<td>S2</td>\n<td>S3</td>\n</tr>\n<tr>\n<td>LDH</td>\n<td>&lt;1.5 × N</td>\n<td>1.5–10 × N</td>\n<td>&nbsp;&gt;10×N</td>\n</tr>\n<tr>\n<td>hCG(MIU/mL)</td>\n<td>&lt;5000</td>\n<td>5000–50,000</td>\n<td>&nbsp;&gt;50,000&nbsp;</td>\n</tr>\n<tr>\n<td>AFP(ng/mL)</td>\n<td>&lt;1000</td>\n<td>1000–10,000</td>\n<td>&nbsp;&gt;10,000</td>\n</tr>\n</tbody>\n</table>\n<div class=\page\ title=\Page 1176\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>N indicates the upper limit of normal for the LDH assay</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1873, 'Surgery', 'PM2119. Most common testicular tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\508\>\n<tbody>\n<tr>\n<td>Pre-pubertal age group</td>\n<td>Yolk sac tumor</td>\n</tr>\n<tr>\n<td>15–34 years</td>\n<td>Germ-cell tumors</td>\n</tr>\n<tr>\n<td>Adults</td>\n<td>Seminomatous and non-seminomatous</td>\n</tr>\n<tr>\n<td>Elderly age group</td>\n<td>Lymphoma</td>\n</tr>\n<tr>\n<td>Germ-cell testicular tumor</td>\n<td>Seminoma</td>\n</tr>\n<tr>\n<td>Bilateral testicular tumor</td>\n<td>Lymphoma</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1874, 'Surgery', 'PM2081. Histologic subtypes of renal cell carcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 1866\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>&nbsp;Clear-cell type:</strong></p>\n<ul>\n<li><strong>Most common type</strong></li>\n<li aria-level=\1\>Originates from proximal convoluted tubules</li>\n<li aria-level=\1\>Caused by deletion of chromosomes 3p &amp; 6p&nbsp;</li>\n<li aria-level=\1\>Associated with von Hippel-Lindau (VHL) disease and tuberous sclerosis</li>\n</ul>\n<p><strong>Papillary type:</strong></p>\n<ul>\n<li aria-level=\1\>Originates from proximal/distal convoluted tubules</li>\n<li aria-level=\1\>Caused by c-met mutation</li>\n<li aria-level=\1\>Histology shows <strong>Psammoma bodies</strong></li>\n<li aria-level=\1\>Associated with hereditary papillary renal cell carcinoma</li>\n<li aria-level=\1\>Micropapillary variant is associated with long term dialysis</li>\n</ul>\n<p><strong>Chromophobe type:</strong></p>\n<ul>\n<li aria-level=\1\><strong>Best prognosis</strong></li>\n<li aria-level=\1\>Originates from intercalated cells of collecting duct</li>\n<li aria-level=\1\>Caused by <strong>loss of multiple chromosomes</strong> (1, 2, 6, 10, 13) and extreme hypodiploidy</li>\n<li aria-level=\1\>Associated with <strong>Birt-Hogg- Dubé syndrome</strong></li>\n<li aria-level=\1\>Histology shows plant-like cells/ resin like nucleus</li>\n<li aria-level=\1\>Cytokeratin positive on IHC&nbsp;</li>\n</ul>\n<p><strong>Collecting (Bellini duct) type:</strong></p>\n<ul>\n<li><strong>Worst prognosis</strong></li>\n<li aria-level=\1\>Originates from collecting tubules</li>\n<li aria-level=\1\>Caused by deletion of 1q &amp; monosomy of multiple chromosomes</li>\n</ul>\n<p><strong>Medullary type:</strong></p>\n<ul>\n<li aria-level=\1\>Poor prognosis</li>\n<li aria-level=\1\>Originates from distal nephron</li>\n<li aria-level=\1\>Associated with <strong>sickle cell anemia</strong></li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n<p>Note:<strong>&nbsp;</strong>Sarcomatoid change can occur infrequently in all types of renal cell carcinoma (RCC) and is an ominous feature.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1875, 'Surgery', 'PM1220. Surgical shunts for ischaemic priapism', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\379\>\n<tbody>\n<tr>\n<td><strong>Shunt site</strong>&nbsp;</td>\n<td><strong>Example&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Corpora&nbsp;glanular&nbsp;shunt&nbsp;</td>\n<td>Winter / Al-Ghorab&nbsp;shunt&nbsp;</td>\n</tr>\n<tr>\n<td>Corpora&nbsp;spongiosal&nbsp;shunt&nbsp;</td>\n<td>Quackel&nbsp;/ Sacher shunt&nbsp;</td>\n</tr>\n<tr>\n<td>Corpora Saphenous shunt&nbsp;</td>\n<td>Grayhack&nbsp;shunt&nbsp;</td>\n</tr>\n<tr>\n<td>Corpora dorsal vein shunt&nbsp;</td>\n<td>Barry shunt&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1876, 'Surgery', 'PM0310. Management of renal and ureteric calculi', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4cfbb28a9c864211aae21deaebd2fc99x1280x2912.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>ESWL: Extracorporeal Shock Wave Lithotripsy</p>\n<p>PCNL:&nbsp;Percutaneous nephrolithotomy</p>\n<p>URS: Ureteroscopic retrieval of stones</p></div><!---->\n      <!---->\n    </div><!---->'),
(1877, 'Surgery', 'PM0309. Radiolucent Renal Stones', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Radiolucent Renal Stones</strong></p>\n<p>Mnemonic: <strong>X UTI</strong></p>\n<ul>\n<li><strong>X</strong>anthine</li>\n<li><strong>U</strong>ric Acid (most common)</li>\n</ul>\n<p>Drug induced renal stones</p>\n<ul>\n<li><strong>T</strong>riamterene</li>\n<li><strong>I</strong>ndinavir</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1878, 'Surgery', 'PM2499. ATLS Primary Survey', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The steps in the ATLS (Advanced Trauma Life Support) include:</p>\n<ul>\n<li><strong>Primary</strong>&nbsp;survey with simultaneous resuscitation – identify and treat what is killing the patient</li>\n<li><strong>Secondary</strong>&nbsp;survey – proceed to identify all other injuries</li>\n<li><strong>Definitive care&nbsp;</strong>– develop a definitive management plan</li>\n</ul>\n<p><strong>Primary Survey: ABCDEs</strong>&nbsp;of trauma care:</p>\n<ul>\n<li><strong>A</strong>irway assessment and protection (maintain <strong>cervical spine stabilization</strong> when appropriate) - If airway obstruction is identified, jaw thrust in cervical injury patients or chin lift is performed.</li>\n<li><strong>B</strong>reathing and ventilation assessment - maintain adequate <strong>oxygenation,&nbsp;</strong>consider non-invasive or invasive ventilation when indicated</li>\n<li><strong>C</strong>irculation assessment (<strong>control hemorrhage, </strong>maintain circulating volume and adequate end-organ perfusion)<strong> -&nbsp;</strong><strong>Two wide-bore (14G to 16G) cannulae</strong> are inserted for intravenous fluid resuscitation.</li>\n<li><strong>D</strong>isability assessment - perform a&nbsp;<strong>basic neurologic evaluation&nbsp;</strong>(AVPU/GCS-P), blood glucose levels</li>\n<li><strong>E</strong>xposure with environmental control - undress the patient and examine thoroughly for possible injuries, prevent hypothermia</li>\n</ul>\n<p><strong>Adjuncts</strong>&nbsp;to the primary survey:</p>\n<ul>\n<li><strong>Blood</strong> collection - CBC, urea and electrolytes, clotting screen, glucose, toxicology, cross-match</li>\n<li>ECG, pulse oximetry, ventilatory rate, capnography, ABG analysis</li>\n<li>Urinary and gastric catheters</li>\n<li>Radiographs of the chest and pelvis are done as a part of the primary survey preferably with a portable x-ray unit. When required, all these x-rays must also be done on pregnant women.</li>\n<li>(e)FAST</li>\n</ul>\n<p>Other more&nbsp;<strong>specialized</strong>&nbsp;forms of&nbsp;<strong>imaging,</strong>&nbsp;such as ultrasound, computerized tomography, angiography, and diagnostic peritoneal lavage, should be considered after the&nbsp;<strong>secondary survey</strong>&nbsp;and only when the patient is&nbsp;<strong>stable after initial resuscitation.</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1879, 'Surgery', 'PM2504. Two-level deep vein thrombosis (DVT) Wells score', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\508\>\n<tbody>\n<tr>\n<td><strong>Clinical features</strong></td>\n<td><strong>Points</strong></td>\n</tr>\n<tr>\n<td>Active cancer (treatment ongoing within 6 months or palliative)</td>\n<td>1</td>\n</tr>\n<tr>\n<td>paralysis, paresis, or recent plaster immobilization of the lower extremities&nbsp;</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Recently bed ridden for 3 days or more or major surgery within 12 weeks requiring general or regional anaesthesia&nbsp;</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Localised tenderness along the distribution of deep venous system</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Entire leg swollen</td>\n<td>1</td>\n</tr>\n<tr>\n<td>calf swelling atleast 3 cm larger than asymptomatic side&nbsp;</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Pitting edema confined to the symptomatic leg</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Collateral superficial veins (Non varicose)</td>\n<td>1</td>\n</tr>\n<tr>\n<td>Previously documented DVT</td>\n<td>1</td>\n</tr>\n<tr>\n<td>An alternative diagnosis is atleast as likely as DVT</td>\n<td>-2</td>\n</tr>\n<tr>\n<td><strong>Clinical probability simplified score</strong></td>\n<td><strong>Points</strong></td>\n</tr>\n<tr>\n<td>DVT Likely</td>\n<td>2 points or more</td>\n</tr>\n<tr>\n<td>DVT Unlikely&nbsp;</td>\n<td>1 points or less&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1880, 'Surgery', 'PM1968. Pancreas - Most Commons', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>M/C cause of <strong>acute</strong> pancreatitis: Gallstones</p>\n<p>M/C cause of <strong>chronic </strong>pancreatitis: Alcohol</p>\n<p>M/C cause of <strong>chronic</strong> pancreatitis <strong>in children</strong>: Cystic fibrosis</p>\n<p>M/C cause of <strong>pancreatic calcification</strong>: Alcohol</p>\n<p>M/C <strong>congenital</strong> variant: Pancreas divisum</p>\n<p>M/C site of <strong>thrombosis</strong> in <strong>chronic</strong> pancreatitis: Splenic vein&nbsp;</p>\n<p>M/C site of <strong>pseudoaneurysm</strong> in <strong>chronic</strong> pancreatitis: Splenic artery&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1881, 'Surgery', 'PM1649. Surgical procedures for chronic pancreatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Duval procedure:</strong> Distal pancreatectomy with Roux-en-Y pancreaticojejunostomy</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6db05009daf44dd486f989ee8dd8c275x1280x1971.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Puestow procedure: </strong>Resection of tail followed by longitudinal pancreaticojejunostomy</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c3679bb15aee4f2985f0f23302681a84x1280x1966.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Partington and Rochelle modification of Puestow procedure: </strong>Elimination of resection of the pancreatic tail</p>\n<p>A <strong>longitudinal pancreatotomy</strong>&nbsp;shows&nbsp;<strong>segmental stenosis</strong> of the pancreatic duct and the presence of intraductal calculi in a patient with chronic<strong> calcific </strong>pancreatitis<strong>.&nbsp;</strong>Following mobilization of a Roux limb of the jejunum, a <strong>longitudinal pancreaticojejunostomy</strong> is performed to permit extensive drainage of the pancreatic duct system.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ff11f76c414b445cb95de206adeab5e1x1280x2335.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1882, 'Surgery', 'PM1647. Resection and Hybrid Surgical Procedures for Chronic Pancreatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Beger’s procedure: Duodenum-preserving pancreatic head resection (DPPHR)</strong></p>\n<ul>\n<li>The completed resection after <strong>transection of the pancreatic neck and subtotal removal of the pancreatic head,</strong> with <strong>preservation of the distal common bile duct and duodenum (Marked A).</strong></li>\n<li>Completion of the reconstruction of the anastomosis to the distal pancreas and to the proximal pancreatic rim by the same Roux limb of the jejunum.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/15f8041170e141ac85eacb95bdf7511ax356x333.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c37ecdf4dc964e78aebbc6c7fcbdae4bx373x307.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Frey’s procedure:</strong></p>\n<ul>\n<li>The <strong>local resection of the pancreatic head</strong> with <strong>longitudinal pancreaticojejunostomy (LR-LPJ)</strong> provides complete decompression of the entire pancreatic ductal system. Reconstruction is performed with a <strong>side-to-side Roux-en-Y pancreaticojejunostomy.</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/bbf335e03bfb4f64b431288b5a21f580x819x674.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Warren’s modification of Beger’s procedure:</strong></p>\n<p><strong>Berne modification (Beger + Frey)&nbsp;</strong>involves excavation of the central portion of the head without formal division of the neck.</p>\n<p>(image below)</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/8530a422baf14d83a64364457f218197x422x497.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Hamburg modification of Frey’s procedure</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/7ebc00f0c14949269afefb8493648225x479x418.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Note:</strong></p>\n<p>Surgical treatments for chronic pancreatitis</p>\n<div class=\page\ title=\Page 1207\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Resection</p>\n<ul>\n<li>Pancreaticoduodenectomy (Kausch–Whipple procedure)</li>\n<li>Pylorus-preserving pancreaticoduodenectomy (Traverso–Longmire)</li>\n<li>Beger procedure</li>\n<li>Near-total or total pancreatectomy</li>\n</ul>\n</div>\n<div class=\column\>\n<p>Decompression/Drainage</p>\n<ul>\n<li>Duval procedure</li>\n<li>Puestow–Gillesby procedure</li>\n<li>Partington–Rochelle procedure (Puestow)</li>\n<li>Izbicki procedure</li>\n</ul>\n</div>\n<div class=\column\>\n<p>Hybrid (resection+decompression)</p>\n<ul>\n<li>Frey procedure</li>\n<li>Hamburg modification</li>\n<li>Berne modification</li>\n</ul>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1883, 'Surgery', 'PM1645. Chronic pancreatitis and pancreatic exocrine insufficiency: TIGAR-O classification system', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Toxic-metabolic</strong></p>\n<ul>\n<li>Alcoholic</li>\n<li>Tobacco smoking</li>\n<li>Hypercalcemia</li>\n<li>Hyperlipidemia</li>\n<li>Chronic renal failure</li>\n<li>Medications—phenacetin abuse</li>\n<li>Toxins—organotin compounds (e.g., dibutyltin dichloride, DBTC)</li>\n</ul>\n<p><strong>Idiopathic</strong></p>\n<ul>\n<li>Early onset</li>\n<li>Late onset</li>\n<li>Tropical</li>\n</ul>\n<p><strong>Genetic</strong></p>\n<ul>\n<li>Cationic trypsinogen (<em><strong>PRSS1</strong></em>)</li>\n<li>Cystic fibrosis transmembrane conductance regulator gene (<em><strong>CFTR</strong></em>)</li>\n<li>Calcium-sensing receptor (<em><strong>CASR</strong></em>)</li>\n<li>Chymotrypsin C gene (<em><strong>CTRC</strong></em>)</li>\n<li>Pancreatic secretory trypsin inhibitor gene (<em><strong>SPINK1</strong></em>)</li>\n</ul>\n<p><strong>Autoimmune</strong></p>\n<ul>\n<li>Type 1 autoimmune chronic pancreatitis</li>\n<li>IgG4 systemic</li>\n<li>Type 2 autoimmune chronic pancreatitis</li>\n</ul>\n<p><strong>Recurrent and severe acute pancreatitis</strong></p>\n<ul>\n<li>Postnecrotic (severe acute pancreatitis)</li>\n<li>Recurrent acute pancreatitis</li>\n<li>Vascular diseases/ischemia</li>\n<li>Radiation-induced</li>\n</ul>\n<p><strong>Obstructive</strong></p>\n<ul>\n<li>Pancreas divisum</li>\n<li>Duct obstruction (e.g., tumor)</li>\n<li>Periampullary duodenal wall cysts</li>\n<li>Posttraumatic pancreatic duct scars</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1884, 'Surgery', 'PM1644. Rosemont’s criteria for the diagnosis of chronic pancreatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Parenchymal features</td>\n<td>Ductal features</td>\n</tr>\n<tr>\n<td>Major criteria</td>\n<td><strong>Major A criteria:</strong>\n<ul>\n<li aria-level=\1\>Hyperechoic foci with post-acoustic shadowing</li>\n</ul>\n<strong>Major B criteria:</strong>\n<ul>\n<li aria-level=\1\>Honeycombing lobularity</li>\n</ul>\n</td>\n<td><strong>Major A criteria:</strong>\n<ul>\n<li aria-level=\1\>Main pancreatic duct calculi</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Minor criteria</td>\n<td>\n<ul>\n<li>Hyperechoic, non-shadowing foci ≥3 mm in length and width</li>\n<li>Lobularity including three or more noncontiguous lobules in the body or tail</li>\n<li>Pancreatic cysts ≥2 mm in short axis</li>\n<li>At least three strands*</li>\n</ul>\n<p><sup>&nbsp;&nbsp; *</sup>Strands are defined as hyperechoic lines ≥3 mm in length seen in at least two different directions in the body or tail of the pancreas.</p>\n</td>\n<td>\n<ul>\n<li>Irregular main pancreatic duct (MPD) contour</li>\n<li>Dilated side branches<sup>+</sup></li>\n<li>Main pancreatic duct dilation (≥3.5 mm in the body or ≥1.5 mm in the tail)</li>\n<li>Hyperechoic MPD margin &gt;50% of the main pancreatic duct in the body and tail.</li>\n</ul>\n<br>&nbsp;<sup>+</sup>≥3 tubular anechoic structures, each one ≥1 mm in width, budding from MPD</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td colspan=\2\>Diagnosis of Chronic Pancreatitis:<br>\n<ul>\n<li aria-level=\1\>Consistent with chronic pancreatitis</li>\n<ul>\n<li aria-level=\2\>1 major A criterion + ≥3 minor criteria</li>\n<li aria-level=\2\>1 major A criterion + major B criterion</li>\n<li aria-level=\2\>2 major A criteria</li>\n</ul>\n</ul>\n<ul>\n<li aria-level=\1\>Suggestive of chronic pancreatitis (requires imaging for confirmation)</li>\n<ul>\n<li aria-level=\2\>1 major A criterion + &lt;3 minor criteria</li>\n<li aria-level=\2\>1 major B criterion + ≥3 minor criteria</li>\n<li aria-level=\2\>≥5 minor criteria</li>\n</ul>\n</ul>\n<ul>\n<li aria-level=\1\>Indeterminate for chronic pancreatitis (requires imaging for confirmation)</li>\n<ul>\n<li aria-level=\2\>3-4 minor criteria in the absence of major criteria</li>\n<li aria-level=\2\>Major B criterion + &lt;3 minor criteria</li>\n</ul>\n</ul>\n<ul>\n<li aria-level=\1\>&nbsp;Normal</li>\n<ul>\n<li aria-level=\2\>&lt;3 minor criteria</li>\n</ul>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1885, 'Surgery', 'PM1641. Clinical Features of Chronic Pancreatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Abdominal pain</strong>: <strong>most common symptom</strong></p>\n<ul>\n<li>Site:\n<ul>\n<li>If infectious foci are in the <strong>head of the pancreas</strong>, then <strong>epigastric and right subcostal pain</strong> is common;</li>\n<li>If the infection is limited to the <strong>left side of the pancreas, left subcostal and back pain</strong> are seen.</li>\n</ul>\n</li>\n<li>Precipitated by food intake, thus <strong>weight loss </strong>is also seen.</li>\n<li>Associated with nausea, vomiting</li>\n</ul>\n<p>Exocrine insufficiency:</p>\n<ul>\n<li><strong>Precedes endocrine insufficiency</strong></li>\n<li>Correlates with morphological changes</li>\n<li>Manifests with <strong>malabsorption symptoms</strong>: steatorrhea, diarrhea.</li>\n<li>Manifests with signs and symptoms of <strong>fat-soluble vitamin deficiency, </strong>such as <strong>bleeding, osteopenia, and osteoporosis: </strong>Severe cases</li>\n</ul>\n<p>Endocrine insufficiency: Diabetes mellitus</p></div><!---->\n      <!---->\n    </div><!---->'),
(1886, 'Surgery', 'PM1640. Pancreatic necrosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Presence of nonviable pancreatic paren­chyma or peripancreatic fat</li>\n<li>20% of patients with AP</li>\n<li>Suspected in patients with prolonged fever, elevated white blood cell count, or progres­sive clinical deterioration</li>\n<li><strong>CECT – investigation of choice</strong>\n<ul>\n<li>Low attenuation areas and presence of <strong>air in parenchyma</strong> (diagnostic feature)</li>\n</ul>\n</li>\n<li>Most common complication is the <strong>infection</strong> (proportional to the amount of necrosis) – usually by <strong>translocation of gut bacteria</strong> and subsequent <strong>multi-organ failure.</strong></li>\n<li>Treatment:\n<ul>\n<li><strong>IV antibiotics – carbapenems</strong> are the first option of treatment because of good penetration into the pancreas and spec­trum coverage. Alternative therapy includes quinolones, metronidazole, third-generation cephalosporins, and piperacillin.</li>\n<li>Definitive treatment of infected pancreatic necrosis is surgical <strong>debridement with necrosectomy, closed con­tinuous irrigation, or open packaging.</strong></li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1887, 'Surgery', 'PM1639. Vascular complications of pancreatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Arterial pseudoaneurysm:</strong></p>\n<ul>\n<li>It is caused by damage to the vessel wall by <strong>pancreatic elastase</strong></li>\n<li>The most common vessel affected is <strong>the splenic artery</strong>, but the superior mesenteric artery (SMA), cystic artery, and&nbsp;gastroduodenal artery (GDA) may also be affected</li>\n<li><strong>Spontaneous rupture</strong> results in <strong>massive bleeding</strong></li>\n<li>Clinical manifestations include sudden onset of abdominal pain, tachycardia, and hypotension.</li>\n<li><strong>CT angiography</strong> is the investigation of choice</li>\n<li>Treatment\n<ul>\n<li>Arterial embolization</li>\n<li>Ligation of the affected vessel in refrac­tory cases</li>\n</ul>\n</li>\n</ul>\n<p><strong>Vascular thrombosis:</strong></p>\n<ul>\n<li>The vessel usually affected is the <strong>splenic vein</strong>, but in severe cases, it can extend into the portal venous system</li>\n<li>Clinical features include splenomegaly, gastric varices, and splenic vein occlusion</li>\n<li>Treatment:\n<ul>\n<li>Mostly conservative</li>\n<li>Throm­bolytics in the acute early phase</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1888, 'Surgery', 'PM1636. SOFA and qSOFA Scores', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Sepsis</strong>&nbsp;is defined as a state of&nbsp;<strong>life-threatening organ dysfunction</strong>&nbsp;that occurs&nbsp;<strong>due to</strong>&nbsp;an unregulated host&nbsp;<strong>immune response to an infection</strong>. To objectively define the beginning of organ dysfunction, <strong>sequential organ failure assessment (SOFA) scoring</strong> is used. The variables in the SOFA score include:</p>\n<ul>\n<li class=\p3\><span class=\s3\><strong>Circulation</strong>&nbsp;- Systolic BP &amp; need for vasopressors and platelet count</span></li>\n<li class=\p3\><span class=\s3\><strong>Respiration</strong>&nbsp;- PaO2/FiO2 &amp; need for mechanical ventilation</span></li>\n<li class=\p3\><span class=\s3\><strong>Mentation</strong>&nbsp;-&nbsp;<strong>Glasgow coma score </strong>(GCS)</span></li>\n<li class=\p3\><span class=\s3\><strong>Hepatic function</strong>&nbsp;-<strong>&nbsp;Bilirubin</strong></span></li>\n<li class=\p3\><span class=\s3\><strong>Renal function</strong>&nbsp;-&nbsp;<strong>Creatinine</strong></span></li>\n</ul>\n<table border=\1\>\n<tbody>\n<tr>\n<td colspan=\6\>Sequential Organ Failure Assessment (SOFA) score</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>0</td>\n<td>1</td>\n<td>2</td>\n<td>3</td>\n<td>4</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cardiovascular</strong></p>\n<p>Hypotension</p>\n</td>\n<td>No hypotension</td>\n<td>\n<p>MAP &lt;70 mmHg</p>\n</td>\n<td>\n<p>Dopamine <span>&lt;</span>5 or <span>epi/norepi ≤0.1¤&nbsp;</span></p>\n</td>\n<td>Dopamine &gt;5 or epi/norepi ≤0.1¤</td>\n<td>Dopamine &gt;15 or epi/norepi &gt;0.1¤&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Coagulation</strong></p>\n<p>Platelets (×10<sup>3</sup> per&nbsp;μL)</p>\n</td>\n<td>&gt;150</td>\n<td>≤150</td>\n<td>≤100</td>\n<td>≤50</td>\n<td>&nbsp;≤20</td>\n</tr>\n<tr>\n<td>\n<p><strong>Respiration</strong></p>\n<p>(PaO<sub>2/</sub>FIO<sub>2</sub>) (mm Hg)</p>\n</td>\n<td>&gt;400</td>\n<td>≤400</td>\n<td>≤300</td>\n<td>≤200 with respiratory support</td>\n<td>≤100 with respiratory support</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mentation</strong></p>\n<p>GCS</p>\n</td>\n<td>15</td>\n<td>13–14</td>\n<td>10–12</td>\n<td>6–9</td>\n<td>&lt;6</td>\n</tr>\n<tr>\n<td>\n<p><strong>Liver</strong></p>\n<p>Bilirubin(μmol/L)</p>\n</td>\n<td>&lt;20</td>\n<td>20–32</td>\n<td>33–101</td>\n<td>102–204</td>\n<td>&gt;204</td>\n</tr>\n<tr>\n<td>\n<p><strong>Kidney</strong></p>\n<p>Creatinine (μmol/L) or urine output</p>\n</td>\n<td>&lt;110</td>\n<td>110–170</td>\n<td>171–299</td>\n<td>300–440 or &lt;500 mL/day</td>\n<td>&nbsp;&gt;440 or &lt;200 mL/day</td>\n</tr>\n<tr>\n<td colspan=\6\>\n<p><strong>MAP =&nbsp;</strong>mean arterial pressure. <strong>Epi</strong> = epinephrine. <strong>Nonrepi</strong> = norepinephrine.&nbsp;<strong>¤ = </strong>Adrenergic agents administered for at least 1 h (doses in&nbsp;μg/kg per min).</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p class=\p1\>&nbsp;</p>\n<p class=\p1\><strong><span class=\s1\>Organ dysfunction</span></strong><span class=\s2\>&nbsp;is identified by a&nbsp;</span><strong><span class=\s1\>SOFA score of&nbsp;≥ 2</span></strong></p>\n<p class=\p1\><span class=\s2\>A<strong>&nbsp;simplified</strong> version, recommended by the Sepsis 3 taskforce, is known as the </span><span class=\s1\><strong>quick sepsis-related organ dysfunction assessment \qSOFA\ score</strong>.&nbsp;</span><span class=\s2\>It includes:</span></p>\n<ul>\n<li class=\p3\><span class=\s3\>Systolic BP ≤100 mmHg</span></li>\n<li class=\p3\><span class=\s3\>Respiratory rate ≥ 22/min</span></li>\n<li class=\p3\><span class=\s3\>Altered mentation/sensorium</span></li>\n</ul>\n<p class=\p2\><span class=\s3\>Each criterion carries 1 point. A&nbsp;</span><strong><span class=\s4\>qSOFA score of ≥ 2</span></strong><span class=\s3\>&nbsp;is associated with&nbsp;</span><span class=\s4\><strong>increased mortality</strong>&nbsp;due to sepsis</span><span class=\s3\>.</span></p>\n<p class=\p1\><strong><span class=\s1\>SOFA vs qSOFA:</span></strong></p>\n<ul>\n<li class=\p3\><strong><span class=\s4\>SOFA</span></strong><span class=\s3\>&nbsp;is a more&nbsp;<strong>comprehensive</strong>&nbsp;and&nbsp;<strong>accurate</strong>&nbsp;scoring system that is&nbsp;</span><span class=\s4\>particularly superior to&nbsp;qSOFA in the&nbsp;<strong>ICU setting.</strong></span></li>\n<li class=\p3\><strong><span class=\s4\>qSOFA</span></strong><span class=\s3\>&nbsp;is a&nbsp;<strong>simplified</strong>&nbsp;derivative of SOFA for&nbsp;<strong>bedside</strong>&nbsp;assessment that is&nbsp;</span><span class=\s4\>particularly useful&nbsp;<strong>outside the ICU setting</strong></span><span class=\s3\>&nbsp;(i.e. ward/emergency department).</span></li>\n</ul>\n<p class=\p2\><span class=\s3\>Thereby, the best description of&nbsp;<strong>sepsis</strong>&nbsp;would be :</span></p>\n<ul>\n<li class=\p3\><span class=\s3\>Suspected or documented infection with&nbsp;<strong>SOFA score ≥ 2</strong><br>OR</span></li>\n<li class=\p3\><span class=\s3\>Suspected or documented infection with&nbsp;<strong>qSOFA score ≥ 2</strong></span></li>\n</ul>\n<p><span class=\s3\>However, note that these scores were originally designed as a&nbsp;<strong>predictive tool</strong>&nbsp;that calculates the&nbsp;<strong>risk of death from sepsis</strong>&nbsp;rather than a diagnostic tool.</span></p></div><!---->\n      <!---->\n    </div><!---->'),
(1889, 'Surgery', 'PM1635. Computed Tomography Severity Index (CTSI)/Balthazar Scoring for Acute Pancreatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\3\><strong>Balthazar Score</strong></td>\n</tr>\n<tr>\n<td><strong>Balthazar Grade</strong></td>\n<td><strong>Appearance on CT</strong></td>\n<td><strong>CT Grade Points</strong></td>\n</tr>\n<tr>\n<td>Grade A</td>\n<td>Normal CT</td>\n<td>0 Points</td>\n</tr>\n<tr>\n<td>Grade B</td>\n<td>Focal or diffuse enlargement of the pancreas</td>\n<td>1 Point</td>\n</tr>\n<tr>\n<td>Grade C</td>\n<td>Pancreatic gland abnormalities and peripancreatic inflammation&nbsp;</td>\n<td>2 Points</td>\n</tr>\n<tr>\n<td>Grade D&nbsp;</td>\n<td>Fluid collection in a single location</td>\n<td>3 Points</td>\n</tr>\n<tr>\n<td>Grade E</td>\n<td>Two or more sites of fluid collection and/ or gas bubbles in, or adjacent to, the pancreas</td>\n<td>4 Points</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Necrosis Score</strong>&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Necrosis Percentage</td>\n<td>CT grade points</td>\n</tr>\n<tr>\n<td>No necrosis</td>\n<td>0 points</td>\n</tr>\n<tr>\n<td>0 to 30% necrosis</td>\n<td>2 points</td>\n</tr>\n<tr>\n<td>30 to 50% necrosis</td>\n<td>4 points</td>\n</tr>\n<tr>\n<td>Over 50% necrosis</td>\n<td>6 points</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<p>The numerical Computed Tomography Severity Index (CTSI) has a <strong>maximum of 10&nbsp;points</strong>, and<strong>&nbsp;</strong>it is the <strong>sum</strong> of the Balthazar grade points and pancreatic necrosis grade points.&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>CTSI score 0-3: Mild pancreatitis</p>\n<p>CTSI score 4-6: Moderate pancreatitis</p>\n<p>CTSI score 7-10: Severe pancreatitis</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1890, 'Surgery', 'PM1632. Assessment of severity of acute pancreatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Bedside Index for Severity of Acute Pancreatitis (BISAP) </strong>includes:\n<ul>\n<li>Blood urea nitrogen, &gt; 25 mg/dL</li>\n<li>Impaired mental status, Glasgow Coma Scale (GCS) score &lt;15</li>\n<li>Systemic inflammatory response syndrome (SIRS)</li>\n<li>Age &gt; 60 years</li>\n<li>Pleural effusion<br>One point is given for each.&nbsp;BISAP score&nbsp;≥ 3 indicates severe pancreatitis.</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Harmless Acute Pancreatitis Score (HAPS)</strong><br>If all the following are present then it is considered non-severe, i.e., no death, no need for dialysis, and no need for ventilation:\n<ul>\n<li>Absence of rebound tenderness or guarding</li>\n<li>Normal hematocrit</li>\n<li>Normal serum creatinine<br><br></li>\n</ul>\n</li>\n<li><strong>Acute Physiology and Chronic Health Evaluation (APACHE II</strong><strong>) </strong>\n<ul>\n<li>A score of 8 or more is considered to be severe</li>\n<li>Can be done at admission and repeated any time</li>\n<li>Complex, not specific for AP, and based on the patient’s age</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Ranson’s score</strong></li>\n<li><strong>Modified Glasgow criteria -&nbsp;</strong>3 or more positive criteria, the disease is considered to be&nbsp;<strong>severe</strong></li>\n<li><strong>Atlanta classification</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1891, 'Surgery', 'PM1627. Laboratory Findings in Acute Pancreatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Elevated serum amylase and serum lipase</strong>\n<ul>\n<li>Serum amylase level rises immediately and peaks in few hours and returns to normal in 3–5 days</li>\n<li>Serum amylase level&nbsp;<strong>lacks specificity</strong></li>\n<li>Serum amylase levels do not correlate with the severity of pancreatitis.</li>\n<li><strong>Serum lipase </strong>is<strong> more specific,</strong> and it is more useful when the&nbsp;patient presents <strong>24–48 hours later</strong></li>\n</ul>\n</li>\n<li>Hyperglycemia</li>\n<li><strong>Hypocalcemia</strong>, hypoalbuminemia</li>\n<li>Leukocytosis</li>\n<li>Elevated serum levels of hepatic enzymes like alanine aminotransferase (ALT)</li>\n<li>Azotemia, due to prerenal acute renal failure in case of severe fluid loss</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1892, 'Surgery', 'PM1626. Clinical Features of Acute Pancreatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Symptoms:</strong></p>\n<ul>\n<li>Acute onset of <strong>epigastric pain</strong>, which is <strong>severe, constant, and refractory</strong> to usual doses of analgesics.</li>\n<li>Typically <strong>radiates to back</strong></li>\n<li><strong>Relieved in the sitting forward position</strong></li>\n<li>Nausea, repeated vomiting, retching, and hiccups</li>\n</ul>\n<p><strong>Signs:</strong></p>\n<ul>\n<li>Hypotension, tachycardia, and tachypnea</li>\n<li><strong>Grey Turner sign (A):</strong> Bluish discoloration of the&nbsp;<strong>flanks</strong></li>\n<li><strong>Cullen’s sign (B):</strong> Bluish discoloration around the&nbsp;<strong>umbilicus</strong></li>\n<li><strong>Fox sign:</strong> Discolouration <strong>below the inguinal ligament</strong></li>\n<li><strong>Pleural effusion (left &gt; right): Dullness on percussion, decreased breath sounds</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/78928c54b3b64e26b96c46fe256cdb41x720x378.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1cf4b407b97446da85893885a52395bfx561x364.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1893, 'Surgery', 'PM1625. Causes of Acute Pancreatitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Common causes</strong></p>\n<ul>\n<li><strong>Gallstones - most common</strong></li>\n<li><strong>Alcohol</strong></li>\n<li><strong>Post-ERCP </strong>(Endoscopic retrograde cholangiopancreatography)</li>\n<li>Blunt trauma, abdomen</li>\n<li>Post-operative (cardiothoracic, upper gastrointestinal, biliary)</li>\n<li>Hypertriglyceridemia</li>\n<li>Sphincter of Oddi dysfunction</li>\n</ul>\n<p><strong>Uncommon causes</strong></p>\n<ul>\n<li><strong>Hyperparathyroidism</strong></li>\n<li><strong>Hypercalcemia</strong></li>\n<li><strong>Deficiency of apolipoprotein CII</strong></li>\n<li>Pancreas divisum</li>\n<li>Periampullary diverticulum</li>\n<li>Vasculitis</li>\n<li>Thrombotic thrombocytopenic purpura (TTP)</li>\n<li>Connective tissue disorders</li>\n<li>Ischemic–hypoperfusion states</li>\n<li>Hereditary pancreatitis</li>\n<li>Cystic fibrosis</li>\n<li>Renal failure</li>\n</ul>\n<p><strong>Drugs</strong></p>\n<ul>\n<li>L-Asparaginase</li>\n<li>Steroids</li>\n<li>Sulfonamides</li>\n<li>Tetracycline</li>\n<li>Valproate</li>\n<li>Azathioprine</li>\n<li>Anti-retroviral drugs</li>\n<li>Estrogens</li>\n<li>Thiazide diuretics</li>\n</ul>\n<p><strong>Rare causes</strong></p>\n<ul>\n<li><strong>Autoimmune</strong></li>\n<li>Infections (mumps, coxsackie B, cytomegalovirus, parasite)</li>\n<li>Malnutrition</li>\n<li>Scorpion bite</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1894, 'Surgery', 'PM1606. Serous cystadenoma of the pancreas', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Benign</strong> with no chances of malignancy.</p>\n<p>Commonly in <strong>females</strong>&nbsp;(female to male ratio - 2:1), older age group</p>\n<p>The site of occurrence of&nbsp;Serous cystadenoma is <strong>uniformly distributed</strong> across the pancreas.</p>\n<p>Gross and microscopic appearance:</p>\n<ul>\n<li>Microcysts giving a <strong>honey-comb appearance</strong></li>\n<li>Glycogen-rich cells</li>\n</ul>\n<p>Computed tomography (CT) findings: <strong>Central calcification</strong>, with radiating septa giving the <strong>sunburst appearance.</strong></p>\n<p>Fluid analysis: mucin negative, low serum levels of carcinoembryonic antigen (CEA) and amylase.</p>\n<p>Treatment: Mainly conservative</p>\n<p>Resection: If symptomatic or if malignancy is suspected</p></div><!---->\n      <!---->\n    </div><!---->'),
(1895, 'Surgery', 'PM1605. Cystic Neoplasm of the Pancreas', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Characteristics</strong></td>\n<td><strong>Serous Cystadenoma</strong></td>\n<td><strong>Mucinous Cystadenoma</strong></td>\n</tr>\n<tr>\n<td>Nature</td>\n<td>Benign</td>\n<td>Benign, but high risk of malignancy</td>\n</tr>\n<tr>\n<td>Epidemiology</td>\n<td>Common in females (F:M = 2:1) and older age&nbsp;<br>Associated with von Hippel Lindau syndrome&nbsp;</td>\n<td>Most common cystic neoplasm of the pancreas&nbsp;<br>Common in perimenopausal females</td>\n</tr>\n<tr>\n<td>Usual site</td>\n<td>\n<p>Usually tail of the pancreas, can be uniformly distributed</p>\n</td>\n<td>Body and tail of the pancreas</td>\n</tr>\n<tr>\n<td>Microscopy</td>\n<td>Microcysts giving a honey-comb appearance Glycogen-rich cells</td>\n<td>Mucin-producing epithelium<br>Ovarian-like stroma<br>Stains positive for estrogen and progesterone</td>\n</tr>\n<tr>\n<td>CT</td>\n<td>Central calcification, with radiating septa giving sunburst appearance.</td>\n<td>\n<p>Solitary cyst with fine septations, surrounded by a rim of calcification.</p>\n<p>Eggshell calcification, large tumor size, or a mural nodule are suggestive of malignancy</p>\n</td>\n</tr>\n<tr>\n<td>Cyst fluid analysis</td>\n<td>\n<p>Mucin negative</p>\n<p>Low CEA and amylase</p>\n</td>\n<td>\n<p>Mucin-rich aspirate</p>\n<p>High CEA and low amylase</p>\n</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>\n<p>Mainly conservative</p>\n<p>Resection: If symptomatic or if malignancy is suspected</p>\n</td>\n<td>Resection (because of risk of malignancy)</td>\n</tr>\n<tr>\n<td>Prognosis</td>\n<td>\n<p>Good</p>\n</td>\n<td>Poor</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1896, 'Surgery', 'PM1375. Clinical features of glucaganoma: 4Ds', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Diabetes – </strong>usually mild and not associated with ketoacidosis</li>\n<li><strong>Dermatitis – </strong>Necrolytic erythema migrans</li>\n<li><strong>Deep vein thrombosis</strong></li>\n<li><strong>Depression</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1897, 'Surgery', 'PM1370. Whipples Triad', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Whipple’s triad </strong>describes the clinical symptoms<strong> of insulinoma.</strong></p>\n<ul>\n<li>Symptoms of<strong> hypoglycemia after fasting or exercise</strong></li>\n<li>Plasma glucose levels<strong> &lt;2.8 mmol/L or 50 mg/dL.</strong></li>\n<li><strong>Relief</strong> of symptoms after&nbsp;<strong>intravenous administration of glucose</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1898, 'Surgery', 'PM1745. Neurological Impairment Examination', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The Medical Research Council (MRC) grading of muscle power</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Grading </strong></td>\n<td><strong>Description </strong></td>\n</tr>\n<tr>\n<td>0</td>\n<td>No movement</td>\n</tr>\n<tr>\n<td>1</td>\n<td>Flicker of movements</td>\n</tr>\n<tr>\n<td>2</td>\n<td>Active movement with gravity elimination</td>\n</tr>\n<tr>\n<td>3</td>\n<td>Active movement against gravity</td>\n</tr>\n<tr>\n<td>4</td>\n<td>Active movement against resistance but power less than full</td>\n</tr>\n<tr>\n<td>5</td>\n<td>Normal power</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The ASIA (American Spinal Injury Association) neurological impairment scale:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Impairment scale </strong></td>\n<td><strong>Description </strong></td>\n</tr>\n<tr>\n<td>A</td>\n<td>Complete impairment</td>\n</tr>\n<tr>\n<td>B</td>\n<td>Sensation present, motor absent</td>\n</tr>\n<tr>\n<td>C</td>\n<td>Sensation present, motor present, but not useful (MRC grade less than 3/5)</td>\n</tr>\n<tr>\n<td>D</td>\n<td>Sensation present, motor useful (MRC grade more than equal to 3/5)</td>\n</tr>\n<tr>\n<td>E</td>\n<td>Normal functions</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1899, 'Surgery', 'PM1304. Psammoma Bodies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Psammoma bodies are visible in the following:</p>\n<ul>\n<li>Meningioma</li>\n<li>Serous cystadenocarcinoma Ovary</li>\n<li>Papillary carcinoma thyroid.</li>\n<li>Papillary type of renal cell carcinoma</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1900, 'Surgery', 'PM0343. Glasgow Coma Scale (GCS)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\ng-scope\>\n<p><strong>GCS Score</strong></p>\n<ul>\n<li class=\ng-binding ng-scope\>13-15 represent mild injury</li>\n<li>9-12 represent moderate injury</li>\n<li>Scores ≤8 represent severe injury </li>\n</ul>\n</div>\n<div class=\ng-scope\>\n<p><strong>Head Injury Severity: Clinical classification</strong>&nbsp;</p>\n</div>\n<table border=\1\ width=\253\>\n<tbody>\n<tr>\n<td>\n<p><strong>Eyes Opening</strong></p>\n</td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Spontaneously</td>\n<td>4</td>\n</tr>\n<tr>\n<td>To verbal command</td>\n<td>3</td>\n</tr>\n<tr>\n<td>To painful stimulus</td>\n<td>2</td>\n</tr>\n<tr>\n<td>Do not open</td>\n<td>1</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 163\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Non-testable</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>NT</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table border=\1\ width=\250\>\n<tbody>\n<tr>\n<td><strong>Verbal response</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Normal-oriented conversation</td>\n<td>5</td>\n</tr>\n<tr>\n<td>Confused</td>\n<td>4</td>\n</tr>\n<tr>\n<td>Inappropriate words only</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Sounds only</td>\n<td>2</td>\n</tr>\n<tr>\n<td>No sounds</td>\n<td>1</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 163\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Non-testable</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>NT</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table border=\1\ width=\242\>\n<tbody>\n<tr>\n<td><strong>Motor Response</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Obeys commands</td>\n<td>6</td>\n</tr>\n<tr>\n<td>Localizes to pain</td>\n<td>5</td>\n</tr>\n<tr>\n<td>Withdrawal/flexion</td>\n<td>4</td>\n</tr>\n<tr>\n<td>Abnormal flexion/Decorticate posturing&nbsp;</td>\n<td>3</td>\n</tr>\n<tr>\n<td>Extension/Decerebrate posturing&nbsp;</td>\n<td>2</td>\n</tr>\n<tr>\n<td>No motor response</td>\n<td>1</td>\n</tr>\n<tr>\n<td>\n<div class=\page\ title=\Page 163\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Non-testable</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>NT</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Minimum value: </strong>3</p>\n<p><strong>Maximum value:</strong> 15</p>\n<ul>\n<li>GCS, in particular, the <strong>motor score</strong>, is the <strong>best predictor of neurological outcome.</strong></li>\n<li>If an area cannot be assessed, no numerical score is given for that region, and it is considered “non-testable.\ (NT)</li>\n<li>In case of <strong>endotracheal intubation or tracheostomy</strong>, the verbal component of the score is <strong>denoted as NT</strong>.</li>\n<li>A score of&nbsp; ‘1’ is not recorded in missing components, instead, NT is used</li>\n<li>when a component is Not Testable, a total score is not recorded because the score will be low and this could be confusing to medical colleagues. This may also imply that the patient is more unwell than they actually are.</li>\n</ul>\n<p>&nbsp;</p>\n<div class=\page\ title=\Page 163\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>NOTE:&nbsp;</strong></p>\n<p>A new parameter, \pupil reactivity score\ has been added to GCS, and now, it is referred to as GCS-P.</p>\n</div>\n</div>\n</div>\n<p>P stands for \Pupils unreactive to light\</p>\n<table border=\1\ width=\160\>\n<tbody>\n<tr>\n<td><strong>Pupils unreactive to light</strong></td>\n<td><strong>Score</strong></td>\n</tr>\n<tr>\n<td>Both pupils</td>\n<td>2</td>\n</tr>\n<tr>\n<td>One pupil</td>\n<td>1&nbsp;</td>\n</tr>\n<tr>\n<td>Neither</td>\n<td>&nbsp;0</td>\n</tr>\n</tbody>\n</table>\n<p><strong>The pupillary score is subtracted</strong> from the GCS score to give the final value. Therefore, the range of GCS-P is 1–15.</p>\n<p><strong>Note:</strong> The minimum frequency of observations for patients with GCS equal to 15 should be as follows, starting after the initial assessment in the emergency department:</p>\n<ul>\n<li class=\p-rich_text_section\>Half-hourly for 2 hours,</li>\n<li class=\p-rich_text_section\>Then 1-hourly for 4 hours,</li>\n<li class=\p-rich_text_section\>2-hourly thereafter.</li>\n</ul>\n<p>Should the patient with GCS equal to 15 deteriorate at any time after the initial 2-hour period, observations should revert to half-hourly and follow the original frequency schedule.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1901, 'Surgery', 'PM1809. Thyroid Malignancy - Most Commons', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Most common<strong> primary</strong> thyroid malignancy – Papillary carcinoma</li>\n<li>Most common thyroid malignancy associated with<strong> radiation</strong> - Papillary carcinoma</li>\n<li>Most common malignancy of thyroid associated with<strong> lymphatic spread</strong> – Papillary carcinoma</li>\n<li>Most common thyroid malignancy associated with <strong>blood and bone metastasis</strong> – Follicular carcinoma</li>\n<li>Most common thyroid malignancy in <strong>iodine sufficient areas</strong> – Papillary carcinoma</li>\n<li>Most common thyroid malignancy in <strong>iodine deficient areas</strong> – Follicular carcinoma</li>\n<li>Most common thyroid malignancy associated with <strong>Multi Nodular Goiter</strong>&nbsp;- Follicular carcinoma</li>\n<li>Thyroid malignancy associated with<strong> amyloid</strong> - Medullary carcinoma</li>\n<li>Thyroid malignancy associated with <strong>MEN 2 syndrome</strong> - Medullary carcinoma</li>\n<li>Most aggressive thyroid malignancy with <strong>worst prognosis</strong> - Anaplastic carcinoma</li>\n<li>Thyroid malignancy with <strong>best prognosis</strong> - Papillary carcinoma</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1902, 'Surgery', 'PM1748. AJCC 8th edition Changes in the TNM staging of Thyroid neoplasms:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Differentiated Thyroid Cancer:</strong></p>\n<ul>\n<li>The <strong>age</strong> <strong>cutoff</strong> used for staging is increased from 45 to <strong>55 years</strong> of age at diagnosis.&nbsp;</li>\n<li><strong>Minor extrathyroidal extension</strong> detected only on histological examination is <strong>removed from the definition of T3</strong> disease and therefore has no impact on either T category or overall stage.</li>\n<li>N1 disease no longer upstages a patient to stage III. If<strong> &lt; 55 years</strong> of age at diagnosis, <strong>N1 disease is stage I</strong>. If <strong>≥ 55 years</strong> of age, <strong>N1 disease is stage II.</strong></li>\n<li><strong>T3a</strong> is a new category for tumors <strong>&gt; 4 cm confined to the thyroid gland</strong></li>\n<li><strong>T3b</strong> is a new category for tumors of any size demonstrating<strong> gross extrathyroidal extension into strap muscles</strong> (sternohyoid, sternothyroid, thyrohyoid or omohyoid muscles)</li>\n<li><strong>Level VII</strong> lymph nodes, previously classified as lateral neck lymph nodes (N1b) is re-classified as central neck lymph nodes <strong>(N1a)</strong> to be more anatomically consistent and because level VII presented significant coding difficulties for tumor registrars, clinicians and researchers.</li>\n<li>In differentiated thyroid cancer, the presence of <strong>distant metastases</strong> <strong>(M1)</strong> in older patients is classified as <strong>IVB</strong> disease rather than IVC disease. Distant metastasis in anaplastic thyroid cancer continues to be classified as IVC disease.</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>TNM staging</td>\n<td>7th AJCC (2010)</td>\n<td><strong>8th AJCC (2018)</strong></td>\n</tr>\n<tr>\n<td>Primary tumor(pT)</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>TX</td>\n<td>Cannot be assessed</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>T0</td>\n<td>No evidence of cancer</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>T1</td>\n<td>Tumor ≤ 2 cm, intrathyroidal\n<ul>\n<li>T1a:&nbsp;≤1 cm, intrathyroidal</li>\n<li>T1b<strong>:</strong>&nbsp;1-2 cm, intrathyroidal</li>\n</ul>\n</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>T2</td>\n<td>\n<div class=\page\ title=\Page 927\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>2-4 cm, intrathyroidal</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>T3</td>\n<td>\n<div class=\page\ title=\Page 927\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>&gt;4 cm limited to the thyroid or any size with minimal extrathyroidal extension (muscle, soft tissue)</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><br>\n<ul>\n<li><strong>T3a:&nbsp;</strong>Tumor <strong>&gt;4 cm limited to the thyroid</strong></li>\n<li><strong>T3b:&nbsp;Gross extrathyroidal extension</strong> invading only <strong>strap muscles</strong> (sternohyoid, sternothyroid, thyrohyoid or omohyoid muscles) from a tumor of any size</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>T4</td>\n<td>\n<div class=\page\ title=\Page 927\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li>T4a Invades subcutaneous tissue, larynx, trachea, esophagus, or RLN</li>\n<li>T4b Invades prevertebral fascia or encases carotid or mediastinal vessels</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>-do-<br><br></p>\n</td>\n</tr>\n<tr>\n<td>Regional lymph nodes (pN)</td>\n</tr>\n<tr>\n<td>NX</td>\n<td>Regional lymph nodes cannot be assessed</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>N0</td>\n<td>No lymph node metastasis</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>N1a</td>\n<td>\n<div class=\page\ title=\Page 927\>\n<div class=\page\ title=\Page 927\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Positive in level VI; unilateral or bilateral disease</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><strong>Metastasis to level VI or VII;&nbsp;</strong>unilateral or bilateral disease</td>\n</tr>\n<tr>\n<td>N1b</td>\n<td>\n<div class=\page\ title=\Page 927\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Metastasis to unilateral, bilateral or contralateral lateral neck lymph nodes (levels I, II, III, IV or V) or retropharyngeal lymph nodes</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>-do-<br><br></td>\n</tr>\n<tr>\n<td>Distant metastasis (pM)</td>\n</tr>\n<tr>\n<td>M0</td>\n<td>No Distant metastasis</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>M1</td>\n<td>Distant metastasis present</td>\n<td>-do-</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>TNM classification of thyroid tumors according to AJCC 7<sup>th</sup> edition vs 8<sup>th</sup> edition:</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\3\>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; TNM CLASSIFICATION of Thyroid tumors</td>\n</tr>\n<tr>\n<td colspan=\3\>PAPILLARY OR FOLLICULAR TUMORS</td>\n</tr>\n<tr>\n<td>Stage</td>\n<td>TNM&nbsp;AJCC 7<sup>th</sup> edition</td>\n<td><strong>TNM AJCC 8<sup>th</sup> edition</strong>&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&lt;45 y</td>\n<td>&nbsp;<strong>&lt;55 y</strong></td>\n</tr>\n<tr>\n<td>\n<p>I</p>\n</td>\n<td>&nbsp;Any T, any N, M0</td>\n<td>&nbsp;-do-</td>\n</tr>\n<tr>\n<td>\n<p>II</p>\n</td>\n<td>&nbsp;Any T, any N, M1</td>\n<td>&nbsp;-do-</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;≥45 y</td>\n<td><strong>&nbsp;&gt;55 y</strong></td>\n</tr>\n<tr>\n<td>I</td>\n<td>&nbsp;T1, N0, M0</td>\n<td>&nbsp;<strong>T1-2</strong>, N0, M0</td>\n</tr>\n<tr>\n<td>II</td>\n<td>&nbsp;T2, N0, M0</td>\n<td>\n<p>&nbsp;T1-2, <strong>N1</strong>, M0</p>\n<p><strong>T3</strong>, <strong>any N</strong>, M0</p>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td>\n<div class=\page\ title=\Page 1572\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>T3, N0, M0</p>\n<p>T1–3, N1a, M0</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><strong>T4a, any N</strong>, M0</td>\n</tr>\n<tr>\n<td>IV A</td>\n<td>\n<p>T4a, N0-1a, M0</p>\n<p>T1-4a, N1b, M0</p>\n</td>\n<td>&nbsp;<strong>T4b, any N</strong>, M0</td>\n</tr>\n<tr>\n<td>&nbsp;IV B</td>\n<td>&nbsp;T4b, any N, M0</td>\n<td>&nbsp;<strong>any T, any N, M1&nbsp;</strong></td>\n</tr>\n<tr>\n<td>\n<p>IV C</p>\n</td>\n<td>\n<p>Any T, any N, M1</p>\n</td>\n<td>\n<p><strong>- deleted-</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\3\>MEDULLARY THYROID CANCER&nbsp;</td>\n</tr>\n<tr>\n<td>Stage</td>\n<td>TNM&nbsp;AJCC 7<sup>th</sup> edition</td>\n<td><strong>TNM AJCC 8<sup>th</sup> edition</strong>&nbsp;</td>\n</tr>\n<tr>\n<td>I</td>\n<td>T1, N0, M0</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>II</td>\n<td>T2–3, N0, M0</td>\n<td>-do- &nbsp;</td>\n</tr>\n<tr>\n<td>III</td>\n<td>T1–3, N1a, M0</td>\n<td>-do-&nbsp;</td>\n</tr>\n<tr>\n<td>IV A</td>\n<td>\n<p>T4a, any N, M0;</p>\n<p>T1-3, N1b, M0&nbsp;</p>\n</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>IV B</td>\n<td>&nbsp;T4b, any N, M0</td>\n<td>-do-</td>\n</tr>\n<tr>\n<td>IV C</td>\n<td>&nbsp;Any T, any N, M1</td>\n<td>-do-</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Anaplastic :</strong></p>\n<ul>\n<li>Unlike previous editions where all anaplastic thyroid cancers were classified as T4 disease, anaplastic cancers now use the<strong> same T&nbsp; definitions as differentiated thyroid cancer</strong>.</li>\n<li><strong>Intrathyroidal disease</strong> (<strong>T1-3a)</strong> is stage <strong>IVA</strong></li>\n<li><strong>Gross extrathyroidal extension</strong>(<strong>T3b,T4)</strong> or <strong>cervical lymph node metastases (N1)</strong> is stage <strong>IVB</strong></li>\n<li><strong>Distant metastases</strong> <strong>(M1)</strong> are stage <strong>IVC</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td colspan=\3\>\n<p>ANAPLASTIC CANCER</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stage</p>\n</td>\n<td>\n<p>TNM&nbsp;AJCC 7<sup>th</sup> edition</p>\n</td>\n<td>&nbsp;<strong>TNM AJCC 8<sup>th</sup>edition</strong>&nbsp; &nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>IV A</p>\n</td>\n<td>&nbsp;T4a, Any N, M0</td>\n<td>&nbsp;<strong>T1-3a, N0,</strong> M0</td>\n</tr>\n<tr>\n<td>&nbsp;IV B</td>\n<td>&nbsp;T4b, Any N, M0</td>\n<td>\n<p>T1-3a, <strong>N1</strong>, M0;</p>\n<p><strong>T3b</strong>, Any N, M0;</p>\n<p><strong>T4</strong>, Any N, M0</p>\n</td>\n</tr>\n<tr>\n<td>IV C</td>\n<td>&nbsp;Any T, Any N, M1</td>\n<td>&nbsp;-do-</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1903, 'Surgery', 'PM1693. Types of Neck Dissections', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Dissection</strong></td>\n<td><strong>LN removed</strong></td>\n<td><strong>Other structures removed/preserved</strong></td>\n</tr>\n<tr>\n<td><strong>RND</strong></td>\n<td>l-V</td>\n<td>CNXI, IJV, SCM removed</td>\n</tr>\n<tr>\n<td><strong>MRND l</strong></td>\n<td>l-V</td>\n<td>CNXI preserved</td>\n</tr>\n<tr>\n<td><strong>MRND ll</strong></td>\n<td>l-V</td>\n<td>CNXI, IJV preserved</td>\n</tr>\n<tr>\n<td><strong>MRND lll</strong></td>\n<td>l-V</td>\n<td>CNXI, IJV, SCM preserved</td>\n</tr>\n<tr>\n<td><strong>END</strong></td>\n<td>l-V</td>\n<td>CNXI, IJV, SCM removed+ one/more LN groups +/- non-lymphatic structures</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>SND</strong></td>\n<td><strong>LN removed</strong></td>\n<td><strong>Primary site of cancer</strong></td>\n</tr>\n<tr>\n<td><strong>Supra-omohyoid</strong></td>\n<td>l-lll</td>\n<td>Oral cavity</td>\n</tr>\n<tr>\n<td><strong>Extended supra-omohyoid</strong></td>\n<td>l-lV</td>\n<td>Oral cavity and oropharynx</td>\n</tr>\n<tr>\n<td><strong>Postero-lateral</strong></td>\n<td>\n<p>ll-V</p>\n</td>\n<td>\n<p>Skin over posterior scalp and upper neck</p>\n</td>\n</tr>\n<tr>\n<td><strong>Lateral</strong></td>\n<td>ll-lV</td>\n<td>\n<p>Oropharynx, hypopharynx,&nbsp;larynx</p>\n</td>\n</tr>\n<tr>\n<td><strong>Anterior(Central)</strong></td>\n<td>Vl</td>\n<td>Thyroid/midline structures</td>\n</tr>\n</tbody>\n</table>\n<p>RND- Radical Neck Dissection; MRND- Modified Radical Neck Dissection; END- Extended&nbsp;Neck Dissection; SND- Selective&nbsp;Neck Dissection</p></div><!---->\n      <!---->\n    </div><!---->'),
(1904, 'Surgery', 'PM1692. Lip reconstruction flaps', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Up to <strong>half of the lip</strong> can be removed and closed primarily.</li>\n<li>Defects encompassing between <strong>one half and two-thirds</strong> of the lip require <strong>augmentation</strong>.</li>\n<li><strong>Karapandzic flap</strong> consists of circumoral incisions with the circular rotation of the skin flaps while <strong>maintaining innervation</strong>.</li>\n<li>When the defect involves the <strong>commissure</strong>, the <strong>Estlander flap </strong>is used, and the&nbsp;<strong>Abbé flap</strong> is used for more <strong>midline defects</strong>.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1905, 'Surgery', 'PM1689. Salivary gland tumors and their frequency', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Most (90%) of the <strong>minor salivary gland</strong> tumors are <strong>malignant</strong>, whereas <strong>parotid gland tumors (90%)</strong> are <strong>benign</strong>.</li>\n<li><strong>Pleomorphic adenoma</strong> is the <strong>most common</strong> tumor of the <strong>parotid.&nbsp;</strong> It is a benign tumor.</li>\n</ul>\n<table width=\540\>\n<tbody>\n<tr>\n<td width=\141\>\n<p><strong>Type</strong><strong> of Salivary gland</strong></p>\n</td>\n<td width=\115\>\n<p><strong>Location</strong></p>\n</td>\n<td width=\124\>\n<p><strong>Frequency of tumor</strong></p>\n</td>\n<td width=\159\>\n<p><strong>Percentage of malignancy</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\141\>\n<p>Major</p>\n</td>\n<td width=\115\>\n<p>Parotid</p>\n</td>\n<td width=\124\>\n<p>Common</p>\n</td>\n<td width=\159\>\n<p>10–20%</p>\n</td>\n</tr>\n<tr>\n<td width=\141\>&nbsp;</td>\n<td width=\115\>\n<p>Submandibular</p>\n</td>\n<td width=\124\>\n<p>Uncommon</p>\n</td>\n<td width=\159\>\n<p>50%</p>\n</td>\n</tr>\n<tr>\n<td width=\141\>&nbsp;</td>\n<td width=\115\>\n<p>Sublingual</p>\n</td>\n<td width=\124\>\n<p>Very rare</p>\n</td>\n<td width=\159\>\n<p>85%</p>\n</td>\n</tr>\n<tr>\n<td width=\141\>\n<p>Minor</p>\n</td>\n<td width=\115\>\n<p>Upper aero-digestive tract</p>\n</td>\n<td width=\124\>\n<p>Rare</p>\n</td>\n<td width=\159\>\n<p>90%</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1906, 'Surgery', 'PM1674. Important points regarding salivary gland tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Most common<strong> neoplasm </strong>of the salivary gland:<strong> Pleomorphic adenoma</strong></li>\n<li>Most common <strong>malignant</strong> tumor of the salivary gland:&nbsp;<strong>Mucoepidermoid carcinoma</strong></li>\n<li>Most common <strong>benign</strong> tumor of the&nbsp;salivary gland in<strong> children:</strong>&nbsp;<strong>Hemangioma</strong></li>\n<li>Most common <strong>malignant</strong> tumor of the&nbsp;salivary gland in <strong>children: Mucoepidermoid carcinoma</strong></li>\n<li>Most common malignant tumor of the minor salivary glands:&nbsp;<strong>Adenoid cystic carcinoma </strong></li>\n<li>Most common gland affected by pleomorphic adenomas: Parotid gland</li>\n<li>Tumor of the salivary gland with <strong>perineural invasion</strong>: Adenoid cystic carcinoma</li>\n<li>Tumor that shows a&nbsp;hot spot in <sup>99m</sup>Tc&nbsp;scan: <strong>Warthin’s tumor</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1907, 'Surgery', 'PM1312. Indications for parathyroidectomy in patients with asymptomatic primary HPT (2013-2014 NIH Consensus Conference Guidelines)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Serum calcium &gt;1 mg/dL above the upper limit of normal</li>\n<li>Renal:&nbsp;<br>\n<ul>\n<li>Reduction in creatinine clearance by 30%</li>\n<li>24-h urine calcium &gt;400 mg/day</li>\n<li>Presence of nephrolithiasis or nephrocalcinosis</li>\n</ul>\n</li>\n<li>Skeletal:&nbsp;\n<ul>\n<li>Decreased bone mineral density (T score &lt;-2.5)</li>\n<li>Presence of vertebral fracture</li>\n</ul>\n</li>\n<li>Age &lt;50 years</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1908, 'Surgery', 'PM1309. Secretion of medullary thyroid tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Medullary thyroid tumor secrete the following:</p>\n<ul>\n<li><strong>Calcitonin </strong></li>\n<li><strong>Carcinoembryonic antigen (CEA)</strong></li>\n<li>Calcitonin gene–related peptide</li>\n<li>Histaminadases</li>\n<li>Prostaglandins E 2 and F 2 α</li>\n<li>Serotonin</li>\n</ul>\n<p>Calcitonin and serotonins are responsible for diarrhea in MTC.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1909, 'Surgery', 'PM1307. Thyroid Surgeries', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Lobectomy</strong> - One entire thyroid lobe is removed.</li>\n<li><strong>Hemithyroidectomy </strong>- Total lobectomy of <strong>one lobe</strong>&nbsp;+isthmusectomy</li>\n<li><strong>Subtotal thyroidectomy</strong> - 2 x subtotal lobectomy (Leaving greater than 1 g of thyroid tissue <strong>on each lobe</strong>)+ isthmusectomy</li>\n<li><strong>Near total thyroidectomy</strong> - Total lobectomy but leaving less than 1 g of tissue adjacent to the RLN at the ligament of Berry <strong>on one lobe&nbsp;</strong>+ isthmusectomy (also known as Hartley-Dunhill procedure)</li>\n<li><strong>Total thyroidectomy</strong> - 2 x total lobectomy + isthmusectomy</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/37d806d8f5f747feb61aeddccca35d7bx1280x1686.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1910, 'Surgery', 'PM1306. Poor Prognostic Factors in Follicular Carcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Age &gt;50 years</li>\n<li>Tumour size &gt;4 cm</li>\n<li>High tumour grade</li>\n<li>Marked vascular invasion</li>\n<li>Extrathyroidal invasion</li>\n<li>Distant metastasis</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1911, 'Surgery', 'PM1255. Bethesda Criteria to Select Patients for MSI Testing', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The Amsterdam criteria <strong>or</strong> one of the following:</p>\n<ul>\n<li>Two cases of HNPCC-associated cancer in one patient, including synchronous or metachronous cancer</li>\n<li>Colon cancer and a first-degree relative with HNPCC-associated cancer and/or colonic adenoma (one case of cancer diagnosed before age 45 years and adenoma diagnosed before age 40 years)</li>\n<li>Colon or endometrial cancer diagnosed before age 45 years</li>\n<li>Right-sided colon cancer that has an undifferentiated pattern (solid, cribriform) or signet cell histopathologic characteristics diagnosed before age 45 years</li>\n<li>Adenomas diagnosed before age 40 years&nbsp;</li>\n</ul>\n<p><strong>Remember: Bethesda criteria is also used for reporting thyroid cytopathology which guides clinical decision.</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1912, 'Surgery', 'PM0785. Radioiodine uptake of thyroid gland', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Radioactive iodine uptake (RAIU) scans are interpreted as follows:</p>\n<ul>\n<li><strong>High</strong> (or normal) radioiodine uptake indicates de-novo synthesis of the hormone. Therefore, there is increased hormone synthesis</li>\n<li><strong>Low</strong> (nearly absent) radioiodine uptake indicates:\n<ul>\n<li>Inflammation and destruction of thyroid tissue with release of the preformed hormone into the circulation</li>\n<li>Extrathyroidal source of thyroid hormone</li>\n</ul>\n</li>\n</ul>\n<p>Conditions with high and low RAIU are given below:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>High RAIU</strong></td>\n<td><strong>Low RAIU</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Graves’ disease</li>\n<li>Toxic multinodular goiter</li>\n<li>Toxic adenoma</li>\n<li>Thyroid cancer</li>\n<li>Hydatidiform mole</li>\n<li>TSH-secreting pituitary adenoma</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Acute phase of Hashimoto’s thyroiditis</li>\n<li>Drug-induced— iodine, amiodarone-induced thyroiditis</li>\n<li>Subacute/ Dequervain thyroiditis</li>\n<li>Radiation thyroiditis</li>\n<li>Metastatic follicular thyroid carcinoma</li>\n<li>Factitious (iatrogenic) thyrotoxicosis</li>\n<li>Struma ovarii (extrathyroid source)</li>\n<li>Hamburger thyrotoxicosis (exogenous source)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/84debe461e9e4ef6a8de25fbe9c71e7fx1280x3027.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1913, 'Surgery', 'PM0782. Werner  classification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Werner classification reflects the severity of the ophthalmopathy.</li>\n<li>It is well known by the acronym of <strong>NO SPECS.</strong></li>\n<li>Each grade is further subdivided as 0-4 and a-c.</li>\n</ul>\n<p><strong>Grades of Werner classification:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Grade</strong></td>\n<td><strong>Feature</strong></td>\n<td><strong>Acronym</strong></td>\n</tr>\n<tr>\n<td>0</td>\n<td>No signs or symptoms</td>\n<td><strong>N</strong></td>\n</tr>\n<tr>\n<td>1</td>\n<td>Only signs (lid retraction)</td>\n<td><strong>O</strong></td>\n</tr>\n<tr>\n<td>2</td>\n<td>Soft tissue involvement (chemosis, grit)</td>\n<td><strong>S</strong></td>\n</tr>\n<tr>\n<td>3</td>\n<td>Proptosis (minimum &lt;23mm, moderate, marked &gt;28mm)</td>\n<td><strong>P</strong></td>\n</tr>\n<tr>\n<td>4</td>\n<td>Extraocular muscle involvement</td>\n<td><strong>E</strong></td>\n</tr>\n<tr>\n<td>5</td>\n<td>Corneal involvement</td>\n<td><strong>C</strong></td>\n</tr>\n<tr>\n<td>6</td>\n<td>Loss of sight</td>\n<td><strong>S</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1914, 'Surgery', 'PM0195. NICE Guidelines for CT in Head Injury', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>National Institute for Health and Care Excellence <strong>(NICE) Guidelines</strong> for Computed Tomography <strong>(CT) in Head Injury</strong></p>\n<p><strong>Indications for CT </strong>imaging <strong>within 1 hour </strong>of following risk factors being identified:</p>\n<div class=\page\ title=\Page 351\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li>Glasgow Coma Score (GCS) &lt;13 at any point</li>\n<li>GCS &lt;15 at 2 hours after injury on assessment in an emergency department</li>\n<li>Focal neurological deficit</li>\n<li>Suspected open, depressed, or basal skull fracture</li>\n<li>More than one episode of vomiting</li>\n<li>Post-traumatic seizure</li>\n</ul>\n<p><strong>Indications for CT </strong>imaging <strong>within 8 hours:</strong></p>\n<ul>\n<li>Age <span>&gt;</span>65 years</li>\n<li>Coagulopathy (e.g., aspirin, warfarin, or rivaroxaban use)</li>\n<li>Dangerous mechanism of injury (e.g., fall from a height, road traffic accident)</li>\n<li>Retrograde amnesia &gt;30 minutes</li>\n</ul>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1915, 'Surgery', 'PM2297. Skin Grafting : Phases of Graft Uptake', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 1968\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Skin graft uptake</strong> occurs in three phases:</p>\n<ol>\n<li><strong>Imbibition </strong>(Plasmatic circulation): During the <strong>first 48 hours,</strong> the graft is nourished with plasma exudate from the host bed capillaries.</li>\n<li><strong>Inosculation:</strong> <strong>C</strong><strong>ut vessels</strong> from the host bed <strong>line up</strong> with the cut ends of the vessels of the graft to form anastomoses.</li>\n<li><strong>Neovascularization:</strong> <strong>B</strong><strong>lood vessels grow</strong> from the recipient bed <strong>into the graft.</strong></li>\n</ol>\n<div class=\page\ title=\Page 1968\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Sensations return to the graft over time, with <strong>reinnervation beginning at approximately 4 to 5 weeks</strong> and being completed by 12 to 24 months. <strong>Pain returns first</strong>, followed by light touch and temperature returning later.</p>\n<p><strong>Note:</strong> Some books give that the 3 phases are imbibition, revascularisation (inosculation+neovascularisation) and organisation (fibrin layer holds the graft in place and this is replaced with fibroblasts by day 7).</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1916, 'Surgery', 'PM2215. Burns – Formulae for Fluid Calculation(Updated according to ATLS 10th edition 2018 guidelines)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Parkland’s formula</strong> gives the total fluid requirement for 24hours. <strong>Half</strong> of this volume is infused in the <strong>first 8 hours</strong>, and the <strong>remaining half</strong> is infused in the <strong>next 16 hours</strong>.</p>\n<p>This formula is recommended for those who have sustained large <strong>deep partial-thickness or full-thickness burns</strong> that cover more than 20% of the TBSA in adults and more than 10% in children.&nbsp;</p>\n<p>Formulas provide a <strong>starting target rate</strong>; Subsequently, the amount of fluid provided should be adjusted based on <strong>urine output</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Category of burn</strong></td>\n<td><strong>Age</strong></td>\n<td><strong>Amount of Ringer’s Lactate given for 24 hours (ml)</strong></td>\n<td><strong>Target urine output (ml/kg/hour)</strong></td>\n</tr>\n<tr>\n<td rowspan=\3\><strong>2nd/3rd-degree burns</strong></td>\n<td>Adults&nbsp;</td>\n<td>2 x weight in kgs x % TBSA</td>\n<td>0.5</td>\n</tr>\n<tr>\n<td>&lt;14 years</td>\n<td>3 x weight in kgs x % TBSA</td>\n<td>1</td>\n</tr>\n<tr>\n<td>&lt; 1 year or &lt;30kgs</td>\n<td>3 x weight in kgs x % TBSA + 5% dextrose on a maintenance rate</td>\n<td>1</td>\n</tr>\n<tr>\n<td><strong>4th-degree burns / Electrical burns</strong></td>\n<td>All ages</td>\n<td>4 x weight in kgs x % TBSA</td>\n<td>1-1.5 (until urine clears)</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Dextrose maintenance:</strong></p>\n<ul>\n<li aria-level=\1\>100 ml/ kg in 24 hours for 10 kg</li>\n<li aria-level=\1\>50 ml/kg for next 10 kg</li>\n<li aria-level=\1\>20 ml/kg for every kg after 20 kg</li>\n</ul>\n<p><strong>Evan’s formula</strong> is used for <strong>normal saline</strong>.</p>\n<p>For the first 24 hours:</p>\n<ul>\n<li aria-level=\1\>Amount of NS administered = weight in kgs x % TBSA</li>\n<li aria-level=\1\>Amount of colloid administered = weight in kgs x % TBSA</li>\n<li aria-level=\1\>5% Dextrose administered= 2000 ml</li>\n</ul>\n<p>After 24 hours, the amount of NS and colloid administered is half. 2000 ml of dextrose is maintained.</p>\n<p><strong>Muir and Barclay’s formula</strong> for colloids:</p>\n<ul>\n<li>1 portion of colloid = (weight in kgs x % TBSA)/2</li>\n<li>6 portions of colloid are administered over 36 hours</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1917, 'Surgery,', 'PM2207. Acute Compartment and Crush Syndromes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>1. Acute Compartment Syndrome</strong></p>\n<p class=\p1\>Acute compartment syndrome is an elevation of the intracompartmental pressure (ICP) which increases the risk for tissue ischemia and necrosis.</p>\n<p><strong>Causes</strong>: Fractures (70%) and severe soft tissue injuries (30%). Common fractures causing compartment syndrome include&nbsp;tibial diaphyseal (most common), distal radius, and forearm fractures.&nbsp;</p>\n<p><strong>Pathology</strong>: Increased pressure in one of&nbsp;the osseofascial compartments due to bleeding, oedema or inflammation. A vicious cycle of ischemia → edema→ ischemia leading to necrosis of the muscles and nerves within the compartment in&nbsp;6 hours or less.&nbsp;</p>\n<p><strong>Clinical features</strong>: Five Ps: Pain,&nbsp;Paraesthesia, Pallor, Paralysis and Pulselessness.&nbsp;</p>\n<p><strong>Management</strong>: Fasciotomy to decompress the threatened compartment if the differential pressure (ΔP) goes &lt; 30 mmHg.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b3795f2c59974b46aed885144c3fb36ax975x813.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>2. Crush Syndrome&nbsp;</strong></p>\n<p>Crush syndrome is the systemic manifestation of muscle necrosis. It is commonly caused due to prolonged external compression of an extremity.&nbsp;</p>\n<p><strong>Causes</strong>: Crush injuries sustained during motor vehicle accidents, earthquakes, mining and other occupational accidents.</p>\n<p><strong>Pathology</strong>: Underperfusion of muscle causes myonecrosis. When the limb is freed, there is a release of toxic metabolites causing reperfusion injury. Reactive oxygen metabolites create further tissue injury. Free myoglobin can get precipitated in the renal glomeruli.&nbsp;</p>\n<p><strong>Clinical features</strong>: The affected limb is pulseless, red, swollen and blistered. Sensation and muscle power may be lost. There can be signs of impaired renal function, metabolic acidosis, hyperkalemia and hypocalcaemia.</p>\n<p><strong>Management</strong>:&nbsp;Encouraging high urine output, alkalization of the urine, hemofiltration, radical excision of dead muscles, fasciotomy if there is compartment syndrome.&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1918, 'Surgery', 'PM1952. Timing of primary cleft lip and palate procedures:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Cleft lip alone</strong></p>\n<ul>\n<li>Unilateral (one side) - One operation at 3–6 months</li>\n<li>Bilateral (both sides) - One operation at 4–5 months</li>\n</ul>\n<p><strong>Cleft palate alone</strong></p>\n<ul>\n<li>Soft palate - Only one operation at 6 months</li>\n<li>Soft and hard palate - Two operations\n<ul>\n<li>Soft palate at 6 months</li>\n<li>Hard palate at 15–18 months</li>\n</ul>\n</li>\n</ul>\n<p><strong>Cleft lip and palate</strong></p>\n<ul>\n<li>Unilateral - Two operations\n<ul>\n<li>Cleft lip and soft palate at 5–6 months</li>\n<li>Hard palate and gum pad with or without lip revision at 15–18 months</li>\n</ul>\n</li>\n<li>Bilateral - Two operations\n<ul>\n<li>Cleft lip and soft palate at 4–5 months</li>\n<li>Hard palate and gum pad with or without lip revision at 15–18 months</li>\n</ul>\n</li>\n</ul>\n<p><strong>Secondary management</strong></p>\n<ul>\n<li>Hearing, Prophylactic myringotomy, Regular audiological testing -&nbsp;6–12 months</li>\n<li>\n<p>Speech, Velopharyngeal surgery, Speech and language therapy -&nbsp;18 months</p>\n</li>\n<li>\n<p>Orthodontic management</p>\n<p>- Mixed dentition -&nbsp;8–10 years<br>- Permanent dentition -&nbsp;14-18 years</p>\n</li>\n<li>\n<p>Excision of maxillary arch, Rhinoplasty -&nbsp;16+ years</p>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1919, 'Surgery', 'PM2156. Indications for Coronary Artery Bypass Grafting (CABG)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Class I indications for CABG</strong> from the American College of Cardiology(ACC) and American Heart Association(AHA).</p>\n<ul>\n<li>Left main disease</li>\n<li>Three-vessel disease with or without proximal LAD disease</li>\n<li>Two vessel disease with proximal LAD disease</li>\n<li>Survivors of sudden cardiac death with presumed ischemia-mediated VT &nbsp;</li>\n</ul>\n<p><strong> Other indications for CABG include the following:</strong></p>\n<ul>\n<li>Disabling angina</li>\n<li>Ongoing ischemia in the setting of a non–ST-segment elevation (MI) that is unresponsive to medical therapy</li>\n<li>Poor LV function but with viable, nonfunctioning myocardium above the anatomic defect that can be revascularized</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1920, 'Orthopaedics,', 'PM2041. Thoracic outlet syndrome and its tests:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Thoracic outlet syndrome (TOS)</strong> is a neurovascular syndrome caused due to the compression of the lower trunk of brachial plexus (C8 and T1) and subclavian vessels in the thoracic outlet between the clavicle, the first rib, and scalene muscles.</p>\n<p>Clinical features due to compression of:</p>\n<ul>\n<li><span class=\fontstyle0\>Brachial plexus: Pain and paraesthesia along the ulnar aspect of the arm.</span></li>\n<li><span class=\fontstyle0\>Subclavian vessels: Cyanosis, cold fingers, pallor and Raynauds phenomenon.</span></li>\n</ul>\n<p><strong>Provocative tests</strong>: Adsons test, Halsteads maneuver, Wrights test, Roos test.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Adson’s test:&nbsp;</strong>The examiner locates the radial pulse while arm is held in extension, external rotation, and slight abduction. The patient is instructed to take a deep breath and turn head towards the test arm while extending the neck.&nbsp;This manoeuvre will tense the anterior and middle scalenes. If there is outlet obstruction, the radial pulse will get diminished or absent on that side.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/84b5e5eb4d1143958be3dd50c53a3787x1280x1429.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Halstead maneuver (reverse Adsons):&nbsp;</strong>The examiner palpates the radial pulse and applies downward traction on the tested extremity while the patient’s neck is hyperextended and rotated to the <strong>opposite side</strong>. Diminished or absent pulse indicates a positive test.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5dfd59610ed4480eb08ec567e78533cdx1280x2558.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Wright’s hyperabduction test:&nbsp;</strong>The examiner palpates the radial pulse and hyper-abducts the arm. The patient takes a deep breath and may rotate or extend his neck for additional effect. Absence of pulse indicates a positive test.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8dde492c1e9b4216982a97ebdbba9d15x1280x1416.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p class=\p1\><strong>Roos test:&nbsp;</strong>The patient abducts the shoulders to 90 degrees and flexes the elbow to 90 degrees. The patient is made to open and close the hand repeatedly for three minutes. The test is positive if the patient is unable to complete the test or experiences cramping, pain, numbness, on the affected side.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d3299a6fd29841c58c0b784671708142x1279x1140.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1921, 'Surgery', 'PM1663. Locations of the Common Mediastinal Masses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Anterior Mediastinum</strong></p>\n</td>\n<td>\n<p><strong>Middle Mediastinum</strong></p>\n</td>\n<td>\n<p><strong>Posterior Mediastinum</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Thymoma </strong><strong>(most common in anterior mediastinum)</strong></p>\n<p>Lymphoma</p>\n<p>Germ cell tumors</p>\n<p>Thyroid and parathyroid<br>masses</p>\n<p>Bronchogenic Cyst</p>\n<p>Aneurysm</p>\n<p>Thymic cyst</p>\n<p>Parathyroid adenoma</p>\n</td>\n<td>\n<p>Cysts (MC in middle mediastinum):</p>\n<ul>\n<li>Pericardial (most common)</li>\n<li>Bronchogenic</li>\n<li>Enterogenous</li>\n<li>Neuroenteric</li>\n</ul>\n<p>Vascular masses (an&nbsp;aneurysm)</p>\n<p>LN enlargement and lymphoma</p>\n<p>Mesenchymal tumors</p>\n<p>Pheochromocytoma</p>\n</td>\n<td>\n<p>Neurogenic tumors&nbsp;</p>\n<p>Meningoceles</p>\n<p>Mesenchymal tumors</p>\n<p>Pheochromocytoma</p>\n<p>Lymphoma</p>\n<p>Bochdalek hernia</p>\n<p>Bronchogenic Cyst</p>\n<p>Enterogenous Cyst</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1922, 'Surgery', 'PM1049. The circle of death/Crown of death/Corona mortis:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>It is a vascular continuation formed by the common iliac, internal iliac, obturator, inferior epigastric, and external iliac vessels.</li>\n<li><strong>Accessory obturator artery</strong> which is a <strong>branch of inferior epigastric artery</strong>, arches over Cooper’s ligament and <strong>joins the normal obturator artery</strong> and forms a <strong>complete vascular ring</strong>.</li>\n<li>Injury leads to torrential haemorrhage which is difficult to control.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ebb18bac0c394f00907132f945123f8ex1280x1244.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1923, 'Surgery', 'PM0583. Signs related to venous thrombosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Sign</strong></p>\n</td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>\n<p>Moses’</p>\n<p>sign&nbsp;</p>\n</td>\n<td>Clinical&nbsp;sign found in patients with deep vein thrombosis of the lower leg involving the posterior&nbsp;tibial&nbsp;veins. The sign is positive if pain is elicited when the calf muscle is compressed forwards against the tibia, but not when the calf muscle is compressed from side to side.&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Homan’s</p>\n<p>sign&nbsp;&nbsp;</p>\n</td>\n<td>Another clinical sign found in patients with deep vein thrombosis. It is the&nbsp;discomfort behind the knee on forced dorsiflexion of the foot.</td>\n</tr>\n<tr>\n<td>\n<p>Lowenberg’s</p>\n<p>sign&nbsp;</p>\n</td>\n<td>Clinical&nbsp;sign found in patients with deep vein thrombosis of the lower leg. The sign is positive when pain is elicited rapidly when a blood pressure cuff is placed around the calf and inflated to 80 mmHg.</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1924, 'Surgery', 'PM0554. Indications for Operative Repair of Aneurysm', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Condition</strong></td>\n<td><strong>Criteria for surgical repair</strong></td>\n</tr>\n<tr>\n<td>Symptomatic aneurysm</td>\n<td>&nbsp;Any size</td>\n</tr>\n<tr>\n<td>Ascending thoracic aortic aneurysm - asymptomatic</td>\n<td>&gt;5.5 cm</td>\n</tr>\n<tr>\n<td>Descending thoracic aortic aneurysm -&nbsp;asymptomatic</td>\n<td>&gt;6 cm</td>\n</tr>\n<tr>\n<td>Abdominal aortic aneurysm -&nbsp;asymptomatic</td>\n<td>&gt;5.5 cm</td>\n</tr>\n<tr>\n<td>Popliteal artery aneurysm - asymptomatic</td>\n<td>&gt;2-3 cm</td>\n</tr>\n<tr>\n<td>Ascending thoracic aortic aneurysm in Marfan’s syndrome or bicuspid aortic valve</td>\n<td>&gt;4-5 cm</td>\n</tr>\n<tr>\n<td>\n<p>Rapidly&nbsp;growing&nbsp;aneurysms&nbsp;</p>\n</td>\n<td>\n<p>&gt;0.5 cm/year for ascending aortic aneurysms</p>\n<p>&gt; 1cm/year for descending aortic aneurysms</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1925, 'Surgery', 'PM0542. Indications for operative repair of thoracic aortic aneurysm', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Clinical scenario</strong></td>\n<td><strong>Indication for operative repair</strong></td>\n</tr>\n<tr>\n<td>Symptomatic aneurysm</td>\n<td>Any size</td>\n</tr>\n<tr>\n<td>Asymptomatic ascending thoracic aortic diameter</td>\n<td>&gt; 5.5 cm</td>\n</tr>\n<tr>\n<td>When the diameter of an ascending aortic aneurysm has increased</td>\n<td>&gt; 0.5 cm per year</td>\n</tr>\n<tr>\n<td>Asymptomatic descending thoracic aortic diameter or</td>\n<td>&gt; 6 cm</td>\n</tr>\n<tr>\n<td>When the diameter of descending&nbsp; aortic aneurysm has increased</td>\n<td>&nbsp;&gt; 1 cm per year</td>\n</tr>\n<tr>\n<td>Asymptomatic ascending thoracic aortic diameter in patients with Marfan’s syndrome or bicuspid aortic valve</td>\n<td>4-5cm</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1926, 'Surgery', 'PM0196. Crawford classification of thoracoabdominal aneurysm:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Extent I - Left subclavian artery to the suprarenal abdominal aorta.</li>\n<li>Extent II - (most extensive type) - Left subclavian artery to the infrarenal abdominal aorta, and they often reach the aortic bifurcation.</li>\n<li>Extent III - Lower descending thoracic aorta (below the sixth rib) to the abdomen.</li>\n<li>Extent IV - Begins at the diaphragmatic hiatus and often involve the entire abdominal aorta.</li>\n<li>Extent V- 6th intercostal space to above the renal artery</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b0759ed161eb4d93804b429546ead698x1280x2559.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1927, 'Surgery', 'PM1115. Clark’s Classification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Level</strong></p>\n</td>\n<td>\n<p><strong>Depth of invasion</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>I</p>\n</td>\n<td>\n<p>Epidermis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>II</p>\n</td>\n<td>\n<p>Invades papillary dermis but doesn’t fill it</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>III</p>\n</td>\n<td>\n<p>Fills papillary dermis, impinging on reticular dermis n=but not invading</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IV</p>\n</td>\n<td>\n<p>Invades reticular dermis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>V</p>\n</td>\n<td>\n<p>Invades subcutaneous tissue</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/99e283b061f24dc299595215e6d7660ax902x595.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1928, 'Surgery', 'PM1114. Breslow’s  Classification of Malignant Melanoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Breslows classification of malignant melanoma:</p>\n<table class=\wikitable\ border=\1\>\n<tbody>\n<tr>\n<th>Stage</th>\n<th>Depth</th>\n</tr>\n<tr>\n<td>Stage I</td>\n<td>≤&nbsp;0.75mm</td>\n</tr>\n<tr>\n<td>Stage II</td>\n<td>0.76&nbsp;mm - 1.50mm</td>\n</tr>\n<tr>\n<td>Stage III</td>\n<td>1.51&nbsp;mm - 4 mm</td>\n</tr>\n<tr>\n<td>Stage IV</td>\n<td>&gt;4 mm<sup class=\reference\></sup></td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>TNM staging based on the thickness of invasion according to AJCC:</p>\n<div class=\page\ title=\Page 754\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li>T1 - ≤1.0 mm</li>\n<li>T2 - 1.01-2.0 mm</li>\n<li>T3 - 2.01-4.0 mm</li>\n<li>T4 - &gt;4.0 mm</li>\n</ul>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/42b06a5ff91d479b80343a49d7fe388ax1280x1019.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1929, 'Surgery', 'PM2507. CEAP Classification of Chronic Lower Extremity Venous Disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 1027\>\n<table><colgroup><col><col><col> </colgroup>\n<tbody>\n<tr>\n<td colspan=\3\>\n<div class=\layoutArea\>\n<div class=\column\>\n<div class=\page\ title=\Page 995\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>CEAP (Clinical-Etiology-Anatomy-Pathophysiology)</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Clinical&nbsp;classification (C)*</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C0</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>No visible or palpable signs of venous disease</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C1</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Telangiectases or reticular veins</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C2</p>\n<p>C2r</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Varicose veins</p>\n<p>Recurrent varicose veins</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C3</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Edema</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C4</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Changes in skin and subcutaneous tissue secondary</p>\n<p>to chronic venous disease</p>\n<p>C4a-Pigmentation or eczema</p>\n</div>\n</div>\n</div>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C4b-Lipodermatosclerosis or atrophie blanche</p>\n<p>C4c-Corona phlebectatica</p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C5</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Healed ulcer</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>C6</p>\n<p>C6r</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Active ulcer</p>\n<p>Recurrent active venous ulcer</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>S</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>With symptoms attributable to venous disease</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>A</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Absence of&nbsp;symptoms attributable to venous disease</p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Etiological</strong>&nbsp;<strong>classification (E)</strong></p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ec</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Congenital (Klippel-Trenaunay syndrome)</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ep</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Primary</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Es</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Secondary (postthrombotic syndrome, trauma)</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Esi</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Secondary (intravenous)</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ese</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Secondary (extravenous)</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ec</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Congenital</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>En</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>No venous cause identified</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Anatomic</strong>&nbsp;<strong>classification</strong> <strong>(A)</strong></p>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>As</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Superficial</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ad</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Deep</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Ap</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Perforator</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>An</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>No venous location identified</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\3\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Patho-physiologic&nbsp;classification (P)</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Pr</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Reflux</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Po</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Obstruction, thrombosis</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Pr,o</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Reflux and obstruction</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\ rowspan=\1\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Pn</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>No venous pathophysiology identified</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table>\n<div class=\page\ title=\Page 1027\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Note:</strong></p>\n<ul>\n<li>The descriptor A (asymptomatic) or S (symptomatic) is placed after the C clinical class.</li>\n<li aria-level=\1\>Telengiactesia refers to tiny intradermal venules &lt;1 mm in diameter.</li>\n<li aria-level=\1\>Reticular veins refer to small dilated subdermal blue veins of 1 to 2.9 mm</li>\n<li aria-level=\1\>Varicose veins refer to dilated tortuous veins &gt;3 mm in diameter</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1930, 'Surgery', 'PM2492. Cancers associated with important oncogenes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\0\>\n<tbody>\n<tr>\n<td>\n<p><strong>Oncogenes</strong></p>\n</td>\n<td><strong>Associated cancers</strong></td>\n</tr>\n<tr>\n<td>\n<p><em>c-MYC</em></p>\n</td>\n<td>\n<p>Burkitt’s lymphoma</p>\n<p>Adenocarcinomas of the breast, lung, and colon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>N-MYC</em></p>\n</td>\n<td>\n<p>Neuroblastoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>L-MYC</em></p>\n</td>\n<td>\n<p>Small-cell carcinoma of the lung</p>\n</td>\n</tr>\n<tr>\n<td><em>K-RAS</em></td>\n<td>Colon, lung, and pancreatic tumors</td>\n</tr>\n<tr>\n<td><em>N-RAS</em></td>\n<td>\n<p>Melanoma</p>\n<p>AML</p>\n</td>\n</tr>\n<tr>\n<td><em>H-RAS</em></td>\n<td>Bladder and kidney tumors</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1931, 'Surgery', 'PM2491. Growth Factor Receptors and Associated Tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Growth factor receptors and Associated Tumors</strong></p>\n<table>\n<tbody>\n<tr>\n<td width=\113\>\n<p>Category</p>\n</td>\n<td width=\113\>\n<p><em>Proto-Oncogene</em></p>\n</td>\n<td width=\113\>\n<p>Mode of activation</p>\n</td>\n<td width=\113\>\n<p>Associated tumor</p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>EGF-receptor family</p>\n</td>\n<td width=\113\>\n<p><em>ERBB1 (EGFR)</em></p>\n<p><em>ERBB2 (HER)</em></p>\n</td>\n<td width=\113\>\n<p>Mutation</p>\n<p>Amplification</p>\n</td>\n<td width=\113\>\n<p>Adenocarcinoma of lung</p>\n<p>Breast carcinoma</p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>FMS- like tyrosine kinase 3</p>\n</td>\n<td width=\113\>\n<p><em>FLT3</em></p>\n</td>\n<td width=\113\>\n<p>Point mutation</p>\n</td>\n<td width=\113\>\n<p>Leukemia</p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>Receptor for neurotrophic factors</p>\n</td>\n<td width=\113\>\n<p><em>RET</em></p>\n</td>\n<td width=\113\>\n<p>Point mutation</p>\n</td>\n<td width=\113\>\n<p>Multiple endocrine neoplasia 2A and B, familial medullary thyroid carcinoma</p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>PDGF receptor</p>\n</td>\n<td width=\113\>\n<p><em>PDGFRB</em></p>\n</td>\n<td width=\113\>\n<p>Overexpression, translocation</p>\n</td>\n<td width=\113\>\n<p>Gliomas, leukemias</p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>Receptor for KIT ligand</p>\n</td>\n<td width=\113\>\n<p><em>KIT</em></p>\n</td>\n<td width=\113\>\n<p>Point mutation</p>\n</td>\n<td width=\113\>\n<p>Gastrointestinal stromal tumors, seminomas, leukemias</p>\n</td>\n</tr>\n<tr>\n<td width=\113\>\n<p>ALK receptors</p>\n</td>\n<td width=\113\>\n<p><em>ALK</em></p>\n</td>\n<td width=\113\>\n<p>Translocation, fusion gene formation</p>\n<p>Point mutation</p>\n</td>\n<td width=\113\>\n<p>Adenocarcinoma of lung, certain lymphomas</p>\n<p>Neuroblastoma</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1932, 'Orthopaedics', 'PM2164. Factors that impair bone healing and cause non-union', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Biological etiologies:</strong></p>\n<ul>\n<li><strong>Local -</strong>\n<ul>\n<li>Excessive soft-tissue stripping</li>\n<li>Bone loss</li>\n<li>Vascular injury</li>\n<li>Radiation</li>\n<li>Infection</li>\n</ul>\n</li>\n<li><strong>Systemic -</strong>&nbsp;\n<ul>\n<li>Age</li>\n<li>Chronic diseases</li>\n<li>Metabolic or endocrine abnormalities (Vit D def)</li>\n<li>Malnutrition</li>\n<li>Smoking</li>\n</ul>\n</li>\n</ul>\n<p><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Mechanical etiologies:</strong></p>\n<ul>\n<li><strong>Malreduction -</strong>\n<ul>\n<li>Malposition</li>\n<li>Malalignment</li>\n<li>Distraction</li>\n</ul>\n</li>\n<li><strong>Inappropriate stabilization -</strong>\n<ul>\n<li>Insufficient or&nbsp;too rigid fixation</li>\n<li>Inappropriate implant choice or position</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1933, 'Orthopaedics', 'PM2159. Orthopedic trauma and associated vascular injuries', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Injuries</strong></td>\n<td><strong>Vessel involved</strong></td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Dislocations:</strong></td>\n</tr>\n<tr>\n<td>Shoulder dislocation</td>\n<td>Axillary</td>\n</tr>\n<tr>\n<td>Posterior dislocation of the elbow</td>\n<td>Brachial</td>\n</tr>\n<tr>\n<td>Hip dislocation</td>\n<td>Femoral</td>\n</tr>\n<tr>\n<td>Knee dislocation</td>\n<td>Popliteal</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Fractures:</strong></td>\n</tr>\n<tr>\n<td>Fracture proximal humerus</td>\n<td>Axillary</td>\n</tr>\n<tr>\n<td>Supracondylar fracture humerus</td>\n<td>Brachial</td>\n</tr>\n<tr>\n<td>Fracture both bones forearm</td>\n<td>Anterior interosseous artery</td>\n</tr>\n<tr>\n<td>First rib fracture</td>\n<td>Subclavian</td>\n</tr>\n<tr>\n<td>Pelvic fracture</td>\n<td>Presacral and internal iliac</td>\n</tr>\n<tr>\n<td>Fracture femur</td>\n<td>Femoral</td>\n</tr>\n<tr>\n<td>Supracondylar fracture femur</td>\n<td>Popliteal</td>\n</tr>\n<tr>\n<td>Proximal tibial fracture</td>\n<td>Popliteal or its branches</td>\n</tr>\n<tr>\n<td>Ankle injuries</td>\n<td>Posterior tibial</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1934, 'Orthopaedics', 'PM2158. Fractures/dislocations and associated nerve injuries', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Fracture/Dislocation</strong></td>\n<td><strong>Nerve injured</strong></td>\n</tr>\n<tr>\n<td>Fracture clavicle</td>\n<td>Brachial plexus</td>\n</tr>\n<tr>\n<td>Anterior or inferior shoulder dislocation</td>\n<td>Axillary (circumflex humeral) nerve</td>\n</tr>\n<tr>\n<td>Proximal humerus fracture</td>\n<td>Axillary nerve</td>\n</tr>\n<tr>\n<td>Shaft of humerus fracture</td>\n<td>Radial nerve</td>\n</tr>\n<tr>\n<td>Supracondylar fracture humerus&nbsp;</td>\n<td>Anterior interosseous nerve &gt; Median nerve &gt; Radial nerve</td>\n</tr>\n<tr>\n<td>Medial condyle of humerus&nbsp;</td>\n<td>Ulnar nerve</td>\n</tr>\n<tr>\n<td>Posterior dislocation elbow</td>\n<td>Ulnar nerve &gt;Median nerve</td>\n</tr>\n<tr>\n<td>Monteggia fracture</td>\n<td>Posterior interosseous nerve</td>\n</tr>\n<tr>\n<td>Volkman’s ischemic contracture</td>\n<td>Anterior interosseous nerve</td>\n</tr>\n<tr>\n<td>Hook of hamate fracture</td>\n<td>Deep branch of the ulnar nerve</td>\n</tr>\n<tr>\n<td>Lunate dislocation<strong>&nbsp;</strong></td>\n<td>Median nerve</td>\n</tr>\n<tr>\n<td>Wrist injury</td>\n<td>Median nerve</td>\n</tr>\n<tr>\n<td>Posterior hip dislocation</td>\n<td>Sciatic nerve</td>\n</tr>\n<tr>\n<td>Anterior dislocation of hip and shaft femur fracture</td>\n<td>Femoral nerve</td>\n</tr>\n<tr>\n<td>Knee dislocation</td>\n<td>Common peroneal nerve</td>\n</tr>\n<tr>\n<td>Proximal tibial fractures and ankle injury</td>\n<td>Posterior tibial nerve</td>\n</tr>\n<tr>\n<td>Fracture neck of the fibula</td>\n<td>Lateral popliteal nerve (common peroneal nerve)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1935, 'Orthopaedics', 'PM2011. Plaster casts and their uses:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp; <strong>Name of cast</strong>&nbsp;&nbsp;</td>\n<td><strong>Usage</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Minerva cast</strong></p>\n</td>\n<td>Cervical and upper thoracic spine disease</td>\n</tr>\n<tr>\n<td>\n<p><strong>Risser’s cast</strong></p>\n</td>\n<td>Scoliosis&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Turn-buckle cast</strong></p>\n</td>\n<td>Scoliosis&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Shoulder spica</strong></p>\n</td>\n<td>Shoulder immobilization&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>U-slab/hanging cast</strong></p>\n</td>\n<td>Fracture of the humerus&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hip spica</strong></p>\n</td>\n<td>Fracture of the femur</td>\n</tr>\n<tr>\n<td>\n<p><strong>Patellar tendon bearing cast</strong></p>\n</td>\n<td>Fracture of tibia</td>\n</tr>\n<tr>\n<td>\n<p><strong>Colle’s cast (handshaking)</strong></p>\n</td>\n<td>Fracture lower end radius</td>\n</tr>\n<tr>\n<td>\n<p><strong>Bachelor cast</strong></p>\n</td>\n<td>Developmental Dysplasia of Hip</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glass holding cast</strong></p>\n</td>\n<td>Fracture scaphoid</td>\n</tr>\n<tr>\n<td>\n<p><strong>Burkhalter cast</strong></p>\n</td>\n<td>Metacarpal or phalangeal fractures</td>\n</tr>\n<tr>\n<td>\n<p><strong>James slab</strong></p>\n</td>\n<td>Metacarpal and phalangeal fracture&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2ddfb024ce794679a717efd532820487x1280x4597.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1936, 'Orthopaedics', 'PM1997. Gustilo and Anderson classification for open fracture', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\5\><strong>Gustilo-Andersons classification for open injuries</strong>&nbsp;&nbsp;&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>Wound</strong></td>\n<td><strong>Level of contamination</strong></td>\n<td><strong>Soft tissue injury</strong></td>\n<td><strong>Bone injury</strong></td>\n</tr>\n<tr>\n<td><strong>I</strong></td>\n<td>&lt;1 cm</td>\n<td>Clean</td>\n<td>Minimal</td>\n<td>Simple, minimal comminution</td>\n</tr>\n<tr>\n<td><strong>II</strong></td>\n<td>&gt;1 cm</td>\n<td>Moderate</td>\n<td>Moderate; some muscle damage</td>\n<td>Moderate comminution</td>\n</tr>\n<tr>\n<td><strong>IIIA</strong></td>\n<td>usually &gt;10 cm</td>\n<td>High</td>\n<td>Severe with crushing</td>\n<td>Usually comminuted; soft tissue coverage of bone possible</td>\n</tr>\n<tr>\n<td><strong>IIIB</strong></td>\n<td>usually &gt;10 cm</td>\n<td>High</td>\n<td>Very severe loss of cover</td>\n<td>Bone cover poor; usually requires soft tissue reconstructive surgery</td>\n</tr>\n<tr>\n<td><strong>IIIC</strong></td>\n<td>usually &gt;10 cm</td>\n<td>High</td>\n<td>Very severe loss of cover; <strong>vascular injury</strong> requiring repair</td>\n<td>Bone cover poor; usually requires soft tissue reconstructive surgery</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><span><br>Management according to Gustilo-Andersons classification:</span></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Types</strong></td>\n<td><strong>Methods of fixation</strong></td>\n</tr>\n<tr>\n<td><strong>Grade &nbsp;I &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</strong></td>\n<td>A technique that is suitable for closed fracture management i.e, debridement and internal fixation by intramedullary nail and plate&nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Grade II, IIIA</strong></td>\n<td>\n<p>Within 6hr same as grade I and after 6hr same as IIIB, IIIC</p>\n</td>\n</tr>\n<tr>\n<td><strong>Grade IIIB, IIIC</strong></td>\n<td>\n<p>Debridement and external fixation</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1937, 'Orthopaedics', 'PM0704. Types of Salter–Harris fractures- Mnemonic', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>There are <strong>nine types</strong> of Salter-Harris fractures. Among these, types I to V are more common.</p>\n<p>The mnemonic \<strong>SALTER</strong>\ can be used to help remember the first five types.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>TYPE&nbsp;</strong></td>\n<td><strong>MNEMONIC</strong></td>\n<td><strong>DESCRIPTION</strong></td>\n</tr>\n<tr>\n<td><strong>Type I </strong></td>\n<td><strong> S</strong> = Slip/straight across</td>\n<td>Transverse fracture through the growth plate</td>\n</tr>\n<tr>\n<td><strong>Type II</strong></td>\n<td><strong>A</strong> = Away</td>\n<td>The fracture lies away from the joint. A fracture through the growth plate and the metaphysis, sparing the epiphysis</td>\n</tr>\n<tr>\n<td><strong>Type III </strong></td>\n<td><strong>L</strong> = Lower</td>\n<td>The fracture is below the physis in the epiphysis.</td>\n</tr>\n<tr>\n<td><strong>Type IV</strong></td>\n<td><strong>TE</strong> = Through Everything</td>\n<td>&nbsp;A fracture through all three elements of the bone, the growth plate, metaphysis, and epiphysis</td>\n</tr>\n<tr>\n<td><strong>Type V </strong></td>\n<td><strong>R</strong> = Rammed (crushed)</td>\n<td>&nbsp;A compression fracture of the growth plate</td>\n</tr>\n</tbody>\n</table>\n<p>Rarer types VI to IX have been added subsequently.</p>\n<div class=\topbullet\>\n<ul>\n<li><strong>Type VI</strong>&nbsp;- Injury to the perichondral structures</li>\n<li><strong>Type VII</strong>&nbsp;- Isolated injury to the epiphyseal plate</li>\n<li><strong>Type VIII</strong>&nbsp;- Isolated injury to the metaphysis, with a potential injury related to endochondral ossification</li>\n<li><strong>Type IX</strong>&nbsp;- Injury to the periosteum that may interfere with membranous growth</li>\n</ul>\n</div>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/70d16f2f00854a4394a72ef62cee9855x1280x2934.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1938, 'Orthopaedics', 'PM0655. Pathological fracture', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Pathological f</strong><span class=\fontstyle0\><strong>ractures</strong> occur with normal stresses in the bones that have been weakened by a change in its structure or through a lytic lesion.</span></p>\n<p><strong>Factors suggestive of a pathologic fracture:</strong></p>\n<ul>\n<li>Fracture after minor trauma</li>\n<li>Pain at the site before the fracture</li>\n<li>Multiple recent fractures</li>\n<li>History of primary malignancy</li>\n</ul>\n<p><strong>Causes:</strong></p>\n<p><strong>1. Generalized bone disease:</strong>&nbsp;</p>\n<ul>\n<li>Osteoporosis</li>\n<li>Metabolic bone diseases</li>\n<li>Osteogenesis imperfecta</li>\n<li>Pagets disease</li>\n<li>Polyostotic fibrous dysplasia</li>\n<li>Myelomatosis</li>\n</ul>\n<p><strong>2. Local benign conditions:</strong></p>\n<ul>\n<li>Chronic infection</li>\n<li>Solitary bone cyst</li>\n<li>Aneurysmal bone cyst</li>\n<li>Chondroma</li>\n</ul>\n<p><strong>3. Primary malignant tumors:</strong></p>\n<ul>\n<li>Chondrosarcoma</li>\n<li>Osteosarcoma</li>\n<li>Ewings tumor</li>\n</ul>\n<p><strong>4. Metastatic tumors</strong></p>\n<ul>\n<li>Mets from breast, lung, kidney, thyroid, colon and prostate</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1939, 'Orthopaedics', 'PM0650. Torticollis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/546443ca02414588bac937884f106e6bx1280x1386.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Torticollis</strong> is a cervical deformity in which the head is rotated and tilted towards one side, with some lateral rotation.</p>\n<p><strong>Causes:</strong></p>\n<ul>\n<li class=\p1\><strong>Congenital torticollis (infantile torticollis)- </strong>\n<ul>\n<li class=\p1\>More common</li>\n<li class=\p1\>Caused due to:\n<ul>\n<li class=\p1\>Malposition in utero</li>\n<li class=\p1\>Birth injury in difficult labour or breech delivery</li>\n</ul>\n</li>\n<li class=\p1\>It is due to sternocleidomastoid (SCM) muscle fibrosis</li>\n</ul>\n</li>\n<li class=\p1\><strong>Secondary torticollis</strong>&nbsp;is an acquired condition and can result due to infections, tumours, inflammatory disorders or trauma.</li>\n</ul>\n<p><strong><span class=\fontstyle0\>Clinical features:</span></strong></p>\n<ul>\n<li class=\p1\>Head tilt towards the affected side,&nbsp;face rotated towards the contralateral shoulder (<strong>cock robin position</strong>).</li>\n<li class=\p1\>A palpable nodule in the affected sternocleidomastoid muscle in the first few weeks after birth, disappearing within a few months.</li>\n<li class=\p1\>Asymmetry of the face (hemihypoplasia) and flattening of one side of the skull (plagiocephaly) may be present.&nbsp;</li>\n</ul>\n<p><strong>Management:</strong></p>\n<ul>\n<li>Conservative treatment:&nbsp;Stretching of the SCM muscle by&nbsp;manipulating the infant’s head manually.&nbsp;</li>\n<li>Operative management: Release of SCM muscle<strong>. </strong>It is delayed until school age.&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1940, 'Orthopaedics', 'PM2325. Methods of reduction of shoulder dislocation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Kochers technique</strong> - TEAM (<strong>T</strong>raction <strong>→</strong>&nbsp;<strong>E</strong>xternal Rotation →&nbsp;<strong>A</strong>dduction →&nbsp;<strong>M</strong>edial Rotation)&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/25d97ccf3047455eb3bec691261b5711x510x568.GIF\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Hippocratic method&nbsp;</strong>- The doctor applies a firm and steady pull on the semi-abducted arm of the patient by keeping his foot on the axilla against the chest wall. The foot is used as the fulcrum.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/563adb46a7004d0a994680906a860148x1280x1055.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Stimsons gravity technique: </strong>Patient is left prone and weight is attached to the elbow or wrist on the affected side. Gravity stretches the muscle and reduction occurs in 15-20 minutes.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cf4dba09b0144793bb5cbeccef5b9e82x1280x1817.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1941, 'Orthopaedics', 'PM2324. Common dislocations at different joints', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>&nbsp;Common dislocation at different joints</strong></td>\n</tr>\n<tr>\n<td><strong>Shoulder</strong></td>\n<td>Anterior&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Elbow</strong></td>\n<td>Posterior and posterolateral</td>\n</tr>\n<tr>\n<td><strong>Wrist</strong></td>\n<td>Lunate</td>\n</tr>\n<tr>\n<td><strong>Spine</strong></td>\n<td>Cervical Spine (anterior C5 over C6)</td>\n</tr>\n<tr>\n<td><strong>Hip</strong></td>\n<td>Posterior</td>\n</tr>\n<tr>\n<td><strong>Knee</strong></td>\n<td>Posterior</td>\n</tr>\n<tr>\n<td><strong>Patella</strong></td>\n<td>Lateral</td>\n</tr>\n<tr>\n<td><strong>Ankle</strong></td>\n<td>Anterolateral</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1942, 'Orthopaedics', 'PM2203. Important tests and signs to assess the function of rotator cuff muscles', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Tests</strong></td>\n<td><strong>Muscles tested</strong></td>\n</tr>\n<tr>\n<td>\n<p>Empty can test</p>\n</td>\n<td>&nbsp;Supraspinatus</td>\n</tr>\n<tr>\n<td>Resisted external rotation</td>\n<td>&nbsp;Infraspinatus</td>\n</tr>\n<tr>\n<td>\n<p>Lift-off test</p>\n<p>Belly press test</p>\n</td>\n<td>&nbsp;Subscapularis</td>\n</tr>\n<tr>\n<td>\n<p>Abduction paradox</p>\n<p>Drop arm sign</p>\n</td>\n<td>&nbsp;Seen in the complete&nbsp; &nbsp;rupture of rotator cuff</td>\n</tr>\n<tr>\n<td>&nbsp;Lag sign</td>\n<td>&nbsp;Seen in tear of&nbsp; &nbsp;supraspinatus or&nbsp; &nbsp;infraspinatus</td>\n</tr>\n<tr>\n<td>&nbsp;Drop sign</td>\n<td>&nbsp;Seen in the tear in the&nbsp; &nbsp;infraspinatus and the&nbsp; &nbsp;posterior part of the&nbsp; &nbsp;rotator cuff</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1943, 'Orthopaedics', 'PM2125. Mechanisms of Injury around the elbow', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>&nbsp; &nbsp; &nbsp;</strong></p>\n<table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>Mechanism&nbsp;of injury</strong></p>\n</td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Injury</strong></td>\n</tr>\n<tr>\n<td><strong>Valgus injury</strong></td>\n<td>\n<ul>\n<li>Fracture head and neck of the radius</li>\n<li>Fracture of medial epicondyle of humerus</li>\n<li>Ulnar collateral ligament injury</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Varus injury</strong></td>\n<td>\n<ul>\n<li>Fracture of lateral epicondyle of humerus</li>\n<li>Radial collateral ligament injury</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Hyperextension injury</strong></td>\n<td>\n<ul>\n<li>Supracondylar fracture humerus</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Axial force</strong></td>\n<td>\n<ul>\n<li>Fracture of capitulum</li>\n<li>Dislocation of the elbow</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Fall on the point of the elbow</strong></td>\n<td>\n<ul>\n<li>Olecranon fracture</li>\n<li>Intercondylar fractures of the humerus</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a12ca8cd3a714175a8b833f27b1767e8x1280x2560.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1944, 'Orthopaedics', 'PM2052. Important conditions of the elbow:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<strong>Condition&nbsp;</strong></span></td>\n<td><span>&nbsp; <strong>Description</strong> &nbsp; &nbsp; &nbsp;</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Tennis elbow</strong></span></p>\n</td>\n<td>\n<p><span>Lateral epicondylitis involving common extensor origin</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Golfers elbow</strong></span></p>\n</td>\n<td>\n<p><span>Medial epicondylitis involving the common flexor-pronator origin</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Baseball pitchers elbow</strong></span></p>\n</td>\n<td>\n<p><span>Damage to the bones or soft tissue attached around the elbow d</span><span>ue to repeated vigorous throwing activities. Hypertrophy of the lower humerus and incongruity of the joint, or loose body formation and osteoarthritis</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Little leaguers elbow</strong></span></p>\n</td>\n<td><span>Partial avulsion of the medial epicondyle</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Javelin throwers elbow</strong></span></p>\n</td>\n<td><span>Avulsion of the tip of olecranon due to overarm action</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Students elbow/Miners elbow</strong></span></p>\n</td>\n<td><span>Olecranon bursitis</span></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Pulled elbow/Nurse maids elbow</strong></span></p>\n</td>\n<td><span>Downward dislocation of the radial head from the annular ligament</span></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1945, 'Orthopaedics', 'PM2033. Important Injuries of the Hand', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Gamekeepers thumb:&nbsp;</strong>It is an injury of the thumb leading to avulsion, rupture or damage of the <strong>ulnar collateral ligament</strong>. It is commonly seen in gamekeepers and following a fall on an outstretched hand.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a2dcf1df7aa547569edb9b23b5b4fe4ex1280x1222.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\mod\>\n<div class=\qtR3Y\>&nbsp;</div>\n<div class=\qtR3Y\><span class=\Y0NH2b CLPzrc\><strong>Mallet finger</strong>/baseball finger: It is a disruption to the <strong>extensor tendon</strong>&nbsp;over the DIP joint. It occurs when a collision with a&nbsp;hard object (e.g., a ball) forces it to flex more than its normal range of motion.</span></div>\n</div>\n<div class=\g\>&nbsp;</div></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e6f1cb40d29a4415833349642c8a605bx1280x844.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Jersey finger</strong>:&nbsp;It is an avulsion injury of the <strong>flexor digitorum profundus</strong> at the insertion of the base of the distal phalanx. The ring finger most commonly involved.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9c2040ddd70745199f16395e93f78b58x1280x988.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Trigger finger</strong>: A <strong>nodule</strong> on the flexor tendon prevents it from moving along the A1 pulley. This causes the finger to be stuck in a flexed position.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3deb8ddc550345bc883002661184a0d4x1280x1157.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Boxers fracture</strong>: It<span class=\Y0NH2b CLPzrc\>&nbsp;is a&nbsp;break&nbsp;in the<strong> neck of the metacarpal</strong>. It is caused by&nbsp;striking an object<strong>&nbsp;</strong>with a closed fist, as seen in boxing. The little finger is the most commonly affected.&nbsp;</span></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1ea28df97a50400b87329ff762655acax1280x1179.JPEG\><!---->\n      </div><!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1946, 'Orthopaedics', 'PM2016. Complications of Colle’s fracture:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Joint stiffness:&nbsp;</strong>Finger stiffness is the <strong>most common</strong> complication. Wrist, elbow, and shoulder are the other joints that become stiff</li>\n<li><strong>Malunion</strong> is the <strong>second most common</strong> complication, and it leads to the \dinner fork\ deformity</li>\n<li>Sudeck’s osteodystrophy/reflex sympathetic dystrophy. Colle’s fracture is the <strong>most</strong> <strong>common</strong> cause of Sudeck’s dystrophy in upper limb</li>\n<li>Rupture of extensor pollicis longus tendon</li>\n<li>Carpal instability&nbsp;</li>\n<li>Triangular-fibro cartilage complex (TFCC) injury and subluxation of the inferior radio-ulnar joint</li>\n<li>Delayed union and non-union are <strong>extremely rare</strong></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1947, 'Orthopaedics', 'PM2015. Tension Band Wiring', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>A&nbsp;<strong>tension band wire</strong>&nbsp;is a form of internal fixation used to convert distraction forces into compression forces, promoting bone healing.</p>\n<p>It is used in:</p>\n<ul>\n<li>Fracture patella</li>\n<li>Fracture olecranon&nbsp;</li>\n<li>Fracture lateral malleolus</li>\n<li>Fracture greater trochanter</li>\n</ul>\n<p>The below image shows tension band wiring for a fracture olecranon</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/7ae08a62681e4cda9a000bc8e7bf2c71x1280x1994.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1948, 'Orthopaedics', 'PM2014. Fractures of necessity', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Fractures of necessity are those that require surgery for management. These include:</p>\n<ul>\n<li>Lateral condyle fracture humerus&nbsp;</li>\n<li>Displaced fractured of olecranon and patella</li>\n<li>Fracture neck of femur</li>\n<li>Galeazzi fracture-dislocation&nbsp;</li>\n<li>Monteggia fracture in adults</li>\n<li>Intra-articular fractures</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1949, 'Orthopaedics', 'PM2013. Three point bony relationship in elbow:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The&nbsp;<strong>three bony points in the elbow</strong> are&nbsp;:</p>\n<ul>\n<li>Tip of the&nbsp;medial epicondyle</li>\n<li>Tip of the&nbsp;lateral epicondyle</li>\n<li>Olecranon</li>\n</ul>\n<p>When the <strong>elbow</strong> is in <strong>90 degrees of flexion</strong>, these points form an&nbsp;isosceles <strong>triangle</strong>. When the elbow is <strong>extended</strong>, they lie transversely in a<strong> straight line</strong>.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c00eaa4fd8a34f2bbe183c84122fea27x1280x1409.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The three-point bony relationship is <strong>maintained</strong> in the case of <strong>supracondylar fracture of the humerus</strong> as the fracture occurs above the level of these bony landmarks.</p>\n<p>Conditions where it is <strong>distorted</strong>:</p>\n<ul>\n<li>Fracture medial condyle and epicondyle</li>\n<li>Fracture lateral condyle and epicondyle</li>\n<li>Intercondylar fracture of humerus</li>\n<li>Fracture olecranon</li>\n<li>Elbow dislocation</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1950, 'Orthopaedics', 'PM2009. Tests for anterior shoulder dislocation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Bryant’s test:&nbsp;</strong>Anterior axillary fold is at a lower level on the dislocated side.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f233d810676246f6a010e89a0a5a0bddx1280x1412.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Dugas test: </strong>The patient is made to place the hand on the opposite shoulder. The examiner then applies gentle pressure on the flexed elbow to make it touch the chest. In shoulder dislocation, the elbow cannot be made to touch the chest.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/993e9fb89e9346deaebb6a42ea3bd38ex600x749.GIF\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Hamilton ruler test:&nbsp;</strong>In a&nbsp;normal shoulder, a ruler (scale) placed on the lateral side of the arm will not touch the lateral condyle of the humerus and the acromion at the same time.</p>\n<p>In anterior shoulder dislocation, the ruler will simultaneously touch the lateral condyle of the humerus and the acromion.&nbsp;</p>\n<p class=\p1\>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4b10dd054e604dde8a83037dfb07e741x1280x1526.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p class=\p1\>&nbsp;</p>\n<p class=\p1\><strong>Callway Test:&nbsp;</strong>The vertical circumference of the axilla is increased on the dislocated side as compared to the normal side.&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/be589ce9527049c88a0adac7b0f18aa4x1280x1412.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1951, 'Orthopaedics', 'PM2001. Named classification systems for  fractures and dislocations', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Classification</strong></span></p>\n</td>\n<td><span><strong>Site</strong></span></td>\n</tr>\n<tr>\n<td>\n<p>Stanmore Instability Classification</p>\n</td>\n<td>Shoulder instability&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Neer’s&nbsp;</p>\n</td>\n<td>Fracture proximal humerus&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Gartland’s</p>\n</td>\n<td>Supracondylar fracture humerus&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Milch’s</p>\n</td>\n<td>&nbsp;Fracture lateral condyle of humerus</td>\n</tr>\n<tr>\n<td>\n<p>Mayo classification</p>\n</td>\n<td>Olecranon fracture</td>\n</tr>\n<tr>\n<td>Denis and AO/ASIF</td>\n<td>Fracture spine</td>\n</tr>\n<tr>\n<td>Anderson and D’Alonzo</td>\n<td>Odontoid fracture</td>\n</tr>\n<tr>\n<td>\n<p>Ferguson and Allen classification</p>\n<p>Subaxial Cervical Spine Injury Classification (SLIC)</p>\n</td>\n<td>Fracture subaxial cervical spine (C3-C7)&nbsp;</td>\n</tr>\n<tr>\n<td>AO-Magerl classification</td>\n<td>Thoracolumbar spine fractures</td>\n</tr>\n<tr>\n<td>Wiltse−Newman classification</td>\n<td>Spondylolisthesis&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Tile classification</p>\n<p>Young and Burgess classification</p>\n</td>\n<td>&nbsp;Pelvis</td>\n</tr>\n<tr>\n<td>\n<p>Judet,</p>\n<p>Letournel’s</p>\n</td>\n<td>Fracture acetabulum&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Pauwel’s</p>\n<p>Garden’s</p>\n</td>\n<td>Fracture neck of femur</td>\n</tr>\n<tr>\n<td>\n<p>Pipkin’s</p>\n</td>\n<td>Fracture head of femur</td>\n</tr>\n<tr>\n<td>\n<p>Boyd &amp; Griffin</p>\n</td>\n<td>Fracture inter trochanter femur</td>\n</tr>\n<tr>\n<td>\n<p>Thompson and Epstein’s</p>\n</td>\n<td>Posterior dislocation of the hip</td>\n</tr>\n<tr>\n<td>Winquist and Hansen’s</td>\n<td>\n<p>Fracture shaft of femur</p>\n</td>\n</tr>\n<tr>\n<td>Hawkin’s</td>\n<td>\n<p>Fracture neck of talus</p>\n</td>\n</tr>\n<tr>\n<td>Bados&nbsp;</td>\n<td>\n<p>Monteggia fracture dislocations&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1952, 'Orthopaedics', 'PM2000. Test for evaluation of glenohumeral joint instability in recurrent dislocation.', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>1. Anterior instability:</strong></p>\n<p><strong>Anterior apprehension test:&nbsp;</strong>In general these manoeuvre mimics the positioning of subluxation or dislocation, application of a force that directs humeral head into abducation and external rotation results in patients apprehension that the joint will dislocate and the patient does not allow the test to be performed.</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8fd48417fd4c49e283b0917a901b3180x227x214.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;Variations include:</p>\n<ul>\n<li><strong>fulcrum test&nbsp;</strong></li>\n<li><strong>crank test</strong></li>\n<li><strong>surprise test</strong></li>\n<li><strong>jobe relocation test</strong></li>\n</ul>\n<p>2. Posterior<strong> instability </strong>(here adduction and internal rotation force is applied):</p>\n<ul>\n<li><strong>Jerk (provocative)test</strong></li>\n<li><strong>posterior apprehension test</strong></li>\n<li><strong>posterior clunk test</strong></li>\n<li><strong>push-pull test.</strong></li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1c5af6fef4244360a6267c72e1332c09x600x298.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>3. Inferior stability test and sign </strong>(indicative of multidirectional instability):</p>\n<ul>\n<li><strong>Sulcus test:&nbsp;</strong>with the patient standing,grasp the arm and pull it down, if there is inferior instability a sulcus will appear between the acromian and the humeral head.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/575b14ad1fc742d7ae6911628a99c864x200x249.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1953, 'Orthopaedics', 'PM1418. Management of Pulseless Supracondylar Fracture', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/91f7ec643add4389971a527b6e830a13x1280x1571.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1954, 'Orthopaedics', 'PM1336. Common X-Ray views', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Schullers view:</strong> Mastoid and temporal bone&nbsp;</p>\n<p><strong>Open mouth view:</strong> Odontoid</p>\n<p><strong>Waters view:</strong>&nbsp;Paranasal sinuses</p>\n<p><strong>Swimmers view:</strong> Cervicothoracic junction</p>\n<p><strong>Stryker notch view:</strong> Hillsachs lesion</p>\n<p><strong>West point axillary view</strong>: Bankarts lesion&nbsp;</p>\n<p><strong>Zanca view:</strong> Acromioclavicular joint</p>\n<p><strong>Oblique view:</strong> Scaphoid</p>\n<p><strong>Judet view:</strong> Acetabulum</p>\n<p><strong>Shentons arch:</strong> Pelvis</p>\n<p><strong>Von Rosen view</strong>: Developmental dysplasia of hip</p>\n<p><strong>Skyline view:</strong> Patella</p>\n<p><strong>Mortise view:</strong> talus&nbsp;</p>\n<p><strong>Brodens view: </strong>Subtalar joint</p>\n<p><strong>Kites view:</strong> CTEV</p></div><!---->\n      <!---->\n    </div><!---->'),
(1955, 'Orthopaedics', 'PM1099. Important angles used in the diagnosis of Orthopedic conditions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Angles</strong></td>\n<td><strong>Conditions&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Carrying angle</td>\n<td>Cubitus varus and cubitus valgus</td>\n</tr>\n<tr>\n<td>Baumanns angle</td>\n<td>Elbow fractures</td>\n</tr>\n<tr>\n<td>Cobbs angle</td>\n<td>Scoliosis</td>\n</tr>\n<tr>\n<td>\n<p>Alpha angle</p>\n<p>Beta angle</p>\n</td>\n<td>Developmental dysplasia of hip</td>\n</tr>\n<tr>\n<td>Southwick angle</td>\n<td>Slipped capital femoral epiphysis</td>\n</tr>\n<tr>\n<td>Neck shaft angle</td>\n<td>Coxa vara</td>\n</tr>\n<tr>\n<td>Q angle</td>\n<td>Patellar alignment</td>\n</tr>\n<tr>\n<td>Kites angle&nbsp;</td>\n<td>Congenital talipes equinus varus</td>\n</tr>\n<tr>\n<td>Mearys angle</td>\n<td>Pes cavus</td>\n</tr>\n<tr>\n<td>\n<p>Bohlers angle</p>\n<p>Gissanes angle</p>\n</td>\n<td>Fracture of calcaneum</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1956, 'Orthopaedics', 'PM0651. Medial and lateral epicondylitis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Tennis elbow or Lateral epicondylitis</strong></p>\n<ul>\n<li>Pain is felt over or below the&nbsp;<strong>lateral epicondyle&nbsp;</strong>of the humerus</li>\n<li>Pain is aggravated by lifting movements</li>\n<li>It is common among tennis players and in those who perform repetitive wrist extension</li>\n<li><strong>Extensor carpi radialis brevis tendon</strong>&nbsp;is commonly involved</li>\n</ul>\n<p><strong>Tests:</strong></p>\n<ul>\n<li><strong>Cozens test: </strong>The patient is asked to pronate the forearm and make&nbsp;a tight fist.&nbsp; Wrist extension against resistance causes pain at the lateral epicondyle</li>\n<li><strong>Mills sign</strong>: Pain at the lateral condyle when the elbow is extended in pronation with a flexed wrist</li>\n<li><strong>Wringing test:</strong> The patient is asked to wring a towel. Pain is felt at the lateral epicondyle in the tennis elbow</li>\n<li><strong>Maudsleys test:&nbsp;</strong>Resisted extension of the middle finger produces pain at the lateral epicondyle</li>\n</ul>\n<p class=\p1\><strong>Treatment:</strong>&nbsp;</p>\n<ul>\n<li><strong>Conservative treatment: </strong>Activity modification and usage of a tennis elbow clasp are sufficient in most cases. Corticosteroid and local anesthetic injections into the tender area may reduce the pain, but is not curative</li>\n<li><strong>Operative treatment: </strong>Detachment of the common extensor muscle from the lateral epicondyle</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8353b774c9954354acd313d2e446a07cx1200x1737.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Golfers elbow or Medial epicondylitis</strong></p>\n<ul>\n<li>Pain is felt over the medial epicondyle of the humerus where pronators have their origin</li>\n<li>Associated with ulnar nerve neuropathy</li>\n<li>Less common than tennis elbow</li>\n</ul>\n<p><strong>Tests:</strong></p>\n<ul>\n<li><strong>Reverse Cozen</strong>: The elbow is kept in slight flexion with the hand and wrist in supination. The examiner attempts to extend the elbow, while the patient is asked to resist this movement with active flexion. If pain is elicited at the medial epicondyle, it suggests golfer’s elbow</li>\n</ul>\n<p><strong>Treatment:</strong>&nbsp;</p>\n<ul>\n<li><strong>Conservative treatment:&nbsp;</strong>Activity modification and pain killers is sufficient in most cases</li>\n<li><strong>Operative treatment:&nbsp;</strong>&nbsp;Excision of the abnormal tendons at the flexor-pronator origin</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/87634f9e04f24b56a296745d43275e9bx1280x1066.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1957, 'Orthopaedics', 'PM0649. Named fractures of the upper limb', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Colles fracture</strong>: Extra-articular fracture of the distal radius with dorsal angulation of the distal bone fragment.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/65a93223993740c495daa155786048ccx1280x1420.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Galeazzi fracture-dislocation</strong>: Fracture of the lower third of the radius and subluxation of the distal radio-ulnar joint.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/46eff51c35a54ce08988149eed8e8e96x1279x1421.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Monteggia fracture-dislocation</strong>:<strong>&nbsp;</strong>Fracture of the shaft of the ulna with dislocation of a proximal radio-ulnar joint.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8cf2fa6ca59d47d79f5eed22bbb29c38x1280x2778.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Barton’s fracture</strong>: Intra-articular fracture of the distal radius. Bartons fracture can be dorsal or volar (reverse Bartons).</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/811391f8302644efb808c405e35235efx1280x1891.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Rolandos fracture</strong>: Intra-articular comminuted fracture of the base of the first metacarpal with a T or Y configuration.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c3bec28a9c1a41b1bc3d923a6dd0cd96x1280x1316.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Smiths fracture</strong>: Reverse Colles fracture. Extra-articular fracture of the distal one-third of the radius with palmar or ventral displacement (Image below).</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/92ac8de8dac8499a8f31180cc8e83371x1280x1133.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Chauffeurs fracture or the Hutchinson fracture</strong>: Fracture of the radial styloid.</p>\n<p><strong>Essex–Lopresti lesion</strong>: Fracture of the radial head with disruption of the interosseous membrane and distal&nbsp;radial ulnar joint ligaments.</p>\n<p><strong>Nightstick fracture</strong>: Isolated fracture of radial or ulnar bone.&nbsp;&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1958, 'Orthopaedics', 'PM2408. Anterior and posterior dislocation of the hip', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Anterior dislocation</strong></td>\n<td><strong>Posterior dislocation</strong></td>\n</tr>\n<tr>\n<td>Prevalence</td>\n<td>Less common</td>\n<td>Most common</td>\n</tr>\n<tr>\n<td>Type of injury</td>\n<td>Deceleration injury/ Fall from height</td>\n<td>Dashboard injury</td>\n</tr>\n<tr>\n<td>Attitude of the limb</td>\n<td>Flexion, abduction, external rotation (FABER)</td>\n<td>Flexion, adduction, internal rotation (FADIR)</td>\n</tr>\n<tr>\n<td>Length of the limb</td>\n<td>Lengthened</td>\n<td>Shortened</td>\n</tr>\n<tr>\n<td>Radiological findings</td>\n<td>\n<ul>\n<li>Femoral head may be seen inferior to the acetabulum</li>\n<li>Femoral head appears <strong>larger</strong> than normal&nbsp;</li>\n<li>Lesser trochanter is <strong>prominent</strong></li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Femoral head is displaced superiorly and laterally</li>\n<li>Femoral head appears <strong>smaller</strong> than normal</li>\n<li>Lesser trochanter is not visualised</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Nerve injured</td>\n<td>&nbsp;Femoral nerve</td>\n<td>&nbsp;Sciatic nerve</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1959, 'Orthopaedics', 'PM2221. Named fractures of the lower limb', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Fracture</strong></td>\n<td><strong>Location</strong></td>\n</tr>\n<tr>\n<td>Hoffa fracture</td>\n<td>Coronal fracture of femoral condyles</td>\n</tr>\n<tr>\n<td>Bumper fracture</td>\n<td>Comminuted fracture of lateral condyle of tibia&nbsp;</td>\n</tr>\n<tr>\n<td>Pilon fracture</td>\n<td>Comminuted intra-articular fracture of the distal end of the tibia&nbsp;</td>\n</tr>\n<tr>\n<td>Tillaux fracture</td>\n<td>Avulsion fracture of the tibia by the anterior tibiofibular ligament</td>\n</tr>\n<tr>\n<td>Runners fracture</td>\n<td>Fracture of the distal shaft of fibula&nbsp;</td>\n</tr>\n<tr>\n<td>Pott’s fracture</td>\n<td>Bimalleolar ankle fracture</td>\n</tr>\n<tr>\n<td>Cotton’s fracture</td>\n<td>Trimalleolar ankle fracture</td>\n</tr>\n<tr>\n<td>Aviators fracture</td>\n<td>Fracture of neck of talus</td>\n</tr>\n<tr>\n<td>Chopart’s fracture</td>\n<td>Fracture between talonavicular and calcaneocuboid joints&nbsp;</td>\n</tr>\n<tr>\n<td>Lisfranc’s fracture-dislocation</td>\n<td>Fracture of metatarsal bases with associated tarsometatarsal dislocation</td>\n</tr>\n<tr>\n<td>March fracture</td>\n<td>Fracture of the neck of 2<sup>nd</sup> or 3<sup>rd</sup> metatarsal</td>\n</tr>\n<tr>\n<td>Jones fracture</td>\n<td>\n<p>Extra-articular fracture at the base of the 5th metatarsal</p>\n</td>\n</tr>\n<tr>\n<td>Dancer’s fracture</td>\n<td>Fracture of distal shaft of the fifth metatarsal</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1960, 'Orthopaedics', 'PM2202. Treatment of fracture neck of femur', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/bb1c42274c1048e188d398495dcc963ex1280x1967.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1961, 'Orthopaedics', 'PM2178. Age wise treatment of fracture shaft of femur', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp;Age group</strong></td>\n<td><strong>&nbsp; &nbsp;Management</strong></td>\n</tr>\n<tr>\n<td>0 - 6 months</td>\n<td>Pavlik harness</td>\n</tr>\n<tr>\n<td>6 months - 5 years</td>\n<td>Spica casting</td>\n</tr>\n<tr>\n<td>5 - 10 years</td>\n<td>\n<p>Flexible intramedullary nails as they cannot tolerate prolonged immobilization by spica cast</p>\n</td>\n</tr>\n<tr>\n<td>&gt;10 years</td>\n<td>Locked intramedullary nail</td>\n</tr>\n</tbody>\n</table>\n<p>Gallows traction&nbsp;can be used in displaced fractures of the femoral shaft in children less than 2 years of age and weight less than 12kgs.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1962, 'Orthopaedics', 'PM2170. Treatment of Genu Valgum', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/78f85e8078cd405c8cc9fd0ed46eedc5x1081x914.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1963, 'Orthopaedics', 'PM2167. Primary and secondary deformities in Clubfoot', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Clubfoot complex</strong></p>\n<p>Primary deformities:</p>\n<ul>\n<li>Equinus</li>\n<li>Varus</li>\n<li>Cavus</li>\n<li>Forefoot adduction</li>\n<li>Internal tibial torsion</li>\n</ul>\n<p>Secondary deformities:</p>\n<ul>\n<li>Concave medial border and convex lateral border</li>\n<li>Reduced foot size</li>\n<li>Forefoot is plantarflexed</li>\n<li>Skin is stretched over dorsum of the foot</li>\n<li>Stumbling gait</li>\n<li>Atrophy of leg muscles</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1964, 'Orthopaedics', 'PM2034. Osteochondritis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Osteochondritis</strong></td>\n<td><strong>Bones affected</strong></td>\n</tr>\n<tr>\n<td>Kienbock</td>\n<td>Lunate</td>\n</tr>\n<tr>\n<td>Scheuermann</td>\n<td>Ring epiphysis of the vertebra</td>\n</tr>\n<tr>\n<td>Perthes</td>\n<td>Proximal femoral epiphysis &nbsp;</td>\n</tr>\n<tr>\n<td>Osgood-Schlatter</td>\n<td>Tibial tuberosity</td>\n</tr>\n<tr>\n<td>Sever</td>\n<td>Calcaneum</td>\n</tr>\n<tr>\n<td>Kohler</td>\n<td>Navicular bone</td>\n</tr>\n<tr>\n<td>Freiberg</td>\n<td>\n<p>Second</p>\n<p>(or 3rd,4th,5th)metatarsal head&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Iselin</td>\n<td>&nbsp;Fifth metatarsal base</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1965, 'Orthopaedics', 'PM1489. Commonly used splints and their indications', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Name of the Splint</strong></span></p>\n</td>\n<td>\n<p><span><strong>Uses</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Used in Lower Limbs</strong></span></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Thomas Splint</p>\n<p>Bohler-Braun splint</p>\n</td>\n<td>\n<p>Fracture femur</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Toe raising splint</p>\n</td>\n<td>\n<p>Foot drop</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dennis Brown splint</p>\n</td>\n<td>\n<p>CTEV</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>Used in Upper Limbs</strong></span></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Cock up splint</p>\n</td>\n<td>\n<p>Radial nerve palsy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Volkmanns turn buckle splint</p>\n<p>&nbsp;</p>\n</td>\n<td>Volkmanns ischemic contracture&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Knuckle bender splint</p>\n</td>\n<td>\n<p>Claw hand (Ulnar Nerve)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Aeroplane splint</p>\n</td>\n<td>\n<p>Brachial plexus injury</p>\n</td>\n</tr>\n<tr>\n<td><span><strong>Used for Spine</strong></span></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Milwaukee brace</p>\n<p>Boston brace</p>\n</td>\n<td>Scoliosis&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>SOMI brace</p>\n</td>\n<td>\n<p>Cervical spine injury</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>ASHE (anterior spinal hyperextension) brace&nbsp;</p>\n</td>\n<td>\n<p>Dorso lumbar spinal injury</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1966, 'Orthopaedics', 'PM2127. Neurological examination in Intervertebral disc prolapse (IVDP)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Disc affected</strong></td>\n<td><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; L3-L4</strong></td>\n<td><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; L4-L5</strong></td>\n<td><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; L5-S1</strong></td>\n</tr>\n<tr>\n<td><strong>Root usually compressed</strong></td>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; L4</td>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; L5</td>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S1</td>\n</tr>\n<tr>\n<td><strong>Reflex diminished</strong></td>\n<td>Knee jerk -Weakness of quadriceps femoris (Westphals sign)</td>\n<td>Medial hamstring reflex</td>\n<td>Ankle jerk - Achilles tendon</td>\n</tr>\n<tr>\n<td><strong>Motor weakness</strong></td>\n<td>\n<p>Quadriceps femoris</p>\n<p>Hip adductors</p>\n</td>\n<td>\n<p>Tibialis anterior</p>\n<p>Extensor hallucis longus</p>\n<p>Gluteus medius</p>\n<p>Extensor digitorum longus and brevis</p>\n</td>\n<td>\n<p>Peroneus longus and brevis</p>\n<p>Gastrocnemius-soleus complex</p>\n<p>Gluteus maximus</p>\n</td>\n</tr>\n<tr>\n<td><strong>Decreased sensation</strong></td>\n<td>\n<p>Posterolateral thigh</p>\n<p>Anterior knee</p>\n<p>Medial malleolus</p>\n<p>Medial foot</p>\n</td>\n<td>\n<p>Anterolateral leg</p>\n<p>Large toe web</p>\n<p>Dorsum of foot</p>\n</td>\n<td>\n<p>Lateral malleolus</p>\n<p>Lateral foot</p>\n<p>Heel</p>\n<p>Web of fourth and ﬁfth toes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Pain distribution</strong></td>\n<td>Anterior thigh</td>\n<td>Posterolateral leg</td>\n<td>Posterior leg, often involves ankle</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d1d2f65b960e47248ed30840a8739848x1280x2558.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1967, 'Orthopaedics', 'PM1477. Named fractures of the vertebra', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Burst&nbsp;</strong>fracture - <strong>Vertical</strong> compression injury</p>\n<p><strong>Chance</strong> fracture - <strong>horizontal</strong> fracture of the vertebral body</p>\n<p><strong>Clay-shovellers</strong> fracture -&nbsp;spinous process fracture of <strong>C6, C7 or T1</strong></p>\n<p><strong>Dens</strong> fracture - <strong>Odontoid</strong> process fracture</p>\n<p><strong>Hangmans</strong> fracture - fracture of both pedicles of <strong>C2</strong></p>\n<p><strong>Holdsworth</strong> fracture -&nbsp;unstable spinal fracture-dislocation at the <strong>thoracolumbar junction</strong></p>\n<p><strong>Jeffersons</strong> fracture - fracture of <strong>first</strong> cervical vertebra</p>\n<p><strong>Motorcyclists</strong>&nbsp;fracture - transverse fracture across <strong>base of the skull</strong></p>\n<p><strong>Whiplashs</strong> injury - hyperextension followed by flexion&nbsp;</p>\n<p><strong>Undertakers</strong> fracture -Post-mortem fracture of the lower cervical spine with <strong>C6-C7 disc disruption</strong>&nbsp;</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1968, 'Orthopaedics', 'PM1448. Coxa Vara', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The Hilgenreiners epiphyseal angle is the angle between the horizontal line joining the center of each hip and the line parallel to physis&nbsp;. Hilgenreiners angle is 30 degrees.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/8728bc31a6b348d6a890c22e562ce718x496x289.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1969, 'Orthopaedics', 'PM1420. Delbet Classification of Hip Fractures in Children', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e1be9d69c6f94670875cee8763c4a5f9x787x749.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><span class=\fontstyle0\>Type I </span><span class=\fontstyle2\>is a fracture-separation of the epiphysis, sometimes the epiphyseal fragment is dislocated from the acetabulum. </span></p>\n<p><span class=\fontstyle0\>Type II </span><span class=\fontstyle2\>is a transcervical fracture of the femoral neck; this is the commonest variety, accounting for almost half of the injuries.</span></p>\n<p><span class=\fontstyle0\>Type III </span><span class=\fontstyle2\>is a basal (cervico-trochanteric) fracture, the second most common injury. </span></p>\n<p><span class=\fontstyle0\>Type IV </span><span class=\fontstyle2\>is an intertrochanteric fracture</span> </p></div><!---->\n      <!---->\n    </div><!---->'),
(1970, 'Orthopaedics', 'PM1379. Ankylosing Spondylitis VS Diffuse idiopathic skeletal hyperostosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>&nbsp;</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;DISH</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; AS</strong></td>\n</tr>\n<tr>\n<td><strong>Etiology</strong></td>\n<td>Idiopathic</td>\n<td>Autoimmune</td>\n</tr>\n<tr>\n<td><strong>Age group</strong></td>\n<td>Older patients (middle-aged)</td>\n<td>Younger patients</td>\n</tr>\n<tr>\n<td><strong>HLA</strong></td>\n<td>No evidence of association with HLA-B27</td>\n<td>Strong association with HLA-B27</td>\n</tr>\n<tr>\n<td><strong>Lab investigations</strong></td>\n<td>Non-specific and inconclusive</td>\n<td>High ESR and CRP</td>\n</tr>\n<tr>\n<td><strong>Syndesmophytes</strong></td>\n<td>Nonmarginal</td>\n<td>Marginal</td>\n</tr>\n<tr>\n<td><strong>Radiograph</strong></td>\n<td>\Flowing candle wax\</td>\n<td>&nbsp;\Bamboo spine\&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Disc space</strong></td>\n<td>Preservation of disc space</td>\n<td>AS in cervical spine will show ossification of disc space&nbsp;</td>\n</tr>\n<tr>\n<td><strong>SI joint involvement</strong></td>\n<td>&nbsp;No involvement (SI joint abnormality generally&nbsp;excludes the&nbsp;diagnosis of DISH)</td>\n<td>&nbsp;Bilateral sacroiliitis</td>\n</tr>\n<tr>\n<td><strong>Associated disease</strong></td>\n<td>Obesity, diabetes mellitus, hypervitaminosis A</td>\n<td>Autoimmune conditions like iritis, uveitis, ulcerative colitis</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1971, 'Orthopaedics', 'PM1378. Important DD for Sacroiliitis in AS', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>&nbsp;</strong><strong>Osteitis condensans ilii</strong></p>\n<ul>\n<li>It occurs as mild to moderate SI joint pain in <strong>postpartum women of 30–40 years of age.</strong>. The symptoms are rarely severe, and the radiographic presentation is classic.</li>\n<li>The triangular sclerosis is <strong>confined to the iliac side of the SI joint</strong>, with <strong>no evidence of the destruction of the SI joint</strong> that occurs as in AS.</li>\n</ul>\n<p>The course of osteitis condensans ilii is almost <strong>always benign</strong>. Hence treatment consists of reassurance and use of analgesics.</p>\n<p>X-ray shows&nbsp;bilateral symmetrical triangular-shaped iliac sclerosis.&nbsp;The sacroiliac joints are normal width, without evidence of inflammatory arthropathy. No&nbsp;bony changes&nbsp;on the sacral side of the joint.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/88361f5894db4a03bf3949ec54018f22x389x390.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1972, 'Orthopaedics', 'PM1350. Differential Diagnosis of Lesions in Spine', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td width=\325\>\n<p><strong>Older than 40 years</strong></p>\n</td>\n<td width=\325\>\n<p><strong>Younger than 30 years</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\325\>\n<p><strong>Metastasis</strong></p>\n</td>\n<td width=\325\>\n<p><strong>Vertebral Body</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\325\>\n<p><strong>Multiple Myeloma</strong></p>\n</td>\n<td width=\325\>\n<p>Histiocytosis</p>\n</td>\n</tr>\n<tr>\n<td width=\325\>\n<p>Hemangioma</p>\n</td>\n<td width=\325\>\n<p>Hemangioma</p>\n</td>\n</tr>\n<tr>\n<td width=\325\>\n<p>Chordoma</p>\n</td>\n<td width=\325\>\n<p><strong>Posterior elements</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\325\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\325\>\n<p>Osteoid Osteoma</p>\n</td>\n</tr>\n<tr>\n<td width=\325\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\325\>\n<p>Osteoblastoma</p>\n</td>\n</tr>\n<tr>\n<td width=\325\>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td width=\325\>\n<p>Aneurysmal bone cyst</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1973, 'Orthopaedics', 'PM1189. Spondylolisthesis classification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>It is the displacement of a vertebra over the other in the <strong>anterior</strong> direction.&nbsp;</p>\n<p><strong>Meyerding Classification</strong> of spondylolisthesis</p>\n<table>\n<tbody>\n<tr>\n<td width=\239\>\n<p><strong>Grade</strong></p>\n</td>\n<td width=\239\>\n<p><strong>Displacement</strong></p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>I</p>\n</td>\n<td width=\239\>\n<p>0-25%</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>II</p>\n</td>\n<td width=\239\>\n<p>26-50%</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>III</p>\n</td>\n<td width=\239\>\n<p>51-75%</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>IV</p>\n</td>\n<td width=\239\>\n<p>76-100%</p>\n</td>\n</tr>\n<tr>\n<td width=\239\>\n<p>V (Spondyloptosis)</p>\n</td>\n<td width=\239\>\n<p>&gt;100%</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8da66fe5170144028f57ba0526eaf668x1059x562.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1974, 'Orthopaedics', 'PM1186. Classification of Congenital Scoliosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\313\>\n<tbody>\n<tr>\n<td>\n<p><strong>Classification of Congential Scoliosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Failure of formation\n<ul>\n<li>Partial failure of formation (wedge vertebra)</li>\n<li>Complete failure of formation (hemivertebra)</li>\n</ul>\n</li>\n<li>Failure of segmentation\n<ul>\n<li>Unilateral failure segmentation (unilateral unsegmented bar)</li>\n<li>Bilateral failure of segmentation (block vertebrate)</li>\n</ul>\n</li>\n<li>Miscellaneous</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(1975, 'Orthopaedics', 'PM1182. Chance Fracture', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Flexion-distraction mechanism of injury results in the <strong>Chance fracture</strong>, usually seen with the use of lap-belts in vehicles (Lap Belt injury).</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/2144df260a20451b9f00e59b8f4bd015x382x354.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1976, 'Orthopaedics', 'PM1181. Column Theory of Spine', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The column theory for vertebral fractures was put forth by Denis.</p>\n<ul>\n<li><strong><span class=\fontstyle0\>Anterior column </span></strong><span class=\fontstyle2\>composed of the anterior 2/3rd of the vertebral body, the anterior part of the intervertebral disc and the anterior longitudinal ligament.</span></li>\n<li><span class=\fontstyle0\><strong>Middle column</strong> </span><span class=\fontstyle2\>comprising the posterior 1/3rd of the vertebral body, the posterior part of the intervertebral disc and the posterior longitudinal ligament.</span></li>\n<li><span class=\fontstyle2\><span class=\fontstyle0\><strong>Posterior column</strong>&nbsp;</span>consists of the pedicles, facet joints, posterior bony arch, interspinous and supraspinous ligaments.</span></li>\n</ul>\n<p><span class=\fontstyle2\> <span class=\fontstyle0\>All fractures involving the middle column and at least one other column should be regarded as unstable.</span> <br> </span></p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(1977, 'Orthopaedics', 'PM1035. Bladder Injuries in Pelvic Fractures', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Because of its location behind the symphysis pubis, the bladder can be injured easily; extraperitoneal (EPBR) bladder rupture is common. In this type of injury, the urine may communicate with the pelvis.</li>\n<li>An intraperitoneal (IPBR) bladder rupture, which is often caused by compression on the distended bladder resulting in rupture of the dome, communicates with the peritoneal cavity but will not contaminate the pelvis</li>\n<li>Bladder injuries occur in up to 10% of pelvic ring fractures, with approximately 60% EPBR, 30% IPBR, and 10% both.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1978, 'Orthopaedics', 'PM1034. Spondylolisthesis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The indications for surgical management in spondylolisthesis are:</p>\n<ul>\n<li>Failure of conservative therapy</li>\n<li>Signs of root compression</li>\n<li>Progressive slipping</li>\n<li>Slip of more than 30% even when painless</li>\n<li>Persistent sciatica</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1979, 'Orthopaedics', 'PM1031. Scheuermann Disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Results from osteonecrosis of the ring apophysis of the vertebral body hence known as <strong>Vertebral Osteochondritis</strong>.</li>\n<li>Leads to rigid structural juvenile kyphosis. <strong>Thoracic involvement</strong> is the most common form.</li>\n<li>Usually appears around the <strong>adolescent growth spurt</strong>. The presenting complaint is either pain in the middle or lower back though concern about deformity is more common.</li>\n<li>Typical Radiographic finding is Schmorl Node - Small radiolucent defects in the subchondral bone.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1980, 'Orthopaedics', 'PM1030. Surgery in Scoliosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>The proper indications of surgery are:</p>\n<ul>\n<li>Curves&gt; 50 degrees in the mature patients</li>\n<li>Curves &gt; 10 degrees with marked rotations</li>\n<li>Double major curves&gt; 30 degrees</li>\n</ul>\n<p>Surgery is also indicated when the curve is over 60 degrees and aims at obtaining fusion at the spine. The most common form of surgical intervention in idiopathic scoliosis is the segmental instrumentation with the multi-back system.</p></div><!---->\n      <!---->\n    </div><!---->'),
(1981, 'Orthopaedics', 'PM1028. Risser Sign', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Rissers classification uses ossification of iliac apophysis to grade the remaining skeletal growth. The ossification progresses from lateral to medial:</p>\n<ul>\n<li>Grade 1- ossification of lateral 25%</li>\n<li>Grade 2- ossification of lateral 50%</li>\n<li>Grade 3- ossification of lateral 75%</li>\n<li>Grade 4- ossification of lateral 100%</li>\n<li>Grade 5- fusion of ilium</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1982, 'Orthopaedics', 'PM1022. SCIWORA', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>SCIWORA</strong>-&nbsp;<strong>S</strong>pinal <strong>C</strong>ord <strong>I</strong>njury <strong>W</strong>ithout <strong>R</strong>adiographic <strong>A</strong>bnormality.</p>\n<p>It is defined as a spinal cord injury in a patient with no visible fracture or dislocation on plain radiographs or CT scans.</p>\n<p>It is almost completely unique to <strong>children</strong>. It is believed to occur because the vertebral column (vertebrae and disc space) in children is more elastic than the spinal cord. Hence,&nbsp;the vertebral column in children can undergo considerable <strong>deformation</strong> without being disrupted. The vertebral column in children can elongate up to 2 inches without disruption, whereas the spinal cord gets injured with only a quarter-inch of elongation.</p>\n<p>X-ray/CT may not show vertebral injuries, but <strong>MRI</strong> shows&nbsp;evidence of <strong>spinal cord injury.</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(1983, 'Orthopaedics', 'PM1021. Jeffersons Fracture', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>A <strong>burst fracture</strong> of <strong>C1</strong> ring resulting from an <strong>axial load</strong> is known as <strong>Jeffersons Fracture</strong>.</p>\n<p>The fracture is identified on the <strong>open-mouth X-ray view</strong> (<strong>odontoid view</strong>).&nbsp;A CT scan will confirm and define the fracture.</p>\n<p>If combined <strong>overhang of lateral processes</strong> of <strong>C1 on C2 &gt; 7mm</strong>&nbsp;in the open-mouth view, the transverse ligament is likely to be ruptured (<strong>rule of Spence</strong>).</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/105a11018c4c472c8e0d2ba072a81e41x1280x1344.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e326d01a8d7147efb75d992709a721f0x1200x1871.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1984, 'Orthopaedics', 'PM0654. Septic arthritis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Septic arthritis and associated organism</strong></td>\n</tr>\n<tr>\n<td colspan=\2\><strong>PATIENT AGE</strong>&nbsp;</td>\n</tr>\n<tr>\n<td>Neonate</td>\n<td><em>Staphylococcus aureus</em></td>\n</tr>\n<tr>\n<td>&lt;2 yr</td>\n<td><em><em>S.aureus,&nbsp;</em></em><em>Haemophilus influenzae</em></td>\n</tr>\n<tr>\n<td>&gt;2 yr</td>\n<td><em>S. aureus</em></td>\n</tr>\n<tr>\n<td>Young adults (healthy, sexually active)</td>\n<td><em>Neisseria gonorrhoeae</em></td>\n</tr>\n<tr>\n<td colspan=\2\><strong>PROSTHESIS</strong></td>\n</tr>\n<tr>\n<td>Early infection</td>\n<td><em>S. epidermidis</em></td>\n</tr>\n<tr>\n<td>Late infection</td>\n<td>Gram-positive cocci, anaerobes</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>OTHER CONDITIONS</strong></td>\n</tr>\n<tr>\n<td>IV drug abusers</td>\n<td>Atypical gram-negative bacilli (e.g. Pseudomonas species)</td>\n</tr>\n<tr>\n<td>Sickle cell anemia, Systematic lupus erythematosus</td>\n<td><em>Salmonella</em> species</td>\n</tr>\n<tr>\n<td>Immunosuppression</td>\n<td><em>S. aureus</em>, <em>Mycobacterium</em> species, fungi</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1985, 'Orthopaedics', 'PM2413. Age wise management of DDH', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>AGE OF THE PATIENT</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MANAGEMENT</strong></td>\n</tr>\n<tr>\n<td>Less than 6 months</td>\n<td>Closed reduction with Pavlik harness or von Rosen splint</td>\n</tr>\n<tr>\n<td>6-18 months</td>\n<td>Closed or open reduction followed by hip spica after reduction</td>\n</tr>\n<tr>\n<td>18-36 months</td>\n<td>Open reduction with femoral shortening and pelvic osteotomy (Salters osteotomy, Pemberton osteotomy, Steel osteotomy)</td>\n</tr>\n<tr>\n<td>3-8 year</td>\n<td>Open reduction with femoral shortening and pelvic osteotomy&nbsp;</td>\n</tr>\n<tr>\n<td>8-18 year</td>\n<td>\n<p>Open procedure with femoral shortening with pelvic osteotomy or total hip replacement</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1986, 'Orthopaedics', 'PM2411. Age wise management of CTEV', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Initial treatment starts with Ponsetis POP cast as early as possible, but within 1 year of age.</p>\n<p>If deformity gets corrected:</p>\n<ul>\n<li>Dennis Brown splint is used till 1 year of age</li>\n<li>After 1 year upto 5 years CTEV shoes are used in day, and Dennis Brown splint is used at night</li>\n</ul>\n<p>If deformity is not corrected or untreated previously:</p>\n<ul>\n<li>1-3 years: Posteromedial soft tissue release (PMSTR)&nbsp;</li>\n<li>3-5 years: Dillwyn Evans procedure</li>\n<li>5-8 years: Dwyer osteotomy</li>\n<li>8-10 years: Wedge tarsectomy</li>\n<li>&gt;10 years: Triple arthrodesis, external fixators</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a1d7a0ec619d4540a6619b318298f007x440x1622.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1987, 'Orthopaedics', 'PM2168. Order of correction of deformities in CTEV', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/384f44ef2e6242c0b5d068c3ac43d88bx579x561.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1988, 'Orthopaedics', 'PM2050. Structures involved in congenital talipes equinovarus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9987da0ba1c445cab6ce1e7d1e9f35f3x1280x928.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1989, 'Orthopaedics', 'PM2043. Standard skeletal survey for suspected child abuse:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<strong>Category&nbsp;</strong></td>\n<td>&nbsp; &nbsp; &nbsp;<strong> View</strong>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Minimum Required views</strong></td>\n<td>\n<ul>\n<li>Anteroposterior views of entire skeleton</li>\n<li>Dedicated views of hands and feet</li>\n<li>Lateral views of axial skeleton-skull and &nbsp;spine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Imaging also suggested</strong></td>\n<td>\n<ul>\n<li>Oblique views of ribs</li>\n<li>Oblique views of the hands and feet</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Optional useful images</strong></td>\n<td>\n<ul>\n<li>Lateral views of the joints-wrists,ankles,knees</li>\n<li>Orthogonal views of any fractures found</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1990, 'Orthopaedics', 'PM1453. Vicker’s Ligament in Madelung Deformity', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Vickers described an abnormal ligament that tethers the lunate to the distal radius proximal to the physis.</li>\n<li>This ligament is believed to impede the growth of the ulnopalmar aspect of the distal radius and is commonly known as the ligament of Vickers.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/d39b609ddf474c6ba7768b6b3aae7982x180x262.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1991, 'Orthopaedics', 'PM1447. Congenital Coxa Vara', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>A painless limp in a child who has just started walking with shortening of the limb, and limitation of abduction and internal rotation is indicative of a case of congenital coxa vara. Angle formed between the head and neck of the femur and its shaft (Mikulicz angle) is decreased to less than 120<sup>o</sup>.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/fc2d1c5b50ef49a3bd8e96422fad8731x403x391.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(1992, 'Orthopaedics', 'PM1442. Blount Disease Classification', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Langenskiold classification is used in Blount’s disease.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/530b470109d94d9faf09796b95714d60x428x457.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1993, 'Orthopaedics', 'PM1431. CTEV Procedures', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/25f043ff91954947b8cecdd07de56565x1280x939.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1994, 'Orthopaedics,', 'PM2198. Vitamin D activation and Rickets', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/fc2bbad956284f25ac60ba74c376ac0ex780x802.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(1995, 'Orthopaedics', 'PM2188. Risk factors for osteoporosis:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Risk factor for osteoporosis</strong></td>\n</tr>\n<tr>\n<td>Low BMI</td>\n</tr>\n<tr>\n<td>Family history of osteoporosis </td>\n</tr>\n<tr>\n<td>Old age</td>\n</tr>\n<tr>\n<td>Previous fragility fracture</td>\n</tr>\n<tr>\n<td>Chronic use of glucocorticoids</td>\n</tr>\n<tr>\n<td>Family history of hip fractures</td>\n</tr>\n<tr>\n<td>Smoking and alcohol intake</td>\n</tr>\n<tr>\n<td>Drugs like anticonvulsants, anticoagulants and thyroid replacement therapy</td>\n</tr>\n<tr>\n<td>Hyperparathyroidism, multiple myeloma, and malabsorption syndrome</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(1996, 'Orthopaedics', 'PM2162. Bone turnover markers', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\ttl\>&nbsp;</div>\n<div class=\cntnt\>\n<table border=\1\ cellspacing=\0\>\n<tbody>\n<tr>\n<td class=\subtitle1_single\><strong>Resorption markers:</strong></td>\n</tr>\n<tr>\n<td class=\indent1\>Pyridinium crosslinks (PYD and DPD)</td>\n</tr>\n<tr>\n<td class=\indent1\>C- and N-telopeptides (CTX, ICTP, NTX)</td>\n</tr>\n<tr>\n<td class=\indent1\>Tartrate-resistant acid phosphatase (TRACP)</td>\n</tr>\n<tr>\n<td class=\indent1\>Cathepsin K</td>\n</tr>\n<tr>\n<td class=\indent1\>Matrix metalloproteinases (MMPs)</td>\n</tr>\n<tr>\n<td class=\indent1\>Urine hydroxyproline</td>\n</tr>\n<tr>\n<td class=\subtitle1_single\><strong>Formation markers:</strong></td>\n</tr>\n<tr>\n<td class=\indent1\>Procollagen type I propeptides</td>\n</tr>\n<tr>\n<td class=\indent2\>C-terminal (PICP)</td>\n</tr>\n<tr>\n<td class=\indent2\>N-terminal (PINP)</td>\n</tr>\n<tr>\n<td class=\indent1\>Osteocalcin (OC)</td>\n</tr>\n<tr>\n<td class=\indent1\>Bone isoform of alkaline phosphatase (BALP)</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(1997, 'Orthopaedics', 'PM1958. Z-score and T-score for osteoporosis:', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong><span>Z-score:</span></strong></p>\n<p><span>It is the number of standard deviations a patient’s BMD(bone mass density) differs from the average BMD of <strong>their age, sex, and ethnicity</strong>.</span></p>\n<p><span>A Z-score of -2 or below should trigger investigations for underlying disease.</span></p>\n<p><strong><span>T-score:</span></strong></p>\n<p><span>It is the BMD at the site when compared to the <strong>young normal reference</strong> mean. It is a comparison of a patient’s BMD to that of a healthy <strong>30-year old</strong>.</span></p>\n<ul>\n<li><span><strong>Normal</strong> is a T-score of -1 or higher.</span></li>\n<li><span><strong>Osteopenia</strong> is defined as a T-score between -1.0 and -2.5.</span></li>\n<li><span><strong>Osteoporosis</strong> is defined as a T-score less than -2.5, that is a BMD which is two and a half standard deviations below the mean of a 30-year old man/woman.</span></li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(1998, 'Paediatrics,', 'PM1859. Important differences between vitamin D and vitamin C deficiencies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\156\>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<div><strong>Vitamin D &nbsp; &nbsp; deficiency&nbsp;&nbsp;<br></strong></div>\n</td>\n<td>\n<div><strong>Vitamin C &nbsp; &nbsp; deficiency<br></strong></div>\n</td>\n</tr>\n<tr>\n<td><strong>Pathology</strong></td>\n<td>Poor mineralization of bone</td>\n<td>Poor osteoid&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; formation</td>\n</tr>\n<tr>\n<td><strong>Clinical features</strong></td>\n<td>\n<p>No/less irritability</p>\n<p>Rachitic rosary (nodularity at the costochondral junction)</p>\n</td>\n<td>\n<p>Irritability is predominant</p>\n<p>Scorbutic rosary (angular &amp; sharp costochondral junction)</p>\n</td>\n</tr>\n<tr>\n<td><strong>Radiological features</strong></td>\n<td>\n<p>Cupping&nbsp;</p>\n<p>Fraying</p>\n<p>Splaying</p>\n</td>\n<td>\n<p>White line of Frankel</p>\n<p>Pelkan spur</p>\n<p>Wimberger ring sign</p>\n<p>Subperiosteal hemorrhage</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Note:</strong> Irritability in scurvy is due to hampered neurotransmitter production (conversion of dopamine to norepinephrine and tryptophan to serotonin requires vitamin C).</p></div><!---->\n      <!---->\n    </div><!---->'),
(1999, 'Orthopaedics,', 'PM1613. Important Clinical Features of Rickets', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ce742f2400be4e62813aa4a052447418x1280x1326.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2000, 'Orthopaedics', 'PM1079. Biochemical parameters in metabolic bone diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Metabolic bone disease</strong></p>\n</td>\n<td><strong>Calcium</strong></td>\n<td><strong>PTH</strong></td>\n<td><strong>Phosphate</strong></td>\n<td><strong>ALP</strong></td>\n</tr>\n<tr>\n<td>\n<p>Rickets / Osteomalacia</p>\n</td>\n<td>&nbsp;↓/N</td>\n<td>&nbsp; &nbsp;↑</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;↓</td>\n<td>&nbsp; &nbsp;↑</td>\n</tr>\n<tr>\n<td>\n<p>Primary</p>\n<p>hyperparathyroidism</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;↑</td>\n<td>&nbsp;&nbsp;&nbsp;↑</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;↓</td>\n<td>&nbsp;↑</td>\n</tr>\n<tr>\n<td>\n<p>Secondary</p>\n<p>hyperparathyroidism</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;↓</td>\n<td>&nbsp;&nbsp; ↑</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;↑</td>\n<td>&nbsp; &nbsp; ↑</td>\n</tr>\n<tr>\n<td>\n<p>Tertiary hyperparathyroidism</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;↑</td>\n<td>&nbsp; &nbsp; ↑</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;↑</td>\n<td>&nbsp; &nbsp;↑</td>\n</tr>\n<tr>\n<td>Osteoporosis</td>\n<td>&nbsp; &nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp; &nbsp; N</td>\n<td>&nbsp; N</td>\n</tr>\n<tr>\n<td>\n<p>Pagets&nbsp;disease</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp; &nbsp; N</td>\n<td>&nbsp; ↑</td>\n</tr>\n<tr>\n<td>\n<p>Osteopetrosis</p>\n</td>\n<td>&nbsp; ↓/N</td>\n<td>↑/N</td>\n<td>&nbsp; &nbsp; ↓/N</td>\n<td>&nbsp; N</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;↑: Increased,&nbsp;&nbsp;↓: Decreased, N: Normal</p></div><!---->\n      <!---->\n    </div><!---->'),
(2001, 'Orthopaedics', 'PM2039. Classification Criteria for Rheumatoid Arthritis - ACR/EULAR (2010)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Criteria</td>\n<td>&nbsp;</td>\n<td>\n<p>Score</p>\n</td>\n</tr>\n<tr>\n<td>Joint involvement</td>\n<td>\n<p>&nbsp;</p>\n<p>1 large joint(shoulder,elbow,hip,knee)</p>\n<p>2-10 large joints</p>\n<p>1-3 small joints(MCP,PIP,IP,MTP,wrist)</p>\n<p>4-10 small joints</p>\n<p>&gt;10 joints(atleast 1 small joint)</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>&nbsp;</p>\n<p>0</p>\n<p>1</p>\n<p>2</p>\n<p>3</p>\n<p>5</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Serology</td>\n<td>\n<p>-ve RF and -ve ACPA</p>\n<p>Low +ve RF or anti-CCP (&lt;3 times ULN)</p>\n<p>High +ve RF or anti-CCP (&gt;3 times ULN)</p>\n</td>\n<td>\n<p>0</p>\n<p>2</p>\n<p>3</p>\n</td>\n</tr>\n<tr>\n<td>Acute phase reactants</td>\n<td>\n<p>Normal CRP and ESR</p>\n<p>Abnormal CRP or ESR</p>\n</td>\n<td>\n<p>0</p>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>Duration of symptoms</td>\n<td>\n<p>&lt;6 weeks</p>\n<p>&gt;=6 weeks</p>\n</td>\n<td>\n<p>0</p>\n<p>1</p>\n</td>\n</tr>\n</tbody>\n</table>\n<div class=\page\ title=\Page 2898\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Maximum score is 10. A score of ≥6 fulfills requirements for definite RA.</p>\n<p>Abbreviations:</p>\n<ul>\n<li>ACPA, anti-citrullinated peptide antibodies;</li>\n<li>CCP, cyclic citrullinated pep- tides;</li>\n<li>IP, interphalangeal joint;</li>\n<li>MCP, metacarpophalangeal joint;</li>\n<li>MTP, metatarsophalangeal joint;</li>\n<li>PIP, proximal interphalangeal joint;</li>\n<li>RF, rheumatoid factor;</li>\n<li>ULN, upper limit of normal.</li>\n</ul>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(2002, 'Orthopaedics', 'PM1920. Diseases and Usual Joints affected', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Disease</td>\n<td>Joint</td>\n</tr>\n<tr>\n<td>Gout</td>\n<td>MTP of great toe</td>\n</tr>\n<tr>\n<td>Pseudogout</td>\n<td>Knee</td>\n</tr>\n<tr>\n<td>Rheumatoid arthritis</td>\n<td>Metacarpophalangeal joint</td>\n</tr>\n<tr>\n<td>Ankylosing spondylitis</td>\n<td>Sacro-iliac joint</td>\n</tr>\n<tr>\n<td>Septic arthritis</td>\n<td>Knee</td>\n</tr>\n<tr>\n<td>Syphilitic arthritis</td>\n<td>Knee</td>\n</tr>\n<tr>\n<td>Gonococcal arthritis</td>\n<td>Knee</td>\n</tr>\n<tr>\n<td>Diabetic Charcot joint</td>\n<td>Foot joint(midtarsal)</td>\n</tr>\n<tr>\n<td>Senile osteoporosis</td>\n<td>Vertebra</td>\n</tr>\n<tr>\n<td><strong>P</strong>agets disease<strong><br></strong></td>\n<td><strong>P</strong>elvis &gt; Femur &gt;Skull &gt;Tibia</td>\n</tr>\n<tr>\n<td>Osteochondritis dissecans</td>\n<td>Knee &gt;Elbow<br>(Most common cause of loose bodies in young)</td>\n</tr>\n<tr>\n<td>Actinomycosis</td>\n<td>Mandible</td>\n</tr>\n<tr>\n<td>Hemophilic arthritis</td>\n<td>Knee(Children-Ankle)</td>\n</tr>\n<tr>\n<td>Acute osteomyelitis</td>\n<td>Lower end of femur(Metaphysis)</td>\n</tr>\n<tr>\n<td>Brodies abscess</td>\n<td>Upper end of tibia</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2003, 'Orthopaedics', 'PM1382. Arthritis Mutilans', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>It is the destructive form of psoriatic arthritis, where there is widespread shortening of digits (TELESCOPING) with ankylosis and contracture in other digits.</p>\n<p><strong>Clinical appearance and Radiograph of Arthritis mutilans</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a113337359a5405cbbc3a1a3bec14150x498x324.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0465b129cc9e40a984fb97eb2ea40b8bx440x316.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(2004, 'Orthopaedics', 'PM1381. Symmetric Polyarthritis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Symmetric polyarthritis occurs in about 40% of psoriatic arthritis.</li>\n<li>It may be indistinguishable from RA in terms of the joints involved, but other features of psoriatic arthritis are also present.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2005, 'Orthopaedics', 'PM1380. Joints Affected by Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Joint affected</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diabetes Mellitus</p>\n</td>\n<td>\n<p>Tarsal &amp; Tarsometatarsal joint</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tabes Dorsalis</p>\n</td>\n<td>\n<p>Knee</p>\n<p>Hip</p>\n<p>Ankle</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Syringomyelia</p>\n</td>\n<td>\n<p>Glenohumeral joint (shoulder)</p>\n<p>Elbow</p>\n<p>Wrist</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2006, 'Orthopaedics', 'PM2200. Seddons  classification of nerve injuries', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Seddons&nbsp;classification includes 3 groups:</p>\n<ol>\n<li>Neuropraxia</li>\n<li>Axonotmesis</li>\n<li>Neurotmesis</li>\n</ol>\n<p><strong>Neuropraxia:</strong></p>\n<ul>\n<li>Reversible physiologic conduction block</li>\n<li>Occurs due to mechanical pressure causing segmental demyelination</li>\n<li>Examples: Saturday night palsy, tourniquet, and crutch palsy</li>\n</ul>\n<p><strong>Axonotmesis:</strong>&nbsp;</p>\n<ul>\n<li>Axonal interruption</li>\n<li>Conduction is lost but the nerve is in continuity and neural tubes are intact</li>\n<li>Examples: Closed fractures and dislocations</li>\n</ul>\n<p><strong>Neurotmesis:&nbsp;</strong></p>\n<ul>\n<li>Division of the nerve trunk</li>\n<li>Endoneurial tube destruction also occurs</li>\n<li>Example: Complete section of nerve in open fractures</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2007, 'Orthopaedics', 'PM2495. Summary of Bone Tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Bone tumor</strong></td>\n<td><strong>Most common site</strong></td>\n<td><strong>Age</strong></td>\n</tr>\n<tr>\n<td>Simple bone cyst</td>\n<td>Proximal Humeral Metaphysis</td>\n<td>&lt;20years</td>\n</tr>\n<tr>\n<td>Enchondroma</td>\n<td>\n<p>Hand bones</p>\n<p>(Metaphysis of small bones of hand)</p>\n</td>\n<td>\n<p>4<sup>th</sup>&nbsp;&amp; 5<sup>th</sup></p>\n<p>Decade</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteochondroma</p>\n<p>(Exostosis)</p>\n</td>\n<td>Distal Femoral Metaphysis</td>\n<td>&lt;18years</td>\n</tr>\n<tr>\n<td>Osteoid osteoma</td>\n<td>Diaphysis of Femur</td>\n<td>\n<p>2<sup>nd</sup>&nbsp;&amp; 3<sup>rd</sup></p>\n<p>decade</p>\n</td>\n</tr>\n<tr>\n<td>Osteoblastoma</td>\n<td>Posterior column of vertebra</td>\n<td>\n<p>2<sup>nd</sup>&nbsp;&amp; 3<sup>rd</sup></p>\n<p>decade</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteoclastoma (GCT)</p>\n</td>\n<td>Distal femoral epiphysis</td>\n<td>\n<p>2<sup>nd</sup> -4<sup>th</sup></p>\n<p>Decade</p>\n</td>\n</tr>\n<tr>\n<td>Aneurysmal Bone Cyst</td>\n<td>Long bone Metaphysis</td>\n<td>&lt;18years</td>\n</tr>\n<tr>\n<td>Osteosarcoma</td>\n<td>Distal Femoral Metaphysis</td>\n<td>\n<p>BIMODAL</p>\n<p>Primary- 2<sup>nd</sup> Decade Secondary-6<sup>th</sup> and 7<sup>th</sup> Decade</p>\n</td>\n</tr>\n<tr>\n<td>Ewings sarcoma</td>\n<td>Diaphysis of Femur</td>\n<td>5-25 years</td>\n</tr>\n<tr>\n<td>Chondrosarcoma</td>\n<td>Any site in the bone - mc in proximal femur</td>\n<td>3<sup>rd</sup>-5<sup>th</sup> decade</td>\n</tr>\n<tr>\n<td>Clear cell chondrosarcoma</td>\n<td>Proximal femoral epiphysis</td>\n<td>&nbsp;3<sup>rd</sup>-5<sup>th</sup> decade</td>\n</tr>\n<tr>\n<td>Adamantinoma</td>\n<td>Diaphysis of Tibia</td>\n<td>&nbsp;20-40 years</td>\n</tr>\n<tr>\n<td>&nbsp;Fibrous dysplasia</td>\n<td>&nbsp;The upper end of femur &gt; tibia</td>\n<td>&nbsp;1st to 3rd decade</td>\n</tr>\n<tr>\n<td>&nbsp;Chordoma</td>\n<td>&nbsp;Sacrum</td>\n<td>&nbsp;5th to 7th decade</td>\n</tr>\n<tr>\n<td>Multiple myeloma</td>\n<td>Vertebrae</td>\n<td>5th to 7th decade</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(2008, 'Orthopaedics', 'PM1943. Enneking System for Staging Benign Musculoskeletal Tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><span><strong>Latent</strong></span></td>\n<td><span><strong>Active</strong></span></td>\n<td><span><strong>Aggressive</strong></span></td>\n</tr>\n<tr>\n<td>Location</td>\n<td><span>Intracapsular</span></td>\n<td><span>Intracapsular</span></td>\n<td><span>Extracapsular</span></td>\n</tr>\n<tr>\n<td>Clinical findings</td>\n<td><span>Often incidental findings.</span></td>\n<td><span>Symptomatic,&nbsp;may present with pathological fracture.</span></td>\n<td><span>Symptomatic</span></td>\n</tr>\n<tr>\n<td>X-ray features</td>\n<td><span>Well defined margin with a thick rim of reactive bone on X ray. No cortical destruction or expansion.</span></td>\n<td><span>Well defined margin and a thin rim of reactive bone on X ray. Narrow zone of activity;&nbsp;limited bone destruction.</span></td>\n<td><span>Bone destruction/soft tissue extension. Metastasis may be present in 5% of patients.</span>&nbsp;</td>\n</tr>\n<tr>\n<td>Examples</td>\n<td>&nbsp;N<span>on-ossifying fibroma</span></td>\n<td>&nbsp;<span>Aneurysmal bone cyst</span></td>\n<td><span>Giant cell tumor</span></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2009, 'Orthopaedics', 'PM1337. Giant Cell Tumours', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Giant cell tumour</strong> is usually eccentrically located in the <strong>epiphysis </strong>but it adopts a <strong>metaphyseal location</strong> in the skeletally immature which includes children. Although, <strong>chondrosarcomas</strong> are <strong>metaphyseal lesions</strong>, <strong>clear cell chondrosarcoma</strong> which is a rare variety usually seen in adults, is an <strong>epiphyseal lesion</strong>.</p></div><!---->\n      <!---->\n    </div><!---->'),
(2010, 'Orthopaedics', 'PM1493. Some Important Traction and Their Uses', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>1) Gallow/Bryant traction:&nbsp;</strong></p>\n<ul>\n<li>Type - Skin traction&nbsp;</li>\n<li>Use -&nbsp;Fracture shaft femur in children below 2 years</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ca9068b3be484aa890c2cdcf144ae69ax315x208.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>2) Perkin traction:&nbsp;</strong></p>\n<ul>\n<li>Type - Skeletal traction&nbsp;</li>\n<li>Use -&nbsp;Fracture shaft femur in adults</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cd82e52a00094730945cb29990c414ebx600x743.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>3) Russell’s traction:&nbsp;</strong></p>\n<ul>\n<li>Type - Skin traction&nbsp;</li>\n<li>Use -&nbsp;Trochanteric fractures</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6356785331eb4819b6d4055e99632f64x1279x1542.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>4) Dunlop/Smith traction:&nbsp;</strong></p>\n<ul>\n<li>Type - Skeletal traction&nbsp;</li>\n<li>Use -&nbsp;Supracondylar fracture humerus</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/812187193a7d4eaa90eafa94ff56cb20x1280x1474.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>5) Bucks traction:&nbsp;</strong></p>\n<ul>\n<li>Most common lower limb traction</li>\n<li>Type - Skin traction&nbsp;</li>\n<li>Use -&nbsp;Femoral fractures, acetabular and hip fractures</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6dc8b1d46819421c8ec20549cefae878x1280x1463.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>6)Crutchfield traction:&nbsp;</strong></p>\n<ul>\n<li>Type - Skeletal traction&nbsp;</li>\n<li>Use -&nbsp;Cervical spine injuries</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2fbcdc3b4e5c446f90df3408aef00788x1063x1333.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>7) Head halter traction:&nbsp;</strong></p>\n<ul>\n<li>Type - Skin traction&nbsp;</li>\n<li>Use - Cervical spine injuries</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/83537b5c921e4919b992cf4b12aeaeaex1063x1718.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>8) Halo-pelvic traction:&nbsp;</strong></p>\n<ul>\n<li>Type - Skeletal traction&nbsp;</li>\n<li>Use - Scoliosis&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/234c8e358bc5464a8eff036d50d773cbx1063x1368.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(2011, 'Orthopaedics', 'PM1017. Orthopedic Instruments', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d3f6d0247c704a669cfad724f363b9eex720x1552.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/84a1042aff90448bb49f5408fed46b9bx720x403.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/306a732260ff4ce2bbc077954052b977x720x540.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0e2b55361d02462d9d349046ab6dc932x800x600.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/8b868b0c26134874a2eeeb9c693faa4dx800x600.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/465c935b02614de4a6ef0c385131f6e5x720x540.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><!---->'),
(2012, 'Orthopaedics', 'PM1519. List of Names of Amputations and Their Levels', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>TYPE</strong><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>LEVEL OF AMPUTATION</strong><strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lisfranc</p>\n</td>\n<td>\n<p>Tarsometatarsal joint<strong>&nbsp;</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chopart&nbsp;</p>\n</td>\n<td>\n<p>Transverse tarsal joints&nbsp;(articulation of calcaneus with cuboid and talus with navicular)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pirogoff</p>\n</td>\n<td>\n<p>Calcaneum is rotated forward to be fused with tibia after vertical section through its middle&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Syme&nbsp;</p>\n</td>\n<td>\n<p>Distal tibia &amp; fibula 0.6 cm proximal to the periphery of ankle joint passing through the dome of the ankle. Involves removal of both medial and lateral malleoli.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Boyd&nbsp;</p>\n</td>\n<td>\n<p>Talectomy, forward shift of the calcaneus and calcaneo-tibial arthrodesis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Sarmiento&nbsp;</p>\n</td>\n<td>\n<p>Distal tibia and fibula: 1.3 cm proximal to the ankle joint and excision of medial and lateral malleoli&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/09ec2c4f725f4f2d8c8ee1d692677ae6x1280x1153.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2013, 'Orthopaedics', 'PM1509. Mechanism of injury and tests for knee injuries', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Structures</strong></td>\n<td><strong>Mechanism of injury</strong></td>\n<td><strong>Tests</strong></td>\n</tr>\n<tr>\n<td>Menisci</td>\n<td>Rotational force</td>\n<td>\n<p>McMurray test</p>\n<p>Apleys grinding test</p>\n<p>Squat test</p>\n<p>Thessaly test</p>\n</td>\n</tr>\n<tr>\n<td>Medial collateral ligament</td>\n<td>Valgus force</td>\n<td>Valgus stress test</td>\n</tr>\n<tr>\n<td>Lateral collateral ligament</td>\n<td>Varus force</td>\n<td>Varus stress test</td>\n</tr>\n<tr>\n<td>Anterior cruciate ligament</td>\n<td>Anterior tibial displacement</td>\n<td>\n<p>Anterior drawer test&nbsp;</p>\n<p>Lachman test</p>\n<p>Pivot shift test</p>\n</td>\n</tr>\n<tr>\n<td>Posterior cruciate ligament</td>\n<td>Posterior tibial displacement</td>\n<td>\n<p>Posterior drawer test</p>\n<p>Sag sign</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(2014, 'Orthopaedics', 'PM1506. Mangled Extremity Severity Score', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table width=\749\>\n<tbody>\n<tr>\n<td colspan=\4\>Mangled Extremity Severity Score</td>\n</tr>\n<tr>\n<td>TYPE</td>\n<td>CHARACTERISTICS</td>\n<td>INJURIES</td>\n<td>POINTS</td>\n</tr>\n<tr>\n<td colspan=\4\>SKELETAL/SOFT-TISSUE GROUP</td>\n</tr>\n<tr>\n<td>1</td>\n<td>Low energy&nbsp;</td>\n<td>Stab wounds, simple closed fractures small-callber gunshot wounds</td>\n<td>1</td>\n</tr>\n<tr>\n<td>2</td>\n<td>Medium energy</td>\n<td>Open or multiple-level fractures, dissociations, moderate crush injuries</td>\n<td>2</td>\n</tr>\n<tr>\n<td>3</td>\n<td>High energy</td>\n<td>Shotgun blast (close range), high-velocity wounds</td>\n<td>3</td>\n</tr>\n<tr>\n<td>4</td>\n<td>Massive crush</td>\n<td>Logging, railroad, oil-rig accidents</td>\n<td>4</td>\n</tr>\n<tr>\n<td colspan=\4\>SHOCK GROUP</td>\n</tr>\n<tr>\n<td>1</td>\n<td>\n<p>Normortensive</p>\n<p>Hemodynamics</p>\n</td>\n<td>Blood pressure stable in field and in operating room</td>\n<td>0</td>\n</tr>\n<tr>\n<td>2</td>\n<td>\n<p>Transiently</p>\n<p>Hypotensive</p>\n</td>\n<td>Blood pressure unstable in field but responsive to intravenous fluids</td>\n<td>1</td>\n</tr>\n<tr>\n<td>3</td>\n<td>\n<p>Prolonged</p>\n<p>Hypotensive</p>\n</td>\n<td>Systolic blood pressure &lt;90 Hg in field and responsive fluid only in operating room</td>\n<td>2</td>\n</tr>\n<tr>\n<td colspan=\4\>\n<p>ISCHEMIA GROUP</p>\n</td>\n</tr>\n<tr>\n<td>1</td>\n<td>\n<p>None</p>\n</td>\n<td>Pulsatile limb without signs of ischemia</td>\n<td>1*</td>\n</tr>\n<tr>\n<td>2</td>\n<td>\n<p>Mild</p>\n</td>\n<td>Diminished pulses without signs of ischemia&nbsp;</td>\n<td>2*</td>\n</tr>\n<tr>\n<td>3</td>\n<td>\n<p>Moderate</p>\n</td>\n<td>No pulse by Doppler, sluggish capillary refill, paresthesia, diminished motor activity</td>\n<td>3*</td>\n</tr>\n<tr>\n<td rowspan=\2\>4</td>\n<td>\n<p>Advanced</p>\n</td>\n<td>Pulseless, cool, paralyzed, and numb without capillary refill</td>\n<td>4*</td>\n</tr>\n<tr>\n<td colspan=\3\>\n<p>* If ischemia time &gt;6 hours, the ischemia score is doubled</p>\n</td>\n</tr>\n<tr>\n<td colspan=\4\>\n<p>AGE GROUP</p>\n</td>\n</tr>\n<tr>\n<td>1</td>\n<td>\n<p>&lt;30 yr</p>\n</td>\n<td>&nbsp;</td>\n<td>0</td>\n</tr>\n<tr>\n<td>2</td>\n<td>\n<p>30-50 yr</p>\n</td>\n<td>&nbsp;</td>\n<td>1</td>\n</tr>\n<tr>\n<td>3</td>\n<td>\n<p>&gt;50 yr</p>\n</td>\n<td>&nbsp;</td>\n<td>2</td>\n</tr>\n</tbody>\n</table>\n<p>MESS score of &lt; 7 is usually associated with salvageable limb.</p>\n<p>MESS score of ≥ 7 is usually associated with the requirement of limb amputation.</p></div><!---->\n      <!---->\n    </div><!---->'),
(2015, 'Orthopaedics', 'PM0035. Avascular Necrosis (AVN)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>It is a rare but severe complication of certain fractures when the blood supply to a segment of bone is affected.&nbsp;</p>\n<p>Common sites of AVN are:</p>\n<ul>\n<li>Head of the femur in fracture neck of femur and posterior dislocation of the hip</li>\n<li>Body of talus in a fracture through the neck of talus</li>\n<li>Proximal pole of the scaphoid in a fracture through the waist of the scaphoid</li>\n<li>Head of the humerus</li>\n<li>The capitulum</li>\n</ul>\n<p>Non-traumatic causes of AVN are:</p>\n<ul>\n<li>Idiopathic</li>\n<li>Steroids</li>\n<li>Sickle cell disease</li>\n<li>Caissons disease</li>\n<li>Gauchers disease</li>\n<li>Lupus Erythematosus</li>\n<li>Radiation therapy</li>\n<li>Alcoholism</li>\n<li>Hyperlipidemia</li>\n</ul>\n<p>Important signs related to avascular necrosis:</p>\n<ul>\n<li><strong>Crescent sign</strong>- Seen in osteonecrosis of the femoral head. It&nbsp;is a subchondral fracture overlying the necrotic segment of the femoral head.</li>\n<li><strong>Hawkins sign</strong>- Seen secondary to the fracture of the neck of the talus. It refers to subchondral lucency of the dome of the talus due to subchondral atrophy. The presence of this sign indicates that the blood supply to the talus is adequate and chances of avascular necrosis are low.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4e7867fc444649f0b55d255878d7e893x742x842.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d7934cf4465b45d5847430db8962e93cx1280x1280.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2016, 'Orthopaedics', 'PM2469. Summary of Bone Tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Bone tumor</strong></td>\n<td><strong>Most common site</strong></td>\n<td><strong>Age</strong></td>\n</tr>\n<tr>\n<td>Simple bone cyst</td>\n<td>Proximal Humeral Metaphysis</td>\n<td>&lt;20years</td>\n</tr>\n<tr>\n<td>Enchondroma</td>\n<td>\n<p>Hand bones</p>\n<p>(Metaphysis of small bones of hand)</p>\n</td>\n<td>\n<p>4<sup>th</sup>&nbsp;&amp; 5<sup>th</sup></p>\n<p>Decade</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteochondroma</p>\n<p>(Exostosis)</p>\n</td>\n<td>Distal Femoral Metaphysis</td>\n<td>&lt;18years</td>\n</tr>\n<tr>\n<td>Osteoid osteoma</td>\n<td>Diaphysis of Femur</td>\n<td>\n<p>2<sup>nd</sup>&nbsp;&amp; 3<sup>rd</sup></p>\n<p>decade</p>\n</td>\n</tr>\n<tr>\n<td>Osteoblastoma</td>\n<td>Posterior column of vertebra</td>\n<td>\n<p>2<sup>nd</sup>&nbsp;&amp; 3<sup>rd</sup></p>\n<p>decade</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteoclastoma (GCT)</p>\n</td>\n<td>Distal femoral epiphysis</td>\n<td>\n<p>2<sup>nd</sup> -4<sup>th</sup></p>\n<p>Decade</p>\n</td>\n</tr>\n<tr>\n<td>Aneurysmal Bone Cyst</td>\n<td>Long bone Metaphysis</td>\n<td>&lt;18years</td>\n</tr>\n<tr>\n<td>Osteosarcoma</td>\n<td>Distal Femoral Metaphysis</td>\n<td>\n<p>BIMODAL</p>\n<p>Primary- 2<sup>nd</sup> Decade Secondary-6<sup>th</sup> and 7<sup>th</sup> Decade</p>\n</td>\n</tr>\n<tr>\n<td>Ewings sarcoma</td>\n<td>Diaphysis of Femur</td>\n<td>5-25 years</td>\n</tr>\n<tr>\n<td>Chondrosarcoma</td>\n<td>Any site in the bone - mc in proximal femur</td>\n<td>3<sup>rd</sup>-5<sup>th</sup> decade</td>\n</tr>\n<tr>\n<td>Clear cell chondrosarcoma</td>\n<td>Proximal femoral epiphysis</td>\n<td>&nbsp;3<sup>rd</sup>-5<sup>th</sup> decade</td>\n</tr>\n<tr>\n<td>Adamantinoma</td>\n<td>Diaphysis of Tibia</td>\n<td>&nbsp;20-40 years</td>\n</tr>\n<tr>\n<td>&nbsp;Fibrous dysplasia</td>\n<td>&nbsp;The upper end of femur &gt; tibia</td>\n<td>&nbsp;1st to 3rd decade</td>\n</tr>\n<tr>\n<td>&nbsp;Chordoma</td>\n<td>&nbsp;Sacrum</td>\n<td>&nbsp;5th to 7th decade</td>\n</tr>\n<tr>\n<td>Multiple myeloma</td>\n<td>Vertebrae</td>\n<td>5th to 7th decade</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(2017, 'Paediatrics', 'PM2394. A comprehensive list of factors that define an infant as being high risk', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div>\n<table>\n<tbody>\n<tr>\n<td><span><strong>DEMOGRAPHIC SOCIAL FACTORS</strong></span>\n<ul>\n<li class=\p1\><span>Maternal age &lt;16 or &gt;40 years</span></li>\n<li class=\p1\><span>Illicit drugs, alcohol, cigarette use</span></li>\n<li class=\p1\><span>Poverty</span></li>\n<li class=\p1\><span>Unmarried</span></li>\n<li class=\p1\><span>Emotional or physical stress</span></li>\n</ul>\n</td>\n<td><span><strong>PAST MEDICAL HISTORY</strong></span>\n<ul>\n<li class=\p1\><span>Genetic disorders</span></li>\n<li class=\p1\><span>Diabetes mellitus</span></li>\n<li class=\p1\><span>Hypertension</span></li>\n<li class=\p1\><span>Asymptomatic bacteriuria</span></li>\n<li class=\p1\><span>Rheumatologic illness <span>(systemic lupus erythematosus)</span></span></li>\n<li class=\p1\><span>Immune-mediated diseases <span>(immunoglobulin G crossing placenta)</span></span></li>\n<li class=\p1\><span>Long-term medications</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span><strong>PREVIOUS PREGNANCY</strong></span>\n<ul>\n<li class=\p1\><span>Intrauterine fetal demise</span></li>\n<li class=\p1\><span>Neonatal death</span></li>\n<li class=\p1\><span>Prematurity</span></li>\n<li class=\p1\><span>Intrauterine growth restriction</span></li>\n<li class=\p1\><span>Congenital malformation</span></li>\n<li class=\p1\><span>Cervical incompetence</span></li>\n<li class=\p1\><span>Blood group sensitization</span></li>\n<li class=\p1\><span>Neonatal jaundice</span></li>\n<li class=\p1\><span>Neonatal thrombocytopenia</span></li>\n<li class=\p1\><span>Hydrops</span></li>\n<li class=\p1\><span>Inborn errors of metabolism</span></li>\n</ul>\n</td>\n<td><span><strong>PRESENT PREGNANCY</strong></span>\n<ul>\n<li><span>Vaginal bleeding <span>(abruptio placentae, placenta previa)</span></span></li>\n<li><span>STDs or Colonizations <span>(HSV, group B streptococcus, chlamydia, syphilis, HBV, HIV)</span></span></li>\n<li class=\p1\><span>Multiple gestations</span></li>\n<li class=\p1\><span>Preeclampsia</span></li>\n<li class=\p1\><span>Premature rupture of membranes</span></li>\n<li class=\p1\><span>Short interpregnancy time</span></li>\n<li class=\p1\><span>Poly/ oligohydramnios</span></li>\n<li class=\p1\><span>Acute medical or surgical illness</span></li>\n<li class=\p1\><span>Inadequate prenatal care</span></li>\n<li class=\p1\><span>Familial or acquired hypercoagulable states</span></li>\n<li class=\p1\><span>Abnormal fetal USG findings</span></li>\n<li class=\p1\><span>Treatment of infertility</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span><strong>LABOR AND DELIVERY</strong></span>\n<ul>\n<li class=\p1\><span>Premature labor (&lt;37 wk)</span></li>\n<li class=\p1\><span>Postterm pregnancy (≥42 wk)</span></li>\n<li class=\p1\><span>Fetal distress</span></li>\n<li class=\p1\><span>Immature lecithin: sphingomyelin ratio</span></li>\n<li class=\p1\><span>Absence of phosphatidylglycerol</span></li>\n<li class=\p1\><span>Breech presentation</span></li>\n<li class=\p1\><span>Meconium-stained liqour</span></li>\n<li class=\p1\><span>Cesarean section</span></li>\n<li class=\p1\><span>Forceps delivery</span></li>\n<li class=\p1\><span>Apgar score &lt;4 at 1 min</span></li>\n</ul>\n</td>\n<td><span><strong>NEONATE</strong></span>\n<ul>\n<li class=\p1\><span>Birthweight &lt;2,500 or &gt;4,000 g</span></li>\n<li class=\p1\><span>Birth &lt;37 or ≥42 wk of gestation</span></li>\n<li class=\p1\><span>Small or large for gestational age</span></li>\n<li class=\p1\><span>Respiratory distress, cyanosis</span></li>\n<li class=\p1\><span>Congenital malformations</span></li>\n<li class=\p1\><span>Pallor, plethora, petechiae</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(2018, 'Paediatrics', 'PM2195. APGAR score', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b8de3fc0585847cab3e28e1f55d906e2x1279x1330.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2019, 'Paediatrics', 'PM2021. Potential adverse reactions to drugs administered in infants', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div>\n<table>\n<tbody>\n<tr>\n<td><strong>Drug</strong></td>\n<td><strong>Side effect</strong></td>\n</tr>\n<tr>\n<td><strong>Oxygen</strong></td>\n<td><strong>Retinopathy of prematurity</strong>, bronchopulmonary dysplasia</td>\n</tr>\n<tr>\n<td><strong>Chloramphenicol</strong></td>\n<td><strong>Gray baby syndrome</strong>, bone marrow suppression</td>\n</tr>\n<tr>\n<td>Vitamin K analogs</td>\n<td>Jaundice</td>\n</tr>\n<tr>\n<td><strong>Tetracycline</strong></td>\n<td><strong>Enamel hypoplasia</strong></td>\n</tr>\n<tr>\n<td>Sodium bicarbonate</td>\n<td>Intraventricular hemorrhage</td>\n</tr>\n<tr>\n<td>Amphotericin</td>\n<td>Anuric renal failure</td>\n</tr>\n<tr>\n<td>Indomethacin</td>\n<td>Oliguria, hyponatremia, intestinal perforation</td>\n</tr>\n<tr>\n<td><strong>Aminoglycosides</strong></td>\n<td><strong>Deafness, renal toxicity</strong></td>\n</tr>\n<tr>\n<td><strong>Erythromycin</strong></td>\n<td><strong>Pyloric stenosis</strong></td>\n</tr>\n<tr>\n<td>Morphine</td>\n<td>Hypotension, urine retention</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(2020, 'Paediatrics', 'PM1828. Caput succedaneum and Cephalohematoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Indicators</strong></td>\n<td><strong>Caput Succedaneum</strong></td>\n<td><strong>Cephalhematoma</strong></td>\n</tr>\n<tr>\n<td>Location</td>\n<td>Presenting part of the head</td>\n<td>The periosteum of skull bone and bone</td>\n</tr>\n<tr>\n<td>Time of appearance&nbsp;</td>\n<td>Immediately after birth</td>\n<td>Several hours after birth</td>\n</tr>\n<tr>\n<td>Cause</td>\n<td>Prolonged labor, causing venous stasis and edema&nbsp;</td>\n<td>Instrumental delivery, causes rupture of emissary veins in skull</td>\n</tr>\n<tr>\n<td>Extent of movement</td>\n<td>Both hemispheres; crosses the suture line</td>\n<td>Individual bones; do not cross the suture lines</td>\n</tr>\n<tr>\n<td>Period of absorption</td>\n<td>2-4 days</td>\n<td>2 weeks to 3 months</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>None</td>\n<td>\n<p>Supportive.</p>\n<p>It can cause neonatal jaundice&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3fa55d5b4d7f42e4a0bba6bb3784ac85x1280x2360.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2021, 'Paediatrics', 'PM1811. Timeline for primitive reflexes', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td>\n<div><strong>Reflex</strong></div>\n</td>\n<td>\n<div><strong>Onset</strong></div>\n</td>\n<td>\n<div><strong>Fully developed&nbsp;</strong></div>\n</td>\n<td>\n<div><strong>Duration</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Palmar grasp </strong></div>\n</td>\n<td>\n<div>28 weeks of gestation</div>\n</td>\n<td>\n<div>32 weeks of gestation</div>\n</td>\n<td>\n<div>2-3 months postnatal</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Rooting </strong></div>\n</td>\n<td>\n<div>32 weeks of gestation</div>\n</td>\n<td>\n<div>36 weeks of gestation</div>\n</td>\n<td>\n<div>Less prominent after 1 month postnatal</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Moro </strong></div>\n</td>\n<td>\n<div>28-32 weeks of gestation</div>\n</td>\n<td>\n<div>37 weeks of gestation</div>\n</td>\n<td>\n<div>5-6 months postnatal</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Tonic neck </strong></div>\n</td>\n<td>\n<div>35 weeks of gestation</div>\n</td>\n<td>\n<div>1 month postnatal</div>\n</td>\n<td>\n<div>3-4 months postnatal</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Parachute </strong></div>\n</td>\n<td>\n<div>7-8 months postnatal</div>\n</td>\n<td>\n<div>10-11 months postnatal</div>\n</td>\n<td>\n<div>Remains throughout life</div>\n</td>\n</tr>\n</tbody>\n</table>\n<p><span>&nbsp;According to Ghai Essential Paediatrics, 9th edition, tonic neck reflex disappears by 4 months of age. According to Nelson Paediatrics, 21st edition, tonic neck reflex disappears by 6 months of age. Hence, the answer depends on the reference chosen by the examiner.</span></p></div><!---->\n      <!---->\n    </div><!---->'),
(2022, 'Paediatrics', 'PM2090. Short stature: Familial vs Constitutional', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>Constitutional Delay</strong></td>\n<td><strong>Familial Short Stature</strong> &nbsp;</td>\n</tr>\n<tr>\n<td>Height</td>\n<td>Short</td>\n<td>Short</td>\n</tr>\n<tr>\n<td><strong>Final Height</strong></td>\n<td><strong>Normal</strong></td>\n<td><strong>Short &nbsp;</strong></td>\n</tr>\n<tr>\n<td>Family history</td>\n<td>Delayed puberty</td>\n<td>Short stature &nbsp;</td>\n</tr>\n<tr>\n<td>Bone age</td>\n<td>Less than chronological age</td>\n<td>Normal &nbsp;</td>\n</tr>\n<tr>\n<td>Puberty</td>\n<td>Delayed</td>\n<td>Normal &nbsp;</td>\n</tr>\n<tr>\n<td>Height velocity</td>\n<td>Normal</td>\n<td>Normal</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2023, 'Paediatrics', 'PM2037. Weight and height changes in children', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div>\n<p>Term newborns may <strong>lose up to 10% of their birth weight</strong> in the first few days of life (due to extracellular fluid losses). Most healthy newborns typically <strong>regain their birth weight by 10 to 14 days</strong>. Thereafter, approximate daily weight gain is as follows :</p>\n<ul>\n<li>0-3 months ~ 30 grams/day</li>\n<li>3-6 months ~ 20 grams/day</li>\n<li>6-12months ~ 12-15 grams/day</li>\n</ul>\n<p><strong>Note :&nbsp;</strong>Infant weight approximately <strong>Doubles</strong> at 4-5 months , <strong>Triples</strong> by 1year and is&nbsp;<strong>4 times</strong> by 2 years of age.</p>\n</div>\n<p><strong>Weight gained with respect to birth weight</strong></p>\n<div>\n<table>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Weight</strong></td>\n</tr>\n<tr>\n<td>5 months</td>\n<td>2 × birth weight</td>\n</tr>\n<tr>\n<td>1 year</td>\n<td>3 × birth weight</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>4 × birth weight</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>5 × birth weight</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Formulae for calculating the weight in children</strong></p>\n</div>\n<div>\n<table>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Formula</strong></td>\n</tr>\n<tr>\n<td>3-12 months</td>\n<td>\n<div>Weight =<span>[age (months) + 9] </span></div>\n<div>2</div>\n</td>\n</tr>\n<tr>\n<td>1-6 years</td>\n<td>Weight = [2×age (years)] + 8</td>\n</tr>\n<tr>\n<td>7-12 years</td>\n<td>\n<div>Weight = <span>[7×age (years) - 5]</span></div>\n<div>2</div>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Height with respect to age</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Height</strong></td>\n</tr>\n<tr>\n<td>At birth</td>\n<td>50 cm</td>\n</tr>\n<tr>\n<td>6 months</td>\n<td>65 cm</td>\n</tr>\n<tr>\n<td>1 year</td>\n<td>75 cm</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>90 cm</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>100 cm</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(2024, 'Paediatrics', 'PM1946. Periods of growth', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Prenatal period</strong></td>\n</tr>\n<tr>\n<td>Zygote</td>\n<td>0 to 14 days of gestation</td>\n</tr>\n<tr>\n<td>Embryo</td>\n<td>3 weeks to 8 weeks</td>\n</tr>\n<tr>\n<td>Fetus</td>\n<td>9 weeks to birth</td>\n</tr>\n<tr>\n<td>Perinatal period</td>\n<td>22 weeks to 7 days after birth</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Postnatal period</strong></td>\n</tr>\n<tr>\n<td>Newborn (neonate)</td>\n<td>First 4 weeks after birth</td>\n</tr>\n<tr>\n<td>Infancy</td>\n<td>The first year</td>\n</tr>\n<tr>\n<td>Toddler</td>\n<td>1 to 3 years</td>\n</tr>\n<tr>\n<td>Preschool child</td>\n<td>3 to 6 years</td>\n</tr>\n<tr>\n<td>School-age child</td>\n<td>6 to 12 years</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\2\><strong>Adolescence</strong></td>\n</tr>\n<tr>\n<td>Early</td>\n<td>10 to 13 yr</td>\n</tr>\n<tr>\n<td>Middle</td>\n<td>14 to 16 yr</td>\n</tr>\n<tr>\n<td>Late</td>\n<td>17 to 19 yr</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2025, 'Paediatrics', 'PM1928. Social and adaptive milestones', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td>\n<div><strong>Age</strong></div>\n</td>\n<td>\n<div><strong>Milestone</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>2 months</div>\n</td>\n<td>\n<div>Social smile</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3 months</div>\n</td>\n<td>\n<div>Recognizes mother</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>6 months</div>\n</td>\n<td>\n<div>Stranger anxiety</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>9 months</div>\n</td>\n<td>\n<div>Waves bye-bye</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>12 months</div>\n</td>\n<td>\n<div>Comes when called</div>\n<div>Plays simple ball game</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>15 months</div>\n</td>\n<td>\n<div>Jargon</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>18&nbsp;months</div>\n</td>\n<td>\n<div>Copies parents in the task</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>2 years</div>\n</td>\n<td>\n<div>Asks for food, drink, toilet</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3 years</div>\n</td>\n<td>\n<div>Shares toys</div>\n<div>Knows full name and gender</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>4 years</div>\n</td>\n<td>\n<div>Plays cooperatively in a group and goes to the toilet alone</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>5 years</div>\n</td>\n<td>\n<div>Helps in household tasks and can dress and undress on its own</div>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2026, 'Paediatrics', 'PM1927. Language milestones', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div>\n<table border=\1\><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Milestone</strong></td>\n</tr>\n<tr>\n<td>1 month</td>\n<td>Alerts to sound</td>\n</tr>\n<tr>\n<td>2 months</td>\n<td>Coos (musical vowel sound)</td>\n</tr>\n<tr>\n<td>4 months</td>\n<td>Laughs aloud</td>\n</tr>\n<tr>\n<td>6 months</td>\n<td>Monosyllables sounds (ma, ba)</td>\n</tr>\n<tr>\n<td>9 months</td>\n<td>Bisyllables (mama, baba)</td>\n</tr>\n<tr>\n<td>12 months</td>\n<td>1-2 words with meaning</td>\n</tr>\n<tr>\n<td>18 months</td>\n<td>8-10 word vocabulary</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>2-3 word sentences (uses pronouns like I, me, you)</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>Asks questions and knows name and gender</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>Sings songs, poems and tells stories</td>\n</tr>\n<tr>\n<td>5 years</td>\n<td>Asks meaning of words</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(2027, 'Paediatrics', 'PM1926. Fine motor milestones', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Milestone</strong></td>\n</tr>\n<tr>\n<td>4 months</td>\n<td>Reaches out for objects with both hands (Bidextrous reach)</td>\n</tr>\n<tr>\n<td>\n<div>6 months</div>\n</td>\n<td>\n<div>Reaches out for objects with one hand (Unidextrous reach) and transfers objects</div>\n</td>\n</tr>\n<tr>\n<td>9 months</td>\n<td>Immature pincer grasp</td>\n</tr>\n<tr>\n<td>12 months</td>\n<td>Mature pincer grasp</td>\n</tr>\n<tr>\n<td>15 months</td>\n<td>Imitates scribbling and builds a tower of 2 blocks</td>\n</tr>\n<tr>\n<td>18 months</td>\n<td>Scribbles and builds a tower of 3 blocks</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>Builds a tower of 6 blocks</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>Builds a tower of 9 blocks and copies a circle</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>Builds a bridge with blocks and copies a cross</td>\n</tr>\n<tr>\n<td>5 years</td>\n<td>Copies a triangle and&nbsp;builds a gate with blocks</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4773a150d41047a29789e417bb2993e1x1280x936.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2028, 'Paediatrics', 'PM0017. Tests for developmental quotient', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Definitive Tests&nbsp;</strong></td>\n<td><strong>Screening tests&nbsp;</strong></td>\n</tr>\n<tr>\n<td>\n<p>-Bayley scales of infant and toddler development</p>\n<p>(Bayley-III)&nbsp;</p>\n<p>-Stanford-Binet Intelligence Scale&nbsp;</p>\n<p>-Wechsler Intelligence Scale&nbsp;</p>\n<p>-Developmental Activities Screening Inventory (DASI-II)&nbsp;</p>\n</td>\n<td>\n<p>-Denver-II developmental screening test&nbsp;</p>\n<p>-Phatak’s Baroda screening test&nbsp;</p>\n<p>-Trivandrum development screening chart&nbsp;</p>\n<p>CAT / CLAMS&nbsp;</p>\n<p>-Goodenough Harris draw-a-man test&nbsp;</p>\n<p>-Gesel figures and block skills&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(2029, 'Paediatrics', 'PM0016. Developmental progression of the grasp', '<div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\"><p><strong>Ulnar palmar grasp</strong></p>\n<p>6 months: object is grasped by the ulnar side of the palm&nbsp;&nbsp;&nbsp;</p>\n<p><img class=\"WACImage SCX139599407\" src=\"data:image/jpeg;base64,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\" width=\"159\" height=\"112\"><span class=\"WACAltTextDescribedBy SCX139599407\"></span><img class=\"WACImage SCX139599407\" src=\"data:image/jpeg;base64,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\" width=\"76\" height=\"110\"></p>\n<p><br><span class=\"WACAltTextDescribedBy SCX139599407\"></span></p>\n<p><strong>Radial palmar grasp </strong></p>\n<p>8-9 months: object is grasped by the radial side of the palm&nbsp;&nbsp;&nbsp;&nbsp;</p>\n<p><img class=\"WACImage SCX220550837\" src=\"data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAYABgAAD/2wBDAAMCAgMCAgMDAwMEAwMEBQgFBQQEBQoHBwYIDAoMDAsKCwsNDhIQDQ4RDgsLEBYQERMUFRUVDA8XGBYUGBIUFRT/2wBDAQMEBAUEBQkFBQkUDQsNFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBT/wAARCAB2AKgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD8rH/1jfWm05/9Y31ptABRRRQAV9cfsq/FBLrT7PQbu68u409hFErN/wAs2kyso91J2nHb/er5HrU8O3d/Y6zZ3GmTNbX0L+ZFMrbdhHJP0wOaAP0T+JHjjS/Aun3ms6ta/alWXyrWwXpcyAfd47KPl9vm7/e8D1T4weMPGFwy3GqSafA7FhYaexjgiVT8q/L8zliGVvX5ccLWLqWqa/8AFXXF1LVG2xQxeVbR/wAESjYwIz95tw+Ynr1Fdx4T+GdxqTRxW6qo3CLzmzhmyA3XBPP0/hH8PygHIySfY7Oa/luJLh0k2S7W/eZ4HzEE54Xnt26MtU7ea5vGjW4kkkRGDRRtIXC46kZ45H4Y25+9X0JY/BWwlsf38bMr7GaSRhny92S24dMYfPH93hhXkepeE7nwRq11pOoxtJ9lYMrdPtMbKMEEd+MH34HG3aAZMkL2skc+355Iw7L1OSfvKOewXj/Z/CnWtmYtStf+WkC4UeW33lO8spz3GUBORz/vVsR27yyW8DKrQJKEuGXARslAT278gr/eamrb7ma3XbC6+WYnb5dpc5Hvydgz/wDY0AeVtobrcXHlXSq8U7/K2V6Sk9TzkKO/Zcfw11ngeM/Z5tLvY/MiVdsK9RtPLA+mdq49mY/3TVqaH7Pq0zeXtiupDKUbH7s7cuvoNrJ+XX+GtCHTx9qjkiWOR4/mDrwGAIZlB9xzzjn8QwBmtoY0m8W6ikaSCSQsY1/h4HI9Qqt7f1rqIdFt7iPypW3QSL5J/uZITOP9pwGb6flVXVoTcMt180nnMHT67icYGMYYc/7e7610lnZlYWZtqzrEHO3kLyAdv4HGfT/doA5uxkfTZP7Oum3OyhwrfxAEM3PsHZj379OKJtHs1vIdXW1W+e1kJuLCZeZV3EMM9QRn8H3V02paPBqi+Uu6Ofg27M2drAZHPTDN0I/+JrnW1KTRpliu1WNVlDrJ0RlQ53ccLgsh2+lAH1F4H0u7XQ9PuNG1iTxF4QkVLiG21Rt9zbQuTjEuf3qr90qeR+le3aPZiK8kW1vLmGBY0YpNIZEb5f8Aa9j/AOO/99fHvwd+LUfgO8mt7pf+JHcsXKdrZmGGjb0V2KMueAf7u6voS1+KFroy2N7Eraxo2qyGK11S3nB8uVcu0EgP3JUx9091oA9S1bT7i/t2We4XYzbtkK7N2w5OeeM5/wAKK5Wz+IllfzQxPHPCskmwtIvG4ADqM9flAooA/Ex/9Y31ptfoc3/BOXwkzY+3eJI/n5fzIW4J/wCufX0/WsvUv+CbulPGz6f4m1SwmbJRby0jmC4xuBwV5Hr6c0AfA/NDY3ccDtX0P8Vv2IviH8OIZL+ytk8W6Ym4vPpSlpUAIwXhPz85/hzXgNvptxdXUdvFHvmk+4vr+f0oAjtbWa9uI4IY2klkbaqL3Jr1rwd8Pptq2sP7yeWQQy3Ma5RTvTof4sZX2P8A31Wl8LfhcLm1ku5Pml3CL+6WLchBnpu6ZNfQWm+HRpuj28FntjuLr5IpOgUk/eH03Jj3253UAZ/hHwbHLH9igh2wIqJM38chcFmX2xtbP6bq9+8L+G4rWONI1+7Ju3KuOxXP1yc/7Z/u9awfB+mwWdvGyx/dUMqsuNufmJI6jPzZ/wCBDHzV6BYyRrGqpuVU/wBS3H3ipK9M9+ntQBYXTYpY/mXar/KWX+H/AGl9c+nf0ry/44eCf7U0eHV0j/0iwYvIirkxxHYz4/3Mda9eX7uxdzJ/Cq8FupGfQehqO+jjurObbtZVU5T+8p5PTsxC8+lAHxr9nNxtlX5tzFty/wAXfrxjB9ep/wB3fTW08ybX3fv7fqrc8MoBGBnts9fu9P73YeKvDZ8K69eWG1lsPMe4hXp1kwy9xuBP/wCvbWXDGdyqvzfaFCbWXlgWKj68hv8AO2gDkfEGkvcQ7oPm2yMsb9pDgAKW5wM7+f8AePWsvQ7qddQhgl+VpG8o7lCHK4OGB6HcVz6Hj+7XoUljH5kiKu6K5kDxr99JMkfr90/r/FXH+JPDM8qtq1qv+lQqkV0y8pIoP+uweufLbOf42/2aAIdLuJLpYbDy9rQ3ZWVZPvxgMVHBxzuX/wAeYdWWvQls5LiRXX5YJMfL9B/qxxwB/Dlem015+q/2teabqX7yFr6FIrplbLxTLjb+LL377cnmu48P3UlvCqysu62XcyqvHJJB9cf63+fWgAa3lZvPiXbOyo6r0CsT3Ye/49zVWbSZbyFrW6sfMi8vlJPvSMN45yOPXPQdcfJW5qEx02xaX/lrHhD6KwBHbuCd2e3yj5tqiuJuPFVxbtvaRo0T5nTvGoH3Vx3I4GPw+9QByN1Y3/gXUvPXzLrTn8tijZ2KcuVOe4I7195fsu/BPQv+FP2+r2+sX2sab4ntE1ObR7pVFvFNmNTMoAyJVIbnP97vzXynp+sWfibTbraqsm4/K3SMbdpUDPpvA9duOlfXX7FutBPhfqnh/d/yB9QmaD1aKUlw3+8xaTPbtQBn3mi+NLfxMunaDb6NfbJYW+1SLsdgeTwTtXCcZQddx+XbRXoFmv8AZ3i6Hcvy3ERVvqxLE/XhhRQB6N5I8z5fdg3XuD/MU5YY22r9nWRVU/LyenOfw/8A11eaHdcSN95/M+Vm6s7LuTcG7NjOT19Oy+K/FL4nX/8Ab154U0GZtNW12LqWsR5E6yFUkMMHHybUkXe2Cc8Db1oA9Q1rwvp8WkyXst1baWttFvP2ySOHcq43kFjjI7Dun/j3xb8bPhL4K8da1ca54Us1j8UuyLcahp9owt7mJnw7SDoWyOGUb88HcK67UvC+kX9wtvcefHqknzQXN5IZhLISR828nDZbGM/jirW2SXQbeW1mks3uLs2tysLYePAdWZW/hDJtAHb60AeE+FfgzrHg3Q/sV5qGls8k+8wxyfPgyAlQpyS2RnpzuropN1nqCvf28kKf6mDcvybdwB9vm+UAH+8p67q9wk8D2FvYx39qscN1DIm6325DR/Pu/JumP9qtbUvBNvf6W0TwssUiu0XmcmP+FTzyTjjPf6tQB5jpK3v2WF2t2Vf3bF29SMHHp/ntXSWt1Ju8qVfLXaVKbcdMA8dt3/svFZ+i2+r+F22wRreQQyCL7BdZwpwGDBhkqDlfWuy0+O28S6at7DbtbsvyTRyYypU42nHfh/8Ax373SgCva3j/ALveu7cpbZ2+ZunOefuf5arzNt3bW/dMwcbevPpng5b8PvVmrZm13RNt+bG5mU4bJIOR6f8AxX+7WlDC7RzRbWaX7rbuuCD6fVj6ZoA8j+NGkp/Z8N1EqrLHMiheQjbt6YzjIB9evavMfs/2X7Qrt/q2do16GMj7wPUjKp/X+GtX9sH4qWvg6zsfDlncQNrd5NDNPtbDWkCEOCT/AA+Y3IH+yz1z3w/8H/ES10GTUvFulta2F1L9qt76bAmjkJ3ANF2Rsr1/+sADY/s/fGqv8rxyBBJtHy7QQM9Fz/D6enFU76RfsMeoxRtug/0e4jXk7R91enYHbz/ebj5q2LW4jlt2R18mdWfzFbkxnq3I9mUZ/rUN9C8Vx9qij8yJ1Kyr/skfe78D5s9zux/FQByesaCtn4dvrrSJIPtTKZUt5FzDGwHzcHqmGYden51wNr8QNQ8P6pY6jq80txbXjOrNC2I4xjc7lMZLLtWRSeu3/erovEnjSy8Hq1vBMt9A67lhVsnJ2Ng88btzfTpn+9j/AAN8LL8VPi9pNndWP2rSIJXuLy3b7uzDr94dCw8vp2agD1q8U3mn7EXcjRh7dY+dy4dsLjqdm3b/AI15LqWj3LLJv+ZkXl1zjaNmBn/Zbbz/AEavo74vfDW8+GNjHqnhPT1vvDMLFbrSlU5tosnMkeP/AEGvnuP4hXGvXUkVn4Xu75fMaIXunt5gc9M5YdRlifQbeaAONt5L/wAK3nm2rNtePbIs2dkqhtuT1/iXg4wf+BV9PfsT/Gi2uPjMuhy+fZy61p80LW03A+0Q7HAzzzt3lT+Hpnz3Rfgn458YNHK2g/8ACP28jD99qVyMxY5xtXJxwvPfvzzXs3wx/ZT0vwbr2k+JrjxZdx63pV2l3BDYxqkLbQMqQQSUYbgcY4lb+7QB9WeLtH+z65bywLtgZkmiP90Z7e3bI/8AZqK7yGGLxR4Zs97fciHzdBHkIzfj82PT/wBmKALnljc25flRiw9WJ388/wDAevTzWr5t+Jnh1NJ+NGsN9sguri9gj1OS2VsvGH+Rt+eOXiYqf7m0mvdm1h185Eba3LFuRztA59yNv07ejfPfii1j1b4reJLqeRvtD33k279DGEiEY6cfMRn0+9/wIAk1bwfB4o0+R/tCwsnz/KxSRcHeSDg8buV7/wAq5Hx14f8AEGk/D2+ZbWO4tWl826kkzHJ9nchXkCjgjHo3HzHrWp4y1jxJ4LtY7y10OfxZZQqGaHTW2Xq5I6KflfGfUZP5V7BpOhz6ytvYXVu32P8AdvMtwylJAOduAdu0szD070AfKa+NPiJ4B8QR6RLqEeteGprRLi31i6gjuXcIu5oS4wQ7Dds3A5H97pXv2g65Pr2m2t4jSXEFyqSwNtysiuMKRjnGDgj8P970jxF8I/DHibSZFvdJg/1D5mtVEM8WQOjDGMbkzXlvwr0nUPB914q8JX11JMmk6lst2mXB8mRQ5/Dec4/2sfwrQBeutNjaPdIvzuzvJu54KHbn1Py0aXYmz1q62/6q5y7K3O6Ren44TP8A+zWtqUP76PYvls+W9SuW6+/PP/Af96oWUW7K/wDDHllTqGXJOPwxn6UAZ91p6NdMy/Ltk3N/s5OMj/6/+zV7SfDd5qTQ2VlGrXrqUiVlyka9Wcj+6vf1+XHDNU0zI0bMzeWq4yzdVwfQ9/SvpD4V+EU8NaH51zbeXf3rb5gy8xx5+VOeR0Un8+tAHjcfwb0+ztfsr6LbXzIv7+S8tlmklZsbpJCwJJbDZ/8AiFovvAMFxHMlxYrNBwrRyLvDAfNyD2KlvavphYYtq7o1b+La38PTgflR/Z9qV2+Svyrn+oP45oA+A/FX7Kd/qXiaS88PNaWdg68w3DMBFIipwMDnndjnPb+7W1oP7LOhabpbRa3cXOsb4Ei/ds0EcY5A+78xLbce/wA3H977g/sWyZo/3K7O3ovI6Y9O1R/8I7YSrzCvyYJ+X6H8+9AHwPcfsF/CO6Zmi8P30PzBj5OqTZUZB7scnceT/td67zwj8EfD3gXTY9O8PabBptuke1nhjHnScHGX6nP6bq+t5PCOmSybmtl+8D75Hyjn8WH/ANao/wDhCdN3bvL+7gj5f9rd/Pn2NAHzR/wiL+W2+ZZF8vbJ5kfyMvyHGOOP8/L81ed6l+zHZXF1qEul6h/Yf27e0kNnbDCyHgsvTk4z/la+028AaWsYVV27cMu3A2kcjGeg+T/PzZjb4d2K/wCqZo2XONqgFQA+Ov8Av8E0AfLln8D7yw0+H7Lql3fXFviK4fdiRmOOQuDjOO30rxfxV8StR8C+JJtNTT5NagjaOHZIpQ7nV2KDp8vPHqdw6bRX6Gr8P7e3ZTDKsCpkfKuPl4BX/dKqua5/xR8BdA8ZW6RapawzOrwyfaY12Tbo3Dx89flYKeaAOU+Htw6+DdHa4+V3tI/ODfI6sRnBHZk+bPIwOerUV39t8MZ4Y/m165l/jVmjiyrcjOdvPB9P4aKAPCtS1SLS9Pvr+fc0FtFJNIkfXao3EDHTI+teB6Xq17qXiKbUdRZWnvpfNa4jUKiyOeIhzjGFTaf97vXul9DFqVrdWUu7Zcq8Lbeu08Ej6V5n4f0GPTbWbS7hY5Ps7OhaT7jbeATjswbd/wDtUAdVb26X9v8AZ/MWGXaVjaTOM4I+vA5/pn7u54d1DULXy4HXzoo/lX5gHwpDADHBYE5z/tf71c/DosSqqxaksaN91Lj59oPPByD8v6VTmkn8GzQ395eQSW8fyM6q+VwdoUqRzu+bNAHuHh28g1RY0ik/0hGAaPptzyWI4+UArg/7Mh+X5q8pkuk1LxZ4iurO3/cJOkPnKwImaKMDJ6dAyr/wGudbxFqus6pdf2beSafo1zmylmVcSXLeYGJTI4iGdvTndkfdY12FjpMWk2a2dvD5cS/KqbcHv19+/wD9dqAKN1b+VHG7tuufkSONuAuRx+nHsP8Ax6rbqrRtO7eYrZ3PJ6dTn/x3Ncb4q+L2mWOrTaRZLPrV/wCYUb7Hhwsrfwq3Ulvp1ra8P/DfxX8QZI5/E0jeF9EVUX+y7dszMDvB3Ef3m2gZ/AdqAOi+EtrH8RviBHKqs3h/R2FxLI3H2mXnCr/3yzEei/7tfVkN9G0m5mX724+nQ/415b4Z0ey8M6fa2Gm2cdnYQ48uFefugkFiPvEb/X+H/aWuqs7h18lvm3HHzewyQfQZHP8AwLFAHYR30bR/M21W6/pjj/gVTR3SLt+ba33hu/hOB/jXJw3m1f8AZXZU324+Xt3f7Z/2cHnp9cf99UAdUtxHt27v4Qu3puHbmpFmTa37zaOVDdNuMjP05/CuV/tA7m+9978cn3/DPvUy33zbdzL820N7dKAOqaZd3ze+f++v8Kcsg/vfL3/E5/lXKx6gdq/N823cGX+LP19f/rVIupH+Ft38Xy/UE/zoA6b+7/wH5W/z7U5fvf7rDH5kfyrm11A/dVvl3Bgu78v0qRdSP975dxXd1Hf/ACRQB0SqWXb8u7jj6HP6U5l3K2F3K3ykf1rnV1JkVV6bv4d3PB4GfptGf/iasLqj7mZW3bev15H4dKAN1gWOxv8A9dFYy6kflTd7fkR29qKAPldvm8z+6u/5fx//AGR/la5f4gQ39hpM2s6RareapbbHNs2R54HHGOd38PFdVt/eNt+X5vvf3SScYx7hRUyr8u3bt3Y+TsoXA28fRun40AfOvhn44aF4gWZ7+6g8MzpJsEd02RnGcq4GAcdd3Q+1WvFXxc8L2FnHEuqLrm1gBa6bu/eSBt+WdwAqkhfwXH8Py+neJvgb4I8YXjXV/occN5Ipi+027GAsGOOi/Lx7j65rkbX9kXwmskLtrGssm0qUZowWXg4LYzjAYigDxfVPih4s8eXkdhpcbWrXEgWHT9N3efL9/AaQ8/oMduK9g0X9mXxJLo8aXvj7ULdny8lnH5rjnIC7t3XmvYvBfw78P+AbPyND0uPT/lLPcbd8zYwCS5ySR9a7CG1PkrtX/lptG3OMkZ7cnA9v4f8AdoA4H4X/AAP8P/DeT7ZbM2oapDB819dKCIwuOI4+ignb/ndXrFnZ/MyqrL833d2eSoX73r8+M9CWXFQ29qPl2sv7tvlbjOGwe38x1ToezaVqoVlb+DcG29dv7xBn07qPpt7pQBNCoWNm3bV27u6bWYlMk/wgrx04+YfKV+a8sZiZvm3bmyd3rznA7ZPP/fVQ2se3d8qr/DIrc+Xj/ln753MSfXt81TRqsW5FZm25Y7mztyc8+n3uKAJOP7u7/e6Yp24+YsTtuY/M27rx69/ypsbHy9u5fnw3ytx0GPT/ADz/ABUL93+Jvl3fLQA7d8vzNy3X+hJ5qZmPzfkVbgcjofTHao127vl+7t+6vO7HUZ7Ubdy7f4VXbu9++OxoAmaT5dxZtvdm4boMH6nrQ0jr975WVefy5/JttN5bc27a24/N97a3XP8Aj6UbR8vy7VZt+3+6Mc4+mc+4oAmaQq25f4en4Yx/7L+Hs1OWQrt2ttX7qt3wc/02/wCVqHnb83ytt/xJ6Y9f/HuKkb7zfxeq+3P+f8/KASLIVVf4dq7R/s8VIsh+6rbd2djdecnjPfHT3quq7fvf7pb6ED+R/wDHqkX+9/Fu/h9Sc/5/ztALCzfxD7rKFC9+RnH/AKDRUa4/77XbuX0HJx/UUUAeA+X83ze+5evB5/M//qqwsL/L/e2/dbqwzwc0Kv8AE3zKjc7eOOatRw/M3y/MzFWVemMpx/3yc0AOhhDblVflZv4v4gegPbhttWI4S3/xXsccn8mohjPy/L8zKPm2/U9B/n/x2rkMJWNvl+5jd/s5OVBNADoV2yR7F+ZW3L8uWXueOc1qW9uFZv7vCF16sAYyp4zjqmP++/8Aer2qny1Zvm3Z2oq53bSG5H8RJ4UHv/wENpRx7Vbb/D8p28j5QRwT1+7xnr19lAJoYzEqsqruVC4T+Fju9PRnPI/Cr0MIVmRGWRl+UMzD5hnAl5yDjDcc8+1Qxr5UkjbVXayKu5shd+AvXkBjxu6/jvq1Hst1h3Kyt5YiCNgOoX0BPc7e/wDdoAdCwaFXRfMRs7WbrtySOScnq2Kk+ddrNukwvH/TTtyOB78f3adt2/M3zbl+6386csb7Y0+9/EGbq2B19D7/AOdoAbfmb/Zzz2obO3d+bfWnL91WX+JtrL2YZz+XFG0fN8rNt+VVbquTkfj/ADoAGX5dv3lXp/tYOMU5vm8xt3349u78jz+HGac38T/e+6x2+o649/frRt+8v8P+zyOBnIHp6UAG794zLuXcwYL/AHQoyB9RTto+7/eY5X8MfyOP8tR/CzN+a/Nyef6r9f8AgNO2lt2373b64K9T9cUAC5+Zvrn8+Mf+O/5+85V3fKzfw7T9D2x6f5/ho+/93+L5/m9yev50fw7v+BfN16YyfwoAcud2/wD2t33u+d1OVfl2r8voy+g9vb5f++f++ms21Wb/AICd3tz+fy1Jt+Zlb5tu5fyIT/P+RQBJu+Ztvy/KMbfQZ6H09PWij+Jm+9tYf8CwCAf/AK/SigDxBQFeUdBFI3TtyAcfgBjNWBHtU4PQAD8Rkj6ZB56/maKKALceFkl28MCQPTBOf59aueSfLjiVypkCuo7Hecgt33Dc3XOAcDiiigDVEYZrmQBSoDE7u6gRsvHQkRuODwGLAfLgVZtyW3FuUWRomb+JghUn9VP19uxRQBfhUpJCCFxhn45xltoUZ6KMdOvGc5Jq1HFtYtjC8McE9CTg+m71oooAeOVAPQfp8wBx68etOX76ju0e/HYjGcH8P1oooAVWTapwzJG2z5upBzx9D3qRVPmIrHdtZo2PqV6fgO1FFADd37tmYt8qnleowRux+Z+vepNp34wuckY7Z3Bfy/8A1dKKKAFICqcdgAG74+Snf3vx/kB/KiigB38ALdSpzt/CnN8q7jz1/m3/AMQ35iiigBSpXKqcuGbGeB94AdP9rmpFAR8dU3+WPXgcE/jz9eetFFACr/q/92Xy/oc9vaiiigD/2Q==\" width=\"131\" height=\"92\"><img class=\"WACImage SCX215536996\" src=\"data:image/jpeg;base64,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\" width=\"134\" height=\"94\"></p>\n<p>&nbsp;</p>\n<p><strong>Immature pincer grasp </strong></p>\n<p>9 months: the object is secured between the adducted thumb and the extended index finger&nbsp;</p>\n<p><img class=\"WACImage SCX155962968\" src=\"data:image/jpeg;base64,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\" width=\"126\" height=\"88\"><span class=\"WACAltTextDescribedBy SCX57151736\"></span><img class=\"WACImage SCX57151736\" src=\"data:image/jpeg;base64,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\" width=\"127\" height=\"90\"></p>\n<p>&nbsp;</p>\n<p><strong>Mature pincer grasp</strong></p>\n<p>12 months: the object is secured between the opposed thumb and the tip of the index finger.&nbsp;&nbsp;&nbsp;</p>\n<p><img class=\"WACImage SCX134039010\" src=\"data:image/jpeg;base64,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');

INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(2030, 'Paediatrics', 'PM0015. Important developmental milestones at various ages', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Developmental milestones&nbsp;</strong></td>\n</tr>\n<tr>\n<td>\n<p><span><strong>At 1 year</strong></span></p>\n<ul>\n<li><span>Motor: Walks with support</span></li>\n<li><span>Adaptive: Mature pincer grasp</span></li>\n<li><span>Language: Speaks a few words</span></li>\n<li><span>Social: Plays simple ball game</span></li>\n<li><span>Domestic mimicry at 18 months</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><span><strong>At 2 years</strong></span></span></p>\n<ul>\n<li><span>Motor: Walks up and downstairs, one step at a time</span></li>\n<li><span>Adaptive: Makes a tower of 6 blocks&nbsp;</span></li>\n<li><span>Language: Simple sentences, a vocabulary of 50-100 words, uses pronouns at 2.5 yrs</span></li>\n<li><span>Social: Asks for food and starts toilet training, listens to stories</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><span><strong>At 3 years</strong></span></span></p>\n<ul>\n<li><span>Motor: Rides tricycle</span></li>\n<li><span>Adaptive: Makes a tower of 9 blocks, handedness is established</span></li>\n<li><span>Language: Knows full name, age, gender</span></li>\n<li><span>Social: Plays simple games and engages in parallel play with other children</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><span><strong>At 4 years</strong></span></span></p>\n<ul>\n<li><span>Motor: Hops</span></li>\n<li><span>Adaptive: Draws square and constructs a bridge with blocks</span></li>\n<li><span>Language: Tells stories</span></li>\n<li><span>Social: Goes to the toilet alone</span></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;<strong>At 5 years</strong>\n<ul>\n<li><span>Motor: Skips</span></li>\n<li><span>Adaptive: Draws a&nbsp;triangle</span></li>\n<li><span>Language: Asks the&nbsp;meaning of words, names 4 colors</span></li>\n<li><span>Social: Dresses and undresses</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2031, 'Paediatrics', 'PM0013. Gross motor milestones', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Milestone</strong></td>\n</tr>\n<tr>\n<td>3 months</td>\n<td>Neck holding</td>\n</tr>\n<tr>\n<td>5 months</td>\n<td>Rolls over</td>\n</tr>\n<tr>\n<td>6 months</td>\n<td>Sits with support</td>\n</tr>\n<tr>\n<td>8 months</td>\n<td>Sits without support</td>\n</tr>\n<tr>\n<td>9 months</td>\n<td>Stands with support</td>\n</tr>\n<tr>\n<td>12 months</td>\n<td>\n<p>Stands without support</p>\n<p>Creeps well</p>\n<p>Walks but falls</p>\n</td>\n</tr>\n<tr>\n<td>15 months</td>\n<td>\n<p>Walks without support</p>\n<p>Creeps upstairs</p>\n</td>\n</tr>\n<tr>\n<td>18 months</td>\n<td>Runs</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>Walks upstairs and downstairs (2 feet/step)</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>\n<p>Walks upstairs with alternate foot</p>\n<p>Rides tricycle</p>\n</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>\n<p>Walks downstairs with alternate foot</p>\n<p>Hopping on 1 foot</p>\n</td>\n</tr>\n<tr>\n<td>5 years</td>\n<td>Can skip without falling to either side</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(2032, 'Paediatrics', 'PM2450. Differences between Marasmus and Kwashiorkar', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Marasmus</strong></span></td>\n<td><span><strong>Kwashiorkor</strong></span></td>\n</tr>\n<tr>\n<td>Seen in infants less than 1 year of age</td>\n<td>\n<p>Seen in older children</p>\n<p>(6 months to 3 years of age)</p>\n</td>\n</tr>\n<tr>\n<td>Total calorie deficit</td>\n<td>Protein deficit</td>\n</tr>\n<tr>\n<td><span>No edema</span></td>\n<td><span>Edema is prominent</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Voracious appetite</span></p>\n<p><span>No apathy</span></p>\n</td>\n<td>\n<p><span>Loss of appetite</span></p>\n<p><span>Apathy</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Severe muscle wasting</span></td>\n<td><span>Muscle wasting mild or absent</span></td>\n</tr>\n<tr>\n<td><span>Prominent ribs</span></td>\n<td>Protuberant abdomen</td>\n</tr>\n<tr>\n<td>\n<p>No Fatty liver</p>\n<p>No subcutaneous fat</p>\n</td>\n<td>\n<p><span>Fatty liver</span></p>\n<p><span> Subcutaneous fat preserved</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Special features:</p>\n<ol>\n<li>Alert</li>\n<li>Loose wrinkled skin&nbsp;</li>\n<li>Baggy pant appearance</li>\n</ol>\n</td>\n<td>\n<p><span>Special features:</span></p>\n<ol>\n<li><span>Moon face</span></li>\n<li><span>Flaky paint dermatosis</span></li>\n<li><span>Flag sign</span></li>\n</ol>\n</td>\n</tr>\n</tbody>\n</table>\n<p>The image below shows&nbsp;<strong>Flag sign </strong>characterised by&nbsp;alternating bands of hypopigmented and normal pigmented areas on the hair strand.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2bf9b82662154bc1bb27ad58c04649f4x1280x1364.851904090268.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p>The image below shows a child with an old wrinkled old man appearance.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/f0411a009a6342ee9a61833d387a7fc3x720x932.PNG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p>The image highlights the differentiating clinical features between marasmus and kwashiorkor</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5b5cb2c46782497abb5654b4d4ca3b25x800x512.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(2033, 'Paediatrics', 'PM2375. Diseases of mitochondrial inheritance', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><span>Caused by <strong>mutations of the mitochondrial genome</strong></span></li>\n<li><span>Inherited <strong>exclusively from the affected mother</strong></span></li>\n<li><span>These diseases include: (mnemonic: <strong>KLMNOP</strong>)</span></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span><strong>Disease</strong></span></p>\n</td>\n<td>\n<p><span><strong>Features</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>K</strong>:<strong>&nbsp;</strong>Kearn- Sayre Syndrome (KSS)</span></p>\n</td>\n<td>\n<p><span>Ophthalmoplegia</span></p>\n<p><span>Pigmentary retinopathy</span></p>\n<p><span>Cardiomyopathy</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>L</strong>: Leigh disease</span></p>\n</td>\n<td>\n<p><span>Subacute necrotizing encephalomyelopathy</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>L</strong>: Leber hereditary optic neuropathy</span></p>\n</td>\n<td>\n<p><span>Acute or subacute vision loss due to B/L optic atrophy</span></p>\n<p><span>Cerebellar ataxia</span></p>\n<p><span>Hyperreflexia</span></p>\n<p><span>Babinski sign</span></p>\n<p><span>Psychiatric symptoms</span></p>\n<p><span>Peripheral neuropathy</span></p>\n<p><span>Cardiac conduction abnormalities</span></p>\n<p><span>Some have white matter lesions</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>M</strong>: MELAS</span></p>\n</td>\n<td>\n<p><span>Mitochondrial myopathy</span></p>\n<p><span>Encephalopathy</span></p>\n<p><span>Lactic acidosis</span></p>\n<p><span>Stroke-like episodes</span></p>\n<p><span>(</span><span>MERRF) Myoclonic epilepsy, </span><strong>ragged red fibers</strong><span> in muscle, ataxia, sensorineural deafness</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>N</strong>: NARP (2 clinical patterns)</span></p>\n</td>\n<td>\n<p><span>1. Neuropathy, ataxia, retinitis pigmentosa, dementia</span></p>\n<p><span>2. Severe infantile encephalopathy with lesions in basal ganglia</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>O</strong>: Chronic progressive external&nbsp;<strong>o</strong>phthalmoplegia (CPEO)</span></p>\n</td>\n<td>\n<p><span>Ophthalmoplegia</span></p>\n<p><span>Cardiomyopathy</span></p>\n<p><span>Ptosis</span></p>\n<p><span>Heart block</span></p>\n<p><span>Ataxia</span></p>\n<p><span>Retinal pigmentation</span></p>\n<p><span>Diabetes</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span><strong>P</strong>: Pearson&nbsp;syndrome</span></p>\n</td>\n<td>\n<p><span>Pancreatic insufficiency</span></p>\n<p><span>Pancytopenia</span></p>\n<p><span>Lactic acidosis</span></p>\n</td>\n</tr>\n</tbody>\n</table>\n<p><span>&nbsp;</span></p></div><!---->\n      <!---->\n    </div><!---->'),
(2034, 'Paediatrics', 'PM1841. Pedigree symbols', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/9ae0644d49e5468aa4815e18c5b8c28fx600x901.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2035, 'Paediatrics,', 'PM0780. Prenatal screening for Down’s syndrome', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>USG findings</strong>\n<ul>\n<li>Intrauterine growth retardation (so decreased blood flow)</li>\n<li>Choroid plexus cysts</li>\n<li>Increased <strong>nuchal translucency &gt;3 mm</strong></li>\n<li>Hypoplastic nasal bone</li>\n<li>Congenital heart defects</li>\n<li>Increased intestinal echogenicity</li>\n<li>Duodenal atresia</li>\n</ul>\n</li>\n<li><strong>Maternal serum markers</strong>\n<ul>\n<li>Decreased: Alpha-fetoprotein (AFP), unconjugated estriol, pregnancy-associated plasma protein-A (PAPP-A)</li>\n<li>Increased: Human chorionic gonadotrophin (HCG), inhibin, neutrophil alkaline phosphatase</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Amniocentesis</strong>: 14<sup>th</sup>-18<sup>th</sup> week of pregnancy</li>\n<li><strong>Chorionic villus sampling</strong>\n<ul>\n<li>10<sup>th</sup> to 12<sup>th</sup> week of pregnancy: Gives the&nbsp;diagnosis in the&nbsp;first trimester</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2036, 'Paediatrics', 'PM1444. Infant nevirapine (NVP) prophylaxis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Birth weight&nbsp;</strong></div>\n</td>\n<td>\n<div><strong>NVP daily dose </strong>(in mg)<strong>&nbsp;</strong></div>\n</td>\n<td>\n<div><strong>NVP daily dose&nbsp;</strong>(in ml)<strong>&nbsp;</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>&lt;2000 gm&nbsp;</div>\n</td>\n<td>\n<div>2mg/kg once daily&nbsp;</div>\n</td>\n<td>\n<div>0.2 mL/kg&nbsp;once daily&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>2000–2500 gm&nbsp;</div>\n</td>\n<td>\n<div>10 mg once daily&nbsp;</div>\n</td>\n<td>\n<div>1 mL once daily&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>&gt;2500 gm&nbsp;</div>\n</td>\n<td>\n<div>15 mg once daily&nbsp;</div>\n</td>\n<td>\n<div>1.5 ml once daily&nbsp;</div>\n</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Duration:</strong> Up to a minimum of 6 weeks. It can be extended to 12 weeks if the duration of ART in pregnant mother falls short of 4 weeks during pregnancy or if the mother is not already on ART during labour.</p></div><!---->\n      <!---->\n    </div><!---->'),
(2037, 'Paediatrics', 'PM1883. Treatment of dehydration based on severity', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Plan A</strong>: For no dehydration or minimal dehydration.&nbsp;ORS is administered after each loose stool.</p>\n<table width=\325\>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Amount&nbsp;</strong></td>\n</tr>\n<tr>\n<td>&lt;2 years</td>\n<td>50–100 mL</td>\n</tr>\n<tr>\n<td>2-10 years</td>\n<td>100–200 mL</td>\n</tr>\n<tr>\n<td>&gt;10 years</td>\n<td>As much fluid as they want</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Plan B</strong>: For moderate dehydration.</p>\n<p>The amount of oral rehydration solution (ORS) to be given is <strong>75 mL/kg body weight</strong> (wt × 75).</p>\n<p><strong>Plan C</strong>: Severe dehydration</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td>First, give<strong> 30 mL/kg in</strong></td>\n<td>Followed by <strong>70 mL/kg in</strong></td>\n<td>Total<strong> 100 mL/kg in</strong></td>\n</tr>\n<tr>\n<td>Infants (under 12 months)</td>\n<td>1 hr</td>\n<td>5 hrs</td>\n<td>&nbsp;6 hrs</td>\n</tr>\n<tr>\n<td>Older</td>\n<td>30 min</td>\n<td>2½ hrs</td>\n<td>&nbsp;3 hrs</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Note:&nbsp;</strong><strong>Ringer lactate</strong> (ideal) or normal saline is used as intravenous fluids.</p></div><!---->\n      <!---->\n    </div><!---->'),
(2038, 'Paediatrics', 'PM1882. Symptoms associated with different levels of dehydration', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><span><strong>Symptoms</strong></span></td>\n<td><span><strong>No or minimal dehydration</strong></span></td>\n<td><span><strong>Mild to moderate dehydration</strong></span></td>\n<td><span><strong>Severe dehydration</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Loss of body weight</strong></span></td>\n<td><span>&lt;3%</span></td>\n<td><span>3–9%</span></td>\n<td><span>&gt;9%</span></td>\n</tr>\n<tr>\n<td><span><strong>Mental status</strong></span></td>\n<td><span>Well; <strong>alert</strong></span></td>\n<td><span>Fatigued or&nbsp;<strong>irritable</strong></span></td>\n<td><span><strong>Lethargic </strong>or unconscious</span></td>\n</tr>\n<tr>\n<td><span><strong>Thirst</strong></span></td>\n<td><span>Drinks normally</span></td>\n<td><span><strong>Thirsty</strong>; eager to drink</span></td>\n<td><span>Drinks poorly</span></td>\n</tr>\n<tr>\n<td><span><strong>Heart rate</strong></span></td>\n<td><span>Normal</span></td>\n<td><span>Normal to increased</span></td>\n<td><span>Tachycardia</span></td>\n</tr>\n<tr>\n<td><span><strong>Quality of pulse</strong></span></td>\n<td><span>Normal</span></td>\n<td><span>Normal to decreased</span></td>\n<td><span>Weak, thready or impalpable</span></td>\n</tr>\n<tr>\n<td><span><strong>Skin turgor test</strong></span></td>\n<td><span>Instant recoil</span></td>\n<td><span><strong>Recoil in &lt;2</strong> <strong>sec</strong></span></td>\n<td><span>Recoil in &gt;2 sec</span></td>\n</tr>\n<tr>\n<td><span><strong>Capillary refill</strong></span></td>\n<td><span>Normal</span></td>\n<td><span>Prolonged</span></td>\n<td><span>Prolonged</span></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2039, 'Paediatrics', 'PM0028. Radiologic features of the major respiratory distress disorders in newborns', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong> Congenital Diaphragmatic Hernia</strong></p>\n<ul>\n<li>Mediastinal shift</li>\n<li>Bowel loops in the left hemithorax</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/26467efcc64f448399d64ee0549179cfx439x599.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Respiratory Distress Syndrome</strong></p>\n<ul>\n<li>Low lung volume</li>\n<li>Symmetric ground-glass opacity (reticulogranular pattern)</li>\n<li>Air bronchogram</li>\n<li>White-out lung (severe disease)</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d6a4922ed6bf4e358741affc867a3976x557x235.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Chest radiograph&nbsp;<strong>(A)</strong>&nbsp;on Day 2: shows reticulogranular opacities throughout both lungs with prominent air bronchograms. The cardiac silhouette is preserved and both lungs are hypoaerated.</p>\n<p>Chest radiograph&nbsp;<strong>(B)</strong>&nbsp;on Day 9 (<strong>untreated</strong>): shows more severe changes. There is obliteration of the cardiac and diaphragmatic contours due to marked opacification, giving a complete&nbsp;<strong>‘white out’</strong>&nbsp;<strong>appearance</strong></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;<strong>Meconium Aspiration Syndrome</strong></p>\n<ul>\n<li>Hyperinflation</li>\n<li>Patchy infiltrates</li>\n<li>Coarse streaking</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ab0054d9b6a648768997515115ee6e3dx744x740.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2040, 'Obstetrics & Gynaecology,', 'PM2028. Concepts of Fetal Circulation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/c5f5c613865d4d4c83b9f14b09d6af27x1280x2558.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Concept 1:</strong></p>\n<p>Oxygenated blood from placenta to the&nbsp;fetus via the left umbilical vein.</p>\n<p><strong>Concept 2:</strong></p>\n<p>Most of the umbilical venous blood shunts via the&nbsp;<strong>ductus venosus</strong> to the inferior vena cava and gets mixed with deoxygenated blood from the&nbsp;lower part of the&nbsp;body and liver.</p>\n<p><strong>Concept 3:</strong></p>\n<p>One-third of blood from the inferior vena cava is directly pumped to the left atrium across the&nbsp;<strong>foramen ovale</strong>; then to the left ventricle;&nbsp;and ejected from there into the ascending aorta, where it supplies the upper body and the brain.</p>\n<p><strong>Concept 4:</strong></p>\n<p>A major portion of blood enters the right ventricle, mixes with blood from the superior vena cava, and ejects into the pulmonary trunk.</p>\n<p><strong>Concept 5:</strong></p>\n<p><strong>Ductus arteriosus</strong> bypasses the lungs, and hence, a major portion pumps into the descending aorta to perfuse the lower part of the&nbsp;body and the umbilical arteries carry blood to the&nbsp;placenta for oxygenation.</p>\n<p><span><strong>&nbsp;</strong></span></p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ed455606f546467ab69c6b4580153829x1280x2558.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2041, 'Paediatrics', 'PM1216. Radiological Signs in Congenital Heart Diseases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div>\n<table width=\5\>\n<tbody>\n<tr>\n<td><strong>Anomaly</strong></td>\n<td><strong>Sign</strong></td>\n</tr>\n<tr>\n<td>Tetralogy of Fallot</td>\n<td>Coeur en sabot</td>\n</tr>\n<tr>\n<td>Transposition of great vessels (TGV)</td>\n<td>Egg on string</td>\n</tr>\n<tr>\n<td>Partial anomalous pulmonary venous return</td>\n<td>Scimitar sign</td>\n</tr>\n<tr>\n<td>Total anomalous pulmonary venous return</td>\n<td>Snowman sign</td>\n</tr>\n<tr>\n<td>Endocardial cushion defects</td>\n<td>Gooseneck sign</td>\n</tr>\n<tr>\n<td>Ebstein anomaly</td>\n<td>Box-shaped heart</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(2042, 'Paediatrics', 'PM1213. Classification of congenital heart disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Acyanotic</strong></div>\n</td>\n<td>\n<div><strong>Cyanotic </strong>(5TE²VP)<strong><br></strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Left to right shunts</strong>:</div>\n<p>Ventricular septal defect (VSD)</p>\n<p>Atrial septal defect (ASD)</p>\n<p>Patent ductus arteriosus (PDA)</p>\n<p><strong>Obstructive lesions</strong>:</p>\n<p>Coarctation of aorta</p>\n<p>Infundibular stenosis</p>\n<p>Pulmonary valve stenosis</p>\n<p>Congenital mitral &amp; tricuspid regurgitation</p>\n</td>\n<td>\n<div><strong>Right to left shunt</strong>:</div>\n<p>Persistent <strong>T</strong>runcus arteriosus</p>\n<p><strong>T</strong>ransposition of great vessels</p>\n<p><strong>T</strong>ricuspid atresia</p>\n<p><strong>T</strong>etrology of Fallot</p>\n<p><strong>T</strong>otal anomalous pulmonary venous communication</p>\n<p><strong>E</strong>bstein anomaly</p>\n<p><strong>E</strong>isenmengers syndrome</p>\n<p><strong>V</strong>SD with pulmonic stenosis</p>\n<p><strong>P</strong>ulmonary arteriovenous malformation</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(2043, 'Paediatrics,', 'PM1987. Variants of Congenital Adrenal Hyperplasia (CAH)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>21-hydroxylase deficiency</strong></td>\n<td><strong>17-hydroxylase deficiency</strong></td>\n<td><strong>11β-hydroxylase deficiency</strong></td>\n<td><strong>3β-HSD deficiency</strong></td>\n</tr>\n<tr>\n<td>\n<p>Deficiency of cortisol and aldosterone</p>\n</td>\n<td>\n<p>Deficiency of cortisol and sex hormones</p>\n</td>\n<td>\n<p>Deficiency of cortisol</p>\n</td>\n<td>\n<p>Deficiency of cortisol, aldosterone, and testosterone</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>↑ in testosterone</p>\n</td>\n<td>↑ in aldosterone</td>\n<td>↑ in deoxycorticosterone (mineralocorticoid) and testosterone&nbsp;</td>\n<td>↑ in DHEA</td>\n</tr>\n<tr>\n<td>Salt wasting crises</td>\n<td>Salt retention and&nbsp; hypertension</td>\n<td>\n<p>Salt retention and&nbsp; hypertension</p>\n</td>\n<td>Salt-wasting crises</td>\n</tr>\n<tr>\n<td>Virilization of females (ambiguous genitalia 46XX) &nbsp;&nbsp;&nbsp;</td>\n<td>Failure of sexual development in females at puberty</td>\n<td>Virilization of females&nbsp; (ambiguous genitalia 46XX)</td>\n<td>Females are mildly<br> virilized (DHEA is a weak androgen)</td>\n</tr>\n<tr>\n<td>Precocious puberty in males</td>\n<td>Males are incompletely virilized (ambiguous genitalia 46XY)</td>\n<td>Precocious puberty in males</td>\n<td>Males are incompletely virilized (ambiguous genitalia 46XY)</td>\n</tr>\n</tbody>\n</table>\n<p><strong>Note</strong>: In&nbsp;11β-hydroxylase deficiency, aldosterone synthetic capacity is normal and some corticosterone is synthesized from progesterone by intact aldosterone synthase enzyme. Thus, it is unusual for patients to manifest signs of adrenal insufficiency.</p>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(2044, 'Obstetrics & Gynaecology', 'PM2338. Sexual Differentiation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/536987446eb543f386274c52bc9e5974x1280x2560.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2045, 'Obstetrics & Gynaecology', 'PM2182. Disorders of Sexual Development', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Complete androgen insensitivity</strong></p>\n</td>\n<td>\n<p><strong>Mullerian agenesis</strong></p>\n</td>\n<td>\n<p><strong>Turner syndrome</strong></p>\n</td>\n<td>\n<p><strong>Complete XY dysgenesis (Swyer syndrome)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cause</strong></p>\n</td>\n<td>\n<p>X-linked mutation of androgen receptor</p>\n</td>\n<td>\n<p>Hypoplastic or absent Mullerian ductal system</p>\n<p><strong>Also called Mayer-Rokitansky-Küster-Hauser&nbsp;syndrome</strong></p>\n</td>\n<td>\n<p>Complete or partial absence of one X chromosome</p>\n</td>\n<td>\n<p>SRY gene mutation on the Y chromosome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Reproductive organs</strong></p>\n</td>\n<td>\n<p>Absent uterus and upper vagina, cryptorchid testis</p>\n</td>\n<td>\n<p>Absent or rudimentary uterus and upper vagina, normal ovaries</p>\n</td>\n<td>\n<p>Normal uterus and vagina, streak gonads</p>\n</td>\n<td>\n<p>Normal uterus and vagina, streak gonads</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Breast</strong></p>\n</td>\n<td>\n<p>Yes</p>\n</td>\n<td>\n<p>Yes</p>\n</td>\n<td>\n<p>Variable</p>\n</td>\n<td>\n<p>No</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Axillary/</strong><strong>Pubic hair</strong></p>\n</td>\n<td>\n<p>Minimal to absent</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Minimal to absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Karyotype</strong></p>\n</td>\n<td>\n<p>46 XY</p>\n</td>\n<td>\n<p>46 XX</p>\n</td>\n<td>\n<p>45 XO or&nbsp;</p>\n<p>45 X mosaicism</p>\n</td>\n<td>\n<p>46 XY</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<p>Note:&nbsp;</p>\n<p>Turners syndrome have different chromosomal anomalies:</p>\n<ul>\n<li>45 XO which is seen in 40-50% patients&nbsp;</li>\n<li>45 X mosaicism (eg,&nbsp;<span class=\nowrap\>45,X/46,XX&nbsp;</span>or&nbsp;<span class=\nowrap\>45,X/47,XXX,</span>&nbsp;or 45,X mosaics with the X chromosome anomalies)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2046, 'Obstetrics & Gynaecology', 'PM2104. Accessory Reproductive Glands in  Male & Female', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Male</strong></td>\n<td><strong>Female</strong></td>\n</tr>\n<tr>\n<td>Prostate gland</td>\n<td>Skene glands /Paraurethral glands&nbsp;</td>\n</tr>\n<tr>\n<td>Cowpers gland (Bulbourethral gland)&nbsp;</td>\n<td>Bartholin gland&nbsp;(Greater vestibular gland)</td>\n</tr>\n<tr>\n<td>Gland of littre (in penile urethra)</td>\n<td>Glands of labia minora and labia majora&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2047, 'Obstetrics & Gynaecology,', 'PM1979. Derivatives of Mesonephric (Wolffian) duct and Paramesonephric (Mullerian) duct', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p class=\p1\><strong>Structures arising from mesonephric/Wolffian duct</strong></p>\n<table width=\406\>\n<tbody>\n<tr>\n<td><strong>Males</strong></td>\n<td><strong>Females</strong></td>\n</tr>\n<tr>\n<td>Ureteric bud and its derivatives</td>\n<td>Ureteric bud and its derivatives</td>\n</tr>\n<tr>\n<td>Trigone of bladder</td>\n<td>Trigone of bladder</td>\n</tr>\n<tr>\n<td>The proximal part of the prostatic urethra</td>\n<td>The posterior wall of the urethra</td>\n</tr>\n<tr>\n<td>Spermatic pathway</td>\n<td>Gartners duct</td>\n</tr>\n<tr>\n<td>Appendix of epididymis</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p class=\p1\><strong>Structures arising from the paramesonephric/Mullerian duct</strong></p>\n<table width=\409\>\n<tbody>\n<tr>\n<td><strong>Males</strong></td>\n<td><strong>Females</strong></td>\n</tr>\n<tr>\n<td>Appendix of testis</td>\n<td>Fallopian tube</td>\n</tr>\n<tr>\n<td>Prostatic utricle</td>\n<td>Uterus</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Cervix</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Upper vaginal wall</td>\n</tr>\n</tbody>\n</table>\n<p class=\p1\>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(2048, 'Obstetrics & Gynaecology', 'PM1912. Mullerian Anomalies', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\ng-scope\>\n<div class=\ng-scope\>\n<p class=\ng-binding\>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Class</strong></td>\n<td><strong>Mullerian anomaly</strong></td>\n<td><strong>Reason/Feature</strong></td>\n<td><strong>Treatment</strong></td>\n<td><strong>Complications</strong></td>\n</tr>\n<tr>\n<td>I</td>\n<td><strong>Uterine hypoplasia or uterine agenesis</strong></td>\n<td>Underdeveloped or non-developed paramesonephric duct</td>\n<td>\n<ul>\n<li>Infertility treatment -surrogacy&nbsp;</li>\n<li>Vaginoplasty for vaginal hypoplasia</li>\n</ul>\n</td>\n<td>Infertility\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>II</td>\n<td><strong>Unicornuate uterus</strong></td>\n<td>Non-developed paramesonephric duct</td>\n<td>Excision of&nbsp;rudimentary horn, if any &nbsp;</td>\n<td>\n<ul>\n<li>Uterine rupture</li>\n<li>Abortions</li>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td><strong>Uterus didelphys</strong></td>\n<td>Unfused paramesonephric duct</td>\n<td>\n<p>Metroplasty- Resection of membrane and fundal recombination. This can be:</p>\n<ul>\n<li>Hysteroscopic</li>\n<li>Open e.g., Strassman metroplasty</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>IV</td>\n<td><strong>Bicornuate uterus&nbsp;</strong></td>\n<td>Lower part is fused whereas upper part is unfused</td>\n<td>Metroplasty in selected cases&nbsp;</td>\n<td>\n<ul>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>V</td>\n<td><strong>Septate uterus&nbsp;</strong></td>\n<td>Septa of fused part persists</td>\n<td>Hysteroscopic septal resection&nbsp;</td>\n<td>\n<ul>\n<li>Infertility</li>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>VI</td>\n<td><strong>Arcuate uterus</strong></td>\n<td>A small indentation at upper part</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>VII</td>\n<td><strong>Diethylstillbesterone (DES), drug related</strong></td>\n<td>T-shaped uterus, shortened and narrow fallopian tubes, cervical collars (Cockscomb cervix)</td>\n<td>&nbsp;</td>\n<td>\n<ul>\n<li>Ectopic pregnancy</li>\n<li>Cervical incompetence</li>\n<li>Clear cell adenocarcinoma of cervix and vagina</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>A common complication is an abortion in the second trimester.</p>\n<p>Arcuate uterus: Some studies report no increase in adverse outcomes, whereas some studies have shown excessive second trimester loss, preterm labor and malpresentations.</p>\n</div>\n</div></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b5daabaa46584f8ca9566b45a6d7c54dx1280x4923.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2049, 'Obstetrics & Gynaecology', 'PM1513. Events of Early Pregnancy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Event</strong></p>\n</td>\n<td>\n<p><strong>Days after</strong></p>\n<p><strong>Ovulation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ovulation</p>\n</td>\n<td>\n<p>0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fertilization</p>\n</td>\n<td>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Entrance of blastocyst into uterine cavity&nbsp;</p>\n</td>\n<td>\n<p>4</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Implantation</p>\n</td>\n<td>\n<p>5</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Formation of trophoblast and attachment to endometrium</p>\n</td>\n<td>\n<p>6</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Onset of trophoblast secretion of HCG</p>\n</td>\n<td>\n<p>8</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HCG “rescue” of corpus luteum</p>\n</td>\n<td>\n<p>10</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2050, 'Obstetrics & Gynaecology', 'PM1403. Fetal Skull Dimensions', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/85a3054e190643c78183fa3e3093f9f1x1280x3161.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Note:&nbsp;</p>\n<p>Shortest diameters of fetal skull:<strong>&nbsp;</strong>Bimastoid -&nbsp;<strong>7.5 cm </strong>(doesnt engage)&nbsp;&lt;<strong>&nbsp;</strong>Bitemporal -&nbsp;<strong>8 cm</strong></p>\n<p>Longest diameter of fetal skull:<strong>&nbsp;</strong>Mentovertical <strong>14 cm</strong>&nbsp;&gt;&nbsp;Submentovertical / occipitofrontal -&nbsp;<strong>11.5cm</strong></p></div><!---->\n      <!---->\n    </div><!---->'),
(2051, 'Obstetrics & Gynaecology', 'PM2161. Hematological changes in pregnancy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td>\n<p><strong>Increases</strong></p>\n</td>\n<td>\n<p><strong>Decreases</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemoglobin <strong>mass</strong></p>\n</td>\n<td>\n<p>Hemoglobin <strong>concentration</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Total plasma protein</strong></p>\n</td>\n<td>\n<p><strong>S.urea/creatinine/uric acid</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Globulin</strong></p>\n</td>\n<td>\n<p>Albumin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neutrophils</p>\n</td>\n<td>\n<p>Platelets</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Fibrinogen</strong></p>\n</td>\n<td>\n<p><strong>Blood urea nitrogen</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Factors 7,8,9,10</strong></p>\n</td>\n<td>\n<p>Factor 11,13</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Insulin</strong></p>\n</td>\n<td>\n<p>S.Na/K/Ca/Mg/I<sub>2</sub></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>LDL,HDL,apolipoprotiens</p>\n</td>\n<td>\n<p>-</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>S.Transferrin</strong> and TIBC(Total</p>\n<p>Iron binding capcity)</p>\n</td>\n<td>\n<p>S.Iron, ferritin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>CRP(C-Reactive protein)</strong></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Placental phosphatase</strong></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Total alkaline phosphatase</strong></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>ESR 4x rise</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2052, 'Obstetrics & Gynaecology', 'PM1815. Cardiovascular changes in pregnancy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li class=\p1\>The resting pulse rate increases by <strong>10 beats</strong>/<strong>min</strong></li>\n<li class=\p1\>The apex is moved laterally&nbsp;</li>\n<li class=\p1\>Cardiac output remains elevated throughout (maximum in the immediate postpartum period)</li>\n<li class=\p1\>X-Ray shows a larger cardiac silhouette (due to benign pericardial effusion and shifted apex)</li>\n<li class=\p1\>ECG: Slight&nbsp;<strong>left axis </strong>deviation</li>\n</ul>\n<p><strong>Heart sounds:</strong></p>\n<ul>\n<li class=\p1\>First heart sound: Loud with an exaggerated split</li>\n<li class=\p1\>Second heart sound: Normal but loud</li>\n<li class=\p1\>Third heart sound: Loud and easily heard</li>\n</ul>\n<p><strong>Murmurs:</strong></p>\n<ul>\n<li>A systolic murmur<strong>&nbsp;</strong>that was intensified during inspiration or expiration</li>\n<li class=\p1\>A soft diastolic murmur (in 20%)</li>\n<li class=\p1\>Continuous murmur&nbsp;arising from the breast vasculature (in 10%)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2053, 'Obstetrics & Gynaecology', 'PM1824. Uterine Signs in Pregnancy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5a7dfb8f0f9e4d07ba5d81059c85b484x1280x2558.194640338505.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2054, 'Obstetrics & Gynaecology', 'PM1392. Amniotic Fluid Volume Regulation in Late Pregnancy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Pathway </strong></td>\n<td><strong>Effect on volume </strong></td>\n<td><strong>Approximate daily volume </strong></td>\n</tr>\n<tr>\n<td>Fetal urination</td>\n<td>Production</td>\n<td>1000</td>\n</tr>\n<tr>\n<td>Fetal swallowing</td>\n<td>Resorption</td>\n<td>750</td>\n</tr>\n<tr>\n<td>Fetal lung fluid secretion</td>\n<td>Production</td>\n<td>350</td>\n</tr>\n<tr>\n<td>Intramembranous flow</td>\n<td>Resorption</td>\n<td>400</td>\n</tr>\n<tr>\n<td>Transmembranous flow</td>\n<td>Resorption</td>\n<td>Minimal</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(2055, 'Obstetrics & Gynaecology', 'PM1396. Change in the amniotic fluid volume through gestation', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Period of gestation </strong> &nbsp;</td>\n<td><strong>Amniotic fluid volume </strong></td>\n</tr>\n<tr>\n<td>10 weeks</td>\n<td>10-20 mL</td>\n</tr>\n<tr>\n<td>16 weeks</td>\n<td>250 mL</td>\n</tr>\n<tr>\n<td>33 weeks</td>\n<td>800 mL</td>\n</tr>\n<tr>\n<td>38-39 weeks</td>\n<td>plateaus at 1000 mL</td>\n</tr>\n<tr>\n<td>40 weeks</td>\n<td>&nbsp;800</td>\n</tr>\n</tbody>\n</table>\n<p>Note: The average volume increases with gestational age, peaking at <strong>800-1000 mL</strong>, which coincides with <strong>36-37</strong> weeks gestation.</p></div><!---->\n      <!---->\n    </div><!---->'),
(2056, 'Obstetrics & Gynaecology', 'PM1033. Beta hCG in pregnancy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>The pattern of beta hCG :</strong></p>\n<div class=\page\ title=\Page 122\>First detectable in plasma&nbsp;7 to 9 days post-LH surge</div>\n<div class=\page\ title=\Page 122\>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ⇓</div>\n<div class=\page\ title=\Page 122\>Doubles every 2 days</div>\n<div class=\page\ title=\Page 122\>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ⇓</div>\n<div class=\page\ title=\Page 122\>Peaks at 8 to 10 weeks of gestation(~<strong>100 IU/mL</strong>)</div>\n<div class=\page\ title=\Page 122\>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ⇓</div>\n<div class=\page\ title=\Page 122\>Begins to decline at&nbsp;10 to 12 weeks</div>\n<div class=\page\ title=\Page 122\>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ⇓</div>\n<div class=\page\ title=\Page 122\>Plateau at 16 weeks till term</div>\n<div class=\page\ title=\Page 122\>&nbsp;</div>\n<ul>\n<li class=\page\ title=\Page 122\>Higher maternal plasma hCG levels- Multifetal pregnancy, <strong>erythroblastosis fetalis</strong>, gestational trophoblastic disease, <strong>Down syndrome</strong>.</li>\n<li class=\page\ title=\Page 122\>Lower hCG plasma levels -early pregnancy wastage and ectopic pregnancy.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(2057, 'Obstetrics & Gynaecology', 'PM1839. Maneuvers for breech delivery', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Pinard’s manoeuvre&nbsp;</strong></p>\n<p>It is used for the delivery of <strong>extended legs</strong> in case of breech delivery.</p>\n<p>Technique:</p>\n<ul>\n<li aria-level=\1\>Flex and abduct the popliteal fossa</li>\n<li aria-level=\1\>Catch hold of the ankle</li>\n<li aria-level=\1\>Pull down along with abduction</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6aa624cb6ac74df887b27ed0db3f7e85x1280x4970.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Lovset’s manoeuvre</strong></p>\n<p>It is used for the delivery of <strong>extended arms</strong> in case of a breech presentation.</p>\n<p>Technique:</p>\n<ul>\n<li aria-level=\1\>Hold the sacrum with the thumb, and the hips and pelvis with other fingers.</li>\n<li aria-level=\1\>Turn the infant 90 degrees to bring the shoulder under pubic symphysis and deliver the anterior shoulder.</li>\n<li aria-level=\1\>Then counter-rotate 180 degrees to engage and deliver the posterior shoulder.&nbsp;</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/bbd5c8755d1242329bac304aad0f9f82x1280x3105.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Modified Prague’s manoeuvre</strong></p>\n<p>It is used in breech presentations to deliver the <strong>aftercoming head</strong> when the back of the fetus fails to rotate to the symphysis.</p>\n<p>Technique:</p>\n<ul>\n<li aria-level=\1\>Grasp the shoulders of the baby from below with two fingers of one hand.</li>\n<li aria-level=\1\>Draw the feet up and over the maternal abdomen with the other hand.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/0fb878bf761548269e792fc999b4e8f0x1280x1868.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Burns-Marshall method</strong></p>\n<p>It is used for delivery of <strong>aftercoming head</strong> in case of breech presentation.</p>\n<p>Technique:</p>\n<ul>\n<li aria-level=\1\>Allow the baby to hang by its own weight.</li>\n<li aria-level=\1\>When the nape of the neck is visible under the pubic arch, grasp the baby by the ankles with a finger in between the two.</li>\n<li aria-level=\1\>Swing the baby in an arc in an upward and forward direction.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/52d2ef75e12c458189a04107a253ae13x1280x5962.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Mauriceau-Smellie-Veit technique</strong></p>\n<p>It is another method that can be used in the delivery of <strong>aftercoming head</strong> in case of breech presentation. It is also called <strong>malar flexion and shoulder traction</strong>.</p>\n<p>Technique:</p>\n<ul>\n<li aria-level=\1\>Place the baby on the supinated left arm with limbs hanging on either side.</li>\n<li aria-level=\1\>Place the index and middle fingers of the left hand on either side over the malar bones.</li>\n<li aria-level=\1\>Place the ring and the little finger of the pronated right hand on the child’s right shoulder, index finger on the left shoulder and middle finger over the suboccipital region.</li>\n<li aria-level=\1\>Traction is given in the downward and backward direction till the nape of the neck is visible.</li>\n<li aria-level=\1\>Thereafter, the baby is carried in an upward and forward direction towards the mother’s abdomen.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/ce9f096a6bee481396bcbe161cbb14a1x1280x1187.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Mnemonic:</strong></p>\n<ul>\n<li aria-level=\1\><strong>Extend the arm</strong> to express Love(<strong>Lovsets</strong>)</li>\n<li aria-level=\1\>Put the fingers in <strong>popliteal</strong> fossa for <strong>Pinards</strong>(P for P)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2058, 'Obstetrics & Gynaecology', 'PM1837. Constriction ring v/s retraction ring in uterus', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>&nbsp;</strong></td>\n<td><strong>Constriction </strong>/&nbsp;<strong>Schroeders ring&nbsp;</strong></td>\n<td><strong>Retraction</strong>/<strong> Bandls ring</strong></td>\n</tr>\n<tr>\n<td><strong>Nature</strong></td>\n<td>Due to incoordinate uterine contraction</td>\n<td>Due to tonic uterine contractions and retractions</td>\n</tr>\n<tr>\n<td><strong>Cause</strong></td>\n<td>Undue irritability of uterus due to injudicious use of oxytocin</td>\n<td>Obstructed labor</td>\n</tr>\n<tr>\n<td><strong>Location</strong></td>\n<td>\n<p>Usually at the junction of the upper and lower segment.</p>\n<p>Location does not alter once formed.</p>\n</td>\n<td>\n<p>Always at the junction of the upper and lower segment.</p>\n<p>Progressively moves upwards after formed.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Per abdomen</strong></td>\n<td><strong>Ring not felt</strong></td>\n<td><strong>Ring is felt</strong></td>\n</tr>\n<tr>\n<td><strong>Per Vaginal</strong></td>\n<td><strong>Ring is felt</strong></td>\n<td><strong>Ring not felt</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/a7d4a31c94434fe79fd9276f1d7d2935x1280x2559.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2059, 'Obstetrics & Gynaecology', 'PM1833. Transvere and vertical incisions in Cesarean section', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Transverse incisions:</strong></p>\n<p><strong>Advantages-</strong></p>\n<ul>\n<li>Follows Langer lines of skin tension, so superior cosmetic results</li>\n<li>Less postoperative pain</li>\n<li>Less fascial wound dehiscence</li>\n<li>Low incidence of incisional hernias</li>\n</ul>\n<p><strong>Disadvantages-</strong></p>\n<ul>\n<li>High infection risks</li>\n<li>Narrow operating space</li>\n<li>Injury to neurovascular bundles</li>\n<li>Reentry during repeat C-section is difficult due to scarring</li>\n</ul>\n<p><strong>Vertical incisions:</strong></p>\n<p><strong>Advantages-</strong></p>\n<ul>\n<li>Quick entry</li>\n<li>Minimal blood loss</li>\n<li>Superior access to the upper<br>abdomen</li>\n<li>Wide operating space</li>\n<li>Flexibility for easy wound extension if necessary</li>\n</ul>\n<p><strong>Disadvantages-</strong></p>\n<ul>\n<li>Poor cosmetic results</li>\n<li>Higher fascial dehiscence&nbsp;</li>\n<li>Higher incisional hernia rates</li>\n<li>Greater postoperative pain</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2060, 'Obstetrics & Gynaecology', 'PM1825. Deceleration patterns on cardiotocography (CTG)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Early deceleration</strong>: seen in head compression</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/01ca2f6239b443139c19f8cfb251123fx720x612.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Late deceleration</strong>:&nbsp;Seen in uteroplacental insufficiency, foetal hypoxia</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d22f1efb031f427abc29cb814976ea47x468x323.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>&nbsp;</p>\n<p><strong>Variable</strong> <strong>deceleration</strong>: Seen in umbilical cord compression</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/034553eba0b7498882645a4cf156f0e0x468x399.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2061, 'Obstetrics & Gynaecology', 'PM1823. Degrees of perineal laceration', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>\n<div><strong>Degree</strong></div>\n</td>\n<td>\n<div class=\bulletIndent1\><strong>Description</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>First-degree</strong></div>\n</td>\n<td>\n<div class=\bulletIndent1\>Injury to the skin and subcutaneous tissue of the perineum and vaginal epithelium only. The perineal muscles remain intact.</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Second-degree</strong></div>\n</td>\n<td>\n<div>Extends into the fascia and musculature of the perineal body. The anal sphincter muscles remain intact.</div>\n</td>\n</tr>\n<tr>\n<td colspan=\2\>\n<div><strong>Third-degree</strong>&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3a</div>\n</td>\n<td>\n<div>&lt;50% of EAS thickness is torn</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3b</div>\n</td>\n<td>\n<div>&gt;50% of EAS thickness is torn</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3c</div>\n</td>\n<td>\n<div>Both EAS and IAS are torn</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Fourth-degree</strong></div>\n</td>\n<td>\n<div>Involves the perineal structures, EAS, IAS and rectal mucosa.</div>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<div class=\page\ title=\Page 214\>&nbsp;</div></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/5fd232bedecd4f8b989d7ee5887696aex1280x7836.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2062, 'Obstetrics & Gynaecology', 'PM1408. Bishop’s Score (Modified)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\ width=\324\>\n<tbody>\n<tr>\n<td><strong>Score</strong></td>\n<td><strong>0</strong></td>\n<td><strong>1</strong></td>\n<td><strong>2</strong></td>\n<td><strong>3</strong></td>\n</tr>\n<tr>\n<td><strong>Dilatation (cm)</strong></td>\n<td>Closed</td>\n<td>1-2</td>\n<td>3-4</td>\n<td>5+</td>\n</tr>\n<tr>\n<td><strong>Cervical length (cm)</strong></td>\n<td>&gt;4</td>\n<td>2-4</td>\n<td>1-2</td>\n<td>&lt;1</td>\n</tr>\n<tr>\n<td><strong>Consistency</strong></td>\n<td>Firm</td>\n<td>Medium</td>\n<td>Soft</td>\n<td>-</td>\n</tr>\n<tr>\n<td><strong>Position</strong></td>\n<td>Posterior</td>\n<td>Midline</td>\n<td>Anterior</td>\n<td>-</td>\n</tr>\n<tr>\n<td><strong>Head-Station</strong></td>\n<td>-3</td>\n<td>-2</td>\n<td>-1, 0</td>\n<td>+1, +2</td>\n</tr>\n</tbody>\n</table>\n<p>Total score = 13</p>\n<p><strong>Favourable</strong>= 6-13</p>\n<p><strong>Unfavourable</strong>= 0-5</p>\n<p><strong>Note:</strong>&nbsp;</p>\n<ul>\n<li>According to NICE guidelines, a score of&nbsp;<strong>6-13</strong>&nbsp;is favorable for induction of labour.</li>\n<li>According to Williams Obstetrics (26th edition), a score of <strong>9 or more</strong> indicates a high likelihood of successful induction.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2063, 'Obstetrics & Gynaecology', 'PM1407. Indications & contraindications for induction of labor', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\p-rich_text_section\><strong>Indications</strong>:</div>\n<ul class=\p-rich_text_list p-rich_text_list__bullet\>\n<li>Uncontrolled maternal diabetes mellitus</li>\n<li>Gestational hypertension</li>\n<li>Pre-eclampsia</li>\n<li>Post-term pregnancy</li>\n<li>Abruption placentae</li>\n<li>Premature rupture of membranes</li>\n<li>Rh-isoimmunization</li>\n<li>Intra-uterine growth restriction (IUGR)</li>\n<li>Intra-uterine death (IUD)</li>\n<li>Oligohydramnios</li>\n</ul>\n<div class=\p-rich_text_section\><strong>Contraindications</strong>:</div>\n<ul class=\p-rich_text_list p-rich_text_list__bullet\>\n<li>Contracted/distorted pelvis and cephalopelvic disproportion</li>\n<li>Placenta previa or vasa previa</li>\n<li>Active genital herpes</li>\n<li>Pelvic tumor &amp; carcinoma cervix</li>\n<li>Transverse lie or footling breech</li>\n<li>Appreciable macrosomia</li>\n<li>Severe hydrocephalus</li>\n<li>Umbilical cord prolapse</li>\n<li>High-risk pregnancy with fetal compromise</li>\n<li>Previous classical cesarean or hysterotomy</li>\n<li>Previous history of uterine rupture</li>\n<li>Pelvic surgeries like vesicovaginal fistula/rectovaginal fistula/pelvic floor repair (third or fourth-degree perineal tears repair)</li>\n<li>Previous 3 or more lower transverse cesarian sections.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2064, 'Obstetrics & Gynaecology', 'PM0044. Mediolateral Episiotomy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>It begins within 3 mm of the midline in the posterior fourchette and is directed laterally at an angle of at least <strong>60 degrees</strong> from the midline. This yields an incision of&nbsp;<strong>45</strong>&nbsp;<strong>degrees</strong> off the midline.</p>\n<p>It is essentially an inflicted second-degree perineal tear.</p>\n<p><strong>Structures cut in mediolateral episiotomy:</strong></p>\n<ul>\n<li>Posterior vaginal wall</li>\n<li>Superficial and deep transverse perineal muscles, bulbospongiosus and part of levator ani</li>\n<li>Fascia covering those muscles</li>\n<li>Transverse perineal branches of pudendal vessels and nerves</li>\n<li>Subcutaneous tissue and skin</li>\n</ul>\n<p><strong>Advantage:</strong> Lesser risk of&nbsp;anal sphincter laceration, hence&nbsp;it is<strong>&nbsp;preferred </strong>over median episiotomy.</p>\n<p><strong>Disadvantage:</strong> Increased blood loss and causes more perineal pain and dyspareunia.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3b63de15769847739008d216f6d7b34cx1280x1669.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2065, 'Obstetrics & Gynaecology', 'PM0043. External cephalic version- indications and contraindications', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>External cephalic version (ECV) is done to bring the favourable cephalic pole in the lower pole of the uterus.</p>\n<p><strong>Indications:</strong></p>\n<ul>\n<li>Breech presentation</li>\n<li>Tranverse lie</li>\n</ul>\n<p><strong>Contraindications:</strong></p>\n<ul>\n<li>APH due to risk of placental separation</li>\n<li>Fetal causes- hyperextension of the neck (<em>\</em>star-<em>gazing\</em> position), large fetus (&gt;3.5 kg), congenital abnormalities, dead fetus, fetal compromise</li>\n<li>Obstetric complications- severe pre-eclampsia, obesity, elderly primigravida, bad obstetric history&nbsp;</li>\n<li>Rh alloimmunization</li>\n<li>Multiple pregnancy</li>\n<li>Ruptured membrane</li>\n<li>Congenital malformations of uterus</li>\n<li>Abnormal CTG</li>\n<li>Contracted pelvis</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2066, 'Obstetrics & Gynaecology', 'PM0042. Vacuum delivery- indications and contraindications', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Indications of ventouse:</strong>&nbsp; &nbsp;&nbsp;</p>\n<p><strong>Therapeutic-</strong></p>\n<ul>\n<li>Fetal distress in second stage</li>\n<li>Maternal distress in second stage</li>\n<li>Prolonged second stage</li>\n<li>Deep transverse arrest and persistent occipitoposterior</li>\n<li>High vacuum for second twin</li>\n</ul>\n<p><strong>Prophylactic-</strong></p>\n<ul>\n<li>Preeclampsia</li>\n<li>VBAC</li>\n<li>Cardiac defects</li>\n<li>Anemia</li>\n</ul>\n<p><strong>Contraindications of ventouse:</strong>&nbsp; &nbsp; &nbsp;</p>\n<ul>\n<li>Preterm head</li>\n<li>Face presentation &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</li>\n<li>Fetal coagulopathy</li>\n<li>Fetal blood sampling</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2067, 'Obstetrics & Gynaecology', 'PM0041. Criteria for forceps delivery', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Procedure</strong></td>\n<td><strong>Criteria</strong></td>\n</tr>\n<tr>\n<td>Outlet forceps</td>\n<td>\n<ul>\n<li>Scalp is visible at the introitus without separating the labia</li>\n<li>Fetal skull has reached pelvic floor</li>\n<li>Fetal head is at or on perineum</li>\n<li>Sagittal suture is in anteroposteriordiameter or right or left occiput anterior or posterior position</li>\n<li>Rotation does not exceed 45 degrees</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Low forceps</td>\n<td>Leading point of fetal skull is at station&nbsp;<span>&gt;</span> +2 cm and not on the pelvic floor:<br>a) Rotation is 45 degrees or less, or<br>b) Rotation is greater than 45 degrees</td>\n</tr>\n<tr>\n<td>Mid forceps</td>\n<td>Station of fetal head is between 0 and +2 cm.</td>\n</tr>\n<tr>\n<td>\n<p>High forceps</p>\n</td>\n<td>Not included in classification. Not used anymore.</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2068, 'Obstetrics & Gynaecology', 'PM0040. Obstetrics forceps', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/3aff6b46801e48ccbc8c0b5b1958c478x600x560.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Commonly used forceps:&nbsp;</p>\n<p><strong>1) Simpson forceps</strong></p>\n<ul>\n<li>The most commonly used types of forceps in outlet delivery.</li>\n<li>Has elongated cephalic curve.</li>\n<li>These are used when there is substantial molding of the fetal head.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/53422ca64da04ca1a0bf2350cf6d8025x1280x1143.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>2) Elliot forceps</strong></p>\n<ul>\n<li>Has an adjustable pin for regulating the lateral pressure on the handles.</li>\n<li>They are used most often when there is minimal molding.</li>\n<li>More suitable for outlet delivery.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/2a99b799e0494721831ed4d66f6eb451x1280x1108.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>3) Kielland forceps</strong></p>\n<ul>\n<li>Has small pelvic curve and a sliding lock.</li>\n<li>Suitable for head with little molding.</li>\n<li>The most common forceps used for rotational delivery.</li>\n<li>Helps correct asynclitism.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/cab2ad62a596485aa475c5e61fc9b23ex1280x1196.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>4) Piper forceps</strong></p>\n<ul>\n<li>Distinct perineal curve.</li>\n<li>Allows for application to the after-coming head in breech delivery.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/46d15861619545899a73faeb532652edx1280x1270.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>5) Tucker-McLane forceps</strong></p>\n<ul>\n<li>Suitable for fetal head with little molding.</li>\n<li>Used in rotational delivery.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/90bdff9bd2e24d76b01753a9d901ce02x1280x1219.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>6) Barton forceps and traction handle</strong></p>\n<ul>\n<li>Used in rotational delivery.</li>\n<li>Most importantly used for delivery of occipitotransverse positions in a platypelloid pelvis.</li>\n<li>It is an obsolete procedure.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b106c6e03bd649ffb4ae8ebc4e209d3dx1280x1213.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2069, 'Obstetrics & Gynaecology', 'PM1829. Causes of oligohydramnios and polyhydramnios', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table cellspacing=\0\ cellpadding=\0\>\n<tbody>\n<tr>\n<td valign=\top\>\n<p><strong>Causes</strong></p>\n</td>\n<td valign=\top\>\n<p><strong>Oligohydramnios</strong></p>\n</td>\n<td valign=\top\>\n<p><strong>Polyhydramnios</strong></p>\n</td>\n</tr>\n<tr>\n<td valign=\top\>\n<p><strong>Maternal</strong></p>\n</td>\n<td valign=\top\>\n<ul>\n<li>Undiagnosed rupture of membrane (most common)</li>\n<li>Spontaneous rupture of membranes</li>\n<li>Post-dated pregnancy</li>\n<li>Preeclampsia</li>\n<li>NSAIDs</li>\n<li>ACE inhibitors</li>\n</ul>\n</td>\n<td valign=\top\>\n<ul>\n<li>Overt diabetes</li>\n<li>Gestational diabetes</li>\n<li>Cardiac disease</li>\n<li>Renal disease</li>\n<li>Liver failure</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td valign=\top\>\n<p><strong>Fetal</strong></p>\n</td>\n<td valign=\top\>\n<ul>\n<li>Fetal anomalies</li>\n<li>Renal agenesis</li>\n<li>Urethral defects\n<ul>\n<li>Posterior valve</li>\n<li>Obstructive uropathy</li>\n</ul>\n</li>\n</ul>\n<p>&nbsp;</p>\n</td>\n<td valign=\top\>\n<ul>\n<li>Multiple gestation</li>\n<li>Neural tube defects</li>\n<li>Abdominal wall defects</li>\n<li>Cleft palate</li>\n<li>Neck masses</li>\n<li>Esophageal atresia</li>\n<li>Aneuploidy</li>\n<li>Hydrops fetalis</li>\n<li>TTTS</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td valign=\top\>\n<p><strong>Placental</strong></p>\n</td>\n<td valign=\top\>\n<p>Failure of secretion:- e.g. Amnion nodosum</p>\n</td>\n<td valign=\top\>\n<p>Chorangioma of placenta</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(2070, 'Obstetrics & Gynaecology', 'PM1822. Clinical classification of Spontaneous Abortion', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Clinical type</strong></td>\n<td><strong>Description</strong>/<strong> Clinical picture</strong></td>\n<td><strong>USG/ Investigations</strong></td>\n</tr>\n<tr>\n<td><strong>Threatened&nbsp;</strong></td>\n<td>\n<div class=\page\ title=\Page 373\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Bloody vaginal discharge or bleeding</p>\n<p><strong>Closed</strong> cervical os</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 374\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Gestational sac/&nbsp;pseudo-gestational sac present</p>\n<p>Fetal cardiac activity present</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Inevitable&nbsp;</strong></td>\n<td>\n<div class=\page\ title=\Page 375\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Gush of vaginal fluid or bleeding</p>\n<p>Cramping or fever</p>\n<p><strong>Dilated</strong> cervical os</p>\n<p>Gross rupture of membranes</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p>Low lying sac</p>\n<p>Oligohydramnios</p>\n</td>\n</tr>\n<tr>\n<td><strong>Incomplete&nbsp;</strong></td>\n<td>\n<div class=\page\ title=\Page 375\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Vaginal bleeding</p>\n<p>Partial or complete placental separation</p>\n<p><strong>Dilated</strong> cervical os</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p>Retained products of conception</p>\n</td>\n</tr>\n<tr>\n<td><strong>Complete&nbsp;</strong></td>\n<td>\n<div class=\page\ title=\Page 375\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Heavy vaginal bleeding with cramps</p>\n<p>Complete placental separation with the passage of tissue or a fetus&nbsp;</p>\n<p><strong>Closed</strong> cervical os</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 375\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Minimally thickened endometrium</p>\n<p>Gestational sac absent</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong><strong>Missed /</strong></strong><strong>early pregnancy failure or loss</strong></td>\n<td>\n<div class=\page\ title=\Page 375\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Dead products of conception that were retained for days, weeks or months in the uterus</p>\n<p><strong>Closed</strong> cervical os</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\page\ title=\Page 375\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Large anechoic sac consistent with an anembryonic gestation</p>\n<p><strong>Serial&nbsp;β-hCG</strong> assays</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Septic</strong>&nbsp;</td>\n<td>\n<div class=\page\ title=\Page 375\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<div class=\page\ title=\Page 375\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>Pelvic infection and sepsis syndrome</p>\n<p>Seen in 1-2% of women with threatened or incomplete miscarriage</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>&nbsp;-</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(2071, 'Obstetrics & Gynaecology', 'PM1441. Conditions Associated with Abnormal MSAFP', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Elevated levels</strong></p>\n<ul>\n<li>Underestimated gestational age</li>\n<li>Multifetal gestations</li>\n<li>Fetal death</li>\n<li>Neural tube defects</li>\n<li>Gastroschisis</li>\n<li>Omphalocele</li>\n<li>Cystic hygroma</li>\n<li>Esophageal or intestinal obstruction</li>\n<li>Liver necrosis</li>\n<li>Renal anomalies</li>\n<li>Cloacal exstrophy</li>\n<li>Osteogenesis imperfecta</li>\n<li>Congenital skin abnormality</li>\n<li>Pilonidal cyst</li>\n<li>Chorioangioma of placenta</li>\n<li>Placenta intervillous thrombosis</li>\n<li>Placental abruption</li>\n<li>Oligohydramnios</li>\n<li>Preeclampsia</li>\n<li>Fetal growth restriction</li>\n<li>Maternal hepatoma or teratoma</li>\n</ul>\n<div class=\page\ title=\Page 306\><strong>&nbsp;Low levels&nbsp;</strong>\n<ul>\n<li>Obesity</li>\n<li>Diabetes mellitus</li>\n<li>Trisomies 21 or 18</li>\n<li>Gestational trophoblastic disease</li>\n<li>Overestimated gestational age</li>\n</ul>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(2072, 'Obstetrics & Gynaecology', 'PM1003. Complications of pregnancy due to fibroids', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Increased risk of abortion or miscarriage</li>\n<li>Preterm labor</li>\n<li>Abnormal presentation</li>\n<li>Accidental hemorrhage</li>\n<li>Dystocic labor</li>\n<li>Postpartum hemorrhage</li>\n<li>Puerperal sepsis</li>\n<li>Uterine inversion</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2073, 'Obstetrics & Gynaecology', 'PM1002. Contraindications to uterine artery embolization', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Absolute contraindications:</strong></p>\n<ul>\n<li>GnRH agonist use</li>\n<li>Asymptomatic fibroids</li>\n<li>Pregnancy</li>\n<li>Pelvic inflammatory disease</li>\n<li>Uterine malignancy</li>\n<li>Calcified fibroid</li>\n</ul>\n<div class=\page\ title=\Page 416\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p><strong>Relative contraindications:</strong></p>\n<ul>\n<li class=\bulletIndent1\>Patient <strong>desirous of</strong> future <strong>pregnancy:</strong> UAE causes poor uterine perfusion and pelvic adhesions,<strong> decreasing fertility.&nbsp;</strong></li>\n<li class=\bulletIndent1\><strong>Postmenopausal</strong> women: Fibroids regress naturally, after menopause. Fibroid enlargement post-menopause raises the suspicion of malignancy.</li>\n<li class=\bulletIndent1\><strong>Subserosal</strong> or <strong>submucosal</strong> fibroids: <strong>Pedunculated</strong> subtypes may <strong>detach</strong> intraperitoneally or within the uterine cavity.&nbsp;This may lead to sterile <strong>peritonitis</strong> or intrauterine <strong>infection.</strong></li>\n<li class=\bulletIndent1\>Size or number of fibroids: <strong>Large</strong> fibroids or a <strong>greater number</strong> of fibroids can cause large amounts of <strong>necrosis</strong> following UAE. This may lead to post-op pain or infection.&nbsp;</li>\n<li class=\bulletIndent1\>Contraindications to radiologic <strong>contrast</strong> agents.</li>\n</ul>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(2074, 'Obstetrics & Gynaecology', 'PM2145. Types of Hysterectomy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Procedure<sup>a</sup></strong></td>\n<td><strong>Type<sup>b</sup></strong></td>\n<td><strong>Parametria and paracolpos</strong></td>\n<td><strong>Uterine vessels</strong></td>\n<td><strong>Uterosacral ligament</strong></td>\n<td><strong>Vagina</strong></td>\n</tr>\n<tr>\n<td>Simple hysterectomy</td>\n<td>I</td>\n<td>Preserve</td>\n<td>Ligate at uterine isthumus</td>\n<td>Transect at uterine insertion</td>\n<td>Preserve</td>\n</tr>\n<tr>\n<td>Modified radical hysterectomy</td>\n<td>II</td>\n<td>Removed medial to ureter</td>\n<td>Ligate at level of ureter</td>\n<td>Transect midway between uterus and rectum</td>\n<td>Remove1-2cm</td>\n</tr>\n<tr>\n<td>Radical abdominal hysterectomy</td>\n<td>III</td>\n<td>Removed medial to uterine vessel origin</td>\n<td>Ligate at origin from internal iliac vessels</td>\n<td>Transect near rectum<sup>e</sup></td>\n<td>Remove ≥ 2 cm</td>\n</tr>\n<tr>\n<td>Type</td>\n<td>IV<sup>c</sup></td>\n<td>Removed medial to uterine vessel origin</td>\n<td>Ligate at origin from internal iliac vessels;ligate superior vesical artery</td>\n<td>Transect near rectum</td>\n<td>Remove 3/4th</td>\n</tr>\n<tr>\n<td>Type</td>\n<td>V<sup>d</sup></td>\n<td>Removed medial to uterine vessel origin</td>\n<td>Ligate at origin from internal iliac vessels; ligate superior vesical artery</td>\n<td>Transect near rectum</td>\n<td>Remove 3/4th</td>\n</tr>\n<tr>\n<td>Radical vaginal hysterectomy</td>\n<td>&nbsp;</td>\n<td>Removed medial to ureter</td>\n<td>Ligate at level of ureter</td>\n<td>Partially removed</td>\n<td>Remove&nbsp;≥ 2 cm</td>\n</tr>\n<tr>\n<td>Radical vaginal trachelectomy</td>\n<td>&nbsp;</td>\n<td>Partially removed</td>\n<td>Ligate descending cervicovaginal branch</td>\n<td>Transect midway between uterus and rectum</td>\n<td>Remove1-2cm</td>\n</tr>\n<tr>\n<td>Radical abdominal hysterectomy</td>\n<td>&nbsp;</td>\n<td>Removed medial to uterine vessel origin</td>\n<td>Ligate at origin from internal iliac vessel</td>\n<td>Transect near rectum</td>\n<td>&nbsp;Remove&nbsp;≥ 2 cm</td>\n</tr>\n</tbody>\n</table>\n<p>Pelvic lymph node dissection accompanies all except simple hysterectomy.</p>\n<p><sup>a</sup>- Hysterectomy includes corpus and cervix removal.For all procedures unaffected ovaries may remain in premenopausal women, but entire adnexa are usually removed in postmenopausal patients.</p>\n<p>b- Rutledge classification of extended hysterectomy.</p>\n<p><sup>c</sup>- Procedure is not used currently in practice.</p>\n<p><sup>d</sup>-With type V bladder and proximal ureter are removed.</p>\n<p><sup>e</sup>- Due to high incidence of postoperative urinary retention ureosacral ligaments are not transected but divided near rectum in current practice.</p></div><!---->\n      <!---->\n    </div><!---->'),
(2075, 'Obstetrics & Gynaecology', 'PM2096. Classification Of Contraceptives Based On Effectiveness', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>Category</td>\n<td>Failure rate in first year</td>\n<td>Contraceptive</td>\n</tr>\n<tr>\n<td>First tier</td>\n<td>&nbsp;&lt; 2 %</td>\n<td>IUCD, Implants, Sterilization</td>\n</tr>\n<tr>\n<td>Second tier</td>\n<td>&nbsp;3-9 %</td>\n<td>Hormonal - oral, injected, transdermal patches, transvaginal rings</td>\n</tr>\n<tr>\n<td>Third tier</td>\n<td>&nbsp;10-20 %</td>\n<td>Barrier, Fertility awareness method</td>\n</tr>\n<tr>\n<td>Fourth tier</td>\n<td>&nbsp;21-30 %</td>\n<td>Spermicidal preparations</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2076, 'Obstetrics & Gynaecology', 'PM1916. Management of Vaginal prolapse', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/62c15d45facb4a2191271bd2488c98d9x1280x822.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2077, 'Obstetrics & Gynaecology', 'PM1915. Management of Uterine prolapse', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Category</strong></td>\n<td><strong>Treatment</strong></td>\n</tr>\n<tr>\n<td>Nulliparous or congenital prolapse&nbsp;</td>\n<td>\n<p>Abdominal sling operations:</p>\n<div class=\page\ title=\Page 374\>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li>Abdominal wall cervicopexy</li>\n<li>Shirodkar’s abdominal sling operation</li>\n<li>Khanna’s abdominal sling operation</li>\n</ul>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>Pregnancy and postnatal period</td>\n<td>\n<ul>\n<li>Ring pessary (up to 16 weeks period of gestation)</li>\n<li>Pelvic floor exercises</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&lt;40 years&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>\n<td>\n<ul>\n<li>Fothergills repair (Manchester operation)</li>\n<li>Shirodkars procedure</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&gt;40 years - with completed family&nbsp;</td>\n<td>Vaginal hysterectomy and pelvic floor repair&nbsp;</td>\n</tr>\n<tr>\n<td>&gt;60 years - unfit for surgery&nbsp;</td>\n<td>\n<ul>\n<li>Le Forts repair</li>\n<li>Colpocleisis</li>\n</ul>\n<p>These are done if the patient doesnt want to retain sexual function&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(2078, 'Obstetrics & Gynaecology', 'PM1349. DeLanceys  levels of support of the genital organs', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Level of support</strong></td>\n<td><strong>Structures forming the support</strong></td>\n<td><strong>Consequence of damage</strong></td>\n</tr>\n<tr>\n<td><strong>Level 1</strong></td>\n<td>\n<p>The <strong>cardinal-uterosacral ligament complex</strong> provides <strong>apical attachment</strong> of the uterus and vaginal vault to the bony sacrum</p>\n</td>\n<td>\n<p>Uterine descent</p>\n<p>Vault descent</p>\n<p>Enterocele</p>\n</td>\n</tr>\n<tr>\n<td><strong>Level 2</strong></td>\n<td>\n<p><strong>Lateral attachments</strong> provide support to the <strong>middle part</strong> of the vagina. The anterior vaginal wall is attached laterally to <strong>arcus tendinous fascia pelvis</strong> and the posterior vaginal wall is attached laterally to the<strong> facia overlying the levator ani muscle</strong>.&nbsp;</p>\n</td>\n<td>\n<p>Cystocele</p>\n<p>Rectocele</p>\n</td>\n</tr>\n<tr>\n<td><strong>Level 3</strong></td>\n<td>\n<p>The <strong>urogenital diaphragm</strong>&nbsp;(Deep perineal muscles &amp;&nbsp;Perineal membrane) and the <strong>perineal body</strong> provide support to the <strong>lower part</strong> of the vagina.&nbsp;</p>\n</td>\n<td>\n<p>Urethrocele</p>\n<p>Gaping introitus</p>\n<p>Deficient perineum</p>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(2079, 'Obstetrics & Gynaecology', 'PM1152. Management of PCOD', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Complaint</strong></td>\n<td><strong>Management</strong> &nbsp;</td>\n</tr>\n<tr>\n<td>Irregular periods</td>\n<td>OCPs</td>\n</tr>\n<tr>\n<td>Obesity</td>\n<td>Lifestyle modification</td>\n</tr>\n<tr>\n<td>Insulin resistance</td>\n<td>Metformin</td>\n</tr>\n<tr>\n<td>Hirsutism /acne</td>\n<td>OCPs with cyproterone acetate</td>\n</tr>\n<tr>\n<td>Infertility</td>\n<td>Clomiphene</td>\n</tr>\n</tbody>\n</table>\n<p>Note: Letrozole is as effective as Clomiphene in treating infertility in PCOD with fewer side effects. However, its pending FDA approval and is used off-label.</p></div><!---->\n      <!---->\n    </div><!---->'),
(2080, 'Obstetrics & Gynaecology', 'PM1151. Endocrinological changes of PCOD', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ol>\n<li>Elevated Estrone/E1 levels.</li>\n<li>LH level is raised over 10 IU/mL. FSH level remains normal to low, but<strong> FSH/LH ratio falls.</strong></li>\n<li>Testosterone and epi-androstenedione levels rise.<br>\n<ul>\n<li><strong>Testosterone elevated but &lt; 200 ng/dL </strong>(normal range 0.2 - 0.8 ng/dL)</li>\n<li>Testosterone &gt; 200 ng/dL suggests androgen-secreting ovarian tumor</li>\n<li>DHEA-S values may be normal or slightly elevated</li>\n<li>DHEA &gt;700 ng/mL suggests adrenal tumour</li>\n</ul>\n</li>\n<li>Serum SHBG is reduced.</li>\n<li><strong>Triglyceride level &gt;150 mg/dL</strong>-hyperlipidaemia HDL &lt;50 mg/dL.</li>\n<li>Fasting blood glucose/fasting insulin &lt;4.5 suggests insulin resistance</li>\n<li>Prolactin is mildly raised in 15% cases</li>\n<li><strong>Fasting insulin is more than 10 mIU/L in PCOS in 50–70%cases</strong></li>\n<li>Thyroid function tests may be abnormal (hypothyroidism)</li>\n<li>17-a-hydroxyprogesterone in the follicular phase &gt;300 ng/dL suggests adrenal hyperplasia due to 21-hydroxylase deficiency.</li>\n<li><strong>Urinary cortisol &lt;50 μg/24 h.</strong></li>\n</ol></div><!---->\n      <!---->\n    </div><!---->'),
(2081, 'Obstetrics & Gynaecology', 'PM1135. Difference between bladder fistula & ureteric fistula', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Bladder fistula&nbsp;&nbsp;</strong></td>\n<td><strong>Ureteric fistula&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Etiology</strong></td>\n<td>\n<p>Obstetric causes:</p>\n<div class=\page\ title=\Page 232\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li>Prolonged obstructed labor</li>\n<li>Instrumental deliveries</li>\n<li>Iatrogenic injury during caesarean section or sling operations</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p>Surgical injury during:</p>\n<ul>\n<li>Abdominal hysterectomy</li>\n<li>Vaginal hysterectomy</li>\n<li>Wertheims hysterectomy</li>\n<li>Laparoscopic surgeries</li>\n<li>Caesarean section</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Clinical features</strong></td>\n<td>\n<p>Dribbling of urine present from the vagina</p>\n<p>The patient is unable to micturate</p>\n</td>\n<td>\n<p>Dribbling of urine present from the vagina</p>\n<p>The patient is able to micturate</p>\n</td>\n</tr>\n<tr>\n<td><strong>Methylene blue 3-swab test</strong></td>\n<td>Middle swab stains with methylene blue &nbsp;</td>\n<td>Uppermost swab stains with urine, but not with methylene blue</td>\n</tr>\n<tr>\n<td><strong>Intravenous pyelography</strong></td>\n<td>Normal</td>\n<td>Hydronephrosis and hydroureter present on the affected side</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(2082, 'Obstetrics & Gynaecology', 'PM1134. Methylene blue - 3 swab test', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>In the&nbsp;<strong>methylene blue 3-swab test</strong>, a catheter is introduced into the bladder through the urethra. The vaginal cavity is packed with three sterile cotton swabs. One at the vault, one at the middle, and one just above the introitus. A diluted solution of methylene blue dye is injected into the bladder using a transurethral catheter. After 15 to 30 minutes, the swabs are removed serially and inspected for dye.</p>\n<p>Interpretation:</p>\n<ul>\n<li>Upper swabs get wet and not stained - the leak is from the ureter: <strong>Ureterovaginal fistula</strong></li>\n<li>Upper swabs get stained - the leak is from the bladder: <strong>Vesicovaginal fistula</strong></li>\n<li>Lower swabs get stained - the leak is from the urethra:&nbsp;<strong>Urethrovaginal fistula</strong></li>\n</ul>\n<p>The given image shows the 3-swab test.</p></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/e42bcea196da4eae990f8d6f14beaf6dx1280x1082.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2083, 'Obstetrics & Gynaecology', 'PM1126. Degrees of uterine descent', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4e1991cc337b41e994e57739222d37d9x1280x6029.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2084, 'Obstetrics & Gynaecology', 'PM1124. Management of genital prolapse', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Category</strong></td>\n<td><strong>Treatment given&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Nulliparous</td>\n<td>Abdominal sling operations&nbsp;</td>\n</tr>\n<tr>\n<td>Pregnancy</td>\n<td>Ring pessary up to 16 weeks &nbsp;</td>\n</tr>\n<tr>\n<td>Postnatal</td>\n<td>\n<p>Ring pessary and pelvic floor exercises for 3–6 months</p>\n<p>Surgery if required thereafter&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Young woman &lt;40 years&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>\n<td>\n<ul>\n<li>Conservative vaginal surgery (fertility-sparing surgery)</li>\n<li>Cystocele, rectocele repair</li>\n<li>Manchester repair</li>\n<li>Sling operation &nbsp;&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>A woman beyond 40 years and multipara&nbsp;</td>\n<td>Vaginal hysterectomy and pelvic floor repair&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2085, 'Obstetrics & Gynaecology', 'PM1123. Degrees of vault prolapse', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>First degree: The vaginal apex is visible at the introitus</li>\n<li>Second degree: The vault protrudes through the introitus</li>\n<li>Third degree: The entire vagina is outside the introitus</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2086, 'Obstetrics & Gynaecology', 'PM1020. Risk factors and protective factors for fibroid', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Risk factors:</strong></p>\n<ul>\n<li>Nulliparity</li>\n<li>Obesity</li>\n<li>Hyper estrogenic state</li>\n<li>Black race</li>\n</ul>\n<p><strong>Protective factors:</strong></p>\n<ul>\n<li>Multiparity</li>\n<li>Smoking</li>\n</ul>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(2087, 'Obstetrics & Gynaecology', 'PM1005. Endometriosis', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Sites of Endometriosis</strong>:</p>\n<ul>\n<li>Pelvic endometriosis: Pelvic peritoneum, the pouch of Douglas, uterosacral ligament.</li>\n<li>Rectovaginal endometriosis.</li>\n<li>Ovarian endometriosis.</li>\n<li>Chocolate cyst of the ovary.</li>\n<li>Other sites—appendix, pelvic lymph nodes.</li>\n<li>Metastatic— lungs, umbilicus, scar endometriosis.</li>\n</ul>\n<div class=\page\ title=\Page 258\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<p>One pathology review revealed that endometriosis has been identified on all organs except the spleen.</p>\n<p><strong>Examination findings in endometriosis</strong>:</p>\n<ul>\n<li>Abdomen: Cystic swelling, fixed and tender.</li>\n<li>Pelvis: Cystic tender mass.</li>\n<li>Vaginal examination: Fixed, tender, retroverted uterus. Tenderness in the lateral fornices (indicative of endometriosis even if no mass).<br>\n<ul>\n<li>Speculum inspection of the Posterior fornix: Bluish/blackish&nbsp;<strong>puckered spots</strong>&nbsp;on speculum, tender to touch.&nbsp;The presence of puckered spots is&nbsp;<strong>pathognomonic</strong>&nbsp;of endometriosis.</li>\n<li>Posterior Fornix Palpation: Uterosacral ligaments &amp; pouch of Douglas feel thickened and shotty with multiple small palpable nodules. This is called the&nbsp;<strong>cobblestone feel of uterosacral ligaments.</strong></li>\n</ul>\n</li>\n</ul>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(2088, 'Obstetrics & Gynaecology', 'PM1004. Indications for treatment in an asymptomatic fibroid', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Infertility caused by a cornual fibroid blocking the tube, or a submucous fibroid causing habitual abortions.</li>\n<li>Any fibroid of more than 12 weeks size</li>\n<li>A pedunculated fibroid which can undergo torsion</li>\n<li>A fibroid causing pressure on the ureter/ bladder, leaving residual urine and causing a urinary infection.</li>\n<li>Rapidly growing fibromyoma in a menopausal woman implying impending malignancy</li>\n<li>When the nature of the tumor cannot be ascertained clinically (laparotomy is needed on this occasion).</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2089, 'Obstetrics & Gynaecology', 'PM1000. Myomectomy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p class=\headingAnchor\><strong>Myomectomy</strong></p>\n<ul>\n<li class=\headingAnchor\>Retains uterus and hence preserves childbearing function.</li>\n<li class=\headingAnchor\>Effective for heavy menstrual bleeding and pelvic pressure.</li>\n<li class=\headingAnchor\>Disadvantage - formation of new clones of abnormal myocytes.</li>\n<li class=\headingAnchor\>Hysteroscopic myomectomy is the procedure of choice for removing intracavitary myomas.</li>\n<li class=\headingAnchor\>Vaginal myomectomy is performed in case, a fibroid prolapses through the cervix.</li>\n</ul></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/d85871d192c5435dbc5db9d643e91318x1280x1022.7362482369534.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/05d580070ec34ee58874c527717369c3x1280x874.6967559943582.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/6e46c219eb494439a07cb1d7cdaff0a1x1280x919.8307475317348.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2090, 'Obstetrics & Gynaecology', 'PM0994. Secondary changes and complications in fibromyomas', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 408\>\n<div class=\section\>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li>Hyaline change, cystic degeneration and atrophy</li>\n<li>Calcareous degeneration, osseous degeneration</li>\n<li>Red degeneration</li>\n<li>Sarcomatous change</li>\n<li>Torsion, hemorrhage</li>\n<li>Infection/ ulceration, particularly in the dependent part of a submucous polyp</li>\n<li>Inversion of the uterus</li>\n<li>Endometrial carcinoma associated with fibromyoma</li>\n<li>Endometrial and myohyperplasia</li>\n<li>Accompanying adenomyosis</li>\n<li>Parasitic fibroid</li>\n</ul>\n</div>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(2091, 'Obstetrics & Gynaecology', 'PM2199. Prevention of parent to child transmission (PPTCT)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Important provisions of PPTCT services for HIV:</p>\n<ul>\n<li>HIV counseling and testing for all pregnant women enrolled in antenatal care with ‘opt out’ option.</li>\n<li>Lifelong ART i.e. <strong>Tenofovir (TDF) + Lamivudine (3TC)+ Dolutegravir (DTG)</strong> administration to all pregnant and breastfeeding HIV-infected women <strong>regardless of CD4 count and clinical stage</strong>.</li>\n<li>Institutional deliveries of HIV-infected mothers</li>\n<li>Care of associated conditions (STI/RTI, TB, opportunistic infections, hypertension, diabetes)</li>\n<li>Exclusive breastfeeding counseling</li>\n<li><strong>Plasma viral load testing</strong> at <strong>32–36 weeks of gestation</strong> to determine the risk of HIV transmission to the baby</li>\n<li aria-level=\1\>Initiation of ARV in babies:<br>\n<ul>\n<li aria-level=\2\>Low-risk infants: <strong>Syrup Nevirapine</strong> from <strong>birth till 6 weeks</strong> of age</li>\n<li aria-level=\2\>High-risk infants: <strong>Syrup Nevirapine+ syrup Zidovudine</strong> either from <strong>birth till 6 weeks</strong> of age (exclusive replacement feeding) or from <strong>birth till 12 weeks</strong> of age (exclusive breastfeeding)</li>\n</ul>\n</li>\n<li>Nutrition counseling and psychosocial support to HIV-infected pregnant women</li>\n<li>Ensure <strong>co-trimoxazole prophylactic therapy (CPT)</strong> and early infant diagnosis using HIV-DNA PCR at 6 weeks of age onwards as per guidelines</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2092, 'Obstetrics & Gynaecology', 'PM1174. Treatment of choice in chronic PID', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div>\n<table width=\171\>\n<tbody>\n<tr>\n<td>\n<p><strong>Patient characteristics</strong></p>\n</td>\n<td>\n<p><strong>Choice of surgery</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Young woman</p>\n</td>\n<td>\n<p>Conservative surgery or&nbsp;Salpingectomy or Salpingo-oophorectomy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>When extensive damage precludes conservative management</p>\n<p>and</p>\n<p>When the patient is multiparous and of an older age group</p>\n</td>\n<td>\n<p>Abdominal hysterectomy with bilateral salpingo-oophorectomy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mild case of PID adequately treated</p>\n<p>and</p>\n<p>Minimal damage&nbsp;but the infection may lead to infertility</p>\n</td>\n<td>\n<p>Tuboplasty</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(2093, 'Obstetrics & Gynaecology', 'PM1173. Organisms Responsible for Pelvic Inflammatory Disease', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 191\><strong><strong>Sexually transmitted:&nbsp;</strong></strong>Gonococcus, Chlamydia, Mycoplasma, Trichomonas&nbsp;<br><strong>Aerobes</strong>:&nbsp;Staphylococci&nbsp;,&nbsp;Streptococci&nbsp;,E. coli</div>\n<div class=\page\ title=\Page 191\><strong>Anaerobes</strong>: Bacteroides fragilis, Peptococcus, Clostridium, Actinomyces (IUD)</div>\n<div class=\page\ title=\Page 191\><strong>Others</strong>:&nbsp;Tubercular salpingitis</div>\n<div class=\page\ title=\Page 191\>&nbsp;</div></div><!---->\n      <!---->\n    </div><!---->'),
(2094, 'Obstetrics & Gynaecology', 'PM0960. Management of female infertility for different causes are as follows', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Etiology</strong></td>\n<td><strong>Investigations</strong></td>\n<td><strong>Management &nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Tubal cause</strong></td>\n<td>\n<ul>\n<li>Hysterosalpingography or sonosalpingography</li>\n<li>Falloscopy</li>\n<li>Salpingography</li>\n<li>Laparoscopic chromotubation</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Laparoscopic adhesiolysis</li>\n<li>Tuboplasty</li>\n<li>Hysteroscopic cannulation and balloonplasty</li>\n<li>If all the above procedures fail or not feasible go for IVF/GIFT&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Ovulation related&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</strong></td>\n<td>\n<ul>\n<li>Ovulation monitoring by ultrasound (BBT, BBI) And&nbsp; Endometrial Biopsy for tuberculosis done&nbsp; &nbsp;&nbsp;</li>\n<li>If the above steps are abnormal, do a hormonal study</li>\n<li>FSH, LH, Prolactin</li>\n<li>E2, P level</li>\n<li>Thyroid and diabetes</li>\n</ul>\n</td>\n<td>\n<ul>\n<li><strong>Clomiphene </strong>and&nbsp;<strong>letrozole</strong></li>\n<li>If it&nbsp;fails, give FSH, LH, GnRH</li>\n<li>Check for a response; if there is no response do IVF Donor egg.</li>\n<li>If all the above measures fail, the final option is to adopt&nbsp;&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Other causes &nbsp;</strong></td>\n<td>Ultrasound, MRI, SSG, hysteroscopy &nbsp;</td>\n<td>Treat the cause &nbsp;</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p>\n<div class=\page\ title=\Page 272\>&nbsp;</div></div><!---->\n      <!---->\n    </div><!---->'),
(2095, 'Obstetrics & Gynaecology', 'PM0958. Indications of artificial insemination', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 259\>\n<div class=\layoutArea\>\n<div class=\column\>\n<ul>\n<li>Chronic medical disorder.</li>\n<li>Oligospermia after sperm washout.</li>\n<li>Impotency—ejaculatory failure.</li>\n<li>Premature ejaculation, retrograde ejaculation.</li>\n<li>Hypospadias.</li>\n<li>Antisperm&nbsp;antibodies in the cervical mucus.</li>\n<li>Unexplained infertility.</li>\n<li>Frozen sperm. If the husband needs to undergo radiotherapy or chemotherapy or is not available at the time of ovulation.</li>\n<li>X–Y fractionation of sperms for sex selection, in genetic and chromosomal abnormality.</li>\n</ul>\n</div>\n</div>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(2096, 'Obstetrics & Gynaecology', 'PM0935. Management of male infertility', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/21055a33ddf44912b0c01f7093aa84b7x1280x1911.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2097, 'Obstetrics & Gynaecology', 'PM0934. Indications for various procedures in Infertility treatment', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Indications of artificial insemination with husbands semen</strong>:</p>\n<ul>\n<li>Chronic medical disorder</li>\n<li>Oligospermia after sperm washout</li>\n<li>Impotency or ejaculatory failure</li>\n<li>Premature ejaculation, retrograde ejaculation</li>\n<li>Hypospadias</li>\n<li>Antisperm&nbsp;antibodies in the cervical mucus</li>\n<li>Unexplained infertility</li>\n<li>Frozen sperm: If the husband needs to undergo radiotherapy or chemotherapy or is not available at the time of ovulation</li>\n<li>X–Y fractionation of sperms for sex selection, in a genetic and chromosomal abnormality</li>\n<li>HIV positive male or female</li>\n</ul>\n<p><strong>Indications for </strong>Intra-cytoplasmic sperm injection<strong> (ICSI) </strong>and&nbsp;gamete intra-fallopian transfer<strong> (GIFT)</strong>:</p>\n<ul>\n<li>Sperm count&nbsp;of less than 5 million/mL</li>\n<li>Absent or reduced sperm motility</li>\n<li>Abnormal sperm morphology</li>\n<li>Previous failed IVF</li>\n<li>Unexplained infertility</li>\n<li>Failure to penetrate zona by sperm as seen in IVF</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2098, 'Obstetrics & Gynaecology', 'PM0933. Semen Analysis : WHO Criteria', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Criteria, Normal values, Lowest reference limits (in brackets)</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Semen analysis </strong></td>\n<td><strong>Normal reference value and minimal reference (in parenthesis) limit</strong></td>\n</tr>\n<tr>\n<td>Volume</td>\n<td>2ml or more (1.4ml)</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>7.2-7.8</td>\n</tr>\n<tr>\n<td>Viscosity</td>\n<td>Less than 3</td>\n</tr>\n<tr>\n<td>Sperm concentration</td>\n<td>20 million/ml (15 million/ml)</td>\n</tr>\n<tr>\n<td>Total sperm count</td>\n<td>More than 40 million/ejaculate</td>\n</tr>\n<tr>\n<td>Motility</td>\n<td>More than 50% progressive forward motility(Progressive motility = 32%)</td>\n</tr>\n<tr>\n<td>Morphology</td>\n<td>More than 4% normal form (lower reference limit)</td>\n</tr>\n<tr>\n<td>Forward progression</td>\n<td>&gt;2 (Scale of 0-4)</td>\n</tr>\n<tr>\n<td>Viability</td>\n<td>75% or more living</td>\n</tr>\n<tr>\n<td>Leucocytes</td>\n<td>Less than 1 million/ml</td>\n</tr>\n<tr>\n<td>Round cells</td>\n<td>Less than 5 million/ml</td>\n</tr>\n<tr>\n<td>Sperm agglutination</td>\n<td>Less than 10 spermatozoa with adherent particles (&lt;2)</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2099, 'Obstetrics & Gynaecology', 'PM0858. Predominant estrogen form in various phases', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Premenopausal</strong> women (non-pregnant): Estradiol</li>\n<li><strong>Pregnant</strong> women: Estriol</li>\n<li><strong>Postmenopausal</strong> women: Estrone</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2100, 'Obstetrics & Gynaecology', 'PM0635. Indications for GIFT (gamete intra-fallopian transfer)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Unexplained infertility</li>\n<li>Failed intrauterine insemination (IUI)</li>\n<li>Male infertility</li>\n<li><strong>Immunological factor in males</strong></li>\n<li><strong>Immunological factors in the cervix</strong></li>\n<li>Donor semen required (rare)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2101, 'Obstetrics & Gynaecology', 'PM0633. Indications for Intra cytoplasmic sperm injection (ICSI)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li><strong>Sperm count less than 5 million/mL.</strong></li>\n<li>Absent or reduced sperm motility.</li>\n<li><strong>Abnormal sperm morphology.</strong></li>\n<li><strong>Previous failed IVF</strong></li>\n<li>Unexplained infertility.</li>\n<li>Failure to penetrate zona by sperm as seen in IVF.</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2102, 'Obstetrics & Gynaecology', 'PM2144. General treatment for primary invasive cervical carcinoma', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Stages</strong></td>\n<td><strong>Fertility preserved</strong></td>\n<td><strong>Fertility not preserved</strong></td>\n</tr>\n<tr>\n<td>IA1</td>\n<td>Cervical conization</td>\n<td>Simple hysterectomy</td>\n</tr>\n<tr>\n<td>IA1 (LVSI)</td>\n<td>Radical trachelectomy and pelvic lymphadenectomy</td>\n<td>Modified radical hysterectomy and pelvic lymphadenectomy</td>\n</tr>\n<tr>\n<td>IA2</td>\n<td>\n<p>1. Cervical conization with extraperitoneal pelvic lymphadenectomy</p>\n<p>2. Radical trachelectomy and pelvic lymphadenectomy</p>\n</td>\n<td>Modified Radical hysterectomy and pelvic lymphadenectomy</td>\n</tr>\n<tr>\n<td>\n<p>IB1</p>\n<p>Some IB2, IIA1</p>\n</td>\n<td>Radical trachelectomy and pelvic lymphadenectomy (or)chemoradiation</td>\n<td>Radical hysterectomy and pelvic lymphadenectomy (or) chemoradiation</td>\n</tr>\n<tr>\n<td>Bulky IB3, IIA2</td>\n<td colspan=\2\>Chemoradiation</td>\n</tr>\n<tr>\n<td>IIB to IVA</td>\n<td colspan=\2\>Chemoradiation or pelvic exenteration&nbsp;</td>\n</tr>\n<tr>\n<td>IVB</td>\n<td colspan=\2\>Palliative chemotherapy or palliative radiotherapy or supportive care</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(2103, 'Obstetrics & Gynaecology', 'PM1903. Staging of Carcinoma Cervix', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Stage I - limited to the cervix</strong></p>\n<ul>\n<li>A: Microscopic lesion\n<ul>\n<li>A1 - stromal invasion &lt;3mm depth</li>\n<li>A2 - a stromal invasion of ≥3 and &lt;5mm depth</li>\n</ul>\n</li>\n<li>B: Macroscopic lesion\n<ul>\n<li>B1 - stromal invasion ≥5mm depth &amp; tumor size &lt;2cm&nbsp;</li>\n<li>B2 - tumor size ≥2cm to &lt;4cm&nbsp;</li>\n<li>B3 - tumor size ≥4cm&nbsp;</li>\n</ul>\n</li>\n</ul>\n<p><strong>Stage II - involves upper 2/3 of vagina</strong></p>\n<ul>\n<li>A: Extends to the upper two-thirds of the vagina without parametrial involvement\n<ul>\n<li>A1 - tumor size &lt;4cm&nbsp;</li>\n<li>A2 - tumor size ≥4cm&nbsp;</li>\n</ul>\n</li>\n<li>B: Extends to parametrium but not upto the pelvic wall.</li>\n</ul>\n<p><strong>Stage III - spreads to lower 1/3 of vagina</strong></p>\n<ul>\n<li>A: Extends to lower 1/3 of the vagina</li>\n<li>B: Extends to the pelvic wall (hydronephrosis/non-functioning kidney)</li>\n<li>C: Involvement of the pelvic and/or para-aortic lymph nodes, irrespective of the tumor size and extent\n<ul>\n<li>C1: pelvic lymph node involved</li>\n<li>C2: para-aortic lymph node&nbsp;involved</li>\n</ul>\n</li>\n</ul>\n<p><strong>Stage IV - metastasis</strong></p>\n<ul>\n<li>A: Bladder/bowel involvement (adjacent pelvic organs)</li>\n<li>B: Distant metastasis</li>\n</ul>\n<p>Note:&nbsp;The involvement of vascular/lymphatic spaces does not change the staging. The lateral extent of the lesion is no longer considered.</p>\n<p>Stage IIIB is the most common stage of presentation.</p></div><!---->\n      <!---->\n    </div><!---->'),
(2104, 'Obstetrics & Gynaecology', 'PM1873. Staging of Ovarian cancer', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Stage I:\n<ul>\n<li>A: Tumor confined to unilateral ovary</li>\n<li>B: Bilateral ovary</li>\n<li>C: Capsule rupture\n<ul>\n<li>C1: Surgical&nbsp; spill</li>\n<li>C2: pre-operative capsule rupture</li>\n<li>C3: malignant ascites</li>\n</ul>\n</li>\n</ul>\n</li>\n<li>Stage II:\n<ul>\n<li>A: Extension to fallopian tubes/ uterus.</li>\n<li>B: Extension to other pelvic intraperitoneal tissues</li>\n</ul>\n</li>\n<li>Stage III:<br>\n<ul>\n<li>A1:Positive retroperitoneal lymph nodes(para-aortic)</li>\n<li>A2:microscopic extrapelvic peritoneal deposits</li>\n<li>B: Macroscopic peritoneal deposits &lt;2cm ± positive retroperitoneal lymph nodes.&nbsp;Includes extension to capsule of liver/spleen.&nbsp;&nbsp;</li>\n<li>C:&nbsp;Macroscopic peritoneal deposits &gt;2cm ± positive retroperitoneal lymph nodes.&nbsp;Includes extension to capsule of liver/spleen.</li>\n</ul>\n</li>\n<li>Stage 4:\n<ul>\n<li>A: Malignant pleural effusion</li>\n<li>B: Extra-abdominal spread/Inguinal lymph node involvement</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2105, 'Obstetrics & Gynaecology', 'PM1872. Markers of Ovarian Neoplasm', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Ovarian tumor</strong></td>\n<td><strong>Tumor marker</strong></td>\n<td><strong>Pathognomonic finding</strong></td>\n</tr>\n<tr>\n<td>\n<p>Epithelial ovarian tumors</p>\n</td>\n<td>CA-125,&nbsp; CA-19-9, CEA</td>\n<td>Psammoma bodies (Serous epithelial tumor)</td>\n</tr>\n<tr>\n<td>Endodermal sinus tumor</td>\n<td>AFP</td>\n<td>Schiller-Duval bodies</td>\n</tr>\n<tr>\n<td>Dysgerminoma</td>\n<td>LDH, PLAP</td>\n<td>Lymphocytic infiltration</td>\n</tr>\n<tr>\n<td>Embryonal carcinoma</td>\n<td>AFP, HCG</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Mature teratoma</td>\n<td>AFP</td>\n<td>Rokitansky protruberance</td>\n</tr>\n<tr>\n<td>Granulosa cell tumor</td>\n<td>Inhibin</td>\n<td>Call–Exner bodies</td>\n</tr>\n<tr>\n<td>Hilus cell tumor</td>\n<td>-</td>\n<td>Reinkes crystal</td>\n</tr>\n<tr>\n<td>Brenner tumor</td>\n<td>-</td>\n<td>Walthard cell nest</td>\n</tr>\n<tr>\n<td>Krukenberg tumor</td>\n<td>-</td>\n<td>Signet-ring cell</td>\n</tr>\n<tr>\n<td>Clear cell tumor</td>\n<td>-</td>\n<td>Hobnail cell</td>\n</tr>\n</tbody>\n</table>\n<p>Dysgerminoma&nbsp;(Mnemonic: DPL= Delhi Premier League)</p>\n<ul>\n<li>D: Dysgerminoma</li>\n<li>P: PLAP (placental alkaline phosphatase)</li>\n<li>L: LDH (lactate dehydrogenase)</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2106, 'Obstetrics & Gynaecology', 'PM1860. Ca.Endometrium staging (Revised FIGO)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/63d7bd1024964af5a59c406cbaa3fc47x1280x3298.JPEG\><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/4a582a55999043d8a33c2034dd59de86x1280x882.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2107, 'Obstetrics & Gynaecology', 'PM1439. Management in Ovarian Malignancy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/b2cf4e67456b4132a6019186ff5430d1x1280x1837.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2108, 'Obstetrics & Gynaecology', 'PM1436. Risk of Malignancy Index', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>RMI&nbsp;=&nbsp;U&nbsp;</strong>x<strong>&nbsp;M&nbsp;</strong>x<strong>&nbsp;CA125</strong></p>\n<div class=\itemizedlist\>\n<ul class=\itemizedlist\>\n<li class=\listitem\>\n<p><strong>U= Ultrasound score.</strong> The ultrasound result is scored 1 point for each of the following characteristics: multilocular cysts, solid areas, metastases, ascites and bilateral lesions. U&nbsp;=&nbsp;0 (for an ultrasound score of 0), U&nbsp;=&nbsp;1 (for an ultrasound score of 1), U&nbsp;=&nbsp;3 (for an ultrasound score of 2–5).</p>\n</li>\n<li class=\listitem\>\n<p><strong>M= Menopausal status</strong>. The menopausal status is scored as 1&nbsp;=&nbsp;pre-menopausal and 3&nbsp;=&nbsp;post-menopausal</p>\n</li>\n<li class=\listitem\><strong>CA125</strong>= Serum CA125 level (IU/ml)</li>\n</ul>\n</div></div><!---->\n      <!---->\n    </div><!---->'),
(2109, 'Obstetrics & Gynaecology', 'PM1435. Staging of Ovarian Carcinoma (FIGO)(Updated)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><ul>\n<li>Stage 1:\n<ul>\n<li>A: Tumor confined to unilateral ovary</li>\n<li>B: Bilateral ovary</li>\n<li>C:\n<ul>\n<li>C1: Surgical&nbsp; spill</li>\n<li>C2: pre-operative capsule rupture</li>\n<li>C3: malignant ascites</li>\n</ul>\n</li>\n</ul>\n</li>\n<li>Stage 2:\n<ul>\n<li>A: Extension to fallopian tubes/ uterus.</li>\n<li>B:Extension to other pelvic intraperitoneal tissues<br>&nbsp;</li>\n</ul>\n</li>\n<li>Stage 3:\n<ul>\n<li>A\n<ul>\n<li>A1:Positive retroperitoneal lymph nodes(para-aortic)</li>\n<li>A2:microscopic extrapelvic peritoneal deposits</li>\n</ul>\n</li>\n<li>B: Macroscopic peritoneal deposits &lt;2cm ± positive retroperitoneal lymph nodes.&nbsp;Includes extension to capsule of liver/spleen.&nbsp;&nbsp;</li>\n<li>C:&nbsp;Macroscopic peritoneal deposits &gt;2cm ± positive retroperitoneal lymph nodes.&nbsp;Includes extension to capsule of liver/spleen.\n<div class=\page\ title=\Page 2\>&nbsp;</div>\n</li>\n</ul>\n</li>\n<li>Stage 4:\n<ul>\n<li>A: Malignant pleural effusion</li>\n<li>B: Extra-abdominal spread/Inguinal lymph node involvement</li>\n</ul>\n</li>\n</ul></div><!---->\n      <!---->\n    </div><!---->'),
(2110, 'Obstetrics & Gynaecology', 'PM1434. Differences between benign & malignant ovarian tumor', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://cdn1.dailyrounds.org/uploads/309e371c5f784cd6a0d327891ae91b01x624x341.PNG\><!---->\n      </div><!---->\n    </div><!---->'),
(2111, 'Obstetrics & Gynaecology', 'PM1433. WHO Classification of Ovarian Tumors', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>I. &nbsp;Epithelial tumors (most common)</strong></p>\n<ul>\n<li>Serous tumors</li>\n<li>Mucinous tumors</li>\n<li>Endometrioid tumors</li>\n<li>Clear cell&nbsp;</li>\n<li>Brenner tumors (transitional cell tumors)</li>\n<li>Seromucinous</li>\n<li>Undifferentiated carcinoma</li>\n</ul>\n<div class=\page\ title=\Page 449\><strong>II. Sex cord-stromal tumors:</strong></div>\n<ul>\n<li>Pure stromal cell tumors-&nbsp;Fibroma, Thecoma,&nbsp;Leydig cell tumor,&nbsp;Steroid cell tumor</li>\n<li>Pure sex cord tumors-&nbsp;Granulosa cell tumor (Adult/Juvenile),&nbsp;Sertoli cell tumor</li>\n<li>Mixed sex cord-stromal tumors- Sertoli–Leydig cell tumors</li>\n</ul>\n<p><strong>III.&nbsp;Germ cell tumors:</strong></p>\n<ul>\n<li>Dysgerminoma</li>\n<li>Endodermal sinus tumor (Yolk sac tumor)</li>\n<li>Embryonal carcinoma</li>\n<li>Polyembryoma</li>\n<li>Non-gestational choriocarcinoma</li>\n<li>Teratoma (Mature/immature)</li>\n<li>Mixed forms</li>\n</ul>\n<p><strong>IV.&nbsp;Gonadoblastoma</strong></p>\n<ul>\n<li>Pure</li>\n<li>Mixed with dysgerminoma or other germ cell tumors</li>\n</ul>\n<p><strong>V. Soft tissue tumors not specific to ovary</strong><br><strong>VI. Miscellaneous tumors</strong><br><strong>VII. Secondary (metastatic) tumors</strong><br><strong>VIII. Tumor-like conditions</strong></p>\n<div class=\page\ title=\Page 449\>&nbsp;</div></div><!---->\n      <!---->\n    </div><!---->'),
(2112, 'Obstetrics & Gynaecology', 'PM1427. Treatment of Vaginal Cancer', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Treatment</strong></td>\n</tr>\n<tr>\n<td><strong>I</strong></td>\n<td>\n<p>Radical hysterectomy, upper vaginectomy, and bilateral pelvic lymphadenectomy</p>\n<p>Radiation therapy: For tumors in the <strong>lower vagina</strong> or <strong>&gt;2 to 3cm</strong> in diameter</p>\n</td>\n</tr>\n<tr>\n<td><strong>II-IV</strong></td>\n<td>\n<p>Chemoradiation (Fluorouracil or Cisplatin)</p>\n<p>Radiation therapy: for those who are not candidates&nbsp;for chemoradiation</p>\n<p>Exenteration: When bladder&nbsp;or bowel is involved</p>\n</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2113, 'Obstetrics & Gynaecology', 'PM1426. Treatment Modality in Vulval Cancer', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Treatment </strong></td>\n</tr>\n<tr>\n<td><strong>1A</strong></td>\n<td>\n<ul>\n<li>&nbsp;Radical wide local excision\n<div class=\layoutArea\>&nbsp;</div>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>1B</strong></td>\n<td>\n<ul>\n<li>Partial vulvectomy + ipsilateral inguinofemoral lymph node dissection</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>II</strong></td>\n<td>\n<ul>\n<li>Tumor 2-4cm – total vulvectomy + B/L groin lymph node dissection</li>\n<li>Tumor &gt;4cm or poorly differentiated – radical vulvectomy + B/L lymphadenectomy + pelvic lymph node dissection</li>\n</ul>\n<div class=\page\ title=\Page 493\>&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td><strong>III</strong></td>\n<td>\n<ul>\n<li>Megavoltage radiotherapy</li>\n<li>Local surgical excision -&nbsp;Radical vulvectomy + B/L lymphadenectomy + pelvic lymph node dissection</li>\n<li>Local recurrence – chemotherapy</li>\n</ul>\n<div class=\page\ title=\Page 493\>&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td><strong>IV</strong></td>\n<td>\n<ul>\n<li>Chemotherapy or radiotherapy</li>\n<li>Local excision on residual tumor</li>\n<li>ipsilateral inguinofemoral lymph node + ve – contralateral node removed</li>\n<li>Femoral lymph node +ve – pelvic lymph node removed</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>&nbsp;</p></div><!---->\n      <!---->\n    </div><!---->'),
(2114, 'Obstetrics & Gynaecology', 'PM1425. Staging of Vulval Cancer (FIGO)', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Features</strong></td>\n</tr>\n<tr>\n<td><strong>I</strong></td>\n<td>Tumor confined to vulva</td>\n</tr>\n<tr>\n<td>IA</td>\n<td>Lesions&nbsp;≤2 cm in size, confined to the vulva or perineum and with stromal invasion&nbsp;≤ 1 mm, no nodal metastasis</td>\n</tr>\n<tr>\n<td>IB</td>\n<td>Lesions &gt;2cm in size or with stromal invasion &gt;1mm , confined to the vulva or perineum, with negative nodes</td>\n</tr>\n<tr>\n<td><strong>II</strong></td>\n<td>Tumor of any size with extension to adjacent perineal structures (lower 1/3<sup>rd</sup> urethra, lower 1/3<sup>rd</sup> vagina, anus) with negative nodes</td>\n</tr>\n<tr>\n<td><strong>III</strong></td>\n<td>Tumor of any size with/without extension to adjacent perineal structures (lower 1/3<sup>rd</sup> urethra, lower 1/3<sup>rd</sup> vagina, anus) with positive inguinofemoral lymph nodes</td>\n</tr>\n<tr>\n<td>IIIA</td>\n<td>i) With 1 lymph node macrometastases (≥5mm) or,</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>ii)1-2 lymph node micrometastases(&lt;5mm)</td>\n</tr>\n<tr>\n<td>IIIB</td>\n<td>i) With 2 or more lymph node macrometastases (≥5mm), or</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>ii) 3 or more lymph node micrometastases (&lt;5 mm)</td>\n</tr>\n<tr>\n<td>IIIC</td>\n<td>With positive nodes with extracapsular spread</td>\n</tr>\n<tr>\n<td><strong>IV</strong></td>\n<td>Tumor invades other regional structures (upper 2/3<sup>rd</sup> urethra, upper 2/3<sup>rd</sup> vagina) or distant structures</td>\n</tr>\n<tr>\n<td>IVA</td>\n<td>Tumour invades any of the following:</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>i) Upper urethral and/or vaginal mucosa, bladder mucosa, rectal mucosa, or fixed to the pelvic bone, or</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>ii) Fixed or ulcerated inguinofemoral lymph nodes</td>\n</tr>\n<tr>\n<td>IVB</td>\n<td>Any distant metastasis including pelvic lymph nodes</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2115, 'Obstetrics & Gynaecology', 'PM1377. Management of endometrial cancer', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p>Surgery is done for staging of the cancer. The surgery done for this purpose is abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and pelvic as well as para-aortic lymph node sampling.</p>\n<table width=\237\>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Treatment</strong></td>\n</tr>\n<tr>\n<td><strong>IA noninvasive&nbsp;</strong></td>\n<td>\n<ul>\n<li>Surgery alone</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>IA</strong></td>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Post-op radiotherapy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>IB</strong></td>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Post-op pelvic radiotherapy 4000-5000 cGy</li>\n<li>Post-op vaginal vault radiotherapy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>II</strong></td>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Post-op brachytherapy</li>\n<li>Post-op external beam radiotherapy</li>\n<li>Wertheims hysterectomy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>III</strong></td>\n<td>\n<ul>\n<li>Inoperable/ Cytoreduction</li>\n<li>Chemotherapy with Doxorubicin+Cisplatin+Paclitaxel</li>\n<li>Medroxyprogesterone&nbsp;adjuvant</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>IV</strong></td>\n<td>\n<ul>\n<li>Inoperable/ Cytoreduction</li>\n<li>Palliative radiotherapy/chemo/ progesterone therapy</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table>\n<p>*This pearl is in line with the FIGO 2010 guidelines. It will be updated according to the FIGO 2023 guidelines after an official treatment guideline is released.</p></div><!---->\n      <!---->\n    </div><!---->'),
(2116, 'Obstetrics & Gynaecology', 'PM1365. 5yr survival rate in Ca Cervix', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>FIGO Staging</strong></td>\n<td><strong>5-year survival Rates</strong></td>\n</tr>\n<tr>\n<td>Stage I</td>\n<td>&gt;90%</td>\n</tr>\n<tr>\n<td>Stage II A</td>\n<td>&gt;80%</td>\n</tr>\n<tr>\n<td>Stage II B</td>\n<td>&gt;65%</td>\n</tr>\n<tr>\n<td>Stage IIIA</td>\n<td>About 45%</td>\n</tr>\n<tr>\n<td>Stage IIIB</td>\n<td>About 35%</td>\n</tr>\n<tr>\n<td>Stage IV</td>\n<td>&lt;15%</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2117, 'Obstetrics & Gynaecology', 'PM1364. Advantage & Disadvantage of Pre & Post Operative Radiotherapy', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><table border=\1\>\n<tbody>\n<tr>\n<td><strong>Advantages</strong></td>\n<td><strong>Disadvantages</strong></td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Preoperative radiation</strong></td>\n</tr>\n<tr>\n<td>Surgically undisturbed<br>tumour bed. Intact<br>vascularity (good<br>oxygenation)</td>\n<td>Precludes accurate<br>pretreatment staging<br>of the disease</td>\n</tr>\n<tr>\n<td>May facilitate surgical<br>dissection, allowing a<br>lesser procedure by<br>shrinking the tumour</td>\n<td>May be considered<br>unnecessary on hindsight,<br>in cases with high chances<br>of cure with surgery alone</td>\n</tr>\n<tr>\n<td>May decrease the<br>likelihood of risk of<br>implantation or<br>dissemination of viable<br>tumour cells during<br>surgical handling of<br>tissues</td>\n<td>Interferes with tissue<br>healing</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>Combined therapy<br>increases the morbidity</td>\n</tr>\n<tr>\n<td colspan=\2\><strong>Postoperative radiation</strong></td>\n</tr>\n<tr>\n<td>Accurate surgical staging</td>\n<td>Surgery may alter the<br>kinetics of tumour<br>proliferation</td>\n</tr>\n<tr>\n<td>Extent of loco-regional<br>disease accurately defined</td>\n<td>Surgery often disturbs<br>tumour vascularity<br>causing hypoxia</td>\n</tr>\n<tr>\n<td>Choice of omitting or<br>selective use of radiation<br>in some patients</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->'),
(2118, 'Obstetrics & Gynaecology', 'PM1359. Management of CIN', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <!---->\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\>\n        <img _ngcontent-smq-c132=\\ class=\img-responsive ng-tns-c132-18 ng-star-inserted\ src=\https://dhmbxeygs57ff.cloudfront.net/uploads/1f5d51f1183f4d35857dd881e7f7f708x1280x1886.JPEG\><!---->\n      </div><!---->\n    </div><!---->'),
(2119, 'Obstetrics & Gynaecology', 'PM1357. Standard staging procedure of Ca Cervix by FIGO guidelines', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><div class=\page\ title=\Page 4\><strong>Physical examination</strong></div>\n<ul>\n<li class=\bulletIndent1\>Speculum, bimanual, and rectovaginal examination- For pelvic examination (primary tumor, uterus, vagina, and parametria)</li>\n<li class=\bulletIndent1\>Palpation of groin and supraclavicular lymph nodes, examination of the right upper quadra- For distant metastases.</li>\n</ul>\n<p><strong>Cervical biopsy</strong></p>\n<ul>\n<li>Colposcopy with directed cervical biopsy or cervical biopsy without colposcopy</li>\n<li>Endocervical curettage</li>\n<li>Conization</li>\n</ul>\n<p><strong>Endoscopy</strong></p>\n<ul>\n<li>Hysteroscopy</li>\n<li>Cystoscopy</li>\n<li>Proctoscopy</li>\n</ul>\n<p><strong>Imaging studies</strong></p>\n<ul>\n<li>Intravenous pyelogram/CT/MR – Evaluation for urinary tract obstruction</li>\n<li>Plain/skeletal radiograph – Evaluation for metastases.</li>\n</ul>\n<p><strong>&nbsp;If readily available and accessible</strong></p>\n<ul>\n<li>CT / PETCT – For assessing pelvic and paraaortic lymph node involvement.</li>\n<li>MRI - To assess tumor size and local extent of disease.</li>\n<li>Ultrasound – This may also be used to assess tumor size and local extent of disease.</li>\n</ul>\n<p><strong>Image-guided&nbsp;biopsy -&nbsp;</strong>If imaging shows sites suspicious for metastatic disease.</p></div><!---->\n      <!---->\n    </div><!---->'),
(2120, 'Obstetrics & Gynaecology', 'PM0945. Risk factors and FIGO staging of Gestational trophoblastic neoplasia', '<div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\ style=\\>\n      <div _ngcontent-smq-c132=\\ class=\ng-tns-c132-18 ng-star-inserted\><p><strong>Risk factors</strong></p>\n<ul>\n<li>Older age</li>\n<li>β-hCG levels &gt; 100,000 mIU/mL</li>\n<li>Uterine size that is large-forgestational age</li>\n<li>Theca-lutein cysts &gt; 6 cm</li>\n<li>Slow decline in β-hCG levels</li>\n<li>Postevacuation uterine sonographic surveillance showing myometrial nodules or hypervascularity may be a predictor of subsequent neoplasia.</li>\n</ul>\n<p>FIGO staging:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage I</strong></td>\n<td><strong>Disease</strong> <strong>confined to the uterus</strong></td>\n</tr>\n<tr>\n<td><strong>Stage II</strong></td>\n<td>GTD extends <strong>outside of the uterus but is limited to the genital structure</strong></td>\n</tr>\n<tr>\n<td><strong>Stage III</strong></td>\n<td><strong>Lung metastasis</strong> with or without genital tract involvement</td>\n</tr>\n<tr>\n<td><strong>Stage IV</strong></td>\n<td><strong>Other metastasis</strong></td>\n</tr>\n</tbody>\n</table></div><!---->\n      <!---->\n    </div><!---->');
INSERT INTO db_pearl_m (pid, subject, pearl_title, pearl_desc) VALUES
(2121, 'Obstetrics & Gynaecology', 'PM2293. Instruments in OBG', '<div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\"></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/59138be1e8d141fe9ebaef4f7e659432x1181x870.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/733db2f903e2492a86c5426c9474709bx1280x938.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1d44522851ed42ec8da170d61c415f12x1159x933.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8cbd2117a78e4c31a4487cddaa43a2c2x871x617.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6d38c784ac734fa3ace7fd390520778ax880x699.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/47aee7f73b87421a9faa3402828666bfx953x721.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/072c8ca058fd4f4d92e6ae299cfdbd04x735x592.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/05dc8444e062403f8c826a7ad52c00d9x759x574.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f40b790592224b05ac1d680696b5c5bcx806x609.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2af70bdfbb4f4253992b9813d001f51dx800x600.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/42a06419caad4e8bb379998dfc73f30cx953x691.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1260a318cf0049718c5175a47f084400x855x654.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/46a8dbc68e894ba8b91d4c14d19b515ex771x677.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4b753a73ddde4ea2acc7c461fb7292a8x762x739.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/26a35cac6bd747bf957fed883a1fd850x922x638.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/91c0754e8b4846c0a6325cbf2e4f8721x1203x701.JPEG\"><!---->\n      </div><!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/12052a1ae2a64be6937c40bbc4009652x750x705.JPEG\"><!---->\n      </div><!---->\n    </div><!---->'),
,,
(2122, 'Obstetrics & Gynaecology', 'PM2497. Uterine Signs in Pregnancy', '<div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\"></div><!---->\n      <!---->\n    </div><div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\" style=\"\">\n      <!---->\n      <div _ngcontent-smq-c132=\"\" class=\"ng-tns-c132-18 ng-star-inserted\">\n        <img _ngcontent-smq-c132=\"\" class=\"img-responsive ng-tns-c132-18 ng-star-inserted\" src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5a7dfb8f0f9e4d07ba5d81059c85b484x1280x2558.194640338505.JPEG\"><!---->\n      </div><!---->\n    </div><!---->');

